2015”N“x –k—¢‘åŠwˆãŠw•”E‘åŠw•a‰@Œ€‹†‹ÆÑW(HTML”Å)


i’FŒŽ–{‚ÅŒäŠm”F‰º‚³‚¢j



‰ð–UŠw (¬ì’PˆÊ)

[Šwp˜_•¶]

110001. [ŒŽ’˜] Model-based verification of hypotheses on the origin of modern Japanese revisited by Bayesian inference based on genome-wide SNP data. Nakagome S1, Sato T1, Ishida H1, Hanihara T1,2, Yamaguchi T1, Kimura R1, Mano S1, Oota H1,2 (1The Asian DNA Repository Consortium): Mol Biol Evol. 2015/6; 32 (6): 1533-43. (ûŒŽP•F1,2, ‘Ÿ“c”ŽŽ÷1,2: 2‰ð–U)

110002. [ŒŽ’˜] How 'circumpolar' is Ainu music? A musical and genetic perspectives on the history of the Japanese archipelago. Savage PE, Matsumae H, Oota H1, Stoneking M, Currie T, Tajima A, Gillan M, Brown S: Ethnomusicology Forum 2015/9; 24 (3): 443-67. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

110003. [ŒŽ’˜] Biochemical Characterization of Medaka (Oryzias latipes) Transgulutaminases, OITGK1 and OITGK2, as Orthologues of Human Keratinocyte-Type Transgulutaminases. Kikuta A, Furukawa E, Ogawa R, Suganuma N, Saitoh M, Nishimaki T, Katsumura T1, Oota H1, Kawamoto T, Tatsukawa H, Hashimoto H, Hitomi K: PLoS One 2015/12; 10 (12): e0144194. (Ÿ‘ºŒ[Žj1, ‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

110004. [ŒŽ’˜] Meiotic recombination counteracts male-biased mutation (male-driven evolution). Mawaribuchi S, Ito M, Ogata M, Oota H1, Katsumura T1, Takamatsu N, Miura I: Proc Biol Sci 2016/1; 283 (1823): 20152628. dx.doi.org/10.1098/rspb.20152691. (‘Ÿ“c”ŽŽ÷1, Ÿ‘ºŒ[Žj1: 1‰ð–U)

120001. [ŒŽ’˜] –쐶ƒƒ_ƒJ‚ÉŒ©o‚³‚ê‚œùN–E‚ÉŠÖ‚·‚é•a—‘gDŠw“IŠŒ©. Œ–Šr”V1, Ÿ‘ºŒ[Žj2, ”ö“c³“ñ, ¬‰êŒú“¿, ¬ìŒ³”V2, ‘Ÿ“c”ŽŽ÷2 (1Œ`‘ÔŒn, 2‰ð–U): ‹›•aŒ€‹†2016/3: 51 (1); 8-14.

522001. [uÀ]yŒÃ‘ãƒQƒmƒ€‚Å‚œ‚Ç‚él—ÞŽjz‘æ3‰ñ: ˆâ“`î•ñ‚©‚ç‚Ý‚œƒlƒAƒ“ƒfƒ‹ƒ^[ƒ‹lEƒfƒjƒ\ƒl. ‘Ÿ“c”ŽŽ÷ (‰ð–U): ×–EHŠw 2015/6; 34 (7): 702-6.


[Šw‰ïEŒ€‹†‰ï“™]

723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÃ‘ãƒQƒmƒ€ƒV[ƒNƒGƒ“ƒVƒ“ƒO‚Ì‚œ‚ß‚Ì‹Zp‰ü—Ç. ‘Ÿ“c”ŽŽ÷1, Šo’£—²Žj1, ƒ‰ƒCƒAƒ“EWEƒVƒ…ƒ~ƒbƒg1, Ÿ‘ºŒ[Žj1, Œ‘O‚Ђë‚Ý, ûŒŽP•F1, ¬ìŒ³”V1, ŽÄ“cO‹I, ²”Œ˜aM, •ª•”“NH, Œ·–{•qs, ²“¡äŠ°, –Ø‘º—º‰î, Î“c@”£ (1‰ð–U): ‘æ69‰ñ (2015”N) “ú–{l—ÞŠw‰ï‘å‰ï (2015/10/10-12), “Œ‹ž.

723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆ­”ü”Œ“‡‚É‚š‚¯‚é“ꕶŽž‘ãlœŒÃ‘ãDNA•ªÍ. Šo’£—²Žj1, ƒ‰ƒCƒAƒ“EWEƒVƒ…ƒ~ƒbƒg1, Œ‘O‚Ђë‚Ý, Ÿ‘ºŒ[Žj1, ‘Ÿ“c”ŽŽ÷1, ûŒŽP•F1, ¬ìŒ³”V1, ŽÄ“cO‹I, –ÎŒŽM¶, ‹ß“¡@C, •Ä“c@õ, ‘ŽR’õ”V, ÝŠy”ŽŒÈ, ŽR“cNO (1‰ð–U): ‘æ69‰ñ (2015”N) “ú–{l—ÞŠw‰ï‘å‰ï (2015/10/10-12), “Œ‹ž.

723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒEƒNƒ‰ƒCƒiEƒ”ƒ@ƒeƒB[ƒo“ŽŒŠlœ‚̌Èâ“`Šw“I‰ðÍ. ƒ‰ƒCƒAƒ“EWEƒVƒ…ƒ~ƒbƒg1, Šo’£—²Žj1, ¬ìŒ³”V1, ‘Ÿ“c”ŽŽ÷1, Œ‘O‚Ђë‚Ý, ŽÄ“cO‹I, ƒWƒ‡[ƒ_ƒ“EƒJ[ƒXƒeƒ“, ƒ~ƒnƒCƒIEƒ\ƒnƒgƒXƒL[ (1‰ð–U): ‘æ69‰ñ (2015”N) “ú–{l—ÞŠw‰ï‘å‰ï (2015/10/10-12), “Œ‹ž.

723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽŸ¢‘ãƒV[ƒPƒ“ƒT[‚É‚æ‚é–kŠC“¹ƒAƒCƒk‚Ì‘SƒQƒmƒ€”z—ñ‰ðÍ. Œ‘O‚Ђë‚Ý, ¬‹àŸº‰À]1, –Ø‘º—º‰î, “c“ˆ@“Ö, ‰Í‘º³“ñ, Ž…Œ’‘Ÿ˜Y, ‘Ÿ“c”ŽŽ÷1, ”ö–{ŒbŽs (1‰ð–U): ‘æ69‰ñ (2015”N) “ú–{l—ÞŠw‰ï‘å‰ï (2015/10/10-12), “Œ‹ž.

723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œ—L‹@Ž¿Žc‘¶ó‹µ‚Ì“ŽŒAˆâÕ‚ÆŠJ’nˆâÕ‚É‚š‚¯‚é”äŠr. Šo’£—²Žj1, ‘Ÿ“c”ŽŽ÷1, •Ä“c@õ (1‰ð–U): ‘æ69‰ñ (2015”N) “ú–{l—ÞŠw‰ï‘å‰ï (2015/10/10-12), “Œ‹ž.

723006. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒjƒzƒ“ƒUƒ‹‚ÌŒŒ’†ƒGƒXƒgƒƒQƒ“‚š‚æ‚уvƒƒQƒXƒeƒƒ“”Z“x•Ï‰»‚É”º‚€ŒŒ‹…‚̈â“`Žq”­Œ»•Ï‰»‚ÌRNA-seq ‚É‚æ‚éƒvƒƒtƒ@ƒCƒŠƒ“ƒO. Ÿ‘ºŒ[Žj1, ‘Ÿ“c”ŽŽ÷1 (1‰ð–U): ‘æ69‰ñ (2015”N) “ú–{l—ÞŠw‰ï‘å‰ï (2015/10/10-12), “Œ‹ž.

723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠŠ—â“K‰ž‚ÉŠÖ‚í‚éUCPIˆâ“`ŽqŒ^ŠÔ‚̃qƒg‚É‚š‚¯‚é”MŽY¶”œ‰ž‚̈Ⴂ. Œ‘º‹MF, Ÿ‘ºŒ[Žj1, –{ˆä@•É, ‘Ÿ“c”ŽŽ÷1, –ȊіΊì (1‰ð–U): ‘æ69‰ñ (2015”N) “ú–{l—ÞŠw‰ï‘å‰ï (2015/10/10-12), “Œ‹ž.

723008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ŒƒAƒWƒAˆâÕo“y”n‚ÌŒÃDNA•ªÍ‚É‚š‚¯‚é•û–@˜_“I‰ü‘P‚Æ‚»‚̉ž—p. Šo’£—²Žj1, Î–Ñ‘Ÿˆê˜Y, ‹e’r‘åŽ÷, ŠÛŽR^Žj, ‘‚@@—Ž, ‰€@@—Ñ, ’ߊԘaK, •Ä“c@õ, ‘Ÿ“c”ŽŽ÷1, ‰Í–ì—FG, ”ŒàV@Œb (1‰ð–U): ‘æ28‰ñ“ú–{ƒEƒ}‰ÈŠw‰ïŠwpW‰ï (2015/11/30-12/1), “Œ‹ž.

723009. [Šw‰ï(‘S‘)] (ˆê”ÊŒû‰‰) ‰ð–UŠw‹³ˆç (u‹`EŽÀK) ‚ÉŠÖ‚·‚éˆêlŽ@. ¬ìŒ³”V1, ‘Ÿ“c”ŽŽ÷1, ŽO‰Y³–Ÿ1, Vˆä—Y‘Ÿ1, ‹Ê–؉p–Ÿ1 (1‰ð–U): ‘æ121‰ñ“ú–{‰ð–UŠw‰ï‘‰ï‘S‘ŠwpW‰ï (2016/3/28-30), •Ÿ“‡.

723010. [Šw‰ï(‘S‘)] (ƒ|ƒXƒ^[) –쐶ƒƒ_ƒJ‚ðƒ‚ƒfƒ‹‚Æ‚µ‚œÁ‰»ŠÇ‚Ì’·‚³‚ð‹K’è‚·‚郁ƒJƒjƒYƒ€‚Ɛi‰»¶•šŠw“IˆÓ‹`‚ÌŒŸØ. Ÿ‘ºŒ[Žj1, ²“¡@Ž, ŽR‰º‰À“ß, Šo’£—²Žj1, ”ö“c³“ñ, ¡ˆä@³, ‹g‰YNŽõ, ¬ìŒ³”V1, ‘Ÿ“c”ŽŽ÷1 (1‰ð–U): ‘æ121‰ñ“ú–{‰ð–UŠw‰ï‘‰ï‘S‘ŠwpW‰ï (2016/3/28-30), •Ÿ“‡.

723011. [Šw‰ï(‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ò’ōœ•ÏŒ`ƒƒ_ƒJ‚Ì”÷×Œ`‘ÔŠw“I‚ÈŠÏŽ@. Œê r”V1, “à“cŒ’‘Ÿ˜Y, Ÿ‘ºŒ[Žj, ‘åŠÑ—TŽq, ”ö“c³“ñ, ¬‰êŒú“¿, ‚‘Š»Žm2, ‘Ÿ“c”ŽŽ÷3, ¬ìŒ³”V3 (1Œ`‘ÔŒn, 2®ŠO, 3‰ð–U): ‘æ121‰ñ“ú–{‰ð–UŠw‰ï‘‰ï‘S‘ŠwpW‰ï (2016/3/28-30), •Ÿ“‡.

723012. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒjƒƒgƒŠ›z—‘ŠúéҌã‘Ì‚©‚çì»‚µ‚œiPS—l×–E‚̉ðÍ. ŽO‰Y³–Ÿ (‰ð–U): ‘æ121‰ñ“ú–{‰ð–UŠw‰ï‘‰ï‘S‘ŠwpW‰ï (2016/3/30), •Ÿ“‡.


‰ð–UŠw (ãã’PˆÊ)

[Šwp˜_•¶]

110005. [ŒŽ’˜] Arf6 guanine-nucleotide exchange factor cytohesin-2 regulates myelination in nerves. Torii T, Ohno N, Miyamoto Y, Kawahara K, Saitoh Y, Nakamura K, Takashima S, Sakagami H1, Tanoue A, Yamauchi J: Biochem Biophys Res Commun 2015/5; 460 (3): 819-25. (ãã—ms1: 1‰ð–U)

110006. [ŒŽ’˜] Novel splice variants in the 5'UTR of Gtf2i expressed in the rat brain: alternative 5'UTRs and differential expression in the neuronal dendrites. Shirai Y, Watanabe M, Sakagami H1, Suzuki T: J Neurochem. 2015/8; 134 (3): 578-89. (ãã—ms1: 1‰ð–U)

110007. [ŒŽ’˜] Arf6 mediates Schwann cell differentiation and myelination. Torii T, Miyamoto Y, Yamamoto M, Ohbuchi K, Tsumura H, Kawahara K, Tanoue A, Sakagami H1, Yamauchi J: Biochem Biophys Res Commun 2015/9; 465 (3): 450-7. (ãã—ms1: 1‰ð–U)

110008. [ŒŽ’˜] Data supporting Arf6 regulation of Schwann cell differentiation and myelination. Torii T, Miyamoto Y, Yamamoto M, Ohbuchi K, Tsumura H, Kawahara K, Tanoue A, Sakagami H1, Yamauchi J: Data Brief 2015/10; 5: 388-95. (ãã—ms1: 1‰ð–U)

110009. [ŒŽ’˜] Stimulation of Sigma-1 Receptor Ameliorates Depressive-like Behaviors in CaMKIV Null Mice. Moriguchi S, Sakagami H1, Yabuki Y, Sasaki Y, Izumi H, Zhang C, Han F, Fukunaga K: Mol Neurobiol 2015/12; 52 (3): 1210-22. (ãã—ms1: 1‰ð–U)

[Šw‰ïEŒ€‹†‰ï“™]

722001. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) BRAG2-Arf6Œo˜H‚É‚æ‚éV‚œ‚ÈAMPAŽó—e‘̃VƒiƒvƒX”­Œ»’²ß‹@\. ãã—ms (‰ð–U): BMB2015 (‘æ86‰ñ“ú–{¶‰»Šw‰ï‘å‰ïE‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï) (2015/12/1-4), _ŒË.

722002. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒVƒiƒvƒXŒã•”‚É‚š‚¯‚éBRAG2-Arf6ƒVƒOƒiƒ‹Œo˜H‚ð‰î‚µ‚œAMPAŽó—e‘Ì—A‘—’²ß‹@\. [’J¹O1, ãã—ms1 (1‰ð–U): ‘æ121‰ñ“ú–{‰ð–UŠw‰ï‘‰ï‘S‘ŠwpW‰ï (2016/3/30), •Ÿ“‡.

723013. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒOƒŠƒVƒ“ì“®«ƒjƒ…[ƒƒ“‚ÅCre‚ð”­Œ»‚·‚éƒ}ƒEƒXŒn“‚ÌŠJ”­ (Generation of a mouse line specifically expressing Cre in glycinergic neurons). Š`è—˜˜a, ãã—ms1, è‘ºŒšŽi, –öì‰Eç•v (1‰ð–U): ‘æ38‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2015/7/28-31), _ŒË.

723014. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) BRAG2‚Íendophilin3‚Æ‚Ì‘ŠŒÝì—p‚ð‰î‚µ‚ăVƒiƒvƒXŒã•”‚Å‚ÌArf6‚ÌŠˆ«‰»‚ÆAMPAŒ^Žó—e‘̂̃Gƒ“ƒhƒTƒCƒg[ƒVƒX‚𒲐߂·‚é (BRAG2 regulates Arf6 activity and AMPAR endocytosis at postsynapses through the interaction with endophilin3). [’J¹O1, ãã—ms1 (1‰ð–U): ‘æ38‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2015/7/28-31), _ŒË.

723015. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ADPƒŠƒ{ƒVƒ‹‰»ˆöŽq6 (Arf6) ‚Í”]‘wŒ`¬‚É‚š‚¢‚Đ_Œo×–E‚̈ړ®‚𐧌䂷‚é (ADP-ribosylation factor 6 (Arf6) regulates neuronal migration through endosomal trafficking during cortical layer formation). ŒŽ@–FL1, ãã—ms1 (1‰ð–U): ‘æ38‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2015/7/28-31), _ŒË.

733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠC”n‹»•±¶ƒVƒiƒvƒX‚É‚š‚¯‚éBRAG2-Arf6ƒVƒOƒiƒ‹Œo˜H‚ð‰î‚µ‚œAMPAŽó—e‘Ì—A‘—‹@\. [’J¹O1, ãã—ms1 (1‰ð–U): “ú–{‰ð–UŠw‰ï‘æ103‰ñŠÖ“ŒŽx•”ŠwpW‰ï (2015/11/7), ‰¡•l.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-110001. [ŒŽ’˜] Positive feedback of NR2B-containing NMDA receptor activity is the initial step toward visual imprinting: a model for juvenile learning. Nakamori T, Sato K, Kinoshita M, Kanamatsu T, Sakagami H1, Tanaka K, Ohki-Hamazaki H: J Neurochem 2015/1; 132 (1): 110-23. (ãã—ms1: 1‰ð–U)


¶—Šw (ìã’PˆÊ)

[Šwp˜_•¶]

220001. [€ŒŽ’˜] ‚ŒŒˆ³ƒ‰ƒbƒg‚Ì“®–¬Œn‰»ŠwŽó—e×–E‚É‚š‚¯‚éƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“‡¬y‘fŠˆ«‚̕ω». ˆé’†—¹1, ìã@—Ï1, ŽR–{‹Ó˜Y, Œ“cGŽ÷, “ú‰º•”’CŽO (1¶—): ‘ŽmŠÚ‘åŠw‘̈猀‹†Š•ñ 2016/3; 34: 73-4.

[Šw‰ïEŒ€‹†‰ï“™]

723016. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒhƒŒƒiƒŠƒ“‚É‚æ‚é”|—{_Œo×–EŽ²õ—A‘—Šˆ“®“x‚Ì‘‰Á‚ªƒtƒ[‰ðÍ–@‚É‚æ‚è’è—ʉ»‚³‚ê‚œ. •Ð‘q@—²1, ˆé’†—¹1, ìã@—Ï1 (1¶—): ‘æ53‰ñ“ú–{¶•š•š—Šw‰ï”N‰ï (2015/9/13), ‹à‘ò.

723017. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Signaling of prostaglandin E receptors, EP3 and EP4 facilitates wound healing and lymphangiogenesis with enhanced recruitment of CD11b+ macrophages in mice. ×–ì‰Á“ÞŽq1,2, ˆé’†—¹1, ìã@—Ï1, ¬‹{@Žü, ”n“ˆ³—²2 (1¶—, 2–ò—): ‘æ89‰ñ“ú–{–ò—Šw‰ï”N‰ï (2016/3/10), ‰¡•l.

723018. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬‘̃‰ƒbƒg‚Ì‘å”]”玿‚©‚ç’P—£‚µ‚œƒjƒ…[ƒƒ“‚̍זE•ª—ô. ”ä—¯ŠÔO”ü (¶—): ‘æ93‰ñ“ú–{¶—Šw‰ï‘å‰ï (2016/3/23), ŽD–y.


¶—Šw (‰ÍŒŽ’PˆÊ)

[Šwp˜_•¶]

110010. [ŒŽ’˜] Sex differences in behavioural and neural responsiveness to mate calls in a parrot. Eda-Fujiwara H, Satoh R1, Hata Y, Yamasaki M, Watanabe A, Zandbergen MA, Okamoto Y, Miyamoto T, Bolhuis JJ: Sci Rep 2016/1; 6: 18481. (²“¡—º•œ1: 1¶—)

110011. [ŒŽ’˜] pH-sensitive expression of calcium-sensing receptor (CaSR) in type-B intercalated cells of the cortical collecting ducts (CCD) in mouse kidney. Yasuoka Y1, Sato Y2, Healy JM, Nonoguchi H3, Kawahara K1: Clin Exp Nephrol 201510; 19 (5): 771-82. (ˆÀ‰ª—L‹IŽq1, ²“¡—Yˆê2, –ìXŒû”ŽŽj3, ‰ÍŒŽŽ‰ë1: 1¶—, 2ˆã—Éq¶Šw•”, 3–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

520001. [‘à]y“ÁW: ‘ŸŠí•‚ŽîE‚€‚ÁŒŒ‚Ì•a‘Ô‚Æ‚»‚ÌŽ¡—Ö@z‘ŸŠí•‚ŽîE‚€‚ÁŒŒ‚Æ‘Sg•‚Žî‚̃ƒJƒjƒYƒ€|‘à|. ‰ÍŒŽŽ‰ë1, ‘哈—F”ü2 (1¶—, 2¶•š•š—Œn): Fluid Management Renaissance 2015/4; 5 (2): 15-20.

522002. [uÀ]y“ÁW: ”ì–ž‚Ɛt‘Ÿz[”ì–ž‚ÉŠÖ‚·‚é•a‘ԂƐtáŠQ] ŒŒs“®‘Ԃُ̈í‚ƐtáŠQ. ‰ÍŒŽŽ‰ë1, ‰º•lF˜Y2, ‹Ñ’J‚܂肱 (1¶—, 2zŠÂŠí“à): t‚Æ“§Í 2015/4; 78 (4): 507-12.

522003. [uÀ]y˜AÚ: ‚₳‚µ‚¢Ä¶ˆã—ÁzŠî‘b•ÒI@Š²×–E‚Æ‘gDÄ¶: iPS×–E‚Ö‚Ì“¹ . ‰ÍŒŽŽ‰ë1, ŽOˆäƒá2 (1¶—, 2”畆): t‚Æ“§Í 2015/4; 78 (4): 467-9.

522004. [uÀ]y˜AÚ: ‚₳‚µ‚¢Ä¶ˆã—ÁzŠî‘b•ÒI@Žóž—‘|ãó”Õ–E (“à×–E‰ò)|ŽOãó—t‚ðŒo‚Ä‘ŸŠíŒ`¬‚Ö. ‰ÍŒŽŽ‰ë1, ŽOˆäƒá2 (1¶—, 2”畆): t‚Æ“§Í 2015/5; 78 (5): 651-3.

522005. [uÀ]y˜AÚ: ‚₳‚µ‚¢Ä¶ˆã—ÁzŠî‘b•ÒI@ƒ_ƒCƒŒƒNƒgEƒŠƒvƒƒOƒ‰ƒ~ƒ“ƒO. ‰ÍŒŽŽ‰ë1, ŽOˆäƒá2 (1¶—, 2”畆): t‚Æ“§Í 2015/6; 78 (6): 795-7.

522006. [uÀ]y“ÁW1: Ž_‰–Šî•œt‚ð—‰ð‚·‚éz[Šî‘b] t‘Ÿ‚©‚ç‚ÌŽ_”rŸ•. ‰ÍŒŽŽ‰ë1, ˆÀ‰ª—L‹IŽq1, ‘哈—F”ü2 (1¶—, 2¶•š•š—Œn): t‚Æ“§Í 2015/8; 79 (2): 195-200.

522007. [uÀ]y“ÁW2: 500†‹L”O: t‘Ÿ•af—Â̗ðŽj‚Æ–¢—ˆzPart 2 Œ»•ÒWˆÏˆõE—ð‘ã•ÒWˆÏˆõ‚©‚ç‚Ì“Á•ÊŠñe@t”A×ŠÇ‚ÌCaŠŽ’mŽó—e‘Ì: ‹ÇÝ‚Æ‹@”\. ‰ÍŒŽŽ‰ë1, ‘哈—F”ü2, ˆÀ‰ª—L‹IŽq1 (1¶—, 2¶•š•š—Œn): t‚Æ“§Í 2015/8; 79 (2): 290-5.

522008. [uÀ]y˜AÚ: ‚₳‚µ‚¢Ä¶ˆã—ÁzŠî‘b•ÒII@ƒqƒgt‘Ÿ‚Ì‹NŒ¹: ’†ŠÔ’†ãó—tà‚©‚ç‘ÌŽ²Š²×–Eà‚É. ‰ÍŒŽŽ‰ë1, ŽOˆäƒá2 (1¶—, 2”畆): t‚Æ“§Í 2015/10; 79 (4): 528-30.

522009. [uÀ]y˜AÚ: ‚₳‚µ‚¢Ä¶ˆã—ÁzŠî‘b•ÒII@tŠ²×–E‚̌Œè‚ƍזE“±“ü—Ö@. ‰ÍŒŽŽ‰ë1, ŽOˆäƒá2 (1¶—, 2”畆): t‚Æ“§Í 2016/1; 80 (1): 7-9.

522010. [uÀ]y“ÁW: t‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“z[‘˜_] t‘ŸƒŠƒnƒrƒŠ‚ðŽx‚Š‚éŠî‘bƒf[ƒ^. ‰ÍŒŽŽ‰ë1, ‹Ñ’J‚܂肱, ç“c«”n2, –ìXŒû”ŽŽj3 (1¶—, 2“à•ª”å‘ãŽÓ“à, 3–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): t‚Æ“§Í 2016/2; 80 (2): 177-81.

522011. [uÀ]y“ÁW: “d‰ðŽ¿‚̐V‚µ‚¢Œ©•ûEl‚Š•ûz[˜] “d‰ðŽ¿‚ƍזE‹@”\§Œä. ‰ÍŒŽŽ‰ë (¶—): t‚Æ“§Í 2016/3; 80 (3): 303-8.

522012. [uÀ]y˜b‘èzt‰“ˆÊ•”ƒlƒtƒƒ“‚ÌCa—A‘—‚ÆTRPVƒ`ƒƒƒlƒ‹. ‰ÍŒŽŽ‰ë1, ‘哈—F”ü2, ˆÀ‰ª—L‹IŽq1 (1¶—, 2¶•š•š—Œn): t‘Ÿ“à‰ÈE”å”AŠí‰È 2015/12; 2 (6): 602-8.

[’˜@‘]

620001. [Šwp‘ (•ª’SŽ·•M)]yStŠÖ˜A‚ð[‚ߑ̉tŠÇ—‚ð‹É‚ß‚ézII. t‘Ÿ‚̑̉tŠÇ—ƒƒJƒjƒYƒ€|S•s‘SŠÇ—‚É‚Ç‚€ŠÖ‚í‚é‚©|@1. t‘Ÿ‚̐…“d‰ðŽ¿ƒoƒ‰ƒ“ƒX‹@\, p.24-34. ‰ÍŒŽŽ‰ë1, ‰º•lF˜Y2 (1¶—, 2zŠÂŠí“à), ŠÄC: Œè‰v“¿, •Ò: ’––”FŒ³2, •¶Œõ“°, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Phosphate depletion-induced metabolic acidosis and alikali urine may be caused by inappropriate stimulation of apical Cl-/HCO3- exchanger (Pendrin) in mouse kidney type B intercalated cells (IC-B). Yasuoka Y1, Oshima T2, Sato Y3, Nonoguchi H4, Kawahara K1: American Society of Nephrology (ASN) Kidney Week 2015 (2015/11/6), San Diego, USA. (ˆÀ‰ª—L‹IŽq1, ‘哈—F”ü2, ²“¡—Yˆê3, –ìXŒû”ŽŽj4, ‰ÍŒŽŽ‰ë1: 1¶—, 2¶•š•š—Œn, 3ˆã—Éq¶Šw•”, 4–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Comparative analysis of vasopressin V1a and V2 receptors distribution in the mammalian kidney. Giesecke T, Koshimizu T, Kawahara K1, Bachmann S, Mutig K1: American Society of Nephrology (ASN) Kidney Week 2015 (2015/11/7), San Diego, USA. (‰ÍŒŽŽ‰ë1: 1¶—)

713003. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) HIF1a and HIF2-Induced erythropoietin production along the nephron. Izumi Y, Yasuoka Y1, Nakayama Y, Inoue H, Mukoyama M, Kawahara K1, Nonoguchi H2: American Society of Nephrology (ASN) Kidney Week 2015 (2015/11/7), San Diego, USA. (ò—Tˆê˜Y, ˆÀ‰ª—L‹IŽq1, ’†ŽR—TŽj, ˆäãGŽ÷, ŒüŽR­Žu, ‰ÍŒŽŽ‰ë1, –ìXŒû”ŽŽj2: 1¶—, 2–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

722003. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Roles of basolateral TASK2 in the kidney proximal tubule for the acid-base balance: lessons from TASK2 KO mice. ‰ÍŒŽŽ‰ë1, ˆÀ‰ª—L‹IŽq1 (1¶—): ‘æ93‰ñ“ú–{¶—Šw‰ï‘å‰ï (2016/3/22), ŽD–y.

723019. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t”A×ŠÇ‚É‚š‚¯‚éhypoxia-inducible factor 2ƒ¿‚Ì”­Œ»‚ÌŒŸ“¢. ò—Tˆê˜Y, ˆÀ‰ª—L‹IŽq1, ’†ŽR—TŽj, ˆäãGŽ÷, ŒüŽR­Žu, ‰ÍŒŽŽ‰ë1, –ìXŒû”ŽŽj2 (1¶—, 2–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5), –ŒŒÃ‰®.

723020. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pHŠŽŽó«Kƒ`ƒƒƒlƒ‹ (TASK2) ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚ÌŽ_‰–Šî’²ß”\. ˆÀ‰ª—L‹IŽq1, ‘哈—F”ü2, ‘å’ː³l, ²“¡—Yˆê3, –Ø‘º@õ, ‰ÍŒŽŽ‰ë1 (1¶—, 2¶•š•š—Œn, 3ˆã—Éq¶Šw•”): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/7), –ŒŒÃ‰®.

723021. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Metabolic acidosis with alkalinuria in phosphate-depriced mice: a role of pendrin in kidney type B intercalated cells. ˆÀ‰ª—L‹IŽq1, ‘哈—F”ü2, ²“¡—Yˆê3, –ìXŒû”ŽŽj4, ‰ÍŒŽŽ‰ë1 (1¶—, 2¶•š•š—Œn, 3ˆã—Éq¶Šw•”, 4–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘æ93‰ñ“ú–{¶—Šw‰ï‘å‰ï (2016/3/23), ŽD–y.

733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’჊ƒ“Hƒ}ƒEƒX‚̍‚CaŒŒÇ‚ª—U”­‚·‚éƒAƒ‹ƒJƒŠ”A‚Æ‘ãŽÓ«ƒAƒVƒh[ƒVƒX‚Ì•ªŽq‹@\. ˆÀ‰ª—L‹IŽq1, ‘哈—F”ü2, ‰ÍŒŽŽ‰ë1 (1¶—, 2¶•š•š—Œn): •œ¬27”N“x¶—Œ€Œ€‹†‰ïu”S–Œ–ƉuŠw‚Æ–Œ—A‘—¶—Šw‚Ì—Z‡v(2015/9/15), ‰ªè.

733003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒoŒûCa‰–-‚Ca”A‚É‚æ‚étW‡ŠÇ‚̐…EŽ_‰–Šî—A‘—‰ž“š. ˆÀ‰ª—L‹IŽq1, ‘哈—F”ü2, ²“¡—Yˆê3, –ìXŒû”ŽŽj4, ‰ÍŒŽŽ‰ë1 (1¶—, 2¶•š•š—Œn, 3ˆã—Éq¶Šw•”, 4–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘æ45‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2015/10/2), “Œ‹ž.


¶‰»Šw

[Šwp˜_•¶]

110012. [ŒŽ’˜] Mammalian Bcnt/Cfdp1, a potential epigenetic factor characterized by an acidic stretch in the disordered N-terminal and Ser250 phosphorylation in the conserved C-terminal regions. Iwashita S, Suzuki T, Yasuda T, Nakashima K, Sakamoto T, Kohno T1, Takahashi I, Kobayashi T, Ohno-Iwashita Y, Imajoh-Ohmi S, Song SY, Dohmae N: Biosci Rep 2015/6; 35 (4) pii: e00228. (‰Í–ìr”V1: 1¶‰»)

110013. [ŒŽ’˜] Serum pro-BDNF/BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: a randomized controlled trial. Matsuoka Y, Nishi D, Tanima Y, Itakura M1, Kojima M, Hamazaki K, Noguchi H, Hamazaki T: Transl Psychiatry 2015/7; 5: e596. (”‘q@œ1: 1¶‰»)

110014. [ŒŽ’˜] Biochemical characterization of a heterotrimeric Gi-protein activator peptide designed from the junction between the intracellular third loop and sixth transmembrane helix in the m4 muscarinic acetylcholine receptor. Terawaki S, Matsubayashi R, Hara K, Onozuka T, Kohno T1, Wakamatsu K: Biochem Biophys Res Commun 2015/7; 463 (1-2): 64-9. (‰Í–ìr”V1: 1¶‰»)

110015. [ŒŽ’˜] Direct interaction between carcinoma cells and cancer associated fibroblasts for the regulation of cancer invasion. Yamaguchi H, Sakai R1: Cancers (Basel) 2015/10; 7 (4): 2054-62. (ä@—²ˆê1: 1¶‰»)

110016. [ŒŽ’˜] 8-Nitro-cGMP Enhances SNARE Complex Formation through S-Guanylation of Cys90 in SNAP25. Kunieda K, Tsutsuki H, Ida T, Kishimoto Y, Kasamatsu S, Sawa T, Goshima N, Itakura M1, Takahashi M1, Akaike T, Ihara H: ACS Chem Neurosci 2015/10; 6 (10): 1715-25. (”‘q@œ1, ‚‹Ž³g1: 1¶‰»)

110017. [ŒŽ’˜] Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis. Ueno H, Tomiyama A, Yamaguchi H, Uekita T, Shirakihara T, Nakashima K, Otani N, Wada K, Sakai R1, Arai H, Mori K: Biochem Biophys Res Commun 2015/12; 468 (1-2): 240-7. (ä@—²ˆê1: 1¶‰»)

110018. [ŒŽ’˜] Malonic acid suppresses mucin-type O-glycan degradation during hydrazine treatment of glycoproteins. Goso Y1: Anal Biochem 2016/3; 496: 35-42. (ŒÜäzsM1: 1¶‰»)

110019. [ŒŽ’˜] Protein stabilizer, NDSB-195, enhances the dynamics of the ƒÀ4 -ƒ¿2 loop of ubiquitin. Wang H, Hosoda K, Ishii T, Arai R, Kohno T1, Terawaki S, Wakamatsu K: J Pept Sci 2016/3; 22 (3): 174-80. (‰Í–ìr”V1: 1¶‰»)

110020. [ŒŽ’˜] Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report. Goto A, Noto H, Noda M, Ueki K, Kasuga M, Tajima N, Ohashi K, Sakai R1, Tsugane S, Hamajima N, Tajima K, Imai K, Nakagama H: Cancer Sci 2016/3; 107 (3): 369-71. (ä@—²ˆê1: 1¶‰»)

120002. [ŒŽ’˜] FT-IRƒXƒyƒNƒgƒ‹‚ðŽg‚Á‚œ“œ…—n‰tö”­‰ß’ö‚̉ðÍ‚É‚æ‚鐅˜a”. ÎˆäˆèŽq1, ŽP@F”V (1¶‰»): “ú–{Ž•‰È‘åŠw‹I—v 2016/3; 45: 21-8.

[Šw‰ïEŒ€‹†‰ï“™]

713004. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Malonic acid suppresses O-glycan degradation during hydrazine treatment of glycoproteins. Goso Y1: 23rd International Symposium on Glycoconjugates (2015/9/17), Split, Croatia. (ŒÜäzsM1: 1¶‰»)

713005. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Identification of ALK-binding phosphotyrosine-containing proteins as the critical regulators of oncogenic properties of neuroblastoma cells. Tomiyama A, Sakai R1: 2015 Asia-pacific Symposium of Neuroblastoma (2015/11/14), Taipei. (ä@—²ˆê1: 1¶‰»)

713006. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells. Yamaguchi H, Yanagihara K, Yashiro M, Sakai R1: Tenth AACR-JCA Joint Conference on Breakthroughs in Cancer Research (2016/2/17), Hawaii, USA. (ä@—²ˆê1: 1¶‰»)

722004. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) AMPAŒ^ƒOƒ‹ƒ^ƒ~ƒ“Ž_Žó—e‘ÌŒ‹‡ƒ^ƒ“ƒpƒNŽ¿ TARPs‚Ì‹@”\‰ðÍ. ”‘q@œ (¶‰»): ‘æ121‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï (2016/3/30), ŒSŽR.

723022. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’á”Z“x—n‰tNMR‰ðÍ‚©‚ç–Ÿ‚ç‚©‚Æ‚È‚Á‚œƒCƒlƒtƒBƒgƒNƒƒ€B‚ÌHKRD ƒhƒƒCƒ“‚̍\‘¢‚Æ‹@”\. ŒÃ”‹±Žq, Œƒ–’J—L‹P, JunGoo Jee, “c’†—˜D, ‰Í–ìr”V1, ‰Á“¡‰xŽq, ŽRèr³, Ž™“ˆ’·ŽŸ˜Y (1¶‰»): ‘æ15‰ñ“ú–{’`”’Ž¿‰ÈŠw‰ï”N‰ï (2015/6/26), “¿“‡.

723023. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒPƒ‚ƒJƒCƒ“Žó—e‘̂̍זE“à—̈æ‚ÉŠÜ‚Ü‚ê‚éƒPƒ‚ƒJƒCƒ“ƒVƒOƒiƒ‹§ŒäˆöŽqƒtƒƒ“ƒgŒ‹‡—̈æ‚̍\‘¢¶•šŠw“I‰ðÍ. Yoshinaga S, Esaki K, Tsuji T, Toda E, Terashima Y, Saitoh T, Kohda D, ‰Í–ìr”V1, Osawa M, Ueda T, Shimada I, Matsushima K, Terasawa H (1¶‰»): ‘æ53‰ñ“ú–{¶•š•š—Šw‰ï”N‰ï (2015/9/15), ‹à‘ò.

723024. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒLƒ‹ƒXˆÝŠà×–E‚É‚š‚¯‚éMet‹y‚щº—¬ƒVƒOƒiƒ‹“`’B•ªŽq‚Ì‹@”\‰ðÍ. ŽRŒû‰pŽ÷, ”’–ØŒŽ‘ôÆ, ä@—²ˆê1 (1¶‰»): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/9), –ŒŒÃ‰®.

723025. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äX‘Ÿ‚ª‚ñ×–E‚É‚š‚¯‚éSide-Population×–E‚Ì“Á«‚Æ‚»‚Ì•ªŽqŠî”Õ. ’†“‡Ž•F, ä@—²ˆê1 (1¶‰»): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/9), –ŒŒÃ‰®.

723026. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _Œo‰èŽî×–E‚É‚š‚¯‚éSHP2‚ÆALK‚ÌŒ‹‡‚Í, _Œo‰èŽî×–E‚ÌŽîᇌŽ«‚𐧌䂷‚é. •xŽRV‘Ÿ, ã–ì‰p–Ÿ, ”’–ØŒŽ‘ôÆ, ’†“‡Ž•F, ŽRŒû‰pŽ÷, XŒ’‘Ÿ˜Y, ä@—²ˆê1 (1¶‰»): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/10), –ŒŒÃ‰®.

723027. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒLƒ‹ƒXˆÝ‚ª‚ñ‚É‚š‚¯‚銈«‰»Žó—e‘ÌŒ‹‡ƒ^ƒ“ƒpƒNŽ¿‚Ì“¯’è‚Æ‹@”\‰ðÍ. ”’–ØŒŽ‘ôÆ, ŽRŒû‰pŽ÷, ä@—²ˆê1 (1¶‰»): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/10), –ŒŒÃ‰®.

723028. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Non-detergent sulfobetaine (NDSB) ‚ªƒ^ƒ“ƒpƒNŽ¿‚̃_ƒCƒiƒ~ƒNƒX‚É‹y‚Ú‚·Œø‰Ê. ‰€@ŠC”~, Îˆä@‹B, ×“c˜a’j, ‰Í–ìr”V1, Ž›˜eTˆê, ŽáŒ@Š] (1¶‰»): ‘æ54‰ñNMR“¢˜_‰ï (2015/11/6), ç—t.

723029. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Two post-translational modifications in mammalian Bcnt/Cfdp1, a potential epigenetic factor: S250 phosphorylation and K268 acetylation in the conserved C-terminal region. Šâ‰ºV‘Ÿ˜Y, ’†“‡Œ’‘Ÿ˜Y, —é–ØŒ’—T, ˆÀ“c•Žk, â–{‘׈ê, ‰Í–ìr”V1, ‚‹Žˆê˜N, ¬—эFˆÀ, ‘å–ìiŽq, ¡é@”E, “°‘O@’Œ, ‘v@Žž‰h (1¶‰»): BMB2015 (‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ 88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï) (2015/12/1), _ŒË.

723030. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _Œo‰èŽî‚ÌALK‘jŠQÜŠŽŽó«‚𐧌䂷‚éALKŒ‹‡ƒŠƒ“Ž_‰»’`”’Ž¿ŒQ. ä@—²ˆê1, •xŽRV‘Ÿ (1¶‰»): BMB2015 (‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï) (2015/12/1), _ŒË.

723031. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –³…ƒqƒhƒ‰ƒWƒ“‚É‚æ‚郀ƒ`ƒ“Œ^“œœØ‚è‚Ÿ‚µ‚É‹y‚Ú‚·ŽãŽ_“Y‰Á‚̉e‹¿. ŒÜäzsM (¶‰»): BMB2015 (‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ 88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï) (2015/12/2), _ŒË.

723032. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) VAMP7‚̓I[ƒgƒtƒ@ƒW[‚𐧌䂵‚ă~ƒgƒRƒ“ƒhƒŠƒA‚̍Pí«ˆÛŽ‚Æ‘æ2‘ŠƒCƒ“ƒXƒŠƒ“•ª”å‚𒲐߂·‚é. Â–ö‹€‘Ÿ1, ¡ò”ü‰À1, ”‘q@œ2, ’¹‹ªŽi3, HŒ³‹`O4, Œ˜e’m¢”T1, ’†“¹—mŽq1, ŠÝ–{‘ñ–1, ŒŽ“c²G1, ‚‹Ž³g2, ‰iŒMÆ1 (1ˆÇ—Ñ‘å, 2¶‰», 3ŒQ”n‘å, 4‘åã‘å): BMB2015 (‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ 88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï) (2015/12/3), _ŒË.

723033. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒbƒg‘Á‰tƒ€ƒ`ƒ“‚ð”FŽ¯‚·‚郂ƒmƒNƒ[ƒiƒ‹R‘̂̍쐻. ‡“c‹I1, ”Ñ“c‘׍L1, –å’J—Tˆê2, ì“‡@—í2, ŒÜäzsM3, ÎŒŽ˜a•F4, Žsì‘ž•¶2, ŒIŒŽ@œ1 (1_“ސìH‘å, 2ˆã—Éq¶Šw•”, 3¶‰», 4•ÛŒ’‰q¶ê–åŠw‰@): BMB2015 (‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ 88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï) (2015/12/3), _ŒË.

733004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž©‘R”ɐB‚Å‚ÍŒn“ˆÛŽ‚ª¢“ï‚ÈSNAP-25ƒmƒbƒNƒCƒ“ƒ}ƒEƒXŒn“‚ɑ΂·‚鐶BHŠw‹Zp‚Ì“K—p ‹v•Û’nœŽi, ²“¡‹M•¶, ˆ¢•”^Œå, ŠŒŽ—Y–ç, ‚‹Ž@W, ŽRX‘D1, ‚‹Ž³g1, ²“¡rÆ2, “Œ@’åG2 (1¶‰», 2ŽÀ“®): ‘æ32‰ñ“®•š¶BHŠwŒ€‹†‰ï (2015/12/5), ìè.

733005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _Œo‰èŽî‚É‚š‚¯‚éALKŽó—e‘̃VƒOƒiƒ‹‚ÌFlotillin-1‚ÆShcC- Shp2Œo˜H‚É‚æ‚鐧Œä. ä@—²ˆê1, •xŽRV‘Ÿ (1¶‰»): ‘æ7‰ñ “ú–{ƒvƒƒeƒCƒ“ƒzƒXƒtƒ@ƒ^[ƒ[Œ€‹†‰ïŠwpW‰ï (2016/1/29), ‰ªè.


•ªŽqˆâ“`Šw

[Šwp˜_•¶]

110021. [ŒŽ’˜] Mirror syndrome associated with fetal transient abnormal myelopoiesis in Down syndrome. Kobayashi Y, Miyoshi T, Matsuyama T, Miyauchi J, Miyashita T1, Ishibashi-Ueda H, Yoshimatsu J: Pathol Int 2015/8; 65 (8): 443-5. (‹{‰ºr”V1: 1•ªŽqˆâ“`)

110022. [ŒŽ’˜] A rare case of a symptomatic tumor found in the groin area: An atypical location unexposed to the known causes. Toyonaga E, Hata H, Nakayama C, Homma E, Miyashita T1, Shimizu H: Case Rep Oncol 2015/11; 8 (3): 536-9. (‹{‰ºr”V1: 1•ªŽqˆâ“`)

110023. [ŒŽ’˜] Chromatin condensation of Xist genomic loci during oogenesis in mice. Fukuda A, Mitani A, Miyashita T1, Umezawa A, Akutsu H: Development 2015/12; 142 (23): 4049-55. (‹{‰ºr”V1: 1•ªŽqˆâ“`)

[’˜@‘]

610001. [Šwp‘ (•ª’SŽ·•M)]yProtein-Protein Interactions: Methods and Applications (Methods in Molecular Biology Vol.1278)zPart IV: Cell-Based Bimolecular Interaction Reporter Assays, Confocal microscopy for intracellular co-localization of proteins, p. 515-26. Miyashita T1, Editors: Cheryl L. Meyerkord, Haian Fu, Humana Press, USA, 2015/4. (‹{‰ºr”V1: 1•ªŽqˆâ“`)

[Šw‰ïEŒ€‹†‰ï“™]

723034. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Establishment of the cell lines with a large genomic deletion by CRISPR/Cas9 system. ’·”ö˜a‰E1, ‚ŽR‹g‰i1, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8-10), –ŒŒÃ‰®.

723035. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) CRISPR/Cas9ƒVƒXƒeƒ€‚ð—p‚¢‚œ2“_“¯ŽžØ’f‚É‚æ‚é–Ú“IƒQƒmƒ€—̈揜‹Ž×–EŠ”‚̍쐻. ‰Á“¡çš, ’·”ö˜a‰E1, ‰£—m”ü, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (2015/12/1-4), _ŒË.

733006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) CRISPR/Cas9ƒVƒXƒeƒ€‚ð—p‚¢‚œLˆæŒ‡‘¹ƒQƒmƒ€‚ð—L‚·‚é×–EŠ”‚̍쐻. ‰Á“¡çš, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‰£—m”ü, ’·”ö˜a‰E1, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ28‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€ (2015/8/6-7), ‘Š–ÍŒŽ.

733007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX‰Šú”t‚É‚š‚¯‚éOct4‚Ì‹@”\‰ðÍ. ŽO’J@‰·, ‹{‰ºr”V1, ˆ¢‹v’ÉpŒ› (1•ªŽqˆâ“`): ‘æ28‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€ (2015/8/6-7), ‘Š–ÍŒŽ.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-320001. [Ç—á] 2‚©ŒŽŒã‚ɉ苅‚ªÄ‘‰Á‚µ‚œˆê‰ß«œ‘ˆÙí‘BÇ‚Ì’Ž‘ŽYŽ™—á. –쑺—DŽq, ‹{“à@, ‘Ÿ“c‰hŽ¡, –öˆä•¶’j, ‹{‰ºr”V1, ÆˆäŒN“T, ˆÉ“¡‰x˜N, œA£Lˆê (1•ªŽqˆâ“`):“ú–{¬Ž™ŒŒ‰tE‚ª‚ñŠw‰ïŽGŽ2015/3; 52 (1): 36-9.


–ò—Šw

[Šwp˜_•¶]

110024. [ŒŽ’˜] The role of vascular endothelial growth factor receptor-1 signaling in compensatory contralateral lung growth following unilateral pneumonectomy. Matsui Y1, Amano H2, Ito Y3, Eshima K4, Tamaki H5, Ogawa F6, Iyoda A, Shibuya M, Kumagai Y6, Satoh Y1, Majima M2: Lab Invest 2015/5; 95 (5): 456-68. (ŒˆäŒ[•v1, “V–ì‰pŽ÷2, ˆÉ“¡‹`–ç3, ]“‡k“ñ4, ‹Ê–؉p–Ÿ5, ¬ìŽj—m6, ŒF’J—YŽ¡6, ²“¡”Vr1, ”n“ˆ³—²2: 1ŒÄ‹zŠíŠO, 2–ò—, 3ŠO‰È, 4–Ɖu, 5‰ð–U, 6—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg)

110025. [ŒŽ’˜] The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia. Amano H1, Kato S2, Ito Y3, Eshima K4, Ogawa F5, Takahashi R6, Sekiguchi K4, Tamaki H7, Sakagami H7, Shibuya M, Majima M1: PLoS One 2015/7; 10 (7): e0131445. (“V–ì‰pŽ÷1, ‰Á“¡L‘Ÿ˜Y2, ˆÉ“¡‹`–ç3, ]“‡k“ñ4, ¬ìŽj—m5, ‚‹Ž@—º6, ŠÖŒû˜aŠé6, ‹Ê–؉p–Ÿ7, ãã—ms7, ”n“ˆ³—²1: 1–ò—, 2zŠÂŠí“à, 3ŠO‰È, 4–Ɖu, 5—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg, 6‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 7‰ð–U)

110026. [ŒŽ’˜] Thromboxane A2 induces blood flow recovery via platelet adhesion to ischaemic regions. Amano H1, Ito Y2, Eshima K3, Kato S4, Ogawa F5, Hosono K1,6, Oba K7, Tamaki H8, Sakagami H8, Shibuya M, Narumiya S, Majima M1: Cardiovasc Res 2015/9; 107 (4): 509-21. (“V–ì‰pŽ÷1, ˆÉ“¡‹`–ç2, ]“‡k“ñ3, ‰Á“¡L‘Ÿ˜Y4, ¬ìŽj—m5, ×–ì‰Á“ÞŽq1,6, ‘å’ë˜al7, ‹Ê–؉p–Ÿ8, ãã—ms8, ”n“ˆ³—²1: 1–ò—, 2ŠO‰È, 3–Ɖu, 4zŠÂŠí“à, 5—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg, 6¶—, 7“à•ª”å‘ãŽÓ“à, 8‰ð–U)

110027. [ŒŽ’˜] Roles of mPGES-1, an inducible prostaglandin E synthase, in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model. Matsuda H1, Hosono K2,3, Tsuru S1, Kurashige C4, Sekiguchi K1, Akira S, Uematsu S, Okamoto H4, Majima M: Life Sci 2015/12; 142: 1-7. (Œ“cO”ü1, ×–ì‰Á“ÞŽq2,3, ’ׯ¢—¢1, åUdçŠG4, ŠÖŒû˜aŠé1, ‰ª–{_Žk4, ”n“ˆ³—²3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—, 4–ƒŒ)

110028. [ŒŽ’˜] Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model. Park K1, Amano H2, Ito Y3, Kashiwagi S4, Yamazaki Y4, Takeda A4, Shibuya M, Kitasato H5, Majima M2: Biomed Pharmacother 2016/3; 78: 140-9. (–p@Œ\ˆê1, “V–ì‰pŽ÷2, ˆÉ“¡‹`–ç3, ”–ؐT–ç4, ŽRèˆÀ°4, •“c@Œ[4, –k—¢‰p˜Y5, ”n“ˆ³—²2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–ò—, 3ŠO‰È, 4Œ`¬E”üŠO, 5ˆã—Éq¶Šw•”)

110029. [ŒŽ’˜] Vascular endothelial growth factor regulates growth of endometrial tissues and angiogenesis in a mouse transplantation model. Sekiguchi K1, Hosono K2,3, Numao A4, Honda M1, Matsuda H1, Amano H3, Kawauchi H4, Shibuya M, Unno N5, Majima M3: Kitasato Med J 2016/3; 46 (1): 15-23. (ŠÖŒû˜aŠé1, ×–ì‰Á“ÞŽq2,3, À”ö²Žq4, –{“c‰ëŽq1, Œ“cO”ü1, “V–ì‰pŽ÷3, ì“à”Žl4, ŠC–ìM–ç5, ”n“ˆ³—²3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—, 4•wl, 5ŽY‰È)

[Šw‰ïEŒ€‹†‰ï“™]

722005. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Roles of Prostaglandins in regulation of plasticity of lymphatics and lymph nodes. ”n“ˆ³—²1, ×–ì‰Á“ÞŽq1,2, “V–ì‰pŽ÷1, “¡“c•üŒb1 (1–ò—, 2¶—): ‘æ89‰ñ“ú–{–ò—Šw‰ï”N‰ï (2016/3/11), ‰¡•l.

723036. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“à–ŒÇ‚Ì”­Ç‚É‚š‚¯‚éVEGF1Œ^Žó—e‘Ì‚Ì–ðŠ„. ŠÖŒû˜aŠé1, ×–ì‰Á“ÞŽq2,3, ²“¡ŠG—¢“Þ, a’J³Žj, ŠC–ìM–ç4, ”n“ˆ³—²3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—, 4ŽY‰È): ‘æ36‰ñ“ú–{‰ŠÇEÄ¶ˆãŠw‰ï (2015/7/21-22), “Œ‹ž.

723037. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŽ¡–ü‚É‚š‚¯‚éVascular Endothelial Growth Factor Receptor 1TKƒVƒOƒiƒ‹‚Ì–ðŠ„. –p@Œ\ˆê1, “V–ì‰pŽ÷2, ×–ì‰Á“ÞŽq2,3, ”–ؐT–ç4, ‚‹Ž@—º1, a’J³Žj, ‹g’|r—T1, •“c@Œ[4, ”n“ˆ³—²2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–ò—, 3¶—, 4Œ`¬E”üŠO): ‘æ36‰ñ“ú–{‰ŠÇEÄ¶ˆãŠw‰ï (2015/7/21-22), “Œ‹ž.

723038. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Role of TP signaling in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model. Œ“cO”ü1, ×–ì‰Á“ÞŽq2,3, ’ׯ¢—¢1, ¬‹{@Žü, ”n“ˆ³—²3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—): ‘æ89‰ñ“ú–{–ò—Šw‰ï”N‰ï (2016/3/10), ‰¡•l.

723039. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Host Derived Bone Marrow Cells Expressing Vascular Endothelial Growth Factor Receptor 1 Regulates Growth of Endometrial Tissues and Angiogenesis in a Mouse Transplantation Model. ŠÖŒû˜aŠé1, ×–ì‰Á“ÞŽq2,3, –{“c‰ëŽq1, ì“à”Žl4, ŠC–ìM–ç5, ”n“ˆ³—²3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—, 4•wl, 5ŽY‰È): ‘æ89‰ñ“ú–{–ò—Šw‰ï”N‰ï (2016/3/10), ‰¡•l.

723017. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Signaling of prostaglandin E receptors, EP3 and EP4 facilitates wound healing and lymphangiogenesis with enhanced recruitment of CD11b+ macrophages in mice. ×–ì‰Á“ÞŽq1,2, ˆé’†—¹1, ìã@—Ï1, ¬‹{@Žü, ”n“ˆ³—²2 (1¶—, 2–ò—): ‘æ89‰ñ“ú–{–ò—Šw‰ï”N‰ï (2016/3/10), ‰¡•l.

733008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŽ¡–ü‚É‚š‚¯‚éVascular Endothelial Growth Factor Receptor 1 Tyrosine Kinase ƒVƒOƒiƒ‹‚Ì–ðŠ„. –p@Œ\ˆê1, “V–ì‰pŽ÷2, ×–ì‰Á“ÞŽq2,3, ”–ؐT–ç4, ‚‹Ž@—º1, a’J³Žj, ‹g’|r—T1, •“c@Œ[4, ”n“ˆ³—²2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–ò—, 3¶—, 4Œ`¬E”üŠO): ‘æ132‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï (2015/7/4), ç—t.


”÷¶•šŠw

[Šwp˜_•¶]

110030. [ŒŽ’˜] Genomics of Clostridium botulinum group III strains. Sakaguchi Y1, Suzuki T, Yamamoto Y, Nishikawa A, Oguma K: Res Microbiol 2015/5; 166 (4): 318-25. (ãŒû‹`•F1: 1”÷¶•š)

110031. [ŒŽ’˜] Characterization of Pseudomonas aeruginosa phage KPP21 belonging to family Podoviridae genus N4-like viruses isolated in Japan. Shigehisa R, Uchiyama J, Kato S, Takemura-Uchiyama I, Yamaguchi K, Miyata R, Ujihara T, Sakaguchi Y1, Okamoto N, Shimakura H, Daibata M, Sakaguchi M, Matsuzaki S: Microbiol Immunol 2016/1; 60 (1): 64-7. (ãŒû‹`•F1: 1”÷¶•š)

520002. [‘à] ˆã—ÃŽ{Ý“à‚̐ݔõ‚â‹@Ší‚ðŠŽõŒ¹‚Æ‚·‚é‰@“àŠŽõ. —с@rŽ¡ (”÷¶•š): –k—¢ˆãŠw 2015/12; 45 (2): 87-94.

521001. [‰ðà] Small Intestinal Bacterial Overgrowth. —с@rŽ¡ (”÷¶•š): ƒhƒNƒ^[ƒTƒƒ“ 2015/4; 59 (5): 342-6.

522013. [uÀ]y“ÁW: Helicobacter Year Book 2014`2015|HelicobacterŒ€‹†‚̍X‚È‚é”ò–ô|zHelicobacter pyloriˆÈŠO‚̃wƒŠƒRƒoƒNƒ^[‘®. —с@rŽ¡ (”÷¶•š): Helicobacter Research 2015/4; 19 (2): 161-8.

522014. [uÀ]yƒVƒŠ[ƒY!! ƒ{ƒcƒŠƒkƒX‹Û‚É‚æ‚鎟Š³ (ƒ{ƒcƒŠƒkƒXÇ)z‘æˆê‰ñ ƒ{ƒcƒŠƒkƒX‹Û‚Ì”­Œ©‚Ì—ðŽj‚ƉuŠw. ãŒû‹`•F (”÷¶•š): ƒTƒ‰ƒ„î•ñŽu‰q¶‚Ì—Fv2015/6.

522015. [uÀ]yƒVƒŠ[ƒY!! ƒ{ƒcƒŠƒkƒX‹Û‚É‚æ‚鎟Š³ (ƒ{ƒcƒŠƒkƒXÇ)z‘æ“ñ‰ñ ƒ{ƒcƒŠƒkƒX‹Û‚Ì•aŒŽˆöŽq‚ƍì—p‹@˜. ãŒû‹`•F (”÷¶•š): ƒTƒ‰ƒ„î•ñŽu‰q¶‚Ì—Fv2015/10.

522016. [uÀ]yƒVƒŠ[ƒY!! ƒ{ƒcƒŠƒkƒX‹Û‚É‚æ‚鎟Š³ (ƒ{ƒcƒŠƒkƒXÇ)z‘æŽO‰ñ ƒ{ƒcƒŠƒkƒXÇ‚̗Տ°Çó. ãŒû‹`•F (”÷¶•š): ƒTƒ‰ƒ„î•ñŽu‰q¶‚Ì—Fv2016/2.

540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y‰ÈŠwŒ€‹†”ï•â•‹àEŠî”ÕŒ€‹† (C)uCŒ^‚ÆDŒ^ƒ{ƒcƒŠƒkƒX“Å‘f•ÏŠ·ƒtƒ@[ƒW‚Ì”ö•”‹z’…ƒ^ƒ“ƒpƒNŽ¿‚ƏhŽå‹ÛƒŒƒZƒvƒ^[‚̉ðÍ (Œ€‹†ŠúŠÔ: •œ¬25”N“x`•œ¬27”N“x, Œ€‹†‘ã•\ŽÒ: ãŒû‹`•F (”÷¶•š))vzuCŒ^‚ÆDŒ^ƒ{ƒcƒŠƒkƒX“Å‘f•ÏŠ·ƒtƒ@[ƒW‚Ì”ö•”‹z’…ƒ^ƒ“ƒpƒNŽ¿‚ƏhŽå‹ÛƒŒƒZƒvƒ^[‚̉ðÍvŒ€‹†ŽÀŽ{ó‹µ•ñ‘ 2015/5.

540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y‰ÈŠwŒ€‹†”ï•â•‹àE’§í“I–G‰èŒ€‹†u“ÁˆÙR‘Ì‚ð—˜—p‚µ‚œ‘œÜ‘ϐ«‹Û‚̐v‘¬Œ€‹†–@‚ÌŠm—§‚ƗՏ°‰ž—p‚ÉŠÖ‚·‚錀‹† (Œ€‹†ŠúŠÔ: •œ¬23”N“x`•œ¬25”N“x, Œ€‹†‘ã•\ŽÒ: ‰ª–{—¹ˆê (”÷¶•š))vzu“ÁˆÙR‘Ì‚ð—˜—p‚µ‚œ‘œÜ‘ϐ«‹Û‚̐v‘¬Œ€‹†–@‚ÌŠm—§‚ƗՏ°‰ž—p‚ÉŠÖ‚·‚錀‹†vÅI•ñ‘ 2016/3.

[’˜@‘]

620002. [Šwp‘ (•ª’SŽ·•M)]yƒRƒ“ƒpƒNƒg”÷¶•šŠw (‰ü’ù‘æ4”Å)z‘æ7Í –ŋۂƏÁ“Å, p.155-62. •œˆä‹`ˆê, —с@rŽ¡1 (1”÷¶•š), •Ò: ¬ŒFœš“ñ, –x“c@”Ž, “ì]“°, “Œ‹ž, 2015/9”­s.

620003. [Šwp‘ (•ª’SŽ·•M)]yƒRƒ“ƒpƒNƒg”÷¶•šŠw (‰ü’ù‘æ4”Å)z‘æ9Í ‘ŸŠíŠŽõÇ@9-6 ŒŒ‰tEƒŠƒ“ƒp‚š‚æ‚Ñ‘SgŠŽõÇ@ŠŽõÇ@A. ×‹Û, p.232-6. •œˆä‹`ˆê, —с@rŽ¡1 (1”÷¶•š), •Ò: ¬ŒFœš“ñ, –x“c@”Ž, “ì]“°, “Œ‹ž, 2015/9”­s.

620004. [Šwp‘ (•ª’SŽ·•M)]yƒRƒ“ƒpƒNƒg”÷¶•šŠw (‰ü’ù‘æ4”Å)z‘æ9Í ‘ŸŠíŠŽõÇ@9-7 ‚»‚Ì‘Œ‚ÌŠŽõÇ@A. æ“V«ŠŽõÇ‚Ù‚©, p.242-7. ’†ž@Ž¡, —с@rŽ¡1 (1”÷¶•š), •Ò: ¬ŒFœš“ñ, –x“c@”Ž, “ì]“°, “Œ‹ž, 2015/9”­s.

620005. [Šwp‘ (•ª’SŽ·•M)]yƒsƒƒŠ‹Ûœ‹ÛŽ¡—Ãp[ƒtƒFƒNƒgƒKƒCƒhz‘æ5Í ƒsƒƒŠœ‹ÛŽ¡—Â̊î‘b’mŽ¯@3. ƒsƒƒŠ‹Û‚ÌŠî‘b’mŽ¯|’m‚Á‚Ä‚š‚«‚œ‚¢ƒsƒƒŠ‹Û‚̍׋ۊw“I“Á’¥, p.169-71. —с@rŽ¡ (”÷¶•š), •Ò: å@MœA, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 2015/10”­s.

620006. [Šwp‘ (•ª’SŽ·•M)]yH. pyloriœ‹Û‚É‚æ‚éˆÝ‚ª‚ñ—\–hí—ª@IARCƒ[ƒLƒ“ƒOƒOƒ‹[ƒv•ñ‘8zSection 2: H. pyloriœ‹Û‚É‚æ‚錒N‚Ö‚ÌŒø‰Ê‚Ɖe‹¿@Helicobacter pylori‚̏W’cœ‹Û‚ª×‹Û‚Ì–òÜ‘ϐ«‚ð—U“±‚·‚éŠëŒ¯«, p.64-8. —с@rŽ¡ (”÷¶•š), ŠÄ–ó: ó³”Ž, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2016/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722006. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Helicobacter pyloriŠŽõÇ‚ÌŠî‘b‚ƉuŠw. —с@rŽ¡ (”÷¶•š): ‘æ21‰ñ“ú–{ƒwƒŠƒRƒoƒNƒ^[Šw‰ïŠwpW‰ï (2015/6/27), _ŒË.

722007. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ×‹ÛŠŽõÇ‚É‚š‚¯‚éf’f–@‚ÆŽ¡—Ö@‚ÌŠJ”­: ƒoƒNƒeƒŠƒIƒtƒ@[ƒW‚Ì—˜—p. “àŽR~•œ, ŒˆäGm, ãŒû‹`•F1, ‰Ô–؏G–Ÿ, Œè–ΓW, ãŒû‰ëO (1”÷¶•š): ‘æ158‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï (2015/9/7), \˜a“c.

723040. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •a‰@ŠÂ‹«×‹Û‰˜õ‚Ì•‰‰×’ጞ‚ÉŽ‘‚·‚铺‡‹à‚Ì“±“ü. ùŒŽ•Žu1, ”š@Ž•F, ‹à“cr˜a, •x@³ˆê, ’ߊۏr˜a, ‹e–엝’ÃŽq, Ä“¡°•v (1”÷¶•š): “ú–{–h‹Û–hꀊw‰ï‘æ42‰ñ”NŽŸ‘å‰ï (2015/9/2), ‘åã.

723041. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ϕϐFER‹Û“º‡‹àuƒNƒŠ[ƒ“ƒuƒ‰ƒCƒgv‚ÌŠJ”­. ”š@Ž•F, “c’†^ŽŸ, ‘åÎŒbˆê˜Y, ùŒŽ•Žu1 (1”÷¶•š): “ú–{“ºŠw‰ï‘æ55‰ñu‰‰‘å‰ï (2015/11/3), “c.

723042. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clostridium difficileŠŽõŠ³ŽÒŽüˆÍŠÂ‹«‚̉è–E‰˜õ. ùŒŽ“S•œ, “n•Ó”ü’q‘ã, ŽR‰z—T”ü, —с@rŽ¡1, XàV—YŽi (1”÷¶•š): ‘æ31‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï¥ŠwpW‰ï (2016/2/19), ‹ž“s.

723043. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The genome sequence of Clostridium botulinum type C phage and functional analysis of gene products. ãŒû‹`•F1, Uchiyama J, Ogura Y, Yamamoto Y, Matsuzaki S, Hayashi T, Matsushita O, Oguma K, —с@rŽ¡1 (1”÷¶•š): ‘æ89‰ñ“ú–{×‹ÛŠw‰ï‘‰ï (2016/3/23), ‘åã.

723044. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŠúˆÝŠàESDŒãÄ”­—\‘ª‚É‚š‚¯‚éH. pylori|JRŒŽ‚ð—p‚¢‚œIgG ƒTƒuƒNƒ‰ƒX‚Ì—L—p«. ‰¡“cŒ›Ž¡, Œ‰º@Ž¡, ŽR–{—R–íŽq, ”üŠÔŒ’•F, Œã“¡˜a‹`, —с@rŽ¡1, ãŒû‹`•F1 (1”÷¶•š): ‘æ89‰ñ“ú–{×‹ÛŠw‰ï‘‰ï (2016/3/23), ‘åã.

723045. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Δ^‹ÛPAO1Š”‚ƃtƒ@[ƒWKPP22‚Ì’ZŠúŠÔi‰»“IŒRŠg‹£‘–‚̉ðÍ. “ߐ{ì’‰–í, “àŽR~•œ, —é–ؐml, ‹{“c—æ“Þ, ŽRŒû‹ÕŠG, “àŽRˆÉ‘ã, ãŒû‹`•F1, ŽÄŽRŒbŒá, ãŒû‰ëO, Œè–ΓW (1”÷¶•š): ‘æ89‰ñ“ú–{×‹ÛŠw‰ï‘‰ï (2016/3/23), ‘åã.

733009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒsƒƒŠ‹Ûƒtƒ@[ƒW‚Ì•ª—£‚ƉðÍ. “àŽR~•œ, ’|“àŒ[W, ‰Á“¡Lˆê˜Y, ãŒû‹`•F1, Š—¶Œ[Ži, ŽŒŽ—²Žq, “àŽRˆÉ‘ã, “‡‘qGŸ, ¡ŒŽs˜N, ãŒû‰ëO, Œè–ΓW (1”÷¶•š): ‘æ2‰ñƒtƒ@[ƒWƒZƒ‰ƒs[—Տ°‰ž—pŒŸ“¢‰ï (2015/7/31), ‰¡•l.

733010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) CŒ^ƒ{ƒcƒŠƒkƒX“Å‘f•ÏŠ·ƒtƒ@[ƒW‚̐¶‘¶‚É•K—v‚ȃQƒmƒ€—̈æ‚̉ðÍ. ãŒû‹`•F1, “àŽR~•œ, Mar’a A Oliva, Antonio J Martin-Galiano, JosŽ M Andreu, ¬–ž‹`r, ŽR–{—R–íŽq, Œè–ΓW, —с@“N–ç, ¬ŒFœš“ñ, —с@rŽ¡1 (1”÷¶•š): •œ¬27”N“xAKPSŒ€‹†W‰ïE‘æ18‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[ (2015/8/6), ‘Š–ÍŒŽ.

733011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒNƒŠƒvƒgƒXƒ|ƒŠƒWƒEƒ€‚Ì”|—{×–E‚É‚æ‚銎õ«•]‰¿. ùŒŽ•Žu1, ‹e–엝’ÃŽq, —с@rŽ¡1 (1”÷¶•š): •œ¬27”N“xAKPSŒ€‹†W‰ïE‘æ18‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[ (2015/8/6), ‘Š–ÍŒŽ.

733012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°‹Û‚ÌgyrA/parCˆâ“`Žq•ÏˆÙ‚É‚æ‚éƒLƒmƒƒ“‘ϐ«‚Í“`’B‚³‚ê‚é‚©? ‰ª–{—¹ˆê1, —с@rŽ¡1 (1”÷¶•š): •œ¬27”N“xAKPSŒ€‹†W‰ïE‘æ18‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[ (2015/8/6), ‘Š–ÍŒŽ.

733013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒWƒFƒbƒgƒ^ƒIƒ‹‚É‚æ‚éŽèŽw‚̍׋ۉ˜õ‚ÌŒŸ“¢. —с@rŽ¡ (”÷¶•š): ‘æ78‰ñ_“ސ쌧ŠŽõÇˆãŠw‰ï (2015/9/12), ‰¡•l.

733014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) CŒ^ƒ{ƒcƒŠƒkƒX“Å‘f•ÏŠ·ƒtƒ@[ƒW‚̃Qƒmƒ€”äŠr‚ƈâ“`Žq‹@”\‰ðÍ. ãŒû‹`•F1, “àŽR~•œ, Mar’a A Oliva, Antonio J Martin-Galiano, JosŽ M Andreu, ¬–ž‹`r, ŽR–{—R–íŽq, Œè–ΓW, —с@“N–ç, ¬ŒFœš“ñ, —с@rŽ¡1 (1”÷¶•š): ‘æ98‰ñ“ú–{×‹ÛŠw‰ïŠw‰ïŠÖ“ŒŽx•”‘‰ï (2015/10/29), “Œ‹ž.

733015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚‘ϐH«ŽE‹Û“º‡‹àƒtƒBƒ‹ƒ€‚É‚æ‚é‰@“àŠÂ‹«×‹Û‰˜õ‚̒ጞ‰». “à“c—R”üŽq, ùŒŽ•Žu1 (1”÷¶•š): •œ¬27”N“x“ú—Õ‹Z‹ãBŽx•”ˆãŠwŒŸžŠw‰ï (2015/11/14), Ž­Ž™“‡.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-110002. [ŒŽ’˜] Identification and characterization of a vitamin D3 decomposition product bactericidal against Helicobacter pylori. Hosoda K, Shimomura H, Wanibuchi K, Masui H, Amgalanbaatar A, Hayashi S1, Takahashi T, Hirai Y: Sci Rep 2015/3; 5: 8860. (—с@rŽ¡1: 1”÷¶•š)

H26-120001. [ŒŽ’˜] “º‡‹à‚ÌŽE‹Û“Á«‚É‹y‚Ú‚·•\–ÊŽ_‰»‚̉e‹¿‚ÆŽ_‰»–hŽ~‘΍ô ùŒŽ•Žu1, ²“¡^‹|, ”š@Ž•F, “í@@‘ì, K@—m“ñ, ˜a“c³•F, Ö“¡°•v (1”÷¶•š): “º‹y‚Ñ“º‡‹à 2015/3; 54 (1): 246-50.

[’˜@‘]

H26-620001. [Šwp‘ (•ª’SŽ·•M)]yƒoƒCƒIƒZ[ƒtƒeƒB‚ðŽx‚Š‚é (CLEAN LIFE 2015)z3Í ‰@“àŠŽõ‚ÌŒ»ó‚Ƒ΍ô‚̏«—ˆ‘œ, p.14-7. ùŒŽ•Žu (”÷¶•š), ˆê”ÊŽÐ’c–@l ŠÂ‹«•¶‰»‘n‘¢Œ€‹†Š, “Œ‹ž, 2015/1”­s.


Šñ¶’ŽŠw

[Šwp˜_•¶]

110032. [ŒŽ’˜] Evaluation of Eimeria krijgsmanni as a murine model for testing the efficacy of anti-parasitic agents. Takeo T, Tanaka T, Matsubayashi M, Tsujio M, Umemiya-Shirafuji R, Tsuji N1, Fujisaki K, Matsui T, Matsuo T: Acta Parasitol. 2015/6; 60 (2): 190-5. (’ҁ@®—˜1: 1Šñ¶’Ž)

110033. [ŒŽ’˜] Bacteria-induced hatching of Trichuris muris eggs occurs without direct contact between eggs and bacteria. Koyama K1: Parasitol Res 2016/1; 115 (1): 437-40. (¬ŽR_ˆê1: 1Šñ¶’Ž)

110034. [ŒŽ’˜] Collection methods of trematode eggs using experimental animal models. Tsubokawa D1, Sugiyama H, Mikami F2, Shibata K, Shibahara T, Fukuda K, Takamiya S, Yamasaki H, Nakamura T1, Tsuji N1: Parasitol Int 2016/1; pii: S1383-5769(16)00007-6. (’ؐì‘åŒå1, ŽOã–[Žq2, ’†‘º@Œ’1, ’ҁ@®—˜1: 1Šñ¶’Ž, 2—\–hˆãŠwŒn)

110035. [ŒŽ’˜] Emergence of multi-acaricide resistant Rhipicephalus ticks and its implication on chemical tick control in Uganda. Vudriko P, Okwee-Acai J, Tayebwa DS, Byaruhanga J, Kakooza S, Wampande E, Omara R, Muhindo JB, Tweyongyere R, Owiny DO, Hatta T1, Tsuji N1, Umemiya-Shirafuji R, Xuan X, Kanameda M, Fujisaki K, Suzuki H: Parasit Vectors 2016/1; 9: 4. (”ª“cŠxŽm1, ’ҁ@®—˜1: 1Šñ¶’Ž)

110036. [ŒŽ’˜] Functional analysis of recombinant 2-Cys peroxiredoxin from the hard tick Haemaphysalis longicornis. Kusakisako K, Masatani T, Miyata T, Galay RL, Maeda H, Talactac MR, Tsuji N1, Mochizuki M, Fujisaki K, Tanaka T: Insect Mol Biol 2016/2; 25 (1): 16-23. (’ҁ@®—˜1: 1Šñ¶’Ž)

110037. [ŒŽ’˜] Virucidal activity of Haemaphysalis longicornis longicin P4 peptide against tick-borne encephalitis virus surrogate Langat virus. Talactac MR, Yoshii K, Maeda H, Kusakisako K, Hernandez EP, Tsuji N1, Fujisaki K, Galay RL, Tanaka T, Mochizuki M: Parasites & Vectors 2016/2; 9: 59. (’ҁ@®—˜1: 1Šñ¶’Ž)

110038. [ŒŽ’˜] Transcriptional profiles of virulent and precocious strains of Eimeria tenella at sporozoite stage; novel biological insight into attenuated asexual development. Matsubayashi M, Kawahara F, Hatta T, Yamagishi J, Miyoshi T, Anisuzzaman, Sasai K, Isobe T, Kita K, Tsuji N1: Infect Genet Evol 2016/6; 40: 54-62. (’ҁ@®—˜1: 1Šñ¶’Ž)

510001. [‘à] Longistatin in tick-saliva targets RAGE. Anisuzzaman, Alim MA, Tsuji N1: Oncotarget 2015/11; 6 (34): 35133-4. (’ҁ@®—˜1: 1Šñ¶’Ž)

[Šw‰ïEŒ€‹†‰ï“™]

712001. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Parasitic and tick-borne diseaseas. Tsuji N1: JICA seminer (2015/4/20), Tsukuba. (’ҁ@®—˜1: 1Šñ¶’Ž)

712002. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Pathobiology of vector tick-host interactions and anti-inflammatory molecules in tick-saliva. Tsuji N1: Medical Entomology Symposium The 36th Annual Meeting of Taiwan Entomological Society (2015/10/30), Taiwan. (’ҁ@®—˜1: 1Šñ¶’Ž)

712003. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) An advanced method for the study of the biological characteristics of the tick, Haemaphysalis longicornis, carrying tick-borne pathogens. Hatta T1: The 2nd Tokyo Vector Encounter (2016/3/2), Tokyo. (”ª“cŠxŽm1: 1Šñ¶’Ž)

723046. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Eimeria tenella‚̃~ƒgƒRƒ“ƒhƒŠƒAŒÄ‹zœy‘fŠˆ«‚Ì‘ª’è‚Æ‘jŠQÜ‚É‚æ‚é’Ž‘ÌŽE–ÅŒø‰Ê. Œ—с@œ, ˆî‰ªƒ_ƒjƒGƒ‹Œ’, ¬Œ’JŒ[‰î, ”ª“cŠxŽm1, ŽOD–Ґ°, ˆé•”@®, ìŒŽŽj–ç, ŽRŠÝ–ç, •FâŒ’Ž™, ²“¡@’g, Žu”g’q¶, ŒŽ“c”ɏt, –k@@Œ‰, ’ҁ@®—˜1 (1Šñ¶’Ž): ‘æ158‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï (2015/9/8), \˜a“c.

723047. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Virucidal activity of Haemaphysalis longicornis longicin P4 peptide against tick-borne encephalitis virus surrogate Langat virus. Melbourne Rio Talactac, DˆäŒ’‘Ÿ˜N, ’ҁ@®—˜1, “¡èK‘ , “c’‡“N–ç, –]ŒŽ‰ë”ü (1Šñ¶’Ž): ‘æ158‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï (2015/9/8), \˜a“c.

723048. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒ^ƒgƒQƒ`ƒ}ƒ_ƒj‚É‚š‚¯‚éƒyƒ‹ƒIƒLƒVƒŒƒhƒLƒVƒ“‚Ì–ðŠ„‚É‚Â‚¢‚Ä. ‘–Ø”—_‘å, Remil Linggatong Galay, ”’“¡—œ‰Â, ‘O“c‘å‹P, ‘å‹v•Û˜a—m, ŒÜ\—’ˆè’j, ’ҁ@®—˜1, –]ŒŽ‰ë”ü, “¡èK‘ , “c’‡“N–ç (1Šñ¶’Ž): ‘æ158‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï (2015/9/8), \˜a“c.

723049. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒxƒNƒ^[ƒ}ƒ_ƒj‘Ì“à‚É‚š‚¯‚éBabesia ovata‘B“®‘Ԃɂ‚¢‚Ă̈êlŽ@. ‘O“c‘å‹P, ”ª“cŠxŽm1, Œ—с@œ, ŽOD–Ґ°, ”’“¡—œ‰Â, ‘å‹v•Û˜a—m, ŒÜ\—’ˆè’j, ’ҁ@®—˜1, –]ŒŽ‰ë”ü, “¡èK‘ , “c’‡“N–ç (1Šñ¶’Ž): ‘æ158‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï (2015/9/8), \˜a“c.

723050. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Experimental evaluation of Haemaphysalis longicornis tick as a potential biologic vector of Japanese encephalitis virus. Goto M, Shimoda H, Maeda K, Maeda H, ”ª“cŠxŽm1, ’ҁ@®—˜1, Tanaka T, Mochizuki M (1Šñ¶’Ž): ‘æ63‰ñ“ú–{ƒEƒBƒ‹ƒXŠw‰ïŠwpW‰ï (2015/11/22), •Ÿ‰ª.

723051. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RŒ{ƒRƒNƒVƒWƒEƒ€Ç–ò‚ÌŠJ”­‚ð–ÚŽw‚µ‚œEimeria tenella Dihydroorotate dehydrogenase‚Ì”­Œ»Ež»‚ÆŒ‹»‰». ’·à_‚Ü‚Ç‚©, ²“¡@’g, Žu”g’q¶, Œ—с@œ, ˆî‰ªƒ_ƒjƒGƒ‹Œ’, ’ҁ@®—˜1, –k@@Œ‰, ŒŽ“c”ɏt (1Šñ¶’Ž): BMB2015 (‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ 88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï) (2015/12/2), _ŒË.

723052. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —c—‚É‚š‚¯‚éEimeria tenellaŽã“ÅŠ”‚̍ìo‚š‚æ‚Ñ•a—‘gDŠw“I‰ðÍ Œ—с@œ, ìŒŽŽj–ç, ”ª“cŠxŽm1, ŽRŠÝ–ç, ˆé•”@®, Ž›–{@ŒM, ‹àŽq@–Ÿ, ùˆä˜a”ü, –k@@Œ‰, ’ҁ@®—˜1 (1Šñ¶’Ž): ‘æ85‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (2016/3/19), ‹{è.

723053. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒPƒjƒAŽYƒRƒCƒ^ƒ}ƒ_ƒjRhipicephalus decoloratus‚É‚š‚¯‚éƒÀƒAƒhƒŒƒiƒŠƒ“—lƒIƒNƒgƒpƒ~ƒ“Žó—e‘̈â“`Žq‚ÌSNP ƒ^ƒCƒsƒ“ƒO ”ª“cŠxŽm1, Muinde Martin D, Oluga Aboge G, Odongo David O, ’|’†º—Y, Ngethe Esther W, ’ҁ@®—˜1 (1Šñ¶’Ž): ‘æ85‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (2016/3/20), ‹{è.

723054. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒ^ƒgƒQƒ`ƒ}ƒ_ƒj‘Ì“à‚É‚š‚¯‚éBabesia ovataˆÚs“®‘Ԃɂ‚¢‚Ä. ‘O“c‘å‹P, ”ª“cŠxŽm1, ’ؐì‘åŒå1, ŽOã–[Žq, Œ—с@œ, ŽOD–Ґ°, ”’“¡—œ‰Â, ‘å‹v•Û˜a—m, ŒÜ\—’ˆè’j, –]ŒŽ‰ë”ü, “¡èK‘ , ’ҁ@®—˜1, “c’‡“N–ç (1Šñ¶’Ž): ‘æ85‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (2016/3/20), ‹{è.

723055. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒxƒlƒYƒGƒ‰•³ü’Ž‚ª—L‚·‚郍ƒ“ƒMƒXƒ^ƒ`ƒ“—l•ªŽq‚̐«ó. ’ؐì‘åŒå1, ”ª“cŠxŽm1, ‘O“c‘å‹P, ŽOã–[Žq, ‹e’n‘א¶, ŠÛŽRŽ¡•F, ’ҁ@®—˜1 (1Šñ¶’Ž): ‘æ85‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (2016/3/20), ‹{è.

731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒ}ƒ_ƒj‚Ì‹zŒŒ‚Æ•aŒŽ‘Ì“`”dƒƒJƒjƒYƒ€. ’ҁ@®—˜ (Šñ¶’Ž): Z—F‰»ŠwŠ”Ž®‰ïŽÐ@Œ’NE”_‹ÆŠÖ˜AŽ–‹ÆŒ€‹†ŠƒZƒ~ƒi[ (2015/7/20), •ó’Ë.

732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”M‘ÑŠŽõÇ‚ƃƒNƒ`ƒ“ ƒ}ƒ_ƒj‚̐¶‘Ô: ‹zŒŒ‚ÆŠŽõÇ”}‰î‚ÌŽd‘g‚Ý. ’ҁ@®—˜ (Šñ¶’Ž): —®‹…‘åŠw”M‘ѐ¶•šŒ—Œ€‹†ƒZƒ“ƒ^[Žs–¯ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€ (2015/8/30), “ß”e.

732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒ}ƒ_ƒj‚̐¶‘Ô: ‹zŒŒ‚Æ•aŒŽ‘Ì“`”d‚ÌŽd‘g‚Ý. ’ҁ@®—˜ (Šñ¶’Ž): ‘æ41‰ñ–k—¢ˆãŠw‰ï‘‰ï (2015/12/12), ‘Š–ÍŒŽ.

733016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒ“ƒ\ƒ“ŒÇ’Ž23KDaƒvƒƒeƒA[ƒ[‚̍y‘f‰»Šw“I«Ž¿‚ɂ‚¢‚Ä. ’ؐì‘åŒå1, ”ª“cŠxŽm1, ŽOã–[Žq, ’†‘º@Œ’, ’ҁ@®—˜1 (1Šñ¶’Ž): ‘æ9‰ñ埒ŽŒ€‹†‰ï (2015/7/18), ŠâŽè.

733017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒ“ƒ\ƒ“ŒÇ’ŽƒVƒXƒeƒCƒ“ƒvƒƒeƒA[ƒ[‚̏hŽå‘gDN“ü‚Ö‚ÌŠÖ—^. ’ؐì‘åŒå1, ”ª“cŠxŽm1, ŽOã–[Žq, ’†‘º@Œ’, ’ҁ@®—˜1 (1Šñ¶’Ž): ‘æ28‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€E‘æ18‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[Œ€‹†W‰ï (2015/8/6), ‘Š–ÍŒŽ

733018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒ“ƒ\ƒ“ŒÇ’ŽƒVƒXƒeƒCƒ“ƒvƒƒeƒA[ƒ[‚ªŽ‚hŽå‘gDN“ü‚ւ̈Ӌ`‚ɂ‚¢‚Ä. ’ؐì‘åŒå1, ”ª“cŠxŽm1, ŽOã–[Žq, ’†‘º@Œ’, ’ҁ@®—˜1 (1Šñ¶’Ž): ‘æ75‰ñ“ú–{Šñ¶’ŽŠw‰ï“Œ“ú–{Žx•”‰ï (2015/9/26), “Œ‹ž.


•a—Šw (‘º‰_’PˆÊ)

[Šwp˜_•¶]

110039. [ŒŽ’˜] L-type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling. Ichinoe M1, Yanagisawa N1, Mikami T, Hana K, Nakada N1, Endou H, Okayasu I, Murakumo Y1: Pathol Res Pract 2015/7; 211 (7): 533-8. (ˆêŒË¹–Ÿ1, –öàVM”V1, ’‡“c“TL1, ‘º‰_–FŽ÷1: 1•a—)

110040. [ŒŽ’˜] High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab. Okina S1, Yanagisawa N2, Yokoyama M1, Sakurai Y1, Numata Y3, Umezawa A3, Higashihara M4, Murakumo Y2: Int J Hematol 2015/12; 102 (6): 662-9. (‰¥@‘cœ1, –öàVM”V2, ‰¡ŽR^Šì1, ŸNˆä–õ‚1, À“c‰êŽq3, ”~‘ò“ÖŽq3, “ŒŒŽ³–Ÿ4, ‘º‰_–FŽ÷2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn, 4ŒŒ‰t“à)

110041. [ŒŽ’˜] L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management. Yanagisawa N1, Satoh T2, Hana K, Ichinoe M1, Nakada N1, Endou H, Okayasu I, Murakumo Y1: Cancer Biomark 2015; 15 (4): 365-74. (–öàVM”V1, ²“¡ˆÐ•¶2, ˆêŒË¹–Ÿ1, ’‡“c“TL1, ‘º‰_–FŽ÷1: 1•a—, 2”å”AŠí)

110042. [ŒŽ’˜] CD109 is a component of exosome secreted from cultured cells. Sakakura H, Mii S, Hagiwara S, Kato T, Yamamoto N, Hibi H, Takahashi M, Murakumo Y1: Biochem Biophys Res Commun 2016/1; 469 (4): 816-22. (‘º‰_–FŽ÷1: 1•a—)

[Šw‰ïEŒ€‹†‰ï“™]

713007. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) EXPRESSION OF CANCER-TYPE AMINO-ACID TRANSPORTER LAT1 IS A PROGNOSIS PREDICTION FACTOR IN BREAST CARCINOMA: COMPARISON BETWEEN TRIPLE NEGATIVE AND NON-TRIPLE-NEGATIVE TYPES. Ichinoe M1, Mikami T, Hana K, Yanagisawa N1, Endou H, Okayasu I, Murakumo Y1: AACR Annual Meeting 2015 (2015/4/22), Philadelphia, USA. (ˆêŒË¹–Ÿ1, –öàVM”V1, ‘º‰_–FŽ÷1: 1•a—)

723056. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹‘Bã”琫Žîᇂɂš‚¯‚é’áŽ_‘f‰ž“šŠÖ˜Aƒ^ƒ“ƒpƒN‚Ì”­Œ»‚ÌŒŸ“¢. ’‡“c“TL1, À“c‰êŽq2, ”~‘ò“ÖŽq2, ŸNˆä–õ‚1, ˆêŒË¹–Ÿ1, –öàVM”V1, Ó@¢ˆ®1, ‘º‰_–FŽ÷1 (1•a—, 2Œ`‘ÔŒn): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/4/30), –ŒŒÃ‰®.

723057. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x‘BŠà‚É‚š‚¯‚éDJ-1‚Ì”­Œ»‚Ɛf’fƒ}[ƒJ[‚Æ‚µ‚Ẳ”\«. “y‰®g, Ó@¢ˆ®1, ’·‰–@—º, ‘º‰_–FŽ÷1, ŽOŽ}@M1, ²“¡—Yˆê (1•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/4/30), –ŒŒÃ‰®.

723058. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ñ‚Ü‚ñ«‘å×–E«B×–EƒŠƒ“ƒpŽî‚É‚š‚¯‚éDNAC•œƒ^ƒ“ƒpƒNREV7”­Œ». ‰¥@‘cœ1, –öàVM”V2, ‰¡ŽR^Šì1, À“c‰êŽq3, ”~‘ò“ÖŽq3, ‘º‰_–FŽ÷2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/4/30), –ŒŒÃ‰®.

723059. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‡ŠOü‚É—U”­‚³‚ê‚é“Ë‘R•ÏˆÙ‚É‚š‚¢‚ÄDNAƒ|ƒŠƒƒ‰[ƒ[EƒC[ƒ^‚ƃCƒIƒ^‚ª”畆×–E‚Æ‘gD‚ʼnʂœ‚·–ðŠ„. ŸNˆä–õ‚1, ‰¡ˆä‰ëK, ’Ë–{“OÆ, ˜kŸº‰p‹@ (1•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/4/30), –ŒŒÃ‰®.

723060. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Microdissection‚ÉŠî‚¢‚œDNAƒ}ƒCƒNƒƒAƒŒƒC‚É‚æ‚é”x‘BŠà”÷¬“û“ª¬•ªˆâ“`Žq”­Œ»‚̉ðÍ. Ó@¢ˆ®1, ’†“‡—TN2, ”~‘ò“ÖŽq3, ’·‰–@—º4, ²“¡—Yˆê4, ˆêŒË¹–Ÿ1, ‘ì˜ad5, ²“¡”Vr2, ‘º‰_–FŽ÷1 (1•a—, 2ŒÄ‹zŠíŠO, 3Œ`‘ÔŒn, 4ˆã—Éq¶Šw•”, 5•úŽËü (Žîá‡)): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/4/30), –ŒŒÃ‰®, “ú–{•a—Šw‰ï‰ïŽ 2015/3; 104 (1): 336.

723061. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) LAT1‚Ì”­Œ»‚Í“ûŠà‚Ì—\ŒãŠÖ˜AˆöŽq‚Å‚ ‚é: triple negative“ûŠà‚Ænon-triple negative“ûŠà‚Ì”äŠr. ˆêŒË¹–Ÿ1, ŽOã“N•v, –öàVM”V1, ‰ÔŽ÷‘ã”ü, ‰““¡Š°Žq, ‰““¡@m, ‰ªˆÀ@ŒM (1•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723062. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) LAT1‚Ì”­Œ»‚Í“ûŠà‚Ì—\ŒãŠÖ˜AˆöŽq‚Å‚ ‚é. ˆêŒË¹–Ÿ1, ŽOã“N•v, –öàVM”V1, ‰ÔŽ÷‘ã”ü, ’‡“c“TL1, •ûGº, ‰““¡@m, ‰ªˆÀ@ŒM, ‘º‰_–FŽ÷1 (1•a—): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8), –ŒŒÃ‰®.

723063. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) REV7‚Ì—}§‚͐ž‘ƒãó×–EŽîᇂ̃VƒXƒvƒ‰ƒ`ƒ“ŠŽŽó«‚𑝋­‚·‚é. ŸNˆä–õ‚1, ‚‹Ž‰ë‰p, ‘º‰_–FŽ÷1 (1•a—): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8), –ŒŒÃ‰®.

723064. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ñ‚Ü‚ñ«‘å×–E«B×–EƒŠƒ“ƒpŽî‚É‚š‚¯‚éDNAC•œƒ^ƒ“ƒpƒNREV7”­Œ»‚Æ—\Œã‰ðÍ. ‰¥@‘cœ1, –öàVM”V2, ‰¡ŽR^Šì1, ’‡“c“TL2, ”~‘ò“ÖŽq3, À“c‰êŽq3, ˆêŒË¹–Ÿ2, Ó@¢ˆ®2, ‘º‰_–FŽ÷2, “ŒŒŽ³–Ÿ4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn, 4ŒŒ‰t“à): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8), –ŒŒÃ‰®.

723065. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹‘Bã”琫Žîᇂɂš‚¯‚é’áŽ_‘f‰ž“šŠÖ˜Aƒ^ƒ“ƒpƒN‚Ì”­Œ»‚ÌŒŸ“¢. ’‡“c“TL1, À“c‰êŽq2, ”~‘ò“ÖŽq2, ŸNˆä–õ‚1, ˆêŒË¹–Ÿ1, –öàVM”V1, Ó@¢ˆ®1, ‘º‰_–FŽ÷1 (1•a—, 2Œ`‘ÔŒn): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8), –ŒŒÃ‰®.

723066. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) L-type amino-acid transporter 1 (LAT1) is prognosis related factor in breast carcinoma: Comparison triple negative breast carcinoma with non-triple-negative breast carcinoma. ˆêŒË¹–Ÿ1, ŽOã“N•v, –öàVM”V1, ‰ÔŽ÷‘ã”ü, ‰““¡Š°Žq, ‰““¡@m, ‰ªˆÀ@ŒM, ‘º‰_–FŽ÷1 (1•a—): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8-10), –ŒŒÃ‰®.

733019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) cŠuŽîᇂÌ1—á. ’‡“c“TL1, ‚‹Ž”Ž”V1, ‘å•”@œ2, ‘º‰_–FŽ÷1 (1•a—, 2ˆã—Éq¶Šw•”): _“ސì•a—ˆã‰ï (2016/1/9), ‰¡•l.


•a—Šw (ŽOŽ}’PˆÊ)

[Šwp˜_•¶]

110043. [ŒŽ’˜] FilGAP, a Rac-specific Rho GTPase-activating protein, is a novel prognostic factor for follicular lymphoma. Nishi T, Takahashi H1, Hashimura M2, Yoshida T1, Ohta Y, Saegusa M1: Cancer Med 2015/6; 4 (6): 808-18. (Œ@’B–ç, ‚‹Ž”Ž”V1, ‹Ž‘º”ü‹I2, ‹g“c@Œ÷1, ŽOŽ}@M1: 1•a—, 2Œ`‘ÔŒn)

110044. [ŒŽ’˜] Transcriptional upregulation of HNF-1ƒÀ by NF-ƒÈB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression. Suzuki E1, Kajita S1, Takahashi H1, Matsumoto T1, Tsuruta T1, Saegusa M1: Lab Invest 2015/8; 95 (8): 962-72. (—é–؃GƒŠ“Þ1, Š“cç”ü”T1, ‚‹Ž”Ž”V1, Œ–{r‰p1, ’ß“c’qŽq1, ŽOŽ}@M1: 1•a—)

110045. [ŒŽ’˜] Distinct ƒÀ-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas. Matsumoto T1, Yamazaki M2, Takahashi H1, Kajita S1, Suzuki E1, Tsuruta T1, Saegusa M1: Am J Clin Pathol 2015/9; 144 (3): 452-63. (Œ–{r‰p1, ŽRè^‰l2, ‚‹Ž”Ž”V1, Š“cç”ü”T1, —é–؃GƒŠ“Þ1, ’ß“c’qŽq1, ŽOŽ}@M1: 1•a—, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110046. [ŒŽ’˜] Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1ƒ¿/Akt axis in glioblastoma. Inukai M1, Hara A2, Yasui Y3, Kumabe T4, Matsumoto T2, Saegusa M2: Hum Pathol 2015/10; 46 (10): 1496-505. (Œ¢Ž”@‰~1, ŒŽ@“ÖŽq2, ˆÀˆä”ü]3, ŒG•”rG4, Œ–{r‰p2, ŽOŽ}@M2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn, 4”]ŠO)

110047. [ŒŽ’˜] Dual functions of Rap1 are crucial for T-cell homeostasis and prevention of spontaneous colitis. Ishihara S, Nishikimi A, Umemoto E, Miyasaka M, Saegusa M1, Katagiri K: Nat Commun 2015/12; 6: 8982. (ŽOŽ}@M1: 1•a—)

110048. [ŒŽ’˜] Spontaneous brain tumor imaging of aged rat by crystal X-ray interferometer-based phase-contrast X-ray CT. Lwin TT, Yoneyama A, Hara A1, Ohbu M2, Maruyama H, Taguchi M, Esashi S, Matsushima T, Terazaki K, Hyodo K, Takeda T: Acta Radiol Open 2016/2; 5 (2): 2058460115626958. (ŒŽ@“ÖŽq1, ‘å•”@œ2: 1•a—, 2ˆã—Éq¶Šw•”)

110049. [ŒŽ’˜] Cooperation of Sox4 with ƒÀ-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma. Inoue H1, Takahashi H2, Hashimura M3, Eshima K4, Akiya M1, Matsumoto T2, Saegusa M2: BMC Cancer 2016/2; 16: 53. (ˆäã‹vŽq1, ‚‹Ž”Ž”V2, ‹Ž‘º”ü‹I3, ]“‡k“ñ4, H’J¹Žj1, Œ–{r‰p2, ŽOŽ}@M2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn, 4–Ɖu)

[Šw‰ïEŒ€‹†‰ï“™]

723067. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ALK—z«—‘‘ƒEŽq‹{ŒŽ”­Šà“÷Žî‚ÍŸ÷‰t«‘BŠà‚̐¬•ª‚ð—L‚·‚é. ŽOŽ}@M (•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723068. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _ŒoäPŽî‚É‚š‚¯‚éALKˆâ“`Žq”­Œ»‚ÍŽîᇌ`‘Ô‚ÆŒŒŠÇƒjƒbƒ`‚ÉŠÖŒW‚·‚é. ŽOŽ}@M (•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723069. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Lefty‚͐³íŽq‹{“à–Œ‚š‚æ‚Ñ—Þ“à–Œ‘BŠà‚Ì‘BE•ª‰»‚𐧌䂷‚é. ŽOŽ}@M (•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723070. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Lefty‚Í—‘‘ƒ–Ÿ×–EŠà‚̐V‹KƒoƒCƒIƒ}[ƒJ[‚Å‚ ‚é. ŽOŽ}@M (•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723071. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰ŠƒoƒCƒIƒ}[ƒJ[olfactomedin 4‚Ì‹@”\“¯’è‚Æ‚»‚̈Ӌ`. ‘åŒF‘ñ–ç, ‹g“c@Œ÷1, ‹ŽŒû@Žû, ‰¡“c@Í, ‰ªˆÀ@ŒM, ŽOŽ}@M1 (1•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723072. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š‚É‚š‚¯‚éƒoƒCƒIƒ}[ƒJ[olfactomedin 4‚Ì”­Œ»‹@˜. ‹ŽŒû@Žû, ‹g“c@Œ÷1, ‘åŒF‘ñ–ç, ‰¡“c@Í, ‰ªˆÀ@ŒM, ŽOŽ}@M1 (1•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723073. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ŠÇƒoƒCƒIƒ}[ƒJ[olfactomedin 4‚Ì”­Œ»‚©‚ç‚Ý‚œ‰ŠÇ«’°ŽŸŠ³‚Ì•aˆö•a‘Ô. ‹g“c@Œ÷ (•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723074. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) FilGAP/RacƒVƒOƒiƒ‹Œn‚ð‰î‚·‚é×–E‰^“®§Œä‚©‚猩‚œastrocytoma—V‘–EZ‹@\‚ÌŒŸ“¢. ŒŽ@“ÖŽq1, ŽOŽ}@M1 (1•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723075. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) AktŒn‚ÍäP‰èŽî‚Ì’áŽ_‘fƒjƒbƒ`ŠÂ‹«‚Ì‚ª‚ñŠ²×–E‰»ˆÛŽ‹@\‚Å‚ ‚é. ŒŽ@“ÖŽq1, Œ¢Ž”@‰~2, ŽOŽ}@M1 (1•a—, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723076. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) isŠú’Œ’°Šà‚̃À-ƒJƒeƒjƒ“/EMT—U“±ŠàŠ²×–E‰»‚É‚æ‚鉻ŠwE•úŽËü—Ö@‚̑ϐ«‹@\‚̉ðÍ. ‚‹Ž”Ž”V1, ’†‘º‹MŒb, ’ß“c’qŽq, ŽOŽ}@M1 (1•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723077. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒÀ-catenin‚š‚æ‚ÑPIK3CAˆâ“`Žq•ÏˆÙ‚ÉŠî‚­Žq‹{“à–ŒÇ«—‘‘ƒ”­Šà‚̉ðÍ. Œ–{r‰p1, ŽRè^‰l, ‚‹Ž”Ž”V1, Š“cç”ü”T1, —é–؃GƒŠ“Þ1, ’ß“c’qŽq, ŽOŽ}@M1 (1•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/2), –ŒŒÃ‰®.

733020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒÀ-catenin‚š‚æ‚ÑPIK3CAˆâ“`Žq•ÏˆÙ‚ÉŠî‚­Žq‹{“à–ŒÇ«—‘‘ƒ”­Šà‚̉ðÍ. Œ–{r‰p1, ŽRè^‰l, ‚‹Ž”Ž”V1, Š“cç”ü”T1, —é–؃GƒŠ“Þ1, ’ß“c’qŽq, ŽOŽ}@M1 (1•a—): ‘æ28‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€E‘æ18‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[Œ€‹†W‰ï (2015/8/6), ‘Š–ÍŒŽ.


‰q¶Šw

[Šwp˜_•¶]

110050. [ŒŽ’˜] The immunotoxic effects of fluoride on mice after subacute administration by evaluating cytokine mRNA expression in splenocytes. Hosokawa M, Tsunoda M1, Liu Y, Nakano K, Itai K, Tsunoda H, Yokoyama K, Aizawa Y1: Fluoride 2015/12; 48 (4): 329-37. (Šp“c³Žj1, ‘ŠàVDŽ¡1: 1‰q¶)

110051. [ŒŽ’˜] Fluoride supplementation in pregnant women for preventing dental caries in the primary teeth of their children. Takahashi R, Ota E, Hoshi K1, Naito T, Toyoshima Y, Yuasa H, Mori R: Cochrane Database of Systematic Reviews 2015/8; Published Online. DOI: 10.1002/14651858.CD011850. (¯@‰À–F1: 1‰q¶)

110052. [ŒŽ’˜] The Diagnosis of Sick House Syndrome: the Contribution of Diagnostic Criteria and Determination of Chemicals in an Indoor Environment. Miyajima E1, Tsunoda M1, Sugiura Y2, Hoshi K1, Kido T, Sakamoto Y3, Sakabe K, Aizawa Y1: Tokai J Exp Clin Med 2015/5; 40 (2): 69-75. (‹{“‡]—¢Žq1, Šp“c³Žj1, ™‰Y—R”üŽq2, ¯@‰À–F1, â–{‘×—3, ‘ŠàVDŽ¡1: 1‰q¶, 2—\–hˆãŠwŒn, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

520003. [‘à] ˆã—ÃŽ{Ý“à‚̐ݔõ‚â‹@Ší‚ðŠŽõŒ¹‚Æ‚·‚é‰@“àŠŽõ. –xŒû•º„ (‰q¶): –k—¢ˆãŠw 2015/12; 45 (2): 87-94.

530001. [‚»‚Ì‘Œ (ƒRƒƒ“ƒg)]yComment on: Biomonitoring of mercury, cadmium, and lead exposure in Japanese children: a cross-sectional study. [Environ Health Prev Med 2015]zBiomonitoring of metal exposure in children in a northern city of Japan. Horiguchi H1: Environ Health Prev Med 2015/7; 20 (4): 314-5. (–xŒû•º„1: 1‰q¶)

530002. [‚»‚Ì‘Œ (ƒRƒƒ“ƒg)]yComment on: Biomonitoring of metal exposure in children in a northern city of Japan. [Environ Health Prev Med 2015]zThe fundamentals of epidemiology and ethics in science. Horiguchi H1: Environ Health Prev Med 2016/1; 21 (1): 53. (–xŒû•º„1: 1‰q¶)

540003. [‚»‚Ì‘Œ (•¶Œ£Ð‰î)] Žó“®‹i‰Œ‚̐ž_“I‰e‹¿. ‹{“‡]—¢Žq1, Šp“c³Žj1, ‘ŠàVDŽ¡1 (1‰q¶): ŽY‹ÆˆãŠwƒWƒƒ[ƒiƒ‹ 2015/11; 38 (6): 93-7.

[’˜@‘]

620007. [Šwp‘] (•ª’SŽ·•M) y¬Ž™ŽŸŠ³f—Â̂œ‚ß‚Ì•a‘Ԑ¶—2 ‰ü’ù5”Å (¬Ž™“à‰È2015”N47Šª‘Š§†)zIX. ’†“Ł@6. d‹à‘® (‰”, …‹â, ƒq‘f), p.959-63. Šp“c³Žj (‰q¶), ‹€•Ò:w¬Ž™“à‰Èxw¬Ž™ŠO‰Èx•ÒWˆÏˆõ‰ï, “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2015/11”­s.

620008. [Šwp‘ (•ª’SŽ·•M)]y‰ü’ù Œš’z•š‚̊‹«‰q¶ŠÇ— (ãŠª) ‘æ3”Łz‘æ4Í Œš’z•š‚̊‹«‰q¶@4.3 Žº“à‹ó‹C‚̐«ó‚ÆŒ’N, p.280-96. Šp“c³Žj (‰q¶), (Œö) “ú–{Œš’z‰q¶ŠÇ—‹³ˆçƒZƒ“ƒ^[, “Œ‹ž, 2015/12”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713008. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The evaluation on the safety of self-assembling peptide gel after the intracranial administration to rats by using an open field test. Tsunoda M1, Sugaya C, Sugiura Y2, Nagai Y, Sakanishi K: Society of Toxicology, 55th Annual Meeting (2016/3/15), New Orleans, Louisiana, USA. (Šp“c³Žj1, ™‰Y—R”üŽq2: 1‰q¶, 2—\–hˆãŠwŒn)

723078. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) »‘¢‹Æ‚É‚š‚¯‚é‰õ“KEê‚­‚è‚Ì‚œ‚ß‚ÌŽó“®‹i‰Œ–hŽ~‘΍ô‚ÉŠÖ‚·‚éˆÓŽ¯’²ž. ‹{“‡]—¢Žq1, Šp“c³Žj1, ™‰Y—R”üŽq2, ›’J‚¿‚Š”ü (1‰q¶, 2—\–hˆãŠwŒn): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/16), ‘åã.

723079. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒgƒŠƒuƒ`ƒ‹ƒXƒY‚ÉŒo‘ٔՁEŒo•ê“û‹y‚Ñ—£“ûŒãŒoŒû”˜˜I‚³‚ê‚œƒƒX‚ÌTokai High Avoiderƒ‰ƒbƒg‚̃I[ƒvƒ“ƒtƒB[ƒ‹ƒhŽŽŒ±. Šp“c³Žj1, ™‰Y—R”üŽq2, ‹{“‡]—¢Žq1, –،ˑž›’, ×ì‚Ü‚äŽq, –xŒû•º„1, ‰““¡@®, “n•Ó@“N (1‰q¶, 2—\–hˆãŠwŒn): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/16), ‘åã.

723080. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“cŒ§“à‚̈ã—Ë@ŠÖ‚É‚š‚¯‚ét‹@”\’ቺŠ³ŽÒ‚ɑ΂·‚éƒJƒhƒ~ƒEƒ€tÇƒXƒNƒŠ[ƒjƒ“ƒO‚ÌŽŽ‚Ý. àV‘º¹l, –xŒû•º„1, ¬ŒF‰xŽq, ŒìŠx‹v, ç—t•SŽq, ‘º“cŸŒh, ‰¡ŽR˜am, ’†‘º³–Ÿ, —OˆäGŽ÷, ¬Œ“c“Ö (1‰q¶): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5), –ŒŒÃ‰®.

723081. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆê”ʏW’c‚É‚š‚¯‚鉻Šw•šŽ¿‰ß•qÇ‚̉”\«‚Æ‹i‰Œ”˜˜I‚ðŠÜ‚ß‚œ‰»Šw•šŽ¿”˜˜I—ð‚ÉŠÖ‚·‚錀‹†. ‹{“‡]—¢Žq1, Šp“c³Žj1, ™‰Y—R”üŽq2, â–{‘×—3, –xŒû•º„1, â•”@v (1‰q¶, 2—\–hˆãŠwŒn, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ24‰ñ“ú–{—Տ°ŠÂ‹«ˆãŠw‰ïŠwpW‰ï (2015/6/6), “Œ‹ž.

723082. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰–‰»ƒgƒŠƒuƒ`ƒ‹ƒXƒY‚É‘ÙŽ™Šú`”­’BŠú”˜˜I‚³‚ê‚œƒƒX‚ÌTokai High Avoiderƒ‰ƒbƒg‚É‚š‚¯‚é‹L‰¯ŠwK”\—Í‚Ì—}§: ƒVƒhƒ}ƒ““dŒ‚‰ñ”ðŽŽŒ±‚É‚æ‚錟“¢. Šp“c³Žj1, ’·’Jì‘ì–í, ›’J‚¿‚Š”ü, ™‰Y—R”üŽq2, –xŒû•º„1, –،ˑž›’, –öàV—T”V, ‰““¡@®, “n•Ó@“N (1‰q¶, 2—\–hˆãŠwŒn): ‘æ26‰ñ“ú–{”÷—ÊŒ³‘fŠw‰ïŠwpW‰ï (2015/7/5), –kŠC“¹.

723083. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŽˆö•Ê•ª—Þ‚ðŠˆ—p‚µ‚œ®Œ`ŠO‰ÈƒNƒŠƒjƒbƒN‚É‚š‚¯‚郊ƒXƒNƒ}ƒlƒWƒƒ“ƒg‚Ö‚ÌŽæ‚è‘g‚Ý. “n粉Öç, “à“c‘U”Ž1, ¯@‰À–F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2‰q¶): ‘æ74‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2015/11/5), ’·è, ‘æ74‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ïŽ˜^W 2015/10; p.486.

723084. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Œ‹ž‚̏­”N–ì‹…/ƒTƒbƒJ[ƒ`[ƒ€Žw“±ŽÒ‚É‚š‚¯‚é‹Ö‰Œ‚ÉŠÖ‚·‚éƒz[ƒ€ƒy[ƒWî•ñ‚Ì’²ž. ¯@‰À–F1, “à“c‘U”Ž2, Šp“c³Žj1, â–{‘×—2, –xŒû•º„1 (1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ74‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2015/11/6), ’·è, ‘æ74‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ïŽ˜^W 2015/10; p.228.

723085. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘S‘‚̏—Žq’†‚¶–ì‹…ƒ`[ƒ€Žw“±ŽÒ‚É‚š‚¯‚é‹Ö‰Œ‚ÉŠÖ‚·‚éƒz[ƒ€ƒy[ƒWî•ñ‚Ì’²ž. ¯@‰À–F1, “à“c‘U”Ž2, Šp“c³Žj1, â–{‘×—2, –xŒû•º„1 (1‰q¶, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ26‰ñ“ú–{‰uŠw‰ïŠwp‘‰ï (2016/1/23), •ÄŽq, Journal of Epidemiology 2016/1; 26 (Suppl 1): 137.

732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Ž{ô‚ւ̃KƒCƒhƒ‰ƒCƒ“Šˆ—p. ¯@‰À–F (‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬27”N“x’ZŠúŒ€Cu’nˆæ•ÛŒ’Žx‰‡‚Ì‚œ‚ß‚Ì•ÛŒ’î•ñˆ—‹ZpŒ€Cvu‹` (2015/12/3), ˜aŒõ.

732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒAƒ“ƒP[ƒg’²ž‰‰K. ˆÀ“¡—Yˆê, ¯@‰À–F1 (1‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬27”N“x’ZŠúŒ€Cu’nˆæ•ÛŒ’Žx‰‡‚Ì‚œ‚ß‚Ì•ÛŒ’î•ñˆ—‹ZpŒ€Cvu‹` (2015/12/9), ˜aŒõ.

733021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒhƒ~ƒEƒ€”˜˜I‚ðŽó‚¯‚œH“cŒ§‚Ì”_‹Æ]Ž–ŽÒ‚ɑ΂·‚é•ÛŒ’‘΍ô. –xŒû•º„1, ¬ŒF‰xŽq, ‘º“cŸŒh, ²X–Ø•q, ‹{–{‰À‘ãŽq, ¬Œ“c“Ö, àV‘º¹l, àV“cŒ«ˆê, —OˆäGŽ÷, ŒFàV—R”üŽq, ‘å–ì’qŽq, ’·“ˆ’qŽq, ‚ŽR—TŽq, Œ“c—¥Žq, –L“ˆ—Ú”üŽq, —é–ØŒiŽq, ŒìŠx‹v, ç—t•SŽq, ‰¡ŽR˜am, ²X–Ø‹œ, ‘å–{’ŒŽ÷, rì@–Ÿ, “¡“cG•¶, ¬–ì’nÍˆê, ‚‹Žr–Ÿ, ²X–ØŽi˜Y, •œŽR@Ž, ’†‘º³–Ÿ (1‰q¶): ‘æ74‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï“Œ–k’n•û‰ï (2015/7/25), H“c.


ŒöO‰q¶Šw

[Šwp˜_•¶]

110053. [ŒŽ’˜] Epigenetic Changes Caused by Occupational Stress in Humans Revealed through Noninvasive Assessment of DNA Methylation of the Tyrosine Hydroxylase Gene. Miyaki K1, Suzuki T1, Song Y, Tsutsumi A1, Kawakami N, Shimazu A, Takahashi M, Inoue A, Kurioka S, Shimbo T: J Neurol Neurol Disord 2015/6; 2 (2): doi: 10.15744/2454-4981.2.201. (‹{–؍Kˆê1, —é–Ø’mŽq1, ’ç@–Ÿƒ1: 1ŒöO‰q¶)

110054. [ŒŽ’˜] Relationship between sickness presenteeism (WHO-HPQ) with depression and sickness absence due to mental disease in a cohort of Japanese workers. Suzuki T1, Miyaki K1, Song Y, Tsutsumi A1, Kawakami N, Shimazu A, Takahashi M, Inoue A, Kurioka S: J Affect Disord 2015/7; 180: 14-20. (—é–Ø’mŽq1, ‹{–؍Kˆê1, ’ç@–Ÿƒ1: 1ŒöO‰q¶)

110055. [ŒŽ’˜] DNA Methylation Status of the Methylenetetrahydrofolate Reductase Gene is associated with Depressive Symptoms in Japanese Workers: A Cross-Sectional Study. Miyaki K1, Song Y, Suzuki T1, Eguchi H1, Kawakami N, Takahashi M, Shimazu A, Inoue A, Kurioka S, Kan C, Tsutsumi A1: J Neurol Neurol Disord 2015/9; 2 (3): doi: 10.15744/2454-4981.2.304. (‹{–؍Kˆê1, —é–Ø’mŽq1, ]Œû@®1, ’ç@–Ÿƒ1: 1ŒöO‰q¶)

110056. [ŒŽ’˜] Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism. Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, Katabami T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T1, Tsuiki M, Shimatsu A, Naruse M: Clin Endocrinol (Oxf) 2015/10; 83 (4): 462-7. (—é–Ø’mŽq1: 1ŒöO‰q¶)

110057. [ŒŽ’˜] Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism. Umakoshi H1, Wada N1, Ichijo T1, Kamemura K1, Matsuda Y1, Fuji Y1, Kai T1, Fukuoka T1, Sakamoto R1, Ogo A1, Suzuki T1,2, Tsuiki M1, Naruse M1 (1WAVES-J Study Group): Clin Endocrinol (Oxf) 2015/12; 83 (6): 768-73. (—é–Ø’mŽq1,2: 2ŒöO‰q¶)

110058. [ŒŽ’˜] Shortened saline infusion test for subtype prediction in primary aldosteronism. Nanba K, Tsuiki M, Umakoshi H, Nanba A, Hirokawa Y, Usui T, Tagami T, Shimatsu A, Suzuki T1, Tanabe A, Naruse M: Endocrine 2015/12; 50 (3): 802-6. (—é–Ø’mŽq1: 1ŒöO‰q¶)

110059. [ŒŽ’˜] Occupational differences in suicide mortality among Japanese men of working age. Wada K, Eguchi H1, Prieto-Merino D, Smith DR: J Affect Disord. 2016/1; 190: 316-21. (]Œû@®1: 1ŒöO‰q¶)

110060. [ŒŽ’˜] Null association between workplace social capital and body mass index. Results from a four-wave panel survey among employees in Japan (J-HOPE study). Tsuboya T, Tsutsumi A1, Kawachi I: Soc Sci Med 2016/2; 150: 1-7. (’ç@–Ÿƒ1: 1ŒöO‰q¶)

110061. [ŒŽ’˜] Work Engagement as a Predictor of Onset of Major Depressive Episode (MDE) among Workers, Independent of Psychological Distress: A 3-Year Prospective Cohort Study. Imamura K, Kawakami N, Inoue A, Shimazu A, Tsutsumi A1, Takahashi M, Totsuzaki T: PLoS One 2016/2; 11 (2): e0148157. (’ç@–Ÿƒ1: 1ŒöO‰q¶)

110062. [ŒŽ’˜] Modification Effects of Changes in Job Demands on Associations Between Changes in Testosterone Levels and Andropause Symptoms: 2-Year Follow-up Study in Male Middle-Aged Japanese Workers. Hirokawa K, Taniguchi T, Fujii Y, Takaki J, Tsutsumi A1: Int J Behav Med 2016/8; 23 (4): 464-72. (’ç@–Ÿƒ1: 1ŒöO‰q¶)

120003. [ŒŽ’˜] ˜J“­ŽÒ‚ÌŽû“ü‚ƃƒ“ƒ^ƒ‹ƒwƒ‹ƒX|E‚Ì•sˆÀ’萫‚É‚æ‚é”}‰îŒø‰Ê‚É’–Ú‚µ‚ā|. ’ç@–Ÿƒ1, ˆäã²b, “‡’ÖŸl, ‚‹Ž³–ç, ìãŒ›l, ŒI‰ªZŽq, ]Œû@®1, ‹{–؍Kˆê1, ‰““c˜a•F, ¬™—R‹N, ŒË’Íè‹M•¶ (1ŒöO‰q¶): Œú¶‚ÌŽw•W 2015/9; 62 (11): 1-8.

120004. [ŒŽ’˜] –«t‘Ÿ•a‚ð“Á’è‚·‚éÛ‚Ì”AŒŸž‚̑Ó–«: “ú–{l’j«˜J“­ŽÒ‚É‚š‚¯‚é”N‘ã•ÊŒŸ“¢. ì“‡³•q, ]Œû@®1, ˜a“ckŽ¡, Žç‰®—˜‰À2, ‰““c˜a•F, ’ç@–Ÿƒ1 (1ŒöO‰q¶, 2ˆãŠw‹³ˆç): Œð’ʈãŠw 2015/6; 69 (3/4): 81-7.

120005. [ŒŽ’˜] —«˜J“­ŽÒ‚̃XƒgƒŒƒX‘΍ô: ˆêŽŸ—\–h‚©‚çŽOŽŸ—\–h‚Ü‚Å. ’ç@–Ÿƒ1, —é–Ø’mŽq1 (1ŒöO‰q¶): ŽY‹ÆƒXƒgƒŒƒXŒ€‹† 2015; 22 (3): 197-202.

510002. [‘à] A behavioral science/behavioral medicine core curriculum proposal for Japanese undergraduate medical education. Tsutsumi A1: Biopsychosoc Med 2015/11; 9: 24. (’ç@–Ÿƒ1: 1ŒöO‰q¶)

520004. [‘à] ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚ƃXƒgƒŒƒXƒ`ƒFƒbƒN§“x. ’ç@–Ÿƒ (ŒöO‰q¶): —\–hˆãŠw 2015/12; 57: 15-8.

522017. [uÀ]y“ÁW: ’nˆæ‚Őf‚邱‚±‚ë‚̃PƒAzEê‚̃ƒ“ƒ^ƒ‹ƒwƒ‹ƒXƒPƒA. ’ç@–Ÿƒ (ŒöO‰q¶): ŒŽŠ§’nˆæˆãŠw 2015/8; 29 (8): 603-7.

522018. [uÀ]y“ÁW: EêŠÂ‹«‰ü‘P‚ƃ|ƒWƒeƒBƒuEƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXzEêŠÂ‹«‰ü‘P‚ƃ|ƒWƒeƒBƒuEƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‚Ì—LŒø«. ’ç@–Ÿƒ (ŒöO‰q¶): ŽY‹Æ•ÛŒ’21 2015/10; 21 (2): 2-5.

522019. [uÀ]y“ÁW: ƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x‚̉^—pEŠˆ—p‚ðl‚Š‚éz’ñŒŸ2: ƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x‚ÌŠˆ—p‚ɂ‚¢‚ā|§“x‚Ì–Ú“I‚𗝉ð‚µ, Ž–‹Æê“à‚ł̃ƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚Ƃ̘A“®‚ð}‚邱‚Ɓ|. ’ç@–Ÿƒ (ŒöO‰q¶): ’n•ûŒö–±ˆõˆÀ‘S‚ÆŒ’Nforum 2015/10; 25 (4): 11-5.

522020. [uÀ]y“ÁW1: •›tŽîᇂ̐f’f‚ÆŽ¡—ÂÌupdatezŒŽ”­«ƒAƒ‹ƒhƒXƒeƒƒ“Ç‚Ì•aŒ^f’f‚É‚š‚¯‚é•›tÃ–¬ƒTƒ“ƒvƒŠƒ“ƒO‚̉ۑè: ‘œŽ{Ýƒf[ƒ^ƒx[ƒX‚̍\’z‚ƗՏ°“IˆÓ‹`. ”n‰z—m‹X, ˜a“c“T’j, ˆêé‹M­, Œ“c—Sˆê, ‹T‘ºK•œ, •Ÿ‰ª•x˜a, “¡ˆä—Yˆê, b”ã’B–ç, â–{—³ˆê, ¬‰Í@~, —é–Ø’mŽq1, ¬Š}ŒŽ’CŽ÷, “ï”g‘œ‹“, —§–Ø”ü, ¬£Œõ‰h (1ŒöO‰q¶): “ú–{“à•ª”åEbó‘BŠO‰ÈŠw‰ïŽGŽ 2015; 32 (4): 220-4.

522021. [uÀ]y“ÁW: s“®ˆãŠw‚̃RƒAƒJƒŠƒLƒ…ƒ‰ƒ€zˆãŠw•”‹³ˆç‚É‚š‚¯‚és“®ˆãŠwEs“®‰ÈŠw: ƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€‚Ì’ñˆÄ. ’ç@–Ÿƒ (ŒöO‰q¶): SgˆãŠw 2016/1; 56 (1): 17-23.

522022. [uÀ]y“ÁW: ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‚ƃXƒgƒŒƒXƒ`ƒFƒbƒNzEê‚É‚š‚¯‚郁ƒ“ƒ^ƒ‹ƒwƒ‹ƒX•s’²‚̃XƒNƒŠ[ƒjƒ“ƒO. ’ç@–Ÿƒ (ŒöO‰q¶): ‘‡Œ’f 2016/3; 43 (2): 313-9.

[’˜@‘]

620009. [Šwp‘ (•ª’SŽ·•M)]yŽÐ‰ï‚ÆŒ’N@Œ’NŠi·‰ðÁ‚ÉŒü‚¯‚œ“‡‰ÈŠw“IƒAƒvƒ[ƒ`z‘æ2Í E‹Æ‚ÆŒ’N, p39-56. ’ç@–Ÿƒ1, _—Ñ”ŽŽj (1ŒöO‰q¶), •Ò: ìãŒ›l, ‹Ž–{‰pŽ÷, ‹ß“¡®ŒÈ, “Œ‹ž‘åŠwo”ʼnï, “Œ‹ž, 2015/4”­s.

620010. [Šwp‘ (•ª’SŽ·•M)]yEê‚̃|ƒWƒeƒBƒuƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXz‘æIII•” ƒZƒ‹ƒtƒ}ƒlƒWƒƒ“ƒg‚Ö‚ÌŠˆ—p@11. ƒ|ƒWƒeƒBƒuS—Šw‚̗́|–L‚©‚ȐS—“IŽ‘–{‚ªƒ[ƒNEƒGƒ“ƒQƒCƒWƒƒ“ƒg‚ð‚‚ß‚é!, p.96-104. ]Œû@® (ŒöO‰q¶), •Ò: “‡’ÖŸl, œM‘–[, “Œ‹ž, 2015/6”­s.

620011. [Šwp‘ (•ª’SŽ·•M)]ys“®ˆãŠwƒeƒLƒXƒgz4. s“®‚̎Љï‰ÈŠw“I—‰ð@b. s“®‚ƎЉï, p.66-72. ’ç@–Ÿƒ1 (1ŒöO‰q¶), •Ò: –쑺@”E, ’ç@–Ÿƒ1, “‡’ÖŸl, ’†”ö–rG, ‹g“àˆê_, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2015/10”­s.

620012. [Šwp‘ (•ª’SŽ·•M)]y“à•ª”å‘ãŽÓ—Տ°Œ€‹†ƒ}ƒjƒ…ƒAƒ‹z‘æ2Í —Տ°Œ€‹†‚ÌŒ€‹†ƒfƒUƒCƒ“‚ÌŽí—ށ@B. ŠÏŽ@Œ€‹†@3. ‰¡’fŒ€‹†, p.15-6. —é–Ø’mŽq (ŒöO‰q¶), •Ò: V•Û‘ì˜Y, ì‘º@F, ¬£Œõ‰h, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/9”­s.

620013. [Šwp‘ (•ª’SŽ·•M)]y“à•ª”å‘ãŽÓ—Տ°Œ€‹†ƒ}ƒjƒ…ƒAƒ‹z‘æ3Í Œ€‹†Œv‰æ‘‚̍\¬‚ƍ쐬@5. ŠÏŽ@‚⑪’è, p.53-4. V•Û‘ì˜Y, —é–Ø’mŽq1 (1ŒöO‰q¶), •Ò: V•Û‘ì˜Y, ì‘º@F, ¬£Œõ‰h, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/9”­s.

620014. [Šwp‘ (•ª’SŽ·•M)]y“à•ª”å‘ãŽÓ—Տ°Œ€‹†ƒ}ƒjƒ…ƒAƒ‹z‘æ5Í “Œv‚̉ðÍ@C. “Œvƒ\ƒtƒg‚ÌŽí—Þ‚Æ“Á’¥, p.127-33. —é–Ø’mŽq (ŒöO‰q¶), •Ò: V•Û‘ì˜Y, ì‘º@F, ¬£Œõ‰h, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/9”­s.

620015. [Šwp‘ (•ª’SŽ·•M)]y“à•ª”å‘ãŽÓ—Տ°Œ€‹†ƒ}ƒjƒ…ƒAƒ‹z‘æ8Í Œ‹‰Ê‰ðÍ‚ÌŽÀ‘H ŽÀÛ‚̃\ƒtƒg‚ðŽg‚Á‚Ä, p.151-201. —é–Ø’mŽq1, V•Û‘ì˜Y (1ŒöO‰q¶), •Ò: V•Û‘ì˜Y, ì‘º@F, ¬£Œõ‰h, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/9”­s.

620016. [Šwp‘ (•ª’SŽ·•M)]yŽÐ‰ïEŠÂ‹«‚ÆŒ’N ŒöO‰q¶Šw 2016”N“x”ŁzCHAPTER 9 ž_•ÛŒ’‘΍ô, p.97-103. •‘ò—mˆê, ’ç@–Ÿƒ1, ’†‘ºDˆê, ”öŒ`—R‹NŽq, Šžêˆê‘¥, ”ö“‡r”V, –q–ìLŽq (1ŒöO‰q¶), •Ò: –öì@—m, âÀ—ÖáÁŸ, ‘Œ, ˆãŽ•–òo”Å, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713009. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The association between occupation and education completed, and general health conditions among Japanese males in their 50s. Eguchi H1: 31st International Congress on Occupational Health (2015/6/1), Korea. (]Œû@®1: 1ŒöO‰q¶)

713010. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Workers' mental disorders: the burden in Japan. Tsutsumi A1: ICOH International Congress Korea 2015 (2015/6/4), Seoul, Korea. (’ç@–Ÿƒ1: 1ŒöO‰q¶)

721001. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ƒXƒgƒŒƒXƒeƒXƒg‚ƐEêf’f. ’ç@–Ÿƒ (ŒöO‰q¶): ‘æ29‰ñ“ú–{ˆãŠw‰ï‘‰ï (2015/4/12), ‹ž“s.

721002. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) E‹Æ«ƒXƒgƒŒƒXƒ‚ƒfƒ‹‚Æ•]‰¿‚Ì“WŠJ. ’ç@–Ÿƒ (ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/14), ‘åã.

721003. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) E‹Æ«ƒXƒgƒŒƒXƒ‚ƒfƒ‹‚ð—p‚¢‚œŒ€‹†‚Æ‚»‚̉ž—p@ŽdŽ–‚Ì—v‹“x\ƒRƒ“ƒgƒ[ƒ‹ƒ‚ƒfƒ‹‚Æ“w—Í•ñV•s‹Ïtƒ‚ƒfƒ‹@”äŠrl@2. “w—́|•ñV•s‹Ïtƒ‚ƒfƒ‹. ’ç@–Ÿƒ (ŒöO‰q¶): ‘æ31‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ïŠwp‘‰ï (2015/11/7), ‘åã.

722008. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ’N‚Å‚à‚¢‚«‚¢‚«‚Æ“­‚¯‚éEêŠÂ‹«‚̏ø¬‚Ì‚œ‚߂Ɂ|ŽY‹Æ•ÛŒ’E‚É‚Å‚«‚邱‚Ɓ|. ]Œû@® (ŒöO‰q¶): l‚ð‘åØ‚É‚·‚éŒo‰cŠw‰ï@‘æ2‰ñ‘S‘‘å‰ï (2015/9/13), “Œ‹ž.

723086. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹i‰Œ‚Ì—L–³•Ê‚É‚Ý‚œŠé‹Æ‚É‚š‚¯‚é‘gD“IŒö³‚Ədž_áŠQ‘Š“–‚̐ž_“I•s’²‚Æ‚ÌŠÖ˜A ˆäã²b, ìãŒ›l, ]Œû@®1, ’ç@–Ÿƒ1 (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/14), ‘åã.

723087. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “­‚­¢‘ã‚Ì’j«‚É‚š‚¯‚éŒÂl“I‚ȉۑè‚ƐS—“IƒXƒgƒŒƒX‘Š“–‚Æ‚ÌŠÖ˜A. ˜a“ckŽ¡, ]Œû@®1, ‰ª‹vƒWƒ…ƒ“, ”óŒû‘P”V (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/14), ‘åã.

723088. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒT[ƒrƒX‹Æ‚ɏ]Ž–‚·‚é˜J“­ŽÒ‚Ì•sˆÀ‚â”Y‚Ý‚ÌŒXŒü’²ž. Žu“cŽOŽl˜Y, –{“c‹ËŽq, ŽR–{‚Ý‚Ç‚è, ŸOç—eŽq, ”Ñ‘º—TŽq, V‹’qŒb, ]Œû@®1 (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/14), ‘åã.

723089. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Eê‚Ö‚ÌOSHMS‚Ì“±“ü‚ª‚à‚œ‚ç‚·ˆÀ‘S‰q¶–Ê‚Å‚ÌŒø‰Ê‚ÉŠÖ‚·‚錀‹†`‘æ19•ñ@Ž©Ž¡‘̐Eê‚É‚š‚¯‚éOSHMS’è’…‚ƈÀ‘S‰q¶Žw•W‚⊈“®‚ւ̉e‹¿•]‰¿`. “n•Ó—TW, b“c–ÎŽ÷, ²X–Ø‹B, ’ß“c—R‹IŽq, ˆÉ“¡ºD, ŒF’JM“ñ, ŒŽ@–M•v, ’ç@–Ÿƒ1, ŠÛŽR³Ž¡, ŽRŒûGŽ÷ (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/14), ‘åã.

723090. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Eê‚Ö‚ÌOSHMS‚Ì“±“ü‚ª‚à‚œ‚ç‚·ˆÀ‘S‰q¶–Ê‚Å‚ÌŒø‰Ê‚ÉŠÖ‚·‚錀‹†`‘æ20•ñ@ƒŠƒXƒN•]‰¿‚ÉŠî‚­ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚̉e‹¿•]‰¿` ’ß“c—R‹IŽq, b“c–ÎŽ÷, ²X–Ø‹B, “n•Ó—TW, ’ç@–Ÿƒ1, ˆÉ“¡ºD, ŒF’JM“ñ, ŒŽ@–M•v, ŠÛŽR³Ž¡, ŽRŒûGŽ÷ (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/14), ‘åã.

723091. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Eê‚Ö‚ÌOSHMS‚Ì“±“ü‚ª‚à‚œ‚ç‚·ˆÀ‘S‰q¶–Ê‚Å‚ÌŒø‰Ê‚ÉŠÖ‚·‚錀‹†`‘æ21•ñ@ŽQ‰ÁŒ^‚̈À‘S‰q¶Šˆ“®‚ňÀ‘S‰q¶Žw•W‚ðHê‚³‚¹‚œŽÀ‘HŽ–—á` ŠÛŽR³Ž¡, b“c–ÎŽ÷, ²X–Ø‹B1, “n•Ó—TW, ’ß“c—R‹IŽq, ˆÉ“¡ºD, ŒF’JM“ñ, ŒŽ@–M•v, ’ç@–Ÿƒ1, ŽRŒûGŽ÷ (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/14), ‘åã.

723092. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†¬‹K–ÍŽ–‹ÆŠ‚É‚š‚¯‚éuŽQ‰ÁŒ^Eê‰ü‘Pv‚ð’Ê‚µ‚œƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚ÌŽæ‚è‘g‚Ý “à“c—z”V, XŒûŽŸ˜Y, ŽRª‰p”V, …–{³Žu, ‹g‰ªç», ŒÜ\—’ç‘ã, ¬“cØ—DŽq, “‡’ÖŸl, ’ç@–Ÿƒ1, ‹ÑŒË“TŽq, ŒŽ’J_Žj, ‹gì‰xŽq, ‹gì@“O, ìãŒ›l (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/15), ‘åã.

723093. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Eˆæ‚É‚š‚¯‚é”­’BáŠQŒXŒüƒXƒNƒŠ[ƒjƒ“ƒOƒeƒXƒgAQ-short‚̑Ó–‚ȃJƒbƒgƒIƒt’l (J-HOPE). —é–Ø’mŽq1, ‹{–؍Kˆê1, ˆäã²b, ìãŒ›l, “‡’ÖŸl, ‚‹Ž³–ç, ŒI‰ªZŽq, ’ç@–Ÿƒ1 (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/15), ‘åã.

723094. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œð‘㐧‹Î–±‚Ì’nˆæŒxŽ@Š¯‚É‚š‚¯‚éE‹Æ«ƒXƒgƒŒƒX‚ƃRƒ‹ƒ`ƒ][ƒ‹‚ÌŠÖ˜A ˆäàVC•œ, ’ç@–Ÿƒ1 (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/15), ‘åã.

723095. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆê”ʘJ“­ŽÒ‚É‚š‚¯‚éŽÐ‰ïŒoÏ“Ió‹µ‚š‚æ‚ѐE–±—vˆö‚Ɣ얞‚Æ‚ÌŠÖ˜A (J-HOPE). ŒI‰ªZŽq, ˆäã²b, ’ç@–Ÿƒ1, ìãŒ›l, “‡’ÖŸl, ]Œû@®1, ‰““c˜a•F, ¬™—R‹N (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/15), ‘åã.

723096. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒWƒ‡ƒuEƒNƒ‰ƒtƒeƒBƒ“ƒO‚ƃ[ƒNEƒGƒ“ƒQƒCƒWƒƒ“ƒg‚š‚æ‚ѐS—“IƒXƒgƒŒƒX”œ‰ž‚Æ‚ÌŠÖ˜A. ŸN’J‚ ‚·‚©, “‡’ÖŸl, ]Œû@®1, _ŽR‹M–€, ŒŽ—Y“ñ˜Y, “ï”gŽs, ìãŒ›l (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/15), ‘åã.

723097. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ï•aŠ³ŽÒ‚̏A˜JŒp‘±Žx‰‡‚ÉŠÖ‚·‚錻ó’²ž: Š³ŽÒƒCƒ“ƒ^ƒrƒ…[‚ð’Ê‚¶‚Ä. ]Œû@®1, ”óŒû‘P”V, ˜a“ckŽ¡ (1ŒöO‰q¶): ‘æ88‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2015/5/16), ‘åã.

723098. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‹K–͐EˆæƒRƒz[ƒg‚ł̈ê”ʏW’c‚É‚š‚¯‚é”­’BáŠQŒXŒü‚ƐEêƒXƒgƒŒƒX‹y‚уTƒ|[ƒg‚Ì—}‚€‚“x‚ɑ΂·‚é‘ŠŒÝì—p. —é–Ø’mŽq1, ‹{–؍Kˆê1, ‹{‰ª@“™2, ‹{’nLŒá2, ]Œû@®1, ’ç@–Ÿƒ1 (1ŒöO‰q¶, 2ž_): ‘æ22‰ñ“ú–{ŽY‹Æž_•ÛŒ’Šw‰ï (2015/6/26-27), “Œ‹ž.

723099. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‹K–͐EˆæƒRƒz[ƒg‚ł̈ê”ʏW’c‚É‚š‚¯‚é”­’BáŠQŒXŒü‚Ì•ª•z‚Æ—}‚€‚‚Ƃ̊֘A. ‹{–؍Kˆê1, —é–Ø’mŽq1, ‹{‰ª@“™2, ‹{’nLŒá2, ]Œû@®1, ’ç@–Ÿƒ1 (1ŒöO‰q¶, 2ž_): ‘æ22‰ñ“ú–{ŽY‹Æž_•ÛŒ’Šw‰ï (2015/6/26-27), “Œ‹ž.

723100. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX•s’²‚Å‹x‹Æ‚µ‚œ˜J“­ŽÒ‚Ì•œE‚ðŽx‰‡‚·‚éfit noteŠÖ˜Aƒc[ƒ‹‚ÌŠJ”­. ’ç@–Ÿƒ (ŒöO‰q¶): ‘æ25‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï@ŽY‹ÆˆãEŽY‹ÆŠÅŒì‘S‘‹Š‹c‰ï (2015/9/18), ŽRŒû.

723101. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ï•a‚𗝗R‚É“­‚«•û‚ɐ§–ñ‚Ì‚ ‚铯—»‚ɑ΂·‚éˆê”ʘJ“­ŽÒ‚̈ӎ¯‚ÉŠÖ˜A‚·‚éS—ŽÐ‰ï“I—vˆö‚ÌŒŸ“¢. ]Œû@®1, ˜a“ckŽ¡, ”óŒû‘P”V (1ŒöO‰q¶): ‘æ25‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï@ŽY‹ÆˆãEŽY‹ÆŠÅŒì‘S‘‹Š‹c‰ï (2015/9/18), ŽRŒû.

723102. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŽ”­«ƒAƒ‹ƒhƒXƒeƒƒ“Ç‚É‚š‚¯‚éCT‰æ‘œ‚É‚æ‚é•a‘€f’f—Š‚š‚æ‚Ñ•›tÃ–¬ƒTƒ“ƒvƒŠƒ“ƒO‚Ì“K‰ž‚ÉŠÖ‚·‚錟“¢. ‹T‘ºK•œ, ¬£Œõ‰h, —§–Ø”ü, ”n‰z—m‹X, Œ“c—Sˆê, “¡ˆä—Yˆê, •Ÿ‰ª‹{˜a, b”ã’B–ç, ¬‰Í@~, â–{—³ˆê, ˜a“c“T’j, ˆêé‹M­, —é–Ø’mŽq1 (1ŒöO‰q¶): ‘æ38‰ñ“ú–{‚ŒŒˆ³Šw‰ï‘‰ï (2015/10/9-11), ˆ€•Q.

723103. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Eê•œ‹Af’f‘ (fit note) ƒVƒXƒeƒ€“±“ü‚̉ۑè. ’ç@–Ÿƒ (ŒöO‰q¶): ‘æ74‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2015/11/4), ’·è.

723104. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “­‚«•û‚ɐ§–ñ‚Ì‚ ‚铯—»‚ɑ΂·‚éˆê”ʘJ“­ŽÒ‚̈ӎ¯‚ÉŠÖ‚·‚錟“¢. ]Œû@®1, ˜a“ckŽ¡, ”óŒû‘P”V (1ŒöO‰q¶): ‘æ74‰ñ“ú–{ŒöO‰q¶Šw‰ï (2015/11/5), ’·è.

731002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Eê‚É‚š‚¯‚郁ƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô. ’ç@–Ÿƒ (ŒöO‰q¶): •œ¬27”N“x“ú–{ŽY‹Æ‰q¶Šw‰ï“ŒŠC’n•û‰ïŠw‰ï (2015/11/14), –ŒŒÃ‰®.

731003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹ß”N‚̃ƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚Ì“®Œü. ’ç@–Ÿƒ (ŒöO‰q¶): ‘æ1‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï’†‘’n•û‰ïŒ€‹†‰ï (2016/2/13), ‰ªŽR.

732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)y‹ß–¢—ˆ‚ÌŽY‹Æ‰q¶•ª–ì‚ÌŒ€‹†‚ÆŽÀ‘H (4)zŽY‹ÆˆãŠˆ“®‚ð‚µ‚È‚ª‚ç‚ÌŒ€‹†Šˆ“®. ]Œû@® (ŒöO‰q¶): “ú–{ŽY‹Æ‰q¶Šw‰ïŠÖ“Œ’n•û‰ï‘æ271‰ñ—á‰ï (2015/12/12), “Œ‹ž.

733022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‹K–͐EˆæW’c‚Å‚ÌŠeŽ©•ÂÇ‚Ì“Á«‚Ì•ª•z‚Æ‚€‚Ǐó‚Æ‚ÌŠÖ˜A. —é–Ø’mŽq1, ‹{–؍Kˆê1, ]Œû@®1, ’ç@–Ÿƒ1 (1ŒöO‰q¶): “ú–{ŽY‹Æ‰q¶Šw‰ïE‘æ57‰ñŽY‹Æž_‰q¶Œ€‹†‰ï (2016/2/20), _“ސì.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H17-522001. [uÀ]yƒgƒsƒbƒNƒX: ƒhƒCƒc‚̍ŐV–ò‹ÇŽ–î (7)zƒWƒFƒlƒŠƒbƒN–ò‚ÌŽg—pó‹µ|ŽQÆ‰¿Ši§“x, Aut-idem–@“™‚É‚æ‚éŒø‰Ê. —é–Ø’mŽq1, ²“¡@‹Ï (1ŒöO‰q¶): ŒŽŠ§–òŽ– 2006/3; 48 (3): 411-6.

[’˜@‘]

H17-620001. [Šwp‘ (•ª’SŽ·•M)]y–ò‘‚í‚©‚èƒKƒCƒhƒuƒbƒNz‘æ2Í ŒÄ‹zŠíŒn‚Ì–ò, p.36-47. •l“cNŽŸ, —é–Ø’mŽq1, ²’|®Žq, ’†‘º—RŠì, “¹‰º‰ÀŽq (1ŒöO‰q¶), ŠÄC: •l“cNŽŸ, ˆãŠwŒ|pŽÐ, “Œ‹ž, 2005/7”­s.

H17-620002. [Šwp‘ (•ª’SŽ·•M)]y–ò‘‚í‚©‚èƒKƒCƒhƒuƒbƒNz‘æ6Í ŒŒ‰tE‘¢ŒŒŠí‚Ì–ò@RŒŒð–ò (1), p.110-1. •l“cNŽŸ, —é–Ø’mŽq1, ²’|®Žq, ’†‘º—RŠì, “¹‰º‰ÀŽq (1ŒöO‰q¶), ŠÄC: •l“cNŽŸ, ˆãŠwŒ|pŽÐ, “Œ‹ž, 2005/7”­s.

H17-620003. [Šwp‘ (•ª’SŽ·•M)]y–ò‘‚í‚©‚èƒKƒCƒhƒuƒbƒNz‘æ7Í ŠŽõÇ‚Ì–ò@•—ÇŒóŒQEƒCƒ“ƒtƒ‹ƒGƒ“ƒUŽ¡—Öò, p.130-1. •l“cNŽŸ, —é–Ø’mŽq1, ²’|®Žq, ’†‘º—RŠì, “¹‰º‰ÀŽq (1ŒöO‰q¶), ŠÄC: •l“cNŽŸ, ˆãŠwŒ|pŽÐ, “Œ‹ž, 2005/7”­s.

H18-620001. [Šwp‘ (•ª’SŽ·•M)]y–ò‘‚í‚©‚èƒKƒCƒhƒuƒbƒN ‰ü’ù”ŁE‘•â”Łz‘æ2Í ŒÄ‹zŠíŒn‚Ì–ò, p.36-47. •l“cNŽŸ, —é–Ø’mŽq1, ²’|®Žq, ’†‘º—RŠì, “¹‰º‰ÀŽq (1ŒöO‰q¶), ŠÄC: •l“cNŽŸ, ˆãŠwŒ|pŽÐ, “Œ‹ž, 2007/3”­s.

H18-620002. [Šwp‘ (•ª’SŽ·•M)]y–ò‘‚í‚©‚èƒKƒCƒhƒuƒbƒN ‰ü’ù”ŁE‘•â”Łz‘æ6Í ŒŒ‰tE‘¢ŒŒŠí‚Ì–ò@RŒŒð–ò (1), p.122-3. •l“cNŽŸ, —é–Ø’mŽq1, ²’|®Žq, ’†‘º—RŠì, “¹‰º‰ÀŽq (1ŒöO‰q¶), ŠÄC: •l“cNŽŸ, ˆãŠwŒ|pŽÐ, “Œ‹ž, 2007/3”­s.

H18-620003. [Šwp‘ (•ª’SŽ·•M)]y–ò‘‚í‚©‚èƒKƒCƒhƒuƒbƒN ‰ü’ù”ŁE‘•â”Łz‘æ7Í ŠŽõÇ‚Ì–ò@•—ÇŒóŒQEƒCƒ“ƒtƒ‹ƒGƒ“ƒUŽ¡—Öò, p.142-3. •l“cNŽŸ, —é–Ø’mŽq1, ²’|®Žq, ’†‘º—RŠì, “¹‰º‰ÀŽq (1ŒöO‰q¶), ŠÄC: •l“cNŽŸ, ˆãŠwŒ|pŽÐ, “Œ‹ž, 2007/3”­s.


–@ˆãŠw

[Šwp˜_•¶]

210001. [€ŒŽ’˜] The case of 2 siblings that identified not only by DNA profiling Maeda K1, Murakami C1, Irie W1, Sasaki C1, Oishi M, Nakamaru N2, Nakamura S1, Kurihara K1: Forensic Science International: Genetics Supplement Series 2015/12; 5: e555-6. (‘O“cˆê•ã1, ‘ºãçŽq1, “ü]@Â1, ²X–ؐçŽõŽq1, ’†ŠÛ®”ü2, ‘åÎ“Žq, ’†‘º–Ίî1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

220002. [€ŒŽ’˜] S‘Ÿ«“Ë‘RŽ€‚̈â“`Žq‰ðÍIII|SCN5Aˆâ“`Žq‚̕ψىðÍ|. ‘ºãçŽq1, ‘O“cˆê•ã1, “ü]@Â1, ‘åÎ“Žq, ²X–ؐçŽõŽq1, ’†ŠÛ®”ü2, ’†‘º–Ίî1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): “ú–{DNA‘œŒ^ 2015; 23: 177-80.

320001. [Ç—á•ñ] ”À‘—Žž‚ÌCTŒŸž‚Å“àˆö«ŠÌ‘Ÿ”j—ô‚É‚æ‚é•aŽ€‚ð‹^‚í‚ê‚œŠO«ŠÌ‘¹‚Ì–UŒŸ—á. ‘O“cˆê•ã1, “ü]@Â1, ‘ºãçŽq1, ²X–ؐçŽõŽq1, ‘åÎ“Žq, ’†ŠÛ®”ü2, ’†‘º–Ίî1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): –@ˆãŠw‚ÌŽÀÛ‚ÆŒ€‹† 2015; 58: 133-7.

[Šw‰ïEŒ€‹†‰ï“™]

713011. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The case of 2 siblings that identified not only by DNA profiling. Maeda K1, Murakami C1, Irie W1, Sasaki C1, Oishi M2, Nakamaru N2, Nakamura S1, Kurihara K1: 26th Congress of the International Society for Forensic Genetics (2015/8/3-9/5), Krakow, Poland. (‘O“cˆê•ã1, ‘ºãçŽq1, “ü]@Â1, ²X–ؐçŽõŽq1, ‘åÎ“Žq2, ’†ŠÛ®”ü2, ’†‘º–Ίî1, ŒIŒŽŽ—R1: 1–@ˆã, 2Œ`‘ÔŒn)

723105. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –@ˆã‰ð–U‚É‚š‚¯‚é’†“Å“Œv’²ž‚ÉŒü‚¯‚œ–ò•šƒXƒNƒŠ[ƒjƒ“ƒOƒƒ\ƒbƒh\’z‚ÌŽæ‘g‚Ý (2). ²X–ؐçŽõŽq1, ŒIŒŽŽ—R1 (1–@ˆã): ‘æ99ŽŸ“ú–{–@ˆãŠw‰ïŠwp‘S‘W‰ï (2015/6/12), ‚’m.

723106. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) DNAŒ^ŠÓ’è‚݂̂ł͐gŒ³“Á’肪•s‰Â”\‚Å‚ ‚Á‚œ1Ž–—á. ‘O“cˆê•ã1, ‘ºãçŽq1, “ü]@Â1, ²X–ؐçŽõŽq1, ‘åÎ“Žq2, ’†ŠÛ®”ü2, ’†‘º–Ίî1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): ‘æ99ŽŸ“ú–{–@ˆãŠw‰ïŠwp‘S‘W‰ï (2015/6/10-12), ‚’m.

723107. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶‘O‚Ì‘¹/Ž€Œã‚Ì‘¹‰ó? “ü]@Â1, ‘ºãçŽq1, ‘O“cˆê•ã1, ²X–ؐçŽõŽq1, ‘åÎ“Žq2, ’†ŠÛ®”ü2, ’†‘º–Ίî1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): ‘æ99ŽŸ“ú–{–@ˆãŠw‰ïŠwp‘S‘W‰ï (2015/6/10-12), ‚’m.

723108. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 3-Methoxy PCP‚š‚æ‚у¿-PHP‚ªŒŸo‚³‚ê‚œˆê–UŒŸ—á. ²X–ؐçŽõŽq1, Ä“¡@„, ŽÂ’Ë’B—Y, “ü]@Â1, ‘ºãçŽq1, ‘O“cˆê•ã1, ’†ŠÛ®”ü2, ‘åÎ“Žq2, ’†‘º–Ίî1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): “ú–{–@’†“ÅŠw‰ï‘æ34”N‰ï (2015/6/26-27), •Ÿ‰ª.

733023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) D16S539‚Étri-allelic pattern‚ª”F‚ß‚ç‚ê‚œeŽqŠÓ’莖—á. ‘ºãçŽq1, ‘O“cˆê•ã1, “ü]@Â1, ²X–ؐçŽõŽq1, ’†ŠÛ®”ü2, ‘åÎ“Žq2, ’†‘º–Ίî1, ŒIŒŽŽ—R1 (1–@ˆã, 2Œ`‘ÔŒn): ‘æ84‰ñ“ú–{–@ˆãŠw‰ïŠwpŠÖ“Œ’n•ûW‰ï (2015/10/24), “Œ‹ž.

733024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –@ˆã‰ð–U‚É‚š‚¯‚é’†“Å“Œv’²ž‚ÉŒü‚¯‚œ–ò•šƒXƒNƒŠ[ƒjƒ“ƒOƒƒ\ƒbƒh\’z‚ÌŽæ‘g‚Ý (3). ˆÀ•”Š°Žq, ‘O‹Ž‹±Žq, ‘D‰zäŽi, ²X–ؐçŽõŽq1, “Þ—Ç–Ÿ“Þ, ‰œ“cŸ”Ž, ‚‘qÊ‰Ø, “c’†’ŒŽq, Šâ|Œö°, ã‘ºŒöˆê, ŒIŒŽŽ—R1, Ž…œšŽq, –؉º”Ž”V, Šâ£”Ž‘Ÿ˜Y (1–@ˆã): ‘æ84‰ñ“ú–{–@ˆãŠw‰ïŠwpŠÖ“Œ’n•ûW‰ï (2015/10/24), “Œ‹ž.


ŽÀŒ±“®•šŠw

[Šwp˜_•¶]

110063. [ŒŽ’˜] Efficacious cryopreservation of 2-cell stage mouse embryos via unvitrified ultrarapid freezing. Azuma S1: KItasato Med J 2015/9; 45 (2): 124-9. (“Œ@’åG1: 1ŽÀ“®)

110064. [ŒŽ’˜] Pharyngeal arch deficiencies affect taste bud development in the circumvallate papilla with aberrant glossopharyngeal nerve formation. Okubo T1, Takada S: Dev Dyn 2015/7; 244 (7): 874-87. (‘å‹v•Û’Œ1: 1ŽÀ“®)

520005. [‘à] TDP-43‚̐¶—“I‹@”\‚ÆALS•a‘Ô‚É‚š‚¯‚éˆÓ‹`. ²“¡rÆ (ŽÀ“®): –k—¢ˆãŠw 2015/12; 45 (2): 79-85.

522023. [uÀ]y“ÁW1: ž_ŽŸŠ³“®•šƒ‚ƒfƒ‹‚̉”\«‚Ɖۑèz3. “‡Žž’²Çƒ‚ƒfƒ‹ƒ}ƒEƒX‚̍s“®‰ðÍ•û–@‚ÌŽŽ‚Ý. ù‰ªr–M, ²“¡’©Žq, ’†‘º@“O, ‘å‹v•Û’Œ1, ²“¡rÆ1, “¡àVM‹`, ‘O“c‹Xr, ¬“c‰À“ÞŽq, ŽðˆäŽŽq, _•ÛKO, ”nìŒb—œŽq, –ؒÐ쏮Žj, –àŽRr•F, ŽRX“N—Y (1ŽÀ“®): “ú–{¶•šŠw“Iž_ˆãŠw‰ïŽ 2015/6; 26 (2): 87-94.

[Šw‰ïEŒ€‹†‰ï“™]

722009. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) TGF-ƒÀƒVƒOƒiƒ‹˜Ži‚É‚æ‚é”]ŒŒŠÇ‚É—^‚Š‚é‰e‹¿. ‰Á“¡‘׉î, ŠÖª—L”ü, –ìè—m–Ÿ, œAìËŽq, “¡“cØ“E, ²“¡rÆ1, ŒàV³–L, ¬–쎛— (1ŽÀ“®): ‘æ38‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2015/7/28), _ŒË.

723109. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ì‚Ì”­Œ»‚ÌŒž­‚̓}ƒEƒX‚̉^“®—ʂ̒ቺ‚ð—U“±‚·‚é. ù‰ªr–M, ²“¡’©Žq, ‘å‹v•Û’Œ1, “¡àVM‹`, ²“¡rÆ1, ¬“c‰À“ÞŽq, ‘O“c‹Xr, “c’†@–«, ŽR–{”ü‹u, ŽðˆäŽŽq, _•ÛKO, ç—t‚³‚š‚è, ”nìŒb—œŽq, ‰¡ŽR•õ‰î (1ŽÀ“®): ‘æ62‰ñ“ú–{ŽÀŒ±“®•šŠw‰ï‘‰ï (2015/5/28), ‹ž“s.

723110. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰Šúãó‚Ì‘ÌŠO”|—{‚ªƒ}ƒEƒX‚ÌŽYŽe”‚š‚æ‚ь‘̂̑ŸŠíd—Ê‚É‹y‚Ú‚·‰e‹¿. ¬“c‰À“ÞŽq, ²“¡rÆ1, ‘O“c‹Xr, ŽðˆäŽŽq, _•ÛKO, “¡àVM‹`, ‰¡ŽR•õ‰î, ù‰ªr–M (1ŽÀ“®): ‘æ62‰ñ“ú–{ŽÀŒ±“®•šŠw‰ï‘‰ï (2015/5/28), ‹ž“s.

723111. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) DRPLAƒ‚ƒfƒ‹ƒ}ƒEƒX‚ɑ΂·‚éƒAƒ“ƒ`ƒZƒ“ƒXƒIƒŠƒSƒkƒNƒŒƒIƒ`ƒh‚É‚æ‚鎡—Â̎Ž‚Ý “¡“cØ“E, ‰Á“¡‘׉î, ²“¡rÆ1, ’ҁ@ÈŽŸ, ŒàV³–L, ¬–쎛— (1ŽÀ“®): ‘æ38‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2015/7/29), _ŒË.

723112. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ì‚ð‰î‚·‚éƒVƒOƒiƒ‹‚É‚æ‚é‰^“®—ʂ̈ێ ù‰ªr–M, ²“¡’©Žq, ’mŒ©‘”ü, ‘O“‡@ƒ, Vˆä@Œd, »ŽR’qŽq, ¬“c‰À“ÞŽq, ‘O“c‹Xr, ŽðˆäŽŽq, _•ÛKO, ”nìŒb—œŽq, ²“¡rÆ1, ‘å‹v•Û’Œ1, “¡àVM‹`, ‰¡ŽR•õ‰î, “ì•”@“Ä (1ŽÀ“®): ‘æ38‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2015/7/30), _ŒË.

723113. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Lineage analysis of Ripply3 expressing cells during the mouse development. ‘å‹v•Û’Œ1, Takada S (1ŽÀ“®): BMB2015 (‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ 88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï) (2015/12/2), _ŒË.

723114. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) D1 dopamine receptor-mediated signal is required to maintain normal motor activity. ù‰ªr–M, ²“¡’©Žq, ’mŒ©‘”ü, ‘å‹v•Û’Œ1, ‘O“‡@ƒ, Vˆä@Œd, »ŽR’qŽq, ¬“c‰À“ÞŽq, ŽðˆäŽŽq, ‘O“c‹Xr, _•ÛKO, ”nìŒb—œŽq, ²“¡rÆ1, “¡àVM‹`, ‰¡ŽR•õ‰î, “ì•”@“Ä (1ŽÀ“®): BMB2015 (‘æ38‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ 88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï) (2015/12/3), _ŒË.

733025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ì‚Ì”­Œ»‚ÌŒž­‚̓}ƒEƒX‚̉^“®—ʂ̒ቺ‚ð—U“±‚·‚é. ù‰ªr–M, ²“¡’©Žq, ‘å‹v•Û’Œ1, “¡àVM‹`, ²“¡rÆ1, ¬“c‰À“ÞŽq, ‘O“c‹Xr, “c’†@–«, ŽR–{”ü‹u, ŽðˆäŽŽq, _•ÛKO, ç—t‚³‚š‚è, ”nìŒb—œŽq, ‰¡ŽR•õ‰î (1ŽÀ“®): •œ¬27”N“x“ú–{¶‰»Šw‰ïŠÖ“ŒŽx•”—á‰ïE‘æ56‰ñVŠƒ¶‰»Šw§˜b‰ï (2015/6/20)CVŠƒ.

733026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒh[ƒpƒ~ƒ“D1Žó—e‘Ì‚ð‰î‚·‚é_Œo“`’B‚Í‘å”]Šî’êŠj‚Ì’ŒÚ˜H‚̏î•ñ“`’B‚Ɖ^“®‚Ì”­Œ»‚É•s‰ÂŒ‡‚Å‚ ‚é. ù‰ªr–M, ²“¡’©Žq, ’mŒ©‘”ü, ‘å‹v•Û’Œ1, ‘O“‡@ƒ, Vˆä@Œd, »ŽR’qŽq, ¬“c‰À“ÞŽq, ŽðˆäŽŽq, ‘O“c‹Xr, _•ÛKO, ”nìŒb—œŽq, ²“¡rÆ1, “¡àVM‹`, ‰¡ŽR•õ‰î, “ì•”@“Ä (1ŽÀ“®): ‘æ32‰ñ“®•š¶BHŠwŒ€‹†‰ï (2015/12/5)Cìè.


–ƉuŠw

[Šwp˜_•¶]

110065. [ŒŽ’˜] Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses. Kubo M, Nagashima R, Ohta E, Maekawa T, Isobe Y, Kurihara M, Eshima K1, Iwabuchi K1, Sasaoka T, Azuma S2, Melrose HL, Farrer MJ, Obata F: J Neuroimmunol 2016/3; 292: 1-8. (]“‡k“ñ1, ŠâŸº˜a–ç1, “Œ@’åG2: 1–Ɖu, 2ŽÀ“®)

110066. [ŒŽ’˜] Differential dependence on nuclear factor-ƒÈB-inducing kinase among natural killer T-cell subsets in their development. Noma H1, Eshima K2, Satoh M2, Iwabuchi K2: Immunology 2015/9; 146 (1): 89-99. (–ìŠÔt1, ]“‡k“ñ2, ²“¡@‰ë2, ŠâŸº˜a–ç2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–Ɖu)

110067. [ŒŽ’˜] Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA. Yamanaka T, Tamauchi H, Suzuki Y, Suzuki H, Horikoshi S, Terashima M, Iwabuchi K1, Habu S, Okumura K, Tomino Y: Immunobiology 2016/4; 221 (4): 577-85. (ŠâŸº˜a–ç1: 1–Ɖu)

110068. [ŒŽ’˜] Adipocyte-specific CD1d-deficiency mitigates diet-induced obesity and insulin resistance in mice. Satoh M1, Hoshino M, Fujita K, Iizuka M, Fujii S, Clingan CS, Van Kaer L, Iwabuchi K1: Sci Rep 2016/6; 6: 28473. (²“¡@‰ë1, ŠâŸº˜a–ç1: 1–Ɖu)

110069. [ŒŽ’˜] Inhibitory function of NKT cells during early induction phase of nickel allergy. Okuno H1, Satoh M2, Takeuchi E2, Eshima K2, Terashima M, Komotori J, Habu S, Tamauchi H, Iwabuchi K2: Immunobiology 2016/7; 221 (7): 833-8. (‰œ–ìL‹³1, ²“¡@‰ë2, ’|“àŒb”üŽq2, ]“‡k“ñ2, ŠâŸº˜a–ç2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–Ɖu)

522024. [uÀ]y“ÁWI : “ÁŽê‚ȃŠƒ“ƒp‹…ŒQ‚̍ŋ߂̘bzNKT×–E‚Ì•ª‰»‚Æ‹@”\|Å‹ß‚̘b‘è‚©‚ç. ŠâŸº˜a–ç (–Ɖu): ‰ŠÇ‚ƖƉu 2015/9; 23 (5): 394-400.

522025. [uÀ]y“ÁW: NKT×–E•W“I—Ö@‚̐V“WŠJz‘ãŽÓ«ŽŸŠ³‚ÆNKT×–E. ²“¡@‰ë1, ŠâŸº˜a–ç1 (1–Ɖu): ˆãŠw‚Ì‚ ‚ä‚Ý 2015/9; 254 (13): 1169-74.

[’˜@‘]

620017. [Šwp‘ (•ª’SŽ·•M)]y–Ɖu—Í“O’ꌀ‹†zNK×–E|Ž©‘R–Ɖu‚̃GƒtƒFƒNƒ^[ˆÈã‚Ì‘¶Ý, p.38-9. ŠâŸº˜a–ç (–Ɖu), •Ò: —щ®ŽŽO˜Y, NPO–@l æ’[ˆã—Ã‚ð‚³‚³‚Š‚é‰ï, “Œ‹ž, 2015/11”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713012. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) NKT cell- adipocyte interaction modulate adipose tissue function Satoh M1, Iwabuchi K1: CD1-MR1 2015 (2015/11/16), Mantra Lorne, Australia. (²“¡@‰ë1, ŠâŸº˜a–ç1: 1–Ɖu)

723115. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) On the in vivo effects of enforced expression of eomesodermin, a T-box family molecule, in naïve T cells on their differentiation and function. ]“‡k“ñ1, –ìŠÔt, ŠâŸº˜a–ç1 (1–Ɖu): ‘æ44‰ñ“ú–{–ƉuŠw‰ïŠwpW‰ï (2015/11/18), ŽD–y.

723116. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Differential dependence on NF-ƒÈB-inducing kinase among NKT cell subsets in their development. ]“‡k“ñ1, –ìŠÔt, ²“¡@‰ë1, ŠâŸº˜a–ç1 (1–Ɖu): ‘æ44‰ñ“ú–{–ƉuŠw‰ïŠwpW‰ï (2015/11/20), ŽD–y.


ˆã—ÃŒo‰cŠw


’nˆæŽ™“¶ž_‰Èˆã—Êw

[Šw‰ïEŒ€‹†‰ï“™]

723117. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –œˆø‚«‚ðŒJ‚è•Ô‚µ‚œ’jŽ™‚ɂ‚¢‚Ă̗Տ°“IlŽ@|ŒÂl—Ö@‚ƉƑ°ƒAƒvƒ[ƒ`‚Æ‚¢‚€Ž‹“_|. ¬—ÑŽÀ‰Ô1, _’Jr‰î1, ¶’n@V2, ˆäãŸ•v3 (1’nˆæŽ™“¶ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ž_): “ú–{ŽvtŠúÂ”NŠúž_ˆãŠw‰ï‘æ28‰ñ‘å‰ï (2015/7/11), ‰¡•l.

723118. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’áƒiƒgƒŠƒEƒ€ŒŒÇ‚É”º‚€ö—ó‘Ô‚ð‹^‚í‚ê‚œ1Ç—á|ƒŠƒGƒ]ƒ“ƒ`[ƒ€‚̈Ӌ`|. _’Jr‰î1, ”’ˆä‹³Žq, ŽO‰Yƒ]2, ¬—ÑŽÀ‰Ô1, ˆäãŸ•v2, ‹{‰ª@“™2 (1’nˆæŽ™“¶ž_, 2ž_): ‘æ28‰ñ“ú–{‘‡•a‰@ž_ˆãŠw‰ï‘‰ï (2015/11/28), “¿“‡.

732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ž_‰ÈƒŠƒGƒ]ƒ“ƒ`[ƒ€‚Ì—L—p«‚ɂ‚¢‚ā`ŠeŽ{Ý‚ÌŽæ‚è‘g‚݂ƍ¡Œã‚̉ۑè. _’Jr‰î (’nˆæŽ™“¶ž_): ‘æ42‰ñ_“ސ쌧SgˆãŠw‰ï‘‰ï‚š‚æ‚ÑŠwpW‰ï (2016/3/5), ‰¡•l.


Ä¶ˆã—ÃŒ`¬ŠO‰ÈŠw


ŒŒ—¬‰ðÍŠw

[Šwp˜_•¶]

110070. [ŒŽ’˜] Dissipative energy loss within the left ventricle detected by vector flow mapping in children: Normal values and effects of age and heart rate. Hayashi T1, Itatani K2, Inuzuka R1, Shimizu N1, Shindo T1, Hirata Y1, Miyaji K3: J Cardiol 2015/11; 66 (5): 403-10. (”Â’JŒcˆê2, ‹{’n@ŠÓ3: 1“Œ‹ž‘åŠw¬Ž™‰È, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO)

[Šw‰ïEŒ€‹†‰ï“™]

713013. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Energy Dynamics of the Intraventricular Vortex after the Mitral Valve Surgery. Itatani K1, Nakashima K2, Kitamura T2, Oka N2, Horai T2, Miyazaki S1, Miyaji K2: AATS Mitral Conclave 2015 (2015/4/23-24), New York, USA. (”Â’JŒcˆê1, ’†“‡Œõ‹M2, –k‘º@—¥2, ‰ª@“¿•F2, •ó—ˆ“N–ç2, ‹{èãĕœ1, ‹{’n@ŠÓ2: 1ŒŒ—¬‰ðÍ, 2S‘ŸŒŒŠÇŠO)

713014. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Vector Flow Mapping and Fluid Dynamics. Itatani K1: ASE2015 26th Annual scientific sessions (2015/6/12-16), Boston, USA. (”Â’JŒcˆê1: 1ŒŒ—¬‰ðÍ)

713015. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Accuracy of small sized vessel flow measurements in 3D cine PC MRI with respiratory navigator gating. Miyazaki S1, Itatani K1, Hata H2, Inoue Y3: 10th World Congress for Microcirculation (2015/9/26), Kyoto, Japan. (‹{èãĕœ1, ”Â’JŒcˆê1, `@”Ž•¶2, ˆäã—D‰î3: 1ŒŒ—¬‰ðÍ, 2•úŽËü•”, 3•úŽËü (‰æ‘œ))

723119. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰^“®•‰‰×SƒGƒR[‚É‚æ‚éŠg’£‘Šú‚̍¶Žº“àˆ³Šr·‚Ì”­¶‹@˜‚ÌŒŸ“¢. Œˆä‚±‚ÆŽq1, ‚‹Ž@Œ’1, ¬—ѐ^‹I1, ŽR“c^—œŽq1, ‹H‘ã‰ë•F1, ”Â’JŒcˆê2, ‹{’n@ŠÓ3, Ž…r–Ÿ1 (1‡“V“°‘åŠw, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO): ‘æ118‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2015/4/17-19), ‘åã, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2015/4; 119 (2): 221.

723120. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™‚©‚琬l‚ÌŠg’£‘Šú‚̍¶Žº“àˆ³Šr·‚Ì”­¶‹@˜. ¬—ѐ^‹I1, ‚‹Ž@Œ’1, Œˆä‚±‚ÆŽq1, ŽR“c^—œŽq1, ‹H‘ã‰ë•F1, ”Â’JŒcˆê2, ‹{’n@ŠÓ3, Ž…r–Ÿ1 (1‡“V“°‘åŠw, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO): ‘æ118‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2015/4/17-19), ‘åã, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2015/4; 119 (2): 280.

723121. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒÄ‹z‚É”º‚€FontanŽèpŒã‚̈³—́E—¬‘¬•Ï“®‚ðÄŒ»‚·‚é‚œ‚߂̐”’l—¬‘̉ðÍ—p‹«ŠEðŒ‚ÌŒŸ“¢. Œã“¡^Ž¡1, ’†‘º‹§“¿1, ”Â’JŒcˆê2, ‹{èãĕœ2, ‰ª@“¿•F3, –{“c@’4, –k‘º@—¥3, •ó—ˆ“N–ç3, Îˆä³_4, ‹{’n@ŠÓ3 (1é‹Ê‘åŠw, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO, 4¬Ž™): ‘æ38‰ñ“ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ï”N‰ï (2015/6/6-7), “Œ‹ž, “ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ïŽ (B&R) 2015/6; 29 (2): 90.

723122. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šg’£‘Šú‚ÉŒŒ‰t—¬“ü‚ð‹ì“®‚š‚æ‚ÑŒžŽã‚³‚¹‚é“ñŽí—ނ̍¶Žº“àˆ³Šr·‚Ì”N—î‚É‚æ‚é•Ï‰». ‚‹Ž@Œ’1, ¬—ѐ^‹I1, ŽR“c^—œŽq1, ‘å–썁“Þ1, “c’†@“o1, ‹H‘ã‰ë•F1, ”Â’JŒcˆê2, ‹{’n@ŠÓ3, Ž…r–Ÿ1 (1‡“V“°‘åŠw, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16-18), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.219.

723123. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒtƒ@ƒ[Žl’¥ÇpŒãŠ³ŽÒ‚É‚š‚¯‚鍶Žº“àˆ³Šr·‚ÌŒŸ“¢. ¬—ѐ^‹I1, ‚‹Ž@Œ’1, ŽR“c^—œŽq1, Œˆä‚±‚ÆŽq1, HŒ³‚©‚‚Ý1, ‹H‘ã‰ë•F1, ìèŽu•Û—¢1, ”Â’JŒcˆê2, ‹{’n@ŠÓ3, Ž…r–Ÿ1 (1‡“V“°‘åŠw, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16-18), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.228.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-522001. [uÀ]y“ÁW: ¬Ž™‚̉摜f’f‚̐i•àzSƒGƒR[}‚ÅŒŒ—¬‚ðf‚é: Vector Flow Mapping‚̃ƒJƒjƒYƒ€. ‹{èãĕœ1, ”Â’JŒcˆê1, ‹{’n@ŠÓ2 (1ŒŒ—¬‰ðÍ, 2S‘ŸŒŒŠÇŠO): zŠÂŠí“à‰È 2015/3; 77 (3): 192-9.


’nˆæ‘‡ˆã—Êw

[Šwp˜_•¶]

521002. [‰ðà]y“ÁW: ‚±‚ê‚Ÿ‚¯‚ ‚ê‚Αåä•v! Common disease‚̃GƒbƒZƒ“ƒVƒƒƒ‹ƒhƒ‰ƒbƒOzƒXƒeƒƒCƒhŠO—p–ò. Îìƒ–ç1, –Ø‘º‘ô–1,2 (1’nˆæ‘‡ˆã—Ã, 2‘‡f—Ã): Gƒm[ƒg 2016/2; 3 (1): 42-79.

[Šw‰ïEŒ€‹†‰ï“™]

723124. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)yŒ»ê‚Å‚Ì‚Ó‚Æ‚µ‚œ‹ð–â‚â‰Û‘èz‚»‚±‚ªŒ€‹†‚̏o”­“_|Ý‘îˆã—Â̗Տ°Œ€‹†‚ÉŽæ‚è‘g‚ލۂ̏á•Ç‚Æ‚µ‚āuƒŠƒT[ƒ`ƒNƒGƒbƒVƒ‡ƒ“‚É—Ž‚Æ‚µž‚Ý‚É‚­‚¢vuŒ€‹†ƒfƒUƒCƒ“‚̍\’z‚É“ïa‚·‚évuƒTƒ“ƒvƒ‹”‚ªŠm•Û‚µ“ï‚¢v‚±‚Æ‚ªl‚Š‚ç‚ê‚é|. VX‰Á“ÞŽq (’nˆæ‘‡ˆã—Ã): ‘æ17‰ñ“ú–{Ý‘îˆãŠw‰ï‚à‚è‚š‚©‘å‰ï (2015/4/25), ·‰ª.

723125. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘ŽÒ‚Ö‹zˆø‚ðs‚€ƒJƒe[ƒeƒ‹‚𕡐”‰ñŽg—p‚©‚ç’P‰ñŽg—p‚֕ύX‚·‚é‚ƁuƒJƒe[ƒeƒ‹‚ªŽŒ‰‚©”Û‚©‚Ì•sˆÀŠŽv‚ÍŒž‚邪uƒJƒe[ƒeƒ‹‚ð”pŠü‚·‚镉’SŠŽv‚ª¶‚¶‚€‚é. VX‰Á“ÞŽq1, ¡‰iŒõ•F, —ѐ^—Žq, ‹ß“¡Gˆê, ŠOŽR“N–ç, –Ø‘º‘ô–2 (1’nˆæ‘‡ˆã—Ã, 2‘‡f—Ã): ‘æ17‰ñ“ú–{Ý‘îˆãŠw‰ï‚à‚è‚š‚©‘å‰ï (2015/4/25), ·‰ª.

732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŒ»ê‚Å‚Ì‚Ó‚Æ‚µ‚œ‹^–â‚â‰Û‘è@‚»‚±‚ªŒ€‹†‚̏o”­“_zÝ‘îˆã—Â̗Տ°Œ€‹†‚ÉŽæ‚è‘g‚ލۂ̉ۑè. VX‰Á“ÞŽq1, –Ø‘º‘ô–2 (1’nˆæ‘‡ˆã—Ã, 2‘‡f—Ã): Ý‘îˆã—Âɂš‚¯‚錀‹†‚̐U‹»‚ÉŒü‚¯‚Ẵ[ƒNƒVƒ‡ƒbƒv (2015/11/1), “Œ‹ž.

H26”N“xˆÈ‘O•ª

[’˜@‘]

H26-620002. [Šwp‘] (•ª’SŽ·•M)y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z‘æ2Í ”畆‰È“I–â‘è@1. Ô‚¢]‚ª‚Å‚«‚œ/2. Ô‚¢áy‚Ý‚Ì‚ ‚é”­]‚ª‘Sg‚É‚Å‚«‚œ/3. Šç‚ɍ•‚¢ƒfƒLƒ‚ƒm‚ª‚Å‚«‚œ/4. ‰A•”‚ª‚©‚ä‚¢‚ñ‚Å‚·/5. …’Ž‚ª‚Å‚«‚œ/6. …áv‚ª‚Å‚«‚œ/7. Šª‚«’Ü‚ª’É‚¢, p.58-73. Îìƒ–ç1 (1’nˆæ‘‡ˆã—Ã), •Ò: –Ø‘º‘ô–1,2, Œ‘º^Ži3 (2‘‡f—Ã, 3Œ‘ºˆã‰@‰@’·), —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-620003. [Šwp‘] (•ª’SŽ·•M)y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z‘æ4Í®Œ`ŠO‰È“I–â‘è@1. ƒxƒbƒh˜e‚Å“®‚¯‚È‚­‚È‚Á‚œ/2. ƒJƒbƒ^[ƒiƒCƒt‚ÅŽw‚ð‚«‚Á‚œ/3. ‹x‚Ý‹x‚Ý‚É‚µ‚©•à‚¯‚È‚¢/4. ‹}‚ɍ˜‚ª’É‚­‚È‚Á‚œD‚¬‚Á‚­‚荘?/5. Œš‚ª’É‚­‚Ä‹“‚ª‚ç‚È‚¢/6. Žè‚É‚ª‚ñ‚ª‚Å‚«‚œ?/7. ‘«‚ð‚Ђ˂Á‚œ/8. œ‘e頏ǂªS”z/9. ˜‚Ì’É‚Ý‚ª‘±‚­/10. Žè‚ðœÜ‚µ‚œ‚©‚à‚µ‚ê‚È‚¢‚̂Ń\ƒtƒgƒV[ƒl‚ðŠª‚­/11. ˜‚ª’É‚¢‚Ì‚Å’ŽË‚ð‚µ‚Ä‚Ù‚µ‚¢, p.84-107. VX‰Á“ÞŽq1 (1’nˆæ‘‡ˆã—Ã), •Ò: –Ø‘º‘ô–1,2, Œ‘º^Ži3 (2‘‡f—Ã, 3Œ‘ºˆã‰@‰@’·), —r“yŽÐ, “Œ‹ž, 2015/3”­s.


Á‰»Ší“à‰ÈŠw

[Šwp˜_•¶]

110071. [ŒŽ’˜] Impact of revisions of the JSCCR guidelines on the treatment of T1 colorectal carcinomas in Japan. Urabe Y, Tanaka S, Saito Y, Igarashi M1,2, Watanabe T, Sugihara K: Z Gastroenterol 2015/4; 53 (4): 291-301. (ŒÜ\—’³L1,2: 1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à)

110072. [ŒŽ’˜] Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer. Naruke A1, Azuma M1, Takeuchi A1, Ishido K1, Katada C1, Sasaki T1, Higuchi K1, Tanabe S2, Saegusa M3, Koizumi W1: Gastric Cancer 2015/4; 18 (2): 262-70. (¬–с@“N1, “Œ@’q1, ’|“à“ÖŽq1, ÎŒËŒªŽŸ1, Œ˜“ce—˜1, ²X–Ø“O1, ”óŒûŸ•F1, “c糁@‘2, ŽOŽ}@M3, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3•a—)

110073. [ŒŽ’˜] A multi-institutional survey on the practice of endoscopic ultrasound (EUS) guided pseudocyst drainage in the Asian EUS group. Teoh AYB, Ho LKY, Dhir VK, Jin ZD, Kida M1, Seo DW, Wang HP, Yang AM, Binmoeller KF, Varadarajulu S: Endosc Int Open 2015/4; 3 (2): E130-3. (–Ø“cŒõL1: 1Á‰»Ší“à)

110074. [ŒŽ’˜] Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Oka S1, Tanaka S1, Saito Y1, Iishi H1, Kudo SE1, Ikematsu H1, Igarashi M1,2,3, Saitoh Y1, Inoue Y1, Kobayashi K1,3,4, Hisabe T1, Tsuruta O1, Sano Y1, Yamano H1, Shimizu S1, Yahagi N1, Watanabe T1, Nakamura H1, Fujii T1, Ishikawa H1, Sugihara K1 (1Colorectal Endoscopic Resection Standardization Implementation Working Group of the Japanese Society for Cancer of the Colon and Rectum): Am J Gastroenterol 2015/5; 110 (5): 697-707. (ŒÜ\—’³L1,2,3, ¬—ѐŽ“T1,3,4: 2‚ª‚ñŒ€—L–Ÿ•a‰@, 3Á‰»Ší“à, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

110075. [ŒŽ’˜] Predictive factors for complications in endoscopic resection of large colorectal lesions: a multicenter prospective study. Wada Y, Kudo SE, Tanaka S, Saito Y, Iishii H, Ikematsu H, Igarashi M1,2, Saitoh Y, Inoue Y, Kobayashi K2,3, Hisabe T, Tsuruta O, Kashida H, Ishikawa H, Sugihara K: Surg Endosc 2015 /5; 29 (5): 1216-22. (ŒÜ\—’³L1,2, ¬—ѐŽ“T2,3: 1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

110076. [ŒŽ’˜] Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer. Watanabe A1, Kida M2, Miyazawa S2, Iwai T3, Okuwaki K2, Kaneko T2, Yamauchi H2, Takezawa M2, Imaizumi H2, Koizumi W2: World J Gastroenterol 2015/5; 21(19): 5979-84. (“n糍WŽ¯1, –Ø“cŒõL2, ‹{àVŽu˜N2, Šâˆä’m‹v3, ‰œ˜e‹»‰î2, ‹àŽq@‹œ2, ŽR“à_Žj2, ’|àVŽO‘ãŽq2, ¡ò@O2, ¬ò˜aŽO˜Y2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Á‰»Ší“à, 3‹~–œ)

110077. [ŒŽ’˜] Adalimumab for the treatment of Japanese patients with intestinal Behet's disease. Tanida S, Inoue N, Kobayashi K1,2, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Nagahori M, Motoya S, Nakamura S, Arora V, Robinson AM, Thakkar RB, Hibi T3: Clin Gastroenterol Hepatol 2015/5; 13 (5): 940-8.e3. (¬—ѐŽ“T1,2, “ú”ä‹I•¶3: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110078. [ŒŽ’˜] No contribution of the ABCB11 p.444A polymorphism in Japanese patients with drug-induced cholestasis. Kagawa T, Hirose S, Arase Y, Oka A, Anzai K, Tsuruya K, Shiraishi K, Orii R, Ieda S, Nakazawa T1, Tomita K, Hokari R, Miura S, Ebinuma H, Saito H, Kitamura T, Horie Y, Okuse C, Wasada M, Inoko H, Tohkin M, Saito Y, Maekawa K, Takikawa H, Mine T: Drug Metab Dispos 2015/5; 43 (5): 691-7. (’†àV‹MG1: 1Á‰»Ší“à)

110079. [ŒŽ’˜] Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Yamamoto Y1, Fujisaki J1, Omae M1, Hirasawa T1, Igarashi M1,2: Dig Endosc 2015/7; 27 (5): 551-61. (ŒÜ\—’³L1,2: 1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à)

110080. [ŒŽ’˜] Adhesion of platelets through thromboxane A2 receptor signaling facilitates liver repair during acute chemical-induced hepatotoxicity. Minamino T1, Ito Y2, Ohkubo H3, Shimuzu Y4, Kojo K4, Nishizwa N4, Amano H5, Narumiya S, Koizumi W1, Majima M5: Life Sci 2015/7; 132: 85-92. (“ì–ì@•×1, ˆÉ“¡‹`–ç2, ‘å‹v•Û”Ž¢3, Ž…—T‹M4, ŒÃé@Œ›4, ŒàVL‹±4, “V–ì‰pŽ÷5, ¬ò˜aŽO˜Y1, ”n“ˆ³—²5: 1Á‰»Ší“à, 2ŠO‰È, 3S‘ŸŒŒŠÇŠO, 4‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 5–ò—)

110081. [ŒŽ’˜] Elemental diet moderates 5-fluorouracil-induced gastrointestinal mucositis through mucus barrier alteration. Kawashima R1,2, Kawakami F1,2, Maekawa T1,2, Yamamoto H3, Koizumi W3, Ichikawa T1,2: Cancer Chemother Pharmacol 2015/8; 76 (2): 269-77. (ì“‡@—í1,2, ìã•¶‹M1,2, ‘Oì’B‘¥1,2, ŽR–{@‘n3, ¬ò˜aŽO˜Y3, Žsì‘ž•¶1,2: 1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3Á‰»Ší“à)

110082. [ŒŽ’˜] A Patient with Pancreatic Castleman's Disease Arising around the Main Pancreatic Duct. Matsumoto T1, Okuwaki K1, Kida M1, Jiang SX2, Imaizumi H1, Yamauchi H1, Miyazawa S1, Iwai T3, Takezawa M1, Tajima H4, Koizumi W1: Intern Med 2015/8; 54 (16): 2007-12. (Œ–{‚–Ÿ1, ‰œ˜e‹»‰î1, –Ø“cŒõL1, Ó@¢ˆ®2, ¡ò@O1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v3, ’|àVŽO‘ãŽq1, “c“‡@O4, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2•a—, 3‹~–œ, 4ŠO‰È)

110083. [ŒŽ’˜] Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography. Hidaka H1, Nakazawa T1, Fujii S, Yanagihara M, Minamino T1, Takada J1, Tanaka Y1, Okuwaki Y1, Shibuya A2, Koizumi W1: Hepatol Res 2015/9; 45 (9): 976-85. (“ú‚@‰›1, ’†àV‹MG1, “ì–ì@•×1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2ˆã—ÊǗ)

110084. [ŒŽ’˜] Structured endoscopic ultrasonography (EUS) training program improved knowledge and skills of trainees: Results from the Asian EUS Group. Wang MH, Dy F, Vu VK, Lim LG, Tayyab GU, Ratanachu-ek T, Samarasekera DN, Dhir V, Jin ZD, Kida M1, Seo DW, Wang HP, Teoh A, Hawes R, Varadarajulu S, Yasuda K, Ho KY: Dig Endosc 2015/9; 27 (6): 687-91. (–Ø“cŒõL1: 1Á‰»Ší“à)

110085. [ŒŽ’˜] Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer. Doi T, Yoshino T, Fuse N, Boku N, Yamazaki K, Koizumi W1, Shimada K, Takinishi Y, Ohtsu A: Invest New Drugs 2015/10; 33 (5): 1068-77. (¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110086. [ŒŽ’˜] Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma. Takada J1, Hidaka H1, Nakazawa T1, Kondo M, Numata K, Tanaka K, Matsunaga K, Okuse C, Kobayashi S, Morimoto M, Ohkawa S, Koizumi W1: BMC Res Notes 2015/10; 8: 609. (‚“cŽ÷ˆê1, “ú‚@‰›1, ’†àV‹M‰p1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

110087. [ŒŽ’˜] Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer. Sunakawa Y, Cao S, Berger MD, Matsusaka S, Yang D, Zhang W, Ning Y, Parekh A, Stremitzer S, Mendez A, Okazaki S, Wakatsuki T, Azuma M1, Shimada K, Watanabe M2, Koizumi W1, Wu AH, Lenz HJ: Pharmacogenomics J 2015/10/27. doi: 10.1038/tpj.2015.77. (“Œ@’q1, “n粏¹•F2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2ŠO‰È)

110088. [ŒŽ’˜] Precordial skin burns after endoscopic submucosal dissection for gastric tube cancer. Miyagi M1, Yoshio T1, Hirasawa T1, Ishiyama A1, Yamamoto Y1, Tsuchida T1, Fujisaki J1, Igarashi M1,2: Dig Endosc 2015/11; 27 (7): 742-6. (ŒÜ\—’³L1,2: 1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à)

110089. [ŒŽ’˜] Th17 cells reflect colon submucosal pathologic changes in active eosinophilic granulomatosis with polyangiitis. Tsurikisawa N1, Oshikata C1, Tsuburai T1, Sugano S1, Nakamura Y1, Shimoda T1,2, Tamama S1,2, Adachi K1,2, Horita A1, Saito I1, Saito H1: BMC Immunol 2015/12; 16: 75. (‰º“c‘ñ–ç1,2, ‹ÊáÁr•œ1,2, ˆÀ’B@Œ£1,2: 1‘—§‘Š–ÍŒŽ•a‰@, 2Á‰»Ší“à)

110090. [ŒŽ’˜] Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Horiuchi Y1, Fujisaki J1, Yamamoto N1, Shimizu T1, Miyamoto Y1, Tomida H1, Taniguchi C1, Morishige K1, Omae M1, Ishiyama A1, Yoshio T1, Hirasawa T1, Yamamoto Y1, Tsuchida T1, Igarashi M1,2, Nakajima T1, Takahashi H3: Gastric Cancer 2016/1; 19 (1): 160-5. (ŒÜ\—’³L1,2: 1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à, 3º˜a‘åŠw“¡‚ª‹u•a‰@)

110091. [ŒŽ’˜] Chemoradiotherapy for patients with recurrent lymph-node metastasis or local recurrence of gastric cancer after curative gastrectomy. Ishido K1, Higuchi K1, Tanabe S1,2, Azuma M1, Sasaki T1, Katada C1, Komori S3, Hayakawa K3, Hosoda K4, Yamashita K4, Katada N4, Koizumi W1: Jpn J Radiol 2016/1; 34 (1): 35-42. (ÎŒËŒªŽŸ1, ”óŒûŸ•F1, “c糁@‘1,2, “Œ@’q1, ²X–Ø“O1, Œ˜“ce—˜1, ¬X³Žq3, ‘ì˜ad3, ×“c@Œj4, ŽR‰ºŒpŽj4, •Ð“c‰Ä–ç4, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3•úŽËü (Žîá‡), 4ŠO‰È)

110092. [ŒŽ’˜] Roles of Capsule Endoscopy and Single-Balloon Enteroscopy in Diagnosing Unexplained Gastrointestinal Bleeding. Ooka S1, Kobayashi K1,2, Kawagishi K1, Kodo M1, Yokoyama K1, Sada M1, Tanabe S1,3, Koizumi W1: Clin Endosc 2016/1; 49 (1): 56-60. (‘剪³•œ1, ¬—ѐŽ“T1,2, ìŠÝ‰Á“Þ1, “n@—D1, ‰¡ŽR@ŒO1, ‹v•Û“c”ü˜a1, “c糁@‘1,3, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã)

110093. [ŒŽ’˜] The frequency of early colorectal cancer derived from sessile serrated adenoma/polyps among 1858 serrated polyps from a single institution. Chino A1, Yamamoto N1, Kato Y1, Morishige K1, Ishikawa H1, Kishihara T1, Fujisaki J1, Ishikawa Y1, Tamegai Y1, Igarashi M1,2: Int J Colorectal Dis 2016/2; 31 (2): 343-9. (ŒÜ\—’³L1,2: 1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à)

110094. [ŒŽ’˜] Systematic review comparing endoscopic, percutaneous and surgical pancreatic pseudocyst drainage. Teoh AY, Dhir V, Jin ZD, Kida M1, Seo DW, Ho KY: World J Gastrointest Endosc 2016/3; 8 (6); 310-8. (–Ø“cŒõL1: 1Á‰»Ší“à)

110095. [ŒŽ’˜] Radiation therapy for localized duodenal low-grade follicular lymphoma. Harada A, Oguchi M, Terui Y, Takeuchi K, Igarashi M1,2, Kozuka T, Harada K, Uno T, Hatake K: J Radiat Res 2016/3. pii: rrw011. [Epub ahead of print] (ŒÜ\—’³L1,2: 1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à)

120006. [ŒŽ’˜] _“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[‚É‚š‚¯‚é80ÎˆÈã‚̍‚—îŽÒ‚ɑ΂·‚é“àŽ‹‹Ÿ“I”S–Œ‰º‘w”—£p (ESD) Ž{só‹µ‚ƈÀ‘S«‚ÌŒŸØ. ˆäŒû–õO1, ¬—с@–Š1, ŽR“c”Žº1, H“¡Ø1, ˆäãr‘Ÿ˜Y1, Œ‘º@Œ«1,2, ’†ŽRž“T1,2, –{‹Ž@C1,2 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): _“ސìˆãŠw‰ïŽGŽ2015/7; 42 (2): 202-5.

120007. [ŒŽ’˜] “–‰@‚É‚š‚¯‚éƒAƒjƒTƒLƒXÇ‚ÌŒ»‹µ‚Æl-ƒƒ“ƒg[ƒ‹•â•‰º‚Ì’Ž‘Ì“Eo. ’Å–Œ³–Ÿ1, š •ª–ΔŽ1,2 (1V•S‡ƒ–‹u‘‡•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/12; 87 (1): 49-52.

120008. [ŒŽ’˜] VIŒ^Pit pattern‚ÆNBIŠg‘åŠÏŽ@‚É‚æ‚é‘å’°T1a-bŠà‚̊ӕʐf’f‚ÌŒ»ó‚Ɛf’f•sˆê’v—á‚ÌŒŸ“¢|ESDÇ—á‚𒆐S‚Ɂ|. ‘å‹÷Š°–Ø1, ˆ×‰äˆä–F˜Y1, •Ð‰ª¯‘Ÿ1, ‹g…Ëˆê1, XdŒ’“ñ˜Y1, ‹à@–Ÿ“N1,2, ÎìŠ°‚1, ŠÝŒŽ‹Pm1, ç–쏻Žq1, ŽR–{’q—Žq1, ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/12; 87 (1): 58-62.

120009. [ŒŽ’˜] ƒ{ƒmƒvƒ‰ƒUƒ“ƒtƒ}ƒ‹Ž_‰–•¹—p‚ÌHelicobacter pyloriœ‹Û‚Ì“–‰@‚̐¬Ñ|]—ˆƒŒƒWƒƒ“‚©‚çV‹KƒŒƒWƒƒ“‚ւ̏œ‹Û—Š„ˆÚ|. ŽOŽ}—zˆê1,2, ”üŒŽÃ1,2, ²“¡@•¶1,2, ‰Á“¡@Ê1,2, ‹gàV“Þ’ÃŽq1,2, ’|‰º’me1, ŽR›œ^‹G1, ×’J@’q1, ‰HœAŒ’m1, ‹g“c@‹I1, ¡è‹M¶1, ŽO‹Ž—˜‰·1, ŒŒ³Ž›ŽâX1,2, ‘åˆä“c³l1,2 (1ŽÐ•Û‘Š–Í–ì•a‰@, 2Á‰»Ší“à): Helicobacter Research 2016/2; 20 (1): 85-8.

210002. [€ŒŽ’˜ (Letters, Techniques and Images)] Future potential of EUS in the upper gastrointestinal tract: Diagnostic potential of endoscopic ultrasonography-elastography for gastric submucosal tumors. Azuma M1, Kusano C, Gotoda T: Digestive Endoscopy 2015/4; 27 (Suppl.1): 23. (“Œ@’q1: 1Á‰»Ší“à)

220003. [€ŒŽ’˜]y“ÁW: ‘Šú‘å’°Šà“àŽ‹‹ŸŽ¡—ÃŒã‚Ì’†E’·ŠúŒo‰ßzŽå‘茀‹†: “àŽ‹‹Ÿ“EœŒã‘å’°T1 (SM) Šà‚Ì“]ˆÚEÄ”­‚ÉŠÖ‚·‚é‘œŽ{Ý‹€“¯Œ€‹†|‘å’°ŠàŒ€‹†‰ïƒvƒƒWƒFƒNƒgŒ€‹†‚ÌŒ‹‰Ê‚©‚ç|. Ä“¡—T•ã, ‰ª@Žu˜Y, “c’†MŽ¡, Ö“¡@–L, ’rŒO˜N, ŒÜ\—’³L1,2, ˜a“cËé, H“¡i‰p, ¬—ѐŽ“T2,3, ˆäã—YŽu, ‰Y‰ªr•v, ”ѐ΍_N, ŽR–ì‘וä, ’ß“c@C, ‰i“cM“ñ, ‘ ŒŽWˆê, ŽRŒû—Tˆê˜Y, ²–ì@”J, Š~“c”ŽŽj, –xŒ‚”Ž, Ö“¡²ˆê, ã–ìGŽ÷, Î•‚ß‚®‚Ý, ÎìGŽ÷, –¡‰ª—mˆê, ‘å‘qN’j, “¡·F”Ž, “n糑–Ÿ, ™ŒŽŒ’ˆê (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ˆÝ‚Æ’° 2015/4; 50 (4): 448-56.

220004. [€ŒŽ’˜] lŠÔƒhƒbƒN‚̐S‘Ÿ’Ž‰¹”gŒŸž‚Ì‘I‘ð‚É‚š‚¯‚éV‚œ‚ÈŽæ‚è‘g‚Ý. Œ‰º‹G1, “n•Ó‚ ‚·‚Í1, ‘“ãç»1, ŒN’ˈè‘ã1, â–{˜a‘ã1, ¬òŽüŽq1,2, ‘ºã‰ë”ü1,3, “Œ–ì‹IŽq1,4, ’|àVŽO‘ãŽq1,2, ‰ª“c@ƒ1,5, ¬—ѐŽ“T1,2,6 (1Œ’N‰ÈŠwƒZƒ“ƒ^[, 2Á‰»Ší“à, 3zŠÂŠí“à, 4äPŒŽ•aEŠŽõ“à, 5–k—¢‘åŠw•ÛŒ’‰q¶ê–åŠw‰@, 6V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘‡Œ’f 2015/9; 42 (5): 492-9.

310001. [Ç—á•ñ] Peliosis hepatis disseminated rapidly throughout the liver in a patient with prostate cancer: a case report. Hidaka H1, Ohbu M2, Nakazawa T1, Matsumoto T1, Shibuya A3, Koizumi W1: J Med Case Rep 2015/9; 9: 194. (“ú‚@‰›1, ‘å•”@œ2, ’†àV‹MG1, Œ–{‚–Ÿ1, a’J–Ÿ—²3, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2ˆã—Éq¶Šw•”, 3ˆã—ÊǗ)

310002. [Ç—á•ñ] A Patient with Pancreatic Castleman's Disease Arising around the Main Pancreatic Duct. Matsumoto T1, Okuwaki K1, Kida M1, Jiang SX2, Imaizumi H1, Yamauchi H1, Miyazawa S1, Iwai T1,3, Takezawa M1, Tajima H4, Koizumi W1: Intern Med 2015/8; 54 (16): 2007-12. (Œ–{‚–Ÿ1, ‰œ˜e‹»‰î1, –Ø“cŒõL1, Ó@¢ˆ®2, ¡ò@O1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1,3, ’|àVŽO‘ãŽq1, “c“‡@O4, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2•a—, 3‹~–œ, 4ŠO‰È)

310003. [Ç—á•ñ] Electrohydraulic lithotripsy under peroral direct cholangioscopy using short-type single-balloon enteroscope for large common bile duct stone in patients with Roux-en-Y gastrectomy. Yamauchi H1, Kida M1, Miyazawa S1, Okuwaki K1, Imaizumi H1, Koizumi W1: Endoscopy 2015; 47 (S 01): E240-1. (ŽR“à_Žj1, –Ø“cŒõL1, ‹{àVŽu˜N1, ‰œ˜e‹»‰î1, ¡ò@O1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

310004. [Ç—á•ñ] Endoscopic ultrasound-guided choledochojejunostomy with a forward-viewing echoendoscope for severe benign bilioenteric stricture in a patient with Child's resection. Kida M1, Yamauchi H1, Okuwaki K1, Miyazawa S1, Imaizumi H1, Iwai T1,2, Koizumi W1: Endoscopy 2015; 47 (Suppl 1 UCTN): E303-4. (–Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, ¡ò@O1, Šâˆä’m‹v1,2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2‹~–œ)

310005. [Ç—á•ñ] Simultaneous side-by-side self-expanding metal stent placement using a two-channel endoscope for a bilioenteric stricture after Child's resection. Okuwaki K1, Yamauchi H1, Kida M1, Imaizumi H1, Miyazawa S1, Iwai T1,2, Koizumi W1: Endoscopy 2016; 48 (S 01): E51-2. (‰œ˜e‹»‰î1, ŽR“à_Žj1, –Ø“cŒõL1, ¡ò@O1, ‹{àVŽu˜N1, Šâˆä’m‹v1,2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2‹~–œ)

310006. [Ç—á•ñ] Cancer emerging from the recurrence of sessile serrated adenoma/polyp resected endoscopically 5 years ago. Chino A1, Nagayama S1, Ishikawa H1, Morishige K1, Kishihara T1, Arai M1, Sugiura Y1, Motoi N1, Yamamoto N1, Tamegai Y1, Igarashi M1,2: Jpn J Clin Oncol 2016 /1; 46 (1): 89-95. (ŒÜ\—’³L1,2: 1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à)

320002. [Ç—á•ñ] š‹‰º“àŽ‹‹ŸŒŸž‚É‚æ‚éš‹‰º•]‰¿‚ÌŽŽ‚Ý. ŽOŽ}—zˆê1,2, ”üŒŽÃ1,2, ‰Á“¡@Ê1,2, ‹gàV“Þ’ÃŽq1,2, ŒŒ³Ž›ŽâX1,2, ‘åˆä“c³l1,2 (1ŽÐ•Û‘Š–Í–ì•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/6; 86 (1): 130-1.

320003. [Ç—á•ñ] ‘œ”­SóŒ‹’°ŒeŽº‚É‚æ‚é‹·ó•”ˆÊ‚ÉPTP‚ª›Æ“ü‚µ‚œ1—á. ”g‘œ–ì‰l‘Ÿ1, ’†–Ú“N•œ1,2, ãŒŽˆê”¿1, –î–ì‹MŽj1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, r–ؐ³—Y1,2, •ÛŠ Šx—Y1, ‰Í–ì@Œå1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/6; 86 (1): 176-7.

320004. [Ç—á•ñ] •¡”‚Ì‘å’°ˆ««‹·ó‚ɑ΂µ“¯Žž‚É‘å’°ƒXƒeƒ“ƒg‚ð‘}“ü‚µ‚œ2—á. ìŠÝ‰Á“Þ1, ‹ß“¡—Y‹I1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬—ѐŽ“T1,2 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Progress of Digestive Endoscopy 2015/6; 86 (1): 180-1.

320005. [Ç—á•ñ] ’Œ’°”S–Œ’EÇŒóŒQ‚ɑ΂µ‚Ä“àŽ‹‹Ÿ“I“Eœ‚ª—LŒø‚Å‚ ‚Á‚œ1—á. ˆäã@‘å1, ŠÝŒŽ‹Pm1, ‘ºŒ—Y•ã1, ‰ª–{P•œ1, ‹à@–Ÿ“N1,2, ÎìŠ°‚1, ç–쏻Žq1, ˆ×‰äˆä–F˜Y1, ŽR–{’q—Žq1, ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/6; 86 (1): 184-5.

320006. [Ç—á•ñ] SMZ‚ðŠÏŽ@‚µ“Ÿ‚œ’Œ’°SMŠà‚Ì1—á. ‹{éŠ²Žj1, ˆ×‰äˆä–F˜Y1, ‹à@–Ÿ“N1,2, ç–쏻Žq1, ŠÝŒŽ‹Pm1, ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/6; 86 (1): 202-3.

320007. [Ç—á•ñ] ÎŠD‰»‚ª’˜–Ÿ‚Èsolid pseudopapillary neoplasm‚Ì1—á. ‘卂Žj¹1, –Ø“cŒõL1, ‰œ˜e‹»‰î1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ¡ò@O1, “c“‡@O2, ‘å•”@œ3, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ŠO‰È, 3ˆã—Éq¶Šw•”): Progress of Digestive Endoscopy 2015/6; 86 (1): 224-5.

320008. [Ç—á•ñ] ‰ð—£«‘å“®–¬áŽ”j—ô‚É‚æ‚éH“¹ú”j‚̐f’f‚ɏ㕔Á‰»ŠÇ“àŽ‹‹Ÿ‚ª—L—p‚Å‚ ‚Á‚œ1—á. ŠâèGˆê˜Y1, –î–ì‹MŽj1,2, ãŒŽˆê”¿1, ’†–Ú“N•œ1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, r–ؐ³—Y1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/12; 87 (1): 90-1.

320009. [Ç—á•ñ] Barrett'sH“¹‚ɐ¶‚¶‚œˆÙŽž«‘œ”­Barrett'sH“¹‘BŠà‚ÉESD‚ðŽ{s‚µ‚œ1—á. ‘å‘O‰ëŽÀ1, “¡è‡Žq1, –x“à—T‰î1, —R—Y•q”V1, ÎŽRW¢Žu1, •œàVr–Ÿ1, ŽR–{—Š³1, “y“c’mG1, ŒÜ\—’³L1,2, ŽR–{’q—Žq1 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/12; 87 (1): 98-9.

320010. [Ç—á•ñ] Á‰»ŠÇoŒŒ‚𔺂€¬’°GIST‚É‚æ‚è‹Ù‹}Žèp‚ð—v‚µ‚œ1—á. ²–ì@“§1, –î–ì‹MŽj2, ˜a“c®‹v1,2, ãŒŽˆê”¿1, ’†–Ú“N•œ1,2, ‹gàV“Þ’ÃŽq1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, r–ؐ³—Y1,2, ²X–؈ꌛ1, ‰Í–ì@Œå1, •—ŠÔ‹Å’j1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/12; 87 (1): 166-7.

320011. [Ç—á•ñ] ‘Šú‘å’°’ᕪ‰»‘BŠà4—á‚ÌŒŸ“¢. ÎìŠ°‚1, ç–쏻Žq1, •Ð‰ª¯‘Ÿ1, ‹g…Ëˆê1, ‘å‹÷Š°–Ø1, XdŒ’“ñ˜Y1, ŠÝŒŽ‹Pm1, ˆ×‰äˆä–F˜Y1, ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Progress of Digestive Endoscopy 2015/12; 87 (1): 180-1.

510003. [‘à] Innovations and techniques for balloon-enteroscope-assisted endoscopic retrograde cholangiopancreatography in patients with altered gastrointestinal anatomy. Yamauchi H1, Kida M1, Imaizumi H1, Okuwaki K1, Miyazawa S1, Iwai T1,2, Koizumi W1: World J Gastroenterol 2015/6; 21 (21): 6460-9. (ŽR“à_Žj1, –Ø“cŒõL1, ¡ò@O1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1,2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2‹~–œ)

510004. [‘à] Diagnosis of Obscure Gastrointestinal Bleeding. Tanabe S1,2: Clin Endosc 2016/2; doi: 10.5946/ce.2016.004. (“c糁@‘1,2: 1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à)

520006. [‘à] ’Ž‰¹”gŒŸž‚É‚š‚¯‚é‰æˆê‰»‚µ‚œ‰æ‘œìo‚𓥂܂Š‚œˆãŽtE‹ZŽtŠÔ‚̉摜î•ñ‹€—L‰»ƒVƒXƒeƒ€‚̍\’z. •Ÿ‰i—˜ŒbŽq1, ŽRŒûGŽ÷1, ŽRè@„1, ì”š@‹v1, ‹à‘òG‹I1, ˆÀ’B@Œ£1,2, ‹à“cŒå˜Y1 (1‘—§‘Š–ÍŒŽ•a‰@, 2Á‰»Ší“à): ˆã—Â̍Lê 2015/5; 55 (5): 4-6.

520007. [‘à] ‘ŠúˆÝŠà‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Â̌»‹µ‚Ə«—ˆ“W–]. “c糁@‘1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à): –k—¢ˆãŠw 2015/6; 45 (1): 1-9.

520008. [‘à] ‘å’°‹˜Ž•óŽ••Ï‚É—R—ˆ‚µ‚œ‘å’°Šà‚̈â“`Žq•ÏˆÙƒvƒƒtƒ@ƒCƒ‹‚ÉŠÖ‚·‚錟“¢. ç–쏻Žq1, ’·ŽR@‘1, ŽR–{’q—Žq1, ‰Í“à@—m1, ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): ‘å˜aØŒ”ƒwƒ‹ƒXà’cŒ€‹†‹ÆÑW 2016/3; 39: 77-81.

521003. [‰ðà]y‰ðà: ‚æ‚­‚í‚©‚é‘å’°ESD/EMRƒKƒCƒhƒ‰ƒCƒ“z ESD/EMR‚ÌŽüpŠúŠÇ—. ŒÜ\—’³L1,2, ç–쏻Žq1, ŠÝŒŽ‹Pm1, ˆ×‰äˆä–F˜Y1 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Intestine 2015/9; 19 (5): 467-74.

522026. [uÀ]y“ÁW: ‰ŠÇ«’°ŽŸŠ³f—Â̍őOüz—Տ°Çó‚©‚牊Ç«’°ŽŸŠ³‚𑁂­f’f‚·‚éƒRƒc. ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): “ú–{ˆãŽt‰ïŽGŽ 2015/4; 144 (1): 35-9.

522027. [uÀ]y“ÁW: isˆÝŠà‚ÌŽ¡—Ð헪zŽ¡–üØœ•s”\‚ȐisEÄ”­ˆÝŠà‚̍ŐVŽ¡—Ð헪|V‚œ‚ÈŽ¡—ÃIƒvƒVƒ‡ƒ“‚Ì“oê|. ¬ò˜aŽO˜Y (Á‰»Ší“à): Approach to Oncology 2015/4; 12: 7-9.

522028. [uÀ]y“ÁW: ’_äXEUS-FNA‚̃Gƒrƒfƒ“ƒX2015|‚±‚Ì5”NŠÔ‚̐i•à|zŒŒŠÇ“àŽ¡—Ã. Šâˆä’m‹v1, –Ø“cŒõL1, ‹àŽq@‹œ1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ’_‚ÆäX 2015/4; 36 (4): 375-8.

522029. [uÀ]y“ÁW: Á‰»Ší“àŽ‹‹Ÿf—Âɂš‚¯‚é“KØ‚È’ÁÃ–@|VƒKƒCƒhƒ‰ƒCƒ“‚̐³‚µ‚¢—‰ðE‰^—p‚Ì‚œ‚߂Ɂ|z 4. “àŽ‹‹Ÿf—Âɂš‚¯‚é’ÁÃ‚̈Ӌ`‚Ƃ킪‘‚ÌŒ»‹µ. “c糁@‘1,2, ²X–Ø“O2, Œ˜“ce—˜2, “Œ@’q2, ÎŒËŒªŽŸ2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à): —ÕଏÁ‰»Ší“à‰È 2015/4; 30 (5): 539-42.

522030. [uÀ]y“ÁW: ‰º•”Á‰»ŠÇ: ‰ŠÇ‚©‚ç‚Ì”­Šàz2-2. ‰ŠÇ”­Šà‚̐f’f@(2) ŠëŒ¯ˆöŽq. ¬—ѐŽ“T1,2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): Intestine 2015/7; 19 (4): 356-60.

522031. [uÀ]y“ÁW: ‘å’°LST (‘€•û”­ˆçŒ^Žîá‡) ‚̐V“WŠJz1-4. ”­¶•”ˆÊ•Ê‚ÉŒ©‚œLST‚Ì“Á’¥. ç–쏻Žq1, XdŒ’“ñ˜Y1, ÎìŠ°‚1, ŠÝŒŽ‹Pm1, ˆ×‰äˆä–F˜N1, ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): —ÕଏÁ‰»Ší“à‰È 2015/7; 30 (9): 1155-62.

522032. [uÀ]y“ÁW: ’×ᇐ«‘å’°‰Š‚̍œKŽ¡—ÂƗՏ°“I–â‘è‚ւ̑΍ôz5-ASA»Ü‚ð‚Ç‚€Žg‚€‚©|‚»‚ÌŽ¡—Ð헪|. ¬—ѐŽ“T1,2, ìŠÝ‰Á“Þ2, ‘剪³•œ2, ‰¡ŽR@ŒO2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): Á‰»Ší‚̗Տ° 2015/8; 18 (4): 345-50.

522033. [uÀ]y“ÁW: “à‰Èƒvƒ‰ƒCƒ}ƒŠƒPƒA‚Ì‚œ‚߂̏Á‰»Šíf—ÃUpdatez¡ŠÌŽŸŠ³@”ñ‘㏞«ŠÌd•Ï. ‰œ˜e—T‰î1, a’J–Ÿ—²1,2 (1Á‰»Ší“à, 2ˆã—ÊǗ): Medicina 2015/9; 52 (10): 1767-9.

522034. [uÀ]y“ÁW: ŒŒ•Ö‚ð‚Ý‚œ‚çz‘˜_@‰º•”Á‰»ŠÇoŒŒ‚ɑ΂·‚éf’fƒAƒ‹ƒSƒŠƒYƒ€. ¬—ѐŽ“T1,2, ‘剪³•œ2, ìŠÝ‰Á“Þ2, ‰¡ŽR@ŒO2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2015/10; 27 (10): 1608-15.

522035. [uÀ]y“ÁWI: ’m‚Á‚Ä‚š‚«‚œ‚¢@Á‰»ŠÇŠà –ò•š—Ö@‚ÌŠî–{z“úíf—ÂŊà‚Æ‘˜‹ö‚µ‚œŽž, Á‰»Ší“à‰Èˆã‚Í‚Ç‚€‘Ήž‚·‚é‚©. ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Á‰»Ší‚̗Տ° 2015/10; 18 (5): 435-40.

522036. [uÀ]y“ÁW: LECS (laparoscopy and endoscopy cooperative surgery) ‚̐V‚œ‚È“WŠJz4-2. ˆÝˆÈŠO‚ւ̉ž—p@(2) ‘å’°‚É‚š‚¯‚éLECS. ˆ×‰äˆä–F˜Y1, ŠÝŒŽ‹Pm1, •Ÿ’·—m‰î1, ç–쏻Žq1, “¡–{‰À–ç1, H‹g‚Žu1, ¬Œ@‹B1, ã–ì‰ëŽ‘1, ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): —ÕଏÁ‰»Ší“à‰È 2015/10; 30 (12): 1551-9.

522037. [uÀ]y“ÁW: ƒ}ƒ‹ƒ`ƒƒfƒBƒAŽž‘ã‚Ì“àŽ‹‹Ÿf—ÁzŠe˜_ [‰æ‘œƒtƒ@ƒCƒŠƒ“ƒOƒVƒXƒeƒ€‚Ì“Á’¥] ƒIƒŠƒ“ƒpƒX: Solemio ENDO. ŠÝŒŽ‹Pm1, ç–쏻Žq1, ŒÜ\—’³L1,2, XdŒ’“ñ˜Y1, ÎìŠ°‚1, ˆ×‰äˆä–F˜Y1 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2015/11; 27 (11): 1761-7.

522038. [uÀ]y“ÁW: ‰ºˆô“ªEèò•”H“¹•\ÝŠà‚Ì“àŽ‹‹Ÿf’f‚ÆŽ¡—ÁzŒûoEˆôA“ª‚Ì“àŽ‹‹ŸŠÏŽ@. ˜a“c‘ñ–ç1, Œ˜“ce—˜1, “c糁@‘1,2, –î–ì‹MŽj1, ÎŒËŒªŽŸ1, “Œ@’q1, ²X–Ø“O1, ‰Á”[Fˆê3, ‰ª–{—·l3, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3Žš•@ˆôAE“ªèòŠO): Á‰»Ší“àŽ‹‹Ÿ 2016/1; 28 (1): 27-35.

522039. [uÀ]y“ÁW: ”x‚ª‚ñEˆÝ‚ª‚ñE‘å’°‚ª‚ñ|‚»‚̃tƒ@[ƒXƒgƒ‰ƒCƒ“‚ðI‚Š‚œ‚ç?z2. ƒZƒJƒ“ƒhƒ‰ƒCƒ“ˆÈ~‚̉»Šw—Ö@Ž¡—Ð헪‚Í?@2) ˆÝ‚ª‚ñ@…@HER2‰A«ˆÝ‚ª‚ñ. –î–ì‹MŽj1, ÎŒËŒªŽŸ1, ²X–Ø“O1 (1Á‰»Ší“à): —Տ°Žîᇃvƒ‰ƒNƒeƒBƒX 2016/2; 12 (1): 41-7.

522040. [uÀ]y“ÁW: –å–¬ˆ³˜ŽiÇ‚̐§Œä|•a‘ÔŒ€‹†‚ÆŽ¡—Â̐i“WzŠT”O, ‹@˜, f’f@‰¢•Ä‚É‚š‚¯‚é–å–¬ˆ³˜ŽiÇŒ€‹†|Baveno VI‚©‚ç|.“ú‚@‰› (Á‰»Ší“à): ŠÌ’_äX 2016/2; 72 (2): 219-23.

522041. [uÀ]y“ÁW: –å–¬ˆ³˜ŽiÇ‚̐§Œä|•a‘ÔŒ€‹†‚ÆŽ¡—Â̐i“WzˆÝEH“¹Ã–¬áŽ‚̃}ƒl[ƒWƒƒ“ƒg@H“¹Ã–¬áŽ”j—ô‚ɑ΂·‚éƒXƒeƒ“ƒgŽ~ŒŒ‚͉”\‚©. •œŽR—Yˆê1, š •ª–ΔŽ1,2, Îˆä¬–Ÿ1, V‘q—˜Œ[1, ’Å–Œ³–Ÿ1, ì‘º—Y„1, –qŽR—TŒ°1, ’†“c‚‰›1, ŒÑ“c@‘ñ1, LÎ˜a³1, ˆä‰ô“¹•v1 (1V•S‡ƒ–‹u‘‡•a‰@, 2Á‰»Ší“à): ŠÌ’_äX 2016/2; 72 (2): 255-9.

522042. [uÀ]y“ÁW: –å–¬ˆ³˜ŽiÇ‚̐§Œä|•a‘ÔŒ€‹†‚ÆŽ¡—Â̐i“WzÀ’k‰ïgŠÌ“à’_ŠÇŠà: Ž¡—ЬÑ‚̉ü‘P‚ð–ÚŽw‚µ‚āh. Žs“c—²•¶, š •ª–ΔŽ1,2, ’J‡M•F, ’†‘ºŒ’Ž¡ (1V•S‡ƒ–‹u‘‡•a‰@, 2Á‰»Ší“à): ŠÌ’_äX 2016/2; 72 (2): 349-61.

522043. [uÀ]y“ÁW: Á‰»ŠÇŒeŽº‚̍ŋ߂̘b‘èz4. \“ñŽw’°ŒeŽº‚ÆŠÖ˜AŽŸŠ³. ¡ò@O1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): —ÕଏÁ‰»Ší“à‰È 2016/3; 31(4): 399-404.

530003. [‚»‚Ì‘Œ (ƒKƒCƒhƒ‰ƒCƒ“)] Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Watanabe T1, Itabashi M1, Shimada Y1, Tanaka S1, Ito Y1, Ajioka Y1, Hamaguchi T1, Hyodo I1, Igarashi M1,2,3, Ishida H1, Ishihara S1, Ishiguro M1, Kanemitsu Y1, Kokudo N1, Muro K1, Ochiai A1, Oguchi M1, Ohkura Y1, Saito Y1, Sakai Y1, Ueno H1, Yoshino T1, Boku N1, Fujimori T1, Koinuma N1, Morita T1, Nishimura G1, Sakata Y1, Takahashi K1, Tsuruta O1, Yamaguchi T1, Yoshida M1, Yamaguchi N1, Kotake K1, Sugihara K1 (1Japanese Society for Cancer of the Colon and Rectum): Int J Clin Oncol 2015/4; 20 (2): 207-39. (ŒÜ\—’³L1,2,3: 2‚ª‚ñŒ€—L–Ÿ•a‰@, 3Á‰»Ší“à)

530004. [‚»‚Ì‘Œ (ƒKƒCƒhƒ‰ƒCƒ“)] JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Tanaka S, Kashida H, Saito Y, Yahagi N, Yamano H, Saito S, Hisabe T, Yao T, Watanabe M, Yoshida M, Kudo SE, Tsuruta O, Sugihara K, Watanabe T, Saitoh Y, Igarashi M1,2, Toyonaga T, Ajioka Y, Ichinose M, Matsui T, Sugita A, Sugano K, Fujimoto K, Tajiri H: Dig Endosc 2015 /5; 27 (4): 417-34. (ŒÜ\—’³L1,2: 1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à)

530005. [‚»‚Ì‘Œ (ƒKƒCƒhƒ‰ƒCƒ“)] Guidelines for sedation in gastroenterological endoscopy. Obara K, Haruma K, Irisawa A, Kaise M, Gotoda T, Sugiyama M, Tanabe S1,2, Horiuchi A, Fujita N, Ozaki M, Yoshida M, Matsui T, Ichinose M, Kaminishi M: Dig Endosc 2015/5; 27 (4): 435-49. (“c糁@‘1,2: 1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à)

540004. [‚»‚Ì‘Œ (ƒKƒCƒhƒ‰ƒCƒ“)] ERCPŒãäX‰ŠƒKƒCƒhƒ‰ƒCƒ“2015. •õ@“OÆ1, –ŸÎ—²‹g1, ˆÉ“¡“S‰p1, ìŒû‹`–Ÿ1, ›–ì@“Ö1, –Ø“cŒõL1,2, ‰Ô“cŒhŽm1, ‹{ìG”V1, ŽRŒû•l1, X›‰•q•v1, ‰º£ì“O1, ’|ŽR‹X“T1, ^‹|r•F1 (1Œú¶˜J“­È“«äXŽŸŠ³’²žŒ€‹†”ǁE“ú–{äX‘ŸŠw‰ï, 2Á‰»Ší“à): äX‘Ÿ 2015/8; 30 (4): 539-84.

[’˜@‘]

620018. [Šwp‘ (•ª’SŽ·•M)]yƒKƒCƒhƒ‰ƒCƒ“ƒTƒ|[ƒgƒnƒ“ƒhƒuƒbƒN@‘å’°Šà2014”N”Łz‘å’°ESD‚Ì“K‰ž‚ÆŽè‹Zã‚Ì’ˆÓ“_, p.61-2. ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à), •Ò: ™ŒŽŒ’ˆê, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2015/4”­s.

620019. [Šwp‘ (•ª’SŽ·•M)]yÅV—Տ°‘å’°ŠàŠw|Šî‘bŒ€‹†‚©‚ç—Տ°‰ž—p‚ց| (“ú–{—Õà¬2015‘Š§†)zVII. ‘å’°Šà‚ÌŒŸžEf’f@2. ŒŽ”­‘ƒ‚̐f’f@(3) Šg‘å“àŽ‹‹ŸŒŸž‚É‚æ‚épit pattern•ª—Þ‚ð—p‚¢‚œ‘å’°‘ŠúŠà‚̐[’B“xf’f, p.273-7. ç–쏻Žq1, ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à), “ú–{—Õ଎Ð, ‘åâ, 2015/4”­s.

620020. [Šwp‘ (•ª’SŽ·•M)]yˆ’u‹ï‚ðŽg‚¢‚±‚È‚· (Á‰»Ší“àŽ‹‹Ÿ8ŒŽ‘‘卆)z[Á‰»ŠÇ‹·óE•ÂÇ‰ðœ] —ǐ«‹·ó‰ðœ@¬’°E‰ñ–Ó•”E‘咰ፍ­«‹·ó‚̃oƒ‹[ƒ“Šg’£p‚É—p‚¢‚鏈’u‹ï‚ðŽg‚¢‚±‚È‚·ƒRƒc, p.1341-3. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1,2 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2015/8”­s.

620021. [Šwp‘ (•ª’SŽ·•M)]yŒŒ‰t“à‰ÈƒNƒŠƒjƒJƒ‹ƒXƒ^ƒ“ƒ_[ƒh ‘æ3”ŁzIV. ‰»Šw—Ö@’†‚ÌŽxŽ—Ö@@5. ŠÌ‰ŠEŠÌ‹@”\áŠQ, p.371-6. “n粐^²1 (1Á‰»Ší“à), •Ò: “ŒŒŽ³–Ÿ2, {‰i^Ži (2ŒŒ‰t“à), •¶Œõ“°, “Œ‹ž, 2015/10”­s.

620022. [Šwp‘ (•ª’SŽ·•M)]yŽÀ—Տ°‚ɖ𗧂ÂIBD“àŽ‹‹Ÿz‘æ2Í IBD‚Ì“àŽ‹‹Ÿf’f@2. ‘ŒŽŸŠ³‚Æ‚ÌŠÓ•Ê 1. ’°ŠÇƒx[ƒ`ƒFƒbƒg•aE’Pƒ«’×á‡, p.37-43. ¬—ѐŽ“T1,2 ‰¡ŽR@ŒO2, ²“c”ü˜a2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à), ŠÄC: “ú”ä‹I•¶3, ŽR–{”Ž“¿, •Ò: ‹vŒ—ˆê, –î–ì’q‘¥ (3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È), “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2015/10”­s.

620023. [Šwp‘ (•ª’SŽ·•M)]yŽÀ—Տ°‚ɖ𗧂ÂIBD“àŽ‹‹Ÿz‘æ5Í “àŽ‹‹Ÿ‚É‚æ‚éIBDƒ‚ƒjƒ^ƒŠƒ“ƒO@[Še˜_] ’×ᇐ«‘å’°‰Š@2. ŠO—ˆ‚ł̃‚ƒjƒ^ƒŠƒ“ƒO@…A—Տ°Çó‚Æ“àŽ‹‹ŸŠŒ©‚ªˆê’v‚µ‚È‚¢Ç—á (Ž¡—Ë­‰»‚ð‚Ç‚€‚â‚Á‚ÄŒˆ‚ß‚é‚©?), p.124-30. ‰¡ŽR@ŒO (Á‰»Ší“à), ŠÄC: “ú”ä‹I•¶, ŽR–{”Ž“¿, •Ò: ‹vŒ—ˆê, –î–ì’q‘¥, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2015/10”­s.

620024. [Šwp‘ (•ª’SŽ·•M)]y–ƉuÇŒóŒQ (‘æ2”Å) I|‚»‚Ì‘Œ‚̖ƉuŽŸŠ³‚ðŠÜ‚߂ā| (•Êû“ú–{—ÕଠV—̈æ•ÊÇŒóŒQƒVƒŠ[ƒY No.34)zI. ‘ŸŠí“ÁˆÙ“IŽ©ŒÈ–ƉuŽŸŠ³@4. Ž©ŒÈ–Ɖu«Á‰»ŠíŽŸŠ³ (Á‰»ŠÇ, ŠÌ’_äX)@(1) Ž©ŒÈ–Ɖu«ˆÏk«ˆÝ‰Š‚̐f’f‚ÆŽ¡—Ã, p.344-7. ÎŒËŒªŽŸ1, “c糁@‘1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã), “ú–{—Õ଎Ð, ‘åã, 2015/11”­s.

620025. [Šwp‘ (•ª’SŽ·•M)]yˆÝ‚ª‚ñ–ò•šŽ¡—ÃQ&Az4. ˆÝ‚ª‚ñ–ò•šŽ¡—Âɗp‚¢‚ç‚ê‚郌ƒWƒƒ“‚ÌŽí—Þ‚Æ“Á’¥‚Í?@CQ16. SP—Ö@ (S-1+CDDP) ‚ð‚Ç‚€Žg‚¢‚±‚È‚·‚©?, p.52-5. ¬ò˜aŽO˜Y (Á‰»Ší“à), •Ò: ²“¡@‰·, ƒ”ƒ@ƒ“ ƒƒfƒBƒJƒ‹, “Œ‹ž, 2015/12”­s.

620026. [Šwp‘ (•ª’SŽ·•M)]yˆÝ‚ª‚ñ–ò•šŽ¡—ÃQ&Az4. ˆÝ‚ª‚ñ–ò•šŽ¡—Âɗp‚¢‚ç‚ê‚郌ƒWƒƒ“‚ÌŽí—Þ‚Æ“Á’¥‚Í?@CQ17. XP—Ö@ (Cape+CDDP) ‚ð‚Ç‚€Žg‚¢‚±‚È‚·‚©?, p.56-7. ¬ò˜aŽO˜Y (Á‰»Ší“à), •Ò: ²“¡@‰·, ƒ”ƒ@ƒ“ ƒƒfƒBƒJƒ‹, “Œ‹ž, 2015/12”­s.

620027. [Šwp‘ (•ª’SŽ·•M)]yˆÝ‚ª‚ñ–ò•šŽ¡—ÃQ&Az4. ˆÝ‚ª‚ñ–ò•šŽ¡—Âɗp‚¢‚ç‚ê‚郌ƒWƒƒ“‚ÌŽí—Þ‚Æ“Á’¥‚Í?@CQ18. SOX—Ö@ (S-1+L-OHP) ‚ð‚Ç‚€Žg‚¢‚±‚È‚·‚©?, p.58-60. ¬ò˜aŽO˜Y (Á‰»Ší“à), •Ò: ²“¡@‰·, ƒ”ƒ@ƒ“ ƒƒfƒBƒJƒ‹, “Œ‹ž, 2015/12”­s.

620028. [Šwp‘ (•ÒW)]y‘å’°ŽŸŠ³NOW 2016 ‘å’°Šà‚̐f’f‚ÆŽ¡—Ãupdatez•ÒWŽåŠ²: ™ŒŽŒ’ˆê, •Ò: ŒÜ\—’³L1,2, “n糑–Ÿ, ‘å‘qN’j (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à), •ÒWŒÚ–â: •“¡“Oˆê˜Y, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2016/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712004. [Šw‰ï (‘Û)] (‘Ûƒ[ƒNƒVƒ‡ƒbƒv) EUS anatomy of Bilio-pancreatic system (Linear). Iwai T1: EUS phantom workshop (2015/4/25), Chia-Yi Christian Hospital, Chiayi City, Taiwan. (Šâˆä’m‹v1: 1Á‰»Ší“à)

712005. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Endoscopic ultrasonography using new functions -tissue harmonic echo, contrast echo, and elastography-. Iwai T1: 17th early GI cancer & 20th EUS meeting (2015/4/26), Chia-Yi Christian Hospital, Chiayi City, Taiwan. (Šâˆä’m‹v1: 1Á‰»Ší“à)

712006. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Balloon-Occluded Retrograde Transvenous Obliteration (B-RTO) from the Standpoint of Gastroenterologists. Hidaka H1: JSIR/ISIR/APCIO 2015 (2015/5/29), Miyazaki, Jpn Intervent Radiol 2015; 30 (suppl): 29. (“ú‚@‰›1: 1Á‰»Ší“à)

712007. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) EUS Anatomy of Bilio-Pancreatic system (Linear). Kida M1: DEST 1st ANNUAL CONGRESS 2015 (2015/8/22-23), Taipei, Taiwan. (–Ø“cŒõL1: 1Á‰»Ší“à)

712008. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) How to perform Guide-wire (GW) for Bilio-Pancreatic Endoscopy. Kida M1: DEST 1st ANNUAL CONGRESS 2015 (2015/8/22-23), Taipei, Taiwan. (–Ø“cŒõL1: 1Á‰»Ší“à)

712009. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) New Era of Endoscopic ultrasonography using New functions-tissue harmonic echo, contrast echo, and elastography-. Kida M1: DEST 1st ANNUAL CONGRESS 2015 (2015/8/22-23), Taipei, Taiwan. (–Ø“cŒõL1: 1Á‰»Ší“à)

712010. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) Technique of EUS-FNA. Kida M1: DEST 1st ANNUAL CONGRESS 2015 (2015/8/22-23), Taipei, Taiwan. (–Ø“cŒõL1: 1Á‰»Ší“à)

712011. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) Endoscopic diagnosis and cancer prevention for superficial squamous cell carcinoma of the esophagus and head and neck. Katada C1: 2015 Summit Forum - Prevention, early diagnosis and treatment of esophageal cancer in China (2015/9/19), Shanghai, China. (Œ˜“ce—˜1: 1Á‰»Ší“à)

712012. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) Indications of EUS-FNA. Kida M1: 1st Asian EUS Congress 2015 (2015/9/11-12), Seoul, Korea. (–Ø“cŒõL1: 1Á‰»Ší“à)

712013. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) Submucosal Tumor (SMT) & Gastric Cancer. Kida M1: 1st Asian EUS Congress 2015 (2015/9/11-12), Seoul, Korea. (–Ø“cŒõL1: 1Á‰»Ší“à)

712014. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) The role of forward viewing echoendoscopes for interventional EUS. Imaizumi H1: The 18th National Academic Endoscopic Ultrasound Conference (2015/10/16), Shanghai, Chaina. (¡ò@O1: 1Á‰»Ší“à)

713016. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Estrogen receptor beta (ERƒÀ) gene polymorphisms as a predictor of overall survival in patients with gastric cancer (GC) from Japan and Los Angeles County (LAC). Parekh A, Sunakawa Y, Cao S, Matsusaka S, Yang D, Zhang W, Wakatsuki T, Ning Y, Stremitzer S, Mendez A, Okazaki S, Elkhoueiry R, Iqbal S, Barzi A, Azuma M1, Watanabe M2, Koizumi W1, Wu A, Lenz HJ: ASCO 2015 (2015/5/29-6/2), Chicago, USA. (“Œ@’q1, “n粏¹•F2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2ŠO‰È)

713017. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) A Case of ulcerative colitis with duodenal lesions that markedly responded to infliximab. Sasaki T1, Kawagishi K1, Yokoyama K1, Uehara K1, Kobayashi K1,2: AOCC 2015 (2015/6/18-20), Beijing, China. (²X–Ø“NŽO1, ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ãŒŽˆê”¿1, ¬—ѐŽ“T1,2: 1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

713018. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Current status of self-injection and associatesd problems in patients with IBD - from the viewpoint of physicians and nurses. Yokoyama K1, Kawagishi K1, Ohoka S1, Sada M1, Kobayashi K1,2, Takizawa K3, Uchida Y3, Yamaguchi Y: AOCC 2015 (2015/6/18-20), Beijing, China. (‰¡ŽR@ŒO1, ìŠÝ‰Á“Þ1, ‘剪³•œ1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ‘êàVD3, “à“c—L‰Á3: 1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3ŠÅŒì•”)

713019. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Patients with infectious coletis suggestive of inflammatory bowel disease. Kawagishi K1, Yokoyama K1, Uehara K1, Sasaki T1, Kato A1, Kobayashi K1,2: AOCC 2015 (2015/6/18-20), Beijing, China. (ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ãŒŽˆê”¿1, ²X–Ø“NŽO1, ‰Á“¡@Ê1, ¬—ѐŽ“T1,2: 1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

713020. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Two patients suspected to have inflammatory bowel disease and autoimmune pancreatitis. Uehara K1, Kawagishi K1, Yokoyama K1, Sasaki T1, Kobayashi K1,2: AOCC 2015 (2015/6/18-20), Beijing, China. (ãŒŽˆê”¿1, ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ²X–Ø“NŽO1, ¬—ѐŽ“T1,2: 1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

713021. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Comparison of diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration with a core biopsy needle and a conventional aspiration needle in the same patients. Miyata E1, Kida M1, Imaizumi H1, Kaneko T1, Yamauchi H1, Okuwaki K1, Miyazawa S1, Iwai T1, Koizumi W1: 1st Asian EUS Congress 2015 (2015/9/11-12), Korea. (‹{“c‰pŽ¡1, –Ø“cŒõL1, ¡ò@O1, ‹àŽq@‹œ1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713022. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Percutaneous transesophageal gastrotubing (PTEG) for the patients that percutaneous endoscopic gastrostomy (PEG) insertion is impossible - usefulness of endoscopically assisted procedure. Murakami M, Nishino K, Murakami S, Mori K, Murakami B, Azuma M1, Tanabe S1,2, Kida M1, Koizumi W1: UEGW 2015 (2015/10/24-28), Barcelona, Spain. (“Œ@’q1, “c糁@‘1,2, –Ø“cŒõL1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã)

713023. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Analyses of progressive disease patients with advanced hepatocellular carcinoma treated with sorafenib: prognoses, treatments, and progression patterns. Yamane K1, Nakazawa T1, Hidaka H1, Kubota K1, Inoue T1, Okuwaki Y1, Tanaka Y1, Takada J1, Shibuya A1,2, Koizumi W1: AASLD THE LIVER MEETING 2015 (2015/11/14), San Francisco, USA. (ŽRªŒhŽq1, ’†àV‹MG1, “ú‚@‰›1, ŒE“cK‰î1, ˆäã’qm1, ‰œ˜e—T‰î1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2ˆã—ÊǗ)

713024. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Prognostic analyses of progressive disease patients with advanced Hepatoma treated with sorafenib. Yamane K1, Nakazawa T1, Hidaka H1, Kubota K1, Inoue T1, Okuwaki Y1, Tanaka Y1, Takada J1, Minamino T1, Shibuya A1,2, Koizumi W1: APASL 2016 (2016/2/22), Tokyo. (ŽRªŒhŽq1, ’†àV‹MG1, “ú‚@‰›1, ŒE“cK‰î1, ˆäã’qm1, ‰œ˜e—T‰î1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, “ì–ì@•×1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2ˆã—ÊǗ)

713025. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Usefulness of, and factors influencing, the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) for the evaluation of short-term treatment response. Kawagishi K1, Yokoyama K1, Kobayashi K1,2: 11th Congress of ECCO (2016/3/16-19), Amsterdam, Netherlands. (ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ¬—ѐŽ“T1,2: 1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

722010. [Šw‰ï (‘S‘)] (Ç—á•ñ) “–‰@‚ÅŒoŒ±‚µ‚œSister Mary Joseph's nodule‚Ì2—á. “ü]ˆõs1, ‰º“c‘ñ–ç1,2, ¬ŽRŽŽ÷1, Œ–{—Y‘Ÿ1, ‹ÊáÁr•œ1,2, ’†‘º—zŽq1, ›–ì@‘1, ˆÀ’B@Œ£1,2, ª–{¹”V1 (1‘—§‘Š–ÍŒŽ•a‰@, 2Á‰»Ší“à): ‘æ101‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2015/4/23-25), å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2015/9; 112 (—Õ‘): A907.

722011. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yŠÌd•Ï‚̕“I‚ȃ}ƒlƒWƒƒ“ƒgz“Á”­«×‹Û«• –Œ‰Š‚ƃvƒƒgƒ“ƒ|ƒ“ƒvƒCƒ“ƒqƒrƒ^[’·Šú“Š—^‚Æ‚ÌŠÖ˜A«|”ñ–ÓŒŸ–³ìˆ×”äŠrŽŽŒ±‚Å‚ÌŒŸ“¢|. “ú‚@‰›1, ’†àV‹MG1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/22), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A54.

722012. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠÌŽŸŠ³f—ÃŒƒxƒ‹‚Ì‚³‚ç‚È‚é‹Ï‚Ä‚ñ‰»‚ð–ÚŽw‚µ‚Ä: Œ»ó‚Ì”cˆ¬‚Æ–¢—ˆ‚Ö‚Ì“W–]zŠÌ×–EŠà‚Ì—\Œã‰ü‘P‚Ì‚œ‚ß‚Ì’nˆæˆã—Â̈Ӌ`. “n粐^²1,2, ‚‹Ž’õl2, ‰¡XOº2 (1Á‰»Ší“à, 2–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/22), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A177.

722013. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒ[ƒNƒVƒ‡ƒbƒv)yÁ‰»ŠÇÃ–¬áŽ‚̐f’fEŽ¡—Â̌»ó‚Ə«—ˆ“W–]: ˆÙŠ«Ã–¬áŽ‚àŠÜ‚ށzˆÝÃ–¬áŽ‚ɑ΂·‚鎡—Ð헪. “ú‚@‰›1, š •ª–ΔŽ1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V•S‡ƒ–‹u‘‡•a‰@): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/29), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 717.

722014. [Šw‰ï (‘S‘)] (ƒvƒŒƒiƒŠ[ƒZƒbƒVƒ‡ƒ“) ‰ŠÇ«’°ŽŸŠ³‚ª‹^‚í‚ê‚œŠŽõ«’°‰Š‚ÌŒŸ“¢. ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ‰Á“¡@Ê1, ‘剪³•œ1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/29), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 736.

722015. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBDŠÖ˜AÁ‰»ŠÇŠà‚ɑ΂·‚é“àŽ‹‹Ÿf—Ẩۑè‚Ə«—ˆ“W–]z’×ᇐ«‘å’°‰ŠŠÖ˜AŽîᇂɑ΂·‚é“àŽ‹‹Ÿf’f‚Ì—L—p«‚Æ–â‘è“_. ¬—ѐŽ“T1,2, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 628.

722016. [Šw‰ï (‘S‘)] (ƒvƒŒƒiƒŠ[ƒZƒbƒVƒ‡ƒ“) “–‰@‚É‚š‚¯‚épŒãÄŒš’°ŠÇ‚ɑ΂·‚éƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ“Ž®¬’°‹«‚ð—p‚¢‚œERCP. ŽR“à_Žj1, –Ø“cŒõL1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ŽO“‡Fm1, ‹àŽq@‹œ1, ¬òŽüŽq1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 741.

722017. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÁ‰»ŠÇ‹·ó‚ɑ΂·‚éƒXƒeƒ“ƒgŽ¡—Ẩۑè‚Ə«—ˆ“W–]z’_äXŠà‚̈««\“ñŽw’°‹·ó‚ɑ΂·‚éÁ‰»ŠÇƒXƒeƒ“ƒg—¯’u‚ÌŒ»ó‚Æ–â‘è“_. ¡’JŠ°ˆÈ1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/31), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 679.

722018. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y–å–¬ˆ³˜ŽiÇ‚ɑ΂·‚éIVRŽ¡—Â̌»ó‚ƍ¡Œã‚Ì“W–]zŒÇ—§«ˆÝÃ–¬áŽŽ¡—Âɑ΂·‚é“ú–{‚Ɛ¢ŠE‚Ì•W€Ž¡—Â̈Ⴂ‚ɂ‚¢‚ā|Do not be like the Galapagos islands|. “ú‚@‰›1, š •ª–ΔŽ1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V•S‡ƒ–‹u‘‡•a‰@): ‘æ22‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (2015/9/10), ‰¡•l, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2015/8; 21 (3): 80.

722019. [Šw‰ï (‘S‘)] (—v–]‰‰‘è)yNASHEASHEƒEƒCƒ‹ƒX«ŠÌd•Ïz‘OŠÌd•Ï‘gD‚É‚š‚¯‚é—Þ“Ž•Ç×–E‚š‚æ‚ъ̐üˆÛ‰»ƒ}[ƒJ[”­Œ»‚Ì”äŠrŒŸ“¢. ‘å•”@œ1, ’†àV‹MG2, “ú‚@‰›2, ŒGŒ³—Y‰î3 (1ˆã—Éq¶Šw•”, 2Á‰»Ší“à, 3ŠO‰È): ‘æ22‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (2015/9/11), ‰¡•l, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2015/8; 21 (3): 142.

722020. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y–å–¬ˆ³˜ŽiÇ‚Ì•a‘Ô‚ÆŽ¡—Ã: Šî‘b‚©‚ç—Տ°‚ցzPortal Hypertension‚ɉ—‚¯‚éV‚œ‚ÈŽw•W|BAVENO VIƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚æ‚è|. “ú‚@‰›1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ22‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (2015/9/11), ‰¡•l, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2015/8; 21 (3): 69.

722021. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y–å–¬ŒŒðÇ‚ÌŽÀ‘Ô: f’f, Ž¡—Ã, —\Œãz–{–M‚É‚š‚¯‚é–å–¬ŒŒðÇ‚ÌŽÀ‘ԁ|‘S‘ƒAƒ“ƒP[ƒg’²žŒ‹‰Ê|. ¬“ˆŽˆê˜Y1, Œ’J³ˆê1, ‰—•Û˜a•F1, ‘Ÿ“c³”V1, ¬ò@~1, š •ª–ΔŽ1,2,3, ’†–ì@–Î1, ’†‘ºŒ’Ž¡1, ’†‘º^ˆê1, “茎‹`”V1, “ú‚@‰›1,3, Œ–{Í•v1, ‘º“‡’ŒÆ1, “n•ÓŒMŽj1, ¬ŒŽŸ•q1 (1“ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŠwpˆÏˆõ‰ï, 2V•S‡ƒ–‹u‘‡•a‰@, 3Á‰»Ší“à): ‘æ22‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (2015/9/11), ‰¡•l, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2015/8; 21 (3): 96.

722022. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y•\ÝŒ^“ªèò•”ŠàEH“¹Šà‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Â̒·ŠúŒo‰ßz‘ŠúH“¹Šà‚ɑ΂·‚é“àŽ‹‹ŸØœŒã‚É”­¶‚·‚éˆÙŽž«‘Œ‘ŸŠíŠà‚ÌŒŸ“¢. Œ˜“ce—˜1,2, •“¡@Šw1 (1JEC study group, 2Á‰»Ší“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/8), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (Suppl 2): 1964.

722023. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y’_äX“àŽ‹‹ŸŒŸžEŽ¡—Ẫgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOzƒoƒ‹[ƒ“Ž®¬’°‹«‚ð—p‚¢‚œERCP‚É‚š‚¯‚éƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO. ŽR“à_Žj1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/9), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (Suppl 2): 2038.

722024. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y–å–¬ˆ³˜ŽiÇ: f’fEŽ¡—Â̍¡Œã‚Ì“WŠJz–å–¬ˆ³˜ŽiÇ‚ɑ΂·‚éOlmesartan Medoxomil‚Ì’·Šú¬Ñ|TGF-ƒÀ1ŽY¶—}§‚͐¶‘¶ŠúŠÔ‚ð‰„’·‚·‚é: 6”NŠÔ‚̒ǐՒ²ž‚©‚ç|. “ú‚@‰›1, š •ª–ΔŽ1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V•S‡ƒ–‹u‘‡•a‰@): ‘æ19‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (JDDW 2015) (2015/10/8), “Œ‹ž, ŠÌ‘Ÿ 2015/9; 56 (Suppl 2): A675.

722025. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yˆùŽð‚Æ”­Šà: –{–M‚̗Տ°E‰uŠwŒ€‹†‚̍őOüzH“¹E“ªèò•”Šà‚Ìfield cancerization‚ƈùŽð‚ÌŠÖ˜A. Œ˜“ce—˜1, •“¡@Šw, ‰¡ŽR@Œ° (1Á‰»Ší“à): •œ¬27”N“xƒAƒ‹ƒR[ƒ‹E–ò•šˆË‘¶ŠÖ˜AŠw‰ï‡“¯Šwp‘‰ï (2015/10/13), _ŒË, “ú–{ƒAƒ‹ƒR[ƒ‹E–ò•šˆãŠw‰ïŽGŽ 2015/8; 50 (4): 187.

722026. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBDŽ¡—Âɂš‚¯‚é“à‰È‚ÆŠO‰È‚̘AŒgz’×ᇐ«‘å’°‰Š“ü‰@—á‚É‚š‚¯‚éÅ‹ßŽ¡—ЬÑ‚Æ“Á’¥‚ɂ‚¢‚Ä. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1,2 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2015/9; 68 (9): 614.

722027. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBD‚ɑ΂·‚éŠàƒT[ƒxƒCƒ‰ƒ“ƒX‚ÌŒ»ó‚ƍ¡Œã‚Ì“W–]z’×ᇐ«‘å’°‰Š‚ɑ΂·‚éŠàƒT[ƒxƒCƒ‰ƒ“ƒXEƒvƒƒOƒ‰ƒ€‚ÌŽÀÛ. ŽÂè@‘å1, ¬—ѐŽ“T2,3, ‹vŒ—ˆê, ’·À@œ, ‚‹ŽŒ«ˆê (1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•‘®•a‰@ŠO‰È, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3Á‰»Ší“à): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2015/9; 68 (9): 619.

722028. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) “ªèò•”•\ÝŠà‚̐f’f‚ÆŽ¡—Ã. Œ˜“ce—˜ (Á‰»Ší“à): ‘æ12‰ñ“ú–{Á‰»ŠÇŠw‰ï‘‰ïŠwpW‰ï (2016/2/26), Vh.

723126. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‰ŠÇ«’°ŽŸŠ³‚É‚š‚¯‚鍂ƒAƒ~ƒ‰[ƒ[ŒŒÇ‚ÆäX‰Š‡•¹—á‚̗Տ°“IŒŸ“¢. ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ‘剪³•œ1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ101‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2015/4/23), å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2015/3; 112 (—Õ‘); A384.

723127. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) TS-1‰Á—ÃŽž‚Ì• …’†5FU”Z“x‚ɑ΂·‚éCART‚̉e‹¿. ‘å–ì@—²1,2, ŽR–{@‘n1,2, ²X–Ø“NŽO2, ¡’JŠ°ˆÈ2, •Êác•üL2, ŒE“cK‰î2, ¬–ìO“ñ1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ101‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2015/4/24), å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2015/3; 112 (—Õ‘); A489.

723128. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹Ù‹}ŠJ‹¹ŠJ• H“¹ˆŸ‘S“E‚ð—v‚µ‚œH“¹ˆÙ•š (—LŠb‹`Ž•) ‚Ì1—á. ’†–Ú“N•œ1,2, ãŒŽˆê”¿2, –î–ì‹MŽj2, Œ}@”üK2, ‘º“c@“Œ2, Î•N_2, r–ؐ³—Y1,2, ‰Í–ì@Œå1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ101‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2015/4/24), å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2015/3; 112 (—Õ‘); A490.

723129. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) NAFLDŠÌ‘gD‚É‚š‚¯‚é“S’Ÿ’…‚š‚æ‚ÑŽ_‰»ƒXƒgƒŒƒXŽY•š”­Œ»‚ÆHCC”­¶‚Æ‚ÌŠÖ˜A. ‘å•”@œ1, ’†àV‹MG2, “ú‚@‰›2, ŒGŒ³—Y‰î3 (1ˆã—Éq¶Šw•”, 2Á‰»Ší“à, 3ŠO‰È): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/2), –ŒŒÃ‰®, “ú–{•a—Šw‰ï‰ïŽ 2015/3; 104 (1): 323.

723130. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒeƒKƒt[ƒ‹EƒMƒƒ‰ƒVƒ‹EƒIƒeƒ‰ƒVƒ‹ƒJƒŠƒEƒ€“Š—^—á‚É‚š‚¯‚éHBVÄŠˆ«‰»‘΍ô‚ÌŒ»ó‚Ɖۑè. ˆÀ’B@‰õ1,2, “ì–ì@•×1,2, “n粐^²1,2, ˆäã’qm3, ŒE“cK‰î1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “ú‚@‰›1, ’†àV‹MG1, a’J–Ÿ—²1,4, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4ˆã—ÊǗ): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/21), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A258.

723131. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) isŠÌ×–EŠà‚ɑ΂·‚éƒ\ƒ‰ƒtƒFƒjƒuŽ¡—Á@•a‘ԐisŒQ (PD) ‚̉ðÍ. ŽRªŒhŽq1, ’†àV‹MG2, ìŒû—C•ã2, ŒE“cK‰î2, “ì–ì@•×2,3, ‚“cŽ÷ˆê2, “c’†Œ«–Ÿ2, ‰œ˜e—T‰î2, ¬–ìO“ñ2,4, “ú‚@‰›2, a’J–Ÿ—²1,5, ¬ò˜aŽO˜Y2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Á‰»Ší“à, 3–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 4ˆÉšŒŽ‹Š“¯•a‰@, 5ˆã—ÊǗ): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/21), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A288.

723132. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) isŠÌ×–EŠà‚ɑ΂·‚éƒ\ƒ‰ƒtƒFƒjƒuŽ¡—Âɂš‚¯‚é‰h—{Žw•W‚ÌŒŸ“¢. ìŒû—C•ã1, ’†àV‹MG1, ŽRªŒhŽq2, “ì–ì@•×1,3, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “ú‚@‰›1, a’J–Ÿ—²1,4, ŒE“cK‰î1, ¬–ìO“ñ1,5, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 4ˆã—ÊǗ, 5ˆÉšŒŽ‹Š“¯•a‰@): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/21), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A294.

723133. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Ž©ŒÈ–Ɖu«ŠÌ‰ŠŠÌ‘gD‚É‚š‚¯‚éIgG—z«Œ`Ž¿×–EZ‚̗Տ°“IˆÓ‹`‚ÌŒŸ“¢@IgGƒTƒuƒNƒ‰ƒX–ˆ‚̉ðÍ. r£‹gF1, ‰ÁìŒšO1, L£rŽ¡1, ”’ÎŒõˆê1, ¬“ˆŽˆê˜Y1, ‚Ž…áÁ“ñ1, “n•ÓŒMŽj1, ’†àV‹MG2, “ú‚@‰›2, Œ–{ŒõŽi1, •õ@“OÆ1 (1“ŒŠC‘åŠw, 2Á‰»Ší“à): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/21), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A296.

723134. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éƒoƒ‹[ƒ“•ÂÇ‰ºŠÌ“®–¬‰»ŠwÇð—Ö@‚̏‰ŠúŒoŒ±. “c’†Œ«–Ÿ1, ’†àV‹MG1, ŒE“cK‰î1, ŽRªŒhŽq2, ˆäã’qm2, “ì–ì@•×1,3, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “ú‚@‰›1, a’J–Ÿ—²1,4, “n粐^²1,3, ¬–ìO“ñ1,5, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 4ˆã—ÊǗ, 5ˆÉšŒŽ‹Š“¯•a‰@): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/21), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A529.

723135. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) NAFLDŠÌ‘gD‚É‚š‚¯‚é“S’Ÿ’…‚š‚æ‚ÑŽ_‰»ƒXƒgƒŒƒXŽY•š”­Œ»‚ÆHCC”­¶‚Æ‚ÌŠÖ˜A. ‘å•”@œ1, ’†àV‹MG2, “ú‚@‰›2, ŒGŒ³—Y‰î3 (1ˆã—Éq¶Šw•”, 2Á‰»Ší“à, 3ŠO‰È): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/22), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A357.

723136. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) EOB MRI‚É‚š‚¯‚éŠÌ×–EŠà”÷¬ŒŒŠÇZ‚̉摜f’f. ’†àV‹MG1, “ú‚@‰›1, ‘å•”@œ2 (1Á‰»Ší“à, 2ˆã—Éq¶Šw•”): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/22), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A365.

723137. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”ñ\‘¢ƒ^ƒ“ƒpƒN•ÏˆÙ‚É‚æ‚éCŒ^–«ŠÌ‰Š‚̗Տ°ŒŸ“¢. ‚“cŽ÷ˆê1, ’†àV‹MG1, ‰œ˜e—T‰î1, ŒE“cK‰î1, ŽRªŒhŽq2, ˆäã’qm2, “ì–ì@•×1, “c’†Œ«–Ÿ1, “ú‚@‰›1, a’J–Ÿ—²1,3, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—ÊǗ): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/22), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A434.

723138. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) HCV‚ɑ΂·‚éInterferon FreeŽ¡—Ã:Daclatasvir (DCV)/Asunaprevir (ASV) •¹—p—Ö@‚̈À‘S«. ŒÃ]N–Ÿ1, ‚“cŽ÷ˆê1, ’†àV‹MG1, ‰œ˜e—T‰î1, “ì–ì@•×1, “c’†Œ«–Ÿ1, “ú‚@‰›1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÊǗ): ‘æ51‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2015/5/22), ŒF–{, ŠÌ‘Ÿ 2015/4; 56 (Suppl 1): A436.

723139. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˆ««ŠÌ–å•”’_“¹‹·ó‚ɑ΂·‚éMetallic stent‚ð—p‚¢‚œSide by side—¯’u–@‚ÌŒŸ“¢. Œ–{‚–Ÿ1, –Ø“cŒõL1, ‰œ˜e‹»‰î1, ìŒû—C•ã1, ‹{“c‰pŽ¡1, ’·’Jì—Í–ç1, ŽO“‡Fm1, ‹àŽq@‹œ1, ¬òŽüŽq1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/29), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 764.

723140. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ’_ŠÇ‘}ŠÇ¢“ï—á‚ɑ΂µ‚ÄäXŠÇƒKƒCƒhƒƒCƒ„[—¯’u–@‚ðs‚Á‚œERCP‚Å‚ÌERCPŒãäX‰Š”­Ç—Š‚ÌŒŸ“¢. ‹{“c‰pŽ¡1, ‰œ˜e‹»‰î1, –Ø“cŒõL1, ìŒû—C•ã1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ŽO“‡Fm1, ‹àŽq@‹œ1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/29), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 769.

723141. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) IgG4ŠÖ˜Ad‰»«’_ŠÇ‰Š (IgG4-SC) ‚ÆŒŽ”­«d‰»«’_ŠÇ‰Š (PSC) ‚ÌŠÓ•Ê‚É‚š‚¯‚éERCP‚Ì—L—p«. ’·’Jì—Í–ç1, ‰œ˜e‹»‰î1, –Ø“cŒõL1, ‹àŽq@‹œ1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/29), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 791.

723142. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “àŽ‹‹Ÿ“I®•œp‚ðŽŽ‚Ý‚œSóŒ‹’°Ž²”P“]Ç‚ÌŒŸ“¢. ‹ß“¡—Y‹I1, ‰¡ŽR@ŒO1, âV“¡—FÆ1, ìŠÝ‰Á“Þ1, ‘剪³•œ1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/29), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 814.

723143. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ’Ž‰¹”g“àŽ‹‹Ÿ‰º”X–EƒhƒŒƒi[ƒW (EUS-CD) ‚Ì’·Šú¬Ñ‚ƍĔ­—á‚ÌŒXŒü. ‹àŽq@‹œ1, –Ø“cŒõL1, ‹{àVŽu˜N1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 824.

723144. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) H“¹Šà“àŽ‹‹Ÿ“IŽ¡—Ì㊳ŽÒ‚É‚š‚¯‚éˆùŽðó‹µ‚ƃˆ[ƒh•sõ‘Ñ’ö“x‚̕ω»‚ÉŠÖ‚·‚錟“¢: ‘œŽ{Ý‘OŒü‚«ŽŽŒ±JEC study‚æ‚è. –x@Œ\‰î1, ‰ª“c—T”V1, ¬Œˆê’j, ’Óc‹Žu, Œ˜“ce—˜2, ‰¡ŽR“OŽ¢, ÎìGŽ÷, •“¡@Šw (1‰ªŽR‘åŠw•a‰@, 2Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 841.

723145. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚Å‚Ì‘å’°ƒXƒeƒ“ƒgŽg—pŒoŒ±‚©‚ç@—L—p«‚Æ’·ŠúŒo‰ß‚Ì–â‘è“_‚ɂ‚¢‚Ä. ’†–Ú“N•œ1,2, ãŒŽˆê”¿2, –î–ì‹MŽj2, Œ}@”üK2, Î•N_2, r–ؐ³—Y1,2, ‰Í–ì@Œå1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 848.

723146. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ’Ž‚—îŽÒ‚Ì‘’_ŠÇŒ‹Î‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Â̐¬Ñ‚ƈÀ‘S«. ŽO“‡Fm1, ŽR“à_Žj1, –Ø“cŒõL1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ‹àŽq@‹œ1, ¬òŽüŽq1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 865.

723147. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ’Ž‚—îŽÒ‚̕֐öŒŒ—z«—á‚ɑ΂·‚é‘å’°“àŽ‹‹ŸŒŸž‚̈Ӌ`. âV“¡—FÆ1, ‰¡ŽR@ŒO1, ‘剪³•œ1, ìŠÝ‰Á“Þ1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 868.

723148. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ãè–åŠÇi“W•a•Ï‚ɑ΂·‚é‘å’°ESD‚ÌŒŸ“¢. Œ–{ˆçG1, ‘剪³•œ1, ŽÂ–؁@Œ[, ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 901.

723149. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éŒoŒû’°ŠÇôòÜƒ‚ƒrƒvƒŒƒbƒv‚ÌŽg—pŒoŒ±. äøŒŽ«—Ç1, ‘剪³•œ1, ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 953.

723150. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ‚ƒrƒvƒŒƒbƒv800ml“à•ž–@‚É‚æ‚é‘å’°“àŽ‹‹Ÿ‘Oˆ’u–@‚ÌŒŸ“¢. ‹v•Û“c—z1, ‘剪³•œ1, ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 954.

723151. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) \“ñŽw’°ESD‚̈À‘S«‚ƍ¡Œã‚Ì“W–]: 2“_ŒÅ’è–@‚Ì—L—p«‚ɂ‚¢‚Ä. ŽR“c”Žº1, –{‹Ž@C1,2, Œ‘º@Œ«1,2, ’†ŽRž“T1,2, ˆäŒû–õO1, ˆäãr‘Ÿ˜Y1, ¬—с@ê 1, H“¡Ø1 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 959.

723152. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é’Ž‚—îŽÒ‚Ì‘ŠúˆÝŠà‚ɑ΂·‚éESD‚ÌŽ¡—ЬÑ. ˜a“c‘ñ–ç1, “c糁@‘1,2, ÎŒËŒªŽŸ1, ²X–Ø“O1, “Œ@’q1, Œ˜“ce—˜1, ”óŒûŸ•F1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 960.

723153. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚é“àŽ‹‹Ÿ“I“û“ª•”Žîᇐ؏œpŒãäX‰Š‚ÌŒŸ“¢. ìŒû—C•ã1, ‰œ˜e‹»‰î1, –Ø“cŒõL1, ‹{“c‰pŽ¡1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ŽO“‡Fm1, ‹àŽq@‹œ1, ¬òŽüŽq1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/31), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 982.

723154. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘ŠúH“¹Šà“àŽ‹‹ŸŽ¡—×á‚É‚š‚¯‚éˆÙŽž«“ªèò•”Šà‚ÌŒŸ“¢. ŽÂè@„1, •“¡@Šw, Œ˜“ce—˜2, Žu‰êŽl, ’©ˆüFG (1‘—§‚ª‚ñŒ€‹†ƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ39‰ñ“ú–{“ªèò•”ŠàŠw‰ïE‘æ4‰ñƒAƒWƒA“ªèò•”ŠàŠw‰ï (2015/6/3-6), _ŒË, “ªèò•”Šà 2015/5; 41 (2): 222.

723155. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹£‡‚©‚ç‹€‘¶E‹€—L‚ց@HIHAƒlƒbƒg‚ª–ÚŽw‚·‚à‚Ì (‰ï‹c˜^). “c’†–Ÿ”ü1, ‘åìLˆê1, ‘å–ì@—²1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ17‰ñ“ú–{ˆã—Ã}ƒlƒWƒƒ“ƒgŠw‰ïŠwp‘‰ï (2015/6/12), ‘åã, “ú–{ˆã—Ã}ƒlƒWƒƒ“ƒgŠw‰ïŽGŽ 2015/6; 16 (suppl): 183.

723156. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰È‚ÅŒoŒ±‚µ‚œTS1äXŠà‚ÌŒŸ“¢. Œ–{‚–Ÿ1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ46‰ñ“ú–{äX‘ŸŠw‰ï‘å‰ï (2015/6/19), –ŒŒÃ‰®, äX‘Ÿ 2015/5; 30 (3): 475.

723157. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) [ŽÀ«Žîᎂɑ΂·‚é’ʏíaspiration needle‚Æcore biopsy needle‚Ì”äŠr. Šâˆä’m‹v1, –Ø“cŒõL1, ’·’Jì—Í–ç1, ‹àŽq@‹œ1, ¬òŽüŽq1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ46‰ñ“ú–{äX‘ŸŠw‰ï‘å‰ï (2015/6/20), –ŒŒÃ‰®, äX‘Ÿ 2015/5; 30 (3): 416.

723158. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚Å‚ÌŽ©ŒÈ–Ɖu«äX‰Š‚ÌŒŸ“¢. ‹àŽq@‹œ1, –Ø“cŒõL1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ46‰ñ“ú–{äX‘ŸŠw‰ï‘å‰ï (2015/6/20), –ŒŒÃ‰®, äX‘Ÿ 2015/5; 30 (3): 509.

723159. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å‘Ú•”‰óŽ€«‹Ø–Œ‰Š‚𗈂µ‚œäXŠÇ“à“û“ª”S‰t«Žîᇔj—ô‚Ì1—á. ŽR“à_Žj1, ¡ò@O1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ‹àŽq@‹œ1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ46‰ñ“ú–{äX‘ŸŠw‰ï‘å‰ï (2015/6/20), –ŒŒÃ‰®, äX‘Ÿ 2015/5; 30 (3): 515.

723160. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) B-RTOŽ{sŽž‚Ƀ}ƒCƒNƒƒJƒe[ƒeƒ‹‚É‚æ‚éˆÝ“àoú”j‚ð‚«‚œ‚µ‚œˆÝÃ–¬áŽ‚Ì1—á. ‘ëì­˜a1, •œìk‘å1, “cŒû’qŽq1, ‘åX’qŽq1, “ü]ˆõs1, ‰º“c‘ñ–ç1,2, ‹ÊáÁr•œ1,2, ’†‘º—zŽq1, ›–ì@‘1,2, ˆÀ’B@Œ£1,2 (1‘—§‘Š–ÍŒŽ•a‰@, 2Á‰»Ší“à): ‘æ22‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (‘æ18‰ñB-RTOŒ€‹†‰ï) (2015/9/11), ‰¡•l, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2015/8; 21 (3): 173.

723161. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚ÌSBE-ERCP‚ðŽg—p‚µ‚œ’_ŠÇ‹ó’°•«‡•”‹·óŠg’£p‚̐¬Ñ. ‹{“c‰pŽ¡1, ŽR“à_Žj1, –Ø“cŒõL1, ìŒû—C•ã1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ŽO“‡Fm1, ‹àŽq@‹œ1, ¬òŽüŽq1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ51‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï (2015/9/18), ‰F“s‹{, ’_“¹ 2015/8; 29 (3): 553.

723162. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÌ×–EŠà‚ɑ΂·‚éŠÌ“®–¬‰»ŠwÇð—Ö@‚É‚š‚¯‚éƒ~ƒŠƒvƒ‰ƒ`ƒ“‚Ì—LŒø«‚ÉŠÖ‚·‚錟“¢: ƒGƒsƒ‹ƒrƒVƒ“‚ð‘ΏƂƂµ‚œƒ‰ƒ“ƒ_ƒ€‰»•ÀsŒQŠÔ”äŠrŽŽŒ±. ‰œ˜e—T‰î1, ’†àV‹MG1, “ì–ì@•×1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, “ú‚@‰›1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÊǗ): ‘æ19‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (JDDW 2015) (2015/10/8), “Œ‹ž, ŠÌ‘Ÿ 2015/9; 56 (suppl 2): A732.

723163. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) isŠÌ×–EŠà‚ɑ΂·‚éƒ\ƒ‰ƒtƒFƒjƒuŽ¡—Âɂš‚¯‚é’·Šú¶‘¶—á‚ÌŒŸ“¢. ŽRªŒhŽq1, ’†àV‹MG2, ìŒû—C•ã2, “ú‚@‰›2, ‰œ˜e—T‰î2, “c’†Œ«–Ÿ2, ‚“cŽ÷ˆê2, “ì–ì@•×2, ŒE“cK‰î2, a’J–Ÿ—²2,3, ¬ò˜aŽO˜Y2, ¬–ìO“ñ2,4, ‘å–ì@—²2,4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Á‰»Ší“à, 3ˆã—ÊǗ, 4ˆÉšŒŽ‹Š“¯•a‰@): ‘æ19‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (JDDW 2015) (2015/10/8), “Œ‹ž, ŠÌ‘Ÿ 2015/9; 56 (suppl 2): A749.

723164. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) is’_“¹Šà‚ɑ΂·‚éGemcitabine/Cisplatin/TS-1•¹—p—Ö@‚̗Տ°‘æ1‘ŠŽŽŒ±. ‹{“c‰pŽ¡1, –Ø“cŒõL1, ‹{àVŽu˜N1, “n糍WŽ¯2, ìŒû—C•ã1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1,3, ŽO“‡Fm1, ‹àŽq@‹œ1, ¬òŽüŽq1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆÉšŒŽ‹Š“¯•a‰@): ‘æ57‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (JDDW 2015) (2015/10/8), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2015/9; 112 (—Õ‘): A879.

723165. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚鏬äXŠà‘Šú”­Œ©‚Ì‚œ‚߂̐f’fƒXƒgƒ‰ƒeƒW[. Œ–{‚–Ÿ1,2, –Ø“cŒõL1, ’·’Jì—Í–ç1, ŽO“‡Fm1, ‹àŽq@‹œ1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆÉšŒŽ‹Š“¯•a‰@): ‘æ57‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (JDDW 2015) (2015/10/9), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2015/9; 112 (—Õ‘): A897.

723166. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šˆ“®Šú’×ᇐ«‘å’°‰Š‚ɑ΂·‚éInfliximab—Ö@‚ÌŽ¡—ЬÑ. âV“¡—FÆ1, ‰¡ŽR@ŒO1, ìŠÝ‰Á“Þ1, ‘剪³•œ1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ57‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (JDDW 2015) (2015/10/10), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2015/9; 112 (—Õ‘): A936.

723167. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yInterventional EUS: ƒGƒrƒfƒ“ƒX‚ƐV‚œ‚È“WŠJz[ŽÀ«Žîᇂɂš‚¯‚éEUS-FNA‚Å‚Ìaspiration needle‚Æcore biopsy needle‚̐¬Ñ‚Ì”äŠr. ‹àŽq@‹œ1, ¡ò@O1, –Ø“cŒõL1 (1Á‰»Ší“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/9), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2030.

723168. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å’°“àŽ‹‹Ÿ”²‹ŽŽžŠÔ‚Æ‘BŽîŒŸo—Š‚ÌŠÖŒW@‘œŽ{Ý‹€“¯Œ€‹†. ‰Í‘º‘ì“ñ1, ”ö“c@‹±, ¬—ѐŽ“T2,3, Œ“c_“ñ, “c’†¹l, –Ø“cŒõL3 (1‹ž“s‘æ“ñÔ\Žš•a‰@, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3Á‰»Ší“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2164.

723169. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å’°ESD‚É‚š‚¯‚éƒfƒBƒXƒ|[ƒUƒuƒ‹ƒXƒ‰ƒCƒfƒBƒ“ƒOƒ`ƒ…[ƒu‚ÌŽg—pŒoŒ±. Œ–{ˆçG1, ‘剪³•œ1, ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬—ѐŽ“T1,2 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2174.

723170. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚鑍’_ŠÇŒ‹ÎÇ‚ɑ΂·‚éEPLBD‚ÌŽ¡—ЬÑ‚ÌŒŸ“¢. “n@—D1, ‰œ˜e‹»‰î1, –Ø“cŒõL1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ŽO“‡Fm1, ‹àŽq@‹œ1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2183.

723171. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚épŒãÄŒš’°ŠÇ‚ɑ΂·‚éshort type Single Balloon Enteroscope‚ð—p‚¢‚œERCPŠÖ˜AŽè‹Z‚̐¬Ñ. ’·’Jì—Í–ç1, ŽR“à_Žj1, –Ø“cŒõL1, ¬òŽüŽq1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2188.

723172. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÌ–å•”ˆ««’_“¹‹·ó‚ɑ΂·‚éSide by side stenting–@‚Ì—L—p«. ìŒû—C•ã1, –Ø“cŒõL1, ‰œ˜e‹»‰î1, ¡’JŠ°ˆÈ1, ‹{“c‰pŽ¡1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1,2, ŽO“‡Fm1, ‹àŽq@‹œ1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆÉšŒŽ‹Š“¯•a‰@): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2194.

723173. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) KKR•a‰@‚É‚š‚¯‚éƒ`[ƒ€ˆã—Â̌ø—p‚ƍ¡Œã‚Ì“W–]: ‘œEŽíƒ`[ƒ€‚Ő„i‚·‚éR‹Û–ò‚Ì“K³Žg—p|ŠŽõÇê–åˆã•sÝ‚̈ã—Ë@ŠÖ‚Å‚àR‹Û–ò‚Ì“K³Žg—p‚͐„i‚Å‚«‚é|. ìè@i1, ŽRèDŠì1,2, ìã’ŒŽ÷, ¬“c˜a‡1, àVŠCŒ’ì1 (1•œ’Ë‹€Ï•a‰@, 2Á‰»Ší“à): ‘æ64‰ñ‹€ÏˆãŠw‰ï (2015/10/14-15), ‚Œ, ‹€Ïˆã•ñ 2015/10; 64 (suppl): 85.

723174. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) HIV”˜˜IŒã—\–h“à•ž–òƒZƒbƒgì¬‚ÌŒŸ“¢. àVŠCŒ’ì1, ‘“cGÍ1, ŽRèDŠì1,2, ìã’ŒŽ÷, ìè@i1, ¬“c˜a‡1 (1•œ’Ë‹€Ï•a‰@, 2Á‰»Ší“à): ‘æ64‰ñ‹€ÏˆãŠw‰ï (2015/10/14-15), ‚Œ, ‹€Ïˆã•ñ 2015/10; 64 (suppl): 154

723175. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰»Šw•úŽËü—Ö@‚ª’˜Œø‚µ‚œãè–åŠÇŠà‚Ì1—á. ‹v•Û“c—z1,2, ŽRèDŠì1,2, ‹ß“¡—Y‹I1,2, –kì”Ž”V1,2, ‰ÍŒèû‘Ÿ˜Y1, ¬–с@“N1,2, ‹e’nG•F1,2, —¢“¹“N•F1,2, à_–Œr–ç1, –ì“o@œ1,2 (1•œ’Ë‹€Ï•a‰@, 2Á‰»Ší“à): ‘æ64‰ñ‹€ÏˆãŠw‰ï (2015/10/15), ‚Œ, ‹€Ïˆã•ñ 2015/10; 64 (Suppl): 185.

723176. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠÉ˜aˆã—ÂƂµ‚Ä‚ÌCART‚̈Ӗ¡‡‚¢|14‰ñCARTŽ{s‚µ‚œisˆÝŠà‚Ì1Ç—á|. ‘å–ì@—²1,2, ’†’JªŒá1,2, “n糗FŠG1, ¡’JŠ°ˆÈ1,2, Œ–{‚–Ÿ1,2, ŽR–{@‘n1,2, ¬–ìO“ñ1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ64‰ñ“ú–{”_‘ºˆãŠw‰ïŠwp‘‰ï (2015/10/22), H“c, “ú–{”_‘ºˆãŠw‰ïŽGŽ 2015/9; 64 (3): 369.

723177. [Šw‰ï (‘S‘)] (—Տ°Œ€CˆãƒZƒbƒVƒ‡ƒ“) TACE•s”\‚—îŽÒ‚ɑ΂µƒ\ƒ‰ƒtƒFƒjƒu“Š—^‚É‚æ‚è’·Šú¶‘¶‚ª“Ÿ‚ç‚ê‚œ1—á. ŠâèGˆê˜Y1, –î–ì‹MŽj1,2, ãŒŽˆê”¿1,2, ’†–Ú“N•œ1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, r–ؐ³—Y1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ64‰ñ“ú–{”_‘ºˆãŠw‰ïŠwp‘‰ï (2015/10/23), H“c, “ú–{”_‘ºˆãŠw‰ïŽGŽ 2015/9; 64 (3): 319.

723178. [Šw‰ï (‘S‘)] (—Տ°Œ€CˆãƒZƒbƒVƒ‡ƒ“) ¬lŽüŠú«šq“fÇ‚Ì1—á. ‘å‹v•Û–F•F1, ”–؍_’š1, ŽRŒûƒ‹P1, •“cKl1, ˆäŒûhˆê˜N1, “Œ•œãđŸ1, ŽR–{@‘n1,2, ¬–ìO“ñ1,2, ‘å–ì@—²1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ64‰ñ“ú–{”_‘ºˆãŠw‰ïŠwp‘‰ï (2015/10/23), H“c, “ú–{”_‘ºˆãŠw‰ïŽGŽ 2015/9; 64 (3): 330.

723179. [Šw‰ï (‘S‘)] (—Տ°Œ€CˆãƒZƒbƒVƒ‡ƒ“) Œƒ‚µ‚¢• ’É‚ð’悵‚œ¬l”­Ç‚̃AƒŒƒ‹ƒM[«Ž‡”Á•a‚Ì1—á. ˆäŒûhˆê˜N1, ¬–ìO“ñ1,2, ’†’JªŒá1,2, “n糗FŠG1, ¡’JŠ°ˆÈ1,2, Œ–{‚–Ÿ1,2, ŽR–{@‘n1,2, ‘å–ì@—²1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ64‰ñ“ú–{”_‘ºˆãŠw‰ïŠwp‘‰ï (2015/10/23), H“c, “ú–{”_‘ºˆãŠw‰ïŽGŽ 2015/9; 64 (3): 331.

723180. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘Þ‰@Œã‚Ì“úí¶Šˆ‚É‹y‚Ú‚·S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚̉e‹¿‚ɂ‚¢‚Ä. ˜a“c”Í•¶1, ‘å–ì@—²2,3, –ìX‘º—e“T1 (1Šò–kŒú¶•a‰@, 2ˆÉšŒŽ‹Š“¯•a‰@, 3Á‰»Ší“à): ‘æ64‰ñ“ú–{”_‘ºˆãŠw‰ïŠwp‘‰ï (2015/10/23), H“c, “ú–{”_‘ºˆãŠw‰ïŽGŽ 2015/9; 64 (3): 521.

723181. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‰È‚É‚š‚¯‚éÚ‹ö‚ÉŠÖ‚·‚éˆÓŽ¯’²ž‚ÆŠˆ“®•ñ. ]è–L‰p1, ˜a“c”Í•¶1, ‘å–ì@—²2,3, ŽR“¡—D–í1 (1Šò–kŒú¶•a‰@, 2ˆÉšŒŽ‹Š“¯•a‰@, 3Á‰»Ší“à): ‘æ64‰ñ“ú–{”_‘ºˆãŠw‰ïŠwp‘‰ï (2015/10/23), H“c, “ú–{”_‘ºˆãŠw‰ïŽGŽ 2015/9; 64 (3): 573.

723182. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œ‹’°ŒŽ”­undifferentiated round cell sarcoma‚Ì1—á. ˆäãr‘Ÿ˜Y1, ¬—с@ê 1, ŽR“c”Žº1, H“¡Ø1, ˆäŒû–õO1, Œ‘º@Œ«1,2, ’†ŽRž“T1,2, –{‹Ž@C1,2, ˜hŒ©Œö‘Ÿ1, ‰¡£’q”V1, ‹T“c—zˆê1, ’|ŽR¹L1, àVè@ãÄ1, ‰–àV@Šw1 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2015/9; 50 (3): 1679.

723183. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Øœ•s”\isEÄ”­‘å’°Šà‚ɑ΂·‚éRegorafenib‚Ì—LŒø«, ˆÀ‘S«‚ÌŒŸ“¢. ‚èŒ[F1, ’†ŽRž“T1,2, Œ‘º@Œ«1,2, ‰–àV@Šw1, ‹ààV@Žü1, •ÐŽR—Y‰î1, ó—˜¹‘å1, •ž•”—F‰ÌŽq1, ÎŽR‘׎j1, À“c@•à1, –{‘º–ÎŽ÷1, ŽðˆäƒŠƒJ (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/31), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2015/9; 50 (3): 2421.

723184. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Stage IVˆÝŠà‚ɑ΂·‚éConversion surgery. ²“¡@•×1, Œ‘º@Œ«1,2, ’†ŽRž“T1,2, –{‹Ž@C1,2, £ãŒ°‹M1, _”öˆêŽ÷1, ‘OàVK’j1, ’†“‡“NŽj1, ÂŽR@“O1, ‘哇@‹M1, —˜–ì@–õ1, ‰v“c@F1, ”öŒ`‚Žm1, ’·@°•F1, ‹gì‹MŒÈ1 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/31), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2015/9; 50 (3): 2640.

723185. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚鑁ŠúˆÝŠà‚ɑ΂·‚éESD‚Ì“K‰žŠO•a•Ï‚ÌŒŸ“¢. –î–ì‹MŽj1, ÎŒËŒªŽŸ1, “c糁@‘1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/18), ‘啪, “ú–{ˆÝŠàŠw‰ï‘‰ï‹LŽ– 2016/3; 88th: 240.

723186. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ESD‚ɂĈݑBG•œã”çŠà‚Ɛf’f‚µ‚œ1—á. •{‹M_1, –î–ì‹MŽj1, “c糁@‘1,2, ‰ÍŒ“Þ’ÃŽq1, “n糍WŽ¯1, ˜a“c‘ñ–ç1, ÎŒËŒªŽŸ1, “Œ@’q1, Œ˜“ce—˜1, ²X–Ø“O1, ¬ò˜aŽO˜Y1, ŽOd–ì_˜N3, ‘å•”@œ4 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3ŠO‰È, 4ˆã—Éq¶Šw•”): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/18), ‘啪, “ú–{ˆÝŠàŠw‰ï‘‰ï‹LŽ– 2016/3; 88th: 245.

723187. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚鑁ŠúˆÝŠà‚Ì“¯Žž‘œ”­EˆÙŽž‘œ”­•a•Ï‚ÌŒŸ“¢. ÎŒËŒªŽŸ1, “c糁@‘1,2, ˜a“c‘ñ–ç1, –î–ì‹MŽj1, “Œ@’q1, Œ˜“ce—˜1, ²X–Ø“O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/18), ‘啪, “ú–{ˆÝŠàŠw‰ï‘‰ï‹LŽ– 2016/3; 88th: 246.

723188. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ESDŽ{sŒã‚ɈݕǓà“]ˆÚ‚ð”F‚ß‚œ‘ŠúˆÝŠà‚̈ê—á. –ƒ¶Œ’ˆê˜N1, ˜a“c‘ñ–ç1, ÎŒËŒªŽŸ1, –î–ì‹MŽj1, “Œ@’q1, Œ˜“ce—˜1, ²X–Ø“O1, “c糁@‘1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/19), ‘啪, “ú–{ˆÝŠàŠw‰ï‘‰ï‹LŽ– 2016/3; 88th: 414.

731004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’Œ’°NET‚̐f’f‚ÆŽ¡—Ã. ‹v•Û“c”ü˜a (Á‰»Ší“à): ‘æ14‰ñŒÃEŒ§‰›Á‰»Ší•aŒ€‹†‰ï (2015/5/13), Œú–Ø.

731005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –k—¢‘åŠw‚É‚š‚¯‚éIBDf—Á|Motivational Interviewing‚ð‚Ç‚€Žg‚¢‚±‚È‚·?|. ‰¡ŽR@ŒO (Á‰»Ší“à): HUMIRA IBD Meeting inŒQ”n (2015/7/10), ‘O‹Ž.

731006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’×ᇐ«‘å’°‰Š‚ÌŽ¡—Âɂ‚¢‚Ä. ‰¡ŽR@ŒO (Á‰»Ší“à): ƒAƒXƒeƒ‰ƒX»–òŽÐ“àu‰‰‰ï (2015/8/24), Œú–Ø.

731007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘Šú‘å’°Šà‚Ì“àŽ‹‹Ÿf’f‚Æ“àŽ‹‹ŸŽ¡—Â̐i•à. ¬—ѐŽ“T1,2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): •œ¬27”N“x¬“cŒŽˆãŽt‰ï‚ª‚ñŒŸf‘‰ï (2015/9/3), ¬“cŒŽ.

731008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŒŽ”­«’_`«ŠÌd•Ï@ÅV‚ÌŽ¡—ÂƓúí¶Šˆ. ’†àV‹MG (Á‰»Ší“à): ‘Š–ÍŒŽŽsŽåÃ“ï•au‰‰‰ï (2015/11/11), ‘Š–ÍŒŽ.

731009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) IBDŽ¡—Âɂš‚¯‚é“ï•a§“x‰ü³‚É‚æ‚銳ŽÒEˆã—Ï]Ž–ŽÒ‚̑Ήž‚̕ω»‚Ɖۑè. ‰¡ŽR@ŒO (Á‰»Ší“à): ‘æ43‰ñ_“ސìIBDƒ~ƒjƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/11/16), ‰¡•l.

731010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’×ᇐ«‘å’°‰Š‚Ì“à‰ÈŽ¡—Á|”S–ŒŽ¡–ü‚ÆŒŸ‚€‚¯‚ê‚ǁEEE|. ‰¡ŽR@ŒO (Á‰»Ší“à): ’×ᇐ«‘å’°‰ŠƒJƒ“ƒtƒ@ƒŒƒ“ƒX2015 (2015/11/27), ‘åã.

731011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Crohn•a‚ÌŽ¡—с‚í‚©‚è. ‰¡ŽR@ŒO (Á‰»Ší“à): ‘Š–̓uƒƒbƒN@ƒNƒ[ƒ“•aŽÐ“à•×‹­‰ï (2015/12/18), ‰¡•l.

731012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) IBD‚Ì“àŽ‹‹Ÿf’f|—Þ‰ŽŸŠ³‚Ƃ̊ӕʐf’f‚âcolitic cancer‚̐f’f‚ðŠÜ‚߂ā|. ¬—ѐŽ“T1,2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): ‘æ177‰ñ‰¡•lÁ‰»Ší“àŽ‹‹Ÿˆã‰ïW’k‰ï (2016/2/10), ‰¡•l.

732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) IBDf’f‚ÌŠî–{ƒAƒ‹ƒSƒŠƒYƒ€|—Տ°Œo‰ß‚Æ“àŽ‹‹ŸŒŸž‚ÌŠî–{‚ð“Ç‚Ý‰ð‚­|. ¬—ѐŽ“T1,2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): ‘æ44‰ñIBD Club JrŒ€‹†‰ï (2015/6/6), “Œ‹ž.

732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ˆô“ªEH“¹Šà‚Ì“àŽ‹‹Ÿ‰æ‘œf’f. Œ˜“ce—˜(Á‰»Ší“à): ‘æ3‰ñ‘Š–ÍŒŽÁ‰»Ší‰æ‘œƒZƒ~ƒi[ (2015/6/15), ‘Š–ÍŒŽ.

732010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ˆô“ªEH“¹Šà‚Ì“àŽ‹‹Ÿf’f‚ÆŽ¡—Ã. Œ˜“ce—˜ (Á‰»Ší“à): ‘æ8‰ñmŒË–Œ’n‹æÁ‰»ŠíŽŸŠ³•×‹­‰ï (2015/6/24), ç—t.

732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ã•”“àŽ‹‹Ÿf’f‚̍őOü ~•a‰@ˆã‚Ì—§ê‚©‚ç. “Œ@’q (Á‰»Ší“à): ‘æ21‰ñ_“ސ쌧Á‰»Ší“àŽ‹‹Ÿ§’k‰ï (2015/9/3), ‰¡•l.

732012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ~ƒjƒŒƒNƒ`ƒƒ[) ¬äXŠà”­Œ©‚Ì‚œ‚߂̐f’fƒXƒgƒ‰ƒeƒW[. Œ–{‚–Ÿ1,2 (1Á‰»Ší“à, 2ˆÉšŒŽ‹Š“¯•a‰@): ‘æ140‰ñ‘Š–ÍŒŽˆÝ‚Æ’°Œ€‹†‰ï (2015/10/28), ‘Š–ÍŒŽ.

732013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÁ‰»ŠÇŽŸŠ³‚ɑ΂·‚é“à‰Èˆã‚ÆŠO‰Èˆã‚̃Rƒ‰ƒ{ƒŒ[ƒVƒ‡ƒ“z“–‰@‚É‚š‚¯‚éˆÝE\“ñŽw’°Žîᇂɑ΂·‚é• o‹Ÿ“àŽ‹‹Ÿ‡“¯Žèp (LECS) ‚ÌŒŸ“¢. ÎŒËŒªŽŸ1, “c糁@‘1,2, ˜a“c‘ñ–ç1, –î–ì‹MŽj1, “Œ@’q1, Œ˜“ce—˜1, ²X–Ø“O1, ¬ò˜aŽO˜Y1, ŒG–{—Y‰î3, •Ð“c‰Ä–ç3 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3ŠO‰È): ‘æ48‰ñ_“ސ쌧Á‰»Ší•aˆãŠw‰ï‘‰ï (2015/10/31), V‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2016/1; 43 (1): 134-5.

732014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ŠÌ×–EŠà‚ÌMRI‚É‚æ‚鈫«“x•]‰¿‚š‚æ‚ѐisŠÌ×–EŠà‚É‚š‚¯‚鎡—ÃŒŸ“¢. ’†àV‹MG (Á‰»Ší“à): ‘æ15‰ñ‰¬ŒEŠÌ’_äXƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/11/18), “Œ‹ž.

732015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) Clinical hot topics in IBD: Using monitoring to tailor treatment in IBD Crohn's disease case. ‰¡ŽR@ŒO (Á‰»Ší“à): IBD Expert alliance Tokyo 2015 (2015/11/23), “Œ‹ž.

732016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ˆô“ªEH“¹‚ª‚ñ‚Ì“àŽ‹‹Ÿf’fEŽ¡—ÂƗ\–h|Å‹ß‚Ì“®Œü|. Œ˜“ce—˜ (Á‰»Ší“à): ‘æ4‰ñ–k—¢‘åŠwˆãŠw•”V¢‹IŠJ”­ƒZƒ“ƒ^[ƒVƒ“ƒ|ƒWƒEƒ€ (2015/11/26), ‘Š–ÍŒŽ.

732017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï] (ƒ[ƒNƒVƒ‡ƒbƒv)yH“¹•a•Ï‚ɑ΂·‚éNBIf’f‚Ì—L—p«‚ÆŒÀŠEzH“¹•\ÝŠà‚ɑ΂·‚éNBIŠg‘åŠÏŽ@‚É‚æ‚ép‘O[’B“xf’f‚̐f’fž“x‚ÌŒŸ“¢. Œ˜“ce—˜1, ˜a“c‘ñ–ç1, ÎŒËŒªŽŸ1, –î–ì‹MŽj1, “Œ@’q1, ²X–Ø“O1, ¬ò˜aŽO˜Y1, “c糁@‘1,2 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”—á‰ï (2015/12/12), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): s86.

732018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yEUS-FNA‚̍ŐV‚̐f’f‚ÆŽ¡—Áz¬ÑEˆÀ‘S«Œüã‚Ì‚œ‚ß‚ÌŽÀÛ‚ƍH•v|’n•ûˆê”Ê•a‰@‚É‚š‚¯‚éEUS-FNA“±“ü‚ÌŒ»ó|. “ì–ì@•×1,2, ‹àŽq@‹œ1,2, ’·’Jì—Í–ç1,2, ˆÀ’B@‰õ1,2, ‚‹ŽW•F1,2, ‘å’ˏr˜a1,2, “cŒŽ‹v”üŽq1, “n粐^²1,2, –Ø“cŒõL2, ¬ò˜aŽO˜Y2 (1–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”—á‰ï (2015/12/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): 106.

732019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠeŽ{Ý‚Ì“Á’¥‚𐶂©‚µ‚œÁ‰»ŠÇÃ–¬áŽ‚̐f’f‚ÆŽ¡—ÁzƒqƒXƒgƒAƒNƒŠƒ‹’“ü‚âB-RTO‚ðŠÜ‚߂ā@¶‘€–å–¬ˆ³˜ŽiÇ‚Ì’·Šú—\Œã‚ÌŒŸ“¢. ŒE“cK‰î1, “ú‚@‰›1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”—á‰ï (2015/12/13), “Œ‹ž, Prog Dig Endosc 88 (Suppl): S88.

732020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï] (ƒVƒ“ƒ|ƒWƒEƒ€)yã•”ESD‚É‚š‚¯‚éTrouble Shootingz‚±‚Ì‹Ç–Ê‚±‚€‚µ‚ďæ‚è‰z‚Š‚œ ESDŒãoŒŒ‚É‚æ‚èoŒŒ«ƒVƒ‡ƒbƒN‚𗈂µ‹Ù‹}ŒŒŠÇ‘¢‰e (IVR) ‚ÅŽ~ŒŒˆ’u‚ðŽ{s‚µ‚œ1—á. Î‹Ž@˜Ð1, –î–ì‹MŽj1, “c糁@‘1,2, ˜a“c‘ñ–ç1, ÎŒËŒªŽŸ1, “Œ@’q1, Œ˜“ce—˜1, ²X–Ø“O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”—á‰ï (2015/12/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): s99.

732021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yEUS-FNA‚̍ŐV‚̐f’f‚ÆŽ¡—Ã: ¬ÑEˆÀ‘S«Œüã‚Ì‚œ‚ß‚ÌŽÀÛ‚ƍH•vz“–‰È‚É‚š‚¯‚épancreatic fluid collection (PFC) ‚ɑ΂·‚é’Ž‰¹”g“àŽ‹‹Ÿ‰ºŽ¡—Â̐¬Ñ. ‹{“c‰pŽ¡1, ‰œ˜e‹»‰î1, –Ø“cŒõL1, ìŒû—C•ã1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ŽO“‡Fm1, ‹àŽq@‹œ1, ¬òŽüŽq1, ŽR“à_Žj1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ë, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”—á‰ï (2015/12/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): s108.

732022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) “ªèò•”•\ÝŠà‚̐f’f‚ÆŽ¡—Ã. Œ˜“ce—˜ (Á‰»Ší“à): ‘æ7‰ñESTABLISHŒ€‹†‰ï (2016/2/5), Ã‰ª.

732023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šî’²u‰‰) isŠÌ×–E‚ª‚ñ‚ÌŽ¡—Ã, “–‰@‚̗Տ°ŒŸ“¢‚©‚ç. ’†àV‹MG (Á‰»Ší“à): ƒ~ƒŠƒvƒ‰ƒGƒŠƒAƒtƒH[ƒ‰ƒ€ in Yokohama (2016/3/29), ‰¡•l.

733027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) Ä”­‚ðŒJ‚è•Ô‚µ‚œƒEƒ‹ƒ\ƒfƒIƒLƒVƒR[ƒ‹Ž_‘’_ŠÇŒ‹Î‚Ì2—á. “n@—D1, ‹{àVŽu˜N1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ¡ò@O1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): “ú–{“à‰ÈŠw‰ï‘æ614‰ñŠÖ“Œ’n•û‰ï (2015/5/9), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï614‰ñ 2015/5; p.29.

733028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰)yGastroenterology Sessionzinvited Discussant. “Œ@’q (Á‰»Ší“à): The 2nd Sino-Japan Medical Exchange Forum (2015/5/13), “Œ‹ž.

733029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) XP + ƒn[ƒZƒvƒ`ƒ“•¹—p—Ö@‚É‚æ‚èˆÝØœp‚ðŽ{s‚µ“Ÿ‚œØœ•s”\isˆÝŠà‚ÌŒŸ“¢. “Œ@’q (Á‰»Ší“à): Kanagawa Gastric Cancer Forum 2015 (2015/5/14), ‰¡•l.

733030. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) 2015‚É‚š‚¯‚éˆÝŠàŽ¡—Â̌»ó. “Œ@’q (Á‰»Ší“à): ‘æ3‰ñã•”Á‰»ŠÇŠO‰È•×‹­‰ï (2015/6/12), ‹·ŽR.

733031. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) ŠPšu‚ðŒ_‹@‚É”­Ç‚µ‚œ• •ÇŒŒŽî‚ɑ΂µTAE‚ª‘tŒø‚µ‚œ1—á. ¬ŽRŽŽ÷1, ‰º“c‘ñ–ç1,2, “ü]ˆõs1, Œ–{—Y‘Ÿ1,2, ‹ÊáÁr•œ1,2, ’†‘º—zŽq1, ›–ì@‘1,2, ˆÀ’B@Œ£1,2, •œìk‘å1, ‘ëì­˜a1 (1‘—§‘Š–ÍŒŽ•a‰@, 2Á‰»Ší“à): “ú–{“à‰ÈŠw‰ï‘æ615‰ñŠÖ“Œ’n•û‰ï (2015/6/13), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï‘æ615‰ñŽ˜^W2015/6; p.24.

733032. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) ‚Ñ‚Ü‚ñZŒ^ãsŒ‹’°ŒŽ”­ˆ««ƒŠƒ“ƒpŽî‚Ì2—á. ‹Ú‘ò‚ ‚肳1, ˆäŒû–õO1, ‚èŒ[F1, •ž•”—F‰ÌŽq1, ŽR“c”Žº1, H“¡Ø1, ˆäãr‘Ÿ˜Y1, Œ‘º@Œ«1,2, ’†ŽRž“T1,2, –{‹Ž@C1,2 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): “ú–{“à‰ÈŠw‰ï‘æ615‰ñŠÖ“Œ’n•û‰ï (2015/6/13), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï615‰ñŽ˜^W 2015/6; p.25.

733033. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Á‰»ŠÇ‚ª‚ñƒXƒNƒŠ[ƒjƒ“ƒO‚É‚š‚¯‚é“àŽ‹‹Ÿ‚̈ʒu‚¯|H“¹ŠàƒŠƒXƒNŒŸf–âf•[‚ÉŠî‚¢‚œ“ªèò•”EH“¹“àŽ‹‹ŸŒŸf‚̗Տ°“I—L—p«|. ‹ß“¡—Y‹I1, Œ˜“ce—˜1, “c糁@‘1,2, ”óŒûŸ•F1, ²X–Ø“O1, “Œ@’q1, ÎŒËŒªŽŸ1, ˜a“c‘ñ–ç1, –î–ì‹MŽj1, ¬ò˜aŽO˜Y1, ‰¡ŽR@Œ° (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ100‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl): 72.

733034. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Á‰»ŠÇoŒŒ‚𔺂€¬’°GIST‚É‚æ‚è‹Ù‹}Žèp‚ð—v‚µ‚œ1—á. ²–ì@“§1, –î–ì‹MŽj1,2, ãŒŽˆê”¿1,2, ’†–Ú“N•œ1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, r–ؐ³—Y1,2, ²X–؈ꌛ1, ‘Šèˆê—Y1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ100‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl): 105.

733035. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ã•”“àŽ‹‹ŸŒŸž‚ɂĉ𗣐«‘å“®–¬”j—ô‚É‚æ‚éH“¹ú”j‚ðŠm”F‚µ“Ÿ‚œˆê—á. ŠâèGˆê˜Y1, –î–ì‹MŽj2, ãŒŽˆê”¿1,2, ’†–Ú“N•œ1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, r–ؐ³—Y1,2, ‹g•@—E1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ100‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl): 112.

733036. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Infliximab‚ª’˜Œø‚µ‚œ\“ñŽw’°•a•Ï‚ð—L‚·‚é’×ᇐ«‘å’°‰Š‚Ì1—á. ˜a“c®‹v1, ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ‘剪³•œ1, ²“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã: ‘æ100‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl): 118.

733037. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒƒLƒ\ƒvƒƒtƒFƒ“ƒiƒgƒŠƒEƒ€“à•ž‚É‚æ‚茰«‰»‚µ‚œ‚ƍl‚Š‚ç‚ê‚œŽ©ŒÈ–Ɖu«ŠÌ‰Š‚Ì1—á. “c’†Œ«–Ÿ1, ’†àV‹MG1, ŒE“cK‰î1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “ú‚@‰›1, “ì–ì@•×1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÊǗ): “ú–{“à‰ÈŠw‰ï‘æ615‰ñŠÖ“Œ’n•û‰ï (2015/6/13), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï615‰ñŽ˜^W 2015/6; p.25.

733038. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”’ŒŒ‹…œ‹Ž—Ö@ERTNF-ƒ¿R‘Ì•¹—p—Ö@‚ª—L—p‚Å‚ ‚Á‚œ’×ᇐ«‘å’°‰Š‚Ì1—á. –ƒ¶Œ’ˆê˜N1, ‰¡ŽR@ŒO1 (1Á‰»Ší“à): ‘æ3‰ñIBD’nˆæˆã—ØAŒg‚̉ï (2015/7/9), ‘Š–ÍŒŽ.

733039. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) HER2—z«ˆÝŠà‚ɑ΂µ‚ĉ»Šw—Ö@‚Å’·Šú¶‘¶‚µ‚œˆê—á. •{‹M_1, “Œ@’q1, ‰ÍŒ“Þ’ÃŽq2, ŽRª‘‹IŽq2, —é–ؐl2, ˜a“c‘ñ–ç1, –î–ì‹MŽj1, ÎŒËŒªŽŸ1, Œ˜“ce—˜1, ²X–Ø“O1, “c糁@‘1,3, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ60‰ñ_“ސìÁ‰»Ší•aŒ€‹†‰ï (2015/7/11), ‰¡•l.

733040. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) “®œ§‚ðŽå‘i‚Æ‚µ‚œupside down stomach‚ð’悵‚œH“¹—ôEƒwƒ‹ƒjƒA‚Ì1—á. ”öã”üŒb1, ÎŒËŒªŽŸ1, “c糁@‘1,2, ˜a“c‘ñ–ç1, –î–ì‹MŽj1, “Œ@’q1, Œ˜“ce—˜1, ²X–Ø“O1, ¬ò˜aŽO˜Y1, X’JGŒõ3 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3ŠO‰È): “ú–{“à‰ÈŠw‰ï‘æ616‰ñŠÖ“Œ’n•û‰ï (2015/7/19), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï616‰ñŽ˜^W 2015/7; p.39.

733041. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) H“¹Šà‚̏WŠw“IŽ¡—Âɂš‚¯‚éV‚œ‚ȉ»Šw—Ö@‚Ì–ðŠ„|DCFƒPƒ‚ƒZƒŒƒNƒVƒ‡ƒ“|. Œ˜“ce—˜1, “Œ@’q1, “c糁@‘1,2, ¬ò˜aŽO˜Y1, ¬X³Žq3, ÎŽR”ŽžŠ3, ‘ì˜ad3, •Ð“c‰Ä–ç4, X’JGŒõ4, ŽR‰ºŒpŽj4 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3•úŽËü (Žîá‡), 4ŠO‰È): ‘æ29‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2015/7/31), ‘Š–ÍŒŽ.

733042. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) äBÃ–¬Çð‚â‹·ó‚É‹Nˆö‚·‚éˆÝÃ–¬áŽ‚Ì’·Šú—\Œã‚ÌŒŸ“¢. “ú‚@‰›1, ŒE“cK‰î1, ŽRªŒhŽq2, ˆäã’qm2, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, ’†àV‹MG1, a’J–Ÿ—²1,3, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—ÊǗ): ‘æ4‰ñäB‘ŸŒ€‹†‰ï (2015/9/11), ‰¡•l, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2015/8; 21 (3): 185.

733043. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒ_ƒNƒ‰ƒ^ƒXƒrƒ‹EƒAƒXƒiƒvƒŒƒrƒ‹•¹—p—Ö@’†‚Ébreakthrough‚𗈂µ‚œCŒ^–«ŠÌ‰Š‚Ì7—á. ŽRªŒhŽq1, ’†àV‹MG2, ˆäã’qm1, ŒE“cK‰î2, “c’†Œ«–Ÿ2, ‚“cŽ÷ˆê2, ‰œ˜e—T‰î2, “ú‚@‰›2, a’J–Ÿ—²2,3, ¬ò˜aŽO˜Y2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Á‰»Ší“à, 3ˆã—ÊǗ): ‘æ30‰ñ_“ސìƒEƒCƒ‹ƒXŠÌ‰ŠƒZƒ~ƒi[ (2015/9/24), ‰¡•l.

733044. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) CTRX‚ª’˜Œø‚µ‚œƒpƒ‰ƒ`ƒtƒX‚̈ê—á. ”‹ŒŽ¹D, ŒE“cK‰î1, “ú‚@‰›1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, ’†àV‹MG1, a’J–Ÿ—²1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÊǗ): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733045. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ESD‚ɂĈݑBG•œã”çŠà‚Ɛf’f‚µ‚œ1—á. •{‹M_1, –î–ì‹MŽj1, ‰ÍŒ“Þ’ÃŽq2, —é–ؐl2, ŽRª‘‹IŽq2, ˜a“c‘ñ–ç1, ÎŒËŒªŽŸ1, “Œ@’q1, Œ˜“ce—˜1, ²X–Ø“O1, ¬ò˜aŽO˜Y1, “c糁@‘1,3, ‘å•”@œ4 (1Á‰»Ší“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã, 4ˆã—Éq¶Šw•”): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733046. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) EUS-FNA‚Őf’f‚µ“Ÿ‚œŠÌ–å•”_ŒoâŽî‚̈ê—á. ‹{“c‰pŽ¡1, ŽR“à_Žj1, –Ø“cŒõL1, ìŒû—C•ã1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ŽO“‡Fm1, ‹àŽq@‹œ1, ¬òŽüŽq1, ‰œ˜e‹»‰î1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733047. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ICGŽŽ–ò‚ð—p‚¢‚œŒŒŠÇ‘¢‰eŒŸž‚ɂďãsŒ‹’°Ã–¬ŠïŒ`‚ð“àŽ‹‹Ÿ‰º‚ÅŠm”F‚µ“Ÿ‚œ1—á. ‹e“c˜a‹M1, ‰º“c‘ñ–ç1,2, ¬ŽRŽŽ÷1, äøŒŽ«—Ç1,2, “ü]ˆõs1, Œ–{—Y‘Ÿ1,2, ‹ÊáÁr•œ1,2, ’†‘º—zŽq1, ›–ì@‘1,2, ˆÀ’B@Œ£1,2, •œìk‘å1, “cŒû’qŽq1, ‘ëì’qŽq1, ‘ëì­˜a1 (1‘—§‘Š–ÍŒŽ•a‰@, 2Á‰»Ší“à): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733048. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‰»Šw•úŽËü—Ö@‚ª’˜Œø‚µ‚œãè–åŠÌŠà‚Ì1—á. ‹v•Û“c—z1,2, ŽRèDŠì1,2, ‹ß“¡—Y‹I1,2, –kì”Ž”V1,2, ‰ÍŒèû‘Ÿ˜Y2, ¬–с@“N1,2, ‹e’nG•F1,2, —¢“¹“N•F1,2, –ì“o@œ1,2 (1Á‰»Ší“à, 2•œ’Ë‹€Ï•a‰@): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733049. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‰»Šw•úŽËü—Ö@‚ÆŠO‰È“IŽ¡—Âɂæ‚èCR‚ÉŽŠ‚Á‚œ“¯Žž3d•¡Šà‚̈ê—á. ˜a“c®‹v1,2, ’†–Ú“N•œ1,2, ŽO“‡Fm1,2, ‹gàV“Þ’ÃŽq1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, r–ؐ³—Y1,2 (1Á‰»Ší“à, 2‘Š–ÍŒŽ‹Š“¯•a‰@): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733050. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠÌŠà‚Æ‚ÌŠÓ•Ê‚É‹ê—¶‚µ‚œŠÌŽîᇂ̈ê—á. –©@®‹M1, “ú‚@‰›1, ˆäã’qm2, ŽRªŒhŽq2, ŒE“cK‰î1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, ’†àV‹MG1, a’J–Ÿ—²1,3, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—ÊǗ): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733051. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) p‘Of’f‚ª¢“ï‚Å‚ ‚Á‚œ’Œ’°inflammatory fibroid polyp‚̈ê—á. ì–ìšæ’ˆ1, ²“c”ü˜a1, ìŠÝ‰Á“Þ1, ‘剪³•œ1, ‰¡ŽR@ŒO1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1, “n粏¹•F3, ˆêŒË¹–Ÿ4, ŽOŽ}@M4 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3ŠO‰È, 4•a—): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733052. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ã’°ŠÔ–Œ“®–¬ÇŒóŒQ‚Æ‚ÌŠÓ•Ê‚ð—v‚µ‚œ\“ñŽw’°Šà‚̈ê—á. –k“‡ŽjŒ[1, ’†–Ú“N•œ1,2, ˜a“c®‹v1,2, ŽO“‡Fm1,2, ‹gàV“Þ’ÃŽq1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, r–ؐ³—Y1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733053. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) V‹KProton Pomp Inhibiter (PPI): Vonoprazan fumarate‚ðŽg—p‚µ‚œH.pyroli (HP) œ‹Û‚Ì“–‰@‚̐¬Ñ|‘æ1•ñ Rabeprazole‚Æ‚Ì”äŠr|. ŽOŽ}—zˆê1,2, ”üŒŽÃ1,2, “ü]@•¶1,2, ’|’J@Ê1,2, ×’J@’q1, ‹g“c@‹I1, ŒŒ³Ž›ŽâX1,2, ‘åˆä“c³l1,2, ‹gàV“Þ’ÃŽq1,2, ¡è‹M¶1, “¹‰º—Y‰î1, Îˆä—²Ži3 (1ŽÐ•Û‘Š–Í–ì•a‰@, 2Á‰»Ší“à, 3ŒŒ‰t“à): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733054. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒ_ƒNƒ‰ƒ^ƒXƒrƒ‹EƒAƒXƒiƒvƒŒƒrƒ‹•¹—p—Ö@’†‚Ébreakthrough‚𗈂µ‚œCŒ^–«ŠÌ‰Š‚Ì7—á. ŽRªŒhŽq1, ’†àV‹MG2, ˆäã’qm1, ŒE“cK‰î2, “c’†Œ«–Ÿ2, ‚“cŽ÷ˆê2, ‰œ˜e—T‰î2, “ú‚@‰›2, a’J–Ÿ—²2,3, ¬ò˜aŽO˜Y2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Á‰»Ší“à, 3ˆã—ÊǗ): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733055. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’E•ª‰»Œ^Ž‰–b“÷Žî‚̈ê—á. ²–ì@“§1, Œ}@”üK1,2, ˜a“c®‹v1,2, ŽO“‡Fm1,2, ‹gàV“Þ’ÃŽq1,2, Î•N_1,2, ‘º“c@“Œ1,2, ’†–Ú“N•œ1,2, r–ؐ³—Y1,2, ‘Šèˆê—Y1, ‰Í–ì@Œå1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733056. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’_ÎƒCƒŒƒEƒX‚ɑ΂µ‚Ä“d‹C…ˆ³ÕŒ‚”gÓp‚ª—LŒø‚Å‚ ‚Á‚œˆê—á. ˆÀ’B@‰õ1,2, ‹àŽq@‹œ1,2, –ƒ¶Œ’ˆê˜N1, ’·’Jì—Í–ç1,2, “ì–ì@•×1,2, “cŒŽ‹v”üŽq1, “n粐^²1,2, –Ø“cŒõL1 (1Á‰»Ší“à, 2–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733057. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ”j—ô, oŒŒ‚µ‚œ’Pƒ«ŠÌùN–E‚ɑ΂µŒoƒJƒe[ƒeƒ‹“I“®–¬Çðp (TAE) ‚ðŽ{s‚µ‚œˆê—á. ŽRé‘ñ–ç, “n粐^²1,2, ˆÀ’B@‰õ1,2, ’·’Jì—Í–ç1,2, ‹àŽq@‹œ1,2, ‚‹ŽW•F1,2, ‘å’ˏr˜a1,2, “ì–ì@•×1,2, “cŒŽ‹v”üŽq1,2, ‰ª“c•—Ï1, ‘º“cWˆê˜Y1, •“c‰Ê—Ñ1, ‰¡XOº1 (1–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2Á‰»Ší“à): “ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‘æ336‰ñ—á‰ï (2015/9/26), “Œ‹ž.

733058. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) Sister Mary Joseph's nodule‚É‚æ‚è”­Œ©‚³‚ê‚œ“à‘Ÿˆ««ŽîᇂÌ2—á. ‹ß“¡—Y‹I1,2, ŽRèDŠì1,2, â“Œ@Œd1, ‹v•Û“c—z1,2, –kì”Ž”V1,2, ‰ÍŒŒ°‘Ÿ˜Y1, ¬–с@“N1,2, ‹e’nG•F1,2, —¢“¹“N•F1,2, –ì“o@œ1,2 (1•œ’Ë‹€Ï•a‰@, 2Á‰»Ší“à): “ú–{“à‰ÈŠw‰ï‘æ618‰ñŠÖ“Œ’n•û‰ï (2015/10/10), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï618‰ñŽ˜^W 2015/10; p.36.

733059. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) EUS-FNA‚Őf’f‚ÉŽŠ‚Á‚œˆ««ƒŠƒ“ƒpŽî‚̈ê—á. ŒE“c@•j1, ŽO“‡Fm1,2, ˜a“c®‹v1,2, ‹gàV“Þ’ÃŽq1,2, ’†–Ú“N•œ1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, “n•Ó–€–ç1,2, r–ؐ³—Y1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ140‰ñ‘Š–ÍŒŽˆÝ‚Æ’°Œ€‹†‰ï (2015/10/28), ‘Š–ÍŒŽ.

733060. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘Ï“œ”\ˆÙí‚ª”­Œ©Œ_‹@‚Æ‚È‚Á‚œŽ©ŒÈ–Ɖu«äX‰Š‚̈ê—á. –©@®‹M1, ‹{àVŽu˜N1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, Šâˆä’m‹v1, ¡ò@O1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ140‰ñ‘Š–ÍŒŽˆÝ‚Æ’°Œ€‹†‰ï (2015/10/28), ‘Š–ÍŒŽ.

733061. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï] (ˆê”ÊŒû‰‰) f’f‚É‹ê—¶‚µ‚œäB‘ŸŒŒŠÇ“÷Žî‚̈ê—á. ŒE“cK‰î1, ‰œ˜e—T‰î1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ’†àV‹MG1, “ú‚@‰›1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ48‰ñ_“ސ쌧Á‰»Ší•aˆãŠw‰ï‘‰ï (2015/10/31), V‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2016/1; 43 (1): 128.

733062. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) ŠÌ‰ŠŒãÄ¶•s—ǐ«•nŒŒ‚Ì1—á. ‘å–ì‰äŽq1, ŽR–{@‘n1,2, ‘å–ì@—²1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï‘æ619‰ñŽ˜^W (2015/11/14), “Œ‹ž, 2015/11; p.28.

733063. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰ºsŒ‹’°‹‘åŒeŽº‚̈ê—á. V‘º’qŒÈ1, ’†–Ú“N•œ1,2, ˜a“c®‹v1,2, ŽO“‡Fm1,2, ‹gàV“Þ’ÃŽq1,2, Œ}@”üK1,2, Î•N_1,2, ‘º“c@“Œ1,2, r–ؐ³—Y1,2, ²X–؈ꌛ1, ‰Í–ì@Œå1, •—ŠÔ‹Å’j1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”—á‰ï (2015/12/12), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): 123.

733064. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œëš‹‚ðŽå‘i‚É‚µ‚Ä—ˆ‰@‚µ‚œH“¹‚ª‚ñ‚Ì1Ç—á@š‹‰ºˆÝƒJƒƒ‰ƒpƒX‚Ì—L—p«‚ɂ‚¢‚Ä. ŽOŽ}—zˆê1,2, ”üŒŽÃ1,2, “ü]@•¶1,2, ’|’J@Ê1,2, Îˆä—²Ži3, ‹Ž–{ƒqƒƒR4, ŽR“à‹M—Y1, –î“àŒŽ’qŽq1, ¡è‹M¶1, ‘åˆä“c³l1,2 (1ŽÐ•Û‘Š–Í–ì•a‰@, 2Á‰»Ší“à, 3ŒŒ‰t“à, 4t‘Ÿ“à): “ú–{“à‰ÈŠw‰ï‘æ620‰ñŠÖ“Œ’n•û‰ï (2015/12/12), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï‘æ620‰ñŽ˜^W 2015/12; p.30.

733065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}‘¬‚É‘‘債‚œ‘å’°Diffuse large B-cell lymphoma‚ÉR-CHOP‚ª’˜Œø‚µ‚œ1—á. ŒÃ“c—S‰ÀŽq, ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ‘剪³•œ1, ‹v•Û“c”ü˜a1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”—á‰ï (2015/12/12), “Œ‹ž.

733066. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï] (êCˆãƒZƒbƒVƒ‡ƒ“) EUS-FNA‚É‚æ‚èp‘O•a—f’f‚µ“Ÿ‚œmixed Acinar endocrine carcinoma‚Ì1—á. –©@®‹M1, ‰œ˜e‹»‰î1, –Ø“cŒõL1, ìŒû—C•ã1, ‹{“c‰pŽ¡1, ’·’Jì—Í–ç1, Œ–{‚–Ÿ1, ŽR“à_Žj1, ‹àŽq@‹œ1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”—á‰ï (2015/12/12), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): s116.

733067. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʉ‰‘è) ŠŽõŒo˜H‚Ì“¯’è‚Å‚«‚È‚©‚Á‚œ‚—î”­ÇƒAƒ[ƒoÔ—Ÿ‘å’°‰Š‚Ì1—á. ‹ß“¡—Y‹I1,2, ŽRèDŠì1,2, Šâ–{—Y‘Ÿ˜Y1, ŽR‰º—Žq1, ”’ì—‰i1, ‹v•Û“c—z1,2, –kì”Ž”V1,2, ‰ÍŒèû‘Ÿ˜Y1, ¬–с@“N1,2, ‹e’nG•F1,2, à_–Œr–ç1, —¢“¹“N•F1,2, –ì“o@œ1,2 (1•œ’Ë‹€Ï•a‰@, 2Á‰»Ší“à): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”—á‰ï (2015/12/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): 128.

733068. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •ÖöŒŒ—z«‚ðŒ_‹@‚É–³Çó‚Å”­Œ©‚³‚ê‚œ’°Œ‹Šj‚Ì1—á. äøŒŽ«—Ç1,2, ‰º“c‘ñ–ç1,2, ¬ŽRŽŽ÷1, ‹e“c˜a‹M1, “ü]ˆõs1, ‹ÊáÁr•œ1,2, ’†‘º—zŽq1, ›–ì@‘1,2, ˆÀ’B@Œ£1,2, Œ}@”üK1,2 (1‘—§‘Š–ÍŒŽ•a‰@, 2Á‰»Ší“à): “ú–{“à‰ÈŠw‰ï‘æ621‰ñŠÖ“Œ’n•û‰ï (2016/2/13), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï‘æ621‰ñŽ˜^W 2016/2; p.31.

733069. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŠúŒŽ”­«’_`«ŠÌd•Ï‚ð‡•¹‚µ‚Ä‚¢‚œ‹}«”­ÇŒ^Ž©ŒÈ–Ɖu«ŠÌ‰Š‚Ì1—á. ‚‹Ž‰ØŽq1, “n粐^²1,2, •“c‰Ê—Ñ1, ˆÀ’B@‰õ1,2, ’·’Jì—Í–ç1,2, ‹àŽq@‹œ1,2, ‚‹ŽW•F1,2, ‘å’ˏr˜a1,2, “ì–ì@•×1,2, “cŒŽ‹v”üŽq1,2 (1–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2Á‰»Ší“à): “ú–{“à‰ÈŠw‰ï‘æ621‰ñŠÖ“Œ’n•û‰ï (2016/2/13), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï‘æ621‰ñŽ˜^W 2016/2; p.33.

733070. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï] (ˆê”ÊŒû‰‰) SAPHOÇŒóŒQ‚Æ’×ᇐ«‘å’°‰Š‚̍‡•¹‚ÉTacrolimus‚ª’˜Œø‚µ‚œ1—á. ‹ààV@, ìŠÝ‰Á“Þ1, ‰¡ŽR@ŒO1, ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y1, ˜a“c’B•F3 (1Á‰»Ší“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3äPŒŽ•aEŠŽõ“à): ‘æ622‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2016/3/12), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï622‰ñ 2016/3; p.58.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-110003. [ŒŽ’˜] Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. Yamaguchi T, Machida N, Morizane C, Kasuga A, Takahashi H, Sudo K, Nishina T, Tobimatsu K, Ishido K1, Furuse J, Boku N, Okusaka T: Cancer Sci 2014/9; 105 (9): 1176-81. (ÎŒËŒªŽŸ1: 1Á‰»Ší“à)

H26-320002. [Ç—á•ñ]y“ÁW: ŠÖß’ɂƔ畆ŽŸŠ³z—Տ°—á: ˆÝŠà‚ª”­Œ©‚³‚ê‚œIgA vasculitis. •ŽRhŽq1, ŽR–{—I”ò1, ‘O“cCŽq1, —é–ؐl1,2, ŒŽ“c@_1, ‘‰Y‹MŽj1 (1•œ’Ë‹€Ï•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ”畆•af—à 2015/2; 37 (2): 143-6.

H26-320003. [Ç—á•ñ] ŒoŒû’_“¹‹Ÿ‚ªp‘Of’f‚É—L—p‚Å‚ ‚Á‚œ’_ŠÇ“à“û“ªóŽîᇂÌ1—á. ì–ìšæ’ˆ1, ‰œ˜e‹»‰î1, –Ø“cŒõL1, ¡ò@O1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ŽR“à_Žj1, ‹àŽq@‹œ1, ’|àVŽO‘ãŽq1, ‘å•”@œ2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—Éq¶Šw•”): ’_“¹ 2015/3; 29 (1): 103-9.

H26-522002. [uÀ]y“ÁW: ‚±‚±‚Ü‚Å‚Å‚«‚é! Á‰»Ší“àŽ‹‹ŸŽ¡—ÁzÁ‰»ŠÇŽŸŠ³@ã•”Á‰»ŠÇoŒŒ‚ɑ΂·‚é“àŽ‹‹Ÿ“IŽ~ŒŒ. “c糁@‘1,2, ÎŒËŒªŽŸ2, “Œ@’q2, Œ˜“ce—˜2, ˜a“c‘ñ–ç2, –î–ì‹MŽj2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2015/3; 45 (3): 295-302.

[’˜@‘]

H26-620004. [Šwp‘ (•ª’SŽ·•M)]y‚ׂ©‚ç‚žW2015 Don'ts in Endoscopy (Á‰»Ší“àŽ‹‹Ÿ2ŒŽ‘‘卆)zuˆÝE\“ñŽw’°v‚ׂ©‚ç‚ž@EUS (ê—p‹@E×Œaƒvƒ[ƒu), p.238-40. –Ø“cŒõL1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2015/2”­s.

H26-620005. [Šwp‘ (•ª’SŽ·•M)]y‚ׂ©‚ç‚žW2015 Don'ts in Endoscopy (Á‰»Ší“àŽ‹‹Ÿ2ŒŽ‘‘卆)zu‘å’°v‚ׂ©‚ç‚ž@‘å’°“àŽ‹‹Ÿ‘}“ü, p.260-1. ç–쏻Žq1, ŠÝŒŽ‹Pm1, ŒÜ\—’³L1,2 (1‚ª‚ñŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2015/2”­s.

H26-620006. [Šwp‘ (•ª’SŽ·•M)]y‚ׂ©‚ç‚žW2015 Don'ts in Endoscopy (Á‰»Ší“àŽ‹‹Ÿ2ŒŽ‘‘卆)zu‘å’°v‚ׂ©‚ç‚ž@EUS|5‚‚ׂ̂©‚ç‚ž, p.270-1. ¬—ѐŽ“T1,2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2015/2”­s.

H26-620007. [Šwp‘ (•ª’SŽ·•M)]y‘‚í‚©‚è Á‰»Ší“àŽ‹‹ŸŠÖ˜AƒKƒCƒhƒ‰ƒCƒ“‚Ì‚·‚×‚Ä (Á‰»Ší“àŽ‹‹Ÿ3ŒŽ‘‘卆)zŠe˜_ [Á‰»ŠÇ‘S”Ê‚É‹y‚Ô‚à‚Ì]@ƒGƒrƒfƒ“ƒX‚ƃRƒ“ƒZƒ“ƒTƒX‚𓝍‡‚µ‚œ’×ᇐ«‘å’°‰Š‚̐f—ÃKƒCƒhƒ‰ƒCƒ“, p.486-9. ¬—ѐŽ“T1,2, ‰¡ŽR@ŒO2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2015/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H26-712001. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) How to Get Maximum Yield with EUS-FNA. Imaizumi H1: Asian EUS group 2015 (2015/2/2), Bangkok, Thai. (¡ò@O1: 1Á‰»Ší“à)

H26-731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’×ᇐ«‘å’°‰ŠŽ¡—Â̍ŋ߂̓®Œü‚Ɛf—ÃKƒCƒhƒ‰ƒCƒ“‰ü’ù‚ÉŒü‚¯‚œŽæ‚è‘g‚Ý. ¬—ѐŽ“T1,2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): ‘æ28‰ñìŒûÁ‰»Ší•a§˜b‰ï (2015/2/12), ìŒû.

H26-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ’ŒŽ‹Œ^EŽÎŽ‹Œ^ƒXƒR[ƒv‚É‚æ‚éInterventonal EUS. –Ø“cŒõL (Á‰»Ší“à): ‘æ14‰ñ‘ÛÁ‰»Ší“àŽ‹‹ŸƒZƒ~ƒi[ (Yokohama Live Demonstration) (2015/3/8), ‰¡•l.

H26-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—á•ñ) ˜’É‚Å”­Ç‚µ, ‹}Œƒ‚ɐis‚µ‚œ‘œ‘ŸŠí•s‘S‚Ì1—á. _ŽR‹X–ç1, ’|“à”ŽŽ÷1, “ìì@ãÄ1, ’F@—ºŽq1, ŒE“cK‰î2, “c’†‰h‘Ÿ˜Y1, ‰ª“cŒöÍ1 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): “ú–{“à‰ÈŠw‰ï‘æ613‰ñŠÖ“Œ’n•û‰ï (2015/3/14), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï613‰ñŽ˜^W 2015/3; p.56.

H26-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒ\ƒ‰ƒtƒFƒjƒu400 mgŠJŽn‚Ì—LŒø«‚ƈÀ‘S«‚ɂ‚¢‚Ä: ‘œŽ{Ý‹€“¯Œ€‹†‚É‚š‚¯‚éPropensity score-matched analysis. ¬—с@’q1, X–{@Šw1, À“c˜aŽi1, ‹ß“¡³W1, ‘åìLˆê1, “ú‚@‰›2, ’†àV‹MG2, ‰œ˜e—T‰î2, ‰œ£çH1, Œ‰iŒõ‘Ÿ˜Y1, —é–Ø’Ê”Ž1, X“c’qŽ‹1, “cŒI³—²1, “c’†Ž–Ÿ1 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ11‰ñ“ú–{ŠÌ‚ª‚ñ•ªŽq•W“IŽ¡—ÃŒ€‹†‰ï (2015/1/31), “Œ‹ž, The Liver Cancer Journal 2015/6; 7 (2): 134-5.

‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È@Á‰»Ší“à‰ÈŠw
Šñ•uÀu‰ŠÇ«’°ŽŸŠ³—Տ°Œ€‹†uÀv

[Šwp˜_•¶]

110096. [ŒŽ’˜] Adalimumab for the treatment of Japanese patients with intestinal Behet's disease. Tanida S, Inoue N, Kobayashi K, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Ngahori M, Motoya S, Nkamura S, Arora V, Robinson AM, Thakkar RB, Hibi T1,2: Clin Gastroenterol Hepatol 2015/5; 13 (5): 940-8.e3. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110097. [ŒŽ’˜] Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C. Chu PS, Ebinuma H, Nakamoto N, Sugiyama K, Usui S, Wakayama Y, Taniki N, Yamaguchi A, Shiba S, Yamagishi Y, Wakita T, Hibi T1,2, Saito H, Kanai T: PLoS One 2015/5; 10 (5): e0125664. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110098. [ŒŽ’˜] Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy. Takayama T, Okamoto S, Hisamatsu T, Naganuma M, Matsuoka K, Mizuno S, Bessho R, Hibi T1,2, Kanai T: PLoS One 2015/6; 10 (6): e0131197. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110099. [ŒŽ’˜] Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohn's Disease: A Prospective Clinical Trial. Suzuki Y, Matsui T, Ito H, Ashida T, Nakamura S, Motoya S, Matsumoto T, Sato N, Ozaki K, Watanabe M, Hibi T1,2: Inflamm Bowel Dis 2015/9; 21 (9): 2114-22. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110100. [ŒŽ’˜] Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission. Hisamatsu T, Ono N, Imaizumi A, Mori M, Suzuki H, Uo M, Hashimoto M, Naganuma M, Matsuoka K, Mizuno S, Kitazume MT, Yajima T, Ogata H, Iwao Y, Hibi T1,2, Kanai T: PLoS One 2015/10; 10 (10): e0140716. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110101. [ŒŽ’˜] A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter. Umeno J, Hisamatsu T, Esaki M, Hirano A, Kubokura N, Asano K, Kochi S, Yanai S, Fuyuno Y, Shimamura K, Hosoe N, Ogata H, Watanabe T, Aoyagi K, Ooi H, Watanabe K, Yasukawa S, Hirai F, Matsui T, Iida M, Yao T, Hibi T1,2, Kosaki K, Kanai T, Kitazono T, Matsumoto T: PLoS Genet 2015/11; 11 (11): e1005581. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110102. [ŒŽ’˜] An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease. Yoshimura N, Yokoyama Y, Matsuoka K, Takahashi H, Iwakiri R, Yamamoto T, Nakagawa T, Fukuchi T, Motoya S, Kunisaki R, Kato S, Hirai F, Ishiguro Y, Tanida S, Hiraoka S, Mitsuyama K, Ishihara S, Tanaka S, Otaka M, Osada T, Kagaya T, Suzuki Y, Nakase H, Hanai H, Watanabe K, Kashiwagi N, Hibi T1,2: BMC Gastroenterol 2015/11; 15: 163. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110103. [ŒŽ’˜] Risk factors for decreased bone mineral density in inflammatory bowel disease: A cross-sectional study. Wada Y, Hisamatsu T, Naganuma M, Matsuoka K, Okamoto S, Inoue N, Yajima T, Kouyama K, Iwao Y, Ogata H, Hibi T1,2, Abe T, Kanai T: Clin Nutr 2015/12; 34 (6): 1202-9. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110104. [ŒŽ’˜] Safety and Efficacy of AJM300, an Oral Antagonist of ƒ¿4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis. Yoshimura N1, Watanabe M1, Motoya S1, Tominaga K1, Matsuoka K1, Iwakiri R1, Watanabe K1, Hibi T1,2,3 (1AJM300 Study Group): Gastroenterology 2015/12; 149 (7): 1775-1783.e2. (“ú”ä‹I•¶1,2,3: 2–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110105. [ŒŽ’˜] Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1). Ooi CJ1, Makharia GK1, Hilmi I1, Gibson PR1, Fock KM1, Ahuja V1, Ling KL1, Lim WC1, Thia KT1, Wei SC1, Leung WK1, Koh PK1, Gearry RB1, Goh KL1, Ouyang Q1, Sollano J1, Manatsathit S1, de Silva HJ1, Rerknimitr R1, Pisespongsa P1, Abu Hassan MR1, Sung J1, Hibi T1,2,3, Boey CC1, Moran N1, Leong RW1 (1Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease): J Gastroenterol Hepatol 2016/1; 31 (1): 45-55. (“ú”ä‹I•¶1,2,3: 2–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110106. [ŒŽ’˜] Asia-Pacific consensus statements on Crohn's disease. Part 2: Management. Ooi CJ1, Makharia GK1, Hilmi I1, Gibson PR1, Fock KM1, Ahuja V1, Ling KL1, Lim WC1, Thia KT1, Wei SC1, Leung WK1, Koh PK1, Gearry RB1, Goh KL1, Ouyang Q1, Sollano J1, Manatsathit S1, de Silva HJ1, Rerknimitr R1, Pisespongsa P1, Abu Hassan MR1, Sung J1, Hibi T1,2,3, Boey CC1, Moran N1, Leong RW1 (1Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease): J Gastroenterol Hepatol 2016/1; 31 (1): 56-68. (“ú”ä‹I•¶1,2,3: 2–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110107. [ŒŽ’˜] Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study. Suzuki Y, Iida M, Ito H, Saida I, Hibi T1,2: Intest Res 2016/1; 14 (1): 50-9. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110108. [ŒŽ’˜] Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn's Disease. Suzuki Y, Iida M, Ito H, Tachikawa N, Hibi T1,2: Drugs R D 2016/3; 16 (1): 35-43. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110109. [ŒŽ’˜] First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis. Kobayashi T, Suzuki Y, Motoya S, Hirai F, Ogata H, Ito H, Sato N, Ozaki K, Watanabe M, Hibi T1,2: J Gastroenterol 2016/3; 51 (3): 241-51. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

120010. [ŒŽ’˜] ‰ŠÇ«’°ŽŸŠ³Š³ŽÒ‚É‚š‚¯‚鍂’£«’°ŠÇôòÜ (ƒ‚ƒrƒvƒŒƒbƒv) ‚ÌŽó—e«, —LŒø«, ˆÀ‘S«‚ÌŒŸ“¢. ‰Á“¡–ƒ—RŽq1, ¬—с@‘ñ1, ˜a“c—R‰Á—˜1, X‚œ‚Ÿ‚Š1, ŽÄ“c‡Žq1, ’†–ì@‰ë1, ‹ÚàV@G1, ’·À@œ1, Î‹Ž‚Æ‚æ‚Ý1, ”~“c’qŽq1, “n•ÓŒ›–Ÿ1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{‘å’°ŒŸžŠw‰ïŽGŽ 2016/3; 32 (2): 91-8.

320012. [Ç—á•ñ] ã•”Á‰»ŠÇ“àŽ‹‹ŸŒŸž‚Å‹ô‘R”­Œ©‚³‚ê‚œHamartomatous inverted polyp‚Ì1—á. Xì@~1, ’†–ì@‰ë1, ¬—с@‘ñ1, ”~“c’qŽq1, Ž…Ž1, ”óŒû@”£1, íŒ@—ß1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2, ‘åì¹‹`1, X‰i³“ñ˜Y1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Progress of Digestive Endoscopy 2015/12; 87 (1): 108-9.


521004. [‰ðà]yˆãŠw—pŒê‰ðàz’Pƒ«’×á‡/’°ŠÇƒx[ƒ`ƒFƒbƒg•a. “ú”ä‹I•¶1,2, ‹vŒ—ˆê (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): G.I.Research 2015/6; 23 (3): 252-3.

521005. [‰ðà]yˆãŠw—pŒê‰ðàzNFIL3 (E4BP4). “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): G.I.Research 2015/6; 23 (3): 254-5.

521006. [‰ðà]yÅVE–ò•šŽ¡—Â̎ÀÛz’×ᇐ«‘å’°‰Š‚É‚š‚¯‚é–ò•šŽ¡—Ã. “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): CLINIC magazine 2015/8; 42 (8): 21-4.

521007. [‰ðà]yŽ¿‹^‰ž“šz—Տ°ˆê”Ê [“à‰È: zŠÂŠí] ’×ᇐ«‘å’°‰Š‚ÌŠ°‰ðˆÛŽ—Ö@‚É‚š‚¯‚é“Š–ò‚Æ‹x–ò. “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{ˆãŽ–V•ñ 2015/9; 4769: 67-8.

521008. [‰ðà]y•a‘ԁEŽ¡—ÃQ&A: “ÁŽêŒ^ƒx[ƒ`ƒFƒbƒg•az’°ŠÇŒ^ƒx[ƒ`ƒFƒbƒg•a‚ɂ‚¢‚Ä‚š‹³‚Š‚­‚Ÿ‚³‚¢. “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): —Տ°‚Ì‚ ‚ä‚Ý 2015/9; 99: 9-10.

522044. [uÀ]y“ÁW: ¶•šŠw“I»Ü‚ª‘ñ‚­IBDf—Â̐VŽž‘ãz‚±‚ê‚©‚çŠú‘Ò‚³‚ê‚鐶•šŠw“I»Ü. “ú”ä‹I•¶1,2, ‹vŒ—ˆê1, ꎓ¡‰rŽq1, –L‰i‹M•F1, ¬—с@‘ñ1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Mebio 2015/8; 32 (8): 78-85.

522045. [uÀ]y“ÁW: “à‰Èƒvƒ‰ƒCƒ}ƒŠƒPƒA‚Ì‚œ‚߂̏Á‰»Šíf—ÃUpdatez¡¬’°E‘å’°ŽŸŠ³@’×ᇐ«‘å’°‰Š. —с@‘ñ1, ’†–ì@‰ë1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Medicina 2015/9; 52 (10): 1714-6.

522046. [uÀ]y“ÁW: ‰ŠÇ«’°ŽŸŠ³|ƒtƒ@[ƒXƒgƒ^ƒbƒ`‚©‚ç’·Šúƒ}ƒlƒWƒƒ“ƒg‚܂Łz‰ŠÇ«’°ŽŸŠ³‚̐f’f@•aŒ^‚ƏdÇ“x‚Ì”»’è. ¬—с@‘ñ1, ’†–ì@‰ë1, ꎓ¡‰rŽq1, –L‰i‹M•F1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “à‰È 2015/10; 116 (4): 565-8.

522047. [uÀ]y“ÁW: IBDƒ`[ƒ€ˆã—Âɂš‚¯‚郁ƒ“ƒo[‚Ì–ðŠ„‚Æ–â‘è“_‚ð–Ÿ‚ç‚©‚É‚·‚é!zIBDƒ`[ƒ€ˆã—Âɂš‚¯‚éˆãŽt (Á‰»Šíˆã) ‚Ì–ðŠ„. ¬—с@‘ñ1, –L‰i‹M•F1, ꎓ¡‰rŽq1, ’†–ì@‰ë1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): IBD Research 2015/12; 9 (4): 238-42.

522048. [uÀ]y“ÁW: IBDƒ`[ƒ€ˆã—Âɂš‚¯‚郁ƒ“ƒo[‚Ì–ðŠ„‚Æ–â‘è“_‚ð–Ÿ‚ç‚©‚É‚·‚é!zIBDƒ`[ƒ€ˆã—Âɂš‚¯‚é–òÜŽt‚Ì–ðŠ„. ”ª–ØàVŒ[Ži1, ‚–ìÆŽq1, ’†‘ºr‹M1, ŠLÀ@1, ¬—с@‘ñ1, ŒŒŽ@”£2, “ú”ä ‹I•¶1,3 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2–òŠw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): IBD Research 2015/12; 9 (4): 257-61.

522049. [uÀ]y“ÁW: ƒ`[ƒ€ˆã—ÁEˆã—ØAŒg‚ðl‚Š‚ézƒ`[ƒ€ˆã—Ã: ‰ŠÇ«’°ŽŸŠ³. “ú”ä ‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ƒNƒŠƒjƒVƒAƒ“ 2016/1; 63 (1): 33-7.

522050. [uÀ]y“ÁW: –ƉuŽŸŠ³Updatez‰ŠÇ«’°ŽŸŠ³Ž¡—Â̗ðŽj‚ƍ¡Œã‚Ì“W–]. “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ƒNƒŠƒjƒVƒAƒ“ 2016/2; 63 (2): 122-6.

522051. [uÀ]y“ÁW: ƒNƒ[ƒ“•aŽ¡—Â̍őOüz1. ‚Ç‚Ì‚æ‚€‚ȏǗá‚ɍRTNF-ƒ¿R‘̐»Ü‚ðŽg‚€‚ׂ«‚©? “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): INTESTINE 2016/3; 20 (2): 127-32.

522052. [uÀ]yf’fuÀ: Ç—á‚©‚çŠw‚ÔIBDŠÓ•Êf’f‚̃Rƒcz‘æ29‰ñ: IBD‚Æ’°ŠÇƒXƒsƒƒw[ƒ^Ç. ”~“c’qŽq1, ¬—с@‘ñ1, “ú”ä‹I•¶1,2, X‰i³“ñ˜Y1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): IBD Research 2016/3; 10 (1): 46-51.

530006. [‚»‚Ì‘Œ (Ž‹“_)] A new start for 'Intestinal Research' as an official journal of AOCC. Hibi T1,2: Intest Res 2016/1; 14 (1): 1. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

540005. [‚»‚Ì‘Œ (‰ï‹c˜^)] ‰ŠÇ«’°ŽŸŠ³Š³ŽÒ‚É‚š‚¯‚鍂’£«’°ŠÇôòÜ (ƒ‚ƒrƒvƒŒƒbƒv) ‚ÌŽó—e«, —LŒø«, ˆÀ‘S«‚ÌŒŸ“¢. ‰Á“¡–ƒ—RŽq1, ˜a“c—R‰Á—˜1, ŽÄ“c‡Žq1, ¬—с@‘ñ1, X‚œ‚Ÿ‚Š1, Î‹Ž‚Æ‚æ‚Ý1, ’†–ì@‰ë1, ‹ÚàV@G1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ŠÖ“ŒÁ‰»Ší“àŽ‹‹Ÿ‹ZŽt‰ïŽ 2015/9; 22: 5-6.

540006. [‚»‚Ì‘Œ (‰ï‹c˜^)] ‰ŠÇ«’°ŽŸŠ³Š³ŽÒ‚É‚š‚¯‚éV‹K’°ŠÇôòÜ‚ÌŽó—e«, —LŒø«, ˆÀ‘S«‚ÌŒŸ“¢|”ñ‰ŠÇ«’°ŽŸŠ³Š³ŽÒ‚Æ‚Ì”äŠr|. ‰Á“¡–ƒ—RŽq1, ˜a“c—R‰Á—˜1, ŽÄ“c‡Žq1, ¬—с@‘ñ1, X‚œ‚Ÿ‚Š1, Î‹Ž‚Æ‚æ‚Ý1, “ú”ä‹I•¶1,2, ’†–ì@‰ë1, ‹ÚàV@G1, ’·À@œ1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{Á‰»Ší“àŽ‹‹Ÿ‹ZŽt‰ï‰ï•ñ 2016/3; 56: 58.

[’˜@‘]

620029. [Šwp‘ (•ª’SŽ·•M)]y“ÁW: “à‰ÈŽŸŠ³‚̐f’fŠî€E•aŒ^•ª—ށEdÇ“x (“à‰È2015”N6ŒŽ‘‘卆)z‘æ2Í Á‰»Ší@‰ŠÇ«’°ŽŸŠ³, p.956-9. ¬—с@‘ñ1, ’†–ì@‰ë1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È), “ì]“°, “Œ‹ž, 2015/6”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722029. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yIBDŽ¡—Ð헪‚É‚š‚¯‚é“àŽ‹‹Ÿ‚Ì–ðŠ„z‘å’°“àŽ‹‹Ÿ‚Æ•Ö’†ƒoƒCƒIƒ}[ƒJ[S100A12‚ð‘g‚ݍ‡‚킹‚œ’×ᇐ«‘å’°‰Š‚ÌŽ¡—Ð헪. ¬—с@‘ñ1, ’†–ì@‰ë1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/29), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 691.

722030. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y”S–Œ–Ɖu‚Ɣ畆–Ɖuz—Տ°–ƉuŠw“IƒAƒvƒ[ƒ`‚©‚ç‚Ý‚œ‰ŠÇ«’°ŽŸŠ³‚ÌŽŸŠ³ŠŽŽó«ˆâ“`Žq. ¬—с@‘ñ1, ’†–ì@‰ë1, –L‰i‹M•F1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ43‰ñ“ú–{—Տ°–ƉuŠw‰ï‘‰ï (2015/10/23), _ŒË, “ú–{—Տ°–ƉuŠw‰ï‰ïŽ 2015/9; 38 (4): 290.

722031. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yIBD‰æ‘œf’fƒ[ƒNƒVƒ‡ƒbƒvzƒNƒ[ƒ“•a‰“ˆÊ‰ñ’°ŒŸõ‚É‚š‚¯‚éŽó“®œ]‹È‚“`’B‘}“ü•”“‹Ú×Œa‘å’°“àŽ‹‹ŸPCF-PQ260L‚Ì—L—p«‚ÌŒŸ“¢|MRƒGƒ“ƒeƒƒOƒ‰ƒtƒB[‚Æ‚Ì“¯“úŽ{s‚ÌŒoŒ±‚æ‚è|. ’†–ì@‰ë,1 ¬—с@‘ñ1, ’†—¢Œ\G1, ”~“c’qŽq1, –L‰i‹M•F1, ꎓ¡‰rŽq1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ33‰ñ“ú–{‘å’°ŒŸžŠw‰ï (2015/11/7), “Œ‹ž, “ú–{‘å’°ŒŸžŠw‰ïŽGŽ 2016/3; 32 (2): 129.

722032. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y‘å’°f—Âɂš‚¯‚é‘œEŽíƒ`[ƒ€ˆã—Áz‰ŠÇ«’°ŽŸŠ³f—Âɂš‚¯‚éƒ`[ƒ€ˆã—Â̈Ӌ`‚ÆŽæ‚è‘g‚Ý. ¬—с@‘ñ1, ’†–ì@‰ë1, “n•ÓŒ›–Ÿ1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/13), –ŒŒÃ‰®, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2015/9; 68 (9): 634.

723189. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ŠÇ«’°ŽŸŠ³Š³ŽÒ‚É‚š‚¯‚郂ƒrƒvƒŒƒbƒv‚ÌŽó—e«, —LŒø«, ˆÀ‘S«‚ÌŒŸ“¢. ’†–ì@‰ë1, ¬—с@‘ñ1, ‰Á“¡–ƒ—RŽq1, ˜a“c—R‰Á—˜1, X‚œ‚Ÿ‚Š1, ŽÄ“c‡Žq1, ‹ÚàV@G1, ’·À@œ1, Î‹Ž‚Æ‚æ‚Ý1, ”~“c’qŽq1, “n•ÓŒ›–Ÿ1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/29-31), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl.1): 820.

723190. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‚Ž‰–bHÛŽæƒ}ƒEƒX‚Ì’°“à×‹Û•Ï‰». •À@’q1, ¬—с@‘ñ1, ’|“à@C1, ŒË“c‹žŽq1, íŒ@—ß1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ24‰ñ“ú–{—Տ°ŠÂ‹«ˆãŠw‰ïŠwpW‰ï (2015/6/6), “Œ‹ž, “ú–{—Տ°ŠÂ‹«ˆãŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W24‰ñ 2015/5; p.54.

723191. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ŠÇ«’°ŽŸŠ³Š³ŽÒ‚É‚š‚¯‚éV‹K’°ŠÇôòÜ‚ÌŽó—e«, —LŒø«, ˆÀ‘S«‚ÌŒŸ“¢|”ñ‰ŠÇ«’°ŽŸŠ³Š³ŽÒ‚Æ‚Ì”äŠr|. ‰Á“¡–ƒ—RŽq1, ¬—с@‘ñ1, ˜a“c—R‰Á—˜1, ŽÄ“c‡Žq1, X‚œ‚Ÿ‚Š1, Î‹Ž‚Æ‚æ‚Ý1, “ú”ä‹I•¶1,2, ’†–ì@‰ë1, ‹ÚàV@G1, ’·À@œ1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/10/8-10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (Suppl.2): 2256.

723192. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒXƒeƒƒCƒh‚ª‘tŒ÷‚µ‚œŠÖß‰ŠÇó‡•¹dÇmicroscopic colitis‚̈ê—á. –L‰i‹M•F1, ¬—с@‘ñ1, Ä“¡‰rŽq1, ’†–ì@‰ë1, ”~“c’qŽq1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ43‰ñ“ú–{—Տ°–ƉuŠw‰ï‘‰ï (2015/10/23), _ŒË, “ú–{—Տ°–ƉuŠw‰ï‰ïŽ 2015/9; 38 (4): 375.

723193. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’×ᇐ«‘å’°‰ŠŠ³ŽÒ‚É‚š‚¯‚éƒ^ƒNƒƒŠƒ€ƒX‚Ì•êW’c–ò•š“®‘Ô‰ðÍ. ŒF”WŒä“°¹‰p1, “c’†@, ŽÂèŒöˆê, ¬—с@‘ñ2, ’|“à@C, •À@’q, ”~“c’qŽq, –L‰i‹M•F2, Ä“¡‰rŽq2, ’†–ì@‰ë2, ‹ÚàV@G2, “n•ÓŒ›–Ÿ2, “n•Ó—R‹I, Î‹Ž‚Æ‚æ‚Ý, Î“cËˆê1, “ú”ä‹I•¶2,3, Ä“¡‘ŸŽõ, ¬—Ñ‹`˜a, Ä“¡‰ër (1–òŠw•”, 2–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{–òŠw‰ï‘æ136”N‰ï (2016/3/27-29), ‰¡•l, “ú–{–òŠw‰ï”N‰ï—vŽ|W 2016/3; 136”N‰ï4†: 111.

723194. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ú–{l‰ŠÇ«’°ŽŸŠ³Š³ŽÒ‚̃`ƒIƒvƒŠƒ“—Ö@‚É‚š‚¯‚éd“Ä‚È”’ŒŒ‹…Œž­Ç‚ÉŠÖ˜A‚·‚éˆâ“`—vˆö‚ÌŒŸ“¢. Šâè^ˆß1, “c’†—fˆê1, ‹ààV‰·Žq1, Â–ØŠwˆê1, ˆÀ“¡@q1, ‰–Œ©‚ß‚®‚Ý1, a’J@Ž1, ‹v•Û“c—Œb1, “ú”ä‹I•¶2,3, ¬‹{ŽR‹MŽq1 (1–òŠw•”, 2–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{–òŠw‰ï‘æ136”N‰ï (2016/3/27-29), ‰¡•l, “ú–{–òŠw‰ï”N‰ï—vŽ|W 2016/3; 136”N‰ï4†: 148.

733071. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰)yŒ€CˆãƒZƒbƒVƒ‡ƒ“zƒXƒNƒŠ[ƒjƒ“ƒOã•”Á‰»ŠÇ“àŽ‹‹ŸŒŸž‚É‚Ä‹ô‘R”­Œ©‚³‚ê‚œHamartomatous inverted polyp‚Ì1—á. Xì@~1, ’†–ì@‰ë1, ¬—с@‘ñ1, ”~“c’qŽq1, Ž…Ž1, ”óŒû@”£1, íŒ@—ß1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2, ‘åì¹‹`1, X‰i³“ñ˜Y1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ100 ‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl 1): 113.

733072. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰)yŒ€CˆãƒZƒbƒVƒ‡ƒ“z\“ñŽw’°”S–Œ‰ºŽîᇂƂ̊ӕʂª¢“ï‚Å‚ ‚Á‚œGastric mucosal prolapse polyp‚Ì1—á. …’J—m—C1, ’†–ì@‰ë1, ”~“c’qŽq1, –L‰i‹M•F1, ꎓ¡‰rŽq1, ¬—с@‘ñ1, ”óŒû@”£1, íŒ@—ß1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2, —é–ØŒcˆê1, X‰i³“ñ˜Y1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ101‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2015/12/12), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): 121.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H24-120001. [ŒŽ’˜] ƒRƒŠƒ“Œ‡–RHƒ}ƒEƒX‚ÌConcanavalin A—U”­«ŠÌáŠQ‚ɑ΂·‚éEdaravone‚ÌŒø‰Ê‚ÌŒŸ“¢. ŒË“c‹žŽq1, íŒ@—ß1, ŒF’J’ŒŽ÷1, ‹àŽq•¶•F1, X‰i³“ñ˜Y1, •œ‹v@Ž¡1, —é–؍K’j1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Á‰»Ší‚ƖƉu 2013.03; 49: 74-81.

H24-310001. [Ç—á•ñ] A case of small intestine type steroid-naïve Crohn disease in which osteomalacia was diagnosed by fractures on the transcervical bone. Ohkura E, Nakano M, Kato Y, Tsunematsu S, Serizawa H, Watanabe N, Kumagai N, Tsuchimoto K, Yajima T, Hibi T1,2: Nihon Shokakibyo Gakkai Zasshi 2012/12; 109 (12): 2082-7. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

H25-120001. [ŒŽ’˜] ‚Ž‰–bHƒ}ƒEƒX‚ÌConcanavalin A—U”­«ŠÌáŠQ‚ɑ΂·‚éƒGƒCƒRƒTƒyƒ“ƒ^ƒGƒ“Ž_‚ÌŒø‰Ê‚ÌŒŸ“¢. ŒË“c‹žŽq1, íŒ@—ß1, Ž…Ž1, ŒF’J’ŒŽ÷1, ‹àŽq•¶•F1, X‰i³“ñ˜Y1, •œ‹v@Ž¡1, ŽR“cD‘¥1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Á‰»Ší‚ƖƉu 2014/3; 50: 90-96.

H25-320001. [Ç—á•ñ] ƒJƒvƒZƒ‹“àŽ‹‹ŸŒŸž‚Å”­Œ©‚³‚ê‚œ\“ñŽw’°‘BŽî‚Ì1—á. •Ÿˆä’‘å1, ’†–ì@‰ë1, ‰Á“¡—T‰ÀŽq1, ¬—с@‘ñ1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, Ž…Ž1, íŒ@—ß1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2, ×]’ŒŽ÷1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Progress of Digestive Endoscopy 2013/12; 83 (1): 128-9.

H25-522001. [uÀ]y“ÁW: ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì‚·‚ׂāzÁ‰»ŠÇƒTƒ‹ƒRƒCƒh[ƒVƒX@‰ŠÇ«’°ŽŸŠ³‚Æ‚Ì‘Š“¯«‚ɂ‚¢‚Ä. ‹Ø–ì’q‹v1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2013/10; 43 (10): 1277-80.

H25-522002. [uÀ]y“ÁW: ‚±‚±‚Ü‚Å—ˆ‚œ, ‰ŠÇ«’°ŽŸŠ³‚̐V“WŠJz’×ᇐ«‘å’°‰Š‚Ì“à‰ÈŽ¡—Á@‹ß”N‚̕ω». “ú”ä‹I•¶1,2, ¬—с@‘ñ1, ’†–ì@‰ë1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2014/3; 44 (3): 311-5.

H25-522003. [uÀ]y“ÁW: ‰ŠÇ«’°ŽŸŠ³‚̉摜f’fmodalityz1-4. ‘å’°“àŽ‹‹Ÿ@(4) ’ŽŠg‘å“àŽ‹‹Ÿ. ¬—с@‘ñ1, ’·À@œ1, •û°•F1, “ú”ä‹I•¶1,2, ‹àˆä—²“T1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): INTESTINE 2014/3; 18 (2): 127-32.

H25-522004. [uÀ]y“ÁW: IBDf—ÂɗL—p‚ȃCƒ“ƒfƒbƒNƒX‚Í‚±‚ê‚Ÿ!zIBDf—ÂɎg—p‚³‚ê‚éƒCƒ“ƒfƒbƒNƒX‚̍¡Œã‚Ì“W–]. ¬—с@‘ñ1, ‹Ø–ì’q‹v1, ‰Á“¡—T‰ÀŽq1, ’†–ì@‰ë1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): IBD Research 2014/3; 8 (1): 37-42.

H26-110004. [ŒŽ’˜] Prominent steatosis with hypermetabolism of the cell line permissive for years of infection with hepatitis C virus. Sugiyama K, Ebinuma H, Nakamoto N, Sakasegawa N, Murakami Y, Chu PS, Usui S, Ishibashi Y, Wakayama Y, Taniki N, Murata H, Saito Y, Fukasawa M, Saito K, Yamagishi Y, Wakita T, Takaku H, Hibi T1,2, Saito H, Kanai T: PLoS One 2014/4; 9 (4): e94460. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

H26-110005. [ŒŽ’˜] A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice. Yokoyama Y, Matsuoka K, Kobayashi T, Sawada K, Fujiyoshi T, Ando T, Ohnishi Y, Ishida T, Oka M, Yamada M, Nakamura T, Ino T, Numata T, Aoki H, Sakou J, Kusada M, Maekawa T, Hibi T1,2: J Crohns Colitis 2014/9; 8 (9): 981-91. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

H26-110006. [ŒŽ’˜] Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease. Watanabe M, Hibi T1,2, Mostafa NM, Chao J, Arora V, Camez A, Petersson J, Thakkar R: J Crohns Colitis 2014/11; 8 (11): 1407-16. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

H26-110007. [ŒŽ’˜] Alteration of angiogenesis in Helicobacter heilmannii-induced mucosa-associated lymphoid tissue lymphoma: interaction with c-Met and hepatocyte growth factor. Nakamura M, Takahashi T, Matsui H, Baniwa Y, Takahashi S, Murayama SY, Serizawa H, Suzuki H, Hibi T1,2: J Gastroenterol Hepatol 2014/12; 29 (Suppl 4): 70-6. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

H26-320004. [Ç—á•ñ] “àŽ‹‹Ÿ‘œ‚̕ω»‚ðŠÏŽ@‰Â”\‚Å‚ ‚Á‚œŒŽ”­«ˆÝƒAƒ~ƒƒCƒh[ƒVƒX‚Ì1—á. ŽO‘î@—í1, ‹Ø–ì’q‹v1, ¬—с@‘ñ1, ‰Á“¡—T‰ÀŽq1, ’†–ì@‰ë1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, “y–{Š°“ñ1, ––X—F_1, X‰i³“ñ˜Y1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Progress of Digestive Endoscopy 2014/6; 84 (1): 88-89.

H26-320005. [Ç—á•ñ] ‘å’°“àŽ‹‹ŸŒŸž‚Å‹ô‘R”­Œ©‚³‚ê‚œ–³ÇŒó«‘å’°ƒAƒjƒTƒLƒXÇ‚Ì1—á. ²X–ØŒ«ˆê1, ‹ÚàV@G1, ’†–ì@‰ë1, ‰Á“¡—T‰ÀŽq1, ¬—с@‘ñ1, Ž…Ž1, íŒ@—ß1, “n•ÓŒ›–Ÿ1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2, ––·—F_1, X‰i³“ñ˜Y1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Progress of Digestive Endoscopy 2014/12; 85 (1): 104-5.

H26-522003. [uÀ]y“ÁW: ’Œ’°“Š—^»Ü|‚±‚ê‚܂ŏWÏ‚³‚ê‚œƒmƒEƒnƒE‚Æ–ò•šŽ¡—Â̍őOüzƒGƒLƒXƒp[ƒg‚ÉŠw‚Ô!@–ò•šŽ¡—Âɂš‚¯‚é’Œ’°“Š—^»Ü‚̈ʒu‚¯‚ÆŠˆ—p‚̃|ƒCƒ“ƒg@E’×ᇐ«‘å’°‰Š. “ú”ä‹I•¶1,2, ¬—с@‘ñ1, ’†–ì@‰ë1, “n•ÓŒ›–Ÿ1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): –ò‹Ç 2014/8; 65 (9): 2426-30.

H26-522004. [uÀ]y“ÁW: ¶•šŠw“I»Ü‚Ì“K‰ž‚ª‚ ‚郊ƒEƒ}ƒ`—Þ‰ŽŸŠ³z‰ŠÇ«’°ŽŸŠ³. “ú”ä‹I•¶1,2, ¬—с@‘ñ1, ’†–ì@‰ë1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Rheumatology Clinical Research 2014/8; 3 (2): 78-82.

H26-522005. [uÀ]y“ÁW: ‰ŠÇ«’°ŽŸŠ³|•a‘ÔŒ€‹†‚©‚ç•W“IŽ¡—Âւ̓WŠJ|z“ú–{”­, ¢ŠE‚Ö: “ú–{‚©‚琢ŠE‚É”­M‚·‚éV‚µ‚¢f’fEŽ¡—Ã. “ú”ä‹I•¶1,2, ¬—с@‘ñ1, ’†–ì@‰ë1, “n•ÓŒ›–Ÿ1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ÅVˆãŠw 2015/2; 70 (2): 280-5.

H26-522006. [uÀ]y“ÁW: Šó­Á‰»ŠíŽŸŠ³‚ɑ΂·‚é–G‰è“IŒ€‹†‚̍őOüz’°ŠÇƒx[ƒ`ƒFƒbƒg•a‚Æ’Pƒ«’×ᇂ̐f’f–@‚⎡—Ö@‚ÍŠm—§‚µ‚œ‚©? “ú”ä‹I•¶1,2, ‹vŒ—ˆê1, ¬—с@‘ñ1, ’†–ì@‰ë1, ˆäã@‰r1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): •ªŽqÁ‰»Ší•a 2015/3; 12 (1): 43-8.

H26-530001. [‚»‚Ì‘Œ (ƒRƒƒ“ƒg)]yComment on: Health-related quality of life and disability in patients with ulcerative colitis and proctocolectomy with ileoanal pouch versus treatment with anti-TNF agents. [J Crohns Colitis. 2014]zUlcerative colitis. Which makes patients happier, surgery or anti-TNF therapy? Kobayashi T, Hibi T1,2: Nat Rev Gastroenterol Hepatol 2014/5; 11 (5): 272-3. (“ú”ä‹I•¶1,2: 1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

[’˜@‘]

H26-620008. [Šwp‘ (•ª’SŽ·•M)]y“à‰ÈŽŸŠ³ÅV‚ÌŽ¡—Á|–Ÿ“ú‚Ö‚ÌŽwj (“à‰È2014”N6ŒŽ‘‘卆)z‘æ2Í Á‰»Ší@’×ᇐ«‘å’°‰Š. “ú”ä‹I•¶1,2, ¬—с@‘ñ1, ’†–ì@‰ë1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È), “ì]“°, “Œ‹ž, 2014/6”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H25-722001. [Šw‰ï (‘S‘)] (ƒvƒŒƒiƒŠ[ƒZƒbƒVƒ‡ƒ“)y“à‚©Ž¡—ÁEŠî‘bz¶•šŠw“I»Ü‚̓Nƒ[ƒ“•a“àᑂɑ΂µ–{“–‚É–³Œø‚È‚Ì‚©?|“àᑂɑ΂·‚鐶•šŠw“I»ÜŽ¡—ЬÑ‚ÌŒŸ“¢|. ¬—с@‘ñ1, Œ‰ªŽ‘P1, ’·À@œ1, ‹vŒ—ˆê1, ˆäã@‰r1, ‹Ø–ì’q‹v1, ’†–ì@‰ë1, “n•ÓŒ›–Ÿ1, •û°•F1, Šâ’j@‘×1, ‹àˆä—²“T1, “ú”ä ‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ68‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2013/11/15), “Œ‹ž, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2013/9; 66 (9): 735.

H25-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éƒNƒ[ƒ“•a‹·ó•a•Ï‚ɑ΂·‚é“àŽ‹‹Ÿ“Iƒoƒ‹[ƒ“Šg’£p‚Ì’·Šú¬Ñ. ¬—с@‘ñ1, ’·À@œ1, ˆäã@‰r1, ‹vŒ—ˆê1, Œ‰ªŽ‘P1, ‹àˆä—²“T1, Šâ’j@‘×1, •û°•F1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ85‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2013/5/10-12), ‹ž“s, Gastroenterological Endoscopy 2013/4; 55 (Suppl.1): 1044.

H25-723002. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬’°‘å’°Œ^ƒNƒ[ƒ“•a‚ɂĒʉ@’†‚ɏ㒰ŠÔ–ŒÃ–¬“à‚Éseptic thrombophlebitis‚ð‚«‚œ‚µ‚œ1Ç—á. ‹Ø–ì’q‹v1, ¬—с@‘ñ1, ’†–ì@‰ë1, “n•ÓŒ›–Ÿ1, ‹Ú‘ò@G1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ68‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2013/11/15), “Œ‹ž, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2013/9; 66 (9): 862.

H25-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŽŸŠ³E•a‘Ԃɉž‚¶‚œ“KØ‚ȏ¬’°f’fEŽ¡—Ð헪z‰“ˆÊ‰ñ’°ŒŸõ‚É‚š‚¯‚éŽó“®œ]‹È‚“`’B‘}“ü•”“‹Ú×Œa‘å’°“àŽ‹‹ŸPCF-PQ260L‚Ì—L—p«‚ÌŒŸ“¢. ’†–ì@‰ë1, ¬—с@‘ñ1, ’†—¢Œ\G1, ‹Ø–ì’q‹v1, ‰Á“¡—T‰ÀŽq1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ97‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2013/12/15), “Œ‹ž, Progress of Digestive Endoscopy 2013/12; 84 (Suppl): 82.

H25-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) 5”N‚ÌŒo‰ß‚Å‘œÊ‚ÈŒ`‘ԕω»‚ð’悵‚œŒŽ”­«ˆÝƒAƒ~ƒƒCƒh[ƒVƒX‚̈ê—á. ŽO‘î@—í1, ‹Ø–ì’q‹v1, ¬—с@‘ñ1, ‰Á“¡—T‰ÀŽq1, ’†–ì@‰ë1, ‹Ú‘ò@G1, “n•ÓŒ›–Ÿ1, “y–{Š°“ñ1, ––·—F_1, X‰i³“ñ˜Y1, ‘åX@‘×1, •û°•F1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ97‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2013/12/15), “Œ‹ž, Progress of Digestive Endoscopy 2013/12; 84 (Suppl): 107.

H26-722001. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y‰ŠÇ«’°ŽŸŠ³‚ÌŽ¡—Ð헪z’×ᇐ«‘å’°‰Š847—á‚ð‘ΏۂƂµ‚œ”’ŒŒ‹…œ‹Ž—Ö@‚Ì‘å‹K–ÍŽg—p¬Ñ’²ž. ¬—с@‘ñ1, Œ‰ªŽ‘P1, ‰¡ŽR—zŽq1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ69‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2014/11/7-8), ‰¡•l, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2014/9; 67 (9): 608.

H26-723001. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š847—á‚ð‘ΏۂƂµ‚œ”’ŒŒ‹…œ‹Ž—Ö@‚Ì‘å‹K–ÍŽg—p¬Ñ’²ž. ¬—с@‘ñ1, Œ‰ªŽ‘P1, ‰¡ŽR—zŽq1, àV“cNŽj1, “¡DŒšŽj1, ˆÀ“¡‹M•¶1, ‘同‰À•¶1, Î“c“N–ç1, ‰ª@­Žu1, ŽR“c‰ëO1, ’†‘º—²Žu1, ˆä–ì—FŽq1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ100‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2014/4/23-26), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2014/9; 111 (—Õ‘‘å‰ï): A891.

H26-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “àŽ‹‹Ÿ“I‚É“Á’¥“I‚ȏŠŒ©‚ðŠÏŽ@‚µ‚Š‚œdÇ’°ƒ`ƒtƒX‚Ì1—á. ”~“c’qŽq1, ¬—с@‘ñ1, ‹Ø–ì’q‹v1, ‰Á“¡—T‰ÀŽq1, Ž…Ž1, ’†–ì@‰ë1, íŒ@—ß1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ87‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2014/5/15-17), •Ÿ‰ª, Gastroenterological Endoscopy 2014/4; 56 (Suppl.1): 1170.

H26-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰“ˆÊ‰ñ’°ŒŸõ‚É‚š‚¯‚éŽó“®œ]‹È‚“`’B‘}“ü•”“‹Ú×Œa‘å’°“àŽ‹‹ŸPCF-PQ260L‚Ì—L—p«‚ÌŒŸ“¢. ’†–ì@‰ë1, ¬—с@‘ñ1, ‹Ø–ì’q‹v1, ‰Á“¡—T‰ÀŽq1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, “ú”ä‹I•¶1,2, ’†—¢Œ\G1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ87‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2014/5/15-17), •Ÿ‰ª, Gastroenterological Endoscopy 2014.04; 56 (Suppl.1): 1173.

H26-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’°ŠÇƒXƒsƒƒw[ƒ^Ç‚Ì“àŽ‹‹Ÿ“IE—Տ°•a—Šw“IŒŸ“¢. ”~“c’qŽq1, ¬—с@‘ñ1, ’†–ì@‰ë1, ‹Ø–ì’q‹v1, ‰Á“¡—T‰ÀŽq1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, X‰i³“ñ˜Y1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ88‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2014/10/23-25), _ŒËGastroenterological Endoscopy 2014/9; 56 (Suppl 2): 3171.

H26-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’×ᇐ«‘å’°‰Š“ü‰@Ž¡—Âɂš‚¯‚é‹ÖH’°ŠÇˆÀÃ‚̈Ӌ`. ¬—с@‘ñ1, ’†–ì@‰ë1, ”~“c’qŽq1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, Î‹Ž‚Æ‚æ‚Ý1, “ú”ä‹I•¶1,2 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ101‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2015/4/23-25), å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2015/3; 112 (—Õ‘‘‰ï): A495.

H26-732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yIBD‚Ì“àŽ‹‹Ÿf’fEŽ¡—ẪRƒczƒNƒ[ƒ“•a‰“ˆÊ‰ñ’°ŒŸõ‚É‚š‚¯‚éŽó“®œ]‹È‚“`’B‘}“ü•”“‹Ú×Œa‘å’°“àŽ‹‹ŸPCF-PQ260L‚Ì—L—p«‚ÌŒŸ“¢. ’†–ì@‰ë1, ¬—с@‘ñ1, ”~“c’qŽq1, ”óŒû@”£1, Ž…Ž1, íŒ@—å1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2, ’†—¢Œ\G1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ99‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2014/12/7), “Œ‹ž, Progress of Digestive Endoscopy 2014/12; 86 (Suppl): 89.

H26-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰)yŒ€CˆãƒZƒbƒVƒ‡ƒ“z•ÂÇ«‰©át‚ðŒ_‹@‚É”­Œ©‚³‚ê‚œPeutz-JeghersŒ^\“ñŽw’°“û“ª•”‰ßŒëŽî‚̈ê—á. Ôâää»1, Ž…Ž1, —é–ØŒcˆê1, ”óŒû@”£1, ”~“c’qŽq1, ŽO‘î@—í1, ‰Á“¡—T‰ÀŽq1, ¬—с@‘ñ1, ’†–ì@‰ë1, íŒ@—ß1, ‹ÚàV@G1, “n•ÓŒ›–Ÿ1, X‰i³“ñ˜Y1, “ú”ä‹I•¶1,2, ‹àˆä—²“T1, “y–{Š°“ñ1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ98‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2014/6/15), “Œ‹ž, Progress of Digestive Endoscopy 2014/12; 86 (Suppl): 116.

H26-733003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Á‰»ŠÇƒ|ƒŠƒ|[ƒVƒXƒtƒHƒ[“àŽ‹‹Ÿ‚̍ۋô‘R”­Œ©‚³‚ê‚œ–³ÇŒó«‘å’°ƒAƒjƒTƒLƒXÇ‚̈ê—á. ²X–ØŒ«ˆê1, ‹ÚàV@G1, ’†–ì@‰ë1, ‰Á“¡—T‰ÀŽq1, Ž…Ž1, ¬—с@‘ñ1, “n•ÓŒ›–Ÿ1, “y–{Š°“ñ1, “ú”ä‹I•¶1,2, ––·—F_1, X‰i³“ñ˜Y1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ98‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2014/6/15), “Œ‹ž, Progress of Digestive Endoscopy 2014/6; 85 (Suppl): 122.

H26-733004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Šˆ“®Šú‚ɐ[•”Ã–¬ŒŒðÇ‚š‚æ‚Ñ”xŒŒðÇðÇ‚ð‡•¹‚µ‚œ’×ᇐ«‘å’°‰Š‚Ì1Ç—á. à_“cÍ—T1, ”~“c’qŽq1, ‹ÚàV@G1, ’†–ì@‰ë1, “n•ÓŒ›–Ÿ1, Ž…Ž1, ¬—с@‘ñ1, “ú”ä‹I•¶1,2, ‹à“c@‹v1, “y–{Š°“ñ1 (1–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ613‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï, (2015/3/14), “Œ‹ž, “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï613‰ñƒvƒƒOƒ‰ƒ€EŽ˜^W 2015/3; p.35.


zŠÂŠí“à‰ÈŠw

[Šwp˜_•¶]

110110. [ŒŽ’˜] Implications of pentraxin 3 levels in patients with acute aortic dissection. Arao K, Fujiwara T, Taniguchi Y, Jinnouchi H, Sasai H, Matsumoto M, Funayama H, Ako J1, Momomura S: Heart Vessels 2015/3; 30 (2): 211-7. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110111. [ŒŽ’˜] Flow Mediated Dilatation Is Reduced with the Progressive Stages of Glomerular Filtration Rate and Albuminuria in Type 2 Diabetic Patients without Coronary Heart Disease. Ito H, Nakashima M, Meguro K1, Furukawa H, Yamashita H, Takaki A, Yukawa C, Omoto T, Shinozaki M, Nishio S, Abe M, Antoku S, Mifune M, Togane M: J Diabetes Res 2015/4; 2015: 728127. (–ڍ•Œ’‘Ÿ˜Y1: 1zŠÂŠí“à)

110112. [ŒŽ’˜] Circadian variation of acute aortic dissection. Seguchi M, Wada H, Sakakura K, Nakagawa T, Ibe T, Ikeda N, Sugawara Y, Ako J1, Momomura S: Int Heart J 2015/5; 56 (3): 324-8. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110113. [ŒŽ’˜] Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES). Kitasato L1, Shimohama T1, Ikeda Y2, Namba S2, Hashikata T2, Kameda R1, Sato N1, Takeuchi I3, Yamaoka-Tojo M4, Tojo T1, Ako J1: Biomed Pharmacother 2015/5; 72: 6-10. (–k—¢—œŽÑ1, ‰º•lF˜Y1, ’r“c—S‹B2, “ï”g‘–퍁2, ”¢•ûŒ’G2, ‹T“c@—Ç1, ²“¡L—m1, ’|“àˆê˜Y3, “ŒžŠ”ü“ÞŽq4, “ŒžŠ‘å‹P1, ˆ¢ŒÃÆ1: 1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‹~–œ, 4ˆã—Éq¶Šw•”)

110114. [ŒŽ’˜] Endothelial Cell Survival under High Glucose Condition: Effect of Rivaroxaban. Kitasato L1, Yamaoka-Tojo M2, Kakizaki R3, Nemoto T3, Namba S3, Hashikata T3, Hashimoto T3, Kameda R1, Shimohama T1, Tojo T1, Ako J1: Clinical Cardiology and Research 2015/5; 2 (1): 1-5. (–k—¢—œŽÑ1, “ŒžŠ”ü“ÞŽq2, Š`è—Ç‘Ÿ3, ª–{Æ¢Žu3, “ï”g‘–퍁3, ”¢•ûŒ’G3, ‹Ž–{‘ñ–í3, ‹T“c@—Ç1, ‰º•lF˜Y1, “ŒžŠ‘å‹P1, ˆ¢ŒÃÆ1: 1zŠÂŠí“à, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110115. [ŒŽ’˜] Early Phase Arterial Reaction Following Drug-Eluting and Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction. Nishio R, Shinke T, Morino Y, Tanabe K, Furuya J, Takizawa K, Ako J1, Kozuma K, Hibi K, Ishii H, Hirohata A, Otsuka Y, Otake H, Takaya T, Hirata K: Int Heart J 2015/7; 56 (4): 389-94. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110116. [ŒŽ’˜] Lower 1,5-anhydroglucitol is associated with denovo coronary artery disease in patients at high cardiovascular risk. Fujiwara T, Yoshida M, Yamada H, Tsukui T, Nakamura T, Sakakura K, Wada H, Arao K, Katayama T, Funayama H, Sugawara Y, Mitsuhashi T, Kakei M, Momomura S, Ako J1: Heart Vessels 2015/7; 30 (4): 469-76. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110117. [ŒŽ’˜] Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis. Namba S1, Yamaoka-Tojo M2, Hashikata T1, Ikeda Y1, Kitasato L3, Hashimoto T1, Shimohama T3, Tojo T3, Takahira N2, Masuda T2, Ako J3: BBA Clin 2015/8; 4: 76-80. (“ï”g‘–퍁1, “ŒžŠ”ü“ÞŽq2, ”¢•ûŒ’G1, ’r“c—S‹B1, –k—¢—œŽÑ3, ‹Ž–{‘ñ–í1, ‰º•lF˜Y3, “ŒžŠ‘å‹P3, ‚•œ®L2, ‘“c@‘ì2, ˆ¢ŒÃÆ3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à)

110118. [ŒŽ’˜] Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-ƒÈB Pathway. Hashikata T1, Yamaoka-Tojo M2, Namba S1, Kitasato L3, Kameda R3, Murakami M3, Niwano H, Shimohama T3, Tojo T3, Ako J3: Int Heart J 2015/9; 56 (5): 544-50. (”¢•ûŒ’G1, “ŒžŠ”ü“ÞŽq2, “ï”g‘–퍁1, –k—¢—œŽÑ3, ‹T“c@—Ç3, ‘ºã‰ë”ü3, ‰º•lF˜Y3, “ŒžŠ‘å‹P3, ˆ¢ŒÃÆ3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à)

110119. [ŒŽ’˜] Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients. Fujiwara T, Yoshida M, Nakamura T, Sakakura K, Wada H, Arao K, Katayama T, Funayama H, Sugawara Y, Mitsuhashi T, Kakei M, Momomura S, Ako J1: Heart Vessels 2015/9; 30 (5): 696-701. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110120. [ŒŽ’˜] Major adverse cardiac and bleeding events associated with non-cardiac surgery in coronary artery disease patients with or without prior percutaneous coronary intervention. Wakabayashi Y, Wada H, Sakakura K, Yamamoto K, Mitsuhashi T, Ako J1, Momomura S: J Cardiol 2015/10; 66 (4): 341-6. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110121. [ŒŽ’˜] Low eicosapentaenoic acid to arachidonic acid ratio is associated with thin-cap fibroatheroma determined by optical coherence tomography. Wakabayashi Y, Funayama H, Ugata Y, Taniguchi Y, Hoshino H, Ako J1, Momomura S: J Cardiol 2015/12; 66 (6): 482-8. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110122. [ŒŽ’˜] Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy. Ikeda Y1, Inomata T2, Iida Y1, Iwamoto-Ishida M2, Nabeta T1, Ishii S2, Sato T2, Yanagisawa T2, Mizutani T3, Naruke T2, Koitabashi T2, Takeuchi I3, Nishii M2, Ako J2: Heart Vessels 2016/4; 31 (4): 545-54. (’r“c—S‹B1, ’––”FŒ³2, ”Ñ“c—Sˆê˜Y1, Î“cŽO˜a2, “ç“c@Œ’1, Îˆär•ã2, ²“¡r[2, –öàV’q‹`2, …’J’m‘×3, ¬–с@’2, ¬”‹Žr”ü2, ’|“àˆê˜Y3, ŒˆäŠîŒp2, ˆ¢ŒÃÆ2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à, 3‹~–œ)

110123. [ŒŽ’˜] Ezetimibe enhances and stabilizes anticoagulant effect of warfarin. Hashikata T1, Yamaoka-Tojo M2, Kakizaki R1, Nemoto T1, Fujiyoshi K1, Namba S1, Kitasato L3, Hashimoto T1, Ishii S3, Kameda R3, Shimohama T3, Tojo T3, Ako J3: Heart Vessels 2016/4. [Epub ahead of print] (”¢•ûŒ’G1, “ŒžŠ”ü“ÞŽq2, Š`è—Ç‘Ÿ1, ª–{Æ¢Žu1, “¡‹g˜a”Ž1, “ï”g‘–퍁1, –k—¢—œŽÑ3, ‹Ž–{‘ñ–í1, Îˆär•ã3, ‹T“c@—Ç3, ‰º•lF˜Y3, “ŒžŠ‘å‹P3, ˆ¢ŒÃÆ3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à)

110124. [ŒŽ’˜] Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention. Fujiwara T, Yoshida M, Akashi N, Yamada H, Tsukui T, Nakamura T, Sakakura K, Wada H, Arao K, Katayama T, Umemoto T, Funayama H, Sugawara Y, Mitsuhashi T, Kakei M, Momomura S, Ako J1: Heart Vessels 2016/6; 31 (6): 855-62. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110125. [ŒŽ’˜] Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient. Ibe T, Wada H, Sakakura K, Ikeda N, Yamada Y, Sugawara Y, Mitsuhashi T, Ako J1, Fujita H, Momomura S: J Cardiol 2016/6; 67 (6): 555-9. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110126. [ŒŽ’˜] Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management. Nabeta T1, Inomata T2, Iida Y1, Ikeda Y1, Iwamoto-Ishida M2, Ishii S2, Naruke T2, Mizutani T3, Shinagawa H2, Koitabashi T2, Takeuchi I3, Ako J2: Heart Vessels 2016/7; 31 (7): 1109-16. (“ç“c@Œ’1, ’––”FŒ³2, ”Ñ“c—Sˆê˜Y1, ’r“c—S‹B1, Î“cŽO˜a2, Îˆär•ã2, ¬–с@’2, …’J’m‘×3, •iì–íl2, ¬”‹Žr”ü2, ’|“àˆê˜Y3, ˆ¢ŒÃÆ2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à, 3‹~–œ)

110127. [ŒŽ’˜] Characteristics of Late-Acquired Incomplete Stent Apposition: A Comparison With First-Generation and Second-Generation Drug-Eluting Stents. Waseda K, Ako J1, Kume T, Fitzgerald PJ, Honda Y: J Invasive Cardiol 2016/8; 28 (8): 323-9. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

110128. [ŒŽ’˜] Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Hashikata T1, Yamaoka-Tojo M2, Kakizaki R1, Nemoto T1, Fujiyoshi K1, Namba S1, Kitasato L3, Hashimoto T1, Kameda R3, Maekawa E3, Shimohama T3, Tojo T3, Ako J3: Heart Vessels 2016/8; 31 (8): 1303-10. (”¢•ûŒ’G1, “ŒžŠ”ü“ÞŽq2, Š`è—Ç‘Ÿ1, ª–{Æ¢Žu1, “¡‹g˜a”Ž1, “ï”g‘–퍁1, –k—¢—œŽÑ3, ‹Ž–{‘ñ–í1, ‹T“c@—Ç3, ‘OìŒb”ü3, ‰º•lF˜Y3, “ŒžŠ‘å‹P3, ˆ¢ŒÃÆ3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à)

120011. [ŒŽ’˜] R‚Ä‚ñ‚©‚ñ–ò“à•žŠ³ŽÒ‚É‚š‚¯‚éƒuƒ‹ƒKƒ_Œ^S“d}‚ÆJ”g‚ÉŠÖ‚·‚錟“¢. Î––¬Æ1, ’ë–ìTˆê2, âV“¡³”Í3, ’†‘º—m”Í1, “¡ÎŽì”ü1, ŒÜ\—’Œš1, ‹gàV’qŽ¡2, ŠÝŒŽ@~2, ‘ºã‰ë”ü2, [’J‰p•œ2, ‹{‰ª@“™3, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à, 3ž_): S‘Ÿ 2015/12; 47 (Suppl 2): 212-8.

310007. [Ç—á•ñ] Deficiency of creatine kinase in a ST-segment elevation myocardial infarction patient with Kartagener syndrome. Hashikata T1, Tojo T2, Namba S1, Kitasato L2, Hashimoto T1, Kameda R2, Shimohama T2, Yamaoka-Tojo M3, Takada F1, Ako J2: Int J Cardiol 2015/3; 182: 31-3. (”¢•ûŒ’G1, “ŒžŠ‘å‹P2, “ï”g‘–퍁1, –k—¢—œŽÑ2, ‹Ž–{‘ñ–í1, ‹T“c@—Ç2, ‰º•lF˜Y2, “ŒžŠ”ü“ÞŽq3, ‚“cŽj’j1, ˆ¢ŒÃÆ2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à, 3ˆã—Éq¶Šw•”)

310008. [Ç—á•ñ] Morphological changes in mitochondria during mechanical unloading observed on electron microscopy: a case report of a bridge to complete recovery in a patient with idiopathic dilated cardiomyopathy. Ikeda Y1, Inomata T2, Fujita T1, Iida Y1, Nabeta T1, Naruke T2, Koitabashi T2, Takeuchi I3, Kitamura T4, Miyaji K4, Ako J2: Cardiovasc Pathol 2015/3-4; 24 (2): 128-31. (’r“c—S‹B1, ’––”FŒ³2, “¡“c“S•œ1, ”Ñ“c—Sˆê˜Y1, “ç“c@Œ’1, ¬–с@’2, ¬”‹Žr”ü2, ’|“àˆê˜Y3, –k‘º@—¥4, ‹{’n@ŠÓ4, ˆ¢ŒÃÆ2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à, 3‹~–œ, 4S‘ŸŒŒŠÇŠO)

310009. [Ç—á•ñ] An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting. Kishihara J1, Niwano S1, Nakamura H2, Igarashi T2, Ishizue N2, Fujiishi T2, Oikawa J1, Murakami M1, Fukaya H1, Ako J1: J Arrhythm 2016/2; 32 (1): 67-9. (ŠÝŒŽ@~1, ’ë–ìTˆê1, ’†‘º—m”Í2, ŒÜ\—’Œ’2, Î––¬Æ2, “¡ÎŽì”ü2, ‹yì@~1, ‘ºã‰ë”ü1, [’J‰p•œ1, ˆ¢ŒÃÆ1: 1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

310010. [Ç—á•ñ] Ruptured saphenous vein graft pseudoaneurysm successfully treated with covered stents. Yonezu K, Funayama H, Katayama T, Yamaguchi A, Ako J1, Momomura S: Cardiovasc Interv Ther 2016/4; 31 (2): 161-3. (ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

521009. [‰ðà] –«S•s‘S‚É‚š‚¯‚éR•s®–¬–òŽ¡—Ã. ’ë–ìTˆê (zŠÂŠí“à): zŠÂŠí“à‰È 2015/5; 77 (5): 498-502.

521010. [‰ðà]yBedside TeachingzV‚µ‚¢RŒŒ¬”–ò. ‰º•lF˜Y1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): ŒÄ‹z‚ƏzŠÂ 2015/11; 63 (11): 1110-7.

522053. [uÀ]y˜AÚ: ŽãƒfƒBƒx[ƒg Debatez“«•‚Žî‚ɑ΂·‚é‘Ήž: ‘œÜ•¹—p‚Ì—§ê‚©‚ç. ’––”FŒ³ (zŠÂŠí“à): Fluid Management Renaissance 2015/4; 5 (2): 84-8.

522054. [uÀ]y“ÁW: ˜V‰»‚ƘV”NŽŸŠ³|Œ€‹†E—Տ°‚̍őOüz‚—îŽÒ‚Ì–«ŽŸŠ³ŠÇ—: ‚—îŽÒ‚É‚š‚¯‚éRŒŒð—Ö@. [’J‰p•œ1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): ˆãŠw‚Ì‚ ‚ä‚Ý 2015/5; 253 (9): 879-83.

522055. [uÀ]y“ÁW: ƒAƒŒƒ‹ƒM[ŽŸŠ³‚̐f—ÂÌpitfalls@DŽ_‹…‚̗Տ°z‘ŸŠí•a•Ï‚𔺂€DŽ_‹…‘‘œÇ@DŽ_‹…«S‹Ø‰Š. ’––”FŒ³ (zŠÂŠí“à): f’f‚ÆŽ¡—à 2015/5; 103 (5): 677-80.

522056. [uÀ]yŠw‰ïƒgƒsƒbƒNƒX: ‹•ŒŒ«SŽŸŠ³‚É‚š‚¯‚éR‹ÃŒÅ–ò‚ÌŽg‚¢•ûzR‹ÃŒÅ–ò‚ð•K—v‚Æ‚·‚銥ŽŸŠ³Š³ŽÒ‚ւ̑Ήž. ˆ¢ŒÃÆ (zŠÂŠí“à): ƒƒfƒBƒJƒ‹’©“ú 2015/6; 44 (6): 37-9.

522057. [uÀ]y“ÁW: Š¥“®–¬ƒJƒe[ƒeƒ‹ƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“‚̍¡Œã‚Ì“WŠJ2015zPCIS–[×“®—á‚É‚š‚¯‚éR‹ÃŒÅ–òERŒŒ¬”–ò•¹—p. [’J‰p•œ1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): ICU‚ÆCCU 2015/6; 39 (6): 369-74.

522058. [uÀ]y“ÁW: S•s‘SƒNƒƒjƒNƒ‹@Š³ŽÒ‚̐l¶‚ÉŠñ‚è“Y‚¢‚È‚ª‚çf‚ézŠO—ˆŠÇ—: –«‚Æ‹}«‚̘Aœ‚ð’f‚¿Ø‚é@[¶ŽºŽûk”\‚ª’ቺ‚µ‚œS•s‘S (HFrEF) ‚Ö‚Ì–ò•šŽ¡—Ã]@ƒtƒƒZƒ~ƒh. ’––”FŒ³ (zŠÂŠí“à): medicina 2015/6; 52 (7): 1116-8.

522059. [uÀ]y“ÁW: zŠÂŠíŽŸŠ³‚Ìtrends & topics 2015zŽ¡—Ã’ïR«S•s‘S‚É‚š‚¯‚é–ò•š—Ö@‚ÌŽÀÛ. ’––”FŒ³ (zŠÂŠí“à): Mebio 2015/7; .32 (7): 12-7.

522060. [uÀ]y“ÁW: DŽ_‹…Z‚𔺂€ŽŸŠ³zŠe˜_: DŽ_‹…Z‚ƐSŽŸŠ³. ’––”FŒ³ (zŠÂŠí“à): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2015/7; 45 (7): 853-6.

522061. [uÀ]y“ÁW: ‚—îŽÒ‚̐SŽŸŠ³Ž¡—Â̐i•à|’áNPŽ¡—Â̐i•à‚𒆐S‚Ɂ|z—Տ°‚ɖ𗧂ÂQ&A@2. ƒXƒeƒ“ƒgA‚Šž‚ÝŒã‚ÌŠ³ŽÒ‚ªŽèp‚ðŽó‚¯‚éÛ‚̍RŒŒ¬”—Ö@‚ɂ‚¢‚Ä‹³‚Š‚Ä‚­‚Ÿ‚³‚¢. ‰º•lF˜Y1, Œ¬“c—º (1zŠÂŠí“à): ˜V”NˆãŠw 2015/7; 53 (7): 741-4.

522062. [uÀ]y“ÁW: S•s‘S‚Á‚ÄŽŸŠ³‚¶‚á‚È‚¢!? ’m‚Á‚Ä‚¢‚é‚æ‚€‚Å’m‚ç‚È‚¢’mŽ¯‚ðˆê‹“‘®— ‚܂邲‚Æ‚š‚³‚ç‚¢! S•s‘Sz3. ‚ ‚ç‚œ‚ß‚ÄŽ¡—Â̊î–{‚ð‰Ÿ‚³‚Š‚æ‚€! ’––”FŒ³ (zŠÂŠí“à): HEART nursing 2015/8; 28 (8): 26-37.

522063. [uÀ]y“ÁW: dÇS•s‘S‚ÌŽ¡—Â͂ǂ€•Ï‚í‚Á‚œ‚Ì‚©, ‚Ç‚€•Ï‚Š‚Ä‚¢‚­‚ׂ«‚©zŽ¡‚·@11. —˜”A–ò‚ÌŽg‚¢•û‚Í‚Ç‚€•Ï‚í‚Á‚œ‚©. ’––”FŒ³ (zŠÂŠí“à): Heart View 2015/8; 19 (8): 82-7.

522064. [uÀ]y“ÁW: S•s‘S‚ð“O’ꗝ‰ð! Šî–{•Ò|ƒi[ƒX‚ª’m‚Á‚Ä‚š‚«‚œ‚¢E‚š‚³‚Š‚Ä‚š‚«‚œ‚¢S•s‘S‚ÌŠî–{Ž–€|z5. –«S•s‘S‚Ì–ò•š—Ö@. ’––”FŒ³ (zŠÂŠí“à): zŠÂŠíƒi[ƒVƒ“ƒO 2015/9; 5 (9): 47-53.

522065. [uÀ]y“ÁW: S•s‘S|‰h—{ŠÇ—‚ÌŽÀ‘Hƒ|ƒCƒ“ƒgzS•s‘SŠ³ŽÒ‚̃`[ƒ€ˆã—Âɂæ‚éŠÇ—. ’––”FŒ³ (zŠÂŠí“à): —Տ°‰h—{ 2015/9; 127 (3): 311-5.

522066. [uÀ]y“ÁW: ‹·SÇE‹•ŒŒ«SŽŸŠ³|ŽÀ’nf—Â̊î–{‚ÆQOL‚È‚ç‚Ñ‚É—\Œã‰ü‘P‚ð‚ß‚Ž‚·ƒ}ƒlƒWƒƒ“ƒgzƒZƒ~ƒi[: ŽÀ’nˆã‰Æ‚ªŠˆ—p‚·‚ׂ«V‚µ‚¢ŒŸž–@‚Æ‚³‚Ü‚Ž‚Ü‚È•a‘Ԃł̐f—ÁEƒ}ƒlƒWƒƒ“ƒg–@‚ðŠw‚ԁ@‹•ŒŒ«SŽŸŠ³‚ɍ‡•¹‚·‚éS–[×“®|‚»‚ÌŠÇ—Žwj‚ƍR‹ÃŒÅ—Ö@|. [’J‰p•œ1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): Medical Practice 2015/10; 32 (10): 1655-60.

522067. [uÀ]y“ÁW S•s‘S‚̃`[ƒ€ˆã—Á|‚—îS•s‘SŠ³ŽÒ‚ð‚Ç‚€Žx‚Š‚é‚©?z[Še˜_] ŠeEŽí‚̐S•s‘Sƒ`[ƒ€‚Ö‚Ì‚©‚©‚í‚è‚Æ–ðŠ„@ŠÇ—‰h—{Žm‚ÌŽ‹“_‚©‚ç. ’––”FŒ³ (zŠÂŠí“à): Medical Alliance 2015/10; 1 (4): 343-9.

522068. [uÀ]y“ÁW: Šó­‚ȐSŒŒŠÇŽŸŠ³‚ðŒ©’Œ‚·zDŽ_‹…‘‘œÇŒóŒQ‚ƐS‡•¹Ç. ’––”FŒ³ (zŠÂŠí“à): zŠÂŠí“à‰È 2015/10; 78 (4): 379-84.

522069. [uÀ]y“ÁW: DAPT‘ålŽ@zŠ³ŽÒƒAƒhƒqƒAƒ‰ƒ“ƒX‚ÆDAPT|’·Šú‚É‚í‚œ‚Á‚ÄŽ¡—ÃŒp‘±‚ð‚·‚é‚œ‚ß‚É. ‰º•lF˜Y (zŠÂŠí“à): Cardio Vascular Contemporary 2015/11; 4 (4): 24-9.

522070. [uÀ]yBedside TeachingzV‚µ‚¢RŒŒ¬”–ò. ‰º•lF˜Y1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): ŒÄ‹z‚ƏzŠÂ 2015/11; 63 (11): 1110-7.

522071. [uÀ]y“ÁW: ƒÀŽÕ’f–ò‚Í‚±‚€Žg‚¢‚±‚È‚¹|Šî–{‚Ì—‰ð‚Əˆ•ûtips|zŽ¡‚·@10. S•s‘S@b. –«S•s‘S‚É‚š‚¯‚éƒÀŽÕ’f–ò‚ÌŽg‚¢•û. ’––”FŒ³ (zŠÂŠí“à): Heart View 2015/12; 19 (13): 81-6.

522072. [uÀ]y“ÁW: ¡Œã‚ðè‚€|10”NŒã‚ÌPCI‚Í‚Ç‚€•Ï‚í‚é‚©?|z ‚—is‚Å‚Ç‚€•Ï‰»‚·‚é? –ڍ•Œ’‘Ÿ˜Y1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): Coronary Intervention 2016/1; 12 (1): 17-21.

522073. [uÀ]y“ÁW: AKI (‹}«táŠQ) ‚ª‘Sg‚É‹y‚Ú‚·ƒCƒ“ƒpƒNƒgzAKI‚Ɖ“Šu‘ŸŠí|S‘Ÿ. ’––”FŒ³ (zŠÂŠí“à): t‘Ÿ“à‰ÈE”å”AŠí‰È 2016/1; 3 (1): 9-13.

522074. [uÀ]y¡ŒŽ‚Ì“ÁW1: “úíŒŸž‚©‚ç‚Ý‚Š‚é•a‘ԁ|S“d}ŒŸž•Òz•p–¬«•s®–¬. ’ë–ìTˆê (zŠÂŠí“à): —Տ°ŒŸž 2016/3; 60 (3): 270-6.

530007. [‚»‚Ì‘Œ (ƒRƒƒ“ƒg)]yComment on: Characterization of patients with angioscopically-detected in-stent mural thrombi genetics of clopidogrel responsiveness and generations of drug-eluting stents. [Circ J. 2015]zIntrastent thrombus what you see is what you get? Shimohama T1, Ako J1: Circ J 2015/1; 79 (1): 41-2. (‰º•lF˜Y1, ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

530008. [‚»‚Ì‘Œ (ƒRƒƒ“ƒg)]yComment on: Association of Adventitial Vasa Vasorum and Inflammation With Coronary Hyperconstriction After Drug-Eluting Stent Implantation in Pigs In Vivo. [Circ J. 2015]zInside Out, Outside in Vasa Vasorum and Coronary Spasm. Shimohama T1, Ako J1: Circ J 2015/7; 79 (8): 1693-4. (‰º•lF˜Y1, ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

530009. [‚»‚Ì‘Œ (ƒRƒƒ“ƒg)]yComment on: Circulating Fibroblast Growth Factor 23 Has a U-Shaped Association With Atrial Fibrillation Prevalence. [Circ J. 2015]zIs Circulating Fibroblast Growth Factor 23 a Surrogate Marker or Active Mediator for the Construction of Atrial Fibrillation Substrate? Niwano S1: Circ J 2015/7; 79 (8): 1685-6. (’ë–ìTˆê1: 1zŠÂŠí“à)

530010. [‚»‚Ì‘Œ (ƒRƒƒ“ƒg)]yComment on: Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification. [Circ J. 2016]zTriple Antithrombotic Therapy - Always One Too Many? Fukaya H1, Ako J1: Circ J 2016/2; 80 (2): 316-7. ([’J‰p•œ1, ˆ¢ŒÃÆ1: 1zŠÂŠí“à)

540007. [‚»‚Ì‘Œ (Editorial Comment)] V‘q˜_•¶‚ɑ΂·‚éEditorial Comment|DŽ_‹…‚ƐSŽŸŠ³. ’––”FŒ³ (zŠÂŠí“à): S‘Ÿ 2015/7; 47 (7): 853.

540008. [‚»‚Ì‘Œ (Editorial Comment)] ŒÃì˜_•¶‚ɑ΂·‚éEditorial Comment|”ì‘åŒ^S‹ØÇ‚É‚š‚¯‚éV‚œ‚ȃŠƒXƒNˆöŽq|Së•”SŽºáŽ. ’––”FŒ³ (zŠÂŠí“à): S‘Ÿ 2016/3; 48 (3): 327.

[’˜@‘]

620030. [Šwp‘ (•ª’SŽ·•M)]yEBMzŠÂŠíŽŸŠ³‚ÌŽ¡—à 2015-2016zII. S•s‘S@B. ‹}«S•s‘SŽ¡—Á@4. ‹}«S•s‘SŽ¡—Âɂš‚¢‚Ĉâ“`Žq‘gŠ·‚ŠŒ^ƒqƒgƒŠƒ‰ƒLƒVƒ“-2‚͏Ǐó‚ðŠÉ˜a‚·‚é‚©?, p.174-7. ’––”FŒ³ (zŠÂŠí“à), ŠÄC: ¬Žºˆê¬, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2015/4”­s.

620031. [Šwp‘ (•ª’SŽ·•M)]yEBMzŠÂŠíŽŸŠ³‚ÌŽ¡—à 2015-2016zIII. •s®–¬245@B. •p–¬«•s®–¬@9. SŽº×“®‚ɑ΂·‚é‹}«Šú‚̑Ώˆ–@‚Í‚Ç‚Ì‚æ‚€‚É‚È‚Á‚Ä‚¢‚é‚Ì‚©?, p.291-5. ’ë–ìTˆê (zŠÂŠí“à), ŠÄC: ¬Žºˆê¬, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2015/4”­s.

620032. [Šwp‘ (•ª’SŽ·•M)]yƒi[ƒX•KŒg! zŠÂŠí‚Ì–òÜƒKƒCƒh (HEART nursing 2015”NtŠú‘Š§)z[2Í ‚ ‚̏zŠÂŠíŽŸŠ³‚É‚Í‚Ç‚ñ‚È–òÜ‚ªŽg‚í‚ê‚é?] (1) S•s‘S (‹}«S•s‘SE–«S•s‘S), p192-4. ’––”FŒ³ (zŠÂŠí“à), ŠÄC: ÔÎ@œ, ƒƒfƒBƒJo”Å, ‘åã, 2015/4”­s.

620033. [Šwp‘ (•ª’SŽ·•M)]yS•s‘Sf—ÃQ&A ƒGƒLƒXƒp[ƒg105l‚©‚ç‚̉ñ“š ‰ü’ù2”ŁzII. S•s‘Sf—ÃQ&A@1. S•s‘S‚̉uŠw@6. ¶Žº‹ìo—Š‚Å‚»‚̐l‚Ì—\Œã‚ª‚í‚©‚é‚Ì‚Å‚µ‚å‚€‚©?, p.95-6. ’––”FŒ³ (zŠÂŠí“à), •Ò: –k•—­Žj, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2015/4”­s.

620034. [Šwp‘ (•ª’SŽ·•M)]yS•s‘Sf—ÃQ&A ƒGƒLƒXƒp[ƒg105l‚©‚ç‚̉ñ“š ‰ü’ù2”ŁzII. S•s‘Sf—ÃQ&A@2. S•s‘S‚Ì•a‘ԁ@1. RAAŒnŠˆ«‰»‚ª‚È‚ºS•s‘S‚Ƃ‚Ȃª‚é‚Ì‚Å‚·‚©?, p.106-7. ’––”FŒ³ (zŠÂŠí“à), •Ò: –k•—­Žj, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2015/4”­s.

620035. [Šwp‘ (•ª’SŽ·•M)]yS•s‘Sf—ÃQ&A ƒGƒLƒXƒp[ƒg105l‚©‚ç‚̉ñ“š ‰ü’ù2”ŁzII. S•s‘Sf—ÃQ&A@5. –«S•s‘S‚Ì–ò•š—Ö@@1. S‹@”\‚ªˆ«‚¢‚¯‚ê‚Ç‚à, Œ³‹C‚Ȑl (NYHAI“x‚Ü‚œ‚ÍII“x) ‚É“à•žŽ¡—Â͕K—v‚È‚Ì‚Å‚µ‚å‚€‚©?, p.226-8. ’––”FŒ³ (zŠÂŠí“à), •Ò: –k•—­Žj, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2015/4”­s.

620036. [Šwp‘ (•ª’SŽ·•M)]yS•s‘Sf—ÃQ&A ƒGƒLƒXƒp[ƒg105l‚©‚ç‚̉ñ“š ‰ü’ù2”ŁzII. S•s‘Sf—ÃQ&A@5. –«S•s‘S‚Ì–ò•š—Ö@@2. –«S•s‘SŠ³ŽÒ‚Å‚ÌŽŠ“K‘̉t—Ê‚Í‚Ç‚Ì‚æ‚€‚ÉŒˆ‚ß‚é‚Ì‚Å‚µ‚å‚€‚©?, p.229-30. ’––”FŒ³ (zŠÂŠí“à), •Ò: –k•—­Žj, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2015/4”­s.

620037. [Šwp‘ (•ª’SŽ·•M)]yS•s‘Sf—ÃQ&A ƒGƒLƒXƒp[ƒg105l‚©‚ç‚̉ñ“š ‰ü’ù2”ŁzII. S•s‘Sf—ÃQ&A@10. S•s‘S‚ð‘S‘Ì‚Æ‚µ‚Ä‚Ç‚€‚Æ‚ç‚Š‚é‚©|from bench to bedside|@3. ƒ^[ƒ~ƒiƒ‹ƒPƒA‚ÌŒ»ó‚Æ, ¡Œã‚Ç‚€‚È‚é‚©‚ð‹³‚Š‚Ä‚­‚Ÿ‚³‚¢, p.442-3. ’––”FŒ³ (zŠÂŠí“à), •Ò: –k•—­Žj, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2015/4”­s.

620038. [Šwp‘ (•ª’SŽ·•M)]yS–[×“®ˆÙ•¶‰»Œð—¬`‘œ–Ê“IƒAƒvƒ[ƒ`‚Ì‚œ‚ß‚Ì‘Î’kW`z5. S•s‘S‚ƐS–[×“®‚Ì–§Ú‚ÈŠÖŒW, p.87-106. ’––”FŒ³ (zŠÂŠí“à), •Ò: ŽR‰º•Žu, ˆã–òƒWƒƒ[ƒiƒ‹, ‘åã, 2015/4”­s.

620039. [Šwp‘ (•ª’SŽ·•M)]y•s®–¬f—ÃNƒŠƒjƒJƒ‹ƒNƒGƒXƒ`ƒ‡ƒ“200z5Í •p–¬‘˜_@Q34. narrow QRS•p”‚̐S“d}ŠÓ•Ê‚ÌŽÀÛ“I•û–@‚Í?, p.45-6. ’ë–ìTˆê (zŠÂŠí“à), •Ò: •œ”öŒ©ŽO, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/4”­s.

620040. [Šwp‘ (•ª’SŽ·•M)]y•s®–¬f—ÃNƒŠƒjƒJƒ‹ƒNƒGƒXƒ`ƒ‡ƒ“200z5Í •p–¬‘˜_@Q35. wide QRS•p”‚̐S“d}ŠÓ•Ê‚ÌŽÀÛ“I•û–@‚Í?, p.47-8. ’ë–ìTˆê (zŠÂŠí“à), •Ò: •œ”öŒ©ŽO, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/4”­s.

620041. [Šwp‘ (•ª’SŽ·•M)]y‚±‚±‚Ü‚Å–Ÿ‚ç‚©‚É‚È‚Á‚œ! ”AŽ_‘ãŽÓƒ[ƒ‹ƒh‚ƍ‚”AŽ_ŒŒÇ‚Ì•a‘ԉ𖟁`f—ÂƈãŠw‚̍őOü`zChapter 5@Practice `ŽíX‚ÌŽŸŠ³ƒŠƒXƒN‚Æ‚µ‚Ă̍‚”AŽ_ŒŒÇ@1. ŠÂŠíŽŸŠ³‚Æ”AŽ_‘ãŽÓ‚ÌŠÖ‚í‚è@…@SŽŸŠ³‚Ì”­Ç‚Æ—\Œã@3) S–[×“®, p.62-7. ’ë–ìTˆê1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à), ŠÄC: ŒàV—CŽŸ, •Ò: ‰º‘ºˆÉˆê˜Y, ‰vè—TÍ, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2015/6”­s.

620042. [Šwp‘ (•ª’SŽ·•M)]yzŠÂŠí‹}«Šúf—Á|Critical Care Cardiology|zƒoƒCƒIƒ}[ƒJ[: ƒgƒƒ|ƒjƒ“, p.62-5. ’––”FŒ³ (zŠÂŠí“à), •Ò: â@r, ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2015/6”­s.

620043. [Šwp‘ (•ª’SŽ·•M)]y•Sí˜B–‚̃Cƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ˆã‚ª‹³‚Š‚鍑ÛŠw‰ï”­•\E‰pŒê˜_•¶ì¬@¬Œ÷‚̔錍z‘æ2Í ‰pŒê˜_•¶‚ð‘‚­@E. ‰pŒê˜_•¶ì¬‚ÌŽÀÛ@e. •û–@ (methods), p.126-33. ‰º•lF˜Y1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à), •Ò: ‘ºŒrÆ, “ì]“°, “Œ‹ž, 2015/7”­s.

620044. [Šwp‘ (•ª’SŽ·•M)]yf’f‚ÆŽ¡—ÂÌABC [No.106 S•s‘S] (ÅVçΛ{•Êû)z‘æ4Í ŠÇ—EŽ¡—Á@ãŽè‚È—˜”A–ò‚ÌŽg‚¢•û, p.129-35. ’––”FŒ³ (zŠÂŠí“à), •Ò: â“c‘׎j, ÅVˆãŠwŽÐ, ‘åã, 2015/8”­s.

620045. [Šwp‘ (•ª’SŽ·•M)]y•s®–¬Ž¡—Ãupdate ‘æ4Šª •s®–¬‚ɑ΂·‚é–ò•šŽ¡—Â̌»ó‚Æ–¢—ˆzII. ãŽº«•s®–¬‚ɑ΂·‚é–ò•šŽ¡—Á@4. S–[×“®‚ɑ΂·‚éƒAƒbƒvƒXƒgƒŠ[ƒ€—Ö@: Œ»Ý‚Å‚Í‚Ç‚€l‚Š‚é‚ׂ«‚©, p.97-101. ’ë–ìTˆê (zŠÂŠí“à), •Ò: ‰œ‘º@Œª, ’r“c—²“¿, ŽR‰º•Žu, ˆäãkˆê, šê“c@_, ˆã–òƒWƒƒ[ƒiƒ‹, ‘åã, 2015/8”­s.

620046. [Šwp‘ (•ª’SŽ·•M)]yElectrocardiography A to Z|S“d}‚̃ŠƒYƒ€‚Æ”g‚ðŒ©‹É‚ß‚é (“ú–{ˆãŽt‰ïŽGŽ ‘æ144ŠªE“Á•Ê† (2) ¶ŠU‹³ˆçƒVƒŠ[ƒY89)zIIIÍ ”gŒ`‚ُ̈í@2. S‹Ø‰Š, p.110-1. ’––”FŒ³ (zŠÂŠí“à), ŠÄC: ˆé•”ŒõÍ, ‰œ‘º@Œª, “ú–{ˆãŽt‰ï, “Œ‹ž, 2015/10”­s.

620047. [Šwp‘ (•ª’SŽ·•M)]yElectrocardiography A to Z|S“d}‚̃ŠƒYƒ€‚Æ”g‚ðŒ©‹É‚ß‚é (“ú–{ˆãŽt‰ïŽGŽ ‘æ144ŠªE“Á•Ê† (2) ¶ŠU‹³ˆçƒVƒŠ[ƒY89)zIIIÍ ”gŒ`‚ُ̈í@3. S–Œ‰Š, p.112-3. ’––”FŒ³ (zŠÂŠí“à), ŠÄC: ˆé•”ŒõÍ, ‰œ‘º@Œª, “ú–{ˆãŽt‰ï, “Œ‹ž, 2015/10”­s.

620048. [Šwp‘ (•ª’SŽ·•M)]y–«S•s‘S‚Ì‚ ‚œ‚炵‚¢ƒPƒA‚ÆŠÇ—@ƒ`[ƒ€ˆã—ÁE’nˆæ˜AŒgEÝ‘îŠÇ—EI––ŠúƒPƒA‚ÌŽÀ‘HzII Šî‘b•Ò: ‰Ÿ‚³‚Š‚Ä‚š‚­‚ׂ«S•s‘S‚̍ŐV’mŽ¯@B. S•s‘S‚̐f’f‚ÆŒŸž–@‚̍ŐV’mŽ¯@3. ‰ESƒJƒe[ƒeƒ‹ŒŸž, p.122-3. ’––”FŒ³ (zŠÂŠí“à), •Ò:•S‘ºLˆê, —é–؁@œ, “ì]“°, “Œ‹ž, 2015/11”­s.

620049. [Šwp‘ (•ª’SŽ·•M)]yEREICU‚Å‚Ì–ò‚ÌŽg‚¢•ûEl‚Š•û2016-'17|ƒGƒLƒXƒp[ƒg‚ÌŽÀ‘H‚Ɣ錍‚ÉŠw‚ԁ| (‹~‹}EW’†Ž¡—à Vol.27—ÕŽž‘Š§†z6. zŠÂŠíŽŸŠ³‚Ì‹Ù‹}Ž¡—Á@SŒ¹«ƒVƒ‡ƒbƒN‚ÌŽ¡—ÃŽwj, p93-5. ’––”FŒ³ (zŠÂŠí“à), •Ò: ‰ªŒ³˜a•¶, ‘Ž‡ˆãŠwŽÐ, “Œ‹ž, 2015/12”­s.

620050. [Šwp‘ (•ª’SŽ·•M)]yEREICU‚Å‚Ì–ò‚ÌŽg‚¢•ûEl‚Š•û2016-'17|ƒGƒLƒXƒp[ƒg‚ÌŽÀ‘H‚Ɣ錍‚ÉŠw‚ԁ| (‹~‹}EW’†Ž¡—à Vol.27—ÕŽž‘Š§†z6. zŠÂŠíŽŸŠ³‚Ì‹Ù‹}Ž¡—Á@Q30. –«S•s‘S, p.e217-23. ’––”FŒ³ (zŠÂŠí“à), •Ò: ‰ªŒ³˜a•¶, ‘Ž‡ˆãŠwŽÐ, “Œ‹ž, 2015/12”­s.

620051. [Šwp‘ (•ª’SŽ·•M)]yEREICU‚Å‚Ì–ò‚ÌŽg‚¢•ûEl‚Š•û2016-'17|ƒGƒLƒXƒp[ƒg‚ÌŽÀ‘H‚Ɣ錍‚ÉŠw‚ԁ| (‹~‹}EW’†Ž¡—à Vol.27—ÕŽž‘Š§†z6. zŠÂŠíŽŸŠ³‚Ì‹Ù‹}Ž¡—Á@S•s‘S‚ÌŽ¡—ÃŽwj, p316-8.@ ’––”FŒ³ (zŠÂŠí“à), •Ò: ‰ªŒ³˜a•¶, ‘Ž‡ˆãŠwŽÐ, “Œ‹ž, 2015/12”­s.

620052. [Šwp‘ (•ª’SŽ·•M)]y‚È‚é‚Ù‚Ç! ‚Æ‚æ‚­‚í‚©‚é S•s‘S‚Å—˜”A–ò‚ðŽg‚¢‚±‚È‚· (Fluid Management Renaissance 6-Suppl.)zPart1 S•s‘S‚Ì‚€‚ÁŒŒƒRƒ“ƒgƒ[ƒ‹‚ð‹†‚ß‚é@III …•ª§ŒÀ‚Í, íŽ¯‚Å‚Í‚È‚¢@S•s‘SŽ¡—Âɐ…•ª§ŒÀ‚Í•K—v‚©?, p.20-5. ’––”FŒ³ (zŠÂŠí“à), •Ò: “›ˆä—T”V, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2016/3”­s.

620053. [Šwp‘ (•ª’SŽ·•M)]y‚±‚±‚ª’m‚è‚œ‚¢ ‹}«S•s‘S‚Ì‹~‹}EW’†Ž¡—ÊǗz3Í ‰Šú‹~‹}Ž¡—Á@3. ‰ŠúŽ¡—ÂɕK—v‚ÈŠî–{–òÜ@D. ŒŒŠÇŠg’£–ò, p.227-37. ’––”FŒ³ (zŠÂŠí“à), •Ò: ²“¡Kl, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2016/3”­s.

620054. [Šwp‘ (•ª’SŽ·•M)]y‚±‚±‚ª’m‚è‚œ‚¢ ‹­S–ò‚Ì‚³‚¶‰ÁŒžz‘æ3Í ‹­S–ò‚ð“Š—^‚·‚ׂ«•a‘ԂƂ́@4. ‹}«S•s‘S|‹•ŒŒ«E”ñ‹•ŒŒ«‚Ì•a‘Ô‚ÆŽ¡—Â̍·ˆÙ, p.103-8. ’––”FŒ³ (zŠÂŠí“à), •Ò: –k•—­Žj, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2016/3”­s.

620055. [Šwp‘ (•ª’SŽ·•M)]y‚±‚±‚ª’m‚è‚œ‚¢ ‹­S–ò‚Ì‚³‚¶‰ÁŒžz‘æ3Í ‹­S–ò‚ð“Š—^‚·‚ׂ«•a‘ԂƂ́@6. ‹}«S•s‘S|‚¢‚©‚É‹­S–ò‚ðweaning‚·‚é‚Ì‚©?, p.116-20. ’––”FŒ³ (zŠÂŠí“à), •Ò: –k•—­Žj, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2016/3”­s.

620056. [Šwp‘ (•ª’SŽ·•M)]yzŠÂŠíŒ€Cƒm[ƒgz‘æ1Í zŠÂŠíŒ€C‚ł̃AƒhƒoƒCƒX@B. ˆã—ÃŒ»ê‚ł̃Rƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“@2. ƒ`[ƒ€ˆã—Ã, p.16-9. ’––”FŒ³ (zŠÂŠí“à), ƒVƒŠ[ƒY‘ŠÄC/Ó”C•ÒW: ‰iˆä—ÇŽO, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2016/3”­s.

620057. [Šwp‘ (•ª’SŽ·•M)]y‚Þ‚­‚݂⑧Ø‚ê‚É‚à‚€¢‚ç‚È‚¢! —˜”A–ò‚̏ãŽè‚ÈŽg‚¢•ûzIII ƒP[ƒX‚©‚çŠw‚ԐS•s‘SŠ³ŽÒ‚ւ̏ãŽè‚È—˜”A–ò‚ÌŽg‚¢•û@J. t‹@”\ˆ«‰»‚Æ—˜”A–ò‘I‘ð‚̍l‚Š•û|ƒ‰ƒVƒbƒNƒX‚ł͐t‹@”\‚ªˆ«‰»‚µ‚œ‚ª, ƒTƒ€ƒXƒJ‚ł͈ێ‚Å‚«‚œÇ—á, p.130-5. ’––”FŒ³ (zŠÂŠí“à), •Ò: ‘ŽR@—, “ì]“°, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713026. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Structural Remodeling in Atrium can be Suppressed by Febuxostat, a Xanthine; Oxidase -Inhibitor, in the Canine Model of Atrial Fibrillation. Yoshizawa T1, Niwano S1, Niwano H, Igarashi T2, Nakamura H2, Fujiishi T2, Ishizue N2, Kishihara J1, Murakami M1, Fukaya H1, Ako J1: Annual Scientific Meeting of Heart Rhythm Society (2015/5/14), San Francisco, USA. (‹gàV’qŽ¡1, ’ë–ìTˆê1, ŒÜ\—’Œš2, ’†‘º—m”Í2, “¡ÎŽì”ü2, Î––¬Æ2, ŠÝŒŽ@~1, ‘ºã‰ë”ü1, [’J‰p•œ1, ˆ¢ŒÃÆ1: 1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713027. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A case of interventional treatment for chronic thrombosis caused by iliac compression syndrome. Meguro K1: EuroPCR 2015 (2015/5/19), Paris, France. (–ڍ•Œ’‘Ÿ˜Y1: 1zŠÂŠí“à)

713028. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Aliskiren Suppresses Extracellular Matrix Genes in Atrial Fibrillation - A Global mRNA Profiling in the Canine Experimental Atrial Fibrillation Model Kishihara J1, Niwano S1, Niwano H, Satoh A1, Igarashi T2, Ishizue N2, Fujiishi T2, Yoshizawa T1, Murakami M1, Fukaya H1, Ako J1: ESC CONGRESS 2015 (2015/8/30), London, UK. (ŠÝŒŽ@~1, ’ë–ìTˆê1, ²“¡@—z1, ŒÜ\—’Œš2, Î––¬Æ2, “¡ÎŽì”ü2, ‹gàV’qŽ¡1, ‘ºã‰ë”ü1, [’J‰p•œ1, ˆ¢ŒÃÆ1: 1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713029. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Linagliptin, a DPP-4 Inhibitor, Suppresses the Electrical Remodeling and Myocardial Injury in Isoproterenol-induced Myocardial Injury Model in Rat. Ishizue N1, Niwano S2, Nakamura H1, Igarashi T1, Fujiishi T1, Yoshizawa T2, Oikawa J, Kishihara J2, Murakami M2, Fukaya H2, Niwano H, Ako J2: ESC CONGRESS 2015 (2015/9/1), London, UK. (Î––¬Æ1, ’ë–ìTˆê2, ’†‘º—m”Í1, ŒÜ\—’Œš1, “¡ÎŽì”ü1, ‹gàV’qŽ¡2, ŠÝŒŽ@~2, ‘ºã‰ë”ü2, [’J‰p•œ2, ˆ¢ŒÃÆ2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à)

713030. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prediction of Upcoming Therapeutic Episodes of ICD through Routine Data in Periodic Device Clinic of ICD Patients. Fujiishi T1, Niwano S2, Murakami M2, Nakamura H1, Igarashi T1, Ishizue N1, Oikawa J, Kishihara J2, Fukaya H2, Niwano H, Ako J2: American Heart Association Scientific Sessions 2015 (2015/11/8), Orland, USA. (“¡ÎŽì”ü1, ’ë–ìTˆê2, ‘ºã‰ë”ü2, ’†‘º—m”Í1, ŒÜ\—’Œš1, Î––¬Æ1, ŠÝŒŽ@~2, [’J‰p•œ2, ˆ¢ŒÃÆ2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à)

721004. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‚—îŽÒ‚̐S–[×“®‚ƍR‹ÃŒÅ—Ö@. ˆ¢ŒÃÆ (zŠÂŠí“à): ‘æ57‰ñ“ú–{˜V”NˆãŠw‰ïŠwpW‰ï (2015/6/14), _“ސì.

721005. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Š¥“®–¬ƒXƒeƒ“ƒg—¯’uŒã‚Ì3d‚̍RŒŒð—Ö@ŠúŠÔ‚Ì’Zk‚ɂ‚¢‚Ä‚ÌŽŽ‚Ý. ‰––ì•û–Ÿ1, ²“¡‘å•ã1, ²“¡F“T1, ‘ºŒ—S‰î1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): ‘æ24‰ñ“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Ž¡—Êw‰ï (CVIT2015) (2015/7/30), •Ÿ‰ª.

721006. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‰ES•s‘S‚̐f’f‚ÆŽ¡—Ã. ’––”FŒ³ (zŠÂŠí“à): ‘æ63‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2015/9/18), ‰¡•l.

721007. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) –Y‚ê‚Ä‚Í‚¢‚¯‚È‚¢Š¥“®–¬ŽŸŠ³‚Ì“ñŽŸ—\–h‚ƍ‡•¹Ç. ‰––ì•û–Ÿ1, ²“¡‘å•ã1, ²“¡F“T1, ‘ºŒ—S‰î1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): ‘æ63‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2015/9/19), ‰¡•l.

721008. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‚¢‚Ü, ‹}«S•s‘SŽ¡—Â͂ǂ€‚ ‚é‚ׂ«‚©. ’––”FŒ³ (zŠÂŠí“à): Samsca Heart Forum 2015 in Sapporo (2015/9/5), ŽD–y.

721009. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) S–[×“®‡•¹S•s‘S‚ɑ΂·‚éƒÀŽÕ’f–ò‚ÌŽg—pˆÓ‹`‚ðl‚Š‚é|S•s‘Sê–åˆã‚Ì—§ê‚©‚ç|. ’––”FŒ³ (zŠÂŠí“à): ‘æ19‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2015/10/22), ‘åã.

721010. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Decongestion‚Ì’ª—¬‚Í‚Ç‚±‚É‚ ‚é‚©. ’––”FŒ³ (zŠÂŠí“à): ‘æ19‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2015/10/24), ‘åã.

721011. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) S•s‘S‚Æ—˜”A–ò. ’––”FŒ³ (zŠÂŠí“à): ‘æ25‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2015/11/21), ‰¡•l.

721012. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) S•s‘SÇ—á‚É‚š‚¯‚éR‹ÃŒÅ—Ö@. ’––”FŒ³ (zŠÂŠí“à): CVMW2015SŒŒŠÇ‘ãŽÓTŠÔ (2015/12/12), _ŒË.

722033. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S‘ŸƒTƒ‹ƒRƒCƒh[ƒVƒX‘˜_. ’––”FŒ³ (zŠÂŠí“à): ‘æ2‰ñCMRƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/5/16), “Œ‹ž.

722034. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S–[×“®‚Ì”][Ç—\–h-NOAC‘卬íŽž‘ã‚̗Տ°Œ»ê‚Ì‘I‘ð- ’ë–ìTˆê (zŠÂŠí“à): TOPIC (Tokyo Percutaneous Cardiovascular Intervention Conference) 2015 (2015/7/9), “Œ‹ž.

722035. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) zŠÂŠíf—Âɗ§‹r‚µ‚œS‘ŸƒAƒ~ƒƒCƒh[ƒVƒX‚̐f’fƒ[ƒNƒtƒ[`f’f—ŠŒüã‚̃qƒ“ƒg‚ð’T‚é. ’––”FŒ³ (zŠÂŠí“à): ‘æ63‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2015/9/19), ‰¡•l.

722036. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ˆã—ÃŒoÏ‚©‚猩‚œS•s‘Sf—Á`ƒGƒrƒfƒ“ƒX‚Í‚Å‚«‚é‚©. ’––”FŒ³ (zŠÂŠí“à): ‘æ19‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2015/10/24), ‘åã.

722037. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Comment on the JACRE Registry. Late Breaking Clinical Trials/ Cohort Studies II Arrhythmia/ Hypertension. ’ë–ìTˆê (zŠÂŠí“à): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/18), å‘ä.

723195. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒRƒƒ“ƒe[ƒ^[. ‰––ì•û–Ÿ (zŠÂŠí“à): slender club tokyo 2015 (2015/4/10), •iì.

723196. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Measurement of L-type fatty acid-binding protein just after cardiac or vascular surgery can predict acute kidney injury. –ڍ•Œ’‘Ÿ˜Y1, Yamaoka H, Akashi H, Iidaka K, Nakata M, Yamashita T, Fujita M, Chinen T, Kikuchi T, Keida T, Ohira H (1zŠÂŠí“à): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/24), ‘åã.

723197. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Febuxostat, a Xanthine-Oxidase-Inhibitor, Suppresses the Structural Remodeling in Atrium through Anti-Oxidative Effect in the Canine Model of Atrial Fibrillation ‹gàV’qŽ¡1, ’ë–ìTˆê1, ’ë–ì—TŒb, ŒÜ\—’Œš2, “¡ÎŽì”ü2, Î––¬Æ2, ŠÝŒŽ@~1, ‘ºã‰ë”ü1, [’J‰p•œ1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/24), ‘åã.

723198. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Effect of TDI Guided Reprogramming to Reduce Inappropriate Shock in ICD Patients and Clinical Predicting Factor Even After the Repeated-Reprogramming. “¡ÎŽì”ü1, ’ë–ìTˆê2, ‘ºã‰ë”ü2, ’†‘º—m”Í1, ŒÜ\—’Œš1, Î––¬Æ1, ‹gàV’qŽ¡2, ŠÝŒŽ@~2, [’J‰p•œ2, ’ë–ì—TŒb, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/24), ‘åã.

723199. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Dipeptidyl Peptidase-4 Inhibitor Improves Endothelial Function Accompanied by an Increase in Anti-atherosclerotic Protein ”¢•ûŒ’G1, “ŒžŠ‘å‹P2, Îˆär•ã2, –k—¢—œŽÑ2, ‹Ž–{‘ñ–í1, ‹T“c@—Ç2, ‰º•lF˜Y2, “ŒžŠ”ü“ÞŽq3, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à, 3ˆã—Éq¶Šw•”): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/25), ‘åã.

723200. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Non-VKA oral anticoagulant (NOAC) in atrial fibrillation patients receiving PCI. ˆ¢ŒÃÆ (zŠÂŠí“à): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/25), ‘åã.

723201. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Anti-thrombotic strategies for CAD patients with atrial fibrillation. ˆ¢ŒÃÆ (zŠÂŠí“à): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/25), ‘åã.

723202. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Left Atrial Stretch and Dominant Frequency of Atrial Fibrillation. Hatakeyama Y, ’ë–ìTˆê1, ‹yì@~, [’J‰p•œ1, “ŒžŠ”ü“ÞŽq2, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2ˆã—Éq¶Šw•”): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/25), ‘åã.

723203. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{l‚Ì“Á«‚ðl—¶‚µ‚œRŒŒð—Ö@‚Ì‚ ‚è•û|ƒKƒCƒhƒ‰ƒCƒ“‚ƗՏ°ƒGƒrƒfƒ“ƒX‚©‚ç‚̍lŽ@|. ˆ¢ŒÃÆ (zŠÂŠí“à): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/26), ‘åã.

723204. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Discrimination of Paroxysmal and Non-paroxysmal Atrial Fibrillation In the Patients with New-onset Atrial Fibrillation. ŒÜ\—’Œš1, ’ë–ìTˆê2, Î––¬Æ1, “¡ÎŽì”ü1, ‹gàV’qŽ¡2, ŠÝŒŽ@~2, [’J‰p•œ2, ’ë–ì—TŒb, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/26), ‘åã.

723205. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Characteristic in left ventricular flow vortex and its energetic efficiency of normal and dilated myocardium. Š`è—Ç‘Ÿ1, “ç“c@Œ’1, Îˆär‰î2, ¬”‹Žr”ü2, ‹{èãĕœ3, ’––”FŒ³2, ”Â’JŒcˆê3, ‹{’n@ŠÓ4, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à, 3ŒŒ—¬‰ðÍ, 4S‘ŸŒŒŠÇŠO): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/24-26), ‘åã.

723206. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) R‹ÃŒÅ–ò‚ƍRŒŒ¬”–ò‚Ì•¹—p. ˆ¢ŒÃÆ (zŠÂŠí“à): ‘æˆê‰ñJ-ISCPŠwpW‰ï‘ÛSŒŒŠÇ–ò•š—Ö@Šw‰ï“ú–{•”‰ï (2015/6/20), ‹ž“s.

723207. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇŽOŽ}•a•Ï‚𔺂€‘å“®–¬•Ù‹·óÇ‚ÉIABP‰º‚ÉBAV‚ðŽ{s‚µ‚œˆê—á. –ڍ•Œ’‘Ÿ˜Y1, …’J’m‘×2, –öàV’q‹`1, ‰º•lF˜Y1, “ŒžŠ‘å‹P1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2‹~–œ): ‘æ6‰ñ“ú–{ŒoƒJƒe[ƒeƒ‹S‘Ÿ•ÙŽ¡—Êw‰ïŠwpW‰ï JTVT2015 (2015/7/5), “Œ‹ž.

723208. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Antiplatelet therapy after PCI in LMT or multivessel disease. ˆ¢ŒÃÆ (zŠÂŠí“à): TOPIC2015 (2015/7/10), “Œ‹ž.

723209. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ž“ǂւ̑Ήž. ˆ¢ŒÃÆ (zŠÂŠí“à): TOPIC2015 (2015/7/11), “Œ‹ž.

723210. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S‹Ø[ÇŠ³ŽÒ‚É‚š‚¯‚é”­Ç‘O‚ÌŠ¥ŠëŒ¯ˆöŽqƒRƒ“ƒgƒ[ƒ‹‚³‚ê‚Ä‚¢‚È‚¢Š³ŽÒ‚̏󋵂ƓÁ’¥. –ڍ•Œ’‘Ÿ˜Y1, ‹e’r’B˜Y, Šª‹M”Ž, “’ìç’ߎq, ŽR‰ªŒ[M, ‘å•œ—mŽi (1zŠÂŠí“à): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/18), •Ÿ‰ª.

723211. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S•s‘SŠ³ŽÒ‚Ì“ü‰@‘Šú‚É•]‰¿‚µ‚œ10m‰õ“K•àsŽž‚̍ō‚S””‚Í, S•s‘SÄ“ü‰@‚ƐS‘ŸŽ€‚Ì—\‘ªˆöŽq‚Æ‚È‚é. ‘OìŒb”ü1, ‘“c@‘ì2, “c’†L–í3, –ìèN•œ4, Œ‘ò—Ç‘Ÿ4, à_èL–Ÿ3,4, _’JŒ’‘Ÿ˜Y4, ŒÜ\—’ˆŸŠóŽq5, ‰Í–ì^—5, Šâ‘º‹M”ü5, –ì“cçt1, ’––”FŒ³1, “ŒžŠ”ü“ÞŽq2, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4ƒŠƒnƒrƒŠ•”, 5ŠÅŒì•”): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/19), •Ÿ‰ª.

723212. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Linagliptin, a DPP-4 Inhibitor, Suppresses the Electrical Remodeling in Isoproterenol-induced Myocardial Injury Model in Rat. Î––¬Æ1, ’ë–ìTˆê2, ’†‘º—m”Í1, ŒÜ\—’Œš1, “¡ÎŽì”ü1, ‹gàV’qŽ¡2, ‹yì@~, ŠÝŒŽ@~2, ‘ºã‰ë”ü2, [’J‰p•œ2, ’ë–ì—TŒb, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/29), ‹ž“s.

723213. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Differences in prevalence and degree of the abnormal early systolic contraction in left bundle branch block with and without prolonged QRS duration (>150ms). Hara H, Kaida T, –xŒû@ˆ€1, ²“¡L—m1, Ito H, ’ë–ìTˆê1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/29), ‹ž“s.

723214. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Predictors for Upcoming ICD Therapeutic Episodes among Common Data in Daily Device Clinic. “¡ÎŽì”ü1, ’ë–ìTˆê2, ‘ºã‰ë”ü2, ’†‘º—m”Í1, ŒÜ\—’Œš1, Î––¬Æ1, ‹gàV’qŽ¡2, ‹yì@~, ŠÝŒŽ@~2, [’J‰p•œ2, ’ë–ì—TŒb, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/29), ‹ž“s.

723215. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Factors Determining Fibrillation Cycle Length in the Surface ECG in Patients with Long-lasting Atrial Fibrillation. ŒÜ\—’Œš1, ’ë–ìTˆê2, Î––¬Æ1, “¡ÎŽì”ü1, ‹gàV’qŽ¡2, ‹yì@~, ŠÝŒŽ@~2, ‘ºã‰ë”ü2, [’J‰p•œ2, –ì“cçt2, ’ë–ì—TŒb, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/29), ‹ž“s.

723216. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Patients' Characteristics and Reasons of Inappropriate Dose Prescription of Non-Vitamin K Dependent Anticoagulants for the Patients with Atrial Fibrillation. [’J‰p•œ1, ’ë–ìTˆê1, ’†‘º—m”Í2, Î––¬Æ2, ŒÜ\—’Œš2, “¡ÎŽì”ü2, ‹gàV’qŽ¡1, ‹yì@~, ²“¡@—z1, ŠÝŒŽ@~1, ‘ºã‰ë”ü1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/30), ‹ž“s.

723217. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A Case with Pacing Failure Caused by Automatic Pacing Threshold Adjustment|A Pit-fall of Automatic Threshold Testing Algorithm of Pacemaker|. ŠÝŒŽ@~1, ’ë–ìTˆê1, ’†‘º—m”Í2, ŒÜ\—’Œš2, Î––¬Æ2, “¡ÎŽì”ü2, ‹gàV’qŽ¡1, ‹yì@~, ²“¡@—z1, ‘ºã‰ë”ü1, [’J‰p•œ1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/30), ‹ž“s.

723218. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Differences in the Anticoagulation Strategy for Atrial Fibrillation between Cardiologists and Non-cardiologist. ²“¡@—z1, [’J‰p•œ1, ‹yì@~, Yasuno N, Kubo T, ’ë–ìTˆê1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/30), ‹ž“s.

723219. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The time course of the change in P wave morphology in cases with new onset atrial fibrillation ‹gàV’qŽ¡1, ’ë–ìTˆê1, ’†‘º—m”Í2, ŒÜ\—’Œš2, “¡ÎŽì”ü2, Î––¬Æ2, ‹yì@~, ŠÝŒŽ@~1, ²“¡@—z1, ‘ºã‰ë”ü1, [’J‰p•œ1, ’ë–ì—TŒb, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/30), ‹ž“s.

723220. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Comparison of circadian, weekly and seasonal variations between electrical storms versus single VF events in patients with Brugada syndrome. Aizawa Y, Takatsuki S, Nakajima K, Kashimura S, Kunitomi A, Katsumata Y, Nishiyama T, Kimura T, Nishiyama N, Fukumoto K, Tanimoto Y, Kaneko Y, ’ë–ìTˆê1, Kurita T, Mitsuhashi T, Noda T, Kamakura S, Shimizu A, Horie M, Aizawa Y, Fukuda K (1zŠÂŠí“à): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/30), ‹ž“s.

723221. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Importance of the Presence of J-wave as a Predictor for Life-threatening Arrhythmia in ICD-implanted patients. Î––¬Æ1, ’ë–ìTˆê2, ’†‘º—m”Í1, ŒÜ\—’Œš1, “¡ÎŽì”ü1, ‹gàV’qŽ¡2, ‹yì@~, ŠÝŒŽ@~2, ‘ºã‰ë”ü2, [’J‰p•œ2, ’ë–ì—TŒb, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/30), ‹ž“s.

723222. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Nifekalant with Rapid Ventricular Pacing Suppressed Incessant Ventricular Tachycardia after Urgent Coronary Artery Bypass Surgery in the Patient with Acute Myocardial Infarction. ’†‘º—m”Í1, [’J‰p•œ2, ’ë–ìTˆê2, ¬–ì—Y‘å2, ‹Ž–{‘ñ–í1, ŒÜ\—’Œš1, “¡ÎŽì”ü1, Î––¬Æ1, ‹gàV’qŽ¡2, ŠÝŒŽ@~2, ‘ºã‰ë”ü2, …’J’m‘×3, ’|“àˆê˜Y3, –k‘º@—¥4, ‹{’n@ŠÓ4, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à, 3‹~–œ, 4S‘ŸŒŒŠÇŠO): ‘æ30‰ñ“ú–{•s®–¬Šw‰ïŠwp‘å‰ïE‘æ32‰ñ“ú–{S“dŠw‰ïŠwpW‰ï ‡“¯Šwp‘å‰ï (2015/7/30), ‹ž“s.

723223. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) One year outcome of retrograde percutaneous balloon aortic valvuloplasty. –ڍ•Œ’‘Ÿ˜Y1, Iidaka K, Nakata M, Yamashita T, Chinen T, Fujita M, Keida T, Ohira H (1zŠÂŠí“à): ‘æ24‰ñ“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Ž¡—Êw‰ï (CVIT2015) (2015/7/30), •Ÿ‰ª.

723224. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Antiplatelet and anticoagulant therapy in patients with acute myocardial infarction and its complications. –ڍ•Œ’‘Ÿ˜Y1, Iidaka K, Nakata M, Yamashita T, Chinen T, Fujita M, Keida T, Ohira H (1zŠÂŠí“à): ‘æ24‰ñ“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Ž¡—Êw‰ï (CVIT2015) (2015/7/31), •Ÿ‰ª.

723225. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é’…—pŒ^Ž©“®œ×“®Ší (WCD) ‚ÌŽg—pŒoŒ±. ŠÝŒŽ@~1, ’ë–ìTˆê1, ’†‘º—m”Í2, ŒÜ\—’Œš2, Î––¬Æ2, “¡ÎŽì”ü2, ‹yì@~, ‘ºã‰ë”ü1, [’J‰p•œ1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ63‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2015/9/19), ‰¡•l.

723226. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘îf—Âƕaf˜AŒg‚ðl‚Š‚é: 2025”N–â‘è‚ÉŒü‚¯‚Ä. ˆ¢ŒÃÆ (zŠÂŠí“à): ‘æ63‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2015/9/20), ‰¡•l.

723227. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RŒŒð–ò‚ðzŠÂŠíE_Œo“à‰Èˆã‚©‚çŠw‚Ñ, Á‰»Šíˆã‚ªl‚Š‚é ˆ¢ŒÃÆ (zŠÂŠí“à): Japan Digestive Disease Week 2015 [JDDW 2015 TOKYO] (2015/10/10), “Œ‹ž.

723228. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MazepŒã‚Ìፍ­‚ðù‰ñ‚·‚é‹H—L‚ȍ¶–[ƒŠƒGƒ“ƒgƒŠ[‚É‚æ‚è•p”­‚·‚é•p””­ì‚ð’悵‚œ1—á. ŠÝŒŽ@~1, [’J‰p•œ1, ’†‘º—m”Í2, ŒÜ\—’Œ’2, Î––¬Æ2, “¡ÎŽì”ü2, ‹yì@~, ‘ºã‰ë”ü1, ’ë–ìTˆê1 (1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘å‰ï2015 (2015/10/16), ŒSŽR.

723229. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S“à–ŒŒ‡‘¹ÇpŒã‚ɍ‡•¹‚µ‚œ¶‰º”xÃ–¬ŽüˆÍ‚ð‰ñ˜H‚Æ‚·‚éS–[•p”‚Ì12—á|Ensite One Map‚Ì—L—p«‚ÆŒÀŠE|. [’J‰p•œ1, ‹M‰ŸŒŽ~, ’ë–ìTˆê1, ’†‘º—m”Í2, ŒÜ\—’Œ’2, “¡ÎŽì”ü2, Î––¬Æ2, ‹gàV’qŽ¡1, ‹yì@~, ²“¡@—z1, ‘ºã‰ë”ü1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘å‰ï2015 (2015/10/16), ŒSŽR.

723230. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’Ž‚—ŽÐ‰ï‚É‚š‚¯‚éR‹ÃŒÅ—Ö@`RŒŒ¬”–ò‚Æ‚Ì•¹—p‚Ì–â‘è“_`. ˆ¢ŒÃÆ (zŠÂŠí“à): ‘æ29‰ñ“ú–{Š¥ŽŸŠ³Šw‰ïŠwpW‰ï (2015/11/20), –kŠC“¹.

723231. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰@ŠO“KØì“®‚𒆐S‚Æ‚µ‚œ’…—pŒ^Ž©“®œ×“®Ší (WCD) ‚ÌŽg—pŒoŒ±. ŠÝŒŽ@~1, ’ë–ìTˆê1, ’†‘º—m”Í2, ŒÜ\—’Œš2, Î––¬Æ2, “¡ÎŽì”ü2, ‹yì@~, ‘ºã‰ë”ü1, [’J‰p•œ1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ8‰ñAž‚݃fƒoƒCƒXŠÖ˜A“~‹G‘å‰ï (2016/2/6), –k‹ãB.

723232. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Shorting the period of Triple Anti-platelet and anti-coagulation therapy: STAP trial. ‰––ì•û–Ÿ1, ²“¡‘å•ã1, ²“¡F“T1, ‘ºŒ—S‰î1, ˆ¢ŒÃÆ1 (1zŠÂŠí“à): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/18), å‘ä.

723233. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ezetimibe Enhances and Stabilizes the Anticoagulant Effect of Warfarin. ”¢•ûŒ’G1, “ŒžŠ”ü“ÞŽq2, “¡‹g˜a”Ž1, Š`è—Ç‘Ÿ1, ‹Ž–{‘ñ–í1, “ç“c@Œ’1, ‰º•lF˜Y3, “ŒžŠ‘å‹P3, ˆ¢ŒÃÆ3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/19), å‘ä.

723234. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Importance of the Presence of J-wave as a Predictor for Life-threatening Arrhythmia in ICD patients. Î––¬Æ1, ’ë–ìTˆê2, ’†‘º—m”Í1, ŒÜ\—’Œš1, “¡ÎŽì”ü1, ‹yì@~, ŠÝŒŽ@~2, ‘ºã‰ë”ü2, [’J‰p•œ2, ’ë–ì—TŒb, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/19), å‘ä.

723235. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Linagliptin Suppresses Atrial Electrical and Structural Remodeling in Canine Model of Atrial Fibrillation. ŒÜ\—’Œš1, ’ë–ìTˆê2, ’ë–ì—TŒb, ’†‘º—m”Í1, Î––¬Æ1, “¡ÎŽì”ü1, ‹gàV’qŽ¡2, ‹yì@~, ŠÝŒŽ@~2, ‘ºã‰ë”ü2, [’J‰p•œ2, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/19), å‘ä.

723236. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prediction of Therapeutic Episodes of ICD through Interrogated Device Data in the Remote Monitoring. “¡ÎŽì”ü1, ’ë–ìTˆê2, ‘ºã‰ë”ü2, ’†‘º—m”Í1, ŒÜ\—’Œš1, Î––¬Æ1, ‹yì@~, ŠÝŒŽ@~2, [’J‰p•œ2, ’ë–ì—TŒb, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/20), å‘ä.

723237. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Anti-oxidant component suppresses the construction of arrhythmogenic substrate in the isoproterenol induced acute myocardial injury. ‹yì@~, ’ë–ìTˆê1, ’ë–ì—TŒb, ’†‘º—m”Í2, ŒÜ\—’Œš2, “¡ÎŽì”ü2, Î––¬Æ2, ‹gàV’qŽ¡1, ŠÝŒŽ@~1, ²“¡@—z1, ‘ºã‰ë”ü1, [’J‰p•œ1, Tamaki H, ˆ¢ŒÃÆ1 (1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/20), å‘ä.

731013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚¢‚Ü, decongestion‚ð‚Ç‚€l‚Š‚é‚©. ’––”FŒ³ (zŠÂŠí“à): After-H10S•s‘SƒZƒ~ƒi[ (2015/5/13), Ž­Ž™“‡.

731014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Š‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒ³ (zŠÂŠí“à): ƒTƒ€ƒXƒJ”­”„4Žü”N‹L”OS•s‘SŽ¡—Êwpu‰‰‰ï (2015/5/15), å‘ä.

731015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚ß‚Ž‚¹ƒNƒŠƒAƒJƒbƒg‚ȐS•s‘SŠÇ—. ’––”FŒ³ (zŠÂŠí“à): S•s‘SŽ¡—Âðl‚Š‚é‰ïin’¹Žæ (2015/6/2), ’¹Žæ.

731016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚Ì”][Ç—\–h|NOAC‘卬íŽž‘ã‚̗Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): V‹KŒoŒûR‹ÃŒÅ–ò“K³Žg—pƒZƒ~ƒi[ in •xŽR (2015/6/3), •xŽR.

731017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Â̓W–]|–ò•šŽ¡—ÂƔñ–ò•šŽ¡—ẪxƒXƒgƒ~ƒbƒNƒX|. ’––”FŒ³ (zŠÂŠí“à): S•s‘SASVŠwpu‰‰ (2015/6/6), “Œ‹ž.

731018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹}«S•s‘SŠÇ—`ƒ|ƒCƒ“ƒg‚Í‚Ç‚±‚©. ’––”FŒ³ (zŠÂŠí“à): 3rd Clinical Discussion for Heart Failure (2015/6/12), ‘O‹Ž.

731019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S‹Ø‘gD«ó‚ÉŠî‚­V‚œ‚ȐS•s‘SŠÇ—`LGEƒKƒCƒhf—Â̎Ž‚Ý. ’––”FŒ³ (zŠÂŠí“à): ‘æ17‰ñŒ]zŠÂŠíÌ«°×Ñ (2015/6/13), Œ].

731020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘Sf—ÍőOü|‚¢‚Ü, decongestion‚ð‚Ç‚€l‚Š‚é‚©|. ’––”FŒ³ (zŠÂŠí“à): “v”gˆã—ÃŒ—˜AŒgŠwpu‰‰‰ï (2015/6/17), “v”g.

731021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚Ì”][Ç—\–h|NOAC‘卬íŽž‘ã‚̗Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): ƒGƒŠƒLƒ…[ƒX”­”„ˆÊŽü”N‹L”Ou‰‰ in V”­“c (2015/6/18), V”­“c.

731022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Š‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒ³ (zŠÂŠí“à): ‹ž“sƒTƒ€ƒXƒJ”­”„5Žü”N‹L”Ou‰‰‰ï (2015/6/19), ‹ž“s.

731023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚Ì”][Ç—\–h|NOAC‘卬íŽž‘ã‚̗Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): ƒGƒŠƒLƒ…[ƒX”­”„ˆÊŽü”N‹L”Ou‰‰ in ”è (2015/6/29), ”è.

731024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚¢‚©‚ɐi‚ß‚é‚©, decongestion‚Ætolvaptan. ’––”FŒ³ (zŠÂŠí“à): How to use Tolvaptan•×‹­‰ï (2015/6/30), ã‰z.

731025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘S‚ð, Œn“—§‚Ä‚Ä, f‚é, Ž¡‚·. ’––”FŒ³ (zŠÂŠí“à): ‘æ15‰ñ•œ¬zŠÂŠí—Տ°Œ€‹†‰ï (2015/7/23), –ŒŒÃ‰®.

731026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): RŒŒð—Ö@ Up to Date 2015 in –k–{ (2015/7/24), –k–{.

731027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Š‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒ³ (zŠÂŠí“à): ‘æ7‰ñ‘q•~S•s‘Su‰‰‰ï (2015/7/24), ‘q•~.

731028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Š‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒ³ (zŠÂŠí“à): S•s‘SƒZƒ~ƒi[ (2015/8/21), “ß”e.

731029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •ïŠ‡“IS•s‘SŠÇ—‚Ö‚Ì’§í. ’––”FŒ³ (zŠÂŠí“à): ‘æ4‰ñzŠÂŠíƒ`[ƒ€ˆã—Âðl‚Š‚é‰ï (2015/9/4), ‹ž“s.

731030. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚¢‚Ü‚È‚º‚š• ‚È‚Ì‚©‚©‚ç?`S•s‘S‚ł̐V‚œ‚È‘ŸŠí˜AŠÖ. ’––”FŒ³ (zŠÂŠí“à): ŠÌES˜AŠÖ‚ðl‚Š‚éŠwpu‰‰‰ï (2015/9/8), ’¬“c.

731031. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Äl: S•s‘Sf—Â̒n—Í‚ð‚‚¯‚é. ’––”FŒ³ (zŠÂŠí“à): ‘æ13‰ñ“Œ‹žSŒŒŠÇƒtƒH[ƒ‰ƒ€ (2015/9/11), “Œ‹ž.

731032. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): ŽO‰YŽsˆãŽt‰ïŠwpu‰‰‰ï2015 (2015/9/15), ŽO‰Y.

731033. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Š‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒ³ (zŠÂŠí“à): ƒTƒ€ƒXƒJ”­”„‹L”Ou‰‰‰ï (2015/9/24), ‹à‘ò.

731034. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) CKD‡•¹S•s‘S‚É‚š‚¯‚éƒgƒ‹ƒoƒvƒ^ƒ“‚Ì—L—p«‚ÌŒŸ“¢. ’––”FŒ³ (zŠÂŠí“à): Samsca Conference in Kanagawa (2015/10/1), ‰¡•l.

731035. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Â̓W–]|–ò•šŽ¡—ÂƔñ–ò•šŽ¡—ẪxƒXƒgƒ~ƒbƒNƒX|. ’––”FŒ³ (zŠÂŠí“à): ‘æ8‰ñzŠÂŒÄ‹záŠQŒ€‹†‰ï (2015/10/2), ‰F“s‹{.

731036. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Â̓W–]|–ò•šŽ¡—ÂƔñ–ò•šŽ¡—ẪxƒXƒgƒ~ƒbƒNƒX|. ’––”FŒ³ (zŠÂŠí“à): ‘æ6‰ñŽRŒ`S•s‘SASVƒ~[ƒeƒBƒ“ƒO (2015/10/8), ŽRŒ`.

731037. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion‚ð[“Ç‚Ý‚·‚é. ’––”FŒ³ (zŠÂŠí“à): ‘æ2‰ñ–k•”‹ãBS•s‘Sƒ~[ƒeƒBƒ“ƒO (2015/10/9), •Ÿ‰ª.

731038. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): Seminar for Thrombosis update -Šú‘Ò‚³‚ê‚éV‚œ‚È‘I‘ðŽˆ- (2015/10/19), ‰¡•l.

731039. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Â̓W–]|–ò•šŽ¡—ÂƔñ–ò•šŽ¡—ẪxƒXƒgƒ~ƒbƒNƒX|. ’––”FŒ³ (zŠÂŠí“à): Šò•ŒASVŠwpu‰‰‰ï (2015/10/30), Šò•Œ.

731040. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹}«S•s‘SŠÇ—‚ÌŒü‚©‚€æ`ãŽº«•p–¬‚É‚Ç‚€‘Λ³‚·‚é‚©. ’––”FŒ³ (zŠÂŠí“à): CVDƒ}ƒl[ƒWƒƒ“ƒgƒZƒ~ƒi[ (2015/11/5), À’Ã.

731041. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰ES•s‘S‚ð‚Ç‚€f‚é‚©. ’––”FŒ³ (zŠÂŠí“à): ‘æ62‰ñV‚³‚Á‚Û‚ëS‘ŸŒŒŠÇ•×‹­‰ï (2015/11/6), ŽD–y.

731042. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Žè‚‚©‚ž‚̐S•s‘S‘ŸŠí˜AŠÖ. ’––”FŒ³ (zŠÂŠí“à): ‘æ12‰ñ‹}«S•s‘SŒ€‹†‰ï (2015/11/14), “Œ‹ž.

731043. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S‹Ø‘gD«ó‚ÉŠî‚­V‚œ‚ȐS•s‘SŠÇ—`LGEƒKƒCƒhf—Â̎Ž‚Ý. ’––”FŒ³ (zŠÂŠí“à): ‘æ107‰ñ“ú–{zŠÂŠíŠw‰ïŽl‘’n•û‰ï (2015/11/14), ‚’m.

731044. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •ïŠ‡“IS•s‘Sf—ẪXƒXƒ`ÅV‚€‚ÁŒŒŽ¡—©‚çƒ`[ƒ€ˆã—Â܂Ł`. ’––”FŒ³ (zŠÂŠí“à): ”ö“¹S•s‘Su‰‰‰ï (2015/11/17), ”ö“¹.

731045. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Š‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒ³ (zŠÂŠí“à): –kÛtolvaptan conference (2015/11/19), ‚’Î.

731046. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Â̍ŐVƒgƒŒƒ“ƒh`decongestion‚ð[“Ç‚Ý‚·‚é. ’––”FŒ³ (zŠÂŠí“à): ‘æ5‰ñH“cS•s‘SŒ€‹†‰ï (2015/11/20), H“c.

731047. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) V‚œ‚Èdecongestion‚Ì’ª—¬‚ðl‚Š‚é. ’––”FŒ³ (zŠÂŠí“à): ‘Š–ÍŒŽƒTƒ€ƒXƒJŠwpu‰‰‰ï (2015/11/25), ‘Š–ÍŒŽ.

731048. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Decongestion‚̐V‚œ‚È’ª—¬. ’––”FŒ³ (zŠÂŠí“à): ‘æ120‰ñ“ú–{zŠÂŠíŠw‰ï‹ß‹E’n•û‰ï (2015/11/28), ‘åã.

731049. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) V‚œ‚Èdecongestion‚Ì’ª—¬‚ðl‚Š‚é. ’––”FŒ³ (zŠÂŠí“à): Šƒ–èS•s‘SŽ¡—Õ׋­‰ï (2015/12/8), Šƒ–è.

731050. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion‚̐V‚œ‚È’ª—¬‚Í‚Ç‚±‚ÉŒü‚©‚€‚Ì‚©. ’––”FŒ³ (zŠÂŠí“à): ‘æ1‰ñOsaka Medical Care Conference (2015/12/10), ‘åã.

731051. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œƒgƒ‹ƒoƒvƒ^ƒ“Šˆ—pƒVƒiƒŠƒI. ’––”FŒ³ (zŠÂŠí“à): ‹à‘òDecongestion Conference (2015/12/16), ‹à‘ò.

731052. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion‚̐V‚œ‚È’ª—¬‚ðl‚Š‚é. ’––”FŒ³ (zŠÂŠí“à): …—˜”A‚ðl‚Š‚é‰ï (2015/12/18), ç—t.

731053. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion‚̐V‚œ‚È’ª—¬‚ðl‚Š‚é. ’––”FŒ³ (zŠÂŠí“à): ‰¡•lŽsŒ•”S•s‘SƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/1/22), ‰¡•l.

731054. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): –Ÿ“ú‚ɖ𗧂S–[×“®ƒg[ƒ^ƒ‹ƒ}ƒl[ƒWƒƒ“ƒg in ‘Š–ÍŒŽ (2016/1/26), ‘Š–ÍŒŽ.

731055. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): “¡‘ò•s®–¬ˆã—ÃZƒ~ƒi[ (2016/1/27), “¡‘ò.

731056. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SÇ—á‚É‚š‚¯‚éR‹ÃŒÅ—Ö@`‰œ‚ª‚í‚©‚Á‚Ä‚¢‚ĉœ‚ª‚í‚©‚Á‚Ä‚¢‚È‚¢‚Ì‚©`. ’––”FŒ³ (zŠÂŠí“à): ƒGƒŠƒLƒ…[ƒX”­”„3Žü”N‹L”Ou‰‰‰ï (2016/2/1), ‹gËŽ›.

731057. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •ïŠ‡“IS•s‘SŠÇ—‚Ö‚Ì’§í. ’––”FŒ³ (zŠÂŠí“à): ‘Š–ÍŒŽˆãŽt‰ï’nˆæˆã—ÃŒ€‹†‰ï (2016/2/9), ‘Š–ÍŒŽ.

731058. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Äl: S•s‘Sf—Â̒n—Í‚ð‚‚¯‚é. ’––”FŒ³ (zŠÂŠí“à): é‹ÊŒ•”’n‹æS•s‘SƒZƒ~ƒi[ (2016/2/12), Š‘ò.

731059. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): Ã“ì•s®–¬ˆã—ØAŒgƒZƒ~ƒi[ (2016/2/15), “¡‘ò.

731060. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŠŽõ«S“à–Œ‰Š‚ÌŠÇ—`ƒ|ƒCƒ“ƒg‚͉œ‚©`. ’––”FŒ³ (zŠÂŠí“à): ‘æ8‰ñ’†‘€zŠÂŠí’S“––òÜŽtƒtƒH[ƒ‰ƒ€ (2016/2/15), ‰¡•l.

731061. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠ³ŽÒ‚̑̉t—ʃRƒ“ƒgƒ[ƒ‹‚ð‚Ç‚€l‚Š‚é‚©. ’––”FŒ³ (zŠÂŠí“à): ‘æ5‰ñ“ŒŠ‹“ì•”S•s‘SŽ¡—ÃJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/2/16), ‰YˆÀ.

731062. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘S‚̕“IŠÇ—‚ƃ`[ƒ€ˆã—Ã. ’––”FŒ³ (zŠÂŠí“à): —Տ°–òŠwŒ€‹†‰ï (2016/2/18), “Œ‹ž.

731063. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Š‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒ³ (zŠÂŠí“à): ŠÙ—Ñ’n‹æS•s‘SŠwpu‰‰‰ï (2016/2/19), ŠÙ—Ñ.

731064. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): Core Member for Thrombosis update|Šú‘Ò‚³‚ê‚éV‚œ‚È‘I‘ðŽˆ| (2016/2/22), ìè.

731065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠ³ŽÒ‚̑̉t—ʃRƒ“ƒgƒ[ƒ‹‚ð‚Ç‚€l‚Š‚é‚©. ’––”FŒ³ (zŠÂŠí“à): ‘æ5‰ñ…—˜”AŒ€‹†‰ï (2016/2/25), ‘åã.

731066. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Š‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒ³ (zŠÂŠí“à): ‘æ5‰ñ‰ÁŒÃìS•s‘SƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/2/26), ‰ÁŒÃì.

731067. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): R‹ÃŒÅ—Ö@•×‹­‰ï in ŠC˜V–Œ (2016/2/29), ŠC˜V–Œ.

731068. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) decongestion‚̐V‚œ‚È’ª—¬‚ðl‚Š‚é. ’––”FŒ³ (zŠÂŠí“à): ˆã—ØAŒg‚©‚çl‚Š‚éS•s‘SŽ¡—Ẩï (2016/3/3), ‹à‘ò.

731069. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰ES•s‘S‚ð‚Ç‚€f‚é‚©? ’––”FŒ³ (zŠÂŠí“à): ‘æ4‰ïŒŽD–yE¬’MzŠÂŠí˜AŒg‚̉ï (2016/3/5), ¬’M.

731070. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): RŒŒðŽ¡—Âðl‚Š‚é‰ï in V‰¡•l (2016/3/7), ‰¡•l.

731071. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): ‘«•¿ãRŒŒð—Ö@‚ðl‚Š‚é‰ï (2016/3/9), ‘«•¿.

731072. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): –Ÿ“ú‚ɖ𗧂S–[×“®ƒg[ƒ^ƒ‹ƒ}ƒl[ƒWƒƒ“ƒg (2016/3/11), ìè.

731073. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Ã-‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð. ’ë–ìTˆê (zŠÂŠí“à): R‹ÃŒÅ—Ö@ Up to date in ¬“cŒŽ (2016/3/15), ¬“cŒŽ.

731074. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): R‹ÃŒÅ—Ö@ƒZƒ~ƒi[@Šú‘Ò‚³‚ê‚éV‚œ‚È‘I‘ðŽˆ (2016/3/22), ‰¡•l.

731075. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •ïŠ‡“IS•s‘SŠÇ—‚Ö‚Ì’§í`decongestion‚ð‚¢‚©‚ɐi‚ß‚é‚©. ’––”FŒ³ (zŠÂŠí“à): ˆ€•QS•s‘SŽ¡—Êwpu‰‰‰ï (2016/3/23), “Œ‰·.

731076. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): –Ÿ“ú‚̐f—©‚ç–𗧂R‹ÃŒÅ—Ö@ƒZƒ~ƒi[ (2016/3/29), ‘å˜a.

732024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): ‰¡{‰êŽsˆãŽt‰ïŠwpu‰‰‰ï (2015/5/11), ‰¡{‰ê.

732025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S–[×“®‚̍RŒŒðŽ¡—Á|‘æ4‚ÌNOAC‚ðŒ}‚Š‚œ—Տ°Œ»ê‚Ì‘I‘ð|. ’ë–ìTˆê (zŠÂŠí“à): “Þ—Ç‚â‚܂ƏzŠÂŠíƒZƒ~ƒi[ (2015/6/6), “Þ—Ç.

732026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S–[×“®‚̍RŒŒð—Ö@|VKA‚ÆNOAC‚Ì–ðŠ„|. ’ë–ìTˆê (zŠÂŠí“à): _“ސ쌧–òÜŽt‰ï–òŠw‡“¯Œ€C‰ï2015 (2015/6/11), ‰¡•l.

732027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Šg’£Œ^S‹ØÇƒŒƒWƒXƒgƒŠŒ€‹†‚ÉŒü‚¯‚Ä. ’––”FŒ³ (zŠÂŠí“à): ‘æ1‰ñ“ú–{S‹ØÇŒ€‹†‰ï (2015/7/4), “Œ‹ž.

732028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”ñ‹•ŒŒ«Sƒ|ƒ“ƒvˆÙí‚É‚š‚¯‚éS‹ØÇ‚̊ӕʐf’fƒXƒeƒbƒv|‘œŽ{Ý’²ž‚©‚ç‚݂錻ó‚Æ–â‘è“_|. ’––”FŒ³ (zŠÂŠí“à): ‘æ1‰ñ“ú–{S‹ØÇŒ€‹†‰ï (2015/7/4), “Œ‹ž.

732029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S‹Ø‘gD‘œ‚ÉŠî‚­V‚œ‚ȐS•s‘SŽ¡—Ð헪. ’––”FŒ³ (zŠÂŠí“à): ‘æ37‰ñS‹Ø¶ŒŸŒ€‹†‰ï (2015/12/11), _ŒË.

732030. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹•ŒŒ«SŽŸŠ³‚É‚š‚¯‚é“Ë‘RŽ€ˆêŽŸ—\–h|‘å‹K–ÍŽŽŒ±‚É‚š‚¯‚éƒGƒrƒfƒ“ƒX‚ÆŽÀ—Տ°|. ’ë–ìTˆê (zŠÂŠí“à): S‘Ÿ“Ë‘RŽ€‚ðl‚Š‚é in ‰¡•l (2016/2/20), ‰¡•l.

733073. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) R‹ÃŒÅ—Ö@‚ƍRŒŒ¬”—Ö@‚Æ‚Ì•¹—p‚Ì–â‘è“_|ƒGƒrƒfƒ“ƒX‘no‚ÉŒü‚¯‚ā|. ˆ¢ŒÃÆ (zŠÂŠí“à): —«zŠÂŠíˆã§˜b‰ï (JJC:JJ-Club) ‘æ4‰ñŠwpu‰‰‰ï (2015/4/25), ‘åã.

733074. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽŠ“K‚ÈDAPTŠúŠÔ‚̃Rƒ“ƒgƒƒo[ƒV[|R‹ÃŒÅ‚Æ‚Ì•¹—p‚Ì–â‘è‚àŠÜ‚߁|. ˆ¢ŒÃÆ (zŠÂŠí“à): “ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Ž¡—Êw‰ï (CVIT) ‘æ33‰ñ“ŒŠC–k—€’n•û‰ï ’n•û‰ïŽåÃƒrƒfƒIƒ‰ƒCƒuƒfƒ‚ƒ“ƒXƒgƒŒ[ƒVƒ‡ƒ“ (2015/5/16), ˆ€’m.

733075. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) SŒŒŠÇƒCƒxƒ“ƒg—}§‚ðl—¶‚µ‚œ“œ”A•aŽ¡—Ð헪`zŠÂŠíê–åˆã‚Ì—§ê‚©‚ç`. ˆ¢ŒÃÆ (zŠÂŠí“à): The 32nd Live Demonstration in KOKURA (2015/5/17), •Ÿ‰ª.

733076. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PCIŠ³ŽÒ‚É‚š‚¯‚éRŒŒ¬”—Ö@|R‹ÃŒÅ—Ö@‚Æ‚Ì•¹—p‚Æ–â‘è‚àŠÜ‚߂ā|. ˆ¢ŒÃÆ (zŠÂŠí“à): ‘æ5‰ñ–L‹Žƒ‰ƒCƒuƒfƒ‚ƒ“ƒXƒgƒŒ[ƒVƒ‡ƒ“ (2015/5/29), ˆ€’m.

733077. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PCIŒã‚Ì•¹—p—Ö@‚Ì–â‘è“_‚ðŽ¡—ÃƒKƒCƒhƒ‰ƒCƒ“‚ƗՏ°ƒGƒrƒfƒ“ƒX‚©‚çlŽ@‚·‚é. ˆ¢ŒÃÆ (zŠÂŠí“à): ‘æ130‰ñ“ú–{zŠÂŠíŠw‰ï–k—€’n•û‰ï (2015/7/12), •Ÿˆä.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-522007. [uÀ] y“ÁW: EBM‚©‚ç‚Ý‚œRŒŒð–ò‚Ì‘I‘ðzIII. Še˜_@3. ƒAƒeƒ[ƒ€ŒŒðÇ‚̍Ĕ­—\–h‚É‚š‚¯‚éRŒŒð–ò‚Ì‘I‘ð@(2) S‹Ø[Ç. ‹Ž–{‘ñ–í1, ˆ¢ŒÃÆ2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ŒŒð‚ƏzŠÂ 2015/1; 23 (1): 31-6.

H26-522008. [uÀ] y“ÁW: S•s‘SŽ¡—Â̍ŐV“®Œüz–«S•s‘S‚ƐS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“: ‚»‚Ì–Ú“I‚ÆŽÀÛ. –ì“cçt (zŠÂŠí“à): CarioVascular Contemporary 2015/3; 4 (1): 40-7.

H26-522009. [uÀ] yƒgƒsƒbƒNƒXzŠ¥“®–¬ƒXƒeƒ“ƒg—¯’uŒã‚ÌDAPT‚Ì’Zk‚Í‚Ç‚±‚܂ʼn”\‚©? ˆ¢ŒÃÆ (zŠÂŠí“à): ƒNƒŠƒjƒVƒAƒ“ 2015/3; 62 (3): 340-5.

H26-522010. [uÀ] yƒWƒ‡ƒCƒ“ƒgƒZƒbƒVƒ‡ƒ“1 (JS1)z–«S•s‘S‚ɉî“ü‚·‚é•ïŠ‡“IS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ÌŽæ‚è‘g‚Ý. “ŒžŠ”ü“ÞŽq1, –q–쏲G2, Š¡’J‰p‹I2, “¡‹g”Ž˜a2, š“ߏrŽ÷3, ŠÖªŒb”üŽq3, ‚‹Ž—R”ü3, ‰“ŒŽ^ˆê3, ¬‘q@Ê1, –Ø‘º‰ë•F1, ‘OìŒb”ü4, –ì“cçt4, Œ‰i“Ä•F1, ‘“c@‘ì1, ˆ¢ŒÃÆ4 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ƒŠƒnƒrƒŠ•”, 4zŠÂŠí“à) S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ 2015/3; 20 (1): 145-50.


_Œo“à‰ÈŠw

[Šwp˜_•¶]

110129. [ŒŽ’˜] Cauda equina conduction time in Guillain-BarrŽ syndrome. Matsumoto H, Hanajima R1, Terao Y, Hashida H, Ugawa Y: J Neurol Sci 2015/4; 351 (1-2): 187-90. (‰Ô“‡—¥Žq1: 1_Œo“à)

110130. [ŒŽ’˜] Hyperleptinemia increases the susceptibility of the cortex to generate cortical spreading depression. Kitamura E1, Kanazawa N2, Hamada J1: Cephalalgia 2015/4; 35 (4): 327-34. (–k‘º‰p“ñ1, ‹ààV’Œ”ü2, à_“cˆê1: 1_Œo“à, 2•a‘ԁEf—ÃŒn)

110131. [ŒŽ’˜] Incidence and extent of TDP-43 accumulation in aging human brain. Uchino A1, Takao M, Hatsuta H, Sumikura H, Nakano Y, Nogami A, Saito Y, Arai T, Nishiyama K1, Murayama S: Acta Neuropathol Commun 2015/6; 3: 35. (“à–쏲Žq1, ŒŽR˜a—˜1: 1_Œo“à)

110132. [ŒŽ’˜] Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Toyoda K, Arihiko S, Toda K, Yamagami H, Kimura K, Furui E, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Mochizuki H, Ito Y, Nakashima T, Takamatsu K, Nishiyama K1, Kario K, Sato S, Koga M, for the SAMURAI Study Investigators: Int J Stroke 2015/8; 10 (6): 836-42. (ŒŽR˜a—˜1: 1_Œo“à)

110133. [ŒŽ’˜] Effects of L-Dopa and pramipexole on plasticity induced by QPS in human motor cortex. Enomoto H, Terao Y, Kadowaki S, Nakamura K, Moriya A, Nakatani-Enomoto S, Kobayashi S, Yoshihara A, Hanajima R1, Ugawa Y: J Neural Transm (Vienna) 2015/9; 122 (9): 1253-61. (‰Ô“‡—¥Žq1: 1_Œo“à)

110134. [ŒŽ’˜] I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3ƒÀ signaling pathway. Ohta E, Nihira T, Uchino A1, Imaizum Y, Okada Y, Akamastu W, Takahashi K, Hayakawa H, Nagai M1, Ohyama M, Ryo M, Ogino M2, Murayama S, Takashima A, Nishiyama K1, Mizuno Y, Mochizuki H, Obata F, okano H: Hum Mol Genet 2015/9; 24 (17): 4879-900. (“à–쏲Žq1, ‰iˆä^‹MŽq1, —À@³•£, ‰¬–ì”üŒbŽq2, ŒŽR˜a—˜1: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

110135. [ŒŽ’˜] Saccade abnormalities associated with focal cerebral lesions - How cortical and basal ganglia commands shape saccades in humans. Terao Y, Fukuda H, Tokushuge S, Nomura Y, Hanajima R1, Ugawa Y: Clin Neurophysiol 2015/9; pii: S1388-2457(15)00929-3. (‰Ô“‡—¥Žq1: 1_Œo“à)

110136. [ŒŽ’˜] Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial. Takizawa S, Tanaka F, Nishiyama K1, Hasegawa Y, Nagata E, Mizuno A, Yutani S, Nakayama T, Kobayashi H, Yanagimachi N, Okazaki T, Kitagawa K; CMB-NOW Study Investigators: J Stroke Cerebrovasc Dis 2015/9; 24 (9): 2143-8. (ŒŽR˜a—˜1: 1_Œo“à)

110137. [ŒŽ’˜] Modulation of error-sensitivity during a prism adaptation task in people with cerebellar degeneration. Hanajima R1, Shadmehr R, Ohminami S, Tsutsumi R1, Shirota Y, Shimizu T1, Tanaka N, Terao Y, Tsuji S, Ugawa Y, Uchimura M, Inoue M, Kitazawa S: J Neurophysiol 2015/10; 114 (4): 2460-71. (‰Ô“‡—¥Žq1, ’ç@—Á‰î1, Ž…’G1: 1_Œo“à)

110138. [ŒŽ’˜] Influence of Zonisamide on the LTP-like Effect Induced by Quadripulse Transcranial Magnetic Stimulation (QPS). Tanaka N, Hanajima R1, Tsutsumi R1, Shimizu T1, Shirota Y, Terao Y, Ugawa Y: Brain Stimul 2015/11-12; 8 (6): 1220-2. (‰Ô“‡—¥Žq1, ’ç@—Á‰î1, Ž…’G1: 1_Œo“à)

110139. [ŒŽ’˜] Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology. Terao Y, Fukuda H, Tokushige S, Inomata-Terada S, Yugeta A, Hamada M, Ichikawa Y, Hanajima R1, Ugawa Y: Clin Neurophysiol 2016/2; 127 (2): 1491-502. (‰Ô“‡—¥Žq1: 1_Œo“à)

110140. [ŒŽ’˜] Somatosensory-evoked potential modulation by quadripulse transcranial magnetic stimulation in patients with benign myoclonus epilepsy. Nakatani-Enomoto S, Hanajima R1, Hamada M, Terao Y, Matsumoto H, Shirota Y, Ohminami S, Okabe S, Hirose M, Nakamura K, Furubayashi T, Groiss SJ, Kobayashi S, Mochizuki H, Enomoto H, Ugawa Y: Clin Neurophysiol 2016/2; 127 (2): 1560-7. (‰Ô“‡—¥Žq1: 1_Œo“à)

110141. [ŒŽ’˜] Abnormal myocardial scintigraphy in a GTP cyclohydrolase 1 mutation carrier with Parkinson's disease. Someko H1, Hanajima R1, Tsutsumi R1, Tominaga N1, Nomura Y, Hoshino K, Nishiyama K1: Mov Disord 2016/3; 31 (3): 422-3. (õ¬‰pO1, ‰Ô“‡—¥Žq1, ’ç@—Á‰î1, •x‰i“Þ•Û”ü1, ŒŽR˜a—˜1: 1_Œo“à)

310011. [Ç—á•ñ] Accumulation of transportin 1 in the fused in sarcoma-positive neuronal inclusions in sporadic amyotrophic lateral sclerosis without FUS mutation. Tokushige S, Sasaki T, Hatsuta H, Uchino A1, Kakuta Y, Shimizu J, Tsuji S, Nakayama T, Imafuku I, Murayama S: Neurology and Clinical Neuroscience 2015/9; 3 (5): 194-6. (“à–쏲Žq1: 1_Œo“à)

310012. [Ç—á•ñ] Reversible tongue muscle atrophy accelerated by early initiation of immunotherapy in anti-MuSK myasthenia gravis: A case report. Kitamura A1, Takiyama Y1, Nakamura M1, Iizuka T1, Nishiayma K1: J Neurol Sci 2016/1; 360: 10-2. (–k‘º‰p“ñ1, ‘êŽR—eŽq1, ’†‘ºŠ²º1, ”ђˍ‚_1, ŒŽR˜a—˜1: 1_Œo“à)

520009. [‘à] ÅV‚̏zŠÂŠíf—ÁE”]‘²’†ˆã—Â̍őOü|RŒŒð—Ö@up date. ˆä“‡‘å•ã1, ŒŽR˜a—˜1 (1_Œo“à): ˆÇ—шãŠw‰ïŽGŽ 2015/10; 44 (4): 125-31.

521011. [‰ðà]yŽ¿‹^‰ž“šz—Տ°ˆê”Ê [“à‰È: _Œo] ŠŽõÇ‚Ö‚Ì‹°•|S‚ª‹­‚¢RNMDAŽó—e‘Ì”]‰ŠŠù‰Š³ŽÒ‚ւ̑Ήž. ”ђˍ‚_ (_Œo“à): “ú–{ˆãŽ–V•ñ 2015/6; 4757: 61-2.

521012. [‰ðà] “úíf—Âɖ𗧂‘åŠw‚©‚猩‚œî•ñ: ‘‚í‚©‚èu”]‘²’†Ž¡—ÃKƒCƒhƒ‰ƒCƒ“v‚̉ü’ùƒ|ƒCƒ“ƒg. ŒŽR˜a—˜ (_Œo“à): _“àˆãƒjƒ…[ƒX 2016/1; 75: 8-9.

522075. [uÀ]yÀ’k‰ï: ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŒ»Ý‚Æ–¢—ˆzƒ]ƒjƒTƒ~ƒh‚̍ì—p‚𒆐S‚ɍl‚Š‚é. ‰Fì‹`ˆê1, ’·’Jì—²•¶, ‘O“c“N–ç, ‰Ô“‡—¥Žq2, [’J@e (1•Ÿ“‡Œ§—§ˆã‰È‘åŠw, 2_Œo“à): Pharma Medica 2015/4; 33 (4): 89-95.

522076. [uÀ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€: ”]‘²’†f—Â̌»Ý, ‰ß‹Ž, –¢—ˆzŽi‰ï‚ÌŒŸ—t. ŒŽR˜a—˜ (_Œo“à): _ŒoŽ¡—Êw 2015/5; 32 (3): 257.

522077. [uÀ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€: ALS‚ÆFTLD‚ÌŒ€‹†EŽ¡—Â̌»Ý’n‚ð’m‚éz2. ‹ØˆÞk«‘€õd‰»Ç‚ÌŒo‰ß‚É‚š‚¯‚é‘O“ª‘€“ª—t•Ï«Ç‡•¹. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—Êw 2015/5; 32 (3): 295-8.

522078. [uÀ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€: ALS‚ÆFTLD‚ÌŒ€‹†EŽ¡—Â̌»Ý’n‚ð’m‚éz4. ‹ØˆÞk«‘€õd‰»Ç‚Æ‘O“ª‘€“ª—t•Ï«Ç‚̗Տ°•a—. “à–쏲Žq1, ‚”ö¹Ž÷ (1_Œo“à): _ŒoŽ¡—Êw 2015/5; 32 (3): 304-9.

522079. [uÀ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€:u‚±‚±‚ë‚ÌŽžŠÔŠwv‚©‚ç–¢—ˆ‚̐_ŒoŽ¡—Âցz3.u‚±‚±‚ë‚ÌŽžŠÔv‚ւ̐_Œo¶—Šw“IƒAƒvƒ[ƒ`. ‰Ô“‡—¥Žq (_Œo“à): _ŒoŽ¡—Êw 2015/5; 32 (3): 379.

522080. [uÀ]y“ÁW/‘Û‰»E‘n–òŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€: _ŒoŽ¡—ÂÌunmet medical needs|‚»‚Ì‰ðŒˆ–@‚ð’T‚éz2. ƒŒƒZƒvƒg‚©‚猩‚œ’nˆæ‚É‚æ‚é_ŒoŽŸŠ³Ž¡—Â̂΂ç‚‚«‚Ì•ªÍ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—Êw 2015/5; 32 (3): 400-3.

522081. [uÀ]y“ÁW/‘Û‰»E‘n–òŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€: _ŒoŽ¡—ÂÌunmet medical needs|‚»‚Ì‰ðŒˆ–@‚ð’T‚éz3-4. ŠeŽŸŠ³‚É‚š‚¯‚éV–ò³”FEŽ¡—Â̎Àî‚ƍ¡Œã‚Ì“W–]: ‹ØˆÞk«‘€õd‰»Ç. ‰¬–ì”üŒbŽq (_Œo“à): _ŒoŽ¡—Êw2015/5; 32 (3): 416-9.

522082. [uÀ]yŽãƒfƒBƒx[ƒgz•Ð“ª’É‚Ì•a‘ԁ|CSD‚Ævascular factor‚Å‚Í‚Ç‚¿‚炪Žå‘Ì‚©: CSD‚ªŽå‘Ì‚Å‚ ‚é. ‘“c@—ã (_Œo“à): Headache Clinical & Science 2015/5; 6 (1): 20-2.

522083. [uÀ]y“ÁW: ”]‚ÌŒ©‚Š‚鉻|\‘¢•Òz_ŒoŽŸŠ³Ž¡—Ãm[ƒg@ƒ~ƒgƒRƒ“ƒhƒŠƒA”]‹ØÇ. ”ђˍ‚_ (_Œo“à): Clinical Neuroscience 2015/6; 33 (6): 712-3.

522084. [uÀ]y“ÁW: i•à‚µ‚œ_Œo“à‰ÈŽŸŠ³‚ÌŽÀ’nf—Á@ˆê”ÊŽÀ’nˆã‰Æ‚ÌŠˆ—p‚ÆŽÀ‘H‚Ì‚œ‚߂ɁzƒZƒ~ƒi[/ ŽÀ’nˆã‰Æ‚ªŠˆ—p‚·‚ׂ«_Œo“à‰ÈŽŸŠ³‚̐f—Â̐i•à‚ÆŽÀÛ@_ŒoƒTƒ‹ƒRƒCƒh[ƒVƒX. õ¬‰pO1, ŒŽR˜a—˜1 (1_Œo“à): Medical Practice 2015/6; 32 (6): 975-80.

522085. [uÀ]y“ÁW: ŠO—ˆ‚É‚š‚¯‚é_ŒoŽŸŠ³‚̐f‚©‚œzŠO—ˆ‚Å‘˜‹ö‚·‚邱‚Æ‚Ì‘œ‚¢_ŒoÇŒó@‚ß‚Ü‚¢. ‰iˆärs, ŒŽR˜a—˜1 (1_Œo“à): —Õଂƌ€‹† 2015/6; 92 (6): 715-21.

522086. [uÀ]y“ÁW: ŽpšE•às|Something new?zŽ¡—Á@‹@”\“I’èˆÊ”]Žèp|‹ÃŒÅp‚Ɛ[•””]ŽhŒƒ—Ö@ (DBS). Ž…˜aŒh1, ‰Ô“‡—¥Žq1 (1_Œo“à): Clinical Neuroscience 2015/7; 33 (7): 831-4.

522087. [uÀ]y“ÁW: Parkinson•a‚ÌŽ¡—Á@“à‰Èˆã‚É•K—v‚ȐV‚µ‚¢’mŒ©z”]ŒŒŠÇáŠQ«ƒp[ƒLƒ“ƒ\ƒjƒYƒ€‚̐V‚µ‚¢f’f–@‚ÆŽ¡—Ã. ŒŽR˜a—˜1, ‹àŽq@Œú1 (1_Œo“à): “ú–{“à‰ÈŠw‰ïŽGŽ 2015/8; 104 (8): 1585-90.

522088. [uÀ]y“ÁW:“ª’ɐf—Â̐V“WŠJz‚ЂƂ­‚¿ƒƒ‚@“ª’ɂƈâ“`Žq. ”ђˍ‚_ (_Œo“à): “ú–{ˆãŽt‰ïŽGŽ 2015/8; 144 (5): 976.

522089. [uÀ]y“ÁW: ”]‘²’†Ž¡—ÃKƒCƒhƒ‰ƒCƒ“2015z1. ”]‘²’†‹}«ŠúŠ³ŽÒ‚Ì‘SgŠÇ—. ‰Oˆä@—É1, ŒŽR˜a—˜1 (1_Œo“à): ”]‚ƏzŠÂ 2015/9; 20 (3): 215-8.

522090. [uÀ]y“ÁW: ×‹Û«‘–Œ‰Š‚̗Տ°‚ƍŐV‚ÌŽ¡—ÁzŠÓ•Êf’f@ŠŽõ«”]‰Š, –TŠŽõ«”]Ç. ”ђˍ‚_ (_Œo“à): Clinical Neuroscience 2015/11; 33 (11): 1265-7.

522091. [uÀ]yƒtƒH[ƒ‰ƒ€ƒŒƒ|[ƒg: •Ð“ª’ɐf—Âð[‚ß‚é`Ç—á‚©‚çŠw‚Ñ, ‚³‚ç‚ɐf—Â̕‚ðL‚°‚éNext Stage‚ց`zŠ³ŽÒ–ž‘«“x‚àf—ÃŒø—Š‚àã‚°‚éƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“p: ŒÀ‚ç‚ê‚œf—ÃŽžŠÔ‚Ì’†‚Å”[“Ÿ‚µ‚Ä‚à‚ç‚€‚œ‚߂̃Rƒc‚ƃc[ƒ‹‚ÌŠˆ—pp. ”у–’J”ü•ô (_Œo“à): Headache Clinical & Science 2015/11; 6 (2): 53-4.

522092. [uÀ]y“ÁW: —Տ°_Œo¶—‚ʼnœ‚ª‚í‚©‚é?@[1] ‹Ø“d}E_Œo“`“±ŒŸžEŽ¥‹CŽhŒƒz¬”]@ƒvƒŠƒYƒ€‡‰ž. ‰Ô“‡—¥Žq (_Œo“à): Clinical Neuroscience 2016/1; 34 (1): 99-101.

522093. [uÀ]yRound Table Discussion (À’k‰ï)zƒp[ƒLƒ“ƒ\ƒ“•a‚É‚š‚¯‚é‘å”]”玿‚̉‘Y«. •yŽRœ•F, ‰Fì‹`ˆê, ‰|–{”Ž”V, ‰Ô“‡—¥Žq1 (1_Œo“à): Frontiers in Parkinson Disease 2015/11; 8 (4): 181-9.

522094. [uÀ]y”]‘²’†‚Í‚±‚€f‚é-VƒKƒCƒhƒ‰ƒCƒ“‚ʼnœ‚ª•Ï‚í‚Á‚œ‚©zÀ’k‰ï: ”]‘²’†f—Â̎ÀÛ|VƒKƒCƒhƒ‰ƒCƒ“‚ÆŽÀ—Տ°‚ð‚‚Ȃ®|. (Ži‰ï) ŒŽR˜a—˜1, –L“cˆê‘¥2, ’O‰H@Œ‰3 (1_Œo“à, 2‘—§zŠÂŠí•aŒ€‹†ƒZƒ“ƒ^[, 3‚É‚íƒtƒ@ƒ~ƒŠ[ƒNƒŠƒjƒbƒN): Medicina 2016/2; 53 (2): 198-205.

530011. [‚»‚Ì‘Œ (Ž˜^)]yPoster Communications: Theme 6 Respiratory and Nutritional ManagementzJAPANESE NEUROLOGISTS RECOMMENDATIONS TO THEIR PATIENTS AND PERSONAL CHOICES TO TRACHEOSTOMY WITH INVASIVE MECHANICAL VENTILATION(TIV) DIVERGE BUT NOT TO NON-INVASIVE MECHANICAL VENTILATION(NIV). Ogino Y1, Ogino M2: Amyotroph Lateral Scler Frontotemporal Degener 2015/10; 16 (suppl 1): 130. (‰¬–ì@—T1, ‰¬–ì”üŒbŽq2: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

530012. [‚»‚Ì‘Œ (Letters)]yNew ObservationszAbnormal myocardial scintigraphy in a GTP cyclohydrolase 1 mutation carrier with Parkinson's disease. Someko H1, Hanajima R1, Tsutsumi R1, Tominaga N1, Nomura Y, Hoshino K, Nishiyama K1: Mov Disord 2016/3; 31 (3): 422-3. (õ¬‰pO1, (‰Ô“‡—¥Žq1, ’ç@—Á‰î1, •x‰i“Þ•Û”ü1, ŒŽR˜a—˜1: 1_Œo“à)

540009. [‚»‚Ì‘Œ (Ž˜^)] ”DP35T‚É‹…–ƒáƒ‚Å‹}«”­Ç‚µ‚œRNMDAŽó—e‘̍R‘Ì—z«‚Ì37Î—«—á. ’†‘ºŠ²º1, ”ђˍ‚_1, ˆä“‡‘å•ã1, ‹àŽq~‘Ÿ˜Y1, ŒŽR˜a—˜1 (1_Œo“à): —Տ°_ŒoŠw, 2015/4; 55 (4): 279.

540010. [‚»‚Ì‘Œ (Ž˜^)]y‘æ211‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ïŽ˜^zƒJƒ“ƒsƒƒoƒNƒ^[ŠŽõŒã, ‘–Œ‰Š‚Æ”A•Â‚ð’悵‚œ1—á. ²X–ØŒ«ˆê, ”у–’J”ü•ô1, à_“cˆê1 (1_Œo“à): —Տ°_ŒoŠw 2015/4 ; 55 (4): 283.

540011. [‚»‚Ì‘Œ (ƒKƒCƒhƒ‰ƒCƒ“)] ƒAƒZƒ^ƒ]ƒ‰ƒ~ƒh (ƒ_ƒCƒAƒ‚ƒbƒNƒX’ŽË—p) “K³Žg—pŽwj@2015”N4ŒŽ. ‚‹Ž@~1, ’·’Jì‘׍O, •ôŒˆê•v, –Ø“à”Ž”V, ›‹àŽ”Ž, ŒŽR˜a—˜2, ²‰êP•v, ‰º£ìŒb‹v, ˆÀÄr‹v, ¬Š}ŒŽ–Mº, –Ø‘º@O, ’F_ˆê˜Y, ’@˜a•v, ’†ìŒŽ÷“ñ, ”šàV@‡, ‹{–{@‹, “ú–{”]‘²’†Šw‰ï/“ú–{”]_ŒoŠO‰ÈŠw‰ï/“ú–{_ŒoŠw‰ï/“ú–{ŠjˆãŠw‰ï/4Šw‰ï‡“¯ƒAƒZƒ^ƒ]ƒ‰ƒ~ƒh“K³Žg—pŽwjì¬ˆÏˆõ‰ï (1‘—§zŠÂŠí•aŒ€‹†ƒZƒ“ƒ^[, 2_Œo“à): ”]‘²’† 2015/7; 37 (4): 281-97.

540012. [‚»‚Ì‘Œ (Ž˜^)] –¡ŠoáŠQ‚Æ‹L–Á—͏áŠQ‚ð’悵‚œRAMPAŽó—e‘Ì”]‰Š‚Ì37Î’j«. õ¬‰pO1, ’ç@—Á‰î1, •x‰i“Þ•Û”ü1, ˆä“‡‘å•ã1, ”ђˍ‚_1, ˆ¢‹v’Óñ•v1, ŒŽR˜a—˜1 (1_Œo“à): —Տ°_ŒoŠw 2015/8; 55 (8): 612.

540013. [‚»‚Ì‘Œ (‰ï‹c˜^)]yƒtƒH[ƒ‰ƒ€ƒŒƒ|[ƒgz‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (‹³ˆçu‰‰) ”]Š²‹NŒ¹à‚̑Ó–«‚Æ”ñ‘Ó–«. ”ђˍ‚_1, –k‘º‰p“ñ1 (1_Œo“à): Headache Clinical & Science 2015/11; 6 (2): 66.

540014. [‚»‚Ì‘Œ] Šw‰ï•ñ. ŒŽR˜a—˜ (_Œo“à): –k—¢‘åŠwˆãŠw•”“¯‘‹‰ï‰ï•ñ 2016/1; 71: 29-30.

[’˜@‘]

620058. [Šwp‘] (•ª’SŽ·•M)y–Ɖu«_ŒoŽŸŠ³|Šî‘bE—Տ°Œ€‹†‚̍ŐV’mŒ©| (“ú–{—Õ଑Š§†No.1085)zVI. ‚»‚Ì‘Œ‚̖Ɖu«_ŒoŽŸŠ³@1. Ž©ŒÈ–Ɖu«”]‰ŠE”]Ç@(3) RNMDAŽó—e‘Ì”]‰Š, p. 607-12. ”ђˍ‚_ (_Œo“à), “ú–{—Õ଎Ð, ‘åã, 2015/9”­s.

620059. [Šwp‘ (•ª’SŽ·•M)]y¡“ú‚ÌŽ¡—ÃŽwj2016”N”Å Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚éz15. _ŒoE‹ØŽŸŠ³@”]ŒŒŠÇáŠQ‚̍‡•¹Ç (Œëš‹«”x‰Š‚𒆐S‚É), p.927-8. ŒŽR˜a—˜ (_Œo“à), ŠÄC: ŽRŒû@“O, –kŒŽŒõ•v, ‘•ÒW: •ŸˆäŽŸ–î, ‚–؁@œ, ¬Žºˆê¬, ˆãŠw‘‰@, “Œ‹ž, 2016/1”­s.

620060. [Šwp‘] (•ª’SŽ·•M)y“úíf—ÂɊˆ‚©‚·f—ÃKƒCƒhƒ‰ƒCƒ“UP-TO-DATE [2016-2017]zVIII. ’†•_ŒoŒnŽŸŠ³@”]‘²’†, p513-20. ‚‹Ž˜a¹1, ŒŽR˜a—˜1 (1_Œo“à), ŠÄC; –å˜e@F, ¬Žºˆê¬, ‹{’n—ÇŽ÷, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2016/2”­s.

620061. [Šwp‘ (•ª’SŽ·•M)]y”]‘²’†ÇŒóŒQz‘æ2•” ŒŒŠÇ‹ÇÝ«ÇŒó@‘æ41Í ¬”]‚̍[Ç, ‘æ42Í ‹«ŠE—̈æ‚̍[Ç, ‘æ43Í ŒÃ“T“Iƒ‰ƒNƒiÇŒóŒQ, ‘æ44Í ‘å”]Šî’êŠj‚̏oŒŒ, ‘æ45Í ”]—tŒ^ (”玿‰º) ‚̏oŒŒ, ‘æ46Í ”]Žº“àoŒŒ, ‘æ47Í ‚­‚à–Œ‰ºoŒŒ, p.452-522. ˆ¢‹v’Óñ•v (_Œo“à), ŠÄ–ó: ¯–쐰•F, ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712015. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) M1 Interneuron function: SICI and pitfall. Hanajima R1: International Symposimu on Magnetic Stimulation (2015/6/6), Tokyo. (‰Ô“‡—¥Žq1: 1_Œo“à)

713031. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Late cerebellar atrophy and long-term outcome in anti-NMDA receptor encephalitis. Iizuka T1, Someko H1, Ohnuma H1, Kubo A1, Nakamura M1, Ishima D1, Kaneko J1, Kitamura E1, Masuda R1, Dalmau J, Nishiyama K1: American Academy of Neurology 2015 Annual Meeting (2015/4/22), Washington, USA. (”ђˍ‚_1, õ¬‰pO1, ‘åÀLŽ÷1, ‹v•Û“ÖŽq1, ’†‘ºŠ²º1, ˆä“‡‘å•ã1, ‹àŽq~‘Ÿ˜Y1, –k‘º‰p“ñ1, ‘“c@—ã1, ŒŽR˜a—˜1: 1_Œo“à)

713032. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Acute Bulbar Palsy as Presentation of Anti-NMDA Receptor Encephalitis: A Case Report. IIzuka T1, Nakamura M1, Ishima D1, Kaneko J1, Dalmau J, Nishiyama K1: American Academy of Neurology 2015 Annual Meeting (2015/4/22), Washington, USA. (”ђˍ‚_1, ’†‘ºŠ²º1, ˆä“‡‘å•ã1, ‹àŽq~‘Ÿ˜Y1, ŒŽR˜a—˜1: 1_Œo“à)

713033. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Physiology and modeling of non-invasive brain stimulation of the human motor cortex. Hanajima R1: The First International Taiwanese Congress of Neurology and 2015 Annual Meeting of Taiwan Neurological Society (2015/5/7),Taiwan. (‰Ô“‡—¥Žq1: 1_Œo“à)

713034. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The migraine prophylactic effect of candesartan and telmisartan on rat CSD model. Kitamura E1, Hamada J1, Kanazawa N1, Nishiyama K1: 17th Congress of the International Headache Society (2015/5/14-17), Spain. (–k‘º‰p“ñ1, à_“cˆê1, ‹ààV’Œ”ü1, ŒŽR˜a—˜1: 1_Œo“à)

713035. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Plasticity induction. Hanajima R1: International Symposimu on Magnetic Stimulation (Ž¥‹CŽhŒƒ‘ÛƒVƒ“ƒ|ƒWƒEƒ€) (2015/6/6), Tokyo. (‰Ô“‡—¥Žq1: 1_Œo“à)

713036. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) JAPANESE NEUROLOGISTS RECOMMENDATIONS TO THEIR PATIENTS AND PERSONAL CHOICES TO TRACHEOSTOMY WITH INVASIVE MECHANICAL VENTILATION(TIV) DIVERGE BUT NOT TO NON-INVASIVE MECHANICAL VENTILATION(NIV). Ogino Y1, Ogino M2: 26th ALS/MND international symposium 2015 (2015/12/11), Orlando, USA, Amyotroph Lateral Scler Frontotemporal Degener 2015; 16 (suppl 1): 130. (‰¬–ì@—T1, ‰¬–ì”üŒbŽq2: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

722038. [Šw‰ï (‘S‘)] (Hot Topics) MELAS‚É‚š‚¯‚é”]‘²’†—l”­ì‚Ì•ªŽq•a‘Ô (Molecular Pathophysiology of Stroke-like Episodes in MELAS). ”ђˍ‚_ (_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/20), VŠƒ.

722039. [Šw‰ï (‘S‘)] (Hot Topics) ”œ•œ’P‘Š«Žl˜A”­Ž¥‹CŽhŒƒ–@‚É‚æ‚é‰^“®–ì‰Â‘Y«•Ï‰»‚Ö‚Ì”N—î‚̉e‹¿ (Age dependency of the LTP like effect by quadri-pulse stimulation (QPS) over M1). ‰Ô“‡—¥Žq (_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/21), VŠƒ.

722040. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) •Ð“ª’É‚Ì•a‘Ô‹@˜—˜_‚̐V‚œ‚È“WŠJ|”]Š²‹NŒ¹à‚̑Ó–«‚Æ”ñ‘Ó–«. à_“cˆê1, ”ђˍ‚_1 (‘㗝”­•\), –k‘º‰p“ñ1 (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/22), VŠƒ, —Տ°_ŒoŠw 2015; 55 (•Êû) :S146.

722041. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰ƒx[ƒVƒbƒN)yÀ’·z”]‘²’†ƒGƒLƒXƒp[ƒg‚ð–ÚŽw‚·_Œo“à‰Èˆã‚Ì‚œ‚߂̏zŠÂŠíŠwŠî‘buÀ. é‘q@Œ’1, ŒŽR˜a—˜2 (1‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[, 2_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/22), VŠƒ.

722042. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹}«”]‰ŠE‹}«”]Ç‚Ì—‰ð‚ð[‚ß‚é‚œ‚߂Ɂ|RNMDAŽó—e‘Ì”]‰Š‚É‚š‚¯‚éf’f‚ÆŽ¡—Ïã‚Ì—¯ˆÓ“_. ”ђˍ‚_ (_Œo“à): ‘æ57‰ñ“ú–{¬Ž™_ŒoŠw‰ïŠwpW‰ï (2015/5/29), ‘åã, ”]‚Æ”­’B 2015; 47 (Suppl): S140.

722043. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ––œ_ŒoáŠQf’f‚É‚š‚¯‚é_Œo’Ž‰¹”gŒŸž‘˜_. ŒŽR˜a—˜ (_Œo“à): ‘æ34‰ñ“ú–{”]_Œo’Ž‰¹”gŠw‰ï‘‰ï (2015/6/5), ‹ž“s.

722044. [Šw‰ï (‘S‘)] (Controversy)yŽi‰ïzŒŽR˜a—˜1, ç—t@i (1_Œo“à): ‘æ9‰ñƒp[ƒLƒ“ƒ\ƒ“•aE‰^“®áŠQŽŸŠ³ƒRƒ“ƒOƒŒƒX (2015/10/16), •iì.

722045. [Šw‰ï (‘S‘)] (Controversy) Œ’NH•i (“`“ˆã—Ã, ”ª¡“€, …‘f…‚ðŠÜ‚Þ) ‚ÍPD‚É—L—p‚©?: CN1-2 No. ‰Ô“‡—¥Žq (_Œo“à): ‘æ9‰ñƒp[ƒLƒ“ƒ\ƒ“•aE‰^“®áŠQŽŸŠ³ƒRƒ“ƒOƒŒƒX (2015/10/16), “Œ‹ž, MDSJ Letters 2016; 9 (1): 1-3.

722046. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒrƒfƒIƒZƒbƒVƒ‡ƒ“) “ŒŒRƒƒ“ƒo[. ‰Ô“‡—¥Žq (_Œo“à): ‘æ9‰ñƒp[ƒLƒ“ƒ\ƒ“•aE‰^“®áŠQŽŸŠ³ƒRƒ“ƒOƒŒƒX (2015/10/16), •iì.

722047. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰)yÀ’·z¬”]_Œo‰ñ˜H‚Ì‚Í‚œ‚ç‚«‚Ɛ¶Œã”­’B. ‰Ô“‡—¥Žq (_Œo“à):‘æ45‰ñ“ú–{—Տ°_Œo¶—Šw‰ïŠwp‘å‰ï/‘æ52‰ñ“ú–{—Տ°_Œo¶—Šw‰ï‹ZpuK‰ï (2015/11/6), ‘åã.

722048. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹ØE_Œo•a•Ï: ƒTƒ‹ƒRƒCƒh[ƒVƒX‚̐V‚µ‚¢f’fŠî€‚Ɛf—ÃKƒCƒhƒ‰ƒCƒ“‚ð‚ß‚®‚Á‚Ä. ŒŽR˜a—˜ (_Œo“à): ‘æ35‰ñ“ú–{ƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰èŽî«ŽŸŠ³Šw‰ï‘‰ï(2015/11/7), ‘åã, “ú–{ƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰èŽî«ŽŸŠ³Šw‰ïŽGŽ 2015; 35 (suppl 1): 34.

722049. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)ySymposium 1zRecent progresses in primary headache disorders: 1-3) Hemiplegic migraine: Is it a typical migraine with aura or a migraine subtype? ”ђˍ‚_ (_Œo“à): ‘æ43‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2015/11/13), “Œ‹ž, “ú–{“ª’ÉŠw‰ïŽ 2016/7; 43 (1): 65-70.

722050. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·z”][ÇŠ³ŽÒ‚É‚š‚¯‚鎉Ž¿ŠÇ—‚̏d—v«. ˆ¢‹v’Óñ•v (_Œo“à): ‘æ43‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2015/11/13), “Œ‹ž.

722051. [Šw‰ï (‘S‘)] (Žs–¯ŒöŠJuÀ) ‚±‚ñ‚È“ª’É, ‚ ‚ñ‚È“ª’É, ‚ ‚È‚œ‚Ì’m‚ç‚È‚¢ƒzƒ“ƒg‚Ì“ª’É. •x‰i“Þ•Û”ü (_Œo“à): ‘æ43‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2015/11/15), “Œ‹ž.

722052. [Šw‰ï (‘S‘)] (Žs–¯ŒöŠJuÀ•Â‰ï‚̈¥ŽA) ‚±‚ñ‚È“ª’É, ‚ ‚ñ‚È“ª’É, ‚ ‚È‚œ‚Ì’m‚ç‚È‚¢ƒzƒ“ƒg‚Ì“ª’É. ŒŽR˜a—˜ (_Œo“à): ‘æ43‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2015/11/15), “Œ‹ž.

722053. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·z_ŒoŽŸŠ³Ž•ž‚ð–ÚŽw‚µ‚œÅV‚̉摜Œ€‹† Ži‰ï‚ÌŒŸ—t. ‰ºà_@r1, ŒŽR˜a—˜2 (1ŽD–yˆã‰È‘åŠwˆãŠw•”_Œo“à‰ÈŠwuÀ, 2_Œo“à): ‘æ33‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2015/11/27), –ŒŒÃ‰®, _ŒoŽ¡—à 2016; 33 (2): 184.

722054. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‹ØˆÞk«‘€õd‰»Ç (ALS) ‚Ì•a‘Ô‚ÆŽ¡—Ã. ŒŽR˜a—˜ (_Œo“à): “ú–{–òŠw‰ï‘æ136”N‰ï (2016/3/28), ‰¡•l.

723238. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘O•â‘«‰^“®–ìE•â‘«‰^“®–ì‚ɑ΂·‚éŒo“ªŠW”œ•œŽ¥‹CŽhŒƒ‚ªŽ‹Šo‰^“®Œn—ñŠwK‚É—^‚Š‚é‰e‹¿. Ž…’G1, ‰Ô“‡—¥Žq1, ‘ã“c—Iˆê˜Y, ’ç@—Á‰î1, “c’†Ms, “¿d^ˆê, à_“c@‰ë, Ž›”öˆÀ¶, ‰Fì‹`ˆê (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/20), VŠƒ.

723239. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒp[ƒLƒ“ƒ\ƒ“•af’f‚Å‚Ì’†ƒGƒlƒ‹ƒM[ƒRƒŠƒ[ƒ^[‚ð—p‚¢‚œMIBGƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚Ì—L—p«. ’†‘ºŠ²º1, –k‘º‰p“ñ1, ‹ààV’Œ”ü2, ˆäã—D‰î3, ŒŽR˜a—˜1 (1_Œo“à, 2•a‘ԁEf—ÃŒn, 3•úŽËü (‰æ‘œ)): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/20), VŠƒ.

723240. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œŒn“ˆÞkÇŠ³ŽÒ‚É‚š‚¯‚鐍‘̘H’¥Œó‚Æ’†•“`“±ŽžŠÔ‚ÌŒŸ“¢. ‘å’ˏ\—¢, à_“c@‰ë, ‰LÀ@“Ö, “¿d^ˆê, Ž…’O1, “c’†Ms, ‰Ô“‡—¥Žq1, Ž›”öˆÀ¶, ’ҁ@ÈŽŸ (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/20), VŠƒ.

723241. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Saccade abnormalities in cerebellar ataxia: comparison between SCD and MSA-C. Ž›”öˆÀ¶, •Ÿ“cGŽ÷, “¿d^ˆê, Œ“crˆê, ‹|í“cWO, ‰Ô“‡—¥Žq1, Hanajima M, à_“c@‰ë, ‰Fì‹`ˆê, ’ҁ@ÈŽŸ (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/20), VŠƒ.

723242. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) QPS‚ð—p‚¢‚œƒp[ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚É‚š‚¯‚éL-DOPA‚É‚æ‚é‘å”]”玿‰Â‘Y«•Ï‰»‚ÌŒŸ“¢. “c’†Ms, ’ç@—Á‰î1, Ž…’O1, Ž›“c‚³‚Æ‚Ý, à_“c@‰ë, Ž›”öˆÀ¶, ‰Fì‹Vˆê, ‰Ô“‡—¥Žq1, ’ҁ@ÈŽŸ (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/21), VŠƒ.

723243. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) rt-PA“Š—^Š³ŽÒ‚É‚š‚¯‚éASPECT‚ÆASPECT DWI‚Ì”äŠr‚Æ“ªŠW“àoŒŒ‚̍‡•¹‚ɂ‚¢‚Ä‚ÌŒŸ“¢. õ¬‰pO1, ‹àŽq~‘Ÿ˜Y1, ‰iˆä•qs1, ‹v•Û“ÖŽq1, ‰Oˆä@—É1, ‘åÀLŽ÷1, ’†‘ºŠ²º1, ˆä“‡‘å•ã1, –k‘º‰p“ñ1, ‘“c@—ã1, ”ђˍ‚_1, ˆ¢‹v’Óñ•v1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/21), VŠƒ.

723244. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰)yÀ’·z‹•ŒŒ«”]‘²’†‚ÌŠî‘b‚ƗՏ°. ŒŽR˜a—˜ (_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/21), VŠƒ.

723245. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Morphine usage in ALS patients on NPPV does not make life prognosisi wors. •x‰i“Þ•Û”ü1, ‰¬–ì”üŒbŽq2, ‰iˆä^‹MŽq1, ‹àŽq~‘Ÿ˜Y1, –k‘º‰p“ñ1, ˆ¢‹v’Óñ•v1, ‹ààV’Œ”ü1, Ryoko Noda, Fuki Wake, ŒŽR˜a—˜1 (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/21), VŠƒ, —Տ°_Œo 2015; 55 (•Êû): S345.

723246. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) pTDP-43 staging of amyotrophic lateral sclerosis,a critical review. “à–쏲Žq1, Yuta Nakano, Hiroyuki Sumikura, Masaki Takao, ŒŽR˜a—˜1, Shigeo Murayama (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/21), VŠƒ, —Տ°_Œo 2015; 55: S350.

723247. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰@ŠO”­Ç‚Ɖ@“à”­Ç”][Ç‚Ì’Ž‹}«ŠúŽ¡—ÃŽ{s‚Ü‚Å‚ÌŽžŠÔŒo‰ß‚Ì”äŠr. ‹v•Û“ÖŽq1, ˆ¢‹v’Óñ•v1, õ¬‰pO1, ‰Oˆä@—É1, ‹àŽq~‘Ÿ˜Y1, –k‘º‰p“ñ1, ‘“c@—ã1, ”ђˍ‚_1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/22), VŠƒ.

723248. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒtƒFƒCƒ“‚Ì”œ•œ’P‘Š«Žl˜A”­Ž¥‹CŽhŒƒ–@ (QPS) ‚É‚æ‚é’·ŠúŒø‰Ê‚ւ̉e‹¿. ’ç@—Á‰î1, “c’†Ms, Ž…’G1, Ž›”öˆÀ¶, ‰Fì‹`ˆê, ‰Ô“‡—¥Žq1 (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/22), VŠƒ.

723249. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒfƒm”ºƒEƒCƒ‹ƒXƒxƒNƒ^[‚ð—p‚¢‚œ•ÏˆÙMatrin 3”­Œ»ƒ}ƒEƒXƒ‚ƒfƒ‹‚̍쐬. Œ”öŒ\«, ŽR‰º@Œ«, “¹‹S‚‚©‚³, Œã@•ü, •U@@–], ‘O“c@”J, ˆÀ“Œ—RŠì—Y, ‰iˆä^‹MŽq1 (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/22), VŠƒ.

723250. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”F’mÇ‚𔺂Á‚œ‹ØˆÞk«‘€õd‰»Ç–UŒŸ”]‚̖Ɖu‘gDŠw“IŒŸ“¢. ‰iˆä^‹MŽq1, ì˜Q@•¶1, ‰¬–ì”üŒbŽq2, ŒŽR˜a—˜1 (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/22), VŠƒ.

723251. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The influence of candesartan on cortical spreading depressin. –k‘º‰p“ñ1, à_“cˆê1, ‹à‘ò’Œ”ü2, ŒŽR˜a—˜1 (1_Œo“à, 2•a‘ԁEf—ÃŒn): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/22), VŠƒ.

723252. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰EŒû‰‰) I2020T LRRK2 iPSC-derived neurons exhibit increased Tau phosphorylation. ‘Ÿ“c‰x˜N1, m•œ—FŽq, “à–쏲Žq2,3, ¡ò—zˆê4, ÔŒ˜a“y4, ‚‹Ž‰Á‘ãŽq5, ‰iˆä^‹MŽq2, ‘åŽR@Šw6, —À@³•£, ‰¬–ì”üŒbŽq7, ‘ºŽR”É—Y3, ‚“‡–Ÿ•F8, ŒŽR˜a—˜2, …–ì”ü–M, –]ŒŽGŽ÷9, ¬”Š•¶–í1, ‰ª–ì‰h”V4 (1ˆã—Éq¶Šw•”, 2_Œo“à, 3“Œ‹ž“sŒ’N’·Žõˆã—ÃZƒ“ƒ^[E‚—îŽÒƒuƒŒƒCƒ“ƒoƒ“ƒN, 4Œcœä‹`m‘å, 5—ÕŒŸ•”, 6ˆÇ—Ñ‘å, 7V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 8‘—§’·Žõˆã—ÃŒ€‹†ƒZƒ“ƒ^[, 9‘åã‘å): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/22), VŠƒ, —Տ°_ŒoŠw 2015; 55 (•Êû): S226.

723253. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Phosphorylated TDP-43 inclusions in the hippocampal formation of ALS patients. ‰iˆä^‹MŽq1, ì˜Q@•¶1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/23), VŠƒ.

723254. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†”]“à‘€‚ðŠÜ‚ޏ¬[Ç‚̗Տ°“IE•úŽËüŠw“IŒŸ“¢. ˆ¢‹v’Óñ•v1, ˆä“‡‘å•ã1, ‹àŽq~‘Ÿ˜Y1, –k‘º‰p“ñ1, ‘“c@—ã1, ‘êŽR—eŽq1, ”ђˍ‚G1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/23), VŠƒ.

723255. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinicall Characteristics of cerebral amyloid angiopathy related inflammation. ‰Oˆä@—É1, ‘“c@—ã1, ˆä“‡‘å•ã1, ‘åÀLŽ÷1, õ¬‰pO1, ’ç@—Á‰î1, ‘åÀ¹D, ‰iˆä^‹MŽq1, •x‰i“Þ•Û”ü1, Š}‘qŽŠŒŸ, ‹àŽq~‘Ÿ˜Y1, ì˜Q@•¶1, ”ђˍ‚_1, ˆ¢‹v’Óñ•v1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/23), VŠƒ.

723256. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é”F’mÇŠO—ˆ‚ÌŒ»ó‚ɂ‚¢‚Ä. ì˜Q@•¶1, ‰iˆä^‹MŽq1, ‚‹Ž@Œb2, ŒŽR˜a—˜1 (1_Œo“à, 2ž_): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/23), VŠƒ.

723257. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Impact of cerebellar atrophy on long-term outcome in anti-NMDAR encephalitis. ”ђˍ‚_1, õ¬‰pO1, ˆä“‡‘å•ã1, ‹àŽq~‘Ÿ˜Y1, –k‘º‰p“ñ1, ‘“c@—ã1, ŒŽR˜a—˜1 (1_Œo“à):‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/23), VŠƒ, —Տ°_Œo 2015; 55: S463.

723258. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·z‚»‚Ì‘Œ‚Ì”]‰Š. ”ђˍ‚_ (_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/23), VŠƒ.

723259. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”][•”ŽhŒƒ—Ö@Ž{sŒã‚̉Ƒ°«ƒp[ƒLƒ“ƒ\ƒ“•a (PARK8) ‚̈ê–UŒŸ—á. “à–쏲Žq (_Œo“à): ‘æ56‰ñ“ú–{_Œo•a—Šw‰ï‘‰ïŠwpŒ€‹†‰ï (2015/6/4), •Ÿ‰ª.

723260. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) I2020T LRRK2 iPSC-derived neurons exhibit increased Tau phosphorylation. ‘Ÿ“c‰x˜N1, m•œ—FŽq, “à–쏲Žq2, ¡ò—zˆê, ‰ª“c—m•œ, ÔŒ˜a“y, ‰iˆä^‹MŽq2, ‚‹Ž‰Á‘ãŽq3, ‘åŽR@Šw, —À@³•£, ‰¬–ì”üŒbŽq4, ‘ºŽR”É—Y, ‚“‡–Ÿ•F, ŒŽR˜a—˜2, …–ì”ü–M, –]ŒŽGŽ÷, ¬”Š•¶–í1, ‰ª–ì‰h”V (1ˆã—Éq¶Šw•”, 2_Œo“à, 3—ÕŒŸ•”, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ38‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2015/7/28), _ŒË.

723261. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”F’mÇ‚𔺂€‹ØˆÞk«‘€õd‰»Ç‚̗Տ°E•a—Šw“I•]‰¿. ‰iˆä^‹MŽq1, ì˜Q@•¶1, ‹ß“¡—TŽq1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ34‰ñ“ú–{”F’mÇŠw‰ïŠwpW‰ï (2015/10/2), ÂX, Dementia Japan 2015/9; 29 (3): 356.

723262. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _ŒoªŽ¥‹CŽhŒƒ–@‚É‚æ‚éã•”˜r_Œo‘páŠQ‚ÌŒŸo. Œ–{‰p”V, “¿d^ˆê, –{ŠÔ—[Žq, Ô–x‚‚®‚Ý, ‰ª•”TŒá, ‰Ô“‡—¥Žq1, Ž›”öˆÀ¶, ‰Fì‹`ˆê (1_Œo“à): ‘æ45‰ñ“ú–{—Տ°_Œo¶—Šw‰ïŠwp‘å‰ï/‘æ52‰ñ“ú–{—Տ°_Œo¶—Šw‰ï‹ZpuK‰ï (2015/11/5), ‘åã, —Տ°_Œo¶—Šw 2015/10; 43 (5): 461.

723263. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘O•â‘«‰^“®–ìE•â‘«‰^“®–ì‚ɑ΂·‚锜•œŒo“ªŠWŽ¥‹CŽhŒƒ‚ªŽ‹Šo‰^“®Œn—ñŠwK‚É—^‚Š‚é‰e‹¿. Ž…’G1, ‰Ô“‡—¥Žq1, ’ç@—Á‰î1, “c’†Ms, “¿d^ˆê, à_“c@‰ë, Ž›”öˆÀ¶, ‰F‰ê‹`ˆê (1_Œo“à): ‘æ45‰ñ“ú–{—Տ°_Œo¶—Šw‰ïŠwp‘å‰ï/‘æ52‰ñ“ú–{—Տ°_Œo¶—Šw‰ï‹ZpuK‰ï (2015/11/6), ‘åã, —Տ°_Œo¶—Šw 2015/10; 43 (5): 402.

723264. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Šjã«¶’Ž‹–ƒáƒ‚Å”­Ç‚µ‚œ¬×–E”xŠà‚ɐ”º‚·‚é–TŽîᇐ«ŠOŠá‹Ø–ƒáƒ‚Ì1—á. ‹àŽq@Œú1, ”ђˍ‚_1, •x‰i“Þ•Û”ü1, ˆä“‡‘å•ã1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ33‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2015/11/26), –ŒŒÃ‰®, _ŒoŽ¡—Êw 2015/9; 32 (5): 757.

723265. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Brachial amyotrophic diplegia‚Æsensory neuronopathy‚ð‡•¹‚µ‚œƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚Ì1—á. •x‰i“Þ•Û”ü1, ”ђˍ‚_1, ‹àŽq@Œú1, ˆä“‡‘å•ã1, ŒŽR˜a—˜1 (1_Œo“à); ‘æ33‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2015/11/27), –ŒŒÃ‰®, _ŒoŽ¡—Êw 2015/9; 32 (5): 782.

723266. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·zˆãŽtƒ|ƒXƒ^[Ž©ŒÈ–Ɖu«”]Ç: ƒP[ƒXƒJƒ“ƒtƒ@ƒŒƒ“ƒX. ”ђˍ‚_ (_Œo“à): ‘æ33‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2015/11/27), –ŒŒÃ‰®.

723267. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) I2020T mutant LRRK2 iPSC-derived neurons exhibit increased Tau phosphorylation. ‘Ÿ“c‰x˜N1, m•œ—FŽq, “à–쏲Žq2, ¡ò—zˆê, ‰ª“c—m•œ, ÔŒ˜a“y, ‚‹Ž‰Á‘ãŽq3, ‰iˆä^‹MŽq2, ‘åŽR@Šw, —À@³•£, ‰¬–ì”üŒbŽq4, ‘ºŽR”É—Y, ‚“‡–Ÿ•F, ŒŽR˜a—˜2, …–ì”ü–M, –]ŒŽGŽ÷, ¬”Š•¶–í1, ‰ª–ì‰h”V (1ˆã—Éq¶Šw•”, 2_Œo“à, 3—ÕŒŸ•”, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ15‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï (2016/3/17-19), ‘åã.

731077. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _Œo“à‰Èˆã‚Í”]‘²’†‚É‚¢‚©‚ÉŠÖ‚í‚é‚ׂ«‚©. ŒŽR˜a—˜ (_Œo“à): ‘æ17‰ñ“¿“‡”]ŒŒŠÇáŠQƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/5/16), “¿“‡.

731078. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œn—ñŠwK‰Û‘è‚Æ”œ•œŒo“ªŠWŽ¥‹CŽhŒƒ‚ð—p‚¢‚œ‘O•â‘«‰^“®–ìE•â‘«‰^“®–ì‚Ì‹@”\‰ðÍ. Ž…’G (_Œo“à): ‘æ7‰ñ‘Š–ÍŒŽE–k—¢_Œo‰ÈŠwƒtƒH[ƒ‰ƒ€ (2015/6/8), _“ސì.

731079. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ž©ŒÈ–Ɖu«_ŒoŽŸŠ³‚̐_ŒoÇŒóŠw|f’f‚ÆŽ¡—Ïã‚Ìpitfall|. ”ђˍ‚_ (_Œo“à): ‘æ12‰ñÃ‰ª_Œo–ƉuƒtƒH[ƒ‰ƒ€(2015/7/3), Ã‰ª.

731080. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ž©ŒÈ–Ɖu«”]‰Š‚Ɛž_Çó: Ž©ŒÈ–Ɖu‹@˜‚©‚ç‚Ý‚œž_áŠQ‚̗Տ°‚Æ•a‘Ô. ”ђˍ‚_ (_Œo“à): ‘æ12‰ñ•xŽR—Տ°ž__ŒoˆãŠwŒ€‹†‰ï (2015/9/11), •xŽR.

731081. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z1Ç—á‚©‚çŽn‚ß‚éV‹KŽ©ŒÈR‘Ì‚Ì’Tõ. ŒŽR˜a—˜ (_Œo“à): _“ސ쌧_Œo–ƉuŽŸŠ³Šwpu‰‰‰ï (2015/10/6), ‘Š–ÍŒŽ.

731082. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zƒp[ƒLƒ“ƒ\ƒ“•a‚̍ŐVî•ñ|f’f‚ÆŽ¡—Á|. ŒŽR˜a—˜ (_Œo“à): ‘æ5‰ñ_“ސìƒp[ƒLƒ“ƒ\ƒ“•aƒtƒH[ƒ‰ƒ€ (2015/10/9), ‰¡•l.

731083. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a/ƒp[ƒLƒ“ƒ\ƒ“ÇŒóŒQ‚ÌŒŸž‹y‚ÑŽ¡—Ã. Ž…˜aŒh (_Œo“à): ‘Š–ÍŒŽƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—ÃŒ€‹†‰ï (2015/10/13), ‘Š–ÍŒŽ.

731084. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ž©ŒÈ–Ɖu«”]‰Š‚̐_ŒoÇŒóŠw|“䂪‰ð‚«–Ÿ‚©‚³‚ê‚é‚Ü‚Å‚Ì‹ê”Y‚ÆŠ‹“¡|. ”ђˍ‚_ (_Œo“à): ‘æ4‰ñKyoto Young Kamogawa Conference (2015/10/30), ‹ž“s.

731085. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—Â̊î‘b. Ž…’G (_Œo“à): Š”Ž®‰ïŽÐƒGƒtƒs[ŽÐ“àu‰‰ (2015/11/18), “Œ‹ž.

731086. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ž•“Ë‹NŽüˆÍ‚̉ŠÇ«ŽŸŠ³‚ɂ‚¢‚Ä. ˆ¢‹v’Óñ•v (_Œo“à): ‘æ191‰ñÃ“ì_Œo’k˜b‰ï (2016/1/12), •œ’Ë.

731087. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zƒp[ƒLƒ“ƒ\ƒ“•a‚Ì–ò•šŽ¡—Á|ƒƒ`ƒSƒ`ƒ““\•tÜ‚ÌŒø‰Ê‚Æ–â‘è“_‚ðŠÜ‚߂ā|. ŒŽR˜a—˜ (_Œo“à): ƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—ÃŒ€‹†‰ï (2016/1/15), ‘Š–ÍŒŽ.

731088. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z‹}«ŠúV‹K”][ÇŽ¡—Öò‚Ì“W–]. –k‘º‰p“ñ (_Œo“à): ‘æ3‰ñ_“ސì”]‘²’†ƒRƒ“ƒ\[ƒVƒAƒ€ (2016/1/22), ‰¡•l.

731089. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Uí‚Ì•a‘Ԑ¶—. ‰Ô“‡—¥Žq (_Œo“à): ‘æ6‰ñƒp[ƒLƒ“ƒ\ƒ“•aQOL§˜b‰ï (2016/2/24), L“‡.

731090. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z‘å”]Šî’êŠj‚Ɖ^“®§Œä. ŒŽR˜a—˜ (_Œo“à): ‘æ17‰ñ_“ސìMovement DisorderƒtƒH[ƒ‰ƒ€ (2016/3/2), ‰¡•l.

731091. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ž©ŒÈ–Ɖu«”]‰Š‚É‚š‚¯‚éÅ‹ß‚Ì“®Œü. ”ђˍ‚_ (_Œo“à): ‘æ4‰ñ‘q•~_Œo–ƉuŽŸŠ³ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/3/10), ‘q•~.

732031. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šî’²u‰‰À’·) ˆã—Ñi×‚É‚š‚¯‚éR‹ÃŒÅ—Ö@. ŒŽR˜a—˜ (_Œo“à): Kanagawa Stroke Core Member Meeting (2015/4/17), ‰¡•l.

732032. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Session2Ži‰ïEClosing Remarks) ŒŽR˜a—˜ (_Œo“à): ŒÃ|Œ§‰›_Œo“à‰Èƒlƒbƒgƒ[ƒN (2015/4/21), Œú–Ø.

732033. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (À’k‰ï)yÀ’·zQOL‚ðl—¶‚µ‚œƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—Âց|CDSŽÀŒ»‚Ì‚œ‚߂̐V‚œ‚È‚é‘I‘ðŽˆ@ƒƒ`ƒSƒ`ƒ““\•tÜ|. ŒŽR˜a—˜ (_Œo“à): 2015/6/22, ‘Š–ÍŒŽ (Clinical Neuroscience ŒfÚ—\’è).

732034. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (À’k‰ïƒfƒBƒXƒJƒbƒTƒ“ƒg) QOL‚ðl—¶‚µ‚œƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—Âց|CDSŽÀŒ»‚Ì‚œ‚߂̐V‚œ‚È‚é‘I‘ðŽˆ@ƒƒ`ƒSƒ`ƒ““\•tÜ|. ’·’JìˆêŽq1, •Ÿ“c—Ï–ç2, ‰Ô“‡—¥Žq1 (1_Œo“à, 2ˆã—Éq¶Šw•”): 2015/6/22, ‘Š–ÍŒŽ (Clinical Neuroscience ŒfÚ—\’è).

732035. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÀ’·z‘êŽR—eŽq (_Œo“à): ‘æ11‰ñŽáŽè_Œo“à‰Èˆã‚Ì‚œ‚ß‚ÌPDf—ÃŽÀ‘Hƒ[ƒNƒVƒ‡ƒbƒv (2015/7/1), ‰¡•l.

732036. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŠJ‰ïˆ¥ŽA) ŒŽR˜a—˜ (_Œo“à): ‘æ1‰ñŽñ“sŒ—_ŒoŽŸŠ³ƒtƒH[ƒ‰ƒ€ (2015/9/18), Vh.

732037. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Session1)yÀ’·zNeurovascular unit‚Ì—§ê‚©‚ç‚Ý‚œ”]ŒŒŠÇáŠQ‚ÌŠî‘b‚ƗՏ°. ŒŽR˜a—˜ (_Œo“à): ‘æ1‰ñŽñ“sŒ—_ŒoŽŸŠ³ƒtƒH[ƒ‰ƒ€ (2015/9/18), Vh.

732038. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒTƒeƒ‰ƒCƒgƒVƒ“ƒ|ƒWƒEƒ€) Opening Remarks. ŒŽR˜a—˜ (_Œo“à): ‘æ2‰ñ_Œo‹Ø’Ž‰¹”gŒ€‹†‰ï (2015/11/5), ‘åã.

732039. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‘‡À’·) ŒŽR˜a—˜ (_Œo“à): Žñ“sŒ—”]‘²’†ƒlƒbƒgƒ[ƒNu‰‰‰ï (2015/12/1), ‘Š–ÍŒŽ.

732040. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŠJ‰ï‚ÌŽ«E•Â‰ï‚ÌŽ«) ŒŽR˜a—˜ (_Œo“à): •œ¬27”N“x ‘æ30‰ñ_Œo“ï•aŒ€C‰ï (2015/12/2), ‘Š–ÍŒŽ.

732041. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒŒƒNƒ`ƒƒ[) ’nˆæˆã—ØAŒg‚ðÄl‚·‚é|ÅV‚ÌŽ¡—Ö@‚ðŽó‚¯‚â‚·‚­‚·‚éˆ×‚ɐi•à‚·‚éALS‚Ö‚ÌŽ¡—Ö@‚ðŒ©˜‚Š‚ā|ƒ‰ƒWƒJƒbƒg“_“HŽ¡—ÂƑΉž/NPPV. ‰iˆä^‹MŽq (_Œo“à): •œ¬27”N“x‘æ30‰ñ_Œo“ï•aŒ€C‰ï (2015/12/2), ‘Š–ÍŒŽ.

732042. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Special Lecture)yÀ’·z‹}«Šú”]ŽåŠ²“®–¬•ÂÇ‚ɑ΂·‚錌ŠÇ“àŽ¡—Â̕à‚݂ƍŋ߂̘b‘è. ŒŽR˜a—˜ (_Œo“à): Sagami Stroke Seminar (2015/12/4), ‘Š–ÍŒŽ.

732043. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŠJ‰ï‚̈¥ŽAEˆê”ʍu‰‰)yÀ’·zƒe[ƒ}: ”]ŒŒŠÇ‚̍\‘¢‚Æ‹@”\‚©‚ç”][Ç”­Ç‹@\‚Ì‘Šˆá‚ð’T‚é. ŒŽR˜a—˜ (_Œo“à): ‘æ8‰ñ‘Š–ÍŒŽE–k—¢_Œo‰ÈŠwƒtƒH[ƒ‰ƒ€ (2015/12/7), ‘Š–ÍŒŽ.

732044. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) –Ɖu«”]_ŒoŽŸŠ³‚Ì•a‘ԂƐf’f. ”ђˍ‚_ (_Œo“à): ‘æ1‰ñMDSJ’nˆæŒ€C‰ïin Ehime (2016/2/14), ˆ€•Q.

733078. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒqƒg‘å”]‰^“®–ì‚É‚š‚¯‚é”ñNP“I‚ȃVƒiƒvƒX‰Â‘Y«‚ÌŒ€‹†. ‰Ô“‡—¥Žq (_Œo“à): ŒÃ|Œ§‰›_Œo“à‰Èƒlƒbƒgƒ[ƒN (2015/4/21), Œú–Ø.

733079. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—Â̍őOü|‚æ‚è—Ç‚¢Ž¡—Âðˆê‚ɍì‚é|. ‘êŽR—eŽq (_Œo“à): ‘æ69‰ñ–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[Žs–¯uÀ (2015/5/16), é‹Ê.

733080. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) RMOGR‘Ì‚ª‘‰t‚Ì‚Ý‚©‚猟o‚³‚ê‚œ‹}‘¬is«Ò‘‰Š‚Ì27Î’j«—á. –ö“c“ÖŽq1, ‹àŽq~‘Ÿ˜Y1, ‰iˆärs1, ‰Oˆä@—É1, ‰Ô“‡—¥Žq1, ”ђˍ‚_1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ213‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2015/6/6), “Œ‹ž, —Տ°_ŒoŠw 2015/10; 55 (10): 774.

733081. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žñ‰º‚ª‚è‚Ì‚Ý‚ð”F‚ß‚œMSA‚̈ê–UŒŸ—á. ‚‹Ž³”N, Œ–{^ˆê, “à–쏲Žq1, ‘ºŽR”É—Y (1_Œo“à): ‘æ110‰ñŠÖ“Œ—Տ°_Œo•a—§˜b‰ï(2015/7/4), “Œ‹ž.

733082. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’·ŠúŠÔ‚̗Տ°Œo‰ß‚ðŠÏŽ@‚µ“Ÿ‚œ81Î’j«ƒp[ƒLƒ“ƒ\ƒ“•a‚̈ê–UŒŸ—á. ’†–ì—Y‘Ÿ, ‹àŠÛ˜a•x, “à–쏲Žq1, “¿ŠÛˆ¢–ë, “¡ƒ–èƒŽq, ‘ºŽR”É—Y (1_Œo“à): ‘æ110‰ñŠÖ“Œ—Տ°_Œo•a—§˜b‰ï(2015/7/4), “Œ‹ž.

733083. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}‘¬‚ÈŒo‰ß‚ð‚œ‚Ç‚Á‚œ‹ØˆÞk«‘€õd‰»Ç‚̈ê—á. ˜aò—BM, “à–쏲Žq1, •“¡_•œ, Š@œ™Z (1_Œo“à): ‘æ110‰ñŠÖ“Œ—Տ°_Œo•a—§˜b‰ï(2015/7/4), “Œ‹ž.

733084. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ascites praecox‚𗈂µ‚œŽûk«S–Œ‰Š‚Ì1—á. “‡“c@Œb, H“¡Ž÷•F, ”óŒû@”£, ”у–’J”ü•ô1, Žu…Gs, ÔÎ@œ (1_Œo“à): ‘æ616‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2015/7/19), “Œ‹ž.

733085. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z‘å“®–¬ŒŽ«”]ÇðÇ‚ɑ΂·‚éV‚œ‚ÈŽ¡—Ð헪|‘ŠúÏ‹É“IŽ‰Ž¿Ž¡—Â̗L—p«|. ŒŽR˜a—˜ (_Œo“à): ESUS-SEM in Yokohama (2015/9/1), ‰¡•l.

733086. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) _ŒoBehcet•a‚Æ‚ÌŠÓ•Ê‚ð—v‚µ, RMOGR‘Ì‚ª—z«‚Å‚ ‚Á‚œRNMDAŽó—e‘Ì”]‰Š‚Ì46Î’j«—á. ˆ¢•”—L‹N1, ‘“c@—ã1, ˆä“‡‘å•ã1, ”ђˍ‚_1, ˆ¢‹v’Óñ•v1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ214‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2015/9/5), “Œ‹ž.

733087. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z•Ï‚í‚é!! ”]‘²’†—\–h. ŒŽR˜a—˜ (_Œo“à): Œ§‰›AF Network Meeting (2015/9/29), ‘Š–ÍŒŽ.

733088. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʉ‰‘è) CMT1‚ÆCIDP•¹‘¶—á‚É‚š‚¯‚éIVIg—Ö@‚ÌŒŸ“¢. ŽRè—¹, Ž…˜aŒh1 (1_Œo“à): _“ސ쌧_Œo–ƉuŽŸŠ³Šwpu‰‰‰ï (2015/10/6), ‘Š–ÍŒŽ.

733089. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)u”F’mÇv‚ÆŒŸ‚í‚ê‚œ‚ç: ‰Æ’ë‚Å‚Å‚«‚邱‚Æ. ì˜Q@•¶ (_Œo“à): ‚Ý‚ñ‚ȂƃIƒŒƒ“ƒWƒJƒtƒF (–ƒ•z’n‹æŽ–‹ÆuÀ) (2015/10/14), “Œ‹ž.

733090. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)u”F’mÇv‚ÆŒŸ‚í‚ê‚œ‚ç: ‰Æ’ë‚Å‚Å‚«‚邱‚Æ. ì˜Q@•¶ (_Œo“à): ‚Ý‚ñ‚ȂƃIƒŒƒ“ƒWƒJƒtƒF (Ôâ’n‹æŽ–‹ÆuÀ) (2015/10/21), “Œ‹ž.

733091. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Å‹ß‚̘b‘è)yÀ’·zŒŽR˜a—˜ (_Œo“à): ‘æ17‰ñ_“ސ쌧_Œo–ƉuƒtƒH[ƒ‰ƒ€ (2015/12/2), ‰¡•l.

733092. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) _Œo“ï•a‚ÌŽå—v‚ȏnjó‚ɂ‚¢‚Ä. ‰Ô“‡—¥Žq (_Œo“à): •œ¬27”N“x ‘æ30‰ñ_Œo“ï•aŒ€C‰ï (2015/12/2), ‘Š–ÍŒŽ.

733093. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zŒŽR˜a—˜ (_Œo“à): ‘æ215‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2015/12/5), “Œ‹ž.

733094. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CMT1A‚ÉCIDP—l‚Ì•a‘Ô‚ð‡•¹‚µ‚œ47Î—«—á. Ž…˜aŒh1, ‰Ô“‡—¥Žq1, ‰Oˆä@—É1, ‹ß“¡—TŽq1, –ö“c“ÖŽq1, ˆ¢‹v’Óñ•v1, ”ђˍ‚_1, ŒŽR˜a—˜1 (1_Œo“à): ‘æ215‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2015/12/5), “Œ‹ž.

733095. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚Å‚ÌCADASIL 5 Ç—á‚Ì‚Ü‚Æ‚ß. ˆä“‡‘å•ã (_Œo“à): ‘æ8‰ñ‘Š–ÍŒŽE–k—¢_Œo‰ÈŠwƒtƒH[ƒ‰ƒ€ (2015/12/7), ‘Š–ÍŒŽ.

733096. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ALS-FTD-Q‰¡’f’²ž. “n•Ó•Û—T, ˆÉ“¡@Œå, ‘«—§@³, ‘«—§–FŽ÷, ‰Ô“‡—¥Žq1, ‰¬–ì”üŒbŽq2, ŒŽR˜a—˜1, –Ø‘º‰p‹I, –‘“c“¹l, ”M“c’ŒŽ÷, “n•ÓG‹v, ‘c•ƒ]Œ³, ‹ÀêˆèŽq, Žsì”Ž—Y, ‹g–ì@‰p, ‰¡“c@C, ˜aò—BM, –î•”—El, –쌳³O, ’·’JìˆêŽq, D“c‰ë–ç, “팩Œö‹`, _’ë@œ, Â–Ø“NÆ, œA]‚ä‚€, ’†“‡Œ’“ñ (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹Æu_Œo•Ï«ŽŸŠ³—̈æ‚É‚š‚¯‚éŠî”Õ“I’²žŒ€‹†v•œ¬27”N“x”ljï‹c (2015/12/18), “Œ‹ž.

733097. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)u”F’mÇv‚̃TƒCƒ“‚É‹C‚¢‚œ‚ç. ì˜Q@•¶ (_Œo“à): ‚Ý‚ñ‚ȂƃIƒŒƒ“ƒWƒJƒtƒF (–ƒ•z’n‹æŽ–‹ÆuÀ) (2016/1/13), “Œ‹ž.

733098. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚É‚š‚¯‚é‹@”\“I’èˆÊ”]ŽèpŽ¡—ÂÆCDS‚ÌŽÀŒ». Ž…˜aŒh (_Œo“à): ƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—ÃŒ€‹†‰ï (2016/1/15), ‘Š–ÍŒŽ.

733099. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚̐³‚µ‚¢—‰ð‚ƍŐVŽ¡—Ö@. ŒŽR˜a—˜ (_Œo“à): ƒxƒlƒbƒZ‚Ì’nˆæˆã—ÃZƒ~ƒi[ (2016/3/6), ’¬“c.

733100. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “àŽ‹‹Ÿ¶ŒŸ‚É‚æ‚èf’f‚µ‚œ\“ñŽw’°Gangliocytic Palaganglioma (GP) ‚Ì1—á. ‘O‚ä‚€‚«, ”~“c’qŽq, ”óŒû@”£, ’†–ì@‰ë, ¬—с@‘ñ, íŒ@—ß, ‹ÚàV@G, —é–ØŒcˆê, ”у–’J”ü•ô1, X‰i³“ñ˜Y (1_Œo“à): ‘æ622‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2016/3/12), “Œ‹ž.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-521001. [‰ðà]y_Œo‘h¶ƒKƒCƒhƒ‰ƒCƒ“z_ŒoŒn‚Ì‘h¶‚ð—v‚·‚鎟Š³‚Æ•a‘Ô (¬l) ”]ŒŒŠÇáŠQ •aŒ^Šm’è‘O‚̏‰—Ã. ŒŽR˜a—˜ (_Œo“à): “ú–{_Œo‹~‹}Šw‰ïŽGŽ 2015/3; 27 (2): 17-8.

H26-522011. [uÀ]ySymposium 22-1: Ž©ŒÈ–Ɖu«”]‰Š‚̍ŋ߂̒mŒ©zRNMDAŽó—e‘Ì”]‰Š‚É‚š‚¯‚é—Տ°ƒXƒyƒNƒgƒ‰ƒ€‚ÆŽ¡—Ð헪: Œ»ó‚Æ–â‘è“_. ”ђˍ‚_1, ˆä“‡‘å•ã1, ‹àŽq~‘Ÿ˜Y1, ŒŽR˜a—˜1 (1_Œo“à): —Տ°_ŒoŠw 2014; 54 (12): 1098-102.

H26-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†ˆÏ‘õ”ï (“«ŽŸŠ³“™Ž•žŒ€‹†Ž–‹Æ)u‘œ”­«d‰»Ç¶‘ÌŽŽ‘ÌŽŽ—¿ƒoƒ“ƒN‚ðŠˆ—p‚µ‚œƒAƒWƒAl“Á—L‚̈â“`ŽqŠÂ‹«ˆöŽq’Tõ‚É‚æ‚é•a‘ԉ𖟁vzˆâ“`EŠÂ‹«ˆöŽqƒŠƒXƒN‰ðÍ|RNMDAŽó—e‘Ì”]‰Š‚É‚š‚¯‚鎡—Â̌»ó‚Æ–â‘è“_. ŒŽR˜a—˜1, ”ђˍ‚_1, ˆä“‡‘å•ã1, •x‰i“Þ•Û”ü1, ‹àŽq~‘Ÿ˜Y1 (1_Œo“à):Œú¶˜J“­‰ÈŠwŒ€‹†ˆÏ‘õ”ï (“«ŽŸŠ³“™Ž•žŒ€‹†Ž–‹Æ)u‘œ”­«d‰»Ç¶‘ÌŽŽ‘ÌŽŽ—¿ƒoƒ“ƒN‚ðŠˆ—p‚µ‚œƒAƒWƒAl“Á—L‚̈â“`ŽqŠÂ‹«ˆöŽq’Tõ‚É‚æ‚é•a‘ԉ𖟁v•œ¬26”N“xˆÏ‘õ‹Æ–±¬‰Ê•ñ‘ 2015/3; p.13-5.

H26-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬26”N“xŒú¶˜J“­ÈŒú¶˜J“­‰ÈŠwŒ€‹†ˆÏ‘õ”ï (“«ŽŸŠ³ŽÀ—p‰»Œ€‹†Ž–‹Æ)uƒ~ƒgƒRƒ“ƒhƒŠƒA•af—Â̎¿‚ð‚‚ß‚é, ƒŒƒWƒXƒgƒŠƒVƒXƒeƒ€‚̍\’z, f’fŠî€Ef—ÃKƒCƒhƒ‰ƒCƒ“‚̍ô’è‚š‚æ‚ѐf’fƒVƒXƒeƒ€‚̐®”õ‚ðs‚€—Տ°Œ€‹†vzƒ~ƒgƒRƒ“ƒhƒŠƒA•af—ÃKƒCƒhƒ‰ƒCƒ“‚̍ô’è. •Ä“c@œ, ’†ì³–@, ‚“ˆ@”Ž, ”ђˍ‚_1, ‹à“c‘å‘Ÿ, ŒÃ‰ê–õ•q (1_Œo“à): Œú¶˜J“­‰ÈŠwŒ€‹†ˆÏ‘õ”ï (“«ŽŸŠ³ŽÀ—p‰»Œ€‹†Ž–‹Æ)uƒ~ƒgƒRƒ“ƒhƒŠƒA•af—Â̎¿‚ð‚‚ß‚é, ƒŒƒWƒXƒgƒŠƒVƒXƒeƒ€‚̍\’z, f’fŠî€Ef—ÃKƒCƒhƒ‰ƒCƒ“‚̍ô’è‚š‚æ‚ѐf’fƒVƒXƒeƒ€‚̐®”õ‚ðs‚€—Տ°Œ€‹†v•œ¬26”N“xˆÏ‘õ‹Æ–±¬‰Ê•ñ‘ 2015/3; p.22-8.

H26-540003. [‚»‚Ì‘Œ (Œ€‹†‰ïŽ‘—¿•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹Æu_Œo•Ï«ŽŸŠ³—̈æ‚É‚š‚¯‚éŠî”Õ“I’²žŒ€‹†vz‹ØˆÞk«‘€õd‰»Ç‚š‚æ‚Ñ‘O“ª‘€“ªŒ^”F’mÇ‚É‚š‚¯‚éALS-FTD-Q’²žŒ€‹†. “n•Ó•Û—T, ‘«—§–FŽ÷, ŒŽR˜a—˜1, ‰Ô“‡—¥Žq1, ‰¬–ì”üŒbŽq2, Ž…r•v, –Ø‘º‰p‹I, ‘c•ƒ]Œ³, “n•ÓG‹v, ”M“c’ŒŽ÷, –‘“c“¹l, ‹ÀêˆèŽq, Žsì”Ž—Y, ‹g–ì@‰p, ‰¡“c@C, ’r“c@Šw, ˜aò—BM, –쌳³O, Â–ؐ³Žu, ’·’JìˆêŽq1, D“c‰ë–ç, ’†“‡Œ’“ñ (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹Æu_Œo•Ï«ŽŸŠ³—̈æ‚É‚š‚¯‚éŠî”Õ“I’²žŒ€‹†v•œ¬26”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2015/3; p.64-7.

[’˜@‘]

H16-620001. [Šwp‘ (•ª’SŽ·•M)]y–Ú‚ÅŒ©‚éƒvƒŠƒIƒ“•az”­ÇŽž‚ɍ¶•s‘S•Ð–ƒáƒ‚ð’悵‚œƒRƒhƒ“200•ÏˆÙCJD, p.62-3. ˆÉ“¡”Ž–Ÿ, ŒÃàV‰p–Ÿ, ‰¬–ì@—T1, ‰¬–ì”üŒbŽq2, Ö“¡–L˜a, ²X–ؐ^‹| (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: “’ó—Ž•F, V‹»ˆãŠwo”ÅŽÐ, “Œ‹ž, 2004/7”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H26-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Variability of quadri-pulse stimulation (QPS) induced plasticity: age effect. Hanajima R1, Tanaka N, Tsutsumi R1, Enomoto H, Abe M, Nakamura K, Kobayashi S, Hamada M, Shimizu T, Terao Y, Ugawa Y: 1st International Brain Stimulation Conference (2015/3/2-4), Singapore. (‰Ô“‡—¥Žq1, ’ç@—Á‰î1: 1_Œo“à)

H26-713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Pathological phenotype of I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family. Ohta E, Nihira T, Imaizumi Y, Akamatsu W, Nagai M1, Takahashi K, Ohyama M, Mizuno Y, Mochizuki H, Obata F, Okano H: The 12th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2015) (2015/3/19), Nice, France. (‰iˆä^‹MŽq1: 1_Œo“à)


ŒŒ‰t“à‰ÈŠw

[Šwp˜_•¶]

110142. [ŒŽ’˜] Acute leukemia during pregnancy: an investigative survey of the past 11 years. Nakajima Y, Hattori Y, Ito S, Ohshima R, Kuwabara H, Machida S, Shirasugi Y, Miyazaki K1, Sakai R, Tomita N, Ando K, Higashihara M1, Ishigatsubo Y, Fujisawa S: International Journal of Laboratory Hematology 2015/4; 37 (2): 174-80. (‹{è_“ñ1, “ŒŒŽ³–Ÿ1: 1ŒŒ‰t“à)

110040. [ŒŽ’˜] High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab. Okina S1, Yanagisawa N2, Yokoyama M1, Sakurai Y1, Numata Y3, Umezawa A3, Higashihara M4, Murakumo Y2: Int J Hematol 2015/12; 102 (6): 662-9. (‰¥@‘cœ1, –öàVM”V2, ‰¡ŽR^Šì1, ŸNˆä–õ‚1, À“c‰êŽq3, ”~‘ò“ÖŽq3, “ŒŒŽ³–Ÿ4, ‘º‰_–FŽ÷2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn, 4ŒŒ‰t“à)

110143. [ŒŽ’˜] Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia. Miyazaki K1, Koike Y, Kunishima S, Ishii R1, Danbara M1, Horie R1, Yatomi Y, Higashihara M1: Hematology 2015/12; 20 (10): 587-92. (‹{è_“ñ1, Îˆä—²Ži1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1: 1ŒŒ‰t“à)

[’˜@‘]

620062. [Šwp‘ (•ª’SŽ·•M)]y“à‰ÈŽŸŠ³‚̐f’fŠî€E•aŒ^•ª—ށEdÇ“x (“à‰È 2015”N6ŒŽ‘‘卆)z<‘æ9Í ŒŒ‰t>@“Á”­«ŒŒ¬”ÂŒž­«Ž‡”Á•a, p.1308-10. ‹{è_“ñ (ŒŒ‰t“à), “ì]“°, “Œ‹ž, 2015/6”­s.

620063. [Šwp‘ (•ª’SŽ·•M)]yAnnual Review ŒŒ‰t 2016zV. ŒŒ¬”ÂŒn@3. ITPŽ¡—Â̍őOü, p.179-90. “ŒŒŽ³–Ÿ1, ‰HŽRŒdˆÈ1, ‹{è_“ñ1 (1ŒŒ‰t“à), •Ò: ‚‹vŽj–›, ¬àVŒh–ç, ‹à‘q@÷, ¬“‡š“ñ, –î•y@—T, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2016/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713037. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Tail Mutations of MYH9 Inhibit the Disassembly of Non-muscle Myosin IIA. Miyazaki K1, Komatsu S, Jung HS, Higashihara M1, Craig R, Ikebe M: The 20th Annual Congress of the European Hematology Association (EHA) (2015/6/12), Vienna, Austria. (‹{è_“ñ1, “ŒŒŽ³–Ÿ1: 1ŒŒ‰t“à)

713038. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) BLEEDING RISK OF SURGERY IN PATIENTS WITH INHERITED PLATELET FUNCTION DISORDERS (IPFD): OUTCOME OF 389 SURGERIES IN 205 PATIENTS. Gresele P, Noris P, Orsini S, Heller P, Santoro C, Bury L, Rezan K, Mezzano D, Falcinelli E, Butta N, Cid AR, Pozo RJ, Miyazaki K1, Fabris F, Fouassier M, Flaujac C, Ozdemir CN, Otomewo O, Melazzini F, Favier R, Cattaneo M, Bussel J, De Maistre E, Henskens Y, De Candia E, Bermejo N, Schlegel N. On behalf of EHA-SWG on thrombocytopenias and platelet function disorders: 20th Congress of European Hematology Association (EHA) (2015/6/13), Vienna, Austria. (‹{è_“ñ1: 1ŒŒ‰t“à)

723058. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ñ‚Ü‚ñ«‘å×–E«B×–EƒŠƒ“ƒpŽî‚É‚š‚¯‚éDNAC•œƒ^ƒ“ƒpƒNREV7”­Œ». ‰¥@‘cœ1, –öàVM”V2, ‰¡ŽR^Šì1, À“c‰êŽq3, ”~‘ò“ÖŽq3, ‘º‰_–FŽ÷2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/4/30), –ŒŒÃ‰®.

723064. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ñ‚Ü‚ñ«‘å×–E«B×–EƒŠƒ“ƒpŽî‚É‚š‚¯‚éDNAC•œƒ^ƒ“ƒpƒNREV7”­Œ»‚Æ—\Œã‰ðÍ. ‰¥@‘cœ1, –öàVM”V2, ‰¡ŽR^Šì1, ’‡“c“TL2, ”~‘ò“ÖŽq3, À“c‰êŽq3, ˆêŒË¹–Ÿ2, Ó@¢ˆ®2, ‘º‰_–FŽ÷2, “ŒŒŽ³–Ÿ4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn, 4ŒŒ‰t“à): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8), –ŒŒÃ‰®.


ŒÄ‹zŠí“à‰ÈŠw

[Šwp˜_•¶]

110144. [ŒŽ’˜] Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations. Igawa S1, Sasaki J2, Otani S1, Ishihara M, Takakura A1, Katagiri M3, Masuda N1: Oncology 2015/9; 89 (5): 275-80. (ˆäì@‘1, ²X–ØŽ¡ˆê˜Y2, ‘å’JçŽq1, ‚‘q@W1, •Ð‹Ë^l3, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3ˆã—Éq¶Šw•”)

110145. [ŒŽ’˜] Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910. Yamada K, Saito H, Kondo T, Murakami S, Masuda N1, Yamamoto M1, Igawa S1, Katono K1, Takiguchi Y, Iwasawa S, Kurimoto R, Okamoto H, Shimokawa T, Hosomi Y, Takagi Y, Kishi K, Ohba M, Oshita F, Watanabe K: Anticancer Res 2015/12; 35 (12): 6705-11. (‰v“c“TK1, ŽR–{—ÏŽq1, ˆäì@‘1, ã‰“–쌒1: 1ŒÄ‹zŠí“à)

110146. [ŒŽ’˜] S100A16 is a Prognostic Marker for Lung Adenocarcinomas. Saito K1, Kobayashi M, Nagashio R2, Ryuge S3, Katono K3, Nakashima H4, Tsuchiya B, Jiang SX5, Saegusa M5, Satoh Y4, Masuda N3, Sato Y2: Asian Pac J Cancer Prev 2015; 16 (16): 7039-44. (âV“¡Œc¹1, ’·‰–@—º2, —Ž‰ØTˆê˜Y3, ã‰“–쌒3, ’†“‡—TN4, Ó@¢ˆ®5, ŽOŽ}@M5, ²“¡”Vr4, ‰v“c“TK3, ²“¡—Yˆê2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3ŒÄ‹zŠí“à, 4ŒÄ‹zŠíŠO, 5•a—)

110147. [ŒŽ’˜] Serum Anti-Gal-3 Autoantibody is a Predictive Marker of the Efficacy of Platinum-Based Chemotherapy against Pulmonary Adenocarcinoma. Yanagita K1, Nagashio R2, Ryuge S3, Katono K3, Jiang SX4, Tsuchiya B, Nakashima H5, Fukuda E, Goshima N, Saegusa M4, Satoh Y5, Masuda N3, Sato Y2: Asian Pac J Cancer Prev 2015; 16 (17): 7959-65. (–ö“cŒ›Œá1, ’·‰–@—º2, —Ž‰ØTˆê˜Y3, ã‰“–쌒3, Ó@¢ˆ®4, , ’†“‡—TN5, ŽOŽ}@M4, ²“¡”Vr5, ‰v“c“TK3, ²“¡—Yˆê2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3ŒÄ‹zŠí“à, 4•a—, 5ŒÄ‹zŠíŠO)

110148. [ŒŽ’˜] Clinicopathological Significance of S100A10 Expression in Lung Adenocarcinomas. Katono K1, Sato Y2, Jiang SX3, Kobayashi M, Saito K, Nagashio R2, Ryuge S1, Satoh Y4, Saegusa M3, Masuda N1: Asian Pac J Cancer Prev 2016/2; 17 (1): 289-94. (ã‰“–쌒1, ²“¡—Yˆê2, Ó@¢ˆ®3, ’·‰–@—º2, —Ž‰ØTˆê˜Y1, ²“¡”Vr4, ŽOŽ}@M3, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3•a—, 4ŒÄ‹zŠíŠO)

110149. [ŒŽ’˜] Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer. Fukui T1, Itabashi M, Ishihara M1, Hiyoshi Y1, Kasajima M1, Igawa S1, Sasaki J2, Masuda N1: BMC Cancer 2016/3; 16: 197. (•Ÿˆä•ü–ç1, ÎŒŽ–¢ŠóŽq1, “ú‹gNO1, Š}“‡^Žu1, ˆäì@‘1, ²X–ØŽ¡ˆê˜Y2, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

310013. [Ç—á•ñ] Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report. Igawa S1, Yanagisawa N2, Niwa H1, Ishihara M1, Hiyoshi Y1, Otani S1, Katono K1, Sasaki J3, Satoh Y4, Masuda N1: Oncol Lett 2015/12; 10 (6): 3519-22. (ˆäì@‘1, –öàVM”V2, ’O‰H‰p”V1, ÎŒŽ–¢ŠóŽq1, “ú‹gNO1, ‘å’JçŽq1, ã‰“–쌒1, ²X–ØŽ¡ˆê˜Y3, ²“¡”Vr4, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2•a—, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 4ŒÄ‹zŠíŠO)

320013. [Ç—á•ñ] TBLB‚ÆEBUS-TBNA‚Ì•¹—p‚ɂĐf’f‚µ“Ÿ‚œ“¯Žž«‘œ”­”xŠà‚Ì1—á. ã‰“–쌒1, ŒŽ“c^–ç1, “ú‹gNO1, Š}“‡^Žu1, ‹v•Û“cŸ1, –î“ߐ£M—Y2, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ŠÅŒìŠw•”): ‹CŠÇŽxŠw 2015/9; 37 (5): 521-5.

[’˜@‘]

620064. [Šwp‘ (•ª’SŽ·•M)]yV”Å ”xŠà“à‰Èf—Ã}ƒjƒ…ƒAƒ‹`EBM‚ÆŽÀ—Տ°‚Ì—§ê‚©‚ç`zIIIÍ ‚»‚Ì‘Œ‚̈««Žîᇁ@3-1. ˆ««‹¹–Œ’†”çŽî, 3-2. ‹¹‘BŽî¥‹¹‘BŠà, p.152-9. ÎŒŽ–¢ŠóŽq1, ˆäì@‘1 (1ŒÄ‹zŠí“à), ŠÄC: ŽR–{M”V, •Ò: ÔŒO˜N, h’JˆÐm, ŽO‰Y@—, çݎL’m, ˆã–òƒWƒƒ[ƒiƒ‹, ‘åã, 2015/4”­s.

620065. [Šwp‘ (–|–óE•ª’SŽ·•M)]yƒŒƒbƒNƒi[ŒÄ‹zŠíŠwzII•Ò: ŒÄ‹zŠíŽŸŠ³Š³ŽÒ‚Ì•]‰¿@14Í Šî–{“I‹¹•”fŽ@‚ÌŽÀ‘H‚ƉðŽß, p.125-32. ‹v•Û“cŸ (ŒÄ‹zŠí“à), ŠÄ–ó: •Ÿ’n‹`”V•, –{ŠÔ¶•v, ŠÛ‘Po”Å, “Œ‹ž, 2015/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722055. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŒÄ‹z‹@”\ŒŸžŽw•W‚Ì–â‘è“_ (V‚µ‚¢³í’l‚₶‚ñ”x–@‚Æ‚ÌŠÖ˜A‚ðŠÜ‚ß‚Ä). ‹v•Û“cŸ (ŒÄ‹zŠí“à): ‘æ55‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2015/4/18), “Œ‹ž.

722056. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰‰ñŽ¡—Âɂš‚¯‚éEGFR-TKI‚ÌŽg‚¢•ª‚¯. ˆäì@‘ (ŒÄ‹zŠí“à): ‘æ56‰ñ“ú–{”xŠàŠw‰ïŠwpW‰ï (2015/11/26), ‰¡•l.

723268. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠis”xŠà‚ɑ΂·‚鉻Šw•úŽËü—Ö@Œø‰Ê‚ÌEGFRˆâ“`Žq•ÏˆÙ‚Ì—L–³‚Å‚Ì”äŠr. ÎŒŽ–¢ŠóŽq, ˆäì@‘1, –Ø‘º”ü’qŽq, Š}“‡^Žu1, “ú‹gNO1, ‘å’JçŽq1, ã‰“–쌒1, —Ž‰ØTˆê˜Y1, •Ÿˆä•ü–ç1, ŽO“¡@‹v2, ‹v•Û“cŸ1, ²X–ØŽ¡ˆê˜Y3, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ŠÅŒìŠw•”, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ55‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2015/4/17), ‹ž“s.

723269. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒGƒNƒ\ƒ][ƒ€ŠÜ—L’`”’Ž¿‚ð–ƉuŒ¹‚ɍ쐻‚µ‚œR‘Ì‚Ì”x‘BŠà‚É‚š‚¯‚錌Žf’fƒ}[ƒJ[‚Æ‚µ‚Ä‚Ì—L—p«‚ɂ‚¢‚Ä. ’·‰–@—º, –ö“cŒ›Œá, ”«‘º˜a’j, —Ž‰ØTˆê˜Y1, Ó@¢ˆ®2, ’†“‡—TN3, “y‰®g, ‘º‰_–FŽ÷2, ŽOŽ}@M2, ²“¡—Yˆê (1ŒÄ‹zŠí“à, 2•a—, 3ŒÄ‹zŠíŠO): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/4/30), –ŒŒÃ‰®.

723270. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒgƒŠƒVƒ“2ŽŸŒ³“d‹C‰j“®–@‚É‚æ‚èŠl“Ÿ‚µ‚œS100A16ƒ^ƒ“ƒpƒNŽ¿‚̐V‹K”x‘BŠà—\Œã—\‘ªƒ}[ƒJ[‚Æ‚µ‚Ä‚Ì—L—p«. Ä“¡Œc‘¿, ¬—с@M, ’·‰–@—º, ”«‘º˜a’j, ‰v“c“TK1, ²“¡”Vr2, Ó@¢ˆ®3, ‘º‰_–FŽ÷3, ŽOŽ}@M3, ²“¡—Yˆê (1ŒÄ‹zŠí“à, 2ŒÄ‹zŠíŠO, 3•a—): ‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï (2015/5/1), –ŒŒÃ‰®.

723271. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”A“ŏǐ«‹¹–Œ‰Š‚É‚š‚¯‚é‹ÇŠ–ƒŒ‰º‹¹o‹ŸŒŸž‚̈Ӌ`. •Ÿˆä•ü–ç1, ŽO“¡@‹v2, ÎŒŽ–¢ŠóŽq, Š}“‡^Žu1, “ú‹gNO1, ‘å’JçŽq1, ã‰“–쌒1, ‚‘q@W1, ˆäì@‘1, ‰¡ê³“T3, ‹v•Û“cŸ1, •Ð‹Ë^l3, –î“ߐ£M—Y2, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ŠÅŒìŠw•”, 3ˆã—Éq¶Šw•”): ‘æ38‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŠwpW‰ï (2015/6/12), “Œ‹ž.

723272. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Evaluation of gefitinib efficacy according to body surface area in patients with NSCLC harboring an EGFR mutation. Š}“‡^Žu1, ˆäì@‘1, ÎŒŽ–¢ŠóŽq, –Ø‘º”ü’qŽq, “팎­ˆê˜Y1, ŒŽ“c^–ç1, ‘å’JçŽq1, ã‰“–쌒1, ²X–ØŽ¡ˆê˜Y2, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ13‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï (2015/7/18), ŽD–y.

723273. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰»Šw—Ö@–¢Ž{s‚—îŽÒispŒãÄ”­”xG•œã”çŠà‚ɑ΂·‚éƒlƒ_ƒvƒ‰ƒ`ƒ“’PÜ—Ö@‚Ì‘æII‘ŠŽŽŒ±. ‘Ÿ—Ç“N•F, h’JˆÐl, ŽO‰Y@—, ¬•éŒ[l, ˆäì@‘1, ŽR–{M”V, ‚‹Ž—˜–Ÿ (1ŒÄ‹zŠí“à): ‘æ56‰ñ“ú–{”xŠàŠw‰ïŠwpW‰ï (2015/11/28), ‰¡•l.

733101. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒžŠŽì—Ö@‚É‚æ‚莡—ÃŒp‘±‚ª‰Â”\‚Æ‚È‚Á‚œƒAƒŒƒNƒ`ƒjƒu‚É‚æ‚é–ò]‚̈ê—á. ”’àV¹”V1, ‹v•Û“cŸ1, ’O‰H‰p”V1, ‚‘q@W1, ‰¡ê³“T2, –î“ߐ£M—Y3, ‰v“c“TK1, “n‘\@W (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”): ‘æ174‰ñ“ú–{”xŠàŠw‰ïŠÖ“ŒŽx•”ŠwpW‰ï (2015/12/5), “Œ‹ž.

733102. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ‘ŸŠí‚É•a•Ï‚ð—L‚µ‹}«‘ˆ«‚𗈂µ‚œƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ”’àV¹”V1, ’†ŒŽ‘P˜N1, ‘O‘ºŒ’Ž¡, ŒŽ“c^–ç1, ’O‰H‰p”V1, ÎŒŽ–¢ŠóŽq, Š}“‡^Žu1, “ú‹gNO1, ‹v•Û“cŸ1, ‰v“c“TK1 (1ŒÄ‹zŠí“à): ‘æ621‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2016/2/13), “Œ‹ž.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-110008. [ŒŽ’˜] Prognostic significance of MYH9 expression in resected non-small cell lung cancer. Katono K1, Sato Y2, Jiang SX3, Kobayashi M, Nagashio R2, Ryuge S1, Fukuda E, Goshima N, Satoh Y4, Saegusa M3, Masuda N1: PLoS One 2015/3; 10 (3): e0121460. (ã‰“–쌒1, ²“¡—Yˆê2, Ó@¢ˆ®3, ’·‰–@—º2, —Ž‰ØTˆê˜Y1, ²“¡”Vr4, ŽOŽ}@M3, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3•a—, 4ŒÄ‹zŠíŠO)


“à•ª”å‘ãŽÓ“à‰ÈŠw

[Šwp˜_•¶]

110150. [ŒŽ’˜] Regulation of growth hormone secretion by (pro)renin receptor. Tani Y1, Yamada S, Inoshita N, Hirata Y, Shichiri M1: Sci Rep 2015/6; 5: 10878. (’J@—SŽŠ1, Žµ—¢áÁ‹`1: 1“à•ª”å‘ãŽÓ“à)

110151. [ŒŽ’˜] SGLT2 inhibitors provide an effective therapeutic option for diabetes complicated with insulin antibodies. Hayashi A1, Takano K1, Kawai S1, Shichiri M1: Endocr J 2016/2; 63 (2): 187-91. (—с@“N”Í1, ‚–ìK˜H1, ‰Í‡¹—FŠó1, Žµ—¢áÁ‹`1: 1“à•ª”å‘ãŽÓ“à)

110152. [ŒŽ’˜] Contrasting effects of stanniocalcin-related polypeptides on macrophage foam cell formation and vascular smooth muscle cell migration. Yamamoto K, Tajima Y, Hasegawa A, Takahashi Y, Kojima M, Watanabe R, Sato K, Shichiri M1, Watanabe T: Peptides 2016/8; 82: 120-7. (Žµ—¢áÁ‹`1: 1“à•ª”å‘ãŽÓ“à)

120012. [ŒŽ’˜] VŠî€GDM”D•w‚ɑ΂·‚錌“œŽ©ŒÈ‘ª’è (SMBG) “±“ü‚Ì—L‰v«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Žsì—‹Žt1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): “œ”A•a‚Æ”DP, 2016; 16 (1): 11-6.

320014. [Ç—á•ñ] Žö“û‚É‚æ‚錌“œ’ቺ‚ðCGM‚ÅŠm”F‚µ“Ÿ‚œCSIIŽg—p’†1Œ^“œ”A•a‚Ì2Ç—á. “‰€@–Ÿ1, Žsì—‹Žt1, ‰Í‡¹—FŠó1, ¯ŽRˆ»Žq1, ˆäãŒõŽq1, —é–Ø—z•F1, ³–ØŽkl1, ‚ˆä‹vm—f1, ŽRŠÝ‹M—m1, ¬ì“Õ˜Y1, —с@“N”Í1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): “œ”A•a‚Æ”DP 2016; 16 (1): 66-71.

[’˜@‘]

620066. [Šwp‘ (•ª’SŽ·•M)]y“ìŽR“°ˆãŠw‘厫“T ‘æ20”Łz‚”AŽ_ŒŒÇ, ‘Œ, p.816, ‘Œ. Žµ—¢áÁ‹` (“à•ª”å‘ãŽÓ“à), “ìŽR“°, “Œ‹ž, 2015/4”­s.

620067. [Šwp‘ (•ª’SŽ·•M)]y‚₳‚µ‚¢äXEÁ‰»ŠÇ_Œo“à•ª”åŽîᇠ–ò•šŽ¡—Âւ̃Aƒvƒ[ƒ`zII. ‰uŠwEf’f@2. äXEÁ‰»ŠÇ_Œo“à•ª”åŽîᇂ̗Տ°Çó‚Ɛf’f, p.16-24. ‚–ìK˜H (“à•ª”å‘ãŽÓ“à), •Ò: ‰œâ‘ñŽu, ˆã–òƒWƒƒ[ƒiƒ‹, ‘åã, 2015/5”­s.

620068. [Šwp‘ (•ª’SŽ·•M)]y¡“ú‚̏¬Ž™Ž¡—ÃŽwj (‘æ16”Å)z7. “à•ª”原Š³@ƒgƒ‰ƒ“ƒWƒVƒ‡ƒ“Šú‚̉º‚‘Ì‹@”\’ቺÇ‚Æ•›t‰ßŒ`¬Ç‚ÌŽ¡—Ã, p.260-1. ‚–ìK˜H (“à•ª”å‘ãŽÓ“à), ‘•ÒW: …Œû@‰ë, Žs‹Ž@Œõ, èŽR@O, ˆãŠw‘‰@, “Œ‹ž, 2015/9”­s.

620069. [Šwp‘ (•ª’SŽ·•M)]yƒNƒbƒVƒ“ƒOÇŒóŒQf—Ã}ƒjƒ…ƒAƒ‹ ‰ü’ù‘æ2”ŁzIII. —Տ°•Ò (Še˜_)@A. ACTHˆË‘¶«ƒNƒbƒVƒ“ƒOÇŒóŒQ@4. ƒNƒbƒVƒ“ƒO•a‚ÌŠÖ˜AŽŸŠ³@f. ˆâ“`«ƒNƒbƒVƒ“ƒOÇŒóŒQ (MEN, MAS), p.133-5. ‚–ìK˜H (“à•ª”å‘ãŽÓ“à), •Ò: •œ“cŒ‹Šì, ¬£Œõ‰h, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/12”­s.

620070. [Šwp‘ (•ª’SŽ·•M)]yƒNƒbƒVƒ“ƒOÇŒóŒQf—Ã}ƒjƒ…ƒAƒ‹ ‰ü’ù‘æ2”ŁzIII. —Տ°•Ò (Še˜_)@B. ACTH”ñˆË‘¶«ƒNƒbƒVƒ“ƒOÇŒóŒQ@4. ƒNƒbƒVƒ“ƒOÇŒóŒQ‚ÌŠÖ˜AŽŸŠ³@c. PPNAD, p.213-5. ‚–ìK˜H (“à•ª”å‘ãŽÓ“à), •Ò: •œ“cŒ‹Šì, ¬£Œõ‰h, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/12”­s.

[Šw‰ïEŒ€‹†‰ï“™]

723274. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) dÇ¬l¬’·ƒzƒ‹ƒ‚ƒ“•ª”å•s‘SÇ‚ɑ΂·‚鐬’·ƒzƒ‹ƒ‚ƒ“•â[—Ö@‚É‚æ‚éˆÀÃŽž‘ãŽÓ—Ê, ‘Ì‘g¬•Ï‰»‚ÌŒŸ“¢. —с@“N”Í1, ‚–ìK˜H1, “‰€@–Ÿ1, ‰Í‡¹—FŠó1, ŠC£ˆ»Žq1, ˆäãŒõŽq1, —é–Ø—z•F1, Žsì—‹Žt1, Š™“c—T“ñ1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ88‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2015/4/23-25), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŽGŽ 2015/4; 91 (1): 268.

723275. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 2‰ñ‚ÌŽ©‘R”DP•ª•Ø‚ðŒoŒ±‚µ‚œ‰–—Þ‘rŽžŒ^æ“V«•›t‰ßŒ`¬‚Ì1—á. ˆäãŒõŽq1, Š™“c—T“ñ1, —é–Ø—z•F1, –öàV^ŽÀ1, —с@“N”Í1, Žsì—‹Žt1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ88‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï(2015/4/23-25), “Œ‹ž, 2015/4; 91 (1): 339.

723276. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “¯‘€•›t‚ɃAƒ‹ƒhƒXƒeƒƒ“ŽY¶‘BŽî (APA) ‚Æaldosterone-producing cell cluster (APCC) ‚ð”F‚ß‚œŒŽ”­«ƒAƒ‹ƒhƒXƒeƒƒ“Ç (PA) ‚ɃRƒ‹ƒ`ƒ][ƒ‹‰ßè•ª”å‚𔺂Á‚œ1—á. ‰Í‡¹—FŠó1, ŽRŠÝ‹M—m1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ88‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2015/4/23-25), “Œ‹ž, 2015/4; 91 (1): 365.

723277. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒCƒ“ƒXƒŠƒ“—Ö@Ž{s’†‚̔얞‡•¹2Œ^“œ”A•a‚ɑ΂·‚éƒ_ƒpƒOƒŠƒtƒƒWƒ“‚ÌŒø‰Ê‚ð‚Ý‚œ2—á. Vˆä—œˆß“ß1, —с@“N”Í1, ŽRŠÝ‹M—m1, Žsì—‹Žt1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ88‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2015/4/23-25), “Œ‹ž, 2015/4; 91 (1): 392.

723278. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) dÇ¬l¬’·ƒzƒ‹ƒ‚ƒ“•ª”å•s‘SÇ‚ɑ΂·‚鐬’·ƒzƒ‹ƒ‚ƒ“•â[—Ö@‚É‚æ‚é“œ‘ãŽÓEŽ‰Ž¿‘ãŽÓ•Ï‰»‚ÌŒŸ“¢. ‚–ìK˜H1, —с@“N”Í1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/21-24), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-228.

723279. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽYŒã‚Ì“œ‘ãŽÓˆÙí‚Ì•]‰¿‚Í75gOGTT‚Å‚æ‚¢‚©`Continuous Glucose Monitoring (CGM) ‚É‚æ‚錟“¢`. ²X–ØŽÑ–ç‰Á1, —с@“N”Í1, ŠC£ˆ»Žq1, Žsì—‹Žt1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/21-24), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-274.

723280. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) CGM‚ð—p‚¢‚œ“œ‘ãŽÓˆÙí‡•¹”D•w‚̐HŒãŒŒ“œpeakŽžŠÔ‚ÌŒŸ“¢`³í‘Ï“œ”\”D•w‚Æ‚Ì”äŠr`. –öàV^ŽÀ1, —с@“N”Í1, ²X–ØŽÑ–ç‰Á1, ‹g–쉑”ü2, Žsì—‹Žt1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/21-24), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-274.

723281. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒCƒ“ƒXƒŠƒ“—Ö@’†‚̔얞2Œ^“œ”A•a5—á‚ւ̃_ƒpƒOƒŠƒtƒƒWƒ“‚ÌŒŒ“œ•Ï“®E‘Ì‘g¬•Ï‰»E”A“œ”rŸ•—ʕω»‚ÌŒŸ“¢. ŽRŠÝ‹M—m1, Vˆä—œˆß“ß1, —с@“N”Í1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/21-24), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-296.

723282. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‚—p—ÊSU–òŽg—pŠ³ŽÒ‚É‚š‚¯‚é, ƒŒƒpƒOƒŠƒjƒh‚𒆐S‚Æ‚µ‚œƒƒgƒzƒ‹ƒ~ƒ“, ƒrƒ‹ƒ_ƒOƒŠƒvƒ`ƒ“‚Ì•¹—pŽ¡—Âւ̕ύX‚ÉŠÖ‚·‚é52TŠÔ‚ÌŒŸ“¢. ‰Í‡¹—FŠó1, —с@“N”Í1, ‚ˆä‹vm—f1, Žsì—‹Žt1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/21-24), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-299.

723283. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) CGM‚Å–Ÿ‚ç‚©‚Æ‚È‚Á‚œ“œ”A•aŒŒ‰t“§ÍŠ³ŽÒ‚ÌŒŒs“®‘Ô‚Ì“Á’¥. —с@“N”Í1, —é–Ø—z•F1, ³–ØŽkl1, ‚ˆä‹vm—f1, ¬ì“Õ˜Y1, ¬ìŒ°Žj2, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/21-24), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-329.

723284. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’ጌ“œ‚ðŽå‘i‚É–k—¢‘åŠw•a‰@‚ð‹Ù‹}Žóf‚µ‚œŠ³ŽÒ‚Ì‹ß”N‚̗Տ°“I“Á’¥. ‘º“cH•ä1, —с@“N”Í1, “‰€@–Ÿ1, ˆäãŒõŽq1, ç“c«”n1, Žsì—‹Žt1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/21-24), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-448.

723285. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚ÅŒoŒ±‚µ‚œRbó‘B–ò‚É‚æ‚é–³è÷—±‹…Ç‚̗Տ°“I“Á’¥. ¯ŽRˆ»Žq1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ58‰ñ“ú–{bó‘BŠw‰ïŠwpW‰ï (2015/11/5-7), •Ÿ“‡, “ú–{“à•ª”åŠw‰ïŽGŽ, 2015; 91 (Suppl): 91.

723286. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 2Œ^“œ”A•a‡•¹”D•w‚Ì•ª•Ø‘OŒã‚̃Cƒ“ƒXƒŠƒ“Žù—v—ʂ̕ω». Žsì—‹Žt1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ31‰ñ“ú–{“œ”A•aE”DPŠw‰ï”NŽŸŠwpW‰ï (2015/11/20-21), “Œ‹ž, “œ”A•a‚Æ”DP 2015/10; 15 (2): S72.

723287. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽYŒã‚Ì“œ‘ãŽÓˆÙí‚Ì•]‰¿‚Æ‚µ‚ăOƒŠƒRƒAƒ‹ƒuƒ~ƒ“‚Ì—L—p«`CGM‚É‚æ‚錟“¢`. ²X–ØŽÑ–ç‰Á1, —с@“N”Í1, “‰€@–Ÿ1, ‰Í‡¹—FŠó1, ‰«èiˆê˜Y1, Žsì—‹Žt1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ31‰ñ“ú–{“œ”A•aE”DPŠw‰ï”NŽŸŠwpW‰ï (2015/11/20-21), “Œ‹ž, “œ”A•a‚Æ”DP 2015/10; 15 (2): S85.

723288. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”A•öÇ‚Ì’·ŠúŒo‰ßŠÏŽ@’†‚ɈƏã•a•Ï‚ª‹}‘¬‚É‘‘債‚œˆê—á. “‰€@–Ÿ1, ³–ØŽkl1, ˆäãŒõŽq1, ç“c«”n1, —с@“N”Í1, ‰«èiˆê˜Y1, Žsì—‹Žt1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1, ˆä‰º®Žq, ŽR“c³ŽO (1“à•ª”å‘ãŽÓ“à): ‘æ25‰ñ—Տ°“à•ª”å‘ãŽÓUpdate (2015/11/27-28), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŽGŽ, 2015; 91: 788.

723289. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •ÏŒ`«ŒÒŠÖßÇ‚Å”­Œ©‚³‚ê‚œ‰Æ‘°«‰º‚‘Ì‘BŽî‚ª‹^‚í‚ê‚é1—á. ˆäãŒõŽq1, Žsì—‹Žt1, ‰Í‡¹—FŠó1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ25‰ñ—Տ°“à•ª”å‘ãŽÓUpdate (2015/11/27-28), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŽGŽ, 2015; 91: 789.

723290. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “«–«äX‰Š‹}«‘ˆ«‚É‚æ‚éäX‰tᑂð”F‚ß‚œMEN1Œ^‚̈ê—á. “cŒû@•ü1, ç“c«”n1, Vˆä—œˆß“ß1, ‘º“cH•ä1, ‰Í‡¹—FŠó1, “‰€@–Ÿ1, ˆäãŒõŽq1, ³–ØŽkl1, —с@“N”Í1, ‰«èiˆê˜Y1, Žsì—‹Žt1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ25‰ñ—Տ°“à•ª”å‘ãŽÓUpdate (2015/11/27-28), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŽGŽ, 2015; 91: 833.

723291. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “û`•ª”å•s‘S‚ðŒ_‹@‚ɐf’f‚³‚ê‚œƒŠƒ“ƒp‹…«‰º‚‘̉Š‚Ì1—á. Vˆä—œˆß“ß1, Š™“c—T“ñ1, —é–Ø—z•F1, ŽRŠÝ‹M—m1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ25‰ñ—Տ°“à•ª”å‘ãŽÓUpdate (2015/11/27-28), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŽGŽ, 2015; 91: 844.

723292. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) RathkeùN–E‚Æ‚ÌŠÓ•Ê‚É‹ê—¶‚µ‚œ, “ªŠWˆô“ªŽîEŠáâ|æ’[•”Ž‹_Œo‰Š‚̍‡•¹—á. ³–ØŽkl1, ‚–ìK˜H1, ŽR“c³ŽO, ˆä‰º®Žq (1“à•ª”å‘ãŽÓ“à): ‘æ26‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2016/2/19-20), •Ÿ“‡.

732045. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) 1Œ^“œ”A•aCSIIÇ—á‚É‚š‚¯‚éŽö“û’†‚ÌŒŒ“œ“®‘Ô. Žsì—‹Žt1, “‰€@–Ÿ1, —с@“N”Í1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ21‰ñ“ú–{¬Ž™EŽvtŠú“œ”A•aŒ€‹†‰ï”NŽŸŠwpW‰ï (2015/7/12), “Œ‹ž, ‘æ21‰ñ“ú–{¬Ž™EŽvtŠú“œ”A•aŒ€‹†‰ï”NŽŸŠwpW‰ïƒvƒƒOƒ‰ƒ€Eu‰‰—vŽ| 2015; p.21-2.

733103. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒWƒAƒ]ƒLƒTƒCƒh‚ŔČŒ‹…Œž­‚ð‚«‚œ‚µ‚œƒCƒ“ƒXƒŠƒm[ƒ}‚Ì1—á. ¬–ì‘וœ, ç“c«”n1, ²X–ØŽÑ–ç‰Á1, ŠC£ˆ»Žq1, ŽRŠÝ‹M—m1, ‰«èiˆê˜Y1, Žsì—‹Žt1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à)F‘æ615‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï—á‰ï (2015/6/13), “Œ‹ž.

733104. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 2Œ^“œ”A•a‚ð”wŒi‚ɍ‚—î‚Å”­Ç‚µ‚œbó‘BŽ©ŒÈR‘Ì—z«, Œ€Ç1Œ^“œ”A•a‚Ì1—á. Vˆä—œˆß“ß1, Žsì—‹Žt1, ‹à‘ò@, ŠC£ˆ»Žq1, “‰€@–Ÿ1, —é–Ø—z•F1, —с@“N”Í1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ32‰ñ_“ސ쓜”A•aŒ€‹†‰ï (2015/6/27), ‰¡•l.

733105. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) RathkeùN–E‚Æ‚ÌŠÓ•Ê‚É‹ê—¶‚µ‚œ, “ªŠWˆô“ªŽîEŠáâ|æ’[•”Ž‹_Œo‰Š‚̍‡•¹—á. ³–ØŽkl1, ‚–ìK˜H1, “cŒû@•ü1, ‰Í‡¹—FŠó1, “‰€@–Ÿ1, Š™“c—T“ñ1, ˆä‰º®Žq, ŽR“c³ŽO, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ16‰ñ“ú–{“à•ª”åŠw‰ïŠÖ“ŒbM‰zŽx•”ŠwpW‰ï (2015/9/25-26), –‹’£.

733106. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˜•”Ò’ŒŠÇ‹·óÇ‚É‚æ‚茰«‰»‚µ, •‰‰×ŽŽŒ±‚ƈâ“`ŽqŒŸõ‚ÅŠm’èf’f‚Å‚«‚œ‚—îŽÒGitelmanÇŒóŒQ‚Ì1—á. ˆäãŒõŽq1, —с@“N”Í1, “‰€@–Ÿ1, Š™“c—T“ñ1, ‚–ìK˜H1, –ì’Ê°‘å, ”Ñ“‡ˆêœ, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ16‰ñ“ú–{“à•ª”åŠw‰ïŠÖ“ŒbM‰zŽx•”ŠwpW‰ï (2015/9/25-26), –‹’£.

733107. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹‘å‘BŽî—lbó‘BŽî‚É‚æ‚è‹C“¹‹·ó‚𗈂µ‚œ1Œ^“œ”A•a‡•¹Ž©ŒÈ–Ɖu«‘œ“à•ª”å‘BÇŒóŒQ‚Ì1—á. ¬ã–ž—¢ŠG, “cŒû@•ü1, —с@“N”Í1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ619‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï—á‰ï (2015/11/14), “Œ‹ž.

733108. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 2Œ^“œ”A•a‚ð”wŒi‚ɍ‚—î‚Å”­Ç‚µ‚œbó‘BŽ©ŒÈR‘Ì—z«, Œ€Ç1Œ^“œ”A•a‚Ì1—á. Vˆä—œˆß“ß1, Žsì—‹Žt1, ŠC£ˆ»Žq1, —é–Ø—z•F1, —с@“N”Í1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2016/1/23), ‰¡•l.

733109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ‰ƒ“ƒŒƒIƒ`ƒh‚É‚æ‚éƒCƒ“ƒXƒŠƒ“•ª”å’ቺ, ‚ŒŒ“œ‚ð”F‚ß‚œæ’[‹‘åÇ‚Ì1—á. –öàV^ŽÀ1, ˆäãŒõŽq1, ‰Í‡¹—FŠó1, “‰€@–Ÿ1, Š™“c—T“ñ1, ‚–ìK˜H1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2016/1/23), ‰¡•l.


t‘Ÿ“à‰ÈŠw

[Šwp˜_•¶]

110153. [ŒŽ’˜] Curative haploidentical BMT in a murine model of X-linked chronic granulomatous disease. Takeuchi Y1, Takeuchi E2, Ishida T, Onodera M, Nakauchi H, Otsu M: Int J Hematol 2015; 102 (1): 111-20. (’|“àN—Y1, ’|“àŒb”üŽq2: 1t‘Ÿ“à, 2–Ɖu)

110154. [ŒŽ’˜] Incidence and clinical significance of anti-moesin autoantibodies in small-vessel vasculitis. Murano J1, Kamata K1, Naito S1, Okamoto T1, Kamata M1, Okina C1, Sano T1, Takeuchi Y1, Aoyama T1: Kitasato Med J 2015/9; 45 (2): 105-13. (‘º–쏇–ç1, Š™“cvšæ1, “à“¡³‹g1, ‰ª–{’qŽq1, Š™“c^—Žq1, ‰¥çŽq1, ²–ì@—²1, ’|“àN—Y1, ÂŽR“ŒŒÜ1: 1t‘Ÿ“à)

120013. [ŒŽ’˜] tŽŸŠ³‚É‚š‚¯‚é”DPŠÇ—|–«t‘Ÿ•a (CKD) Š³ŽÒ‚Ì”DP‚ƏoŽY34—á‚ÌŒoŒ±|. Š™“cvšæ1, “V–ì@Š®2, ’|“àN—Y3, ’·ê@‘×3, ²–ì@—²3, ÂŽR“ŒŒÜ3, “¡“c˜aŒÈ, Ž…Œ’Žj, –q–앐Žu, ‹Ž–{ƒqƒƒR3, ’†–ì‘fŽq, “à“¡³‹g3, ‰ª–{’qŽq3, ‘º–쏇–ç3, ‰¥çŽq3, Š™“c^—Žq3, ‹{àV¹Žq, ¬ì‚Ý‚ä‚«4, ŽðˆäŒ’Žj3, Š™“c•‡”ü3 (1‘Š–Í‘å–ì“à‰ÈEtƒNƒŠƒjƒbƒN, 2ŽY‰È, 3t‘Ÿ“à, 4‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): t‚Æ“§Í 2015/11; 79 (5): 782-5.

120014. [ŒŽ’˜] “§Í“±“üŠú‚É‚š‚¯‚éƒNƒGƒ“Ž_‘æ“ñ“S…˜a•š (ƒŠƒIƒiÒ) ‚̃Šƒ“ŠÇ—‚š‚æ‚Ñ•nŒŒ‚ɑ΂·‚é—Տ°Œø‰Ê. ’·ê@‘×1,2, ‘º–쏇–ç1,2, Š™“c^—Žq1,2, “‡“c–F—²1,2, –q–앐Žu, ’·ê@G, –ìXŒû”ŽŽj1, “‡“c@”£ (1–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“à): V–ò‚ƗՏ° 2015/9; 64(9): 983-9.

220005. [€ŒŽ’˜] Œ©‚鎉Ž¿‚̃y[ƒWqŽ‰Ž¿‘ãŽÓˆÙírLCATŒ‡‘¹Ç‚ÌŠp–ŒŠŒ©‚Ɛt‘gD•a•Ï‚Ì“Á’¥. “à“¡³‹g1, Š™“cvšæ1 (1t‘Ÿ“à): The Lipid 2015/4; 26 (2): 96-9.

320015. [Ç—á•ñ] ŒŒ‰t“§Í“±“üŽž‚É‚Ý‚ç‚ê‚œ‹U«”xÇðÇ‚𔺂€ƒwƒpƒŠƒ“‹Nˆö«ŒŒ¬”ÂŒž­Ç (HIT) ‚Ì1—á. “n˜ð—œŽÑŽq1, ÂŽR“ŒŒÜ1, Š™“c^—Žq1, ‹{àV¹Žq1, ¬ì‚Ý‚ä‚«2, ‰¥çŽq, ‘º–쏇–ç1, “c’†@Œ\, ÂŽR‰ë‘¥, ’†–ì‘fŽq, ²–ì@—²1, Š™“cvšæ1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{t‘ŸŠw‰ïŽ 2015/10; 57 (7): 1248-52.

320016. [Ç—á•ñ] ŒŒ«‹¹…‚ð’悵‹¹o‹Ÿ‰º‹¹–Œ¶ŒŸ‚É‚Ä”A“ŏǐ«‹¹–Œ‰Š‚Ɛf’f‚µ‚œˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚Ì3—á. ²–ì@—²1, ‚‹Ž@—É1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, ¬ì‚Ý‚ä‚«2, Š™“c^—Žq1, ‘º–쏇–ç1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ’|“àN—Y1, ‚‘q@W3, ŽO“¡@‹v4, Š™“cvšæ5 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ŒÄ‹zŠí“à, 4ŠÅŒìŠw•”, 5‘Š–Í‘å–ì“à‰ÈEtƒNƒŠƒjƒbƒN): “§Í‰ïŽ 2016/3; 49 (3): 233-9.

522095. [uÀ] yŒ©‚鎉Ž¿‚̃y[ƒW <Ž‰Ž¿‘ãŽÓˆÙí>zLCATŒ‡‘¹Ç‚ÌŠp–ŒŠŒ©‚Ɛt‘gD•a•Ï‚Ì“Á’¥. “à“¡³‹g1, Š™“cvšæ1 (1t‘Ÿ“à): The Lipid 2015/4; 26 (2): 4-7.

522096. [uÀ] ˆÚAŠ³ŽÒ‚ւ̉h—{Žw“±‚̏d—v«|“à‰Èˆã‚Ì—§ê‚©‚ç|. “à“¡³‹g1, ’|“àN—Y1 (1t‘Ÿ“à): Current Issues in Nutriton 2015; 28: 3-4.

522097. [uÀ]y“ÁW: “d‰ðŽ¿‚̐V‚µ‚¢Œ©•ûEl‚Š•ûz [Ž_‰–Šîƒoƒ‰ƒ“ƒX‚Æ“d‰ðŽ¿ˆÙí]@‘ãŽÓ«ƒAƒVƒh[ƒVƒX‚ƃJƒŠƒEƒ€ˆÙí. –ìXŒû”ŽŽj1, ’·ê@‘×1,2, “‡“c–F—²1,2, “‡“c@”£ (1–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“à): t‚Æ“§Í 2016/3; 80 (3): 375-8.

[Šw‰ïEŒ€‹†‰ï“™]

713039. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The Glomerular Parietal Epithelial Cell Phenotype Depends On SPARC Levels. Naito S1: American Society of Nephrology (ASN) Kidney Week 2015 ( 2015/11/5), San Diego, USA. (“à“¡³‹g1: 1t‘Ÿ“à)

723293. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –«t‘Ÿ•a (CKD) Š³ŽÒ‚É‚š‚¯‚éFebuxostat‚ÌŒø‰Ê‚ɂ‚¢‚Ä. ³–Ø‹M‹³1, ÂŽR“ŒŒÜ1, ‚‹Ž@—É1, “‡“c–F—²1, ‹{àV¹Žq1, ‰ª–{’qŽq1, “à“¡³‹g1, ²–ì@—²1, ’|“àN—Y1, Š™“cvšæ2 (1t‘Ÿ“à, 2‘Š–Í‘å–ì“à‰ÈEtƒNƒŠƒjƒbƒN): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5), –ŒŒÃ‰®, 2015/4; 57 (3): 525.

723294. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –«t‘Ÿ•a (CKD) ‚̐t‹@”\áŠQis‚É”º‚€‘㏞«tK”rŸ•”\‚Ì‘œ—l«. ¬ì‚Ý‚ä‚«1, â–{®“o2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—ËZp‹³ˆç): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5), –ŒŒÃ‰®, 2015/4; 57 (3): 543.

723295. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒlƒtƒ[ƒ[ÇŒóŒQ‚ð‡•¹‚µ‚œANCAŠÖ˜AŒŒŠÇ‰ŠÇ—á‚ÌŒŸ“¢. ’·ê@‘×1,2, –q–앐Žu, ‘º–쏇–ç1,2, Š™“c^—Žq1,2, “‡“c–F—²1,2, –ìXŒû”ŽŽj1, “‡“c@”£ (1–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“à): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/6), –ŒŒÃ‰®, 2015/4; 57 (3): 548.

723296. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”ŒŒŽ‘ÌŒ`¬«t‰Š‚É‚š‚¯‚éƒ{[ƒ}ƒ“ùN•Ç×–E‚̍זE‘B‚ÆEMT‚É‚š‚¯‚éSM22ƒ¿‚Ì–ðŠ„. “à“¡³‹g1, Š™“cvšæ2, ƒXƒ`ƒ…ƒA[ƒgEƒVƒƒƒ“ƒNƒ‰ƒ“ƒh (1t‘Ÿ“à, 2‘Š–Í‘å–ì“à‰ÈEtƒNƒŠƒjƒbƒN): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/7), –ŒŒÃ‰®.

723297. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šˆ«Ž_‘f‚̓AƒŠƒXƒgƒƒLƒAŽ_‚É‚æ‚é‹}«táŠQis‚ð‰ü‘P‚·‚é. ’|“àN—Y1, ’|“àŒb”üŽq2, Š™“cvšæ1, ‰ÍŒŽŽ‰ë3 (1t‘Ÿ“à, 2–Ɖu, 3¶—): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/7), –ŒŒÃ‰®.

723298. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “«ƒlƒtƒ[ƒ[ÇŒóŒQ‚ð’悵Ž…‹…‘Ì‚É‘ƒó•ªß«d‰»•a•Ï‚ð”F‚ß‚œSLE‚̈ê—á. ŠÖ–{ŒbŽq1, ²–ì@—²1, ˆ¢•”“N–ç1, ŠÖ“c—åŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, Š™“c^—Žq1, ¬ì‚Ý‚ä‚«2, ‘º–쏇–ç1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ’|“àN—Y1, óˆä—FŠî, ¬–“³Žq, ŽæGK (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5-7), –ŒŒÃ‰®, 2015/4; 57 (3): 947.

723299. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘Sg«•‚Žî, ŒŒ¬”ÂŒž­, t‹@”\’ቺ‚Å”­Ç‚µ‚œPOEMSÇŒóŒQ‚Ì1—á. ˆ¢•”“N–ç1, ²–ì@—²1, ŠÖ–{ŒbŽq1, ŠÖ“c—åŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, Š™“c^—Žq1, ¬ì‚Ý‚ä‚«2, ‘º–쏇–ç1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ’|“àN—Y1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5-7), –ŒŒÃ‰®, 2015/4; 57 (3): 950.

723300. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) PTUŠÖ˜AANCAŒŒŠÇ‰Š‚É–Œ«tÇ‚𔺂Á‚œˆê—á. “‡“c–F—²1, “à“¡³‹g1, ŠÖ–{ŒbŽq1, ˆ¢•”“N–ç1, ‚‹Ž@—É1, ³–Ø‹M‹³1, Š™“c^—Žq1, ‘º–쏇–ç1, ÂŽR“ŒŒÜ1, ²–ì@—²1, ’|“àN—Y1 (1t‘Ÿ“à): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5-7), –ŒŒÃ‰®, 2015/4; 57 (3): 966.

723301. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‚—î”­ÇMCNSŠ°‰ðŒã‚ÉSLE‚𔭏ǂµ‚œ1—á. ³–Ø‹M‹³1, “à“¡³‹g1, ˆ¢•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—åŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ’|“à˜a”Ž2, ¬ì‚Ý‚ä‚«2, Š™“c^—Žq1, ‘º–쏇–ç1, ÂŽR“ŒŒÜ1, ²–ì@—²1, ’|“àN—Y1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5-7), –ŒŒÃ‰®, 2015/4; 57 (3): 980.

723302. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆ««ƒŠƒ“ƒpŽî‚ð‡•¹‚µ‚œImmunotactoidtÇ‚Ì1—á. ‚‹Ž@—É1, Š™“c^—Žq1, ˆ¢•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—åŽq1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, ¬ì‚Ý‚ä‚«2, ‘º–쏇–ç1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ²–ì@—²1, ’|“àN—Y1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5-7), –ŒŒÃ‰®, 2015/4; 57 (3): 1011.

723303. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘œ”­ŒŒŠÇ‰Š«“÷‰èŽîÇ (GPA) Ž¡—Ã’†‚ɍDŽ_‹…Z‚𔺂€”畆ŒŒŠÇ‰Š‚ð‡•¹‚µ‚œŒŒ‰t“§ÍŠ³ŽÒ‚̈ê—á. “‡“c–F—²1, ²–ì@—²1, ŠÖ“c—åŽq1, ‚‹Ž@—É1, ³–Ø‹M‹³1, ’|“à˜a”Ž,2, ‹{àV¹Žq1, ¬ì‚Ý‚ä‚«,2, Š™“c^—Žq1, ‘º–쏇–ç1, ‰ª–{’qŽq1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ’|“àN—Y1, Š™“cvšæ3 (1t‘Ÿ“à, ,2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‘Š–Í‘å–ì“à‰ÈEtƒNƒŠƒjƒbƒN): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/26), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2015/5; 48 (suppl 1): 83.

723304. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “§Í“±“üŠú‚É‚š‚¯‚éƒNƒGƒ“Ž_‘æ“ñ“S…˜a•š (ƒŠƒIƒi) ‚Ì•nŒŒ‚ɑ΂·‚éŒø‰Ê‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ’·ê@‘×1, –q–앐Žu, ‘º–쏇–ç1,2, Š™“c^—Žq1,2, “‡“c–F—²1, –ìXŒû”ŽŽj1, “‡“c@”£ (1–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, ,2t‘Ÿ“à): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/26), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2015/5; 48 (suppl 1): 191.

723305. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠŽõ«S“à–Œ‰Š‚𔭏ǂµGaƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚ªf’f‚É—L—p‚Å‚ ‚Á‚œˆÛŽ“§ÍŠ³ŽÒ‚Ì1—á. ³–Ø‹M‹³1, ÂŽR“ŒŒÜ1, ˆ¢•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—åŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ’|“à˜a”Ž2, ‹{àV¹Žq1, ¬ì‚Ý‚ä‚«2, Š™“c^—Žq1, ‰¥çŽq1, ‘º–쏇–ç1, ‰ª–{’qŽq1, “à“¡³‹g1, ²–ì@—²1, ’|“àN—Y1, Š™“cvšæ3 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‘Š–Í‘å–ì“à‰ÈEtƒNƒŠƒjƒbƒN): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/28), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2015/5; 48 (suppl 1): 160.

723306. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹¹–Œ¶ŒŸ‚ɂĐüˆÛ‘f«‹¹–Œ‰Š‚ð”F‚ß‚œˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚Ì3—á. ²–ì@—²1, ŠÖ“c—åŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, ‹{àV¹Žq1, Š™“c^—Žq1, ¬ì‚Ý‚ä‚«2, ‰¥çŽq1, ‘º–쏇–ç1, ‰ª–{’qŽq1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ’|“àN—Y1, Š™“cvšæ3 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‘Š–Í‘å–ì“à‰ÈEtƒNƒŠƒjƒbƒN): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/28), ‰¡•l, “ú–{“§ÍˆãŠw‰ïŽGŽ 2015/5; 48 (suppl 1): 284.

732046. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ŒŒ‰t“§Í‚É‚š‚¯‚éHŽ–—Ö@. “à“¡³‹g (t‘Ÿ“à): ‘æ11‰ñ‚³‚ª‚ݖ쌌‰tò‰»‹Zp§˜b‰ï‘‰ïE•×‹­‰ï (2015/7/12), ’¬“c.

732047. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) t‘Ÿ‚Ì‚š˜b. “à“¡³‹g (t‘Ÿ“à): Œ’NƒtƒFƒXƒ^ (2015/10/17), ‘Š–ÍŒŽ.

733110. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) t‘ŸMRI‚Őt‘Ÿ•Ó‰—DˆÊ‚É‘œ”‚Ì”÷¬ùN–E‚ð”F‚ß‚œt‹@”\’ቺŠ³ŽÒ‚Ì1—á. ŠÖ–{ŒbŽq1, ÂŽR“ŒŒÜ1, ˆ¢•”“N–ç1, ‚‹Ž@—É1, ’|“à˜a”Ž2, ³–Ø‹M‹³1, “‡“c–F—²1, ¬ì‚Ý‚ä‚«2, Š™“c^—Žq1, ‘º–쏇–ç1, “à“¡³‹g1, ²–ì@—²1, ’|“àN—Y1, Š™“cvšæ3 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‘Š–Í‘å–ì“à‰ÈEtƒNƒŠƒjƒbƒN): ‘æ89‰ñ_“ސìtŒ€‹†‰ï (2015/5/23), ‰¡•l.

733111. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “÷Šá“IŒŒ”A‚ªoŒ»‚µ‹}‘¬‚ɐtáŠQ‚ªis‚µ‚œ“œ”A•a«tÇ‚̈ê—á. ˆ¢•”“N–ç1, ÂŽR“ŒŒÜ1, ŠÖ–{ŒbŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, Š™“c^—Žq1, ¬ì‚Ý‚ä‚«2, ‘º–쏇–ç1, “à“¡³‹g1, ²–ì@—²1, ’|“àN—Y1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ64‰ñ_“ސìt‰ŠŒ€‹†‰ï (2015/9/19), ‰¡•l.

733112. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “«ƒlƒtƒ[ƒ[ÇŒóŒQ‚ð’悵Ž…‹…‘Ì‚É‘ƒó•ªß«d‰»•a•Ï‚ð”F‚ß‚œSLE‚̈ê—á. ŠÖ–{ŒbŽq1, ²–ì@—²1, ˆ¢•”“N–ç1, ŠÖ“c—åŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, Š™“c^—Žq1, ¬ì‚Ý‚ä‚«2, ‘º–쏇–ç1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ’|“àN—Y1, óˆä—FŠî3, ¬–“³Žq3, ŽæGK3 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ŠC˜V–Œ‘‡•a‰@): ‘æ45‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2015/10/2), “Œ‹ž.

733113. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘Sg«•‚Žî, ŒŒ¬”ÂŒž­, t‹@”\’ቺ‚Å”­Ç‚µ‚œPOEMSÇŒóŒQ‚Ì1—á. ˆ¢•”“N–ç1, ²–ì@—²1, ŠÖ–{ŒbŽq1, ŠÖ“c—åŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, Š™“c^—Žq1, ¬ì‚Ý‚ä‚«2, ‘º–쏇–ç1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ’|“àN—Y1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ45‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2015/10/2), “Œ‹ž.

733114. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) PTUŠÖ˜AANCAŒŒŠÇ‰Š‚É–Œ«tÇ‚𔺂Á‚œˆê—á. “‡“c–F—²1, “à“¡³‹g1, ŠÖ–{ŒbŽq1, ˆ¢•”“N–ç1, ‚‹Ž@—É1, ³–Ø‹M‹³1, Š™“c^—Žq1, ‘º–쏇–ç1, ÂŽR“ŒŒÜ1, ²–ì@—²1, ’|“àN—Y1 (1t‘Ÿ“à): ‘æ45‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2015/10/2), “Œ‹ž.

733115. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚—î”­ÇMCNSŠ°‰ðŒã‚ÉSLE‚𔭏ǂµ‚œ1—á. ³–Ø‹M‹³1, “à“¡³‹g1, ˆ¢•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—åŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ’|“à˜a”Ž2, ¬ì‚Ý‚ä‚«2, Š™“c^—Žq1, ‘º–쏇–ç1, ÂŽR“ŒŒÜ1, ²–ì@—²1, ’|“àN—Y1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ45‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2015/10/2), “Œ‹ž.

733116. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆ««ƒŠƒ“ƒpŽî‚ð‡•¹‚µ‚œImmunotactoidtÇ‚Ì1—á. ‚‹Ž@—É1, Š™“c^—Žq1, ˆ¢•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—åŽq1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, ¬ì‚Ý‚ä‚«2, ‘º–쏇–ç1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ²–ì@—²1, ’|“àN—Y1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ45‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2015/10/3), “Œ‹ž.

733117. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “§Í“±“ü1”N”ŒŒã‚ɍĔ­‚ð”F‚ß‚œRŠî’ê–ŒR‘ÌŒ^t‰Š‚̈ê—á. ’·ê@‘×1, “‡“c–F—²1, ‘º–쏇–ç1,2, Š™“c^—Žq1,2, –q–앐Žu, –ìXŒû”ŽŽj1, “‡“c@”£ (1–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“à): ‘æ45‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2015/10/3), “Œ‹ž, “ú–{t‘ŸŠw‰ïŽ 2015/9; 56 (7): 967.

733118. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ{[ƒ}ƒ“ùN•Ç‘O‹ì×–E‚Ì’²ßˆöŽq. “à“¡³‹g (t‘Ÿ“à): ‘æ28‰ñ–Ÿ“ú‚̐t‘Ÿ•a“œ”A•a‚ðl‚Š‚éŽáŽè‚̉ï (2015/10/10), ‰¡•l.

733119. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “§Í“±“üŠú‚ɓ«• …‚ð‡•¹‚µ• oÃ–¬ƒVƒƒƒ“ƒg—¯’u‚É‚ÄŒy‰õ‚µ‚œíõF‘Ì—D«‘œ”­«”X–Et‚Ì1—á. •x‰i‘åŽu, ²–ì@—²1, ˆ¢•”“N–ç1, ŠÖ–{ŒbŽq1, ‚‹Ž@—É1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, ¬ì‚Ý‚ä‚«2, Š™“c^—Žq1, ‘º–쏇–ç1, “à“¡³‹g1, ÂŽR“ŒŒÜ1, ’|“àN—Y1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ90‰ñ_“ސìtŒ€‹†‰ï (2015/11/22), ‰¡•l.

733120. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žs”Ì’Á’É–ò•ž—pŒã‚É”­Ç‚µ‚œ‰¡–ä‹Ø—Z‰ðÇ‚Ì1—á. —é–Ø—Ž‘Ÿ˜Y, ’·ê@‘×1,2, “‡“c–F—²1,2, —é–؍¹—R”ü, ‰ª“c”Ž”ü, ‚‹Ž‰ØŽq, ŽRè‘ñ–ç, –ìXŒû”ŽŽj1, “‡“c@”£, œA£—²ˆê1,3 (1–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“à, 3_Œo“à): “ú–{“à‰ÈŠw‰ï‘æ620‰ñŠÖ“Œ’n•û‰ï (2015/12/12), “Œ‹ž.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H25-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•¶•”‰ÈŠwÈ‰ÈŠwŒ€‹†”ï•â•‹àuœ‘‘¢ŒŒŠ²×–E‘B§ŒäƒVƒXƒeƒ€‚ð—p‚¢‚œœ‘ƒLƒƒŠƒYƒ€“±“ü‚ƃqƒgŽŸŠ³ƒ‚ƒfƒ‹Ž¡—à (Œ€‹†‘ã•\ŽÒ: ’|“àN—Y)vz’|“àN—Y (t‘Ÿ“à): 2010`2012”N“xŒ€‹†¬‰Ê•ñ‘ 2015/6; 1-5.

H26-110009. [ŒŽ’˜] A new mouse experimental model of focal segmental glomerulosclerosis produced by the administration of polyclonal anti-mouse nephrin antibody. Okina C1, Kamata K1, Okamoto T1, Kamata M1, Murano J1, Naito S1, Aoyama T1, Yamanaka N: Kitasato Med J 2015/3; 45 (1): 29-37. (‰¥çŽq1, Š™“cvšæ1, ‰ª–{’qŽq1, Š™“c^—Žq1, ‘º–쏇–ç1, “à“¡³‹g1, ÂŽR“ŒŒÜ1: 1t‘Ÿ“à)

H26-320006. [Ç—á•ñ] ”DP––Šú‚Ƀlƒtƒ[ƒ[ÇŒóŒQ‚ð’悵Ž…‹…‘̏ã”ç×–E‚É’˜–Ÿ‚ȕϐ«‘œ‚ð”F‚ß‚œˆê—á. ‚‹Ž@—É1, ÂŽR“ŒŒÜ1, ŠÖ“c—åŽq1, “‡“c–F—²1, ³–Ø‹M‹³1, ’|“à˜a”Ž2, ŽðˆäŒ’Žj1, ¬ì‚Ý‚ä‚«2, ‹{àV¹Žq1, Š™“c^—Žq1, ‰¥çŽq1, ‘º–쏇–ç1, ‰ª–{’qŽq1, “à“¡³‹g1, ²–ì@—²1, ’|“àN—Y1, Š™“cvšæ1 (1t‘Ÿ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): t‰ŠÇ—ጀ‹† 2015/2; 31: 127-46.


äPŒŽ•aEŠŽõ“à‰ÈŠw

[Šwp˜_•¶]

110155. [ŒŽ’˜] Enhanced expression of mRNA for FLT3 in bone marrow CD34+ cells in rheumatoid arthritis. Hirohata S1, Yanagida T, Tomita T, Yoshikawa H: Inflammation Regeneration 2015; 35 (5): 255-60. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

110156. [ŒŽ’˜] Liver damage in patients with polymyositis and dermatomyositis. Wada T1, Abe G1, Kudou T1, Ogawa E1, Nagai T1, Tanaka S1, Hirohata S1: Kitasato Med J 2016/3; 46 (1): 40-6. (˜a“c’B•F1, ˆÀ•”Šw˜N1, H“¡—Y‘å1, ¬ì‰p—C1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

110157. [ŒŽ’˜] Effects of certolizumab pegol on human monocytes. Hoshiyama T1, Matsueda Y2, Tono T2, Arinuma Y2, Nagai T2, Hirohata S2: Kitasato Med J 2016/3; 46 (1): 60-6. (¯ŽR—²s1, ŒŽ}@—C2, “Œ–ìr—T2, —LÀ—ǍK2, ‰iˆä—§•v2, œA”šr¬2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2äPŒŽ•aEŠŽõ“à)

110158. [ŒŽ’˜] Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus. Ogawa E1, Nagai T1, Sakuma Y2, Arinuma Y1, Hirohata S1: Mod Rheumatol 2016/6; 26 (3): 377-83. (¬ì‰p—C1, ‰iˆä—§•v1, ²‹vŠÔ—TŽq2, —LÀ—ǍK1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

320017. [Ç—á•ñ] ‘€“ª“®–¬¶ŒŸ‚Å‹×–E«“®–¬‰Š‚ð”F‚ß‚œHLA-B52—z«‘å“®–¬‰Š‚̈ê—á. ‘‘@M”Ž1, ’J@@–Œ1, ŒŽ}@—C1, ŒŽ@—º—S1, ˆÀ•”Šw˜N1, —LÀ—ǍK1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ŠÖ“ŒƒŠƒEƒ}ƒ` 2015/5; 48: 177-84.

320018. [Ç—á•ñ] “«‚̍Ĕ­«”xŒ‹ß«•a•Ï‚ɑ΂µ‚ÄRituximab‚Ì‘tŒø‚µ‚œGranulomatosis with Polyangitis (GPA) ‚̈ê—á. Ž™‹Ê‰ØŽq1, H“¡—Y‘å1, —LÀ—ǍK1, ’J@@–Œ1, ŒŽ}@—C1, ‘‘@M”Ž1, ˆÀ•”Šw˜N1, ¬ì‰p—C1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ŠÖ“ŒƒŠƒEƒ}ƒ` 2016/3; 49: 261-7.

522098. [uÀ]y“ÁW: ƒGƒŠƒeƒ}ƒg[ƒfƒX‚ðf‚éz_Œo‡•¹Ç (CNSƒ‹[ƒvƒX) ‚̐f’f‚ÆŽ¡—Ã. œA”šr¬ (äPŒŽ•aEŠŽõ“à): MB Derma 2015/9; 235: 53-60.

522099. [uÀ]y–Ɖu«_ŒoŽŸŠ³|•a‘ԉ𖟂Ǝ¡—Â̍őOüzŠe˜_ [‚»‚Ì‘Œ‚̖Ɖu«_ŒoŽŸŠ³]@‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì’†•_Œo•a•Ï. œA”šr¬ (äPŒŽ•aEŠŽõ“à): ˆãŠw‚Ì•à‚Ý 2015/10; 255 (5): 549-56.

522100. [uÀ]y“ÁW: ”x‚ŒŒˆ³Çf—Â̖ڎw‚·ƒS[ƒ‹zState of the Art: äPŒŽ•a‚É”º‚€”x‚ŒŒˆ³Ç. “c’†Z–Ÿ (äPŒŽ•aEŠŽõ“à): Pulmonary Hypertension Update 2015/11; 1 (2): 236-43.

522101. [uÀ]yŽãƒ[ƒNƒVƒ‡ƒbƒv: äPŒŽ•a‚̐V‹KŽ¡—Ázƒx[ƒ`ƒFƒbƒg•a‚̐_Œo•a•Ï. œA”šr¬ (äPŒŽ•aEŠŽõ“à): —Տ°ƒŠƒEƒ}ƒ` 2015; 27 (4): 288-95.

[’˜@‘]

611002. [Šwp‘ (•ÒW)]yBehcet's Disease: Progress in recent years and unmet needs for the futurez Editor: Hirohata S1, Nova Science Publishers, USA, 2015/10. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

620071. [Šwp‘ (•ª’SŽ·•M)]y–Ɖu«_ŒoŽŸŠ³|Šî‘bE—Տ°Œ€‹†‚̍ŐV’mŒ©| (“ú–{—Õ଑Š§† (No.1085)zVI. ‚»‚Ì‘Œ‚̖Ɖu«_ŒoŽŸŠ³@2. äPŒŽ•a‚š‚æ‚Ñ—Þ‰ŽŸŠ³‚É”º‚€_ŒoE‹ØáŠQ@(6) _ŒoBehcet•a, p.673-9. œA”šr¬ (äPŒŽ•aEŠŽõ“à), “ú–{—Õ଎Ð, ‘åã, 2015/9”­s.

620072. [Šwp‘ (•ª’SŽ·•M)]yƒŠƒEƒ}ƒ`EäPŒŽ•af—ÃnƒCƒOƒŒ[ƒh •ªŽq•W“I/BioŽž‘ã‚̃ŠƒEƒ}ƒ`EäPŒŽ•aŽ¡—ÃXƒgƒ‰ƒeƒW[z6Í ‹­”çÇ@3. ”x‚ŒŒˆ³Ç‚̐f’f, —Տ°•ª—Þ‚ÆŽ¡—Ã, p.233-44. “c’†Z–Ÿ (äPŒŽ•aEŠŽõ“à), ƒVƒŠ[ƒY•ÒW: ŽOXŒo¢, ŒK–Œ³—², ƒQƒXƒg•ÒW: Œ–{@Œ÷, •Û“cW•, •¶Œõ“°, “Œ‹ž, 2015/10”­s.

620073. [Šwp‘ (•ª’SŽ·•M)]y`‘Šúf’fEŽ¡—Â̂œ‚߂́`”x‚ŒŒˆ³Ç Q&AzPart 2 ”x‚ŒŒˆ³Ç‚Ì‘Šúf’f‚ð‚ß‚Ž‚·@Q3 ”x‚ŒŒˆ³Ç‚Ì‘Šúf’f‚Í‚È‚º‚Ђ‚悀‚È‚Ì‚Å‚µ‚å‚€‚©. Ž¡—Éî“ü‚̃^ƒCƒ~ƒ“ƒO‚ª—\Œã‚É‹y‚Ú‚·‰e‹¿‚ð‹³‚Š‚Ä‚­‚Ÿ‚³‚¢, p.88-91. “c’†Z–Ÿ (äPŒŽ•aEŠŽõ“à), •Ò: •Ÿ“cŒbˆê, æ’[ˆãŠwŽÐ, “Œ‹ž, 2015/10”­s.

621001. [Šwp‘ (•ÒW)]yƒx[ƒ`ƒFƒbƒg•az•Ò: œA”šr¬ (äPŒŽ•aEŠŽõ“à), •¶Œõ“°, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713040. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Characteristic changes in histopathology of synovial tissues from patients with rheumatoid arthritis treated with tocilizumab. Hirohata S1, Abe A, Murasawa A, Tomita T, Yoshikawa H: EULAR 2015 (2015/6/12), Rome, Italy. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713041. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Blood-brain barrier damages in the pathogenesis of acute confusional state in systemic lupus erythematosus. Hirohata S1, Arinuma Y1, Yanagida T, Yoshio T: LUPUS 2015 (2015/9/4), Vienna, Austria. (œA”šr¬1, —LÀ—ǍK1: 1äPŒŽ•aEŠŽõ“à)

713042. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Long-term outcome of chronic progressive neurological manifestations in Behcet's disease Hirohata S1, Kikuchi H, Sawada S, Nagafuchi H, Kuwana M, Takeno M, Ishigatsubo Y: 22rd World Congress of Neurology (WCN 2015) (2015/11/2), Santiago, Chile. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713043. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Expression of mRNA for Peptidylarginine Deiminase Type 2 and Type 4 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis. Nagai T1, Tomita T, Yoshikawa H, Hirohata S1: 2015 ACR/ARHP Annual Meeting (2015/11/8), San Francisco, USA. (‰iˆä—§•v1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713044. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Association of Antibodies to the NR1 Subunit of N-Methyl-D-Aspartate Receptors with Neuropsychiatric Systemic Lupus Erythematosus. Ogawa E1, Nagai T1, Sakuma Y, Arinuma Y1, Hirohata S1: 2015 ACR/ARHP Annual Meeting (2015/11/9), San Francisco, USA. (¬ì‰p—C1, ‰iˆä—§•v1, —LÀ—ǍK1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713045. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Association of Anti-Glutamate Receptor Subunit NR2 Antibody and Psychiatric Disorder in Patients with Primary Sjšgren Syndrome. Arinuma Y1, Sakuma Y, Ogawa E1, Wada T1, Nagai T1, Tanaka S1, Hirohata S1: 2015 ACR/ARHP Annual Meeting (2015/11/10), San Francisco, USA. (—LÀ—ǍK1, ¬ì‰p—C1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713046. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Differential Effects of IL-6 Blockade Tocilizumab and TNF Inhibitors on the Reduced Angiogenesis and Lining Layer Degeneration in Synovial Tissues from Patients with Rheumatoid Arthritis. Hirohata S1, Arinuma Y1, Yanagida T, Yoshio T: 2015 ACR/ARHP Annual Meeting (2015/11/10), San Francisco, USA. (œA”šr¬1, —LÀ—ǍK1: 1äPŒŽ•aEŠŽõ“à)

713047. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Influences of Various Factors on Survival of Patients Treated with Pulmonary Arterial Hypertension-Specific Drugs Combination Therapy in Patients with Connective Tissue Diseases. Tanaka S1, Matsueda Y, Ogawa E1, Okada J, Hirohata S1: 2015 ACR/ARHP Annual Meeting (2015/11/10), San Francisco, USA. (“c’†Z–Ÿ1, ¬ì‰p—C1, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

722057. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “«’†•_Œoƒ‹[ƒvƒX‚Ì•a‘Ô. œA”šr¬ (äPŒŽ•aEŠŽõ“à): ‘æ59‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2015/4/24), –ŒŒÃ‰®.

722058. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Ž©ŒÈ–ƉuŽŸŠ³‚Ì’†•_Œo•a•Ï. œA”šr¬ (äPŒŽ•aEŠŽõ“à): ‘æ43‰ñ“ú–{—Տ°–ƉuŠw‰ï‘‰ï (2015/10/22), _ŒË.

723307. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒXŠ³ŽÒ‚Ì”DP‚ƏoŽY‚ɂ‚¢‚Ä. ’J@@–Œ1, —LÀ—ǍK1, ‰iˆä—§•v1, Ž™‹Ê‰ØŽq1, ŒŽ}@—C1, ‘‘@M”Ž1, ¬ì‰p—C1, ˜a“c’B•F1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ59‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2015/4/23), –ŒŒÃ‰®.

723308. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«ƒXƒeƒBƒ‹•a‚ɑ΂·‚éƒgƒVƒŠƒYƒ}ƒu (TCZ) ‚Ì—LŒø«‚ÉŠÖ‚·‚錟“¢. Ž™‹Ê‰ØŽq1, ‘‘@M”Ž1, “c’†Z–Ÿ1, ’J@@–Œ1, ŒŽ}@—C1, ¬ì ‰p—C1, —LÀ—ǍK1, ‰iˆä—§•v1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ59‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2015/4/23), –ŒŒÃ‰®.

723309. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) NinJa2013‚É‚š‚¯‚éƒ^ƒNƒƒŠƒ€ƒX‚𒆐S‚Æ‚µ‚œ2Ü•¹—p—Ö@‚̉ðÍ. ¬ì‰p—C1, “c’†Z–Ÿ1, ŒŽ}@—C1, ‘‘@M”Ž1, —LÀ—ǍK1, ˜a“c’B•F1, ‰iˆä—§•v1, œA”šr¬1, Œˆä—˜_, ácŠÔdl (1äPŒŽ•aEŠŽõ“à): ‘æ59‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2015/4/24), –ŒŒÃ‰®.

723310. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒZƒ‹ƒgƒŠƒYƒ}ƒuƒyƒSƒ‹‚̃qƒg’P‹…‚ɑ΂·‚éŒø‰Ê‚ÌŒŸ“¢. ¯ŽR—²s, ²‹vŠÔ—TŽq, —LÀ—ǍK1, ‰iˆä—§•v1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ59‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2015/4/24), –ŒŒÃ‰®.

723311. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`Š³ŽÒœ‘CD34—z«×–E‚É‚š‚¯‚éPAD2 mRNA‚Ì”­Œ»‚ÌŒŸ“¢. ‰iˆä—§•v1, •y“c“N–ç, ‹gìGŽ÷, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ59‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2015/4/24), –ŒŒÃ‰®.

723312. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰È‚ÅŒoŒ±‚µ‚œClinically Amyopatic Dermatomyositis (CADM) ‚É‚š‚¯‚éRCADMR‘Ì‚ðŠÜ‚ß‚œ—Տ°“I“Á’¥‚ÌŒŸ“¢. ‘‘@M”Ž1, ’J@@–Œ1, Ž™‹Ê‰ØŽq1, ŒŽ}@—C1, ¬ì‰p—C1, —LÀ—ǍK1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ59‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2015/4/24), –ŒŒÃ‰®.

723313. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) LILRA4‘œŒ^‚Æ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚ÌŠÖ˜A‚ÌŒŸ“¢. ìè@ˆ», ŒÃì@G, ‹ß“¡—T–ç, ˆÉ“¡@‘, Œ–{@Œ÷, ‘¶^‹K—Y, “V–ì_•¶, {“cºŽq, ’·‰ªÍ•œ, £ŒËŒû‹žŒá, ‰iˆä—§•v1, œA”šr¬1, “‡“c_‘Ÿ, ™ˆäÍ“ñ, ‰ª–{@‹, ç—tŽÀs, ––Œ‰hˆê, ‘å–ì@Ž , •ÐŽR‰ë•v, ‰ª–{–ŸŽq, ‰Í–ì@”£, ‚è–F¬, ‹Ž–{”ŽŽj, Z“cF”V, ácŠÔdl, “y‰®®”V (1äPŒŽ•aEŠŽõ“à): ‘æ59‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2015/4/25), –ŒŒÃ‰®.

723314. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†•_Œoƒ‹[ƒvƒX‚É‚š‚¯‚錌ŽC5”Z“x‚ÌŒŸ“¢. ²‹vŠÔ—TŽq, —LÀ—ǍK1, ‰iˆä—§•v1, ¯ŽR—²s, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ59‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï (2015/4/25), –ŒŒÃ‰®.

723315. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Long-term outcome of chronic progressive neuro-Behcet's disease. œA”šr¬1, ‹e’nO•q, ‘ò“c“NŽ¡, ‰iŸº—TŽq, ŒK–Œ³—², Šx–ìŒõ—m, Îƒ–’Ø—Ç–Ÿ (1äPŒŽ•aEŠŽõ“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/23), VŠƒ.

723316. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒZƒ‹ƒgƒŠƒYƒ}ƒuƒyƒSƒ‹‚̃qƒg’P‹…‚ɑ΂·‚éŒø‰Ê‚ÌŒŸ“¢. ¯ŽR—²s, ŒŽ}@—C1, ‰iˆä—§•v1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ43‰ñ“ú–{—Տ°–ƉuŠw‰ï‘‰ï (2015/10/22), _ŒË.

723317. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†•_Œoƒ‹[ƒvƒX‚É‚š‚¯‚éC5a‚ÌŒŸ“¢. ²‹vŠÔ—TŽq, ŒŽ}@—C1, ¯ŽR—²s, ‰iˆä—§•v1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ43‰ñ“ú–{–ƉuŠw‰ï‘‰ï (2015/10/22), _ŒË.

723318. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éHIV/AIDSŠ³ŽÒ‚̏A˜Jó‹µ‚ɂ‚¢‚Ä. ‰Á“¡@Î, ˜a“c’B•F1, ꎓ¡‘Žq2, ŒŽRW‘ã2, —F“c‹g‘¥3, Œ–{Œ\—S3, ‘O“cŒiŽq2, ‚ŽR—zŽq4 (1äPŒŽ•a¥ŠŽõ“à, 2ŠÅŒì•”, 3–òÜ•”, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ29‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ïE‘‰ï (2015/11/30), “Œ‹ž.

733121. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ÁˆÙ‚Ȕ畆Çó‚ð’悵‚œd•¡Šà‡•¹”畆‹Ø‰Š‚Ì1—á. •x‰i‘åŽu, ‘‘@M”Ž1, ’J@@–Œ1, Ž™‹Ê‰ØŽq1, ŒŽ}@—C1, ¬ì‰p—C1, —LÀ—ǍK1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ614‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2015/5/9), “Œ‹ž.

733122. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹‘å‹ó“Ž«•a•Ï‚𔺂Á‚œHIV/AIDSŠ³ŽÒ‚̈ê—á. ˆäãG‰î, Ž™‹Ê‰ØŽq1, ˜a“c’B•F1, ’J@@–Œ1, “c’†’mŽ÷1, ˆÀ•”Šw˜N1, H“¡—Y‘å1, ¬ì‰p—C1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ78‰ñ_“ސ쌧ŠŽõÇˆãŠw‰ï (2015/9/12), ‰¡•l.

733123. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ”­ŒŒŠÇ‰Š«“÷‰èŽîÇ‚̉Á—Ã’†‚ɃmƒJƒ‹ƒWƒAŠŽõÇ‚𔺂Á‚œˆê—á. ’J@@–Œ1, ‰iˆä—§•v1, “c’†’mŽ÷1, Ž™‹Ê‰ØŽq1, ˆÀ•”Šw˜N1, H“¡—Y‘å1, ¬ì‰p—C1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ78‰ñ_“ސ쌧ŠŽõÇˆãŠw‰ï (2015/9/12), ‰¡•l.

733124. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’˜–Ÿ‚È”’Ž¿•a•Ï‚ð’悵‘œÊ‚È’†•_ŒoÇó‚̍ĔR‚ðŒJ‚è•Ô‚µŽ¡—Âɓïa‚µ‚œNPSLE‚Ì1—á. ì‹v•Û•à, ¬ì‰p—C1, ’J@@–Œ1, Ž™‹Ê‰ØŽq1, “c’†’mŽ÷1, ˆÀ•”Šw˜N1, H“¡—Y‘å1, ‰iˆä—§•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ618‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2015/10/10), “Œ‹ž.

733125. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ØŒŽ«y‘f‚̏㏞‚Æ’˜–Ÿ‚Èš‹‰ºáŠQ‚𗈂œ‚µ‘œ”­«‹Ø‰Š‚ÆŽv‚í‚ê‚œ1—á. ‹à•£—DŽ÷, ‰iˆä—§•v1, ’J@@–Œ1, ˆÀ•”Šw˜N1, H“¡—Y‘å1, ¬ì‰p—C1, “c’†Z–Ÿ1, œA”šr¬1, Žº@Œc’Œ (1äPŒŽ•aEŠŽõ“à): ‘æ621‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2016/2/13), “Œ‹ž.

H26”N“xˆÈ‘O•ª

[’˜@‘]

H26-620009. [Šwp‘ (•ª’SŽ·•M)]y¡“ú‚̐f’fŽwj (‘æ7”Å)zII. ŽŸŠ³•Ò@2. _ŒoE‹ØŽŸŠ³@_ŒoBehet•a, p.683-5. œA”šr¬ (äPŒŽ•aEŠŽõ“à), ‘•ÒW: ‹ààVˆê˜Y, ‰iˆä—ÇŽO, ˆãŠw‘‰@, “Œ‹ž, 2015/3”­s.


ŠO‰ÈŠw
[Šwp˜_•¶]

110159. [ŒŽ’˜] Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure model. Tanaka M, Shinoda M, Takayanagi A, Oshima G, Nishiyama R1, Fukuda K, Yagi H, Hayashida T, Masugi Y, Suda K, Yamada S, Miyasho T, Hibi T, Abe Y, Kitago M, Obara H, Itano O, Takeuchi H, Sakamoto M, Tanabe M, Maruyama I, Kitagawa Y: J Surg Res 2015/4; 194 (2): 571-80. (ŒŽR@—º1: 1ŠO‰È)

110160. [ŒŽ’˜] Preoperative administration of polysaccharide Kureha and reduced plasma transforming growth factor-ƒÀ in patients with advanced gastric cancer: A randomized clinical trial. Yamashita K1, Sakuramoto S, Mieno H1, Nemoto M, Shibata T, Katada N, Ohtsuki S, Sakamoto Y2, Hoshi K3, Wang G, Hemmi O, Satoh T, Kikuchi S4, Watanabe M1: Mol Clin Oncol 2015/5; 3 (3): 471-8. (ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, •Ð“c‰Ä–ç1, â–{‘×—2, ¯@‰À–F3, ‹e’rŽj˜Y4, “n粏¹•F1: 1ŠO‰È, 2—Տ°Œ€‹†EŠé‰æ, 3‰q¶, 44•a‰@˜AŒg‹³ˆç)

110161. [ŒŽ’˜] Prognostic impact of venous invasion in stage IB node-negative gastric cancer. Araki I1, Hosoda K1, Yamashita K1, Katada N1, Sakuramoto S, Moriya H1, Mieno H1, Ema A1, Kikuchi S2, Mikami T, Watanabe M1: Gastric Cancer 2015/6; 18 (2): 297-305. (r–؈ꕺ‘Ÿ1, ×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ŽOd–ì_˜N1, ]ŠÔ@—æ1, ‹e’rŽj˜Y2, “n粏¹•F1: 1ŠO‰È, 24•a‰@˜AŒg‹³ˆç)

110162. [ŒŽ’˜] Laparoscopic versus open distal gastrectomy for early gastric cancer in Japan: long-term clinical outcomes of a randomized clinical trial. Yamashita K1, Sakuramoto S, Kikuchi S2, Futawatari N1, Katada N1, Hosoda K1, Moriya H1, Mieno H1, Watanabe M1: Surg Today 2015/7. DOI: 10.1007/s00595-015-1221-4. (ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “ñ“nM]1, •Ð“c‰Ä–ç1, ×“c@Œj1, X’JGŒõ1, ŽOd–ì_˜N1, “n粏¹•F1: 1ŠO‰È, 24•a‰@˜AŒg‹³ˆç)

110163. [ŒŽ’˜] Clinicopathological Evaluation and Prognostic Analysis in Breast Cancer Patients with Brain Metastasis. Minatani N1, Tanino H2, Kosaka Y2, Kikuchi M2, Nishimiya H2, Waraya M2, Katoh H2, Enomoto T2, Sengoku N2, Watanabe M2: Journal of Cancer Therapy 2015/8; 6 (8): 727-34. (“ì’JØ•äŽq1, ’J–ì—Tˆê2, ¬â–ùŒ«2, ‹e’r^—Žq2, Œ‹{—mŽj2, ˜m’J”ü“Þ2, ‰Á“¡@O2, ‰|–{‘ñ–Î2, åÎ‹I•F2, “n粏¹•F2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È)

110164. [ŒŽ’˜] Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13. Kawamata H1, Yamashita K1, Kojo K2, Ushiku H2, Ooki A1, Watanabe M1: Genomics 2015/8; 106 (2): 71-5. (‰Í–”@Š°1, ŽR‰ºŒpŽj1, ŒÃé@Œ›2, ‹‹vGŽ÷2, ‘å–؁@‹Å1, “n粏¹•F1: 1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110165. [ŒŽ’˜] Multicenter comparative study of laparoscopic and open distal pancreatectomy using propensity score-matching. Nakamura M1, Wakabayashi G1, Miyasaka Y1, Tanaka M1, Morikawa T1, Unno M1, Tajima H1,2, Kumamoto Y1,2, Satoi S1, Kwon M1, Toyama H1, Ku Y1, Yoshitomi H1, Nara S1, Shimada K1, Yokoyama T1, Miyagawa S1, Toyama Y1, Yanaga K1, Fujii T1, Kodera Y1, Tomiyama Y3, Miyata H3, Takahara T3, Beppu T3, Yamaue H3, Miyazaki M3, Takada T3 (1Study Group of JHBPS, 3Study Group of JSEPS): J Hepatobiliary Pancreat Sci 2015/10; 22 (10): 731-6. (“c“‡@O1,2, ŒGŒ³—Y‰î1,2: 2ŠO‰È)

110166. [ŒŽ’˜] A Risk Model for Surgical Site Infection in the Gastric Cancer Surgery Using Data of 790 Patients. Ushiku H1, Hosoda K2, Yamashita K2, Katada N2, Kikuchi S3, Tsuruta H4, Watanabe M2: Dig Surg 2015/10; 32 (6): 472-9. (‹‹vGŽ÷1, ×“c@Œj2, ŽR‰ºŒpŽj2, •Ð“c‰Ä–ç2, ‹e’rŽj˜Y3, ’ß“c—z˜a4, “n粏¹•F2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 34•a‰@˜AŒg‹³ˆç, 4ˆã—Éq¶Šw•”)

110167. [ŒŽ’˜] Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype. Waraya M1, Yamashita K1, Ema A1, Katada N1, Kikuchi S2, Watanabe M1: PLoS One 2015/10; 10 (10): e0139902. (˜m’J”ü“Þ1, ŽR‰ºŒpŽj1, ]ŠÔ@—æ1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏¹•F1: 1ŠO‰È, 24•a‰@˜AŒg‹³ˆç)

110168. [ŒŽ’˜] Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction. Hosoda K1, Yamashita K1, Katada N1, Watanabe M1: Gen Thorac Cardiovasc Surg 2015/10; 63 (10): 549-56. (×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, “n粏¹•F1: 1ŠO‰È)

110169. [ŒŽ’˜] Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test. Yamashita K1, Ushiku H2, Katada N1, Hosoda K1, Moriya H1, Mieno H1, Kikuchi S3, Hoshi K4, Watanabe M1: Eur J Surg Oncol 2015/10; 41 (10): 1324-32. (ŽR‰ºŒpŽj1, ‹‹vGŽ÷2, •Ð“c‰Ä–ç1, ×“c@Œj1, X’JGŒõ1, ŽOd–ì_˜N1, ‹e’rŽj˜Y3, ¯@‰À–F4, “n粏¹•F1: 1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 34•a‰@˜AŒg‹³ˆç, 4‰q¶)

110170. [ŒŽ’˜] The Impact of c-Fos/Activator Protein-1 Inhibition on Allogeneic Pancreatic Islet Transplantation. Yoshida T, Yamashita K, Watanabe M1, Koshizuka Y, Kuraya D, Ogura M, Asahi Y, Ono H, Emoto S, Mizukami T, Kobayashi N, Shibasaki S, Tomaru U, Kamachi H, Matsushita M, Shiozawa S, Hirono S, Todo S: Am J Transplant 2015/10; 15 (10): 2565-75. (“n粏¹•F1: 1ŠO‰È)

110171. [ŒŽ’˜] A peripheral primitive neuroectodermal tumor originating from the pancreas: a case report and review of the literature. Nishizawa N1, Kumamoto Y2, Igarashi K1, Nishiyama R2, Tajima H2, Kawamata H2, Kaizu T2, Watanabe M2: Surg Case Rep 2015/12; 1: 80. (ŒàVL‹±1, ŒGŒ³—Y‰î2, ŒÜ\—’ˆê°1, ŒŽR@—º2, “c“‡@O2, ‰Í–”@Š°2, ŠC’ËMŽj2, “n粏¹•F2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È)

110172. [ŒŽ’˜] Predictive factors for lymph node metastasis in additional gastrectomy after endoscopic resection of cT1aN0 gastric cancer. Ishii S1, Yamashita K2, Kato H2, Nishizawa N1, Ushiku H1, Mieno H2, Moriya H2, Hosoda K2, Katada N2, Kikuchi S3, Tanabe S4, Koizumi W5, Saegusa M6, Watanabe M2: Surg Today 2015/12. DOI: 10.1007/s00595-015-1281-5. (Îˆä@’q1, ŽR‰ºŒpŽj2, ‰Á“¡@O2, ŒàVL‹±1, ‹‹vGŽ÷1, ŽOd–ì_˜N2, X’JGŒõ2, ×“c@Œj2, •Ð“c‰Ä–ç2, ‹e’rŽj˜Y3, “c糁@‘4, ¬ò˜aŽO˜Y5, ŽOŽ}@M6, “n粏¹•F2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 34•a‰@˜AŒg‹³ˆç, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã, 5Á‰»Ší“à, 6•a—)

110173. [ŒŽ’˜] Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study). Hasegawa Y1, Tanino H1,2, Horiguchi J1, Miura D1, Ishikawa T1, Hayashi M1, Takao S1, Kim SJ1, Yamagami K1, Miyashita M1, Konishi M1, Shigeoka Y1, Suzuki M1, Taguchi T1, Kubota T1, Akazawa K1, Kohno N1 (1JONIE Study Group): PLoS One 2015/12; 10 (12): e0143643. (’J–ì—Tˆê1,2: 2ŠO‰È)

110174. [ŒŽ’˜] Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer. Kikuchi M1, Yamashita K2, Waraya M2, Minatani N1, Ushiku H1, Kojo K1, Ema A2, Kosaka Y2, Katoh H2, Sengoku N2, Enomoto T2, Tanino H2, Sawanobori M, Watanabe M2: Oncotarget 2016/1; 7 (2): 1741-53. (‹e’r^—Žq1, ŽR‰ºŒpŽj2, ˜m’J”ü“Þ2, “ì’JØ•äŽq1, ‹‹vGŽ÷1, ŒÃé@Œ›1, ]ŠÔ@—æ2, ¬â–ùŒ«2, ‰Á“¡@O2, åÎ‹I•F2, ‰|–{‘ñ–Î2, ’J–ì—Tˆê2, “n粏¹•F2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È)

110175. [ŒŽ’˜] Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis. Nakayama N, Yamashita K1, Tanaka T2, Kawamata H1, Ooki A1, Sato T1, Nakamura T1, Watanabe M1: Clin Exp Metastasis 2016/1; 33 (1): 3-13. (ŽR‰ºŒpŽj1, “c’†r“¹2, ‰Í–”@Š°1, ‘å–؁@‹Å1, ²“¡•˜Y1, ’†‘º—²r1, “n粏¹•F1: 1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110176. [ŒŽ’˜] Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer. Minatani N1, Waraya M2, Yamashita K2, Kikuchi M1, Ushiku H1, Kojo K1, Ema A2, Nishimiya H2, Kosaka Y2, Katoh H2, Sengoku N2, Tanino H2, Sidransky D, Watanabe M2: PLoS One 2016/1; 11 (1): e0144862. (“ì’JØ•äŽq1, ˜m’J”ü“Þ2, ŽR‰ºŒpŽj2, ‹e’r^—Žq1, ‹‹vGŽ÷1, ŒÃé@Œ›1, ]ŠÔ@—æ2, Œ‹{—mŽj2, ¬â–ùŒ«2, ‰Á“¡@O2, åÎ‹I•F2, ’J–ì—Tˆê2, “n粏¹•F2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È)

110177. [ŒŽ’˜] Laparoscopic Surgery is Useful for Preventing Recurrence of Small Bowel Obstruction After Surgery for Postoperative Small Bowel Obstruction. Nakamura T1, Sato T1, Naito M1, Ogura N, Yamanashi T1, Miura H1, Tsutsui A1, Yamashita K1, Watanabe M1: Surg Laparosc Endosc Percutan Tech 2016/2; 26 (1): e1-4. (’†‘º—²r1, ²“¡•˜Y1, “à“¡³‹K1, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ŽR‰ºŒpŽj1, “n粏¹•F1: 1ŠO‰È)

110178. [ŒŽ’˜] Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer. Yamashita K1, Hosoda K1, Ema A1, Watanabe M1: Eur J Surg Oncol 201/3. doi: 10.1016/j.ejso.2016.03.001. (ŽR‰ºŒpŽj1, ×“c@Œj1, ]ŠÔ@—æ1, “n粏¹•F1: 1ŠO‰È)

110179. [ŒŽ’˜] Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy. Kosaka Y1, Tanino H1, Sengoku N1, Minatani N2, Kikuchi M2, Nishimiya H1, Waraya M2, Katoh H1, Enomoto T1, Sato T1, Kuranami M, Watanabe M1: Support Care Cancer 2016/3; 24 (3): 1405-11. (¬â–ùŒ«1, ’J–ì—Tˆê1, åÎ‹I•F1, “ì’JØ•äŽq2, ‹e’r^—Žq2, Œ‹{—mŽj1, ˜m’J”ü“Þ2, ‰Á“¡@O1, ‰|–{‘ñ–Î1, ²“¡•˜Y1, “n粏¹•F1: 1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110180. [ŒŽ’˜] Anatomical Knowledge for the Infra-Pyloric Vein Preservation during the Laparoscopy-Assisted Pylorus-Preserving Gastrectomy. Nishizawa N1, Yamashita K2, Shinohara H, Sakuramoto S, Hosoda K2, Watanabe M2: Dig Surg 2016; 33 (5): 363-70. (ŒàVL‹±1, ŽR‰ºŒpŽj2, ×“c@Œj2, “n粏¹•F2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È)

110181. [ŒŽ’˜] Potential benefits of laparoscopy-assisted proximal gastrectomy with esophagogastrostomy for cT1 upper-third gastric cancer. Hosoda K1, Yamashita K1, Katada N1, Moriya H1, Mieno H1, Shibata T, Sakuramoto S, Kikuchi S2, Watanabe M1: Surg Endosc 2016/8; 30 (8): 3426-36. (×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ŽOd–ì_˜N1, ‹e’rŽj˜Y2, “n粏¹•F1: 1ŠO‰È, 24•a‰@˜AŒg‹³ˆç)

110182. [ŒŽ’˜] A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1). Sato T1, Hayakawa K2, Tomita N, Noda M, Kamikonya N, Watanabe T, Kato D, Sakai Y, Hiraoka M, Shimada M, Ikushima H, Baba H, Oya N, Oya M, Nemoto-Murofushi K, Takeuchi M, Watanabe M1: Radiother Oncol 2016/8; 120 (2): 222-7. (²“¡•˜Y1, ‘ì˜ad2, “n粏¹•F1: 1ŠO‰È, 2•úŽËü (Žîá‡))

310014. [Ç—á•ñ] Liver Metastasis from Mixed Acinar-Endocrine Carcinoma of the Pancreas: A Case Report and Review of the Literature. Kumamoto Y1, Kaizu T1, Tajima H1, Kawamata H1, Nishiyama R1, Watanabe M1: J Liver Clin Res 2015/4; 2 (2): 1015. (ŒGŒ³—Y‰î1, ŠC’ËMŽj1, “c“‡@O1, ‰Í–”@Š°1, ŒŽR@—º1, “n粏¹•F1: 1ŠO‰È)

310015. [Ç—á•ñ] Case report of a laparoscopically resected rectal villous tumor associated with electrolyte depletion syndrome. Igarashi K1, Nakamura T1, Sato T1, Tsutsui A1, Miura H1, Ogura N, Naito M1, Yamanashi T1, Watanabe M1: Asian J Endosc Surg 2015/5; 8 (2): 185-7. (ŒÜ\—’ˆê°1, ’†‘º—²r1, ²“¡•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ¬‘q’Œl, “à“¡³‹K1, ŽR—œ‚L1, “n粏¹•F1: 1ŠO‰È)

310016. [Ç—á•ñ] Two Cases of Pathological Complete Response to Neoadjuvant Chemoradiation Therapy in Pancreatic Cancer. Fujii-Nishimura Y, Nishiyama R1, Kitago M, Masugi Y, Ueno A, Aiura K, Kawachi S, Kawaida M, Abe Y, Shinoda M, Itano O, Tanimoto A, Sakamoto M: Keio J Med 2015/6; 64 (2): 26-31. (ŒŽR@—º1: 1ŠO‰È)

310017. [Ç—á•ñ] A rapidly growing epidermoid cyst in an intrapancreatic accessory spleen treated by laparoscopic spleen-preserving distal pancreatectomy: Report of a case. Kumamoto Y1, Kaizu T1, Tajima H1, Kubo H1, Nishiyama R1, Watanabe M1: Int Surg 2015/6/2. [Epub ahead of print] (ŒGŒ³—Y‰î1, ŠC’ËMŽj1, “c“‡@O1, ‹v•Û”CŽj1, ŒŽR@—º1, “n粏¹•F1: 1ŠO‰È)

310018. [Ç—á•ñ] Retroperitoneal schwannoma between the inferior vena cava and the abdominal aorta resected by laparoscopic surgery: A case report. Nishizawa N1, Kumamoto Y2, Hirata M3, Watanabe M2: Asian J Endosc Surg 2015/8; 8 (3): 361-4. (ŒàVL‹±1, ŒGŒ³—Y‰î2, •œ“cŒõ”Ž3, “n粏¹•F2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

320019. [Ç—á•ñ] –Ó’°ŒeŽºoŒŒTAEŒã‚É’°ŠÇ‹•ŒŒ‚Ì‚œ‚ß• o‹Ÿ•â•‰ºŽèp‚ðŽ{s‚µ‚œ1—á. ”‹ŒŽçŒb1, ’†‘º—²r1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ”óŒû@Ši1, b”ã“c•Žu1, ŽR—œ‚L1, “à“¡³‹K1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È, 2•úŽËü (‰æ‘œ)): “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2016/3; 36 (3): 609-12.

520010. [‘à]yLower G.I./Colon and Rectum Cancer ‘å’°ŠàzIII. Œ‹’°E’Œ’°Šà‚ɑ΂·‚é•â•‰»ŠwE‰»Šw•úŽËü—Ö@. ²“¡•˜Y1, ’†‘º—²r1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ¬â–ùŒ«1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): Šà‚Ɖ»Šw—Ö@ 2015/11; 42 (11): 1368-73.

522102. [uÀ]y“ÁW: ‘å’°• o‹Ÿ‰ºŽèp|‡•¹Çƒ[ƒ‚ð‚ß‚Ž‚µ‚œ”éô|zŽèpŽè‹Z@• o‹Ÿ‰º‰¡sŒ‹’°Øœp ¬‘q’Œl, “n粏¹•F1, ²“¡•˜Y1, “à“¡³‹K1, ŽR—œ‚L1 (1ŠO‰È): Žèp 2015/4; 69 (5): 705-12.

522103. [uÀ]y“ÁW: ‘å’°Šàf—ÃUpdatezŠî‘b‚ÌUpdate@‘å’°Šà‚̈â“`ŽqˆÙí‚Ì“Á’¥‚Ɛ¶•šŠw“IˆÓ‹`. ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ˆãŠw‚Ì‚ ‚ä‚Ý 2015/6; 253 (10): 945-51.

522104. [uÀ]yuÀ: ‘æ28‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€z• o‹Ÿ‰º‘å’°ŠàŽèp‚Í’áNP‚Æ‚¢‚Š‚é‚©. ’†‘º—²r1, ²“¡•˜Y1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): –k—¢ˆãŠw 2015/6; 45 (1): 41-6.

522105. [uÀ]y“ÁW: ‘̍o‹Ÿ‰º ã•”Á‰»ŠÇŽèpz‘̍o‹Ÿ‰ºH“¹ŠàŽèpzIII. ‚»‚Ì‘Œ@2. ‹t—¬«H“¹‰Š. •Ð“c‰Ä–ç1, X’JGŒõ1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ŠO‰È 2015/7; 77 (7): 805-11.

522106. [uÀ]y“ÁW: ƒGƒLƒXƒp[ƒg‚̏Á‰»ŠÇ•«‡‚ðŠw‚ԁz‘å’°ŠO‰È‚É‚š‚¯‚éÁ‰»ŠÇ•«‡‚̃Rƒc|Œ‹’°. “à“¡³‹K1, ’†‘º—²r1, ²“¡•˜Y1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ŒÃé@Œ›2, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): —Տ°ŠO‰È 2015/10; 70 (10): 1231-4.

522107. [uÀ]y“ÁW: “àŽ‹‹ŸŠO‰ÈŽèp‚̏Á‰»ŠÇ•«‡|ƒRƒc‚ƃsƒbƒgƒtƒH[ƒ‹zII. Œ‹’°E’Œ’°—̈æ@1. • o‹Ÿ‰ºŒ‹’°Øœp‚É‚š‚¯‚éˆÀ‘S‚ȑ̍oŠO‹@”\“I’[X•«‡. ŽR—œ‚L1, ’†‘º—²r1, ²“¡•˜Y1, “à“¡³‹K1, ×“c@Œj1, ¬‘q’Œl, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): Žèp 2016/1; 70 (1): 29-34.

522108. [uÀ]y“ÁW: ‘å’°ESD/EMRƒKƒCƒhƒ‰ƒCƒ“‚̐³‚µ‚¢‰^—p‚Ì‚œ‚߂Ɂz3. ŠO‰Èˆã‚Ì—§ê‚©‚ç‚Ý‚œVƒKƒCƒhƒ‰ƒCƒ“‚Æ‚»‚̉ۑè. ²“¡•˜Y1, ’†‘º—²r1, ¬â–ùŒ«1, “à“¡³‹K1, ŽR—œ‚L1, “n粏¹•F1 (1ŠO‰È): —ÕଏÁ‰»Ší“à‰È 2016/1; 31 (1): 77-83.

522109. [uÀ]y“ÁW: ‚ª‚ñ’áNPŽ¡—Â̍ŐV’mŒ©z[Šî‘b] Á‰»ŠÇ‚ª‚ñ (H“¹EˆÝE‘å’°) ‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚ÌŒ»‹µ‚Æ“W–]. ŽR—œ‚L1, ’†‘º—²r1, ²“¡•˜Y1, “à“¡³‹K1, ×“c@Œj1, ¬‘q’Œl, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ÅVçΛ{ 2016/3; 71 (3): 365-71.

522110. [uÀ]y“ÁW: is‘å’°Šà‚ɑ΂·‚é“àŽ‹‹ŸŠO‰ÈŽèp‚ÌŒÀŠEzII. Še˜_@5. ‹ÇŠis’Œ’°Šà‚ɑ΂·‚é“àŽ‹‹Ÿ‰ºŽèp. ŽO‰YŒ[Žõ1, ’†‘º—²r1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, “›ˆä“ÖŽq1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ŠO‰È 2016/3; 78 (3): 256-63.

[’˜@‘]

620074. [Šwp‘ (•ª’SŽ·•M)]y‚í‚©‚è‚â‚·‚¢Á‰»ŠíŠàŽ¡—ẪRƒ“ƒZƒ“ƒTƒX (Á‰»ŠíŠO‰È2015”N4ŒŽ‘Š§†)zIII. ‘å’°Šà‚̐f’f‚ÆŽ¡—Á@4. Œ‹’°Šà‚ÌŠO‰ÈŽ¡—Á@2) • o‹Ÿ‰ºŽèp, p.635-9. “à“¡³‹K1, “n粏¹•F1 (1ŠO‰È), •Ò:uÁ‰»ŠíŠO‰Èv•ÒWˆÏˆõ‰ï, ‚Ö‚é‚·o”Å, “Œ‹ž, 2015/4”­s.

620075. [Šwp‘ (•ª’SŽ·•M)]yÁ‰»ŠíEˆê”ÊŠO‰ÈŽèp‚ÌPearls & Tips|ƒƒ“ƒ‰ƒ“ƒNã‚ÌŽèp‚ð’B¬‚·‚é‹Z‚Æ’mŒb (—Տ°ŠO‰È2015”N10ŒŽ† (‘Š§†))z1. H“¹@H“¹ƒAƒJƒ‰ƒVƒAŽèp, p.34-40. •Ð“c‰Ä–ç1, X’JGŒõ1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ×“c@Œj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç), ˆãŠw‘‰@, “Œ‹ž, 2015/10”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713048. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery for locally advanced sigmoid colon cancer: short and long-term clinical outcomes. Yamanashi T1, Sato T1, Tsutsui A1, Miura H1, Ogura N, Naito M1, Nakamura T1, Watanabe M1: Digestive Disorders Federation 2015 (DDF2015) (2015/6/22), London, UK. (ŽR—œ‚L1, ²“¡•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, “à“¡³‹K1, ’†‘º—²r1, “n粏¹•F1: 1ŠO‰È)

713049. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery for rectal cancer after preoperative chemoradiotherapy. Nakamura T1, Sato T1, Tsutsui A1, Miura H1, Ogura N, Naito M1, Yamanashi T1, Watanabe M1: Digestive Disorders Federation 2015(DDF2015) (2015/6/22), London, UK. (’†‘º—²r1, ²“¡•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, “à“¡³‹K1, ŽR—œ‚L1, “n粏¹•F1: 1ŠO‰È)

713050. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A risk model for surgical site infection in the gastric cancer surgery using date of 790 patients. Hosoda K1: 46th World Congress of Surgery (2015/8/26), Bangkok, Thai. (×“c@Œj1: 1ŠO‰È)

713051. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery with the vascular pedicleligation using automatic stapling device for until T2 left side colon cancer. Naito M1, Sato T1, Nakamura T1, Ogura N, Yamanashi T1, Miura H1, Tsutsui A1, Kojo K2, Yokoi K2, Watanabe M1: 3rd International Conference of Federation of Asia Clinical Oncology (FACO) (2015/10/30), Kyoto. (“à“¡³‹K1, ²“¡•˜Y1, ’†‘º—²r1, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ŒÃé@Œ›2, ‰¡ˆäŒ\Œå2, “n粏¹•F1: 1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713052. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Early and accurate prediction of pathological response by magnetic resonance imaging andultrasonography in patients undergoing neoadjuvant chemotherapy for operable breast cancer. Kaise H, Ishikawa T, Miura D, Hasegawa Y, Horiguchi J, Hayashi M, Takao S, Kim SJ, Tanino H1, Miyashita M, Konishi M, Shigeoka Y, Yamagami K, Suzuki M, Taguchi T, Akazawa K, Kohno N: 38th Annual Meeting of San Antonio Breast Cancer Symposium (2015/12/11), San Antonio, USA. (’J–ì—Tˆê1: 1ŠO‰È)

713053. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Exploring immunomodulatory effects of zoledronic acid in breast cancer from clinical trial result of neoadjuvant chemotherapy with zoledronic acid: JONIE-1 study. Sangai T, Sato E, Ishikawa T, Kaise H, Hasegawa Y, Miura D, Takao S, Suzuki M, Tanino H1, Horiguchi J, Akazawa K, Yamada A, Kohno N: 38th Annual Meeting of San Antonio Breast Cancer Symposium (2015/12/11), San Antonio, USA. (’J–ì—Tˆê1: 1ŠO‰È)

713054. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) EN-BLOC STAPLING TRANSECTION OF GLISSONIAN PEDICLES AND LHV FOR LAPAROSCOPIC LEFT LATERAL SECTIONECTOMY. Kaizu T1, Kumamoto Y1, Tajima H1, Nishiyama R1, Kawamata H1, Watanabe M1: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES2016) (2016/3/16), Boston, USA. (ŠC’ËMŽj1, ŒG–{—Y‰î1, “c“‡@O1, ŒŽR@—º1, ‰Í–”@Š°1, “n粏¹•F1: 1ŠO‰È)

713055. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Technically safety and oncological validity of laparoscopic surgery in elderly patients with colon cancer. Kojo K1, Naito M2, Watanabe M2, Yamanashi T2, Miura H2, Tsutsui A2, Ogura N, Yokoi K1, Sato T2, Nakamura T2: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES2016) (2016/3/16), Boston, USA. (ŒÃé@Œ›1, “à“¡³‹K2, “n粏¹•F2, ŽR—œ‚L2, ŽO‰YŒ[šæ2, “›ˆä“ÖŽq2, ‰¡ˆäŒ\Œå1, ²“¡•˜Y2, ’†‘º—²r2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È)

713056. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The validity for the laparoscopic colorectal surgery using the absorbable adhesion barrier made of oxidized regenerated cellulose. Naito M1, Watanabe M1, Kojo K2, Yamanashi T1, Ogura N, Miura H1, Tsutsui A1, Sato T1, Nakamura T1: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES2016) (2016/3/16), Boston, USA. (“à“¡³‹K1, “n粏¹•F1, ŒÃé@Œ›2, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ²“¡•˜Y1, ’†‘º—²r1: 1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

722059. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yH“¹Šà‚̏p‘O•â•—Ö@‚ÌŒ÷ßz•â•—Ö@–³Œø—á‚Ì‘I•Ê‚ÆŽüpŠú‚̑΍ô|H“¹Šà‚̏p‘O•â•—Ö@‚ÌŒ÷ß|. ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, Œ˜“ce—˜2, ”óŒûŸ•F, ×“c@Œj1, ŽOd–ì_˜Y1, ¬X³Žq3, ‹e’rŽj˜Y4, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à, 3•úŽËü (Žîá‡), 44•a‰@˜AŒg‹³ˆç): ‘æ69‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2015/7/3), ‰¡•l, ‘æ69‰ñ“ú–{H“¹Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2015/7; 69: 27.

722060. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) H“¹Šà‚̃GƒsƒQƒmƒ€‰ðÍ‚ÆŽ¡—̕ʉ»‚Ö‚Ì“W–]. ŽR‰ºŒpŽj1, ‹‹vGŽ÷2, X’JGŒõ1, ×“c@Œj1, ŽOd–ì_˜N1, ]ŠÔ@—æ1, •Ð“c‰Ä–ç1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

722061. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘å’°Šà‚̕⏕‰»Šw—Ö@‚̌•ʉ»‚ð–ÚŽw‚µ‚Ä. ²“¡•˜Y1, ’†‘º—²r1, “à“¡³‹K1, “n粏¹•F1 (1ŠO‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s.

722062. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹ÇŠis‰º•”’Œ’°Šà‚ɑ΂·‚éWŠw“IŽ¡—Á`p‘O‰»Šw•úŽËü—Ö@ (NCRT) ‚ð—p‚¢‚œí—ª`. ²“¡•˜Y1, ’†‘º—²r1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®.

722063. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –TƒXƒg[ƒ}ƒwƒ‹ƒjƒA‚̊댯ˆöŽq‚ÌŒŸ“¢. ’†‘º—²r1, ²“¡•˜Y1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®.

722064. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒƒ{ƒbƒgŽx‰‡ˆÝØœp‚Ì“±“ü‚ɍۂ·‚éˆÀ‘SŠÇ—: Team STEPPS‚Æ‚Ì—Z‡. •Ð“c‰Ä–ç1, ×“c@Œj1, ŽOd–ì_˜N1, œA–ìŒbŽq, —§–ì@‘, rˆä—L”ü, X’JGŒõ1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

722065. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) The clinical outcome of conversion surgery after DCS chemotherapy in unresectable gastric cancer. ×“c@Œj1, X’JGŒõ1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, “n粏¹•F1 (1ŠO‰È): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/19), ‘啪.

723319. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A single center experience of Laparoscopic liver resections with a central focus on the right posterior sectionectomy. ŠC’ËMŽj1, ŒGŒ³—Y‰î1, ‹v•Û”CŽj1, “c“‡@O1, ŒŽR@—º1, “n粏¹•F1 (1ŠO‰È): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/16), –ŒŒÃ‰®.

723320. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚“xisˆÝŠà‚ɑ΂·‚éDocetaxel + CDDP + S-1 (DCS) —Ö@Œã‚ÌŽèp¬Ñ. ŽOd–ì_˜N1, •Ð“c‰Ä–ç1, X’JGŒõ1, ×“c@Œj1, ”óŒûŸ•F2, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y3, ¬ò˜aŽO˜Y2, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à, 34•a‰@˜AŒg‹³ˆç): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/16), –ŒŒÃ‰®.

723321. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹ŠàNear T4Ç—á‚ɑ΂·‚鎡—Ð헪. ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ×“c@Œj1, ŽOd–ì_˜N1, ]ŠÔ@—æ1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/16), –ŒŒÃ‰®.

723322. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘€‰çˆÊ‹C‹¹ + ƒƒ“ƒ|ƒCƒ“ƒg”Œ• ‰çˆÊ–@‚É‚æ‚é’èŒ^Žèp. •Ð“c‰Ä–ç1, X’JGŒõ1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ×“c@Œj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/16), –ŒŒÃ‰®.

723323. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ•Ï—ʉðÍ‚ð—p‚¢‚œ‘ŠúˆÝŠàESDŒã’ljÁŠO‰ÈØœÇ—á‚É‚š‚¯‚郊ƒ“ƒpß“]ˆÚ—\‘ªˆöŽqSM2ˆÈ[‚š‚æ‚э‚“xƒŠƒ“ƒpŠÇNP (ly2/ly3) ‚Ì“¯’è. Îˆä@’q1, ŽR‰ºŒpŽj2, ŽOd–ì_˜N2, X’JGŒõ2, ×“c@Œj2, •Ð“c‰Ä–ç2, ‹e’rŽj˜Y3, ¬ò˜aŽO˜Y4, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 34•a‰@˜AŒg‹³ˆç, 4Á‰»Ší“à): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/16), –ŒŒÃ‰®.

723324. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ûŠàŠ”‰»×–E‚ɑ΂·‚éƒtƒFƒjƒ‹ƒuƒ`ƒŒ[ƒg‚ÌŒø‰Ê‹y‚ÑŽ¡—ÃŒø‰Ê—\‘ªˆâ“`Žq‚Ì’Tõ. ‹e’r^—Žq1, ŽR‰ºŒpŽj1, ˜m’J”ü“Þ1, “ì’JØ•äŽq2, ‹‹vGŽ÷2, ŒÃé@Œ›2, ]ŠÔ@—æ1, Œ‹{—mŽj1, ¬â–ùŒ«1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/16), –ŒŒÃ‰®.

723325. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹‘åH“¹—ôEƒwƒ‹ƒjƒA‚ɑ΂·‚éŠO‰ÈŽ¡—Â̎¡—ÃŒø‰Ê‚Æ–â‘è“_`ˆÝH“¹‹t—¬‚Ì•a‘Ô•]‰¿‚ÌŠÏ“_‚©‚ç`. ×“c@Œj1, •Ð“c‰Ä–ç1, ŽOd–슰˜N1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/17), –ŒŒÃ‰®.

723326. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘O‰»Šw•úŽËüŽ¡—ÃŒã‚Ì• o‹Ÿ‰ºŽèp. ’†‘º—²r1, ²“¡•˜Y1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, “n粏¹•F1 (1ŠO‰È): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/17), –ŒŒÃ‰®.

723327. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà‚É‚š‚¯‚éSurgicalsiteinfection‚̃ŠƒXƒNˆöŽq—\‘ª. “c’†r“¹1, ²“¡•˜Y2, ŽR‰ºŒpŽj2, “›ˆä“ÖŽq2, ŽO‰YŒ[šæ2, ŽR—œ‚L2, ¬‘q’Œl, “à“¡³‹K2, ’†‘º—²r2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/17), –ŒŒÃ‰®.

723328. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà‡•¹’×ᇐ«‘å’°‰Š‚ɑ΂·‚éŠO‰ÈŽ¡—Â̕ϑJ‚Ɛ¬Ñ. “à“¡³‹K1, ’†‘º—²r1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/17), –ŒŒÃ‰®.

723329. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º—H–å•Û‘¶ˆÝØœp (Laparoscopy-Assisted Pylorus-Preserving Gastrectomy: LAPPG) ‚É‚š‚¯‚é—H–剺Ã–¬‚Ì•ªŽ}ƒpƒ^[ƒ“‚ÆŽèp¬Ñ. ŒàVL‹±1, ŽR‰ºŒpŽj2, ŸN–{Mˆê, Îˆä@’q1, ‹‹vGŽ÷1, ]ŠÔ@—æ2, ŽOd–ì_˜N2, X’JGŒõ2, ×“c@Œj2, •Ð“c‰Ä–ç2, ‹e’rŽj˜Y3, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 34•a‰@˜AŒg‹³ˆç): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/17), –ŒŒÃ‰®.

723330. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠà‚É‚š‚¯‚éŠà“ÁˆÙ“ICysteine dioxygenase type 1 (CDO1) ˆâ“`Žq‚ÌDNAƒƒ`ƒ‹‰»‚̗Տ°“IˆÓ‹`. ×“c@Œj1, ŽR‰ºŒpŽj1, ‹‹vGŽ÷2, ŽOd–ì_˜N1, X’JGŒõ1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y3, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 34•a‰@˜AŒg‹³ˆç): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/17), –ŒŒÃ‰®.

723331. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Stage I/II‘å’°Šà‚É‚š‚¯‚éÄ”­ŠëŒ¯ˆöŽq‚š‚æ‚Ñ—\Œã—\‘ªˆöŽq‚ÌŒŸ“¢. ŒÃé@Œ›1, “à“¡³‹K2, ŽR‰ºŒpŽj2, ²“¡•˜Y2, ¬‘q’Œl, ŽR—œ‚L2, ŽO‰YŒ[šæ2, “›ˆä“ÖŽq2, ’†‘º—²r2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/18), –ŒŒÃ‰®.

723332. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠà‚É‚š‚¯‚éŠà“ÁˆÙ“ICysteine dioxygenase type 1 (CDO1) ˆâ“`Žq‚ÌDNAƒƒ`ƒ‹‰» ‚̗Տ°“IˆÓ‹`. ]ŠÔ@—æ1, ŽR‰ºŒpŽj1, ‹‹vGŽ÷2, ŽOd–ì_˜N1, X’JGŒõ1, ×“c@Œj1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y3, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 34•a‰@˜AŒg‹³ˆç): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/18), –ŒŒÃ‰®.

723333. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹‘åH“¹—ôEƒwƒ‹ƒjƒA‚ɑ΂·‚éŠO‰ÈŽ¡—Â̎¡—ÃŒø‰Ê‚Æ–â‘è“_`ˆÝH“¹‹t—¬‚Ì•a‘Ô•]‰¿‚ÌŠÏ“_‚©‚ç`. X’JGŒõ1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/18), –ŒŒÃ‰®.

723334. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠisSóŒ‹’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚Ì—L—p«|T4Ç—á‚É‚š‚¯‚éŽèpŽè‹Z‚̃|ƒCƒ“ƒg|. ŽR—œ‚L1, ²“¡•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ¬‘q’Œl, “à“¡³‹K1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/18), –ŒŒÃ‰®.

723335. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒã•â•‰»Šw—Ö@‚ðŽ{s‚³‚ê‚œStageIIIŒ‹’°Šà‚Ì—\ŒãˆöŽq‰ðÍ. ‰¡ˆäŒ\Œå1, “à“¡³‹K2, ŽR‰ºŒpŽj2, ŒÃé@Œ›1, “›ˆä“ÖŽq2, ŽO‰YŒ[šæ2, ŽR—œ‚L2, ¬‘q’Œl, ²“¡•˜Y2, ’†‘º—²r2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/18), –ŒŒÃ‰®.

723336. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “àŽ‹‹ŸŽ¡—Âɂæ‚茋Îœ‹Ž‚ðs‚Á‚œ¬Ž™‘’_ŠÇŒ‹Î2—á. Š`ŒŽ@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ52‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï (2015/5/28), _ŒË.

723337. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Borderline resectableäXŠà‚Æ‚»‚ÌŽ¡—ÕûjBorderline resectableäXŠà‚ÆUnresectableäXŠà‚ɑ΂µ, p‘OŽ¡—ÃŒã‚ÉR0Øœ‚µ‚œÇ—á‚̏p‘O‰æ‘œ‚Æ•a—‚̘š—£. “c“‡@O1, ŒGŒ³—Y‰î1, ŒŽR@—º1, ‹v•Û”CŽj1, ŠC’ËMŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ27‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï (2015/6/11), “Œ‹ž.

723338. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –À‚í‚È‚¢ŠmŽÀ‚ÈäX•«‡p‚ð–ÚŽw‚µ‚Ä Š`“cŒŽ–@‚̃Rƒ“ƒZƒvƒg‚𒉎À‚ɍČ»‚·‚é‚œ‚ß‚ÌäX‹ó’°ŠÑ’Ê–§’…•«‡–@‚̍H•v. ŒGŒ³—Y‰î1, ŠC’ËMŽj1, “c“‡@O1, ‹v•Û”CŽj1, ŒŽR@—º1, •Ð‹ËŠ°”V, ŒÃ“cˆê“¿, ‚‹Ž’õl1, “n粏¹•F1 (1ŠO‰È): ‘æ27‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï (2015/6/11), “Œ‹ž.

723339. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºŠÌØœ‚É‚š‚¯‚é×ŒaççŽq‚̉ž—p. ŠC’ËMŽj1, ŒGŒ³—Y‰î1, “c“‡@O1, ‹v•Û”CŽj1, ŒŽR@—º1, “n粏¹•F1 (1ŠO‰È): ‘æ27‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï (2015/6/12), “Œ‹ž.

723340. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äX”X–E«ŽŸŠ³‚ÌŽ¡—Õûj IPMN‚ÌŽèp“K‰ž‚ÆŽŠ“KpŽ®‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ŒŽR@—º1, ŒGŒ³—Y‰î1, “c“‡@O1, ‹v•Û”CŽj1, ŠC’ËMŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ27‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï (2015/6/12), “Œ‹ž.

723341. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~‹}ŠO—ˆ‚Å‘}ŠÇ‚ðŽ{s‚µ‚œèò•”ùN–E«ŽîáŽ2—á. Š`ŒŽ@’m1, “c’†@Œ‰2, •“cŒ›Žq1, ˆÀ“¡@Žõ3, ‰i·—T‰ÀŽq3, ŒŽŒûŒ[”V‰î3 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3¬Ž™): ‘æ29‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ïŠwpW‰ï (2015/6/12), ‚³‚¢‚œ‚Ü.

723342. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) f’fEŽ¡—Âɋꗶ‚µ‚œ“ûŽ™‹}«‰AùNÇ2Ç—á. æс@—T—º1, “c’†@Œ‰2, •“cŒ›Žq1, Š`ŒŽ@’m1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ29‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ïŠwpW‰ï (2015/6/12), ‚³‚¢‚œ‚Ü.

723343. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) IPMN‚̏pŒãfollow‚ÉŠÖ‚í‚鏔–â‘è IPMNpŒã‚ÌŽcäXÄ”­‚ÆŽcäXIPMN‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ŒŽR@—º1, ŒGŒ³—Y‰î1, “c“‡@O1, ‹v•Û”CŽj1, ŠC’ËMŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ46‰ñ“ú–{äX‘ŸŠw‰ï‘å‰ï (2015/6/20), –ŒŒÃ‰®.

723344. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) IPMN‚̏pŒãfollow‚ÉŠÖ‚í‚鏔–â‘è IPMNpŒãŽcäXØœ88—á‚ÌŒŸ“¢‚©‚猩‚œpŒãfollow‚Ì–â‘è“_. ‘ëì@õ, –k‹œ@ŽÀ, ‰Í–”@Š°1, ”–ì@—, Œˆä~ˆê (1ŠO‰È): ‘æ46‰ñ“ú–{äX‘ŸŠw‰ï‘å‰ï (2015/6/20), –ŒŒÃ‰®.

723345. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ûŠà‚É‚š‚¯‚éHOPXˆâ“`Žqƒƒ`ƒ‹‰»‚̗Տ°“IˆÓ‹`. ‹e’r^—Žq1, ŽR‰ºŒpŽj1, ˜m’J”ü“Þ1, “ì’JØ•äŽq2, Œ‹{—mŽj1, ‰Á“¡@O1, ¬â–ùŒ«1, åÎ‹I•F1, ‰|–{‘ñ–Î1, ’J–ì—Tˆê1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2015/7/2), “Œ‹ž.

723346. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ûŠàp‘O‰»Šw—Ö@ (PST) Ç—á‚É‚š‚¯‚éSPECT/CT‚ð—p‚¢‚œƒZ ƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpß”­Œ»‚Ì•ªÍ. åU•À@Ÿ, Œ‹{—mŽj1, ˜m’J”ü“Þ1, åÎ‹I•F1, ’J–ì—Tˆê1, “n粏¹•F1 (1ŠO‰È): ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2015/7/2), “Œ‹ž.

723347. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) FECŽ{s“ûŠàŠ³ŽÒ‚É‚š‚¯‚é”­”M«D’†‹…Œž­Ç”­Ç‚ÉŠÖ‚·‚錟“¢. Œï]‚ß‚®‚Ý1, ‹e’r^—Žq1, “ì’JØ•äŽq2, Œ‹{—mŽj1, ‰Á“¡@O1, ¬â–ùŒ«1, ‰|–{‘ñ–Î1, åÎ‹I•F1, ’J–ì—Tˆê1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2015/7/3), “Œ‹ž.

723348. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘O‰»Šw—Ö@‚ðŽ{s‚µ‚œtriple negative“ûŠàÇ—á‚É‚š‚¯‚é BRCAness‚ÉŠÖ‚·‚錟“¢. –ŸÎ’èŽq, ¬âŒ«–ù1, “ì’JØ•äŽq2, ‹e’r^—Žq1, ˜m’J”ü“Þ1, ‰|–{‘ñ–Î1, åÎ‹I•F1, ’J–ì—Tˆê1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2015/7/3), “Œ‹ž.

723349. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éPTX + Bv| FEC‚É‚æ‚éPST‚ÌŒŸ“¢. “¡–ìŽjD1, ‰Í–ì—uŽq1, “ì’JØ•äŽq2, ‹e’r^—Žq1, Œ‹{—mŽj1, ˜m’J”ü“Þ1, ‰Á“¡@O1, ‰|–{‘ñ–Î1, ’J–ì—Tˆê1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2015/7/3), “Œ‹ž.

723350. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ûŠàŽ¡—Âɂš‚¯‚étri-weekly nab-paclitaxel ‚Æweekly paclitaxel ‚Ì•›ì—p’²ž. Œ‹{—mŽj1, ˜m’J”ü“Þ1, ¬â–ùŒ«1, åÎ‹I•F1, ’J–ì—Tˆê1, Œú“cKˆê˜Y2 (1ŠO‰È, 2–òÜ•”): ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2015/7/3), “Œ‹ž.

723351. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ûŠà‚É‚š‚¯‚éCDO1ˆâ“`Žqƒƒ`ƒ‹‰»‚ƗՏ°•a—Šw“IˆöŽq‚ÌŒŸ“¢. ˜m’J”ü“Þ1, ‹e’r^—Žq1, Œ‹{—mŽj1, ¬â–ùŒ«1, ‰Á“¡@O1, ‰|–{‘ñ–Î1, åÎ‹I•F1, ’J–ì—Tˆê1, “n粏¹•F1 (1ŠO‰È): ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2015/7/2-4), “Œ‹ž.

723352. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹ˆÝŠÇŠíŠB•«‡‚̍H•v. X’JGŒõ1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ69‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2015/7/3), ‰¡•l.

723353. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹‰^“®áŠQ‚̐f—Á|V‚µ‚¢f’f–@‚ƍłà—LŒø‚ÈŽ¡—Âɂ‚¢‚ā|ƒAƒJƒ‰ƒVƒA‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚̐¬Ñ‚Æ–â‘è“_: ’ŒüŒ^‚ƃVƒOƒ‚ƒCƒhŒ^‚Ì”äŠr. •Ð“c‰Ä–ç1, X’JGŒõ1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ69‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2015/7/3), ‰¡•l.

723354. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹Šà‚̏p‘O•â•—Ö@‚ÌŒ÷ß|•â•—Ö@–³Œø—á‚Ì‘I•Ê‚ÆŽüpŠú‚̑΍ô: H“¹Šà‚̏p‘O•â•—Ö@‚ÌŒ÷ß. ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, Œ˜“ce—˜2, ”óŒûŸ•F2, ×“c@Œj1, ŽOd–ì_˜Y1, ¬X³Žq3, ‹e’rŽj˜Y4, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à, 3•úŽËü (Žîá‡), 44•a‰@˜AŒg‹³ˆç): ‘æ69‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2015/7/3), ‰¡•l.

723355. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹ŠàpŒã‡•¹Ç‚̃ŠƒXƒN‰ðÍ. ×“c@Œj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ŒàVL‹±2, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ‹e’rŽj˜Y3, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 34•a‰@˜AŒg‹³ˆç): ‘æ69‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2015/7/3), ‰¡•l.

723356. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Š`“cŒŽ–@‚̃Rƒ“ƒZƒvƒg‚ðŽÀŒ»‚·‚é‚œ‚ß‚ÌäX‹ó’°ŠÑ’Ê–§’…•«‡–@‚É‚š‚¯‚éH•v. ŒGŒ³—Y‰î1, ŠC’ËMŽj1, “c“‡@O1, ‹v•Û”CŽj1, ŒŽR@—º1, •Ð‹ËŠ°”V, ŒÃ“cˆê“¿, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/15), •lŒ.

723357. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹o‹Ÿ‰ºH“¹ŠàŽèp: ‘€‰çˆÊ‹C‹¹+ƒƒ“ƒ|ƒCƒ“ƒg”Œ• ‰çˆÊ–@‚É‚æ‚écŠuƒŠƒ“ƒpßŠfŽ‚̍H•v. •Ð“c‰Ä–ç1, X’JGŒõ1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ×“c@Œj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/15), •lŒ.

723358. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –ü’…«ƒCƒŒƒEƒX‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚ÌŒŸ“¢. “›ˆä“ÖŽq1, ’†‘º—²r1, ŽO‰YŒ[šæ1, ŒÃé@Œ›2, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ²“¡•˜Y1, Îˆä—ǍK, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/15), •lŒ.

723359. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) cStage II/IIIH“¹Šà‚ɑ΂·‚éDCF“±“ü—Ö@‚É‚æ‚échemoselection‚̗Տ°“Iƒ|ƒeƒ“ƒVƒƒƒ‹. ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, Œ˜“ce—˜2, X’JGŒõ1, ×“c@Œj1, ŽOd–ì_˜N1, ¬X³Žq3, ‹e’rŽj˜Y4, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à, 3•úŽËü (Žîá‡), 44•a‰@˜AŒg‹³ˆç): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/16), •lŒ.

723360. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠisŒ‹’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚Ì—L—p«|T4Ç—á‚É‚š‚¯‚éŽèpŽè‹Z|. ŽR—œ‚L1, ²“¡•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ¬‘q’Œl, “à“¡³‹K1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/16), •lŒ.

723361. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹—ÞŠî’ê×–EŠà (BSC) ‚̗Տ°•a—Šw“I“Á’¥‚Æ–â‘è“_. ”óŒû@Ši1, X’JGŒõ1, “¡—яДü, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y2, ‘å•”@œ3, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç, 3ˆã—Éq¶Šw•”): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/16), •lŒ.

723362. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) isˆÝŠàŠ³ŽÒ‚É‚š‚¯‚épŒã•â•‰»Šw—Ö@ŠŽŽó«—\‘ª-Cysteine dioxygenase type 1ˆâ“`ŽqDNAƒƒ`ƒ‹‰»‚ð—p‚¢‚Ä. ]ŠÔ@—æ1, ŽR‰ºŒpŽj1, ‹‹vGŽ÷2, ŽOd–ì_˜N1, X’JGŒõ1, ×“c@Œj1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y3, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 34•a‰@˜AŒg‹³ˆç): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/16), •lŒ.

723363. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • –Œ“]ˆÚ—z« (P1 and/or CY1) ˆÝŠà‚ɑ΂·‚éDCS—Ö@Œã‚Ìconversion surgery. ŽOd–ì_˜N1, •Ð“c‰Ä–ç1, X’JGŒõ1, ×“c@Œj1, ”óŒûŸ•F, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, ¬ò˜aŽO˜Y3, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç, 3Á‰»Ší“à): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/16), •lŒ.

723364. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Collard•Ï–@—p‚¢‚œH“¹ˆÝŠÇ•«‡‚̍H•v`ŠmŽÀ‚ȍČš‚ð–ÚŽw‚µ‚ā`. X’JGŒõ1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/17), •lŒ.

723365. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) IPMN‚ÌŽèp“K‰ž‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ŒŽR@—º1, ŒGŒ³—Y‰î1, “c“‡@O1, ‹v•Û”CŽj1, ŠC’ËMŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/17), •lŒ.

723366. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ï‰A‘nŠŽõ‚̊댯ˆöŽq‚ÌŒŸ“¢. ’†‘º—²r1, ²“¡•˜Y1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/17), •lŒ.

723367. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠis’Œ’°Šà‚ɑ΂·‚鎊“K‚ȏWŠw“IŽ¡—Ã‚ðŒŸ“¢‚·‚é`p‘O‰»Šw•úŽËü—Ö@‚Æ• o‹Ÿ‰ºŽèp‚ÌŽ¡—ЬÑ`. “à“¡³‹K1, ²“¡•˜Y1, ’†‘º—²r1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/17), •lŒ.

723368. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ‹’°ŠàpStage III‚Ì“–‰@‚É‚š‚¯‚鎡—ЬÑ (75ÎˆÈã‚Æ74ÎˆÈ‰º‚Ì”äŠr). ŽO‰YŒ[šæ1, ’†‘º—²r1, “›ˆä“ÖŽq1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/17), •lŒ.

723369. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹ˆÝÚ‡•”‘ŠúŠà‚ÌŽ¡—Ð헪. ×“c@Œj1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, X’JGŒõ1, ŽOd–ì_˜N1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/17), •lŒ.

723370. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºÄŠÌØœÇ—á‚ÌŒŸ“¢. ŠC’ËMŽj1, ŒGŒ³—Y‰î1, ŒŽR@—º1, “c“‡@O1, ‹v•Û”CŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/17), •lŒ.

723371. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º”ö‘€äXØœ‚ł̃sƒbƒgƒtƒH[ƒ‹‚Æ‚»‚̍H•v. “c“‡@O1, ŒGŒ³—Y‰î1, ŒŽR@—º1, ‹v•Û”CŽj1, ŠC’ËMŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2015/7/17), •lŒ.

723372. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šài“W‚É‚š‚¯‚鍜‘—R—ˆ—}§×–E‚̈Ӌ`. ‰Á“¡@O1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ24‰ñ“ú–{‚ª‚ñ“]ˆÚŠw‰ïŠwpW‰ïE‘‰ï (2015/7/24), ‘åã.

723373. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒgƒ}•Âœ‘n‚ð—˜—p‚µ‚œ• o‹Ÿ‰ºŠÌØœ. “¡“cãĕœ1, ŠC’ËMŽj1, “¡”örˆò1, ’†Œ@—º1, ŒŽR@—º1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒ³—Y‰î1, “n粏¹•F1 (1ŠO‰È): 4th Reduced Port Surgery Forum 2015 in Akita (2015/8/1), H“c.

723374. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º”ö‘€äXØœ (LDP) ‚ł̍׌aƒŠƒgƒ‰ƒNƒ^[‚ÌŽg—pŒoŒ±. “c“‡@O1, ŒGŒ³—Y‰î1, ŒŽR@—º1, ‰Í–”@Š°1, ŠC’ËMŽj1, “n粏¹•F1 (1ŠO‰È): 4th Reduced Port Surgery Forum 2015 in Akita (2015/8/1), H“c.

723375. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è) ’_“¹•ÂœÇpŒã–å–¬ˆ³˜ŽiÇ‚É”º‚€ˆÝH“¹Ã–¬áŽ‚ɑ΂µ“àŽ‹‹Ÿ“IÃ–¬áŽŒ‹ãFpEVL‚ðs‚¢, ŠÌˆÚA‚܂ŗǍD‚ÉŒo‰ß‚Å‚«‚œ“ûŽ™‚Ì1—á. •“cŒ›Žq1, “ú‚@‰›2, ŽRªŒhŽq3, “c’†@Œ‰4, Š`ŒŽ@’m1, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ22‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (2015/9/10), ‰¡•l, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2015/8; 21 (3): 148.

723376. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’_ùN‰Œ«“®–¬áŽ”j—ô‚É‚æ‚è’_”X“àoŒŒ‚𗈂µ‚œ1—á. ‰Í–”@Š°1, ‘ëì@õ, Œˆä~ˆê (1ŠO‰È): ‘æ51‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï (2015/9/17), ‰F“s‹{.

723377. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PPARƒÂ‚ÍCD11b + CD103 + Ž÷ó×–E‚ð‰î‚µ‚ĉŠÇŠÖ˜A‘å’°Žîá‡. ‰Á“¡@O1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8), –ŒŒÃ‰®.

723378. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‘å’°ŠàŽèp‚Í’áNP‚Æ‚¢‚Š‚é‚©. ’†‘º—²r1, “n粏¹•F1, ²“¡•˜Y1 (1ŠO‰È): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8), –ŒŒÃ‰®.

723379. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹Šà‚É‚š‚¯‚é—\Œã—\‘ªƒoƒCƒIƒ}[ƒJ[ CDO1ˆâ“`Žqƒƒ`ƒ‹‰». ŽR‰ºŒpŽj1, ‹‹vGŽ÷2, ]ŠÔ@—æ1, X’JGŒõ1, ×“c@Œj1, ŽOd–ì_˜N1, •Ð“c‰Ä–ç1, ‰Á“¡@O1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/9), –ŒŒÃ‰®.

723380. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) is‰º•”’Œ’°Šà‚ɑ΂·‚ép‘O‰»Šw•úŽËü—Ö@‚ÌŽ¡—Õ]‰¿‚Æ’·Šú—\Œã. ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/9), “Œ‹ž.

723381. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà‚ÌŠÌ“]ˆÚÇ—á‚ɑ΂·‚鎡—Ð헪. ²“¡•˜Y (ŠO‰È): ‘æ23‰ñ“ú–{Á‰»ŠíŠÖ˜AŠw‰ïTŠÔ (JDDW 2015) (2015/10/9), “Œ‹ž.

723382. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Pure laparoscopic caudate hepatectomy for cancer:Surgical technique and a report of a case. ŒŽR@—º1, ŠC’ËMŽj1, ‰Í–”@Š°1, “c“‡@O1, ŒG–{—Y‰î1, “n粏¹•F1 (1ŠO‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

723383. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Siewert type IIH“¹ˆÝÚ‡•”‘BŠà‚ɑ΂·‚郊ƒ“ƒpßŠsŽŒø‰Ê‚ÆŽŠ“KŠsŽ”͈Í. ×“c@Œj1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, X’JGŒõ1, ŽOd–ì_˜N1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

723384. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Stage II/IIIŒ‹’°Šà‚̍Ĕ­ƒŠƒXƒN—\‘ª‚Æ‚µ‚Ä‚ÌOncotype Dx Colon Cancer Assay‚Ì—L—p«. ‹ààVˆ®é, ŽR’†’|t, ŽRèŒ’‘Ÿ˜Y, ŽRŒûŒ€¬, Žº@@Œ\, ’r“c³F, “í–{“N–ç, A’|G”V, ²“¡•˜Y1, ‰Á“¡Œ’Žu, m‰È’q—T, ‰«@‰pŽŸ, Ô–؁@‹†, ‘å‹Ž–õ—Y, ‹g–ìF”V (1ŠO‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

723385. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹Šà‚̃GƒsƒQƒmƒ€‰ðÍ‚ÆŽ¡—̕ʉ»‚Ö‚Ì“W–]. ŽR‰ºŒpŽj1, ‹‹vGŽ÷2, X’JGŒõ1, ×“c@Œj1, ŽOd–ì_˜N1, ]ŠÔ@—æ1, •Ð“c‰Ä–ç1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

723386. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‹³Žº‚É‚š‚¯‚éStage IIIŒ‹’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŒ‹’°Žèp‚Ì’·Šú¬Ñ. ‰¡ˆäŒ\Œå1, “à“¡³‹K2, “c’†r“¹1, ŒÃé@Œ›1, “›ˆä“ÖŽq2, ŽO‰YŒ[šæ2, ŽR—œ‚L2, ¬‘q’Œl, ’†‘º—²r2, ²“¡•˜Y2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s.

723387. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‘å’°Øœ‚ðŽ{s‚µ‚œStage I/II Œ‹’°Šà‚É‚š‚¯‚é—\ŒãˆöŽq‚ÌŒŸ“¢. ŒÃé@Œ›1, “à“¡³‹K2, ‰Á“¡@O2, ²“¡•˜Y2, ’†‘º—²r2, ¬‘q’Œl, ŽR—œ‚L2, ŽO‰YŒ[šæ2, “›ˆä“ÖŽq2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s.

723388. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”牺–„‚ߍž‚ÝŒ^’†SÃ–¬ƒ|[ƒg‚̍‡•¹Ç‚ÌŒŸ“¢. ’†‘º—²r1, ²“¡•˜Y1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/31), ‹ž“s.

723389. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒvƒƒvƒ‰ƒmƒ[ƒ‹“à•ž‚É‚æ‚èk¬‚ð”F‚ß‚œKlippel-TrenaunayÇŒóŒQ‚Ì1—á. Š`ŒŽ@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ31‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïH‹GƒVƒ“ƒ|ƒWƒEƒ€ (2015/10/31), ŒF–{.

723390. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Japan Clinical Oncology Group Study JCOG0404 (ŠJ• vs• o‹Ÿ‘å’°Øœ) ‚É‚š‚¯‚éŽ{ÝŠÔ·‚̉ðÍ. •ÐŽR@G, ŽR–{¹ˆê˜Y, âV“¡“T’j, âV“¡CŽ¡, “¡ˆä³ˆê, ¬Œ•¶—Y, Ä“c–F‹v, ’·’Jì”Žr, ‰ª“‡³ƒ, @‘œN”Ž, ²“¡•˜Y1, ”º“oGs, ‰ÔˆäPˆê, ’––“‰ëŽj, –k–쐳„, “‡“cˆÀ”Ž (1ŠO‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®.

723391. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery for locally advanced T4a colon cancer –treatment outcomes and prognostic factors-. ŽR—œ‚L1, ²“¡•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ¬‘q’Œl, “à“¡³‹K1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®.

723392. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) StageIII‘å’°ŠàpŒã‚ÌŽŠ“K‚ȃT[ƒxƒCƒ‰ƒ“ƒX‚ɑ΂·‚錟“¢. ŒÃé@Œ›1, “à“¡³‹K2, ²“¡•˜Y2, ’†‘º—²r2, ¬‘q’Œl, ŽR—œ‚L2, ŽO‰YŒ[šæ2, “›ˆä“ÖŽq2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®.

723393. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—’°ŠàŠ³ŽÒ‚É‚š‚¯‚épŒã•â•—Ö@‚Ì•K—v«. ŽO‰YŒ[šæ1, ’†‘º—²r1, “›ˆä“ÖŽq1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®.

723394. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š‚ɑ΂·‚é• o‹Ÿ‰º‘å’°‘S“Ep‚Ì—L—p«‚ÌŒŸ“¢‚Æ•‹y‚Ì‚œ‚߂̍H•v. “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ¬àV•œ‘Ÿ1, ’r“c@“Ä1, ŒÃé@Œ›2, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®.

723395. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éstage 4‘å’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚ÌŒŸ“¢. “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ŒÃé@Œ›2, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®.

723396. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 85ÎˆÈã‚Ì’Ž‚—îŽÒ‚ɑ΂·‚é‘å’°ŠàŽèp‚̑Ó–«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. óŒŽŽj‘ì, Œˆä~ˆê, Î“c—mŽ÷, ŠÖ–{Nl, ¬‘q³Ž¡, ‰Í–”@Š°1, ‚ŽR@L, ‘ëì@õ, ŒŽ“c—T‹v, ²“¡“¹•v (1ŠO‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/13-14), –ŒŒÃ‰®.

723397. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠisŒ‹’°ŠàT4aÇ—á‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚ÌŒŸ“¢|Ž¡—ЬÑ‚Æ—\Œã—\‘ªˆöŽq|. ŽR—œ‚L1, ²“¡•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ¬‘q’Œl, “à“¡³‹K1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/13-14), –ŒŒÃ‰®.

723398. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 3 ESDŽ{sŒã‚ɒljÁØœ‚ðs‚Á‚œ‘ŠúˆÝŠà‚Ì1—á. •œ—ÇŽÑŒŽ, ŽOd–ì_˜N1, ŒŽ“cG‹P1, ŽO‘º—I—S, ‰¡“c˜aŽq1, X’JGŒõ1, ×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723399. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒRƒ“ƒsƒ…[ƒ^ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚É‚æ‚éˆÝŠà‚̐V‚µ‚¢f’f–@: MD-CT‚ð—p‚¢‚œŽîᇂÌ3ŽŸŒ³—§‘̍\’z, ‘̐ϒl‘ª’è‚̗Տ°“IˆÓ‹`‚Ə«—ˆ‚Ö‚Ì“W–]. ‹e’rŽj˜Y1, ŽOd–ì_˜N2, X’JGŒõ2, ×“c@Œj2, ŽR‰ºŒpŽj2, •Ð“c‰Ä–ç2, “n粏¹•F2 (14•a‰@˜AŒg‹³ˆç, 2ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723400. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒ{ƒbƒgŽx‰‡ˆÝØœp‚Ì“±“ü‚ɍۂ·‚éƒsƒbƒgƒtƒH[ƒ‹‚Ƒ΍ô. •Ð“c‰Ä–ç1, ×“c@Œj1, ŽOd–ì_˜N1, X’JGŒõ1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723401. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹Ù‹}ŽèpŒã‹~–œ‚µ“Ÿ‚œ, ’_ŠÇƒXƒeƒ“ƒgˆí’E‚É‚æ‚鏬’°úE‚Ì1—á. ŽO‘º—I—S, ×“c@Œj1, ŒŽ“cG‹P1, ‰¡“c˜aŽq1, ŽOd–ì_˜N1, X’JGŒõ1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723402. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽcˆÝŠàŽèp—á‚É‚š‚¯‚é—Տ°•a—Šw“I—\ŒãˆöŽq‚ÌŒŸ“¢‚ƈӋ`. ]ŠÔ@—æ1, ŽR‰ºŒpŽj1, “ì’JØ•äŽq2, ‹‹vGŽ÷2, ŒàVL‹±2, Îˆä@’q2, ŽOd–ì_˜N1, X’JGŒõ1, ×“c@Œj1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y3, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 34•a‰@˜AŒg‹³ˆç): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723403. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ã•”“àŽ‹‹Ÿ“I”S–Œ‰º‘w”—£p (ESD) Œã‚ɒljÁØœ‚ðs‚Á‚œ‘ŠúˆÝ‘BG•œã”çŠà‚̈ê—á. Œ–{ŒõŒ\, ŽOd–ì_˜N1, •yˆä‘å“ñ˜Y, ‰¡“c˜aŽq1, ŒŽ“cG‹P1, X’JGŒõ1, ×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723404. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹Šà‚ɑ΂·‚é Minimally invasive surgery (MIS). ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ×“c@Œj1, ŽOd–ì_˜N1, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723405. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºŽèp‚ɂĐ؏œ‚µ“Ÿ‚œ‚“x’_ŠÇZ‚𔺂€‘å’°ŠàŠÌ“]ˆÚ‚Ì2—á. Îèƒ˜Y, ŒŽR@—º1, “¡“cãĕœ1, “¡”örˆò1, ’†Œ@—º1, ‰Í–”@Š°1, “c“‡@O1, ŠC’ËMŽj1, ŒGŒ³—Y‰î1, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723406. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‘å’°ŠàŽèp‚É‚š‚¯‚é‘nŠŽõŠëŒ¯ˆöŽq‚ÌŒŸ“¢. ’†‘º—²r1, ²“¡•˜Y1, ŽR‰ºŒpŽj1, “à“¡³‹K1, ŽR—œ‚L1, ¬‘q’Œl, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723407. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ•â•‰º•¬–å‘€ˆÝØœŒã‚ÌMII-pH study‚ð—p‚¢‚œ•a‘Ô‰ðÍ. ŸN’J”ü‹MŽq1, •Ð“c‰Ä–ç1, X’JGŒõ1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723408. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€“ûŠàpŒã‚ÌŒo‰ß’†‚É”F‚ß‚œƒCƒŒƒEƒX‚𔺂€’Œ’°“]ˆÚ‚Ì1—á. ‰iˆäˆŸˆß, åÎ‹I•F1, “¡–ìŽjD1, ‰Í–ì—uŽq1, M‘ŸºŽq1, ‹e’r^—Žq1, “ì’JØ•äŽq2, ˜m’J”ü“Þ1, ¬â–ùŒ«1, ‰|–{‘ñ–Î1, ’J–ì—Tˆê1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.

723409. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MII|pH‚ªŽ¡—ÕûjŒˆ’è‚É—L—p‚Å‚ ‚Á‚œ‹‘åH“¹—ôEƒwƒ‹ƒjƒA‚̈ê—á. ‰¡“c˜aŽq1, X’JGŒõ1, ŒŽ“cG‹P1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/27), •Ÿ‰ª.

723410. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) iN«ƒCƒŒƒEƒX‚𗈂µ‚œMeckelŒeŽº‚̈ê—á. ‰––¡ŒcŽq, ¬›žŒc‘Ÿ, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ²“¡•˜Y1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/27), •Ÿ‰ª.

723411. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒãŠÌ”^á‡‚ð‡•¹‚µ‚œ–Ó’°Šà‚Ì1—á. ”óŒû@Ši1, ’†‘º—²r1, ”‹ŒŽçŒb1, b”ã“c•Žu1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/27), •Ÿ‰ª.

723412. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —«ŠO‰Èˆã‚ª–ÚŽw‚·f—ÉȂÖ. “›ˆä“ÖŽq1, •“cŒ›Žq1, ˜m’J”ü“Þ1, M‘ŸºŽq1, ‹e’r^—Žq1, “ì’JØ•äŽq2, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/27), •Ÿ‰ª.

723413. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­«¬’°‹·ó‚Ì1—á. ¬›žŒc‘Ÿ, ’†‘º—²r1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ²“¡•˜Y1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/27), •Ÿ‰ª.

723414. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‚ÉŽèp‚µ‚Š‚œ–Ó’°ŒeŽºoŒŒTAEŒã‚ɔĔ­«• –Œ‰Š‚ð’悵‚œ1—á. ”‹ŒŽçŒb1, ’†‘º—²r1, ²“¡•˜Y1, ”óŒû@Ši1, b”ã“c•Žu1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/27), •Ÿ‰ª.

723415. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘Od—±ŽqüŽ¡—Âðs‚Á‚œäX“ª•”Šà‚̈ê—á. “¡”örˆò1, ŠC’ËMŽj1, “¡“cãĕœ1, ’†Œ@—º1, ŒŽR@—º1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒ³—Y‰î1, ‰ª“c’Œ”ü, ˆÀŒ@œ, ŽR“c@Ž , ˆéè—R‰À, “n粏¹•F1 (1ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/28), •Ÿ‰ª.

723416. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ•â•‰ºˆÝ‘S“Ep‚É‚š‚¯‚éH“¹‹ó’°•«‡–@|Orvil‚©‚çFEEA‚ց|. ×“c@Œj1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, X’JGŒõ1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/28), •Ÿ‰ª.

723417. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ä`•”¬ØŠJ•¢•zÚ’…“à—e‰t”rœŒã‚É“Eo‚µ‚œã• •”¬nŠïŒ`Žî‚Ì1—á. Š`ŒŽ@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ57‰ñ“ú–{¬Ž™ŒŒ‰tE‚ª‚ñŠw‰ïŠwpW‰ï (2015/11/27), b•{.

723418. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –{–M‚ÌSSI—\–hƒoƒ“ƒhƒ‹‚ÌŒü‚©‚€æ‚Í? ’†‘º—²r (ŠO‰È): ‘æ28‰ñ“ú–{ŠO‰ÈŠŽõÇŠw‰ï‘‰ïŠwpW‰ï (2015/12/3), –ŒŒÃ‰®.

723419. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Orvil‚ðŽg—p‚µ‚œ• o‹Ÿ‰º•¬–å‘€ˆÝØœp‚É‚š‚¯‚éH“¹ŽcˆÝ•«‡. ×“c@Œj1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, X’JGŒõ1, ŽOd–ì_˜N1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/10), ‘åã.

723420. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰¡sŒ‹’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚Ì’èŒ^‰»‚Ö‚ÌŽæ‚è‘g‚Ý. ¬‘q’Œl, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ŽR—œ‚L1, “à“¡³‹K1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/10), ‘åã.

723421. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž_‰»Ä¶ƒZƒ‹ƒ[ƒX‡¬‹zŽû«–ü’…–hŽ~ÜƒCƒ“ƒ^[ƒV[ƒh‚̈À‘S«E—L—p«‚ɑ΂·‚é‘OŒü‚«–³ìˆ×”äŠrŽŽŒ±. ŽO‰YŒ[šæ1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, “›ˆä“ÖŽq1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/10), ‘åã.

723422. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘€‰çˆÊ‹¹o‹Ÿ‰ºH“¹Øœp‚ł̏p–ì“WŠJ‚̍H•v. X’JGŒõ1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/10), ‘åã.

723423. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‚ɐ؏œ‰Â”\‚Å‚ ‚Á‚œŒã• –ŒŒŽ”­«‚̐¬nùN–E«ŠïŒ`Žî‚Ì1—á. b”ã“c•Žu1, ŽO‰YŒ[šæ1, ”‹ŒŽçŒb1, ”óŒû@Ši1, “›ˆä“ÖŽq1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/10), ‘åã.

723424. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºˆÝŠÇì¬‚̍H•v. ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ×“c@Œj1, ŽOd–ì_˜N1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/10), ‘åã.

723425. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PHYSIOMESHTM‚ð—p‚¢‚Ä• o‹Ÿ‰ºƒwƒ‹ƒjƒAC•œp‚ðs‚Á‚œSpigelƒwƒ‹ƒjƒA‚Ì1—á. ŒŽ“cG‹P1, ×“c@Œj1, ‰¡“c˜aŽq1, ŽOd–ì_˜N1, X’JGŒõ1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

723426. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠisSóŒ‹’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŽèp|Ž¡—ЬÑ‚Æ—\ŒãˆöŽq‚ÌŒŸ“¢|. ŽR—œ‚L1, ²“¡•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ¬‘q’Œl, “à“¡³‹K1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

723427. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒeŽº‰Š‚É‚æ‚éSóŒ‹’°äNã÷ᑂɑ΂·‚é• o‹Ÿ‰ºŽèp6—á‚ÌŒŸ“¢. Îˆä@’q1, ’†‘º—²r2, “›ˆä“ÖŽq2, ŽO‰YŒ[šæ2, ŽR—œ‚L2, “à“¡³‹K2, ²“¡•˜Y2, ŽR‰ºŒpŽj2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

723428. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒã‰ñ•œ‘£i‚ð–ÚŽw‚µ‚œpŒãáu’ÉŠÇ—`ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“Ã’‰t‚ðŽg—p‚µ‚ā`. “à“¡³‹K (ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

723429. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰È‚Å‚Ì• o‹Ÿ‰ºŠÌØœ‚É‚š‚¯‚éPringle–@‚ÌŽè‹Z‚Ɛ¬Ñ. ŒŽR@—º1, ŠC’ËMŽj1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒ³—Y‰î1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

723430. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºˆÝØœ‚É‚š‚¯‚é, ŠsŽ•”ˆÊ‚ɉž‚¶‚œƒfƒoƒCƒX‚ÌŽg‚¢•ª‚¯. ŽOd–ì_˜N1, •Ð“c‰Ä–ç1, X’JGŒõ1, ×“c@Œj1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

723431. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ŸŒ‹’°ŠàŽèp‚̏pŒã‡•¹Ç‚ÌŒŸ“¢. ’†‘º—²r1, ²“¡•˜Y1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

723432. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –ü’…«’°•ÂÇ‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚Ì—L—p«‚ÌŒŸ“¢. “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ²“¡•˜Y1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

723433. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š‚ɑ΂·‚é• o‹Ÿ‰º‘å’°‘S“Ep‚ÌŽ¡—ЬÑ. “à“¡³‹K1, ²“¡•˜Y1, ’†‘º—²r1, ¬àV•œ‘Ÿ1, ’r“c@“Ä1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ŒÃé@Œ›2, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

723434. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “àŽ‹‹ŸŠO‰ÈŽèp‚Ì‹³ˆç‚ōłà‘åØ‚È‚±‚Ƃ͉œ‚©? ²“¡•˜Y1, ’†‘º—²r1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

723435. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º‚ɐ؏œ‚µ‚Š‚œ, • •ÇŽ‰–bŽî‚̈ê—á. ‰¡“c˜aŽq1, ’†‘º—²r1, ‘åò—z‰î2, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ŽR—œ‚L1, “à“¡³‹K1, ŽR‰ºŒpŽj1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

723436. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºŽèp‚ɂĐ؏œ‚µ“Ÿ‚œ‚“x’_ŠÇZ‚𔺂€‘å’°ŠàŠÌ“]ˆÚ‚̈ê—á. “¡“cãĕœ1, ŒŽR@—º1, ’†Œ@—º1, ‰Í–”@Š°1, “c“‡@O1, ŠC’ËMŽj1, ŒGŒ³—Y‰î1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

723437. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º”ö‘€äXØœ‚Ì’èŒ^‰»‚Ö‚ÌŽŽ‚Ý. “c“‡@O1, ŒGŒ³—Y‰î1, ŒŽR@—º1, ‰Í–”@Š°1, ŠC’ËMŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

723438. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ᑍEE”^á‡‚ð‡•¹‚µ‚œƒNƒ[ƒ“•a‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚Ì’ZŠú¬Ñ. ŒÃé@Œ›1, “à“¡³‹K2, ’†‘º—²r2, ²“¡•˜Y2, ¬‘q’Œl, ŽR—œ‚L2, ŽO‰YŒ[šæ2, “›ˆä“ÖŽq2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

723439. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ•â•‰º‚ɐ؏œ‚µ‚œ‰ñ’°’°ŠÇd•¡Ç‚Ì3—á. Š`ŒŽ@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

723440. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒã’°•ÂÇ‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚Ì—L—p«. ’†‘º—²r1, ²“¡•˜Y1, “à“¡³‹K1, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ52‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2016/3/3), “Œ‹ž.

723441. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{èòŠà‚ɑ΂µ‚ĉ»Šw•úŽËü—Ö@Œã‚ɈŸ‹}«Šú‚É’°•ÂÇ‚ð‚«‚œ‚µ‚œ1—á. Îˆä@’q1, ’†‘º—²r2, ²“¡•˜Y2, “à“¡³‹K2, ŽR—œ‚L2, “c’†r“¹1, ŽR‰ºŒpŽj2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ52‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2016/3/4), “Œ‹ž, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2016/2; 36 (2): 469.

723442. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬’°úE‚𐶂¶‚œIIŒ^’°ŠÇÇŒ^T×–E«ƒŠƒ“ƒpŽî‚Ì1—á. ‘å—F’ŒŽ÷1, X’JGŒõ1, Žt”ö”ɍF, b”ã“c•Žu1, ”óŒû@Ši1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ52‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2016/3/3-4), “Œ‹ž, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2016/2; 36 (2): 453.

723443. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠà‚É‚š‚¯‚éHelicobacter PyloriŠŽõ‚ÆŠà/ž‘ƒRŒŽ (CTA) ˆâ“`Žq”­Œ»‚ÌŠÖ˜A«‚ÌŒŸ“¢. ]ŠÔ@—æ1, “ñ“nM]1, •ŸŽR@—², ‚‹Ž’õl1, Œ@”ªŽk, “n粏¹•F1 (1ŠO‰È): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/18), •Ê•{.

723444. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ê–ʂɉž‚¶‚Ä“d‹CƒƒX‚ÆLCS‚ðŽg‚¢•ª‚¯‚éNo.6ŠsŽ. ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ×“c@Œj1, X’JGŒõ1, •Ð“c‰Ä–ç1, “n粏¹•F1 (1ŠO‰È): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/18), •Ê•{.

723445. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹ˆÝÚ‡•”Šà‚ɑ΂·‚éWŠw“IŽ¡—Ã. ×“c@Œj1, ŽR‰ºŒpŽj1, X’JGŒõ1, ŽOd–ì_˜N1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/18), •Ê•{.

723446. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º•¬–å‘€ˆÝØœp‚É‚š‚¯‚éŠÏ‰¹ŠJ‚«–@‚É‚æ‚éH“¹ŽcˆÝ•«‡. ×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, X’JGŒõ1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/18), •Ê•{.

723447. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Challenge for peritoneal dissemination of gastric cancer from a molecular point of view. ×“c@Œj1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ]ŠÔ@—æ1, ‹‹vGŽ÷2, X’JGŒõ1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/19), •Ê•{.

723448. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The clinical outcome of conversion surgery after DCS chemotherapy in unresectable gastric cancer Department of Surgery. ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ]ŠÔ@—æ1, ‹‹vGŽ÷2, ×“c@Œj1, X’JGŒõ1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ88‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2016/3/19), •Ê•{.

733126. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­«¬’°‹·ó‚̈ê—á. ¬›žŒc‘Ÿ, ’†‘º—²r1, ²“¡•˜Y1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ41‰ñ_“ސì‘å’°ãè–原Š³§˜b‰ï (2015/5/12), ‰¡•l.

733127. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶‘€Œ‹’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŽèpŽè‹Z|äBœ]‹È•”Žö“®‚̃|ƒCƒ“ƒg|. ŽR—œ‚L1, ²“¡•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šæ1, ¬‘q’Œl, “à“¡³‹K1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ69‰ñŽèpŽè‹ZŒ€‹†‰ï (2015/5/15), ‚è.

733128. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Collard•Ï–@‚É‚æ‚éH“¹ˆÝŠÇ‹@ŠB•«‡‚̍H•v. X’JGŒõ1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ69‰ñŽèpŽè‹ZŒ€‹†‰ï (2015/5/15), ‚è.

733129. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹‘å• •Çፍ­ƒwƒ‹ƒjƒA‚ɑ΂·‚é• o‹Ÿ‰ºŽèp. ŠC’ËMŽj1, ŒGŒ³—Y‰î1, “c“‡@O1, ŒŽR@—º1, ‹v•Û”CŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ69‰ñŽèpŽè‹ZŒ€‹†‰ï (2015/5/15), ‚è.

733130. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º—H–å‘€ˆÝØœp‚ł̊ȕցEˆÀ‘S‚È‹t埓®Roux-en-YÄŒš. ŽOd–ì_˜N1, •Ð“c‰Ä–ç1, ¬›žŒc‘Ÿ, X’JGŒõ1, ×“c@Œj1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ69‰ñŽèpŽè‹ZŒ€‹†‰ï (2015/5/15), ‚è.

733131. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°pŒã‚̓«‡•¹Ç‚ɑ΂·‚錟“¢‚Ƒ΍ô. ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ69‰ñŽèpŽè‹ZŒ€‹†‰ï (2015/5/16), ‚è.

733132. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –Ó’°ŒeŽºoŒŒ‚ɑ΂µ‚ÄTAEŒã‚ɔĔ­«• –Œ‰Š‚ð’悵‚œˆê—á. ”‹ŒŽçŒb1, ’†‘º—²r1, ²“¡•˜Y1, ”óŒû@Ši1, b”ã“c•Žu1, “à“¡³‹K1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ837‰ñŠO‰ÈW’k‰ï (2015/6/13), “Œ‹ž.

733133. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°ŠàŠÌ“]ˆÚÇ—á‚ɑ΂·‚éŠÌØœp‚ÌŒŸ“¢. ¬–ì—¢q1, ç–ìTˆê˜Y1, ]ŠÔ@—æ1, ˜a“c@Ž¡1, ‹v•Û”CŽj1, ‹ß“¡NŽj1, ‚‹Ž’õl1, Œ@”ªŽk, “n粏¹•F1 (1ŠO‰È): ‘æ83‰ñ‘å’°ŠàŒ€‹†‰ï (2015/7/3), ‹v—¯•Ä.

733134. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚̐isEÄ”­‘å’°Šà‚ɑ΂·‚éCurBÇ—á‚ÌŽ¡—ЬÑ. ŽO‰YŒ[šæ1, ’†‘º—²r1, “›ˆä“ÖŽq1, ŽR—œ‚L1, ¬‘q’Œl, “à“¡³‹K1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ83‰ñ‘å’°ŠàŒ€‹†‰ï (2015/7/3), ‹v—¯•Ä.

733135. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠà‚ɑ΂·‚郍ƒ{ƒbƒgŽx‰‡• o‹Ÿ‰ºˆÝØœp‚Ì“±“ü. ×“c@Œj1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, X’JGŒõ1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ48‰ñ_“ސìˆÝŠàŽ¡—ÃŒ€‹†‰ï (2015/7/4), ‰¡•l.

733136. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝH“¹‹t—¬Çó‚ð’悳‚È‚©‚Á‚œ‹‘åH“¹—ôEƒwƒ‹ƒjƒA2Ç—á‚ÌŽ¡—ÃŒoŒ±. ‰¡“c˜aŽq1, X’JGŒõ1, ŒŽ“cG‹P1, ŽOd–ì_˜N1, ×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ24‰ñÁ‰»ŠíŽŸŠ³•a‘ÔŽ¡—ÃŒ€‹†‰ï (2015/9/12), “Œ‹ž.

733137. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‹³Žº‚É‚š‚¯‚é• o‹Ÿ‰ºƒCƒŒƒEƒX‰ðœp‚ɑ΂·‚éŽè‹Z‚̍H•v. “n•”WŽq, “à“¡³‹K1, ²“¡•˜Y1, ’†‘º—²r1, ¬‘q’Œl, ŽR—œ‚L1, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, ’†”nŠî”Ž1, “n粏¹•F1 (1ŠO‰È): ‘æ143‰ñ_“ސ쌧—Տ°ŠO‰ÈˆãŠw‰ïW’k‰ï (2015/9/26), ‰¡•l.

733138. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Klippel-TrenaunayÇŒóŒQ‚ɃÀƒuƒƒbƒJ[“à•žŽ¡—ª—LŒø‚Å‚ ‚Á‚œ1—á. Š`ŒŽ@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ63‰ñ_“ސ쏬Ž™Žîᇌ€‹†‰ï (2015/10/3), ‰¡•l.

733139. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) CDO1ˆâ“`Žqƒvƒƒ‚[ƒ^[—̈æ‚̍‚ƒƒ`ƒ‹‰»‚ÍStage II/IIIˆÝŠà, Stage IIIŒ‹’°Šà‚É‚š‚¯‚鉻Šw—Ö@ŠŽŽó«‚Æ‘ŠŠÖ‚·‚é. ‰¡ˆäŒ\Œå1, ŽR‰ºŒpŽj2, Îˆä@’q1, “c’†r“¹1, ŒàVL‹±1, ‰Á“¡@O2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ35‰ñ“ú–{•ªŽqŽîᇃ}[ƒJ[Œ€‹†‰ï (2015/10/7), –ŒŒÃ‰®.

733140. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà‚É‚š‚¯‚éŠÌ“]ˆÚ”\Šl“Ÿ‚ÉŠÖ˜A‚·‚égenomic gain‚ɂ‚¢‚Ä. “c’†r“¹1, ŽR‰ºŒpŽj2, Îˆä@’q1 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ35‰ñ“ú–{•ªŽqŽîᇃ}[ƒJ[Œ€‹†‰ï (2015/10/7), –ŒŒÃ‰®.

733141. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠà• o×–Ef‚É‚š‚¯‚éƒoƒCƒIƒ}[ƒJ[‚Æ‚µ‚Ä‚ÌCDO1ˆâ“`ŽqDNAƒƒ`ƒ‹‰»‚ÌŒŸ“¢. ‹‹vGŽ÷1, ŽR‰ºŒpŽj2, ]ŠÔ@—æ2, ˜m’J”ü“Þ2, ‰Á“¡@O2, ×“c@Œj2, X’JGŒõ2, ŽOd–ì_˜N2, ŒÃé@Œ›1, ‹e’r^—Žq2, “ì’JØ•äŽq1, Îˆä@’q1, “c’†r“¹1, ‰¡ˆäŒ\Œå1, ŒàVL‹±1, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ35‰ñ“ú–{•ªŽqŽîᇃ}[ƒJ[Œ€‹†‰ï (2015/10/7), –ŒŒÃ‰®.

733142. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ûŠà‚É‚š‚¯‚éCDO1ˆâ“`ŽqMethylation‚̗Տ°•a—Šw“IˆÓ‹`. “ì’JØ•äŽq1, ŽR‰ºŒpŽj2, Œ‹{—mŽj2, ˜m’J”ü“Þ2, ¬â–ùŒ«2, ‹e’r^—Žq2, ŒÃé@Œ›1, ‹‹vGŽ÷1, ]ŠÔ@—æ2, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È): ‘æ35‰ñ“ú–{•ªŽqŽîᇃ}[ƒJ[Œ€‹†‰ï (2015/10/7), –ŒŒÃ‰®.

733143. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ûŠàŠ”‰»×–E‚ɑ΂·‚éƒtƒFƒjƒ‹ƒuƒ`ƒŒ[ƒg‚Ì—}§Œø‰Ê‹y‚Ñ’ïR«ŒŽˆöˆâ“`Žq‚Ì’Tõ. ‹e’r^—Žq1, ŽR‰ºŒpŽj1, ˜m’J”ü“Þ1, ¬â–ùŒ«1, “ì’JØ•äŽq2, Œ‹{—mŽj1, ‹‹vGŽ÷2, ŒÃé@Œ›2, ]ŠÔ@—æ1, “n粏¹•F1 (1ŠO‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ35‰ñ“ú–{•ªŽqŽîᇃ}[ƒJ[Œ€‹†‰ï (2015/10/7), –ŒŒÃ‰®.

733144. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) æ“V«\“ñŽw’°•ÂœÇpŒã‚ÉäXŠÇŠg’£‚ÆäXŠÇ“àƒKƒX‚ð”F‚ß‚œ2—á. Š`ŒŽ@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ50‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2015/10/10), ‚³‚¢‚œ‚Ü.

733145. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ä`ŠOŽîᎂª‘‘債‚œBeckwith-WiedemannÇŒóŒQ‚Ì1—á. “¡”örˆò1, •“cŒ›Žq1, Š`ŒŽ@’m1, “c’†@Œ‰2 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ50‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2015/10/10), ‚³‚¢‚œ‚Ü.

733146. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX• –Œ‰Š‚ɑ΂·‚é‰z›X‰ÁžQ“’‚̍R‰ŠÇì—p‚ÌŒŸ“¢. •“cŒ›Žq1, “c’†@Œ‰2, Š`ŒŽ@’m1, “n粏¹•F1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ20‰ñ“ú–{¬Ž™ŠO‰ÈŠ¿•ûŒ€‹†‰ï (2015/10/30), ŒF–{.

733147. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ•â•‰º‚ɈÀ‘S‚ɐ؏œ‚µ“Ÿ‚œ‰ñ’°’°ŠÇd•¡Ç‚Ì3—á. Š`ŒŽ@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ35‰ñ“ú–{¬Ž™“àŽ‹‹ŸŠO‰ÈEŽèpŽè‹ZŒ€‹†‰ï (2015/10/30), ŒF–{.

733148. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ––œÃ–¬‘}“üŽ®’†SÃ–¬ƒJƒe[ƒeƒ‹”²‹Ž¢“ï—á‚ÌŒŸ“¢. ‰ª–{–¢‹FŽq1, “c’†@Œ‰2, •“cŒ›Žq1, Š`ŒŽ@’m1, “n粏¹•F1 (1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ45‰ñ“ú–{¬Ž™ŠO‰È‘ãŽÓŒ€‹†‰ï (2015/10/30), ŒF–{.

733149. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å“®–¬ŽüˆÍƒŠƒ“ƒpß“]ˆÚ‚𔺂€isˆÝŠà‚ɑ΂·‚éDCS—Ö@Œã‚ÌŽèp¬Ñ. ŽOd–ì_˜N1, •Ð“c‰Ä–ç1, X’JGŒõ1, “Œ@’q2, ×“c@Œj1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y3, ¬ò˜aŽO˜Y2, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à, 34•a‰@˜AŒg‹³ˆç): ‘æ45‰ñˆÝŠO‰ÈEpŒãáŠQŒ€‹†‰ï (2015/11/6), –ŒŒÃ‰®.

733150. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºˆÝØœ‚É‚š‚¯‚é“d‹CƒƒX‚ð—p‚¢‚œ—H–剺ƒŠƒ“ƒpßŠsŽŽè‹Z. ×“c@Œj1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, X’JGŒõ1, •Ð“c‰Ä–ç1, “n粏¹•F1 (1ŠO‰È): ‘æ45‰ñˆÝŠO‰ÈEpŒãáŠQŒ€‹†‰ï (2015/11/7), –ŒŒÃ‰®.

733151. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Telangiectatic/inflammatory adenoma‚ÆŽv‚í‚ê‚éŠÌŒ‹ß«•a•Ï‚̈ê—á. ŒŽR@—º1, ‘å•”@œ2, ‰Í–”@Š°1, “c“‡@O1, ŠC’ËMŽj1, ŒGŒ³—Y‰î1, “n粏¹•F1 (1ŠO‰È, 2ˆã—Éq¶Šw•”): ‘æ52‰ñŠÌŠàÇ—ጟ“¢‰ï (2015/11/7), “Œ‹ž.

733152. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºŠÌØœ‚É‚š‚¯‚éPringle–@‚ÌŽè‹Z‚Ɛ¬Ñ`“Á‚ɉE—tŒnŽîᇂɑ΂·‚éŠÌØœ‚ÌŒŸ“¢`. ŒŽR@—º1, ŠC’ËMŽj1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒ³—Y‰î1, “n粏¹•F1 (1ŠO‰È): ‘æ9‰ñŠÌ‘Ÿ“àŽ‹‹ŸŠO‰ÈŒ€‹†‰ï (2015/11/25), •Ÿ‰ª.

733153. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºŠÌØœ‚É‚š‚¯‚é’_`˜R‘΍ô. ŠC’ËMŽj1, ŒGŒ³—Y‰î1, ŒŽR@—º1, “c“‡@O1, ‰Í–”@Š°1, “n粏¹•F1 (1ŠO‰È): ‘æ9‰ñŠÌ‘Ÿ“àŽ‹‹ŸŠO‰ÈŒ€‹†‰ï (2015/11/25), •Ÿ‰ª.

733154. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) NAC-DCS‚ª’˜Œø‚µØœ‰Â”\‚Æ‚È‚Á‚œ• o“à‹‘åŽîᎂ𔺂€isˆÝŠà‚̈ê—á. ‘å—F’ŒŽ÷, b”ã“c•Žu1, ”óŒû@Ši1, Žt”ö”ɍF, ŽOd–ì_˜N1, X’JGŒõ1, ×“c@Œj1, ŽR‰ºŒpŽj1, “n粏¹•F1 (1ŠO‰È): ‘æ49‰ñ_“ސìˆÝŠàŽ¡—ÃŒ€‹†‰ï (2015/12/5), ‰¡•l.

733155. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘Of’f‚É“ïa‚µ‚œˆÝNeuroendocrine cell carcinoma‚Ì1—á. ”óŒû@Ši1, ŽOd–ì_˜N1, X’JGŒõ1, ×“c@Œj1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y2, “n粏¹•F1 (1ŠO‰È, 24•a‰@˜AŒg‹³ˆç): ‘æ49‰ñ_“ސìˆÝŠàŽ¡—ÃŒ€‹†‰ï (2015/12/5), ‰¡•l.

733156. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Øœ•s”\ˆÝŠà‚ɑ΂·‚éDocetaxel + CDDP + S-1 (DCS) —Ö@Œã‚ÌŽèp¬Ñ. ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, X’JGŒõ1, ×“c@Œj1, “Œ@’q2, “c糁@‘3, ¬ò˜aŽO˜Y2, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ49‰ñ_“ސìˆÝŠàŽ¡—ÃŒ€‹†‰ï (2015/12/5), ‰¡•l.

733157. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) TAMISŽè‹Z, ŽèpŠí‹ï‚ð—p‚¢‚œ• o‹Ÿ‰º• ‰ï‰AŽ®’Œ’°Ø’fp. ²“¡•˜Y1, ’†‘º—²r1, “à“¡³‹K1, ŽR—œ‚L1, ŽO‰YŒ[šæ1, ì‘º”ü‹IŽq2, ŒŒŽN”ü3, Ž‹{”ü‰r3, —F‰i—T”ü3, “n•Ó¹D2, “n粏¹•F1 (1ŠO‰È, 2“Œ•a‰@ŠÅŒì•”, 3ŠÅŒì•”): ‘æ38‰ñ_“ސìƒXƒg[ƒ}Œ€‹†‰ï (2015/12/19), _“ސì, ‘æ38‰ñ_“ސìƒXƒg[ƒ}Œ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2015/12; p.16.

733158. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«“û‘B”^ᇂ̈ê—á. “¡–ìŽjD1, åÎ‹I•F1, ‰Í–ì—uŽq1, ‹e’r^—Žq1, M‘ŸºŽq1, ˜m’J”ü“Þ1, ¬â–ùŒ«1, ‰Á“¡@O1, ‰|–{‘ñ–Î1, ’J–ì—Tˆê1, “n粏¹•F1 (1ŠO‰È): ‘æ839‰ñŠO‰ÈW’k‰ï (2015/12/12), “Œ‹ž.

733159. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰º”ö‘€äXØœp‚Å‚ÌŒoŒ±‚ƍH•v. “c“‡@O1, ŒGŒ³—Y‰î1, ŒŽR@—º1, ‰Í–”@Š°1, ŠC’ËMŽj1, •Ð‹ËŠ°”V1, “n粏¹•F1 (1ŠO‰È): ‘æ7‰ñäX‘Ÿ“àŽ‹‹ŸŠO‰ÈŒ€‹†‰ï (2015/12/13), ‹ž“s.

733160. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • –Œ”dŽí‚ð‚Æ‚à‚È‚€Ç—á‚É‚š‚¯‚é“KØ‚ÈM1•ª—Þ–@‚ÌŒŸ“¢. “à“¡³‹K1, ’†‘º—²r1, ²“¡•˜Y1, ŽR—œ‚L1, ¬‘q’Œl, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, “n粏¹•F1 (1ŠO‰È): ‘æ84‰ñ‘å’°ŠàŒ€‹†‰ï (2016/1/15), ŒF–{.

733161. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰»Šw—Ö@Ž{sŒã‚É‘å’°ŠàŠÌ“]ˆÚ‚ª‹^‚í‚ê‚œ1—á. “¡”örˆò1, ŒŽR@—º1,‘å•”@œ2, ‰Í–”@Š°1, “c“‡@O1, ŠC’ËMŽj1, ŒGŒ³—Y‰î1, “n粏¹•F1 (1ŠO‰È, 2ˆã—Éq¶Šw•”): ‘æ840‰ñŠO‰ÈW’k‰ï (2016/3/12), “Œ‹ž.

733162. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰E‘€‰¡sŒ‹’°Šà‚ɑ΂·‚é’†Œ‹’°“®–¬—̈æ‚̃Šƒ“ƒpßŠsŽŽè‹Z. “›ˆä“ÖŽq (ŠO‰È): _“ސì‘å’°ŽŸŠ³• o‰ºŽèpƒZƒ~ƒi[‘æ17‰ñŠwpW‰ï (2016/3/25), ‰¡•l.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-110010. [ŒŽ’˜] Benefit of neoadjuvant chemotherapy for Siewert type II esophagogastric junction adenocarcinoma. Hosoda K1, Yamashita K1, Katada N1, Moriya H1, Mieno H1, Sakuramoto S, Kikuchi S2, Watanabe M1: Anticancer Res 2015/1; 35 (1): 419-25. (×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ŽOd–ì_˜N1, ‹e’rŽj˜Y2, “n粏¹•F1: 1ŠO‰È, 24•a‰@˜AŒg‹³ˆç)

H26-110011. [ŒŽ’˜] Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma. Hosoda K1, Yamashita K1, Katada N1, Moriya H1, Mieno H1, Sakuramoto S, Kikuchi S2, Watanabe M1: Anticancer Res 2015/1; 35 (1): 445-56. (×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ŽOd–ì_˜N1, ‹e’rŽj˜Y2, “n粏¹•F1: 1ŠO‰È, 24•a‰@˜AŒg‹³ˆç)

H26-110012. [ŒŽ’˜] Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer. Hosoda K1, Yamashita K1, Katada N1, Moriya H1, Mieno H1, Sakuramoto S, Kikuchi S2, Watanabe M1: Surg Today 2015/1; 45 (1): 68-77. (×“c@Œj1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ŽOd–ì_˜N1, ‹e’rŽj˜Y2, “n粏¹•F1: 1ŠO‰È, 24•a‰@˜AŒg‹³ˆç)

H26-110013. [ŒŽ’˜] Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment. Yamashita K1, Hosoda K1, Katada N1, Moriya H1, Mieno H1, Higuchi K2, Sasaki T2, Katada C2, Sakuramoto S, Tanabe S3, Koizumi W2, Kikuchi S4, Watanabe M1: Anticancer Res 2015/2; 35 (2): 897-906. (ŽR‰ºŒpŽj1, ×“c@Œj1, •Ð“c‰Ä–ç1, X’JGŒõ1, ŽOd–ì_˜N1, ”óŒûŸ•F2, ²X–Ø“O2, Œ˜“ce—˜2, “c糁@‘3, ¬ò˜aŽO˜Y2, ‹e’rŽj˜Y4, “n粏¹•F1: 1ŠO‰È, 2Á‰»Ší“à, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã, 44•a‰@˜AŒg‹³ˆç)

H26-310001. [Ç—á•ñ] Laparoscopic resection of a small-bowel gastrointestinal stromal tumor (GIST): a case of report Ishii S1, Nakamura T2, Kojima K1, Tsutsui A2, Miura H2, Sato T2, Jiang SX3, Watanabe M2: Kitasato Med J 2015/3; 45 (1): 86-9. (Îˆä@’q1, ’†‘º—²r2, ¬›žŒc‘Ÿ1, “›ˆä“ÖŽq2, ŽO‰YŒ[Žõ2, ²“¡•˜Y2, Ó@¢ˆ®3, “n粏¹•F2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 3•a—)

H26-310002. [Ç—á•ñ] The first case report of reduced port surgery for preoperatively diagnosed intestinal malrotation in an adult. Watanabe E, Nakamura T1, Tanaka K2, Miura H1, Tsutsui A1, Takeda N1, Watanabe M1: Kitasato Med J 2015/3; 45 (1): 90-3. (’†‘º—²r1, “c’†@Œ‰2, ŽO‰YŒ[šæ1, “›ˆä“ÖŽq1, •“cŒ›Žq1, “n粏¹•F1: 1ŠO‰È, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã)

H26-320007. [Ç—á•ñ] ƒAƒ“ƒP[ƒg’²ž‚ÉŠî‚¢‚œ_“ސ쌧Žå—vŽ{Ý‚É‚š‚¯‚é‰EŒ‹’°Šà‚ɑ΂·‚é• o‹ŸŽèp‚ÌŽ¡—ÃŒ»‹µ. ŠÖì_Ži, •Ç“‡N˜Y, ²“¡•˜Y1, ‰–àV@Šw, ŒŽR•Û”äŒÃ, š êK‹Ï, ‹{“‡L‹X, “c’†~ˆê (1ŠO‰È): _“ސìˆãŠw‰ïŽGŽ 2015/1; 42 (1): 7-11.

H26-320008. [Ç—á•ñ] HER2—z«Stage IVH“¹ZˆÝŠà‚ɑ΂µ‚ÄCapecitabine+Cisplatin + Trastuzumab•¹—p—Ö@‚ª‘tŒø‚µ‚œ1—á. Îˆä@’q1, ×“c@Œj2, •Ð“c‰Ä–ç2, X’JGŒõ2, ŽR‰ºŒpŽj2, ŽOd–ì_˜N2, ’‡“c“TL3, ‹e’rŽj˜Y4, “n粏¹•F2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 3•a—, 44•a‰@˜AŒg‹³ˆç) “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ 2015/2; 40 (1): 35-43.

H26-522012. [uÀ] yÀ’k‰ïz’Œ’°Šà‚ɑ΂·‚鎡—Õûj‚ðl‚Š‚é. ‘å“cv—R, Žsì–õŽj, ²“¡•˜Y1, “c’†@², “n糁@ƒ (1ŠO‰È): Šà‚̗Տ° 2015/3; 61 (2): 131-8.

[’˜@‘]

H26-620010. [Šwp‘ (•ª’SŽ·•M)]y• o‹Ÿ‰ºÁ‰»ŠíŠO‰ÈŽèp@•W€Žè‹ZƒVƒŠ[ƒY1@ã•”Á‰»ŠÇzI. H“¹ŽŸŠ³‚ɑ΂·‚é“àŽ‹‹ŸŠO‰ÈŽèp@—ǐ«ŽŸŠ³‚ÌŽèp@‹t—¬«H“¹‰Š‚ÌŽèp, p.14-23. •Ð“c‰Ä–ç1, X’JGŒõ1, “n粏¹•F1 (1ŠO‰È), •Ò: –kì—YŒõ, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2015/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H26-723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶‰ºŽˆŽî’¯‚ðŽå‘i‚Æ‚µ‚Đf’f‚³‚ê‚œ¶‘’°œ“®–¬áŽ‚ɉº‘åÃ–¬ŒŒðÇ‚ð‡•¹‚µ‚œˆê—á. ŠÖ–{Nl, ŒŽ“c—T‹v, Î“c—mŽ÷, ¬‘q³Ž¡, ‰Í–”@Š°1, óŒŽŽj‘ì, ‘ëì@õ, ‚ŽR@L, ²“¡“¹•v, ŒŒŽŒ’‘Ÿ˜Y, ”öŒŽG–Ÿ, Œˆä~ˆê, –kì—YŒõ (1ŠO‰È): ‘æ51‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2015/3/5-6), ‹ž“s, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2015/2; 35 (2): 437.

H26-723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠàpŒã‚ɏcŠu”^á‡‚ð‚«‚œ‚µ‚œ1—á. ó‰ª‰ël, ²“¡“¹•v, ŠÖ–{Nl, Î“c—mŽ÷, ŒŽ“c—S‹v, ‚ŽR@L, ‘ëì@õ, óŒŽŽj‘ì, ¬‘q³Ž¡, ‰Í–”@Š°1, Œˆä~ˆê (1ŠO‰È): ‘æ51‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2015/3/5-6), ‹ž“s, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2015/2; 35 (2): 485.

H26-723008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äXŠÇoŒŒ‚ðŒ_‹@‚É”­Œ©‚³‚ê‚œäXŠà‚Ì1—á. Î“c—mŽ÷, ‘ëì@õ, ‰Í–”@Š°1, ŠÖ–{Nl, ¬‘q³Ž¡, óŒŽŽj‘ì, ‚ŽR@L, ŒŽ“c—T‹v, ²“¡“¹•v, Œˆä~ˆê (1ŠO‰È): ‘æ51‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2015/3/5-6), ‹ž“s, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ 2015/2; 35 (2): 521.


S‘ŸŒŒŠÇŠO‰ÈŠw

[Šwp˜_•¶]

110183. [ŒŽ’˜] Useful surgical instruments for the resection of subaortic stenosis. Tanaka Y1, Miyamoto T1, Minami K2, Miyaji K1: J Thorac Cardiovasc Surg 2015/8; 150 (2): 421-2. (“c’†—C‹M1, ‹{–{—²Ži1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2–kŠÖ“ŒzŠÂŠí•a‰@)

110184. [ŒŽ’˜] Optimal Graft Size of Modified Blalock-Taussig Shunt for Biventricular Circulation in Neonates and Small Infants. Shibata M1, Itatani K2, Oka N1, Yoshii T1, Nakamura Y1, Kitamura T1, Horai T1, Miyaji K1: Int Heart J 2015/9; 56 (5): 533-6. (ŽÄ“c[á1, ”Â’JŒcˆê2, ‰ª@“¿•F1, ‹gˆä@„1, ’†‘º—SŠó1, –k‘º@—¥1, •ó—ˆ“N–ç1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ŒŒ—¬‰ðÍ)

110185. [ŒŽ’˜] Total Cavopulmonary Connection is Superior to Atriopulmonary Connection Fontan in Preventing Thrombus Formation: Computer Simulation of Flow-Related Blood Coagulation. Sughimoto K1, Okauchi K, Zannino D, Brizard CP, Liang F, Sugawara M, Liu H, Tsubota K: Pediatr Cardiol 2015/10; 36 (7): 1436-41. (™–{Wˆê1: 1S‘ŸŒŒŠÇŠO)

110186. [ŒŽ’˜] Forward Flow Through the Pulmonary Valve After Bidirectional Cavopulmonary Shunt Benefits Patients at Fontan Operation. Sughimoto K1, Zannino D, Mathew J, Weintraub RG, Brizard CP, d'Udekem Y, Konstantinov IE: Ann Thorac Surg 2015/10; 100 (4): 1390-6; discussion 1396-7. (™–{Wˆê1: 1S‘ŸŒŒŠÇŠO)

110187. [ŒŽ’˜] Impact of the entry site on late outcome in acute Stanford type B aortic dissectionõ. Kitamura T1, Torii S2, Oka N1, Horai T1, Itatani K3, Yoshii T1, Nakamura Y1, Shibata M1, Tamura T1, Araki H1, Matsunaga Y1, Sato H4, Miyaji K1: Eur J Cardiothorac Surg 2015/11; 48 (5): 655-61. (–k‘º@—¥1, ’¹ˆäWŽO2, ‰ª@“¿•F1, •ó—ˆ“N–ç1, ”Â’JŒcˆê3, ‹gˆä@„1, ’†‘º—SŠó1, ŽÄ“c[á1, “c‘º’q‹I1, r‹Lt“Þ1, Œ‰iŒc—õ1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3ŒŒ—¬‰ðÍŠw, 4‘—§•ÛŒ’ˆã—ÉȊw‰@)

110188. [ŒŽ’˜] Norwood Procedure Performed on a Patient With Trisomy 13. Oka N1, Inoue T1, Shibata M1, Yoshii T1, Nakamura Y1, Araki H1, Matsunaga Y1, Tamura T1, Itatani K2, Horai T1, Kitamura T1, Torii S3, Miyaji K1: Int Heart J 2016/1; 57 (1): 121-2. (‰ª@“¿•F1, ˆäã’“¹1, ŽÄ“c[á1, ‹gˆä@„1, ’†‘º—SŠó1, r‹Lt“Þ1, Œ‰iŒc—õ1, “c‘º’q‹I1, ”Â’JŒcˆê2, •ó—ˆ“N–ç1, –k‘º@—¥1, ’¹ˆäWŽO3, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ŒŒ—¬‰ðÍ, 3ˆã—ËZp‹³ˆç)

110189. [ŒŽ’˜] Influence of Cardiac Function and Loading Conditions on the Myocardial Performance Index - Theoretical Analysis Based on a Mathematical Model. Inuzuka R, Kuwata S, Kurishima C, Liang F, Sughimoto K1, Senzaki H: Circ J 2016/1; 80 (1): 148-56. (™–{Wˆê1: 1S‘ŸŒŒŠÇŠO)

110190. [ŒŽ’˜] Mid-term outcome with pericardial patch augmentation for redo left atrioventricular valve repair in atrioventricular septal defectõ. Sughimoto K1, d'Udekem Y, Konstantinov IE, Brizard CP: Eur J Cardiothorac Surg 2016/1; 49 (1): 157-66. (™–{Wˆê1: 1S‘ŸŒŒŠÇŠO)

120015. [ŒŽ’˜] ‹ìo—Š‚̒ቺ‚µ‚œ¶Žº‚É‚š‚¢‚Ä‹ìoŠú‚É‚š‚¯‚é‰Q‚ÌŽ‘±ŽžŠÔ‚͉„’·‚·‚é: vector flow mapping‚É‚æ‚é‰ðÍ. •Ÿ“c‰„º1, ”Â’JŒcˆê2, –Ø‘ºŒöˆê3, ŠC˜VŒŽ•¶4, ªŠÝˆê–Ÿ5, ‰F–슿¬3, ‹{’n@ŠÓ6, ‘q—ѐ³•F1, ’|’†@Ž7 (1ŒQ”n‘åŠw‘ŸŠí•a‘Ô“à‰ÈŠw, 2ŒŒ—¬‰ðÍ, 3“Œ‹ž‘åŠwˆãŠw•”•t‘®•a‰@zŠÂŠí“à‰È, 4‚ª‚ñŒ€‹†‰ï—L–Ÿ•a‰@ŒŸž•”, 5ƒƒ“ƒW[ƒXŒ€‹†Šƒ^ƒXƒ}ƒjƒA, 6S‘ŸŒŒŠÇŠO, 7“ú–{‘åŠw”‹Ž•a‰@zŠÂŠí“à‰È): ’Ž‰¹”gˆãŠw 2016/3; 43 (2): 291-301.

210003. [€ŒŽ’˜] Single ventricle: repair of atrioventricular valve using the bridging technique. Konstantinov IE, Sughimoto K1, Brizard CP, d'Udekem Y: Multimed Man Cardiothorac Surg 2015/9; 2015. pii: mmv027. doi: 10.1093/mmcts/mmv027. Print 2015. (™–{Wˆê1: 1S‘ŸŒŒŠÇŠO)

210004. [€ŒŽ’˜] Skeletonization of the Recurrent Laryngeal Nerve During Norwood Procedure and Aortic Arch Repair. Sughimoto K1, Pratap H, Konstantinov IE, Brizard CP, d'Udekem Y: Ann Thorac Surg 2015/10; 100 (4): 1473-5. (™–{Wˆê1: 1S‘ŸŒŒŠÇŠO)

310019. [Ç—á•ñ] Perioperative Multiple Pulmonary Embolism in a Patient with Giant Right Atrial Myxoma: Report of a Case. Nakashima K1, Hanayama N1, Kitamura T1, Sakaki K1, Nie M2, Miyaji K1: Kyobu Geka 2016/2; 69 (2): 152-5. (’†“‡Œõ‹M1, ‰ØŽR’Œ“ñ1, –k‘º@—¥1, åŒ’Ži˜N1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ŠC˜V–Œ‘‡•a‰@)

310020. [Ç—á•ñ] Emergency Surgery for Acute Pulmonary Embolism. Sakaki K1, Nie M2, Sasahara A1, Nakashima K1, Ohara K2, Miyaji K1: Kyobu Geka 2016/3; 69 (3): 197-200. (åŒ’Ži˜N1, ùŒŽ‘–L1, ’†“‡Œõ‹M1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ŠC˜V–Œ‘‡•a‰@)

521013. [‰ðà]yŽ¿‹^‰ž“šz[ŠO‰È: S‘ŸŒŒŠÇ] ¬Ž™S‘ŸŠO‰È—̈æ‚É‚š‚¯‚é“àŽ‹‹Ÿ‰ºŽèp. ‹{’n@ŠÓ1, ‘å’ˏrÆ2 (1S‘ŸŒŒŠÇŠO, 2“Œ‹ž“s—§‘œ–€‘‡ˆã—ÃZƒ“ƒ^[): “ú–{ˆãŽ–V•ñ 2015/9; 4767: 59-60.

521014. [‰ðà]yŽ¿‹^‰ž“šz[ŠO‰È: S‘ŸŒŒŠÇ] Ž©ŒÈS–Œ‚ðŽg—p‚µ‚œ‘å“®–¬•ÙÄŒšp. ”öèd”V1, ‹{’n@ŠÓ2 (1“Œ–M‘åŠwˆã—ÃZƒ“ƒ^[‘å‹Ž•a‰@, 2S‘ŸŒŒŠÇŠO): “ú–{ˆãŽ–V•ñ 2015/9; 4769: 63.

522111. [uÀ] y“ÁW: S‘ŸŒŒŠÇŠO‰È ‘O•ÒzpŽ®•Ê‚ÉŠw‚ԐS‘ŸŒŒŠÇŽèp: dÇS•s‘S@3. ‹@”\«‘m–X•Ù•Âœ•s‘SÇ‚ɑ΂·‚éŠO‰ÈŽèp‚Ì“K‰ž‚ƃ^ƒCƒ~ƒ“ƒO. •ó—ˆ“N–ç (S‘ŸŒŒŠÇŠO): Intensivist 2015/10; 7 (4): 871-7.

[’˜@‘]

620076. [Šwp‘] (•ª’SŽ·•M)yp‘O&pŒãƒPƒA‚à‚®‚ñ‚®‚ñ‚í‚©‚é@–Ú‚ÅŒ©‚Ä—‰ð! ƒi[ƒX‚Ì‚œ‚߂̐S‘ŸŠO‰ÈŽèp‚̏pŽ®•ÊƒPƒAƒrƒWƒ…ƒAƒ‹ƒKƒCƒh (ƒn[ƒgƒi[ƒVƒ“ƒO2015”NH‹G‘Š§)z‘æ4Í –Ú‚ÅŒ©‚Ä—‰ð!@S‘ŸŠO‰ÈŽèp‚̏pŽ®•pŽ®•ÊƒPƒAƒæ“V«SŽŸŠ³‚ɑ΂·‚éŽèp„ [5] ƒtƒ@ƒ[Žl’¥Ç‚ɑ΂·‚éŽèp, p.188-93. ‹{’n@ŠÓ1, ìã‘å•ã2 (1S‘ŸŒŒŠÇŠO, 2ŠÅŒì•”), ŠÄC: ‹{–{L“ñ, ƒƒfƒBƒJo”Å, ‘åã, 2015/10”­s.

620077. [Šwp‘] (•ª’SŽ·•M)yS‘ŸŠO‰Èf—Âɂ݂éˆãŠw—¯Šw‚ւ̃pƒXƒ|[ƒg@ƒVƒŠ[ƒY“ú•ÄˆãŠwŒð—¬No.15z•’ʂ́g‘h‚Ì•’ʂ́g•a‰@h‚ł̃gƒŒ[ƒjƒ“ƒO, p.197-214. –k‘º@—¥ (S‘ŸŒŒŠÇŠO), •Ò: Œö‰và’c–@l“ú•ÄˆãŠwˆã—Ì𗬍à’c, ‚͂鏑–[, “Œ‹ž, 2015/10”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713057. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Video-assisted thoracoscopic interruption of patent ductus arteriosus (VATS-PDA). Miyaji K1: The 9th International Joint Meeting China,Germany and Japan 2015 (2015/9/17), Bad Oeynhausen, Germany. (‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO)

713058. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Clinical usefulness of compression stockings for asymptomatic deep vein thrombosis of the lower extremity. Ohkubo H1: The 16th congress of Asian society for vascular surgery and The 10th Asian Venous forum 2015 (2015/12/1-4), Thailand. (‘å‹v•Û”Ž¢1: 1S‘ŸŒŒŠÇŠO)

713059. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Fusion of 3D Ultrasound and Cardiac-MRI Shows Motional Intra-Cardiac Blood Flow In the Whole Cardiac Cycle. Sughimoto K1, Shimamura Y2, Liu H3, Tsubota K3, Miyaji K1, Yoshii T1, Torii S4, Kitamura T1, Hirata M5, Mishima T1, Horai T1, Haneishi H2: HVS Scientific Meeting 2016 (2016/3/17-19), New York, USA. (™–{Wˆê1, ‹{’n@ŠÓ1, ‹gˆä@„1, ’¹ˆäWŽO4, –k‘º@—¥1, •œ“cŒõ”Ž5, ”ü“‡—˜º1, •ó—ˆ“N–ç1: 1S‘ŸŒŒŠÇŠO, 2ç—t‘åŠwƒtƒƒ“ƒeƒBƒAˆãHŠwƒZƒ“ƒ^[, 3ç—t‘åŠw‘åŠw‰@HŠwŒ€‹†‰È, 4ˆã—ËZp‹³ˆç, 5V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

721013. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Blood flow dynamic improvement with aneurysm repair detected by a patient-specific model of multiple aortic aneurysms. ™–{Wˆê (S‘ŸŒŒŠÇŠO): ‘æ29‰ñ“ú–{S‘ŸŒŒŠÇ“àŽ‹‹ŸŠw‰ï (2015/9/26), ‘åã.

723449. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹}«AŒ^‘å“®–¬‰ð—£Žèp‚É‚š‚¯‚éãs‘å“®–¬’ŒÚ‘—ŒŒ–@. ŽR–{Ms1, æс@³Šî1, ùŒŽ‘–L2, ¬ŒŽ–M‹`1, •ó—ˆ“N–ç2, –k‘º@—¥2, ‹{’n@ŠÓ2 (1ŠC˜V–Œ‘‡•a‰@, 2S‘ŸŒŒŠÇŠO): ‘æ43‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2015/6/3-5), ‰¡•l, “ú–{ŒŒŠÇŠO‰ÈŠw‰ïŽGŽ 2015/6; 24 (3): 339.

723450. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) AŒ^‹}«‘å“®–¬‰ð—£ŽèpŽž‚̐^o’ŒÚ‘—ŒŒ. –k‘º@—¥1, ’¹ˆäWŽO2, ‰ª@“¿•F1, •œ“cŒõ”Ž3, •ó—ˆ“N–ç1, ”Â’JŒcˆê4, “c‘ºK•ä1, ”ü“‡—˜º1, ‹gˆä@„1, ’†‘º—SŠó1, “c‘º’q‹I1, r‹Lt“Þ1, Œ‰iŒc—õ1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 4ŒŒ—¬‰ðÍ): ‘æ43‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2015/6/3-5), ‰¡•l, “ú–{ŒŒŠÇŠO‰ÈŠw‰ïŽGŽ 2015/6; 24 (3): 427.

723451. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰Œ‘zŽèpsimulation‚ð—p‚¢‚œ‹|•”‘å“®–¬áŽ‚ÌŽ¡—Ð헪: DebranchTEVAR‚Æ‘S‹|•”’uŠ·‚ÌŒŒ—¬“®‘Ô•]‰¿. •ó—ˆ“N–ç1, ”Â’JŒcˆê2, “c‘º’q‹I1, –k‘º@—¥1, ‹{èãĕœ2, ’¹ˆäWŽO3, •œ“cŒõ”Ž4, ‰ª@“¿•F1, “c‘ºK•ä1, ”ü“‡—˜–Ÿ1, ’†‘º—SŠó1, ŽÄ“c[á1, r‹Lt“Þ1, ‹gˆä@„1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŒŒ—¬‰ðÍ, 3ˆã—ËZp‹³ˆç, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ43‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2015/6/3-5), ‰¡•l, “ú–{ŒŒŠÇŠO‰ÈŠw‰ïŽGŽ 2015/6; 24 (3): 512.

723452. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚銎õ«• •”‘å“®–¬áŽ‚ɑ΂·‚éŽèpŒoŒ±. ”ü“‡—˜º1, •œ“cŒõ”Ž2, “c‘ºK•ä1, ‘å‹v•Û”Ž¢1, ’¹ˆäWŽO3, –k‘º@—¥1, ‰ª@“¿•F1, •ó—ˆ“N–ç1, ”Â’JŒcˆê4, ’†‘º—SŠó1, ŽÄ“c[á1, “c‘º’q‹I1, r‹LtØ1, Œ‰iŒc—õ1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3ˆã—ËZp‹³ˆç, 4ŒŒ—¬‰ðÍ): ‘æ43‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2015/6/3-5), ‰¡•l, “ú–{ŒŒŠÇŠO‰ÈŠw‰ïŽGŽ 2015/6; 24 (3): 570.

723453. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¶‘å‘Ú“®–¬úŽh‚É‚æ‚éPCIŽ{sŒã‚ÉŠŽõ«‰Œ«‘å‘Ú“®–¬áŽ‚ð‡•¹‚µ‚œ1ŽèpÇ—á. ùŒŽ‘–L1, æс@³Šî2, ŽR–{Ms2, ¬ŒŽ–M‹`2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŠC˜V–Œ‘‡•a‰@): ‘æ43‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2015/6/3-5), ‰¡•l, “ú–{ŒŒŠÇŠO‰ÈŠw‰ïŽGŽ 2015/6; 24 (3): 602.

723454. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) EVARpŒã, ‹r•ÂÇ‚ɑ΂µ‚ĒljÁŽ¡—Âð—v‚µ‚œ2—á. “c‘ºK•ä1, •œ“cŒõ”Ž2, ”ü“‡—˜º1, ‘å‹v•Û”Ž¢1, Œ‰iŒc—õ1, r‹Lt“Þ1, “c‘º’q‹I1, ŽÄ“c[á1, ’†‘º—SŠó1, ”Â’JŒcˆê3, •ó—ˆ“N–ç1, ‰ª@“¿•F1, –k‘º@—¥1, ’¹ˆäWŽO4, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3ŒŒ—¬‰ðÍ, 4ˆã—ËZp‹³ˆç): ‘æ43‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2015/6/3-5), ‰¡•l, “ú–{ŒŒŠÇŠO‰ÈŠw‰ïŽGŽ 2015/6; 24 (3): 690.

723455. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ñdƒpƒbƒ`•Âœ–@‚É‚æ‚éSŽº’†ŠuúEŽèp‚̐¬Ñ. •ó—ˆ“N–ç1, –k‘º@—¥1, ’¹ˆäWŽO2, “c‘º’q‹I1, r‹Lt“Þ1, ”Â’JŒcˆê3, ‰ª@“¿•F1, ’†‘º—SŠó1, Œ‰iŒc—õ1, •œ“cŒõ”Ž4, “c‘ºK•ä1, ”ü“‡—˜º1, ‹gˆä@„1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3ŒŒ—¬‰ðÍ, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ20‰ñ“ú–{Š¥“®–¬ŠO‰ÈŠw‰ïŠwp‘å‰ï (2015/7/9-10), ‹ž“s, “ú–{Š¥“®–¬ŠO‰ÈŠw‰ïŽGŽ 2015/7; Suppl: 103.

723456. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‚µ‚¢ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“ˆãŠw‚̏¬Ž™zŠÂŠíˆã—Âւ̉ž—p|ƒRƒ“ƒsƒ…[ƒ^[ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚É‚æ‚錌s“®‘ԏ㎊“KŒ`ó‚ÉŠî‚¢‚œ”x“®–¬Œ`¬p|. ‹{’n@ŠÓ1, ‹{èãĕœ2, ”Â’JŒcˆê2, ‰ª@“¿•F1, ’†‘º—SŠó1, ‹gˆä@„1, Œ‰iŒc—õ1 (1S‘ŸŒŒŠÇŠO, 2ŒŒ—¬‰ðÍ): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16-18), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.104.

723457. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘̏d1 kg–¢–ž‚Ì’Ž’áo¶‘̏dŽ™‚ɑ΂·‚é“àŽ‹‹Ÿ‰º“®–¬ŠÇ•Âœp. ‹{’n@ŠÓ1, ‰ª@“¿•F1, ’†‘º—SŠó1, ‹gˆä@„1, Œ‰iŒc—õ1, Îˆä³_2 (1S‘ŸŒŒŠÇŠO, 2¬Ž™): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16-18), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.163.

723458. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šg’£‘Šú¶Žº“àˆ³Šr·‚š‚æ‚э¶Žº•ÏŒ`•]‰¿‚É‚æ‚é, ¬Ž™‚ª‚ñŽ¡—ÃŒã‚̐S‹@”\’ቺ‚Ì‘Šú”­Œ©. dŒõK‰h1, ‚‹Ž@Œ’1, ŽR“c^—œŽq1, HŒ³‚©‚‚Ý1, âŒû²’m1, “¡‘ºƒ–ç1, Ä“¡³”Ž1, ‹H‘ã‰ë•F1, ‹{’n@ŠÓ2, ”Â’JŒcˆê3, Ž…r–Ÿ1 (1‡“V“°‘åŠw, 2S‘ŸŒŒŠÇŠO, 3ŒŒ—¬‰ðÍ): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16-18), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.228.

723459. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) æ“V«SŽŸŠ³C•œpŒã30”NˆÈãŒo‰ß‚µ‚œ”x‚ŒŒˆ³‚𔺂€”x“®–¬•Ù‹t—¬‚ɑ΂·‚é”x“®–¬•Ù’uŠ·p‚Ì2—á. ‰ª@“¿•F1, ’†‘º—SŠó1, Œ‰iŒc—õ1, r‹Lt“Þ1, “c‘º’q‹I1, •ó—ˆ“N–ç1, –k‘º@—¥1, ’¹ˆäWŽO2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16-18), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.385.

723460. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹·¬‘å“®–¬•Ù—ւ𔺂€IAA/CoA complex‚ɑ΂·‚é“–‰@‚É‚š‚¯‚鎡—Õûj‚ÌŒŸ“¢. ‹gˆä@„1, ’†‘º—SŠó1, ‘å—F—EŽ÷1, ’¹ˆäWŽO2, –k‘º@—¥1, •ó—ˆ“N–ç1, “c’†—C‹M1, ‹ß“¡@^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç): ‘æ68‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/10/19), _ŒË, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ 2015/10; suppl: 81.

723461. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –«BŒ^‘å“®–¬‰ð—£‚ɑ΂·‚é‘æ1¢‘ãTEVAR‚̉“Šu¬Ñ. –k‘º@—¥1, ’¹ˆäWŽO2, •œ“cŒõ”Ž3, •ó—ˆ“N–ç1, ‹gˆä@„1, ’†‘º—SŠó1, “c’†—C‹M1, ‹ß“¡@^1, ‘å—F—EŽ÷1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ68‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/10/19), _ŒË, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ 2015/10; suppl: 162.

723462. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ñdƒpƒbƒ`•Âœ–@‚É‚æ‚éSŽº’†ŠuúEŽèp‚̐¬Ñ. •ó—ˆ“N–ç1, –k‘º@—¥1, ’¹ˆäWŽO2, “c’†—C‹M1, ‹ß“¡@^1, ™–{Wˆê1, ‹gˆä@„1, Œ‘ã‘ì–ç1, •œ“cŒõ”Ž3, ”ü“‡—˜º1, ‘å‹v•Û”Ž¢1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ29‰ñ“ú–{Š¥ŽŸŠ³Šw‰ïŠwpW‰ï (2015/11/20-21), ŽD–y.

723463. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A Larger Bioprosthetic Valve Provides Lower Pressure Gradient across the Pulmonary Valve for Redo Pulmonary Valve Replacement in Adolescents and Adults. ™–{Wˆê1, ‹{’n@ŠÓ1, ‹gˆä@„1, ’¹ˆäW‘¢2, –k‘º@—¥1, •œ“cŒõ”Ž3, ”ü“‡—˜º1, •ó—ˆ“N–ç1, —F•Û‹M”Ž1, Îˆä³_4, –Ø‘ºƒl4, ˆÀ“¡@Žõ4, –kì“ÄŽj4, •ô”öŒb—œ4, ‰ª@“¿•F1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 4¬Ž™): ‘æ18‰ñ“ú–{¬læ“V«SŽŸŠ³Šw‰ï‘‰ïEŠwpW‰ï (2016/1/16), ‘åã.

723464. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¶S’áŒ`¬ÇŒóŒQ‚ɑ΂·‚鍇•¹Ç‰ñ”ð‚ÉŒü‚¯‚œŽ¡—Ð헪. ‹gˆä@„1, Œ‘ã‘ì–ç1, ’†‘º—SŠó1, ™–{Wˆê1, ‹ß“¡@^1, “c’†—C‹M1, ‘å‹v•Û”Ž¢1, •ó—ˆ“N–ç1, ”ü“‡—˜º1, •œ“cŒõ”Ž2, –k‘º@—¥1, ’¹ˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3ˆã—ËZp‹³ˆç): ‘æ46‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2016/2/15-17), –ŒŒÃ‰®.

723465. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) bulging sinus•tePTFE monocusp patch‚š‚æ‚Ñtricusp conduit‚ð—p‚¢‚œRVOTR‚Ì’†Šú¬Ñ. Œ‘ã‘ì–ç1, ™–{Wˆê1, ’†‘º—SŠó1, ‹gˆä@„1, ’¹ˆäWŽO2, –k‘º@—¥1, •ó—ˆ“N–ç1, •œ“cŒõ”Ž3, ”ü“‡—˜º1, —F•Û‹M”Ž1, ‘å‹v•Û”Ž¢1, “c’†—C‹M1, ‹ß“¡@^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2016/2/15-17), –ŒŒÃ‰®.

723466. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) AŒ^‹}«‘å“®–¬‰ð—£ŽèpŽž‚̐^o’ŒÚ‘—ŒŒ. ‹ß“¡@^1, –k‘º@—¥1, ’¹ˆäWŽO2, •œ“cŒõ”Ž3, •ó—ˆ“N–ç1, ’†‘º—SŠó1, ‹gˆä@„1, “c’†—C‹M1, ‘å—F—EŽ÷1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2016/2/15-17), –ŒŒÃ‰®.

723467. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚銎õ«S“à–Œ‰Š‚ɑ΂·‚鎡—ÃŒoŒ±. •ó—ˆ“N–ç1, –k‘º@—¥1, ’¹ˆäWŽO2, •œ“cŒõ”Ž3, ”ü“‡—˜º1, “c’†—C‹M1, ‘å‹v•Û”Ž¢1, ‹ß“¡@^1, ™–{Wˆê1, ‹gˆä@„1, ’†‘º—SŠó1, Œ‘ã‘ì–ç1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2016/2/15-17), –ŒŒÃ‰®.

723468. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹CŠÇ“®–¬á‘‚ɑ΂·‚éƒXƒeƒ“ƒgƒOƒ‰ƒtƒg“à‘}p‚Ì2—á. ‘å‹v•Û”Ž¢1, ”ü“‡—˜º1, •œ“cŒõ”Ž2, ‹ß“¡@^1, “c’†—C‹M1, ‹gˆä@„1, ’†‘º—SŠó1, ™–{Wˆê1, •ó—ˆ“N–ç1, –k‘º@—¥1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2016/2/15-17), –ŒŒÃ‰®.

733163. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘å“®–¬‰ð—£“à–Œ‹T—ô‚ÌŒð˜A‰¡’f‚É‹Nˆö‚·‚閝«‘å“®–¬•Ù•Âœ•s‘SÇ‚Ì1—á. ‹ß“¡@^1, –k‘º@—¥1, ’¹ˆäWŽO2, •œ“cŒõ”Ž3, •ó—ˆ“N–ç1, ”Â’JŒcˆê4, ’†‘º—SŠó1, ‹gˆä@„1, “c’†—C‹M1, ‘å—F—EŽ÷1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 4ŒŒ—¬‰ðÍ): ‘æ168‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2015/6/27), “Œ‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2015/6; 168: 11.

733164. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”xÃ–¬•Âœ, ”xÃ–¬’áŒ`¬‚̈ê—á. ‹{“c—L—Œb1, ’†‘º—SŠó2, ‹ß“¡@^2, ‘å—F—EŽ÷2, “c’†—S‹M2, ‹gˆä@„2, •ó—ˆ“N–ç2, –k‘º@—¥2, ’¹ˆäWŽO3, ‹{’n@ŠÓ2 (1Œ€Cˆã, 2S‘ŸŒŒŠÇŠO, 3ˆã—ËZp‹³ˆç): ‘æ168‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2015/6/27), “Œ‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2015/6; 168: 12.

733165. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Long segment CoA‚ɑ΂µlHŒŒŠÇ‚É‚æ‚éinterposition‚ðŽ{s‚µ‚œ12ÎŽ™‚Ì1—á. ™–{Wˆê1, ‹{’n@ŠÓ1, ‹gˆä@„1, ‹ß“¡@^1, Îˆä³_2, –Ø‘ºƒl2, ˆÀ“¡@Žõ2, –kì“ÄŽj2, •ô”öŒb—œ2 (1S‘ŸŒŒŠÇŠO, 2¬Ž™): ‘æ11‰ñ_“ސ쏬Ž™zŠÂŠíŒ€‹†‰ï (2015/10/31), ‰¡•l.

733166. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰Eœœ‰º“®–¬‹NŽnˆÙí‚𔺂€‹}«AŒ^‘å“®–¬‰ð—£‚ɑ΂·‚é2Šú“IŽèp. ŽO’J—D‘Ÿ˜N1, –k‘º@—¥2, ’¹ˆäWŽO3, •ó—ˆ“N–ç2, Œ‘ã‘ì–ç2, •œ“cŒõ”Ž4, ”ü“‡—˜–Ÿ2, ‘å‹v•Û”Ž¢2, ™–{Wˆê2, ‹gˆä@„2, —F•Û‹M”Ž2, ‹ß“¡@^2, ‹{’n@ŠÓ2 (1Œ€Cˆã, 2S‘ŸŒŒŠÇŠO, 3ˆã—ËZp‹³ˆç, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ169‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2015/11/7), “Œ‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2015/11; 169: 16.

733167. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬lŠú‚ɐS•s‘S‚𔭏ǂµ‚œC³‘匌ŠÇ“]ˆÊ‚Ì1—á. Œ‘ã‘ì–ç1, ™–{Wˆê1, ’†‘º—SŠó1, ‹gˆä@„1, ’¹ˆäWŽO2, –k‘º@—¥1, •ó—ˆ“N–ç1, —F•Û‹M”Ž1, “c’†—C‹M1, ‹ß“¡@^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç): ‘æ169‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2015/11/7), “Œ‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2015/11; 169: 37.

733168. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒtƒ@ƒ[Žl’¥Ç, ”x“®–¬•Âœ, Žå—v‘Ì”x‘€•›ŒŒs, ’†S”x“®–¬’áŒ`¬‚ɑ΂µ‚ďW‡‰»‚ðs‚í‚ž‚ɍªŽ¡Žèp‚ðŽ{s‚µ‚Š‚œ1—á. ‹ß“¡@^1, ™–{Wˆê1, ‹gˆä@„1, ’¹ˆäWŽO2, –k‘º@—¥1, •ó—ˆ“N–ç1, —F•Û‹M”Ž1, Œ‘ã‘ì–ç1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç): ‘æ170‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2016/3/12), ‰¡•l, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2016/3; 170: 7.

733169. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žá”NŽÒŠŽõ«S“à–Œ‰Š‚ɑ΂µ‚Ä‘m–X•ÙEäFõE“û“ª‹Ø‚ðˆê–‡‚ÌŽ©ŒÈS–Œ‚ŏC•œ‚µ‚œˆê—á. —с@GŒ›1, ŽR–{Ms, –k‘º@—¥1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘æ170‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2016/3/12), ‰¡•l, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2016/3; 170: 21.

733170. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ÄX”­‚𗈂œ‚µ‚œS‘Ÿ”S‰tŽî‚̈ê—á. Œ‘ã‘ì–ç1, •ó—ˆ“N–ç1, ’¹ˆäWŽO2, •œ“cŒõ”Ž3, –k‘º@—¥1, ”ü“‡—˜º1, —F•Û‹M”Ž1, ‘å‹v•Û”Ž¢1, ™–{Wˆê1, ‹gˆä@„1, ‹ß“¡@^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆã—ËZp‹³ˆç, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ170‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2016/3/12), ‰¡•l, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2016/3; 170: 22.


ŒÄ‹zŠíŠO‰ÈŠw

[Šwp˜_•¶]

110191. [ŒŽ’˜] Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance. Nakashima H1, Jiang SX2, Sato Y3, Hoshi K4, Matsumoto T2, Nagashio R3, Kobayashi M, Matsuo Y, Shiomi K1, Hayakawa K5, Saegusa M2, Satoh Y1: Pathol Int 2015/4; 65 (4): 183-92. (’†“‡—TN1, Ó@¢ˆ®2, ²“¡—Yˆê3, ¯@‰À–F4, Œ–{r‰p2, ’·‰–@—º3, ‰–Œ©@˜a1, ‘ì˜ad5, ŽOŽ}@M2, ²“¡”Vr1: 1ŒÄ‹zŠíŠO, 2•a—, 3ˆã—Éq¶Šw, 4‰q¶, 5•úŽËü (Žîá‡))

110024. [ŒŽ’˜] The role of vascular endothelial growth factor receptor-1 signaling in compensatory contralateral lung growth following unilateral pneumonectomy. Matsui Y1, Amano H2, Ito Y, Eshima K3, Tamaki H4, Ogawa F5, Iyoda A, Shibuya M, Kumagai Y5, Satoh Y1, Majima M2: Lab Invest 2015/5; 95 (5): 456-68. (ŒˆäŒ[•v1, “V–ì‰pŽ÷2, ]“‡k“ñ3, ‹Ê–؉p–Ÿ4, ¬ìŽj—m5, ŒF’J—YŽ¡5, ²“¡”Vr1, ”n“ˆ³—²2: 1ŒÄ‹zŠíŠO, 2–ò—, 3–Ɖu, 4‰ð–U, 5—Տ°Œ€‹†EƒvƒƒWƒFƒNƒg)

110192. [ŒŽ’˜] Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma. Saito Y, Nagae G, Motoi N, Miyauchi E, Ninomiya H, Uehara H, Mun M, Okumura S, Ohyanagi F, Nishio M, Satoh Y1, Aburatani H, Ishikawa Y: Cancer Sci 2016/3; 107 (3): 320-5. (²“¡”Vr1: 1ŒÄ‹zŠíŠO)

310021. [Ç—á•ñ] Abnormal branching of the left lingular pulmonary artery diagnosed by three-dimensional computed tomographic angiography in a patient with lung cancer: a case report. Sonoda D1, Mikubo M2, Shiomi K1, Satoh Y1: J Cardiothorac Surg 2016/1; 11: 17. (‰€“c@‘å1, ŽOŒE«Žj2, ‰–Œ©@˜a1, ²“¡”Vr1: 1ŒÄ‹zŠíŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

320020. [Ç—á•ñ] EBUS-TBNA‚ÅŠm’èf’f‚É‚¢‚œ‚ç‚ž‹¹o‹Ÿ‰ºcŠuƒŠƒ“ƒpß¶ŒŸ‚Őf’f‚µ‚œƒzƒWƒLƒ“ƒŠƒ“ƒpŽî1—á. ¬–쌳Žk1, ‰€“c@‘å1, ’†“‡—TN1, ‰–Œ©@˜a1, âŒû@”E, ‹g“c@Œ÷2, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2•a—): _“ސì×–E‰ïŽ 2015/9; 20 (1): 46-50.

522112. [uÀ] “ú–{”xŠàŠw‰ïE“ú–{—Տ°×–EŠw‰ï@2Šw‰ï‡“¯ˆÏˆõ‰ï•ñ: ”x‚ª‚ñŒŸf‚É‚š‚¯‚éš\ႍזEf‚̐f’fˆê’v«‚Æ•W€‰». ²“¡‰ë”ü, ŽÄ@Œõ”N, âV“¡‘׋I, ²“¡”Vr1, a’J@Œ‰, “y“cŒh–Ÿ, ’†ŽR•x—Y, •ó—ˆ@ˆÐ, ’r“c“¿•F, ‰ÍŒŽ@‰h, ŽO‰YO”V, ’†“ˆ—²‘Ÿ˜Y, “cŒû–Ÿ”ü, –î‰H“cˆêM, “‡Š_“ñ‰ÀŽq, _”ö~Žq, ’·”ö@—Î, ŽO‘î^Ži, ‰ºìKO, “c’†—Ç‘Ÿ, ‰““¡çŒ° (1ŒÄ‹zŠíŠO) ”xŠà 2015/12; 55 (6): 859-65.

540015. [‚»‚Ì‘Œ]yŒ€‹†‚ÌŽü•Ó‚©‚çzŒÄ‹zŠíŠO‰Èˆã‚ÆŒ€‹†. ²“¡”Vr (ŒÄ‹zŠíŠO): ŒÄ‹z 2015/8; 34 (8): 741-2.

[’˜@‘]

621002. [Šwp‘ (•ÒW)]y×–EfƒKƒCƒhƒ‰ƒCƒ“4@ŒÄ‹zŠíE‹¹‘BE‘̍o‰tEƒŠƒ“ƒpß 2015”N”Łz•Ò: “ú–{—Տ°×–EŠw‰ï (•›ˆÏˆõ’·: ²“¡”Vr (ŒÄ‹zŠíŠO)), ‹àŒŽo”Å, “Œ‹ž, 2015/6”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713060. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) High vimentin expression in micropapillary component of lung adenocarcinomas. Nakashima H1, Jiang SX2, Sato Y, Hoshi K3, Matsumoto T2, Nagashio R, Kobayashi M, Matsuo Y, Shiomi K1, Hayakawa K4, Saegusa M2, Satoh Y1: The 16th World Conference on Lung Cancer (2015/9/7), Denver, USA. (’†“‡—TN1, Ó@¢ˆ®2, ¯@‰À–F3, Œ–{r‰p2, ‰–Œ©@˜a1, ‘ì˜ad4, ŽOŽ}@M2, ²“¡”Vr1: 1ŒÄ‹zŠíŠO, 2•a—, 3‰q¶, 4•úŽËü (Žîá‡))

713061. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Pleomorphic carcinoma of the lung: a clinicopathologic study of 23 resected cases. Sonoda D1, Ono M1, Kondo Y1, Hayashi S1, Mikubo M2, Nakashima H1, Matsui Y1, Ichinoe M3, Shiomi K1, Jiang SX3, Murakumo Y3, Satoh Y1: The 16th World Conference on Lung Cancer (2015/9/7), Denver, USA. (‰€“c@‘å1, ¬–쌳Žk1, ‹ß“¡‘אl1, —с@ËŽq1, ŽOŒE«Žj2, ’†“‡—TN1, ŒˆäŒ[•v1, ˆêŒË¹–Ÿ3, ‰–Œ©@˜a1, Ó@¢ˆ®3, ‘º‰_–FŽ÷3, ²“¡”Vr1: 1ŒÄ‹zŠíŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3•a—)

713062. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Investigation for the Optimum Resectable Pathological Size of Small Solitary Metastasis from Colorectal Cancers. Sakao Y, Kuroda H, Okumura T, Boku N, Hishida T, Ohde Y, Yoshiya K, Higashiyama M, Adachi H, Satoh Y1, Kameyama K, Kanzaki M, Yoshimura M, Hata Y, Matsuura M, Chen F, Yoshida K, Sasaki H, Horio H, Takenoyama M, Yamashita M, Hashimoto T, Fujita A, Okumura M, Funai K, Shiono S, Asano H, Suzuki M, Hoshi E, Shiraishi Y, Nakayama M, Yamazaki N, Matsuo T, Miyazawa H, Sato Y, Takao M, Nakayama H, Yamada S, Shimizu K, Kataoka M, Nakamura H, Watanabe T, Suzuki H, Akamine S, Tsunezuka Y, Nakata M, Kadokura M, Hyodo I, Mori K, Kondo H: The 16th World Conference on Lung Cancer (2015/9/8), Denver, USA. (²“¡”Vr1: 1ŒÄ‹zŠíŠO)

723469. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”xë•”‘O•û‹¹•ÇZ”xŠà‚ɑ΂·‚鋹œ³’†ØŠJ‚ÉŒz•”ØŠJ‚ð‰Á‚Š‚œƒAƒvƒ[ƒ``ƒVƒ“ƒvƒ‹‚©‚”ėp«‚ª‚‚¢`. ‰–Œ©@˜a (ŒÄ‹zŠíŠO): ‘æ32‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2015/5/14), ‚Œ.

723470. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”xë•”‘O•ûZ”xŠà‚ɑ΂µ‹¹œ³’†ØŠJ‚ÉŒz•”ØŠJ‚ð‰Á‚Š‚Đ؏œ‚ðs‚Á‚œ1—á`ƒVƒ“ƒvƒ‹‚©‚”ėp«‚̍‚‚¢ƒAƒvƒ[ƒ``. ‰–Œ©@˜a1, ŽOŒE«Žj2, ŒˆäŒ[•v1, ‰€“c@‘å1, ‹ß“¡‘אl1, ¬–쌳Žk1, ’†“‡—TN1, –k‘º@—¥3, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3S‘ŸŒŒŠÇŠO): ‘æ32‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2015/5/15), ‚Œ.

723471. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –Å‹Û’²®ƒ^ƒ‹ƒN‚É‚æ‚é–ü’…—Ö@Œã‚Ì‹¹o“à‚̏ó‘Ô. —с@ËŽq1, ˆäã€l, –x“cˆ»Žq, âV“¡¶˜N, ¬–쌳Žk1, ‹ß“¡‘אl1, ‰€“c@‘å1, ŽOŒE«Žj2, ’†“‡—TN1, ŒˆäŒ[•v1, ‰–Œ©@˜a1, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ŒÄ‹zŠí“à, 4•a—): ‘æ32‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2015/5/15), ‚Œ.

723472. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) EBUS-TBNA‚ŃTƒ‹ƒRƒCƒh[ƒVƒX‚Ɛf’f‚µŒo‰ßŠÏŽ@’†‚Éš\ႍזEf‚É‚Ä”­Œ©‚³‚ê‚œ”x‘BŠà‚̈ê—á. ¬–쌳Žk1, ‹ß“¡‘אl1, —с@ËŽq1, ‰€“c@‘å1, ŽOŒE«Žj2, ’†“‡—TN1, ŒˆäŒ[•v1, ‰–Œ©@˜a1, ’O‰H‰p”V3, ‚‘q@W3, ‹v•Û“cŸ3, ‰v“c“TK3, –öàVM”V4, ˆêŒË¹–Ÿ4, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ŒÄ‹zŠí“à, 4•a—): ‘æ38‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŠwpW‰ï (2015/6/12), “Œ‹ž.

723473. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Highly frequent postoperative up- staging of lung adenocarcinomas with micropapillary component. ’†“‡—TN1, Ó@¢ˆ®2, ŽOŽ}@M2, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2•a—): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8-10), –ŒŒÃ‰®.

723474. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) micropapillary component‚ð—L‚·‚é”x‘BŠà‚ƏpŒã•a—•aŠúup-staging‚Æ‚ÌŠÖ˜A. ’†“‡—TN1, Ó@¢ˆ®2, ¬–쌳Žk1, —с@ËŽq1, ‰€“c@‘å1, ŒˆäŒ[•v1, ‰–Œ©@˜a1, ŽOŽ}@M2, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2•a—): ‘æ56‰ñ“ú–{”xŠàŠw‰ïŠwpW‰ï (2015/11/26-28), ‰¡•l.

H26”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H26-733005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇ‹Ø–³—͏ǂɑ΂·‚錕ó“Ë‹N‰ºƒAƒvƒ[ƒ` (+ ‘€‹¹•”•â•ƒ|[ƒg) ‚É‚æ‚鋹o‹Ÿ‰ºŠg‘勹‘B“Eop‚Ì’èŒ^‰». ‰–Œ©@˜a (ŒÄ‹zŠíŠO): ‘æ34‰ñ“ú–{‹¹‘BŒ€‹†‰ï (2015/2/7), ‘Š–ÍŒŽ.


”]_ŒoŠO‰ÈŠw

[Šwp˜_•¶]

110193. [ŒŽ’˜] Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients. Kanamori M, Higa T, Sonoda Y, Murakami S, Dodo M, Kitamura H, Taguchi K, Shibata T, Watanabe M, Suzuki H, Shibahara I, Saito R, Yamashita Y, Kumabe T1, Yamamoto M, Motohashi H, Tominaga T: Neuro Oncol 2015/4; 17 (4): 555-65. (ŒG•”rG1: 1”]ŠO)

110194. [ŒŽ’˜] Vaginal Delivery under Epidural Analgesia in Pregnant Women with a Diagnosis of Moyamoya Disease. Sato K1, Yamada M1, Okutomi T2, Kato R3, Unno N4, Fujii K1, Kumabe T1: J Stroke Cerebrovasc Dis 2015/5; 24 (5): 921-4. (²“¡Œör1, ŽR“c@Ÿ1, ‰œ•xr”V2, ‰Á“¡—¢ŠG3, ŠC–ìM–ç4, “¡ˆäŽF1, ŒG•”rG1: 1”]ŠO, 2–ƒŒ, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã, 4ŽY‰È)

110195. [ŒŽ’˜] Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor. Yang X, Saito R, Nakamura T, Zhang R, Sonoda Y, Kumabe T1, Forsayeth J, Bankiewicz K, Tominaga T: Drug Deliv 2015/7: 1-6. [Epub ahead of print] (ŒG•”rG1: 1”]ŠO)

110196. [ŒŽ’˜] Moist-condition Training for Cerebrovascular Anastomosis: A Practical Step after Mastering Basic Manipulations. Shimizu S1, Sekiguchi T1, Mochizuki T, Sato K1, Koizumi H2, Nakayama K, Yamamoto I, Kumabe T1: Neurol Med Chir (Tokyo) 2015/8; 55 (8): 689-92. (Ž…@ú1, ŠÖŒû•üŽq1, –]ŒŽ’O, ²“¡Œör1, ¬òŠ°”V2, ’†ŽRŒ«Ži, ŽR–{—E•v, ŒG•”rG1: 1”]ŠO, 2‹~–œ)

110197. [ŒŽ’˜] Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors. Takami H, Fukushima S, Fukuoka K, Suzuki T, Yanagisawa T, Matsushita Y, Nakamura T, Arita H, Mukasa A, Saito N, Kanamori M, Kumabe T1, Tominaga T, Kobayashi K, Nagane M, Iuchi T, Tamura K, Maehara T, Sugiyama K, Nakada M, Kanemura Y, Nonaka M, Yokogami K, Takeshima H, Narita Y, Shibui S, Nakazato Y, Nishikawa R, Ichimura K, Matsutani M: J Neurooncol 2015/8; 124 (1): 23-32. (ŒG•”rG1: 1”]ŠO)

110198. [ŒŽ’˜] Intraoperative Ultrasonography during Drainage for Chronic Subdural Hematomas: A Technique to Release Isolated Deep-seated Hematomas--Technical Note. Shimizu S1, Mochizuki T, Osawa S1, Kumabe T1: Neurol Med Chir (Tokyo) 2015/9; 55 (9): 761-5. (Ž…@ú1, –]ŒŽ’O, ‘åàV¬”V1, ŒG•”rG1: 1”]ŠO)

110199. [ŒŽ’˜] Edamame sigh in syringomyelia: a pattern of syrinx dilation correlated with spared thermal nociception. Shimizu S1, Mochizuki T, Sekiguchi T1, Osawa S1, Kawai T, kohno M, Sagiuchi T, Kumabe T1: J Spine Res 2015/9; 6 (9): 1407-15. (Ž…@ú1, –]ŒŽ’O, ŠÖŒû•üŽq1, ‘åàV¬”V1, ‰Íˆä‘ì–ç, ‰Í–ìS”Í, ë“à—²—Y, ŒG•”rG1 :1”]ŠO)

110200. [ŒŽ’˜] Intraoperative monitoring during decompression of the spinal cord and spinal nerves using transcranial motor-evoked potentials: The law of twenty percent. Tanaka S, Hirao J, Oka H1, Akimoto J, Takanashi J, Yamada J: J Clin Neurosci 2015/9; 22 (9): 1403-7. (‰ª@GG1: 1”]ŠO)

110201. [ŒŽ’˜] Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1/Akt axis in glioblastoma. Inukai M1, Hara A2, Yasui Y3, Kumabe T4, Matsumoto T2, Saegusa M2: Hum Pathol 2015/10; 46 (10): 1496-505. (Œ¢Ž”@‰~1, ŒŽ@“ÖŽq2, ˆÀˆä”ü]3, ŒG•”rG4, Œ–{r‰p2, ŽOŽ}@M2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn, 4”]ŠO)

110202. [ŒŽ’˜] A comparative study of the extent of cerebral microvascular injury following whole-brain irradiation versus reduced-field irradiation in long-term survivors of intracranial germ cell tumors. Li L, Mugikura S, Kumabe T1, Murata T, Mori E, Takase K, Jingu K, Takahashi S: Radiother Oncol 2015/11; 117 (2): 302-7. (ŒG•”rG1: 1”]ŠO)

110203. [ŒŽ’˜] Modified One-piece Supraorbital Approach for Orbital Tumors: Widely Preserved Orbital Roof in a Self-fitting Flap. Shimizu S1, Osawa S1, Sekiguchi T1, Mochizuki T, Oka H1, Kumabe T1: J Neurol Surg B Skull Base 2015/12; 76 (6): 459-63. (Ž…@ú1, ‘åàV¬”V1, ŠÖŒû•üŽq1, –]ŒŽ’O, ‰ª@GG1, ŒG•”rG1: 1”]ŠO)

110204. [ŒŽ’˜] Low Stroke Rate of Carotid Stenosis Under the Guideline-Oriented Medical Treatment Compared With Surgical Treatment. Sato K1, Fujiyoshi K2, Hoshi K3, Noda C4, Yamaoka-Tojo M5, Ako J4, Kumabe T1: Int Heart J 2016/1; 57 (1): 80-6. (²“¡Œör1, “¡‹g˜a”Ž2, ¯@‰À–F3, –ì“cçt4, “ŒžŠ”ü“ÞŽq5, ˆ¢ŒÃÆ4, ŒG•”rG1: 1”]ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‰q¶, 4zŠÂŠí“à, 5ˆã—Éq¶Šw•”)

110205. [ŒŽ’˜] Divergent clonal selection dominates medulloblastoma at recurrence. Morrissy AS, Garzia L, Shih DJ, Zuyderduyn S, Huang X, Skowron P, Remke M, Cavalli FM, Ramaswamy V, Lindsay PE, Jelveh S, Donovan LK, Wang X, Luu B, Zayne K, Li Y, Mayoh C, Thiessen N, Mercier E, Mungall KL, Ma Y, Tse K, Zeng T, Shumansky K, Roth AJ, Shah S, Farooq H, Kijima N, Holgado BL, Lee JJ, Matan-Lithwick S, Liu J, Mack SC, Manno A, Michealraj KA, Nor C, Peacock J, Qin L, Reimand J, Rolider A, Thompson YY, Wu X, Pugh T, Ally A, Bilenky M, Butterfield YS, Carlsen R, Cheng Y, Chuah E, Corbett RD, Dhalla N, He A, Lee D, Li HI, Long W, Mayo M, Plettner P, Qian JQ, Schein JE, Tam A, Wong T, Birol I, Zhao Y, Faria CC, Pimentel J, Nunes S, Shalaby T, Grotzer M, Pollack IF, Hamilton RL, Li XN, Bendel AE, Fults DW, Walter AW, Kumabe T1, Tominaga T, Collins VP, Cho YJ, Hoffman C, Lyden D, Wisoff JH, Garvin JH Jr, Stearns DS, Massimi L, Sch_ller U, Sterba J, Zitterbart K, Puget S, Ayrault O, Dunn SE, Tirapelli DP, Carlotti CG, Wheeler H, Hallahan AR, Ingram W, MacDonald TJ, Olson JJ, Van Meir EG, Lee JY, Wang KC, Kim SK, Cho BK, Pietsch T, Fleischhack G, Tippelt S, Ra YS, Bailey S, Lindsey JC, Clifford SC, Eberhart CG, Cooper MK, Packer RJ, Massimino M, Garre ML, Bartels U, Tabori U, Hawkins CE, Dirks P, Bouffet E, Rutka JT, Wechsler-Reya RJ, Weiss WA, Collier LS, Dupuy AJ, Korshunov A, Jones DT, Kool M, Northcott PA, Pfister SM, Largaespada DA, Mungall AJ, Moore RA, Jabado N, Bader GD, Jones SJ, Malkin D, Marra MA, Taylor MD: Nature 2016/1; 529 (7586): 351-7. (ŒG•”rG1: 1”]ŠO)

110206. [ŒŽ’˜] Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease. Sato K1, Yamada M1, Kuroda H1, Yamamoto D1, Asano Y2, Inoue Y2, Fujii K, Kumabe T1: Am J Neuroradiol 2016/3; 37: 1244-8. (²“¡Œör1, ŽR“c@Ÿ1, •“c”Ž‹I1, ŽR–{‘å•ã1, ó–ì—Y“ñ2, ˆäã—D‰î2, ŒG•”rG1: 1”]ŠO, 2•úŽËü (‰æ‘œ))

110207. [ŒŽ’˜] Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor. Yang X, Saito R, Nakamura T, Zhang R, Sonoda Y, Kumabe T1, Forsayeth J, Bankiewicz K, Tominaga T: Drug Deliv 2016; 23 (3): 771-6. (ŒG•”rG1: 1”]ŠO)

220006. [€ŒŽ’˜] –¬—‘p (choroidal fissure) ‹ß–T‚ÌŽèp‚É•K—v‚È”÷¬ŠO‰È‰ð–U. ‰ª@GG1, ‰Í“‡‰ë“ž, Ž…@ú1, ‘åàV¬”V1, ²“¡Œör1, ‹v{”ü^—1, “¡ˆäŽF1, Albert L Rhoton Jr (1”]ŠO): ”]_ŒoŠO‰ÈƒWƒƒ[ƒiƒ‹ 2015/10; 24 (Suppl 2): 73-9.

310022. [Ç—á•ñ] Chronic Phase Intracranial Hemorrhage Caused by Ruptured Pseudoaneurysm Induced by Carmustine Wafer Implantation for Insulo-opercular Anaplastic Astrocytoma: A Case Report. Sato K1, Dan M1, Yamamoto D1, Miyajima Y, Hara A2, Kumabe T1: Neurol Med Chir (Tokyo) 2015/11; 55 (11): 848-51. (²“¡Œör1, ’h@@[1, ŽR–{‘å•ã1, ‹{“‡—Ç‹P, ŒŽ@“ÖŽq2, ŒG•”rG1: 1”]ŠO, 2•a—)

310023. [Ç—á•ñ] The Appropriate Surgical Approach to a Greater Petrosal Nerve Schwannoma in the Setting of Temporal Lobe Edema. Kusumi M1, Oka H1, Aliabadi H, Sato S1, Kumabe T1: World Neurosurg 2016/1; 85: 364. (‹v{”ü^—1, ‰ª@GG1, ²“¡Ÿl1, ŒG•”rG1: 1”]ŠO)

521015. [‰ðà]yƒeƒNƒjƒJƒ‹Eƒm[ƒgzŠO‘€Œã“ª‰ºƒAƒvƒ[ƒ`‚É‚š‚¯‚éd–ŒˆêŽŸ•Âœ‚̍H•v|ƒtƒBƒuƒŠƒ“ŒÐƒR[ƒeƒB[ƒ“ƒO‚É‚æ‚éd–Œ‚Ì•ÛŽŒ|. Ž…@ú1, –]ŒŽ’O, ‘åàV¬”V1, ŠÖŒû•üŽq1, ŒG•”rG1 (1”]ŠO): ”]_ŒoŠO‰È 2015/8; 43 (8): 709-12.

521016. [‰ðà]y‰ð–U‚𒆐S‚Æ‚µ‚œ”]_ŒoŽèpŽè‹ZzÒ‘‘“àŽîᇎèp‚É‚š‚¯‚éÒ‘‘O•û‚Ì”÷¬ŠO‰È‰ð–U‚ÆŽèp‚ÌŽÀÛ. ŽOˆäŒö•F, Ž…@ú1, ŽO“‡‘å“¿ (1”]ŠO): ”]_ŒoŠO‰È 2016/1; 44 (1): 19-28.

521017. [‰ðà]yƒeƒNƒjƒJƒ‹Eƒm[ƒgzLkŽ®ƒXƒgƒ‰ƒbƒv‚ð—p‚¢‚œŠJ“ªp’†‚Ì‹zˆøŠÇ—Ž‰º–hŽ~. Ž…@ú1, –]ŒŽ’O, ‘åàV¬”V1, ŠÖŒû•üŽq1, ¬òŠ°”V2, ŒG•”rG1 (1”]ŠO, 2‹~–œ): ”]_ŒoŠO‰È 2016/2; 44 (2): 111-3.

522113. [uÀ]y“ÁW: –ƒŒ‰Èˆã‚É•K—v‚È”]_Œoƒ‚ƒjƒ^ƒŠƒ“ƒOz”]_ŒoŠO‰È‚É‚š‚¯‚éABR. ²“¡Ÿl1, ¬–ìàV—T–ç2, ŒG•”rG1, ‰ª–{_Žk3 (1”]ŠO, 2—ÕŒŸ•”, 3–ƒŒ): –ƒŒ 2015/5; 64 (5): 502-7.

[’˜@‘]

610003. [Šwp‘ (•ª’SŽ·•M)]yPosterior fossa tumots in childrenz[Pathologies in Pediatric Posterior Fossa Tumors: Rare Tumors] Posterior Fossa Choroid Plexus Tumor, p.723-43. Morota N, Kumabe T1, Kakita A1 Editors: … MM, Cinalli G, Maixer W, Sainte-Rose C, Springer, 2015. (ŒG•”rG1: 1”]ŠO)

620078. [Šwp‘] (•ª’SŽ·•M)y¬Ž™ŒŒ‰tEŽîᇊwz‘æ2Í ¬Ž™‚ª‚ñ@D ¬Ž™‚ª‚ñ‚É‚š‚¯‚鎡—Ö@@[ŠO‰ÈŽ¡—Ã]@1 ”]Žîá‡, p.147-52. ŒG•”rG (”]ŠO), •Ò: “ú–{¬Ž™ŒŒ‰tE‚ª‚ñŠw‰ï, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/11”­s.

620079. [Šwp‘ (•ª’SŽ·•M)]y”]ŒŒŠÇ“àŽ¡—Â̐i•à2016@Ž¡—Í¢“ï‚È”]“®–¬áŽ|‚Ç‚€Ž¡—·‚é‚©?`”]ŒŒŠÇ“àŽ¡—Ãuƒ‰ƒbƒVƒ…ƒAƒbƒvƒZƒ~ƒi[2015`zIV. Ž„‚Ȃ炱‚€Ž¡—·‚é, ‚±‚€Ž¡—µ‚œ|‹}«ÄŠJ’ʂȂǁ@…@CT based revascularization|ÄŠJ’ÊŽžŠÔ’Zk‚É‚æ‚é“]‹AŒüã‚ÌŽŽ‚݁|, p.87-91. ‹ß“¡—³Žj1, Œ–{NŽj (1”]ŠO), •Ò: âˆäMK, ]–ʐ³K, ŒŠÛ—SŽi, ‹{’n@–Î, ‹g‘ºaˆê, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/11”­s.

620080. [Šwp‘] (•ª’SŽ·•M)yVNS NOW No.4@”]EÒ‘ŽîᇓEo‚Ì‚œ‚߂̈ø‚«o‚µ@ŽîᇓEo‚̃Rƒc‚ƃsƒbƒgƒtƒH[ƒ‹zII Še˜_@ƒOƒŠƒI[ƒ}“Eop@ŒŒŠÇ‘¹‚ð”ð‚¯‚é‚œ‚ß‚É, p.66-73. ŒG•”rG (”]ŠO), •Ò: X“c–Ÿ•v, ˆÉ’B@ŒM, ‹e“cŒ’ˆê˜Y, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2015/12”­s

620081. [Šwp‘] (•ª’SŽ·•M)y”]_ŒoŠO‰ÈŠw ‰ü’ù12”Å IIz11Í ”]Žîᇁ@3. Ž¡—Á@1. Žèp, p.1408-22. ŒG•”rG (”]ŠO), ‘•ÒW: ‘Ÿ“c•x—Y, •Ò: ìŒŽM—², –ìèˆê•F, ‹g•ôrŽ÷, Žá—яr•F, ‹à–F“°, 2016/3”­s.

620082. [Šwp‘ (•ª’SŽ·•M)]y”]_ŒoŠO‰ÈŠw ‰ü’ù12”Å IIz11Í ”]Žîᇁ@6. ‘ÙŽ™«Žîá‡, p.1583-603. ‰ª@GG (”]ŠO), ‘•ÒW: ‘Ÿ“c•x—Y, •Ò: ìŒŽM—², –ìè˜a•F, ‹g•ôrŽ÷, Žá—яr•F, ‹à–F“°, ‹ž“s, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

711001. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Surgeries of gliomas and perforating arteries. Kumabe T1: The 9th Symposium of CHA Neurological Center (2015/11/14), Pangyo, Korea. (ŒG•”rG1: 1”]ŠO)

712016. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) Stereotactic radiosurgery for recurrent malignant neuroepithelial tumors. Kumabe T1, Jokura H, Akabane A, Saito R, Kanamori M, Yamashita Y, Sonoda Y, Kawagishi J, Kawai K, Tominaga T: ‘æ12‰ñ‘Û’èˆÊ•úŽËüŽ¡—Êw‰ïŠwp‘å‰ï (2015/6/8), ‰¡•l. (ŒG•”rG1, é‘q‰pŽj, Ô‰H@“Ö, âV“¡—³‘Ÿ, ‹àX­”V, ŽR‰º—m“ñ, ‰€“c‡•F, ìŠÝ@, ì‡Œª‰î ,•y‰i’î“ñ: 1”]ŠO)

713063. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Germinomas can be diagnosed without histrogical verification. Saito R, Sonoda Y, Kanamori M, Kawaguchi T, Kumabe T1, Tominaga T: The 4th International CNS Germ Cell Tumour Symposium (2015/4/14), Tokyo. (ŒG•”rG1: 1”]ŠO)

713064. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Differences of histrogical and clinical characterstics in the teratoma during the treatment for intracranial germ cell tumors. Kanamori M, Kumabe T1, Watanabe M, Saito R, Yamashita Y, Sonoda Y, Tominaga T: The 4th International CNS Germ Cell Tumour Symposium (2015/4/15), Tokyo. (ŒG•”rG1: 1”]ŠO)

713065. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Intraoperative ultrasonography during drainage for chronic subdural hematomas: A technique to release isolated deep-seated hematomas -Technical Note-. Shimizu S1, Mochizuki T, Osawa S1, Kumabe T1: 83rd American Association of Neurological Surgeons Annual Scientific Meeting (2015/5/2-6), Washington DC, USA. (Ž…@ú1, –]ŒŽ’O, ‘åàV¬”V1, ŒG•”rG1: 1”]ŠO)

713066. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Repeat surgery and stereotactic radiosurgery for recurrent malignant neuroepithelial tumors. Kumabe T1: 12th Meeting of the Asian Society for Neuro-Oncology (2015/9/17), Manila, Philippine. (ŒG•”rG1: 1”]ŠO)

713067. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Re-evaluation of the usefulness of intraoperative computed tomography for neurosurgical procedures in intraoperative magnetic resonance imaging era. Dan M1, Yamamoto D1, Sato Y, Kuroda H1, Miyajima Y, Sato K1, Kumabe T1: The 20th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (2015/11/20), San Antonio, USA. (’h@@[1, ŽR–{‘å•ã1, ²“¡—Yˆê, •“c”Ž‹I1, ‹{“‡—Ç‹P, ²“¡Œör1, ŒG•”rG1: 1”]ŠO)

713068. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Multicenter retrospective study to compare chemoradiotherapy with temozolomide or ACNU in 535 anaplastic gliomas Muragaki Y, Narita Y, Kumabe T1, Nakamura H, Nagane M, Ikuta S, Maruyama T, Uzuka T, Ito T, Beppu T, Takano S, Arakawa Y, Kobayashi H, Wakabayashi T, Sugiyama K, Hashimoto N, Saito R, Nishikawa R, Kayama T, Shibui S: The 20th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (2015/11/20), San Antonio, USA. (ŒG•”rG1: 1”]ŠO)

713069. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Surgeries of gliomas and perforating arteries. Kumabe T1: 1st Quadrennial Meeting of Walter E. Dandy Neurosurgical Society (2015/11/22), Dubai, UAE. (ŒG•”rG1: 1”]ŠO)

721014. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ŠoÁ‰ºŽèp‚ÉŠÖ‚·‚é“d‹C¶—Šw‚ÌŠî–{. ²“¡Ÿl (”]ŠO): ‘æ13‰ñ“ú–{Awake SurgeryŠw‰ï (2015/9/24), –ŒŒÃ‰®.

722066. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) IDH–쐶Œ^grade 3_ŒoäPŽî‚Ì•a—‘œ‚Æ—\Œã. ‰€“c‡•F, —é–Ø”Ž‹`, “n•Ó‚Ý‚©, ŽÄŒŽˆê—z, âV“¡—³‘Ÿ, ‹àX­”V, ŒG•”rG1, •y‰i’î“ñ (1”]ŠO): ‘æ33‰ñ“ú–{”]Žîᇕa—Šw‰ï (2015/5/29), ‚Œ.

722067. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ”]ŽîᇓEop‚É‚š‚¯‚é‰A‹É’P‹É”玿ŽhŒƒ‚É‚æ‚éMEPƒ‚ƒjƒ^ƒŠƒ“ƒO. ²“¡Ÿl1, ¬–ìàV—T–ç2, ‹{“‡—Ç‹P, ŒG•”rG1 (1”]ŠO, 2—ÕŒŸ•”): ‘æ21‰ñ“ú–{”]_Œoƒ‚ƒjƒ^ƒŠƒ“ƒOŠw‰ï (2015/6/27), “Œ‹ž.

722068. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) Œ‹ß«d‰»Ç‚É”º‚Á‚œãˆß‰º‹×–E¯×–EŽî‚ÌŽ¡—Ã. ŒG•”rG (”]ŠO): ‘æ3‰ñ“ú–{Œ‹ß«d‰»ÇŠw‰ïŠwp‘‰ï (2015/10/17), “Œ‹ž.

722069. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) _ŒoäPŽî“Eo‚Ì—ðŽj|Å‘åŒÀ‚ÌŽîᇓEo‹y‚эŏ¬ŒÀ‚ÌŽèp‡•¹Ç‚ð–ÚŽw‚µ‚ā|. ŒG•”rG (”]ŠO): ‘æ35‰ñ“ú–{”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX‘‰ï (2015/5/9), ‰¡•l.

722070. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ŠoÁ‰ºŽèp: Summary of Awake Surgery for Gliomas. ŒG•”rG (”]ŠO): ‘æ20‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2015/9/26), –ŒŒÃ‰®.

722071. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) –{–M‰‚̍ŐV3D_Œo“àŽ‹‹Ÿ (Visionsense V3) ‚Ì”]_ŒoŽèp‚Ö‚Ì“±“ü‚ÉŒü‚¯‚Ä. ‰ª@GG1, ‹v{”ü^—1, ‹ß“¡GŽ¡1 (1”]ŠO): ‘æ25‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2016/3/26), VŠƒ.

723475. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]_ŒoŠO‰ÈŽèp‚É‚š‚¯‚éVŒ^ƒoƒCƒ|[ƒ‰ [ƒxƒUƒŠƒEƒX]: ‚»‚ÌŠî‘b‚š‚æ‚їՏ°ã‚Ì“Á’¥. ‰ª@GG1, ‹v{”ü^—1, ‹ß“¡G–è1 (1”]ŠO): ‘æ24‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2015/4/3), ‘åã.

723476. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “àèò“®–¬‚Æ‘€•›ŒŒs˜H•]‰¿‚ÉŠî‚¢‚œŒã“ªŠWâ|ƒAƒvƒ[ƒ`. ‹v{”ü^—1, ‰ª@GG1, ‹ß“¡G–è1, ŒG•”rG1 (1”]ŠO): ‘æ24‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2015/4/3), ‘åã.

723477. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Vim-thalamotomy Œã‚̐_ŒoS—Šw“IŒŸ“¢. ²“¡Ÿl1, ‘êŽR—eŽq2, “n•ÓŽ¬, ‹{“‡—Ç‹P, ŒŽR˜a—˜2, ŒG•”rG1 (1”]ŠO, 2_Œo“à): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/20), VŠƒ.

723478. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) NF1‚ɍ‡•¹‚µ‚œpleomorphic xanthoastrocytoma. •“c”Ž‹I1, ŒG•”rG1, “’àV@ò1, ŒŽ@“ÖŽq2, âV“¡—³‘Ÿ, ‰€“c‡•F, “n•Ó‚ä‚©, •y‰i’î“ñ (1”]ŠO, 2•a—): ‘æ33‰ñ“ú–{”]Žîᇕa—Šw‰ïŠwpW‰ï (2015/5/29), ‚Œ.

723479. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ÞŒ`¬«_ŒoäPŽî‚É‚š‚¯‚éIDH1 R132Hƒ^ƒ“ƒpƒNŽ¿‚Æ—\Œã‚ÉŠÖ‚·‚錟“¢. ‹àX­”V, “n•Ó‚Ý‚©, —é–Ø”Ž‹`, ŽÄŒŽˆê—z, âV“¡—³‘Ÿ, ‰€“c‡•F, ŒG•”rG1, •y‰i’î“ñ (1”]ŠO): ‘æ33‰ñ“ú–{”]Žîᇕa—Šw‰ïŠwpW‰ï (2015/5/29-30), ‚Œ.

723480. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –«d–Œ‰ºŒŒŽîƒhƒŒƒi[ƒWp‚É‚š‚¯‚ép’†ƒGƒR[: ŒÇ—§‚µ‚œ[•”ŒŒŽî‚ðŠJ•ú‚·‚éŽè‹Z. Ž…@ú1, –]ŒŽ’O, ‘åàV¬”V1, ŒG•”rG1 (1”]ŠO): ‘æ15‰ñ“ú–{p’†‰æ‘œî•ñŠw‰ï (2015/6/20), “Œ‹ž.

723481. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”]ŠO‰ÈŽèp‚É‚š‚¯‚ép’†CT‚Ì—L—p«. ’h@@[1, ŽR–{‘å•ã1, •“c”Ž‹I1, ‹{“‡—Ç‹P, ²“¡Œör1, ŒG•”rG1 (1”]ŠO): ‘æ15‰ñ“ú–{p’†‰æ‘œî•ñŠw‰ï (2015/6/20), “Œ‹ž.

723482. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ò‘d–Œ“®Ã–¬á‘‚É‚š‚¯‚éƒVƒƒƒ“ƒg‚Æ“±oÃ–¬d–ŒŠÑ’Ê•”‚̍‚ˆÊ•sˆê’v. ‘åàV¬”V1, Ž…@ú1, –]ŒŽ’O, ’†ŽRŒ«Ži, ŽR–{—E•v, ‹ß“¡—³Žj1, ŒG•”rG1 (1”]ŠO): ‘æ30‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2015/6/25), ŽD–y.

723483. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆ««_ŒoäPŽî‚É‚š‚¯‚éNRF2Œo˜HŠˆ«‰»‚Æ—\Œã‚ÉŠÖ‚·‚錟“¢. ‹àX­”V, ”ä‰Ã„Žu, ‰€“c‡•F, ‘ºã¹•œ, –k‘º‘åŽu, •SX”ü“Þ, ŽÄ“c—ŽO, “n粂݂©, —é–Ø”Ž‹`, ŽÄŒŽˆê—z, âV“¡—³‘Ÿ, ŽR‰º—m“ñ, ŒG•”rG1, ŽR–{‰ë”V, –{‹Ž‚قÂÝ, •y‰i’î“ñ (1”]ŠO): ‘æ16‰ñ“ú–{•ªŽq”]_ŒoŠO‰ÈŠw‰ï (2015/8/29), •lŒ.

723484. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Ò‘‘“àŽîᇎèp‚É‚š‚¯‚éÒ‘‘O•û‚Ì”÷¬‰ð–U. ŽOˆäŒö•F, Ž…@ú1, ŽO“‡‘å“¿ (1”]ŠO): ‘æ22‰ñ“ú–{Ò’ŁEÒ‘_ŒoŽèpŽè‹ZŠw‰ïŠwpW‰ï (2015/9/18), “Œ‹ž.

723485. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘O°“Ë‹N‘–ŒŽî‚ɑ΂·‚é‘O°“Ë‹NØœ‚Ì•K—v«. ‹v{”ü^—1, ‰ª@GG1, ‹ß“¡GŽ¡1, ŒG•”rG1 (1”]ŠO): ‘æ20‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2015/9/25), –ŒŒÃ‰®.

723486. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒL[ƒz[ƒ‹Žèp‚Å“Eo‰Â”\‚Å‚ ‚Á‚œãˆß‰º‹‘å×–E«¯×–EŽî‚Ì1—á. ‹ß“¡GŽ¡1, ‹v{”ü^—1, ‰ª@GG1 (1”]ŠO): ‘æ20‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2015/9/26), –ŒŒÃ‰®.

723487. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚ÅŒoŒ±‚µ‚œ3—á‚ÌGorlinÇŒóŒQ‚Ì•ªŽqˆâ“`Šw“IŒŸ“¢. Œ–{çq1, ‹{‰ºr”V2, ‰ª@GG1, ŒG•”rG1 (1”]ŠO, 2•ªŽqˆâ“`): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwp‘‰ï (2015/10/14), ŽD–y.

723488. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —Տ°“I‚Ésecondary glioblastoma‚Æ”»’f‚³‚ê‚éäP‰èŽî‚ÌIDHˆâ“`ŽqˆÙí. ²“¡—Yˆê1, Œ¢Ž”@‰~2, ŒŽ@“ÖŽq3, ŒG•”rG4 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3•a—, 4”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwp‘‰ï (2015/10/14), ŽD–y.

723489. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘O°“Ë‹N‘–ŒŽî‚ɑ΂·‚é‘O°“Ë‹NØœ‚Ì•K—v«. ‹v{”ü^—1, ‰ª@GG1, ‹ß“¡GŽ¡1, ŒG•”rG1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwp‘‰ï (2015/10/14), ŽD–y.

723490. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) èò•”•úŽËüÆŽËŒãèò“®–¬‹·ó‚ɑ΂·‚éƒXƒeƒ“ƒg—¯’up. ŽR–{‘å•ã1, ‹ß“¡—³Žj1, ‹{â˜aO1, ¬òŠ°”V2, ’†ŒŽ–M», ŒG•”rG1 (1”]ŠO, 2‹~–œ): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwp‘‰ï (2015/10/14), ŽD–y.

723491. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) PACS‚ð—p‚¢‚œ‹@”\“I’èˆÊ”]Žèp’†Xü‰æ‘œˆ—. ²“¡Ÿl1, “n•ÓŽ¬, ’h@@[1, Ž…˜aŒh2, ‰Ô“‡—¥Žq2, ŒG•”rG1 (1”]ŠO, 2_Œo“à): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwpW‰ï (2015/10/14), ŽD–y.

723492. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –«d–Œ‰ºŒŒŽîƒhƒŒƒi[ƒWp‚É‚š‚¯‚ép’†ƒGƒR[: ŒÇ—§‚µ‚œ[•”ŒŒŽî‚ðŠJ•ú‚·‚éŽè‹Z. Ž…@ú1, –]ŒŽ’O, ‘åàV¬”V1, ŒG•”rG1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwpW‰ï (2015/10/14), ŽD–y.

723493. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˆ««_ŒoäPŽî‚ɑ΂·‚éƒJƒ‹ƒ€ƒXƒ`ƒ“ƒEƒGƒn[ƒXEƒeƒ‚ƒ]ƒƒ~ƒhEƒxƒoƒVƒYƒ}ƒu•¡‡—Ö@‚É•K—v‚Æ‚·‚é”ï—p. ŒG•”rG1, ’h@@[1, ŽR–{‘å•ã1, •“c”Ž‹I1, ²“¡—Yˆê2, ‹{“‡—Ç‹P, ²“¡Ÿl1 (1”]ŠO, 2ˆã—Éq¶Šw•”): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwpW‰ï (2015/10/15), ŽD–y.

723494. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”j—ô’ōœ“®–¬áŽ‚ɑ΂·‚ée“®–¬•ÂÇp‚Ì’·Šú“]‹A. ‹ß“¡—³Žj1, ŒG•”rG1, Œ–{NŽj, ²“¡Œ’ˆê, ‰““¡‰p“¿, •y‰i’î“ñ (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwpW‰ï (2015/10/15), ŽD–y.

723495. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]ŠO‰ÈŽèp‚É‚š‚¯‚ép’†CT‚Ì—L—p«. ’h@@[1, ŽR–{‘å•ã1, •“c”Ž‹I1, ‹{“‡—Ç‹P, ²“¡Œör1, ŒG•”rG1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwp‘‰ï (2015/10/15), ŽD–y.

723496. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚鈫«_ŒoäPŽî‚ɑ΂·‚éƒJƒ‹ƒ€ƒXƒ`ƒ“ƒEƒGƒn[ƒXŽg—pÇ—á‚ÌŽ¡—ЬÑ‚ƍ‡•¹Ç. •“c”Ž‹I1, ²“¡—Yˆê2, ‹{â˜aO1, ’h@@[1, ŽR–{‘å•ã1, ‹{“‡—Ç‹P, ²“¡Ÿl1, ŒG•”rG1 (1”]ŠO, 2ˆã—Éq¶Šw•”): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwpW‰ï (2015/10/16), ŽD–y.

723497. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MRIƒ‚ƒjƒ^ƒŠƒ“ƒO‰ºƒjƒgƒƒ\ƒEƒŒƒAÜConvection-enhanced delivery‚É‚æ‚é_ŒoŽîV‹KŽ¡—Ö@‚ÌŠJ”­. âV“¡—³‘Ÿ, ‰€“c‡•F. ¯Ži‘ñ‘å, j¶V–ç, áÁ–ì@—B, ’·“ì‰ëŽu, ‹àX­”V, ŒG•”rG1, •y‰i’î“ñ (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwp‘‰ï (2015/10/16), ŽD–y.

723498. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “ªŠWˆô“ªŽî‚ɑ΂·‚é_Œo“àŽ‹‹ŸŽèpí—ª. ‰ª@GG1, Scheithauer BW, Perry A, Prevedello DM, Ludecke DK, Perneczky A (1”]ŠO): ‘æ22‰ñ“ú–{_Œo“àŽ‹‹ŸŠw‰ï (2015/11/5), Œ“‡.

723499. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒL[ƒz[ƒ‹Žèp‚Å“Eo‰Â”\‚Å‚ ‚Á‚œãˆß‰º‹×–E«¯×–EŽî‚Ì1—á. ‹ß“¡GŽ¡1, ‹v{”ü^—1, ‰ª@GG1 (1”]ŠO): ‘æ22‰ñ“ú–{_Œo“àŽ‹‹ŸŠw‰ï (2015/11/6), Œ“‡.

723500. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]“®–¬áŽ‚ɑ΂·‚é᎓àÇðpŒã‚ɐú’ÊŽ}[Ç‚𐶂¶‚œ2—á. ‹{â˜aO1, ‹ß“¡—³Žj1, ŽR–{‘å•ã1, ¬òŠ°”V2, ’†ŒŽ–M», ŒG•”rG1 (1”]ŠO, 2‹~–œ): ‘æ31‰ñNPO–@l“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2015/11/20), ‰ªŽR.

723501. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) èò•”•úŽËüÆŽËŒã‚ɐ¶‚¶‚œèò“®–¬‹·ó‚ɑ΂·‚éƒXƒeƒ“ƒg—¯Ž¡p‚Ì“Á’¥‹y‚ÑŽ¡—ЬÑ. ŽR–{‘å•ã1, ‹ß“¡—³Žj1, ‹{â˜aO1, ¬òŠ°”V2, ’†ŒŽ–M», ŒG•”rG1 (1”]ŠO, 2‹~–œ): ‘æ31‰ñNPO–@l“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2015/11/20), ‰ªŽR.

723502. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‰Šú‰æ‘œ•]‰¿‚ÉCT‚ð—p‚¢‚œŒŒð‰ñŽû—Ö@‚Ì—LŒø«‚ƈÀ‘S«. ‹ß“¡—³Žj1, ’†ŒŽ–M», ˆ¢•”Ž’q1, ŽR–{‘å•ã1, ’h@@[1, ‹{â˜aO1, ŒG•”rG1, ˆä“‡‘å•ã2, ŒŽR˜a—˜2 (1”]ŠO, 2_Œo“à): ‘æ31‰ñNPO–@l“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2015/11/20), ‰ªŽR, JNET: Journal of Neuroendovascular Therapy 2015; 9 (6): S271.

723503. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚鈫«_ŒoäPŽî‚ɑ΂·‚éƒJƒ‹ƒ€ƒXƒ`ƒ“ƒEƒGƒn[ƒXŽg—pÇ—á‚ÉŽ¡—ЬÑ‚ƍ‡•¹Ç. ŒG•”rG1, ’h@@[1, •“c”Ž‹I1, ‹{â˜aO1, ŽR–{‘å•ã1, ‹{“‡—Ç‹P, ‘åàV¬”V1, ²“¡Ÿl1 (1”]ŠO): ‘æ33‰ñ“ú–{”]Žîᇊw‰ïŠwpW‰ï (2015/12/6), ‹ž“s.

723504. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Bevacizumab‚𕹗p‚µ‚œÄ”­diffuse intrinsic pontine glioma‚ÌŽ¡—Ã. ²“¡—Yˆê1, ’h@@[2, ŽR–{‘å•ã2, •“c”Ž‹I2, Œ¢Ž”@‰~3, ŒŽ@“ÖŽq4, ŒG•”rG2 (1ˆã—Éq¶Šw•”, 2”]ŠO, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4•a—): ‘æ33‰ñ“ú–{”]Žîᇊw‰ïŠwpW‰ï (2015/12/6), ‹ž“s.

723505. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) äP‰èŽî‚Ì‹Uòó”z—ñ•”—̈æ‚É‚š‚¯‚éHIF-1/AktŒnŠˆ«‰»‚ð‰î‚µ‚œ‚ª‚ñŠ²×–E‰»ˆÛŽ. Œ¢Ž”@‰~1, ŒŽ@“ÖŽq2, ˆÀˆä”ü]3, ŽOŽ}@M2, ŒG•”rG4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn, 4”]ŠO): ‘æ33‰ñ“ú–{”]Žîᇊw‰ïŠwpW‰ï (2015/12/6-8), ‹ž“s.

723506. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠmŽÀ‚ÈŽO³_Œo’ÉŽèp‚ð–ÚŽw‚µ‚Ä: —lX‚ÈŒŽˆö‚©‚ç. ‹v{”ü^—1, ‰ª@GG1, ‹ß“¡GŽ¡1, ŒG•”rG1 (1”]ŠO): ‘æ18‰ñ“ú–{”]_ŒoŒžˆ³pŠw‰ï (2016/1/21), å‘ä.

723507. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘O°“Ë‹N‹ß–T‘–ŒŽî‚ɑ΂·‚é‘O°“Ë‹NØœ‚̍H•v: ƒhƒŠƒ‹‚ƍœççŽq‚Ŏ葁‚­s‚€•û–@. ‹v{”ü^—1, ‰ª@GG1, ‹ß“¡GŽ¡1, ŒG•”rG1 (1”]ŠO): ‘æ25‰ñ”]_ŒoŠO‰ÈŽèp‚Æ‹@ŠíŠw‰ï (2016/3/25), VŠƒ.

731092. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _ŒoäPŽîŽèp‚Æ“K‰ž‚Æ•û–@. ŒG•”rG (”]ŠO): ‘æ79‰ñŽRŒ`”]_ŒoŠO‰È§˜b‰ï (2015/4/25), ŽRŒ`.

731093. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]Žîᇂɂš‚¯‚éƒAƒoƒXƒ`ƒ“—Ö@‚ɂ‚¢‚Ä. ŒG•”rG (”]ŠO): ‘q•~”]ŽîᇃJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/5/14), ‘q•~.

731094. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _ŒoäPŽî‚ÌŽèp: ’èŒ^“IŽèp‚ð–ÚŽw‚µ‚Ä. ŒG•”rG (”]ŠO): ‘æ8‰ñSkill-building Neurosurgical Conference (2015/5/16), ŽD–y.

731095. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Long insular artery. ŒG•”rG (”]ŠO): ‘æ5‰ñƒOƒŠƒI[ƒ}ŽèpŽè‹ZƒCƒ“ƒ^[ƒlƒbƒgƒ‰ƒCƒuƒZƒ~ƒi[ (2015/6/3), “Œ‹ž.

731096. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _ŒoäPŽîŽèp: Gliadel ‚𕹗p‚µ‚Ä. ŒG•”rG (”]ŠO): ŽOdƒOƒŠƒI[ƒ}u‰‰‰ï (2015/6/5), “Œ‹ž.

731097. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒAƒoƒXƒ`ƒ“‚𕹗p‚µ‚œäP‰èŽî‚ÌŽ¡—Âƌ»’iŠK‚Ü‚Å‚ÌŒ‹‰Ê. ŒG•”rG (”]ŠO): ‘æ2‰ñˆ««_ŒoäPŽîƒZƒ~ƒi[ (2015/7/15), “Œ‹ž.

731098. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ˆ««_ŒoäPŽî‚ɑ΂·‚éBevacizumab‚ð—p‚¢‚œWŠw“IŽ¡—Âɂ‚¢‚Ä. ŒG•”rG (”]ŠO): ’†ŠOeƒZƒ~ƒi[on Brain Tumor (2015/7/29), “Œ‹ž.

731099. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒOƒŠƒI[ƒ}‚ɑ΂·‚éƒAƒoƒXƒ`ƒ“‚Ì–ðŠ„. ŒG•”rG (”]ŠO): ˆ««”]ŽîᇃJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/9/4), ‰¡•l.

731100. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ˆ««_ŒoäPŽî‚ɑ΂·‚鉻Šw—Ö@‚ð‘O’ñ‚Æ‚µ‚œ‰Â‹y“I“Eop. ŒG•”rG (”]ŠO): ŽO‰Í”]Žîᇎ¡—ÃŒ€‹†‰ï (2015/9/24), ˆÀé.

731101. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰»Šw—Ö@‚ð‘O’ñ‚Æ‚µ‚œ_ŒoäPŽî“Eop. ŒG•”rG (”]ŠO): ‘æ8‰ñìŒ§”]Žîᇊwpu‰‰‰ï (2015/10/30), ‚Œ.

731102. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _ŒoäPŽî (ˆ««”]Žîá‡) ‚ÌŽ¡—Âɂ‚¢‚Ä. ŒG•”rG (”]ŠO): •œ¬27”N“x“ì“Œ–k˜A‡ŠwpŠw‰ï (2015/11/3), ŒSŽR.

731103. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒMƒŠƒAƒfƒ‹‚𕹗p‚µ‚œˆ««_ŒoäPŽî‚ÌŽèp. ŒG•”rG (”]ŠO): ƒOƒŠƒI[ƒ}u‰‰‰ï (2015/11/28), Ã‰ª.

731104. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]_ŒoŠO‰È‚É‚š‚¯‚éŽîᇐ«ŽŸŠ³‚̍ŐVŠO‰ÈŽ¡—Ã. ‰ª@GG (”]ŠO): EPA Stroke Clinical Seminar (2016/2/10), ã”ö.

731105. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Žèp‚É”äd‚ð‚š‚¢‚œoptic hypothalamic glioma‚ÌŽ¡—Ã. ŒG•”rG (”]ŠO): ‰±‹·ŠÔ”]_ŒoŠO‰ÈŠwpu‰‰‰ï (2016/2/26), –ŒŒÃ‰®.

731106. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _ŒoäPŽîŽèp: ‰œ‚ð–Ú•W‚Æ‚µ‚ж‚«‚é‚Ì‚©? ŒG•”rG (”]ŠO): Neurosurgery conference in Akita (2016/3/4), H“c.

731107. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) VŽèˆø‚«EŠCŠOƒKƒCƒhƒ‰ƒCƒ“‚ÌŽ¡—ÖڕW’l‚Æ‚»‚̐ݒ荪‹’ƒGƒrƒfƒ“ƒX. ‰ª@GG (”]ŠO): ƒAƒNƒƒƒKƒŠ[ (2016/3/5), “Œ‹ž.

732048. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) “‡•”_ŒoäPŽî‚ÌŽèp (Surgery of insular gliomas). ŒG•”rG (”]ŠO): ‘æ29‰ñ“ú–{”÷¬”]_ŒoŠO‰È‰ð–UŒ€‹†‰ï (2015/4/12), –ŒŒÃ‰®.

732049. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) 10”NŠÔ¶–œ—\Œã‰„’·‚ð–ÚŽw‚µ‚œƒAƒNƒƒƒKƒŠ[f—ÍőOü. ‰ª@GG (”]ŠO): “Œ“ú–{À’k‰ï (2015/11/20), “Œ‹ž.

733171. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) èò“®–¬E‰ð–U‚ðl‚Š‚œãøÃ–¬EŽîᇎèp. ‹v{”ü^—1, ‰ª@GG1, ‹ß“¡GŽ¡1, ŒG•”rG1 (1”]ŠO): ‘æ29‰ñ“ú–{”÷¬”]_ŒoŠO‰È‰ð–UŒ€‹†‰ï (2015/4/11), –ŒŒÃ‰®.

733172. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’®_ŒoŽîᇂɑ΂·‚é“àŽš“¹‰ð•úŽž‚É’ˆÓ‚µ‚Ä‚¢‚邱‚Æ. ‹v{”ü^—1, ‰ª@GG1, ‹ß“¡GŽ¡1, ŒG•”rG1 (1”]ŠO): ‘æ70‰ñŠÖ“Œ”]_ŒoŠO‰È§˜b‰ï (2015/6/13), “Œ‹ž.

733173. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ãó×–EŽî‚Ö‚Ì•úŽËüŽ¡—Ã27”NŒã‚É”]“®–¬áŽ”j—ô‚ðŒJ‚è•Ô‚µ‚œ1—á. •“c”Ž‹I1, ’h@@[1, ŽR–{‘å•ã1, ˆ¢•”Ž’q1, ¬òŠ°”V2, ’†ŒŽ–M», ²“¡Œör1, ‹ß“¡—³Žj1, ŒG•”rG1 (1”]ŠO, 2‹~–œ): ‘æ9‰ñŠÖ“Œ¬Ž™”]ŽîᇃJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/8/22), “Œ‹ž.

733174. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ”j—ô‰E“àŒz“®–¬ŒãŒð’Ê“®–¬•ªŠò•””]“®–¬áŽ‚ɑ΂·‚é᎓àÇðpŒã‚ÉŒãŒð’Ê“®–¬ú’ÊŽ}—̈æ‚ɍ[Ç‚ð’悵‚œ1—á. ‹{â˜aO1, ‹ß“¡—³Žj1, ŽR–{‘å•ã1, ¬òŠ°”V2, ’†ŒŽ–M», ŒG•”rG1 (1”]ŠO, 2‹~–œ): ‘æ127‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”ŠwpW‰ï (2015/9/12), “Œ‹ž.

733175. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) _Œo“àŽ‹‹Ÿ‰ºŒŒŽîœ‹Ž‚É‚Ä‹~–œ‚µ“Ÿ‚œŠO«¬”]oŒŒ‚̈ê—á. ‹TŽR¹K1, ¬òŠ°”V2, ŽR–{‘å•ã1, ’h@@[1, ŒG•”rG1 (1”]ŠO, 2‹~–œ): ‘æ127‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”ŠwpW‰ï (2015/9/12), “Œ‹ž.

733176. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘å”]Š™ƒeƒ“ƒg‘–ŒŽî‚ɍ‡•¹‚µ‚œd–Œ“®Ã–¬á‘‚Ì1—á. ŽR–{‘å•ã1, ‹ß“¡—³Žj1, ‹{â˜aO1, ²“¡—Yˆê2, ¬òŠ°”V3, ŒG•”rG1 (1”]ŠO, 2ˆã—Éq¶Šw•”, 3‹~–œ): ‘æ127‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”ŠwpW‰ï (2015/9/12), “Œ‹ž.

733177. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Occipital trans-tentorial approach‚É‚Ä‘S“E‚µ“Ÿ‚œ”]_Œo‚𔭐¶•ê’n‚Æ‚º‚ž‘å‚«‚­‹Ž‚ɐi“W‚µ‚œƒeƒ“ƒg‰_ŒoâŽî‚Ì1—á. ²“¡—Yˆê1, ’h@@[2, H’J¹Žj3, ŒŽ@“ÖŽq3, ŒG•”rG2 (1ˆã—Éq¶Šw•”, 2”]ŠO, 3•a—): ‘æ127‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”ŠwpW‰ï (2015/9/12), “Œ‹ž.

733178. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Non-Vitamin K Antagonist Oral Anticoagulant (NOACs) “à•žŠ³ŽÒ‚É‚š‚¯‚铪ŠW“àoŒŒ‚Ì“Á’¥. ‹ß“¡—³Žj1, ŒG•”rG1, ˆä“‡‘å•ã2, ŒŽR˜a—˜2 (1”]ŠO, 2_Œo“à): ‘æ27‰ñ_“ސìStroke Forum (2016/3/11), ‰¡•l.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-110014. [ŒŽ’˜] OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy. Shibahara I1, Saito R, Zhang R, Chonan M, Shoji T, Kanamori M, Sonoda Y, Kumabe T1, Kanehira M, Kikuchi T, So T, Watanabe T, Takahashi H, Iwabuchi E, Tanaka Y, Shibahara Y, Sasano H, Ishii N, Tominaga T: Mol Cancer 2015/2; 14 (1): 41. (ŽÄŒŽˆê—z1, ŒG•”rG1: 1”]ŠO)

H26-310003. [Ç—á•ñ] Vim thalamotomy in a patient with Holmes' tremor and palatal tremor - Pathophysiological considerations. Maki F, Sato S1, Watanabe K, Yanagisawa T, Hagiwara Y, Shimizu T, Hasegawa Y: BMC Neurol 2015/3; 15: 26. (²“¡Ÿl1: 1”]ŠO)

[’˜@‘]

H26-620011. [Šwp‘ (•ª’SŽ·•M)]y“àŒz“®–¬áŽ (ICA Aneurysm) ‚Ì‚·‚ׂā|‰“ˆÊ•” (supraclinoid)z4Í ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚ÆŽèpEIVR ‚ÌŽÀÛ@<2> ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚ÆIVR ‚ÌŽÀÛ@(B) ÇŒó«IC-PC (2), p.179-81. ‹ß“¡—³Žj1, Œ–{NŽj (1”]ŠO), ŠÄC: •ó‹àŽ”Ž, •Ò: ˆäì–[•v, ‹{’n@–Î, ƒƒfƒBƒJo”Å, , 2015/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H26-723009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]“àoŒŒ‚Å”­Ç‚µ‚œŠO‰ÈŒã–¬—‘p“®–¬–•Á•”‚ÌŠŽõ«”]“®–¬áŽ‚̈ê—á. ’Jè‹`“¿, ”Ñ“cG•v, ˆ¢•”Ž’q1, ‹ß“¡—³Žj1, ŒG•”rG1 (1”]ŠO): ‘æ44‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï (2015/3/26), L“‡.


¬Ž™‰ÈŠw

[Šwp˜_•¶]

110208. [ŒŽ’˜] Clinical utility of the plasma brain natriuretic peptide level in monitoring tetralogy of fallot patients over the long term after initial intracardiac repair: considerations for pulmonary valve replacement. Kitagawa A1, Oka N2, Kimura S1, Ando H1, Honda T1, Takanashi M1, Mineo E1, Miyaji K3, Ishii M1: Pediatr Cardiol 2015/4; 36 (4): 752-8. (–kì“ÄŽj1, ‰ª@“¿•F2, –Ø‘ºƒl1, ˆÀ“¡@Žõ1, –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, ‹{’n@ŠÓ3, Îˆä³_1: 1¬Ž™, 2˜a‰ÌŽRŒ§—§ˆã‰È‘åŠw, 3S‘ŸŒŒŠÇŠO)

110209. [ŒŽ’˜] The efficacy of levetiracetam for focal seizures and its blood levels in children. Iwasaki T1, Toki T1, Nonoda Y1, Ishii M1: Brain Dev 2015/9; 37 (8): 773-9. (Šâèr”V1, “yŠò@•œ1, –ìX“c–L1, Îˆä³_1: 1¬Ž™)

110210. [ŒŽ’˜] The Effectiveness of Lamotrigine and Its Blood Levels for Pediatric Epilepsy. Iwasaki T1, Toki T1, Nonoda Y1, Ishii M1: Am J Ther 2015/8/20. [Epub ahead of print] doi: 10.1097/MJT.0000000000000332. (Šâèr”V1, “yŠò@•œ1, –ìX“c–L1, Îˆä³_1: 1¬Ž™)

120016. [ŒŽ’˜] ’Ž‘ŽYŽ™‚Ì–¢nŽ™“®–¬ŠÇ‚ɑ΂·‚é“àŽ‹‹Ÿ‰º“®–¬ŠÇ•Âœp‚Ì—\ŒãÝ‘Ù25TˆÈ‰º‚ð‘ΏۂƂµ‚œŒŸ“¢. çݎ@Šw1, ‹{’n@ŠÓ2, ŽRŒûˆ»”T1, ‘剪–ƒ—1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ŒÏè‰ëŽq1, ‚—œ@Šw1, “¡•‹`l1,3, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO, 3‘Š–Í‘ä•a‰@): “ú–{ŽüŽYŠúEV¶Ž™Šw‰ïŽGŽ 2015/12; 51 (4): 1161-6.

120017. [ŒŽ’˜] Œ{—‘ƒAƒŒƒ‹ƒM[‚Ɛڎí—Ê‚ª‘—Ê‚Æ‚È‚Á‚œƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒƒNƒ`ƒ“‚Ì ˆÀ‘S«‚ÉŠÖ‚·‚錟“¢. ‘å’JŽF1,2, “¡–{‚Ü‚ä1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽGŽ 2015/12; 29 (5): 665-75.

120018. [ŒŽ’˜] “ûŽ™‚ɑ΂·‚é•sŠˆ‰»ƒƒNƒ`ƒ““¯ŽžÚŽí‚Ì—LŠQŽ–Û‚ÉŠÖ‚·‚錟“¢. ‘å’JŽF1,2, Œ–{“TŽq1, “¡–{‚Ü‚ä1, ˆîŠ_@“µ1,2, ‰¡ŠÖ—Sˆê˜Y1,2, ‹k“cˆê‹P1,2, ŠJ“c”ü•Û3, ŒÏè‰ëŽq2, ’†‘ºM–ç1,2, ‰¡“csŽj2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™, 3–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): “ú–{”_‘ºˆãŠw‰ïŽGŽ 2016/1; 64 (5): 798-807.

310024. [Ç—á•ñ] Azuki Bean Allergy in a Japanese Child: a Case Report. Ohtani K1,2, Fujimoto M1, Inagaki H1, Kitsuda K1, Kitsunezaki M2, Nakamura S1,2: Juntendo Medical Journal 2015/6; 61 (3): 302-4. (‘å’JŽF1,2, “¡–{‚Ü‚ä1, ˆîŠ_@“µ1, ‹k“cˆê‹P1, ŒÏè‰ëŽq2, ’†‘ºM–ç1,2: 1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™)

310025. [Ç—á•ñ] Right ventricular failure with high echoic ventricular wall change after foetoscopic laser photocoagulation: a case report of a donor in twin-to-twin transfusion syndrome. Mineo E1, Honda T1, Ishii M1: Cardiology in the Young 2016/1 (1): 155-7. (•ô”öŒb—œ1, –{“c@’1, Îˆä³_1: 1¬Ž™)

320021. [Ç—á•ñ] ìè•a•s‘SŒ^‚Æ‚µ‚ÄŽ¡—³‚ê‚œ‚ˆÀ“®–¬‰Š‚Ì”N’·Ž™—á. ‹Ž–{‰è‹v”ü1, ]”gŒËF•ã1, îŒŽ‹`l1, •û¹•œ1, Îˆä³_1 (1¬Ž™): S‘Ÿ 2015/12; 47 (12): 1466-7.

320022. [Ç—á•ñ] –ƉuƒOƒƒuƒŠƒ““Š—^Œã‚ɃAƒiƒtƒBƒ‰ƒV[‚ð”F‚ß, ‰‰ñŽ¡—ÂƂµ‚ăCƒ“ƒtƒŠƒVƒLƒ}ƒu‚ðŽg—p‚µ‚œìè•aÄ”­—á. îŒŽ‹`l1, •û¹•œ1, ]”gŒËF•ã1, Îˆä³_1 (1¬Ž™): S‘Ÿ 2015/12; 47 (12): 1471-2.

320023. [Ç—á•ñ] _ŒoŠw“I‚É—\Œã—ǍD‚Å‚ ‚Á‚œ“ÁŽêŽ¡—ÂðŽ{s‚µ‚œ‹}«‰óŽ€«”]Ç‚Ì2Ç—á. ”’ˆäG’Œ1, ˆÀ“¡@Žõ1, •ô”öŒb—œ1, –ìX“c–L1, Šâér”V1, Îˆä³_1 (1¬Ž™): “ú–{¬Ž™‹~‹}ˆãŠw‰ïŽGŽ 2015/12; 15 (1): 51-4.

320024. [Ç—á•ñ] ESBLŽY¶‘å’°‹Û‚É‚æ‚éV¶Ž™‚̏dÇ×‹Û«‘–Œ‰Š‚Ì1—á. ‚—œ@Šw1, çݎ@Šw1, ŽRŒûˆ»”T1, ‘剪–ƒ—1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu2, ŒÏè‰ëŽq1, –ì“n³•F3, Îˆä³_1 (1¬Ž™, 2–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 3‚·‚­‚·‚­‚ ‚©‚¿‚á‚ñ‚±‚Ç‚àƒNƒŠƒjƒbƒN): “ú–{ŽüŽYŠúEV¶Ž™Šw‰ïŽGŽ 2015/12; 51 (4): 1253-9.

521018. [‰ðà]y‰ðà: ˆã—p’Ž‰¹”gz”x‘ÌŒŒ—¬”ä‚𒎉¹”g‚Å•]‰¿‚·‚é. –{“c@’1, Îˆä³_1 (1¬Ž™): ’Ž‰¹”gTECHNO 2015/8; 27 (4): 72-6.

522114. [uÀ]y“ÁW: ƒ}ƒ‹ƒ`ƒ‚ƒ_ƒŠƒeƒB‚É‚æ‚éCardiac Imaging 2015 [—Տ°•Ò]|”ñNP“IS‘Ÿ‰æ‘œf’f‚ÌŒ`‘ԏî•ñ‚©‚ç‹@”\•]‰¿‚Ö‚Ì“WŠJ|zIII. US‚̃Xƒgƒ‰ƒeƒW[ & ƒAƒEƒgƒJƒ€@E—Տ°Ž{Ý‚©‚ç‚Ì•ñ|SƒGƒR[‚̗Տ°“I—L—p«‚Æ‹Zpi•à@4. ¬Ž™zŠÂŠíf—Âɂš‚¯‚é’Ž‰¹”gf’f‘•’u‚Ì—L—p«|Vector Flow MappingƒGƒR[‚ÅŒŒ—¬‚ðf‚é. –{“c@’1, ”Â’JŒcˆê2, Îˆä³_1 (1¬Ž™, 2ŒŒ—¬‰ðÍ): INNERVISION 2015/5; 30 (5): 58-60.

522115. [uÀ]yInformation: “ú–{zŠÂŠíŠw‰ï@‘æ11‰ñƒvƒŒƒXƒZƒ~ƒi[@æ“V«S‘Ÿ•a‚̈ꐶ‚ðf‚é. iŠw, A‹Æ, ”DP, oŽYz¬læ“V«SŽŸŠ³‚Ì”DP‚Æ•ª•Ø. Îˆä³_ (¬Ž™): THERAPEUTIC RESEARCH 2015/9; 36 (9): 831-2.

[’˜@‘]

620083. [Šwp‘] (•ª’SŽ·•M)y—\–hÚŽí‚ÌŒ»ê‚ō¢‚ç‚È‚¢@‚Ü‚é‚í‚©‚胏ƒNƒ`ƒ“Q•A@‘æ1”ŁzII. Q&A@1. ƒƒNƒ`ƒ“‘S”Ê, p.102-4, p.105-7, p.108-9. ²“¡‰Á‘ãŽq1, Îˆä³_1 (1¬Ž™), •Ò: ’†–ì‹MŽi, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 2015/4”­s.

620084. [Šwp‘] (•ª’SŽ·•M)y“à‰ÈˆãE¬Ž™‰ÈŒ€Cˆã‚Ì‚œ‚߂́@¬Ž™‹~‹}Ž¡—ÃKƒCƒhƒ‰ƒCƒ“@‰ü’ù‘æ3”ŁzIII. ‚š‚à‚È‹~‹}ŽŸŠ³@C. zŠÂŠíŽŸŠ³@4. ìè•a, p.241-6. Îˆä³_1, îŒŽ‹`l1 (1¬Ž™), •Ò: ŽsìŒõ‘Ÿ˜Y, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/4”­s.

620085. [Šwp‘] (•ª’SŽ·•M)yÃ’—p–ƉuƒOƒƒuƒŠƒ“»Üƒnƒ“ƒhƒuƒbƒNz “K‰žŽŸŠ³‚ÆŽ¡—Á@4) ìè•a‹}«Šú, p.93-102. Îˆä³_ (¬Ž™), ŠÄC: ³‰ª@“O, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2015/4”­s.

620086. [Šwp‘] (•ª’SŽ·•M)yìè•a‚ÌŠî–{ ‘æ1”Å‘æ1üz‡•¹Ç: S‘ŸŒŒŠÇŒn‚̍‡•¹Ç, p.54-61. Îˆä³_ (¬Ž™), ‘ŠÄC: ìè•xì, ŠÄC: à_‰ªŒšé, ã‘º@–Î, ì¬: “ú–{ìè•aŠw‰ï, ‹Š˜aŠé‰æ, “Œ‹ž, 2015/5”­s.

620087. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̏¬Ž™Ž¡—ÃŽwj@‘æ16”Łz14. zŠÂŠíŽŸŠ³@‘”xÃ–¬ŠÒ—¬ˆÙí, p.514-5. Îˆä³_ (¬Ž™), ‘•ÒW: …Œû@‰ë, Žs‹Ž@Œõ, èŽR@O, ˆãŠw‘‰@, “Œ‹ž, 2015/9”­s.

620088. [Šwp‘] (•ª’SŽ·•M)y¬læ“V«SŽŸŠ³ƒp[ƒtƒFƒNƒgƒKƒCƒhzIII. –¢Ž¡—Â̐¬læ“V«SŽŸŠ³‚Ì•a‘Ô‚ÆŽ¡—Á@7. ìè•a«Š¥“®–¬áŽ, p.157-62. Îˆä³_1, –Ž“cL”ü2 (1¬Ž™, 2”Ñ’ËŽs—§•a‰@), •Ò: Ô–Ø’õ–è, ˆÉ“¡@_, •¶Œõ“°, “Œ‹ž, 2015/9”­s.

620089. [Šwp‘] (•ª’SŽ·•M)y—v“_‚ð‚š‚³‚Š‚鏬Ž™‹~‹}Eƒvƒ‰ƒCƒ}ƒŠƒPƒA@ƒsƒbƒgƒtƒH[ƒ‹Ç—á‚©‚çŠw‚Ú‚€!zIVÍ. ’m‚Á‚Ä‚š‚­‚ׂ«ÇŒó‚Æ‚»‚̑Ήž@I. ìè•a, p.186-8. Îˆä³_ (¬Ž™), •Ò: ŽsìŒõ‘Ÿ˜Y, “ì]“°, “Œ‹ž, 2015/11”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713070. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) First experiences of Penumbra coil 400 in small children: two cases report. Takanashi M1, Kimura S1, Mineo E1, Honda T1, Kitagawa A1, Ando H1, Tomita H2, Ishii M1: PICS-AICS AP 2015 (2015/4/1-4), Taipei, Taiwan. (‚—œ@Šw1, –Ø‘ºƒl1, •ô”öŒb—œ1, –{“c@’1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, •x“c@‰p2, Îˆä³_1: 1¬Ž™, 2º˜a‘åŠw‰¡•lŽs–k•”•a‰@zŠÂŠíƒZƒ“ƒ^[)

713071. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical Utility of the Level of Plasma Brain Natriuretic Peptide in Tetralogy of Fallot Patients Long-Term After Initial Intracardiac Repair: Consideration for Pulmonary Valve Replacement. Kitagawa A1, Oka N2, Mineo E1, Takanashi M1, Honda T1, Ando H1, Kimura S1, Miyaji K2, Ishii M1: The 11th Asian Society for Pediatric Research (2015/4/16), Osaka. (–kì“ÄŽj1, ‰ª@“¿•F2, •ô”öŒb—œ1, ‚—œ@Šw1, –{“c@’1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‹{’n@ŠÓ2, Îˆä³_1: 1¬Ž™, 2S‘ŸŒŒŠÇŠO)

713072. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Analysis of Immunological Function of Infants with Congenital Heart Disease after Cardiopulmonary Bypass Surgery: Evaluation of the Optimum Timing of Vaccination. Takanashi M1, Ogata S1, Honda T1, Nomoto K1, Mineo E1, Kitagawa A1 , Ando H1, Kimura S1, Oka N2, Miyaji K2, Ishii M1: The 11th Asian Society for Pediatric Research (2015/4/16), Osaka. (‚—œ@Šw1, •û¹•œ1, –{“c@’1, –쌳‚¯‚¢Žq1, •ô”öŒb—œ1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‰ª@“¿•F2, ‹{’n@ŠÓ2, Îˆä³_1: 1¬Ž™, 2S‘ŸŒŒŠÇŠO)

713073. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Long-term prognosis after methylpredonisolone-pulse combination therapy for refractory Kawasaki Disease. Ebato T1, Ogihara Y1, Ogata S1, Ishii M1: The 11th Asian Society for Pediatric Research (2015/4/16), Osaka. (]”gŒËF•ã1, îŒŽ‹`l1, •û¹•œ1, Îˆä³_1: 1¬Ž™)

713074. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Importance of measuring blood levels of topiramate as polytherapy for epileptic children. Toki T1, Iwsaki T1, Ishii M1: The 13th Asian and Oceanian Congress of Child Neurology (2015/5/14-17), Taipei, Taiwan. (“yŠò@•œ1, Šâér”V1, Îˆä³_1: 1¬Ž™)

713075. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Influence of Aortic Dilatation and Aortic Valve Regurgitation for Plasma Brain Natriuretic Peptide Level in Patients with Fontan Procedure. Kitagawa A1, Kimura S1, Mineo E1, Takanashi M1, Honda T1, Ando H1, Miyaji K2, Ishii M1: 49th Annual Meeting of the Association for European Paediatric and Congenital Cardiology (AEPC 2015), (2015/5/20-23), Prague, Czech. (–kì“ÄŽj1, –Ø‘ºƒl1, •ô”öŒb—œ1, ‚—œ@Šw1, –{“c@’1, ˆÀ“¡@Žõ1, ‹{’n@ŠÓ2, Îˆä³_1: 1¬Ž™, 2S‘ŸŒŒŠÇŠO)

721015. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ƒ`[ƒ€‚Ì—Í: ‘ÙŽ™Šú‚ɏdÇS•s‘S‚ð’悵‚œ‘å“®–¬¶Žºƒgƒ“ƒlƒ‹Ç‚̈ê—á. –Ø‘ºƒl1, ˆÀ“¡@Žõ1, –kì“ÄŽj1, –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, çݎ@Šw1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ22‰ñ“ú–{‘ÙŽ™S‘Ÿ•aŠw‰ïŠwpW‰ï (2016/2/19), “Œ‹ž.

722072. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) V‹KR‚Ä‚ñ‚©‚ñ–ò‚É‚ÍŒŒ’†”Z“x‘ª’è‚Í•K—v‚È‚¢?`TDM‚ÉŠî‚¢‚œŽ¡—Ð헪‚Ì‚·‚·‚߁`. Šâèr”V (¬Ž™): ‘æ57‰ñ“ú–{¬Ž™_ŒoŠw‰ïŠwpW‰ï (2015/5/28), ‘åã.

722073. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ìè•aŒ€‹† Up to Date@–ƉuƒOƒƒuƒŠƒ“‚̍R‰ŠÇƒƒJƒjƒYƒ€: V‹K•ªŽq‹@\‚̉ð–Ÿ. •û¹•œ (¬Ž™): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16), “Œ‹ž.

722074. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŒŒ—¬‰ÂŽ‹‰»‹Zp (VFM) ‚ªØ‚èŠJ‚­V‚œ‚ȏzŠÂŠí‰æ‘œf’f. –{“c@’1, ”Â’JŒcˆê2, ‹{èãĕœ2, ‚—œ@Šw1, •ô”öŒb—œ1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‰ª@“¿•F3, ‹{’n@ŠÓ3, Îˆä³_1 (1¬Ž™, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16), “Œ‹ž.

722075. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒCƒuƒjƒ“ƒOƒVƒ“ƒ|ƒWƒEƒ€: ƒXƒeƒƒCƒh‰Šú•¹—p—Ö@‚ÌŒø‰Ê‚ÌŒŸØzìè•a‰‰ñ–ƉuƒOƒƒuƒŠƒ“—Ö@•s‰ž—\‘ªŒQ‚ɑ΂·‚郁ƒ`ƒ‹ƒvƒŒƒhƒjƒ“ƒpƒ‹ƒX•¹—p—Ö@‚Ì’·ŠúŒo‰ß: ’PŽ{ÝŒã•ûŽ‹–ì“IŒŸ“¢. •û¹•œ1, îŒŽ‹`l1, ]”gŒËF•ã1, Îˆä³_1 (1¬Ž™): ‘æ35‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2015/10/9), Ž­Ž™“‡.

723508. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒIƒvƒ\ƒNƒ[ƒkƒXEƒ~ƒIƒNƒ[ƒkƒXÇŒóŒQ‚©‚ç_Œo‰èŽî‚Ɛf’f, ‘Šú‚ÉŽ¡—Éî“ü‚µ‚œ1—á. ®–ì@Žõ1, “yŠò@•œ1, ©@L–ç1, ˆÀ“¡@Žõ1, Šâèr”V1, Îˆä³_1 (1¬Ž™): ‘æ118‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2015/4/17), ‘åã.

723509. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘J‰„«‰©át, ŠÌ•s‘S‚ð‚«‚œ‚µ‚œƒTƒ‰ƒZƒ~ƒA‚Ì1—á. “c‘º—C•œ1, HŽR˜a­1, ”’ˆäG’Œ1, ‰i·—T‰ÀŽq1, ŽRŒûˆ»”T1, ‰¡ŠÖ—Sˆê˜Y1, ŒÏè‰ëŽq1, “¡•‹`l1, çݎ@Šw1, Îˆä³_1 (1¬Ž™): ‘æ118‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2015/4/17), ‘åã.

723510. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ÅŒoŒ±‚µ‚œäPŒŽ•a‡•¹”DP75Ç—á‚Ì•ê‘Ì‹y‚ÑŽ™‚Ì“Á’¥. ŽRŒûˆ»”T1, îŒŽ‹`l1, ‘剪–ƒ—1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ŒÇè‰ëŽq1, çݎ@Šw1, •û¹•œ1, â“Œ—R‹I1,2, Îˆä³_1 (1¬Ž™, 2–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘æ118‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2015/4/19), ‘åã.

723511. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ÁˆÙ“IIgE’l‚̐„ˆÚ‚ƐH•šŒoŒû•‰‰×ŽŽŒ±‚ÌŒ‹‰Ê‚ɂ‚¢‚Ä. ‘å’JŽF1,2, ˆîŠ_@“µ1,2, ‰¡ŠÖ—Sˆê˜Y1,2, ’†‘ºM–ç1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ118‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2015/4/17-19), ‘åã.

723512. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“à”­ˆç’x‰„ƒ‰ƒbƒgƒ‚ƒfƒ‹‚ÌŠŒFŽ‰–b‘gD‚É‚š‚¯‚é’E‹€–ð’`”’Ž¿1‚š‚æ‚уAƒNƒAƒ|ƒŠƒ“7‚Ì”­Œ»‚ÌŒŸ“¢. ‹k“cˆê‹P1, ŽÄŽRŒ[Žq1, ‘å’Ь”V1, ‰¡“csŽj2, “c‹v•ÛŒ›s3, Œ‰YM•v4 (1¬Ž™, 2‘Š–ÍŒŽ‹Š“¯•a‰@, 3‡“V“°‘åŠw, 4¹“¿‘åŠw): ‘æ88‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2015/4/23), “Œ‹ž.

723513. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ÁˆÙ“IIgE’l‚̐„ˆÚ‚ƐH•šŒoŒû•‰‰×ŽŽŒ±‚ÌŒ‹‰Ê‚ɂ‚¢‚Ä. ‘å’JŽF1,2, ˆîŠ_@“µ1,2, ‰¡ŠÖ—Sˆê˜Y1,2, ’†‘ºM–ç1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ64‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïŠwp‘å‰ï (2015/5/26-28), “Œ‹ž.

723514. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œƒ‘‚·‚éACHD: ‰äX‚É‹‚ß‚ç‚ê‚Ä‚¢‚é‚»‚ÌŠoŒå. Îˆä³_ (¬Ž™): The Echo Live2015 (2015/5/30), ‘åã.

723515. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚鏬Ž™ŠOŠ³ŽÒ‚ÌŒŸ“¢. “c‘º—C•œ1, •ô”öŒb—œ1, Œ–{“TŽq1, ˆÀ“¡@Žõ1, Îˆä³_1 (1¬Ž™): ‘æ29‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ïŠwpW‰ï (2015/6/12), ‘å‹{.

723516. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÄ‹z•â•‚ð—v‚µ‚œRSƒEƒCƒ‹ƒXŠŽõÇ—á‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Œ–{“TŽq1, ‹àŽq’‰O1, •ô”öŒb—œ1, ˆÀ“¡@Žõ1, Îˆä³_1 (1¬Ž™): ‘æ29‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ïŠwpW‰ï (2015/6/13), ‘å‹{.

723517. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰@¬Ž™‰È‚ÅŒoŒ±‚µ‚œ‹ß”N‚̐­”N‚É‚š‚¯‚鎩ŽE4Ç—á. •’ms•ã1, Œ–{“TŽq1, •ô”öŒb—œ1, ˆÀ“¡@Žõ1, Îˆä³_1 (1¬Ž™): ‘æ29‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ïŠwpW‰ï (2015/6/13), ‘å‹{.

723518. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –¢nŽ™PDA‚ÌŽèpŽžŠú‚ª’ZŠú—\Œã‚É—^‚Š‚é‰e‹¿‚ɂ‚¢‚Ä çݎ@Šw1, ŽRŒûˆ»”T1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ŒÏè‰ëŽq1, Îˆä³_1 (1¬Ž™): ‘æ51‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2015/7/11), •Ÿ‰ª.

723519. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒWƒAƒ]ƒLƒVƒh‚É‚æ‚è•‚Žî, –R”A‚𗈂µ‚œBeckwith-WiedemannÇŒóŒQ (BWS) ‚̈ê—á. ”’ˆäG’Œ1, HŽR˜a­1, ŽRŒûˆ»”T1, ‰¡ŠÖ—Sˆê˜Y1, ŒÏè‰ëŽq1, çݎ@Šw1, Îˆä³_1 (1¬Ž™): ‘æ51‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2015/7/11), •Ÿ‰ª.

723520. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “œ”A•a•ê‘Ì‚æ‚èo¶‚µ‚œ, dÇ“x‚̈قȂé”ö•”‘ލsÇŒóŒQ‚Ì2—á. ŽRŒûˆ»”T1, çݎ@Šw1, ‚—œ@Šw1, ‘剪–ƒ—1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ŒÏè‰ëŽq1, ‹àˆä—Y“ñ2, ŠC–ìM–ç2, Îˆä³_1 (1¬Ž™, 2ŽY‰È): ‘æ51‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2015/7/11), •Ÿ‰ª.

723521. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Speckle Tracking of tricuspid annular displacement‚ð—p‚¢‚œ¬Ž™Šúæ“V«SŽŸŠ³‚É‚š‚¯‚é‰EŽºŽûk”\•]‰¿. –Ø‘ºƒl1, ˆÀ“¡@Žõ1, –kì“ÄŽj1, –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, Îˆä³_1 (1¬Ž™): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16), “Œ‹ž.

723522. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) æ“V«SŽŸŠ³‚ÌŒŒs“®‘ԕω»•]‰¿: microRNAƒAƒŒƒC‰ðÍ. –{“c@’1, ‚—œ@Šw1, –쌳‚¯‚¢Žq1, •ô”öŒb—œ1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‰ª@“¿•F2, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.192.

723523. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –¢nŽ™“®–¬ŠÇŠJ‘¶Ç‚ɑ΂·‚é“àŽ‹‹Ÿ‰º“®–¬ŠÇ•Âœp (Video-assisted thoraco-scopic surgical interruption of patent ductus arteriosus; VATS-PDA) ‚Ì—L—p«. •ô”öŒb—œ1, –Ø‘ºƒl1, ‚—œ@Šw1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.249.

723524. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰E–[“àˆÙíŠu•Ç‚ƐSŽG‰¹‚Å”­Œ©‚³‚ê‚œValsalva“Ž‰E–[ᑂ̓ûŽ™—á. ‚—œ@Šw1, –Ø‘ºƒl1, •ô”öŒb—œ1, –{“c@’1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, Îˆä³_1 (1¬Ž™): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16), “Œ‹ž.

723525. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒHƒ“ƒ^ƒ“pŒã‰“ŠuŠú‚É‚š‚¯‚錌s“®‘Ô•]‰¿: S‘ŸMRI‚š‚æ‚Ñ”]«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh‚ÌŠÖ˜A«. –kì“ÄŽj1, ‰ª@“¿•F2, •ô”öŒb—œ1, ‚—œ@Šw1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.319.

723526. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‚µ‚¢ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“ˆãŠw‚̏¬Ž™zŠÂŠíˆã—Âւ̉ž—p|ŒŒ—¬‰ÂŽ‹‰»‹Zp (VFM) ‚ªØ‚èŠJ‚­V‚œ‚ȏzŠÂŠí‰æ‘œf’f|. –{“c@’1, ”Â’JŒcˆê2, ‹{èãĕœ2, ‚—œ@Šw1, •ô”öŒb—œ1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‰ª@“¿•F3, ‹{’n@ŠÓ3, Îˆä³_1 (1¬Ž™, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO): ‘æ51‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2015/7/16-18), “Œ‹ž, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2015/7; 31 (Suppl 1): S1.103.

723527. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å“®–¬•Ù•Âœ•s‘SÇ‚̓tƒHƒ“ƒ^ƒ“pŒã‰“ŠuŠú‚É‚š‚¯‚éS‹@”\áŠQ‚̊댯ˆöŽq‚Æ‚È‚è‚€‚é‚©? S‘ŸMRI‚É‚æ‚錟“¢. –kì“ÄŽj1, •ô”öŒb—œ1, ˆÀ“¡@Žõ1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ63‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2015/9/19), ‰¡•l.

723528. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Š‘ΓI‚ȍ‚ƒJƒ‹ƒVƒEƒ€”AÇ‚æ‚èƒJƒ‹ƒVƒEƒ€ŠŽ’mŽó—e‘Ì‚ÌŠˆ«Œ^•ÏˆÙ‚ðf’f‚µ“Ÿ‚œ1—á. ‹k“cˆê‹P1, –쌳‚¯‚¢Žq1, “c‹v•ÛŒ›s2, ‘å’Ь”V1, ŽÄŽRŒ[Žq1, •—’£áÁ—R”ü3, ‰¡“csŽj4, Îˆä³_1 (1¬Ž™, 2‡“V“°‘åŠwˆãŠw•”¬Ž™‰È, 3•—‚ÌŽq‚±‚Ç‚àƒNƒŠƒjƒbƒN, 4‚悱“c‚±‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ49‰ñ“ú–{¬Ž™“à•ª”åŠw‰ïŠwpW‰ï (2015/10/9), “Œ‹ž.

723529. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«ìè•a‚É‚š‚¯‚é3rd line‚Ì—L—p«, ˆÀ‘S«: ’PŽ{ÝŒŸ“¢. ]”gŒËF•ã1, îŒŽ‹`l1, •û¹•œ1, Îˆä³_1 (1¬Ž™): ‘æ35‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2015/10/10), Ž­Ž™“‡.

723530. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†•_ŒoÇó‚ð‡•¹‚µ‚œìè•a‚̗Տ°“IŒŸ“¢. ]”gŒËF•ã1, îŒŽ‹`l1, •û¹•œ1, Îˆä³_1 (1¬Ž™): ‘æ35‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2015/10/10), Ž­Ž™“‡.

723531. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ÅŒoŒ±‚µ‚œ‹‘劥“®–¬áŽ‡•¹ìè•a‚̗Տ°“IŒŸ“¢. îŒŽ‹`l1, ]”gŒËF•ã1, •û¹•œ1, Îˆä³_1 (1¬Ž™): ‘æ35‰ñ“ú–{ìè•aŠw‰ïEŠwpW‰ï (2015/10/10), Ž­Ž™“‡.

723532. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@10”NŠÔ‚Ì’Ž’áo¶‘̏dŽ™‚É‚š‚¯‚éÁ‰»ŠÇúE‚ð‹^‚¢ŠO‰È“Iˆ’u‚ðs‚Á‚œÇ—á‚ÌŒŸ“¢. çݎ@Šw1, ŽRŒûˆ»”T1, ‘剪–ƒ—1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ŒÏè‰ëŽq1, Îˆä³_1 (1¬Ž™): ‘æ60‰ñ“ú–{V¶Ž™¬ˆçˆãŠw‰ïEŠwpW‰ï (2015/10/24), ·‰ª.

723533. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) NICUƒxƒbƒg‚Ì‘°‚ª’nˆæŽüŽYŠúˆã—Ã‚É‚à‚œ‚炵‚œ‰e‹¿. ŒÏè‰ëŽq1, çݎ@Šw1, ŽRŒûˆ»”T1, ‘剪–ƒ—1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ‘同—fŽq2, –]ŒŽƒŽq2, Îˆä³_1, ŠC–ìM–ç2 (1¬Ž™, 2ŽY‰È): ‘æ60‰ñ“ú–{V¶Ž™¬ˆçˆãŠw‰ïEŠwpW‰ï (2015/10/25), ·‰ª.

723534. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Late PretermŽ™‚̌ċzáŠQ‚ɂ‚¢‚Ä. ŽRŒûˆ»”T1, çݎ@Šw1, ‰i·—T‰ÀŽq1, ‘剪–ƒ—1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ŒÏè‰ëŽq1, “¡•‹`l, ¡ˆäƒD1, Îˆä³_1 (1¬Ž™): ‘æ60‰ñ“ú–{V¶Ž™¬ˆçˆãŠw‰ïEŠwpW‰ï (2015/10/25), ·‰ª.

723535. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Extreme delta brush‚ªRNMDAŽó—e‘Ì”]‰Š‚̐f’f‚É—L—p‚Å‚ ‚Á‚œ14Î—Žq—á. “yŠò@•œ1, Šâèr”V1, Îˆä³_1, ‚‹ŽK—˜2 (1¬Ž™, 2Ã‰ª‚Ä‚ñ‚©‚ñ_Œoˆã—ÃZƒ“ƒ^[): ‘æ49‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ïŠwpW‰ï (2015/10/31), ’·è.

723536. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒqƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒXŠŽõÇ‚ɑ΂·‚éModified Pulmonary Index Score‚Ì—L—p«. ‘å’JŽF1,2, ˆîŠ_@“µ1,2, ‚—œ@Šw1, Œì‹ÅŽq1, ‰¡ŠÖ—Sˆê˜Y1, ’†‘ºM–ç1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ47‰ñ“ú–{¬Ž™ŠŽõÇŠw‰ï‘‰ïEŠwpW‰ï (2015/10/31-11/1), •Ÿ“‡.

723537. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÙ‚È‚éŒo‰ß‚ð’H‚Á‚œ¬Ž™dÇ–ò]2—á‚̗Տ°“I“Á’¥. ®–ì@Žõ1, “¡–{‚Ü‚ä, ]”gŒËF•ã1, îŒŽ‹`l1, •û¹•œ1, Îˆä³_1 (1¬Ž™): ‘æ52‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï (2015/11/22), “Þ—Ç.

723538. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”D•w‚ɑ΂·‚鎙‚̃AƒŒƒ‹ƒM[ŽŸŠ³‚ÉŠÖ‚·‚éˆÓŽ¯’²ž. ‘å’JŽF1,2, ˆîŠ_@“µ1, ‚—œ@Šw1, Œì‹ÅŽq1, ‰¡ŠÖ—Sˆê˜Y1, ’†‘ºM–ç1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ52‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï (2015/11/21-22), “Þ—Ç.

723539. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒHƒ“ƒ^ƒ“pŒã‰“ŠuŠúÇ—á‚ɑ΂·‚éƒ{ƒZƒ“ƒ^ƒ“‚ÌŽ¡—ÃŒø‰Ê: S‘ŸMRI‚ð—p‚¢‚œŒŸ“¢. –kì“ÄŽj1, •ô”öŒb—œ1, ‚—œ@Šw1, –{“c@’1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ18‰ñ“ú–{¬læ“V«SŽŸŠ³Šw‰ï‘‰ïEŠwpW‰ï (2016/1/16), ‘åã.

723540. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰EŽº—¬o˜HŒ`¬pŒã‰“ŠuŠú‚É‚š‚¯‚éS‘ŸMRI‚Ì—L—p«: SƒGƒR[‚š‚æ‚ÑŒŒŠÇ‘¢‰e‚Æ‚Ì”äŠr. –kì“ÄŽj1, •ô”öŒb—œ1, ‚—œ@Šw1, –{“c@’1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO): ‘æ18‰ñ“ú–{¬læ“V«SŽŸŠ³Šw‰ï‘‰ïEŠwpW‰ï (2016/1/16), ‘åã.

723541. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ü‹È‚𔺂Á‚œ––œ«”x“®–¬‚̍‚“x‹·ó•a•Ï‚ɑ΂·‚鎡—ÃŒoŒ±: ƒoƒ‹[ƒ“Šg’£Œ^ƒXƒeƒ“ƒg‚Æ’Ž‚‘ψ³ƒoƒ‹[ƒ“‚ð—p‚¢‚œ1Ç—á. –kì“ÄŽj1, –Ø‘ºƒl1, •ô”öŒb—œ1, ‚—œ@Šw1, ˆÀ“¡@Žõ1, •x“c@‰p2, Îˆä³_1 (1¬Ž™, 2º˜a‘åŠw‰¡•lŽs–k•”•a‰@): ‘æ27‰ñ“ú–{Pediatric Interventional CardiologyŠw‰ïŠwpW‰ï (2016/1/28), L“‡.

723542. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V‘fÞ‚̃RƒCƒ‹‚ð—p‚¢‚Ä‘€•›ŒŒs˜H‚ɃRƒCƒ‹Çðp‚ðŽ{s‚µ‚œ6—á‚̗Տ°ŒŸ“¢. ‚—œ@Šw1, –Ø‘ºƒl1, •ô”öŒb—œ1, –{“c@’1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, •x“c@‰p2, Îˆä³_1 (1¬Ž™, 2º˜a‘åŠw‰¡•lŽs–k•”•a‰@): ‘æ27‰ñ“ú–{Pediatric Interventional CardiologyŠw‰ïŠwpW‰ï (2016/1/28), L“‡.

723543. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •s®–¬Œ¹«‰EŽºS‹ØÇ‚Í‘ÙŽ™Šú‚É”­Ç‚µ‚€‚é: TMEM43ˆâ“`Žq•ÏˆÙ‚𔺂Á‚œ1—á. –{“c@’1, ‹àˆä—Y“ñ2, ‘å–쐹Žq, ˆÀ“¡@Žõ1, –{“c‰ëŽq2, ’ë–ìTˆê3, Îˆä³_1 (1¬Ž™, 2ŽY‰È, 3zŠÂŠí“à): ‘æ22‰ñ“ú–{‘ÙŽ™S‘Ÿ•aŠw‰ïŠwpW‰ï (2016/2/19), “Œ‹ž.

723544. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Micro RNA Array Analysis in Infants with Ventricular Septal Defect. –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, Îˆä³_1 (1¬Ž™): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/20), å‘ä.

723545. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Four-Dimensional Magnetic Resonance Imaging (4D-MRI) Flow Energy Loss: New Insight into Fontan Circulation in Adult Patients. –kì“ÄŽj1, ”Â’JŒcˆê2, •ô”öŒb—œ1, ‚—œ@Šw1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‹{’n@ŠÓ3, Îˆä³_1 (1¬Ž™, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/20), å‘ä.

731108. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ìè•a‚ÌŒø‰Ê“I‹}«ŠúŽ¡—Ã: ƒƒJƒjƒYƒ€‚̉ð–Ÿ. Îˆä³_ (¬Ž™): ‘æ8‰ñŠò•Œ–ƉuEŠŽõEìè•aŒ€‹†‰ï (2015/7/23), Šò•Œ.

731109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬læ“V«SŽŸŠ³‚ðŽæ‚芪‚­”–â‘è. Îˆä³_ (¬Ž™): “ú–{zŠÂŠíŠw‰ïî•ñL•ñˆÏˆõ‰ï‘æ11‰ñƒvƒŒƒXƒZƒ~ƒi[ (2015/8/4), “Œ‹ž.

731110. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚̍ŐV‚Ì’mŒ©. Îˆä³_ (¬Ž™): ‘æ27‰ñˆëŠò“‡Œ’N‘åŠwu‰‰‰ï (2015/11/28), ’·è.

731111. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “«ìè•a‚ɑ΂·‚é–k—¢‘åŠw¬Ž™‰È‚Ì‹}«ŠúŽ¡—Ð헪: SŒŒŠÇ‡•¹Ç‚ÌŒŸ“¢. Îˆä³_ (¬Ž™): ‘æ11‰ñ_“ސ쌧ìè•aŒ€‹†‰ï (2016/2/27), V‰¡•l.

733179. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}Œƒ‚ÈŒo‰ß‚ð‚œ‚Ç‚Á‚œ”xÃ–¬•ÂœÇ (CPVA) ‚Ì1—á. ‹{“c—L—Œb1, –kì“ÄŽj2, •’ms•ã2, ˆÀ“¡@Žõ2, –Ø‘ºƒl2, çݎ@Šw2, Îˆä³_2, ’†‘º—SŠó3, ‹{’n@ŠÓ3 (1Œ€Cˆã, 2¬Ž™, 3S‘ŸŒŒŠÇŠO): ‘æ34‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2015/4/11), ‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2015/7; 42 (2): 294.

733180. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ìè•a•s‘SŒ^‚Æ‚µ‚ÄŽ¡—³‚ê‚œ‚ˆÀ“®–¬‰Š‚Ì1—Ž™—á. ‹Ž–{‰è‹v”ü1, ]”gŒËF•ã1, îŒŽ‹`l1, •û¹•œ1, Îˆä³_1 (1¬Ž™): ‘æ34‰ñŠÖ“Œìè•aŒ€‹†‰ï (2015/6/20), “Œ‹ž.

733181. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –ƉuƒOƒƒuƒŠƒ““Š—^Œã‚ɃAƒiƒtƒBƒ‰ƒLƒV[—lÇó‚ð”F‚ß‚œ‚œ‚ß, ‰‰ñŽ¡—ÂƂµ‚ăCƒ“ƒtƒŠƒVƒLƒ}ƒu‚ðŽg—p‚µ‚œìè•aÄ”­—á. îŒŽ‹`l1, ]”gŒËF•ã1, •û¹•œ1, Îˆä³_1 (1¬Ž™): ‘æ34‰ñŠÖ“Œìè•aŒ€‹†‰ï (2015/6/20), “Œ‹ž.

733182. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) áz¹‚ð‰”­‚Æ‚µ‚œ”í‹s‘ÒŽ™‚Ì1—á. Œ“c®Žj1, ˆÀ“¡@Žõ1, ”’ˆäG’Œ1, Œ–{“TŽq1, “yŠò@•œ1, •ô”öŒb—œ1, “¡•‹`l1,2, Îˆä³_1 (1¬Ž™, 2‘Š–Í‘ä•a‰@): ‘æ335‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ïE‘‰ï (2015/6/27), ‰¡•l.

733183. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “úíf—Âɂš‚¯‚éŠë‹}“IÇ—á@‹}«”]Ç. “yŠò@•œ (¬Ž™): ‘æ394‰ñ‘Š–ÍŒŽŽs¬Ž™‰Èˆã‰ïŒŽ—፧˜b‰ï (2015/7/22), ‘Š–ÍŒŽ.

733184. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Clinically isolated syndrome‚É‚š‚¯‚éŠÓ•Ê‚É‘gD¶ŒŸ‚ª—L—p‚Å‚ ‚Á‚œ”]Š²ƒOƒŠƒI[ƒ}‚Ì8Î’jŽ™—á. “yŠò@•œ1, Šâèr”V1, Îˆä³_1 (1¬Ž™): ‘æ56‰ñ_“ސ쏬Ž™_Œo§˜b‰ï (2015/7/25), ‰¡•l.

733185. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒgƒs[«”畆‰Š@f—ẪRƒc. ‘å’JŽF1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ƒ}ƒ‹ƒzŠ”Ž®‰ïŽÐŽÐ“àŒ€C‰ï (2015/10/13), Œú–Ø.

733186. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) æ“V«SŽŸŠ³Ž™‚É‚š‚¯‚élHS”xŽèpŒã‚ÌŽŠ“K—\–hÚŽíŽžŠú. ‚—œ@Šw (¬Ž™): ‘æ14‰ñ–k—¢Pediatrics Seminar (‘æ396‰ñ‘Š–ÍŒŽ¬Ž™‰Èˆã‰ïŒŽ—˜b‰ï) (2015/10/28), ‘Š–ÍŒŽ.

733187. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”N’·Ž™ƒtƒ@ƒ[Žl’¥Ç‚̈ê—á. –Ø‘ºƒl1, ˆÀ“¡@Žõ1, –{“c@’1, –kì“ÄŽj1, ‚—œ@Šw1, •ô”öŒb—œ1, Îˆä³_1 (1¬Ž™): ‘æ11‰ñ_“ސ쏬Ž™zŠÂŠíŒ€‹†‰ï (2015/10/31), ‰¡•l.

733188. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶SŽº“àEnergy Loss‚͉œ‚𔜉f‚·‚é‚©H|SŽºŠÖ˜A‚ÉŠÖ‚·‚éV‚œ‚È’mŒ©|. –{“c@’1, ”Â’JŒcˆê2, ‚—œ@Šw1, –kì“ÄŽj1, ˆÀ“¡@Žõ1, –Ø‘ºƒl1, ‹{èãĕœ2, ‹{’n@ŠÓ3, Îˆä³_1 (1¬Ž™, 2ŒŒ—¬‰ðÍ, 3S‘ŸŒŒŠÇŠO): ‘æ5‰ñŒŒ—¬‰ï (2015/11/21), “Œ‹ž.

733189. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H•šƒAƒŒƒ‹ƒM[‚ÌŠÇ—‚Í‚Ç‚€‚·‚éH`”­Ç‹@˜‚š‚æ‚Ñ“ÁˆÙ“IIgE’l‚̐„ˆÚ‚ÆŠ°‰ð‚ɂ‚¢‚ā`. ‘å’JŽF1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘œ–€“ì•”’nˆæ•a‰@’nˆæ˜AŒg‰ï (2015/11/25), “Œ‹ž.

733190. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’Ž‰¹”gŒŸž‚ª‹t—¬«tÇ‚Ì‘Šú”­Œ©‚É—L—p‚Ÿ‚Á‚œ1—á. ‹àŽq‰ë‹I1, ©@L–ç2, Œì‹ÅŽq1, ’†‘ºM–ç1, Œ@·G3, Îˆä³_1 (1¬Ž™, 2‹~–œ, 3”å”AŠí): ‘æ337‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސì’n•û‰ï/‘æ57‰ñ¬Ž™‰È•ª‰È‰ï (2015/11/28), ‰¡•l.

733191. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ä‚ñ‚©‚ñˆã—Â̍őOü|”­ì—}§‚Ì‚œ‚߂Ɂ|. Šâér”V (¬Ž™): Žs–¯ŒöŠJuÀ (2015/12/12), _“ސì.

733192. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’·ŠúŠÔ‚̉ºŽˆ’ɂ𔺂¢f’f‚É‹ê—¶‚µ‚œƒ}ƒCƒRƒvƒ‰ƒYƒ}ŠŽõÇ‚Ì1—á. ‚—œ@Šw (¬Ž™): ‘æ399‰ñ‘Š–ÍŒŽŽs¬Ž™‰Èˆã‰ïŒŽ—˜b‰ï (2016/1/20), ‘Š–ÍŒŽ.

733193. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H•šƒAƒŒƒ‹ƒM[‚Ì‚¢‚Ü, ‚±‚ê‚©‚ç. ‘å’JŽF1,2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2¬Ž™): ‘æ31‰ñŽs–¯ŒöŠJuÀ (2016/1/25), ‘Š–ÍŒŽ.

733194. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‚Ç‚à‚Ì‚Ä‚ñ‚©‚ñ|Šî–{“I’mŽ¯‚Ɛ¶Šˆ‚ɂ‚¢‚ā|. Šâér”V (¬Ž™): •œ¬27”N“x¬Ž™–«“Á’莟•au‰‰‰ï (2016/2/12), _“ސì.

733195. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ìè•a‚ÌŽ©‘R–Ɖu§Œä‹@\‚̉ð–Ÿ: ìè•aImmune-Profile‰ðÍ. ]”gŒËF•ã1, •û¹•œ1, îŒŽ‹`l1, Îˆä³_1 (1¬Ž™): ‘æ11‰ñ_“ސ쌧ìè•aŒ€‹†‰ï (2016/2/27), V‰¡•l.

733196. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •ïŠ‡ˆã—Ч“x‰º‚Å‚Ì”N’·ìè•aŽ™‚ɑ΂·‚é–ƉuƒOƒƒuƒŠƒ“—Ö@‚Ì–â‘è“_. ®–ì@Žõ1, •û¹•œ1, ]”gŒËF•ã1, îŒŽ‹`l1, rˆäN•v2, Îˆä³_1 (1¬Ž™, 2f—Ïî•ñŠÇ—Žº): ‘æ11‰ñ_“ސ쌧ìè•aŒ€‹†‰ï (2016/2/27), V‰¡•l.

733197. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’·ŠúŠÔ‚̉ºŽˆ’ɂ𔺂¢f’f‚É‹ê—¶‚µ‚œƒ}ƒCƒRƒvƒ‰ƒYƒ}ŠŽõÇ‚Ì1—á. ‚—œ@Šw (¬Ž™): ‘æ2‰ñ–k‘ŠE‘œ–€’nˆæ¬Ž™‰È˜AŒgƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/2/29), _“ސì.

733198. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇSgáŠQŽ™‚̍ݑîŽx‰‡‚É‚š‚¯‚é‘åŠw•a‰@‚Æ‚µ‚Ä‚ÌŽŽ‚Ý. Šâèr”V1, ŒŽŒûŒ[”V‰î1, ŒÏè‰ëŽq1, Îˆä³_1 (1¬Ž™): ‘æ339‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï/‘æ33‰ñ_“ސ쏬Ž™‰Èˆã‰ï‘‰ï (2016/3/12), ‰¡•l.

733199. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”xŒŒÇ«ÇðÇ (septic pulmonary embolism: SPE) ‚ð‡•¹‚µ‚œ‰»”^«å’°ŠÖß‰Š‚Ì1’jŽ™—á. ì‘º“TŽq1, ì“cF‘Ÿ1, ‹àŽq’‰O1, Îˆä³_1 (1¬Ž™): ‘æ339‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï/‘æ33‰ñ_“ސ쏬Ž™‰Èˆã‰ï‘‰ï (2016/3/12), ‰¡•l.

733200. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) æ“V«ŠÌ‰èŽî‚̈ê—á. Œ“c®Žj1, ¬ã—T‰ÀŽq1, Š`ŒŽ@’m2, HŽR˜a­1, ŒÏè‰ëŽq1, •“cŒ›Žq2, çݎ@Šw1, “c’†@Œ‰3, Îˆä³_1 (1¬Ž™, 2ŠO‰È, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ64‰ñ_“ސ쏬Ž™Žîᇌ€‹†‰ï (2016/3/26), ‰¡•l.


ŽY‰ÈŠw^•wl‰ÈŠw

[Šwp˜_•¶]

110211. [ŒŽ’˜] Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A). Kato T, Takashima A, Kasamatsu T, Nakamura K, Mizusawa J, Nakanishi T, Takeshima N, Kamiura S, Onda T1, Sumi T, Takano M, Nakai H, Saito T, Fujiwara K, Yokoyama M, Itamochi H, Takehara K, Yokota H, Mizunoe T, Takeda S, Sonoda K, Shiozawa T, Kawabata T, Honma S, Fukuda H, Yaegashi N, Yoshikawa H, Konishi I, Kamura T (Gynecologic Oncology Study Group of the Japan Clinical Oncology Group): Gynecol Oncol 2015/4; 137 (1): 34-9. (‰¶“c‹MŽu1: 1•wl)

110212. [ŒŽ’˜] Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients. Iwase H1, Takada T1, Iitsuka C, Nomura H, Abe A, Taniguchi T, Takizawa K: J Gynecol Oncol 2015/10; 26 (4): 303-10. (Šâ£tŽq1, ‚“c‹±b1: 1•wl)

110213. [ŒŽ’˜] Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity. Ishiguro T, Sato A, Ohata H, Ikarashi Y, Takahashi RU, Ochiya T, Yoshida M, Tsuda H, Onda T1, Kato T, Kasamatsu T, Enomoto T, Tanaka K, Nakagama H, Okamoto K: Cancer Res 2016/1; 76 (1): 150-60. (‰¶“c‹MŽu1: 1•wl)

110029. [ŒŽ’˜] Vascular endothelial growth factor regulates growth of endometrial tissues and angiogenesis in a mouse transplantation model. Sekiguchi K1, Hosono K2,3, Numao A4, Honda M1, Matsuda H1, Amano H3, Kawauchi H4, Shibuya M, Unno N5, Majima M3: Kitasato Med J 2016/3; 46 (1): 15-23. (ŠÖŒû˜aŠé1, ×–ì‰Á“ÞŽq2,3, À”ö²Žq4, –{“c‰ëŽq1, Œ“cO”ü1, “V–ì‰pŽ÷3, ì“à”Žl4, ŠC–ìM–ç5, ”n“ˆ³—²3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—, 4•wl, 5ŽY‰È)

120019. [ŒŽ’˜] ‹æˆæ’Á’É–@‚É‚æ‚é–³’É•ª•Ø‚ÆŽq‹{’ꈳ”—–@. ŒàVW‘ã1, “V–ì@Š®1, “‡‰ª‹¶1, ŠÖŒû˜aŠé2, ‘同—fŽq1, ‰Í–ìÆŽq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2015/9; 51 (3): 1003-8.

120020. [ŒŽ’˜] “–‰@‚É‚š‚¯‚鏃ˆŒ^Žq‹{‘Ì•”Ÿ÷‰t«‘BŠà13—á‚ÌŽ¡—ЬÑ. ŒÃì³‹`1, Šâ£tŽq1, ¬–ìd–ž1, ‚“c‹±b1, Vˆä@“w1, Vˆä³G1, ‰¶“c‹MŽu1 (1•wl): _“ސìŽY‰È•wl‰ÈŠw‰ïŽ 2015/9; 52 (1): 19-23.

320025. [Ç—á•ñ] ‘Ù”Õƒ|ƒŠ[ƒv‚̐f’fEŽ¡—Âɂš‚¯‚é3D-CTA‚Ì—L—p«. ‰º“c—²m1, ì“à”Žl1, ”‘q²Žq1, ‰¬–ì‹|ŠóŽq1, ‰¶“c‹MŽu1, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): _“ސ쌧ŽY‰È•wl‰ÈŠw‰ïŽ 2015/9; 52 (1): 24-7.

320026. [Ç—á•ñ] •ª•ØŒã‘å—ʏoŒŒ2Ç—á‚ɑ΂·‚éBakriƒoƒ‹[ƒ“‚ÌŽg—pŒoŒ±. ‰““¡^ˆê1, –]ŒŽƒŽq2, ‰Í–ìÆŽq2, “‡‰ª‹¶2, ŒàVW‘ã2, Îì—²ŽO2, ‘同—fŽq2, ‹àˆä—Y“ñ2, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): _“ސ쌧ŽY‰È•wl‰ÈŠw‰ïŽ 2015/9; 52 (1): 57-9.

320027. [Ç—á•ñ] ‰‰ñŽ¡—ÃŽž‚ÍŽq‹{‹ØŽî‚Ɛf’f‚³‚ê, ”x“]ˆÚ‚ð‚«‚œ‚µ—‘‘ƒ«õŽîᇗގ—Žq‹{ŽîᇂƔ»–Ÿ‚µ‚œˆê—á. ‹g‘º‰ÃL1, Vˆä³G1, ¬–ìd–ž1, ‚“c‹±b1, Šâ£tŽq1, Š“cç”ü”T2, ‘å•”@œ3, ‰¶“c‹MŽu1 (1•wl, 2•a—, 3ˆã—Éq¶Šw•”): _“ސ쌧ŽY‰È•wl‰ÈŠw‰ïŽ 2016/2; 52 (2): 148-53.

510005. [‘à] Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives. Matsumoto K, Onda T1, Yaegashi N: Jpn J Clin Oncol 2015/5; 45 (5): 408-10. (‰¶“c‹MŽu1: 1•wl)

510006. [‘à] Minimization of curative surgery for treatment of early cervical cancer: a review. Arimoto T, Kawana K, Adachi K, Ikeda Y, Nagasaka K, Tsuruga T, Yamashita A, Oda K, Ishikawa M, Kasamatsu T, Onda T1, Konishi I, Yoshikawa H, Yaegashi N (Gynecologic Cancer Study Group of the Japan Clinical Oncology Group): Jpn J Clin Oncol 2015/7; 45 (7): 611-6. (‰¶“c‹MŽu1: 1•wl)

[Šw‰ïEŒ€‹†‰ï“™]

713076. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Age-Related Normograms of AMH Level in Infertile Women in Japan. Kamisawa E, Nakayama M, Kawauchi H1, Asada Y: IFFS/JSRM international meeting 2015 (2015/4/26-29), Yokohama, Japan. (ì“à”Žl1: 1•wl)

722076. [Šw‰ï (‘S‘)] (ƒNƒŠƒjƒJƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) |—‘‘ƒ‚ª‚ñ‰»Šw—Ö@‚̃^ƒCƒ~ƒ“ƒO‚Æ—\Œã|—‘‘ƒŠà‚É‚š‚¯‚éNAC‚Æ—\Œã. ‰¶“c‹MŽu (•wl): ‘æ12‰ñ•wl‰È‚ª‚ñ‰ï‹c (2015/6/26-27), Œyˆä‘ò.

722077. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Treatment invasiveness of neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers. ‰¶“c‹MŽu (•wl): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29-31), ‹ž“s.

722078. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ÐŠQŽž‚É‚š‚¯‚éŽüŽYŠúˆã—ÃŽù—v‹Ït‚ÉŠÖ‚·‚錟“¢. •ž•”‹¿Žq (ŽY‰È): ‘æ21‰ñ“ú–{W’cÐŠQˆãŠw‰ï‘‰ïEŠwpW‰ï (2016/2/27-29), ŽRŒ`.

723546. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“®–¬ÇðpŒã‚Ì•ª•Ø—\Œã. ŒŽRD1, “‡‰ª‹¶1, •ž•”‹¿Žq1, ŒàVW‘ã1, Îì—²ŽO1, ‘同—fŽq1, ‰Í–ìÆŽq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ‰¶“c‹MŽu3, ŠC–ìM–ç1 (1ŽY‰È, 2•úŽËü (‰æ‘œ), 3•wl): ‘æ67‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/4/9-12), ‰¡•l.

723547. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒ¬”ÂŒž­«ŽŸŠ³‡•¹”DP7Ç—á‚ÉŽ{s‚µ‚œƒŒƒ~ƒtƒFƒ“ƒ^ƒjƒ‹‚É‚æ‚éŒoÃ–¬“IŠ³ŽÒŽ©ŒÈ’²ß’Á’É–@‚̈À‘S«‚ÌŒŸ“¢. ŒàVW‘ã1, –]ŒŽƒŽq1, ‘同—fŽq1, ‰Í–ìÆŽq1, Îì—²ŽO1, “‡‰ª‹¶1, ŠÖŒû˜aŠé2, ‹àˆä—Y“ñ1, “V–ì@Š®1, ‰Á“¡—¢ŠG3, ŠC–ìM–ç1 (1ŽY‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ67‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/4/9-12), ‰¡•l.

723548. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ÙŽ™ƒwƒŠƒJƒ‹3D-CT‚Æ‘ÙŽ™MRI‚ɂďo¶‘O‚É”n”ö‘ލsÇŒóŒQ (caudal regression syndrome) ‚Ɛf’f‚µ‚œˆê—á. ‹g‘º‰ÃL1, ‹àˆä—Y“ñ1, ‘同—fŽq1, ‰Í–ìÆŽq1, Îì—²ŽO1, “‡‰ª‹¶1, ŒàVW‘ã1, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ67‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/4/9-12), ‰¡•l.

723549. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{èò•”_Œo“à•ª”åŽîᇂɑ΂·‚éWŠw“IŽ¡—Âð’Tõ‚·‚é‘œŽ{Ý‹€“¯ŠÏŽ@Œ€‹†. ÎìŒõ–ç, Š}Œ‚O, ‰Á“¡’B–î, ‰ª“c’qŽu, ‚–쐭Žu, ‰×Œ©‚æ‚€Žq, —é–؉À¢, ’JŒû‹`ŽÀ, ‚‹Žˆê², —L–{‹M‰p, ‹à“c—eG, Šâ“c@‘ì, ¬–ìd–ž1, Ž™‹ÊÈ“ñ, ‹{–{@‹­, ’†Œ@“§, …–ì”ü, ”nê@’·, Œ–{‰À–ç, ’†ˆä‰pŸ, –ì‰ÍF[, —L‹g˜a–ç, ˆäã‹MŽj, ‰¡ŽR³r, âV“¡•¶—_, ì”š‹X‘ã, ‹v‚@˜j, ‰¶“c‹MŽu1, ”ªdŠ~L¶ (1•wl): ‘æ67‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/4/9-12), ‰¡•l.

723550. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{èò‚ª‚ñ‚ɑ΂·‚鍪Ž¡“IRT/CCRTŒã‚ÌŽîᇎc‘¶—á‚É‚š‚¯‚éŽq‹{“Eop‚ÌŽÀŽ{ó‹µ|JCOG•wl‰ÈŽîᇃOƒ‹[ƒv‚É‚š‚¯‚éƒAƒ“ƒP[ƒg’²ž|. •ŒG@F, ‘Ÿ“csM, Š}Œ‚O, ŠŽRL–Ÿ, ì‘º’ŒŽ÷, Šì‘œì—º, ¯Žq’‰G, ‚–ì’‰•v, ’|ŒŽ˜aG, ¬—Ñ—T–Ÿ, ‰¶“c‹MŽu1, ”ªdŠ~L¶ (1•wl): ‘æ67‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/4/9-12), ‰¡•l.

723551. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆÙŠ«”DP‚ɑ΂·‚é”ñŠÏŒŒŽ¡—Â̌Ÿ“¢. –{“c‰ëŽq1, Šâ’[r•ã2, ”‘q²Žq2, ì“à”Žl2, ‰¶“c‹MŽu2, ŠC–ìM–ç3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•wl, 3ŽY‰È): ‘æ67‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/4/9-12), ‰¡•l.

723552. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —‘ŠÇŠÔŽ¿•””DP‚ɑ΂·‚é”ñŠÏŒŒ“IŽ¡—Â̌Ÿ“¢. Šâ’[r•ã1, –{“c‰ëŽq2, ”‘q²Žq1, ì“à”Žl1, ‰¶“c‹MŽu1, ŠC–ìM–ç3 (1•wl, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ŽY‰È): ‘æ67‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/4/9-12), ‰¡•l.

723553. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ÅdÇŒ^ƒ¿ƒTƒ‰ƒZƒ~ƒA¶‘¶—á‚̈â“`Šw“I‰ðÍ. –{“c‰ëŽq1, –]ŒŽƒŽq2, HŽR˜a­3, ŒÏè‰ëŽq3, r–؏®”ü, ‘同—fŽq2, ŠC–ìM–ç2, ‚“cŽj’j1 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŽY‰È, 3¬Ž™): ‘æ39‰ñ“ú–{ˆâ“`ƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ï (2015/6/25-28), ç—t.

723554. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éVŒ^o¶‘OŒŸž‚ÌŒ»ó‚Æ, ƒAƒ“ƒP[ƒg‚©‚ç“Ÿ‚ç‚ê‚œŒŸž‚̎󂯎~‚߁EˆÓŽuŒˆ’è‰ß’ö‚Ì’j—·‚ɂ‚¢‚Ä. r–؏®”ü, •Ÿ“c@—ß, –x‚ ‚·‚©, –]ŒŽƒŽq1, ‚“cŽj’j2 (1ŽY‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ39‰ñ“ú–{ˆâ“`ƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ï (2015/6/25-28), ç—t.

723555. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰–Ž_ƒŠƒgƒhƒŠƒ“’·ŠúŽ‘±Ã–¬“à“Š—^‚̈À‘S«‚ÌŒã•ûŽ‹“IŒŸ“¢. “‡‰ª‹¶1, –]ŒŽƒŽq1, •ž•”‹¿Žq1, ŠÖŒû˜aŠé2, ŒàVW‘ã1, Îì—²ŽO1, ‘同—fŽq1, ‰Í–ìÆŽq1, ‹àˆä—Y“ñ1, ŠC–ìM–ç1 (1ŽY‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ51‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2015/7/10-12), •Ÿ‰ª.

723556. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ñãO–Ñ–Œ“ñ—r–Œ‘o‘Ù, ˆêŽ™”­ˆç•s‘S‚É‚š‚¯‚éV¶Ž™—\Œã‚ÉŠÖ‚·‚錟“¢. ‰Í–ìÆŽq1, “‡‰ª‹¶1, ŒàVW‘ã1, ‘同—fŽq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ51‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2015/7/12), •Ÿ‰ª.

723036. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{“à–ŒÇ‚Ì”­Ç‚É‚š‚¯‚éVEGF1Œ^Žó—e‘Ì‚Ì–ðŠ„. ŠÖŒû˜aŠé1, ×–ì‰Á“ÞŽq2,3, ²“¡ŠG—¢“Þ, a’J³Žj, ŠC–ìM–ç4, ”n“ˆ³—²3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—, 4ŽY‰È): ‘æ36‰ñ“ú–{‰ŠÇÄ¶ˆãŠw‰ï‘‰ï (2015/7/21-22), “Œ‹ž.

723557. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]“]ˆÚ‚ðŠÜ‚Þ‘œ‘ŸŠí“]ˆÚ‚𗈂µ‚È‚ª‚ç—Տ°“IŠ®‘SŠ°‰ð‚ÉŽŠ‚Á‚œ’ᕪ‰»Œ^Žq‹{‘Ì•”—Þ“à–Œ‘BŠà4BŠú‚̈ê—á. àV’n—R‹IŽq1, Šâ£tŽq1, ’†‘ºŠîŠ°1, ŒÃ]–ŸŽq1, ‘P•œ¹–퍁1, ²“¡‰p‹M1, ¬–ìd–ž1, ‚“c‹±b1, Vˆä³G1, ‰¶“c‹MŽu1 (1•wl): ‘æ57‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï (2015/8/7-9), ·‰ª.

723558. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{‘ÌŠà‚̍Ĕ­—lŽ®‚ƍĔ­•”ˆÊ•ÊŽ¡—ЬÑ‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Šâ£tŽq1, ²“¡‰p‹M1, ¬–ìd–ž1, Vˆä@“w1, ‚“c‹±b1, Vˆä³G1, ‰¶“c‹MŽu1 (1•wl): ‘æ57‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï (2015/8/7-9), ·‰ª.

723559. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰ES–[“à‚܂ł̐Ö¬“ài“W‚ð”F‚ß‚œŽq‹{“à–ŒŠÔŽ¿“÷Žî‚̈ê—á. ‰““¡^ˆê1, ‚“c‹±b1, ‹g‘º‰ÃL1, ²“¡‰p‹M1, ¬–ìd–ž1, Šâ£tŽq1, Vˆä³G1, ‰¶“c‹MŽu1 (1•wl): ‘æ57‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï (2015/8/7-9), ·‰ª.

723560. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) CDGP‚ð—p‚¢‚œCCRT‚ÌŒŸ“¢. ‘P•œ¹–퍁1, ‚“c‹±b1, ²“¡‰p‹M1, ¬–ìd–ž1, Šâ£tŽq1, Vˆä³G1, ‰¶“c‹MŽu1 (1•wl): ‘æ57‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï (2015/8/7-9), ·‰ª.

723561. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Žq‹{èò•”_Œo“à•ª”åŽîᇂɑ΂·‚é‘œŽ{Ý‹€“¯ŠÏŽ@Œ€‹†|isŠúÇ—á‚̉ðÍ|. ÎìŒõ–ç, Š}Œ‚O, ’†Œ@“§, …–ì”ü, ”nê@’·, Œ–{‰À–ç, ’†ˆä‰pŸ, –ì‰ÍF[, —L‹g˜a–ç, ˆäã‹MŽj, ‰¡ŽR³r, âV“¡•¶—_, ì”š‹X‘ã, ‹v‚@˜j, ’Óc@‹Ï, •Ÿ‰i^Ž¡, â–{–s•F, ‰Á—ˆPšæ, ‰¶“c‹MŽu1, ”ªdŠ~L¶ (1•wl): ‘æ57‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï (2015/8/7-9), ·‰ª.

723562. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{èò•”_Œo“à•ª”åŽîᇂɑ΂·‚é‘œŽ{Ý‹€“¯ŠÏŽ@Œ€‹†|‘ŠúÇ—á‚̉ðÍ|. ÎìŒõ–ç, Š}Œ‚O, ‰Á“¡’B–î, ‰ª“c’qŽu, ‚–쐭Žu, ‰×Œ©‚æ‚€Žq, —é–؉À¢, ’JŒû‹`ŽÀ, Šâ“c@‘ì, ‚‹Žˆê², —L–{‹M‰p, ‹à“c—eG, ¬–ìd–ž1, Ž™‹ÊÈ“ñ, ‹{–{@‹­, ’Óc@‹Ï, •Ÿ‰i^Ž¡, â–{–s•F, ‰Á—ˆPšæ, ”ªdŠ~L¶ (1•wl): ‘æ57‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï (2015/8/7-9), ·‰ª.

723563. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) • •”–c–ž‚ð10”NŠÔ•ú’u‚µ‚Ä‚¢‚œ’Ž‹‘å—‘‘ƒŠà‚̈ê—á. ŒŽRD1, Vˆä³G1, ²“¡‰p‹M1, ¬–ìd–ž1, ‚“c‹±b1, Šâ£tŽq1, ‰¶“c‹MŽu1 (1•wl): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29-31), ‹ž“s.

723564. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{èòŠàIB2, IIA2, IIBŠúŽèpÇ—á‚̗Տ°“IŒŸ“¢. ‚“c‹±b1, ²“¡‰p‹M1, ‘P•œ¹–퍁1, ¬–ìd–ž1, Šâ£tŽq1, Vˆä³G1, ‰¶“c‹MŽu1 (1•wl): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29-31), ‹ž“s.

723565. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹¹…×–Ef—z«‚ŗՏ°isŠú…¢Šú‚Æ‚È‚Á‚œ—‘‘ƒ”S‰t«‹«ŠEˆ««ŽîᇂÌ1—á. ŒÃì³‹`1, Vˆä³G1, –öàVM”V2, ‘P•œ¹–퍁1, “cŽG—L‹I3, ²“¡‰p‹M1, ¬–ìd–ž1, ‚“c‹±b1, Šâ£tŽq1, ‘º‰_–FŽ÷2, ‰¶“c‹MŽu1 (1•wl, 2•a—, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ54‰ñ“ú–{—Տ°×–EŠw‰ïHŠú‘å‰ï (2015/11/21-22), –ŒŒÃ‰®.

723039. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Host Derived Bone Marrow Cells Expressing Vascular Endothelial Growth Factor Receptor 1 Regulates Growth of Endometrial Tissues and Angiogenesis in a Mouse Transplantation Model. ŠÖŒû˜aŠé1, ×–ì‰Á“ÞŽq2,3, –{“c‰ëŽq1, ì“à”Žl4, ŠC–ìM–ç5, ”n“ˆ³—²3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—, 4•wl, 5ŽY‰È): ‘æ89‰ñ“ú–{–ò—Šw‰ï”N‰ï (2016/3/10), ‰¡•l.

731112. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) —‘‘ƒŽîᇍ‡•¹”DP‚Ì2—á. Šâ£tŽq (•wl): •œ¬27”N“xÃ‰ªŽY‰È•wl‰ÈŠw‰ïŠwpW‰ï (2015/11/15), •lŒ.

731113. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Žq‹{‘Ì‚ª‚ñ‚̍ŋ߂̌XŒü‚Ƙb‘è|f’f‚©‚玡—Â܂Ł| Šâ£tŽq (•wl): Žq‹{‚ª‚ñW’cŒŸfˆãŽtuK‰ï (Ã‰ªŒ§ŽY‰È•wl‰ÈŠw‰ï) (2015/11/15), •lŒ.

733201. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) •Û‘¶“I‚ÉŠÇ—‚µ‚œ—Տ°“I–ü’…‘Ù”Õ‚Ì1—á. “‡‰ª‹¶1, ‹g‘º‰ÃL1, •ž•”‹¿Žq1, ŒàVW‘ã1, ŠÖŒû˜aŠé2, Îì—²ŽO1, ‘同—fŽq1, ‰Í–ìÆŽq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ129‰ñŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2015/6/20-21), “Œ‹ž.

733202. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žqᒔ­ì‚ɑ΂·‚é—°Ž_ƒ}ƒOƒlƒVƒEƒ€Ž¡—ẪsƒbƒgƒtƒH[ƒ‹. ‰““¡^ˆê1, ŠÖŒû˜aŠé2, “‡‰ª‹¶1, ‰Í–ìÆŽq1, ‘同—fŽq1, Îì—²ŽO1, ŒàVW‘ã1, •ž•”‹¿Žq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ‰¶“c‹MŽu3, ŠC–ìM–ç1 (1ŽY‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3•wl): ‘æ373‰ñŽl…‰ï (2015/7/1), “Œ‹ž.

733203. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”DP’†‚É”’ŒŒ•a‚Ɛf’f‚µ‚œ2Ç—á. ˆÉ“¡ŽÀ1, ŒŽRD1, ‘同—fŽq1, ‰Í–ìÆŽq1, Îì—²ŽO1, “‡‰ª‹¶1, ŒàVW‘ã1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ410‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/7/4), ‰¡•l.

733204. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é40ÎˆÈã‚Ì’P‘ُ‰ŽY—á‚ÌŽüŽYŠú—\Œã. ‹g‘º‰ÃL1, ‹gŒŽ@ˆê1, ”‘q²Žq2, Œˆä•¶”T, ˆÀ“¡G”ü, –ì“c–Fl, –]ŒŽˆ€˜Y2 (1ŽY‰È, 2•wl): ‘æ130‰ñŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2015/10/24-25), “Œ‹ž.

733205. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚éƒxƒoƒVƒcƒ}ƒuŽ¡—ÏǗá‚ÌŒŸ“¢. Vˆä@“w1, ‰““¡^ˆê1, Vˆä‰r”ü2, ’F@‰pŽ÷1, –x“cˆ»Žq, âV“¡¶˜N (1•wl, 2ŽY‰È): ‘æ412‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/11/14), ‘Š–Í‘å–ì.

733206. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) WunderlichÇŒóŒQ‚ÆOHVIRA|‚»‚̐f’f‚ÆŽ¡—Á|. ŒŽRD1, ì“à”Žl1, –{“c‰ëŽq2, Šâ’[r•ã1, ”‘q²Žq1, ‰¶“c‹MŽu1, ŠC–ìM–ç3 (1•wl, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ŽY‰È): ‘æ412‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/11/14), ‘Š–Í‘å–ì.

733207. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚à‚â‚à‚â•a‡•¹”DP3Ç—á‚Ì•ª•ØŠÇ—. ˆÉ“¡ŽÀ1, ‘同—fŽq1, “‡‰ª‹¶1, ‰Í–ìÆŽq1, ŒàVW‘ã1, Îì—²ŽO1, ŠÖŒû˜aŠé2, •ž•”‹¿Žq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ412‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/11/14), ‘Š–Í‘å–ì.

733208. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚é150cmˆÈ‰º‚Ì’P‘ُ‰ŽY—á‚ÌŽüŽYŠú—\Œã. ‹g‘º‰ÃL1, ‹gŒŽ@ˆê1, ”‘q²Žq2, Œˆä•¶”T, ˆÀ“¡G”ü, –ì“c–Fl, –]ŒŽˆ€˜Y2 (1ŽY‰È, 2•wl): ‘æ412‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/11/14), ‘Š–Í‘å–ì.

733209. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”DP‰E’†Šú‚ɐ[•”Ã–¬ŒŒðÇ‚𔭏ǂµ‚œ4Ç—á‚ÌŽüŽYŠúŠÇ—. •‰i@’q, ‰Í–ìÆŽq1, ŒàVW‘ã1, “‡‰ª‹¶1, ‘同—fŽq1, Îì—²ŽO1, ŠÖŒû˜aŠé2, •ž•”‹¿Žq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)): ‘æ412‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2015/11/14), ‘Š–Í‘å–ì.

733210. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰ES–[“à‚܂ŐÖ¬“ài“W‚ð”F‚ß‚œŽq‹{“à–ŒŠÔŽ¿“÷Žî‚̈ê—á. ‰““¡^ˆê1, ‚“c‹±b1, ‹g‘º‰ÃL1, ²“¡‰p‹M1, ¬–ìd–ž1, Šâ£tŽq1, Vˆä³G1, ŠC–ìM–ç2, ‰¶“c‹MŽu1 (1•wl, 2ŽY‰È): ‘æ374‰ñŽl…‰ï (2015/12/2), “Œ‹ž.

733211. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •œ¬26”N“x”­Œ©Žq‹{‚ª‚ñÇ—á. Vˆä³G (•wl): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïEŽq‹{‚ª‚ñŒŸf•”‰ï‡“¯Œ€C‰ï (2016/2/17), ‘Š–Í‘å–ì.

733212. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”À‘—Œã‚ÌŒo‰ß. “‡‰ª‹¶ (ŽY‰È): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïEŽq‹{‚ª‚ñŒŸf•”‰ï‡“¯Œ€C‰ï (2016/2/17), ‘Š–Í‘å–ì.

733213. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽüŽYŠúˆã—ÃAƒbƒvƒf[ƒg (•ª•ØŠÄŽ‹‚ÆŠO—ˆ‚Å‚Ì’ˆÓ“_) •a“‚É‚š‚¯‚éŽüŽYŠúˆã—Ã: •ª•ØŠÄŽ‹“lje‰ðà. –]ŒŽƒŽq (ŽY‰È): ‘æ20‰ñ_“ސ쌧Œ§ˆæ’n‹æŽY•wl‰ÈŒ€C‰ï (2016/3/10), ‘Š–Í‘å–ì.

733214. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{ŽèpŒã”DP‚ɑ΂µƒŠƒXƒN•]‰¿‚ƏpŽ®‚É‹ê—¶‚µ‚œˆê—á. çݎ“ޏ”ü, •ž•”‹¿Žq1, ŒàVW‘ã1, “‡‰ª‹¶1, Îì—²ŽO1, ‰Í–ìÆŽq1, ‘同—fŽq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ413‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2016/3/12), ‰¡•l.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H25-320002. [Ç—á•ñ] Žq‹{‚ª‚ñŒŸf‚ÅAGC‚Ɛf’f‚³‚ê‚œ•ª—tó“àèò•”‘B‰ßŒ`¬‚Ì1—á. •ž•”‹¿Žq1, Œˆä•¶”T, ª–{—æŽq, ‘å–ì@•×, ‘å‰ÍŒŽ‘, ’‡“c“TL2, ã–V•qŽq (1ŽY‰È, 2•a—): “ú–{—Տ°×–EŠw‰ï_“ސ쌧Žx•”‰ïŽ 2013/7; 18 (1): 75-80.

H26-120002. [ŒŽ’˜] ‘S‘ŽY•wl‰ÈˆãŽt‚̋Ζ±ŽÀ‘Ô‚ÉŠÖ‚·‚錀‹†|“ú–{ŽY‰È•wl‰ÈŠw‰ïˆã—ÉüŠvˆÏˆõ‰ïE“ú–{ŽY•wl‰Èˆã‰ï‹Î–±ˆã•”‰ï‹€“¯’²ž|. ’†ˆäÍl, ŠC–ìM–ç1 (1ŽY‰È): “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2015/1; 50 (4): 1281-8.

H26-320009. [Ç—á•ñ] Žq‹{‹ØŽîŠjopŒã‚É”­¶‚µ‚œŽq‹{“à–ŒŠÔŽ¿•œŠŠ‹Ø¬‡ŽîᇂÌ1—á. —é–ØŒ€Ž‘, ‚“c‹±b1, “¡ˆä’B–ç, ²ŽR°—º, ”‰ª“Þ‰›, ¬ò”ü“ÞŽq, Š`–ؐ¬Žq, ’†“c^–Ø, ¬“‡rs (1•wl): “Œ‹žŽY‰È•wl‰ÈŠw‰ï‰ïŽ 2014; 63 (2): 255-60.

[Šw‰ïEŒ€‹†‰ï“™]

H19-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{èò•”‚É”­¶‚µ‚œadenoid cystic carcinoma (ACC) ‚Ì1—á. ŠÖŒû˜aŠé1, À“c@Ê1, ¡ˆä@ˆ€1, ¬–ìd–ž1, Šp“cV•œ1, ã–V•qŽq1, ŠC–ìM–ç1 (1ŽY•w): ‘æ380‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n•û•”‰ï (2007/11/11), _“ސì.

H23-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}«äX‰Š‡•¹”DP‚̈ê—á. ŒÃì³‹`1, –]ŒŽƒŽq1, •ž•”‹¿Žq1, ŠÖŒû˜aŠé1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ396‰ñ_“ސ쌧ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2011/11/13), ‘Š–ÍŒŽ.

H24-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MCA-PSV‚ðŽw•W‚Æ‚µ‚œtwin anemia-polycythemia sequence (TAPS) ‚Ì1—á. ‘P•œ¹–퍁1, “‡‰ª‹¶1, –]ŒŽƒŽq1, ‹àˆä—Y“ñ1, “V–ì@Š®1, ‰¶“c‹MŽu2, ŠC–ìM–ç1 (1ŽY‰È, 2•wl): ‘æ401‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ï (2013/3/9), ‰¡•l.

H25-722002. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”DP‚ŒŒˆ³ÇŒóŒQ^”DP‚ŒŒˆ³tÇ‚Ì”DPE•ª•Ø—\Œã. ‰Í–ìÆŽq1, •ž•”‹¿Žq1, “c“‡ˆ»Žq1, “‡‰ª‹¶1, ŒàVW‘ã1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ117‰ñ“ú–{ŽY‰È–ƒŒŠw‰ïŠwpW‰ï (2013/11/30), “Œ‹ž.

H25-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Žq‹{“à—eœ‹ŽpŒã‚É”­¶‚µ‚œŽq‹{“®Ã–¬ŠïŒ`‚̈ê—á. ‰Í–ìÆŽq1, ‹àˆä—Y“ñ1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ86‰ñ“ú–{’Ž‰¹”gˆãŠw‰ïŠwpW‰ï (2013/5/24-26), ‘åã.

H25-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“à–ŒŠà‚É‚š‚¯‚ésurvivin variant forms‚Ì”­Œ»‚ƃKƒ“×–E‘B§Œä‹@\‚É‹y‚Ú‚·‰e‹¿. “cŽG—L‹I1, ŒŽ@“ÖŽq2, ‹Ž‘º”ü‹I3, ŽOŽ}@M2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—, 3Œ`‘ÔŒn): ‘æ102‰ñ“ú–{•a—Šw‰ï‘‰ï (2013/6/6-8), ŽD–y.

H25-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •ª•ØŒãŠë‹@“IoŒŒ‚ɑ΂·‚éŒoƒJƒe[ƒeƒ‹“I“®–¬Çðp (TAE) ‚Ì—L—p«. “‡‰ª‹¶1, ‘P•œ¹–퍁1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ49‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2013/7/14-16), ‰¡•l.

H25-723006. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆêŽ™‚ªDandy WalkerÇŒóŒQ‚̈êãO–Ñ–Œ“ñ—r–Œ‘o‘Ù—á. ŒÃ]–ŸŽq1, –]ŒŽƒŽq1, ‘同—fŽq1, ‹àˆä—Y“ñ1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ49‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2013/7/14-16), ‰¡•l.

H25-723007. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ³ŠúŽYŒoäT•ª•Ø‚É‚š‚¯‚éˆê‰ß«‘œŒÄ‹z‚ÉŠÖ‚·‚錟“¢. ‰Í–ìÆŽq1, “V–ì@Š®1, –]ŒŽƒŽq1, ‹àˆä—Y“ñ1, ‘同—fŽq1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ49‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2013/7/14-16), ‰¡•l.

H25-723008. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘ÙŽ™’†‘å”]“®–¬ŒŒ—¬‘¬“x (MCA-PSV) ‚ðŽw•W‚ÉŠÇ—‚µ‚œTAPS (twin anemia-polycythemia sequence) ‚̈ê—á. ‘P•œ¹–퍁1, “‡‰ª‹¶1, –]ŒŽƒŽq1, ‹àˆä—Y“ñ1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ49‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2013/7/14-16), ‰¡•l.

H25-723009. [Šw‰ï (‘S‘)] ˆê”ÊŒû‰‰) –³’É•ª•Ø‚É‚š‚¯‚éŽq‹{’ꈳ”—–@‚ÌŽÀŽ{ó‹µ‚ƍ‡•¹Ç. ŒàVW‘ã1, ‘同—fŽq1, ‰Í–ìÆŽq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY‰È): ‘æ117‰ñ“ú–{ŽY‰È–ƒŒŠw‰ïŠwpW‰ï (2013/11/30), “Œ‹ž.

H25-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Dienogest“Š—^’†‚ÉŒŒ‰t”Zk‚ð”F‚ß‚œÇ—á‚ÌŒŸ“¢. ‹g‘º‰ÃL1, ì“à”Žl1, ”‘q²Žq1, ‰¬–ì‹|ŠóŽq1, Îì‰ëˆê1, ‰¶“c‹MŽu1, ŠC–ìM–ç2 (1•wl, 2ŽY‰È): ‘æ125‰ñŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2013/6/15-16), “Œ‹ž.

H26-712002. [Šw‰ï (‘Û)] (Oral session) The Effect of Lifestyle Factors on Anti-Mullerian Hormone (AMH) l evels in infertile Japanese women. Nakayama M, Kamisawa E, Kawauchi H1, Asada Y: American Society for Reproductive Medicine (ASRM) 2014 Annual Meeting (2014/10/18-22), hawaii, Honolulu. (ì“à”Žl1: 1•wl)

H26-722002. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Ä”­—‘‘ƒ‚ª‚ñ‚ÌŽ¡—Ð헪|QOL‚̈ێ‚ð–ÚŽw‚µ‚ā|. Šâ£tŽq (•wl): ‘æ66‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2014/4/18-20), “Œ‹ž.

H26-723010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“à–ŒŠà‚É‚š‚¯‚éSurvivin-ƒ¢Ex3‚̃Aƒ|ƒg[ƒVƒX—U“±”\‚̏ؖŸ‚Æ‚»‚Ì•ªŽqƒƒJƒjƒYƒ€‚̉ð–Ÿ. “cŽG—L‹I1, ŒŽ@“ÖŽq2, ŽOŽ}@M2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2•a—): ‘æ103‰ñ“ú–{•a—Šw‰ï‘‰ï (2014/4/26), L“‡.

H26-723011. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) AMH‚ÉŠÖ˜A‚·‚鐶ŠˆKŠµ‚Æ•ê–º‚̐¢‘ãŠÔ”D›s. ãàV‰xŽq, ’†ŽR”ü—R‹I, ì“à”Žl1, ó“c‹`³, ‰–’J‰ë‰p, ‹g“cmH, Œ©”ö•ÛK, –¥‰Y”Ž”V (1•wl): ‘æ59‰ñ“ú–{¶BˆãŠw‰ïŠwpu‰‰‰ïE‘‰ï (2014/12/4-5), “Œ‹ž.

H26-733006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽY•wl‰Èˆã—ÉüŠvƒOƒ‰ƒ“ƒhƒfƒUƒCƒ“2015‚ɂ‚¢‚Ä. ŠC–ìM–ç (ŽY‰È): ‘æ43‰ñ‹{éŒ§ŽüŽYŠúˆã—ͧ˜b‰ïE‘æ595‰ñ‹{éŽY‰È•wl‰ÈŠw‰ïW’k‰ï (2015/1/17), å‘ä.

H26-733007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”DP’†‚ÉŒŽˆö•s–Ÿ‚Ì”w•”’ɂ𗈂œ‚µ‚œ1—á. ‰º“c—²m1, ‹gŒŽ@ˆê1, ”‘q²Žq2, Œˆä•¶”T, ˆÀ“¡G”ü. “cŒû@–Ÿ (1ŽY‰È, 2•wl): ‘æ409‰ñ_“ސìŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï(2015/3/7), ‰¡•l.


®Œ`ŠO‰ÈŠw

[Šwp˜_•¶]

110214. [ŒŽ’˜] Should we use cortical bone screws for cortical bone trajectory? Ueno M, Sakai R1, Tanaka K2, Inoue G3, Uchida K3, Imura T3, Saito W3, Nakazawa T3, Takahira N1, Mabuchi K1, Takaso M3: J Neurosurg Spine 2015/4; 22 (4): 416-21. (Žðˆä—˜“Þ1, “c’†Œ’œ2, ˆäã@Œº3, “à“cŒ’‘Ÿ˜Y3, ˆä‘º‹M”V3, âV“¡@˜j3, ’†àVr”V3, ‚•œ®L1, ”nŸºŽŽ‘1, ‚‘Š»Žm3: 1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3®ŠO)

110215. [ŒŽ’˜] Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder. Saito W1, Uchida K1, Matsushita O, Inoue G1, Sekiguchi H1, Aikawa J2, Fujimaki H2, Takaso M1: J Orthop Surg Res 2015/5; 10: 59. (âV“¡@˜j1, “à“cŒ’‘Ÿ˜Y1, ˆäã@Œº1, ŠÖŒû—T”V1, ‘Šì@~2, “¡ŠªŽõŽq2, ‚‘Š»Žm1: 1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

110216. [ŒŽ’˜] Safety and Efficacy of Continuous Epidural Anesthesia Following Scoliosis Surgery in Respiratory-Impaired Neuromuscular Children: A Pilot Study. Saito W1, Inoue G1, Imura T1, Takenami T2, Ueno M, Nakazawa T1, Uchida K1, Takahira N3, Takaso M1: Spine Deformity 2015/5; 3 (3): 272-6. (âV“¡@˜j1, ˆäã@Œº1, ˆä‘º‹M”V1, ’|˜Q–¯]2, ’†àVr”V1, “à“cŒ’‘Ÿ˜Y1, ‚•œ®L3, ‚‘Š»Žm1: 1®ŠO, 2–ƒŒ, 3ˆã—Éq¶Šw•”)

110217. [ŒŽ’˜] Triclosan-coated sutures reduce wound infections after spinal surgery: a retrospective, nonrandomized, clinical study. Ueno M, Saito W1, Yamagata M, Imura T1, Inoue G1, Nakazawa T1, Takahira N2, Uchida K1, Fukahori N, Shimomura K, Takaso M1: Spine J 2015/5; 15 (5): 933-8. (âV“¡@˜j1, ˆä‘º‹M”V1, ˆäã@Œº1, ’†àVr”V1, ‚•œ®L2, “à“cŒ’‘Ÿ˜Y1, ‚‘Š»Žm1: 1®ŠO, 2ˆã—Éq¶Šw•”)

110218. [ŒŽ’˜] CD11c(+) macrophages and levels of TNF-ƒ¿ and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidaemia. Uchida K1, Satoh M2, Inoue G1, Onuma K1, Miyagi M1, Iwabuchi K2, Takaso M1: Clin Exp Immunol 2015/6; 180 (3): 551-9. (“à“cŒ’‘Ÿ˜Y1, ²“¡@‰ë2, ˆäã@Œº1, ¬ÀŒ«Ž¡1, ‹{é³s1, ŠâŸº˜a–ç2, ‚‘Š»Žm1: 1®ŠO, 2–Ɖu)

110219. [ŒŽ’˜] Loxoprofen sodium and celecoxib for postoperative pain in patients after spinal surgery: a randomized comparative study. Sekiguchi H1, Inoue G2, Nakazawa T2, Imura T2, Saito W2, Uchida K2, Miyagi M2, Takahira N3, Takaso M2: J Orthop Sci 2015/7; 20 (4): 617-23. (ŠÖŒû—T”V1, ˆäã@Œº2, ’†àVr”V2, ˆä‘º‹M”V2, âV“¡@˜j2, “à“cŒ’‘Ÿ˜Y2, ‹{é³s2, ‚•œ®L3, ‚‘Š»Žm2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2®ŠO, 3ˆã—Éq¶Šw•”)

110220. [ŒŽ’˜] Mini-Open Anterior Retroperitoneal Lumbar Interbody Fusion: Oblique Lateral Interbody Fusion for Lumbar Spinal Degeneration Disease. Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Miyagi M1, Kamoda H, Suzuki M, Kubota G, Sakuma Y, Oikawa Y, Inage K, Sainoh T, Sato J, Fujimoto K, Shiga Y, Abe K, Toyone T, Inoue G1, Takahashi K: Yonsei Med J 2015/7; 56 (4): 1051-9. (‹{é³s1, ˆäã@Œº1: 1®ŠO)

110221. [ŒŽ’˜] More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kuniyoshi K, Aoki Y, Nakamura J, Miyagi M1, Suzuki M, Kubota G, Inage K, Sainoh T, Sato J, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Inoue G1, Takahashi K: Asian Spine J 2015/8; 9 (4): 573-80. (‹{é³s1, ˆäã@Œº1: 1®ŠO)

110222. [ŒŽ’˜] Treatment of nocturnal leg cramps by blockade of the medial branch of the deep peroneal nerve after lumbar spine surgery. Imura T1, Inoue G1, Nakazawa T1, Miyagi M1, Saito W1, Uchida K1, Namba T1, Shirasawa E1, Takahira N2, Takaso M1: Brain Behav 2015/9; 5 (9): e00370. (ˆä‘º‹M”V1, ˆäã@Œº1, ’†àVr”V1, ‹{é³s1, âV“¡@˜j1, “à“cŒ’‘Ÿ˜Y1, “ï”gF“¿1, ”’àV‰hŽ÷1, ‚•œ®L2, ‚‘Š»Žm1: 1®ŠO, 2ˆã—Éq¶Šw•”)

110223. [ŒŽ’˜] Anti-RANKL antibodies decrease CGRP expression in dorsal root ganglion neurons innervating injured lumbar intervertebral discs in rats. Sato M, Inage K, Sakuma Y, Sato J, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kuniyoshi K, Aoki Y, Nakamura J, Miyagi M1, Suzuki M, Kubota G, Sainoh T, Fujimoto K, Shiga Y, Abe K, Kanamoto H, Inoue G1, Takahashi K, Ohtori S: Eur Spine J 2015/9; 24 (9): 2017-22. (‹{é³s1, ˆäã@Œº1: 1®ŠO)

110224. [ŒŽ’˜] Efficacy of Direct Injection of Etanercept into Knee Joints for Pain in Moderate and Severe Knee Osteoarthritis. Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Miyagi M1, Kamoda H, Suzuki M, Kubota G, Sakuma Y, Oikawa Y, Inage K, Sainoh T, Sato J, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Toyone T, Inoue G1, Takahashi K: Yonsei Med J 2015/9; 56 (5): 1379-83. (‹{é³s1, ˆäã@Œº1: 1®ŠO)

110225. [ŒŽ’˜] Diffusion tensor imaging of lumbar spinal nerve in subjects with degenerative lumbar disorders. Oikawa Y, Eguchi Y, Inoue G1, Yamauchi K, Orita S, Kamoda H, Ishikawa T, Miyagi M1, Suzuki M, Sakuma Y, Kubota G, Inage K, Saino T, Sato H, Ando H, Kojima M, Okumura K, Masuda Y, Watanabe A, Takahashi K, Ohtori S: Magn Reson Imaging 2015/10; 33 (8): 956-61. (ˆäã@Œº1, ‹{é³s1: 1®ŠO)

110226. [ŒŽ’˜] Interleukin-6 and interleukin-6 receptor expression, localization, and involvement in pain-sensing neuron activation in a mouse intervertebral disc injury model. Sainoh T, Orita S, Miyagi M1, Sakuma Y, Yamauchi K, Suzuki M, Kubota G, Oikawa Y, Inage K, Sato J, Fujimoto K, Shiga Y, Inoue G1, Aoki Y, Takahashi K, Ohtori S: J Orthop Res 2015/10; 33 (10): 1508-14. (‹{é³s1, ˆäã@Œº1: 1®ŠO)

110227. [ŒŽ’˜] Decreased calcitonin gene-related peptide expression in the dorsal root ganglia of TNF-deficient mice in a monoiodoacetate-induced knee osteoarthritis model. Taniguchi A, Ishikawa T, Miyagi M1, Kamoda H, Sakuma Y, Oikawa Y, Kubota G, Inage K, Sainoh T, Nakamura J, Aoki Y, Toyone T, Inoue G1, Suzuki M, Yamauchi K, Suzuki T, Takahashi K, Ohtori S, Orita S: Int J Clin Exp Pathol 2015/10; 8 (10): 12967-71. (‹{é³s1, ˆäã@Œº1: 1®ŠO)

110228. [ŒŽ’˜] Alendronate does not prevent long bone fragility in an inactive rat model. Naruse K1, Uchida K1, Suto M, Miyagawa K, Kawata A, Urabe K1, Takaso M1, Itoman M, Mikuni-Takagaki Y: J Bone Miner Metab 2015/10. [Epub ahead of print] (¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, è•”@Œ›1, ‚‘Š»Žm1: 1®ŠO)

110229. [ŒŽ’˜] Modified Open-Door Laminoplasty Using a Ceramic Spacer and Suture Fixation for Cervical Myelopathy. Ozawa T, Toyone T, Shiboi R, Inada K, Oikawa Y, Takahashi K, Ohtori S, Inoue G1, Miyagi M1, Ishikawa T, Shirahata T, Kudo Y, Inagaki K: Yonsei Med J 2015/11; 56 (6): 1651-5. (ˆäã@Œº1, ‹{é³s1: 1®ŠO)

110230. [ŒŽ’˜] Efficacy of hyaluronic acid or steroid injections for the treatment of a rat model of rotator cuff injury. Yamaguchi T, Ochiai N, Sasaki Y, Kijima T, Hashimoto E, Sasaki Y, Kenmoku T1, Yamazaki H, Miyagi M1, Ohtori S, Takahashi K: J Orthop Res 2015/12; 33 (12): 1861-7. (Œ©–Ú’q‹I1, ‹{é³s1: 1®ŠO)

110231. [ŒŽ’˜] Elution Characteristics of Vancomycin, Gentamicin, and Vancomycin/Gentamicin Combination from Calcium Phosphate Cement. Uchino M1, Sugo K, Naruse K1, Uchida K1, Hirakawa N1, Toyama M1, Miyajima M1, Urabe K1: Advances in Orthopedic Surgery 2015; 2015: Article ID 257925, 5 pages. (“à–쐳—²1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, •œì‹IŽq1, “hŽR³G1, ‹{“‡Œº—z1, è•”@Œ›1: 1®ŠO)

110232. [ŒŽ’˜] Hyaluronic Acid (800 kDa) Supplementation of University of Wisconsin Solution Improves Viability of Osteochondral Grafts and Reduces Matrix Metalloproteinase Expression during Cold Preservation. Yamada T1, Uchida K2, Onuma K2, Inoue G2, Aikawa J1, Takano S1, Sekiguchi H1, Fujimaki H1, Miyagi M2, Takaso M2: Scientific World Journal 2015; 2015: 631369. (ŽR“c‘ñÆ1, “à“cŒ’‘Ÿ˜Y2, ¬ÀŒ«Ž¡2, ˆäã@Œº2, ‘Šì@~1, ‚–쏞‘Ÿ˜Y1, ŠÖŒû—T”V1, “¡ŠªŽõŽq1, ‹{é³s2, ‚‘Š»Žm2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2®ŠO)

110233. [ŒŽ’˜] Synovial macrophage-derived IL-1ƒÀ regulates the calcitonin receptor in osteoarthritic mice. Takano S1, Uchida K1, Miyagi M2, Inoue G2, Aikawa J1, Fujimaki H1, Minatani A2, Sato M3, Iwabuchi K3, Takaso M2: Clin Exp Immunol 2016/1; 183 (1): 143-9. (‚–쏞‘Ÿ˜Y1, “à“cŒ’‘Ÿ˜Y2, ‹{é³s2, ˆäã@Œº2, ‘Šì@~1, “¡ŠªŽõŽq1, “ì’J@~2, ²“¡@‰ë3, ŠâŸº˜a–ç3, ‚‘Š»Žm2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2®ŠO, 3–Ɖu)

120021. [ŒŽ’˜] “Æ•à‰Â”\‚È”]«–ƒáƒŽ™‚̌Ҋ֐ߋü‹ÈSk, ˜’Å‘Oœ^•ÏŒ`‚ɑ΂·‚éŒÒŠÖß‹Ø‰ð—£p‚ÌŒø‰Ê. Œ”ö@“Ä, Œ”ö@—², ‘Šì@~1, Šâ£@‘å2, “¡ŠªŽõŽq1 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2®ŠO): “ú–{”]«–ƒáƒ‚ÌŠO‰ÈŒ€‹†‰ïŽ 2015/6; 25: 5-9.

120022. [ŒŽ’˜] yŒoŒ±‚ƍlŽ@zŽèªŠÇÇŒóŒQ‚ɑ΂·‚ép‘O‚©‚ç‚̃ƒNƒVƒjƒAƒEƒCƒ‹ƒXÚŽí‰Æ“e‰ŠÇ”畆’Šo‰t“Š—^‚Ì—LŒø«‚ÌŒŸ“¢. Œ©–Ú’q‹I1, Šâ‘qØ•äŽq, ¬ÀŒ«Ž¡1, ‚•œ®L2, ‰Á“¡‹`Ž¡, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ®Œ`ŠO‰È 2015/7; 66 (7): 615-9.

120023. [ŒŽ’˜] ‚¢‚í‚ä‚éborderline dysplasia‚ɑ΂·‚éŒÒŠÖß‹ŸŽ‹‰ºŽèp‚ƍœØ‚èp‚ÌŽ¡—ЬÑ‚Ì”äŠr. •Ÿ“‡Œ’‰î1, ‚•œ®L2, “àŽRŸ•¶1, X’JŒõr1, ŽR–{‹–Ÿ1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): Hip Joint 2015/8; 41 (Suppl): 48-50.

120024. [ŒŽ’˜] ŒÒŠÖßœØ‚èp‚Å‹r‰„’·‚à“¯Žž‚ɍs‚Š‚œ3Ç—á. ŽR–{‹–Ÿ1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): Hip Joint 2015/8; 41 (Suppl): 154-8.

120025. [ŒŽ’˜] Š³ŽÒ—§‹rŒ^ŒÒŠÖßŽŸŠ³•]‰¿–@ (JHEQ) ‚ð—p‚¢‚œŒÒŠÖß‰·‘¶Žèp‚ÌŒpŽž“I‚ȗՏ°¬Ñ. X’JŒõr1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, •õŠÝ—mŽŸ˜Y1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): Hip Joint 2015/8; 41 (Suppl): 171-5.

120026. [ŒŽ’˜] ŒÒŠÖßO‘¹Š³ŽÒ‚̉ºŽˆ‹@”\‚ÉŠÖ‚·‚錟“¢|femoroacetabular impingement‚Æ‚»‚Ì‘Œ‚̐¬ˆö‚Å‚Ì”äŠr|. Žsì‹M•¶, š“ߏrŽ÷, …–ìŒö•ã, —é–ؗǘa, •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, ‚‘Š»Žm1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): Hip Joint 2015/8; 41 (Suppl): 304-8.

120027. [ŒŽ’˜] PCRƒ‰ƒeƒ‰ƒ‹ƒtƒ[–@‚ð—p‚¢‚œŒÒŠÖß×‹ÛŒŸž‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢|×‹Û”|—{ŒŸž‚Æ‚Ì”äŠr|. •õŠÝ—mŽŸ˜Y1, “àŽRŸ•¶1, ŽR–{‹–Ÿ1, X’JŒõr1, •Ÿ“‡Œ’‰î1, ‚•œ®L2, Žë–ì—Lì3, Œ‘º–Ÿl, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”, 3—ÕŒŸŠw): Hip Joint 2015/8; 41 (Suppl): 763-8.

120028. [ŒŽ’˜] Ž©‰Æƒnƒ€ƒXƒgƒŠƒ“ƒOƒXäF‚ð—p‚¢‚œ‘«ŠÖß‹ŸŽ‹‰º‘O‹—äCx‘Ñ, æùäCx‘эČšp‚ÌŒoŒ±. “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ŠÖŒû—T”V2, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{‘«‚ÌŠO‰ÈŠw‰ïŽGŽ 2015/9; 36 (1): 189-94.

120029. [ŒŽ’˜] “]ˆÚŒ^‘å‘ڍœèò•”œÜ‚ɑ΂·‚éanterolateral-supine approach‚É‚æ‚élHŒÒŠÖß‘S’uŠ·p‚ÌŒoŒ±. “hŽR³G1, ‹{“‡Œº—z1, •œì‹IŽq1, ¬£NŽ¡1, “à–쐳—²1, è•”@Œ›1 (1®ŠO): “ú–{lHŠÖßŠw‰ïŽ 2015/12; 45: 197-8.

120030. [ŒŽ’˜] “¯ŽíœˆÚAp‚𕹗p‚µ‚œlH•GŠÖßÄ’uŠ·p‚ÌŽ¡—ЬÑ. Šâ£@‘å1, ‘Šì@~2, “ŒŽR—玡1, “ì’J@~1, ‚–쏞‘Ÿ˜Y2, Œ}@@Šw1, ¬£NŽ¡1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{lHŠÖßŠw‰ïŽ 2015/12; 45: 687-8.

120031. [ŒŽ’˜] ã˜rœ‹ßˆÊ•”œÜ‚ɑ΂·‚é“àŒÅ’è–@‚Ì”äŠr. Žðˆä—˜“Þ1, ”nŸºŽŽ‘1, “à–쐳—²2, è•”@Œ›2, ˆÉ“¡‘åŠí, “c’†Œ’œ, ’†”ö«‹P (1ˆã—Éq¶Šw•”, 2®ŠO): œÜ 2016/2; 38 (1): 210-4.

310026. [Ç—á•ñ] Surgical treatment of an atlantoaxial fracture after a delayed diagnosis in a comatose patient. Imura T1, Inoue G1, Nakazawa T1, Saito W1, Takaso M1: Eur Spine J 2015/5; 24 (Suppl 4): S623-7. (ˆä‘º‹M”V1, ˆäã@Œº1, ’†àVr”V1, âV“¡@˜j1, ‚‘Š»Žm1: 1®ŠO)

320028. [Ç—á•ñ] Ž¡—Âɓïa‚µ‚œGaucher•a‚É‚æ‚é•ÏŒ`«ŒÒŠÖßÇ‚ɑ΂µ‚Ä—Œ‘€lHŒÒŠÖß’uŠ·p‚ðŽ{s‚µ‚œ1—á (A case of bilateral total hip arthroplasty in Gaucher disease-related osteoarthritis). ”’àV‰hŽ÷1, ŽR–{‹–Ÿ1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚‘Š»Žm1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ïŽGŽ 2015/4; 46 (2): 80-5.

320029. [Ç—á•ñ] —Œ‘€‚É”­¶‚µ‚œäCœ‹Øáz«G•œ‘«‚ɑ΂µAccessory Anterolateral Talar Facet‚Ì‹ŸŽ‹‰ºØœp‚ª’˜Œø‚µ‚œ1—á. ¯Ži^‘Ÿ˜Y1, “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ŠÖŒû—T”V2, ¬£NŽ¡1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{‘«‚ÌŠO‰ÈŠw‰ïŽGŽ 2015/9; 36 (1): 329-33.

320030. [Ç—á•ñ] —Œ‘€‘«ŠÖßŠO‘€•sˆÀ’èÇ‚ɑ΂µ—Œ‘€“¯Žž‚ÉŽ©‰Æ”–‹ØäF‚É‚æ‚éŠÖß‹Ÿ‰ºATFLÄŒšp‚ðŽ{s‚µ‚œ1—á. ’叡@Ê, “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ŠÖŒû—T”V2, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{‘«‚ÌŠO‰ÈŠw‰ïŽGŽ 2015/9; 36 (1): 345-8.

320031. [Ç—á•ñ] Ž¡—Âɓïa‚µ‚œlH•GŠÖß’uŠ·pŒãè÷ãœÜ‚Ì1—á: “¯ŽíœˆÚA‚ð—p‚¢‚Ă̑Ώˆ. Œ}@@Šw1, Šâ£@‘å1, ‘Šì@~2, “ŒŽR—玡1, “ì’J@~1, ‚–쏞‘Ÿ˜Y2, ¬£NŽ¡1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{lHŠÖßŠw‰ïŽ 2015/12; 45: 585-6.

522116. [uÀ]yŽãƒVƒ“ƒ|ƒWƒEƒ€: ŒÒŠÖß‹Ÿ‚ÌŒ»ó‚Ɖ”\«zFAI‚ÆŠ°œ‰PŒ`¬•s‘S‚Ì•a‘Ô‚ÆŠT”O. •Ÿ“‡Œ’‰î1, ‚•œ®L2, “àŽRŸ•¶1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): —Տ°®Œ`ŠO‰È 2015/5; 50 (5): 405-508.

522117. [uÀ]y“ÁW: lHŠÖßŽüˆÍŠŽõzPJIf’f‚É‚š‚¯‚éV‚µ‚¢•ªŽq¶•šŠw“IŽè–@‚ÌŽŽ‚݁|PCRƒ‰ƒeƒ‰ƒ‹ƒtƒ[–@‚É‚æ‚év‘¬ˆâ“`Žq×‹ÛŒŸž–@|. “àŽRŸ•¶1, ŸNˆäŒc‘¢2, •õŠÝ—mŽŸ˜Y1, ŽR–{‹–Ÿ1, X’JŒõr1, •Ÿ“‡Œ’‰î1, ‚•œ®L3, Žë–ì—Lì4, ‚‘Š»Žm1 (1®ŠO, 2—ÕŒŸ•”, 3ˆã—Éq¶Šw•”, 4—ÕŒŸŠw): ŠÖßŠO‰È 2015/9; 34 (9): 28-34.

522118. [uÀ]y¬“ÁW: R‹Û–òER^‹Û–ò‚ðˆÀ‘S‚ÉŽg‚¢‚±‚È‚·|•›ì—p‚ð–h‚®ÅV’mŒ©‚©‚çzƒŠƒ|ƒyƒvƒ`ƒhŒn–ò: ƒ_ƒvƒgƒ}ƒCƒVƒ“. “àŽRŸ•¶1, ‚ŽR—zŽq2, ‰Ô–؏G–Ÿ (1®ŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŠŽõ‚ƍR‹Û–ò 2015/9; 18 (3): 279-83.

522119. [uÀ]y“ÁW: lHŒÒŠÖß’uŠ·pzœPrimary THA@lHŒÒŠÖßŽüˆÍœÜ‚ɑ΂·‚鎡—ẪRƒc‚ƃsƒbƒgƒtƒH[ƒ‹. “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): Bone Joint Nerve 2015/10; 5 (4): 785-93.

522120. [uÀ]y“ÁW: 3Dƒ‚ƒfƒ‹E3DƒvƒŠƒ“ƒ^[‚ð—˜—p‚µ‚œ®Œ`ŠO‰ÈŽèpzII. ®Œ`ŠO‰È•ª–ì‚ւ̉ž—p@ŒÒŠÖßŠO‰È‚É‚š‚¯‚éŽOŽŸŒ³ƒ‚ƒfƒ‹‚ÌŠˆ—p. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, ‚‘Š»Žm1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ŠÖßŠO‰È 2016/2; 35 (2): 154-9.

530013. [‚»‚Ì‘Œ (Ž˜^)]yThe International Society for Technology in Arthroplasty (ISTA), 27th Annual CongresszHEMIARTHROPLASTY FOR THE TREATMENT OF ELDERLY PROXIMAL HUMERUS PSEUDOARTHROSIS: CASE REPORT. Kenmoku T1, Miyajima G1, Higashiyama R1, Takahira N2, Takaso M1: Bone Joint J 2016/1; 98-B (SUPP 2): 100. (Œ©–Ú’q‹I1, ‹{“‡Œº—z1, “ŒŽR—玡1, ‚•œ®L2, ‚‘Š»Žm1: 1®ŠO, 2ˆã—Éq¶Šw•”)

[’˜@‘]

620090. [Šwp‘ (•ª’SŽ·•M)]yã˜rE•IE‘O˜r‚ÌŽèp@®Œ`ŠO‰ÈŽèpƒCƒ‰ƒXƒgƒŒƒCƒeƒbƒhzI. i“ü–@@ã˜r‚ւ̃Aƒvƒ[ƒ`@ã˜rœœè÷•”‚ւ̃Aƒvƒ[ƒ`, p.2-5. è•”@Œ›1, “à–쐳—²1 (1®ŠO), ‘•ÒW: ŒËŽR–Fº, ê–å•ÒW: ‹à’J•¶‘¥, ’†ŽR‘“X, “Œ‹ž, 2015/6”­s.

620091. [Šwp‘ (•ª’SŽ·•M)]y‘ŸŠíˆÚA‚Æ‚»‚̃R[ƒfƒBƒl[ƒVƒ‡ƒ“ Šî‘b‚©‚牞—p‚܂ŁzŠî‘bˆãŠw@ˆÚA‚ÉŠÖ‚í‚é‘ŸŠí‘gD‚̉ð–U¶—, p.218-22. —Տ°ˆãŠw@‘ŸŠí“Eop‚ƈڐAp‚ÌŽÀÛ, p.500-4. ¬£NŽ¡1, è•”@Œ›1, Ž…–ž·Œ› (1®ŠO), ŠÄC: Ž›‰ª@Œd, •Ò: ‚‹ŽŽj˜N, •Ÿ›ž‹³ˆÌ, ‰¡“c—Ts, ˆ°Š ~‘Ÿ˜Y, ¬’†ßŽq, “ú–{ˆãŠwŠÙ, “Œ‹ž, 2015/6”­s.

620092. [Šwp‘ (•ª’SŽ·•M)]y®Œ`ŠO‰È—̈æ‚É‚š‚¯‚éˆÚAˆã—à (•Êû®Œ`ŠO‰ÈNo.68)zI. ‘˜_@2. “¯ŽíœˆÚA‚ƍœƒoƒ“ƒN@lHŒÒŠÖßÄ’uŠ·p‚É‚š‚¯‚é”F’è‘gDƒoƒ“ƒN‚©‚ç‹Ÿ‹‹‚³‚ê‚œ•Û‘¶“¯Žíœ‚̈À‘S«‚Æ—L—p«, p.59-63. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, •õŠÝ—mŽŸ˜Y1, ˆäã@Œº1, ‚‘Š»Žm1, ‚•œ®L2, Š}ŒŽ‚Ý‚Ç‚è3, Ž…–ž·Œ›3 (1®ŠO, 2ˆã—Éq¶Šw•”, 3–k—¢‘åŠw•a‰@œƒoƒ“ƒN), •Ò: ‘åì@~, “ì]“°, “Œ‹ž, 2015/10”­s.

620093. [Šwp‘ (•ª’SŽ·•M)]y®Œ`ŠO‰È—̈æ‚É‚š‚¯‚éˆÚAˆã—à (•Êû®Œ`ŠO‰ÈNo.68)zI. ‘˜_@2. “¯ŽíœˆÚA‚ƍœƒoƒ“ƒN@–k—¢‘åŠw•a‰@œƒoƒ“ƒN’ñ‹Ÿ“¯Žíœ‚É‚š‚¯‚éƒgƒŒ[ƒTƒrƒŠƒeƒB‚ð—p‚¢‚œˆÀ‘S«‚ÌŒŸØ, p.64-8. •Ÿ“‡Œ’‰î1, ˆäã@Œº1, è•”@Œ›1, “àŽRŸ•¶1, “à“cŒ’‘Ÿ˜Y1, ¬£NŽ¡1, Š}ŒŽ‚Ý‚Ç‚è, Ž…–ž·Œ›, ‚‘Š»Žm1 (1®ŠO), •Ò: ‘åì@~, “ì]“°, “Œ‹ž, 2015/10”­s.

620094. [Šwp‘ (•ª’SŽ·•M)]y‘Ì‘€—Ö@ƒI[ƒ‹ƒuƒbƒN ‚ЂƂ߂ł킩‚éŒø‰Ê“I‚È‹Ø‚ÌŽg‚¢•ûz3Í ŽÀ‘H ‚¢‚Ž‘Ì‘€‚ÌŽw“±@|Œ’N‘i‚Ì‚œ‚ß‚Ì‘Ì‘€|@08. ƒƒRƒ‚‘Ì‘€, p.88-9. •Ÿ“‡Œ’‰î1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”), •Ò: ‚•œ®L2, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712017. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) the current status and trends in bone grafting and the issue of banked bone allografts in Japan based on the sixth nationwide survey of bone grafting from 2010 to 2014. Urabe K1: 24th Congress of the European Association of Tissue Banks (2015/10/1), Spilt, Croatia. (è•”@Œ›1: 1®ŠO)

713077. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A Case Report Of Brodie Abscess Treated With Ankle Arthroscopy And Mini-Open Curettage. Nakawaki M1, Higasiyama R1, Aikawa J2, Iwase D1, Minatani A1, Sekiguchi H2, Takano S2, Takahira N3, Takano S1: Congrs AFJO 2015 Association France-Japon d'OrthopŽdie (2015/6/5), Saint-Malo, France. (’†˜e[Í1, “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ŠÖŒû—T”V2, ‚–쏞‘Ÿ˜Y2, ‚•œ®L3, ‚‘Š»Žm1: 1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”)

713078. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Anatomical Arthroscopic ATFL and CFL Reconstruction Using An Autogenous Hamstring Tendon By 3-portal Technique. Higasiyama R1, Aikawa J2, Iwase D1, Minatani A1, Sekiguchi H2, Yoshihira T1, Nakawaki M1, Watanabe H, Kenmoku T1, Fukushima K1, Takaso M1: Congrs AFJO 2015 Association France-Japon d'OrthopŽdie (2015/6/5), Saint-Malo, France. (“ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ŠÖŒû—T”V2, ‘P•œ“N•v1, ’†˜e[Í1, “n粗T”V, Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚‘Š»Žm1: 1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713079. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Lateral Ligament Reconstruction Of The Ankle Using Bone-Patellar Tendon-Bone Allograft: A Case Report Of Two Patients. Minatani A1, Higasiyama R1, Aikawa J2, Iwase D1, Takano S2, Uchida K1, Watanabe H, Urabe K1, Takaso M1: Congrs AFJO 2015 Association France-Japon d'OrthopŽdie (2015/6/5), Saint-Malo, France. (“ì’J@~1, “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, ‚–쏞‘Ÿ˜Y2, “à“cŒ’‘Ÿ˜Y1, “n粗T”V, è•”@Œ›1, ‚‘Š»Žm1: 1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713080. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Popliteofibular Ligament Reconstruction Using A Remnant Of The Lateral Collateral Ligament: A Report Of Two Cases. Iwase D1, Higasiyama R1, Aikawa J2, Minatani A1, Takano S2, Watanabe H, Uchida K1, Naruse K1, Urabe K1, Inoue G1, Takaso M1: Congrs AFJO 2015 Association France-Japon d'OrthopŽdie (2015/6/5), Saint-Malo, France. (Šâ£@‘å1, “ŒŽR—玡1, ‘Šì@~2, “ì’J@~1, ‚–쏞‘Ÿ˜Y2, “n粗T”V, “à“cŒ’‘Ÿ˜Y1, ¬£NŽ¡1, è•”@Œ›1, ˆäã@Œº1, ‚‘Š»Žm1: 1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713081. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Arthroscopic Anterior Talofibular Ligament Reconstruction And Arthroscopy-Assisted Calcaneofibular Ligament Reconstruction Using An Autogenous Hamstring Tendon. Higasiyama R1, Aikawa J2, Minatani A1, Iwase D1, Sekiguchi H2, Takano S2, Shoji S1, Watanabe H, Kenmoku T1, Fukushima K1, Watanabe E, Takaso M1: 10th Biennial ISAKOS congress 2015 (2015/6/7), Lyon, France. (“ŒŽR—玡1, ‘Šì@~2, “ì’J@~1, Šâ£@‘å1, ŠÖŒû—T”V2, ‚–쏞‘Ÿ˜Y2, ¯Ži^‘Ÿ˜Y1, “n粗T”V, Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, “n糉pˆê˜Y, ‚‘Š»Žm1: 1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713082. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Treatment of nocturnal leg cramps by medial branch blockade of the deep peroneal nerve following lumbar surgery. Imura T1: ISSLS 2015 (2015/6/11), San Francisco, USA (ˆä‘º‹M”V1: 1®ŠO)

713083. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Arthroscopic Anterior Talofibular Ligament Reconstruction with Arthroscopy-Assisted or Arthroscopic Calcaneofibular Ligament Reconstruction Using an Autogenous Hamstirng Tendon. Higasiyama R1, Aikawa J2, Iwase D1, Minatani A1, Yoshihira T1, Sekiguchi H2, Shoji S1, Watanabe H, Kenmoku T1, Fukushima K1, Naruse K1, Urabe K1, Watanabe H, Takaso M1: American Orthopaedic Foot and Ankle Society (AOFAS) Annual Meeting 2015 (2015/7/15), Long Beach, California, USA. (“ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ‘P•œ“N•v1, ŠÖŒû—T”V2, ¯Ži^‘Ÿ˜Y1, “n粗T”V, Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ¬£NŽ¡1, è•”@Œ›1, “n糉pˆê˜Y, ‚‘Š»Žm1: 1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

721016. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ŒÒŠÖß‹Ÿ‚̃ZƒbƒgƒAƒbƒv|ŒÒŠÖßŠO‰Èˆã‚ªŒÒŠÖß‹Ÿ‚ðŽn‚ß‚é‚œ‚ß‚É, ‚»‚µ‚Ä‘±‚¯‚Ä‚¢‚­‚œ‚߂Ɂ|. •Ÿ“‡Œ’‰î (®ŠO): ‘æ42‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2015/10/30), ‘åã.

722079. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘«ŠÖßŒã•ûƒCƒ“ƒsƒ“ƒWƒƒ“ƒgÇŒóŒQ‚Æ‘«ŠÖßŠO‘€•sˆÀ’èÇ‚̍‡•¹—á‚ÌŽ¡—ÃŒoŒ±. “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ŠÖŒû—T”V2, ‘P•œ“N•v1, Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ7‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (JOSKAS) (2015/6/18), ŽD–y.

722080. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) FAI‚ÉŠÖ‚·‚éŒÒŠÖßŠw‰ïf’fŽwj‚ÉŠî‚­‘œŽ{Ý‰uŠw’²ž. •Ÿ“‡Œ’‰î1, ŽRè‘ô–, ¬—Ñ’ŒŽÀ, “¡ˆä‰p‹I, ‹Ž–{TŒá, “¡ˆä­“¿, ’†“‡N°, “àŽRŸ•¶1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ42‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2015/10/30), ‘åã

722081. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Revision THA‚É‚š‚¯‚鍜ƒoƒ“ƒN‚ðŠˆ—p‚µ‚œ‚“xœŒ‡‘¹‘Ώˆ–@. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, •õŠÝ—mŽŸ˜Y1, ˆäã@Œº1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ42‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2015/10/31), ‘åã.

722082. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “–‰È‚É‚š‚¯‚é, lHŒÒŠÖßŠ°œ‰P‘€|ƒZƒƒ“ƒgƒŒƒXƒJƒbƒv‚É‹‚ß‚é‚à‚́|. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, Žðˆä—˜“Þ2, X’JŒõr1, ŽR–{‹–Ÿ1, ”nŸºŽŽ‘2, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ43‰ñ“ú–{ŠÖß•aŠw‰ï (2015/11/5), ŽD–y.

722083. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) lHŒÒŠÖß’uŠ·ppŒãŠŽõ‚ÌŽ¡—Á|R‹Û–òŠÜ—LƒZƒƒ“ƒgƒXƒy[ƒT[‚ð—p‚¢‚œ“ñŠú“IÄ’uŠ·p|. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ŽR–{‹–Ÿ1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ43‰ñ“ú–{ŠÖß•aŠw‰ï (2015/11/6), ŽD–y, ‘æ43‰ñ“ú–{ŠÖß•aŠw‰ïŽ˜^W 2015; p.455.

723566. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`•IŠÖßŽü•ÓœÜ‚ɑ΂·‚éˆêŠú“IlH•IŠÖß’uŠ·p‚ÌŽ¡—ÃŒoŒ±. ¬ÀŒ«Ž¡1, “¡“c@Œì, “àŽRŸ•¶1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): “ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠwpW‰ï (2015/4/25), –ŒŒÃ‰®.

723567. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽOŽŸŒ³‰æ‘œˆ—ƒ[ƒNƒXƒe[ƒVƒ‡ƒ“‚ð—p‚¢‚œŠ°œ‰P«”í•¢‚ÌŒ`‘ÔŒv‘ª|ZedHip‚É‚æ‚鍜«”í•¢‚Æ‚Ì”äŠr|. X’JŒõr1, “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ88‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2015/5/21), _ŒË.

723568. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖß’uŠ·ppŒãŠŽõ‚ɑ΂µƒCƒ“ƒvƒ‰ƒ“ƒg‰·‘¶‚ðŽŽ‚Ý‚œÇ—á‚ÌŒŸ“¢. Šâ£@‘å1, ‘Šì@~2, “ŒŽR—玡1, “ì’J@~1, ‚–쏞‘Ÿ˜Y2, è•”@Œ›1, ¬£NŽ¡1, “¡“c@Œì, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ88‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2015/5/23), _ŒË.

723569. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŠOŒÅ’èŠíMultiPlanar MiniRail‚ðŽg—p‚µ‚œ¬Ž™’‹Œ«žôœ“ª’E‰P‚ɑ΂·‚éŽÚœ‹ž³œØ‚èp‚ÌŽ¡—ÃŒoŒ±. ¬ÀŒ«Ž¡1, ’†˜e[Í1, Œ©–Ú’q‹I1, “¡ŠªŽõŽq2, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ88‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2015/5/23), _ŒË.

723570. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽOŽŸŒ³CT‰æ‘œ‚ð—p‚¢‚œŠ°œ‰P‰ñ“]œØ‚èp (CPO) ‘OŒã‚ÌŠ°œ‰P”í•¢‚Ì’è—Ê“I•]‰¿. “càV@—È1, X’JŒõr1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ88‰ñ“ú–{®Œ`ŠO‰ÈŠwpW‰ï (2015/5/24), _ŒË.

723571. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž©‰Æƒnƒ€ƒXƒgƒŠƒ“ƒOƒXäF‚É‚æ‚éŠÖß‹Ÿ‰ºATFLÄŒšp‚Ɗ֐ߋŸŽx‰‡‰ºCFLÄŒšp. “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ŠÖŒû—T”V2, ‚–쏞‘Ÿ˜Y2, ¯Ži^‘Ÿ˜Y1, “n粗T”V, è•”@Œ›1, “n糉pˆê˜Y, ‚‘Š»Žm1 (11®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ88‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2015/5/24), _ŒË.

723572. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –ì‹…•I‚ƌҊ֐߉“®ˆæ§ŒÀ‚Æ‚ÌŠÖ˜A«‚ÉŠÖ‚·‚錟“¢. Œ©–Ú’q‹I1, –Œ‘q’Œd2, ¬ÀŒ«Ž¡1, ’†˜e[Í1, “càV@—È1, •Ÿ“‡Œ’‰î1, “ŒŽR—玡1, ‚•œ®L3, ‹{“‡Œº—z1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ88‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2015/5/24), _ŒË.

723573. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆãŠw¶‚É‚š‚¯‚鐮Œ`ŠO‰ÈŠw‚Ì”FŽ¯’²ž: ®Œ`ŠO‰È‚ðŽu–]‚·‚é‚«‚Á‚©‚¯‚Í? Œ©–Ú’q‹I1, ‘‘Tˆê˜Y, —é–ؐ’‹v, —é–Ø“Õ–ç, —é–Ø—Ž‘Ÿ˜Y, âŒû@•–, âV“¡ˆŸŠó, –Ø”Š‚ ‚â“ß, ˆäã@Œº1, ’†àVr”V1, ‚‘Š»Žm1 (1®ŠO): ‘æ88‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2015/5/21-24), _ŒË.

723574. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@®Œ`ŠO‰È•a“‚É‚š‚¯‚éƒ_ƒvƒgƒ}ƒCƒVƒ“‚̈À‘S«‚Æ—LŒø«. “àŽRŸ•¶1, ‚ŽR—zŽq2, ‰Ô–؏G–Ÿ, ˜a“c’B•F3, ’†‘º³Ž÷, ²“¡çŒb4, “ñ–{–öL5, ‘åìŒŽ—TŽ÷6, •õŠÝ—mŽŸ˜Y1, »ìŒc‰î7, ‚‘Š»Žm1 (1®ŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3äPŒŽ•aEŠŽõ“à, 4‹~–œ, 5—ÕŒŸ•”, 6–òÜ•”, 7ŠŽõŠÇ—Žº): ‘æ63‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2015/6/5), “Œ‹ž, ‘æ63‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ïŽ˜^W 2015; p.164.

723575. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯‘€lHŒÒŠÖßElH•GŠÖßpŒãŠŽõ‚ɑ΂µ‚Ä‘å‘ڍœ‘S’·‚̍R‹Û–òŠÜ—LƒZƒƒ“ƒgƒXƒy[ƒT[‚ðŽ{s‚µ‚œ1—á. •õŠÝ—mŽŸ˜Y1, “àŽRŸ•¶1, ‚ŽR—zŽq2, ‰Ô–؏G–Ÿ, “ñ–{–öL3, ’†‘º³Ž÷, ²“¡çŒb4, »ìŒc‰î5, ‚‘Š»Žm1 (1®ŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3—ÕŒŸ•”, 4‹~–œ, 5ŠŽõŠÇ—Žº): ‘æ63‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2015/6/5), “Œ‹ž, ‘æ63‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ïŽ˜^W 2015; p.193.

723576. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é•GŠÖß‹ŸSk‚ɑ΂·‚éŠÖß‹ŸŽ‹‰ºŽó“®p‚ÌŽ¡—ЬÑ. Šâ£@‘å1, ‘Šì@~2, “ŒŽR—玡1, “ì’J@~1, ‚–쏞‘Ÿ˜Y2, ¬£NŽ¡1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ7‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (JOSKAS) (2015/6/19), ŽD–y.

723577. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “§ÍŠ³ŽÒ‚É”­¶‚µ‚œ‘å‘ÚŽl“ª‹ØäF’f—ô‚̈ê—á. ‚“c@Œ€1, “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ‘P•œ“N•v1, Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ7‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (JOSKAS) (2015/6/19), ŽD–y.

723578. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€•GŠÖß‹ŸŽèpŒã‚ɐ[•”Ã–¬ŒŒðÇ, ”xÇðÇ‚𔭏ǂµ‚œ1—á. “ì’J@~1, ‘Šì@~2, “ŒŽR—玡1, Šâ£@‘å1, ‚–쏞‘Ÿ˜Y2, ’†˜e[Í1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ7‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (JOSKAS) (2015/6/19), ŽD–y.

723579. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äCœœEì¬‚ðH•v‚µ‚œ‰ð–UŠw“I‹ŸŽ‹‰ºATFL/CFLÄŒšp‚̏¬ŒoŒ±. “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ‘P•œ“N•v1, ŠÖŒû—T”V2, Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ7‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (JOSKAS) (2015/6/19), ŽD–y.

723580. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äF”Â’f—ô‚Æ•ÏŒ`«ŒÒŠÖßÇ‚Ìáu’ɈöŽq‚Ì”äŠr@RT-PCR–@‚ð—p‚¢‚œŒŸ“¢. Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•œ®L2, ’†˜e[Í1, “ŒŽR—玡1, —Ž‡M–õ, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ7‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (JOSKAS) (2015/6/19), ŽD–y.

723581. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯‘€lHŒÒŠÖßlH•GŠÖßpŒãMRSAŠŽõ‚ɑ΂µ‚Ä“ñŠú“I‚ɐlH‘å‘ڍœ’uŠ·p‚ðŽ{s‚µ‚œ1—á. •õŠÝ—mŽŸ˜Y1, “àŽRŸ•¶1, ŽR–{‹–Ÿ1, X’JŒõr1, Šâ£@‘å1, ’†˜e[Í1, •Ÿ“‡Œ’‰î1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ38‰ñ“ú–{œEŠÖßŠŽõÇŠw‰ï (2015/7/3), ì, ‘æ38‰ñ“ú–{œEŠÖßŠŽõÇŠw‰ïŽ˜^W 2015; p.101.

723582. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Propidium monoazide ˆ—‚É‚æ‚莡—ÃŒø‰Ê‚ð”»’è‚Å‚«‚œlHŒÒŠÖßpŒãMRSAŠŽõ‚Ì1—á. “àŽRŸ•¶1, •õŠÝ—mŽŸ˜Y1, ŽR–{‹–Ÿ1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ38‰ñ“ú–{œEŠÖßŠŽõÇŠw‰ï (2015/7/4), ì, ƒvƒƒOƒ‰ƒ€EŽ˜^W 2015; p.135.

723583. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯ŽíœˆÚAp‚̐f—ÕñV‰ü’è‚ÉŒü‚¯‚œ‘̐ς ‚œ‚è‚Ì“¯Žíœ‘gDì»”ï—p‚ÌŽZo. Š}ŒŽ‚Ý‚Ç‚è, “à“cŒ’‘Ÿ˜Y1, ˆäã@Œº1, ‘å’JŒö‹M, “àŽRŸ•¶1, ˆä‘º‹M”V1, •Ÿ“‡Œ’‰î1, ¬£NŽ¡1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO): ‘æ14‰ñ“ú–{‘gDˆÚAŠw‰ï‘‰ïEŠwpW‰ï (2015/8/29), ‘åã.

723584. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯Žíœ•t‚«ƒAƒLƒŒƒXäF‚ð—p‚¢‚œŠÖß‹ŸŽ‹‰º‘O‹—äCx‘эČšp‚ðŽ{s‚µ‚œ1—á. “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ŠÖŒû—T”V2, ‚–쏞‘Ÿ˜Y2, “à“cŒ’‘Ÿ˜Y1, ¬£NŽ¡1, è•”@Œ›1, ˆäã@Œº1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ14‰ñ“ú–{‘gDˆÚAŠw‰ï‘‰ïEŠwpW‰ï (2015/8/29), ‘åã.

723585. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ¶‘̃hƒi[‚©‚çÌŽæ‚µ‚œäFEx‘Ñ‘gDˆÚA‚ÌŒ»ó. ‘å’JŒö‹M, ˆäã@Œº1, “à“cŒ’‘Ÿ˜Y1, “ŒŽR—玡1, “àŽRŸ•¶1, ’†àVr”V1, Œ©–Ú’q‹I1, ¬£NŽ¡1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO): ‘æ14‰ñ“ú–{‘gDˆÚAŠw‰ï‘‰ïEŠwpW‰ï (2015/8/29), ‘åã.

723586. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ð–UŠw“I2d‘©ACLÄŒšp‚É‹ŸŽ‹‰ºALLÄŒšp‚𕹗p‚µ‚œ1—á. “ŒŽR—玡1, ‘P•œ“N•v1, ŠÖŒû—T”V2, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, “n糉pˆê˜Y, “n粗T”V, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ41‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï (2015/9/11), ‹ž“s.

723587. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •GŠÖß‹ŸŽ‹‰º‘OŠO‘€x‘Ñ (ALL) •â‹­p‚ÌCadaver‚Å‚ÌŽŽ‚Ý. “ŒŽR—玡1, “n糉pˆê˜Y, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ‘P•œ“N•v1, ŠÖŒû—T”V2, Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ41‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï (2015/9/11), ‹ž“s.

723588. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÒŠÖß‹ŸŽ‹‰ºŽèpŠ³ŽÒ‚É‚š‚¯‚éáu’É‚ÆŠŠ–Œ“à‰ŠÇ«ƒTƒCƒgƒJƒCƒ“”­Œ»‚ÌŠÖ˜A. •Ÿ“‡Œ’‰î1, ˆäã@Œº1, “¡ŠªŽõŽq2, “à“cŒ’‘Ÿ˜Y1, ‹{é³s1, ŽR–{‹–Ÿ1, X’JŒõr1, “àŽRŸ•¶1, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ30‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2015/10/22), •xŽR.

723589. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÒŠÖß‹ŸŽ‹‰ºŽèp‚É‚š‚¯‚é[•”Ã–¬ŒŒðÇ‚Ì”­¶—Š. •Ÿ“‡Œ’‰î1, ‚•œ®L2, “àŽRŸ•¶1, X’JŒõr1, ŽR–{‹–Ÿ1, Œ©–Ú’q‹I1, “ŒŽR—玡1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ7‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (2015/10/24-25), ŽD–y.

723590. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÒŠÖß‹ŸŽèp‚͌Ҋ֐߉·‘¶Žèp‚Ì1‚‚ɂȂ蓟‚é‚©?|50ÎˆÈã‚ÉŽ{s‚µ‚œŒÒŠÖß‹ŸŽ‹‰ºŽèp‚ÌŽ¡—ЬÑ|. X’JŒõr1, •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, ‚•œ®L2, ŽR–{‹–Ÿ1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ7‰ñ“ú–{ŠÖß‹ŸE•GEƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ï (2015/10/24-25), ŽD–y.

723591. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯ŽíƒAƒLƒŒƒXäF‚ð—p‚¢‚œ‰ð–UŠw“I‹ŸŽ‹‰ºATFLECFLÄŒšp‚ðŽ{s‚µ‚œƒoƒŒƒŠ[ƒi‚Ì1—á. “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ŠÖŒû—T”V2, ‚–쏞‘Ÿ˜Y2, “càV@—È1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ40‰ñ“ú–{‘«‚ÌŠO‰ÈŠw‰ïŠwpW‰ï (2015/10/29), ç—t.

723592. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äCœ‹ØäF’E‰P‚ɑ΂µŒã‘«•”“àŽ‹‹Ÿ‰ºPeroneal Groove Deepening‚ðŽ{s‚µ‚œ1—á. “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ‘P•œ“N•v1, ŠÖŒû—T”V2, ‚–쏞‘Ÿ˜Y2, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ40‰ñ“ú–{‘«‚ÌŠO‰ÈŠw‰ïŠwpW‰ï (2015/10/29), ç—t.

723593. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽOŽŸŒ³‰æ‘œˆ—ƒ[ƒNƒXƒe[ƒVƒ‡ƒ“‚É‚æ‚銰œ‰P‘OEŒã”P‚Ì•]‰¿|³íŒÒ‚ÆŠ°œ‰P‰ñ“]œØ‚èp (CPO) —á‚Æ‚Ì”äŠr|. X’JŒõr1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, •õŠÝ—mŽŸ˜Y1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ42‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2015/10/31), ‘åã, ‘æ42‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ïŽ˜^W 2015; p.488.

723594. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Hip Spine Syndrome: ŒÒŠÖß’É‚ðŽå‘i‚É—ˆ‰@‚µ‚œŠ³ŽÒ‚̐ҒŒƒAƒ‰ƒCƒƒ“ƒg‚ÉŠÖ‚·‚錟“¢. ‹{é³s1, •Ÿ“‡Œ’‰î1, ˆäã@Œº1, ’†àVr”V1, ˆä‘º‹M”V1, âV“¡@˜j1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ49‰ñ“ú–{‘€œ]ÇŠw‰ï (2015/11/5), VŠƒ.

723595. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 2014”N‚Ü‚Å‚Ì4”NŠÔ‚Ì•xŽmŽs’†ŠwZ‰^“®‰ïŽí–ځu‚Þ‚©‚Å‹£‘–v‚ÌŠO’²ž. “ŒŽR—玡1, ¯@‰À–F2, ‘Šì@~3, Šâ£@‘å1, “ì’J@~1, Œ©–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ˆäã@Œº1, “n粗T”V, ‚•œ®L4, ¬–ì‰Ã[, –Ø“‡ä”Ž, “n糉pˆê˜Y, ‚‘Š»Žm1 (1®ŠO, 2‰q¶, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—Տ°ƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï (2015/11/8), _ŒË, “ú–{—Տ°ƒXƒ|[ƒcˆãŠw‰ïŽ 2015/10; 23 (4): S277.

723596. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) d“x”]«–ƒáƒŽ™‚ɑ΂·‚éãŽˆ‹Ø‰ð—£pŽèp‚ÌŒø‰Ê. Œ”ö@“Ä, Œ”ö@—², ‚–ØŒ’Žu, ’Ëvˆä—m•œ, ‘Šì@~1, Šâ£@‘å2, “í–{‘׎m (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2®ŠO): ‘æ26‰ñ“ú–{¬Ž™®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (2015/12/4), Šò•Œ.

723597. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹à‘®ƒAƒŒƒ‹ƒM[Š³ŽÒ‚ɑ΂·‚élH•GŠÖßÄ’uŠ·p‚ÌŒŸ“¢. “ì’J@~1, ‘Šì@~2, “ŒŽR—玡1, Šâ£@‘å1, ‚–쏞‘Ÿ˜Y2, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ46‰ñ“ú–{lHŠÖßŠw‰ï (2016/2/26), ‘åã.

723598. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lHŒÒŠÖßƒZƒƒ“ƒgƒŒƒXƒJƒbƒv‚Ì•\–ÊŒ`ó‚ª‚à‚œ‚ç‚·‰ŠúŒÅ’萫‚Ö‚ÌŒø‰Ê‚ÌŒŸ“¢. •Ÿ“‡Œ’‰î1, Žðˆä—˜“Þ2, “àŽRŸ•¶1, X’JŒõr1, ŽR–{‹–Ÿ1, ‚•œ®L2, ”nŸºŽŽ‘2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{lHŠÖßŠw‰ï (2016/2/27), ‘åã.

723599. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ñŽŸ«•ÏŒ`«ŒÒŠÖßÇ‚ɑ΂·‚éE1ƒ‰ƒCƒi[‚ð—p‚¢‚œTHAŒã‚Ì–€–ÕŒv‘ª|‹à‘®œ“ª‚ƃZƒ‰ƒ~ƒbƒNœ“ª‚Ì‘OŒü‚«–³ìˆ×‰»‘œŽ{Ý‹€“¯Œ€‹†|. ‹Ž@OŽk1, —k@—TŒ’1, FŠ™@—º1, –؉º_ˆê2, ‹àŽq”Ž“¿3, “àŽRŸ•¶4, ‹àŽ¡—L•F5 (1’†’Õa‰@, 2•Ÿ‰ª‘å, 3–k—¢Œ€‹†Š•a‰@, 4®ŠO, 5Œc‘å): ‘æ46‰ñ“ú–{lHŠÖßŠw‰ï (2016/2/27), ‘åã, ‘æ46‰ñ“ú–{lHŠÖßŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2016; 46th: 418.

723600. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’ZŠú‚ŃlƒbƒN‚ªÜ‘¹‚µ‚œModularŒ^ƒZƒƒ“ƒgƒŒƒXlHŒÒŠÖß‚ÌŒŽˆö’²ž‚ƍĔ­–hŽ~ô‚ÌŒŸ“¢. “àŽRŸ•¶1, ŽR–{‹–Ÿ1, X’JŒõr1, •Ÿ“‡Œ’‰î1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1, Gio Rgini Luca2, Pressacco Michele2, ‚•œ®L3 (1®ŠO, 2“ú–{ƒŠƒ}, 3ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{lHŠÖßŠw‰ï (2016/2/27), ‘åã, ‘æ46‰ñ“ú–{lHŠÖßŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2016; 46th: 463.

723601. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‘ڍœ‘oŒ`‘ԂƐlHŒÒŠÖßƒXƒeƒ€ŽüˆÍ•”‚É‚š‚¯‚鉞—Í•ª•z‚ÌŠÖŒW. •Ä”öᩐ³1, ”nŸºŽŽ‘2, Žðˆä—˜“Þ2, ’†”ö«‹P1, ‚•œ®L2, “àŽRŸ•¶3, •Ÿ“‡Œ’‰î3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3®ŠO): ‘æ46‰ñ“ú–{lHŠÖßŠw‰ï (2016/2/27), ‘åã, ‘æ46‰ñ“ú–{lHŠÖßŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2016; 46th: 475.

723602. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶•šŠw“I»ÜŽg—p‚É”º‚€lHŒÒŠÖß’x”­«ŠŽõ‚ð‹^‚Á‚œÇ—á‚ÌŒŸ“¢. X’JŒõr1, “àŽRŸ•¶1, •õŠÝ—mŽŸ˜Y1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{lHŠÖßŠw‰ï (2016/2/27), ‘åã, ‘æ46‰ñ“ú–{lHŠÖßŠw‰ïŽ˜^W 2016; p.563.

723603. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÒŠÖß’É‚ð—L‚·‚銳ŽÒ‚̐ҒŒƒAƒ‰ƒCƒƒ“ƒg: Hip Spine Syndrome‚Ì•a‘Ô‚ÉŠÖ‚·‚錟“¢. ‹{é³s1, •Ÿ“‡Œ’‰î1, ˆäã@Œº1, ’†àVr”V1, ˆä‘º‹M”V1, âV“¡@˜j1, “ï”gF“¿1, ”’àV‰hŽ÷1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ6‰ñ“ú–{¬lÒ’Œ•ÏŒ`Šw‰ï (2016/3/12), VŠƒ.

723604. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÒŠÖß’ÉŠ³ŽÒ‚É‚š‚¯‚鍜”ÕŒXŽÎŠp‘ª’èŒë·‚ÉŠÖ‚·‚錟“¢. ¯Ži^‘Ÿ˜Y1, ‹{é³s1, •Ÿ“‡Œ’‰î1, ˆäã@Œº1, ’†àVr”V1, ˆä‘º‹M”V1, âV“¡@˜j1, “ï”gF“¿1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ6‰ñ“ú–{¬lÒ’Œ•ÏŒ`Šw‰ï (2016/3/12), VŠƒ.

723605. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬lÒ’Œ•ÏŒ`Žèp‚É‚š‚¯‚épŒã–ž‘«“x‚ÉŠÖ‚·‚錟“¢. “ï”gF“¿1, ˆäã@Œº1, ’†àVr”V1, ˆä‘º‹M”V1, ‹{é³s1, âV“¡@˜j1, ”’àV‰hŽ÷1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ6‰ñ“ú–{¬lÒ’Œ•ÏŒ`Šw‰ï (2016/3/12), VŠƒ.

731114. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬£NŽ¡ (®ŠO): é‹ÊŒ§‘å‹{ŽsˆãŽt‰ïŠwpu‰‰‰ï (2015/4/1), ‚³‚¢‚œ‚Ü.

731115. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬£NŽ¡ (®ŠO): ‘æ3‰ñé‹Ê‰^“®Šíáu’ɃZƒ~ƒi[ (2015/4/8), é‹Ê.

731116. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) FAI‚ÆŠ°œ‰PŒ`¬•s‘S‚Ì•a‘Ô”cˆ¬. •Ÿ“‡Œ’‰î (®ŠO): Hip arthroscopy basic course (2015/4/11), “Œ‹ž.

731117. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) FAI‚ÌŠT”O‚Ɛf’f. •Ÿ“‡Œ’‰î (®ŠO): Hip arthroscopic basic course (2015/4/11), “Œ‹ž.

731118. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŒÒŠÖßŠO‰Èˆã‚ªŒÒŠÖß‹Ÿ‚ð‚·‚éˆÓ–¡‚Æ‚»‚Ì‚œ‚߂̏€”õ. •Ÿ“‡Œ’‰î (®ŠO): Hip arthroscopic basic course (2015/4/11), “Œ‹ž.

731119. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬£NŽ¡ (®ŠO): L“‡Œ§—Տ°®Œ`ŠO‰Èˆã‰ï (2015/4/11), L“‡.

731120. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚—îŽÒœ‘e頏ǂ̓Á’¥‚ƏT1‰ñƒeƒŠƒpƒ‰ƒ`ƒhŽ¡—Á|œÜŽ¡–ü‘£iŒø‰Ê‚𒆐S‚Ɂ|. ¬£NŽ¡ (®ŠO): ‘æ1‰ñœ‘e頏ǐ«œÜ—\–hƒZƒ~ƒi[ (2015/6/11), ˆïé.

731121. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Evidence‚©‚ç‚Ý‚éFAI. •Ÿ“‡Œ’‰î (®ŠO): ‘æ9‰ñOsaka hip meeting under 50 (2015/9/12), ‘åã.

731122. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰ºŽˆ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. “ŒŽR—玡 (®ŠO): ‘æ8‰ñƒZƒ‰ƒsƒXƒgŽ‘ŠiŒp‘±Œ€C‰ï (2015/10/10), ç—t.

731123. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŒÒŠÖßŠO‰Èˆã‚ªs‚€ŒÒŠÖß‹Ÿ|“K‰ž”»’f, ƒZƒbƒgƒAƒbƒv, ŽèpŽè‹Z|. •Ÿ“‡Œ’‰î (®ŠO): ŒÒŠÖßŽáŽè‚̉ï 2015 (2015/11/28), “Œ‹ž.

732050. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) allograft‚ł̉ð–UŠw“IACLÄŒšp‚̍H•v. “ŒŽR—玡 (®ŠO): ‘æ31‰ñ_“ސ쐮Œ`ŽèpŽè‹ZŒ€‹†‰ï (2015/6/12), ‰¡•l.

732051. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŠÖßƒŠƒEƒ}ƒ`ŽèŽwŽÚ‘€•ÎˆÊ‚ɑ΂·‚鎡—Ð헪. ¬ÀŒ«Ž¡1, “¡“c@Œì, “c“‡Gˆê˜Y1, “¡ŠªŽõŽq2, Œ©–Ú’q‹I1, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ115‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï (2015/9/5), ‰¡•l.

732052. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “]ˆÚ«Ò’ÅŽîᇂɑ΂·‚éŽèp¬Ñ. ˆä‘º‹M”V1, ˆäã@Œº1, ’†àVr”V1, ‹{é³s1, “ï”gF“¿1, ’†˜e[Í1, ‚‘Š»Žm1 (1®ŠO): ‘æ156‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï (2016/3/12), ‰¡•l.

733215. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’ZŠúŠÔ‚Ì‚€‚¿‚ɐL‹ØäF’E‰P‚É‚æ‚éŽèŽwL“WáŠQ‚𐶂¶‚œŠÖßƒŠƒEƒ}ƒ`‚Ì1—á. “c“‡Gˆê˜Y1, ¬ÀŒ«Ž¡1, ‚‘Š»Žm1 (1®ŠO): –k‘Š®Œ`ŠO‰ÈŒ€‹†‰ï (2015/6/11), ‘Š–ÍŒŽ.

733216. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰»Šw•šŽ¿‰ß•qÇ‚ð‡•¹‚µ‚œŠ³ŽÒ‚̐lHŒÒŠÖßÄ’uŠ·p‚ðŽ{s‚µ‚œ1—á. ‘º“cK—C1, •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, ŽR–{‹–Ÿ1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ïŒŽ—á‰ï‘æ677‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï (2015/6/27), “Œ‹ž.

733217. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯‘€lHŒÒŠÖßElH•GŠÖßpŒãMRSAŠŽõ‚ɑ΂µ‚Ä“ñŠú“IlH‘å‘ڍœ‘S’uŠ·p‚ðŽ{s‚µ‚œ1—á. •õŠÝ—mŽŸ˜Y1, “àŽRŸ•¶1, ŽR–{‹–Ÿ1, X’JŒõr1, •Ÿ“‡Œ’‰î1, ‚‘Š»Žm1, ‚ŽR—zŽq2, ˜a“c’B•F3, “ñ–{–öL4, ‚•œ®L5, ‰Ô–؏G–Ÿ (1®ŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3äPŒŽ•aEŠŽõ“à, 4—ÕŒŸ•”, 5ˆã—Éq¶Šw•”): MRSAƒtƒH[ƒ‰ƒ€ (2015/7/11), “Œ‹ž.

733218. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lHŒÒŠÖß‚ª‰·‘¶‚Å‚«‚œpŒã‘ŠúMRSAŠŽõ‚Ì2—á. “àŽRŸ•¶1, ‚ŽR—zŽq2, ‰Ô–؏G–Ÿ, X’JŒõr1, ˜a“c’B•F3, “ñ–{–öL4, ŸNˆäŒc‘¢4, “¡–Ø‚­‚ÉŽq5, ’†‘º³Ž÷6, ²“¡çŒb7, ‘åìŒŽ—TŽ÷8, »ìŒc‰î5, ‚‘Š»Žm1 (1®ŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3äPŒŽ•aEŠŽõ“à, 4—ÕŒŸ•”, 5ŠŽõŠÇ—Žº, 6ˆã—Éq¶Šw•”, 7‹~–œ, 8–òÜ•”): MRSAƒtƒH[ƒ‰ƒ€2015 (2015/7/11), “Œ‹ž.

733219. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ®Œ`ŠO‰ÈŽŸŠ³‚É‚š‚¯‚éMRSAŠŽõ‚ɑ΂·‚éƒoƒ“ƒRƒ}ƒCƒVƒ“‚Ì—LŒø«. “c“‡Gˆê˜Y1, “àŽRŸ•¶1, ŽR–{‹–Ÿ1, X’JŒõr1, •Ÿ“‡Œ’‰î1, ‚‘Š»Žm1, ‚ŽR—zŽq2, ˜a“c’B•F3, “ñ–{–öL4, ‚•œ®L5, ‰Ô–؏G–Ÿ (1®ŠO, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3äPŒŽ•aEŠŽõ“à, 4—ÕŒŸ•”, 5ˆã—Éq¶Šw•”): MRSAƒtƒH[ƒ‰ƒ€2015 (2015/7/11), “Œ‹ž.

733220. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lHŠÖß’uŠ·pŒã‚ÌŠŽõ‚ɑ΂·‚é“–‰@‚Å‚ÌŽŽ‚Ý. “àŽRŸ•¶ (®ŠO): ‘æ2‰ñMRSAŠŽõÇƒZƒ~ƒi[ (2015/7/17), ‰¡•l.

733221. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖß‰·‘¶Žèp (time saving surgery) ‚ƈʒu‚¯‚ç‚ê‚éŒÒŠÖß‹ŸŽ‹‰ºŽèp. •Ÿ“‡Œ’‰î1, ‚•œ®L2, “àŽRŸ•¶1, X’JŒõr1, ŽR–{‹–Ÿ1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ23‰ñHip Forum (2015/7/31), _ŒË, ‘æ23‰ñHip ForumŽ˜^W 2015; p.21.

733222. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž„‚͋‰çˆÊBauerƒAƒvƒ[ƒ`‚©‚ç‹Â‰çˆÊ‘O‘€•ûƒAƒvƒ[ƒ`‚Ö•Ï‚Š‚œ. ‚•œ®L1, •Ÿ“‡Œ’‰î2, ŽR–{‹–Ÿ2, X’JŒõr2, “àŽRŸ•¶2 (1ˆã—Éq¶Šw•”, 2®ŠO): ‘æ23‰ñHip Forum (2015/7/31), _ŒË, ‘æ23‰ñHip ForumŽ˜^W 2015: p.36.

733223. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒeƒƒCƒh«•Gœ‰óŽ€‚É‚æ‚éL”͈͍œ“Œ‡‘¹‚ɑ΂·‚鎩‰Æœ“ˆÚAp‚ÌŽ¡—ЬÑ. •œì‹IŽq1, ¬£NŽ¡1, “ì’J@~1, “ŒŽR—玡1, Šâ£@‘å1, “hŽR³G1, ‹{“‡Œº—z1, “à–쐳—²1, ‚‘Š»Žm1, è•”@Œ›1 (1®ŠO): ‘æ64‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2015/9/11), •Ÿ“‡.

733224. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lHŠÖßŽüˆÍŠŽõ‚É‚š‚¯‚é16SƒŠƒ{ƒ][ƒ€RNA—z«—á‚̃V[ƒPƒ“ƒX‰ðÍ‚É‚æ‚é‹N‰Š‹ÛŒŸõ‚ÌŽŽ‚Ý. “àŽRŸ•¶1, ŸNˆäŒc‘¢2, •õŠÝ—mŽŸ˜Y1, X’JŒõr1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, Žë–ì—Lì3, ‚•œ®L4, ‚‘Š»Žm1 (1®ŠO, 2—ÕŒŸ•”, 3—ÕŒŸŠw, 4ˆã—Éq¶Šw•”): ‘æ64‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2015/9/11), •Ÿ“‡, “Œ“ú–{®Ð‰ïŽ 2015; 27 (3): 293.

733225. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰E‰ºŽˆ“®Ã–¬ŠïŒ`‚𔺂Á‚œ•ÏŒ`«ŒÒŠÖßÇ‚ɑ΂µlHŒÒŠÖß‘S’uŠ·p‚ðŽ{s‚µ‚œ1—á. ‘å’|—IÆ1, “àŽRŸ•¶1, X’JŒõr1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, •“cW‹`1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ64‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2015/9/11), •Ÿ“‡, “Œ“ú–{®Ð‰ïŽ 2015; 27 (3): 298.

733226. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÒŠÖßŒã•û’E‰P‚𔺂€‘å‘ڍœœ“ªœÜ‚ɑ΂µsurgical dislocation‚ð—p‚¢‚œœÚ‡pŒã‚ɐ¶‚¶‚œ•ÏŒ`«ŒÒŠÖßÇ‚Ì1—á. •“cW‹`1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, ‘å’|—IÆ1, ’†˜e[Í1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ64‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2015/9/11), •Ÿ“‡, “Œ“ú–{®Ð‰ïŽ 2015; 27 (3): 301.

733227. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’ZŠúŠÔ‚Ì‚€‚¿‚ɐL‹ØäF’E‰P‚É‚æ‚éŽèŽwL“WáŠQ‚𐶂¶‚œŠÖßƒŠƒEƒ}ƒ`‚Ì1—á. “c“‡Gˆê˜Y1, ¬ÀŒ«Ž¡1, Œ©–Ú’q‹I1, “¡ŠªŽõŽq2, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ64‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2015/9/11), •Ÿ“‡.

733228. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÒŠÖßO‘¹Š³ŽÒ‚ÌŽ¡—Õûj‚ÌŒˆ’è‚Épain DETECT‚ª—L—p‚Å‚ ‚Á‚œ1—á. ’†˜e[Í1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ŽR–{‹–Ÿ1, “àŽRŸ•¶1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ11‰ñ“ú–{ŒÒŠÖß‹ŸŒ€‹†‰ï (2015/9/5), ‰ªŽR

733229. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Pincer•ÏŒ`‚𔺂€ŠŠ–Œ«œ“ŽîÇ‚ɑ΂·‚鎡—ÃŒoŒ±. X’JŒõr1, •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, ŽR–{‹–Ÿ1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ11‰ñ“ú–{ŒÒŠÖß‹ŸŒ€‹†‰ï (2015/9/5), ‰ªŽR.

733230. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖß‰tCRP’l‘ª’è‚͐lHŠÖßŽüˆÍŠŽõÇ‚̐f’f‚É—L—p‚©? •õŠÝ—mŽŸ˜Y1, “àŽRŸ•¶1, ŸNˆäŒc‘¢2, ŽR–{‹–Ÿ1, X’JŒõr1, •Ÿ“‡Œ’‰î1, Šâ£@‘å1, Žë–ì—Lì3, ‚•œ®L4, ‚‘Š»Žm1 (1®ŠO, 2—ÕŒŸ•”, 3—ÕŒŸŠw, 4ˆã—Éq¶Šw•”): ‘æ43‰ñŠÖ“ŒŒÒŠÖß§˜b‰ï (2015/9/26), “Œ‹ž.

733231. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) JefferyŒ^œÜ‚ɍ‡•¹‚µ‚œ“à‘€ãè÷‹UŠÖß‚ɑ΂µ‹UŠÖßŽèp‚ðs‚Á‚œ1—á. ¬ŽR’q‹v1, ¬ÀŒ«Ž¡1, Œ©–Ú’q‹I1, ‚“c@Œ€1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ21‰ñ_“ސìãŽˆŠO‰ÈŒ€‹†‰ï (2015/10/17), ‰¡•l.

733232. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽOŽŸŒ³‘ª’è‚ð—p‚¢‚œŒÒŠÖß‚É“­‚­—Í‚Ì’è—Ê•]‰¿‚Ö‚Ì’§í. Šâ£@‘å1, ‘Šì@~2, “¡ŠªŽõŽq2, “ŒŽR—玡1, “ì’J@~1, ‚‘Š»Žm1, Œ”ö@—², Œ”ö@“Ä, ]’[ˆê”Ž (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ32‰ñ“ú–{”]«–ƒáƒ‚ÌŠO‰ÈŒ€‹†‰ï (2015/10/17), ‘åã.

733233. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]«–ƒáƒë‘«•ÏŒ`‚ɑ΂·‚鉺‘ÚŽO“ª‹Ø‰„’·pŒã‚Ìæù‘«•ÏŒ`. Œ”ö@“Ä, Œ”ö@—², ‚–ØŒ’Žu, ‘Šì@~1, Šâ£@‘å2, “¡ŠªŽõŽq1, “í–{‘׎m (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2®ŠO): ‘æ32‰ñ“ú–{”]«–ƒáƒ‚ÌŠO‰ÈŒ€‹†‰ï (2015/10/17), ‘åã.

733234. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •GŠÖßŒã•ûŠÖß”X“à‚É‘¶Ý‚·‚éŠÖß“à—V—£‘̂ɑ΂µŠÖß‹ŸŽ‹‰º“Eop‚ðs‚Á‚œ2—á. è•”@Œ›1, “à–쐳—²1, •œì‹IŽq1, “hŽR³G1, ‹{“‡Œº—z1 (1®ŠO): –k‘«—§ŒSŽsˆãŽt‰ïˆãŠw‰ï (2015/10/17), é‹Ê.

733235. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠO«L”͈͓Œ‡‘¹‚ɑ΂µŽ©‰Æ”|—{“×–EˆÚAp‚ðs‚Á‚œ2—á. è•”@Œ›1, ¬£NŽ¡1, “à–쐳—²1, •œì‹IŽq1, “hŽR³G1, ‹{“‡Œº—z1 (1®ŠO): –k‘«—§ŒSŽsˆãŽt‰ïˆãŠw‰ï (2015/10/17), é‹Ê.

733236. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 12Î”­Ç, L”͈͉󎀃yƒ‹ƒeƒX•a‚ÉŽ{s‚µ‚œ“à”œ‰ñ“]œØ‚èp (ROWO) ‚Ì1—á. •õŠÝ—mŽŸ˜Y1, “àŽRŸ•¶1, X’JŒõr1, ŽR–{‹–Ÿ1, •Ÿ“‡Œ’‰î1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ13‰ñŒÒOsteotomy‚ðŒê‚é‰ï (2015/10/31), ‘åã.

733237. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÒŠÖß‹ŸŽ‹‰º‚ɉÁ—µ‚œF‘f«ãO–ÑŒ‹ß«ŠŠ–Œ‰Š‚Ì1—á. •“cW‹`1, •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, ŽR–{‹–Ÿ1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ47‰ñ–kE‘Š®Œ`ŠO‰Èˆã‰ï (2015/11/19), ‘Š–ÍŒŽ.

733238. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •GŠWœ’E‰P‚Æ‘O\ŽšèՑђf—ô‚𓯎ž‚Ɏ󏝂µ‚œˆêÇ—á. ‘º“cK—C1, “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ¬ŽR’q‹v1, •“cW‹`1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): –k‘Š®Œ`ŠO‰Èˆã‰ï (2015/11/19), ‘Š–ÍŒŽ.

733239. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äF”Â’f—ô‚Æ•ÏŒ`«ŒÒŠÖßÇ‚Ìáu’ɈöŽq‚Ì”äŠr. Œ©–Ú’q‹I1, ‹{é³s1, “ŒŽR—玡1, ˆäã@Œº1, ‚‘Š»Žm1 (1®ŠO): ‘æ1322‰ñç—tˆãŠwŠE®Œ`ŠO‰È—á‰ï (2015/12/6), ç—t.

733240. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •GŠWœ’E‰P‚Æ‘O\Žšx‘Ñ’f—ô‚𓯎ž‚Ɏ󏝂µ‚œ1Ç—á. ‘º“cK—S1, “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, “ì’J@~1, ¬ŽR’q‹v1, •“cW‹`1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ679‰ñŠÖ“Œ®ÐŠOŠO‰ÈŠw‰ï@ŒŽ—á‰ï (2015/12/19), “Œ‹ž.

733241. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ceramic-on-polyethylene THApŒã‚ɍœ—n‰ð‚𔺂€“î•”‘gD•a•Ï‚𐶂¶‚œ1—á. X’JŒõr1, “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, •õŠÝ—mŽŸ˜Y1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ56‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2016/3/25), •iì, ŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ïŽGŽ 2016/3; 47 (—ÕŽž‘Š§): 64.

733242. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 12Î”­Ç, L”͈͉󎀃yƒ‹ƒeƒX•a‚ɑ΂µ‚Ä“à”œ‰ñ“]œØ‚èp‚ðŽ{s‚µ‚œ1—á. “àŽRŸ•¶1, •õŠÝ—mŽŸ˜Y1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ŽR–{‹–Ÿ1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ56‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2016/3/25), •iì, ŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ïŽGŽ 2016/3; 47 (—ÕŽž‘Š§): 65.

733243. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”–‹ØäF‚ð—p‚¢‚œ‹ŸŽ‹‰ºŒã‹—äCèՑэȚp‚Ìcadaver‚Å‚ÌŽŽ‚Ý. “ŒŽR—玡1, ‘Šì@~2 Šâ£@‘å1, “ì’J@~1, ¯Ži^‘Ÿ˜Y1, ‚‹ŽŒª“ñ, “y‰®–ŸO, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ56‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2016/3/25), •iì.

733244. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 85ÎˆÈã‚Ì’Ž‚—îŽÒ‚ɑ΂·‚élH•GŠÖß‘S’uŠ·p‚Ì’ZŠú¬Ñ. •“cW‹`1, Šâ£@‘å1, ‘Šì@~2, “ŒŽR—玡1, “ì’J@~1, ‚–쏞‘Ÿ˜Y2, ¬ŽR’q‹v1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ56‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2016/3/26), •iì.

733245. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯Žíœ•t‚«•GŠWäF‚ð—p‚¢‚œ’·•ûŒ`œE‘O\ŽšèՑэȚpŒã‚Ì•G‹Ø—Í‚ÌŒŸ“¢. “ì’J@~1, “ŒŽR—玡1, ‘Šì@~2, Šâ£@‘å1, ‚–쏞‘Ÿ˜Y2, “à“cŒ’‘Ÿ˜Y1, ˆäã@Œº1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ56‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2016/3/26), •iì.

733246. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`ŽèŠÖß•a•Ï‚ɑ΂·‚éWrist fusion rod—p‚¢‚œŽèŠÖß‘SŒÅ’èp‚ÌŽ¡—ÃŒoŒ±. ¬ÀŒ«Ž¡1, “¡“c@Œì, Œ©–Ú’q‹I1, •ì_Žm1, “¡ŠªŽõŽq2, ‚•œ®L3, ‚‘Š»Žm1 (1®ŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ56‰ñŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ï (2016/3/26), •iì.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-110015. [ŒŽ’˜] Effectioveness of deep peronel nerve block for the manegement of lumbar disease with leg cramps. Imura T1, Inoue G1, Nakazawa T1, Ueno M, Saito W1. Uchida K1, Adachi K, Takahira N2, Takaso M1: Journal of spine research 2015/2; 6 (2): 119-24. (ˆä‘º‹M”V1, ˆäã@Œº1, ’†àVr”V1, âV“¡@˜j1. “à“cŒ’‘Ÿ˜Y1, ‚•œ®L2, ‚‘Š»Žm1: 1®ŠO, 2ˆã—Éq¶Šw•”)

[Šw‰ïEŒ€‹†‰ï“™]

H26-731002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬£NŽ¡ (®ŠO): ”ªŒË®Œ`ŠO‰Èˆã‰ïŠwpu‰‰‰ï (2014/7/9), ”ªŒË.


Œ`¬ŠO‰ÈE”ü—eŠO‰ÈŠw

[Šwp˜_•¶]

110234. [ŒŽ’˜] Free flap transfer to preserve main arterial flow in early reconstruction of open fracture in the lower extremity. Nemoto M1, Ishikawa S1, Kounoike N1, Sugimoto T1, Takeda A1: Plast Surg Int 2015; 2015: 213892. (ª–{@[1, ÎìS‰î1, ƒ’r“Þ’ÃŽq1, ™–{F”V1, •“c@Œ[1: 1Œ`¬E”üŠO)

110235. [ŒŽ’˜] Clinical features of primary vein grafts in free tissue transfers. Nemoto M1, Kumazawa K2, Uchinuma E, Kounoike N1, Takeda A1: Plast Surg Int 2015; 2015: 481402. (ª–{@[1, ŒFàVŒ›ˆê2, “àÀ‰hŽ÷, ƒ’r“Þ’ÃŽq1, •“c@Œ[1: 1Œ`¬E”üŠO, 2‹~–œ)

110236. [ŒŽ’˜] Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia. Yoshitake T, Takeda A1, Ohki K, Inoue Y, Yamawaki T, Otsuka S, Akimoto M1, Nemoto M1, Shimakura Y1, Sato A: J Dermatol 2015/7; 42 (7): 735-8. (•“c@Œ[1, H–{•ôŽ1, ª–{@[1, “‡‘qNl1: 1Œ`¬E”üŠO)

110237. [ŒŽ’˜] Facial nerve palsy and Frey's syndrome in parotid surgery. Sugimoto T1, Akimoto M1, Nemoto M1, Kounoike N1, Ishikawa S1, Himi K, Uchinuma E, Takeda A1: Kitasato Med J 2015/9; 45 (2): 114-7. (™–{F”V1, H–{•ôŽ1, ª–{@[1, ƒ’r“Þ’ÃŽq1, ÎìS‰î1, “àÀ‰hŽ÷, •“c@Œ[1: 1Œ`¬E”üŠO)

110238. [ŒŽ’˜] Surgical treatment of cutaneous squamous cell carcinoma in Japanese patient aged 85 years and older compared with below 85 years. Kounoike N1, Akimoto M1, Nemoto M1, Ishikawa S1, Sugimoto T1, Takeda A1: Kitasato Med J 2015/9; 45 (2): 118-23. (ƒ’r“Þ’ÃŽq1, H–{•ôŽ1, ª–{@[1, ÎìS‰î1, ™–{F”V1, •“c@Œ[1: 1Œ`¬E”üŠO)

110239. [ŒŽ’˜] Investigation of factors affecting postoperative recurrence of basal cell carcinomas. Sugimoto Y1, Takeda A1, Akimoto M1, Sugimoto T1, Kajita S2, Uchinuma E: Kitasato Med J 2016/3; 46 (1): 47-52. (™–{‰À1, •“c@Œ[1, H–{•ôŽ1, ™–{F”V1, Š“cç”ü”T2, “àÀ‰hŽ÷: 1Œ`¬E”üŠO, 2•a—)

110028. [ŒŽ’˜] Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model. Park K1, Amano H2, Ito Y3, Kashiwagi S4, Yamazaki Y4, Takeda A4, Shibuya M, Kitasato H5, Majima M2: Biomed Pharmacother 2016/3; 78: 140-9. (–p@Œ\ˆê1, “V–ì‰pŽ÷2, ˆÉ“¡‹`–ç3, ”–ؐT–ç4, ŽRèˆÀ°4, •“c@Œ[4, –k—¢‰p˜Y5, ”n“ˆ³—²2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–ò—, 3ŠO‰È, 4Œ`¬E”üŠO, 5ˆã—Éq¶Šw•”)

120032. [ŒŽ’˜] “–‰È‚ÅŒoŒ±‚µ‚œŽè•”Ž‰–bŽî9—á‚ÌŒŸ“¢. ÎìS‰î1, ™–{F”V1, ƒ’r“Þ’ÃŽq1, ª–{@[1, •“c@Œ[1 (1Œ`¬E”üŠO): –k—¢ˆãŠw 2015/6; 45 (1): 21-6.

520011. [‘à] “€Œ‹•Û‘¶Ž©‰Æœ‘gD—R—ˆŠÔ—tŒn×–E‚̈Ӌ`. ŽRèˆÀ°1, •“c@Œ[1 (1Œ`¬E”üŠO): –k—¢ˆãŠw 2015/6; 45 (1): 11-20.

522121. [uÀ]y“ÁW: ”ü—eˆã—Â̍‡•¹Ç‚©‚çŠw‚Ô1|ƒtƒBƒ‰[•Ò|zƒnƒCƒhƒƒLƒVƒAƒpƒ^ƒCƒg’“üÜ‚É‚æ‚錌ŠÇÇð‚ª‹^‚í‚ê‚œ1—á. “‡‘qNl1, •“c@Œ[1 (1Œ`¬E”üŠO): Œ`¬ŠO‰È 2015/9; 58 (9): 968-71.

[’˜@‘]

620095. [Šwp‘ (•ª’SŽ·•M)]yŽè‘«‚̐æ“VˆÙí‚Í‚±‚€Ž¡—·‚é (PEPARS No.103)z‘œæä, ‘œ‡æäÇ, p.78-85. ª–{@[1, •“c@Œ[1 (1Œ`¬E”üŠO), •Ò: •Ÿ–{ŒbŽO, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 2015/7”­s.

620096. [Šwp‘ (•ª’SŽ·•M)]y”ü—eŠO‰È‚É•K{‚ÌŒ`¬ŠO‰È‚ÌŠî–{’mŽ¯‚ÆŽè‹Z (Œ`¬ŠO‰È‘æ58Šª‘Š§†)zVII. ”畆Š×‰š•ÏŒ`‚Ö‚ÌŽ‰–bˆÚA (’“ü)@”畆Š×‰š•ÏŒ`‚Ö‚ÌŽ‰–bˆÚA (’“ü)š[Šç–Ê‚Ì‚µ‚í‚Æ‚è, —ÖŠsŒ`¬], S138-45. “‡‘qNl1, •“c@Œ[1, Žðˆä’Œ•F2 (1Œ`¬E”üŠO, 2é–{ƒNƒŠƒjƒcƒN‹âÀ‰@), Žœ“°o”Å, “Œ‹ž, 2015/9”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713084. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Multidisciplinary Treatment for Correction of Malocclusion due to Maxillofacial Deformity from Fracture. Yamazaki Y1, Sugimoto T1, Takeda A1: ‘æ16‰ñ‘Û“ªŠWŠç–ÊŠO‰ÈŠw‰ï (2015/9/17), ç—t. (ŽRèˆÀ°1, ™–{F”V1, •“c@Œ[1: 1Œ`¬E”üŠO)

722084. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘åŠw‚É‚š‚¯‚éŒ`¬ŠO‰ÈˆãŽtˆç¬‚Ì‚œ‚ß‚Ì‹³ˆç. •“c@Œ[1, ª–{@[1, “‡‘qNl1, H–{•ôŽ1, ™–{F”V1, ŽRèˆÀ°1, “àÀ‰hŽ÷ (1Œ`¬E”üŠO): ‘æ58‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2015/4/9), ‹ž“s.

722085. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ”ü—eŠO‰È‡•¹Ç (“–‰@‚É‚š‚¯‚é”ü—eˆã—͇•¹Ç—á‚ÌŒŸ“¢). •“c@Œ[1, “‡‘qNl1, ÎìS‰î1 (1Œ`¬E”üŠO): ‘æ38‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2015/9/22), ‰¡•l.

722086. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “€Œ‹•Û‘¶Ž©‰Æ‘gD—R—ˆŠÔ—tŒn×–E‚̈Ӌ`. ŽRèˆÀ°1, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ24‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2015/10/8), ŠâŽè.

722087. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) “–Ž{Ý‚É‚š‚¯‚錌ŠÇ•«‡•”ŒŒð‚ɑ΂·‚é‹~ÏŽèp. ª–{@[1, ŒFàVŒ›ˆê2, H–{•ôŽ1, ƒ’r“Þ’ÃŽq1, •“c@Œ[1 (1Œ`¬E”üŠO, 2‹~–œ): ‘æ42‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ïŠwpW‰ï (2015/11/26), é‹Ê.

723606. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Invasive Extramammary Paget's Disease‚ÌŒŸ“¢. H–{•ôŽ1, ƒ’r“Þ’ÃŽq1, Žç’JˆŸŠóŽq, ••”—í“Þ, •º“ª“O–ç1, •Ÿˆä’‘å1, ŒÃì‹M–ç, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ58‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2015/4/8-10), ‹ž“s.

723607. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”w•”Osteolipoma‚Ì1—á. ŒÃì‹M–ç, H–{•ôŽ1, Žç’JˆŸŠóŽq, ƒ’r“Þ’ÃŽq1, •Ÿˆä’‘å1, •º“ª“O–ç1, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ58‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2015/4/8-10), ‹ž“s.

723608. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‹K–D‡‘n—pƒnƒCƒhƒƒRƒƒCƒh‘n”í•¢Þ‚ÌŽg—pŒoŒ±. ƒ’r“Þ’ÃŽq1, Žç’JˆŸŠóŽq, •º“ª“O–ç1, •Ÿˆä’‘å1, H–{•ôŽ1, ª–{@[1, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ58‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2015/4/8-10), ‹ž“s.

723609. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ™ù‹Ø“àŒŒŠÇŠïŒ`‚Ì1—á. Žç’JˆŸŠóŽq, ™–{F”V1, H–{•ôŽ1, ÎìS‰î1, •XŒ©˜a–€, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ58‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2015/4/8-10), ‹ž“s.

723610. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŽˆö•s–Ÿ‚Ì• ’ɁE”­”M‚Å”­Ç‚µ, ‹Ø•Ù‚É‚æ‚éÄŒš‚ðs‚Á‚œ’pœœ‘‰Š‚Ì‹}«‘žˆ«. ˆêŽr¢, ŽR“c’Œl1, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ58‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2015/4/8-10), ‹ž“s.

723611. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 16ÎˆÈ~‚ɍs‚Á‚œŽèæ“VˆÙíC³p‚ÌŒŸ“¢. ª–{@[1, ŒFàVŒ›ˆê2, ÎìS‰î1, H–{•ôŽ1 (1Œ`¬E”üŠO, 2‹~–œ): ‘æ58‰ñ“ú–{ŽèŠO‰ÈŠw‰ïŠwpW‰ï (2015/4/16-17), “Œ‹ž.

723612. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •Ð‘€OŠ{ŒûŠW—ô‚ÌŠ{‹ž³ŽèpŒã‚Ì•]‰¿. ŽRèˆÀ°1, ™–{F”V1, Î“n–õ•v, £èWˆê˜Y1, •“c@Œ[1, “àÀ‰hŽ÷ (1Œ`¬E”üŠO): ‘æ39‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2015/5/21), “Œ‹ž.

723613. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚ōs‚Á‚Ä‚¢‚éãŠ{‹“ãp‚ɂ‚¢‚Ä. ™–{F”V1, ŽRèˆÀ°1, •“c@Œ[1, Î“n–õ•v, ˆî–іΖÚ, •{ìr•F (1Œ`¬E”üŠO): ‘æ25‰ñ“Á’è”ñ‰c—˜Šˆ“®–@l“ú–{Š{•ÏŒ`ÇŠw‰ï‘‰ïEŠwp‘å‰ï (2015/6/4), “Œ‹ž.

723614. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘OŽ••”Ž•“÷œ–Œ‚ð‰·‘¶‚µ‚œLe Fort IŒ^œØ‚èp. ŽRèˆÀ°1, ’r–{”ɍO, ™–{F”V1, •“c@Œ[1, ˆî–ÑŽœŽ©, •{ìr•F (1Œ`¬E”üŠO): ‘æ25‰ñ“Á’è”ñ‰c—˜Šˆ“®–@l“ú–{Š{•ÏŒ`ÇŠw‰ï‘‰ïEŠwp‘å‰ï (2015/6/5), “Œ‹ž.

723615. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚ōs‚Á‚Ä‚¢‚éãŠ{œŒãp‚Ì•]‰¿. ™–{F”V1, ŽRèˆÀ°1, •“c@Œ[1, Î“n–õ•v, ˆî–ÑŽœŽ©, •{ìr•F (1Œ`¬E”üŠO): ‘æ25‰ñ“Á’è”ñ‰c—˜Šˆ“®–@l“ú–{Š{•ÏŒ`ÇŠw‰ï‘‰ïEŠwp‘å‰ï (2015/6/5), “Œ‹ž.

723616. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dƒNƒƒ€Ž_ƒJƒŠƒEƒ€‚É‚æ‚鉻Šw‘¹‚Ì1—á. •Ÿˆä’‘å1, ŒFàVŒ›ˆê1, •º“ª“O–ç1, H–{•ôŽ1, ª–{@[1, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ41‰ñ“ú–{”MŠw‰ï‘‰ïEŠwpW‰ï (2015/6/18), –ŒŒÃ‰®.

723037. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŽ¡–ü‚É‚š‚¯‚éVascular Endothelial Growth Factor Receptor 1 TKƒVƒOƒiƒ‹‚Ì–ðŠ„. –p@Œ\ˆê1, “V–ì‰pŽ÷2, ×–ì‰Á“ÞŽq2,3, ”–ؐT–ç4, ‚‹Ž@—º1, a’J³Žj, ‹g’|r—T1, •“c@Œ[4, ”n“ˆ³—²2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–ò—, 3¶—, 4Œ`¬E”üŠO): ‘æ36‰ñ“ú–{‰ŠÇEÄ¶ˆãŠw‰ï (2015/7/21-22), “Œ‹ž.

723617. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”ñƒXƒeƒƒCƒhR‰ŠÇ–ò‚É‚æ‚èoŒŒŒXŒü‚ª•’·‚³‚ê‚œ“ª•”Ž‰–bŽî‚Ì1—á. ÎìS‰î1, •–ö”ü—¢1, ƒ’r“Þ’ÃŽq1, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ7‰ñ“ú–{‘nŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2015/7/24-25), “Œ‹ž.

723618. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘Œ‰@‚ÅŽ{s‚³‚ê‚œŠááىº‚Žèp‚̏C³‚ð‚Ç‚€‚·‚é‚©. “‡‘qNl1, •“c@Œ[1 (1Œ`¬E”üŠO): ‘æ38‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2015/9/22), ‰¡•l.

723619. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –Ñ•ïÄ¶ˆã—Â̑O—Տ°ŽŽŒ±ƒ‚ƒfƒ‹‚ÌŠJ”­. ‹g’|r—T1, •“c@Œ[2, ª–{@[2, H–{•ôŽ2, –öàV³”V, –L“‡Œö‰h, ’ҁ@@F, ²“¡–Ÿ’j (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Œ`¬E”üŠO): ‘æ24‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2015/10/8), ŠâŽè.

723620. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚ōs‚Á‚Ä‚¢‚éãŠ{œ‹“ãp. ™–{F”V1, •“c@Œ[1, ŽRèˆÀ°1 (1Œ`¬E”üŠO): ‘æ33‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2015/11/12), •ó’Ë.

723621. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “€Œ‹•Û‘¶ä`‘Ñ—R—ˆŠÔ—tŒn×–E‚̍œŒ`¬”\‚ÌŒŸ“¢. ”nêŽq, ŽRèˆÀ°1, ‘]ª—R”üŽq2, Î•‹§Žj, ™–{F”V1, ŒFàVŒ›ˆê3, •“c@Œ[1 (1Œ`¬E”üŠO, 2•a‘ԁEf—ÃŒn, 3‹~–œ): ‘æ15‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï (2016/3/17), ‘åã.

723622. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “€Œ‹•Û‘¶‚³‚ê‚œƒqƒgœ‘gD—R—ˆŠÔ—tŒn×–E‚Ì”|—{ãŽ‚É‚æ‚鍜Œ`¬”\. ™–{F”V1, ŽRèˆÀ°1, ŒFàVŒ›ˆê2, ‘]ª—R”üŽq3, •“c@Œ[1 (1Œ`¬E”üŠO, 2‹~–œ, 3•a‘ԁEf—ÃŒn): ‘æ15‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï (2016/3/17), ‘åã.

723623. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘gDˆÚA‚ð—˜—p‚µ‚œƒqƒg”畆Œn•Û—LSCIDƒ}ƒEƒX‚ÌŠJ”­. ‹g’|r—T1, •“c@Œ[2, ª–{@[2, H–{•ôŽ2, “‡‘qNl2, ™–{F”V2, –öàV³”V, –L“‡Œö‰h, ’ҁ@@F, ²“¡–Ÿ’j (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Œ`¬E”üŠO): ‘æ15‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï (2016/3/19), ‘åã.

731124. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –Ñ”¯Ž¡—Â̌»ó‚Ɖ”\«. •“c@Œ[ (Œ`¬E”üŠO): ‘æ98‰ñ‹ãBE‰«“êŒ`¬ŠO‰ÈŠw‰ï (2015/6/27), •Ÿ‰ª.

733008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŽ¡–ü‚É‚š‚¯‚éVascular Endothelial Growth Factor Receptor 1 Tyrosine KinaseƒVƒOƒiƒ‹‚Ì–ðŠ„. –p@Œ\ˆê1, “V–ì‰pŽ÷2, ×–ì‰Á“ÞŽq2,3, ”–ؐT–ç4, ‚‹Ž@—º1, a’J³Žj, ‹g’|r—T1, •“c@Œ[4, ”n“ˆ³—²2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–ò—, 3¶—, 4Œ`¬E”üŠO): ‘æ132‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï (2015/7/4), ç—t.

733247. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†Žèœ–ü‡Ç‚Ì1—á. ª–{@[ (Œ`¬E”üŠO): ‘æ7‰ñŠÖ“ŒãŽˆæ“VˆÙíÇ—ጟ“¢‰ï (2015/7/15), `‹æ.

733248. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒûOŒûŠW—ôŠ³ŽÒ‚ÌŠO‰È“I‹ž³Ž¡—Ã. ŽRèˆÀ° (Œ`¬E”üŠO): •œ¬27”N“x‰Ä‚ÌŒûO—ôEŒûŠW—ô‹ž³Ž¡—Õ׋­‰ï (2015/8/27), _“ސì.

733249. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) WŠw“I™ù‡ÄŒš‚É‚š‚¯‚鎕‰ÈƒCƒ“ƒvƒ‰ƒ“ƒgŽ¡—Â̈Ӌ`. ŽRèˆÀ° (Œ`¬E”üŠO): International Team for Implantology study club (2015/9/4), _“ސì.

733250. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’…ˆß’…‰Î”M‚Ì3—á. •Ÿˆä’‘å1, ŒFàVŒ›ˆê2, H–{•ôŽ1, ª–{@[1, •“c@Œ[1 (1Œ`¬E”üŠO, 2‹~–œ): ‘æ23‰ñVh”MƒtƒH[ƒ‰ƒ€ (2015/9/11), Vh‹æ.

733251. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠ‰Aˆ³•Âœ—Ö@‚ðŽg—p‚µ‚ÄŽ¡—Âðs‚Á‚œ‹¹œœ‘‰Š. ˆêŽr¢, ŽR“c’Œl1 (1Œ`¬E”üŠO): ‘æ18‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2015/10/12), _“ސì.

733252. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Õ‚ª”äŠr“I–Ú—§‚œ‚È‚¢ŒûŠp‹“ãŽèp. “‡‘qNl (Œ`¬E”üŠO): ‘æ6‰ñJAAS“Œ‹žƒ‰ƒCƒuƒtƒH[ƒ‰ƒ€ (2015/10/25), “Œ‹ž.

733253. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žá”N—«‚̉A•”‚É”­Ç‚µ‚œ“î•”Žîá‡. ˆêŽr¢, ŽR“c’Œl1 (1Œ`¬E”üŠO): •œ¬27”N_“ސ쌧Œ`¬ŠO‰ÈÇ—ጟ“¢‰ï (2015), _“ސì.

733254. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žè•””M‚̐A”çŒÅ’è‚ÉNPWT‚ð—p‚¢‚œ3—á. •º“ª“O–ç1, ŒFàVŒ›ˆê2, ª–{@[1, •–ö”ü—¢1, H–{•ôŽ1, •“c@Œ[1 (1Œ`¬E”üŠO, 2‹~–œ): ‘æ24‰ñ“ú–{”MŠw‰ïŠÖ“Œ’n•û‰ï (2016/2/20), “Œ‹ž.

733255. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚édÇ”MŠ³ŽÒÝ‰@“ú”‚ÌŒ»ó. ª–{@[1, ŒFàVŒ›ˆê2, H–{•ôŽ1, ƒ’r“Þ’ÃŽq1, ó—˜@–õ2, •“c@Œ[1 (1Œ`¬E”üŠO, 2‹~–œ): ‘æ24‰ñ“ú–{”MŠw‰ïŠÖ“Œ’n•û‰ï (2016/2/20), “Œ‹ž.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H25-110001. [ŒŽ’˜] Immediate Reconstruction After Removal of Nasal Prosthesis Using Diced Cartilage Wrapped With Temporal Fascia. Takeda A1, Akimoto M1, Ishikawa S1, Sugimoto T1, Himi K, Shimakura Y1, Furuyama N, Nakakita N: J Craniofac Surg 2014/3; 25 (2): 535-8. (•“c@Œ[1, H–{•ôŽ1, ÎìS‰î1, ™–{F”V1, “‡‘qNl1: 1Œ`¬E”üŠO)

H25-522005. [uÀ]y“ÁW2: Žè‚Í‚¶‚ß‚Æ‚·‚é˜Io•”‚É‚š‚¯‚éMicrosurgical reconstruction‚̐®—e“I”z—¶z”ç•ÙC³‚ð—v‚µ‚œŽlŽˆÄŒš—á‚ÌŒŸ“¢|‹@”\“I, ®—e“IŽlŽˆÄŒš‚ð–ÚŽw‚µ‚ā|. ª–{@[1, ŒFàVŒ›ˆê2, ÎìS‰î1, ƒ’r“Þ’ÃŽq1, “àÀ‰hŽ÷3 (1Œ`¬E”üŠO, 2‹~–œ, 3–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[) “ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ï‰ïŽ 2013/; 26 (2): 55-60.

H26-110016. [ŒŽ’˜] Development of cultured dermal substitute composed of hyaluronic acid and collagen spongy sheet containing fibroblasts and epidermal growth factor. Kuroyanagi M1, Yamamoto A, Shimizu N, Ishihara E, Ohno H, Takeda A1, Kuroyanagi Y: J Biomater Sci Polym Ed 2014; 25 (11): 1133-43. (•–ö”ü—¢1, •“c@Œ[1: 1Œ`¬E”üŠO)

H26-110017. [ŒŽ’˜] Development of anti-adhesive spongy sheet composed of hyaluronic acid and collagen containing epidermal growth factor. Kuroyanagi M1, Yamamoto A, Shimizu N, Toi A, Inomata T, Takeda A1, Kuroyanagi Y: J Biomater Sci Polym Ed 2014; 25 (12): 1253-65. (•–ö”ü—¢1, •“c@Œ[1: 1Œ`¬E”üŠO)

[Šw‰ïEŒ€‹†‰ï“™]

H26-722003. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) •@•”’“üŽ¡—͇•¹Ç‚Ì5—á “‡‘qNl1, •“c@Œ[1, ’r“c‹Ó¶, Xìˆê•F (1Œ`¬E”üŠO): ‘æ37‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2014/9/4), “Œ‹ž.

H26-723012. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’·Šú“€Œ‹•Û‘¶‚³‚ê‚œƒqƒgœ‘gD—R—ˆŠÔ—tŒn×–E‚̈À‘S«. ™–{F”V1, ŽRèˆÀ°1, ‘]ª—R”üŽq2, ŒFàVŒ›ˆê3, •“c@Œ[1 (1Œ`¬E”üŠO, 2•a‘ԁEf—ÃŒn, 3‹~–œ): ‘æ14‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï (2015/3/19), _“ސì.

H26-733008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€žô‘€—ñŒ`¬•s‘S‚Ì1—á|¡Œã‚ÌŽ¡—Õûj‚ɂ‚¢‚ā|. ª–{@[ (Œ`¬E”üŠO): ‘æ6‰ñŠÖ“ŒãŽˆæ“VˆÙíÇ—ጟ“¢‰ï (2015/1/18), `‹æ.


”畆‰ÈŠw

[Šwp˜_•¶]

110240. [ŒŽ’˜] From hair to heart: nestin-expressing hair-follicle-associated pluripotent (HAP) stem cells differentiate to beating cardiac muscle cells. Yashiro M1, Mii S1, Aki R1, Hamada Y2, Arakawa N, Kawahara K3, Hoffman RM, Amoh Y1: Cell Cycle 2015/7; 14 (14): 2362-6. (‰®‘㐳W1, ŽOˆäƒá1, ˆÀåY—Ljê1, •l“c—SŽq2, ‰ÍŒŽŽ‰ë3, “V‰HN”V1: 1”畆, 2•a‘ԁEf—ÃŒn, 3¶—)

110241. [ŒŽ’˜] Long-Term Extensive Ectopic Hair Growth on the Spinal Cord of Mice from Transplanted Whisker Follicles. Cao W, Li L, Mii S1, Amoh Y1, Liu F, Hoffman RM: PLoS One 2015/8; 10 (8): e0133475. (ŽOˆäƒá1, “V‰HN”V1: 1”畆)

110242. [ŒŽ’˜] Cryopreservation of the Hair Follicle Maintains Pluripotency of Nestin-Expressing Hair Follicle-Associated Pluripotent Stem Cells. Kajiura S1, Mii S1, Aki R1, Hamada Y2, Arakawa N, Kawahara K3, Li L, Katsuoka K, Hoffman RM, Amoh Y1: Tissue Eng Part C Methods 2015/8; 21 (8): 825-31. (Š‰Y’qŽk1, ŽOˆäƒá1, ˆÀåY—Ljê1, •l“c—SŽq2, ‰ÍŒŽŽ‰ë3, “V‰HN”V1: 1”畆, 2•a‘ԁEf—ÃŒn, 3¶—)

110243. [ŒŽ’˜] Reduced expression of dermcidin, a peptide active against propionibacterium acnes, in sweat of patients with acne vulgaris. Nakano T, Yoshino T, Fujimura T1, Arai S, Mukuno A, Sato N1, Katsuoka K: Acta Derm Venereol 2015/9; 95 (7): 783-6. (“¡‘º‹¿’j1, ²“¡’ŒÆ1: 1”畆)

110244. [ŒŽ’˜] Extensive Hair-Shaft Elongation by Isolated Mouse Whisker Follicles in Very Long-Term GelfoamÒ Histoculture. Cao W, Li L, Mii S1, Amoh Y1, Liu F, Hoffman RM: PLoS One 2015/10; 10 (9): e0138005. (ŽOˆäƒá1, “V‰HN”V1: 1”畆)

110245. [ŒŽ’˜] NUP160-SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma. Shimozono N, Jinnin M, Masuawa M1, Masuzawa M, Wang Z, Hirano A, Tomozawa Y, Etho-Kira T, Kajihara I, Harada M, Fukushima S, Ihn H: Cancer Res 2015/11; 75 (21): 4458-65. (‘àV^ŽÀŽq1: 1”畆)

120033. [ŒŽ’˜] ƒQƒ€ƒVƒ^ƒrƒ“‚ª‘tŒø‚µ‚œisŠú‹Ûó‘§“÷Ç‚Ì2—á‚ÆŠCŠO•ñ—á‚Ì•¶Œ£“IlŽ@. ‘àV^ŽÀŽq1, ‚{@”Ž1, “V‰HN”V1 (1”畆): Šà‚Ɖ»Šw—Ö@ 2015/12; 42 (13): 2451-5.

210005. [€ŒŽ’˜]yNotezImmune Milk Suppresses Herpes Simplex Virus Type 1. Masuzawa M, Masuzawa M1, Arakawa N, Hamada Y2, Tamauchi H, Morita M, Nishiyama S, Sato Y: J Nutr Sci Vitaminol (Tokyo) 2016; 62 (1): 67-70. (‘àV^ŽÀŽq1, •l“c—SŽq2: 1”畆, 2•a‘ԁEf—ÃŒn)

310027. [Ç—á•ñ] A case of Kikuchi's disease (histiocytic necrotizing lymphoadenitis) with histiocytic cutaneous involvement. Obara K1, Amoh Y1: Rheumatol Int 2015/6; 35 (6): 1111-3. (¬ŒŽGÆ1, “V‰HN”V1: 1”畆)

540016. [‚»‚Ì‘Œ (ƒKƒCƒhƒ‰ƒCƒ“)]y“ú–{”畆‰ÈŠw‰ïƒKƒCƒhƒ‰ƒCƒ“z“ª•”ŒŒŠÇ“÷Žîf—ÃKƒCƒhƒ‰ƒCƒ“. ‘àVŠ²’j, ’|’†G–ç, ‘º“c@“N, ‘ºãMŽi, “cŒû—¢Žj, ó‰zŒ’Ž¡, ‘àV^ŽÀŽq1, ‘ì˜ad2, ŒÃ‰êOŽu, “y“c“N–ç (1”畆, 2•úŽËü (Žîá‡)): “ú–{”畆‰ÈŠw‰ïŽGŽ 2015/9; 125 (10): 1871-88.

540017. [‚»‚Ì‘Œ (Šw‰ïŽ˜^)]y“Œ‹ž’n•û‰ï‘æ863‰ñ`‘æ864‰ñ—á‰ï (Žl’n‹æ•ª‰ï)zˆâ“`«•â‘ÌŒ‡‘¹Ç‚ð‹^‚Á‚œDLE‚Ì1—á. ‘O“‡‰pŽ÷1, “n˜ð@W1, ŽOˆäƒá1, “V‰HN”V1, “c’†Z–Ÿ2 (1”畆, 2äPŒŽ•a¥ŠŽõ“à): “ú–{”畆‰ÈŠw‰ïŽGŽ 2016/2; 126 (2): 190.

[Šw‰ïEŒ€‹†‰ï“™]

713085. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Effect of Pazopanib for advanced cutaneous angiosarcoma as a second-line treatment after Taxane chemotherapy. Masuzawa M1, Hori T1, Obara K1, Mii S1, Amoh Y1: 23rd World congress of Dermatology (2015/6/8-13), Vancouver, Canada. (‘àV^ŽÀŽq1, –x@’qs1, ¬ŒŽGÆ1, ŽOˆäƒá1, “V‰HN”V1: 1”畆)

713086. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Nestin Expressing cells in the hair follicle innervated injured nerve differentiate into neurons in vitro and vivo. Mii S1, Duong J, Uchugonova A, Liu F, Tran B, Amoh Y1, Hoffman RM: 9th World Congress for Hair Research (2015/11/19), Miami, USA. (ŽOˆäƒá1, “V‰HN”V1: 1”畆)

713087. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Hair follicle pluripotent stem cells can differentiate to cardiac muscle cells. Amoh Y1, Yashiro M1, Mii S1, Aki R1, Hamada Y2, Arakawa N, Kawahara K3, Hoffman RM: 9th World Congress for Hair Research (2015/11/20), Miami, USA. (“V‰HN”V1, ‰®‘㐳W1, ŽOˆäƒá1, ˆÀåY—Ljê1, •l“c—SŽq2, ‰ÍŒŽŽ‰ë3: 1”畆, 2•a‘ԁEŒ`‘ÔŒn, 3¶—)

723624. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ––œ_Œo‚É‚ ‚éƒlƒXƒ`ƒ“—z«×–E‚͐_ŒoáŠQŽž‚ɐ_Œo×–E‚É•ª‰»‚·‚é. ŽOˆäƒá1, “V‰HN”V1, Hoffman RM (1”畆): ‘æ30‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2015/6/26), ŽD–y.

723625. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ª•”ŒŒŠÇ“÷Žî‚ɑ΂·‚éTomotherapy‚É‚æ‚é‘S“ª”ç•úŽËüŽ¡—Ã: L”͐Z—á‚ɑ΂·‚é’§í“IŽ¡—Ã. ‘àV^ŽÀŽq1, –x@’qs1, ‚–ì“N˜Y1, “n˜ð@W1, ŠÖŒûˆ©ˆß2, ŽOˆäƒá1, “V‰HN”V1, ‘ì˜ad2 (1”畆, 2•úŽËü (Žîá‡)): ‘æ31‰ñ“ú–{”畆ˆ««Žîᇊw‰ïŠwp‘å‰ï (2015/7/3), ‘åã, “ú–{”畆ˆ««Žîᇊw‰ïŠwp‘å‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2015/7; 31: 132.

723626. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Enterococcus faecalis EC-12‚̐ێ悪qí«‚ŽáŒ‚É‹y‚Ú‚·‰e‹¿. ˆÉ’n’m“N¶, ²“¡’ŒÆ1, “¡‘º‹¿’j1 (1”畆): “ú–{“ûŽ_‹ÛŠw‰ï2015”N“x‘å‰ï (2015/7/11), Žsì.

723627. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Pencil in cup‚ðl‚Š‚é. ‘O“‡‰pŽ÷1, ŒŽR_”ü, ˆÀåY—Ljê1, “n˜ð@W1, “V‰HN”V1 (1”畆): ‘æ30‰ñ“ú–{Š£áŠw‰ïŠwp‘å‰ï (2015/9/4), –ŒŒÃ‰®.

723628. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Unique regions in the Mycobacterium leprae Mce1A protein associated with the initial transmission of leprosy. Viesta Fadlitha beby, ²“¡’ŒÆ1, Idris Irfan, Rachman Fatul, “¡‘º‹¿’j1, Takimoto H (1”畆): ‘æ89‰ñ“ú–{×‹ÛŠw‰ï‘‰ï (2016/3/24), ‘åã.

732053. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –ѕ×–E‚Ì‘œ•ª‰Â”\|S‘Ÿ‚ɖт͐¶‚Š‚È‚¢‚ª–Ñ‚©‚çS‘Ÿ‚Í‚Å‚«‚é|. “V‰HN”V (”畆): ‘æ79‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žE“ª•”Žx•”‡“¯Šwp‘å‰ï (2016/2/20), “Œ‹ž.

733256. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ––œ_ŒoüˆÛ‚̃lƒXƒ`ƒ“—z«×–E‚͏ŠQC•œ‰ß’ö‚Ő_ŒoEƒOƒŠƒA×–E‚É•ª‰»‚·‚é. ŽOˆäƒá1, ‰ÍŒŽŽ‰ë2, Robert M Hoffman, “V‰HN”V1 (1”畆, 2¶—): ¶—ŠwŒ€‹†ŠŒ€‹†‰ï¶‘̃VƒOƒiƒ‹ƒ_ƒCƒiƒ~ƒNƒX (2015/9/3), ‰ªè.

733257. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Coma blister‚Ì1—á. ŽOˆäƒá1, “V‰HN”V1 (1”畆): ‘æ862‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2015/9/12), “Œ‹ž.

733258. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’܍b‰º”^ᇂƎv‚í‚ê‚œƒqƒgƒpƒsƒ[ƒ}ƒEƒBƒ‹ƒX (HPV) 11Œ^—z«‚̒܏°ƒ{[ƒGƒ“•a. ‘àV^ŽÀŽq1, “n˜ð@W1, “V‰HN”V1, ƒ’r“Þ’ÃŽq2, ŒŽ@˜a–î, –k—¢‰p˜Y3 (1”畆, 2Œ`¬E”üŠO, 3ˆã—Éq¶Šw•”): ‘æ863‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2015/11/14), “Œ‹ž.

733259. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ”­ŒŒŠÇ‰Š«“÷‰èŽîÇ (Wegener“÷‰èŽî) ‚Ì1—á. •ÐŽR’qŒbŽq1, “¿‰içt2, ŒŽ@”ü•ü2, ŽRè@“N2, ŽRã”ü]3 (1”畆, 2‘å˜aŽs—§•a‰@, 3‘Š–Í‘ä•a‰@): “ú–{”畆‰ÈŠw‰ï‘æ864‰ñ“Œ‹ž’n•û‰ï (2015/12/19), _“ސì.

733260. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) KL-6‚̍‚’l‚ðŽŠ‚µ‚œˆ««Žîᇍ‡•¹”畆‹Ø‰Š‚Ì3—á. ŽOˆäƒá1, ˆÀåY—Ljê1, ‘àV^ŽÀŽq1, ‹{àV—ŒbŽq1, “àŠC—F—1, “V‰HN”V1 (1”畆): ‘æ39‰ñ”畆–¬ŠÇEäPŒŽ•aŒ€‹†‰ï (2016/1/22), ‚’m.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H14-522001. [uÀ]y“ÁW: ¬Ž™‚̔畆•az—Տ°—á: ––œŒŒŠ²×–EˆÚAŒã‚ɐ¶‚¶‚œGVHD. ˆÀåY—Ljê1, ŒŽ“c°”ü, ‰q“¡@Œõ (1”畆): ”畆•af—à 2003/3; 25 (3): 299-302.

H16-522001. [uÀ]y“ÁW: ‘«æä‚̉óásE’×ᇁz—Տ°—á: •ÂÇ«“®–¬d‰»Ç. ˆÀåY—Ljê1, óˆä‚Æ‚µŽq, VˆätŽ} (1”畆): ”畆•af—à 2005/1; 27 (1): 47-50.

H18-522001. [uÀ]y“ÁW: •·‚«Šµ‚ê‚È‚¢ÇŒóŒQz—Տ°—á: OlmstedÇŒóŒQ. ˆÀåY—Ljê1, ŒŽ“c°”ü, ‰q“¡@Œõ, ˆÀŒ—L‹I, ‘å–î’B’j (1”畆): ”畆•af—à 2006/12; 28 (12): 299-302.

H22-110001. [ŒŽ’˜] Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients. Maejima H1, Taniguchi T1, Watarai A1, Aki R1, Katsuoka K1: J Dermatol 2010/7; 37 (7): 647-56. (‘O“‡‰pŽ÷1, ’JŒû—F‘¥1, “x˜ð@W1, ˆÀåY—Ljê1, Ÿ‰ªŒ›¶1: 1”畆)

H22-120001. [ŒŽ’˜] ƒIƒƒpƒ^ƒWƒ“‰–Ž_‰– (ƒAƒŒƒƒbƒN) ‚Ì–«“Á”­«å@–ƒ]‚ɑ΂·‚鑝—ÊŒø‰Ê‚ÌŒŸ“¢. VŽRŽj˜N1, ’JŒû—F‘¥1, “c•ÓŒ’ˆê1, ‘O“cˆŸŠóŽq, ˆÀåY—Ljê1, ŽOˆäƒá1, “í@@•‘, “V‰HN”V1, ‘O“‡‰pŽ÷1, Œü–ì@“N1, âV“¡“T[1, Vˆä@’B1, Ÿ‰ªŒ›¶1 (1”畆): Progress in Medicine 2010/8; 30 (8): 2233-7.

H24-110001. [ŒŽ’˜] Fluorescent proteins enhance UVC PDT of cancer cells. Momiyama M, Suetsugu A, Kimura H, Kishimoto H, Aki R1, Yamada A, Sakurada H, Chishima T, Bouvet M, Bulgakova NN, Endo I, Hoffman RM: Anticancer Res 2012/10; 32 (10): 4327-30. (ˆÀåY—Ljê1: 1”畆)

H24-110002. [ŒŽ’˜] Imaging the efficacy of UVC irradiation on superficial brain tumors and metastasis in live mice at the subcellular level. Momiyama M, Suetsugu A, Kimura H, Kishimoto H, Aki R1, Yamada A, Sakurada H, Chishima T, Bouvet M, Endo I, Hoffman RM: J Cell Biochem 2013/2; 114 (2): 428-34. (ˆÀåY—Ljê1: 1”畆)

H26-522013. [uÀ]y‘æ30‰ñ“ú–{”畆ˆ««Žîᇊw‰ïƒVƒ“ƒ|ƒWƒEƒ€6zŠÉ˜aˆã—ÂƔ畆‰È2014: ”畆Šà‚ƃŠƒ“ƒpŠÇáŠV@ƒŠƒ“ƒp•‚Žî‚É‘±”­‚·‚é–¬ŠÇ“÷Žî. ‘àV^ŽÀŽq (”畆): Skin Cancer 2014/11; 29 (2): 131-3.

[Šw‰ïEŒ€‹†‰ï“™]

H26-733009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒŒƒC‚Ì‹›—‘‚É‚æ‚éƒAƒiƒtƒBƒ‰ƒLƒV[‚Ì1—á. “Œ‹V“ß’ÃŽq1, ‰®‘ã–¢‰À1, ‘O“‡‰pŽ÷1, ‚{@”Ž1, “V‰HN”V1, “í@@•‘ (1”畆):“ú–{”畆‰ÈŠw‰ï‘æ857‰ñ“Œ‹ž’n•û‰ï (2014/11/15), ç—t, “ú–{”畆‰ÈŠw‰ïŽGŽ 2014/9; 124 (10): 1963.

H26-733010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠO‰È“IØœ‚ƏpŒã‰»Šw—Ö@‚ª—LŒø‚Å‚ ‚Á‚œ‹¹•”‚Ì•úŽËüÆŽËŒãŒŒŠÇ“÷Žî. ‘àV^ŽÀŽq1, Š‰Y’qŽk1, “V‰HN”V1, H–{•ôŽ (1”畆): ‘æ859‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2015/1/17), “Œ‹ž.

H26-733011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž•“÷•Ó—΂ɐ¶‚¶‚œqí«“VávጂÌ1—á. •ÐŽR’qŒbŽq1, âV“¡‹±Žq1, “¿‰içt2, ¬àV’m—Ï2, Îˆä•¶l, ‹Ž–{@—²3 (1”畆, 2‘å˜aŽs—§•a‰@, 3‹v—¯•Ä‘åŠw): “ú–{”畆‰ÈŠw‰ï‘æ859‰ñ“Œ‹ž’n•û‰ï (2015/1/17), _“ސì.


”å”AŠí‰ÈŠw

[Šwp˜_•¶]

110246. [ŒŽ’˜] Conditional survival after radical nephroureterectomy for upper tract carcinoma. Ploussard G, Xylinas E, Lotan Y, Novara G, Margulis V, Roupret M, Matsumoto K1, Karakiewicz PI, Montorsi F, Remzi M, Seitz C, Scherr DS, Kapoor A, Fairey AS, Rendon R, Izawa J, Black PC, Lacombe L, Shariat SF, Kassouf W: Eur Urol 2015/4; 67 (4): 803-12. (Œ–{˜a«1: 1”å”AŠí)

110247. [ŒŽ’˜] Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction: long-term results. Nishi M1, Tsuchida M1, Ikeda M1, Matsuda D1, Iwamura M1: Int J Urol 2015/4; 22 (4): 368-71. (Œ@·G1, “y“c–š”ü1, ’r“cŸb1, Œ“c‘å‰î1, Šâ‘º³Žk1: 1”å”AŠí)

110248. [ŒŽ’˜] Laparoscopic Retroperitoneal Nephroureterectomy is a Safe and Adherent Modality for Obese Patients with Upper Urinary Tract Urothelial Carcinoma. Matsumoto K1, Hirayama T1, Kobayashi K1, Hirano S1, Nishi M1, Ishii D1, Tabata K1, Fujita T1, Iwamura M1: Asian Pac J Cancer Prev 2015/4; 16 (8): 3223-7. (Œ–{˜a«1, •œŽR‹M”Ž1, ¬—ÑŒ’‘Ÿ˜Y1, •œ–ìC•œ1, Œ@·G1, Îˆä‘å•ã1, “c”šŒ’ˆê1, “¡“c“N•v1, Šâ‘º³Žk1: 1”å”AŠí)

110249. [ŒŽ’˜] Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS). Saito S, Ito K, Yorozu A, Aoki M, Koga H, Satoh T1, Ohashi T, Shigematsu N, Maruo S, Kikuchi T, Kojima S, Dokiya T, Fukushima M, Yamanaka H: Int J Clin Oncol 2015/4; 20 (2): 375-85. (²“¡ˆÐ•¶1: 1”å”AŠí)

110250. [ŒŽ’˜] Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression. Noguchi M, Arai G, Matsumoto K1, Naito S, Moriya F, Suekane S, Komatsu N Matsueda S, Sasada T, Yamada A, Kakuma T, Itoh K: Cancer Immunol Immunother 2015/4; 64 (4): 493-505. (Œ–{˜a«1: 1”å”AŠí)

110251. [ŒŽ’˜] A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer. Ueda Y, Matsubara N, Takizawa I, Nishiyama T, Tabata K1, Satoh T1, Kamiya N, Suzuki H, Kawahara T, Uemura H: Jpn J Clin Oncol 2015/4; 45 (8): 774-9. (“c”šŒ’ˆê1, ²“¡ˆÐ•¶1: 1”å”AŠí)

110252. [ŒŽ’˜] Enhanced central memory cluster of differentiation 8+ and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy. Kubo M1, Satoh T2, Tabata K2, Tsumura H2, Iwamura M2, Baba S2, Thompson TC, Obata F1: Mol Clin Oncol 2015/5; 3 (3): 515-21. (‹v•Û@œ1, ²“¡ˆÐ•¶2, “c”šŒ’ˆê2, ’ѺGN2, Šâ‘º³Žk2, ”nêŽu˜Y2, ¬”Š•¶–í1: 1ˆã—Éq¶Šw•”, 2”å”AŠí)

110253. [ŒŽ’˜] Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model. Abe T, Ishii D1, Gorbacheva V, Kohei N, Tsuda H, Tanaka T, Dvorina N, Nonomura N, Takahara S, Valujskikh A, Baldwin WM 3rd, Fairchild RL: Am J Transplant 2015/5; 15 (5): 1192-204. (Îˆä‘å•ã1: 1”å”AŠí)

110254. [ŒŽ’˜] AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies. Omlin A, Jones RJ, van der Noll R, Satoh T1, Niwakawa M, Smith SA, Graham J, Ong M, Finkelman RD, Schellens JHM, Zivi A, Crespo M, Riisnaes R, Nava-Rodrigues D, Malone MD, Dive C, Sloane R, Moore D, Alumkal JJ, Dymond A, Dickinson PA, Ranson M, Clack G, de Bono J, Elliott T: Invest New Drugs 2015/6; 33 (3): 679-90. (²“¡ˆÐ•¶1: 1”å”AŠí)

110255. [ŒŽ’˜] GLIPR1-ƒ¢TM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells. Karanika S, Karantanos T, Kurosaka S1, Wang J, Hirayama T1, Yang G, Park S, Golstov AA, Tanimoto R, Li L, Thompson TC: Mol Cancer 2015/6; 14 (122): 1-13. (•âáÁ“ñ1, •œŽR‹M”Ž1: 1”å”AŠí)

110256. [ŒŽ’˜] Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study. Nuhn P, Novara G, Seitz C, Gupta A, Matsumoto K1, Kassouf W, Walton TJ, Fritsche HM, Tritschler S, Martinez-Salamanca JI, Ficarra V, Karakiewicz PI, Mazzoleni G, Shariat SF, Bastian PJ: World J Urol 2015/7; 33 (7): 1005-13. (Œ–{˜a«1: 1”å”AŠí)

110257. [ŒŽ’˜] Protein expression profile related to cisplatin resistance in bladder cancer cell lines detected by two-dimensional gel electrophoresis. Taoka Y1, Matsumoto K1, Ohashi K, Minamida S1, Hagiwara M1, Nagi S1, Saito T2, Kodera Y2, Iwamura M1: Biomed Res 2015/8; 36 (4): 253-61. (“c‰ª‰ÀŒ›1, Œ–{˜a«1, “ì“c@—@1, ”‹ŒŽ³”Ž1, –Œ–؏l1, Ö“¡’B–ç2, ¬Ž›‹`’j2, Šâ‘º³Žk1: 1”å”AŠí, 2—Šw•”)

110258. [ŒŽ’˜] Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma. Fujii Y, Ikeda M1, Kurosawa K, Tabata M, Kamigaito T, Hosoda C, Okaneya T: Int J Clin Oncol 2015/8; 20 (4): 802-7. (’r“cŸb1: 1”å”AŠí)

110259. [ŒŽ’˜] Effect of Ang-2-VEGF-A Bispecific Antibody in Renal Cell Carcinoma. Bessho H1, Wong B, Huang D, Tan J, Ong CK, Iwamura M1, Hart S, Dangl M, Thomas M, Teh BT: Cancer Invest 2015/9; 33 (8): 378-86. (•ÊŠ‰pŽ¡1, Šâ‘º³Žk1: 1”å”AŠí)

110260. [ŒŽ’˜] Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy. Tabata M, Ikeda M1, Urakami S, Takahashi S, Sakaguchi K, Kurosawa K, Okaneya T: Jpn J Clin Oncol 2015/10; 45 (10): 963-7. (’r“cŸb1: 1”å”AŠí)

110261. [ŒŽ’˜] Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapy. Tsumura H1, Satoh T1, Ishiyama H2, Hirano S1, Tabata K1, Kurosaka S1, Matsumoto K1, Fujita T1, Kitano M2, Baba S1, Hayakawa K2, Iwamura M1: World J Radiol 2015/12; 7 (12): 494-500. (’ѺGN1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, •œ–ìC•œ1, “c”šŒ’ˆê1, •âáÁ“ñ1, Œ–{˜a«1, “¡“c“N•v1, –k–ì‰ëŽj2, ”nêŽu˜Y1, ‘ì˜ad2, Šâ‘º³Žk1: 1”å”AŠí, 2•úŽËü (Žîá‡))

110262. [ŒŽ’˜] An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy. Noguchi M, Matsumoto K1, Uemura H, Arai G, Eto M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Kakuma T, Itoh K: Clin Cancer Res 2016/1; 22 (1): 54-60. (Œ–{˜a«1: 1”å”AŠí)

110263. [ŒŽ’˜] Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-GuŽrin Instillation Therapy for Nonmuscle Invasive Bladder Cancer. Yokomizo A, Kanimoto Y, Okamura T, Ozono S, Koga H, Iwamura M1, Tanaka H, Takahashi S, Tsushima T, Kanayama H, Akaza H, Shinohara N, Mugiya S, Nomata K, Nakamura T, Naito S: J Urol 2016/1; 195 (1): 41-6. (Šâ‘º³Žk1: 1”å”AŠí)

110264. [ŒŽ’˜] Incremental Expression of 14-3-3 Protein Beta/Alpha in Urine Correlates with Advanced Stage and Poor Survival in Patients with Clear Cell Renal Cell Carcinoma. Kaneko S1, Matsumoto K1, Minamida S1, Hirayama T1, Fujita T1, Kodera Y2, Iwamura M1: Asian Pac J Cancer Prev 2016/2; 17 (3): 1399-404. (‹àŽqŽu•Û1, Œ–{˜a«1, “ì“c@—@1, •œŽR‹M”Ž1, “¡“c“N•v1, ¬Ž›‹`’j2, Šâ‘º³Žk1: 1”å”AŠí, 2—Šw•” (•š—))

120034. [ŒŽ’˜] ƒAƒ‹ƒMƒ“Ž_ƒiƒgƒŠƒEƒ€‚ð—p‚¢‚œƒZƒ‹ƒuƒƒbƒN–@‚ÌŒŸ“¢. “c’†@Œ\1, Œ‘º—R—¢1,2, rˆä‚ä‚èŽq2, Š`ÀœA–M3, ’¬“c‘å•ã3, ŽR‰º˜a–ç3, Œ–{˜a«4, ‘å•”@œ2, ²“¡—Yˆê2, •ž•”@Šw2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3•a—•”, 4”å”AŠí): _“ސì×–E‰ïŽ 2015/8; 20 (1): 15-23.

120035. [ŒŽ’˜] Œã• –Œ“î•”“÷Žî‚̗Տ°•a—Šw“IŒŸ“¢‚ÆŽ¡—ЬÑ. •àV˜aG, ‰YãTŽi, ’r“cŸb1, “c”š^—œŽq, ‘º“c_Ž, ‰ªª’J—˜ˆê (1”å”AŠí): ”å”AŠí‰È‹I—v 2015/11; 61 (11): 419-26.

220007. [€ŒŽ’˜]y‘æ79‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï‹L˜^W@ƒVƒ“ƒ|ƒWƒEƒ€I: ”å”AŠí‰È—̈æPETf’f‚Ìcutting edgez‘O—§‘BŠà‚ɑ΂·‚éV‹KPETf’f|F-18•WŽ¯”ñ“V‘RŒ^ƒAƒ~ƒmŽ_‚ð—p‚¢‚œ‘æI/II‘ŠŽŽŒ±|. ‹àŽqŽu•Û1, ²“¡ˆÐ•¶1, ˆäã—D‰î2, ó–ì—Y“ñ2, “c”šŒ’ˆê1, ’ѺGN1, ‚Œû@‘å1, ŒŽ@•q«2, ÎŽR”ŽžŠ3, ‘ì˜ad3, ”nêŽu˜Y1, Šâ‘º³Žk1 (1”å”AŠí, 2•úŽËü (‰æ‘œ), 3•úŽËü (Žîá‡)): ”å”AŠíŠO‰È 2015/5; 28 (—Õ‘): 577-9.

220008. [€ŒŽ’˜]y‘æ79‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï‹L˜^W@ƒVƒ“ƒ|ƒWƒEƒ€5: ƒnƒCƒŠƒXƒN‘O—§‘BŠà‚Ö‚Ì’§íz3. Very-high-risk‘O—§‘BŠà‚ɑ΂·‚é“à•ª”å—Ö@‚ÆŠOÆŽË•¹—p‚É‚æ‚éHDR brachytherapy‚Ì—L—p«. ’ѺGN1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê1, –k–ì‰ëŽj2, •âáÁ“ñ1, ŠÖŒûˆ©ˆß2, ìã³Œå2, ¬X³Žq2, ‘ì˜ad2, Šâ‘º³Žk1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ”å”AŠíŠO‰È 2015/5; 28 (—Õ‘): 623-5.

220009. [€ŒŽ’˜]y‘æ79‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï‹L˜^W@ƒVƒ“ƒ|ƒWƒEƒ€9: ŒÀ‹Ç«‘O—§‘BŠà‚̃AƒEƒgƒJƒ€‚ð—\‘ª‚·‚é|”A‹Ö§E«‹@”\‚Ì“_‚©‚çz3. ŒÀ‹Ç«‘O—§‘BŠà‚ɑ΂·‚é•úŽËüŽ¡—Ã: «‹@”\‚ÌŒŸ“¢. ¬—ÑŒ’‘Ÿ˜Y1, ²“¡ˆÐ•¶1, ’ѺGN1, “c”šŒ’ˆê1, –Ø‘º«‹M, ™“c@“Ö1, Œ‰ºˆêm, Žu‘º@“N, –]ŒŽN•œ1, ÎŽR”ŽžŠ2, ‘ì˜ad2, ”nêŽu˜Y1, Šâ‘º³Žk1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ”å”AŠíŠO‰È 2015/5; 28 (—Õ‘): 689-91.

220010. [€ŒŽ’˜]y‘æ79‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï‹L˜^W@ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“: ‚ƒŠƒXƒNŒÀ‹Ç«E‹ÇŠZ‘O—§‘B‚ª‚ñ‚ÌŽ¡—Ð헪z3. HDRƒuƒ‰ƒLƒZƒ‰ƒs[‚̈Ӌ`. •œ–ìC•œ1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, –k–ì‰ëŽj, ’ѺGN1, “c”šŒ’ˆê1, ¬—ÑŒ’‘Ÿ˜Y1, –]ŒŽN•œ1, ‹àŽqŽu•Û1, ŠÖŒûˆ©ˆß2, ìã³Œå2, ’|’†_“ñ2, ‘ì˜ad2, ”nêŽu˜Y1, Šâ‘º³Žk1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ”å”AŠíŠO‰È 2015/8; 28 (8): 1433-5.

320032. [Ç—á•ñ] •Û‘¶“IŽ¡—ª‘tŒø‚µ‚œ‹CŽî«äNã÷‰Š‚Ì1—á. ™“c‰ÀŽq, ÝŠy•q–ç, “¡“c“N•v1 (1”å”AŠí): —Տ°”å”AŠí‰È 2015/4; 69 (5): 405-7.

320033. [Ç—á•ñ] ƒzƒ‹ƒ~ƒEƒ€Eƒ„ƒOƒŒ[ƒU[‚É‚æ‚é•\Ý«äNã÷Žîᇐ؏œp (Holmium: YAG Laser Resection of Bladder Tumor: HoLRBT) ‚Ì1—á. ™“c‰ÀŽq, ÝŠy•q–ç, •œŽR‹M”Ž1, “¡“c“N•v1 ,‹g“cˆê¬2, ‹v•Û¯ˆê, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ”å”AŠí‰È‹I—v 2015/10; 61 (10): 401-3.

320034. [Ç—á•ñ] ”A“¹ƒXƒeƒ“ƒg‚̈ړ®‚É‚æ‚é”A“¹‹·óÇ—á‚ɑ΂µŒo‰ï‰A“I‚É”A“¹Œ`¬p‚ƃzƒ‹ƒ~ƒEƒ€Eƒ„ƒOƒŒ[ƒU[‘O—§‘BŠjop‚ðŽ{s‚µ‚œ1—á. ™“c‰ÀŽq, ÝŠy•q–ç, •œŽR‹M”Ž1, “¡“c“N•v1, ‹g“cˆê¬2, ‹v•Û¯ˆê, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ”å”AŠíŠO‰È 2015/12; 28 (12): 1933-8.

320035. [Ç—á•ñ] ŠJ• ƒhƒŒƒi[ƒWp‚ÅŒy‰õ‚µ‚œ”牺‹CŽî‚𔺂€‹CŽî«t᱐t‰Š‚Ì1—á. Žu‘º‘sˆê˜N1, “c”šŒ’ˆê1, ‚Œû@‘å1, “V–쓝”V1, Œ@·G1, “¡“c“N•v1, Œ–{˜a«1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1 (1”å”AŠí): ”å”AŠí‰È‹I—v 2015/12; 61 (12): 493-7.

520012. [‘à]yPresent and Futurez‘O—§‘BŠà‚ɑ΂·‚éfocal therapy: AUA2015‚ł̃fƒBƒx[ƒg‚𓥂܂Š‚Ä. ²“¡ˆÐ•¶ (”å”AŠí): Urology Today 2016/3; 23 (1): 66-7.

522122. [uÀ] ‹ÃŒÅEŽ~ŒŒƒfƒoƒCƒX‚̈À‘S‚ÈŽg‚¢•û. Šâ‘º³Žk (”å”AŠí): “ú–{”å”AŠí‰ÈŠw‰ï2015”N‘²Œã‹³ˆçƒeƒLƒXƒg 2015/4; 20 (1): 206-15. (‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï 2015‘²Œã‹³ˆçƒvƒƒOƒ‰ƒ€)

522123. [uÀ]yŽ¿‹^‰ž“šzProÌPro [”å”AŠí‰È] ‘O—§‘BŠà•úŽËüŽ¡—ÃŒã‚̋ǏŠÄ”­‚ւ̑΍ô (‰¡a@Wš²“¡ˆÐ•¶). ‰¡a@W, ²“¡ˆÐ•¶1 (1”å”AŠí): “ú–{ˆãŽ–V•ñ 2015/6; 4756: 59.

522124. [uÀ]yŽ¿‹^‰ž“šzProÌPro [”å”AŠí‰È] ‘O—§‘BŠà•úŽËüŽ¡—ÃŒã‚̐«‹@”\áŠQ‚ւ̑Ήž (²“¡ˆÐ•¶š–Ø‘º«‹M). ²“¡ˆÐ•¶1, –Ø‘º«‹M (1”å”AŠí): “ú–{ˆãŽ–V•ñ 2015/8; 4766: 58-9.

522125. [uÀ]y“ÁW: “d‹C‰j“®‚̃tƒƒ“ƒeƒBƒA2015zäNã÷ŠàŠÖ˜A’`”’‚Ì“¯’è`“ñŽŸŒ³“d‹C‰j“®‚ðŠÜ‚ÞƒvƒƒeƒI[ƒ€‰ðÍ`. Œ–{˜a« (”å”AŠí): “d‹C‰j“® 2015 2015/9; 59 (2): 121-2.

522126. [uÀ]y“ÁW2: ‘O—§‘B”ì‘åÇŽèp‚̃Rƒc‚ƃgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOz3. HoLEP (ƒzƒ‹ƒ~ƒEƒ€ƒŒ[ƒU[‚É‚æ‚é‘O—§‘BŠjop) ‚̃Rƒc‚ƃgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO. ÝŠy•q–ç, ™“c‰ÀŽq, ‹v•Û¯ˆê, •œŽR‹M”Ž1, Šâ‘º³Žk1 (1”å”AŠí): Prostate Journal 2015/10; 2 (2): 261-7.

522127. [uÀ]y‘æ28‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€zƒƒ{ƒbƒgŽx‰‡• o‹Ÿ‰º‘O—§‘B‘S“Eœp‚ÌŽèp¬Ñ|• o‹Ÿ‰ºªŽ¡“I‘O—§‘B‘S“Eœp‚Æ‚Ì”äŠr|. “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, ’ѺGN1, •œŽR‹M”Ž1, Œ@·G1, “¡“c“N•v1, Œ–{˜a«1, Šâ‘º³Žk1 (1”å”AŠí): –k—¢ˆãŠw 2015/12; 45 (2): 103-7.

522128. [uÀ]y“ÁW: ‘O—§‘BŠà|Šî‘bE—Տ°Œ€‹†‚̍ŐV’mŒ©|zIII. ÅV‚̗Տ°Œ€‹†@11. ‘O—§‘BŠàœ“]ˆÚ‚̐f’f‚ƏWŠw“IŽ¡—Â̍ŐV’mŒ©. ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2 (1”å”AŠí, 2•úŽËü (‰æ‘œ)): “ú–{—Õଠ2016/1; 74 (1): 129-36.

540018. [‚»‚Ì‘Œ] •›‰@’· (f—Ã’S“–) ‚ɏA”C‚µ‚Ä. Šâ‘º³Žk (”å”AŠí): –k—¢‘åŠw•a‰@ƒjƒ…[ƒX 2015/8; 510: 2.

540019. [‚»‚Ì‘Œ]yÀ’k‰ï z‹Žš’ïR«‘O—§‘BŠà (CRPC) ‚ւ̐V‚œ‚ȃAƒvƒ[ƒ` `CRPCŽ¡—Âɂš‚¯‚é–òÜ‘I‘ð‚̃L[ƒ|ƒCƒ“ƒg`. Ži‰ï: ⚁@‘Ps, oÈŽÒ: Eleni Efstathiou, —é–ØŒ[‰x, ²“¡ˆÐ•¶1 (1”å”AŠí): ”å”AŠíŠO‰È 2015/8; 28 (8): 1467-73.

540020. [‚»‚Ì‘Œ] tˆÚAƒ`[ƒ€‚©‚ç”­M‚·‚étˆÚAŠ³ŽÒ‚̉h—{ŠÇ—. ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): CION‰h—{EHŽ–ƒjƒ…[ƒX 2015/10; 28: 1.

540021. [‚»‚Ì‘Œ] tˆÚAŠ³ŽÒ‚ւ̉h—{Žw“±‚Ì•K—v«, ŽwŽŠ‚̃|ƒCƒ“ƒg|ŠO‰Èˆã‚Ì—§ê‚©‚ç|. Îˆä‘å•ã (”å”AŠí): CION‰h—{EHŽ–ƒjƒ…[ƒX 2015/10; 28: 2-3.

540022. [‚»‚Ì‘Œ] –k—¢ˆÚAƒZƒ~ƒi[‚ÉŠñ‚¹‚ā|ƒWƒFƒlƒŠƒbƒNˆã–ò•i‚ւ̑Ήž|. Îˆä‘å•ã (”å”AŠí): 17th KITASATOˆÚAŽs–¯ƒZƒ~ƒi[ 2015/10; p.4.

540023. [‚»‚Ì‘Œ] ”å”AŠí‰È‚É‚š‚¯‚é• o‹ŸŽèp. Šâ‘º³Žk1, ‰Í“à–ŸG, ¬ŒŽ@q (1”å”AŠí): –Ÿ“ú‚ÌŽ¡—ÃŽwj 2015/12; ƒ‰ƒWƒINIKKEI ˆãŠw“Á•Ê”Ô‘g.

[’˜@‘]

620097. [Šwp‘] (•ª’SŽ·•M)y‰Æ‘°«Žîᇊw|‰Æ‘°«Žîᇂ̍ŐVŒ€‹†“®Œü| (“ú–{—Õଠ‘Š§†No.1083)zII. Še˜_@1. ÇŒóŒQ@(21) Hereditary papillary renal cell carcinoma (ˆâ“`«“û“ªót×–EŠà), p.153-6. “¡“c“N•v1, Šâ‘º³Žk1 (1”å”AŠí), “ú–{—Õ଎Ð, ‘åã, 2015/8”­s.

620098. [Šwp‘] (•ª’SŽ·•M)yTumor syndromes (—Տ°‰æ‘œ2015”N10ŒŽ‘Š§†)z[‘æ5Í] ˆâ“`«tŽîᇁ@2. ˆâ“`«“û“ªót×–EŠà (HPRC)@CLINICAL Findings p.165-6. “¡“c“N•v1, Šâ‘º³Žk1 (1”å”AŠí), Šé‰æE•Ò: ‘Δn‹`l, •Ò: ŽR“c³M, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2015/9”­s.

620099. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̏¬Ž™Ž¡—ÃŽwj (‘æ16”Å)z17. ¶BŠíŽŸŠ³@•ïŒs, ‹T“ª•ï”牊, p.659. Šâ‘º³Žk (”å”AŠí), ‘•ÒW: …Œû@‰ë, Žs‹Ž@Œõ, èŽR@O, ˆãŠw‘‰@, “Œ‹ž, 2015/9”­s.

620100. [Šwp‘] (•ª’SŽ·•M)y‘O—§‘BŠà‚Æ’j«œ‘e頏ǁ|ÅVœŠÇ—ƒ}ƒjƒ…ƒAƒ‹ (‰ü’ù‘æ2”Å)zœ“]ˆÚf’f‚É‚š‚¯‚éPET/CT, p174-5. ²“¡ˆÐ•¶ (”å”AŠí), •Ò: ×ˆäF”V, Œ“‡@í, ˆãŠw}‘o”Å, “Œ‹ž, 2015/10”­s.

620101. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽwj (2016”N”Å)z19. ”å”AŠí‰ÈŽŸŠ³@”A“¹Žîᇠ(”A“¹ƒJƒ‹ƒ“ƒNƒ‹‚ðŠÜ‚Þ), p1201. Šâ‘º³Žk (”å”AŠí), ŠÄC: ŽRŒû@“O, –kŒŽŒõ•v, ‘•ÒW: •ŸˆäŽŸ–î, ‚–؁@œ, ¬Žºˆê¬, ˆãŠw‘‰@, “Œ‹ž, 2016/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712018. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Focal Therapy for Pca. Satoh T1: 110th Annual Meeting American Urological Association (2015/5/18), New Orleans, USA. (²“¡ˆÐ•¶1: 1”å”AŠí)

712019. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Tips and Tricks of Laparoscopy Pyeloplasty -Conventional Laparosocopy. Iwamura M1: The 32rd Japan-Korea Urological Congress (2015/9/19), Seoul, Korea. (Šâ‘º³Žk1: 1”å”AŠí)

713088. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Prognostic impact of C-reactive protein kinetics for advanced renal cell carcinoma treated with sunitinib. Fujita T1, Tabata K1, Ishii D1, Matsumoto K1, Yoshida K2, Iwamura M1: 2015 ASCO Annual Meeting (2015/5/29), Chicago, USA. (“¡“c“N•v1, “c”šŒ’ˆê1, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬2, Šâ‘º³Žk1: 1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã)

713089. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Everolimus Combined With Early Tacrolimus Minimization In Renal Transplantation: Multicenter Study In Japan. Hattori Y, Teranishi J, Ishii D1, Yoshida K2, Imai N, Kawarazaki H, Shibagaki Y, Sasaki H, Chikaraishi T, Tomikawa S, Marui Y, Nakamura M: 14th Congress of the Asian Society of Transplantation (2015/8/24), Singapore. (Îˆä‘å•ã1, ‹g“cˆê¬2: 1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã)

713090. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Survey On Anxiety And Behavior For Overseas Travel Of Renal Transplant Patients. Ikeda M1, Ishii D1, Noguchi F2, Tanaka M2, Iwamura M1, Yoshida K3: 14th Congress of the Asian Society of Transplantation (2015/8/24), Singapor. (’r“c¬]1, Îˆä‘å•ã1, –ìŒû•¶”T2, “c’†”üŽ÷2, Šâ‘º³Žk1, ‹g“cˆê¬3: 1”å”AŠí, 2ŠÅŒì•”, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã)

713091. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Three Year Clinical Outcomes Of Once-Daily Tacrolimus Extented-Release Formulation versus Twice-Daily Tacrolimus In De Novo Kidney Transplantation. Yoshida K1,2, Ishii D2, Kohguchi D2, Ohyama T2, Mochizuki K2, Takeuchi Y3, Wakai H, Noguchi F4, Tanaka M4, Ikeda M2: 14th Congress of the Asian Society of Transplantation (2015/8/24), Singapore. (‹g“cˆê¬1,2, Îˆä‘å•ã2, ‚Œû@‘å2, ‘åŽR“N•œ2, –]ŒŽN•œ2, ’|“àN—Y3, Žáˆä—zŠó, –ìŒû•¶”T4, “c’†”üŽ÷4, ’r“c¬]2: 1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí, 3t‘Ÿ“à, 4ŠÅŒì•”)

713092. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Long-Term Follow-Up Of Anti-HLA Antibodies Post Kidney Transplantation Using With Flow-Panel Reactive Antibody. Ishii D1, Kobayashi K1, Hirano S1, Hirayama T1, Tabata K1, Wakai H, Takeuchi Y2, Noguchi F3, Ikeda M1, Iwamura M1, Yoshida K4: 14th Congress of the Asian Society of Transplantation (2015/8/25), Singapore. (Îˆä‘å•ã1, ¬—ÑŒ’‘Ÿ˜Y1, •œ–ìC•œ1, •œŽR‹M”Ž1, “c”šŒ’ˆê1, Žáˆä—zŠó, ’|“àN—Y2, –ìŒû•¶”T3, ’r“c¬]1, Šâ‘º³Žk1, ‹g“cˆê¬4: 1”å”AŠí, 2t‘Ÿ“à, 3ŠÅŒì•”, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã)

713093. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) BUILDING A BALANCED TRUST RELATIONSHIP BETWEEN THE RENAL TRANSPLANT PATIENT ASSOCIATION AND RENAL TRANSPLANT MEDICAL PROFESSIONALS. Ikeda M1, Ishii D1, Hirano S1, Noguchi F2 Yoshida T3, Sakamoto M, Komagata K, Iwamura M1, Yoshida K4: 17th Congress of the European Society for Organ Transplantation (2015/9/13), Brussels, Belgium. (’r“c¬]1, Îˆä‘å•ã1, •œ–ìC•œ1, –ìŒû•¶”T2, ‹g“c•üŽq3, Šâ‘º³Žk1, ‹g“cˆê¬4: 1”å”AŠí, 2ŠÅŒì•”, 3‰h—{•”, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã)

713094. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) EVEROLIMUS, TAC-ER AND MMF DE NOVO RENAL TRANSPLANT RESULTED GOOD GRAFT FUNCTION. Yoshida K1,2, Ishii D2, Takeuchi Y3, Wakai H, Kohguchi D2, Noguchi F4, Ikeda M2, Tanaka M4: 17th Congress of the European Society for Organ Transplantation (2015/9/16), Brussels, Belgium. (‹g“cˆê¬1,2, Îˆä‘å•ã2, ’|“àN—Y3, Žáˆä—zŠó, ‚Œû@‘å2, –ìŒû•¶”T4, ’r“c¬]2, “c’†”üŽ÷4: 1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí, 3t‘Ÿ“à, 4ŠÅŒì•”)

713095. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Renal functional outcomes after laparoscopic partial nephrectomy using dynamic renal scintigraphy. Fujita T1, Nishi M1, Tabata K1, Matsumoto K1, Yoshida K2, Iwamura M1: 33rd World Congress of Endourology & SWL (2015/10/2), London, UK. (“¡“c“N•v1, Œ@·G1, “c”šŒ’ˆê1, Œ–{˜a«1, ‹g“cˆê¬2, Šâ‘º³Žk1: 1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã)

713096. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Transition to robot-assisted laparoscopic prostatectomy is associated with a reduction of positive surgical margin. Tabata K1, Sato T1, Matsumoto K1, Tsumura H1, Hirayama T1, Nishi M1, Fujita T1, Ishii D1, Yoshida K2, Iwamura M1: 33rd World Congress of Endourology & SWL (2015/10/3), London, UK. (“c”šŒ’ˆê1, ²“¡ˆÐ•¶1, Œ–{˜a«1, ’ѺGN1, •œŽR‹M”Ž1, Œ@·G1, “¡“c“N•v1, Îˆä‘å•ã1, ‹g“cˆê¬2, Šâ‘º³Žk1: 1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã)

713097. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Impact of prior platinum on patients receiving salvage systemic therapy for advanced urothelial carcinoma. Sonpavde G, Pond GR, Di Lorenzo G, Buonerba C, Rozzi A, Lanzetta G, Necchi A, Giannatempo P, Raggi D, Matsumoto K1, Choueiri TK, Mullane S, Niegisch G, Albers P, Lee JL, Kitamura H, Kume H, Bellmunt J: 2016 Genitourinary Cancers Symposium (2016/1/7), San Francisco, USA. (Œ–{˜a«1: 1”å”AŠí)

713098. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) High-grade hydronephrosis is sustained even in patents with improved renal function after laparoscopic pyeloplasty for ureteropelvic junction obstruction. Nishi M1, Matsumoto K1, Tabata K1, Ishii D1, Tsumura H1, Hirayama T1, Fujita T1, Iwamura M1: EAU 2016 (The 31st European Association of Urology Congress) (2016/3/12), Munchen, Germany. (Œ@·G1, Œ–{˜a«1, “c”šŒ’ˆê1, Îˆä‘å•ã1, ’ѺGN1, •œŽR‹M”Ž1, “¡“c“N•v1, Šâ‘º³Žk1: 1”å”AŠí)

722088. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) • o‹Ÿ‰ºt“Eœp‚ÌŠî–{Žè‹Z`ENSEAL‚ÌŽg‚¢•û`. Šâ‘º³Žk (”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

722089. [Šw‰ï (‘S‘)] (‘²Œã‹³ˆçƒvƒƒOƒ‰ƒ€) ”å”AŠí• o‹ŸŽèp‚ÌŠî–{Žè‹Z. Ž›’n•q˜Y, ‰HŸº—F‘¥, Šâ‘º³Žk1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/19), ‹à‘ò.

722090. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘Šú‚ª‚ñ‚ÌŽ¡—à (”ñŠÏŒŒ“IŽ¡—Ã). ²“¡ˆÐ•¶ (”å”AŠí): ‘æ18‰ñ“ú–{ˆãŠw‰ïŒöŠJƒtƒH[ƒ‰ƒ€ (2015/7/4), “Œ‹ž.

722091. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) äNã÷ŠàŠÖ˜A’`”’‚Ì“¯’è`“ñŽŸŒ³“d‹C‰j“®‚ðŠÜ‚ÞƒvƒƒeƒI[ƒ€‰ðÍ`. Œ–{˜a« (”å”AŠí): ‘æ66‰ñ“ú–{“d‹C‰j“®Šw‰ï‘‰ï (2015/9/5), “Œ‹ž.

722092. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) tˆÚA‚É‚š‚¯‚é–ò•š—Ö@‚̏d—v«. ‹g“cˆê¬1,2, Îˆä‘å•ã2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ9‰ñ“ú–{t‘Ÿ•a–ò•š—Ö@Šw‰ï ŠwpW‰ïE‘‰ï2015 (2015/10/25), å‘ä.

722093. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv ) ‘O—§‘BŠàœ“]ˆÚ‚ɑ΂·‚éƒ]ƒŒƒhƒƒ“Ž_‘Šú•¹—p“à•ª”å—Ö@‚Ì—LŒø«: ZAPCAŽŽŒ±Œ‹‰Ê•ñ. _”g‘åŒÈ, ‰ê–{•qs, •À–؏rˆê, “¡–{ŽG, ²“¡•¶Œ›, ¬“cL‘Ÿ˜Y, ²“¡ˆÐ•¶1, âV“¡‰p˜Y, ™Œ³Š²Žj, ’à“‡@~, ‘CX’ŒÆ, ‰oì@W, Žðˆä‰pŽ÷, Ž›’n•q˜Y, ¬ì@C (1”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

722094. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv )y‘O—§‘B: ‘O—§‘B‚ª‚ñ•úŽËü—Ö@‚̐V‚œ‚ȍH•vz•úŽËüŽ¡—ÃŒã‚̋ǏŠÄ”­‘O—§‘BŠà‚ɑ΂·‚éfocal salvage HDR brachytherapy‚ÌŒŸ“¢. ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, ’ѺGN1, “c”šŒ’ˆê1, ŒŽ@•q«3, –öàVM”V4, ’r“cŸb1, •âáÁ“ñ1, –k–ì‰ëŽj2, ”nêŽu˜Y1, ˆäã—D‰î3, ‘ì˜ad2, Šâ‘º³Žk1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3•úŽËü (‰æ‘œ), 4•a—): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2015/9; 50 (3): 387.

722095. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ŽÀ—Տ°‚©‚çl‚Š‚鍡Œã‚ÌCRPCŽ¡—Ð헪`“ú–{‚©‚ç‚̃Gƒrƒfƒ“ƒX‚ÆŽg—pŒoŒ±‚𓥂܂Š‚ā`. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

722096. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv ) ”ñ“]ˆÚ«tŠà‚É‚š‚¯‚郊ƒ“ƒpßŠsŽ‚Ì–ðŠ„. ‰YãTŽi, •àV˜aG, ’r“cŸb1, ãŒû˜aŽ , ˆÀHt‹P, ‰i–{«ˆê, ‰ª@@—D, ‰ªª’J—˜ˆê (1”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s.

722097. [Šw‰ï (‘S‘)] (JSE‹³ˆçƒvƒƒOƒ‰ƒ€) • o‹ŸŽèp‚É‚š‚¯‚éƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO. Šâ‘º³Žk (”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/19), Vh, Japanese Journal of Endourology 2015; 28 (3): 150/

722098. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ã• •”Žèp—ð‚Ì‚ ‚é•›tEt• o‹Ÿ‰ºŽèp. “¡“c“N•v1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/21), Vh.

722099. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • •”ŽèpŠù‰—ð‚̓ƒ{ƒbƒgŽx‰‡• o‹Ÿ‰º‘O—§‘B‘S“Eœp (RALP) ‚ɉe‹¿‚ð‹y‚Ú‚·‚©? Šâ‘º³Žk1, “c”šŒ’ˆê1, ’ѺGN1, ²“¡ˆÐ•¶1 (1”å”AŠí): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

722100. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • o‹Ÿ‰º‘O—§‘B‘S“E“Eop‚É‚š‚¯‚鍂‰ð‘œ“x3DƒCƒ[ƒWƒVƒXƒeƒ€‚Ì—L—p«: ‚‰ð‘œ“x2DƒCƒ[ƒWƒVƒXƒeƒ€‚Æ‚Ì–³ìˆ×”äŠrŽŽŒ±. –؉ºG•¶, ’†ì@Œ’, ‰PˆäK’j, Šâ‘º³Žk1, ˆÉ“¡–ŸG, ‹{“ˆ@“N, ¯@º•v, rˆä—zˆê, ”nêŽu˜Y1, Ž›’n•q˜Y, Œ“cŒöŽu (1”å”AŠí): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

722101. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) tˆÚA‚É‚š‚¯‚éƒ`[ƒ€ˆã—Â̏d—v« (ƒI[ƒo[ƒrƒ…[). ‹g“cˆê¬1,2, Îˆä‘å•ã2, –ìŒû•¶”T3, ’r“c¬]2, ‹{â—Dl4, ‹g“c•üŽq5, Œ‘ò—Ç‘Ÿ6 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí, 3ŠÅŒì•”, 4–òÜ•”, 5‰h—{•”, 6ƒŠƒnƒrƒŠ•”): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/24), ’¹Žæ.

722102. [Šw‰ï (‘S‘)] (Educational Lecture) ”å”AŠí• o‹Ÿ‹Zp”F’è‚ÉŒü‚¯‚œªŽ¡“It“Eœp‚ÌŠî–{Žè‹Z. Šâ‘º³Žk (”å”AŠí): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/10), ‘åã.

723629. [Šw‰ï (‘S‘)] (‘‰ïÜ‰ž•åƒ|ƒXƒ^[EŒû‰‰) ƒnƒCƒŠƒXƒN‘O—§‘BŠà‚É‚š‚¯‚éHigh-dose-rate brachytherapy: —\Œã—\‘ªˆöŽq‚Æ‚µ‚Ä‚ÌPSA nadir‚ÌŒŸ“¢. ’ѺGN1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, ÎŽR”ŽžŠ2, ìã³Œá2, ŠÖŒûˆ©ˆß2, ¬X³Žq2, ’r“cŸb1, •âáÁ“ñ1, “¡“c“N•v1, ‘ì˜ad2, Šâ‘º³Žk1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò, “ú–{”å”AŠí‰ÈŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W (CD|ROM) 2015; 103rd: ROMBUNNO. AOP-132.

723630. [Šw‰ï (‘S‘)] (‘‰ïÜ‰ž•åƒ|ƒXƒ^[EŒû‰‰) t”AŠÇ‘S“Eœp‚É‚š‚¯‚郊ƒ“ƒpßŠsŽ‚ÌŽ¡—ÓIˆÓ‹`. ’r“cŸb1, Œ–{˜a«1, —§‰Ô‹MŽj1, •œ–ìC•œ1, ãŒû˜aŽ , •àV˜aG, ‰YãTŽi, “¡“c“N•v1, ‰ªª’J—˜ˆê, Šâ‘º³Žk1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723631. [Šw‰ï (‘S‘)] (‘‰ïÜ‰ž•åƒ|ƒXƒ^[EŒû‰‰) “œ”A•aŒŒ‰t“§ÍŠ³ŽÒ‚Ö‚ÌŠÈ•Ö‚ÈŒŒ“œŠÇ—HŽ–—Ö@: Šî‘bƒJ[ƒ{ƒJƒEƒ“ƒg–@—L—p«‚š‚æ‚Ñ‚»‚Ì•K—v«‚ÌŒŸ“¢. •º“¡@“§, ŽOãŒ›Žq, –k“‡KŽ}, ”ò“c”ü•ä, ‘q“cN‹v, Îˆä‘å•ã1,Žáˆä—zŠó, ‰““¡’‰—Y, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723632. [Šw‰ï (‘S‘)] (‘‰ïÜ‰ž•åƒ|ƒXƒ^[EŒû‰‰) äNã÷Šà•a—–{•W–{‚É‚š‚¯‚éperiplakin”­Œ»‚ÉŠÖ‚·‚錟“¢. •œ–ìC•œ1, Œ–{˜a«1, ’r“cŸb1, ¬—ÑŒ’‘Ÿ˜Y1, Š™“c—TŽq, ŽÔ@‰pr, “¡“c“N•v1, ²“¡—Yˆê2, ‰oì@W, Šâ‘º³Žk1 (1”å”AŠí, 2ˆã—Éq¶Šw•”): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723633. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 2ŽŸtˆÚAŒã‘Šú‚É1ŽŸˆÚAt‚É”­Ç‚µ‚œ‹CŽî«t᱐t‰Š. ¬—ÑŒ’‘Ÿ˜Y1, ‹g“cˆê¬2, Îˆä‘å•ã1, –]ŒŽN•œ1, ‘åŽR“N•œ1, ‚Œû@‘å1, ì‘º•ä1, ‚‹Ž—Tˆê˜Y, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723634. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒŽperiplakin‚ÌäNã÷ŠàÇ—á‚Å‚Ì“®‘Ô‚ÉŠÖ‚·‚錟“¢. —§‰Ô‹MŽj1, Œ–{˜a«1, –]ŒŽN•œ1, •œŽR‹M”Ž1, Œ@·G1, Îˆä‘å•ã1, Ÿ“c^s, “¡“c“N•v1, ²“¡—Yˆê2, Šâ‘º³Žk1 (1”å”AŠí, 2ˆã—Éq¶Šw•”): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723635. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž©ŒÈR‘̉ðÍ‚ð—˜—p‚µ‚œäNã÷ŠàŠ³ŽÒ‚É‚š‚¯‚錌Ž’†Žîᇊ֘ARŒŽ‚Ì’Tõ. –]ŒŽN•œ1, Œ–{˜a«1, •œŽR‹M”Ž1, ¬—ÑŒ’‘Ÿ˜Y1, Œ@·G1, ’ѺGN1, “c”šŒ’ˆê1 ,“¡“c“N•v1, ²“¡—Yˆê2, Šâ‘º³Žk1 (1”å”AŠí, 2ˆã—Éq¶Šw•”): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723636. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”DP…tÇ‚ÌŒŸ“¢. “y‹Ž³l1, •œˆäËŽi, •œŽR‹M”Ž1, “c”šŒ’ˆê1, “¡“c“N•v1 ,Šâ‘º³Žk1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723637. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠŒF×–EŽî‚ÌŽèp’†•sˆÀ’è‚ȏzŠÂ“®‘Ô‚ð—\‘ª‚·‚éˆöŽq‚ÌŒŸ“¢. ãŒû˜aŽ , ‰ª@@—D, ‚‹Ž^‘Ÿ˜N, “c”š^—œŽq, ’r“cŸb1, •àV˜aG, ‰YãTŽi, ‰ªª’J—˜ˆê (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723638. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Gemcitabin/Docetaxel•¹—p‰»Šw—Ö@ (GD—Ö@) ‚É‚æ‚èSD‚ðˆÛŽ‚µ‚Ä‚¢‚éÄ”­Œã• –ŒŽ‰–b“÷Žî (”S‰tŒ^) ‚̈ê—á. “c”š^—œŽq, ‚‹Ž^‘Ÿ˜N, ãŒû˜aŽ , ’r“cŸb1, •àV˜aG, ‰YãTŽi, ‰ªª’J—˜ˆê (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723639. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”x–¬ŠÇ‹ØŽîÇ‚ɍ‡•¹‚µ‚œ‘œ”­tŒŒŠÇ‹ØŽ‰–bŽî‚Ì1—á. ‚‹Ž^‘Ÿ˜N, “c”š^—œŽq, ãŒû˜aŽ , ’r“cŸb1, •àV˜aG, ‰YãTŽi, ‰ªª’J—˜ˆê (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723640. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹Ø‘w”ñZ«äNã÷Šà‚ɑ΂·‚鏉‰ñTURBTŽž‚ÌŽîᇐ؏œŽüˆÍ, ’ê•”¶ŒŸ‚ÌŒŸ“¢. ‘ºã‘אŽ1, ‘呐@—m, “¡é‹M‹³, ‰F“s‹{‘ñŽ¡ (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723641. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒhƒŒƒi[ƒW‚ð—v‚µ‚œŒ‹Î«t᱐t‰Š‚̗Տ°“IŒŸ“¢. ‘OŽR—Ç‘Ÿ1, ŽR“c‘׎j1, ‘åì‚ ‚³Žq, ìã’B‰›, Œ“c‘å‰î1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723642. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”A˜H’°ŠÇᑂɑ΂µ‚ÄOTSC (Over The Scope Clip) ƒVƒXƒeƒ€‚ðŽg—p‚µ‚œ2Ç—á. ŽR“c‘׎j1, ‘OŽR—Ç‘Ÿ1, ‘åì‚ ‚³Žq, ‰œ–ì‹I•F, ìã’B‰›, Œ“c‘å‰î1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/18), ‹à‘ò.

723643. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) is«t×–EŠà‚ɑ΂·‚éIL-2 + IFN-a + tegafur uracil (IAT) —Ö@‘æII‘ŠŽŽŒ±. ‰Á“¡’qK, Šâ‘º³Žk1 ,“¡“c“N•v, ¡ˆä’q”V, Ö“¡œˆê, ‘åé‹g‘¥, ì“c@–], •y“c‘P•F (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/19), ‹à‘ò.

723644. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰»Šw—Ö@ŠùŽ¡—Ðis«”A˜Hã”çŠà‚ɑ΂·‚éGemcitabin/Nedaplatin—Ö@‚ÌŒŸ“¢. Œ–{˜a«1, •œŽR‹M”Ž1, ’r“cŸb1, Œ@·G1, ’ѺGN1, Îˆä‘å•ã1, “c”šŒ’ˆê1, “¡“c“N•v1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/19), ‹à‘ò.

723645. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹Žš’ïR«‘O—§‘BŠà‚É‚š‚¯‚éEnzalutamide‚ÌŽg—pŒoŒ±. Žu‘º‘sˆê˜N1, “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, ’ѺGN1, “V–쓝”V1, ì‘º•ä1, —§‰Ô‹MŽj1, ª–{—Žq1, Îˆä‘å•ã1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/19), ‹à‘ò.

723646. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹Žš’ïR«‘O—§‘BŠà‚ɑ΂·‚éV‹KŽ¡—Öò‚ÌŽg—pŒoŒ±. ‘åŽR“N•œ1, Žá“c•”—zŽi1, ‰œ–ì‹I•F, Šâ‘º³Žk1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/19), ‹à‘ò.

723647. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) TUR-P, HolepŒã‚ÉŒ©‚‚©‚Á‚œ‘O—§‘BŠà‚̗Տ°“IŒŸ“¢. ‰œ–ì‹I•F, Žá“c•”—zŽi1, ‘åŽR“N•œ1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/19), ‹à‘ò.

723648. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Šú‘O—§‘B‚ª‚ñ‚ɑ΂µ‚ăAƒ“ƒhƒƒQƒ“œ‹Ž—Ö@‚É‚æ‚é‘O—§‘B‘̐Ϗk¬Œã‚ÉŽ{s‚µ‚œŒo”A“¹“Iƒ}ƒCƒNƒ”g‚‰·“x—Ö@‚É‚æ‚鑁Šú‘O—§‘BŠà‚Ì—LŒø‚ÈŽ¡—Ö@: 12”N‚ÌŽ¡—ÃŒoŒ±. aŒûG”V, ¬ŽÄ@Œ’, dé@—T, —é–Ø—²‘å, ‘ŠŒŽ³O, ’†žŠO—², ™“c@“Ö1, Žu‘º@“N (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/19), ‹à‘ò.

723649. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹Ÿ‰º‘O—§‘B‘S“Eœp‚̏‰ŠúŽ¡—ЬÑ: • o‹Ÿ‰º‘O—§‘B‘S“Eœp‚Æ‚Ì”äŠr. “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, ’ѺGN1, ¬—ÑŒ’‘Ÿ˜Y1, •œŽR‹M”Ž1, Œ@·G1, Žu‘º‘sˆê˜N1, “V–쓝”V1, “¡“c“N•v1, Œ–{˜a«1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/20), ‹à‘ò.

723650. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ªŽ¡“I‘O—§‘B‘S“EœpŒã‚Ì”AŽž‹Ö‚É‚š‚¯‚élH”A“¹Š‡–ñ‹Ø‚Ì—L—p«. •œŽR‹M”Ž1, •âáÁ“ñ1, Žu‘º‘sˆê˜N1, ì‘º•ä1, •œ–ìC•œ1, Œ–{˜a«1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/20), ‹à‘ò.

723651. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éƒ`ƒƒVƒ“ƒLƒi[ƒ[‘jŠQ–òŽ¡—Âɂš‚¯‚éC”œ‰ž«’`”’‚̈Ӌ`. “¡“c“N•v1, •œŽR‹M”Ž1, Îˆä‘å•ã1, “c”šŒ’ˆê1, Œ–{˜a«1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/20), ‹à‘ò.

723652. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚郍ƒ{ƒbƒgŽx‰‡• o‹Ÿ‰º‘O—§‘B“Eœp‚̏‰ŠúŒoŒ±. ‚“cŽ¡Žq1, ‰©@‰p–Î, Žá“c•”—zŽi1, “y‹Ž³l1, ‘å–x@—, Šâ‘º³Žk1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/20), ‹à‘ò.

723653. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é‹CäNã÷‰ºcohen–@‚ÌŽ¡—ЬÑ. ì‘º•ä1, Œ@·G1, •œŽR‹M”Ž1, ’ѺGN1, “c”šŒ’ˆê1, Îˆä‘å•ã1, “¡“c“N•v1, Œ–{˜a«1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/20), ‹à‘ò.

723654. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é• o‹Ÿ‰ºäNã÷‘S“Eœp‚̗Տ°“IŒŸ“¢. –Œ–؏l1, •œ–ìC•œ1, ’r“cŸb1, “ì“c@—@1, “c”šŒ’ˆê1, ‰©@‰p–Î, “c‰ª‰ÀŒ›1, Â@‹Pº, Šâ‘º³Žk1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/20), ‹à‘ò.

723655. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “¯Ží‘¢ŒŒŠ²×–EˆÚAŒã‚̃EƒBƒ‹ƒX«oŒŒ«äNã÷‰Š‚ɑ΂·‚é”å”AŠí‰È“IŠO‰ÈŽ¡—Â̈Ӌ`. •àV˜aG, ‚‹Ž^‘Ÿ˜N, “c”š^—œŽq, ãŒû˜aŽ , ’r“cŸb1, ‰YãTŽi, ‘º“c_Ž, ‰ªª’J—˜ˆê, Î–ȈêÆ, ’JŒûCˆê (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/20), ‹à‘ò.

723656. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚錋Î«t᱐t‰Š‚̗Տ°“IŒŸ“¢. Žá“c•”—zŽi1, ‰œ–ì‹I•F, ‘åŽR“N•œ1 (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/20), ‹à‘ò.

723657. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒAƒ“ƒhƒƒQƒ“œ‹Ž—Ö@‚É”º‚€œ‘e頏Ç: ƒfƒmƒXƒ}ƒu60 mg»Ü‚É‚š‚¯‚é’áƒJƒ‹ƒVƒEƒ€ŒŒÇ‚ÌŒŸ“¢. ‚Œû@‘å1, ²“¡ˆÐ•¶1, ’ѺGN1, “c”šŒ’ˆê1, ¬—ÑŒ’‘Ÿ˜Y1, –]ŒŽN•œ1, •œŽR‹M”Ž1, ‹àŽqŽu•Û1, “ì“c@—@1, ‰ªè”ü‘ãŽq2, Šâ‘º³Žk1 (1”å”AŠí, 2–òÜ•”): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/21), ‹à‘ò.

723658. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) tˆÚAŒã‚̐t”A˜HŒnˆ««Žîᇔ­¶Ç—á‚ÌŒŸ“¢. Îˆä‘å•ã1, ‹g“cˆê¬2, –]ŒŽN•œ1, ¬—ÑŒ’‘Ÿ˜Y1, •œ–ìC•œ1, ª–{—Žq1, Žáˆä—zŠó, ’r“c¬]1, “¡“c“N•v1, ‰““¡’‰—Y, ‚‹Ž—Tˆê˜Y, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/21), ‹à‘ò.

723659. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘O—§‘BŠà‘Ò‹@—Ö@‚É‚š‚¯‚éV‹KƒoƒCƒIƒ}[ƒJ[: ‚ª‚ñŒ^ƒAƒ~ƒmŽ_ƒgƒ‰ƒ“ƒXƒ|[ƒ^[LAT1‚Ì—L—p«. ²“¡ˆÐ•¶1, –öàVM”V2, ‰ªˆÀ@ŒM2, “c”šŒ’ˆê1, ’ѺGN1, ‰““¡@m, ”nêŽu˜Y1, ‘º‰_–FŽ÷2, Šâ‘º³Žk1 (1”å”AŠí, 2•a—): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/21), ‹à‘ò.

723660. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “à•ª”å—Ö@’†‚Ì‘O—§‘BŠàÇ—á‚Ì‘O—§‘B”ì‘åÇ‚ɑ΂µƒzƒ‹ƒ~ƒEƒ€EƒŒ[ƒU[‘O—§‘BŠjop (HoLEP) ‚ðŽ{s‚µ‚œ2—á. ™“c‰ÀŽq, ÝŠy•q–ç, ™“c@“Ö1, •œŽR‹M”Ž1, “¡“c“N•v1, Žu‘º@“N, ‹g“cˆê¬2, ‹v•Û¯ˆê, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/21), ‹à‘ò.

723661. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) •›tŽèp89Ç—á‚ÌŒŸ“¢. ‰ªª’J—˜ˆê, ‰YãTŽi, •àV˜aG, ’r“cŸb1, ãŒû˜aŽ , “c”š^—œŽq, ‚‹Ž^‘Ÿ˜N, –ìèŒ\‰Ä (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/21), ‹à‘ò.

723662. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) tŠà‚É‚š‚¯‚郊ƒ“ƒpßŠsŽ‚̈Ӌ`‚ðÄl‚·‚é. ‰YãTŽi, •àV˜aG, ’r“cŸb1, “c”š^—œŽq, ãŒû˜aŽ , ‚‹ŽV‘Ÿ˜N, ‰ª@@—D, ‰ªª’J—˜ˆê (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/21), ‹à‘ò.

723663. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PCA3ƒXƒRƒA‚ÆPSA free/total”ä‚ð—p‚¢‚œ—vŽ¡—ÑO—§‘BŠà—\‘ªƒmƒ‚ƒOƒ‰ƒ€‚̍쐬. ‘å“Œ‹MŽu, •ÊŠ‰pŽ¡1, ‰z“c’|˜N, rì@F, …–ì—²ˆê, ’†“‡@~ (1”å”AŠí): ‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/4/21), ‹à‘ò.

723664. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) tŠà‚̍Ĕ­‚͍‚—ŽÒ‚Ù‚Ç—\Œã•s—Ç‚©? ‰ªª’J—˜ˆê, ’r“cŸb1, ãŒû˜aŽ , •àV˜aG, “c”š^—œŽq, ‚‹Ž^‘Ÿ˜N, ‰YãTŽi (1”å”AŠí): ‘æ28‰ñ“ú–{˜V”N”å”AŠí‰ÈŠw‰ï (2015/5/9), •lŒ.

723665. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) LDL‹z’…—Ö@‚ÆŒŒ‰t“§Í‚Ì“¯Žž•¹—p—Ö@Ž{s‚ɂ‚¢‚Ä‚ÌŽŽ‚Ý. ‰Í‘º”ŽŽq, Žáˆä—zŠó, à_èG—æŽq, “c•Ó–¢—ˆ, “n粒qŽq, ˆ¢•”“ޒÔü, –Ø‘ºŠG”ü, •º“¡@“§, ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/26), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 640.

723666. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”p—pÇŒóŒQŠ³ŽÒ‚ª•às‰Â”\‚Æ‚È‚Á‚œÇ—á`ˆ€‘·‚ƃo[ƒWƒ“ƒ[ƒh‚ð•à‚Þ‚œ‚߂Ɂ`. ŠÚ–ì—Y‹M, –Ø‘ºŠG”ü, œA]–r–€, ”üK—¯”ü, ›@—L‹I, Žáˆä—zŠó, •º“¡@“§, ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/26), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 686.

723667. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–ƒNƒŠƒjƒbƒN‚É‚š‚¯‚éVAŠÇ—‚ÌŒŸ“¢. ŒK“c”䍻], ã‘º@ŒO, ‹à“cKi, ‚‹Ž”ÍŽq, ¬—јa‘ã, “º’J_”ü, ŠÛŽR–ƒ—¢, Žsì@–Ÿ, Ž‹{—Ç‘Ÿ, ‹g“c@àˆ, Îˆä‘å•ã1, ‹g“cˆê¬2, óˆä’qŠî (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/26), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 703.

723668. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–ƒNƒŠƒjƒbƒN‚Ì‹³ˆçŽå”C‚Æ‚µ‚ĐVlŠÅŒìŽt‚Ö‚ÌŽw“±`“–ƒNƒŠƒjƒbƒN‚̃}ƒjƒ…ƒAƒ‹‚ðŠî‚ÉŽw“±‚ðŽn‚ß‚Ä. ––‰i—TŽq, —Ž‡^Šó, ‚‹Ž@—º, ‚‹Ž_—Y, Šp“c—²r, —é–؁@‘å, ‹g“cˆê¬1,2, Îˆä‘å•ã2, ‚‹Ž—Tˆê˜Y (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/26), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 729.

723669. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘OŠóŽßon-line HDF‚ÍFGF-23‚̏œ‹Ž‚É—D‚ê‚Ä‚¢‚é. ŒIŒŽ‰ÀF, ŽR“à•‡”ü, ×’JLŠC, ’r糓ޕێq, ’J—Ñ—R”ü, •œ“cŒbˆê, Š™“c‚¯‚¢Žq, •àVD, âV“¡@‹B, Îˆä‘å•ã1, ²“¡ˆÐ•¶1, Žá—Ñ–õ‹v, ŸNˆäŒ’Ž¡ (1”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 558.

723670. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆÚAt‹@”\”pâŒã‚ɍݑ‰t“§Í‚𓱓ü‚µ‚œ7Ç—á. Žáˆä—zŠó, ˆ¢•”“ޒÔü, ‰Í‘º”ŽŽq, ™–{’ŒŽq, –Ø‘ºŠG”ü, ŽR’†—¢‰À, •º“¡@“§, ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 753.

723671. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚š‚¯‚é•n¢Š³ŽÒ‚ɑ΂·‚éˆÛŽ“§Í“±“ü‚ÌŒoŒ±. ŠÃ—˜‰ÀŽj, ’†“ˆÍ‹M, ŒŒŽO˜a, Žáˆä—zŠó, “葺—F—², ’·ÀrG, ¬‹v•ÛŒªˆê, •º“¡@“§, ŽÄŒŽL‹v, ‹g“cˆê¬1,2, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 756.

723672. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚š‚¯‚铧Í‰tŽò‰». ‰Y•Órˆê˜Y, ¬“‡@–G, “葺—F—², –Ø‘ºŠG”ü, ˆ¢•”“ޒÔü, ×–썂Žu, Žáˆä—zŠó, ¬‹v•ÛŒªˆê, ’†“‡Í‹M, •º“¡@“§, ‹g“cˆê¬1,2, ’|àV^Œá, ìŒGŽ÷ (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 756.

723673. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ~ƒƒƒ“ƒ}[‚É‚š‚¯‚铧Í‰tŽò‰»Žx‰‡Šˆ“®. –Ø‘ºŠG”ü, ˆ¢•”“ޒÔü, ¬“‡@–G, ÷‘ò‹Mr, ÷‘ò—ž”T, ‰Y•Órˆê˜Y, ‘ëàVˆŸ—R”ü, ˆÀ•”‹M”V, ¬—Ñ‚±‚žŒb, “葺—F—², ¬‹v•ÛŒªˆê, Žáˆä—zŠó, •º“¡@“§, ‹g“cˆê¬1,2, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 756.

723674. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒxƒgƒiƒ€‚É‚š‚¯‚铧Í‰tŽò‰»‚Ö‚ÌŽæ‚è‘g‚ÝŽx‰‡. ŒŒŽO˜a, ¬‹v•ÛŒªˆê, “c’†³ŒÈ, ¬“‡@–G, “葺—F—², Žáˆä—zŠó, ’†“ˆÍ‹M, •º“¡@“§, ŽÄŒŽL‹v, ‹g“cˆê¬1,2, ’|àV^Œá, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 756.

723675. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚š‚¯‚铧ÍŠÖ˜Aˆã—Ï]Ž–ŽÒˆç¬Žx‰‡ƒvƒƒWƒFƒNƒg. Žáˆä—zŠó, •º“¡@“§, ¬‹v•ÛŒªˆê, “葺—F—², ’·ÀrG, ’†“ˆÍ‹M, ŽÄŒŽL‹v, ‹g“cˆê¬1,2, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 757.

723676. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒxƒgƒiƒ€Eƒ~ƒƒƒ“ƒ}[EƒJƒ“ƒ{ƒWƒA‚É‚š‚¯‚ét“§ÍŠÖ˜AŠwp‘gD‚̏ó‹µ. ŒŒŽO˜a, ¬‹v•ÛŒªˆê, ¬“‡@–G, “葺—F—², Žáˆä—zŠó, ’†“ˆÍ‹M, •º“¡@“§, ŽÄŒŽL‹v, ‹g“cˆê¬1,2, ’|àV^Œá, ŽR‰º–Ÿ‘×, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 757.

723677. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “œ”A•a“§ÍŠ³ŽÒ‚̉ž—pƒJ[ƒ{ƒJƒEƒ“ƒg“±“üŒø‰Ê. ŽOãŒ›Žq, •º“¡@“§, ‘å’†‰ÀŽq, “c”šŒ’ˆê1, “¡“c“N•v1, Œ–{˜a«1, ²“¡ˆÐ•¶1, ”ò“c”ü•ä, ‘q“cN‹v, –k“‡KŽ} (1”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 788.

723678. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ut•s‘Sƒ`[ƒ€ˆã—ÃŒ€‹†‰ïv‚Ö‚Æ“WŠJ‚µ‚œ6”NŠÔ‚ÌŠˆ“®. ’r“c¬]1, –ìŒû•¶”T2, “c’†”üŽ÷2, ¬âŽu•Û, Îˆä‘å•ã1, ‹g“cˆê¬3 (1”å”AŠí, 2ŠÅŒì•”, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 793.

723679. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) tˆÚAŒã‚Ì“§ÍÄ“±“üÇ—á‚̗Տ°“IŒŸ“¢. Îˆä‘å•ã1, ¬—ÑŒ’‘Ÿ˜Y1, •œ–ìC•œ1, Œ–{˜a«1, Žáˆä—zŠó, ’r“c¬]1, –ìŒû•¶”T2, ’|“àN—Y3, Šâ‘º³Žk1, ‹g“cˆê¬4 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 811.

723680. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒKƒ“ƒ}ü–Å‹Û‰ñ˜H‚ÌŽg—pŒoŒ±. •œ–ì’š‹v, Â–Ø–ÎŽ÷, ‚‹Ž@—º, ‚‹Ž_—Y, Šp“c—²r, —é–؁@‘å, ‹g“cˆê¬1,2, Îˆä‘å•ã2, ‚‹Ž—Tˆê˜Y (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 853.

723681. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒjƒvƒŽÐ»ƒwƒ‚ƒ_ƒCƒAƒtƒBƒ‹ƒ^FIX-210Seco‚̐«”\•]‰¿. ×’JLŠC, ŽR“à•‡”ü, ŒIŒŽ‰ÀF, ’r糓ޕێq, ’J—Ñ—R”ü, •œ“cŒbˆê, •àVD, —é–؁@•à, âV“¡@‹B, Îˆä‘å•ã1, ²“¡ˆÐ•¶1, ‹g“cˆê¬2, ŸNˆäŒ’Ž¡ (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/28), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 922.

723682. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “œ”A•aHDŠ³ŽÒ‚Å‚ÌDPP-4‘jŠQ–òƒTƒLƒTƒOƒŠƒvƒ`ƒ“‚ÌŒø‰Ê: ƒCƒ“ƒXƒŠƒ““Š—^—ÊŒž­Œø‰ÊÇ—á‚Ì‘¶Ý. •º“¡@“§, ’|ìŸŽ¡, Žu‘º@“N, ¬–““ñ–ç, “à“c–Lº, ‰““¡’‰—Y, ”nêŽu˜Y1, ”ò“c”ü•ä, ‘q“cN‹v, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/28), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 931.

723683. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰EtŒ‹Î‚É‚æ‚è”sŒŒÇ‚ð’悵‚œ“§ÍÇ—á‚ɑ΂µƒzƒ‹ƒ~ƒEƒ€EƒŒ[ƒU[‚ðŽg—p‚µ‚œŒo”A“¹“I”AŠÇŒ‹Î”jÓp‚ðŽ{s‚µ‚œˆê—á. ™“c‰ÀŽq, ÝŠy•q–ç, ²“¡’Œ”V, ‘å’JŠ°”V, ˆÉŒŽŒº‰p, ™“c@“Ö1, Žu‘º@“N, ˜ZŠp@Žü, “¡“c“N•v1, ‹g“cˆê¬2, ‹v•Û¯ˆê, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/28), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 949.

723684. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “§ÍƒNƒŠƒjƒbƒN‚É‚š‚¯‚éî•ñƒZƒLƒ…ƒŠƒeƒB‘΍ô. “n糗FŽq, ŽR’†—¢‰À, –kè‘Žq, ‹g•G”ü, ‘ëŽR—tŽq, ”üK—¯”ü, Žáˆä—zŠó, •º“¡@“§, ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/28), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 960.

723685. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹ß—׏Z–¯‚ÌŠñ•t‚É‚æ‚蓧Í“±“ü‚ÉŽŠ‚Á‚œƒJƒ“ƒ{ƒWƒA‚Å‚Ì––Šút•s‘SŠ³ŽÒ‚Ì“§Íó‹µ‚Ɖh—{ó‘Ô. Žáˆä—zŠó, ’·ÀrG, •º“¡@“§, ‹g“cˆê¬1,2, ìŒGŽ÷, –k“‡KŽ}, “c‘º’qŽq (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ3‰ñ“ú–{t•s‘S‰h—{Œ€‹†‰ïŠwpW‰ïE‘‰ï (2015/7/5), ‰¡•l.

723686. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹ÃŒÅ—Ö@Œp‘±‰º‚ÅŽ{s‚µ‚œƒzƒ‹ƒ~ƒEƒ€EƒŒ[ƒU[‚ð—p‚¢‚œŒo”A“¹“I”AŠÇÓÎp‚ÌŒŸ“¢. ™“c‰ÀŽq, ‹v•Û¯ˆê, •œŽR‹M”Ž1, “¡“c“N•v1, ‹g“cˆê¬2, ÝŠy•q–ç, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): “ú–{”A˜HŒ‹ÎÇŠw‰ï‘æ25‰ñŠwpW‰ï (2015/8/28), ˆ®ì, “ú–{”A˜HŒ‹ÎÇŠw‰ïŽ 2015; 14 (2): 96-7.

723687. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”ñƒVƒXƒ`ƒ“Œ‹Î‚ð‘ΏۂƂµ‚œ¬Ž™Œ‹ÎŽ¡—Â̌oŒ±. Œ@·G1, “¡“c“N•v1, •œŽR‹M”Ž1, ’ѺGN1, Œ–{˜a«1, Îì@–í1, ˆÀ“¡–š”ü1, ì‘º•ä1, ŠÛ@“T•v, Šâ‘º³Žk1 (1”å”AŠí): “ú–{”A˜HŒ‹ÎÇŠw‰ï‘æ25‰ñŠwpW‰ï (2015/8/29), ˆ®ì, “ú–{”A˜HŒ‹ÎÇŠw‰ïŽ 2015; 14 (2): 202-3.

723688. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚étˆÚAŒã‚̍RHLAR‘ÌŒŸž‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Îˆä‘å•ã1, ”‹ŒŽ³”Ž1, ¬—ÑŒ’‘Ÿ˜Y1, •œ–ìC•œ1, Œ–{˜a«1, Žáˆä—zŠó, ’r“c¬]1, –ìŒû•¶”T2, “ü–Ø‹GŒb2, ‹g“cˆê¬3, Šâ‘º³Žk1 (1”å”AŠí, 2ŠÅŒì•”, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ24‰ñ“ú–{‘gD“K‡«Šw‰ï‘å‰ï (2015/9/10), …ŒË.

723689. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) tˆÚAŒã‚̃mƒ“ƒAƒhƒqƒAƒ‰ƒ“ƒX‚É‚æ‚ét‹@”\ˆ«‰»Ç—á‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Îˆä‘å•ã1, •œ–ìC•œ1, Œ–{˜a«1, •œŽR‹M”Ž1, ’r“c¬]1, Žáˆä—zŠó, ‹{â—Dl2, ˆî–ì@Š°2, –ìŒû•¶”T3, Šâ‘º³Žk1, ‹g“cˆê¬4 (1”å”AŠí, 2–òÜ•”, 3ŠÅŒì•”, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ51‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2015/10/2), ŒF–{): ˆÚA 2015; 50 (‘‰ï—ÕŽž): 322.

723690. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) tˆÚAŠ³ŽÒ‚Æ“§ÍŠ³ŽÒ‚Ì•ž–òŠÇ—, ‹Ù‹}ÐŠQŽž‚Ì”õ‚Š‚ÌŽÀ‘Ô’²ž. ’r“c¬]1, –ìŒû•¶”T2, ¬‘q—TK, ‹{â—Dl3, Îˆä‘å•ã1, Šâ‘º³Žk1, ‹g“cˆê¬4 (1”å”AŠí, 2ŠÅŒì•”, 3–òÜ•”, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ51‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2015/10/3), ŒF–{, ˆÚA 2015; 50 (‘‰ï—ÕŽž): 380.

723691. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒŽperiplakin‚ð—p‚¢‚œäNã÷Šà‚É‚š‚¯‚éŽîᇃ}[ƒJ[‚ÌŒŸ“¢. –]ŒŽN•œ1, Œ–{˜a«1, “c”šŒ’ˆê1 ,“¡“c“N•v1, ’©’·@‹B, –쑺•¶•v, ²“¡—Yˆê2, Šâ‘º³Žk1 (1”å”AŠí, 2ˆã—Éq¶Šw•”): ‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2015/10/8), –ŒŒÃ‰®.

723692. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒnƒCƒŠƒXƒN‘O—§‘BŠà‚É‚š‚¯‚éHDR brachytherapy: —\Œã—\‘ªˆöŽq‚Æ‚µ‚Ä‚ÌPSA nadir‚ÌŒŸ“¢. ’ѺGN1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, ÎŽR”ŽžŠ2, ìã³Œå2, ŠÖŒûˆ©ˆß2, ¬X³Žq2, ’r“cŸb1, •âáÁ“ñ1, “¡“c“N•v1, ”nêŽu˜Y1, ‘ì˜ad2, Šâ‘º³Žk1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2015/9; 50 (3): 940.

723693. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹Žš’ïR«‘O—§‘BŠà‚ɑ΂·‚éAbiraterone“Š—^Œã‚Ì "ALP-bounce" ‚ÌŒŸ“¢. “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, ’ѺGN1, •œŽR‹M”Ž1, Œ@·G1, “¡“c“N•v1, Œ–{˜a«1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

723694. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹Žš’ïR«‘O—§‘BŠà‚ɑ΂·‚éƒAƒrƒ‰ƒeƒƒ“Œã‚̃hƒZƒ^ƒLƒZƒ‹Ž¡—Ã: ‘œŽ{Ý‹€“¯Œã•û“IŽŽŒ±. ã‘º”ŽŽi, ‰ÍŒŽ’Ži, ã“c—T“ñ˜Y, ‘ëàVˆí‘å, ŒŽR@•×, “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, _’J’Œl, —é–ØŒ[‰x, ŒŒŽLW (1”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

723695. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) C”œ‰ž«’`”’‚’l‚̐is«t×–EŠà‚ɑ΂·‚éƒXƒjƒ`ƒjƒuŽ¡—Âɂš‚¯‚éŒø‰Ê—\‘ªˆöŽq‚ÌŒŸ“¢. “¡“c“N•v1, ’ѺGN1, “c”šŒ’ˆê1, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s.

723696. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ã•””A˜Hã”çŠà‚ł̌㕠–ŒƒAƒvƒ[ƒ`t᱔AŠÇ‘S“Eœp‚ɑ΂·‚éBMI‚̉e‹¿‚ɂ‚¢‚Ä. Œ–{˜a«1, •œŽR‹M”Ž1, Œ@·G1, Îˆä‘å•ã1, “c”šŒ’ˆê1, “¡“c“N•v1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s.

723697. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) t”AŠÇ‘S“Eœp‚É‚š‚¯‚郊ƒ“ƒpßŠsŽ‚Ì–ðŠ„. ’r“cŸb1, Œ–{˜a«1, ãŒû˜aŽ , •àV˜aG, ‰YãTŽi, “¡“c“N•v1, “ü]@Œ[1, ‰ªª’J—˜ˆê, Šâ‘º³Žk1 (1”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s.

723698. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) äNã÷Šà‚ɑ΂·‚éäNã÷‘S“Eœp‚ÌŽ¡—ЬÑ: ‘œŽ{Ý‹€“¯Œ€‹†. Œ–{–Ÿ•F, ’†ì@“O, ‹à’J~Žu, ’r“cŸb1, ’†Œ‘׈ê, ì‡„l, ‹{ìm•œ, “cŒû@Œd, —é–؊, ŒÃ‰ê•¶—², ’·£@‘×, ‹ß“¡–õŽi, ‰ªª’J—˜ˆê, “c’†—Ç“T, –{ŠÔ”V•v (1”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s.

723699. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) äNã÷”A˜Hã”çŠà‚É‚š‚¯‚é“]ˆÚ‘ƒØœp. ’†ì@“O, ‹à’J~Žu, ’r“cŸb1, Œ–{–Ÿ•F, ì‡„l, ‹g“c•c, “cŒû@Œd, •Ä’Ž—Ljò, ‰i“c­‹`, ’·£@‘×, ‹ß“¡–õŽi, •y“c‹žˆê, “c’†—Ç“T, ‹v•ÄtŠì, –{ŠÔ”V•v (1”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/30), ‹ž“s.

723700. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œã• –Œ“î•”“÷Žî‚̗Տ°•a—Šw“IŒŸ“¢‚ÆŽ¡—ЬÑ. •àV˜aG, ‰ª@@—D, ‰i–{«ˆê, ˆÀHt‹P, ãŒû˜aŽ , ’r“cŸb1, ‰YãTŽi, ‘º“c_Ž, ‰ªª’J—˜ˆê (1”å”AŠí): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/31), ‹ž“s.

723701. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é‘O—§‘B¶ŒŸƒpƒXƒoƒŠƒAƒ“ƒX•ªÍ|‡•¹ÇŒž­‚ÌŽŽ‚݁|. Ôˆä–õ], ‘ºã‘אŽ1, ×’JØ•ä”ü, •U@—DŽq, ‘ŠŒŽ˜aŽ}, ‘å’ˍFŽq, “¡é‹M‹³, ‰F“s‹{‘ñŽ¡, ‚–ì–õŒá (1”å”AŠí): ‘æ16‰ñ“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŠwpW‰ï (2015/11/13), •‘•l.

723702. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒƒ{ƒbƒgŽx‰‡• o‹Ÿ‰º‘O—§‘B‘S“EœpŒã‚Ì‘Šú”A‹Ö§‚É‚š‚¯‚é”AŽž‹Ö—Š (ULR) ‚ÌŒŸ“¢. “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, ’ѺGN1, Œ–{˜a«1, Œ@·G1, •œŽR‹M”Ž1, Îˆä‘å•ã1, –Ȋс@ãÄ1, â“c—T‰î1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/19), Vh.

723703. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŽ”­•s–ŸŠà‚̐f’f‚É‚š‚¯‚é• o‹Ÿ‰ºŽîᇐ¶ŒŸp‚Ì—L—p«. ¬—ÑŒ’‘Ÿ˜Y1, “¡“c“N•v1, ”‹ŒŽ³”Ž1, ª–{—Žq1, •œ–ìC•œ1, Œ–{˜a«1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/19), Vh.

723704. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œã• –ŒŒŽ”­_ŒoŒŽ«Žîᇂɑ΂·‚é• o‹Ÿ‰º“Eœp. •œŽR‹M”Ž1, “¡“c“N•v1, ”‹ŒŽ³”Ž1, ¬—ÑŒ’‘Ÿ˜Y1, Œ@·G1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/19), Vh.

723705. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) • o‹Ÿ‰ºäNã÷‘S“Eœp‚ÌŒŸØ|ŠJ• äNã÷‘S“Eœp‚Æ‚Ì”äŠrŒŸ“¢|. “ì“c@—@1, –Œ–؏l1, •œ–ìC•œ1, ‚Œû@‘å1, “c”šŒ’ˆê1, ‰©@‰p–Î, “c‰ª‰ÀŒ›1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/19), Vh.

723706. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) tÌŽæEŸó—¬Œã‚ɐtŒ‹Î‚ð“Eo‚µˆÚA‚µ‚œ¶‘̐tˆÚA‚Ì2Ç—á. Îˆä‘å•ã1, •œ–ìC•œ1, ”‹ŒŽ³”Ž1, ¬—ÑŒ’‘Ÿ˜Y1, Œ@·G1, “¡“c“N•v1, Œ–{˜a«1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/20), Vh, Japanese Journal of Endourology 2015; 28 (3): 189.

723707. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ¬l‚̐…tÇ‚ɑ΂·‚é• o‹Ÿ‰ºt᱌`¬p3—á‚ÌŒŸ“¢. ‰ªª’J—˜ˆê, ’r“cŸb1, Šâ‘º³Žk1, ‰ª@@—D, “c”š^—œŽq, ãŒû˜aŽ , •àV˜aG, ‰YãTŽi (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/20), Vh.

723708. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚é• o‹Ÿ‰ºt᱌`¬p. Œ@·G1, “¡“c“N•v1, •œ–ìC•œ1, “c”šŒ’ˆê1, •œŽR‹M”Ž1, ’ѺGN1, Œ–{˜a«1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/20), Vh.

723709. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘Œ‰Èˆ««Žîᇂɔº‚€…tÇ‚ɑ΂·‚é‹à‘®”AŠÇƒXƒeƒ“ƒg‚̏‰ŠúŽg—pŒoŒ±. ”‹ŒŽ³”Ž1, “¡“c“N•v1, “V–쓝”V1, Žu‘º‘sˆê˜N1, —§‰Ô‹MŽj1, •œ–ìC•œ1, ¬—ÑŒ’‘Ÿ˜Y1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/20), Vh.

723710. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) • o‹Ÿ‰ºt᱌`¬p‚É‚š‚¯‚épŒã‘Šú…tÁŽž—á‚Ɛ…t•s•Ï—á‚ÌŠ³ŽÒ”wŒi‚ɂ‚¢‚Ä‚ÌŒŸ“¢. •œ–ìC•œ1, Œ@·G1, ¬—ÑŒ’‘Ÿ˜Y1, •œŽR‹M”Ž1, ’ѺGN1, “c”šŒ’ˆê1, “¡“c“N•v1, Œ–{˜a«1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/20), Vh.

723711. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “àŽ‹‹Ÿ‚ðŽg—p‚µ‚È‚¢’j«‚Ì”AŠÇƒXƒeƒ“ƒgŒðŠ·‚ÌŒŸ“¢. ‘ºã‘אŽ1, ‘呐@—m, “¡é‹M‹³, ‰F“s‹{‘ñŽ¡ (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/20), Vh.

723712. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹Ÿ‰ºªŽ¡“IäNã÷“Eœp‚É‚š‚¯‚éŽüpŠú¬Ñ‚ɂ‚¢‚ā`‰ŠúÇ—á‚ÌŒ‹‰Ê`. Œ–{˜a«1, “c”šŒ’ˆê1, •œŽR‹M”Ž1, ”‹ŒŽ³”Ž1, ’ѺGN1, “¡“c“N•v1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/21), Vh.

723713. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é• o‹Ÿ‰ºt•”•ªØœp‚̏‰ŠúŒoŒ±. ‚Œû@‘å1, “ì“c@—@1, –Œ–؏l1, •œ–ìC•œ1, “¡“c“N•v1, “c‰ª‰ÀŒ›1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/21), Vh.

723714. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) • o‹Ÿ‰ºt•”•ªØœp‚É‚š‚¯‚éR.E.N.A.L. Nephrometry score ‚ÌŒŸ“¢. “¡“c“N•v1, Œ@·G1, •œŽR‹M”Ž1, Îˆä‘å•ã1, “c”šŒ’ˆê1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ29‰ñ“ú–{”å”AŠí“àŽ‹‹ŸŠw‰ï‘‰ï (2015/11/21), Vh.

723715. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒCƒRƒfƒLƒXƒgƒŠƒ““§Í‰t‚ÅŽct‹@”\’·ŠúˆÛŽ‚ª‰Â”\‚Å‚ ‚Á‚œ1—á. •œ–ìC•œ1, Îˆä‘å•ã1, ”‹ŒŽ³”Ž1, —§‰Ô‹MŽj1, Žáˆä—zŠó, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ21‰ñ“ú–{• –Œ“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/11/28), å‘ä.

723716. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹Ÿ‰º‘O—§‘B“Eœp‚ÌŽüpŠú‡•¹Ç‚Æ’ZŠú¬Ñ. ‰©@‰p–Î, ‚“cŽ¡Žq1, –]ŒŽN•œ1, Žá“c•”—zŽi1, “y‹Ž³l1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/10), ‘åã.

723717. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ¬l—á‚ɑ΂·‚é• o‹Ÿ‰ºäNã÷”AŠÇV•«‡p. Œ@·G1, “¡“c“N•v1, Îˆä‘å•ã1, Œ–{˜a«1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

723718. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) t“®‘ÔƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ð—p‚¢‚œ• o‹Ÿ‰ºt•”•ªØœpŒãt‹@”\‚ÌŒŸ“¢. “¡“c“N•v1, Œ@·G1, “c”šŒ’ˆê1 ,Îˆä‘å•ã1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/12), ‘åã.

723719. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) íõF‘Ì—D«‘œ”­«ùN–EtŠ³ŽÒ‚ɑ΂·‚étˆÚA‚ÌŒŸ“¢. Îˆä‘å•ã1, ”‹ŒŽ³”Ž1, ì‘º•ä1, Žáˆä—zŠó, Œ–{˜a«1, •œŽR‹M”Ž1, –ìŒû•¶”T2, ’|“àN—Y3, ‹g“cˆê¬4, Šâ‘º³Žk1 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/23), •ÄŽq.

723720. [Šw‰ï (‘S‘)] (Award Session) ˆê”ÊŽs–¯‚Ö‚Ì‘ŸŠíˆÚA•‹yŒ[”­‚Ì’·ŠúŒp‘±Šˆ“®‚ÌŽÀÛ‚ƃ|ƒCƒ“ƒg. ’r“c¬]1, Îˆä‘å•ã1, ì‘º•ä1, –ìŒû•¶”T2, rì–@Žq2, ‚‹Ž@Œb2, ‹g“c•üŽq3, “c’†”üŽ÷2, Šâ‘º³Žk1, ‹g“cˆê¬4 (1”å”AŠí, 2ŠÅŒì•”, 3‰h—{•”, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/24), •ÄŽq.

723721. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒƒTƒ‰ƒWƒ“‚É‚æ‚étáŠQ‚ɑ΂µtˆÚAŽ{sŒã‚ÉUC‚ªÄ”R‚µ‚œˆê—á. ”‹ŒŽ³”Ž1, Îˆä‘å•ã1, •œ–ìC•œ1, ª–{—Žq1, ì‘º•ä1, •œŽR‹M”Ž1, ‹g“cˆê¬2, –ìŒû•¶”T3, ’r“c¬]1, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3ŠÅŒì•”): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/25), •ÄŽq.

731125. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) • o‹Ÿ‰ºt‘Ÿ“Eop‹Zp”F’èˆãŽæ“Ÿ‚ð–ÚŽw‚µ‚Ä. Šâ‘º³Žk (”å”AŠí): ‘æ6‰ñ‘åãEndo UrologyŒ€‹†‰ï (2015/5/22), ‘åã.

731126. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Office Urology‚É‚š‚¯‚émCRPCŽ¡—Ã: ƒAƒrƒ‰ƒeƒƒ“Žg—p‚̃|ƒCƒ“ƒg‚ƑΉž. ²“¡ˆÐ•¶ (”å”AŠí): _“ސìCRPC Seminar (2015/5/28), ‰¡•l.

731127. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹Žš’ïR«‘O—§‘BŠà‚ɑ΂·‚鎡—ÃXƒgƒ‰ƒ^ƒW[‚̍čl. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ85‰ñL“‡”å”AŠí‰Èˆã‰ï (2015/6/13), L“‡.

731128. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) • o‹ŸEƒƒ{ƒbƒgŽèp‚É‚š‚¯‚郊ƒXƒNŠÇ—|ƒmƒ“EƒeƒNƒjƒJƒ‹ƒXƒLƒ‹‚̏d—v«‚ɂ‚¢‚ā|. Šâ‘º³Žk (”å”AŠí): ‘æ138‰ñ“Œ–k”å”AŠí‰È’k˜b‰ïE‘æ8‰ñ‘O—§‘BŠàƒZƒ~ƒi[ (2015/6/29), å‘ä.

731129. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒAƒrƒ‰ƒeƒƒ“‚Ì“Á«‚ð—‰ð‚·‚é|—Տ°Žg—p‚É‚š‚¯‚éƒ}ƒl[ƒWƒƒ“ƒg‚̃|ƒCƒ“ƒg|. ²“¡ˆÐ•¶ (”å”AŠí): CRPC WEBƒZƒ~ƒi[ (2015/7/2), “Œ‹ž.

731130. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹Žš’ïR«‘O—§‘BŠà‚ɑ΂·‚鎡—ÃXƒgƒ‰ƒeƒW[‚̍čl. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ20‰ñã_‘O—§‘BŽŸŠ³ƒZƒ~ƒi[ (2015/7/16), Œ‹{.

731131. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬Ž™‚Ì• o‹ŸŽèp. Œ@·G (”å”AŠí): Œà”å”AŠí‰È‰ï (2015/7/16), Œà.

731132. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) RALP“±“ü‰Šú100—á‚ÌŽ¡—ÃŽÀÑ`LRP600—á‚Æ‚Ì”äŠr`. Šâ‘º³Žk (”å”AŠí): ‘æ5‰ñŽs“à‚Å‘O—§‘BŠà‚ðl‚Š‚é‰ï (2015/7/24), L“‡.

731133. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ADPKDf—ÂɊւ·‚éÅ‹ß‚̘b‘è|ùN–EtŠO—ˆ‚ƃgƒ‹ƒoƒvƒ^ƒ“|. ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘Š–ÍŒŽADPKD•af˜AŒg‚̉ï (2015/7/24), ‘Š–ÍŒŽ.

731134. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •ïŠ‡“I‘O—§‘B‚ª‚ñ’nˆæ˜AŒg: Kitasato Prostate Cancer Network (KP-Net) ‚É‚æ‚銳ŽÒŽx‰‡‚ÌŽæ‚è‘g‚Ý‚ÆŒø‰Ê`CRPC‚ɑ΂·‚éV‚œ‚È“WŠJ`. ²“¡ˆÐ•¶ (”å”AŠí): CRPC‚ðl‚Š‚é‰ï (2015/7/30), ‰¡•l.

731135. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) is«äNã÷Šà‚ÌŽ¡—Ã. Œ–{˜a« (”å”AŠí): –k‹ãBŽs”å”AŠí‰Èˆã‰ï•œ¬27”N“x‘æ3‰ñŒ€C‰ï (2015/7/30), –k‹ãB.

731136. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘O—§‘BŠà‚̐f’f‚ÆŽ¡—ÃAƒbƒvƒf[ƒg2015. ²“¡ˆÐ•¶ (”å”AŠí): ’nˆæ˜AŒgŠwpu‰‰‰ï (2015/8/26), ‘O‹Ž.

731137. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹Žš’ïR«‘O—§‘BŠà‚ɑ΂·‚鎡—ÃXƒgƒ‰ƒeƒW[‚̍čl. ²“¡ˆÐ•¶ (”å”AŠí): CRPCŠwpu‰‰‰ï (2015/8/27), b•{.

731138. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) MOCRPC‚̃Xƒgƒ‰ƒeƒW[‚ɂ‚¢‚Ä. ²“¡ˆÐ•¶ (”å”AŠí): Prostate Cancer Academia (2015/9/5), “Œ‹ž.

731139. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) MO CRPC‚ɑ΂·‚é‹~Ï•úŽËü—Ö@. ’ѺGN (”å”AŠí): ‘O—§‘BŠàŽ¡—Íu‰‰‰ï (2015/9/8), ‘Š–ÍŒŽ.

731140. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹Zp”F’è‚ÉŒü‚¯‚œ”å”AŠí• o‹ŸŽèp‚ÌŠî–{Žè‹Z. Šâ‘º³Žk (”å”AŠí): ‘æ71‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒQ”n’n•û‰ï (2015/10/24), ‚è.

731141. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) LRP‚ÌŒoŒ±‚ÍRALP“±“ü‚ɐ¶‚©‚³‚ê‚é‚©? Šâ‘º³Žk (”å”AŠí): Expert Operation Forum for Urologist (2015/11/6), ‘åã.

731142. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “–‰@‚É‚š‚¯‚étˆÚAƒ`[ƒ€ˆã—Í\¬. ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ11‰ñ“ì‘åãtˆÚAE“§Íˆã—ÃŒ€‹†‰ï (2015/11/19), ‘åã.

731143. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •ïŠ‡“I‘O—§‘B‚ª‚ñ’nˆæ˜AŒg: kitasato Prostate Cancer Network (KP-Net) ‚É‚æ‚銳ŽÒŽx‰‡‚ÌŽæ‚è‘g‚Ý‚ÆŒø‰Ê`CRPC‚ɑ΂·‚éV‚œ‚È“WŠJ`. ²“¡ˆÐ•¶ (”å”AŠí): CRPC‚̘AŒg‚ðl‚Š‚é‰ï (2015/11/26), •Ÿ‰ª.

731144. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Office Urology‚É‚š‚¯‚é‹Žš’ïR«‘O—§‘BŠà`V‚µ‚¢—Տ°•]‰¿‚ƐV‚œ‚È“W–]`. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ130‰ñ‘œ–€”å”AŠí‰Èˆã‰ï (2015/11/27), •‘ –ì.

731145. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “–‰@‚É‚š‚¯‚é”r”AáŠQ‚ÌŽ¡—Âɂ‚¢‚Ä. •œŽR‹M”Ž (”å”AŠí): ‘æ6‰ñUrology Conference in Sagamihara (2016/1/27), ‘Š–ÍŒŽ.

731146. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒV[ƒh—Ö@‘˜_. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ19‰ñƒˆƒE‘f125ƒV[ƒhüŒ¹‚É‚æ‚é‘O—§‘BŠà‰i‹v‘}“ü–§••¬üŒ¹Ž¡—Â̈À‘SŽæˆµuK‰ï (2016/2/27), “Œ‹ž.

732054. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘O—§‘B”ì‘åÇ‡•¹‰ßŠˆ“®äNã÷Ç—á‚ɑ΂·‚éƒiƒtƒgƒsƒWƒ‹‚Ì—L—p«‚ÌŒŸ“¢: ƒiƒtƒgƒsƒWƒ‹’P“ÆŒQ VS ƒiƒtƒgƒsƒWƒ‹ + RƒRƒŠƒ“Ü`‘ŠúŽ©ŠoÇó‰ü‘PŒø‰Ê‚Ì”äŠr`. Œ@·G1, ‘ºã‘אŽ1, ‘呐@—m, “¡é‹M‹³, ‰F“s‹{‘ñŽ¡, ÝŠy•q–ç, •âáÁ“ñ1, ¬—ÑŒ’‘Ÿ˜Y1, ‘OŽR—Ç‘Ÿ1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ9‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2015/4/4), “Œ‹ž.

732055. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Ç—á‚©‚çŠw‚Ô‘O—§‘B‚ª‚ñ–ò•šŽ¡—Ã: ŠÏŽ@‚̃|ƒCƒ“ƒg‚Æ•›ì—p‘΍ô. ²“¡ˆÐ•¶ (”å”AŠí):ŠÅŒìŽtWEBƒVƒ“ƒ|ƒWƒEƒ€ (2015/6/18), “Œ‹ž.

732056. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒAƒ“ƒhƒƒQƒ“‚Æ‹Žš’ïR«‘O—§‘BŠà: WŠw“IEŒQ—YŠ„‹’Ž¡—Â𐮗‚·‚é. ²“¡ˆÐ•¶ (”å”AŠí):‘æ15‰ñ“ú–{Men's HealthˆãŠw‰ï (2015/9/4), é‹Ê.

732057. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ŠeƒŠƒXƒN‚É‚š‚¯‚鎡—ÃXƒgƒ‰ƒeƒW[‚ÌŽÀÛ. Œ–{˜a« (”å”AŠí):‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/26), Vh.

732058. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) T1bÇ—á‚ɑ΂·‚ét•”•ªØœp. “¡“c“N•v1, Šâ‘º³Žk1 (1”å”AŠí):‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/26), Vh.

732059. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒAƒrƒ‰ƒeƒƒ“‚̃Gƒrƒfƒ“ƒX‚ƍœK‚ÈŠ³ŽÒ‘œ‚Æ‚Í? ²“¡ˆÐ•¶ (”å”AŠí):‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/26), Vh.

732060. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‘O—§‘BŠà‹ÇŠŽ¡—ÃŒã‚̋ǏŠÄ”­f’fƒXƒgƒ‰ƒeƒW[. ²“¡ˆÐ•¶ (”å”AŠí):‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), Vh.

732061. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) t×–EŠàŽ¡—Âɂš‚¯‚郔ƒFƒgƒŠƒGƒ“ƒg‚Ì–ðŠ„. ’†“‡MK, –ì–{„Žj, “¡“c“N•v1 (1”å”AŠí):WEST KANAGAWA RCC CONFERENCE (2015/10/9), Œú–Ø.

732062. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒrƒfƒIƒfƒBƒXƒJƒbƒVƒ‡ƒ“) • o‹Ÿ‰ºt᱌`¬p. Šâ‘º³Žk (”å”AŠí):‘æ13‰ñMB”å”AŠíŽèpƒrƒfƒIƒfƒBƒXƒJƒbƒVƒ‡ƒ“ (2015/10/10), Œ–{.

732063. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) V‚œ‚È’mŒ©‚©‚ç, ‚±‚ê‚©‚ç‚Ì“ú–{‚ÌŽÀ—Տ°‚ðl‚Š‚é`CRPC‚ł͉œ‚ðdŽ‹‚·‚é‚ׂ«‚È‚Ì‚©`. ²“¡ˆÐ•¶ (”å”AŠí):Update on CRPC in TOKYO (2015/10/24), “Œ‹ž.

732064. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ~ƒjƒŒƒNƒ`ƒƒ[) –k—¢‘åŠw‚É‚š‚¯‚ét×–E‚ª‚ñ•›ì—pƒ}ƒl[ƒWƒƒ“ƒg‚Ì‚œ‚ß‚Ì–âf•[“±“ü‚ÌŒoˆÜ. “¡“c“N•v (”å”AŠí):‘æ10‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2015/11/7), Vh.

732065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Kitasato Prostate Cancer Network (KP-Net)‚É‚æ‚銳ŽÒŽx‰‡‚ÌŽæ‚è‘g‚Ý‚ÆŒø‰Ê: CRPC‚É‚š‚¯‚éV‚œ‚È”­“W. ²“¡ˆÐ•¶ (”å”AŠí):‘æ89‰ñ_“ސ쌧”å”AŠí‰Èˆã‰ï (2015/11/14), V‰¡•l.

733261. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’Œ’°ŠàpŒã ”AŠÇ‘¹, Š®‘S—£’f‚̈ê—á. –Œ–؏l1, “ì“c@—@1, “c‰ª‰ÀŒ›1, ’؈ärŽ÷ (1”å”AŠí):‘æ9‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2015/4/4), Vh.

733262. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) • o‹Ÿ‰ºt“Eœp‚É‚š‚¯‚étÃ–¬‘¹‚Ì1—á. ‚“cŽ¡Žq1, ‰©@‰p–Î (1”å”AŠí):‘æ9‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2015/4/4), Vh.

733263. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “–‰@‚Å‚Ì‘Œ‰È‚ÌŽèp‚̍‡•¹Ç‚Æ‚»‚̑Ήž‚ɂ‚¢‚Ä. ‘åŽR“N•œ1, Žá“c•”—zŽi1, ‰œ–ì‹I•F (1”å”AŠí):‘æ9‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2015/4/4), Vh.

733264. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) 2Œ^“œ”A•a‚É‚æ‚é––Šút•s‘SŠ³ŽÒ‚ɑ΂·‚étˆÚA‚ÌŒŸ“¢. Îˆä‘å•ã1, •œ–ìC•œ1, ¬—ÑŒ’‘Ÿ˜Y1, ’r“c¬]1, –ìŒû•¶”T2, Žáˆä—zŠó, Šâ‘º³Žk1, ’|“àN—Y3, ‹g“cˆê¬4 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ26‰ñ_“ސìˆÚAˆãŠw‰ï (2015/6/6), ‰¡•l.

733265. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) 2Œ^“œ”A•a‚É‚æ‚é––Šút•s‘SŠ³ŽÒ‚ɑ΂·‚étˆÚA‚ÌŒŸ“¢. •œ–ìC•œ1, Îˆä‘å•ã1, ¬—ÑŒ’‘Ÿ˜Y1, ’r“c¬]1, –ìŒû•¶”T2, ’|“àN—Y3, Žáˆä—zŠó, Šâ‘º³Žk1, ‹g“cˆê¬4 (1”å”AŠí, 2ŠÅŒì•”, 3t‘Ÿ“à, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ21‰ñ“ú–{ˆÚA–ò•š—Ö@Œ€‹†‰ï (2015/6/13), “Œ‹ž, ¡“ú‚̈ڐA 2015; 28 (6): 696-7.

733266. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‰Œo‚É‚æ‚Á‚Ä–Ÿ‚ç‚©‚É‚È‚Á‚œWunderlichÇŒóŒQ‚̈ê—á. –Ȋс@ãÄ1, Œ@·G1, •œŽR‹M”Ž1, ’ѺGN1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Œ–{˜a«1, ”‹ŒŽ³”Ž1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ88‰ñ_“ސ쌧”å”AŠí‰Èˆã‰ï (2015/6/13), ‰¡•l.

733267. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) tŠà‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚Ÿ‚Á‚œtˆ««ƒŠƒ“ƒpŽî‚Ì1—á. ‘åŽR“N•œ1, Žá“c•”—zŽi1, ‰œ–ì‹I•F (1”å”AŠí):‘æ88‰ñ_“ސ쌧”å”AŠí‰Èˆã‰ï (2015/6/13), ‰¡•l.

733268. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ¶‘̐tˆÚAŒã”AŠÇ‹·ó‚ɑ΂µ‚ÄŽ©ŒÈt᱁|ˆÚAt”t•«‡‚ð‚š‚±‚È‚Á‚œ1Ç—á. Îˆä‘å•ã1, ¬—ÑŒ’‘Ÿ˜Y1, •œ–ìC•œ1, –]ŒŽN•œ1, Žáˆä—zŠó, Šâ‘º³Žk1, ‹g“cˆê¬2 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ24‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2015/7/3), –k‹ãB.

733269. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Non-metastatic castration resistant prostate cancer‚ɑ΂·‚é‹~Ï•úŽËü—Ö@‚ÌŒŸ“¢. ’ѺGN1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, Žu‘º‘sˆê˜N1, “¡“c“N•v1, Šâ‘º³Žk1, ìã³Œå2, ŠÖŒûˆ©ˆß2, –k–ì‰ëŽj2, ÎŽR”ŽžŠ2, ‘ì˜ad2 (1”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ32‰ñ_“ސ쌧‘O—§‘BŽîᇌ€‹†‰ï (2015/7/4), V‰¡•l.

733270. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) • o‹Ÿ‰º¶‘̐tˆÚAƒhƒi[‚̏pŒãƒtƒHƒ[ƒAƒbƒv‚Æ—\Œã‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Îˆä‘å•ã1, ¬—ÑŒ’‘Ÿ˜Y1, •œ–ìC•œ1, •œŽR‹M”Ž1, “¡“c“N•v1, “c’†”üŽ÷2, –ìŒû•¶”T2, ‹g“c•üŽq3, ’r“c¬]1, Žáˆä—zŠó, ’|“àN—Y4, Šâ‘º³Žk1, ‹g“cˆê¬5 (1”å”AŠí, 2ŠÅŒì•”, 3‰h—{•”, 4t‘Ÿ“à, 5V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ31‰ñtˆÚAEŒŒŠÇŠO‰ÈŒ€‹†‰ï (2015/7/10), “úŒõ.

733271. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) _“ސ쌧‚É‚š‚¯‚étˆÚAˆã—ÁEt•s‘SŽ¡—Â̏î•ñ‹€—LŠˆ“®‚ÌŽæ‚è‘g‚Ý. ’r“c¬]1, –ìŒû•¶”T2, ’†–ڐ^—Žq, ŸNˆä—TŽq, Ö“¡—R”üŽq, ¬âŽu•Û, “c’†”üŽ÷2, Îˆä‘å•ã1, Šâ‘º³Žk1, ‹g“cˆê¬3 (1”å”AŠí, 2ŠÅŒì•”, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ31‰ñtˆÚAEŒŒŠÇŠO‰ÈŒ€‹†‰ï (2015/7/11), “úŒõ.

733272. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) C”œ‰ž«’`”’‚’lÇ—á‚ɑ΂·‚éƒXƒjƒ`ƒjƒuŽ¡—Âɂš‚¯‚éŒø‰Ê—\‘ªˆöŽq‚ÌŒŸ“¢. “¡“c“N•v1, “c”šŒ’ˆê1, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ46‰ñtŠàŒ€‹†‰ï (2015/7/19), •iì.

733273. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) tŽîᇂƂ̊ӕʂð—v‚µ‚œPEComa‚Ì1—á. V‘º’qŒÈ, ‘ºã‘אŽ1, “¡é‹M‹³, ‰F“s‹{‘ñŽ¡, Šâ‘º³Žk1 (1”å”AŠí):‘æ52‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2015/9/17), ‰¡•l, ”å”AŠíŠO‰È 2016/1; 29 (1): 90.

733274. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Žá”N«tŠàE‘œ”­ŠÌ“]ˆÚÇ—á‚Ƀpƒ]ƒpƒjƒu‚ª’˜Œø‚µ‚œ1—á. Žá“c•”—zŽi1, ‘åŽR“N•œ1, ‰œ–ì‹I•F (1”å”AŠí):‘æ52‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2015/9/17), ‰¡•l, ”å”AŠíŠO‰È 2016/1; 29 (1): 90.

733275. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) calciphylaxisis‚É‚æ‚è‰AŒsØ’f‚ÉŽŠ‚Á‚œ–«ˆÛŽ“§ÍŠ³ŽÒ‚̈ê—á. â“c—T‰î1, Îˆä‘å•ã1, •œ–ìC•œ1, ”‹ŒŽ³”Ž1, Œ@·G1, “c”šŒ’ˆê1, “¡“c“N•v1, Œ–{˜a«1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ52‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2015/9/17), ‰¡•l, ”å”AŠíŠO‰È 2016/1; 29 (1): 92.

733276. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) tᱟ󗬌‹Î—n‰ð—Ö@‚ª‘tŒø‚µ‚œƒVƒXƒ`ƒ“Œ‹Î‚Ì2Ç—á3Œ‹Î. —§‰Ô‹MŽj1, ˆÀ“¡–š”ü1, Îì@–í1, ŠÛ@“T•v, Šâ‘º³Žk1 (1”å”AŠí):‘æ52‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2015/9/17), ‰¡•l, ”å”AŠíŠO‰È 2016/1; 29 (1): 93.

733277. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ‹ßÚ‘ŸŠí‡•¹Øœ‚ð—v‚µ‚œŠŒF×–EŽî. â“c—T‰î1, •œŽR‹M”Ž1, ì‘º•ä1, ¬—ÑŒ’‘Ÿ˜Y1, “¡“c“N•v1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/26), Vh.

733278. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Non-metastatic castration resistant prostate cancer‚ɑ΂·‚é‹~Ï•úŽËü—Ö@‚ÌŒŸ“¢. ’ѺGN1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, ÎŽR”ŽžŠ2, ìã³Œá2, ŠÖŒûˆ©ˆß2, Žu‘º‘sˆê˜N1, •œŽR‹M”Ž1, â“c—T‰î1, •âáÁ“ñ1, “¡“c“N•v1, ‘ì˜ad2, Šâ‘º³Žk1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), Vh.

733279. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Š®‘Sd•¡t᱔AŠÇ‚ɍ‡•¹‚µ‚œäNã÷”AŠÇ‹t—¬Ç‚ɑ΂·‚é‹CäNã÷‰ºäNã÷”AŠÇV•«‡p. –Ȋс@ãÄ1, Œ@·G1, Žu‘º‘sˆê˜N1, ”‹ŒŽ³”Ž1, •œŽR‹M”Ž1, ’ѺGN1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Œ–{˜a«1, ‚‹Ž—Tˆê˜Y, Šâ‘º³Žk1 (1”å”AŠí): ‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), Vh.

733280. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) •úŽËüŽ¡—ÃŒã‚̋ǏŠÄ”­‘O—§‘BŠà‚ɑ΂·‚éfocal salvage HDR brachytherapy‚ÌŒŸ“¢: prospective pilot study. —§‰Ô‹MŽj1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, ’ѺGN1 ,“c”šŒ’ˆê1, ŒŽ@•q«3, –öàVM”V4, ’r“cŸb1, •âáÁ“ñ1, –k–ì‰ëŽj2, ”nêŽu˜Y1, ‘ì˜ad2, Šâ‘º³Žk1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3•úŽËü (‰æ‘œ), 4•a—): ‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), Vh.

733281. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠO‰A•”‚É”­¶‚µ‚œ’E•ª‰»Œ^Ž‰–b“÷Žî‚Ì1—á. ˆÀHt‹P, ‰ª@@—D, ‰i–{«ˆê, ãŒû˜aŽ , ’r“cŸb1, •àV˜aG, ‰YãTŽi ,‰ªª’J—˜ˆê (1”å”AŠí):‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), Vh.

733282. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) 35Î–¢–ž‚É”­¶‚µ‚œäNã÷Šà‚̗Տ°“I“Á’¥‚ɂ‚¢‚Ä. •œ–ìC•œ1, Œ–{˜a«1, ŽR“c‘׎j1, •œŽR‹M”Ž1, Œ@·G1, ’ѺGN1, “¡“c“N•v1, Šâ‘º³Žk1 (1”å”AŠí):‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), Vh.

733283. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ‹Žš’ïR«‘O—§‘BŠà‚ɑ΂·‚éAbiraterone“Š—^Žž‚ÌALP-bounce‚ÌŒŸ“¢. “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, ’ѺGN1, •œŽR‹M”Ž1, –Ȋс@ãÄ1, â“c—T‰î1, Žu‘º‘sˆê˜N1, “V–쓝”V1, —§‰Ô‹MŽj1, Îˆä‘å•ã1, Šâ‘º³Žk1 (1”å”AŠí):‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), Vh.

733284. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ”AŠÇäNã÷ˆÚs•”‚̍Ĕ­”A˜Hã”çŠà‚ɑ΂µ‚Ä, •”•ªØœpEäNã÷”AŠÇV•«‡p‚ðŽ{s‚µ‚œ1—á. Žu‘º‘sˆê˜N1, Œ–{˜a«1, â“c—T‰î1, ”‹ŒŽ³”Ž1, Œ@·G1, ’ѺGN1, “c‰ª‰ÀŒ›1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), Vh.

733285. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ”畆‹Ø‰Š‚ð‡•¹‚µ‚œ”AŠÇŠà‚Ì1—á. “V–쓝”V1, Œ–{˜a«1, –Ȋс@ãÄ1, ì‘º•ä1, Îˆä‘å•ã1, “c”šŒ’ˆê1, “ü]@Œ[1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), Vh.

733286. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ”AŠÇŽîᇂɑ΂µ‚Ä”AŠÇ‹Ÿ‰ºƒŒ[ƒU[Øœp‚ðs‚Á‚œ1—á. ŽR‰º‰p”V1, Îˆä~ˆê˜Y1, –{“c’qŽk1, X‰i³“ñ˜Y, ‚“ˆ—Í–í, ‚‹Ž—Tˆê˜Y, –å˜e˜ab, “ü]@Œ[1 (1”å”AŠí): ‘æ80‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2015/9/27), “Œ‹ž.

733287. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) CRPCŽ¡—Âɂš‚¯‚鍡Œã‚Ì“W–]. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ22‰ñ“Œ‹ž‘O—§‘BŠàƒtƒH[ƒ‰ƒ€ (2015/10/17), “Œ‹ž.

733288. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠeŽ{Ý‚ÌŒ»ó•ñ. Îˆä‘å•ã1, ‚‹Ž@Œb (1”å”AŠí): ‘æ2‰ñ‘S‘‘ŸŠíˆÚAˆã—ÃŽx‰‡•”–åu‰‰‰ï (2015/10/24), –ŒŒÃ‰®.

733289. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) f’f‚É‹ê—¶‚µ‚œSóŒ‹’°äNã÷ᑂ̈ê—á. “V–쓝”V1, ŽR‰º‰p”V, ’r“cŸb1, “ü]@Œ[1 (1”å”AŠí): ‘æ10‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2015/11/7), Vh.

733290. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒ}ƒSƒbƒgƒeƒ‰ƒs[‚ðs‚Á‚œ‰AùN”^ᇂ̈ê—á. ŽR“c‘׎j1, ‘OŽR—Ç‘Ÿ1, Œ“c‘å‰î1, ¯@@‹œ (1”å”AŠí): ‘æ10‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2015/11/7), Vh.

733291. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Œo’Œ’°“I‘O—§‘B¶ŒŸ‘O‚Ì•Ö”|—{‚É‚æ‚étargetingR‹Û–ò“Š—^‚Ì—L—p«‚ɂ‚¢‚Ä. Žu‘º‘sˆê˜N1, ‚Œû@‘å1, “ì“c@—@1, “c‰ª‰ÀŒ›1 (1”å”AŠí): ‘æ10‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2015/11/7), Vh.

733292. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Œo’Œ’°“I‘O—§‘B¶ŒŸŒã—L”M«ŠŽõÇ‚ɑ΂·‚éƒZƒtƒƒ^ƒ][ƒ‹‚Ì—LŒø«‚ÌŒŸ“¢. ‘ºã‘אŽ1, –{“c’qŽk1, ¬—ÑŒ’‘Ÿ˜Y1, ‘呐@—m, “¡é‹M‹³, ÝŠy•q–ç, ‰F“s‹{‘ñŽ¡ (1”å”AŠí): ‘æ67‰ñŒ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/11/7), •Ÿ‰ª, Œ“ú–{”å”AŠí‰ÈŠw‰ïŽ 2015/10; 77 (‘Š§): 134.

733293. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) “ûâô‹¹‚ð‡•¹‚µ‚œIgG4ŠÖ˜AŒã• –ŒüˆÛÇ‚Ì1—á. àF’J—z•œ, ‘ºã‘אŽ1, ‘呐@—m, “¡é‹M‹³, ‰F“s‹{‘ñŽ¡ (1”å”AŠí): ‘æ67‰ñŒ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2015/11/7), •Ÿ‰ª, Œ“ú–{”å”AŠí‰ÈŠw‰ïŽ 2015/10; 77 (‘Š§): 168.

733294. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹Ø‘w”ñZ«äNã÷Šà‚ɑ΂·‚éBCG“±“üEˆÛŽ—Ö@‚ÉŠÖ‚·‚錟“¢. Œ–{˜a«1, •œŽR‹M”Ž1, ’ѺGN1, “c”šŒ’ˆê1, “¡“c“N•v1, “ü]@Œ[1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ8‰ñBCG’“ü—Ö@Œ€‹†‰ï (2015/11/13), “Œ‹ž.

733295. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) •›t•s‘S‚ð‡•¹‚µ‚œ—Œ‘€•›tˆ««ƒŠƒ“ƒpŽî‚̈ê—á. â“c—T‰î1, ’ѺGN1, –Ȋс@ãÄ1, ì‘º•ä1, ”‹ŒŽ³”Ž1, ‰Í‡¹—FŠó2, ‚–ìK˜H2, ƒEƒbƒhƒnƒ€ƒX—æŽq3, •œŽR‹M”Ž1, “c”šŒ’ˆê1, “¡“c“N•v1, Šâ‘º³Žk1 (1”å”AŠí, 2“à•ª”å‘ãŽÓ“à, 3•úŽËü (‰æ‘œ)): ‘æ89‰ñ_“ސ쌧”å”AŠí‰Èˆã‰ï (2015/11/14), V‰¡•l.

733296. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) HIVŠŽõŽÒ‚É”­Ç‚µ‚œäNã÷Šà‚Ì1—á. â“c—T‰î1, •œŽR‹M”Ž1, ì‘º•ä1, Œ–{˜a«1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ16‰ñ_“ސ쐫ŠŽõÇŠw‰ï (2016/2/13), ‰¡•l.

733297. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ”AŠÇƒXƒeƒ“ƒg‚ð—¯’u‚¹‚žŒo‰ßŠÏŽ@‚µ“Ÿ‚œ”Aᑂð—L‚·‚é•¡ŽG[Ý«t‘¹‚̈ê—á. –Ȋс@ãÄ1, Œ@·G1, ì‘º•ä1, •œŽR‹M”Ž1, ’ѺGN1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Œ–{˜a«1, –Œ–؏l1, ‹g“cˆê¬2, Šâ‘º³Žk1 (1”å”AŠí, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ53‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2016/2/18), ‰¡•l.

733298. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Š®‘Sd•¡t–ДAŠÇ‡•¹äNã÷”AŠÇ‹t—¬Ç‚ɑ΂·‚é‹CäNã÷‰ºäNã÷”AŠÇV•«‡p. Œ@·G1, –Ȋс@ãÄ1, ”‹ŒŽ³”Ž1, •œŽR‹M”Ž1, “¡“c“N•v1, Œ–{˜a«1, Šâ‘º³Žk1 (1”å”AŠí): ‘æ12‰ñ_“ސì”å”AŠíƒrƒfƒIƒtƒH[ƒ‰ƒ€ (2016/3/5), ‰¡•l.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-110018. [ŒŽ’˜] Targeting Poly (ADP-Ribose) Polymerase and the c-Myb-TopBP1-ATR-Chk1 Signaling Pathway in Castration-Resistant Prostate Cancer. Li L, Chang W, Yang G, Ren C, Park S, Karantanos T, Karanika S, Wang J, Yin J, Shah PK, Hirayama T1, Dobashi M1, Zhang W, Efstathiou E, Maity SN, Aparicio AM, Li Ning Tapia EM, Troncoso P, Broom B, Xiao L, Lee HS, Lee JS, Corn PG, Navone N, Thompson TC: Sci Signal 2014/5; 7 (326): 1-25. (•œŽR‹M”Ž1, “y‹Ž³l1: 1”å”AŠí)

H26-110019. [ŒŽ’˜] Postmortem radiation safety and issues pertaining to permanent prostate seed implantation in Japan. Satoh T1, Dokiya T, Yamanaka H, Saito S, Ishiyama H2, Itami J, Shibuya H, Nakano T, Shigematsu N, Aoki M, Egawa S, Hashimoto M, Nishimura T, Yorozu A: Brachytherapy 2015/3; 14 (2): 136-41. (²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2: 1”å”AŠí, 2•úŽËü (Žîá‡))

[Šw‰ïEŒ€‹†‰ï“™]

H26-723013. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒAƒ‹ƒMƒ“Ž_ƒiƒgƒŠƒEƒ€‚ð—p‚¢‚œƒZƒ‹ƒuƒƒbƒN–@‚É‚š‚¯‚éÅ“Kì»–@‚ÌŠm—§‚š‚æ‚Ñ‚»‚Ì“Á’¥. “c’†@Œ\1, Œ‘º—R—¢1, rˆä‚ä‚èŽq2, Š`ÀœA–M3, ’¬“c‘å•ã3, ŽR‰º˜a–ç3, Œ–{˜a«4, ‘å•”@œ2, ²“¡—Yˆê2, •ž•”@Šw2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3•a—•”, 4”å”AŠí): ‘æ53‰ñ“ú–{—Տ°×–EŠw‰ïHŠú‘å‰ï (2014/11/8), ‰ºŠÖ.

H26-733012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ƒAƒ‹ƒMƒ“Ž_ƒiƒgƒŠƒEƒ€‚ð—p‚¢‚œƒZƒ‹ƒuƒƒbƒN–@‚ÌŒŸ“¢. “c’†@Œ\1, Œ‘º—R—¢1, rˆä‚ä‚èŽq2, Š`ÀœA–M3, ’¬“c‘å•ã3, ŽR‰º˜a–ç3, Œ–{˜a«4, ‘å•”@œ2, ²“¡—Yˆê2, •ž•”@Šw2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3•a—•”, 4”å”AŠí): ‘æ33‰ñ_“ސ쌧—Տ°×–EŠw‰ïŠwpW‰ï (2014/10/4), ‘Š–ÍŒŽ.


Šá‰ÈŠw

[Šwp˜_•¶]

110265. [ŒŽ’˜] Comparison of Astigmatic Correction after Femtosecond Lenticule Extraction and Small-Incision Lenticule Extraction for Myopic Astigmatism. Kobashi H1, Kamiya K1, Mohamed A Ali2, Igarashi A1, Mohamed Ehab M Elewa2, Shimizu K1 (2Department of Ophthalmology, Faculty of Medicine, Minia University, Minia, Egypt): PLoS One 2015/4; 10 (4): e0123408. (¬‹Ž‰p’·1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1: 1Šá‰È)

110266. [ŒŽ’˜] Anterior and Posterior Corneal Astigmatism after Refractive Lenticule Extraction for Myopic Astigmatism. Kamiya K1, Shimizu K1, Yamagishi M, Igarashi A1, Kobashi H1: J Ophthalmol 2015/5; 2015: 915853. (_’J˜aF1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, ¬‹Ž‰p’·1: 1Šá‰È)

110267. [ŒŽ’˜] Computer Simulation of Color Confusion for Dichromats in Video Device Gamut under Proportionality Law. Fukuda H, Hara S, Asakawa K1, Ishikawa H1, Noshiro M, Katuya M: IPSJ Transactions on Computer Vision and Applications 2015/5; 7: 41-9. (óì@Œ«1, Îì@‹Ï1: 1ˆã—Éq¶Šw•”)

110268. [ŒŽ’˜] Effect of Myopic Defocus on Visual Acuity after Phakic Intraocular Lens Implantation and Wavefront-guided Laser in Situ Keratomileusis. Kamiya K1, Shimizu K1, Igarashi A1, Kawamorita T2: Scientific Reports 2015/5; 5: 10456. (_’J˜aF1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, ìŽç“c‘ñŽu2: 1Šá‰È, 2ˆã—Éq¶Šw•”)

110269. [ŒŽ’˜] Clinical utility of femtosecond laser-assisted astigmatic keratotomy after cataract surgery. Nejima R1,2, Terada Y1, Mori Y1,2, Ogata M1, Minami K1, Miyata K1: Jpn J Ophthalmol 2015/5; 59 (4): 209-15. (Žq“‡—Ç•œ1,2, X@—mÄ1,2: 1‹{“cŠá‰È•a‰@, 2Šá‰È)

110270. [ŒŽ’˜] Swedish Interactive Threshold Algorithm for central visual field defects unrelated to nerve fiber layer. Hirasawa K1, Shoji N1: Graefes Arch Clin Exp Ophthalmol 2016/5; 254 (5): 845-54. (•œàVˆê–@1, ¯ŽiMs1: 1ˆã—Éq¶Šw•”)

110271. [ŒŽ’˜] Effects of Different Levels of Intraocular Stray Light on Kinetic Perimetry Findings. Hirasawa K1, Shoji N1, Isono K, Tsuchiya M: PLoS One 2015/5; 10 (5): e0127159. (•œàVˆê–@1, ¯ŽiMs1: 1ˆã—Éq¶Šw•”)

110272. [ŒŽ’˜] Enhanced Depth Imaging of Central Laminar Thickness in Optic Neuropathy: Comparison with Normal Eyes. Suntaree Thitiwichienlert, Ishikawa H1, Asakawa K1, Ikeda T2, Shimizu K2: Neuro-Ophthalmology 2015/6; 39 (4): 166-74. (Îì@‹Ï1, óì@Œ«1, ’r“c“N–ç2, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

110273. [ŒŽ’˜] Effect of Intraocular Forward Scattering and Corneal Higher-Order Aberrations on Visual Acuity after Descemet's Stripping Automated Endothelial Keratoplasty Kamiya K1, Asato H1, Shimizu K1, Kobashi H1, Igarashi A1: PLoS One 2015/6; 10 (6): e0131110. (_’J˜aF1, ˆÀ—¢@“µ1, Ž…Œö–ç1, ¬‹Ž‰p’·1, ŒÜ\—’ÍŽj1: 1Šá‰È)

110274. [ŒŽ’˜] Long-term observation of surface light scattering in a foldable acrylic intraocular lens. Mitaya K1, Honbo M1, Nejima R1,2, Minami K1, Amano S1: J Cataract Refract Surg 2015/6; 41 (6): 1205-9. (Žq“‡—Ç•œ1,2: 1‹{“cŠá‰È•a‰@, 2Šá‰È)

110275. [ŒŽ’˜] Pupillary Size and Light Reflex in Premature Infants. Ikeda T1, Ishikawa H2, Shimizu K1, Asakawa K2, Goseki T1: Neuro-Ophthalmology 2015/7; 39 (4): 175-8. (’r“c“N–ç1, Îì@‹Ï2, Ž…Œö–ç1, óì@Œ«2, ŒãŠÖ—˜–Ÿ1: 1Šá‰È, 2ˆã—Éq¶Šw•”)

110276. [ŒŽ’˜] Comparison of Subjective Refraction under Binocular and Monocular Conditions in Myopic Subjects. Kobashi H1, Kamiya K1, Handa T2, Ando W1, Kawamorita T2, Igarashi A1, Shimizu K1: Scientific Reports 2015/7; 5: 12606. (¬‹Ž‰p’·1, _’J˜aF1, ”Œ“c’m–ç2, ˆÀ“¡˜a‰ÌŽq1, ìŽç“c‘ñŽu2, ŒÜ\—’ÍŽj1, Ž…Œö–ç1: 1Šá‰È, 2ˆã—Éq¶Šw•”)

110277. [ŒŽ’˜] Repeatability, Reproducibility, and Comparability of Subjective and Objective Measurements of Intraocular Forward Scattering in Healthy Subjects. Iijima A1, Shimizu K2, Kobashi H2, Saito A2, Kamiya K2: Biomed Res Int 2015/7; 2015: 925217. (”Ñ“‡ˆè‰Ã1, Ž…Œö–ç2, ¬‹Ž‰p’·2, âV“¡@Ê2, _’J˜aF2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È)

110278. [ŒŽ’˜] Revalidating the usefulness of a "sector-wise regression" approach to predict glaucomatous visual function progression. Hirasawa K1, Murata H, Asaoka RInvest Ophthalmol Vis Sci 2015/7; 56 (8): 4332-5. (•œàVˆê–@1: 1ˆã—Éq¶Šw•”)

110279. [ŒŽ’˜] Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery. Igarashi A1, Kamiya K1, Kobashi H1, Shimizu K1: Cornea 2015/8; 34 (8): 895-900. (ŒÜ\—’ÍŽj1, _’J˜aF1, ¬‹Ž‰p’·1, Ž…Œö–ç1: 1Šá‰È)

110280. [ŒŽ’˜] Effect of Optical Defocus on the Kinetic Perimetry in Young Myopic Participants. Hirasawa K1, Shoji N1: Curr Eye Res 2015/8; 40 (8): 847-52. (•œàVˆê–@1, ¯ŽiMs1: 1ˆã—Éq¶Šw•”)

110281. [ŒŽ’˜] The Relationship Between Visual Acuity and the Reproducibility of Visual Field Measurements in Glaucoma Patients. Matsuura M, Hirasawa K1, Murata H, Asaoka R: Invest Ophthalmol Vis Sci 2015/8; 56 (9): 5630-5. (•œàVˆê–@1: 1ˆã—Éq¶Šw•”)

110282. [ŒŽ’˜] Effects of mydriasis and miosis on kinetic perimetry findings in normal participants. Hirasawa K1, Shoji N1, Kobashi C, Yamanashi A: Graefes Arch Clin Exp Ophthalmol 2015/8; 253 (8): 1341-6. (•œàVˆê–@1, ¯ŽiMs1: 1ˆã—Éq¶Šw•”)

110283. [ŒŽ’˜] Intraocular Scattering after Instillation of Diquafosol Ophthalmic Solution. Kobashi H1, Kamiya K1, Igarashi A1, Miyake T1, Shimizu K1: Optom Vis Sci 2015/9; 92 (9): e303-9. (¬‹Ž‰p’·1, _’J˜aF1, ŒÜ\—’ÍŽj1, ŽO‘îr”V1, Ž…Œö–ç1: 1Šá‰È)

110284. [ŒŽ’˜] Correlation between disc damage likelihood scale with stereoscopic fundus camera and visual field index of Humphrey field analyzer. Asakawa K1, Kato S: The Journal of Ophthalmic Photography 2015/10; 37 (2): 67-70. (óì@Œ«1: 1ˆã—Éq¶Šw•”)

110285. [ŒŽ’˜] Intraocular lens power calculation in cases with posterior keratoconus. Tamaoki A1,2, Kojima T3, Hasegawa A2, Nakamura H2, Tanaka K1, Ichikawa K2,4: J Cataract Refract Surg 2015/10; 41 (10): 2190-5. (Žsìˆê•v2,4: 1MB‘åŠw‘åŠw‰@‘‡HŠwŒnŒ€‹†‰È, 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 3Šò•ŒÔ\Žš•a‰@, 4Šá‰È)

110286. [ŒŽ’˜] Assessment of Anterior, Posterior, and Total Central Corneal Astigmatism in Eyes With Keratoconus. Kamiya K1, Shimizu K1, Igarashi A1, Miyake T1: Am J Ophthalmol 2015/11; 160 (5): 851-7. (_’J˜aF1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, ŽO‘îr”V1: 1Šá‰È)

110287. [ŒŽ’˜] Central islands: rate and effect on visual recovery after phototherapeutic keratectomy. Hashimoto A, Kamiya K1, Shimizu K1, Igarashi A1, Kobashi H1: Jpn J Ophthalmol 2015/11; 59 (6): 409-14. (‹Ž–{“Ä•¶, _’J˜aF1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, ¬‹Ž‰p’·1: 1Šá‰È)

110288. [ŒŽ’˜] SUPPLEMENTAL SCLERAL BUCKLE IN VITRECTOMY FOR THE REPAIR OF RHEGMATOGENOUS RETINAL DETACHMENT: A Systematic Review of Literature and Meta-Analysis. Totsuka K, Inui H, Roggia MF, Hirasawa K1, Noda Y, Ueta T: Retina 2015/11; 35 (11): 2423-31. (•œàVˆê–@1: 1ˆã—Éq¶Šw•”)

110289. [ŒŽ’˜] Comparison of the Normal, Preperimetric Glaucoma, and Glaucomatous Eyes with Upper-Hemifield Defects Using SD-OCT. Fujimura F1, Shoji N1, Hirasawa K1, Matsumura K2, Morita T2,3, Shimizu K2: Open Journal of Ophthalmology 2015/11; 5 (4): 167-73. (“¡‘º•‡²Žq1, ¯ŽiMs1, •œàVˆê–@1, Œ‘ºˆêO2, X“c“N–ç2,3, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È, 3–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

110290. [ŒŽ’˜] Area densitometry using rotating Scheimpflug photography for posterior capsule opacification and surface light scattering analyses. Minami K1, Honbo M1, Mori Y1,2, Kataoka Y1, Miyata K1: J Cataract Refract Surg 2015/11; 41 (11): 2444-9. (X@—mÄ1,2: 1‹{“cŠá‰È•a‰@, 2Šá‰È)

110291. [ŒŽ’˜] Visual and refractive outcomes of small incision lenticule extraction for the correction of myopia: 1-year follow-up. Kamiya K1, Shimizu K1, Igarashi A1, Kobashi H1: BMJ Open 2015/11; 5 (11): e008268. (_’J˜aF1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, ¬‹Ž‰p’·1: 1Šá‰È)

110292. [ŒŽ’˜] Predictability of Intraocular Lens Power Calculation After Simultaneous Pterygium Excision and Cataract Surgery. Kamiya K1, Shimizu K1, Iijima K2, Shoji N3, Kobashi H1: Medicine (Baltimore) (2015/12; 94 (52): e2232. (_’J˜aF1, Ž…Œö–ç1, ”Ñ“‡@Œh2, ¯ŽiMs3, ¬‹Ž‰p’·1: 1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”)

110293. [ŒŽ’˜] Modified iPad for treatment of amblyopia: a preliminary study. Handa T1, Ishikawa H1, Shoji N1, Ikeda T2, Totsuka S2, Goseki T2, Shimizu K2: J AAPOS 2015/12; 19 (6): 552-4. (”Œ“c’m–ç1, Îì@‹Ï1, ¯ŽiMs1, ’r“c“N–ç2, ŒË’ˁ@Œå2, ŒãŠÖ—˜–Ÿ2, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

120036. [ŒŽ’˜] ƒŒƒ{ƒtƒƒLƒTƒVƒ“1.5%“_Šá‰t‚É‚æ‚鏬Ž™‚ÌŠá‰ÈŽüpŠú‚É‚š‚¯‚錞‹Û‰»—Ö@‚ÌŒŸ“¢. ŠL“c’qŽq1, Ž›“c—T‹IŽq2, Žq“‡—Ç•œ1,3, –ìŒû‚ä‚©‚è1, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2“Œ‹žˆã‰ÈŽ•‰È‘åŠw, 3Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2015/4; 32 (4): 573-6.

120037. [ŒŽ’˜] “ú–{”­‚ÌŽŸ¢‘ã—ŒŠáŽ‹‹@”\ŒŸžEŒP—û‘•’u|3D Visual Function Trainer-ORTe|. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): Šá‰È—Տ°‹I—v 2015/5; 8 (5): 332-7.

120038. [ŒŽ’˜] ƒqƒg…»‘̏ã”ç×–E‚ÌŠj, ×–EŽ¿”ä‚ÉŠÖ‚·‚é’²ž. ó–ì@—º1, ”n“ˆŽ”@2, “à“¡®‹v3, ŽR–{’ŒŽ÷4, Žsìˆê•v3,5 (1“Æ—§s­–@l’nˆæˆã—Ë@”\„i‹@\’†‹ž•a‰@, 2Šá‰È–ŸŠá‰@, 3’†‹žŠá‰È, 4“¡“c•ÛŒ’‰q¶‘åŠw‹€“¯—˜—pŒ€‹†Ž{Ý•ªŽq¶•šŠw, 5Šá‰È): “ú–{”’“àáŠw‰ïŽ 2015/6; 27: 63-7.

120039. [ŒŽ’˜] –k—¢‘åŠw•a‰@‚É‚š‚¯‚éŽÎˆÊ‹ßŽ‹‚ÌŽèp¬Ñ. ²“¡@Ži1, ŒãŠÖ—˜–Ÿ1, åŒŽŽµd2, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): Šá‰È—Տ°‹I—v 2015/6; 8 (6): 399-402.

120040. [ŒŽ’˜] ‘œÅ“_Šá“àƒŒƒ“ƒY‚̗Տ°¬Ñ. ‚‹Ž³‰p1,2, ¬Œ^—3,4, _’J˜aF4, ¬‹Ž‰p’·4, ŒÜ\—’ÍŽj4, Ž…Œö–ç4 (1ŽR‰€•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‘Ûˆã—ÕŸŽƒ‘åŠwŽO“c•a‰@, 4Šá‰È): IOL&RS 2015/6; 29 (2): 238-45.

120041. [ŒŽ’˜] ŒÄ‹zƒŠƒYƒ€‚ª“µEŒa‚Ì—h‚炬‚É—^‚Š‚é‰e‹¿. –]ŒŽ_Žu1, –å”nˆ€”ü1, Vˆä“cF—T1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2Šá‰È): _ŒoŠá‰È 2015/6; 32 (2): 148-53.

120042. [ŒŽ’˜] ³íŽÒE•s“¯Ž‹ŽãŽ‹Š³ŽÒ‚É‚š‚¯‚éˆÙ‚È‚Á‚œðŒ‰º‚Å‚ÌŒõŽhŒƒ‚É‚æ‚é‘ÎŒõ”œŽË‚ÌŒŸ“¢. ŒË’ˁ@Œå1, Îì@‹Ï2, ŒãŠÖ—˜–Ÿ1, ’r“c“N–ç1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): _ŒoŠá‰È 2015/6; 32 (2): 154-60.

120043. [ŒŽ’˜] ’·ŠúŠÔÄ”­‚ðŒJ‚è•Ô‚µ‚œŠáâ|ŒŒŽî‚Ì1—á. Î“c@‹Å1,2, Œ–{_”V1,2, ’r“c“N–ç2, œA“c’š•v3, Ž…Œö–ç2 (1‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@Šá‰È, 2Šá‰È, 3‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@”]_ŒoŠO‰È): ‚ ‚œ‚炵‚¢Šá‰È 2015/6; 32 (6): 913-7.

120044. [ŒŽ’˜] ŽÕ•ÂƒŒƒ“ƒY (ƒIƒNƒ‹ƒAÒ) ‚É‚æ‚éŽãŽ‹Ž¡—Âւ̉ž—p. ‰i–ì‰ëŽq1, ‘åˆä“c‹I˜a1, ŽRèK‰Á1, ŒX—çŽq1, Îˆä—SŽq1, “ì‰_@Š²1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): Šá‰È—Տ°‹I—v 2015/7; 8 (7): 484-7.

120045. [ŒŽ’˜] “Œ‹ž“sA¬ŠwZ‚É‚š‚¯‚é‹üÜ•ª•z’²ž. åŒŽŽµd1, Îì@‹Ï1, Ôè–ƒˆß2, ŽOˆä‹`‹v2 (1ˆã—Éq¶Šw•”, 2‹îž‚݂‚¢Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2015/7; 32 (7): 1057-60.

120046. [ŒŽ’˜] ŠO«—Γàá‚ɑ΂µTrabectome҂ð—p‚¢‚œüˆÛ’Œ‘ѐ؊Jp‚ª—LŒø‚Å‚ ‚Á‚œˆê—á. ¬Œû@—D1, ŒŽ@CÆ1, “n糎OŒP2,3, Žsìˆê•v2,3 (1‘å—Y‰ï‘æˆê•a‰@Šá‰È, 2’†‹žŠá‰È, 3Šá‰È): Šá‰È—Տ°‹I—v 2015/9; 8 (9): 661-4.

120047. [ŒŽ’˜] Navigation laser NAVILAS҂Ŗэ׌ŒŠÇ᎒ŒÚ‹ÃŒÅ‚ðs‚Á‚œ“œ”A•a‰©”ÁÇ3—á5Šá‚ÌŒo‰ß. ²“¡—T”V1, Žsìˆê•v2,3, “à“¡®‹v2, ‹g“c‘¥•F4, ²”Œ’‰Ž’˜N5, ‰¡ŽR@ãÄ5, X@r’j1, ŽðˆäKO2 (1”Ñ“cŽs—§•a‰@Šá‰È, 2’†‹žŠá‰È, 3Šá‰È, 4Šò•ŒÔ\Žš•a‰@Šá‰È, 5JCHO’†‹ž•a‰@Šá‰È): Šá‰È—Տ°‹I—v 2015/9; 8 (9): 679-84.

120048. [ŒŽ’˜] ”’“àáÇ—á‚É‚š‚¯‚éƒt[ƒŠƒGƒhƒƒCƒ“•ûŽ®‚ƃ^ƒCƒ€ƒhƒƒCƒ“•ûŽ®‚É‚æ‚éŒõŠwŽ®ŠáŽ²’·‘ª’è‚Ì”äŠr. ‹Ê’u–Ÿ–ì1,2, ¬“‡—²Ži3, ’·’JìˆŸ—¢1, ’†‘º‰pŽ÷1, ‹Ž’Ü—Ç‘Ÿ1, ˆÉ“¡Žu‘ã”ü1, “c’†@Ž2, Žsìˆê•v1,4,5 (1’†‹ž•a‰@, 2MB‘åŠw‘åŠw‰@‘‡HŠwŒnŒ€‹†‰È, 3Šò•ŒÔ\Žš•a‰@, 4’†‹žŠá‰È, 5Šá‰È): IOL&RS 2015/9; 29 (3): 378-83.

120049. [ŒŽ’˜] Laser in situ keratomileusis‚ÆSmall incision lenticule extraction‚̏pŒã¬Ñ‚Ì”äŠr. àV–؈»Žq1, ’·’JìˆŸ—¢2, ¬“‡—²Ži1,2, ’†‘º—Fº2, •Ð‰ª“”Ž2, Žsìˆê•v3,4 (1Šò•ŒÔ\Žš•a‰@, 2–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3’†‹žŠá‰È, 4Šá‰È): IOL&RS 2015/9; 29 (3): 384-90.

120050. [ŒŽ’˜] –Ô–ŒF‘f•Ï«Ç‚Ì㵖Ÿ¶‹N‚É‚š‚¯‚é“ÁˆÙ“I”g’·. ŽR“c–ŸŽq1,2, Vˆä“cF—T2,3, x•‰³—Y2, ’‡”‘@‘1 (1‘—§áŠQŽÒƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•a‰@, 2‘Ûˆã—ÕŸŽƒ‘åŠw‘åŠw‰@ˆã—ÕŸŽƒŠwŒ€‹†‰È•ÛŒ’ˆã—ÊwêUŽ‹‹@”\—Ö@Šw•ª–ì, 3Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2015/9; 32 (9): 1349-54.

120051. [ŒŽ’˜] Œ’íŽÒ‚É‚š‚¯‚éˆÃ‡‰žŽžŠÔ‚ªRAPDx_‚Ì‘ª’茋‰Ê‚ƍČ»«‚É‹y‚Ú‚·‰e‹¿. ²“¡@Ži1, ŒãŠÖ—˜–Ÿ1, óì@Œ«2, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): _ŒoŠá‰È 2015/9; 32 (3): 263-8.

120052. [ŒŽ’˜] ‘яóŠp–Œ•Ï«Ç‚ƃyƒ‹[ƒVƒhŠp–Œ•Ï«Ç‚Ì•¹”­—á‚ɃGƒLƒVƒ}ƒŒ[ƒU[‹üÜ‹ž³Žèp•¹—pŠp–ŒƒRƒ‰[ƒQƒ“ƒNƒƒXƒŠƒ“ƒLƒ“ƒO‚ðŽ{s‚µ‚œ1Ç—á. –Ø‘º“TŒh1, ¬‹Ž‰p’·1, ŒÜ\—’ÍŽj1, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È): IOL&RS 2015/12; 29 (4): 528-32.

120053. [ŒŽ’˜] ^‹Û«Šp–Œ‰Š‚ÉŠÖ‚·‚é‘œŽ{Ý‹€“¯‘OŒü‚«ŠÏŽ@Œ€‹†|Š³ŽÒ”wŒiE—Տ°ŠŒ©EŽ¡—ÁE—\Œã‚ÌŒ»‹µ|. ˆäãKŽŸ1, ‘å‹Ž—Tˆê2, —é–؁@’2, ‰º‘º‰Ãˆê3, •Ÿ“c¹•F3, ŠO‰€çŒb4, `–ì@Š°5, ]Œû@—m6, ²X–؍‚é7, ¯@Å’q8, »“c~Žq9, ó—˜œŽu9, –îŒû‹MŽu10, ꠑº_ˆê11, ‰¡‘qr“ñ12, –]ŒŽŽ•¶13, –å“c—V14, Žq“‡—Ç•œ15,16; ^‹Û«Šp–Œ‰Š‘œŽ{ÝƒXƒ^ƒfƒBƒOƒ‹[ƒv (1’¹Žæ‘åŠw, 2ˆ€•Q‘åŠw, 3‹ß‹E‘åŠw, 4‹ž“s•{—§ˆã‰È‘åŠw, 5ƒ‹ƒ~ƒl‚Í‚œ‚ÌŠá‰È, 6“¿“‡‘åŠw, 7o“cŠá‰È•a‰@, 8“¡Ž}Žs—§‘‡•a‰@, 9‘åã‘åŠwˆãŠw•”•‘®•a‰@—Տ°ŒŸž•”, 10ç—t‘å^‹ÛˆãŠwŒ€‹†ƒZƒ“ƒ^[, 11’é‹ž‘åŠwˆã^‹ÛŒ€‹†ƒZƒ“ƒ^[, 12“Œ–k‘åŠw, 13Šò•Œ‘åŠw, 14‹v—¯•Ä‘åŠw, 15‹{“cŠá‰È•a‰@, 16Šá‰È): “ú–{Šá‰È›{˜ðŽGŽ 2016/1; 120 (1): 5-16.

120054. [ŒŽ’˜] ^‹Û«Šp–Œ‰Š‚ÉŠÖ‚·‚é‘œŽ{Ý‹€“¯‘OŒü‚«ŠÏŽ@Œ€‹†|^‹Û‚Ì“¯’è‚Æ–òÜŠŽŽó«ŒŸž‚ɂ‚¢‚ā|. »“c~Žq1, ó—˜œŽu1, ˆäãKŽŸ2, ‘å‹Ž—Tˆê3, —é–؁@’3, ‰º‘º‰Ãˆê4, •Ÿ“c¹•F4, ŠO‰€çŒb5, `–ì@Š°6, ]Œû@—m7, ²X–؍‚é8, ¯@Å’q9, –îŒû‹MŽu10, ꠑº_ˆê11, ‰¡‘qr“ñ12, –]ŒŽŽ•¶13, –å“c—V14, Žq“‡—Ç•œ15,16; ^‹Û«Šp–Œ‰Š‘œŽ{ÝƒXƒ^ƒfƒBƒOƒ‹[ƒv (1‘åã‘åŠwˆãŠw•”•‘®•a‰@—Տ°ŒŸž•”, 2’¹Žæ‘åŠw, 3ˆ€•Q‘åŠw, 4‹ß‹E‘åŠw, 5‹ž“s•{—§ˆã‰È‘åŠw, 6ƒ‹ƒ~ƒl‚Í‚œ‚ÌŠá‰È, 7“¿“‡‘åŠw, 8o“cŠá‰È•a‰@, 9“¡Ž}Žs—§‘‡•a‰@, 10ç—t‘åŠw^‹ÛˆãŠwŒ€‹†ƒZƒ“ƒ^[, 11’é‹ž‘åŠwˆã^‹ÛŒ€‹†ƒZƒ“ƒ^[, 12“Œ–k‘åŠw, 13Šò•Œ‘åŠw, 14‹v—¯•Ä‘åŠw, 15‹{“cŠá‰È•a‰@, 16Šá‰È): “ú–{Šá‰È›{˜ðŽGŽ 2016/1; 120 (1): 17-27.

120055. [ŒŽ’˜] 3D Visual Function Trainer-ORTe‚ÌŠáˆÊEŠá‹…‰^“®ŒŸž‚Ì‘Œ‹@Ží‚Ƃ̌݊·«ŒŸ“¢ (Measurements of eye position and movements using 3D Visual Function Trainer ORTe-comparison with other instruments-). ŒË’˘aŽq1, Îì@‹Ï2, ”Œ“c’m–ç2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): Šá‰È—Տ°‹I—v 2016/2; 9 (2): 169-72.

120056. [ŒŽ’˜] Œ’íŽá”NŠá‚É‚š‚¯‚鍂ŽŸ”g–ÊŽû·‚Æ”N—î•Ï‰»: ‘æ2•ñ (Relationship between higher-order wavefront aberrations and age in children). âV“¡@Ê1, ˆÉ“¡”ü¹ŠG2, ìŽç“c‘ñŽu2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): Šá‰È—Տ°‹I—v 2016/2; 9 (2): 173-8.

120057. [ŒŽ’˜] Ž‹ü‰ðÍ‘•’u‚É‚æ‚鉓Œ©E‹ßŒ©‚ł̕ЊáŽÕ•ÂŽž‚ÌŠáˆÊ‘ª’è‚ÆŒð‘ãƒvƒŠƒYƒ€ŽÕ•ÂŽŽŒ±‚Å‚ÌŠáˆÊ‚Ì”äŠr. Žl”V‹{—C”n1, ‚‹Ž—RŽk1, –ìã‹Žu1, Vˆä“cF—T1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2Šá‰È): Šá‰È—Տ°‹I—v 2016/3; 9 (3): 230-3.

120058. [ŒŽ’˜] Ž‹ü‰ðÍ‘•’u‚ð—˜—p‚µ‚œ—Z‘œœ‹ŽŠáˆÊ‘ª’è‚É‚š‚¯‚éŽÕ•ÂŽžŠÔ‚ÌŒŸ“¢. ‚‹Ž—RŽk1, Žl”V‹{—C”n1, –ìã‹Žu1, Vˆä“cF—T1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2Šá‰È): Šá‰È—Տ°‹I—v 2016/3; 9 (3): 234-7.

120059. [ŒŽ’˜] ”]—ÀŒ‡‘¹Ç‚ÉŽ—‚œ‚“x…“ªÇÇ—á‚Ì—ŒŠáŽ‹‹@”\. –]ŒŽ_Žu1, ŒŽ@’Œl1,3, “àŽRmŽu1, ¬’¬—SŽq1, ’ËŒŽ–ƒ—R‰À2, ¬–ì—¢‹KŽq2, Vˆä“cF—T1,3 (1‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2‘Ûˆã—ÕŸŽƒ‘åŠw•a‰@Šá‰È, 3Šá‰È): Šá‰È—Տ°‹I—v 2016/3; 9 (3): 264-7.

310028. [Ç—á•ñ] Fixation Duration Changes in Rett Syndrome after Habilitation Intervention. Hirano D, Hayashi K, Onose Y, Ishii M, Miyauchi M, Sekimori H, Taniguchi T, Shimoizumi H, Niida T1,2: Int J Phys Med Rehabil 2015/4; 3 (3): 1000271. (Vˆä“cF—T1,2: 1‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2Šá‰È)

310029. [Ç—á•ñ] Processes and effects of correction with eyeglasses in a child with severe motor and intellectual disabilities: A case report. Hirano D, Minagawa C, Umehara S, Hayashi K, Onose Y, Sekimorim H, Taniguchi T, Komachi Y, Shimoizumi H, Niida T1,2: Clinical Case Reports and Reviews 2015/9; 1 (8): 179-81. (Vˆä“cF—T1,2: 1‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2Šá‰È)

310030. [Ç—á•ñ] Interface Fluid Syndrome Induced by Uncontrolled Intraocular Pressure Without Triggering Factors After LASIK in a Glaucoma Patient: A Case Report. Shoji N1, Ishida A2, Haruki T2, Matsumura K2, Kasahara M2, Shimizu K2: Medicine (Baltimore) (2015/9; 94 (39): e1609. (¯ŽiMs1, Î“c@‹Å2, t–ؐ’G2, Œ‘ºˆêO2, Š}ŒŽ³s2, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

320036. [Ç—á•ñ] Šá‹ØŒ^dÇ‹Ø–³—͏ǂɂæ‚閃ა«ŠOŽÎŽ‹‚ɑ΂µ, ã‰º’Œ‹Ø‘S•ˆÚ“®p‚ª—LŒø‚Å‚ ‚Á‚œˆê—á. —Žˆä‰‘Žq1, ŒãŠÖ—˜–Ÿ2, Îì@‹Ï3, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3ˆã—Éq¶Šw•”): _ŒoŠá‰È 2015/6; 32 (2): 161-4.

320037. [Ç—á•ñ] ‰E“ª’žŒã“ª—toŒŒ‚É‚æ‚èçt–©•s‘SŒ^ŠOŽÎŽ‹‚𔭏ǂµ‚œ1—á. Š—¶^—1, ŒŽ@’Œl1,2,3, ŒN“‡^ƒ1, —é–Ø—T”ü1,3, Œü–ì˜a—Y1,3 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 2‘Ûˆã—ÕŸŽƒ‘åŠw, 3Šá‰È): _ŒoŠá‰È 2015/12; 32 (4): 377-83.

320038. [Ç—á•ñ] Ä”­«Ž‹_Œo‰Š‚̏Ǘá‚ÉIgG4ŠÖ˜AŠáŽŸŠ³‚ÌŠÖ—^‚ª‹^‚í‚ê‚œˆê—á. X@@—D1,2, ŽRã–ŸŽq1,3, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,3 (1ˆäãŠá‰È•a‰@, 2“Œ‹ž—Žqˆã‰È‘åŠw, 3Šá‰È): _ŒoŠá‰È 2016/3; 33 (1): 32-6.

410001. [—Տ°ŽŽŒ±] Effect of femtosecond laser setting on visual performance after small-incision lenticule extraction for myopia. Kamiya K1, Shimizu K1, Igarashi A1, Kobashi H1: Br J Ophthalmol 2015/10; 99 (10): 1381-7. (_’J˜aF1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, ¬‹Ž‰p’·1: 1Šá‰È)

510007. [‘à] Pupil light response to predict the state of retinal degeneration in rabbits with rhodopsin P347L mutation. Asakawa K1: NEW JOURNAL STUDIES-Academy Express Asia Pacific Edition- 2015/10. (óì@Œ«1: 1ˆã—Éq¶Šw•”)

520013. [‘à] Leberˆâ“`«Ž‹_ŒoÇ”F’èŠî€. ’†‘º@œ1, ŽO‘º@Ž¡2, Žá‘q‰ë“o3,4, ˆî’J@‘å5, ’†àV@“O6, ”’_Žj—Y7 (1_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ€‹†‰ÈŠá‰ÈŠw•ª–ì, 2•ºŒÉˆã‰È‘åŠwŠá‰ÈŠw‹³Žº, 3ˆäãŠá‰È•a‰@, 4Šá‰È, 5•Ÿˆä‘åŠwˆãŠw•”Šá‰ÈŠw‹³Žº, 6“Œ–k‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰ÈŠá‰ÈŠw•ª–ì, 7‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–ò‘‡Œ€‹†‰ÈŠá‰ÈŠw): “ú–{Šá‰È›{˜ðŽGŽ 2015/5; 119 (5): 339-46.

521019. [‰ðà] ¡Žž‚Ì–ï‰î‚ÈŠ³ŽÒ‚É‚€‚Ü‚­‘Ώˆ‚·‚é‚É‚Í. _’J˜aF (Šá‰È): VISION TIMES 2015/8; 22 (3): 19-25.

521020. [‰ðà]yŽèpŠí‹ïzƒoƒCƒIƒƒgƒŠ[IOLƒ}ƒXƒ^[700. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): IOL&RS 2015/9; 29 (3): 403-5.

521021. [‰ðà]y”’“àá‚Ì‚©‚·‚݁E‚ڂ₯E“ñdŽ‹E‚Ü‚Ô‚µ‚³‚ªÁ‚Š‚œ! Ž©—͂ň«‰»‚ð–h‚¢‚ŃrƒbƒNƒŠ‰ñ•œ! Ž‹ŠEƒNƒŠƒA! –Ú‚Ì‘÷‚èŽæ‚葬ŒøƒNƒŠƒjƒbƒNz˜VŠá‚Í, ŽÀ‚Í”’“àá‚̏‰ŠúÇó‚Å, ˜VŠá‚Ő…»‘Ì‚Ì’e—Í‚ª’ቺ‚µ‚Ä”’‘÷‚ªi‚Þ‚Æ‚í‚©‚Á‚œ. Ž…Œö–ç (Šá‰È): ‚í‚©‚³–²MOOK 2015/11; 15: 10-1.

521022. [‰ðà]y”’“àá‚Ì‚©‚·‚݁E‚ڂ₯E“ñdŽ‹E‚Ü‚Ô‚µ‚³‚ªÁ‚Š‚œ! Ž©—͂ň«‰»‚ð–h‚¢‚ŃrƒbƒNƒŠ‰ñ•œ! Ž‹ŠEƒNƒŠƒA! –Ú‚Ì‘÷‚èŽæ‚葬ŒøƒNƒŠƒjƒbƒNzl‹C‚̋ߎ‹‹ž³Žèp [ƒŒ[ƒVƒbƒN] ‚ðs‚Á‚œl‚ÍŽá‚­‚µ‚Ä”’“àá‚É‚È‚é‹°‚ꂪ‚ ‚è—v’ˆÓ. Ž…Œö–ç (Šá‰È): ‚í‚©‚³–²MOOK 2015/11; 15: 12.

521023. [‰ðà]yŠá‰Èˆã‚ÌŽèˆø‚« <852>z‹üÜ‹ž³Žèp‚Ì‚ ‚œ‚炵‚¢“WŠJ@SMILE. _’J˜aF (Šá‰È): “ú–{‚ÌŠá‰È 2015/11; 86 (11): 1584-5.

521024. [‰ðà]y_ŒoŠá‰È“ü–åƒVƒŠ[ƒY107z‹ÇÝf’f|Ž‹_Œo‚̊ӕʐf’f|. Žs糋`Í1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È): _ŒoŠá‰È 2015/12; 32 (4): 387-93.

521025. [‰ðà] ”’“àáE‹üÜŽèp‚̘_“_: ‹üÜ‹ž³ŽèpŒã‚̋ߎ‹‰». ¬‹Ž‰p’· (Šá‰È): IOL&RS 2015/12; 29 (4): 569-71.

522129. [uÀ]y“ÁW (2): ŠáŽŸŠ³‚ÆŽÎŽ‹Žèpz”’“àá‚ÆŽÎŽ‹Žèp. ŒãŠÖ—˜–Ÿ (Šá‰È): Šá‰ÈŽèp 2015/4; 28 (2): 183-8.

522130. [uÀ]y“ÁW: Šp–ŒˆÚAp‚̍Őæ’[‚Æ“K‰žz4. ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚É‚æ‚éPKP. _’J˜aF (Šá‰È): OCULISTA 2015/5; 26: 23-9.

522131. [uÀ]y“ÁW3: ”’“àá‚ÆQOLz”’“àá‚Ɖ^“]. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): “ú–{”’“àáŠw‰ïŽ 2015/6; 27: 45-6.

522132. [uÀ]y“ÁW: —¬o˜HÄŒšp‚Ì“K‰ž‚Æ”äŠrz9. —¬o˜HÄŒšp‚Ì”äŠr. ¯ŽiMs (ˆã—Éq¶Šw•”): OCULISTA 2015/6; 27: 58-67.

522133. [uÀ]y“ÁW: o‘µ‚Á‚œƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒYz“ÁW‚É‚ ‚œ‚Á‚Ä. _’J˜aF1, ‘å“à‰ë”V2 (1Šá‰È, 2‘å“àŠá‰È): IOL&RS 2015/6; 29 (2): 188.

522134. [uÀ]y“ÁW: o‘µ‚Á‚œƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒYzŒã–[Œ^ƒg[ƒŠƒbƒN—L…»‘ÌŠá“àƒŒƒ“ƒY. ŒÜ\—’ÍŽj (Šá‰È): IOL&RS 2015/6; 29 (2): 189-92.

522135. [uÀ]y“ÁW: NMOÅ‘OüzRƒAƒNƒAƒ|ƒŠƒ“4R‘Ì—z«Ž‹_Œo‰Š‚ÌŽ‹–ìáŠQƒpƒ^[ƒ“‚ÌŒŸ“¢. ŽRã–ŸŽq1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): _ŒoŠá‰È 2015/6; 32 (2): 135-41.

522136. [uÀ]y_ŒoŠá‰È“ü–åƒVƒŠ[ƒY105z‹ÇÝf’f|“µEŠŒ©‚©‚çÓ”C•a‘ƒ‚𐄑ª‚·‚é|. Îì@‹Ï (ˆã—Éq¶Šw•”): _ŒoŠá‰È 2015/6; 32 (2): 168-70.

522137. [uÀ]y“ÁW: ÅV‚̗ΓàáŽ¡—Áz—Γàá‚̐VŽèp2: MIGS ‚Æ‚±‚ê‚ÉŠÖ˜A‚µ‚œV‚µ‚¢pŽ®. ¯ŽiMs (ˆã—Éq¶Šw•”): ‚ ‚œ‚炵‚¢Šá‰È 2015/6; 32 (6): 813-20.

522138. [uÀ]yCLƒoƒgƒ‹ƒƒCƒ„ƒ‹ƒT[ƒhƒXƒe[ƒW@‘æ40‰ñzƒn[ƒhƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚̃PƒA. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): “ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ïŽ 2015/6; 57 (2): 87-96.

522139. [uÀ]y˜AÚ: p‘OEpŒãŠÇ—‚̍¢“ï‚ÈŠ³ŽÒ‚ւ̑Ήžz“û—cŽ™‚š‚æ‚ѐž_”­’B’x‘؂̗ΓàáŠ³ŽÒ‚ւ̑Ήž. Œ‘ºˆêO1, ¯ŽiMs2 (1Šá‰È, 2ˆã—Éq¶Šw•”): Šá‰ÈŽèp 2015/7; 28 (3): 393-6.

522140. [uÀ]y“ÁW: —Ž‹‚̐f—Ãupdatez2. [—Ž‹‚ÆŽ‹‹@”\] ³—Ž‹E•s³—Ž‹‚ÆŽ‹‹@”\. _’J˜aF (Šá‰È): OCULISTA 2015/8; 29: 7-13.

522141. [uÀ]y“ÁW: —Ž‹‚̐f—Ãupdatez3. [—Ž‹‚ÌŒŸž–@E•]‰¿–@-1] ³—Ž‹‚ÌŒŸž–@‚Æ•]‰¿–@. ”Ñ“c‰Ã•F (Šá‰È): OCULISTA 2015/8; 29: 14-20.

522142. [uÀ]y“ÁW: Šá‰Èˆã‚Ì‚œ‚߂̐SgˆãŠwz7. _ŒoŠá‰È‚ƐSgˆãŠw. ŽRã–ŸŽq1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): OCULISTA 2015/9; 30: 46-50.

522143. [uÀ]y“ÁW: –Ô–ŒEŽ‹_Œo‚̐_Œo•ÛŒì‚ƍжz˜˜_. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): _ŒoŠá‰È 2015/9; 32 (3): 233.

522144. [uÀ]y˜AÚ: –ÚŽw‚¹! Šá‚ÌŒ`¬ŠO‰ÈƒGƒLƒXƒp[ƒgz‰ºŠááÙ“à”œÇŽèp|ŒÕ‚ÌŠª! Œ–{_”V1,2 (1‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@, 2Šá‰È): —Տ°Šá‰È 2015/10; 69 (10): 1464-9.

522145. [uÀ]y‚í‚©‚è‚â‚·‚¢—Տ°uÀz•Ð“ª’É‚ÌŠá‰È—Տ°‚ÆŽ‹‹@”\ˆÙí. ŒŽ@’Œl1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠw, 2Šá‰È): “ú–{‚ÌŠá‰È 2015/11; 86 (11): 1565-72.

522146. [uÀ]y‘æ“ñ“ÁW: Šá‰ÈƒXƒ^ƒbƒt‚à‚±‚±‚Ü‚Å’m‚Á‚Ä‚š‚«‚œ‚¢!@‘OŠá•”‚̍ŐVŽèpz<1> ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚É‚æ‚éŠp–ŒˆÚAp. _’J˜aF (Šá‰È): Šá‰ÈƒPƒA 2015/12; 17 (12): 66-9.

522147. [uÀ]y“ÁW: Šá“àƒŒƒ“ƒY‚̃|ƒCƒ“ƒg‚ƍ‡•¹Ç‘΍ôz2. Šá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“. ˆÉ“¡”ü¹ŠG1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): OCULISTA 2015/12; 33: 10-6.

522148. [uÀ]y“ÁW: Šá“àƒŒƒ“ƒY‚̃|ƒCƒ“ƒg‚ƍ‡•¹Ç‘΍ôz5. ‰~Šp–ŒŠá‚É‚š‚¯‚éŠá“àƒŒƒ“ƒY‚Ì‘I‘ð. ŒÜ\—’ÍŽj (Šá‰È): OCULISTA 2015/12; 33: 31-6.

522149. [uÀ]y“ÁW: Šá“àƒŒƒ“ƒY‚̃|ƒCƒ“ƒg‚ƍ‡•¹Ç‘΍ôz7. ’Ž’ZŠáŽ²’·Šá‚ɑ΂·‚éIOL piggyback. ”Ñ“c‰Ã•F (Šá‰È): OCULISTA 2015/12; 33: 46-50.

522150. [uÀ]y“ÁW: LASIKŒŸØz“ÁW‚É‚ ‚œ‚Á‚Ä. ’†‘º—Fº1, _’J˜aF2 (1–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 2Šá‰È): IOL&RS 2015/12; 29 (4): 496.

522151. [uÀ]y“ÁW: LASIKŒŸØz’·Šú¬Ñ. ¬‹Ž‰p’· (Šá‰È): IOL&RS 2015/12; 29 (4): 508-10.

522152. [uÀ]y—Տ°ƒZƒ~ƒi[zLASIKŠá‚ÌIOL“x”ŒvŽZŽ®. ”Ñ“c‰Ã•F (Šá‰È): IOL&RS 2015/12; 29 (4): 582-5.

522153. [uÀ]y˜AÚ: Therapeuticsz‚ ‚È‚œ‚à‚Å‚«‚é_ŒoŠá‰ÈŽŸŠ³‚ÌŽ¡—Á@Šááق¯‚¢‚ê‚ñ. ŒãŠÖ—˜–Ÿ (Šá‰È): Šá‰ÈƒOƒ‰ƒtƒBƒbƒN 2015/12; 4 (6): 581-4.

522154. [uÀ]y“ÁW: Šá“àƒŒƒ“ƒYƒAƒbƒvƒf[ƒgzLASIKŠá‚ÌŠá“àƒŒƒ“ƒY‚Ì‘I‚Ñ•û. _’J˜aF (Šá‰È): —Տ°Šá‰È 2016/1; 70 (1): 48-57.

522155. [uÀ]y“ÁW: ‹c˜_‚Ì‘œ‚¢ŠáŽ¡—Á|Œš‘O‚Æ–{‰¹|z5. ”’“àáŽèp|’PÅ“_ƒŒƒ“ƒY VS. ‘œÅ“_ƒŒƒ“ƒY|. _’J˜aF (Šá‰È): Šá‰È 2016/1; 58 (1): 31-5.

522156. [uÀ] Šp–Œ‹üÜ‹ž³ŽèpŒã‚Ì”’“àáŽèp. ”Ñ“c‰Ã•F (Šá‰È): “ú–{‚ÌŠá‰È 2016/2; 87 (2): 29-34.

522157. [uÀ]y“ÁW: –ƒáƒ«ŽÎŽ‹z–ƒáƒ«ŽÎŽ‹‚Ì”ñŠÏŒŒ“IŽ¡—Ã. ŒãŠÖ—˜–Ÿ (Šá‰È): _ŒoŠá‰È 2016/3; 33 (1): 16-22.

530014. [‚»‚Ì‘Œ (Letters Reply)]yLetters ReplyzMyopic eyes develop cataracts at an earlier age. Iijima K1,2, Shimizu K3, Kamiya K3, Igarashi A3, Komatsu M3,4: J Cataract Refract Surg 2015/5; 41 (5): 1126-7. (”Ñ“‡@Œh1,2, Ž…Œö–ç3, _’J˜aF3, ŒÜ\—’ÍŽj3, ¬Œ^—3,4: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠC˜V–Œ‘‡•a‰@, 3Šá‰È, 4‘Ûˆã—ÕŸŽƒ‘åŠwŽO“c•a‰@)

530015. [‚»‚Ì‘Œ (Letters to the Editor)] Why do melanopsin-containing retinal ganglion cells have the greatest sensitivity to blue light? Asakawa K1, Ishikawa H1: Acta Ophthalmol 2015/6; 93 (4): e308-9. (óì@Œ«1, Îì@‹Ï1: 1ˆã—Éq¶Šw•”)

530016. [‚»‚Ì‘Œ (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“)]yAsian SectionzApplication of Functional Near-infrared Spectroscopy to Ophthalmology. Iwata Y1, Ishikawa H2: _ŒoŠá‰È 2015/6; 32 (2): 207-10. (Šâ“c@—y1, Îì@‹Ï2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”)

530017. [‚»‚Ì‘Œ (Letters to the Editor)] Peep Into Visual Acuity Chart Through an Opening: A New Concept of Binocular Open-view Visual Acuity Test. Handa T1, Shoji N1, Shimizu K2: J Refract Surg 2015/7; 31 (7): 493-4. (”Œ“c’m–ç1, ¯ŽiMs1, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

530018. [‚»‚Ì‘Œ (Letters to the Editor)] Effects of pupil dilation on objective refraction. Iwata Y1, Handa T2, Shoji N2, Ishikawa H2, Shimizu K3: Acta Ophthalmol 2015/7; 2015: 12792. (Šâ“c@—y1, ”Œ“c’m–ç2, ¯ŽiMs2, Îì@‹Ï2, Ž…Œö–ç3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3Šá‰È)

530019. [‚»‚Ì‘Œ (’²žŒ€‹†•ñ)] Functional and morphological study of retinal photoreceptor cell degeneration in transgenic rabbits with a Pro347Leu rhodopsin mutation. Asakawa K1, Ishikawa H1, Uga S2, Mashimo K2, Shimizu K2, Kondo M, Terasaki H: Jpn J Ophthalmol 2015/9; 59 (5): 353-63. (óì@Œ«1, Îì@‹Ï1, ‰F‰ê–ÎŽO2, áÁ‰º‹I”ü‘ã2, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

540024. [‚»‚Ì‘Œ (ƒIƒ“ƒ‰ƒCƒ“‹LŽ–)] ‚Š, ’m‚ç‚È‚©‚Á‚œ!@Ž‹—Í‚É”Y‚Þ“­‚«—Žq‚É‹³‚Š‚œ‚¢uICLvŽèp‚Æ‚Í. Ž…Œö–ç (Šá‰È): BizLady 2015/4; http://bizlady.jp/archives/98927.

540025. [‚»‚Ì‘Œ (V•·‹LŽ–)] Žg—p–@Žç‚èƒgƒ‰ƒuƒ‹–h‚®@’†‚¶‚Å‘‚Š‚éƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): ’©“úV•·‘S‘”Å 2015/5/6.

540026. [‚»‚Ì‘Œ (Šª“ªŒŸ)] Leberˆâ“`«Ž‹_ŒoÇ|‚»‚Ì–â‘è“_‚ƍ¡Œã‚̉ۑè|(Leber's Hereditary Optic Neuropathy: The Problems and Future Challenges). Îì@‹Ï (ˆã—Éq¶Šw•”): “ú–{Šá‰È›{˜ðŽGŽ 2015/5; 119 (5): 337-8.

540027. [‚»‚Ì‘Œ (ƒgƒsƒbƒNƒX)]yŠw‰ïƒgƒsƒbƒNƒX: ‘æ38‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ïzƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚̍őOü. Ž…Œö–ç (Šá‰È): “ú–{Šá‰È›{˜ðŽGŽ 2015/5; 119 (5): 363-4.

540028. [‚»‚Ì‘Œ] (ŠÄ–ó) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“àáŽèp‚̍‡•¹Ç‚ð‰ñ”ð‚·‚é‚œ‚ß‚É. _’J˜aF (Šá‰È): VISION TIMES 2015/5; 22 (2): 5-11.

540029. [‚»‚Ì‘Œ (ŠO‘Ž—v——) ‰~Šp–Œ‚ɑ΂·‚éŒã–[Œ^—Ž‹‹ž³—L…»‘ÌŠá“àƒŒƒ“ƒY‘}“üp‚̏pŒã3”N¬Ñ. _’J˜aF1, Ž…Œö–ç1, ¬‹Ž‰p’·1, ŒÜ\—’ÍŽj1, ¬Œ^—1,2, ’†‘º’O—Y3, ¬“‡—²Ži4, ’†‘º—Fº5 (1Šá‰È, 2ŽR‰€•a‰@Šá‰È, 3’†‘ºŠá‰È, 4Šò•ŒÔ\Žš•a‰@Šá‰È, 5–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN): “ú–{Šá‰È›{˜ðŽGŽ 2015/6; 119 (6): 423.

540030. [‚»‚Ì‘Œ (‘•])]yBook Review ‘•]zu_ŒoŠá‰Èf—Â̂Ăт«@•a—ð‚ƐfŽ@‚©‚瓱‚­ŠÓ•ÊŽŸŠ³vÎì@O. u_ŒoŠá‰ÈŠw‚ðŠw‚Ԑl‚Ì‚œ‚߂ɁvŽO‘º@Ž¡. u_ŒoŠá‰Èf’fƒNƒ[ƒYƒAƒbƒvv•~“‡ŒhŒå. Œü–ì˜a—Y1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È): _ŒoŠá‰È 2015/6; 32 (2): 179-81.

540031. [‚»‚Ì‘Œ (ŠCŠO•¶Œ£Ð‰î)] Journal of Neurophysiology. Vˆä“cF—T1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠw, 2Šá‰È): _ŒoŠá‰È 2015/6; 32 (2): 204-5.

540032. [‚»‚Ì‘Œ (Šw‰ï•ñ)] Asia ARVO 2015•ñ. Îì@‹Ï (ˆã—Éq¶Šw•”): _ŒoŠá‰È 2015/6; 32 (2): 200-1.

540033. [‚»‚Ì‘Œ (ƒgƒsƒbƒNƒX)] SMILE. _’J˜aF (Šá‰È): Šá‰ÈŽèp 2015/7; 28 (3): 369-71.

540034. [‚»‚Ì‘Œ (’²ž•ñ)] ‚š’m‚点: Šá‰ÈŠwZˆã‚ÌŠwZ‚É‚š‚¯‚éƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠÖ˜A‚ÌŒ[”­ŽÀŽ{‚ÌŽÀ‘Ô’²žWŒv•ñ. ŽR‰ºG–Ÿ1, ‚‹Ž˜a”Ž1, ”ˆä^—Žq1, Š`“c“N•F1, ‰F’ÃŒ©‹`ˆê1,2, ‹{‰Y@“O1, •Ÿ‰ºŒöŽq1, ŽRŠÝ’Œ–î1, ‚–ì@”É1 (1“ú–{Šá‰Èˆã‰ï, 2Šá‰È): “ú–{‚ÌŠá‰È 2015/8; 86 (8): 1183-9.

540035. [‚»‚Ì‘Œ (Šw‰ïˆóÛ‹L)] ‘æ32‰ñ“ú–{ŠáŽîᇊw‰ï@Šw‰ïˆóÛ‹L@ˆê”ʍu‰‰ (1). ”–؍LÆ1,2, ‹v•Û“c•qM3 (1Ã‰ªŒ§—§‚ª‚ñƒZƒ“ƒ^[, 2Šá‰È, 3–ŒŒÃ‰®ˆã—ÃZƒ“ƒ^[): “ú–{ŠáŽîᇊw‰ïŽ 2015/9; 4: 19-20.

540036. [‚»‚Ì‘Œ (•ÒWŠé‰æ)]y“ÁW: Šá‰Èˆã‚Ì‚œ‚߂̐SgˆãŠwz•ÒWŠé‰æ‚É‚ ‚œ‚Á‚āc. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): OCULISTA 2015/9; 30: ‘O•t1.

540037. [‚»‚Ì‘Œ (Šw‰ïˆóÛ‹L)] ISOO 2015‚ÉŽQ‰Á‚µ‚Ä. ”–؍LÆ1,2 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 2Šá‰È): “ú–{ŠáŽîᇊw‰ïŽ 2015/9; 4: 44-5.

540038. [‚»‚Ì‘Œ (ƒŒƒ|[ƒg)]yÅV‹@ŠíƒŒƒ|[ƒgz–Ô–Œ“dˆÊRETeval (ƒŒƒ`ƒoƒ‹) Introduction. ŒãŠÖ—˜–Ÿ (Šá‰È): _ŒoŠá‰È 2015/9; 32 (3): 309.

540039. [‚»‚Ì‘Œ (ƒŒƒ|[ƒg)]yÅV‹@ŠíƒŒƒ|[ƒgz–Ô–Œ“dˆÊRETeval (ƒŒƒ`ƒoƒ‹) User's Comments. óì@Œ«1, ŽO‘îr”V2 (1ˆã—Éq¶Šw•”, 2Šá‰È): _ŒoŠá‰È 2015/9; 32 (3): 311-2.

540040. [‚»‚Ì‘Œ (Šª“ªŒŸ)] Šª“ªŒŸ|¡‚»‚±‚É‚ ‚éŠë‹@|. _’J˜aF (Šá‰È): Šá‰ÈŽèp 2015/10; 28 (4): 475.

540041. [‚»‚Ì‘Œ (ŽGŽ‹LŽ–)] ŽŸ¢‘ã‹ßŽ‹‹ž³uŠá“àƒRƒ“ƒ^ƒNƒgv‚ňÀS•–ž‘«‚Ȑ¶Šˆ. Ž…Œö–ç (Šá‰È): CREA 2015/10; 312: 142-3.

540042. [‚»‚Ì‘Œ] (ŠÄ–ó) ‘œÅ“_«‚É‘ã‚í‚éIOL‚Ì‘I‘ðŽˆ IOL Alternatives to Multifocality. _’J˜aF (Šá‰È): VISION TIMES 2015/11; 22 (4): 8-12.

540043. [‚»‚Ì‘Œ (•ÒWŠé‰æ)]y“ÁW: Šá“àƒŒƒ“ƒY‚̃|ƒCƒ“ƒg‚ƍ‡•¹Ç‘΍ôz•ÒWŠé‰æ‚É‚ ‚œ‚Á‚āc. Ž…Œö–ç (Šá‰È): OCULISTA 2015/12; 33: ‘O•t1.

540044. [‚»‚Ì‘Œ] Šw‰ï‚֍s‚±‚€@‘æ4‰ñ. _’J˜aF (Šá‰È): IOL&RS 2015/12; 29 (4): 597-8.

540045. [‚»‚Ì‘Œ (Q&A)]yƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“ƒR[ƒi[zƒGƒLƒXƒp[ƒg‚É•·‚­: ‰ñ“š2. _’J˜aF (Šá‰È): IOL&RS 2015/12; 29 (4): 606-7.

540046. [‚»‚Ì‘Œ (ŠCŠO•¶Œ£Ð‰î)] Journal of Neurophysiology 113 (3) (4) (6) (9), 2015. Vˆä“cF—T1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠw, 2Šá‰È): _ŒoŠá‰È 2015/12; 32 (4): 415-7.

540047. [‚»‚Ì‘Œ (—Տ°•ñ)] AŠwŽžŒ’Nf’f‚É‚š‚¯‚é‰Æ’ë‚š‚æ‚ÑŒ’fŽžŽ‹—ÍŒŸžŒ‹‰Ê‚Ì”äŠrŒŸ“¢. “¡‘º•‡²Žq1, ”Œ“c’m–ç1, ìŽç“c‘ñŽu1, ¯ŽiMs1, Ží“c–F˜Y2,3, Ž…Œö–ç3 (1ˆã—Éq¶Šw•”, 2Ží“cŠá‰Èˆã‰@, 3Šá‰È): —Տ°Šá‰È 2016/1; 70 (1): 97-101.

540048. [‚»‚Ì‘Œ (ŽGŽ‹LŽ–)] ¡, ’–ڂ̐V‚µ‚¢‹ßŽ‹‹ž³p: Šá“àƒRƒ“ƒ^ƒNƒguICLvŽ¡—Âʼnõ“K‚È–ˆ“ú! Ž…Œö–ç (Šá‰È): GINGER 2016/2; 8 (2): 178-9.

540049. [‚»‚Ì‘Œ (ƒgƒsƒbƒNƒX)]yŠw‰ïƒgƒsƒbƒNƒX: ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ïz˜VŽ‹‹ž³‚̍ŐVî•ñ. Ž…Œö–ç (Šá‰È): “ú–{Šá‰È›{˜ðŽGŽ 2016/2; 120 (2): 131.

540050. [‚»‚Ì‘Œ (ƒŒƒ|[ƒg)]yÅV‹@ŠíƒŒƒ|[ƒgzTobiiŽÐ»@Šá‹…‰^“®Œv‘ª‘•’u@Introduction. ŒãŠÖ—˜–Ÿ (Šá‰È): _ŒoŠá‰È 2016/3; 33 (1): 47.

540051. [‚»‚Ì‘Œ (Šw‰ïˆóÛ‹L)] ‘æ31‰ñ‘Û“µEŠw‰ï. Šâ“c@—y (‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): _ŒoŠá‰È 2016/3; 33 (1): 53.

540052. [‚»‚Ì‘Œ (Šw‰ïˆóÛ‹L)] The 8th Asian Neuro-Ophthalmology Society (ASNOS) Meeting. óì@Œ« (ˆã—Éq¶Šw•”): _ŒoŠá‰È 2016/3; 33 (1): 54-6.

540053. [‚»‚Ì‘Œ (ŠCŠO•¶Œ£Ð‰î)] Journal of Neurophysiology 114 (2) (3) (5), 2015. Vˆä“cF—T1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠw, 2Šá‰È): _ŒoŠá‰È 2016/3; 33 (1): 60-1.

[’˜@‘]

610004. [Šwp‘] (•ª’SŽ·•M)ySmall Incision Lenticule Extraction (SMILE): Principles, Techniques, Complication Management, and Future ConceptszOverview of Clinical Results for Low and Moderate Myopia, p.75-82. Shimizu K1, Kamiya K1, Igarashi A1, Kobashi H1, Ikeuchi R1,2, Editor: Sekundo W, Springer, 2015/8. (Ž…Œö–ç1, _’J˜aF1, ŒÜ\—’ÍŽj1, ¬‹Ž‰p’·1, ’r“à—œŠG1,2: 1Šá‰È, 2–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

620102. [Šwp‘] (•ª’SŽ·•M)yŠá‰È‹ÇŠŽ¡—Öòƒf[ƒ^ƒuƒbƒNzVII. ŽU“µ, ’²ß–ƒáƒ–ò@ŠT—v‚ÆŽg‚¢•û. ŒãŠÖ—˜–Ÿ (Šá‰È), •Ò: ‹g•yŒ’Žu, “‡è@, ‘º“c•q‹K, ƒƒWƒJƒ‹ƒŒƒrƒ…[ŽÐ, “Œ‹ž, 2015/4”­s.

620103. [Šwp‘] (•ª’SŽ·•M) ‘æ109‰ñˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘. Žs糋`Í1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È), •Ò: ˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘•ÒWˆÏˆõ‰ï, ˆãŠw•]˜_ŽÐ, “Œ‹ž, 2015/4”­s.

620104. [Šwp‘] (•ª’SŽ·•M) ‘æ109‰ñˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘. ŒãŠÖ—˜–Ÿ (Šá‰È), •Ò: ˆãŽt‘‰ÆŽŽŒ±–â‘è‰ðà‘•ÒWˆÏˆõ‰ï, ˆãŠw•]˜_ŽÐ, “Œ‹ž, 2015/4”­s.

620105. [Šwp‘] (•ª’SŽ·•M)yê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒCIII@Šá‰Èf—ÂƊ֘A–@‹Kz3. ˆã–ò•iˆã—Ë@Ší“™–@ (‹Œ–òŽ––@) ‚ƃRƒ“ƒ^ƒNƒgƒŒƒ“ƒY@ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚̏ˆ•û‚Ɣ̔„‚̏ó‹µ. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È), •Ò: ’¹ŽR—Cˆê3, ‘º“c•q‹K3 (3MB‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2015/8”­s.

620106. [Šwp‘] (•ª’SŽ·•M)y•af˜AŒgVŽž‘ã!@Šá‰ÈŠJ‹Æˆã‚Ì‚œ‚߂̐f—ÁE˜AŒgƒ|ƒCƒ“ƒg30z3. Šááىº‚@‰Á—‚Ì‚Ý‚Å‚Í‚È‚¢. Œ©“Š‚·‚Æ•|‚¢—Ž‚Æ‚µŒŠ! ŒãŠÖ—˜–Ÿ1 (1Šá‰È), •Ò: ŒŒ³@r2, ‹gìŒ[Ži3 (2“Œ‹ž’üM•a‰@, 3‹gìŠá‰ÈƒNƒŠƒjƒbƒN), f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/10”­s.

620107. [Šwp‘] (•ª’SŽ·•M)yŽ©—¥_Œo‹@”\ŒŸž ‘æ5”ŁzŠe˜_@F. Šá‹…Œn@5. ’²ß‹@”\ŒŸž. óì@Œ«1, Îì@‹Ï1, Œü–ì˜a—Y2,3 (1ˆã—Éq¶Šw•”, 2_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 3Šá‰È), •Ò: “ú–{Ž©—¥_ŒoŠw‰ï, •¶Œõ“°, “Œ‹ž, 2015/10”­s.

620108. [Šwp‘] (•ª’SŽ·•M)yŠá‰È—Տ°ƒGƒLƒXƒp[ƒg@—ΓàáŽ¡—ẪAƒbƒvƒf[ƒgz‘æ7Í ƒgƒ‰ƒxƒNƒƒgƒ~[‚Æ—¬o˜HÄŒšp@V ƒgƒ‰ƒxƒNƒƒgƒ~[‚Ì—Þ‰Žèp. ¯ŽiMs (ˆã—Éq¶Šw•”), •Ò: ™ŽR˜a‹v, ’JŒŽGM, ˆãŠw‘‰@, “Œ‹ž, 2015/10”­s.

620109. [Šwp‘] (•ª’SŽ·•M)yŠá‰È—Տ°ƒGƒLƒXƒp[ƒg@’m‚Á‚Ä‚š‚«‚œ‚¢ŠáŽîᇐf—Áz‘æ2Í@‘˜_@Topics@‘Œ‰È—̈æ‚̈««Žîᇎ¡—Âɔº‚€Šá‰È“I‡•¹Ç‚Ƒ΍ô. ”–؍LÆ1,2 (1Ã‰ªŒ§—§‚ª‚ñƒZƒ“ƒ^[, 2Šá‰È), •Ò: ‘哇_ˆê, Œã“¡@_, ˆãŠw‘‰@, “Œ‹ž, 2015/10”­s.

620110. [Šwp‘] (•ª’SŽ·•M)yŠá‰È—Տ°ƒGƒLƒXƒp[ƒg@’m‚Á‚Ä‚š‚«‚œ‚¢ŠáŽîᇐf—Áz‘æ2Í@‘˜_@Topics@ƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpß¶ŒŸ. ”–؍LÆ1,2 (1Ã‰ªŒ§—§‚ª‚ñƒZƒ“ƒ^[, 2Šá‰È), •Ò: ‘哇_ˆê, Œã“¡@_, ˆãŠw‘‰@, “Œ‹ž, 2015/10”­s.

620111. [Šwp‘] (•ª’SŽ·•M)yƒ`[ƒ€Š`è‚ÌŠO—ˆŠáŒ`¬Žèpz[‰ºŠááٓàEŠO”œÇ]@Kakizaki–@. Œ–{_”V1,2 (1‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@, 2Šá‰È), •Ò’˜: Š`è—T•F3 (3ˆ€’mˆã‰È‘åŠw), ƒƒfƒBƒJo”Å, ‘åã, 2016/1”­s.

620112. [Šwp‘] (•ª’SŽ·•M)yƒ`[ƒ€Š`è‚ÌŠO—ˆŠáŒ`¬Žèpz[‰ºŠááٓàEŠO”œÇ]@Wheeler-Hisatomi–@. Œ–{_”V1,2 (1‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@, 2Šá‰È), •Ò’˜: Š`è—T•F3 (3ˆ€’mˆã‰È‘åŠw), ƒƒfƒBƒJo”Å, ‘åã, 2016/1”­s.

620113. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŽŸŠ³ÅV‚ÌŽ¡—Ã2016-2018z‚æ‚­‚Ý‚éŠáÇŒó‚Ɗӕʐf’f@8. Šááى^“®ˆÙí (‚Ü‚Ô‚œ‚ªŠJ‚©‚È‚¢). Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È), •Ò: ‘å‹Ž—Tˆê, ”’_Žj—Y, ‘ºã@», “ì]“°, “Œ‹ž, 2016/3”­s.

620114. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŽŸŠ³ÅV‚ÌŽ¡—Ã2016-2018zIV. ‚»‚Ì‘Œ‚ÌŽŸŠ³@4. _ŒoŠá‰ÈŽŸŠ³@1 “µE‹Ù’£Ç. Îì@‹Ï (ˆã—Éq¶Šw•”), •Ò: ‘å‹Ž—Tˆê, ”’_Žj—Y, ‘ºã@», “ì]“°, “Œ‹ž, 2016/3”­s.

620115. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŽŸŠ³ÅV‚ÌŽ¡—Ã2016-2018zIV. ‚»‚Ì‘Œ‚ÌŽŸŠ³@4. _ŒoŠá‰ÈŽŸŠ³@9 ’²ßáz¹. Ž…Œö–ç1, ŒãŠÖ—˜–Ÿ1 (1Šá‰È), •Ò: ‘å‹Ž—Tˆê, ”’_Žj—Y, ‘ºã@», “ì]“°, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

711002. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Rotation of Toric IOL. Shimizu K1: 20th Annual Joint Meeting of SOI, OSN & AICCER (2015/5/17), Milan, Italy. (Ž…Œö–ç1: 1Šá‰È)

712020. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Redefining Refractive Boundaries with the Visian ICL "Long-term outcomes after KS-AquaPORT (Central Hole ICL)". Shimizu K1: 2015 Panel Symposium Series at the ASCRS San Diego (2015/4/19), San Diego, USA. (Ž…Œö–ç1: 1Šá‰È)

712021. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) My career: 20/20. Shimizu K1: 2015 G. F. Jan Worst Medal Lectureship at ASCRS (2015/4/19), San Diego, USA. (Ž…Œö–ç1: 1Šá‰È)

712022. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Development and Clinical Result of Hole ICL (KS-AP). Shimizu K1: 20th Annual Joint Meeting of SOI, OSN & AICCER (2015/5/16), Milan, Italy. (Ž…Œö–ç1: 1Šá‰È)

712023. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) New Viscoless Pre-loaded Injector (2007 & Now). Shimizu K1: APACRS-SEF Symposium (SNEC 25th Anniversary International Meeting) (2015/5/23), Singapore. (Ž…Œö–ç1: 1Šá‰È)

712024. [Šw‰ï (‘Û)] ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·zSolutions To Symmetry - Correcting Astigmatism. Pangputhipong P, Shimizu K1: 28th APACRS Annual Meeting (2015/8/6), Kuala Lumpur, Malaysia. (Ž…Œö–ç1: 1Šá‰È)

712025. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Rotation of Toric IOL. Shimizu K1: 28th APACRS Annual Meeting (2015/8/6), Kuala Lumpur, Malaysia. (Ž…Œö–ç1: 1Šá‰È)

712026. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Phakic IOLs. Shimizu K1: 28th APACRS Annual Meeting (2015/8/7), Kuala Lumpur, Malaysia. (Ž…Œö–ç1: 1Šá‰È)

712027. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Top Gun - Refractive & Cataract Surgery Tips. Shimizu K1: 28th APACRS Annual Meeting (2015/8/8), Kuala Lumpur, Malaysia. (Ž…Œö–ç1: 1Šá‰È)

712028. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Long-term Clinical Outcomes of the Visian ICL KS-AP. Shimizu K1: 12th Visian ICL International Experts Symposium in Barcelona (2015/9/3), Barcelona, Spain. (Ž…Œö–ç1: 1Šá‰È)

712029. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Rod, cone and melanopsin-containing retinal ganglion cell contributions to the pupil light response. Asakawa K1: The 8th Asian Neuro-Ophthalmology Society Congress (2015/10/24), Beijing, China. (óì@Œ«1: 1ˆã—Éq¶Šw•”)

713099. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Correlation between factors related with previous myopic laser in situ keratomileusis and refractive error after intraocular lens implantation. Minami K1, Mori Y1,2, Amano S1,3, Miyata K1, Kamiya K2, Shimizu K2: ARVO 2015 Annual Meeting (2015/5/5), Denver, USA. (X@—mÄ1,2, _’J˜aF2, Ž…Œö–ç2: 1‹{“cŠá‰È•a‰@, 2Šá‰È, 3ˆäãŠá‰Èˆã‰@)

713100. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) CHARACTERISTIC OF "SIZE MODULATION STANDARD AUTOMATED PERIMETRY" WITH OCTOPUS600 PERIMETER FOR GLAUCOMATOUS VISUAL FIELD LOSS. Hirasawa K1, Matsumura K2, Kasahara M2, Ikeuchi R2, Takahashi M2, Tujisawa T2, Shoji N1, Shimizu K2: 6th WORLD GLAUCOMA CONGRESS (2015/6/6-9),Hong Kong, China. (•œàVˆê–@1, Œ‘ºˆêO2, Š}ŒŽ³s2, ’r“à—œŠG2, ‚‹ŽŽÀŠóŽq2, ’ÒàV’C•F2, ¯ŽiMs1, Ž…Œö–ç2: 1ˆã—Éq¶Šw•”, 2Šá‰È)

713101. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Two cases of conjunctival squamous cell carcinoma requiring orbital exenteration. Kashiwagi H1,2, Onitsuka T, Nakagawa M, Ito I, Yoshikawa S, Suda T, Komori M: XVIIth International Society of Ocular Oncology (2015/6/19), Paris, France. (”–؍LÆ1,2: 1Ã‰ªŒ§—§‚ª‚ñƒZƒ“ƒ^[, 2Šá‰È)

713102. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰EFree Paper) Visual and Refractive Outcomes of Small Incision Lenticule Extraction for the Correction of Myopia: Three-Year Follow-Up. Kobashi H1: 28th APACRS Annual Meeting (2015/8/7), Kuala Lumpur, Malaysia. (¬‹Ž‰p’·1: 1Šá‰È)

713103. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Effect of pupil dilation on objective and subjective refraction. Iwata Y1, Ishikawa H2: 31st International Pupil Colloquium 2015 (2015/9/14-16), Oxford, UK. (Šâ“c@—y1, Îì@‹Ï2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”)

713104. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Pupillary size and light reflex in premature infants. Ikeda T1, Ishikawa H2, Asakawa K2, Goseki T1, Shimizu K1: 31st International Pupil Colloquium 2015 (2015/9/14-16), Oxford, UK. (’r“c“N–ç1, Îì@‹Ï2, óì@Œ«2, ŒãŠÖ—˜–Ÿ1, Ž…Œö–ç1: 1Šá‰È, 2ˆã—Éq¶Šw•”)

713105. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰EFree Paper) Adenoid cystic carcinoma manifesting as unilateral eye movement limitation and anisocoria: a case report. Chen SC, Sato N1, Ikeda T1, Goseki T1, Ishikawa H2, Tseng G-l, Chen C-C, Woung L-C, Liou S-W: IPOS VII Pre-Academy Meeting "Strabismus and Pediatric Plastics" (2015/11/13), Las Vegas, USA. (²“¡M”V1, ’r“c“N–ç1, ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2: 1Šá‰È, 2ˆã—Éq¶Šw•”)

721017. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) …»‘Ì‚š‚æ‚ÑIOL‚Ì“§‰ß“Á«‚Ì–ðŠ„. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ54‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ41‰ñ…»‘ÌŒ€‹†‰ï (2015/9/19), ˆ€’m.

721018. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ’m‚Á‚ĈÀSgæ“VFŠoˆÙíh, ’m‚ç‚È‚¢‚Æ•|‚¢gŒã“VFŠoˆÙíh. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ57‰ñ“ú–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2015/10/31), ’·–ì.

722103. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šp–ŒŽŸŠ³‚ÌŠá‹…ŒõŠw“Á« (Optical Quality in Eyes with Corneal Disease). _’J˜aF (Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

722104. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Šp–ŒŒ`óŽŸŠ³‚Ì”’“àáŽèp. _’J˜aF (Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

722105. [Šw‰ï (‘S‘)] (ŽóÜu‰‰) Water Cleft‚É‚š‚¯‚éŒõŠwƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“. ‚‹ŽˆËŽq1, ìŽç“c‘ñŽu2, ŠÖ@—S‰î1, ŽO“c“N‘å1, ‹v•Û]—1, ²X–Ø—m1 (1‹à‘òˆã‘å, 2ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/17), –kŠC“¹.

722106. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) —Ž‹‚ÆŽ‹‹@”\. _’J˜aF (Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/17), –kŠC“¹.

722107. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˆã—ÃŽÒ‚ÌŒŸ“®‚ƐS—Êá‰È The role of ophthalmic psychomedicine on various ocular discomforts. Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/17), –kŠC“¹.

722108. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zSWEPT SourceƒoƒCƒIƒƒgƒŠ[TM IOLƒ}ƒXƒ^[700`ŒŸžž“x‚ÌŒüã‚Å, Žèp‚àX‚ɐžŠm‚Ɂ`. Žsìˆê•v1,2 (1’†‹ž•a‰@, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/17), –kŠC“¹.

722109. [Šw‰ï (‘S‘)] (Best of AAO)y‰ðàŽÒz”’“àá‚š‚æ‚Ñ‹üÜRefractive Surgery. _’J˜aF1, ŽOŒË‰ªŽÆ2 (1Šá‰È, 2–kŒË“c‰w‘O‚Ý‚Æ‚š‚©Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/18), –kŠC“¹.

722110. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ORTe‚ÆOcclu-pad҂ɂæ‚éƒpƒ‰ƒ_ƒCƒ€ƒVƒtƒg`—ŒŠáŠJ•ú‰º‚É‚š‚¯‚éí—ª“IŽ‹”\‹ž³Œv‰æ`. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/18), –kŠC“¹.

722111. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) Ž‹‹@”\‚É‚š‚¯‚éF‚Ì–ðŠ„ (The color role in visual function). Žsìˆê•v1,2 (1’†‹ž•a‰@, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/19), –kŠC“¹.

722112. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Šáˆ³•â³’lIOPcc‚̍¡Œã‚Ì“W–]`Ž‹–ì‚Æ‚ÌŠÖ˜A«`. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ4‰ñ“ú–{Ž‹–ìŠw‰ïŠwpW‰ï (2015/5/31), Îì.

722113. [Šw‰ï (‘S‘)] (ƒI[ƒvƒ“ƒtƒH[ƒ‰ƒ€) “ú–{‚̃Xƒ^ƒ“ƒ_[ƒh‚͐¢ŠE‚̃Xƒ^ƒ“ƒ_[ƒh‚©?|JSCRS‰ïˆõƒAƒ“ƒP[ƒg’²ž‚ÆŠCŠO‚Ì”äŠr| (Do Japanese standards match international standards? -Comparison of JSCRS member surveys and those of US and Europe). Richard A Lewis, Roberto Bellucci, Damien Gatinel, Masaki Sato, _’J˜aF1 (1Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/19), “Œ‹ž.

722114. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’†‹žŠá‰È‚É‚š‚¯‚éƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“àáŽèp‚̗Տ°ŽÀÑ. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/19), “Œ‹ž.

722115. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‚Ý‚ñ‚Ȃōl‚Š‚é”’“àáŽèp@‰œŒÌãŽè‚­‚¢‚©‚È‚¢‚Ì‚©, ‚Ç‚€‹³‚Š‚ê‚Ηǂ¢‚Ì‚©. —é–Ø‹v°1, ŽOŒË‰ªŽÆ2, ‘å“à‰ë”V3, ”Ñ“c‰Ã•F4 (1“ú–{ˆã‘åE•‘ ¬™, 2–kŒË“c‰w‘O‚Ý‚Æ‚š‚©Šá‰È, 3‘å“àŠá‰È, 4Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/19), “Œ‹ž.

722116. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX)yƒI[ƒKƒiƒCƒU[z‚Ý‚ñ‚Ȃōl‚Š‚é”’“àáŽèp: QOV‚É‚±‚Ÿ‚í‚ë‚€. ”Ñ“c‰Ã•F1, ŽÄ@‘ô–ç2 (1Šá‰È, 2“Œ‹žŽœŒbˆã‘å‘æŽO•a‰@): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/19), “Œ‹ž.

722117. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‚Ý‚ñ‚Ȃōl‚Š‚é”’“àáŽèp: QOV‚É‚±‚Ÿ‚í‚ë‚€. ”Ñ“c‰Ã•F1, ŽÄ@‘ô–ç2, Œã“¡Œ›m3, ¬ì’qˆê˜Y4, ’¹‹G¬5 (1Šá‰È, 2“Œ‹žŽœŒbˆã‘å‘æŽO•a‰@, 3àՋŠˆã‘å, 4“Œ‹žŽœŒbˆã‘å, 5Œcœä‘å): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/19), “Œ‹ž.

722118. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zIOLƒ}ƒXƒ^[700Ž‹Šo‰»ƒoƒCƒIƒƒgƒŠ[Žž‘ã‚Ì“ž—ˆ. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/19), “Œ‹ž.

722119. [Šw‰ï (‘S‘)] (‹L”Ou‰‰)yŽi‰ïzJSCRS 30Žü”N‹L”Ou‰‰. Ž…Œö–ç (Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

722120. [Šw‰ï (‘S‘)] (JSCRSƒvƒ‰ƒNƒeƒBƒX)yƒ‚ƒfƒŒ[ƒ^[z‹üÜ‹ž³ŽèpŠ³ŽÒ‚̐fŽ@–@. Îˆä@Ž1, _’J˜aF2 (1‚³‚¢‚œ‚ܐԏ\Žš•a‰@, 2Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

722121. [Šw‰ï (‘S‘)] (JSCRSƒvƒ‰ƒNƒeƒBƒX) ‹üÜ‹ž³–@‚ÆŠáŒõŠw`•Û‘¶—Ö@‚ÆŽèp—Ö@‚̈Ⴂ`. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

722122. [Šw‰ï (‘S‘)] (JSCRSƒvƒ‰ƒNƒeƒBƒX) Šp–Œ‹üÜ‹ž³Žèp‚ÆŠáŒõŠw. _’J˜aF (Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

722123. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) Œõü’ǐՓx”ŒvŽZOKULIX‚É‚š‚¯‚éOA-2000‚̉”\«. ‘å’JLˆê˜Y1,2 (1Ž­Ž™“‡‹{“cŠá‰È, 2Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

722124. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) LuxORTM LX3: ”’“àáŽèp‚É“Á‰»‚µ‚œV‚µ‚¢Œ°”÷‹Ÿ. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

722125. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) JSCRS “Á•Ê•ñ`JSCRS ƒAƒ“ƒP[ƒg’²žƒ[ƒLƒ“ƒOƒOƒ‹[ƒv`‹üÜ‹ž³ŽèpƒAƒ“ƒP[ƒg’²ž. _’J˜aF (Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/21), “Œ‹ž.

722126. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Best of JSCRS@ˆê”ʉ‰‘葍•] (‹üÜ‹ž³ŽèpŠÖ˜A). _’J˜aF1, •B“c@–q2 (1Šá‰È, 2‹ž“s•{ˆã‘å): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/21), “Œ‹ž.

722127. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šp–ŒŽŸŠ³‚ւ̃g[ƒŠƒbƒNŠá“àƒŒƒ“ƒY. _’J˜aF (Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/21), “Œ‹ž.

722128. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Ž¡—ÃI@”ñŠÏŒŒ“IE•Û‘¶“IŽ¡—Ã. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

722129. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) Œ‹–ŒùNíÝ‹Û. Žq“‡—Ç•œ1,2 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ52‰ñ“ú–{ŠáŠŽõÇŠw‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/11), ‘åã.

722130. [Šw‰ï (‘S‘)] (ŽÀK)yƒCƒ“ƒXƒgƒ‰ƒNƒ^[z‘æ6‰ñJAOI“h–•ŒŸ‹ŸƒXƒLƒ‹ƒgƒ‰ƒ“ƒXƒtƒ@[. ˆäã’q”V1, Žq“‡—Ç•œ2,3, –ìŒû‚ä‚©‚è2, ŒË“c—Ç‘Ÿ˜Y4, –Lì^O5, ²X–Ø—T”ü6, ]Œû@—m7, ¬”Š”Žl8, ŒËŠ‘å•ã9, —é–؁@’10, ‹ßŠÔ‘׈ê˜Y4, ’†ì@®11, `–ì@Š°12, ¯@Å’q13 (1‘œª‹L”OŠá‰È•a‰@, 2‹{“cŠá‰È•a‰@, 3Šá‰È, 4L“‡‘å, 5“Œ–k‘åŠw•a‰@f—ËZp•”, 6ã‘å”÷¶•š•aŒ€‹†‰ï—Տ°ŒŸž•”, 7‹ß‹E‘åEä, 8Ž©Ž¡ˆã‘å, 9ŒQ”n‘å, 10ˆ€•Q‘å, 11“¿“‡f—ÏŠ, 12ƒ‹ƒ~ƒl‚Í‚œ‚ÌŠá‰È, 13‘—§’·Žõˆã—ÃŒ€‹†ƒZƒ“ƒ^[): ‘æ52‰ñ“ú–{ŠáŠŽõÇŠw‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/11), ‘åã.

722131. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[zQOV & ADL. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/11), ˆ€’m.

722132. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —ŒŠáŽ‹‚ł݂鎋–ìáŠQ‚ւ̃Aƒvƒ[ƒ`. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/11), ˆ€’m.

722133. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) —ΓàáŽ¡—Âɔº‚€Šá•\–ʏíÝ×‹Û‘p‚ւ̉e‹¿|”’“àáŽüpŠú‚̍R¶Ü‚Ì‘I‘ð|. ‘å’JLˆê˜Y1,2 (1Ž­Ž™“‡‹{“cŠá‰È, 2Šá‰È): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/12), ˆ€’m.

722134. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‘±”­—Γàá‚Ì”’“àáŽèp. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/12), ˆ€’m.

722135. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[z”’“àá‚Ì—\–h‚ÆŽ¡—Ã. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ54‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ41‰ñ…»‘ÌŒ€‹†‰ï (2015/9/19), ˆ€’m.

722136. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) …»‘̘̂c‚Ý‚ÆŠá“àƒŒƒ“ƒY. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ54‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ41‰ñ…»‘ÌŒ€‹†‰ï (2015/9/19), ˆ€’m.

722137. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ”’“àá‚Ì•›•aŒ^‚ÆŽèp“K‰ž. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): ‘æ54‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ41‰ñ…»‘ÌŒ€‹†‰ï (2015/9/20), ˆ€’m.

722138. [Šw‰ï (‘S‘)] (Žs–¯ŒöŠJ) ƒ{ƒPE•s–°ÇE‚ŒŒˆ³Ç‚Ü‚ÅŽ¡‚é”’“àáŽ¡—Ã. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ54‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ41‰ñ…»‘ÌŒ€‹†‰ï (2015/9/20), ˆ€’m.

722139. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —L…»‘ÌŠá“àƒŒƒ“ƒY. _’J˜aF (Šá‰È): ‘æ51‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2015/9/26), ‰ªŽR.

722140. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —§‘ÌŽ‹‚Æ—§‘̉f‘œ’mŠo‚Ì•]‰¿Ž². ”Œ“c’m–ç (ˆã—Éq¶Šw•”): ‘æ51‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2015/9/26), ‰ªŽR.

722141. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) Ž‹—ÍŒŸž‚ÉŠÖ‚·‚é‘œŽ{ÝƒAƒ“ƒP[ƒg’²ž. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): ‘æ51‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2015/9/26), ‰ªŽR.

722142. [Šw‰ï (‘S‘)] (Hands-onƒZƒ~ƒi[) ƒ{ƒcƒŠƒkƒX“Å‘f»Ü‚̎戵‚¢‚ɂ‚¢‚Ä. ŒãŠÖ—˜–Ÿ (Šá‰È): “ú–{ƒ{ƒcƒŠƒkƒXŽ¡—Êw‰ï‘æ2‰ñŠwp‘å‰ï (2015/10/2), “Œ‹ž.

722143. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) “àŽ‹‹Ÿ•¹—pÉŽq‘ÌŽèp@—L—p«‚Æ’iŠK“IK“Ÿ–@. ‹g“c‘¥•F1, ²“¡—T”V2, Œ‰iŒ÷ˆê3, X@r’j2, ‰¡ŽR@ãÄ4, ‰Á‰ê’BŽu4,5 (1Šò•ŒÔ\Žš•a‰@, 2”Ñ“cŽs—§•a‰@, 3ŠÛ‚Ì“à‚܂‚ȂªŠá‰È, 4’†‹ž•a‰@, 5Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/22), ˆ€’m.

722144. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‰~Šp–Œ‚ɑ΂·‚é‹üÜ‹ž³Žèp. _’J˜aF (Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722145. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[z˜VŽ‹‹ž³‚̍ŐVî•ñ. Ž…Œö–ç1, ƒrƒbƒZƒ“‹{“‡OŽq2 (1Šá‰È, 2“Œ‹žŽ•‘åE…“¹‹Ž): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722146. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@. ”Ñ“c‰Ã•F (Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722147. [Šw‰ï (‘S‘)] (ŽóÜu‰‰) Žü•Ó•”ó‘O–[Šá‚Ì‘OŒü‚«Œ€‹†‚Ì’†ŠÔ‰ðÍ: Šp–Œ“à”ç×–E–§“x‚Æ‹÷Šp‹ŸŠŒ©‚̕ω». ŽO“ˆOˆê1, –“–Ø’Œ”ü2, äo“ߌŽ—Žq3, ‘å’JLˆê˜Y4,5, Žðˆä@Š°3, •xŠ“Ö’j6, ‘ŠŒŽ@ˆê7, ‹{“c˜a“T4, àVŒûºˆê3, Šâ£ˆ€Žq8, V‰Æ@áÁ2 (1“Œ‹ž’üM•a‰@, 2ŠÖ“Œ’†‰›•a‰@, 3—®‹…‘å, 4‹{“cŠá‰È•a‰@, 5Šá‰È, 6“Œ’†–ì‚Æ‚Ý‚Ç‚±‚ëŠá‰È, 7Žl’J‚µ‚ç‚ÆŠá‰È, 8‚œ‚¶‚݊␣Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722148. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) Ç—á‚©‚çŠw‚ÔŠp–ŒŠŽõÇ‚ÌŽ¡—Ð헪. —é–؁@’1,2, ]Œû@—m2,3, Žq“‡—Ç•œ2,4,5, ¯Å’q2,6, •ž•”‹M–Ÿ2,7, ˆäã’q”V2,8, ŒËŠ‘å•ã2,9 (1ˆ€•Q‘å, 2OMICŒ€‹†‰ï, 3‹ß‹E‘åEä, 4‹{“cŠá‰È•a‰@, 5Šá‰È, 6‘—§’·Žõˆã—ÃŒ€‹†ƒZƒ“ƒ^[, 7“Œ‹žˆã‘å, 8‘œª‹L”OŠá‰È•a‰@, 9ŒQ”n‘å): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722149. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) –Ÿ“ú‚©‚ç‚·‚®ŽÀ‘H! ‚‹@”\Šá“àƒŒƒ“ƒY‚̏ãŽè‚ÈŽg‚¢•û. ‹{“c˜a“T1, _’J˜aF2, ’†‘º–M•F3, –xŒû_Žj4, ªŠÝˆê”T5 (1‹{“cŠá‰È•a‰@, 2Šá‰È, 3‚œ‚È‚µ’†‘ºŠá‰È, 4“Œ‹žŽœŒbˆã‘åE‘æŽO, 5Œcœä‘å): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722150. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) “œ”A•aŠ³ŽÒ‚ÌŽ¡—Õûj10|‚±‚ñ‚ÈŽž‚Ç‚€‚·‚é|. ‰Á“¡@‘1, A–Ø–ƒ—¢2, ‚–ì‰ë•F3,4, ˆÀ“¡L˜N5, Œ‘º”ü‘ã6 (1“Œ‹ž‘å, 2‘åãˆã‘å, 3‘Ûˆã—ÕŸŽƒ‘åE”MŠC, 4Šá‰È, 5VŠƒ‘æ“ñ•a‰@, 6‰i“cŠá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722151. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) Ž¡—ÃKƒCƒhƒ‰ƒCƒ“‚ÌŒŸ“¢‚Æ‹qŠÏ“IŽ¡—Õ]‰¿–@‚ÌŒŸ“¢. Žsìˆê•v1,2 (1’†‹ž•a‰@, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722152. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‹É‘Šú—Γàá‚ÌŽ¡—Ã. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722153. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·z‰·ŒÌ’mV@Šp–ŒŒ`ó‰ðÍ‚Æ—Ž‹‹ž³p. ¬—с@Œ°1, _’J˜aF2 (1‹à‘ò‘åŠw, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722154. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) My Career 20/20. Ž…Œö–ç (Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

722155. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‘OŠá•”pŽÒ‚Ì‚œ‚ß‚Ì, ”j”XE‡•¹Çˆ—ƒtƒ‹ƒR[ƒX. ”Ñ“c‰Ã•F1, ‘å“à‰ë”V2, Œ“‡”Ž”V3, ‘Ÿ“cr•F4 (1Šá‰È, 2‘å“àŠá‰È, 3àՋŠˆã‘å, 4‡“V‘åEÃ‰ª): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722156. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ŠwZŒ’f‚É‚š‚¯‚éFŠoŒŸž‚Ì‚ ‚è•û‚ƗՏ°f’f‚š‚æ‚ÑŽw“±. Žsìˆê•v1,2, ’†‘º‰pŽ÷3, ‘º–Ø‘•c4, ’†‘º‚©‚š‚é5, ŽRoVˆê4, ‰ª“‡@C6, “c•ÓÙŽq1 (1’†‹žŠá‰È, 2Šá‰È, 3’†‹ž•a‰@, 4Ž ‰êˆã‘å, 5—Žqˆã‘å, 6”ªdF‘哇Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722157. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ”’“àáƒT[ƒWƒƒƒ“‚à•KŒ©! LI•s—v! ŠÑ’ʍE•t‚«—L…»‘ÌŠá“àƒŒƒ“ƒY‚ðƒ}ƒXƒ^[‚µ‚æ‚€. ’†‘º—Fº1, Žsìˆê•v2,3, _’J˜aF3, –kàV¢Žu”Ž4, Ž…Œö–ç3 (1–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 2’†‹ž•a‰@, 3Šá‰È, 4_ŒË_“ސìƒAƒCƒNƒŠƒjƒbƒN): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722158. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒNƒ‹ƒYƒX) Ž‹_Œo‰Šf’f, ŒŸž‚̍őOü. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722159. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·z”ò–ô‚·‚郌ƒ“ƒYƒXƒ^[‚Ì‘‡—Í. Ž…Œö–ç (Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722160. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) LS900‚ð—p‚¢‚œŠp–Œ‹üÜ‹ž³ŽèpŒã‚ÌIOL“x”ŒvŽZ. ”Ñ“c‰Ã•F (Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722161. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) –{–M‚É‚š‚¯‚éƒgƒ‰ƒxƒNƒg[ƒ€Žèp‚Ì’·Šú¬Ñ. “n糎OŒP1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722162. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) ƒgƒ‰ƒxƒNƒg[ƒ€Žèp: Ÿˆ‚ª•·‚«‚œ‚¢Part II. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722163. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·zICL‚©‚çŽn‚ß‚é‹üÜ‹ž³Žèp. Ž…Œö–ç1, Žsìˆê•v1,2 (1Šá‰È, 2’†‹žŠá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722164. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ICL‚©‚çŽn‚ß‚é‹üÜ‹ž³Žèp. ŒÜ\—’ÍŽj (Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

722165. [Šw‰ï (‘S‘)] (ƒtƒFƒAƒEƒFƒ‹ƒZƒ~ƒi[)yÀ’·z¬Ž™‚̃Rƒ“ƒgƒNƒgƒŒƒ“ƒY‚Ì–â‘è“_. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/25), ˆ€’m.

722166. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) Šá‹…ŒõŠwŒn‚š‚æ‚ÑŽ‹ŠoŒn‚̉Á—î•Ï‰»‚ÆŒð’ʈÀ‘S. ìŽç“c‘ñŽu (ˆã—Éq¶Šw•”): ‘æ57‰ñ“ú–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2015/10/31), ’·–ì.

722167. [Šw‰ï (‘S‘)] (“¢˜_‰ï)yÀ’·zFŠoŒŸž‚ƐFŠoˆÙí. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ57‰ñ“ú–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2015/10/31), ’·–ì.

722168. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) FŠoŒŸž‚Ì–¢—ˆ@Œ©‚Š•û‚̐”’l‰». Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ57‰ñ“ú–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2015/10/31), ’·–ì.

722169. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·z“ü–å@ŠááÙáz¹. Îì@‹Ï1, ŒãŠÖ—˜–Ÿ2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/7), é‹Ê.

722170. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zAŒ^ƒ{ƒcƒŠƒkƒX“Å‘f»Ü@ƒ{ƒgƒbƒNƒXҁ@uKEŽÀ‹ZƒZƒ~ƒi[ (ŽÎŽ‹). Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/7), é‹Ê.

722171. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) AŒ^ƒ{ƒcƒŠƒkƒX“Å‘f»Ü@ƒ{ƒgƒbƒNƒXҁ@uKEŽÀ‹ZƒZƒ~ƒi[ (ŽÎŽ‹). ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/7), é‹Ê.

722172. [Šw‰ï (‘S‘)] (¶ŠU‹³ˆçƒZƒ~ƒi[) “µE‚Ì–ðŠ„E”œ‰ž‚̍čl. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ56‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2015/11/7), “Œ‹ž.

722173. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) Šp–Œƒp[ƒcˆÚA‚Ì“K‰ž‚Ə€”õ. Žq“‡—Ç•œ1,2 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/29), •Ÿ‰ª.

722174. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ”’“àápŒãŠá“à‰Š. X@—mÄ1,2 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/30), •Ÿ‰ª.

722175. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX)yƒI[ƒKƒiƒCƒU[z—ΓàáŽèpŠí‹ïƒgƒ‰ƒxƒNƒg[ƒ€‚É‚æ‚é—¬o˜HÄŒšp‚ÌŠT—v‚ÆŽèp“K‰ž, Žèp¬Ñ‚ɂ‚¢‚Ä. Žsìˆê•v1,2, “n糎OŒP1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/30), •Ÿ‰ª.

722176. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) —ΓàáŽèpŠí‹ïƒgƒ‰ƒxƒNƒg[ƒ€‚É‚æ‚é—¬o˜HÄŒšp‚ÌŠT—v‚ÆŽèp“K‰ž, Žèp¬Ñ‚ɂ‚¢‚Ä. “n糎OŒP1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/30), •Ÿ‰ª.

722177. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‹}«–Ô–Œ‰óŽ€‚ɑ΂·‚鑁ŠúÉŽq‘ÌŽèp. ‚–ì‰ë•F1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠwE”MŠC, 2Šá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/30), •Ÿ‰ª.

722178. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ¶‘Ì”FØ“Š‰e‘•’uƒT[ƒWƒJƒ‹ƒKƒCƒ_ƒ“ƒX‚̃Gƒrƒfƒ“ƒX. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/31), •Ÿ‰ª.

722179. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šp–Œ‹üÜ‹ž³pŒã‚ÌŽ‹‹@”\. X@—mÄ1,2 (1‹{“cŠá‰È•a‰@, 2Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18), ’·–ì.

722180. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šp–Œ•Ï«Ç‚ÌŽ‹‹@”\. _’J˜aF (Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18), ’·–ì.

722181. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zLa Derni`ere Classe|ÅŒã‚Ì, Žö‹Æ|Šp–ŒŽŸŠ³‚ւ̃g[ƒŠƒbƒNIOL‚̉ž—p. Ž…Œö–ç (Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18), ’·–ì.

722182. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ŠeŽíƒg[ƒŠƒbƒNIOL‚̏pŒã‰ñ“]¬Ñ. X@—mÄ1,2 (1‹{“cŠá‰È•a‰@, 2Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18), ’·–ì.

722183. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‰~Šp–Œ‚ւ̃g[ƒŠƒbƒNIOL‚ÌŽg—p¬Ñ. ŽO‘îr”V1,2 (1‰¡{‰êŽs‚€‚í‚Ü‚¿•a‰@, 2Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18), ’·–ì.

722184. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zŠp–Œ! ƒiƒCƒgƒXƒN[ƒv in Œyˆä‘ò. Ž…Œö–ç (Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18), ’·–ì.

722185. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) •S•·‚͈ê—Ü‚É‚µ‚©‚ž, , , , —܂̓Eƒ\‚ð‚‚©‚È‚¢!? ”Œ“c’m–ç (ˆã—Éq¶Šw•”): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18), ’·–ì.

722186. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·zŠp–Œ‚ðG‚ç‚È‚¢‹üÜ‹ž³Žèp. Ž…Œö–ç (Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/19), ’·–ì.

722187. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) Ž„‚ªLASIK‚ð‚â‚ß‚ÄKS-AP‚ð‘I‘ð‚·‚é——R. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/19), ’·–ì.

722188. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) Šp–Œ‹üÜ‹ž³Žèp‚ÆKS-AP‚Ì”äŠr. ŒÜ\—’ÍŽj (Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/19), ’·–ì.

722189. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‘æ2‰ñ‘S‘Šp–Œ‘IŽèŒ 2016. ŒÜ\—’ÍŽj1, ¬‹Ž‰p’·1, ‚‹Ž³‰p1 (1Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/19), ’·–ì.

722190. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zi‰»‚·‚éŠp–ŒŽèp@p’†OCT‚ÆFSƒŒ[ƒU[‚ʼnœ‚ª•Ï‚í‚é‚Ì‚©? Ž…Œö–ç (Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/19), ’·–ì.

722191. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) i‰»‚·‚éŠp–ŒŽèp@p’†OCT‚ÆFSƒŒ[ƒU[‚ʼnœ‚ª•Ï‚í‚é‚Ì‚©? _’J˜aF (Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/19), ’·–ì.

722192. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·zƒŒ[ƒU[Šp–ŒŽèpŠv–œ! Part…¢ ƒŒ[ƒU[Šp–ŒˆÚA10”N‚Ì”­“W‚Æ‚±‚ê‚©‚ç. Ž…Œö–ç (Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/20), ’·–ì.

722193. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) Šp–ŒˆÚA‚É‚š‚¯‚郌[ƒU[‚ÌŒ÷Ñ. _’J˜aF (Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/20), ’·–ì.

723722. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ^ƒuƒŒƒbƒgŒ^Ž‹”\ŒP—û‘•’u (Occlu-padÒ) ‚ð—p‚¢‚œŽãŽ‹ŒP—û•ñ. ”Œ“c’m–ç1, Îì@‹Ï1, ¯ŽiMs1, ’r“c“N–ç2, ŒË’ˁ@Œå2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723723. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹}«–Ô–Œ‰óŽ€‚ɑ΂·‚éƒKƒ“ƒVƒNƒƒrƒ‹ÉŽq‘Ì“à’ŽË. ‰ÃŽRŽÀŠóŽq1, Žs糋`Í1,2, Š}ŒŽ³s1, ‚‹Ž³‰p1, –ö“c’q•F1, Ž…Œö–ç1 (1Šá‰È, 2_“ސ쎕‰È‘åE‰¡•lƒNƒŠƒjƒbƒN): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723724. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽŸŠ³•Ê‚É‚š‚¯‚éFunctional Vision Score•ª—Þ‚ð—p‚¢‚œŽ‹ŠoáŠQ“™‹‰‚Ì—L—p«. –öàV”üˆßŽq1,2, ‰Á“¡@‘1, ¬—Ñ‚ß‚®‚Ý1, “n糖œ—¢Žq1, —Ž‡áÁ‹IŽq1 (1“Œ‹ž‘å, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723725. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰~Šp–ŒŠá‚É‚š‚¯‚éŠp–Œ‘O–Ê‚š‚æ‚ÑŒã–Ê—Ž‹•ª•z. ŒÜ\—’ÍŽj1, _’J˜aF1, ¬‹Ž‰p’·1, ŽO‘îr”V1, ’r“à—œŠG1, ìŽç“c‘ñŽu2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723726. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒXƒŠƒbƒgƒXƒLƒƒƒ“‚ÆSS-OCT‚É‚æ‚éHaigisŽ®‚̏pŒã‹üÜŒë·‚ÌŒŸ“¢. ‹Ê’u–Ÿ–ì1,2, ¬“‡—²Ži3, ’†‘º‰pŽ÷1, ‹Ž’Ü—Ç‘Ÿ1, “c’†@Ž2, Žsìˆê•v1,4,5 (1’†‹ž•a‰@, 2MB‘åE‘‡HŠw, 3Šò•ŒÔ\Žš•a‰@, 4’†‹žŠá‰È, 5Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723727. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “µEŒa‚ª—‡ŠáŽ‹—Í‚š‚æ‚ÑŽ©Šo‹üÜ‚Ö‹y‚Ú‚·‰e‹¿‚ÌŒŸ“¢. ¬‹Ž‰p’·1, ”Œ“c’m–ç2, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723728. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹üÜEŽ‹‹@”\2. _’J˜aF (Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723729. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) _ŒoŠá‰È1. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723730. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹_Œo‰Š‚Ì•aŒ^‚ƗՏ°‘œ‚ÌŒŸ“¢. ”’à_V‘œ˜N1,2, •“érŽ2, àV‘º—T³2, “c’†—Œb2, ŽRã–ŸŽq3,4, ŽàVŒ¹O5, Žá‘q‰ë“o3,4 (1JR“Œ‹ž‘‡•a‰@, 2“Œ‹ž‘å, 3ˆäãŠá‰È•a‰@, 4Šá‰È, 5ŽàVŠá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723731. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒhƒ‰ƒCƒAƒC‚ÆŠááÙáz¹‚̐f’f‚ɂ‚¢‚Ä‚ÌŒŸ“¢. »ìLŠC1, ŽRã–ŸŽq1,2, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723732. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹‘å“û“ª‚̗Տ°‘œ‚ÆŽ‹–쏊Œ©‚ɂ‚¢‚Ä‚ÌŒŸ“¢. X@@—D1, ŽRã–ŸŽq1,2, XŽR@—Á1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723733. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠáŽ²’·‚ÆŠp–Œ‘O–ʁEŒã–Ê‹È—Š”ŒŒa‚ÌŒŸ“¢. íœAr‘Ÿ˜Y1, Ž…Œö–ç1, Š±ì—¢ŠG1, ”Ñ“c‰Ã•F1, “V–엝Œb1, ²“¡M”V1, ”Ñ“‡@Œh1 (1Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723734. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰~Šp–Œ‚ɑ΂·‚é”’“àáŽèp‚Ì—\‘ª«‚Əp‘OˆöŽq‚ÌŒŸ“¢. ”Ñ“‡@Œh1, Ž…Œö–ç1, ¬‹Ž‰p’·1, “V–엝Œb1, _’J˜aF1 (1Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723735. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šp–Œ‹üÜ‹ž³ŽèpŠá‚É‚š‚¯‚éŠp–Œ‹È—Š”ŒŒa‘OŒã–Ê”ä‚ÆŠp–Œ‹üÜ—Í. ”Ñ“c‰Ã•F1, Ž…Œö–ç1, Š±ì—¢ŠG1, íœAr‘Ÿ˜Y1, “V–엝Œb1, ²“¡M”V1, ”Ñ“‡@Œh1 (1Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723736. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒhƒ‰ƒCƒAƒC‚©ŠááÙáz¹‚©•Ž‚ç‚킵‚¢Ç—á‚ɑ΂·‚郌ƒoƒ~ƒsƒh‚ÌŒø‰Ê. ‰Í–{‚Ђë”ü1, ŽRã–ŸŽq1,2, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723737. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 3D Visual Function Trainer ORTe‚ð—p‚¢‚œŽãŽ‹ŒP—û•ñ. ŒË’ˁ@Œå1, ”Œ“c’m–ç2, Îì@‹Ï2, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723738. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŽÎŽ‹ƒXƒNƒŠ[ƒjƒ“ƒO‚Ì‚œ‚ß‚ÌŽ©‹LŽ®Ž¿–â•\‚ÌŠJ”­y‘æ“ñ•ñz. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723739. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘Š–ÍŒŽŽsAŠw‘OŒ’Nf’f‚É‚š‚¯‚鎋—ÍŒŸžŽÀŽ{•ñ. “¡‘º•‡²Žq1, ”Œ“c’m–ç1, ìŽç“c‘ñŽu1, Šâ“c@ê¡2, ¯ŽiMs1, Ž…Œö–ç3 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723740. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “Œ‹ž“s¬Š}ŒŽ‘º‚̏¬’†Šw¶‚É‚š‚¯‚鎋—Í‚ÌŒo”N„ˆÚ. ˆÉ“¡”ü¹ŠG1, Ž…Œö–ç2, ìŽç“c‘ñŽu1, ¯ŽiMs1 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723741. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰“Ž‹Šá‚É‚š‚¯‚é‹üÜ·‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Š±ì—¢ŠG1, ˆÉ“¡”ü¹ŠG2, ìŽç“c‘ñŽu2, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723742. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Hole ICL‚̃Œƒ“ƒYŒXŽÎ‚ªŠá‹…“à–[…‹““®‚É—^‚Š‚é‰e‹¿. ìŽç“c‘ñŽu1, ˆÉ“¡”ü¹ŠG1, ¯ŽiMs1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723743. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “Eo‰Æ“e“µEŽU‘å‹Ø‚ɑ΂·‚éBrimonidine‚Ì–ò—ì—p. —Žˆä‰‘Žq1, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/16), –kŠC“¹.

723744. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “µEŒa‚ðl—¶‚µ‚œŠá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@‚̗Տ°¬Ñ. ]•—Ft1, “V–엝Œb1, ”Ñ“c‰Ã•F1, ˆÉ“¡”ü¹ŠG2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/17), –kŠC“¹.

723745. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·zŠwp“WŽŠ@—ΓàáŽ‹–ì. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/17), –kŠC“¹.

723746. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “œ”A•a‰©”Á•‚Žî‚ɑ΂·‚郉ƒjƒrƒYƒ}ƒuÉŽq‘Ì’ŽË‚Ì’ZŠúŽ¡—ЬÑ. ’h”Vã˜a•F1, ™’J“Ä•F1, Œ‰ª‘å•ã2, •œàVˆê–@3 (1‚Ÿ‚ñ‚Ì‚€‚ŠŠá‰ÈƒNƒŠƒjƒbƒN, 2ìè‚š‚®‚çŠá‰ÈƒNƒŠƒjƒbƒN, 3ˆã—Éq¶Šw•”): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/17), –kŠC“¹.

723747. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) OCTOPUS600Ž‹–ìŒv24-2‚ÆHumphreyŽ‹–ìŒv24-2‚Ì”äŠr. •œàVˆê–@1, Š}ŒŽ³s2, Œ‘ºˆêO2, ’r“à—œŠG2, ¯ŽiMs1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ119‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2015/4/17), –kŠC“¹.

723748. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆê”ʍu‰‰II. ”’“yéÆ1, ¯ŽiMs2 (1Žl’J‚µ‚ç‚ÆŠá‰È, 2ˆã—Éq¶Šw•”): ‘æ4‰ñ“ú–{Ž‹–ìŠw‰ïŠwpW‰ï (2015/5/30), Îì.

723749. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šp–Œ‹üÜ—͂̕ω»‚ªOCTŽB‘œ‚É‹y‚Ú‚·‰e‹¿. •œàVˆê–@1, ¯ŽiMs1 (1ˆã—Éq¶Šw•”): ‘æ4‰ñ“ú–{Ž‹–ìŠw‰ïŠwpW‰ï (2015/5/31), Îì.

723750. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘}“ü‘O, Œã‚É‚š‚¯‚éIOL‘S’·‚̕ω»: ‰æ‘œ‰ðÍ‚ðŽg—p‚µ‚œ”äŠr. ”n“ˆŽ”@1, Žsì@Œc2, ŽðˆäKO3, “à“¡®‹v3,4, ˆé’J®‹P4, •Ð‰ª“”Ž4, ’†‘º—Fº4, Žsìˆê•v3,5 (1Šá‰È–ŸŠá‰@, 2Šò•ŒÔ\Žš•a‰@, 3’†‹žŠá‰È, 4–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 5Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/19), “Œ‹ž.

723751. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”’“àáŽèp‘OŠ³ŽÒ‚ÆŒ’N¬l‚ÌŒ‹–Œ”XíÝ‹Û‘p‚Æ–òÜŠŽŽó«‚Ì”äŠrŒŸ“¢. ‰Á‰ê’J•¶ŠG1, ‹{•‰‘y‰î2, ¬a’Žj2, Žq“‡—Ç•œ2,3, –ìŒû‚ä‚©‚è2, ”ª–؏²Žq2, Šâè‘ô–ç2, ‹{“c˜a“T2 (1Ž­Ž™“‡‹{“cŠá‰È, 2‹{“cŠá‰È, 3Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

723752. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“àáŽèp‚É‚š‚¯‚鎩ŠoƒAƒ“ƒP[ƒg‹y‚яp‘OŒã‚ÌŠá•\–ʏáŠQ‚ÌŒŸ“¢. ‚–Ø–ƒ—¢1, ¬“‡—²Ži2, ’†‘º‰pŽ÷1, Žsì@Œc2, “Žˆä—¢ŠG3, ŽðˆäKO3, “à“¡®‹v3, Žsìˆê•v3,4 (1’†‹ž•a‰@, 2Šò•ŒÔ\Žš•a‰@, 3’†‹žŠá‰È, 4Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

723753. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹üÜ‹ž³Žèp‚É‚š‚¯‚éƒtƒ‰ƒbƒvì»‚Ì—L–³‚ªƒIƒLƒ…ƒ‰[ƒT[ƒtƒFƒX‚É‹y‚Ú‚·‰e‹¿: ƒƒ^ƒAƒiƒŠƒVƒX. ¬‹Ž‰p’·1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

723754. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šp–Œ—Ž‹Šá‚ɑ΂·‚éƒmƒ“ƒg[ƒŠƒbƒNŒã–[Œ^—L…»‘ÌŠá“àƒŒƒ“ƒY‚̏pŒãŽ‹—͂ɉe‹¿‚ð‹y‚Ú‚·ˆöŽq‚ÌŒŸ“¢. ŒÜ\—’ÍŽj1, _’J˜aF1, ¬‹Ž‰p’·1, Ž…Œö–ç1 (1Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

723755. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ICLpŒã‚Ì”’“àá. ’†‘º—Fº1, ‹g“c—zŽq1, ˆé’J®‹P1, •Ð‰ª“”Ž1, ¬“‡—²Ži2, Žsìˆê•v3,4 (1–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 2Šò•ŒÔ\Žš•a‰@, 3’†‹žŠá‰È, 4Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

723756. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO‚̏‰ŠúE’†Šú¬Ñ‚Ì•ñ. ¬“‡—²Ži1, Xì“Žq2, “n•”@ŠÂ3, ²“¡—T–ç3, ’†‘º—Fº2, ‹Ê’u–Ÿ–ì4, Žsìˆê•v5,6 (1Šò•ŒÔ\Žš•a‰@, 2–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3²“¡—T–çŠá‰Èˆã‰@, 4’†‹ž•a‰@, 5’†‹žŠá‰È, 6Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

723757. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“àáŽèp‚ƒʏí‚Ì”’“àáŽèp‚̏pŒã–Ô–ŒŒú‚Ì”äŠr. Žsì@Œc1, ¬“‡—²Ži1, “Žˆä—¢ŠG2, ŽðˆäKO2, ‰Á“¡Km2, ‚–Ø–ƒ—¢3, ‹Ê’u–Ÿ–ì3, ’†‘º‰pŽ÷3, Žsìˆê•v3,4 (1Šò•ŒÔ\Žš•a‰@, 2’†‹žŠá‰È, 3’†‹ž•a‰@, 4Šá‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/20), “Œ‹ž.

723758. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šá“àƒŒƒ“ƒY•ÎˆÊÇ—á‚Ì”wŒiˆöŽq‚ÌŒŸ“¢. ²“¡M”V1, ”Ñ“c‰Ã•F1, Ž…Œö–ç1, ”Ñ“‡@Œh2, íœAr‘Ÿ˜Y1, ŠFì—FŒ›1, “V–엝Œb1 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ30‰ñJSCRSŠwp‘‰ï (2015/6/21), “Œ‹ž.

723759. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 3D Visual Function Trainer-ORTe‚É‚æ‚鎡—ª‘tŒø‚µ‚œçt–©•s‘S‚̈êÇ—á. ‚–ì”ü‘ã1, ¬Š}ŒŽF—S1, ”Œ“c’m–ç2 (1¬Š}ŒŽŠá‰ÈƒNƒŠƒjƒbƒN, 2ˆã—Éq¶Šw•”): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

723760. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “Œ‹ž“s¬Š}ŒŽ‘º‚̏¬’†Šw¶‚É‚š‚¯‚é—‡ŠáŽ‹—͂̐„ˆÚ. ˆÉ“¡”ü¹ŠG1, Ž…Œö–ç2, ìŽç“c‘ñŽu1, ¯ŽiMs1 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

723761. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 3D Visual Function Trainer-ORTe‚ÌŠáˆÊEŠá‹…‰^“®ŒŸž‚Ì‘Œ‹@Ží‚Ƃ̌݊·«ŒŸ“¢. ŒË’˘aŽq1, Îì@‹Ï2, ”Œ“c’m–ç2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

723762. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 3D Visual Function Trainer-ORTe‚̏ãŽÎ‹Ø–ƒáƒŠ³ŽÒ‚ւ̉ž—p. •Û‰È”üŠó1, Îì@‹Ï2, ŒãŠÖ—˜–Ÿ1, ”Œ“c’m–ç2, ŒË’˘aŽq1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

723763. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œ’íŽá”NŠá‚É‚š‚¯‚鍂ŽŸ”g–ÊŽû·‚Æ”N—î: ‘æ2•ñ. Ö“¡@Ê1, ˆÉ“¡”ü¹ŠG2, ìŽç“c‘ñŽu2, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

723764. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž‹ü‰ðÍ‘•’u‚É‚æ‚鉓Œ©E‹ßŒ©‚ł̕ЊáŽÕ•ÂŽž‚ÌŠáˆÊ‘ª’è‚ÆAPCT‚Å‚ÌŠáˆÊ‚Ì”äŠr. Žl”V‹{—C”n1, ‚‹Ž—RŽk1, –ìã‹Žu1, Vˆä“cF—T1,2 (1‘Ûˆã—ÕŸŽƒ‘å, 2Šá‰È): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

723765. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž‹ü‰ðÍ‘•’u‚ð—˜—p‚µ‚œ—Z‘œœ‹ŽŠáˆÊ‘ª’è‚É‚š‚¯‚éŽÕ•ÂŽžŠÔ‚ÌŒŸ“¢. ‚‹Ž—RŽk1, Žl”V‹{—C”n1, –ìã‹Žu1, Vˆä“cF—T1,2 (1‘Ûˆã—ÕŸŽƒ‘å, 2Šá‰È): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

723766. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]—ÀŒ‡‘¹Ç‚ÉŽ—‚œ‚“x…“ªÇÇ—á‚Ì—ŒŠáŽ‹‹@”\. –]ŒŽ_Žu1, ŒŽ@’Œl1,2, “àŽRmŽu1, ¬’¬—SŽq1, ’ËŒŽ–ƒ—R‰À3, ¬–ì—¢‹KŽq3, Vˆä“cF—T1,2 (1‘Ûˆã—ÕŸŽƒ‘å, 2Šá‰È, 3‘Ûˆã—ÕŸŽƒ‘å•a‰@): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

723767. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”æ‚ê–Ú, “ª’É‚ÌŒ[”­‚É‚æ‚è—ˆ‰@‚µ‚œŠ³ŽÒ‚ÌŽŸŠ³‚Æ‹üÜ‹ž³‚̏d—v«. ŒN“‡^ƒ1, ŒŽ@’Œl1,2,3, Žs糋`Í1,3, “àŽRmŽu2, ×’J—R‹IŽq1, Š—¶^—1, Œü–ì˜a—Y1,3 (1_“ސ쎕‘åE‰¡•lƒNƒŠƒjƒbƒN, 2‘Ûˆã—ÕŸŽƒ‘åEŽ‹‹@”\—Ö@, 3Šá‰È): ‘æ71‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï/‘æ40‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï‘‰ï (2015/7/3), •ºŒÉ.

723768. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ×‹Û«Šp–Œ‰ŠÇ—á‚É‚š‚¯‚é”N—î‘w•Ê‚Ì•ª—£‹Û‚Æ–òÜŠŽŽó«‚ÌŒŸ“¢. Žq“‡—Ç•œ1,2, ‹{•‰‘y‰î1, –ìŒû‚ä‚©‚è1, ”ª–؏²Žq1, Šâè‘ô–ç1, ‹{“c˜a“T1 (1‹{“cŠá‰È, 2Šá‰È): ‘æ52‰ñ“ú–{ŠáŠŽõÇŠw‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/10), ‘åã.

723769. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Moraxella‘®‚É‚æ‚éŠp–Œ‰Š‚Ì‘œŽ{Ý’²ž. ˆäã‰p‹I1,2, —é–؁@’1,2, •ž•”‹M–Ÿ2,3, Žq“‡—Ç•œ2,4,5, ŒËŠ‘å•ã2,6, ¯@Å’q2, ]Œû@—m2, ‘å‹Ž—Tˆê1 (1ˆ€•Q‘å, 2OMIC working group, 3“Œ‹žˆã‘å, 4‹{“cŠá‰È, 5Šá‰È, 6ŒQ”n‘å): ‘æ52‰ñ“ú–{ŠáŠŽõÇŠw‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/10), ‘åã.

723770. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œ‹–ŒùN“à‚š‚æ‚Ñ•@o“à‚æ‚蕪—£‚³‚ê‚œMRSE‚Ì“¯ˆê«‚ÌŒŸ“¢. â–{‘¥•q1, Ž…Œö–ç1, ’†‘º³Ž÷2, –k—¢‰p˜Y2 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ52‰ñ“ú–{ŠáŠŽõÇŠw‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/11), ‘åã.

723771. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒPƒA1. ‰F’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): ‘æ58‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/11), ‘åã.

723772. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) MPSŽg—pŽÒ‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒYƒPƒAŽw“±‚ÌŒø‰Ê‚ƃŒƒ“ƒYƒP[ƒX‚̍׋ې”‚ÌŠÖŒW. “àŽRmŽu1, ŒÃìŽì‹I1, ‰Á“¡@•‘1, —é–؈€”ü1, œA£^—R1, [’×L‰À—¢1, ŒÃìŒb“Þ1, ‰F’ÃŒ©‹`ˆê2,3, Vˆä“cF—T1,3 (1‘•Ÿ‘压‹@”\, 2‰F’ÃŒ©Šá‰Èˆã‰@, 3Šá‰È): ‘æ58‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/11), ‘åã.

723773. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •œ¬26”N“x‰¡•lŽs, “¡‘òŽs‚Ì’†‚¶‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹µ’²ž. â–{‘¥•q1,2, ŽOˆäŒ’³1, ‰F’ÃŒ©‹`ˆê1,2, Ží“c–F˜Y1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ58‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/11), ‘åã.

723774. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •œ¬26”N“x_“ސ쌧‚ÌŠwZ‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—p’²ž. ‰F’ÃŒ©‹`ˆê1,2, â–{‘¥•q1,2, ¬Œû˜a‹v1, ‰ª“c@—T1, ‰œ˜eŒ«ˆê1,2, ‹àˆä@Œõ1, ¬’r@Œ’1, Ží“c–F˜Y1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ58‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/11), ‘åã.

723775. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •œ¬26”N“x_“ސ쌧‚ÌŠwZ‚̃Jƒ‰[ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—p’²ž. ‰F’ÃŒ©‹`ˆê1,2, â–{‘¥•q1,2, ¬Œû˜a‹v1, ‰ª“c@—T1, ‰œ˜eŒ«ˆê1,2, ‹àˆä@Œõ1, ¬’r@Œ’1, Ží“c–F˜Y1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ58‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/11), ‘åã.

723776. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰»Šw—Ö@‚â•úŽËü—Ö@‚É‚æ‚é—Ü“¹áŠQ‚É, —܊ǃ`ƒ…[ƒu‘}“ü‚ðŽ{s‚µ‚œ18—á‚ÌŒŸ“¢. ”–؍LÆ1,2, ˆÀˆä”ŽŽj3, Œ‘ºœˆê˜Y4, ‘ºŽRds5, {“c–«Žm6 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 2Šá‰È, 3Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Á‰ÎŠí“à‰È, 4Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[“û‘BŠO‰È, 5Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[—zŽqüŽ¡—ÉÈ, 6Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[“ªèò•”ŠO‰È): ‘æ4‰ñ“ú–{—Ü“¹E—܉tŠw‰ï‘‰ï (ƒtƒH[ƒTƒ€2015‘åã) (2015/7/11), ‘åã.

723777. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒŠƒpƒXƒWƒ‹‰–Ž_‰–…˜a•š“_Šá‰t‚ª‘ÎŒõ”œŽË‚š‚æ‚ыߌ©”œ‰ž‚É‹y‚Ú‚·‰e‹¿. ²“¡@Ži1, Îì@‹Ï2, ŒãŠÖ—˜–Ÿ1, óì@Œ«2, ŽRŒû@ƒ1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ35‰ñ“ú–{Šá–ò—Šw‰ï (2015/9/6), “Œ‹ž.

723778. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒgƒ‰ƒxƒNƒg[ƒ€Žèp‚ªŠp–Œ“à”ç×–E–§“x‚Ö‹y‚Ú‚·‰e‹¿. Š}ŒŽ³s1, ¯ŽiMs2, X“c“N–ç1, Œ‘ºˆêO1, ‰Í–ì—Y—º1, –Ø‘º“TŒh1, •ÄŽR@—È1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/11), ˆ€’m.

723779. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) OCTOPUS600Ž‹–ìŒv10-2‚ÆHumphreyŽ‹–ìŒv10-2‚Ì”äŠr. ‚‹Ž‰ÄŽÀ1, ²“¡@Ži1, Œ‘ºˆêO1, Š}ŒŽ³s1, •œàVˆê–@2, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/11), ˆ€’m.

723780. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹–ì‚̍Č»«‚ÆŽ‹—Í‚ÌŠÖ˜A. Œ‰Y«l1, •œàVˆê–@2, ‘º“c”ŽŽj1, ’©‰ª@—º1 (1“Œ‹ž‘å, 2ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/11), ˆ€’m.

723781. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —ΓàáŠá‚É‚š‚¯‚éFŽ‹—Í‘ª’è‚ÌŒŸ“¢. ‘å“à‡Žq1, –ʍ‚@Žq1, ²“¡‚͂鍁1, ‘å—¢“N–ç1, ²“¡—T”V1, ˆÉ“¡@ˆ²1, ‘ŠàV“Þ”¿Žq1, “c’†–FŽ÷2, š •û•FŽu1, Žsìˆê•v2,3, ’†àV@“O1 (1“Œ–k‘å, 2’†‹žŠá‰È, 3Šá‰È): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/11), ˆ€’m.

723782. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹ûÇŒóŒQ‚̐V‚µ‚¢ˆâ“`ŽqˆÙíCACNA1A. ”öè•õ¶1, aŒû®‘¥2, ’†–쑏Žq3, ^“çLˆê4, —с@@Œ€4, •—ŠÔ¬‘×5, o“c—²ˆê6, X@—mÄ7,8, ‹{“c˜a“T7, ™ŽR˜a‹v9, “Œo•ü–€9, çŒŽ‰x•v10, ˆäãŒ«Ž¡11, ÎŽq’qŽm12, ‹g“cW•q12, –ö@¹G13, –Ø“à—Ç–Ÿ13, ‘ŠŒŽ@ˆê14, ‘å‹Ž@•×15, ŸNˆäŽõ–ç16, ™–{‹MŽq17, ’†”nGŽ÷17, X@˜a•F18, ˆî’J@‘å19, ‹v•Û“c•qº3, ‹g‘º’·‹v20, Tin Aung21, Chiea Chuen Khor22 (1”öèŠá‰È, 2aŒûŠá‰È, 3‘啪‘å, 4—ÑŠá‰È•a‰@, 5VéŠá‰Èˆã‰@, 6o“cŠá‰È•a‰@, 7‹{“cŠá‰È•a‰@, 8Šá‰È, 9‹à‘ò‘å, 10çŒŽŠá‰È, 11ˆäãŠá‰È•a‰@, 12ˆ®ìˆã‘å, 13L“‡‘å, 14“Œ‹ž‘å, 15‘å‹ŽŠá‰È, 16‘œª‹L”OŠá‰È•a‰@, 17‹{è‘å, 18‹ž“s•{ˆã‘å, 19•Ÿˆä‘å, 20‹ž“s‘å, 21Singapore National Eye Center, 22Genome Institute of Singapore): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/11), ˆ€’m.

723783. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘œÜ“_Šá•¹—p—ΓàáŠ³ŽÒ‚ɃŠƒpƒXƒWƒ‹‰–Ž_‰–…˜a•š“_Šá–ò‚̒ljÁ“Š—^‚ð‚š‚±‚È‚Á‚œÇ—á‚̊ሳ‰º~Œø‰Ê. –Ø‘º“TŒh1, ‰Í–ì—Y—º1, Š}ŒŽ³s1, Œ‘ºˆêO1, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/11), ˆ€’m.

723784. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ³íŠáˆ³—ΓàáŠ³ŽÒ‚É‚š‚¯‚éƒGƒNƒXƒvƒŒƒX—Γàá¬Ñ‚Ì’†ŠÔ•ñ. ¬a’Žj1, ‘ŠŒŽ@ˆê2, ”’“yéÆ3, ‘å’JLˆê˜Y4,5, o“c—²ˆê6, ‹Ž–{‹`O7, ‹{“c˜a“T1 (1‹{“cŠá‰È, 2“Œ‹ž‘å, 3Žl’J‚µ‚ç‚ÆŠá‰È, 4Ž­Ž™“‡‹{“cŠá‰È, 5Šá‰È, 6o“cŠá‰È, 7^³‰ï•xŽR•a‰@): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/12), ˆ€’m.

723785. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒŠÇV¶—Γàá‚É‚š‚¯‚éTrabeculectomy‚ÆEX-PRESSҕ¹—pàh‰ßŽèp‚Ì”äŠr. ‰Í–ì—Y—º1, ¯ŽiMs2, Œ‘ºˆêO1, Š}ŒŽ³s1, –Ø‘º“TŒh1, •ÄŽR@—È1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/12), ˆ€’m.

723786. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z‰æ‘œ1. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/12), ˆ€’m.

723787. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šp–Œ¶‘Ì—ÍŠw“Á«‚ðl—¶‚É“ü‚ê‚œ2Ží‚̊ሳŒv‚̊ሳ’l‚Ì”äŠr. ‹œ‰E‹ß”ŽN1, •œàVˆê–@2, Š}ŒŽ³s1, Œ‘ºˆêO1, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/12), ˆ€’m.

723788. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹@”\“Iàh‰ß–E‚ð—L‚·‚銳ŽÒ‚É‚š‚¯‚錋–ŒíÝ×‹Û‘p‚Ì“Á’¥. ‘å’JLˆê˜Y1,2, ‘ŠŒŽ@ˆê3, ó—˜œŽu4, ”ª–؏²Žq1, ¬a’Žj1, Šâè‘ô–ç1, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2Šá‰È, 3“Œ‹ž‘å, 4‘åã‘å): ‘æ26‰ñ“ú–{—ΓàáŠw‰ï (2015/9/12), ˆ€’m.

723789. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”’“àáŽèp‘OŒã‚ÌŽ†FŽ‹—Í‚ð—p‚¢‚œFŽ‹—Í‚Ì”äŠr‚ɂ‚¢‚Ä. ‰¡ŽR@ãÄ1, “c’†–FŽ÷2, ’†‘º‰pŽ÷1, “c粏َq3, “Žˆä—ŠG3, ‰Á“¡Km3, “c’†@Ž4, Žsìˆê•v2,5 (1’†‹ž•a‰@, 2’†‹žƒƒfƒBƒJƒ‹, 3’†‹žŠá‰È, 4MB‘åŠwŠwpŒ€‹†‰@HŠw•”, 5Šá‰È): ‘æ54‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ41‰ñ…»‘ÌŒ€‹†‰ï (2015/9/18), ˆ€’m.

723790. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ßÔŠO•ªŒõ–@‚ð—p‚¢‚œV¶Ž™‚Ì‘ŒŠo“IŽ‹‹@”\ŒŸž‚ÌŽŽ‚Ý (‘æ2•ñ). Šâ“c@—y1, ’r“c“N–ç2, Îì@‹Ï3, ”Œ“c’m–ç3, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3ˆã—Éq¶Šw•”): ‘æ51‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2015/9/26), ‰ªŽR.

723791. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 3ŽŸŒ³ž–§…»‘̃‚ƒfƒ‹‚ð—p‚¢‚œ’²ß‚Ì—ÍŠwƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‰ðÍ. ìŽç“c‘ñŽu1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ51‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2015/9/26), ‰ªŽR.

723792. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[‚É‚š‚¯‚é, ‚Ô‚Ç‚€–Œˆ««•FŽî14—á‚Ì‘Š‡. ”–؍LÆ1,2, Ž…Ë•v1, ‹gìŽü²1, ˆÉ“¡ˆÈ’m˜Y1, “n粗íŽq1, ’†ì‰ë—T1, ‘œ‹v‰À¬3, {‰êº•F4 (1Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 2Šá‰È, 3Ã‰ªŒ§—§•a‰@Žîᇓà‰È, 4Ã‰ªÏ¶‰ï•a‰@ŠÉ˜aˆã—ÉÈ): ‘æ33‰ñ“ú–{ŠáŽîᇊw‰ï (2015/10/3), “‡ª.

723793. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Laser in situ keratomileusis‚Æphotorefractive keratectomypŒã10”N‚̈À’萫‚Ì”äŠr. X@—mÄ1,2, ”ª–Ø—I•ã1, ”ö•û”ü—R‹I1, Žq“‡—Ç•œ1,2, “ìŒcˆê˜Y1, _’J˜aF2, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/22), ˆ€’m.

723794. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Small Incision Lenticule Extraction (SMILE) ‚̃Gƒlƒ‹ƒM[Å“K‰»‚ÌŒŸ“¢. _’J˜aF1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, ¬‹Ž‰p’·1 (1Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/22), ˆ€’m.

723795. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÑ’ʍE•t‚«Œã–[Œ^—L…»‘ÌŠá“àƒŒƒ“ƒY‘}“üpŒã‚É‚š‚¯‚鎩Šo“I‘O•ûŽU—‚Ì’è—Ê“IŒŸ“¢. ”Ñ“‡ˆè‰Ã1, Ž…Œö–ç1, ŽRŠÝ^‹|, ¬‹Ž‰p’·1, ŒÜ\—’ÍŽj1, _’J˜aF1 (1Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/22), ˆ€’m.

723796. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”’“àáŽèp—pƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚ð—p‚¢‚œ—Ž‹‹ž³p‚̏pŒã’ZŠú¬Ñ. Žsì@Œc1, ¬“‡—²Ži1, “Žˆä—ŠG2, ŽðˆäKO2, ‰Á“¡Km2, ‚–Ø–ƒ—¢3, ‹Ê’u–Ÿ–ì3, ’†‘º‰pŽ÷3, Žsìˆê•v2,4 (1Šò•ŒÔ\Žš•a‰@, 2’†‹žŠá‰È, 3’†‹ž•a‰@, 4Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/22), ˆ€’m.

723797. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰~Šp–ŒŠá‚ƃtƒFƒ€ƒZƒJƒ“ƒhƒŒ[ƒU[‘S‘wŠp–ŒˆÚAŒã‰~Šp–ŒŠá‚ÌŽ‹‹@”\”äŠr. ŒÜ\—’ÍŽj1, _’J˜aF1, ¬‹Ž‰p’·1, Ž…Œö–ç1 (1Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/22), ˆ€’m.

723798. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) LENSTAR@LS900‚̉ÁŽZˆ—‚É‚æ‚鑪’è‰Â”\—Š‚ƏpŒã‹üÜŒë·. –îƒm–Ú‹ž•œ1, ”Ñ“c‰Ã•F1,2, Ž…Œö–ç1 (1Šá‰È, 2“Œ–ŒŒú–Ø•a‰@): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/22), ˆ€’m.

723799. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˜A‘±‰~Œ`Ø”XpŽž‚̐…»‘Ì“®—h‚ðŠî‚É‚µ‚œƒ`ƒ“¬‘ѐƎã’ö“x‚Ì•ª—Þ‚ðp’†ŠŒ©. ’JŒûd—Y1, ¬‘ò’‰•F1, “c’†—Tˆê˜N1, –ØŒŽ^ˆê1, ‘å’Î’qG1,2, Œã“¡—m•œ1, —é–ؐçt1, Ž›è@Ê1, ”·–{@É1 (1¬‘òŠá‰È“à‰È•a‰@, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/22), ˆ€’m.

723800. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŽüpŠú‚É‚š‚¯‚éR‹Û“_Šá–ò‚ÌŒ‹–ŒùNíÝ‹Û‚ɑ΂·‚éŒoŽž“I‰e‹¿. Žq“‡—Ç•œ1,2, X@—mÄ1,2, ‹{•‰‘y‰î1, —ÑŽ›@Œ’1, ¬a’Žj1, ŠL“c’qŽq1, –ìŒû‚ä‚©‚è1, ”ª–؏²Žq1, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/22), ˆ€’m.

723801. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œ’íŽÒ‚ÌRAPDx_‘ª’茋‰Ê‚É‚š‚¯‚鐫•ÊE”N—î‚̉e‹¿‚Ɗ’l‚ÌŒŸ“¢. ²“¡@Ži1, ŒãŠÖ—˜–Ÿ1, óì@Œ«2, Îì@‹Ï2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

723802. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) GoldmannŽ‹–ì‚É‚š‚¯‚éŽÀ‘ªIII-4e‚Ɛ„‘ªIII-4e‚ð—p‚¢‚œFunctional Field Score‚Ì”äŠr. –öàV”üˆßŽq1,2, ‰Á“¡@‘1, ¬—Ñ‚ß‚®‚Ý1, –kàV–œ—¢Žq1, —Ž‡áÁ‹IŽq1 (1“Œ‹ž‘å, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

723803. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽOŽŸŒ³‰æ‘œ‚ðŽg—p‚µ‚œƒqƒg…»‘̂̑̐ϑª’è. ”n“ˆŽ”@1, Žsì@Œc2, ŽðˆäKO3, “à“¡®‹v3, ˆé’J®‹P4, •Ð‰ª“”Ž4, ’†‘º—Fº4, Žsìˆê•v3,5 (1–ŸŠá‰@, 2Šò•ŒÔ\Žš•a‰@, 3’†‹žŠá‰È, 4–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 5Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

723804. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) p‘O‹ž³Ž‹—͗ǍD—á‚É‚š‚¯‚é”’“àáŽèpÇ—á‚Ì”wŒiˆöŽq‚ÌŒŸ“¢. ŠFì—FŒ›1, Ž…Œö–ç1, ²“¡M”V1, ”Ñ“c‰Ã•F1 (1Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

723805. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘œÅ“_Šá“àƒŒƒ“ƒYŒðŠ·Ç—á‚Ì”wŒiˆöŽq‚ÌŒŸ“¢. Î“c@‹Å1, Ž…Œö–ç1, ”Ñ“c‰Ã•F1, ˆÉ“¡”ü¹ŠG2 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

723806. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@‚Ì—ŒŠáŽ‹‹@”\‚ÌŒŸ“¢. ˆÉ“¡”ü¹ŠG1, Ž…Œö–ç2, ”Ñ“c‰Ã•F2, ìŽç“c‘ñŽu1, ¯ŽiMs1 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

723807. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) is«‰~Šp–ŒÇ—á‚É‚š‚¯‚éŠp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO‘OŒã‚ÌŠp–Œ‚̐¶‘Ì—ÍŠw“Á«‚̕ω». ¬“‡—²Ži1,2, Œ“c’m–ç2, ’†‘º—Fº2, Žsìˆê•v3,4 (1Šò•ŒÔ\Žš•a‰@, 2–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3’†‹žŠá‰È, 4Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

723808. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž¡—Ã’ïR«‚ÌŠŽõ«Šp–Œ’×ᇂɑ΂µ‚ÄŠp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO•¹—p‚ª’˜Œø‚µ‚œˆê—á. ‰Í–ì—Y—º1, _’J˜aF1, ŒÜ\—’ÍŽj1, ¬‹Ž‰p’·1, Ž…Œö–ç1 (1Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/23), ˆ€’m.

723809. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œ’íŽÒ‚É‚š‚¯‚éƒuƒŠƒ‚ƒjƒWƒ““_Šá‘OŒã‚Ì‹üÜE“µEŒa•Ï‰». ‰Á“¡ŽÑ–1, _’J˜aF1, ŒÜ\—’ÍŽj1, ¬‹Ž‰p’·1, Ž…Œö–ç1 (1Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723810. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹üÜ‹ž³ŽèpŒã‚Ì–éŠÔƒOƒŒƒAEƒnƒ[‚ɑ΂·‚éƒuƒŠƒ‚ƒjƒWƒ““_ŠáŒø‰Ê‚ÌŒŸ“¢. ˆÀ“¡˜a‰ÌŽq1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723811. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’·[“x‘OŠá•”ŒõŠ±Â’f‘wŒv‚ð—p‚¢‚œ–Ñ—laŠÔ‹——£‚Ì’ŒÚŒv‘ª‚Æ—\‘ªˆöŽq‚ÌŒŸ“¢. ‚‹Ž³‰p1,2, ²“¡M”V3, ¬‹Ž‰p’·3, ŒÜ\—’ÍŽj3, _’J˜aF3, Ž…Œö–ç3 (1ŽR‰€•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723812. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) íõF‘Ì—D«Ž‹_ŒoˆÞk‹^‚¢—á‚É‚š‚¯‚éOPA1ˆâ“`Žq•ÏˆÙ. “¡Šª‘ñ˜Y1, –öì@ˆ€1, ‚@@’O1, Vˆä‰p‰î1, Šâ“c•¶”T1,2, ’†’J@’q1, ˆî’J@‘å3, A–Ø’qŽu4, ]–{”Ž•¶5, ŸŠC@C6, ŽO‘º@Ž¡7, Žá‘q‰ë“o6,8, ‘ºã@»1 (1‡“V‘å, 2‚¢‚í‚œŠá‰È, 3•Ÿˆä‘å, 4VŠƒ‘å, 5ˆã‰ÈŽ•‰È‘å, 6ˆäãŠá‰È•a‰@, 7•ºŒÉ‘å, 8Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723813. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘S‘wŠp–ŒˆÚAŒã‚É‚š‚¯‚éŽU—‚ÆŽû·‚ªŽ‹‹@”\‚É‹y‚Ú‚·‰e‹¿. ¬‹Ž‰p’·1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723814. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘S‘wŠp–ŒˆÚAp‚ÆŠp–Œ“à”çˆÚAp‚É‚š‚¯‚épŒã’·Šú‚ÌŽ‹‹@”\‚Ì”äŠr. ‹{•‰‘y‰î1, “¿—¯r•F1, —с@Ž›Œ’1, X@—mÄ1,2, Žq“‡—Ç•œ1,2, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723815. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z—Γàá: Žèp1. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723816. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·z‹üÜ‹ž³EŽ‹‹@”\2. _’J˜aF (Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723817. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) SMILEŽèp‚É‚š‚¯‚éŠp–ŒŒã–ʕω»‚ɂ‚¢‚Ä. ‹g“c—zŽq1, ’†‘º—Fº1, •Ð‰ª“”Ž1, •Ð‰ª–ƒ—R1, ˆé’J®‹P1, ¬“‡—²Ži1,2,3, Žsìˆê•v3,4 (1–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 2Šò•ŒÔ\Žš•a‰@, 3’†‹ž•a‰@, 4Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723818. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —¬‘Ì—ÍŠw‰ðÍ‚ð—p‚¢‚œHole ICL‚Ì–[…“®‘Ô‚ªŠp–Œ“à”ç‚É—^‚Š‚é‰e‹¿. ìŽç“c‘ñŽu1, Ž…Œö–ç2, ˆÉ“¡”ü¹ŠG1, ¯ŽiMs1 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723819. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Accu-Temp_‚É‚æ‚錋–Œ’oŠÉÇŽèp. ’†Œ@Šî1,2, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2•‘ –ìÔ\Žš•a‰@): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723820. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÔŸ[«ŠOŽÎŽ‹‚̐³ˆÊ‰»‚É”º‚€çt–©, ’²ß•Ï‰»|ŽÎˆÊ‹ßŽ‹‚Ì—L–³‚Å‚Ì”äŠr|. åŒŽŽµd1, Îì@‹Ï1, ŒãŠÖ—˜–Ÿ2, ’r“c“N–ç2, —Žˆä‰‘Žq3, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723821. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ^ƒuƒŒƒbƒgŒ^Ž‹”\ŒP—û‘•’uOcclu-pad҂ð—p‚¢‚œŽãŽ‹ŒP—ûŒø‰Ê. ŒË’ˁ@Œå1, ”Œ“c’m–ç2, Îì@‹Ï2, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723822. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚Æ‚»‚ÌŠÖ˜A•a‰@‚É‚š‚¯‚é–¢nŽ™–Ô–ŒÇf—Â̌»ó. ’r“c“N–ç1, Ž…Œö–ç1, —Žˆä‰‘Žq2, Î“c@‹Å1, ŒãŠÖ—˜–Ÿ1, Îì@‹Ï3 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723823. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) RAQP4R‘Ì—z«Ž‹_Œo‰Š‚Ì”­ÇŽžŠú‚š‚¯‚é‹Gß“I•Ï“®‚ÌŒŸ“¢. ŽRã–ŸŽq1,2, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723824. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹}«œ‘«”’ŒŒ•aœ‘Š°‰ðŠú‚ɍĔ­‚ðŒJ‚è•Ô‚µ‚œZ«Ž‹_ŒoÇ‚Ì1—á. ’rã–õŽq1, “c’†rˆê1,2, ‚‹Ž”üK1,2, ‚–ì–í“Þ1 (1•‘ –ìÔ\Žš•a‰@, 2Šá‰È): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/24), ˆ€’m.

723825. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —ΓàáŠ³ŽÒ‚ÌQOL‚̕“I•]‰¿‹y‚ÑQOL‚ɉe‹¿‚ð—^‚Š‚éˆöŽq‚ÌŒŸ“¢. •œàV—T‘ã1, Œ‰Y«l1, •œàVˆê–@1,2, ‘º“c”ŽŽj1, ŠÔŽRçq1, ’©‰ª@—º1 (1“Œ‹ž‘å, 2ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/25), ˆ€’m.

723826. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —ΓàáŠ³ŽÒ‚ÌQOL‚̕“I•]‰¿‚Ì‚œ‚ß‚Ìitem bank‚̍쐬. •œàVˆê–@1,2, Œ‰Y«l1, •œàV—T‘ã1, ‘º“c”ŽŽj1, ŠÔŽRçq1, ’©‰ª@—º1 (1“Œ‹ž‘å, 2ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/25), ˆ€’m.

723827. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹ûÇŒóŒQ‚É‚š‚¯‚éLOXL1ˆâ“`ŽqˆÙí‚Ì“ÁŽê«. ”öè•õ¶1, aŒû®‘¥2, ’†–쑏Žq3, ^“çLˆê4, —с@@Œ€4, •—ŠÔ¬‘×5, o“c—²ˆê6, X@—mÄ7,8, ‹{“c˜a“T7, ™ŽR˜a‹v9, “Œo•ü–€9, çŒŽ‰x•v10, ˆäãŒ«Ž¡11, ÎŽq’qŽm12, ‹g“cW•q12, –ö@¹G13, –Ø“à—Ç–Ÿ13, ‘ŠŒŽ@ˆê14, ‘å‹Ž@•×15, ŸNˆäŽõ–ç16, ™–{‹MŽq17, ’†”nGŽ÷17, X@˜a•F18, ˆî’J@‘å19, ‹v•Û“c•qº3, ‹g‘º’·‹v20, Tin Aung21, Chiea Chuen-Khor22 (1”öèŠá‰È, 2aŒûŠá‰È, 3‘啪‘å, 4—ÑŠá‰È•a‰@, 5VéŠá‰Èˆã‰@, 6o“cŠá‰È•a‰@, 7‹{“cŠá‰È•a‰@, 8Šá‰È, 9‹à‘ò‘å, 10çŒŽŠá‰È, 11ˆäãŠá‰È•a‰@, 12ˆ®ìˆã‘å, 13L“‡‘å, 14“Œ‹ž‘å, 15‘å‹ŽŠá‰È, 16‘œª‹L”OŠá‰È•a‰@, 17‹{è‘å, 18‹ž“s•{ˆã‘å, 19•Ÿˆä‘å, 20‹ž“s‘å, 21Singapore Nat Eye Ctr, 22Genome Inst of Singapore): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/25), ˆ€’m.

723828. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z_ŒoŠá‰È. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/25), ˆ€’m.

723829. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”]Ò‘‰tŒž­Ç‚Ì‘¶Ý‚ª”»–Ÿ‚µ‚œ“ªèò•”ŠOŒã‚ÌŠáÇó‚ÌŒŸ“¢. Vˆä‚ä‚è‚ 1, ŽRã–ŸŽq1,2, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2, ‚‹Ž_ˆê3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3ŽR‰€•a‰@): ‘æ69‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2015/10/25), ˆ€’m.

723830. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —⊎Ü‚Ì—L–³‚É‚æ‚éŠáŽüˆÍ‰·ãª–@‚ªŽ‹‹@”\‚â”]Šˆ“®‚É—^‚Š‚é‰e‹¿. “‡“c—TŽq1, ”ѐXØŒŽ1, ˆäŠ_’ʐl1, Šâ“c@—y2, óì@Œ«3, Îì@‹Ï3 (1‰Ô‰€Š”Ž®‰ïŽÐƒp[ƒ\ƒiƒ‹ƒwƒ‹ƒXƒPƒAŒ€‹†Š, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ68‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2015/10/30), ˆ€’m.

723831. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒQ[ƒ€‹@Ší‚ª‹ßŒ©”œ‰ž‚É—^‚Š‚é‰e‹¿. ‘Ÿ“c@—€1, ŒŽ@’Œl2,3, Œü–ì˜a—Y3,4 (1‘Ûˆã—ÕŸŽƒ‘åŠw‘åŠw‰@, 2‘Ûˆã—ÕŸŽƒ‘åŠw, 3Šá‰È, 4_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒN): ‘æ68‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2015/10/30), ˆ€’m.

723832. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·zˆê”ʍu‰‰I. Žsìˆê•v1,2 (1’†‹žŠá‰È, 2Šá‰È): ‘æ57‰ñ“ú–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2015/10/31), ’·–ì.

723833. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —ôEŒŽ«–Ô–Œ”—£‚ɑ΂·‚éŠá“à“àŽ‹‹Ÿ‚𕹗p‚µ‚œ¬ØŠJÉŽq‘ÌŽèp‚̐¬Ñ. ‰¡ŽR@ãÄ1, ‰Á‰ê’BŽu1,2, X@r’j3, Œ“c‘וã1, ²”Œ’‰Ž’˜N1, ²“¡—T”V3, ‹g“c‘¥•F4, ™‰ª—EŠó1, ’¹ˆärŠó1, Žsìˆê•v2,5 (1’†‹ž•a‰@, 2Šá‰È, 3”Ñ“cŽs—§•a‰@, 4Šò•ŒÔ\Žš•a‰@, 5’†‹žŠá‰È): ‘æ57‰ñ“ú–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2015/10/31), ’·–ì.

723834. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) dS“®—hŒvUM-BAR II‚ð—p‚¢‚œÄŒ»«‚ÌŒŸ“¢. ‹ààV³Œp1, óì@Œ«2, ìŽç“c‘ñŽu2, ‹›—¢@”Ž3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3‘åãlŠÔ‰ÈŠw‘åŠw): ‘æ57‰ñ“ú–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2015/10/31), ’·–ì.

723835. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 3Œ^3FŠo‚ð—p‚¢‚œ‚—îŽÒFŠoÄŒ»–@‚ÌŒŸ“¢. “B‹{@I1, “c’†–FŽ÷2, “c’†@Ž1, ‰¡ŽR@ãÄ3, ’†‘º‰pŽ÷3, Žsìˆê•v2,4, “c粏َq2 (1MB‘åŠw, 2’†‹žŠá‰È, 3’†‹ž•a‰@, 4Šá‰È): ‘æ57‰ñ“ú–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2015/10/31), ’·–ì.

723836. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·zŠáâ|EŽîᇑŒ. ŽRã–ŸŽq1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/6), é‹Ê.

723837. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰)yÀ’·z‚ŽŸŽ‹‹@”\E“µEEŒŸž. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/6), é‹Ê.

723838. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™•Ð“ª’É‚Ì’²ß‹@”\áŠQ‚©‚ç‚Ý‚œŽ‹Šo•a‘Ԑ¶—‚̍lŽ@. ŒŽ@’Œl1,2, ŒN“‡^ƒ3, Š—¶^—4, —é–Ø—T”ü2,3, Žs糋`Í2,3, Vˆä“cF—T1,2, Œü–ì˜a—Y2,3, ŒÜ\—’‹v‰À4 (1‘Ûˆã—ÕŸŽƒ‘åŠw, 2Šá‰È, 3_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 4•xŽm’ʃNƒŠƒjƒbƒN“ª’ÉŠO—ˆ): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/6), é‹Ê.

723839. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 㵖ŸŠ³ŽÒ‚É‚Ý‚ç‚ê‚œŽ‹°‚Ƒяó‰ñ‚Ì”]“œ‘ãŽÓ˜Ži. —é–؍K‹v1,2,3, ŽàVŒ¹O2,4, Žá‘q‰ë“o5,6, Î“nŠìˆê3, ‘å–ì‹žŽq2, ÎˆäŒ«“ñ3 (1ŽO“‡‘‡•a‰@, 2“Œ‹žˆã‰ÈŽ•‰È‘åŠw, 3“Œ‹ž“sŒ’N’·Žõˆã—ÃZƒ“ƒ^[_Œo‰æ‘œŒ€‹†ƒ`[ƒ€, 4ŽàVŠá‰Èˆã‰@, 5ˆäãŠá‰È•a‰@, 6Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/6), é‹Ê.

723840. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘œ”­«d‰»Ç‚ÆŽ‹_ŒoÒ‘‰Š‚É‚š‚¯‚鉩”Á•”–Ô–Œ“à‘wŒú‚Ì”äŠrŒŸ“¢. ¬–ì—¢‹KŽq1, ŒŽ@’Œl1,2,3, “cì’©Žq1, ’ËŒŽ–ƒ—R‰À1, …—¬’‰•F1, X@Œ\‰î1, Vˆä“cF—T1,2,3 (1‘Ûˆã—ÕŸŽƒ‘åŠw•a‰@, 2‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 3Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/6), é‹Ê.

723841. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •s“¯Ž‹ŽãŽ‹‚É‚š‚¯‚铵E”œŽË‚̍¶‰E·. ŒË’ˁ@Œå1, Îì@‹Ï2, ŒãŠÖ—˜–Ÿ1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/6), é‹Ê.

723842. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ^ƒuƒŒƒbƒgŒ^Ž‹‹@”\ŒŸžŒP—ûŠíOcclu-Pad‚ÌŽ‹Šo–ì‚ɑ΂·‚éŒø‰ÊŒŸØ. Šâ“c@—y1, Îì@‹Ï2, ”Œ“c’m–ç2, Ž…Œö–ç3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/6), é‹Ê.

723843. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ªˆÊ•ÏŠ·‚É”º‚€Šááىº‚‚̈ê—á. ”Ñ“‡@ˆ»1, ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, Ž…Œö–ç1, ‹v{”ü^—3 (1Šá‰È, 2ˆã—Éq¶Šw•”, 3”]ŠO): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/6), é‹Ê.

723844. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹_ŒoŽŸŠ³‚É‚š‚¯‚éRAPDx҂ð—p‚¢‚œ‘Š‘ΓI“µE‹S˜HáŠQ‚š‚æ‚Ñ‘ÎŒõ”œŽË‚Ì•]‰¿. ²“¡@Ži1, ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, óì@Œ«2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/6), é‹Ê.

723845. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œ‹–Œ—ôŒã–ü’…‚É‚æ‚éŠO“]áŠQ‚Ì1—á. ŽRã–ŸŽq1,2, ‰–ì”ü“ÞŽq1, Šâ²^‹|1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/7), é‹Ê.

723846. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŽˆö•s–Ÿ‚ÌŽ‹_ŒoˆÞk‚Ń~ƒgƒRƒ“ƒhƒŠƒADNA•ÏˆÙ‚ð”F‚ß‚œ¬Ž™‚Ì1—á. Šâ²^‹|1, Vˆä‚ä‚è‚ 1, ŽRã–ŸŽq1,2, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/7), é‹Ê.

723847. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒŒ[ƒxƒ‹ˆâ“`«Ž‹_ŒoÇ‚̐V‹K”­ÇŽÒ”‚ÉŠÖ‚·‚é‰uŠw’²ž. ã“cD1, X›‰—SŠî2, ”’_Žj—Y2, •~“‡ŒhŒå3, Îì@‹Ï4, Žá‘q‰ë“o5,6, ’†‘º@œ1 (1_ŒË‘åŠw, 2‰ªŽR‘åŠw, 3“Œ‹žŽœŒbˆã‰È‘åŠw, 4ˆã—Éq¶Šw•”, 5ˆäãŠá‰È•a‰@, 6Šá‰È): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/7), é‹Ê.

723848. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”ñ“TŒ^“I‚È“®–¬‰Š«‹•ŒŒ«Ž‹_ŒoÇ‚Ì2—á. ŠL“c’qŽq1, ‰Ô’J~Žq2, ’†‘ºƒ„ƒXŽq2, ’†ŒŽ³²1, ‘å’JLˆê˜Y2,3, ‹{“c˜a“T1, ’†”nGŽ÷4 (1‹{“cŠá‰È•a‰@, 2Ž­Ž™“‡‹{“cŠá‰È, 3Šá‰È, 4‹{è‘åŠw): ‘æ53‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2015/11/7), é‹Ê.

723849. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹³ˆçEƒ[ƒrƒWƒ‡ƒ“E”­’B. ”Œ“c’m–ç1, Vˆäç‰êŽq (1ˆã—Éq¶Šw•”): ‘æ56‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2015/11/7), “Œ‹ž.

723850. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒÅŽ‹–Ú•W‚Ì‘å‚«‚³‚̈Ⴂ‚É‚æ‚鎋–쌟ž’†‚ÌŽ‹ü“®—h. •œàVˆê–@1, ‰ª–ì‰ÄØ, ‰z’n—¹Žq, M–ØŽáØ, ¯ŽiMs1 (1ˆã—Éq¶Šw•”): ‘æ56‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2015/11/7-8), “Œ‹ž.

723851. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¯óÉŽq‘̏ǂɂš‚¯‚éÉŽq‘ÌŽèp‘OŒã‚̐FŽ‹—͂̕ω». ‰¡ŽR@ãÄ1, ‰Á‰ê’BŽu1,2, ‹g“c‘¥•F3, ²“¡—T”V4, Œ“c‘וã1, X@r’j4, ™‰ª—EŠó1, “c’†–FŽ÷5, “c’†@Ž6, Žsìˆê•v2,7 (1’†‹ž•a‰@, 2Šá‰È, 3Šò•ŒÔ\Žš•a‰@, 4”Ñ“cŽs—§•a‰@, 5Š”Ž®‰ïŽÐ’†‹žƒƒfƒBƒJƒ‹, 6MB‘åEHŠw•”, 7’†‹žŠá‰È): ‘æ54‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ïE‘æ32‰ñ“ú–{ŠázŠÂŠw‰ï‡“¯Šw‰ï (2015/12/5), “Œ‹ž.

723852. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) FC-304&FL-301 (VŒ^“àŽ‹‹Ÿ) ‚ÆFT203F (‹ŒŒ^) ‚̗Տ°‚É‚š‚¯‚é”äŠr. ‰Á‰ê’BŽu1,2, ‹g“c‘¥•F3, ²“¡—T”V4, Œ“c‘וã1, ‰¡ŽR@ãÄ1, X@r’j4 (1’†‹ž•a‰@, 2Šá‰È, 3Šò•ŒÔ\Žš•a‰@, 4”Ñ“cŽs—§•a‰@): ‘æ54‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ïE‘æ32‰ñ“ú–{ŠázŠÂŠw‰ï‡“¯Šw‰ï (2015/12/5), “Œ‹ž.

723853. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ó‹C’uŠ·‰º‚Ì“àŽ‹‹ŸŽèpŽž‚É”­¶‚·‚鎋”F«’ቺ‚ÌŒŽˆö‚Ƒ΍ô. Œ“c‘וã1, ‰Á‰ê’BŽu1,2, Žsìˆê•v2,3, ‹g“c‘¥•F4, ²“¡—T”V5, ‰¡ŽR@ãÄ1, X@r’j5, “ˆ@çq3 (1’†‹ž•a‰@, 2Šá‰È, 3’†‹žŠá‰È, 4Šò•ŒÔ\Žš•a‰@, 5”Ñ“cŽs—§•a‰@): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/29), •Ÿ‰ª.

723854. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šp–Œ“à”ç×–E–§“xŒž­—á‚É‚š‚¯‚é”’“àáŽèp‚̐¬Ñ. ‹{•‰‘y‰î1, X@—mÄ1,2, ¬–ì@‹ª1, ”ö•û”ü—R‹I1, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/30), •Ÿ‰ª.

723855. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰©”Á‰ºŒŒŽî‚ɑ΂·‚é–Ô–Œ‰º“àŽ‹‹ŸŽèp. ‰Á‰ê’BŽu1,2, ‹g“c‘¥•F3, ²“¡—T”V4, Œ“c‘וã1, ‰¡ŽR@ãÄ1, X@r’j4, Žsìˆê•v2,5 (1’†‹ž•a‰@, 2Šá‰È, 3Šò•ŒÔ\Žš•a‰@, 4”Ñ“cŽs—§•a‰@, 5’†‹žŠá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/30), •Ÿ‰ª.

723856. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –«Šú–Ô–ŒÃ–¬•ªŽ}•ÂÇÇ‚̉©”Á•‚Žî‚ɑ΂·‚éƒiƒrƒQ[ƒVƒ‡ƒ“ƒŒ[ƒU[‚ÌŒø‰Ê‚ÌŒŸ“¢. ²“¡—T”V1, ‰Á‰ê’BŽu2,3, Žsìˆê•v3,4, ‹g“c‘¥•F5, ‰¡ŽR@ãÄ2, X@r’j1, Œ“c‘וã2, “à“¡®‹v4 (1”Ñ“cŽs—§•a‰@, 2’†‹ž•a‰@, 3Šá‰È, 4’†‹žŠá‰È, 5Šò•ŒÔ\Žš•a‰@): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/30), •Ÿ‰ª.

723857. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘OùNØŠJ’ŒŒã‚ƏpI—¹’Œ‘O‚Ì‘OùNØŠJ‘‹‚Ì”äŠr. ”n“ˆŽ”@1, Žsì@Œc2, ŽðˆäKO3, “à“¡®‹v3, ˆé’J®‹P4, •Ð‰ª“”Ž4, ’†‘º—Fº4, Žsìˆê•v3,5 (1Šá‰È–ŸŠá‰@, 2Šò•ŒÔ\Žš•a‰@, 3’†‹žŠá‰È, 4–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 5Šá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/30), •Ÿ‰ª.

723858. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“àáŽèp‚ƒʏí‚Ì”’“àáŽèp‚̏pŒãŽä‹NŠp–Œ—Ž‹‚Ì”äŠr. Žsì@Œc1, ¬“‡—²Ži1, “Žˆä—ŠG2, ŽðˆäKO2, ‰Á“¡Km2, ‚–Ø–ƒ—¢3, ‹Ê’u–Ÿ–ì3, Žsìˆê•v2,4 (1Šò•ŒÔ\Žš•a‰@, 2’†‹žŠá‰È, 3’†‹ž•a‰@, 4Šá‰È): ‘æ39‰ñ“ú–{Šá‰ÈŽèpŠw‰ïŠwp‘‰ï (2016/1/30), •Ÿ‰ª.

723859. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) è÷—±óŠp–Œ•Ï«‚É‚š‚¯‚é‘O•ûEŒã•ûŽU—‚š‚æ‚ÑŽû·‚ªŽ‹‹@”\‚É‹y‚Ú‚·‰e‹¿‚ÌŒŸ“¢. _’J˜aF1, ¬‹Ž‰p’·1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18), ’·–ì.

723860. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —܉tbreak pattern‚Ì–Ô—…“I‰ðÍ. ’†Œ@Šî1,2, ––œA@~3, ŒÜ\—’ÍŽj1, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2•‘ –ìÔ\Žš•a‰@, 3ƒgƒvƒRƒ“): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/20), ’·–ì.

723861. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) …áv«Šp–ŒÇ‚ɑ΂·‚éŠp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO‚ÌŒø‰Ê‚Ì’·Šú“IŒŸ“¢. ¬–ì@‹ª1, Ž›“c—T‹IŽq2, X@—mÄ1,3, Žq“‡—Ç•œ1,3, ”ö•û”ü—R‹I1, “ìŒcˆê˜Y1, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2“Œ‹ž“sŒ’N’·Žõˆã—ÃZƒ“ƒ^[, 3Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18-20), ’·–ì.

723862. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šp–ŒˆÚA•Ð•s‘S—á‚ɑ΂·‚éBoston keratoprosthesis‚Æ‘S‘wŠp–ŒˆÚAp‚̏pŒã¬Ñ”äŠr. —ÑŽ›@Œ’1, “¿—¯r•F1, ¬–ì@‹ª1, ‹{•‰‘y‰î1, Žq“‡—Ç•œ1,2, X@—mÄ1,2, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18-20), ’·–ì.

723863. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šp–Œ“à”çˆÚApŒã‚ÌŽû·EŽU—‚ªŽ‹‹@”\‚É‹y‚Ú‚·‰e‹¿‚ÌŒŸ“¢. ˆÀ—¢@“µ1,2, ŒÜ\—’ÍŽj2, ¬‹Ž‰p’·2, _’J˜aF2, —é–؉ëM1,2, Ž…Œö–ç2 (1‘Ûˆã—ÕŸŽƒ‘å, 2Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18-20), ’·–ì.

723864. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘S‘wŠp–ŒˆÚApŒãƒhƒ‰ƒCƒAƒC‚É‚š‚¯‚郌ƒoƒ~ƒsƒgEƒWƒNƒAƒzƒ\ƒ‹ƒiƒgƒŠƒEƒ€“_ŠáŒø‰Ê”äŠr. ¬‹Ž‰p’·1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18-20), ’·–ì.

723865. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Boston KeratoprosthesisŒã‚ÉŠŽõ«Šp–Œ‰Š‚𔭏ǂµ‚œ3—á‚ÌŒŸ“¢. Žq“‡—Ç•œ1,2, X@—mÄ1,2, —ÑŽ›@Œ’1, ¬–ì@‹ª1, –ìŒû‚ä‚©‚è1, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18-20), ’·–ì.

723866. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šp–Œ‘O–Ê“|—Ž‹Ç—á‚É‚š‚¯‚é‘OŠá•”OCT‚Å‘ª’肵‚œKeratometric‚ÆReal‚̍·‚ÌŒŸ“¢. ’·’JìˆŸ—¢1, ¬“‡—²Ži2, ‹Ê’u–Ÿ–ì1, ŽR–{^Ø1, ‰Á‰ê’BŽu1,3, Žsìˆê•v3,4 (1’†‹ž•a‰@, 2Šò•ŒÔ\Žš•a‰@, 3Šá‰È, 4’†‹žŠá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘æ40‰ñ“ú–{Šp–ŒŠw‰ï‘‰ïE‘æ32‰ñ“ú–{Šp–ŒˆÚAŠw‰ï) (2016/2/18-20), ’·–ì.

731147. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) —Γàá‚ÌŽ¡—Ë­‰»‚̃^ƒCƒ~ƒ“ƒO. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ3‰ñŠÖ“ŒGlaucoma Meet The Specialist (2015/4/25), “Œ‹ž.

731148. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z¬Ž™‚̋ߎ‹is–hŽ~‚̍l‚Š•û. Ží“c–F˜Y1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ128‰ñ_“ސ쌧Šá‰ÈW’k‰ï (‘æ57‰ñ_“ސìˆãŠw‰ï•ª‰È‰ï) (2015/5/24), _“ސì.

731149. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŠáŠŽõÇƒP[ƒXƒtƒ@ƒCƒ‹. _’J˜aF (Šá‰È): ‘æ6‰ñOSKA (Ocular Surface Seminar in Kanagawa) (2015/6/4), _“ސì.

731150. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “ú“à•Ï“®‚ðl—¶‚µ‚œ—ΓàáŽ¡—Ã. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ9‰ñ‚³‚ª‚ÝŠá‰ÈŒ€‹†‰ï (2015/6/26), _“ސì.

731151. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zOCT‚ð—p‚¢‚œ‰Á—”Á•Ï«‚̐f’fƒAƒbƒvƒf[ƒg. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ9‰ñ‚³‚ª‚ÝŠá‰ÈŒ€‹†‰ï (2015/6/26), _“ސì.

731152. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z•Ï‰»‚µ‚‚‚ ‚é—ΓàáŽ¡—Ã. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ15‰ñ_“ސìŠá‰ÈƒZƒ~ƒi[ (2015/7/2), _“ސì.

731153. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z—ΓàáŽ¡—à Update. ¯ŽiMs (ˆã—Éq¶Šw•”): —ΓàáŽ¡—Âɂš‚¯‚éROCK‘jŠQ–ò‚ðl‚Š‚é‰ï (2015/7/8), _“ސì.

731154. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽŸ¢‘ã‚Ì‹üÜ‹ž³Žèp@ReLExEHole ICL. _’J˜aF (Šá‰È): ‘æ2‰ñ‘åXŠp–ŒƒiƒCƒgƒZƒ~ƒi[ (2015/7/27), “Œ‹ž.

731155. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) OCT‚ð—p‚¢‚œ—Γàáf’f. ¯ŽiMs (ˆã—Éq¶Šw•”): ƒAƒCƒtƒ@ƒKƒ“Ò“_Šá‰t0.1%”­”„3Žü”Nƒ‹ƒ~ƒKƒ“Ò“_Šá‰t0.03%”­”„5Žü”N‹L”Ou‰‰‰ïin_“ސì (2015/8/20), _“ސì.

731156. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z—Γàá‚̍ŋ߂̘b‘è. Ž…Œö–ç (Šá‰È): ƒAƒCƒtƒ@ƒKƒ“Ò“_Šá‰t0.1%”­”„3Žü”Nƒ‹ƒ~ƒKƒ“Ò“_Šá‰t0.03%”­”„5Žü”N‹L”Ou‰‰‰ïin_“ސì (2015/8/20), _“ސì.

731157. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zˆã—Ñi×‚ÌŒ»ó‚Æ–â‘è`Šá‰ÈŽ–—á‚𒆐S‚Ɂ`. ‰F’ÃŒ©‹`ˆê1,2 (1‰¡•lŽsŠá‰Èˆã‰ï, 2Šá‰È): ‘æ17‰ñ‰¡•lŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2015/9/30), _“ސì.

731158. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z“Á•Êu‰‰. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

731159. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) My Career 20/20. Ž…Œö–ç (Šá‰È): ‘æ13‰ñBay Ophthalmic Surgical Seminar (2015/10/31), _“ސì.

731160. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z“Á•Êu‰‰…@. ‰F’ÃŒ©‹`ˆê1,2 (1‰¡•lŽsŠá‰Èˆã‰ï, 2Šá‰È): ‘æ13‰ñ‰¡•l—Տ°Šá‰ÈƒVƒ“ƒ|ƒWƒEƒ€ (2015/11/21), _“ސì.

731161. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z‰~‚ðŠÜ‚ß‚œƒIƒLƒ…ƒ‰[ƒT[ƒtƒFƒX‚̍жEÄŒš (—\’è). _’J˜aF (Šá‰È): ‘æ7‰ñOSKA (Ocular Surface Seminar in Kanagawa) (2015/12/3), _“ސì.

732066. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) —ΓàáŽ¡—Â̍l‚Š•û. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ6‰ñSaitama Ophthalmology Seminar (2015/4/4), é‹Ê.

732067. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ŠwZˆã‚Ì’nˆæˆã—Âւ̑Ήž. ‰F’ÃŒ©‹`ˆê1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ128‰ñ_“ސ쌧Šá‰ÈW’k‰ï (‘æ57‰ñ_“ސìˆãŠw‰ï•ª‰È‰ï) (2015/5/24), _“ސì.

732068. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zŠeŽ{Ý‚©‚ç‚Ì”­•\. Žs糋`Í1,2 (1_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È): ‘æ10‰ñ_“ސ쉩”ÁŒ€‹†‰ï (2015/5/30), _“ސì.

732069. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) “–‰@‚É‚š‚¯‚鉩”ÁŽŸŠ³f—Âɂ‚¢‚Ä. “c–ì‹Mr1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠw”MŠC•a‰@, 2Šá‰È): ‘æ10‰ñ_“ސ쉩”ÁŒ€‹†‰ï (2015/5/30), _“ސì.

732070. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“¢˜_‰ï) DME‚̐f’f‚š‚æ‚ÑŽ¡—ÑI‘ðŽˆ. Žs糋`Í1,2, ”’’J@“O2, ŒüŒã“ñ˜Y3, —é–ؐ’O4 (1_“ސ쎕‰È‘åŠw•t‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È, 3¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw•a‰@, 4“ŒŠC‘åŠwˆãŠw•”ê–åf—ÊwŒn): ‘æ10‰ñ_“ސ쉩”ÁŒ€‹†‰ï (2015/5/30), _“ސì.

732071. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) —Տ°_ŒoŠá‰È`–Ÿ“ú‚©‚çŽg‚Š‚éƒRƒc`. ŒãŠÖ—˜–Ÿ (Šá‰È): –kŠC“¹‘åŠwŠá‰ÈƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/6/1), –kŠC“¹.

732072. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) My Career 20/20. Ž…Œö–ç (Šá‰È): ‘æ48‰ñ“¹“ìŠá‰ÈW’k‰ï (2015/6/6), –kŠC“¹.

732073. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) Ž‹×–EŠOß‚Ì•a‹C. Žs糋`Í1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È): ‘æ8‰ñ‰¡•lŠá‰ÈfX˜AŒg‚̉ï (2015/6/12), _“ސì.

732074. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) IFIS‚ÌŒŽˆö‚Ɛ¬ˆö`Ž„‚̏¬‚³‚È’ïR`. ‘å–ìWŽi1,2 (1‘å–ìŠá‰Èˆã‰@, 2Šá‰È): ‘æ8‰ñ‰¡•lŠá‰ÈfX˜AŒg‚̉ï (2015/6/12), _“ސì.

732075. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) _“ސ쎕‰È‚É‚š‚¯‚éŽÎŽ‹Žèp. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ8‰ñ‰¡•lŠá‰ÈfX˜AŒg‚̉ï (2015/6/12), _“ސì.

732076. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) Ç—á’掊 (ŒäÐ‰î—á‚Ì’†‚©‚ç). Œü–ì˜a—Y1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È): ‘æ8‰ñ‰¡•lŠá‰ÈfX˜AŒg‚̉ï (2015/6/12), _“ސì.

732077. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ‰Á—î‚Ƃ̏ãŽè‚Ȃ‚«‚ ‚¢•û. Ž…Œö–ç (Šá‰È): ‘æ65‰ñŠá‰ÈƒZƒ~ƒi[ (Šá‰È—F‚̉ï) (2015/6/14), “Œ‹ž.

732078. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) —˜”AÜ‚ª‘tŒø‚µ‚œ‚ÆŽv‚í‚ê‚錌ŠÇ•a•Ï‚𔺂í‚È‚¢–Ô–ŒF‘fã”甍—£‚Ì1—á. “c–ì‹Mr1,2 (1Šá‰È, 2‘Ûˆã—ÕŸŽƒ‘åŠw”MŠC•a‰@): ‘æ2‰ñAMD Expert Clinical Conference`AMDŽ¡—Âɂš‚¯‚éRVEGF–ò‚Ì–ðŠ„‚ðl‚Š‚é` (2015/7/5), “Œ‹ž.

732079. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z–³…»‘ÌŠá‚É‚š‚¢‚Ä–D’…‚ð•K—v‚Æ‚µ‚È‚¢V‚µ‚¢–Ñ—laŒÅ’èŠá“àƒŒƒ“ƒY‚ÌŒŸ“¢. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ48‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2015/7/9), _“ސì.

732080. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“¢˜_‰ï) ƒI[ƒvƒ““¢˜_‰ï. Žs糋`Í1,2, Œ–{_”V2,3 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È, 3‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@): ‘æ12‰ñ_“ސ쌧Šá‰ÈDMƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/8/1), _“ސì.

732081. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z“ú–{_ŒoŠá‰ÈŠw‰ï”F’èuK‰ï. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ31‰ñ^’߃Zƒ~ƒi[ (_ŒoŠá‰Èh”‘•×‹­‰ï) (2015/8/30), VŠƒ.

732082. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) Å‹ß‚Ì•ÛŒ¯¿‹‚ɂ‚¢‚Ä. Œ–{_”V1,2 (1‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@, 2Šá‰È): Š™‘q‚È‚¬‚³‚̉ï (2015/9/1), _“ސì.

732083. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zFŠo‚Ì‘œ—l«‚ƐF‚̃oƒŠƒAƒtƒŠ[. ‰F’ÃŒ©‹`ˆê1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ6‰ñ_“ސìŠá‰Èˆã—Ï]Ž–ŽÒ•×‹­‰ï|ƒRƒƒfƒBƒJƒ‹, ˆãŽt‚Ý‚ñ‚Ȃ̍u‰‰‰ï| (2015/9/26), _“ސì.

732084. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z_ŒoŠá‰È‚ňµ‚€ŽŸŠ³‚Æ‚»‚ÌŽ¡—Ã. Ží“c–F˜Y1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ6‰ñ_“ސìŠá‰Èˆã—Ï]Ž–ŽÒ•×‹­‰ï|ƒRƒƒfƒBƒJƒ‹, ˆãŽt‚Ý‚ñ‚Ȃ̍u‰‰‰ï| (2015/9/26), _“ސì.

732085. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) _ŒoŠá‰È‚ňµ‚€ŽŸŠ³‚Æ‚»‚ÌŽ¡—Ã. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ6‰ñ_“ސìŠá‰Èˆã—Ï]Ž–ŽÒ•×‹­‰ï|ƒRƒƒfƒBƒJƒ‹, ˆãŽt‚Ý‚ñ‚Ȃ̍u‰‰‰ï| (2015/9/26), _“ސì.

732086. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zV‚µ‚¢Ž‹_ŒoŽŸŠ³‚ÌŽ¡—Â̓W–]|iPS×–E‚ð—p‚¢‚œÄ¶ˆã—ÂƑn–ò|. ‰F’ÃŒ©‹`ˆê1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ16‰ñ_“ސ쌧Šá‰ÈŠwpu‰‰‰ï (2015/9/26), _“ސì.

732087. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z‹³ˆçu‰‰. _’J˜aF (Šá‰È): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

732088. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ”’“àáŽèp‚̃gƒsƒbƒNƒX. ”Ñ“c‰Ã•F (Šá‰È): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

732089. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ŠC˜V–Œ‘‡•a‰@‚É‚š‚¯‚éŽèpŽ¡—Â̎ÀÛ`”’“àá, Šp–ŒˆÚA, —L…»‘ÌŠá“àƒŒƒ“ƒY`. ‘ŠàV‘å•ã1,2 (1ŠC˜V–Œ‘‡•a‰@, 2Šá‰È): ÃŒŠá‰Èˆã‰ïŠwpu‰‰‰ïEƒXƒ^ƒbƒtuK‰ï (2015/10/3), _“ސì.

732090. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) “ü–å_ŒoŠá‰È. ŒãŠÖ—˜–Ÿ (Šá‰È): ÃŒŠá‰Èˆã‰ïŠwpu‰‰‰ïEƒXƒ^ƒbƒtuK‰ï (2015/10/3), _“ސì.

732091. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ”’“àá‚ÆŒŸ‚í‚ê‚œ‚ç. Ž…Œö–ç (Šá‰È): ‘æ14‰ñ–k—¢‘åŠwˆãŠw•”“¯‘‹‰ï@Žs–¯ŒöŠJuÀ (2015/10/10), _“ސì.

732092. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zu‰‰‰ï. Žs糋`Í1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È): ‘æ33‰ñ_“ސ샍[ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒN (KLVN) Œ€C‰ï (2015/10/10), _“ސì.

732093. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) Ž‹_ŒoŽŸŠ³‚ɂ‚¢‚Ä. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ33‰ñ_“ސ샍[ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒN (KLVN) Œ€C‰ï (2015/10/10), _“ސì.

732094. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zŽ‹_ŒoÇ‚Æ‚»‚Ì—ÞŽ—ŽŸŠ³. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ6‰ñÃŒŠá‰ÈƒAƒJƒfƒ~[ (2015/10/14), _“ސì.

732095. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) Ž‹_ŒoÇ‚Æ‚»‚Ì—ÞŽ—ŽŸŠ³. Žs糋`Í1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È): ‘æ6‰ñÃŒŠá‰ÈƒAƒJƒfƒ~[ (2015/10/14), _“ސì.

732096. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z“ïÇ—á‚̐…»‘̍Čšp. Ž…Œö–ç (Šá‰È): ‘æ6‰ñÃŒŠá‰ÈƒAƒJƒfƒ~[ (2015/10/14), _“ސì.

732097. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“¢˜_‰ï)yÀ’·z”’“àáŽèp“Ç—á. —é–ؐ’O1, ”Ñ“c‰Ã•F2 (1“ŒŠC‘åŠw, 2Šá‰È): ‘æ6‰ñƒRƒ‹ƒjƒAƒtƒFƒCƒRƒZƒ~ƒi[ (2015/11/27), _“ސì.

732098. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z‚—îŽÒ—Γàá‚Ì—¯ˆÓ“_‚Æ‚ ‚œ‚炵‚¢–ò•šŽ¡—Ẩ”\«. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ49‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2015/12/10), _“ސì.

732099. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z•œ¬26”N_“ސ쌧’†ŠwZE‚Z‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹µ. Ží“c–F˜Y1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ5‰ñ_“ސ쌧Ž‹”\ŒP—ûŽm‚̉ï (2016/1/23), _“ސì.

732100. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) •œ¬26”N_“ސ쌧’†ŠwZE‚Z‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹µ. ‰F’ÃŒ©‹`ˆê1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ‘æ5‰ñ_“ސ쌧Ž‹”\ŒP—ûŽm‚̉ï (2016/1/23), _“ސì.

732101. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) —Տ°‚ɖ𗧂Ž‹—ÍŒŸž‚̐V‚œ‚ȃAƒvƒ[ƒ`. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): ‘æ5‰ñ_“ސ쌧Ž‹”\ŒP—ûŽm‚̉ï (2016/1/23), _“ސì.

732102. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z–k—¢‘åŠwŠá‰È‚ÌŠe”Ç‚ÌŽæ‚è‘g‚Ý‚ÆŒ»ó. Ž…Œö–ç (Šá‰È): ‘æ12E13‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2016/1/28), _“ސì.

732103. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ŽÎŽ‹E_ŒoŠá‰È‚ɂ‚¢‚Ä. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ12E13‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2016/1/28), _“ސì.

732104. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) Šp–Œ, ‹üÜ‹ž³Žèp‚ɂ‚¢‚Ä. _’J˜aF (Šá‰È): ‘æ12E13‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2016/1/28), _“ސì.

732105. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ”’“àá‚ɂ‚¢‚Ä. ”Ñ“c‰Ã•F (Šá‰È): ‘æ12E13‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2016/1/28), _“ސì.

732106. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) —Γàá‚ɂ‚¢‚Ä. Œ‘ºˆêO (Šá‰È): ‘æ12E13‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2016/1/28), _“ސì.

732107. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) –Ô–ŒÉŽq‘̂ɂ‚¢‚Ä. –ö“c’q•F (Šá‰È): ‘æ12E13‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2016/1/28), _“ސì.

732108. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zOCT‚𕹗p‚·‚éŠá’ê“lje‚ÌŽÀÛ. ŽRì–퐶1,2 (1‘å˜aŽs—§•a‰@, 2Šá‰È): ‘å˜aŽsŠwpu‰‰‰ï (2016/2/3), _“ސì.

732109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z‚ß‚Ü‚¢‚ÆŠáU. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ3‰ñ_“ސ쏬Ž™Šá‰ÈE_ŒoŠá‰ÈƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/2/4), _“ސì.

732110. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·zƒJƒ‰[ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ð‚Æ‚è‚Ü‚­”–â‘è|ƒŒƒ“ƒY‚Ì‘P‚µˆ«‚µ‚ƃ†[ƒU[•Ê‘Ώˆ–@|. ‰F’ÃŒ©‹`ˆê1,2 (1_“ސ쌧Šá‰Èˆã‰ï, 2Šá‰È): ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYƒZƒ~ƒi[EƒCƒ“_“ސì (2016/2/6), _“ސì.

732111. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) “úíRž‚É‚š‚¯‚钍ˆÓ“_. Œ–{_”V1,2 (1‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@, 2Šá‰È): •œ¬27”N“x_“ސ쌧Šá‰Èˆã‰ï@Œ’•Û§˜b‰ï (2016/2/27), _“ސì.

733299. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šáâ|“à‹‘åŠC–ȏ󌌊ǎî‚̈ê—á. ’rã–õŽq1, “c’†rˆê1,2, ’†Œ@Šî1,2, ãb@Šo1, ‚‹Ž”üK1,2, X“c—F”ü1,2, ŒŽ@–r–ç1, ‹Ê’u³Žj1, ŒËª@C1 (1•‘ –ìÔ\Žš•a‰@, 2Šá‰È): ‘æ6‰ñ“Œ‹ž‘œ–€Šá‰È˜AŒgƒZƒ~ƒi[ (2015/4/25), “Œ‹ž.

733300. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘€“ª“®–¬‰Š—l‚̏njó‚ð’悵, Ž‹_Œo–Ô–Œ‰Š—lŠá’ê‚ðŽŠ‚µ‚œ“Á”­«”ìŒú«d–Œ‰Š‚Ì1—á. ‹g“c@Š°1,2, ’†‘º@Ž1, ›’JŒcŽO1 (1“Œ‹ž“s—§_Œo•a‰@, 2Šá‰È): ‘æ6‰ñ“Œ‹ž‘œ–€Šá‰È˜AŒgƒZƒ~ƒi[ (2015/4/25), “Œ‹ž.

733301. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –D’…‚ ‚ꂱ‚ê. ”Ñ“c‰Ã•F (Šá‰È): ‘æ5‰ñƒRƒ‹ƒjƒAƒtƒFƒCƒRƒZƒ~ƒi[ (2015/5/21), _“ސì.

733302. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá“àƒŒƒ“ƒY•ÎˆÊÇ—á‚Ì”wŒiˆöŽq‚ÌŒŸ“¢. ”Ñ“c‰Ã•F1, Ž…Œö–ç1, ²“¡M”V1, “V–엝Œb1, íœAr‘Ÿ˜Y1, ”Ñ“‡@Œh2, ŠFì—FŒ›1 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ7‰ñ_“ސìŠá‰ÈŠw‰ï (2015/5/24), _“ސì.

733303. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá“àƒŠƒ“ƒpŽî‚ð‹^‚¢ÉŽq‘ÌŽèp‚ðŽ{s‚µ‚œÇ—á‚ÌŒŸ“¢. ’Ò‘ò’C•F1, ŽO‘îr”V1, ”’’J@“O1, –ö“c’q•F1, Ž…Œö–ç1 (1Šá‰È): ‘æ7‰ñ_“ސìŠá‰ÈŠw‰ï (2015/5/24), _“ސì.

733304. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z‰‰‘è6-11. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ7‰ñ_“ސìŠá‰ÈŠw‰ï (2015/5/24), _“ސì.

733305. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒŒŠÇV¶—Γàá‚É‚š‚¯‚éTrabeculectomy‚ÆEX-PRESSҗ¯’up‚Ì”äŠr. ‰Í–ì—Y—º1, Š}ŒŽ³s1, Œ‘ºˆêO1, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ7‰ñ_“ސìŠá‰ÈŠw‰ï (2015/5/24), _“ސì.

733306. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá‹ØŒ^dÇ‹Ø–³—͏ǂɂæ‚閃ა«ŠOŽÎŽ‹‚ɑ΂µ, ã‰º’Œ‹Ø‘S•ˆÚ“®p (Œ“c–@) ‚ª—LŒø‚Å‚ ‚Á‚œˆê—á. —Žˆä‰‘Žq1, ŒãŠÖ—˜–Ÿ2, Îì@‹Ï3, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3ˆã—Éq¶Šw•”): ‘æ7‰ñ_“ސìŠá‰ÈŠw‰ï (2015/5/24), _“ސì.

733307. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) …áv«Šp–ŒÇ‚ɑ΂·‚é‘S‘wŠp–ŒˆÚAp‚ÆŠp–Œ“à”çˆÚAp‚̏pŒã3”N‚̐¬Ñ”äŠr. —ÑŽ›@Œ’1, “¿—¯r•F1, ‹{•‰‘y‰î1, X@—mÄ1,2, Žq“‡—Ç•œ1,2, ‹{“c˜a“T1 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ85‰ñ‹ãBŠá‰ÈŠw‰ï (2015/5/29), Ž­Ž™“‡.

733308. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šp–ŒˆÚAŒã‚ÌŠá•\–Ê‚ÆŽ‹‹@”\. ¬‹Ž‰p’· (Šá‰È): ƒ€ƒRƒXƒ^“_Šá‰t”­”„3Žü”Nu‰‰‰ï (2015/6/11), _“ސì.

733109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒOƒ‰ƒiƒeƒbƒN“_Šá‰t0.4%‚ÌŽg—pŒoŒ±|‘åŠw•a‰@‹Î–±ˆã‚Ì—§ê‚©‚ç|. –Ø‘º“TŒh (Šá‰È): —ΓàáŽ¡—Âɂš‚¯‚éROCK‘jŠQ–ò‚ðl‚Š‚é‰ï (2015/7/8), _“ސì.

733310. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰ºŒü‚«“ªˆÊ‚ÅŠááىº‚‚ªoŒ»‚·‚éˆê—á. ”Ñ“‡@ˆ»1, ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, Ž…Œö–ç1, ‹v{”ü^—3 (1Šá‰È, 2ˆã—Éq¶Šw•”, 3”]ŠO): ‘æ31‰ñ^’߃Zƒ~ƒi[ (_ŒoŠá‰Èh”‘•×‹­‰ï) (2015/8/29), VŠƒ.

733311. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹ßÔŠO•ªŒõ–@‚ÌŠá‰È—̈æ‚ւ̉ž—p. Šâ“c@—y1, ’r“c“N–ç2, ”Œ“c’m–ç3, Îì@‹Ï3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3ˆã—Éq¶Šw•”): ‘æ31‰ñ^’߃Zƒ~ƒi[ (_ŒoŠá‰Èh”‘•×‹­‰ï) (2015/8/29), VŠƒ.

733312. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œð’ÊŠOŒã‚Ì’²ßáŠQ‚ÉBlood PatchŽ¡—ª—LŒø‚Å‚ ‚Á‚œ1—á. ”Ÿº‹±Žq1, ŽRã–ŸŽq1,2, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2, Îì@‹Ï3, ‚‹Ž_ˆê4 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3ˆã—Éq¶Šw•”, 4ŽR‰€•a‰@): ‘æ31‰ñ^’߃Zƒ~ƒi[ (_ŒoŠá‰Èh”‘•×‹­‰ï) (2015/8/29), VŠƒ.

733313. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒŽˆö•s–Ÿ‚ÌŽ‹_ŒoˆÞk‚Ń~ƒgƒRƒ“ƒhƒŠƒADNA•ÏˆÙ‚ð”F‚ß‚œ¬Ž™‚Ì1—á. Šâ²^‹|1, Vˆä‚ä‚è‚ 1, ŽRã–ŸŽq1,2, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ31‰ñ^’߃Zƒ~ƒi[ (_ŒoŠá‰Èh”‘•×‹­‰ï) (2015/8/30), VŠƒ.

733314. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zˆê”ʉ‰‘è. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

733315. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) IOLŒÅ’荢“ïÇ—á‚ɑ΂·‚éSulcus-subcapsular fixation ‚̗Տ°¬Ñ. ’Ò‘ò’C•F1, Ž…Œö–ç1, Î“c@‹Å1, ²“¡M”V1, ”Ñ“c‰Ã•F1 (1Šá‰È): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

733316. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ã‰ªŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[ŠJ‰@‚©‚ç13”NŠÔ‚Ì‘Š‡. ”–؍LÆ1,2, Ž…Œö–ç2 (1Ã‰ªŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

733317. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚ÆŠÖ˜A•a‰@‚É‚š‚¯‚é–¢nŽ™–Ô–ŒÇ‚̐f—ЬÑ. ’r“c“N–ç1, —Žˆä‰‘Žq2, Î“c@‹Å1, ŒãŠÖ—˜–Ÿ1, Îì@‹Ï3, Ž…Œö–ç1 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

733318. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚ð—p‚¢‚œ‘S‘wŠp–ŒˆÚA‚Æ•\‘wŠp–ŒˆÚA‚̗Տ°¬Ñ. ¬‹Ž‰p’·1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1 (1Šá‰È): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

733319. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) p‘OŠáˆ³•Ê‚É•ª‚¯‚œƒgƒ‰ƒxƒNƒg[ƒ€Žèp‚̐¬Ñ. Š}ŒŽ³s1, ¯ŽiMs2, Œ‘ºˆêO1, ‰Í–ì—Y—º1, –Ø‘º“TŒh1, •ÄŽR@—È1, X“c“N–ç1,3, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”, 3–k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

733320. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚é‰ß‹Ž5”NŠÔ‚Ì—ôEŒŽ«–Ô–Œ”—£‚̏pŒã¬Ñ. ”Ñ“‡@ˆ»1, –ö“c’q•F1, ”’’J@“O1, ŠFì—FŒ›1, ‹àŽRr‰î1, Ž…Œö–ç1 (1Šá‰È): ‘æ51‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސì.

733321. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) RTNF-ƒ¿ƒ‚ƒmƒNƒ[ƒiƒ‹R‘ÌŽ¡—ÃŒo‰ß’†‚É”]Š²•a•Ï‚É‚æ‚éãŽÎ‹Ø–ƒŒ‚ð”F‚ß‚œ1—á. Žs糋`Í1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN, 2Šá‰È): Infliximab Conference on Behcet Disease2015 (2015/10/2), “Œ‹ž.

733322. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zˆê”ʉ‰‘è/“Á•Êu‰‰. —é–؍N”V1, ¯ŽiMs2 (1“ŒŠC‘åŠw, 2ˆã—Éq¶Šw•”): ‘æ13‰ñBay Ophthalmic Surgical Seminar (2015/10/31), _“ސì.

733323. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá“àƒŒƒ“ƒY–D’…pÇ—á‚Ì”wŒiˆöŽq‚ÆŽèp‚̍H•v. ”Ñ“c‰Ã•F (Šá‰È): ‘æ13‰ñBay Ophthalmic Surgical Seminar (2015/10/31), _“ސì.

733324. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŽèpI—¹Žž‚̊ሳ•Ê‚É•ª‚¯‚œƒgƒ‰ƒxƒNƒg[ƒ€Žèp‚Ì’ZŠú¬Ñ. ’Ò‘ò’C•F1, Š}ŒŽ³s1, ¯ŽiMs2, Œ‘ºˆêO1, –Ø‘º“TŒh1, ‹àŽRr‰î1, X“c“N–ç1, •ÄŽR@—È1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ32‰ñ_“ސ쌧—Γàá’k˜b‰ï (2016/2/13), _“ސì.

733325. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Sˆö«Ž‹ŠoáŠQ‚Ɗ펿«_ŒoŠá‰ÈŽŸŠ³. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ8‰ñ_“ސìƒNƒƒXƒI[ƒo[ƒVƒ“ƒ|ƒWƒEƒ€ (2016/3/19), _“ސì.


Žš•@ˆôA‰ÈŠw

[Šwp˜_•¶]

110294. [ŒŽ’˜] A case of atypical teratoid/rhabdoid tumor in the internal auditory canal. Yamaguchi T1, Oka H2, Kijima C, Sano H3, Watanabe H1, Okamoto M1: Auris Nasus Larynx 2015/4; 42 (2): 163-6. (ŽRŒû’mŽq1, ‰ª@GG2, ²–ì@”£3, “n•Ó—T”V1, ‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO, 2”]ŠO, 3ˆã—Éq¶Šw•”)

110295. [ŒŽ’˜] One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control? Nakayama M1, Miyamoto S1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1, Okamoto M1: Jpn J Clin Oncol. 2015 /8; 45 (8): 732-7. (’†ŽR–Ÿm1, ‹{–{r•ã1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, ’·’J•”³”V1, ‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO)

120060. [ŒŽ’˜]yU40ƒVƒ“ƒ|ƒWƒEƒ€9: Larynx/Pharynx/Esophagusz“–‰@‚É‚š‚¯‚éŒoŒû“I“àŽ‹‹Ÿ‰ºŽèp‚̗Տ°“IŒŸ“¢. ‰Á”[Fˆê1, ‹{–{r•ã1, ’†ŽR–Ÿm1, Œ˜“ce—˜2, Ž–ì—R”y1, ‰ª–{—·l1 (1Žš•@ˆôAE“ªèòŠO, 2Á‰»Ší“à):“ªèò•”Šà 2015/10; 41 (3): 339-42.

310031. [Ç—á•ñ] Congenital mucocele of the gland Bandin-Nuhn. Ochiai A1, Nakayama M1: Oxf Med Case Reports 2015/12; 2015 (12): 374-5. (—Ž‡@“Ö1, ’†ŽR–Ÿm1: 1Žš•@ˆôAE“ªèòŠO)

310032. [Ç—á•ñ] Remarkably improved intractable otitis media by treatment in accordance with clinical practice guidelines for the diagnosis and management of acute otitis media in children: a case report. Ochiai A1, Suzuki T1: Kitasato Med J 2016/3; 46 (1): 81-5. (—Ž‡@“Ö1, —é–Ø—§r1: 1Žš•@ˆôAE“ªèòŠO)

310033. [Ç—á•ñ] Endoscopic sinus surgery under the navigation system for a frontal sinus cyst: a case report. Ochiai A1, Suzuki T1: Kitasato Med J 2016/3; 46 (1): 86-90. (—Ž‡@“Ö1, —é–Ø—§r1: 1Žš•@ˆôAE“ªèòŠO)

320039. [Ç—á•ñ] ‘œ”­«_Œo–ƒáƒ‚𗈂µ‚œ¬Ž™ˆôŒã”^ᇂÌ1—á. ‘匎‘ìÆ1, ‰ª–{—·l1, ’·À‰p–Ÿ2, –q@“ÖŽq1, “ߐ{–ì’qŒõ1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): “ú–{Žš•@ˆôA‰ÈŠw‰ï‰ï•ñ 2015/5; 118 (5): 657-61.

320040. [Ç—á•ñ] Œ‹Šj‚É‚æ‚èèòÃ–¬ÇŒóŒQ‚š‚æ‚Ñ”ìŒú«d–Œ‰Š‚ð’悵‚œ1—á. ‹{–{r•ã1, ’†ŽR–Ÿm1, ‰ª–{—·l1 (1Žš•@ˆôAE“ªèòŠO): A“ª 2015/12; 27 (2): 108-13.

320041. [Ç—á•ñ] ŠO•@ÄŒšp‚ðŽ{s‚µ‚œ’Ž‚—î•@oŠà—á. ‰Á”[Fˆê1, ‹{–{r•ã1, ’†ŽR–Ÿm1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): Žš•@ˆôA‰È—Տ° 2016/1; 109 (1): 35-40.

522158. [uÀ]y“ÁW: ÅV‚Ì•â’®Šíf—Á|•â’®Ší‚É‚æ‚é’®ŠoƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“z‚±‚ê‚©‚ç•â’®ŠíŠO—ˆ‚ð‚Í‚¶‚ß‚é‚œ‚ß‚É. ²–ì@”£ (Žš•@ˆôAE“ªèòŠO): Žš•@ˆôA‰ÈE“ªèò•”ŠO‰È 2015/4; 87 (4): 294-301.

522159. [uÀ]y“ÁW: “àŽ‹‹ŸŽ¡—Á|“à‰È‚ÆŠO‰È‚̃Rƒ‰ƒ{ƒŒ[ƒVƒ‡ƒ“zŠe˜_@Žš•@ˆôA‰È‚ƏÁ‰»Ší“à‰È‚̘AŒg‚É‚æ‚éˆô“ª•\ÝŠà‚ɑ΂·‚éELPS. ‰Á”[Fˆê1, ‰ª–{—·l1, Œ˜“ce—˜2, ˆêŒË¹–Ÿ3, ’†ŽR–Ÿm1, ‹{–{r•ã1, Ž–ì—R”y1, ˜a“c‘ñ–ç2, “c糁@‘4 (1Žš•@ˆôAE“ªèòŠO, 2Á‰»Ší“à, 3•a—, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): Á‰»Ší“àŽ‹‹Ÿ 2015/9; 27 (9): 1506-12.

522160. [uÀ]y‘æ29‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€zA“ªŠà‚Ì‹@”\‰·‘¶Ž¡—Á|‰»Šw•úŽËü—Ö@‚ƍA“ªˆŸ‘S“Eop‚Ì–ðŠ„|. ŒÃ–؏Ȍá1, ‹{–{r•ã1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, ’†ŽR–Ÿm1 (1Žš•@ˆôAE“ªèòŠO): –k—¢ˆãŠw 2015/12; 45 (2): 109-12.

[’˜@‘]

620116. [Šwp‘] (•ª’SŽ·•M)y“Ë”­«“ï’®update (ENTONI No.183)z“Ë”­«“ï’®‚ƃXƒgƒŒƒX, p. 51-7. “n•Ó—T”V1, ²–ì@”£2 (1Žš•@ˆôAE“ªèòŠO, 2ˆã—Éq¶Šw•”), •Ò: ˆÉ“¡²‹I, ‘S“ú–{•a‰@o”ʼnï,“Œ‹ž, 2015/8”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712030. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Supracricoid laryngectomy: 17 years' experience in Japan. Nakayama M1, Miyamoto S1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1: World Congress on Larynx Cancer 2015 (2015/6/26-30), Cairns, Australia. (’†ŽR–Ÿm1, ‹{–{r•ã1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, ’·’J•”³”V1: 1Žš•@ˆôAE“ªèòŠO)

712031. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Transoral surgeries for s uperficial hypopharyngeal cancers. Nakayama M1: 16th Japan-Korea Joint meeting of Otorhinolaryngology-Head and neck Surgery (2016/3/29), Tokyo. (’†ŽR–Ÿm1: 1Žš•@ˆôAE“ªèòŠO)

713106. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The Transitions of Treatment and Survival of Patients with Hypopharyngeal Carcinoma During 43 Years. Miyamoto S1, Nakayama M1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1, Hayakawa K2, Okamoto M1: ‘æ39‰ñ“ú–{“ªèò•”ŠàŠw‰ïE‘æ4‰ñƒAƒWƒA“ªèò•”ŠàŠw‰ï (2015/6/4), _ŒË. (‹{–{r•ã1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, ’·’J•”³”V1, ‘ì˜ad2, ‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO, 2•úŽËü (Žîá‡))

713107. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) “àŽ‹‹Ÿ“IˆôA“ªŽèp (ELPS) ‚Ì“K‰ž‚ÆŒÀŠE. ‰ª–{—·l1, ’†ŽR–Ÿm1, Œ˜“ce—˜2, ‹{–{r•ã1, ‰Á”[Fˆê1, Ž–ì—R”y1, ×–ì_Žj1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO, 2Á‰»Ší“à): ‘æ39‰ñ“ú–{“ªèò•”ŠàŠw‰ïE‘æ4‰ñƒAƒWƒA“ªèò•”ŠàŠw‰ï (2015/6/4), _ŒË.

713108. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘O‰»Šw—Ö@‚É‚æ‚è•a—Šw“ICR‚ª“Ÿ‚ç‚ê‚œ’†ˆô“ª‘€•ÇŠà‚Ì2Ç—á. ’·’J•”³”V1, ‹{–{r•ã1, ‰Á”[Fˆê1, ‰ª–{—·l1, Ž–ì—R”y1, ’†ŽR–Ÿm1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): ‘æ39‰ñ“ú–{“ªèò•”ŠàŠw‰ïE‘æ4‰ñƒAƒWƒA“ªèò•”ŠàŠw‰ï (2015/6/4), _ŒË.

713109. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) One Hundred Supracricoid Laryngectomies with Cricohyoidoepiglottopexy. Nakayama M1, Miyamoto S1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1: ‘æ39‰ñ“ú–{“ªèò•”ŠàŠw‰ïE‘æ4‰ñƒAƒWƒA“ªèò•”ŠàŠw‰ï (2015/6/5), _ŒË. (’†ŽR–Ÿm1, ‹{–{r•ã1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, ’·’J•”³”V1: 1Žš•@ˆôAE“ªèòŠO)

713110. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Clinical Study of Transoral Endoscopic Pharyngeal Surgery. Kano K1, Miyamoto S1, Nakayama M1, Katada C2, Seino Y1, Okamoto T1, Okamoto M1: ‘æ39‰ñ“ú–{“ªèò•”ŠàŠw‰ïE‘æ4‰ñƒAƒWƒA“ªèò•”ŠàŠw‰ï (2015/6/5), _ŒË. (‰Á”[Fˆê1, ‹{–{r•ã1, ’†ŽR–Ÿm1, Œ˜“ce—˜2, Ž–ì—R”y1, ‰ª–{—·l1, ‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO, 2Á‰»Ší“à)

713111. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Persistent Symptoms patients with Idiopathic Sudden Sensorineural Hearing Loss. Sano H1, Watanabe H2, Ino T2, Maki A2, Nakagawa T2, Okamoto M2: 3rd Congress of European ORL-HNS (2015/6/7-11), Prague, Czech Republic. (²–ì@”£1, “n•Ó—T”V2, ’–@Œ’Žu2, –q@“ÖŽq2, ’†ì‹Mm2, ‰ª–{–ql2: 1ˆã—Éq¶Šw•”, 2Žš•@ˆôAE“ªèòŠO)

713112. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Invertigation of Status Against Stress Load Before Onset of Idiopathic Sudden Sensorineural Hearing Loss. Watanabe H1, Sano H2, Maki A1, Ino T1, Ono Y, Nakagawa T1, Okamoto M1: 3rd Congress of European ORL-HNS (2015/6/7-11), Prague, Czech Republic. (“n•Ó—T”V1, ²–ì@”£2, –q@“ÖŽq1, ’–@Œ’Žu1, ¬–ì—Yˆê, ’†ì‹Mm1,‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO, 2ˆã—Éq¶Šw•”)

713113. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Anti-Leukotriene Strategy by Endoscopic Sinussurgery. Yamaguchi T1, Ishii T1, Yamamoto K, Okamoto M1: 3rd Congress of European ORL-HNS (72015/6/7-11), Prague, Czech Republic. (ŽRŒû’mŽq1, Îˆä–L‘Ÿ1, ŽR–{ˆê”Ž, ‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO)

713114. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Arandomized Double-Blind,Placebo-Controlled Clinical Trial to Evalute the Efficacy of Hangekobokuto in Adult Patients with Chronic Tinnitus. Ino T1, Odaguchi H, Wakasugi A, Sano H2, Watanabe H1, Okamoto M1, Hoshi K3, Hanawa T4: 3rd Congress of European ORL-HNS (72015/6/7-11), Prague, Czech Republic. (’–@Œ’Žu1, ¬“cŒû_, Žá™ˆÀŠó”T, ²–ì@”£2, “n•Ó—T”V1, ‰ª–{–ql1, ¯@‰À–F3, ‰Ô—Öšæ•F4: 1Žš•@ˆôAE“ªèòŠO, 2ˆã—Éq¶Šw•”, 3‰q¶, 4“Œ—mˆãŠw‹³ˆç)

713115. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Prognosis and laryngeal preservation of supraglottic cancer versus glottic cancer. Miyamoto S1, Nakayama M1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1, Okamoto M1: World Congress on Larynx Cancer 2015 (2015/6/26-30), Cairns, Australia. (‹{–{r•ã1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, ’·’J•”³”V1, ‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO)

713116. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Long-term swallowing outcome and displacement of preserved larynx after supracricoid laryngectomy with cricohyoidepiglotto-pexy. Seino Y1, Nakayama M1, Miyamoto S1, Kano K1, Okamoto M1: World Congress on Larynx Cancer 2015. 2015.6.26-30. Cairns, Australia. (Ž–ì—R”y1, ’†ŽR–Ÿm1, ‹{–{r•ã1, ‰Á”[Fˆê1, ‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO)

713117. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Two cases of laryngeal schwannoma resected by different approaches. Kano K1, Miyamoto S1, Nakayama M1, Seino Y1, Hasebe M1, Okamoto M1: World Congress on Larynx Cancer 2015 (2015/6/26-30), Cairns, Australia. (‰Á”[Fˆê1, ‹{–{r•ã1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ’·’J•”³”V1, ‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO)

713118. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) A case that is superficial HPC resected by hybrid approaches. Hasebe M1, Miyamoto S1, Kano K1, Okamoto T1, Nakayama M1, Okamoto M1: World Congress on Larynx Cancer 2015 (2015/6/26-30), Cairns, Australia. (’·’J•”³”V1, ‹{–{r•ã1, ‰Á”[Fˆê1, ‰ª–{—·l1, ’†ŽR–Ÿm1, ‰ª–{–ql1: 1Žš•@ˆôAE“ªèòŠO)

713119. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Actions to be taken for foreign children with hearing loss. Maki A1, Sano H2, Nakagawa T1, Yamashita T1: 16th Japan-Korea Joint Meeting of Otolaryngology-Head and Neck Surgery (2016/3/28-30), Tokyo. (–q@“ÖŽq1, ²–ì@”£2, ’†ì‹Mm1, ŽR‰º@‘ñ1: 1Žš•@ˆôAE“ªèòŠO, 2ˆã—Éq¶Šw•”)

722194. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) “ªèò•”Šà‚ɑ΂·‚é’áNPŽ¡—Â̐V“WŠJ|A“ªŠà: ‰»Šw•úŽËü—Ö@‚ÌŽž‘ã‚É‚š‚¯‚éA“ªˆŸ‘S“Eop‚̈ʒu‚¯|. ’†ŽR–Ÿm (Žš•@ˆôAE“ªèòŠO): ‘æ116‰ñ“ú–{Žš•@ˆôA‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/5/20-23), “Œ‹ž, “ú–{Žš•@ˆôA‰ÈŠw‰ï‰ï•ñ 2015/10; 118: 1204-11.

722195. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) ‹qŠÏ“I•]‰¿–@FAQ: •@ŒÄ‹z¶—‚Ì—‰ð‚Æ‹qŠÏ“I•]‰¿–@‚̉ž—p. ‘å–ØŠ²•¶ (Žš•@ˆôAE“ªèòŠO): ‘æ54‰ñ“ú–{•@‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/3), L“‡.

722196. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) A“ªˆŸ‘S“Eop: pŒã”­º‚̃ƒJƒjƒYƒ€. ’†ŽR–Ÿm (Žš•@ˆôAE“ªèòŠO): ‘æ60‰ñ“ú–{‰¹ºŒŸŒêˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/15), –ŒŒÃ‰®.

723867. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆÙ‚È‚é•û–@‚Ő؏œ‚µ‚œA“ª_ŒoâŽî‚Ì2—á. ‰Á”[Fˆê1, ‹{–{r•ã1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{—·l1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): ‘æ27‰ñ“ú–{A“ª‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/4/9), “Œ‹ž.

723868. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚é”ñº–åŒ^A“ªŠà‚ɑ΂·‚鎡—ЬÑ. ‹{–{r•ã1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): ‘æ27‰ñ“ú–{A“ª‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/4/9), “Œ‹ž.

723869. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) š‹‰ºŽž’ɂ𔺂€èò’Å‘Ocx‘эœ‰»Ç‚É‚š‚¢‚ÄŽèpŽ¡—ª—LŒø‚Å‚ ‚Á‚œˆêÇ—á. Ž–ì—R”y1, —é–Ø—§r1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): ‘æ27‰ñ“ú–{A“ª‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/4/10), “Œ‹ž.

723870. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ºˆô“ªŠà‚Ì“àŽ‹‹Ÿf’f•û–@‚̍H•v. ‰ª–{—·l1, ×–ì_Žj1, ’†ŽR–Ÿm1, ‹{–{r•ã1, ‰Á”[Fˆê1, Ž–ì—R”y1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): ‘æ27‰ñ“ú–{A“ª‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/4/10), “Œ‹ž.

723871. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@ŒûŠW—ôƒ`[ƒ€f—Âɂš‚¯‚鎚•@ˆôA‰ÈŽóf‚ɂ‚¢‚Ä‚ÌŒŸ“¢. –q@“ÖŽq1, ‘匎‘ìÆ1, –Ø‘ºŽé—¢1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): ‘æ10‰ñ“ú–{¬Ž™Žš•@ˆôA‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/5/8), Œyˆä‘ò.

723872. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚鏬Ž™‹CŠÇØŠJÇ—á‚ÌŒŸ“¢. –Ø‘ºŽé—¢1, ‘匎‘ìÆ1, –q@“ÖŽq1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): ‘æ10‰ñ“ú–{¬Ž™Žš•@ˆôA‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/5/8), Œyˆä‘ò.

723873. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™‡–°Žž–³ŒÄ‹zÇŒóŒQ‚É‚š‚¯‚éOSA-18“ú–{Œê”Å‚Ì—L—p«‚ÌŒŸ“¢. ‘匎‘ìÆ1, –q@“ÖŽq1, –Ø‘ºŽé—¢1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): ‘æ10‰ñ“ú–{¬Ž™Žš•@ˆôA‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/5/9), Œyˆä‘ò.

723874. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical Study of Transoral Endoscopic Pharyngeal Surgery. ‰Á”[Fˆê1, ‹{–{r•ã1, ’†ŽR–Ÿm1, Œ˜“ce—˜2, Ž–ì—R”y1, ‰ª–{—·l1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO, 2Á‰»Ší“à): ‘æ39‰ñ“ú–{“ªèò•”ŠàŠw‰ïE‘æ4‰ñƒAƒWƒA“ªèò•”ŠàŠw‰ï (2015/6/3-6), _ŒË, “ªèò•”Šà 2015/5; 41 (2): 155.

723875. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “àŽ‹‹Ÿ“IˆôA“ªŽèp (ELPS) ‚Ì“K‰ž‚ÆŒÀŠE. ‰ª–{—·l1, ’†ŽR–Ÿm1, Œ˜“ce—˜2, ‹{–{r•ã1, ‰Á”[Fˆê1, Ž–ì—R”y1, ×–ì_Žj1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO, 2Á‰»Ší“à): ‘æ39‰ñ“ú–{“ªèò•”ŠàŠw‰ïE‘æ4‰ñƒAƒWƒA“ªèò•”ŠàŠw‰ï (2015/6/3-6), _ŒË, “ªèò•”Šà 2015/5; 41 (2): 197.

723876. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ã‚É”­¶‚µ‚œ_ŒoâŽîÇ—á. ’†ì‹Mm1, ’†ŽR–Ÿm1, ‰Á”[Fˆê1, –àŽR•Û1, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO): ‘æ77‰ñŽš•@ˆôA‰È—Տ°Šw‰ï‘‰ïEŠwpu‰‰‰ï (2015/6/25), •lŒ.

723877. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ESS‚É•K—v‚È”S–ŒØŠJŽè‹Z‚ÌŠî–{‚Ɖž—p. —é–Ø—§r1, –àŽR•Û1, —é–؈»Žq1, ‰ª–{–ql1, ‘å–ØŠ²•¶1 (1Žš•@ˆôAE“ªèòŠO): ‘æ54‰ñ“ú–{•@‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/3), L“‡.

723878. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ZŒ^•›•@o^‹ÛÇ‹^‚¢—á‚ւ̑Ήž|Ž©Œ±—á‚©‚ç‚̍lŽ@|. –àŽR•Û1, —é–Ø—§r1, —é–؈»Žq1, ‰ª–{–ql1, ‘å–ØŠ²•¶1 (1Žš•@ˆôAE“ªèòŠO): ‘æ54‰ñ“ú–{•@‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/3), L“‡.

723879. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •@ŒÄ‹záŠQ‚ÆŒûo“àŠ£‘‡‚Æ‚ÌŠÖŒW‚ɂ‚¢‚ÄŒŸ“¢. ‘å–ØŠ²•¶1, ’†ÀŽ‘ŽÀ1 (1Žš•@ˆôAE“ªèòŠO): ‘æ54‰ñ“ú–{•@‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/3), L“‡.

723880. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚éRamsay HuntÇŒóŒQ‚̐…“—‘яóáv]R‘̉¿‚̐„ˆÚ‚ÆŠç–ʐ_Œo–ƒáƒ‚Ì—\Œã. ŽRŒû’mŽq1, ²–ì@”£2, ‰ª–{–ql1 (1Žš•@ˆôAE“ªèòŠO, 2ˆã—Éq¶Šw•”): ‘æ25‰ñ“ú–{Žš‰ÈŠw‰ï‘‰ïŠwpu‰‰‰ï (2015/10/7-10), ’·è.

723881. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÏk«‘€õd‰»Ç (ALS) ‚Ìš‹‰º“àŽ‹‹ŸŒŸž‚ÌŒŸ“¢. ×–ì_Žj1, Ž–ì—R”y1, ˆÀ“cØ•ä, á–{—R”ü, ‹gàVŒ’‘Ÿ˜Y, •Ÿ“c—Ï–ç2 (1Žš•@ˆôAE“ªèòŠO, 2ˆã—Éq¶Šw•”): ‘æ60‰ñ“ú–{‰¹ºŒŸŒêˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/16), –ŒŒÃ‰®.

723882. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) A“ªˆŸ‘S“Eop‚É‚š‚¯‚éš‹‰ºŽž‚̐Vº–å‹@”\. Ž–ì—R”y1, ’†ŽR–Ÿm1, ‹{–{r•ã1, —é–Ø—§r1, ‰Á”[Fˆê1 (1Žš•@ˆôAE“ªèòŠO): ‘æ60‰ñ“ú–{‰¹ºŒŸŒêˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/16), –ŒŒÃ‰®.

723883. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —v‰îŒì‚—îŽÒ‚Ì’®Šo•]‰¿|’®—ÍŒŸž|. ˆäã—ŠG, —é–ØŒbŽq1, ”~ŒŽKŒb, `@ŽáØ1, Ž…@•œ, ²–ì@”£1, ‰ª–{–ql2 (1ˆã—Éq¶Šw•”, 2Žš•@ˆôAE“ªèòŠO): ‘æ60‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/22), “Œ‹ž.

723884. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —v‰îŒì‚—îŽÒ‚Ì’®Šo•]‰¿|‰îŒìEˆõ‚Ì“ï’®”FŽ¯‚Ɖî“ü‘O‚̑Ήž|. —é–ØŒbŽq1, ˆäã—ŠG, ”~ŒŽKŒb, `@ŽáØ1, Ž…@•œ, ²–ì@”£1, ‰ª–{–ql2 (1ˆã—Éq¶Šw•”, 2Žš•@ˆôAE“ªèòŠO): ‘æ60‰ñ“ú–{’®ŠoŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/22), “Œ‹ž.

723885. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éŒãŠú‚—îŽÒ‚Ì•â’®Ší‘•—p‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ”~ŒŽKŒb, ˆäã—ŠG, —é–ØŒbŽq1, ŒŽ@—R‹I1, ’†ì‹Mm2, –q@“ÖŽq2, ²–ì@”£1 (1ˆã—Éq¶Šw•”, 2Žš•@ˆôAE“ªèòŠO): ‘æ60‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/22), “Œ‹ž.

723886. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •â’®Ší•Ð‘€‘•—p‚É‚æ‚é’®—̓Œƒxƒ‹‚ƌꉹ–Ÿ—Ä“x‚̕ω»‚ÉŠÖ‚·‚錟“¢. ’†ì‹Mm1, –q@“ÖŽq1, ˆäã—ŠG, ”~ŒŽKŒb, —é–ØŒbŽq2, ŒŽ@—R‹I2, ²–ì@”£2 (1Žš•@ˆôAE“ªèòŠO, 2ˆã—Éq¶Šw•”): ‘æ60‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/22), “Œ‹ž.

723887. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒyE’†“™“x“ï’®‚ɑ΂·‚é•â’®Šíw“ü•¬§“x‚ð—˜—p‚µ‚œ¬Ž™Ç—á‚ÌŒŸ“¢. –q@“ÖŽq1, ˆäã—ŠG, ”~ŒŽKŒb, ’†ì‹Mm1, ŒŽ@—R‹I2, —é–ØŒbŽq2, ²–ì@”£2 (1Žš•@ˆôAE“ªèòŠO, 2ˆã—Éq¶Šw•”): ‘æ60‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/10/23), “Œ‹ž.

723888. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œo•@‚—¬—ÊŽ_‘f“Š—^ (Nasal High FlowTM) Žg—pŠ³ŽÒ‚Ìš‹‰º•]‰¿‚ƑΉž. —é–Ø—§r1, Ž–ì—R”y1, ×–ì_Žj1, V“c‹`—m1 (1Žš•@ˆôAE“ªèòŠO): ‘æ67‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2015/11/19), •Ÿ“‡.

723889. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž©‘î—×{‚É‚æ‚èÛHš‹‰ºáŠQ‚̉ü‘P‚ª‚Ý‚ç‚ê‚œ”F’mÇŠ³ŽÒ‚Ì1—á. V“c‹`—m1, —é–Ø—§r1, Ž–ì—R”y1, ×–ì_Žj1 (1Žš•@ˆôAE“ªèòŠO): ‘æ67‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2015/11/19), •Ÿ“‡.

723890. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž•‚ÌŠš‚ݕȂ̏C³‚É‚æ‚è‰ü‘P‚µ‚œCostenÇŒóŒQ—á. —Ž‡@“Ö1, “¿‘Œú“ñ, ’†ì‹M”V1, ’·À‰p–Ÿ2 (1Žš•@ˆôAE“ªèòŠO, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ74‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/11/26), Šò•Œ, Equilibrium Res (—\eW) 2015; 74 (5): 472.

723891. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “àŽšáŠQ‚ƃXƒgƒŒƒX‚ÌŠÖ˜A«‚̉𖟁|Inositol trisphosphate receptor type|1ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚Ì’®ŠoáŠQ. ’·À‰p–Ÿ1, Ö“¡—Yˆê˜Y, ‰ÍŒŽŽ‰ë2, ‰ª–{–ql3, “¿‘Œú“ñ, ŒäŽqŽÄŽ•F (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2¶—, 3Žš•@ˆôAE“ªèòŠO): ‘æ74‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2015/11/27), Šò•Œ, Equilibrium Res (—\eW) 2015; 74 (5): 435.

723892. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠO‰È“IŽ¡—Âðs‚Á‚œ—Œ‘€ˆÙŽž«‹¹œŠÖß”^ᇏǗá. ‰Á”[Fˆê1, ‹{–{r•ã1, ’†ŽR–Ÿm1, –àŽR•Û1, Ž–ì—R”y1, ‰ª–{—·l1 (1Žš•@ˆôAE“ªèòŠO): ‘æ26‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2016/1/28), –ŒŒÃ‰®.

723893. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “àŽ‹‹Ÿ‰º—֏óˆô“ª‹ØØ’fp‚ðŽ{s‚µ‚œ‘œ”­«‹Ø‰Š‚É‚æ‚éš‹‰ºáŠQ‚Ì1Ç—á. Ž–ì—R”y1, —é–Ø—§r1, ’·’J•”³”V1, ’†ŽR–Ÿm1 (1Žš•@ˆôAE“ªèòŠO): ‘æ26‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2016/1/28), –ŒŒÃ‰®.

723894. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Supracricoid Laryngectomy‚̏pŒãŠŽõ‚ðŒž­‚³‚¹‚é‚œ‚ß‚Ì—¯ˆÓ“_. ‹{–{r•ã1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, –àŽR•Û1 (1Žš•@ˆôAE“ªèòŠO): ‘æ26‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2016/1/29), –ŒŒÃ‰®.

723895. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •›ˆô“ªŠÔŒ„Œs“Ë‘O‹æ‚̗ǐ«Žîᇂɑ΂·‚épŽ®‚ɂ‚¢‚Ä‚ÌŒŸ“¢. –àŽR•Û1, ‹{–{r•ã1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, ’†ŽR–Ÿm1 (1Žš•@ˆôAE“ªèòŠO): ‘æ26‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2016/1/29), –ŒŒÃ‰®.

723896. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–ƒZƒ“ƒ^[‚É‚š‚¯‚é•›ˆô“ªŠÔŒ„Žîá‡114—á‚ÌŒŸ“¢. Œ–؁@’1, ŽO‰YO‹K, ‘œ“c—Yˆê˜Y, ‘•£’B•v, •šŒ©ç’ˆ, ’––“@“O, ›–ìçŒh, ‰ª–{ˆÉì (1Žš•@ˆôAE“ªèòŠO): ‘æ26‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‘‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï. (2016/1/29), –ŒŒÃ‰®.

733326. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È“ï’®f—Â̌»‹µ. ’†ì‹Mm (Žš•@ˆôAE“ªèòŠO): ‘Š–ÍŒŽŽš•@‰Èˆã‰ï (2015/6/18), ‘Š–Í‘å–ì.

733327. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚鏬Ž™èò•””^ᇂ̌Ÿ“¢. ‘匎‘ìÆ (Žš•@ˆôAE“ªèòŠO): ‘æ9‰ñ‘Š–ÍŒŽDRIAOMSu‰‰‰ï (2015/6/30), ’¬“c.

733328. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ï‹É“I‚ȊɘaƒPƒA‚ðŽ{s‚µ‚œbó‘Bàh–EŠà‚̈ê—á. ’·’J•”³”V1, ’†ŽR–Ÿm1, ’ç@ãĕœ1, ‰Á”[Fˆê1, ‰ª–{—·l1, Ž–ì—R”y1, ‹{–{r•ã1 (1Žš•@ˆôAE“ªèòŠO): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï ‘æ171‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2015/7/11), ‰¡•l.

733329. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éÆŽËŒãÄ”­—á‚ɑ΂·‚铪•”ŠsŽp. ‰Á”[Fˆê (Žš•@ˆôAE“ªèòŠO): ‘æ28‰ñ_“ސ쌧Žš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŽèpŽè‹ZŒ€‹†‰ï (2015/7/16), ‰¡•l.

733330. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “ªèò•”EH“¹“¯Žž«d•¡Šà‚ɑ΂·‚鎡—Â̌ã•ûŽ‹“IŒŸ“¢. ‰ª–{—·l (Žš•@ˆôAE“ªèòŠO): ‘æ32‰ñEGMRŒ€‹†‰ï (2015/7/17), “Œ‹ž.

733331. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •@•›•@oŽèpÇ—á‚É‚š‚¯‚éDŽ_‹…«•›•@o‰Š‚ÌŒŸ“¢. —é–؈»Žq1, ‰iˆä_–€1, ’ç@ãĕœ1, —é–Ø—§r1 (1Žš•@ˆôAE“ªèòŠO): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ172‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2015/9/5), ‰¡•l.

733332. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘ŠúŠOØŠJ‚ª—LŒø‚Å‚ ‚Á‚œ•s‰Âèò•””^ᇂÌ2Ç—á. V“c‹`—m1, Ž–ì—R”y1, ’ç@ãĕœ1, ’†ŽR–Ÿm1 (1Žš•@ˆôAE“ªèòŠO): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ172‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2015/9/5), ‰¡•l.

733333. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™‚Ì•@ƒAƒŒƒ‹ƒM[‚Ɛ‡–°áŠQ. ‘å–ØŠ²•¶ (Žš•@ˆôAE“ªèòŠO): ‘æ1‰ñŒ§‰›’nˆæŽš•@ˆôA‰ÈŒ€‹†‰ï (2015/11/11), –k–{.

733334. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚̐f—Â̌»ó. ‘å‹ŽŒ’‘Ÿ˜Y (Žš•@ˆôAE“ªèòŠO): ‘æ1‰ñŒ§‰›’nˆæŽš•@ˆôA‰ÈŒ€‹†‰ï (2015/11/11), –k–{.

733335. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™‚̐‡–°Žž–³ŒÄ‹z‚ɂ‚¢‚Ä. ‘匎‘ìÆ (Žš•@ˆôAE“ªèòŠO): ‘Š–ÍŒŽŽš•@‰Èˆã‰ïŠwpu‰‰‰ï (2015/11/12), ’¬“c.

733336. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •›ˆô“ªŠÔŒ„Œs‘O‹æ‚Ì‘œŒ`‘BŽî‚ɑ΂·‚épŽ®‚ɂ‚¢‚Ä. –àŽR•Û1, ‹{–{r•ã1, Ž–ì—R”y1, ‰ª–{—·l1, ‰Á”[Fˆê1, ’·’J•”³”V1, ’†ŽR–Ÿm1 (1Žš•@ˆôAE“ªèòŠO): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ173‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2015/12/5), ‰¡•l.

733337. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™ˆô“ªŠO‚̗Տ°“IŒŸ“¢. ’ç@ãĕœ1, ‘匎‘ìÆ1, ’·’J•”³”V1, ’†ŽR–Ÿm1 (1Žš•@ˆôAE“ªèòŠO): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ173‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2015/12/5), ‰¡•l.

733338. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) p‘Of’f‚É‹ê—¶‚µ‚œ•@oŽîᇂÌ1—á. –Ø‘ºŽé—¢1, “n•Ó—T”V1, ’–@Œ’Žu1 (1Žš•@ˆôAE“ªèòŠO): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ173‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2015/12/5), ‰¡•l.

733339. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚鏬Šw¶‚̃ƒjƒG[ƒ‹•a. —Ž‡@“Ö1, ’†ì‹M”V1, ’·À‰p–Ÿ2 (1Žš•@ˆôAE“ªèòŠO, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ17‰ñ_“ސì‚ß‚Ü‚¢ƒtƒH[ƒ‰ƒ€ (2016/2/4), ‰¡•l.

733340. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒAƒŒƒ‹ƒM[«•@‰ŠŽ¡—Â̍ŐV“®Œü. —é–Ø—§r (Žš•@ˆôAE“ªèòŠO): Alergy Forum in Sagamihara`ƒfƒBƒŒƒOƒ‰”­”„3Žü”N‹L”Ou‰‰‰ï (2016/2/18), ’¬“c.

733341. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒfƒBƒŒƒOƒ‰”z‡ù‚ÌŽg—pŒoŒ±‚ɂ‚¢‚Ä. ’–@Œ’Žu (Žš•@ˆôAE“ªèòŠO): Alergy Forum in Sagamihara`ƒfƒBƒŒƒOƒ‰”­”„3Žü”N‹L”Ou‰‰‰ï (2016/2/18), ’¬“c.

733342. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) —Œ‘€lH“àŽš–„‚ߍž‚ݏp‚ðs‚Á‚œ¬Ž™—á‚Ì’·ŠúŒo‰ß. –q@“ÖŽq1, ²–ì@”£2, ’†ì‹Mm1, ŽR‰º@‘ñ1 (1Žš•@ˆôAE“ªèòŠO, 2ˆã—Éq¶Šw•”): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ174‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2015/3/26), ‰¡•l.

733343. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒoH“¹SƒGƒR[‚É‚æ‚鉺ˆô“ªŠO‚̈ê—á. ŒÃ–؏Ȍá1, ‰iˆä_–€1, ŽR‰º@‘ñ1 (1Žš•@ˆôAE“ªèòŠO): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ174‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2015/3/26), ‰¡•l.


ž_‰ÈŠw

[Šwp˜_•¶]

110296. [ŒŽ’˜] Epileptogenesis and epileptic maturation in phosphorylation site-specific SNAP-25 mutant mice. Watanabe S1, Yamamori S2, Otsuka S, Saito M3, Suzuki E, Kataoka M, Miyaoka H3, Takahashi M2: Epilepsy Research 2015/9; 115: 30-44. (“n•Ó@Ž 1, ŽRX‘D2, âV“¡³”Í3, ‹{‰ª@“™3, ‚‹Ž³g2: 1¶•š•š—Œn, 2¶‰», 3ž_)

110297. [ŒŽ’˜] Social skills training improves clinical residents' communication skills. Yutani M, Takahashi M1, Takizawa T, Miyaoka H1: Kitasato Med J 2016/3; 46 (1): 53-9. (–û’JŒ³‹K, ‚‹Ž@Œb1, ‘êàV‹B–î, ‹{‰ª@“™1: 1ž_)

120061. [ŒŽ’˜] ”F’mÇŠ³ŽÒ‚ɑ΂·‚鎕‰Èf—Â̍¢“‚Æ‚»‚Ì”wŒi—vˆö‚ÉŠÖ‚·‚錀‹†. ‰º‘º—TŒ©Žq, ‘åÎ@’q1, œA‰ªF—z1, ‚‹Ž@Œb1, ‹{‰ª@“™1 (1ž_): “ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŽ 2015/6; 17 (2): 116-22.

120062. [ŒŽ’˜] ’nˆæ‚̉‡•E‚ªŠŽ‚¶‚Ä‚¢‚é”F’mÇƒPƒA‚ðŽÀ‘H‚·‚éã‚ł̉ۑè‚Æ‚»‚Ì”wŒi—vˆö‚ÉŠÖ‚·‚錀‹†|‘Š–ÍŒŽŽs‚̃Aƒ“ƒP[ƒg’²ž‚©‚çlŽ@‚·‚é|. ‰º‘º—TŒ©Žq, ‘åÎ@’q1, œA‰ªF—z1, ‚‹Ž@Œb1, ‹{‰ª@“™1 (1ž_): “ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŽ 2016/3; 18 (1): 10-8.

521026. [‰ðà]yŽ¿‹^‰ž“šzProÌPro [ž_‰È] ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•š‚É‚š‚¯‚éí—p—ʈˑ¶‚ÌŒ`¬‹@˜. àVŽR@“§ (ž_): “ú–{ˆãŽ–V•ñ 2015/9; 4769: 63-4.

522161. [uÀ]y—Տ°ŒŸžƒJƒŒƒbƒW: ”F’mÇz”F’mÇ‚Ì‘Šúf’f‚ɖ𗧂”]”g. âV“¡³”Í (ž_): ˆã—ÂƌŸž‹@Ší¥ŽŽ–ò 2015/6; 38 (3): 295-9.

522162. [uÀ]y“Á•ÊŠé‰æ: ˆË‘¶‚ÆšnD|‚â‚ß‚ç‚ê‚È‚¢S—zS—E‚Ö‚ÌŠú‘Ò. ‹{‰ª@“™ (ž_): ‚±‚±‚ë‚̉Ȋw 2015/7; 182: 1.

522163. [uÀ]y“Á•ÊŠé‰æ: ˆË‘¶‚ÆšnD|‚â‚ß‚ç‚ê‚È‚¢S—zŠ—¶—TŽi, ‹{‰ª@“™1 (1ž_): ‚±‚±‚ë‚̉Ȋw 2015/7; 182: 11.

522164. [uÀ]y“Á•ÊŠé‰æ: ˆË‘¶‚ÆšnD|‚â‚ß‚ç‚ê‚È‚¢S—zˆË‘¶Ç‚Æšn•ÈáŠQ@ƒAƒ‹ƒR[ƒ‹ˆË‘¶Ç‚̐S—‚Æ‚»‚ÌŽx‰‡. àVŽR@“§ (ž_): ‚±‚±‚ë‚̉Ȋw 2015/7; 182: 32-6.

522165. [uÀ]y“ÁW: ŽŒø«’ŽË»Ü‚̈Ӌ`Älz“ÁW‚É‚ ‚œ‚Á‚Ä. ‹{‰ª@“™ (ž_): ž_‰ÈŽ¡—Êw 2015/7; 30 (7): 865.

522166. [uÀ]y“ÁW: ŽÀ’n“à‰Èˆã‚ð–K‚ê‚é‘Œ‰È‚ÌŽŸŠ³‚Ì“úíf—ÂƑΏˆ–@|‚»‚Ì1 (¬Ž™‰ÈEž_‰ÈE”畆‰ÈE®Œ`ŠO‰È)zŠe˜_: ŽÀ’n“à‰Èˆã‚̐f—ÂƐê–åˆã‚Ƃ̘AŒg‚ÌŽÀÛ‚Æ—¯ˆÓ“_@ž_‰ÈŽŸŠ³: ƒAƒ‹ƒR[ƒ‹ˆË‘¶Ç. àVŽR@“§ (ž_): Medical Practice 2015/8; 32 (8): 1307-12.

522167. [uÀ]y“ÁW: Ž©•ÂÇƒXƒyƒNƒgƒ‰ƒ€áŠQ‚̗Տ°‚ð–â‚€|Œ©Žž‚í‚ê‚œž_—Ö@“IŽ‹“_z<‘æ1•”: ž_—Ö@“IŽ‹“_>@‘ål‚ÌŽ©•ÂÇƒXƒyƒNƒgƒ‰ƒ€áŠQ‚̐ž_‰Èˆã—Á|Ž¡—Âɂ‚Ȃª‚é–ʐځ|. ‹{‰ª@“™ (ž_): ž_—Ö@ 2015/8; 41 (4): 14-8.

522168. [uÀ]y˜AÚ: “à‰Èˆã‚ª’m‚Á‚Ä‚š‚­‚ׂ«ž_ŽŸŠ³‚Ì’mŽ¯z‘Ì‚ª‚Ÿ‚é‚­‚Ä, “f‚«‹C‚ª‚·‚é‚ñ‚Å‚·. ‚²”Ñ‚àH‚ׂç‚ê‚È‚¢‚Ì‚Å, “_“H‚µ‚ĉº‚³‚¢. àVŽR@“§ (ž_): “à‰È 2015/9; 116 (3): 511-6.

522169. [uÀ]y“ÁW: Ž¡—Âði‚ß‚éã‚Å‚Ì•aŽ¯, •aŠŽIIz¬Ž™‚Ì”­’BáŠQ‚É‚š‚¢‚Ä•aŽ¯‚ðŠl“Ÿ‚³‚¹‚邱‚Ƃ̐¥”ñ‚ð‚ß‚®‚Á‚Ä. ˆäãŸ•v (ž_): ž_‰ÈŽ¡—Êw 2015/10; 30 (10): 1315-20.

522170. [uÀ]y“ÁW: ƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x‚Ì‹`–±‰»‚ƐEê‚̃ƒ“ƒ^ƒ‹ƒwƒ‹ƒXz‹³ˆõ‚̃ƒ“ƒ^ƒ‹ƒwƒ‹ƒX‚̉ۑè‚ÆŽæ‚è‘g‚Ý. ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_): ž_‰ÈŽ¡—Êw 2016/1; 31 (1): 89-94.

522171. [uÀ]y‘æ15‰ñˆã—ÃtƒH[ƒ‰ƒ€ƒŒƒ|[ƒg ‰ºz’nˆæ•ïŠ‡ƒPƒAŽž‘ã‚É‚š‚¯‚é”F’mÇ’nˆæ˜AŒgƒNƒŠƒeƒBƒJƒ‹ƒpƒXˆã—ÁE‰îŒì‚Ì‚±‚ê‚©‚ç‚Ì’ª—¬. ‰º‘º—TŒ©Žq, ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_): ƒƒfƒBƒJƒ‹ƒNƒI[ƒ‹ 2016/2; 255: 26-30.

540054. [‚»‚Ì‘Œ]y’n•û‰ï•ñ: “Œ‹žž_ˆãŠw‰ï‘æ103‰ñŠwpW‰ïz‰º‚‘Ì‘BŽî‚ð‡•¹‚µ‚œdÇ‚€‚•a‚̏Ǘá‚É‚š‚¯‚éC³Œ^“d‹C‚¯‚¢‚ê‚ñ—Ö@. “n糁@Œ÷1, —›@‰p_1, âV“¡³”Í1, ‹{‰ª@“™1 (1ž_): ž__ŒoŠwŽGŽ 2015/11; 117 (11): 941.

[Šw‰ïEŒ€‹†‰ï“™]

721019. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) yŽi‰ïz‚¢‚Ì‚¿‚ɂ‚¢‚čl‚Š‚é. ˆäãŸ•v (ž_): ‘æ33‰ñ“ú–{Â”NŠúž_—Ö@Šw‰ï‘‰ï (2015/11/28), ”ª‰€Žq.

722197. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ž_ˆãŠw‚ƃƒfƒBƒAƒŠƒeƒ‰ƒV[. ‹{‰ª@“™ (ž_): ‘æ111‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2015/6/4), ‘åã.

722198. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰)yŽi‰ïz‚€‚•a‚Ì–ò•š—Ö@‚̏”–â‘è. ˆäãŸ•v (ž_): “ú–{ŽvtŠúÂ”NŠúž_ˆãŠw‰ï‘æ28‰ñ‘å‰ï (2015/7/12), ‰¡•l.

722199. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ‚€‚•a‚Ì–ò•š—Ö@‚̏”–â‘è. ‹{‰ª@“™ (ž_): “ú–{ŽvtŠúÂ”NŠúž_ˆãŠw‰ï‘æ28‰ñ‘å‰ï (2015/7/12), ‰¡•l.

722200. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒPƒAƒ}ƒl[ƒWƒƒ[‚©‚猩‚œˆã—ÂƉîŒì‚̘AŒgƒc[ƒ‹‚Æ‚µ‚Ä‚Ì”F’mÇ’nˆæ˜AŒgƒNƒŠƒjƒJƒ‹ƒpƒX. ‰i–ìŒb”üŽq, –{‘œ—], ‘åÎ@’q1, –؉º—æŽq1, ’†‘º“Þ“Þ, ‰º‘º—TŒ©Žq, ‹{‰ª@“™1 (1ž_): ‘æ16‰ñ“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŠwpW‰ï (2015/11/14), ‰YˆÀ.

722201. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) _“ސ쌧‚̐ž_‰È‹~‹}ˆã—ÂƉü³ž_•ÛŒ’•ŸŽƒ–@|–â‘è“_‚ƑΉž|. ‹{‰ª@“™ (ž_): ‘æ23‰ñ“ú–{ž_‰È‹~‹}Šw‰ïŠwp‘‰ï (2015/12/11), –ŒŒÃ‰®.

723897. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) í—p—Ê‚Ìnortriptyline•ž—p’†‚ɐž_‰^“®”­ì‚ð‚«‚œ‚µ‚œˆê—á. ‹Ž–{@Ž÷1, ‰ÄŽR@‘ì2, ‹{’nLŒá1, ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_, 2’nˆæŽ™“¶ž_): ‘æ111‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2015/6/4), ‘åã.

723898. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw“Œ•a‰@‚É‚š‚¯‚é_Œo«–³H—~Ç‚Ì“ü‰@s“®§ŒÀ—Ö@‚ÌŽÀ‘Ô. ŽRŠp@Œ\1, ‹Ž–{¹–õ1, —Lˆä_ˆê1, ŸNˆäGŽ÷1, ‚‹ŽŒb—1, ˆäãŸ•v1, Ö“¡³”Í1, ‹{‰ª@“™1 (1ž_): ‘æ111‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2015/6/5), ‘åã.

723899. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _“ސ쌧‘Š–ÍŒŽŽs‚É‚š‚¯‚é”F’mÇ’nˆæ˜AŒgƒpƒX‚ÌŒ»ó‚Ɖۑè. ›I@‘P‹M1, ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_): ‘æ111‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2015/6/6), ‘åã.

723900. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ’íŽÒ‚š‚æ‚ÑŒy“x”F’máŠQŠ³ŽÒ‚É‚š‚¯‚é”F’m‹@”\‚̉Á—•Ï‰»‚ɂ‚¢‚Ä. ÎˆäŒõŽ÷, ‚‹Ž@Œb1, ‘êàV‹B–î2, ‘åÎ@’q1, Vˆä‹v–«3, ‹{‰ª@“™1 (1ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‹~–œ): ‘æ30‰ñ“ú–{˜V”Nž_ˆãŠw‰ï (2015/6/13), ‰¡•l.

723117. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –œˆø‚«‚ðŒJ‚è•Ô‚µ‚œ’jŽ™‚ɂ‚¢‚Ă̗Տ°“IlŽ@|ŒÂl—Ö@‚ƉƑ°ƒAƒvƒ[ƒ`‚Æ‚¢‚€Ž‹“_|. ¬—ÑŽÀ‰Ô1, _’Jr‰î1, ¶’n@V2, ˆäãŸ•v3 (1’nˆæŽ™“¶ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ž_): “ú–{ŽvtŠúÂ”NŠúž_ˆãŠw‰ï‘æ28‰ñ‘å‰ï (2015/7/11), ‰¡•l.

723901. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Rey-Osterrieth@•¡ŽG}Œ`ŒŸž|”œ‰ž}‚Ì—ÞŒ^‰»‚Æ”­’BáŠQŽåf’f‚Æ‚ÌŠÖ˜A|. ˆäãŸ•v1, ŽÄ@—æŽq, ˜a“c^—Žq, ‹{‰ª@“™1 (1ž_): ‘æ56‰ñ“ú–{Ž™“¶Â”Nž_ˆãŠw‰ï‘‰ï (2015/9/30), ‰¡•l.

723902. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)yŽi‰ïz’nˆæ˜AŒg@Žx‰‡. ˆäãŸ•v (ž_): ‘æ56‰ñ“ú–{Ž™“¶Â”Nž_ˆãŠw‰ï‘‰ï (2015/9/30), ‰¡•l.

723903. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ž_•aÇó‚ð‡•¹‚µ‚œdÇ_Œo«‚₹Ç‚Ì2Ç—á. –k–ƒŠóŽq1, —Lˆä_ˆê1, ‚‹ŽŒb—1, ‹{‰ª@“™1 (1ž_): ‘æ19‰ñ“ú–{ÛHáŠQŠw‰ïŠwpW‰ï (2015/10/24), •Ÿ‰ª.

723118. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’áƒiƒgƒŠƒEƒ€ŒŒÇ‚É”º‚€ö—ó‘Ô‚ð‹^‚í‚ê‚œ1Ç—á|ƒŠƒGƒ]ƒ“ƒ`[ƒ€‚̈Ӌ`|. _’Jr‰î1, ”’ˆä‹³Žq, ŽO‰Yƒ]2, ¬—ÑŽÀ‰Ô1, ˆäãŸ•v2, ‹{‰ª@“™2 (1’nˆæŽ™“¶ž_, 2ž_): ‘æ28‰ñ“ú–{‘‡•a‰@ž_ˆãŠw‰ï‘‰ï (2015/11/28), “¿“‡.

731162. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚€‚•a: –ò•š—Ö@ˆÈ‘O‚ɍl‚Š‚é‚ׂ«‚±‚Æ. ‹{‰ª@“™ (ž_): ‘æ32‰ñˆ€•QŒ§ž__ŒoŠw‰ï (2015/6/13), ŒŽR.

731163. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Eˆæ‚É‚š‚¯‚é‚€‚•a‚Æ‚»‚ÌŽü•Ó‚ւ̑Ήž. ‹{‰ª@“™ (ž_): ŽY‹Æƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXŒ€C‰ï (•Ÿ“‡ˆãŽt‰ïEˆÉ’BˆãŽt‰ïEˆÀ’BˆãŽt‰ï) (2016/2/12), •Ÿ“‡.

731164. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŒŽˆö‚ÌŒ©‚‚©‚ç‚È‚¢’ɂ݂̍l‚Š•û‚ƑΉž. ‹{‰ª@“™ (ž_): ‘æ43‰ñ•ºŒÉŒ§ž_ˆã—Êwpu‰‰‰ï (2016/3/12), _ŒË.

732112. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçƒZƒ~ƒi[) ’m”\E”F’m‚Ì”­’B‚Æ’m”\ŒŸž. ˆäãŸ•v (ž_): ‘æ17‰ñ“ú–{¬Ž™ž_ˆãŠwŒ€‹†‰ï (2015/8/21), _ŒË.

732113. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) R‚Ä‚ñ‚©‚ñ–ò‚̏ˆ•û•ÏX‚ɂ‚¢‚Ä âV“¡³”Í (ž_): ‘Š–ÍŒŽ’†–k•”‚Ì‚Ä‚ñ‚©‚ñŽ¡—Âðl‚Š‚é‰ï (2015/11/17), ‘Š–ÍŒŽ.

732114. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ‘ål‚Ì”­’BáŠQ‚Ƃ́H`Šî–{“I‚È—‰ð‚ƑΉž‚ÌŽd•û‚ɂ‚¢‚ā`. ‹{‰ª@“™ (ž_): •œ¬27”N“x”DPEoŽYŽx‰‡‘̐§‚­‚莖‹ÆŒ€C‰ï _“ސ쌧Œú–Ø•ÛŒ’•ŸŽƒŽ––±Š‘å˜aƒZƒ“ƒ^[ (2016/2/3), ‘å˜aŽs.

732115. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·zž_‰ÈƒŠƒGƒ]ƒ“ƒ`[ƒ€‚Ì—L—p«‚ɂ‚¢‚ā`ŠeŽ{Ý‚ÌŽæ‚è‘g‚݂ƍ¡Œã‚̉ۑè. ŽR–{Œ«Ži, ‹{’n‰p—Y1 (1ž_): ‘æ42‰ñ_“ސ쌧SgˆãŠw‰ï‘‰ï‚š‚æ‚ÑŠwpW‰ï (2016/3/5), ‰¡•l.

732116. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) S—–Ê‚É”z—¶‚µ‚œ–ʐڂƐž_—Ö@. ‹{‰ª@“™ (ž_): ‘æ42‰ñ_“ސ쌧SgˆãŠw‰ïŠwp‘‰ï‚š‚æ‚ÑŠwpW‰ï (2016/3/5), ‰¡•l.

732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ž_‰ÈƒŠƒGƒ]ƒ“ƒ`[ƒ€‚Ì—L—p«‚ɂ‚¢‚ā`ŠeŽ{Ý‚ÌŽæ‚è‘g‚݂ƍ¡Œã‚̉ۑè. _’Jr‰î (’nˆæŽ™“¶ž_): ‘æ42‰ñ_“ސ쌧SgˆãŠw‰ï‘‰ï‚š‚æ‚ÑŠwpW‰ï (2016/3/5), ‰¡•l.

733344. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒp[ƒLƒ“ƒ\ƒ“•a‚Ɛf’f‚³‚ê‚œ–òÜ«‘ÌŠO˜HÇó. ˆäã•üŽq1, ‰ÄŽR@‘ì2, ‹{‰ª@“™1 (1ž_, 2’nˆæŽ™“¶ž_): “Œ‹žž_ˆãŠw‰ï‘æ104‰ñŠwpW‰ï (2015/7/4), “Œ‹ž.

733345. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹CŽ¿•ª—Þdifficult child‚ƍl‚Š‚ç‚ê‚œ¬Šw¶—Ž™‚ÌŽ¡—ÃŒo‰ß. ˆäãŸ•v (ž_): ‘æ64‰ñ_“ސ쎙“¶Â”Nž_ˆãŠwŒ€‹†‰ï (2015/7/11), ‰¡•l.

733346. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ÛHš‹‰º‚Ì–â‘è‚ÅŽ•‰Èê–åŠO—ˆ‚ðŽóf‚µ‚œŽ™“¶‚ɑ΂·‚鐞_‰Èˆã‚Ì‚©‚©‚í‚è‚ɂ‚¢‚Ä. ‹{’n‰p—Y1, ŽR–{¹’Œ, ‘å‹v•Û^ˆß (1ž_): ‘æ41‰ñ_“ސ쌧SgˆãŠw‰ï‘‰ï‚š‚æ‚ÑŠwpW‰ï (2015/9/26), ‰¡•l.

733347. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) m-ECT‚ðŽÀŽ{‚µ‚œ‹‘å‚­‚à–Œ‚Ì‚€–E‚ð‡•¹‚µ‚œdÇ‚€‚•aÇ—á. ‹Ž–{¹–õ1, ‰ÄŽR@‘ì2, ‹{’nLŒá1, ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_, 2’nˆæŽ™“¶ž_): “Œ‹žž_ˆãŠw‰ï‘æ105‰ñŠwpW‰ï (2015/11/14), “Œ‹ž.

733348. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Rbó‘BŽ©ŒÈR‘Ì—z«‚ð‚µ‚ß‚µ‚œŽYåñŠúž_•a‚Ì1—á. ‘º™@–G1, ³–؍—Ñ1, ›I@‘P‹M1, ‹g‘º—LŠó1, ‰ÄŽR@‘ì2, ‹{’nLŒá1, ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_, 2’nˆæŽ™“¶ž_): “Œ‹žž_ˆãŠw‰ï‘æ105‰ñŠwpW‰ï (2015/11/14), “Œ‹ž.

733349. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”­Ç‚©‚玡—ÊJŽn‚Ü‚Å‚ÉŽžŠÔ‚ð—v‚µ‚œ_Œo”~“Å‚Ì1—á. ‹g‘º—LŠó1, ›I@‘P‹M1, ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_): “Œ‹žž_ˆãŠw‰ï‘æ105‰ñŠwpW‰ï (2015/11/14), “Œ‹ž.

733350. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÔŒ‡«”š”­Ç‚ª‹^‚í‚ê‚œ¬Šw¶—Ž™‚ÌŽ¡—ÃŒo‰ß. ˆäãŸ•v (ž_): ‘æ29‰ñ“ú–{¬Ž™ž_ˆãŠwŒ€‹†‰ï (2016/2/27), ‘å’Ã.

733351. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ—l‚Ȑž_Çó‚ð’悵, ƒrƒ^ƒ~ƒ“B12Œ‡–R«”]Ç‚ð‹^‚Á‚œ1—á. ¬àV@Šî1, ›I@‘P‹M1, ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_): “Œ‹žž_ˆãŠw‰ï‘æ106‰ñŠwpW‰ï (2016/3/12), “Œ‹ž.


•úŽËü‰ÈŠw (‰æ‘œf’fŠw)

[Šwp˜_•¶]

110298. [ŒŽ’˜] Methods of CT Dose Estimation in Whole-Body 18F-FDG PET/CT. Inoue Y1, Nagahara K2, Tanaka Y2, Miyatake H2, Hata H2, Hara T1: J Nucl Med 2015/5; 56 (5): 695-700. ( ˆäã—D‰î1, ‰iŒŽ˜aŒ›2, “c’†’õl2, ‹{•”ä˜CŽ÷2, `@”Ž•¶2, ŒŽ@•q«1: 1•úŽËü (‰æ‘œ), 2•úŽËü•”)

110299. [ŒŽ’˜] Effect of the Energy Window Width on the Estimation of Renal Function from Dynamic Renal Scintigraphy with 99mTc-MAG3. Asano Y1, Ohzeki Y2, Inoue Y1: Open J Med Imaging 2015/6 ; 5 (2): 37-41. (ó–ì—Y“ñ1, ‘åŠÖ—T‰î2, ˆäã—D‰î1: 1•úŽËü (‰æ‘œ), 2•úŽËü•”)

110300. [ŒŽ’˜] Assessment of MRI Contrast Agent Kinetics via Retro-Orbital Injection in Mice: Comparison with Tail Vein Injection. Wang F1,2, Nojima M3, Inoue Y4, Ohtomo K5, Kiryu S1: PLoS One 2015/6; 10 (6): e0129326. (ˆäã—D‰î4: 1“Œ‹ž‘åŠw, 2ŽR“Œ‘åŠw (’†‘), 3“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š, 4•úŽËü (‰æ‘œ), 5“Œ‹ž‘åŠw‘åŠw‰@)

110301. [ŒŽ’˜] Validity of the mediastinum as a reference region to evaluate cardiac accumulation of iodine-123 metaiodobenzylguanidine. Inoue Y1, Abe Y2, Asano Y1, Kikuchi K2: Ann Nucl Med 2015/8; 29 (7): 650-7. (ˆäã—D‰î1, ˆ¢•”@–L2, ó–ì—Y“ñ1, ‹e’r@Œh2: 1•úŽËü (‰æ‘œ), 2•úŽËü•”)

110302. [ŒŽ’˜] MONITORING DOSE-LENGTH PRODUCT IN COMPUTED TOMOGRAPHY OF THE CHEST CONSIDERING SEX AND BODY WEIGHT. Inoue Y1, Nagahara K2, Hayakawa N2, Hanawa H2 , Hata H2: Radiat Prot Dosimetry 2015/9. pii: ncv401. [Epub ahead of print] (ˆäã—D‰î1, ‰iŒŽ˜aŒ›2, ‘ì’Œ“¹2, ”·@G“T2, `@”Ž•¶2: 1•úŽËü (‰æ‘œ), 2•úŽËü•”)

110303. [ŒŽ’˜] Source analysis of stimulus-preceding negativity constrained by functional magnetic resonance imaging. Kotani Y1, Ohgami Y1, Ishiwata T2, Arai J3, Kiryu S4, Inoue Y5: Biol Psychol 2015/10; 111: 53-64. (ˆäã—D‰î5: 1“Œ‹žH‹Æ‘åŠw, 2—§‹³‘åŠw, 3ƒ_ƒCƒLƒ“H‹ÆŠ”Ž®‰ïŽÐ, 4“Œ‹ž‘åŠw, 5•úŽËü (‰æ‘œ))

110304. [ŒŽ’˜] Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial. Suzuki H1, Inoue Y2, Fujimoto H3, Yonese J4, Tanabe K5, Fukasawa S6, Inoue T7, Saito S8, Ueno M9, Otaka A10: Jpn J Clin Oncol 2016/2; 46 (2): 152-62. (ˆäã—D‰î2: 1“Œ–M‘åŠwˆã—ÃZƒ“ƒ^[²‘q•a‰@”å”AŠí‰È, 2•úŽËü (‰æ‘œ), 3‘—§‚ª‚ñŒ€‹†ƒZƒ“ƒ^[”å”AŠí‰È, 4Œö‰và’c–@l‚ª‚ñŒ€‹†‰ï—L–Ÿ•a‰@”å”AŠí‰È, 5“Œ‹ž—Žqˆã‰È‘åŠw•a‰@t‘Ÿ•a‘‡ˆã—ÃZƒ“ƒ^[”å”AŠí‰È, 6ç—tŒ§‚ª‚ñƒZƒ“ƒ^[”å”AŠí‰È, 7‰¡•lŽs—§‘åŠw•‘®•a‰@”å”AŠí‰È, 8“Æ—§s­–@l‘—§•a‰@‹@\“Œ‹žˆã—ÃZƒ“ƒ^[”å”AŠí‰È, 9é‹Êˆã‰È‘åŠw‘Ûˆã—ÃZƒ“ƒ^[”å”AŠíŽîᇉÈ, 10“ú–{ƒƒWƒtƒBƒWƒbƒNƒXŠ”Ž®‰ïŽÐ)

511001. [‰ðà] Interventional radiology for critical hemorrhage in obstetrics: Japanese Society of Interventional Radiology (JSIR) procedural guidelines. Sone M1, Nakajima Y2, Woodhams R3, Shioyama Y4, Tsurusaki M5, Hiraki T6, Yoshimatsu M2, Hyodoh H7, Kubo T8, Takeda S9, Minakami H10: Jpn J Radiol 2015/4; 33 (4): 233-40. (ƒEƒbƒhƒnƒ€ƒX—æŽq3: 1‘—§‚ª‚ñŒ€‹†ƒZƒ“ƒ^[’†‰›•a‰@•úŽËüf’f‰È, 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠwˆãŠw•”•úŽËüˆãŠw, 3•úŽËü (‰æ‘œ), 4àՋŠˆã‰È‘åŠw•úŽËüˆãŠwuÀ, 5‹ß‹E‘åŠwˆãŠw•”•úŽËüˆãŠwuÀ•úŽËüf’fŠw, 6‰ªŽR‘åŠwˆãŠw•”•úŽËüˆãŠw, 7ŽD–yˆã‰È‘åŠwˆãŠw•”•úŽËüf’fŠw, 8‘—§¬ˆçˆã—ÃŒ€‹†ƒZƒ“ƒ^[ŽüŽYŠúE•ê«f—ÃZƒ“ƒ^[ŽY‰È, 9‡“V“°‘åŠwˆãŠw•”ŽY•wl‰ÈŠwuÀ, 10–kŠC“¹‘åŠw‘åŠw‰@ˆãŠwŒ€‹†‰ÈˆãŠwêU¶BE”­’BˆãŠwuÀŽY‰ÈE¶BˆãŠw•ª–ì)

520014. [‘à]y“ÁW: ”]_ŒoE“ªèò•”‚̐f’f‚ÆŽ¡—Ãupdatez‘à: “ª•”MRIŠgŽU‹­’²‘œ‚É‚š‚¯‚é—Œ‘€‘å”]”Œ‹…‘œ”­—±ó‚M†ˆæ. ŒŽ@•q«1, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ)): —Տ°•úŽËü 2015/5; 60 (5): 613-20.

521027. [‰ðà]y‚±‚±‚ª’m‚è‚œ‚¢!z‰æ‘œf’f2015”N1ŒŽ†“ÁWu•@•›•@o—̈æ‚̉摜f’f|minimum requirement|v. ‰Á“¡”ŽŠî, •‚F—Ž‘Ÿ˜Y1 (1•úŽËü (‰æ‘œ)): ‰æ‘œf’f 2015/5; 35 (7): 864-7.

[’˜@‘]

620117. [Šwp‘] (•ª’SŽ·•M)y‹~‹}‰æ‘œf’f‚Ì‚·‚×‚Ä (—Տ°•úŽËü2015”N11ŒŽ—ÕŽž‘Š§† (60Šª 11†))z¡‘˜_@“ªèò•”, p.1356-9. •‚F—Ž‘Ÿ˜Y (•úŽËü (‰æ‘œ)), •Ò: —Տ°•úŽËü•ÒWˆÏˆõ‰ï, ‹àŒŽo”Å, “Œ‹ž, 2015/11”­s.

620118. [Šwp‘] (•ª’SŽ·•M)y“ªèò•”‰æ‘œf’f‚É•K—v•s‰ÂŒ‡‚ȗՏ°E‰æ‘œ‰ð–Uz5. “ªŠW’ê, p.70-86. “¡“cWŽj1, Žðˆä@C2, ™–{‰pŽ¡1, –L“cŒ\Žq3, Îì–qŽq4, ’Ë–{@_5, X@@€6, •‚F—Ž‘Ÿ˜Y7, ¬‹Ê—²’j8, ’·“êT“ñ9, ’r“ckŽm10, ‘OŒŽ@–«11, àV“c@•q11, ’†ŽRŒ\Žq12, ‰ª‘ºŒõ‰p13, •Ä’ÍNˆê14, ’†‘º@‘ì14, –Ø‘ºKŠó15, “c’†GŽq16, Šp@”ü²14 (1Ž©Ž¡ˆã‰È‘åŠw•úŽËüˆãŠwuÀ, 2ƒ{ƒXƒgƒ“‘åŠwEƒ{ƒXƒgƒ“ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•úŽËü‰È, 3’é‹ž‘åŠwˆãŠw•”•úŽËü‰ÈŠwuÀ, 4¹—ꉡ•l•a‰@•úŽËüf’f‰È, 5Ã‰ªŽs—§Ž…•a‰@•úŽËüf’f‰È, 6“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È¶‘Ì•š—ˆãŠwêU•úŽËüˆãŠwuÀ•úŽËüf’fŠw•ª–ì, 7•úŽËü (‰æ‘œ), 8‹{è‘åŠwˆãŠw•”•a‘Ô‰ðÍˆãŠwuÀ•úŽËüˆãŠw•ª–ì, 9–ŒŒÃ‰®‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È‘‡ˆãŠwêU‚ŽŸˆã—p‰ÈŠwuÀ—ÊŽqˆãŠw•ª–ì, 10ŠÖŒˆã‰È‘åŠw•‘®‘êˆä•a‰@•úŽËü‰È, 11ŠÖŒˆã‰È‘åŠw•‘®–‡•û•a‰@, 12Žs—§ˆÉ’O•a‰@•úŽËü‰È, 13Ï¶‰ï’†’Õa‰@PETƒZƒ“ƒ^[, 14’·è‘åŠwŽ•Šw•”“ªèò•”•úŽËüŠw•ª–ì, 15º˜a‘åŠwŽ•Šw•”Œûo•a‘Ԑf’f‰ÈŠwuÀŽ•‰È•úŽËüˆãŠw•”–å, 16‚ª‚ñŒ€‹†‰ï—L–Ÿ•a‰@‰æ‘œf’f•”), •Ò: ”öK”Ž–ç17 (17“Œ‹žŽœŒb‰ïˆã‰È‘åŠw•úŽËüˆãŠwuÀ), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712032. [Šw‰ï (‘Û)] (‘ÛŽx‰‡) IR management for obstetric hemorrhage. Woodhams R1: JCR‘ÛŽx‰‡Šˆ“® (2016/3/18-22), Ho Chi Minh, Vietnam. (ƒEƒbƒhƒnƒ€ƒX—æŽq1: 1•úŽËü (‰æ‘œ))

713120. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Anticipation process is faster for facial stimulus than for word and symbolic stimuli: fMRI con-strained source analysis on stimulus-preceding negativity. Kotani Y1, Ohgami Y1, Arai J2, Kiryu S3, Inoue Y4: 2015 Annual Meeting of the Organization of Human Brain Mapping (2015/6/14-18), Honolulu, USA, Poster Listing Book 2015; p.79. (ˆäã—D‰î4: 1“Œ‹žH‹Æ‘åŠw, 2ƒ_ƒCƒLƒ“H‹ÆŠ”Ž®‰ïŽÐ, 3“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È, 4•úŽËü (‰æ‘œ))

713121. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Spatial components of stimulus-preceding negativity prior to unilateral stimulus presentation. Ohgami Y1, Kotani Y1, Arai J2, Kiryu S3, Inoue Y4: 2015 Annual Meeting of the Organization of Human Brain Mapping (2015/6/14-18), Honolulu, USA, Poster Listing Book 2015; p.80. (ˆäã—D‰î4: 1“Œ‹žH‹Æ‘åŠw, 2ƒ_ƒCƒLƒ“H‹ÆŠ”Ž®‰ïŽÐ, 3“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È, 4•úŽËü (‰æ‘œ))

713122. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Double D technique for saccular aortic aneurysm: a solution to challenging anatomy for bifurcated stent-graft placement. Woodhams R1, Nishimaki H2, Sakurai Y2, Murakami K3, Ogawa Y3, Chiba K2, Ono H2, Chikada M2, Hase S4, Nishimura J4, Miyairi T2: CIRSE2015 (2015/9/26-30), Lisbon, Portugal. (ƒEƒbƒhƒnƒ€ƒX—æŽq1: 1•úŽËü (‰æ‘œ), 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠwS‘ŸŒŒŠÇŠO‰È, 3¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw•úŽËüˆãŠw, 4ìèK•a‰@•úŽËüIVR‰È)

713123. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) A multi-institutional survey of transcatheter arterial embolization for type II endoleak after endovascular aortic repair: a retrospective study of technical aspects and outcomes. Ogawa Y1, Nishimaki H2, Osuga K3, Ikeda O4, Hongo N5, Iwakoshi S6, Kawasaki R7, Woodhams R8, Yamaguchi M9, Kamiya M10, Kanematsu M11, Honda M12, Kaminou T13, Koizumi J14, Kichikawa K15: CIRSE2015 (2015/9/29), Lisbon, Portugal. (ƒEƒbƒhƒnƒ€ƒX—æŽq8: 1¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw•úŽËüˆãŠw, 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠwS‘ŸŒŒŠÇŠO‰È, 3‘åã‘åŠw•úŽËüˆãŠw, 4ŒF–{‘åŠw•úŽËü‰È, 5‘啪‘åŠwˆãŠw•”•úŽËüˆãŠwuÀ, 6“Þ—ÇŒ§—§ˆã‰È‘åŠw•úŽËü‰È, 7•ºŒÉŒ§—§•P˜HzŠÂŠí•aƒZƒ“ƒ^[, 8•úŽËü (‰æ‘œ), 9_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ€‹†‰È“à‰ÈŒnuÀ•úŽËüˆãŠw•ª–ì, 10•lŒˆã‰È‘åŠw•úŽËüˆãŠw, 11Šò•Œ‘åŠwˆãŠw•”•‘®•a‰@•úŽËü‰È, 12Ï¶‰ï‰F“s‹{•a‰@•úŽËü‰È, 13’¹Žæ‘åŠw•úŽËü‰È, 14“ŒŠC‘åŠwˆãŠw•”•‘®•a‰@‰æ‘œf’f‰È, 15“Þ—ÇŒ§—§ˆã‰È‘åŠw•úŽËü‰È)

713124. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Neural substrates of early and late stimulus-preceding negativity: fMRI-constrained ERP source analysis (poster version). Kotani Y1, Ohgami Y1, Arai J2, Kiryu S3, Inoue Y4: The 55th Annual Meeting of Society for Psychophysiological Research (2015/9/30-10/4), Seattle, USA, Psychophysiology 2015; 52 (suppl 1): S72. (ˆäã—D‰î4: 1“Œ‹žH‹Æ‘åŠw, 2ƒ_ƒCƒLƒ“H‹ÆŠ”Ž®‰ïŽÐ, 3“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È, 4•úŽËü (‰æ‘œ))

713125. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effect of unilateral stimulus presentation on components of stimulus-preceding negativity. Ohgami Y1, Kotani Y1, Arai J2, Kiryu S3, Inoue Y4: The 55th Annual Meeting of Society for Psychophysiological Research (2015/9/30-10/4), Seattle, USA, Psychophysiology 2015; 52 (suppl 1): S72. (ˆäã—D‰î4: 1“Œ‹žH‹Æ‘åŠw, 2ƒ_ƒCƒLƒ“H‹ÆŠ”Ž®‰ïŽÐ, 3“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È, 4•úŽËü (‰æ‘œ))

713126. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Abnormal Low Signal on T2-weighted MR imaging in Head and Neck Tumors and Tumor-like Conditions. Ukisu R1, Inoue Y1: AOCNR2015 (2015/11/5-7), Fukuoka, AOCNR2015 Program and Abstract 2015/8; p.135. (•‚F—Ž‘Ÿ˜Y1, ˆäã—D‰î1: 1•úŽËü (‰æ‘œ))

721020. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ŽÀ‘H! ŠjˆãŠw“lje‚̃Rƒc‹³‚Š‚Ü‚·. ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‘æ51‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ï (2015/10/2), ·‰ª, ‘æ51‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ïŽ˜^W 2015/9; p.S392.

722202. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰)y“û‘B: “û‘B‚c‚v‚h‚Æãüâ|ƒŠƒ“ƒpßUS‚Ìupdate informationz“û‘BŠgŽU‹­’²‰æ‘œ‚Ì‘‡—‰ð. ƒEƒbƒhƒnƒ€ƒX—æŽq (•úŽËü (‰æ‘œ)): ‘æ74‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2015/4/18), ‰¡•l, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ 2015/2; p.S119.

722203. [Šw‰ï (‘S‘)] (‹³ˆç“WŽŠ) CT and MR Imaging of Head and Neck Lesions in the Immunocompromised Patients. •‚F—Ž‘Ÿ˜Y1, ŽRª‘ñ˜Y1, ‘å’ˈŸ¹–¢1, “‡“c—Œb1, ŒŽ@•q«1, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ)): ‘æ74‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2015/4/16-19), ‰¡•l, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ 2015/2; p.S149-50.

722204. [Šw‰ï (‘S‘)] (‹³ˆç“WŽŠ) Key points on adrenal venous sampling. •›tÃ–¬ƒTƒ“ƒvƒŠƒ“ƒO‚Ì—v“_. ¬Š}ŒŽ‹1, ˆäã—D‰î1, •‚F—Ž‘Ÿ˜Y1, Œ‰iŒh“ñ1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ó–ì—Y“ñ1, “¡ˆä@Š]1, “ü]‚‚®‚Ý1, ŒŽ@•q«1, ŽRª‘ñ˜Y1 (1•úŽËü (‰æ‘œ)): ‘æ74‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2015/4/16-19), ‰¡•l, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ 2015/2; p.S165.

722205. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ‘O’u–ü’…‘ٔՂɑ΂·‚éIVR. ƒEƒbƒhƒnƒ€ƒX—æŽq (•úŽËü (‰æ‘œ)): ‘æ51‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2015/7/12), •Ÿ‰ª, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2015/6; 51 (2): 610.

722206. [Šw‰ï (‘S‘)] (‹³ˆç“WŽŠ) èò“®–¬â|‰ð–UEŽB‘œEf’f|. •‚F—Ž‘Ÿ˜Y1, ›ŒŽ’g“l1, ŽRª‘ñ˜Y1, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ)): ‘æ51‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ï (2015/10/2-4), ·‰ª, ‘æ51‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ïŽ˜^W 2015/9; p.S513.

723904. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Peritumoral liver parenchymal enhancement on GD-EOB-DTPA-enhanced MRI invarious liver tumors (Gd-EOB-DTPA‘¢‰eMRI‚ÌŽîᇎüŠÌŽÀŽ¿‘‹­Œø‰Ê‚ÌŒŸ“¢). Œ‰iŒh“ñ1, ˆäã—D‰î1, ¬Š}ŒŽ‹1, “¡ˆä@Š]1, “‡“c—Œb1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŽRª‘ñ˜Y1, ‘å’ˈŸ¹–¢1, —é–Ø•¶•v1, ‰º–ìŒ\ˆê˜Y1 (1•úŽËü (‰æ‘œ)): ‘æ74‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2015/4/17), ‰¡•l, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ 2015/2; p.S201.

723905. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÔŽ¿«MR ƒŠƒ“ƒp‘¢‰e‚É‚æ‚éƒ}ƒEƒX‰ŠÇ«ƒŠƒ“ƒpß‚ÌŒŸ“¢: ‚•ªŽqƒ~ƒZƒ‹‘¢‰eÜ‚Ægadofl uorine P‚Ì”äŠr. (Assessment of infl ammatory lymph nodes in mice with intersitital MR lymphography: comparative study with polymeric micelle MR contrast agent and gadofl uorine P). ÔˆäGs1, ‹Ë¶@–Î1, ”’Îvˆê2, ‰¡ŽR¹K2, ’†”W—ǍN1, ˆäã—D‰î3, ‘å—F@–M4 (1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È, 2“Œ‹žŽœŒb‰ïˆã‰È‘åŠw‘‡ˆã‰ÈŠwŒ€‹†ƒZƒ“ƒ^[, 3•úŽËü (‰æ‘œ), 4“Œ‹ž‘åŠwˆãŠw•”•úŽËü‰È): ‘æ10‰ñ“ú–{•ªŽqƒCƒ[ƒWƒ“ƒOŠw‰ï (2015/5/20), “Œ‹ž, JSMI Report 2015/4; 8 (2): 131.

723906. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) •Ð‘€ŽhŒƒ’掊‚ÆŠÖ˜A‚·‚éŽhŒƒæs‰A«“dˆÊ (SPN) ‚Ì‹óŠÔ¬•ª. ‘åãi”ü1, ¬’J‘ב¥1, Vˆäˆê˜Y2, ‹Ë¶@–Î3, ˆäã—D‰î4 (1“Œ‹žH‹Æ‘åŠw, 2ƒ_ƒCƒLƒ“H‹ÆŠ”Ž®‰ïŽÐ, 3“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È, 4•úŽËü (‰æ‘œ)): ‘æ33‰ñ“ú–{¶—S—Šw‰ï‘å‰ï (2015/5/23-24), ‘åã, ‘æ33‰ñ“ú–{¶—S—Šw‰ï‘å‰ïƒvƒƒOƒ‰ƒ€¥—\eW 2015/5; p.14.

723907. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠçŽhŒƒ—\Šú‚Í‹L†ŽhŒƒ—\Šú‚æ‚è‚à‘‚­ˆ—‚³‚ê‚é|fMRI§–ñ•t‚«ƒ_ƒCƒ|[ƒ‹•ªÍ|. ¬’J‘ב¥1, ‘åãi”ü1, Vˆäˆê˜Y2, ‹Ë¶@–Î3, ˆäã—D‰î4 (1“Œ‹žH‹Æ‘åŠw, 2ƒ_ƒCƒLƒ“H‹ÆŠ”Ž®‰ïŽÐ, 3“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È, 4•úŽËü (‰æ‘œ)): ‘æ33‰ñ“ú–{¶—S—Šw‰ï‘å‰ï (2015/5/23-24), ‘åã, ‘æ33‰ñ“ú–{¶—S—Šw‰ï‘å‰ïƒvƒƒOƒ‰ƒ€¥—\eW 2015/5; p.14.

723908. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) The correlation between recanalization of embolized artery and blood coagulation parameters during TAE for primary postpartum hemorrhage. ƒEƒbƒhƒnƒ€ƒX—æŽq1, “¡ˆä@Š]1, ¬Š}ŒŽ‹1, ŽRª‘ñ˜Y1, ‰º–ìŒ\ˆê˜Y1, ŒŽ@•q«1, Œ‰iŒh“ñ1, ŒŠª@”Ž2, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠwS‘ŸŒŒŠÇŠO‰È): ‘æ44‰ñIVRŠw‰ï‘‰ï (2015/5/30), ‹{è, “ú–{ƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒiƒ‹ƒ‰ƒWƒIƒƒW[Šw‰ïŽGŽ 2015/5; 30 (Suppl): 51.

723909. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”ñƒAƒ‹ƒR[ƒ‹«Ž‰–bŠÌ‰Šƒ‚ƒfƒ‹ƒ}ƒEƒX‚̍‚•ªŽqƒ~ƒZƒ‹‘¢‰eMRI‚É‚š‚¯‚éT1ŠÉ˜aŽžŠÔ‘ª’è‚Ì•]‰¿. ‹Ë¶@Ž 1, ”’Î@v2, ‰¡ŽR¹K2, ÔˆäGs1, ’†•°—ǍN1, ˆäã—D‰î3, ‘å—F@–M4 (1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È, 2“Œ‹žŽœŒbˆã‰È‘åŠw‘‡ˆã‰ÈŠwŒ€‹†ƒZƒ“ƒ^[, 3•úŽËü (‰æ‘œ), 4“Œ‹ž‘åŠwˆãŠw•”•úŽËü‰È): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/10), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ïŽGŽ 2015/8; 35 (suppl): 333.

723910. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠÌ“]ˆÚŽüˆÍ‚É‚š‚¯‚éGd-EOB-DTPA‘¢‰eMRI‘‹­Œø‰ÊˆÙí‚Ì•a—Šw“IŒŸ“¢. Œ‰iŒh“ñ1, ˆäã—D‰î1, ŽOŽ}@M2, ¬Š}ŒŽ‹1, “¡ˆä@Š]1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŽRª‘ñ˜Y1, ‘å’ˈŸ¹–¢1, ‰º–ìŒ\ˆê˜Y1, ›ŒŽ’g“l1 (1•úŽËü (‰æ‘œ), 2•a—): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/11), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ïŽGŽ (2015/8; 35 (suppl): 269.

723911. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚•ªŽqƒ~ƒZƒ‹‚ð—p‚¢‚œƒ}ƒEƒXŠÔŽ¿«MRƒŠƒ“ƒp‘¢‰e‚Ì•]‰¿: gadofluorine P‚Æ‚Ì”äŠr. ÔˆäGs1, ‹Ë¶@–Î1, ”’Îvˆê2, ‰¡ŽR¹K2, ’†”W—ǍN1, ˆäã—D‰î3, ‘å—F@–M4 (1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•t‘®•a‰@•úŽËü‰È, 2“Œ‹žŽœŒbˆã‰È‘åŠw‘‡ˆã‰ÈŠwŒ€‹†ƒZƒ“ƒ^[, 3•úŽËü (‰æ‘œ), 4“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È•úŽËüˆãŠwuÀ): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/11), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ïŽGŽ 2015/8; 35 (suppl): 353.

723912. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Navigator-gating‚ð—p‚¢‚œGd-EOB-DTPA‘¢‰eMRI‚̉掿•]‰¿. ¬Š}ŒŽ‹1, ˆäã—D‰î1, Œ‰iŒh“ñ1, “¡ˆä@Š]1, `@”Ž•¶2, ‹{–{”ä˜CŽ÷2, ŠâŠÙ—YŽ¡3 (1•úŽËü (‰æ‘œ), 2•úŽËü•”, 3GEƒwƒ‹ƒXƒPƒAEƒWƒƒƒpƒ“): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/12), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ïŽGŽ 2015/8; 35 (suppl): 306.

723913. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) 3T MRI‘•’u‚Å‚ÌGd-EOB-DTPA‘¢‰eMRI‚É‚š‚¯‚é‹Ïˆê«•â³‚ªŠÌM†’è—ÊŽw•W‚É—^‚Š‚é‰e‹¿. ¬Š}ŒŽ‹1, ˆäã—D‰î1, Œ‰iŒh“ñ1, “¡ˆä@Š]1, `@”Ž•¶2 (1•úŽËü (‰æ‘œ), 2•úŽËü•”): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/12), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ïŽGŽ 2015/8; 35 (suppl): 309.

723914. [Šw‰ï (‘S‘)] (PDFƒ|ƒXƒ^[) “ª•”MRI“lje‚É‚š‚¯‚é‰æ‘œ•\ŽŠðŒ’²®–@‚ÉŠÖ‚·‚錟“¢. ŒŽ@•q«1, ˆäã—D‰î1, •‚F—Ž‘Ÿ˜Y1, `@”Ž•¶2, ˆä—́@~2 (1•úŽËü (‰æ‘œ), 2•úŽËü•”): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/10-12), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ïŽGŽ 2015/8; 35 (suppl): 421.

723915. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒCƒ[ƒWƒCƒ“ƒ^[ƒvƒŠƒe[ƒVƒ‡ƒ“ƒZƒbƒVƒ‡ƒ“1 Ç—á3 (o‘è‚Ɖðà). •‚F—Ž‘Ÿ˜Y (•úŽËü (‰æ‘œ): ‘æ51‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ï (2015/10/3), ·‰ª.

723916. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) A“ª_ŒoâŽî‚Ì2—á. ›ŒŽ’g“l1, •‚F—Ž‘Ÿ˜Y1, ŽRª‘ñ˜Y1, ˆäã—D‰î1, ‰Á”[Fˆê2, —é–؃GƒŠ“Þ3, ŽOŽ}@M3, Ó@¢ˆ®3 (1•úŽËü (‰æ‘œ), 2Žš•@ˆôAE“ªèòŠO, 3•a—): ‘æ51‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ï (2015/10/4), ·‰ª, ‘æ51‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ïŽ˜^W 2015/9; p.S553.

723917. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “ª•”ˆÈŠO‚̈««Žîᇐf’f–Ú“I‚ÅŽ{s‚³‚ê‚œ‘SgFDG-PET/CT‚Å‚Ì“ª•”ŠŒ©‚Ì•]‰¿. ó–ì—Y“ñ1, ˆäã—D‰î1, ‘å’ˈŸ¹–¢1, ŽRª‘ñ˜Y1, ŒŽ@•q«1, ‹{•”ä˜CŽ÷2 (1•úŽËü (‰æ‘œ), 2•úŽËü•”): ‘æ55‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ï (2015/11/6), “Œ‹ž, ŠjˆãŠw 2015/9; 52 (3): 283.

731165. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “úíf—Âłµ‚΂µ‚Α˜‹ö‚·‚铪èò•”ŽŸŠ³|CTEMRI‚Ì‚±‚±‚É’–ځ|. •‚F—Ž‘Ÿ˜Y (•úŽËü (‰æ‘œ)): ‘æ24‰ñŽR—z¥ŽR‰ARadiologyUpdateŠwpu‰‰‰ï (2015/5/16), ‰ªŽR.

731166. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽY‰ÈoŒŒIVR‚ÌŒ»Ý‚̃Rƒ“ƒZƒ“ƒTƒX‚ƍ¡Œã‚Ì“W–]. ƒEƒbƒhƒnƒ€ƒX—æŽq (•úŽËü (‰æ‘œ)): ‘æ13‰ñˆ€’mŽq‹{‹ØŽîÇð—Ö@ŒŸ“¢‰ï (2015/6/19), ’·‹vŽè.

731167. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) FDG PET/CT‚Ì—L—p«‚Æ—¯ˆÓ“_. ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‘æ23‰ñMBŠjˆãŠwŒ€‹†‰ï (2015/6/27), Œ–{.

731168. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) PET/CT‚̃ƒ“ƒ|ƒCƒ“ƒgƒŒƒbƒXƒ“|Žîᇐf—ÂɊˆ‚©‚·‚œ‚߂Ɂ|. ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‘æ44‰ñ’f‘w‰f‘œŒ€‹†‰ï (2015/10/23), “Œ‹ž.

731169. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S‹ØŒŒ—¬SPECT: ‚»‚̏ŠŒ©‚Í–{•š‚Å‚·‚©? ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‘æ44‰ñ’f‘w‰f‘œŒ€‹†‰ï (2015/10/24), “Œ‹ž, ’f‘w‰f‘œŒ€‹†‰ïŽGŽ 2015/9; 42 (2): 20.

731170. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Çó‚©‚ç‚Ý‚œ“ªèò•”CTEMRIf’f‚̐i‚ß•û. •‚F—Ž‘Ÿ˜Y (•úŽËü (‰æ‘œ)): ‘æ26‰ñŽR‰AƒfƒWƒ^ƒ‹‰æ‘œŒ€‹†‰ï (2016/2/13), Œ].

732117. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) PETf’f‚̃tƒƒ“ƒgƒ‰ƒCƒ“ ƒAƒ~ƒmŽ_ƒCƒ[ƒWƒ“ƒO (FACBC). ˆäã—D‰î (•úŽËü (‰æ‘œ)): ‘æ29‰ñJCRƒ~ƒbƒhƒEƒBƒ“ƒ^[ƒZƒ~ƒi[ (2016/1/24), •Ÿ‰ª.

732118. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) –ڐV‚µ‚¢EŽšV‚µ‚¢ŽŸŠ³‚̉摜f’f@ŠjˆãŠw. ˆäã—D‰î (•úŽËü (‰æ‘œ)): “ú–{ˆãŠw•úŽËüŠw‰ïŠÖ“Œ’n•û‰ïƒZƒ~ƒi[ (2016/2/7), “Œ‹ž.

733352. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ãA“ª_ŒoâŽî‚Ì1—á. ŽRª‘ñ˜Y1, •‚F—Ž‘Ÿ˜Y1, ‘å’ˈŸ¹–¢1, “‡“c—Œb1, ˆäã—D‰î1, ‰Á”[Fˆê2, —é–؃GƒŠ“Þ3, ŽOŽ}@M3 (1•úŽËü (‰æ‘œ), 2Žš•@ˆôAE“ªèòŠO, 3•a—): ‘æ44‰ñ“ªèò•”E‹¹•”‰æ‘œŒ€‹†‰ï (2015/5/23), “Œ‹ž.

733353. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “ª•”MRIŠgŽU‹­’²‘œ‚É‚š‚¯‚é—Œ‘€‘å”]”Œ‹…‘œ”­—±ó‚M†ˆæ. ŒŽ@•q« (•úŽËü (‰æ‘œ)): ‘æ10‰ñ–k—¢ŒŒŠÇƒtƒH[ƒ‰ƒ€ (2015/6/1), ‘Š–ÍŒŽ.

733354. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “ª•”ˆÈŠO‚̈««Žîᇐf’f–Ú“I‚ÅŽ{s‚³‚ê‚œFDG-PET/CT‚Å‚Ì“ª•”ŠŒ©‚ɂ‚¢‚Ä. ó–ì—Y“ñ1, ˆäã—D‰î1, ‘å’ˈŸ¹–¢1, ›ŒŽ’g“l1, ‰º–ìŒ\ˆê˜Y1, ŽRª‘ñ˜Y1, ŒŽ@•q«1, ‹{•”ä˜CŽ÷2, ‹e’r@Œh2 (1•úŽËü (‰æ‘œ), 2•úŽËü•”): ‘æ83‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2015/7/11), “Œ‹ž, ŠjˆãŠw 2015/11; 52 (4): 390-1.

733355. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž~ŒŒ‚É“ïa‚µ‚œŽY‰ÈoŒŒ‚̈ê—á. ƒEƒbƒhƒnƒ€ƒX—æŽq (•úŽËü (‰æ‘œ): ‘æ479‰ñ“Œ‹žƒAƒ“ƒMƒIEIVR‰ï (2016/1/14), “Œ‹ž.

733356. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) A case of chronic expanding hematoma after total hip arthroplasty; Angiographic findings at preoperative embolization. ›ŒŽ’g“l1, ƒEƒbƒhƒnƒ€ƒX—æŽq1, “¡ˆä@Š]1, “àŽRŸ•¶2, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2®ŠO): ‘æ27‰ñ“ú–{œ“î•”•úŽËüŒ€‹†‰ï (2016/1/29), “Œ‹ž.


•úŽËü‰ÈŠw (•úŽËüŽîᇊw)

[Šwp˜_•¶]

110305. [ŒŽ’˜] Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa K, Hareyama M, Takai Y, Hayakawa K1, Mitsuhashi N, Ishikura S: Int J Radiat Oncol Biol Phys 2015/12; 93 (5): 989-96. (‘ì˜ad1: 1•úŽËü (Žîá‡))

110306. [ŒŽ’˜] Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapy. Ishiyama H1, Satoh T2, Yorozu A, Saito S, Kataoka M, Hashine K, Nakamura R, Tanji S, Masui K, Okihara K, Ohashi T, Momma T, Aoki M, Miki K, Kato M, Morita M, Katayama N, Nasu Y, Kawanaka T, Fukumori T, Ito F, Shiroki R, Baba Y, Inadome A, Yoshioka Y, Takayama H, Hayakawa K1: J Radiat Res 2016/1; 57 (1): 68-74. (ÎŽR”ŽžŠ1, ²“¡ˆÐ•¶2, ‘ì˜ad1: 1•úŽËü (Žîá‡), 2”å”AŠí)

110307. [ŒŽ’˜] Dosimetry of permanent interstitial prostate brachytherapy for an interoperative procedure, using O-arm based CT and TRUS. Ishiyama H1, Sekiguchi A1, Satoh T2, Tsumura H2, Takenaka K1, Kawakami S1, Tabata K2, Kobayashi K2, Iwamura M2, Hayakawa K1: J Contemp Brachytherapy 2016/2; 8 (1): 7-16. (ÎŽR”ŽžŠ1, ŠÖŒûˆ©ˆß1, ²“¡ˆÐ•¶2, ’ѺGN2, ’|’†_“ñ1, ìã³Œå1, “c”šŒ’ˆê2, ¬—ÑŒ’‘Ÿ˜Y2, Šâ‘º³Žk2, ‘ì˜ad1: 1•úŽËü (Žîá‡), 2”å”AŠí)

521028. [‰ðà] ‹¹•”•úŽËüÆŽË’ljÁ‚Ì“K‰žÇ—á‚Ì‘I‘ð‚É‚ÍŒŸ“¢‚ª•K—v. ‘ì˜ad (•úŽËü (Žîá‡)): The Mainichi Medical Journal 2016/1; 11 (6): 331.

522172. [uÀ]y“ÁW: ‘å’°Šàf—ÃUpdatezŽ¡—ÂÌUpdate@E‘å’°Šà‚ɑ΂·‚é•úŽËüŽ¡—Â̈Ӌ`‚Ɖž—p. ‘ì˜ad (•úŽËü (Žîá‡)): ˆãŠw‚Ì‚ ‚ä‚Ý 2015/6; 253 (10): 1059-64.

522173. [uÀ]y“ÁW: ”x‚ª‚ñŠ³ŽÒ‚ÌŽ¡—ÂƃPƒAÅ‘Oüz ”x‚ª‚ñ‚ÌŽ¡—Ö@‚ð’m‚é@•úŽËü—Ö@. ‘ì˜ad (•úŽËü (Žîá‡)): ‚ª‚ñŠÅŒì 2015/9; 20 (6): 613-5.

522174. [uÀ]y“ÁW: —LŠQŽ–Û‚ð‚¢‚©‚É–hŽ~‚·‚é‚©?z‚Í‚¶‚ß‚É. ‘ì˜ad1, ‚ˆä—ǐq (1•úŽËü (Žîá‡)): —Տ°•úŽËü 2015/10; 60 (10): 1205-7

[’˜@‘]

610005. [Šwp‘ (•ª’SŽ·•M)]yStereotactic Body Radiation Therapy: Principles and PracticeszChapter 12. International Experience, p.151-62. Hayakawa K1, Editor: Nagata Y, Springer, 2015/8. (‘ì˜ad1: 1•úŽËü (Žîá‡))

[Šw‰ïEŒ€‹†‰ï“™]

712033. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Combined Use of Molecular Targeting Drugs in Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer. Hayakawa K1: ICRR2015 (2015/5/26), Kyoto, ICRR2015 Pocket Program 2015/5; 15th: 72. (‘ì˜ad1: 1•úŽËü (Žîá‡))

712034. [Šw‰ï (‘Û)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zHayakawa K1: ICRR2015 (2015/5/29), Kyoto, ICRR2015 Pocket Program 2015/5; 15th: 205. (‘ì˜ad1: 1•úŽËü (Žîá‡))

713127. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Assessment of Intraoperative CT By The O-armÒ Imaging System: Early Experience. Kawakami S1, Ishiyama H1, Satoh T2, Tsumura H2, Sekiguchi A1, Takenaka K1, Komori S1, Soda I1, Iwamura M2, Hayakawa K1: ICRR2015 (2015/5/26), Kyoto, ICRR2015 Pocket Program 2015/5; 15th: 97. (ìã³Œå1, ÎŽR”ŽžŠ1, ²“¡ˆÐ•¶2, ’ѺGN2, ŠÖŒûˆ©ˆß1, ’|’†_“ñ1, ¬X³Žq1, ‘“c@Ši1, Šâ‘º³Žk2, ‘ì˜ad1: 1•úŽËü (Žîá‡), 2”å”AŠí)

713128. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Retrospective Evaluation of the Feasibility of Definitive CRT after Treatment with Docetaxel, Cisplatin, and 5-Fluorouracil in ESCC. Komori S1, Katada C2, Katada N3, Sugawara M4, Takahashi K5, Ishiyama H1, Higuchi K2, Yamashita K3, Moriya H3, Tanabe S6, Koizumi W2, Hayakawa K1: ICRR2015 (2015/5/26), Kyoto, ICRR2015 Pocket Program 2015/5; 15th: 155. (¬X³Žq1, Œ˜“ce—˜2, •Ð“c‰Ä–ç3, ›ŒŽ[L4, ‚‹Ž‚©‚š‚é5, ÎŽR”ŽžŠ1, ”óŒûŸ•F2, ŽR‰ºŒpŽj3, X’JGŒõ3, “c糁@‘6, ¬ò˜aŽO˜Y2, ‘ì˜ad1: 1•úŽËü (Žîá‡), 2Á‰»Ší“à, 3ŠO‰È, 4–òÜ•”, 5ŠÅŒì•”, 6V¢‹Iˆã—ÁEæ’[ˆã—Ã)

722207. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) –Ÿ“ú‚©‚çŽg‚Š‚éƒNƒCƒbƒNƒŠƒ“ƒN|13Ž{Ý‚Ì“±“üŒoŒ±‚©‚ç|. ÎŽR”ŽžŠ (•úŽËü (Žîá‡)): ¬üŒ¹Ž¡—Õ”‰ï‘æ17‰ñŠwp‘å‰ï (2015/6/26), ‘å‹{, ¬üŒ¹Ž¡—Õ”‰ï‘æ17‰ñŠwp‘å‰ïƒvƒƒOƒ‰ƒ€ 2015/6; 4.

722208. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÀ’·z”xŠà‚̍‚ž“x•úŽËüŽ¡—Âɂš‚¯‚é•ïŠ‡“I•úŽËüŽî­Šw. ‘ì˜ad (•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï (2015/11/19), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï•ñ•¶W 2015/11; p.6.

722209. [Šw‰ï (‘S‘)] (—Ž–’·•ñ)yÀ’·z“ú–{”xŠàŠw‰ï: ‚±‚̈ê”N‚Ì•à‚݂Ə«—ˆ. ‘ì˜ad (•úŽËü (Žîá‡)): ‘æ56‰ñ“ú–{”xŠàŠw‰ïŠwpW‰ï (2015/11/27), ‰¡•l, ”xŠà 2015/10; 55 (5): 72.

722210. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yƒfƒBƒXƒJƒbƒTƒ“ƒgz”]“]ˆÚ. ‘ì˜ad (•úŽËü (Žîá‡)): ‘æ56‰ñ“ú–{”xŠàŠw‰ïŠwpW‰ï (2015/11/28), ‰¡•l, ”xŠà 2015/10; 55 (5): 103.

722211. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zTrueBeam STx‚É‚š‚¯‚éFlattening filter freeƒr[ƒ€‚Ì“±“ü‚Ə‰Šú—Տ°ŒoŒ±. ‘ì˜ad (•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ï‘æ29‰ñ‚ž“x•úŽËüŠO•”ÆŽË•”‰ïŠwp‘å‰ï (2016/2/27), “Œ‹ž, ‘æ29‰ñ‚ž“x•úŽËüŠO•”ÆŽË•”‰ïŠwp‘å‰ïŽ˜^W 2016/2; p.16.

722212. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “ú–{l‘O—§‘BŠàŠ³ŽÒ‚ɑ΂·‚é’èˆÊ•úŽËüŽ¡—Â̌oŒ±. ÎŽR”ŽžŠ1, ‘ì˜ad1 (1•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ï‘æ29‰ñ‚ž“x•úŽËüŠO•”ÆŽË•”‰ïŠwp‘å‰ï (2016/2/27), “Œ‹ž, ‘æ29‰ñ‚ž“x•úŽËüŠO•”ÆŽË•”‰ïŠwp‘å‰ïŽ˜^W 2016/2; p.32.

723918. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Definitive chemoradiotherapy for the patients with neuroendocrine carcinoma of the esophagus. ¬X³Žq1, Œ˜“ce—˜2, ‹g“c@Œ÷3, “Œ@’q2, ÎŒËŒªŽŸ2, ìã³Œå1, ÎŽR”ŽžŠ1, “c糁@‘4, ¬ò˜aŽO˜Y2, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2Á‰»Ší“à, 3•a—, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï (2015/11/19), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï•ñ•¶W 2015/11; p.198.

723919. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Whole scalp irradiation with Helical Tomotherapy for angiosarcoma. ŠÖŒûˆ©ˆß1, ÎŽR”ŽžŠ1, ‘àV^ŽÀŽq2, ¬X³Žq1, ‘“c@Ši1, ’|’†_“ñ1, –ìàVää»‰Ô1, “V‰HN”V2, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2”畆): “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï (2015/11/19), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï•ñ•¶W 2015/11; p.264.

723920. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Comparison of 3D printing materials for customized bolus in radiotherapy. ‘“c@Ši1, ÎŽR”ŽžŠ1, –ì“c–Η˜2, Žñ“¡éº2, —]ŒêŽ‹I3, ¬X³Žq1, ŠÖŒûˆ©ˆß1, ìã³Œå1, ’|’†_“ñ1, –ìàVää»‰Ô1, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï (2015/11/20), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï•ñ•¶W 2015/11; p.224.

723921. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) A case of massive squamous cell carcioma of the breast treated with successful radiotherapy and curative operation. –ìàVää»‰Ô1, ¬X³Žq1, åÎ‹I•F2, ÎŽR”ŽžŠ1, ŒŽ@“ÖŽq3, ‘“c@Ši1, ŠÖŒûˆ©ˆß1, ’|’†_“ñ1, ’J–씎ˆê2, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2ŠO‰È, 3•a—): “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï (2015/11/20), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï•ñ•¶W 2015/11; p.302.

723922. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Quality of life after radiotherapy for patients with head and neck cancer: Comparison of acute phase responses between 3DCRT and IMRT. ’|’†_“ñ1, ÎŽR”ŽžŠ1, ¬X³Žq1, ‘“c@Ši1, ŠÖŒûˆ©ˆß1, ìã³Œå1, –ìàVää»‰Ô1 (1•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï (2015/11/21), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï•ñ•¶W 2015/11; p.338.

723923. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Evaluation of incident reports in radiotherapy: comparison between conventional linac and Tomotherapy system. ÎŽR”ŽžŠ1, Žñ“¡éº2, Ž›è„Žj2, –ì“c–Η˜2, —]ŒêŽ‹I3, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï (2015/11/21), ŒQ”n.

723924. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Stereotactic body radiotherapy (SBRT) for 661. operable stage I nonsmall cell lung cancer. ‘同@—m, ‰–ŽR‘P”V, Œ–{N’j, ‚ŽRŒ«“ñ, Œ”öKŒ›, ‹{ì‘Žj, ŽR‰º‰pb, Œ‰º°—Y, Â–؏¹•F, “ñ•rŒ\“ñ, –Ø‘º’qŽ÷, ÎŽR”ŽžŠ1, ‘ºã’Œ–ç, ’†“cŒ’¶, •“c“Ä–ç, ‰F–ì@—², –ì‹{‘ô–, ¬ì˜a•F (1•úŽËü (Žîá‡)): ‘æ56‰ñ“ú–{”xŠàŠw‰ïŠwpW‰ï (2015/11/26), ‰¡•l, ”xŠà 2015/10; 55 (5): 419.

723925. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 3DƒvƒŠƒ“ƒ^[‚ō쐬‚µ‚œƒ{[ƒ‰ƒX‚ðŽg—p‚µ‚œŒŒŠÇ“÷Žî‘S“ª”çÆŽË (IMRT) ‚ɂ‚¢‚Ä‚ÌŒ€‹†. ‘“c@Ši1, ÎŽR”ŽžŠ1, Ž›è„Žj2, Žñ“¡éº2, ŠÖŒûˆ©ˆß1, ’|’†_“ñ1, –ìàVää»‰Ô1, ¬X³Žq1, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü•”): “ú–{•úŽËüŽîᇊw‰ï‘æ29‰ñ‚ž“x•úŽËüŠO•”ÆŽË•”‰ïŠwp‘å‰ï (2016/2/27), “Œ‹ž, ‘æ29‰ñ‚ž“x•úŽËüŠO•”ÆŽË•”‰ïŠwp‘å‰ïŽ˜^W 2016/2; p.71.

732119. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰)y•úŽË«“¯ˆÊŒ³‘f‹y‚Ñ•úŽËü”­¶‘•’u‚ÌŽæ‚舵‚¢Izƒ`[ƒ€ˆã—Âƈã—ÈÀ‘S. ‘ì˜ad (•úŽËü (Žîá‡)): •œ¬27”N“xu•úŽËü (f—Ã) ‹Æ–±]Ž–ŽÒ‚Ì‹³ˆçŒP—û(uK‰ï)v(2015/4/26), ìè.

732120. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) d—±ŽqüŽ¡—ÂɊú‘Ò‚·‚邱‚Æ. ‘ì˜ad (•úŽËü (Žîá‡)): •œ¬27”N“xd—±ŽqüŽ¡—Íu‰‰‰ï (2015/10/3), ‰¡•l.

732121. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) ŠÉ™‚ÈŒo‰ß‚ð’H‚Á‚Ä‚¢‚é’ᕪ‰»”x‘BŠà: ‰“Šu“]ˆÚ‚̈ê—á. ¬X³Žq (•úŽËü (Žîá‡)): •œ¬27”N“x_“ސ쌧•úŽËüˆã‰ï‘‰ï‹y‚Ñ‘æ56‰ñ—á‰ï (2015/10/10), ‰¡•l.

732122. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) ”x‚ª‚ñ‚ÌŠT—v. ‘ì˜ad (•úŽËü (Žîá‡)): ”x‚ª‚ñˆã—ÁEŽŸŠ³Œ[”­‚Ì‚œ‚ß‚ÌŽs–¯ŒöŠJuÀ (2015/11/8), H—tŒŽ.

732123. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éƒV[ƒh—Ö@ŠÖ˜AƒCƒ“ƒVƒfƒ“ƒg‚̏WŒv: ŠO•”ÆŽË‚Æ‚Ì”äŠr. ÎŽR”ŽžŠ (•úŽËü (Žîá‡)): ‘æ12‰ñ‘O—§‘BŠà–§••¬üŒ¹‰i‹v‘}“üŽ¡—ÃŒ€‹†‰ï (2016/1/24), “Œ‹ž.

732124. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‰‰) TrueBeam 8NW Xü‚Ì—L—p«‚ɂ‚¢‚Ä. ‘ì˜ad (•úŽËü (Žîá‡)): 2016ƒoƒŠƒAƒ“ƒZƒ~ƒi[ (2016/2/28), “Œ‹ž.

732125. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) •úŽËü‚É‚æ‚éDNA‘¹‚ɑ΂·‚郁ƒ`ƒIƒjƒ“‚Ì–hŒìŒø‰Ê. ’·–쏫‘ã1, ˆÉ“¡‘ŸÄ2, —]ŒêŽ‹I3, ÎŽR”ŽžŠ4, ‘ì˜ad4 (1ˆã—Éq¶Šw•”, 2—Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4•úŽËü (Žîá‡)): ‘æ58‰ñ‰¡•l•úŽËüŽ¡—ͧ˜b‰ï (2016/3/7), ‰¡•l.

732126. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) ƒAƒ~ƒmŽ_‚É‚æ‚é•úŽËü–hŒìŒø‰Ê‚ÌŒŸ“¢|ƒvƒ‰ƒXƒ~ƒhDNA‘¹‚Ì•]‰¿|. ˆÉ“¡‘ŸÄ1, ’·–쏫‘å2, —]ŒêŽ‹I3, ÎŽR”ŽžŠ4, ‘ì˜ad4 (1—Šw•”, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4•úŽËü (Žîá‡)): ‘æ58‰ñ‰¡•l•úŽËüŽ¡—ͧ˜b‰ï (2016/3/7), ‰¡•l.

732127. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) 3DƒvƒŠƒ“ƒ^[‚ō쐬‚µ‚œƒ{[ƒ‰ƒX‚ðŽg—p‚µ‚œŒŒŠÇ“÷Žî‘S“ª”çÆŽË‚ɂ‚¢‚Ä‚ÌŒ€‹†. ‘“c@Ši1, ÎŽR”ŽžŠ1, Ž›è„Žj2, Žñ“¡éº2, ŠÖŒûˆ©ˆß1, ¬X³Žq1, ’|’†_“ñ1, –ìàVää»‰Ô1, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü•”): ‘æ58‰ñ‰¡•l•úŽËüŽ¡—ͧ˜b‰ï (2016/3/7), ‰¡•l.

732128. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) ”x‚ª‚ñ‚̐VTNM•ª—ނɂ‚¢‚Ä. ‘ì˜ad (•úŽËü (Žîá‡)): ‘æ58‰ñ‰¡•l•úŽËüŽ¡—ͧ˜b‰ï (2016/3/7), ‰¡•l.

733357. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ‰ƒCƒuƒfƒ‚ƒRƒƒ“ƒe[ƒ^[. ÎŽR”ŽžŠ (•úŽËü (Žîá‡)): ‘æ17‰ñƒˆƒE‘f125ƒV[ƒhüŒ¹‰i‹v‘}“ü‚É‚æ‚é‘O—§‘BŠà–§••¬üŒ¹—Ö@‹ZpuK‰ï (2015/7/4), “Œ‹ž.

733358. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) d—±Žqü‚É‚æ‚éDNA‘¹‚ɑ΂·‚郁ƒ`ƒIƒjƒ“‚Ì–hŒìŒø‰Ê. —]ŒêŽ‹I1, ‘ºŽRçŒbŽq, –]ŒŽ‘åŽ÷1, Œ‰º–ŸO1, ˆÉ“¡‘ŸÄ2, “¡àV‹`Ž÷1, ¬àV‘ñŠC3, •œŽR—ºˆê, ÎŽR”ŽžŠ4, ‘ì˜ad4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2—Šw•”, 3ˆã—Éq¶Šw•”, 4•úŽËü (Žîá‡)): ‘æ18‰ñŠàŽ¡—ѝŠŽŒ€‹†ƒVƒ“ƒ|ƒWƒEƒ€ (2016/2/6), “Þ—Ç.


–ƒŒ‰ÈŠw

[Šwp˜_•¶]

110308. [ŒŽ’˜] Reduction in the soles of graduated compression stockings prevents falls without reducing the preventive effect for venous stasis. Kuroiwa M1, Takahira N2, Ujihashi Y3, Miida K4, Arai Y5, Kawatani H5: Thrombosis Research 2015/5; 135 (5): 877-81. (•Šâ­”V1, ‚•œ®L2, ‰FŽ¡‹Ž‘PŸ3, Œ©ˆä“c˜a³4, rˆä—L”ü5, ì’JOŽq5: 1–ƒŒ, 2ˆã—Éq¶Šw•”, 3—ÕŒŸ•”, 4ƒŠƒnƒrƒŠ•”, 5ˆã—Â̎¿EˆÀ‘S„iŽº)

110309. [ŒŽ’˜] Changes in the incidence, case fatality rate, and characteristics of symptomatic perioperative pulmonary thromboembolism in Japan: Results of the 2002-2011 Japanese Society of Anesthesiologists Perioperative Pulmonary Thromboembolism (JSA-PTE) Study. Kuroiwa M1, Morimatsu H, Tsuzaki K, Irita K, Sanuki M, Nakatsuka H, Nakamura M: J Anesth 2015/6; 29 (3): 433-41. (•Šâ­”V1: 1–ƒŒ)

110027. [ŒŽ’˜] Roles of mPGES-1, an inducible prostaglandin E synthase, in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model. Matsuda H1, Hosono K2,3, Tsuru S1, Kurashige C4, Sekiguchi K1, Akira S, Uematsu S, Okamoto H4, Majima M3: Life Sci 2015/12; 142: 1-7. (Œ“cOŽq1, ×–ì‰Á“ÞŽq2,3, ’ׯ¢—¢1, åUdçŠG4, ŠÖŒû˜aŠé1, ‰ª–{_Žk4, ”n“ˆ³—²3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—, 4–ƒŒ)

310034. [Ç—á•ñ] Elective use of surgical cricothyroidotomy for maxillofacial fracture fixation with contraindication of nasotracheal intubation: a case report. Kuroiwa M1, Kumazawa K2, Ito S1, Arai M3, Okamoto H1: JA Clinical Reports 2015/10; 1 (16). DOI: 10.1186/s40981-015-0021-6. (•Šâ­”V1, ŒFàVŒ›ˆê2, ˆÉ“¡‘s•œ1, Vˆä³N3, ‰ª–{_Žk1: 1–ƒŒ, 2‹~–œ, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

320042. [Ç—á•ñ] ‡–°Žž–³ŒÄ‹zÇŒóŒQ‚ð‡•¹‚µ‚œd“x”ì–žŠ³ŽÒ‚Ì–ƒŒŒoŒ±. “c’†ˆê¶1, ’|˜Q–¯]1, ”g—¢ƒŽq, ‹àŽq°, “¡“c“ߌb1, ‰ª–{_Žk1 (1–ƒŒ): –ƒŒ 2015/4; 64 (4): 400-3.

520015. [‘à] ŽüpŠú‚š‚æ‚ÑŽüŽYŠú‚É‚š‚¯‚éÃ–¬ŒŒðÇðÇ. •Šâ­”V (–ƒŒ): “ú–{ŽY•wl‰È¥V¶Ž™ŒŒ‰tŠw‰ïŽ 2015/5; 25 (1): 63-73.

522175. [uÀ]y“ÁW: –³’É•ª•ØUp to Datez10. Ò‘‚­‚à–Œ‰ºd–ŒŠO•¹—p’Á’É–@ (CSEA) ‚É‚æ‚é–³’É•ª•Ø. ‰œ•xr”V (–ƒŒ): ŽY‰È‚Æ•wl‰È 2015/5; 82 (5): 527-32.

522176. [uÀ]y˜AÚ: Ç—ጟ“¢ ‚æ‚­‚ ‚éƒgƒ‰ƒuƒ‹‚ðæ‚è‰z‚Š‚æ‚€ 4zpŒã‚̍R‹ÃŒÅ—Ö@’†‚É, d–ŒŠOƒJƒe[ƒeƒ‹‚ðŒë‚Á‚Ä”²‹Ž‚µ‚œ|d–ŒŠOŒŒŽî‚̏Ǐ󂪂 ‚éê‡‚Í, ’Œ‚¿‚ɐê–åˆã‚Ö. ç“cˆºŽq1, •Šâ­”V1 (1–ƒŒ): LiSA 2015/5; 22 (5): 501-3.

522177. [uÀ]y“ÁW: ŽüŽYŠú‚Ì’É‚Ý‚ÆŒü‚«‡‚€zŽY‰È@”D•w‚Ì’É‚Ý: ”ñ”D•w‚Æ‚Ì‘Šˆá. ‰œ•xr”V (–ƒŒ): ŽüŽYŠúˆãŠw 2015/12; 45 (12): 1685-8.

540055. [‚»‚Ì‘Œ]y‘æ118‰ñ“ú–{ŽY‰È–ƒŒŠw‰ïz‰ï’·u‰‰: ——ŒÌlV‚Ì—·‚ÅŒ©‚‚¯‚œƒZƒŒƒ“ƒfƒBƒsƒeƒB[. ‰œ•xr”V (–ƒŒ): •ª•Ø‚Æ–ƒŒ 2015/11; 97: 1-4.

[’˜@‘]

620119. [Šwp‘ (•ª’SŽ·•M)]y‚Ü‚ê‚ÈŽŸŠ³‚Ì–ƒŒAtoZz9. “à•ª”原Š³@[bó‘B] bó‘B‹@”\˜ŽiÇ, p.331-2. ×ìKŠó1, ‰Á“¡—¢ŠG2 (1–ƒŒ, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã), •Ò: ‚è^‹|, ‰Í–{¹Žu, –Ø“àŒbŽq, ”’_‹‘Ÿ˜Y, ”‹•œ@“N, •¶Œõ“°, “Œ‹ž, 2015/5”­s.

620120. [Šwp‘ (•ª’SŽ·•M)]y‚Ü‚ê‚ÈŽŸŠ³‚Ì–ƒŒAtoZz17. ”DPE•ª•Ø‚̍‡•¹Ç@‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX, p.564-5. “úŒür•ã1, ‰œ•xr”V1 (1–ƒŒ), •Ò: ‚è^‹|, ‰Í–{¹Žu, –Ø“àŒbŽq, ”’_‹‘Ÿ˜Y, ”‹•œ@“N, •¶Œõ“°, “Œ‹ž, 2015/5”­s.

620121. [Šwp‘ (•ª’SŽ·•M)]y–ƒŒ‰Èˆã‚Ì‚œ‚ß‚Ì‹æˆæ–ƒŒƒXƒ^ƒ“ƒ_[ƒh@Ví—ª‚ÉŠî‚­–ƒŒEŽüpŠúˆãŠwz8Í ‹æˆæ–ƒŒ‚̉ž—p@8-2. ’鉀ØŠJp‚̃|ƒCƒ“ƒg, p.262-70. ‰œ•xr”V (–ƒŒ), ŠÄC: X“c@Œ‰, ê–å•ÒW: ‰¡ŽR³®, ’†ŽR‘“X, “Œ‹ž, 2015/10”­s.

621003. [Šwp‘ (ŠÄCE•ÒW)]yƒ|ƒPƒbƒg”»@‹C“¹ŠÇ—ƒKƒCƒhƒuƒbƒNzŠÄC: ‰ª–{_Žk1, •Ò: •Šâ­”V1 (1–ƒŒ), ^‹»ŒðˆÕˆã‘o”Å•”, “Œ‹ž, 2015/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713129. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Intraoperative rise in intraocular pressure in the prone position. Tanaka K1, Takenami T1, Yamasita A1, Suzuki T2, Sakai M1, Okamoto H1: ASA 2015: American Society of Anesthesiologists Annual Meeting (2015/10/24-28), San Diego, USA. (“c’†ˆê¶1, ’|˜Q–¯]1, ŽR‰º@“Ö1, —é–Ø’mŽq2, ãˆä䝗LŽq1, ‰ª–{_Žk1: 1–ƒŒ, 2ŒöO‰q¶)

723926. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒIƒsƒIƒCƒhí—pŠ³ŽÒ‚É‚š‚¯‚銎Šo臒l‚Ì’²ž. ŠÖ“cº•F1, ‹àˆäº•¶2, —с@Œol1, ’·ŒŽ—R‹M1, r@«’q1, ‰ª–{_Žk1 (1–ƒŒ, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/28), _ŒË.

723927. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆŸÉŽ_—R—ˆ‚̈êŽ_‰»’‚‘f‚É‚æ‚é”]•ÛŒìì—p‹@˜‚ÌŒŸ“¢. ˆÀ“¡ŽõŒb1, Œ“cO”ü1, ¬âN°2, Vˆä³N3, ‰ª–{_Žk2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–ƒŒ, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/28), _ŒË.

723928. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ØƒWƒXƒgƒƒtƒB[‚É‘±”­‚µ‚œÇŒó«‘€œ^Ç‚É‚š‚¯‚éŽüpŠúŠÇ—‚ÌŒŸ“¢. “¡–ìŽÑ‹M1, ŒË“c‰ë–ç1, H“¡‰Â“ÞŽq1, ŽÂŒŽŒcŽq1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/28), _ŒË.

723929. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p’†NO‚ð‹z“ü‚µ‚œ¬Ž™S‘ŸŽèpÇ—á‚ÌŒŸ“¢. “¡“c“ߌb1, “c’†ˆê¶1, ãˆä䝗LŽq1, ŒË“c‰ë–ç1, ¬âN°1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/28), _ŒË.

723930. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’Ž’áo¶‘̏dŽ™‚É‚š‚¯‚鋹o‹Ÿ‰º“®–¬ŠÇ•Âœp (VATS-PDA) ‚ÌŽüpŠúŠÇ—: 41Ç—á‚ÌŒŸ“¢. ‘ºŒ–Ÿ“ú1, H“¡‰Â“ÞŽq1, ŽÂŒŽŒcŽq1, “¡–ìŽÑ‹M1, ŠÖ“cº•F1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/28), _ŒË.

723931. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å“®–¬•Ù‹·óÇŠ³ŽÒ‚Ì”ñS‘ŸŽèp‚É‚š‚¯‚éŽüpŠúŠÇ—‚ÌŒŸ“¢. H“¡‰Â“ÞŽq1, Œ”ö‰À1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/29), _ŒË.

723932. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • ‰çˆÊŽèp’†‚ÌŒoŽž“IŠáˆ³•Ï‰». “c’†ˆê¶1, ’|˜Q–¯]1, ŽR‰º@“Ö1, ’r“c“N–ç2, —é–Ø’qŽq3, ‰ª–{_Žk1 (1–ƒŒ, 2Šá‰È, 3ŒöO‰q¶): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/29), _ŒË.

723933. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«’ɂɑ΂·‚éŠÂ‹«‚̉e‹¿. —é–Ø›’Žk1, ‹àˆäº•¶2, —с@Œol1, ’·ŒŽ—R‹M1, ‰ª–{_Žk1 (1–ƒŒ, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/29), _ŒË.

723934. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«’ɂɑ΂·‚éŠÂ‹«‚̕ω». —é–Ø›’Žk1, ‹àˆäº•¶2, —с@Œol1, ’·ŒŽ—R‹M1, ‰ª–{_Žk1 (1–ƒŒ, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/29), _ŒË.

723935. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œz•”‚š‚æ‚Ñ‹¹•”‚ÌŽ‘±Ò‘‚­‚à–Œ‰º–ƒŒ‚É‚æ‚è—ǍD‚ÉŠÇ—‚Å‚«‚œ“«Šà«’É‚Ì1Ç—á. r@«’q1, —с@Œol1, ’·ŒŽ—R‹M1, ‹àˆäº•¶2 (1–ƒŒ, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ49‰ñ‘å‰ï (2015/7/25), ‘åã.

723936. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«‚ª‚ñ«’ÉŠ³ŽÒ‚ɑ΂·‚鎝‘±Ò‘‚­‚à–Œ‰º–ƒŒ‚ÌŒã‚ëŒü‚«ŒŸ“¢. —с@Œol1, ’·ŒŽ—R‹M1, ‹àˆäº•¶2 (1–ƒŒ, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ49‰ñ‘å‰ï (2015/7/25), ‘åã.

723937. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶Žº‘å“®–¬ƒgƒ“ƒlƒ‹‚ɑ΂·‚éV¶Ž™‹Ù‹}Žèp‚Ì1—á. H“¡‰Â“ÞŽq1, ¬âN°1, ŒË“c‰ë–ç1, “úŒür•ã1, ˆÀ“¡ŽõŒb2, ‰ª–{_Žk1 (1–ƒŒ, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ20‰ñŠwp‘å‰ï (2015/10/10), •Ÿ‰ª.

723938. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å“®–¬•Ù’uŠ·pŒã‚É•ÙŽüˆÍ‹t—¬‚𐶂¶TEE‚É‚æ‚鑁Šú”­Œ©EC•œ‚ª‰Â”\‚Å‚ ‚Á‚œ1—á. Œ”ö‰À1, ¬âN°1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ20‰ñŠwp‘å‰ï (2015/10/10), •Ÿ‰ª.

723939. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x“®–¬iNpŒã‚̐SŽº’†ŠuŒ‡‘¹Çƒpƒbƒ`•Âœ‹vp‚Åthree patch repair (Brom) •Ï–@‚ð—p‚¢‚œÇ—á‚Ì–ƒŒŒoŒ±. ŽÂŒŽŒcŽq1, ŒË“c‰ë–ç1, ¬âN°1, Œ”ö‰À1, ˆÀ“¡ŽõŒb2, ‰ª–{_Žk1 (1–ƒŒ, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ20‰ñŠwp‘å‰ï (2015/10/10), •Ÿ‰ª

723940. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒð—\–h—p‚̘A‘±ˆ³”—‘•’u‚É‚æ‚èƒr[ƒ`ƒ`ƒFƒAˆÊ‚ÌŒŒˆ³’ቺ‚ð—}‚Š‚ç‚ê‚œ1—á. ‹{“c—L—Œb, ‘å’Ë’q‹v1, ¬âN°1, ŒË“c‰ë–ç1, •Šâ­”V1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ20‰ñŠwp‘å‰ï (2015/10/11), •Ÿ‰ª

723941. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒRƒ“ƒgƒ[ƒ‹•s—Ç‚Ì‹‘åbó‘BŽîᇂ̖ƒŒŒoŒ±. •s•·ˆê‹M1, ‘å’Ë’q‹v1, ¬âN°1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ35‰ñ‘å‰ï (2015/10/21), ‰¡•l

723942. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) AngelmanÇŒóŒQŠ³ŽÒ‚Ì• o‹Ÿ‰º’_ùN“Eop‚Ì–ƒŒŒoŒ±. –ì“c@ŒO, åUdçŠG1, …àV‹³Žq1, –ì“c‹g˜a, Ÿ–”“¿ˆê (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ35‰ñ‘å‰ï (2015/10/22), ‰¡•l

723943. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ô”­“Id–ŒúŽhŒãŽ‘±Ò‘‚­‚à–Œ‰º–ƒŒ‚É‚æ‚èpŒãŠÇ—‚ðs‚Á‚œ2Ç—á. –ì˜H–ƒ”ü, Œ–{ŽœŠ°, ç“cˆºŽq1, ŠÖŒû—R‰À—¢1, —é–Ø–ƒ—t1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ35‰ñ‘å‰ï (2015/10/22), ‰¡•l

723038. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Role of TP signaling in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model. Œ“cO”ü1, ×–ì‰Á“ÞŽq2,3, ’ׯ¢—¢1, ¬‹{@Žü, ”n“ˆ³—²3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2¶—, 3–ò—): ‘æ89‰ñ“ú–{–ò—Šw‰ï”N‰ï (2016/3/10), ‰¡•l.

732129. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒKƒCƒhƒ‰ƒCƒ“‚ÉŒ©‚éƒn[ƒgƒ`[ƒ€‚Ì–ðŠ„. ‰ª–{_Žk (–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ïŠÖ“ŒbM‰zE“Œ‹žŽx•”‘æ55‰ñ‡“¯ŠwpW‰ï (2015/9/5), ‰¡•l

733359. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p’†‚ÌNasal High FlowTMŽg—p‚ª, ‹CŠÇ‘}ŠÇ‚̉ñ”ð‚É—L—p‚Å‚ ‚Á‚œ, ‚“x¬‡«Š·‹CáŠQ‡•¹ŠJ• ŽèpÇ—á. “¡“c“ߌb1, ŒàV‹`”V1, Vˆä³N2, ˆÉ“¡‘s•œ1, •Šâ­”V1, ‰ª–{_Žk1 (1–ƒŒ, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{–ƒŒ‰ÈŠw‰ïŠÖ“ŒbM‰zE“Œ‹žŽx•”‘æ55‰ñ‡“¯ŠwpW‰ï (2015/9/5), ‰¡•l

733360. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å—ʂ̐SùN‰t’™—¯‚ɑ΂·‚鋹o‹Ÿ‰ºS”XƒhƒŒƒi[ƒW‚ð–TÒ’ŃuƒƒbƒN•¹—p‘Sg–ƒŒ‚ÅŠÇ—‚µ‚œ1—á. ‹g‘ºŒOŽq1, ‘“c—S–ç, ‰ª“c”ü», ”–ؐ­Œ›, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ïŠÖ“ŒbM‰zE“Œ‹žŽx•”‘æ55‰ñ‡“¯ŠwpW‰ï (2015/9/5), ‰¡•l.

H26”N“xˆÈ‘O•ª

[’˜@‘]

H26-620012. [Šwp‘ (•ª’SŽ·•M)]y“ìŽR“°ˆãŠw‘厫“T ‘æ20”ŁzƒŠƒ“ƒp‹…—AŒŒ, p.2573-4. •Šâ­”V (–ƒŒ), “ìŽR“°, “Œ‹ž, 2015/3”­s.


—Տ°ŒŸžf’fŠw

[Šw‰ïEŒ€‹†‰ï“™]

732130. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) R-CPC (Reversed-Clinicopathological Conference). Žë–ì—Lì (—ÕŒŸŠw): •œ¬27”N“xŒŸžà–ŸE‘Š’k‚ª‚Å‚«‚é—Տ°ŒŸž‹ZŽtˆç¬uK‰ï (2015/10/18), ‘Š–ÍŒŽ.


—AŒŒE×–EˆÚAŠw

[Šwp˜_•¶]

540056. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (ˆã–ò•iEˆã—Ë@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ€‹†Ž–‹Æ)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆÀ‘SŠÄŽ‹) ‘̐§‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†vz•lŒû@Œ÷, ‰Á“¡‰hŽj, “c’†’©Žu, •Ä‘º—YŽm, “¡ˆäN•F, ‰ªè@m, “ú–ì@Šw, –L“c‹ã˜N, ŒÜ\—’Ž , •œ@—Í‘¢, •S£r–ç, –kàV~ˆê, ‰œŽR”üŽ÷, ‘åŒG@˜a, Îˆä”Ž”V, ‘å’JTˆê1, ‘åâŒ°’Ê, ’†ŽR‹”V, Œ‰ª²•ÛŽq, ¬‚ç‰ÁŽq (1—AŒŒE×–EˆÚA): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (ˆã–ò•iEˆã—Ë@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ€‹†Ž–‹Æ)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆÀ‘SŠÄŽ‹) ‘̐§‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†v•œ¬25”N“x`•œ¬27”N“x‘‡Œ€‹†•ñ‘ 2016/3; p.3-12.

540057. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (ˆã–ò•iEˆã—Ë@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ€‹†Ž–‹Æ)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆÀ‘SŠÄŽ‹) ‘̐§‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†vz•lŒû@Œ÷, ‰Á“¡‰hŽj, “c’†’©Žu, •Ä‘º—YŽm, “¡ˆäN•F, ‰ªè@m, “ú–ì@Šw, –L“c‹ã˜N, ŒÜ\—’Ž , •œ@—Í‘¢, •S£r–ç, –kàV~ˆê, ‰œŽR”üŽ÷, ‘åŒG@˜a, Îˆä”Ž”V, ‘å’JTˆê1, ‘åâŒ°’Ê, ’†ŽR‹”V, Œ‰ª²•ÛŽq, ¬‚ç‰ÁŽq (1—AŒŒE×–EˆÚA): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (ˆã–ò•iEˆã—Ë@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ€‹†Ž–‹Æ)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆÀ‘SŠÄŽ‹) ‘̐§‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2016/3; p.3-9.

540058. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (ˆã–ò•iEˆã—Ë@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ€‹†Ž–‹Æ)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆÀ‘SŠÄŽ‹) ‘̐§‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†vzV‚œ‚ÈŒŒ‰t»ÜŠÇ—î•ñŽûW‚Ì‚œ‚߂̃Iƒ“ƒ‰ƒCƒ“ƒVƒXƒeƒ€‚ÌŠJ”­. •lŒû@Œ÷, ‹I–ìCˆê, ‘å’JTˆê1, ÎâG–å, “ú–ì@Šw, Îˆä”Ž”V, “ú–ì@Šw, –L“c‹ã˜N, ŒÜ\—’Ž , •œ@—Í‘¢, Îˆä”Ž”V, ‘åãŒ°’Ê, “¡ˆäN•F, ‰Á“¡‰hŽj, –kàV~ˆê, ‘åŒG@˜a, Œ‰ª²•ÛŽq (1—AŒŒE×–EˆÚA): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (ˆã–ò•iEˆã—Ë@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ€‹†Ž–‹Æ)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆÀ‘SŠÄŽ‹) ‘̐§‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2016/3; p.13-25.

540059. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (ˆã–ò•iEˆã—Ë@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ€‹†Ž–‹Æ)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆÀ‘SŠÄŽ‹) ‘̐§‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†vzV‚œ‚ÈŒŒ‰t»ÜŠÇ—î•ñŽûW‚Ì‚œ‚߂̃Iƒ“ƒ‰ƒCƒ“ƒVƒXƒeƒ€‚ÌŠJ”­. •lŒû@Œ÷, ‹I–ìCˆê, ‘å’JTˆê1, ÎâG–å, “ú–ì@Šw, Îˆä”Ž”V, “ú–ì@Šw, –L“c‹ã˜N, ŒÜ\—’Ž , •œ@—Í‘¢, Îˆä”Ž”V, ‘åãŒ°’Ê, “¡ˆäN•F, ‰Á“¡‰hŽj, –kàV~ˆê, ‘åŒG@˜a, Œ‰ª²•ÛŽq (1—AŒŒE×–EˆÚA): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (ˆã–ò•iEˆã—Ë@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ€‹†Ž–‹Æ)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆÀ‘SŠÄŽ‹) ‘̐§‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†v•ª’SŒ€‹†•ñ‘ 2016/3; p.15-28.

[’˜@‘]

620122. [Šwp‘ (•ª’SŽ·•M)]yl‚Š‚é—Տ°ŒŸž@ƒXƒNƒŠ[ƒjƒ“ƒOŒŸž‚ňُí’l‚ð‚Ý‚œ‚ç?z‘æIÍ ˆÙí’l[“ǂ݃OƒŒ[ƒhƒAƒbƒv@11. ‘’`”’‚’l, p.64-8. ‘å’JTˆê (—AŒŒE×–EˆÚA), •Ò: Œ”öŽû“ñ, •¶Œõ“°, “Œ‹ž, 2015/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

723944. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Šú”xŠàŠ³ŽÒ‚ð‘ΏۂƂµ‚œ‘œŽíŠù’mŽîᇃ}[ƒJ[‚ɑ΂·‚鎩ŒÈR‘Ì‚Ì“¯Žž‘ª’è‚Æ‚»‚̗Տ°“I—L—p«. ”«‘º˜a’j1, ’·‰–@—º1, ²“¡—Yˆê1, ‘å’JTˆê2, Žë–ì—Lì3, Ô¯@“§4 (1ˆã—Éq¶Šw•”, 2—AŒŒE×–EˆÚA, 3—ÕŒŸŠw, 4‘‡f—Ã): ‘æ62‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ï (2015/11/19-22), Šò•Œ.


‹~–œ‹~‹}ˆãŠw

[Šwp˜_•¶]

110310. [ŒŽ’˜] Hybrid treatment combining emergency surgery and intraoperative interventional radiology for severe trauma. Kataoka Y1, Minehara H1, Kashimi F1, Hanajima T1, Yamaya T1, Nishimaki H, Asari Y1: Injury 2016/1; 47 (1): 59-63. (•Ð‰ª—Sˆê1, •ôŒŽG¹1, Š~Œ©•¶Ž}1, ‰Ô“‡@Ž‘1, ŽR’J—§‘å1, ó—˜@–õ1: 1‹~–œ)

110311. [ŒŽ’˜] Impact of clinical nutritional education for fifth year medical students through the attendance of NST rounds for critically ill patieants: a prospective interventional study in Japan. Kan'o T1, Kataoka Y1, Soma K, Asari Y1: Austin Critical Care Journal 2015; 2 (1): 1-4. (_œä’m“¹1, •Ð‰ª—Sˆê1, ó—˜@–õ1: 1‹~–œ)

522178. [uÀ]y“ÁW: dÇŠ³ŽÒ‚É‚š‚¯‚é‹}«Šú‰h—{—Ö@; ˜_“_‚̐®—zŒo’°‰h—{‚Ì•s‘«•ª‚Í‚¢‚Ö¬‰h—{‚Å•â‘«‚·‚é‚ׂ«‚©. _œä’m“¹ (‹~–œ): “ú–{Ã–¬Œo’°‰h—{Šw‰ïŽGŽ 2015/4; 30 (2): 669-73.

522179. [uÀ]y“ÁW: Žcˆâ‚·‚éÇó‚Í‚Ç‚±‚܂ʼnñ•œ‚·‚é‚©z“‡Žž’²Ç‚ÌŽcˆâÇó. Vˆä‹v–« (‹~–œ): ž_‰ÈŽ¡—Êw 2015/6; 30 (6): 727-30.

522180. [uÀ]y“ÁW: dÇ•a‘Ԃ̉h—{:—Ö@ ÅV‚Ì’mŽ¯‚Æ‚»‚ÌŽÀ‘Hz5. ‰h—{‘g¬@Ž‰–b‚ÌŽí—Þ‚ÆŽ‰–b“ûÜ. _œä’m“¹ (‹~–œ): ‹~‹}EW’†Ž¡—à 2015/8; 27 (7): 591-8.

522181. [uÀ]y“ÁW: —Տ°‰h—{; ’–ڂ̘b‘èzƒ`[ƒ€‚ÅŽæ‚è‘g‚Þ‰h—{ŠÇ—. •Ð‰ª—Sˆê (‹~–œ): ‹~‹}ˆãŠw 2015/11; 39 (12): 1721-6.

[’˜@‘]

620123. [Šwp‘ (•ª’SŽ·•M)]y‰h—{—Ö@‚̃sƒbƒgƒtƒH[ƒ‹ ‚æ‚è‚æ‚¢‰h—{ƒPƒA‚Ì‚œ‚ß‚É (—Տ°‰h—{—ÕŽž‘Š§†126 (6))zPart3 Ã–¬‰h—{@•âŠ®“IÃ–¬‰h—{ (SPN) ‚Æ‚Í‚È‚É‚©?, p.878-84. _œä’m“¹ (‹~–œ), Šé‰æ: ²X–؉ë–ç, ˆãŽ•–òo”Å, “Œ‹ž, 2015/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722213. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) •ïŠ‡“Iƒ`[ƒ€ˆã—Âɂæ‚édÇŠOŠ³ŽÒŠÇ—. •Ð‰ª—Sˆê1, _œä’m“¹1, •ž•”@1, ‰Ô“‡@Ž‘1, ‹{è“¹‹P2, _•Û•‘¥2, ó—˜@–õ1 (1‹~–œ, 2ƒŠƒnƒrƒŠ•”): ‘æ29‰ñ“ú–{ŠOŠw‰ï‘‰ïEŠwpW‰ï (2015/6/12), ŽD–y.

722214. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) dÇŠOŠ³ŽÒ‚̉h—{ŠÇ—‚̏dÇ«. •Ð‰ª—Sˆê1, ‰Ô“‡@Ž‘1, ó—˜@–õ1 (1‹~–œ): ‘æ7‰ñAcute Care SurgeryŠw‰ïŠwpW‰ï (2015/10/4), •Ÿ‰ª.

722215. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹~–œ‹~‹}ƒZƒ“ƒ^[‚É”À‘—‚³‚ꐞ_ŽŸŠ³‚ª‹^‚í‚ê‚œŠ³ŽÒ‚ɑ΂·‚é‘Ήž. Vˆä‹v–«1, ˆäãŸ•v2, ó—˜@–õ1, ‹{‰ª@“™2 (1‹~–œ, 2ž_): ‘æ28‰ñ“ú–{‘‡•a‰@ž_ˆãŠw‰ï‘‰ï (2015/11/28), “¿“‡.

722216. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹~‹}EW’†Ž¡—×̈æ‚É‚š‚¯‚郊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Ɖh—{ŠÇ—‚ɑ΂·‚é•ïŠ‡“Iƒ`[ƒ€ˆã—Â̗L—p«. •Ð‰ª—Sˆê1, _œä’m“¹1, “y‰®Žu•Û2, ²“¡ÆŽq3, ó—˜@–õ1 (1‹~–œ, 2ŠÅŒì•”, 3‰h—{•”): ‘æ31‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ïŠwpW‰ï (2016/2/26), •Ÿ‰ª.

722217. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • •”œ”ÕŠO‚ɑ΂·‚é‹Ù‹}Žèp‚ÆIVR‚̃Rƒ“ƒrƒl[ƒVƒ‡ƒ“Ž¡—Â̗L—p«‚š‚æ‚ÑIVR‚ÌŒÀŠE. •Ð‰ª—Sˆê1, ‰Ô“‡@Ž‘1, Š~Œ©•¶Ž}1, ŽR’J—§‘å1, ¬‘q’Œl1, ó—˜@–õ1 (1‹~–œ): ‘æ52‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2016/3/4), “Œ‹ž.

723945. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éS—Óà‰ÈŠO—ˆ‚ł̗Տ°“IŒXŒü‚ÉŠÖ‚µ‚Ä. Vˆä‹v–«1, ‘å‹v•Û’z¢, ‰Á“¡Œ[Žq (1‹~–œ): ‘æ111‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2015/6/4-6), ‘åã.

723946. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠOÇ—á‚ɑ΂·‚é–k—¢‘åŠw•a‰@ƒhƒNƒ^[ƒJ[ƒVƒXƒeƒ€‚Ì—L—p«. ŽR’J—§‘å1, _œä’m“¹1, ‘“c’q¬1, ’©ŒG’õ—²1, ˆîŠ_‘דl1, •ž•”@1, ’|“àˆê˜Y1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ18‰ñ“ú–{—Տ°‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2015/6/5), •xŽR.

723947. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–ƒZƒ“ƒ^[‚É‚š‚¯‚éŠO«t“®–¬ (–{Š²) ‘¹‚ÌŽ¡—ÃŒoŒ±. Š~Œ©•¶Ž}1, ŽR’J—§‘å1, ’©ŒG’õ—²1, ˆîŠ_‘דl1, ‰Ô“‡@Ž‘1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ29‰ñ“ú–{ŠOŠw‰ï (2015/6/11), ŽD–y.

723948. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é• •”Žh‘nÇ—á‚ÌŒŸ“¢. ‰Ô“‡@Ž‘1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ29‰ñ“ú–{ŠOŠw‰ï (2015/6/11), ŽD–y.

723949. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Injury severity score 9ˆÈã‚ÌŠOŠ³ŽÒ‚É‚š‚¯‚é—ˆ‰@Žž‰h—{•]‰¿‚Æ—\Œã. _œä’m“¹1, •Ð‰ª—Sˆê1, ‰Ô“‡@Ž‘1, ’†’JŒ€“l1, ˆîŠ_‘דl1, ŽR’J—§‘å1, ’©ŒG’õ—²1, ‘“c’q¬1, ’|“àˆê˜Y1, ó—˜@–õ1 (1‹~–œ): ‘æ29‰ñ“ú–{ŠOŠw‰ï (2015/6/12), ŽD–y.

723950. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇœ”ՍœÜ‚ɍ‡•¹‚µ‚œ’°œÃ–¬‘¹‚ɑ΂·‚éÃ–¬‘¢‰e‚Ì—L—p«. •Ð‰ª—Sˆê1, Š~Œ©•¶Ž}1, ŽR’J—§‘å1, ‰Ô“‡@Ž‘1, ‰Í‘º@’Œ2, •ôŒŽG¹1, ó—˜@–õ1 (1‹~–œ, 2®ŠO): ‘æ29‰ñ“ú–{ŠOŠw‰ï (2015/6/12), ŽD–y.

723951. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) D‚«‚ȏˆ•ûE“ŸˆÓ‚ȏˆ•û@ˆÀ‘S‚ÈŠ³ŽÒŠÇ—‚ªs‚Š‚žˆã—Ï]Ž–ŽÒ‚ª”æ•Ÿ‚·‚és“®‚É‚Í—}ŠÌŽUq‹~‹}W’†Ž¡—×̈æ‚Å‚ÌŽg—pŒoŒ±r. _œä’m“¹ (‹~–œ): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/12-14), •xŽR.

723952. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œy“x”F’máŠQ‚É‚š‚¯‚é‘å”]”’Ž¿•a•Ï‚Æ“®–¬d‰»E¶ŠˆKŠµ‚ÌŠÖ˜A. Vˆä‹v–«1, ‚‹Ž@Œb2, ’†“‡Œ[‰î2, ‘åÎ@’q2, ‹{‰ª@“™2 (1‹~–œ, 2ž_): ‘æ34‰ñ“ú–{”F’mÇŠw‰ïŠwpW‰ï (2015/10/2), ÂX.

723953. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œ”ՍœÜ‚ɍ‡•¹‚·‚éiliac vein injury‚ɑ΂·‚éƒAƒvƒ[ƒ`. •Ð‰ª—Sˆê1, ‰Ô“‡@Ž‘1, ó—˜@–õ1 (1‹~–œ): ‘æ7‰ñ“ú–{Acute Care SurgeryŠw‰ï (2015/10/3), •Ÿ‰ª.

723954. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é‹Ù‹}ŠJ• Žèp‚ðŽ{s‚µ‚œ”sŒŒÇ«DICÇ—á‚ÌŒŸ“¢. ‰Ô“‡@Ž‘1, •Ð‰ª—Sˆê1, ¬‘q’Œl1, ó—˜@–õ1 (1‹~–œ): ‘æ7‰ñ“ú–{Acute Care SurgeryŠw‰ï (2015/10/3), •Ÿ‰ª.

723955. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠO«”]“àŒŒŽî‚ɑ΂·‚é_Œo“àŽ‹‹Ÿ“IŒŒŽîœ‹Žp‚Ì—L—p«‚ÌŒŸ“¢. ¬òŠ°”V1, ŽR–{‘å•ã2, •“c”Ž‹I2, ŒG•”rG2 (1‹~–œ, 2”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ74‰ñŠwp‘‰ï (2015/10/15), ŽD–y.

723956. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰@ŠOS”x’âŽ~Ç—á‚Ì”äŠr‚É‚æ‚é‘ÌŠOzŠÂŽ®S”x‘h¶–@‚Ì—LŒø«‚ÌŒŸ“¢. ŠÛ‹ŽFº1, ’|“àˆê˜Y1, •ž•”@1, _œä’m“¹1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ43‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2015/10/21), “Œ‹ž

723957. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “àŽ‹‹Ÿ“I‚É“Eo‚µ‚Š‚œŒoãè–å“I’Œ’°ˆÙ•š‚Ì1—á. •Ð•ô³á©, ’†’JŒ€“l1, ŽR’J—§‘å1, ŠÛ‹ŽFº1, •ž•”@1, ’|“àˆê˜Y1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ43‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2015/10/21), “Œ‹ž

723958. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚鐞_ŽŸŠ³‡•¹Ç—á‚ւ̑Ήž. ŽR’J—§‘å1, Vˆä‹v–«1, _œä’m“¹1, ²“¡çŒb1, •ž•”@1, ’|“àˆê˜Y1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ43‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2015/10/23), “Œ‹ž

723959. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠO«”]“àŒŒŽî‚ɑ΂·‚é_Œo“àŽ‹‹Ÿ“IŒŒŽîœ‹Žp‚Ì—L—p«‚ÌŒŸ“¢. ¬òŠ°”V1, ŽR–{‘å•ã2, ‹TŽR¹K2, ’h@@[2, ŒG•”rG2 (1‹~–œ, 2”]ŠO): ‘æ22‰ñ“ú–{_Œo“àŽ‹‹ŸŠw‰ï (2015/11/6), Œ“‡.

723960. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Spontaneous Extraperitoneal Hemorrhage‚̗Տ°“IŒŸ“¢. ŠÛ‹ŽFº1, ŽR’J—§‘å1, ’|“àˆê˜Y1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ43‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2016/2/12), _ŒË

723961. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ÅŒoŒ±‚µ‚œ”j•—Ç—á‚ÌŒŸ“¢. ŽR’J—§‘å1, •ž•”@1, _œä’m“¹1, ’|“àˆê˜Y1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ43‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2016/2/12), _ŒË

723962. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇŠ³ŽÒ‚É‚š‚¯‚錌‰tŒŸžƒf[ƒ^‚É‚æ‚é‰h—{•]‰¿‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. ‰““¡¬Žq, •Ð‰ª—Sˆê1, _œä’m“¹1, ²“¡ÆŽq2, ‹ß“¡‰{Žq2 (1‹~–œ, 2‰h—{•”): ‘æ31‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ïŠwpW‰ï (2016/2/25), •Ÿ‰ª

723963. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰fŽžf’f‚Å‚«‚È‚©‚Á‚œ’°ŠÔ–Œ’f—ô‚Ì1—á. ‰Ô“‡@Ž‘1, •Ð‰ª—Sˆê1, ¬‘q’Œl1, ó—˜@–õ1 (1‹~–œ): ‘æ52‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï (2016/3/4), “Œ‹ž

723964. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) œ‘gD—R—ˆŠÔ—tŒn×–E‚̐¶•šŠw“IŒŸ“¢. ŒFàVŒ›ˆê1, ŽRèˆÀ°2, ™–{F”V2, ”nêŽq, ‘]ª—R”üŽq3, •“c@Œ[2 (1‹~–œ, 2Œ`¬E”üŠO, 3•a‘ԁEf—ÃŒn): ‘æ15‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï (2016/3/19), ‘åã.

733361. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒnƒ“ƒ`ƒ“ƒgƒ“•‘“¥•aŠ³ŽÒ‚ÌŽ©ŽEŠé}‚É‚æ‚é“]—ŽŠO‚ªl‚Š‚ç‚ê‚œÇ—á‚ÉŠÖ‚µ‚Ä‚ÌŒŸ“¢. Vˆä‹v–«1, ˆäãŸ•v2, ‹{’n‰p—Y2, ‹{‰ª@“™2 (1‹~–œ, 2ž_): ‘æ41‰ñ_“ސ쌧SgˆãŠw‰ï‘‰ï‚š‚æ‚ÑŠwpW‰ï (2015/9/26), _“ސì

733362. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šç–ʍœœÜ‚ɑ΂·‚éŒÅ’è‹ï‚ª’Ž‚‚É’â‘Ø‚µŠO‰ÈŽèp‚É‚Ä“Eo‚µ‚œ1—á. ŒÃ“c—S‰ÀŽq, _œä’m“¹1, ŽR’J—§‘å1, ŒFàVŒ›ˆê1, ‰Ô“‡@Ž‘1, ¬‘q’Œl1, ’|“àˆê˜Y1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ï (2016/2/6), “Œ‹ž

733363. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~‹}ŠO—ˆ‚Őf’f‚̂‚©‚È‚©‚Á‚œ—Œ‘€Ž‹°[Ç‚̈ê—á. ”‹ŒŽ¹D, _œä’m“¹1, ‘“c’q¬1, ’©ŒG’õ—²1, ŠÛ‹ŽFº1, ŽR’J—§‘å1, ˆîŠ_‘דl1, ‰Ô“‡@Ž‘1, •ž•”@1, Š~Œ©•¶Ž}1, ’|“àˆê˜Y1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ï (2016/2/6), “Œ‹ž

733364. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œÊ‚ȐS“d}•Ï‰»‚ð”F‚ß‚œƒeƒIƒtƒBƒŠƒ“’†“łɑ΂µWŠw“I‚ÈŽ¡—ª—LŒø‚Å‚ ‚Á‚œˆê—á. —§ì¹Æ, _œä’m“¹1, ‘“c’q¬1, ’©ŒG’õ—²1, ŠÛ‹ŽFº1, ŽR’J—§‘å1, ˆîŠ_‘דl1, ‰Ô“‡@Ž‘1, •ž•”@1, Š~Œ©•¶Ž}1, ’|“àˆê˜Y1, •Ð‰ª—Sˆê1, ó—˜@–õ1 (1‹~–œ): ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ï (2016/2/6), “Œ‹ž

733365. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~–œ‹~‹}ÐŠQˆã—ŸƒZƒ“ƒ^[‚É”À‘—‚³‚ê‚œ‹Gß‚â”À‘—ŽžŠÔ‘сE—j“ú‚Æ‚ÌŠÖŒW«‚ÉŠÖ‚µ‚Ä. Vˆä‹v–«1, ˆäãŸ•v2, ‹{’n‰p—Y2, ‘åÎ@’q2, ó—˜@–õ1, ‹{‰ª@“™2 (1‹~–œ, 2ž_): ‘æ42‰ñ_“ސ쌧SgˆãŠw‰ï‘‰ï‚š‚æ‚ÑŠwpW‰ï (2016/3/5), ‰¡•l

733366. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~–œ‹~‹}ƒZƒ“ƒ^[‚ÉŽ©ŽEŠé}‚Å”À‘—‚³‚ê‚œŠ³ŽÒ‚Ì‹Gß‚â”À‘—ŽžŠÔ‘сE—j“ú‚ɂ‚¢‚Ä. Vˆä‹v–«1, ˆäãŸ•v2, ‹{’n‰p—Y2, ‘åÎ@’q2, ó—˜@–õ1, ‹{‰ª@“™2 (1‹~–œ, 2ž_): ‘æ42‰ñ_“ސ쌧SgˆãŠw‰ï‘‰ï‚š‚æ‚ÑŠwpW‰ï (2016/3/5), ‰¡•l.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-310004. [Ç—á•ñ] Refractory status epilepticus, circulatory collapse after cardiac arrest, and acute respiratory distress syndrome caused by severe isolated fluvoxamine poisoning: a case report. Kan'o T1, Kamijo Y1, Hattori J1, Kashimi F1, Sato C1, Yoshimura K: Acute Medicine & Surgery 20151/; 2 (1): 53-5. (_œä’m“¹1,ãžŠ‹gl1, •ž•”@1, Š~Œ©•¶Ž}1, ²“¡çŒb1: 1‹~–œ)


‘‡f—ÈãŠw

[Šwp˜_•¶]

110312. [ŒŽ’˜] Medical explanations to family members in the foyer and hallway during home medical care visits. Kimura T1CMatsuzaki MCImanaga T, Akahoshi T1: Kitasato Med J 2015/9; 45 (2): 130-7. (–Ø‘º‘ô–1, Ô¯@“§1: 1‘‡f—Ã)

110313. [ŒŽ’˜] Clinical Background of Attendance by Patient's Family during Home Medical Care Visits. Kimura T1, Imanaga T, Matsuzaki M, Akahoshi T1: Journal of General and Family Medicine 2015/12; 16 (4): 271-80. (–Ø‘º‘ô–1, Ô¯@“§1: 1‘‡f—Ã)

120063. [ŒŽ’˜] Ý‘îˆã—Âɂš‚¯‚éˆãŽtE–K–âŠÅŒìŽt‚É‚æ‚éˆÝá‘ŒðŠ·‚ÉŠÖ‚·‚é’²ž. –Ø‘º‘ô–1, ‹g]@Œå, “y‰®—ÚŒ©Žq, ì‰z³•œ, •œŒŽ²“lŽi (1‘‡f—Ã): “úÝˆã‰ïŽ 2015/7; 17 (1): 11-9.

521029. [‰ðà] ‚—îŽÒ‚ƃAƒƒ}ƒeƒ‰ƒs[. –Ø‘º‘ô– (‘‡f—Ã): AEAJ (ƒAƒƒ}ŠÂ‹«‹Š‰ï‹@ŠÖŽ) 2015//9; 77: 26-9.

522182. [uÀ]y“ÁW: ŽÀ‘H! “ª’ɐf—Á|“ª’É‚É”Y‚ÞŠ³ŽÒ‚ð‚Ç‚€f‚Ä‚Ç‚€Ž¡‚·?zÀ’k‰ï: ‚±‚ê‚©‚ç‚Ì“ª’ɂ̃`[ƒ€ˆã—Âðl‚Š‚é. Ži‰ï: ŒÜ\—’‹v‰À, ó–ì‰ê—Y, ŒÜ–ì—R‰À—1, ”n™ˆ»Žq (1‘‡f—Ã): —Տ°ŽGŽ“à‰È 2015/5; 115 (5): 823-31.

522183. [uÀ]yƒVƒ“ƒ|ƒWƒEƒ€2-3z“ª’ÉŠ¿•ûŽ¡—Â̎ÀÛ. ŒÜ–ì—R‰À— (‘‡f—Ã): “ª’ÉŠw‰ïŽ 2015/7; 42 (1): 102-5.

522184. [uÀ]yƒVƒ“ƒ|ƒWƒEƒ€zÝ‘îˆã—Âɂš‚¯‚éuˆã—ÁE‰îŒì˜AŒgv‚̍¡“ú“IˆÓ‹`. –Ø‘º‘ô– (‘‡f—Ã): “úÝˆã‰ïŽ 2015/7; 17 (1): 123.

540060. [‚»‚Ì‘Œ] ƒvƒ‰ƒ^ƒiƒX: Ý‘îf—Âɂš‚¯‚éˆã—ψ’uŽÀŽ{‚Ì”»’f. –Ø‘º‘ô– (‘‡f—Ã): TŠ§“ú–{ˆãŽ–V–@ 2015/4; 4746: 1.

540061. [‚»‚Ì‘Œ (Editorial)] ¡‚±‚»ƒvƒ‰ƒCƒ}ƒŠEƒPƒA—̈æ‚̗Տ°E‹³ˆç‚ÉŠÖ‚·‚éî•ñ”­M‚ð! –Ø‘º‘ô– (‘‡f—Ã): “ú–{ƒvƒ‰ƒCƒ}ƒŠEƒPƒA˜A‡Šw‰ïŽ 2015/12; 38 (4): 334.

[’˜@‘]

620124. [Šwp‘ (•ª’SŽ·•M)]y‘‡f—Ðê–åˆãƒVƒŠ[ƒY@‘‡f—Ðê–åˆã‚̃Jƒ‹ƒe|ƒvƒƒuƒŒƒ€ƒŠƒXƒg‚ÉŠî‚­f—Â̎ÀÛz‚—îŠú@Še˜_@12. ‹•Žã‚—îŽÒEQ‚œ‚«‚è, p.138-9. –Ø‘º‘ô– (‘‡f—Ã), •ÒWŽåŠ²: ‘ê“SŽü, ê–å•ÒW, ‰¡—ÑŒ«ˆê, ’†ŽR‘“X, “Œ‹ž, 2015/7”­s.

620125. [Šwp‘ (•ª’SŽ·•M)]y‘‡f—Ðê–åˆãƒVƒŠ[ƒY@‘‡f—Ðê–åˆã‚̃Jƒ‹ƒe|ƒvƒƒuƒŒƒ€ƒŠƒXƒg‚ÉŠî‚­f—Â̎ÀÛz‚—îŠú@Še˜_@13. “Æ‹E•Â‚¶‚±‚à‚è, p.140-1. –Ø‘º‘ô– (‘‡f—Ã), •ÒWŽåŠ²: ‘ê“SŽü, ê–å•ÒW, ‰¡—ÑŒ«ˆê, ’†ŽR‘“X, “Œ‹ž, 2015/7”­s.

622126. [Šwp‘ (–|–ó)]yl‚Š‚é‹Zp —Տ°“IŽvl‚𕪐͂·‚é ‰ü’ù‘æ3”Å (Symptom to Diagnosis: An Evidence-Based Guide)z’|–{@‹B (‘‡f—Ã), “úŒoBPŽÐ, “Œ‹ž, 2015/6”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722218. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Ý‘îˆã—Âɂš‚¯‚éˆã—ÁE‰îŒì˜AŒg‚̍¡“ú“IˆÓ‹`. –Ø‘º‘ô– (‘‡f—Ã): ‘æ17‰ñ“ú–{Ý‘îˆãŠw‰ï‚à‚è‚š‚©‘å‰ï (2015/4/25), ·‰ª.

723965. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒOƒ‹[ƒvf—ÂŖK–âf—Âðs‚€ÛuŒÂX‚̈ãŽt‚É‚æ‚Á‚Äà–Ÿ‚·‚é u“à—e‚ªˆá‚€v‚ƉƑ°‚ªŠŽ‚¶‚邱‚Ƃ́u–K–âŠÔŠu‚ª’·‚¢‚±‚Ɓv uˆãŽt‚ɉï˜b‚ðŽÕ‚ç‚ê‚œ‰Æ‘°‚ÌŒoŒ±v‚ÆŠÖŒW‚µ‚Ä‚¢‚é. –Ø‘º‘ô–1, ¡‰iŒõ•F, Œè~l, ⚍F‘Ÿ˜Y1, ŒÜ–¡ˆê‰p, Ô¯@“§1 (1‘‡f—Ã): ‘æ17‰ñ“ú–{Ý‘îˆãŠw‰ï‚à‚è‚š‚©‘å‰ï (2015/4/25), ·‰ª.

723966. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘‚ñI––ŠúŠ³ŽÒ‚É‚š‚¢‚Ä, ƒRƒ‹ƒ`ƒRƒXƒeƒƒCƒh“Š—^‚É‚æ‚é ŒoŒûÛŽæ—ʂ̉ü‘P‚Ì—L–³‚Í—\Œã—\‘ª‚É—L—p‚Å‚ ‚é. ¡‰iŒõ•F, ŠOŽR“N–ç, ‹ß“¡Gˆê, –Ø‘º‘ô–1 (1‘‡f—Ã): ‘æ17‰ñ“ú–{Ý‘îˆãŠw‰ï‚à‚è‚š‚©‘å‰ï (2015/4/25), ·‰ª.

723967. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –K–âŠÅŒì‚É‚š‚¯‚éƒJƒe[ƒeƒ‹ŒðŠ·ˆ’u‚ÌŽÀŽ{ó‹µ‚Æ’nˆæ“Á«‚ÌŠÖ˜A. •œ–ì@‰›, ‹g]@Œå, –Ø‘º‘ô–1, –ìŒû–ƒˆßŽq, ì‰z³•œ, •œŒŽ²“lŽi (1‘‡f—Ã): ‘æ17‰ñ“ú–{Ý‘îˆãŠw‰ï‚à‚è‚š‚©‘å‰ï (2015/4/25), ·‰ª.

723968. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –K–âf—Âɂš‚¯‚éƒJƒe[ƒeƒ‹ŒðŠ·ˆ’u‚ÌŽÀŽ{ó‹µ‚Æ’nˆæ“Á«‚Æ‚ÌŠÖ˜A. –Ø‘º‘ô–1, ‹g]@Œå, ì‰z³•œ, •œŒŽ²“lŽi, ”Ñ“‡Ÿ–î, ŽR’†@’ (1‘‡f—Ã): ‘æ17‰ñ“ú–{Ý‘îˆãŠw‰ï‚à‚è‚š‚©‘å‰ï (2015/4/25), ·‰ª.

723969. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘îˆã—Âɂš‚¯‚éˆãŽtE–K–âŠÅŒìŽt‚É‚æ‚éˆÝá‘ŒðŠ·‚ÉŠÖ‚·‚é’²ž. –Ø‘º‘ô– (‘‡f—Ã): ‘æ6‰ñ“ú–{ƒvƒ‰ƒCƒ}ƒŠEƒPƒA˜A‡Šw‰ïŠwp‘å‰ï (2015/6/14), ‚‚­‚Î.

H26”N“xˆÈ‘O•ª

[’˜@‘]

H26-620013. [Šwp‘ (•ª’SŽ·•M)]y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z˜Íg—Š‚ê‚éŽåŽ¡ˆãh‚Æ‚µ‚č‚—îŽÒ‚ðf‚éÛ‚̐S“Ÿ@1. ‚—îŽÒ‚ɐê–åf—ÉȂðÐ‰î‚·‚é‚©”Û‚©‚Ì”»’f, p.16-7. –Ø‘º‘ô–1 (1‘‡f—Ã), •Ò: –Ø‘º‘ô–1, Œ‘º^Ži, —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-620014. [Šwp‘ (•ª’SŽ·•M)]y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z˜Íg—Š‚ê‚éŽåŽ¡ˆãh‚Æ‚µ‚č‚—îŽÒ‚ðf‚éÛ‚̐S“Ÿ@2. ‚—îŽÒ‚ɐê–åf—ÉȂðŽóf‚µ‚Ä‚à‚ç‚€‘O‚Ɏ厡ˆã‚ªs‚€‚ׂ«‚±‚Æ, p.18-9. –Ø‘º‘ô–1 (1‘‡f—Ã), •Ò: –Ø‘º‘ô–1, Œ‘º^Ži, —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-620015. [Šwp‘ (•ª’SŽ·•M)]y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z‘æ5Í Žš•@ˆôA‰È“I–â‘è@1. •à‚­‚ƃtƒ‰ƒtƒ‰‚·‚é (–«‚Ì”ñ‰ñ“]«‚ß‚Ü‚¢ŠŽ), p.108-9. –Ø‘º‘ô–1, ¬ì–ΗY (1‘‡f—Ã), •Ò: –Ø‘º‘ô–1, Œ‘º^Ži, —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-620016. [Šwp‘ (•ª’SŽ·•M)]y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z‘æ5Í Žš•@ˆôA‰È“I–â‘è@2. ‰Æ‘°‚©‚ç“ï’®‚Æ‚¢‚í‚ê‚Ä‚¢‚邪, –{l‚Í•â’®Ší‚ðŠó–]‚µ‚È‚¢ (“ï’®‚ւ̑Ήž), p.110-1. –Ø‘º‘ô–1, ¬ì–ΗY (1‘‡f—Ã), •Ò: –Ø‘º‘ô–1, Œ‘º^Ži, —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-620017. [Šwp‘ (•ª’SŽ·•M)]y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z‘æ5Í Žš•@ˆôA‰È“I–â‘è@3. ‰œ”N‚àŽš‘~‚«‚ð‚µ‚Ä‚¢‚Ü‚¹‚ñ (ŽšCðÇ), p.112-3. –Ø‘º‘ô–1, ¬ì–ΗY (1‘‡f—Ã), •Ò: –Ø‘º‘ô–1, Œ‘º^Ži, —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-620018. [Šwp‘ (•ª’SŽ·•M)]y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z‘æ5Í Žš•@ˆôA‰È“I–â‘è@4. •@ŒŒ‚ªo‚ÄŽ~‚Ü‚ç‚È‚¢ (•@oŒŒ), p.114-6. –Ø‘º‘ô–1, ¬ì–ΗY (1‘‡f—Ã), •Ò: –Ø‘º‘ô–1, Œ‘º^Ži, —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-620019. [Šwp‘ (•ª’SŽ·•M)]y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z‘æ5Í Žš•@ˆôA‰È“I–â‘è@5. Žš‚Ì’†‚ª‚©‚ä‚¢ (ŠOŽš“¹‰Š), p.118-9. –Ø‘º‘ô–1, ¬ì–ΗY (1‘‡f—Ã), •Ò: –Ø‘º‘ô–1, Œ‘º^Ži, —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-620020. [Šwp‘ (•ª’SŽ·•M)]y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z‘æ5Í Žš•@ˆôA‰È“I–â‘è@6. •@…‚ª‚‚ê‚Ä‚­‚é (•@‰Š), p.120-1. –Ø‘º‘ô–1, ¬ì–ΗY (1‘‡f—Ã), •Ò: –Ø‘º‘ô–1, Œ‘º^Ži, —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-620021. [Šwp‘] (•ª’SŽ·•M)y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z‘æ11Í ‰h—{EƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Ì–â‘è@1. ‚±‚̍‚—îŽÒ‚Í‚¢‚Á‚œ‚¢‰œ‚ª‚Å‚«‚ĉœ‚ª‚Å‚«‚È‚¢‚Ì‚Å‚ ‚ë‚€‚©?/2. ‚±‚ÌŠ³ŽÒ‚̉h—{‚͏\•ª‚È‚Ì‚Å‚ ‚ë‚€‚©/3. Qž‚ñ‚Å‚©‚ç‘«˜‚ªŽã‚Á‚Ä‚µ‚Ü‚Á‚œ/4. Š³ŽÒ‚ªÄ‚Ñ“]‚΂Ȃ¢‚œ‚ß‚É‚Í‚Ç‚€‚·‚ê‚΂悢‚Ì‚©/5. HŽ–“à—e‚âH‚ׂ³‚¹•û‚Ō뚋‚ðŒž‚ç‚·‚É‚Í/6. •Ð–ƒáƒ‚Ö‚Ì”z—¶‚ð‚µ‚œ‚¢/7. ‚Ü‚œŒû‚©‚çH‚ׂœ‚¢!, p.178-195. –Ø‘º‘ô–1 (1‘‡f—Ã), •Ò: –Ø‘º‘ô–1, Œ‘º^Ži, —r“yŽÐ, “Œ‹ž, 2015/3”­s.

H26-621001. [Šwp‘ (•ÒW)]y—Š‚ê‚éŽåŽ¡ˆã‚É‚È‚é‚œ‚߂̍‚—îŽÒf—ẪRƒc‚ðŠe‰Èê–åˆã‚ª‹³‚Š‚Ü‚·z•Ò: –Ø‘º‘ô–1, Œ‘º^Ži (1‘‡f—Ã), —r“yŽÐ, “Œ‹ž, 2015/3”­s.


ˆãŠw•”•‘®ˆãŠw‹³ˆçŒ€‹†ŠJ”­ƒZƒ“ƒ^[

ˆãŠw‹³ˆçŒ€‹†•”–å

[Šwp˜_•¶]

522185. [uÀ]y“ÁW:u–K–âf—Ávu’nˆæ˜AŒgvuƒvƒ‰ƒCƒ}ƒŠEƒPƒAvuŠÅŽæ‚èv...... ‚©‚©‚è‚‚¯ˆã‚Ì‹­‰»‘zŠÅŽæ‚è. ç—tG‹B (ˆãŠw‹³ˆç): CLINIC BAMBOO 2015/11; 416: 18-9.

[Šw‰ïEŒ€‹†‰ï“™]

713130. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prospective study on explanation by visiting nurse / care manager and the place of death of terminal cancer patients. Chiba H1, Moriya R1, Onozawa S, Ogata T, Ito M: Mixed Methods International Research Association ASIA Regional Conference^JSMMR (‘Û¬‡Œ€‹†–@Šw‰ïƒAƒWƒA’nˆæ‰ï‹c/‘æ1‰ñ“ú–{¬‡Œ€‹†–@Šw‰ï) (2015/9/20), ‘åã. (ç—tG‹B1, Žç‰®—˜‰À1, ¬–ì‘òŽ , ”öŒ`—Ï–Ÿ, ˆÉ“¡“¹Æ: 1ˆãŠw‹³ˆç)

722219. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰ß‹Ž10”NŠÔ‚Ì“ú–{ˆã—ÁE•a‰@ŠÇ—Šw‰ïŽ‚Æ‘‰ïŽ˜^‚©‚ç‚Ý‚œŠwp—pŒê‚Ì’è—Ê“I•ªÍ. ç—tG‹B1, ˆÉ“¡“¹Æ, ’rèŸ], ÜˆäF’j, •›“‡G‹v, •šŒ©ŽG, XŽR”ü’mŽq, ŽR‰º“N˜Y, ŽR–{Œõº, ˆÉ“¡Ol (1ˆãŠw‹³ˆç): ‘æ53‰ñ“ú–{ˆã—ÁE•a‰@ŠÇ—Šw‰ïŠwp‘‰ï (2015/11/6), •Ÿ‰ª.


ŠwKŽx‰‡Œ€‹†•”–å


ˆãŠwŒŽ˜_Œ€‹†•”–å


ˆã—ÈÀ‘SEŠÇ—ŠwŒ€‹†•”–å

[Šwp˜_•¶]

110314. [ŒŽ’˜] Evidence-based clinical practice guidelines for liver cirrhosis 2015. Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, Shibuya A1, Seike M, Nagoshi S, Segawa M, Tsubouchi H, Moriwaki H, Kato A, Hashimoto E, Michitaka K, Murawaki T, Sugano K, Watanabe M, Shimosegawa T: J Gastroenterol 2016/7; 51 (7): 629-50. (a’J–Ÿ—²1: 1ˆã—ÊǗ)

[’˜@‘]

620127. [Šwp‘ (•ª’SŽ·•M)]yŠÌd•Ïf—ÃKƒCƒhƒ‰ƒCƒ“2015 ‰ü’ù‘æ2”Łz‘æ3Í Ž¡—Á@2. RƒEƒCƒ‹ƒX—Ö@, p.30-51. a’J–Ÿ—² (ˆã—ÊǗ), •Ò: “ú–{Á‰»Ší•aŠw‰ï, “ì]“°, “Œ‹ž, 2015/10”­s.

620128. [Šwp‘ (‹€’˜)]yMBA—¬ƒP[ƒXƒƒ\ƒbƒh‚ÅŠw‚Ôˆã—ÃŒo‰c“ü–åIIza’J–Ÿ—²1, ’†àV@’B, ŒŒŽ—R”ü, åè@‰pŸª, ’ç@’B˜Y, ²“¡”T—Žq2, “‡‹v”üŽq (1ˆã—ÊǗ, 2ˆã—ÃŒo‰c), “úŒoBPŽÐ, “Œ‹ž, 2016/1”­s.


ˆã—ËZp‹³ˆçŒ€‹†•”–å

[’˜@‘]

620129. [Šwp‘ (•ª’SŽ·•M)]yƒNƒGƒbƒVƒ‡ƒ“Eƒoƒ“ƒN@ŠÅŒìŽt‘‰ÆŽŽŒ±–â‘è‰ðà2016zEtE”å”AŠíŽŸŠ³@–«t‘Ÿ•a, p.278-9. â–{®“o (ˆã—ËZp‹³ˆç), ƒƒfƒBƒbƒNƒƒfƒBƒA, “Œ‹ž, 2015/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

723970. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«t‘Ÿ•a (CKD) ‚̐t‹@”\áŠQis‚É”º‚€‘㏞«tK”rŸ•”\‚Ì‘œ—l«. â–{®“o1, ¬ì‚Ý‚ä‚«2 (1ˆã—ËZp‹³ˆç, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ58‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2015/6/5), –ŒŒÃ‰®.


ˆã—Ïî•ñ‹³ˆçŒ€‹†•”–å

[’˜@‘]

620130. [Šwp‘ (’P’˜)]yQƒVƒŠ[ƒY@V¶—Šw ‘æ6”Łz ’|“àº”Ž (ˆã—Ïî•ñ‹³ˆç), “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 2015/9”­s.


“Œ—mˆãŠw‹³ˆçŒ€‹†•”–å

[Šwp˜_•¶]

110315. [ŒŽ’˜] Antidepressive-like effect of a Kampo (traditional Japanese) medicine, kososan (Xiang Su San) in a stress-induced depression-like mouse model: Proteomic analysis of hypothalamus. Nagai T1, Hashimoto R, Okuda SM, Kodera Y, Oh-Ishi M, Maeda T, Ito N, Hanawa T1,2, Kiyohara H1, Yamada H: Traditional & Kampo Medicine 2015/9; 2 (2): 50-9. (‰Ô—Öšæ•F1,2: 1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç)

320043. [Ç—á•ñ] –k—¢“ŒˆãŒ€f—Ø^‚©‚ç (135): ‘hŽU‚É‚æ‚è’E–яǁEŽŒ]‚ª‰ü‘P‚µ‚œˆê—á. •äÏ@÷1, ì“çˆÉW1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): Š¿•û‚̗Տ° 2015/4; 62 (4): 695-700.

320044. [Ç—á•ñ] –k—¢“ŒˆãŒ€f—Ø^‚©‚ç (136): Ž{‹„‚É‚æ‚苹‹ê‚µ‚³‚ªŠÉ˜a‚µ‚œˆêÇ—á. ˆÉ“¡—Yˆê1, ‘š~@‘s1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): Š¿•û‚̗Տ° 2015/5; 62 (5): 901-4.

320045. [Ç—á•ñ] ˆô’†–k—¢“ŒˆãŒ€f—Ø^‚©‚ç (137): àtäg‚Í”F‚ß‚È‚¢‚ª”Œ‰ÄŒú–p“’‚ª—LŒø‚Ÿ‚Á‚œŽo–…‚̏Ǘá. X—T‹IŽq1, —é–Ø–M•F1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): Š¿•û‚̗Տ° 2015/6; 62 (6): 1096-100.

320046. [Ç—á•ñ] ‰©@‚É‚æ‚é–ò•š«ŠÌáŠQ‚ª‹^‚í‚ê‚œ3—á|Å‹ßŒoŒ±‚µ‚œŽ©ŠoÇó‚Ì–R‚µ‚¢Ç—á‚©‚ç|. ‹yì“N˜Y1, ŒÜ–ì—R‰À—1,2, •Ÿ“c’mŒ°, –xì•üŒb1, –x“cL–ž1, X—T‹IŽq1, ì“çˆÉW1, Î–Ñ’B–ç1, ¬“cŒû_1, Žá™ˆÀŠó”T1, ‰œ•xr”V3, ‰Ô—Öšæ•F1,4 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2‘‡f—Ã, 3–ƒŒ, 4“Œ—mˆãŠw‹³ˆç): “ú–{“Œ—mˆãŠw‰ïŽGŽ 2015/7; 66 (3): 212-7.

320047. [Ç—á•ñ] ”~‰JŽž‚É”­Ç‚·‚éŽè‘«‚Ì’É‚Ý‚É”’žQ•Žq“’‚ª’˜Œø‚µ‚œ1Ç—á. X—T‹IŽq1, —é–Ø–M•F1, ‹yì“N˜Y1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): “ú–{“Œ—mˆãŠw‰ïŽGŽ 2015/8; 66 (3): 250-5.

320048. [Ç—á•ñ] –k—¢“ŒˆãŒ€f—Ø^‚©‚ç (138): ‘œŠŸÇ‚É乗èŠÃ‘“’‚ª—LŒø‚Å‚ ‚Á‚œ1—á. ‹yì“N˜Y1, Î–Ñ’B–ç1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): Š¿•û‚̗Տ° 2015/8; 62 (8): 1388-91.

320049. [Ç—á•ñ] –k—¢“ŒˆãŒ€f—Ø^‚© ‚ç (139): ”DP’†‚ɏoŒ»‚µ‚œ‘Á‰t‰ß‘œ‚ɌܗèŽU—¿‚ª—LŒø‚Å‚ ‚Á‚œˆê—á. ì“çˆÉW1, ¯–ì‘ì”V1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): Š¿•û‚̗Տ° 2015/9; 62 (9): 1526-30.

320050. [Ç—á•ñ] –k—¢“ŒˆãŒ€f—Ø^‚©‚ç (140): Žl‹tŽU‚ª‘tŒø‚µ‚œ•Ð“ª’ɂ̏Ǘá. —é–Ø–M•F1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): Š¿•û‚̗Տ° 2015/10; 62 (10): 1711-8.

320051. [Ç—á•ñ] –k—¢“ŒˆãŒ€f—Ø^‚©‚ç (141): DŽ_‹…«’†Žš‰Š‚ÉŽÄ–p“’ƒGƒLƒX‚ª—L—p‚Å‚ ‚Á‚œ1Ç—á. Î–Ñ’B–ç1, ¬“cŒû_1, ‹yì“N˜Y1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): Š¿•û‚̗Տ° 2015/11; 62 (11): 1839-43.

320052. [Ç—á•ñ] –k—¢“ŒˆãŒ€f—Ø^‚©‚ç (142): ƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒã‚Ì‘Ì’²•s—ǂɏ¬ŽÄŒÓ“’‚ª—LŒø‚Å‚ ‚Á‚œˆê—á. Â–Ø‚ä‚©‚è1, ¯–ì‘ì”V1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): Š¿•û‚̗Տ° 2015/12; 62 (12): 2038-42.

320053. [Ç—á•ñ] —Çžk“’—LŒø—á‚ÌŒŸ“¢. •äÏ@÷1, ¯–ì‘ì”V1, ‹yì“N˜Y1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): “ú–{“Œ—mˆãŠwŽGŽ 2016/1; 67 (1): 45-9.

320054. [Ç—á•ñ] –k—¢“ŒˆãŒ€f—Ø^‚©‚ç (143): ”w•”‚Ì—â‚Š‚ɐŽŽŒ‰»á‚“’‚ª‘tŒø‚µ‚œ1—á. ¯–ì‘ì”V1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): Š¿•û‚̗Տ° 2016/1; 63 (1): 121-5.

522186. [uÀ]y“ÁW: Ž©—¥_Œo‚ð‚à‚€ˆê“xl‚Š‚ézŽ©—¥_Œo‚̐§Œä@Š¿•ûˆãŠwEŠ¿•û–ò‚ÆŽ©—¥_Œo. ‹yì“N˜Y1, ¬“cŒû_1, Žá™ˆÀŠó”T1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): JOHNS 2015/8; 31 (8): 1049-52.

[Šw‰ïEŒ€‹†‰ï“™]

712035. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Treatment with Kampo Medicine for otologic disorders. Ishige T1, Odaguchi H1, Hanawa T1,2: International Congress on Complementary Medicine Research 2015 (2015/5/14), Jeju, Korea. (Î–Ñ’B–ç1, ¬“cŒû_1, ‰Ô—֏r•F1,2: 1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç)

712036. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Daikenchuto, a Kampo medicine, ameliorates postoperative ileus by anti-inflammatory action through nicotinic acetylcholine receptors. Oikawa T1, Endo M1, Hori M, Ozaki H, Hanawa T1,2: 3rd International Symposium for Japanese Kampo Medicine (2015/6/19), Vienna, Austria. (‹yì“N˜Y1, ‰““¡^—1, ‰Ô—֏r•F1,2: 1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç)

712037. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Kampo practice standardization project. Odaguchi H1, Wakasugi A1, Sekine M1, Ishige T1, Ito Y1, Kawanabe T1, Mitsuma T, Shimada Y, Shibahara N, Arai M, Namiki T, Muramatsu S, Hanawa T1,2: 3rd International Symposium for Japanese Kampo Medicine (2015/6/19), Vienna, Austria. (¬“cŒû_1, Žá™ˆÀŠó”T1, ŠÖª–ƒ—Žq1, Î–Ñ’B–ç1, ˆÉ“¡—Yˆê1, ì“çˆÉW1, ‰Ô—֏r•F1,2: 1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç)

712038. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) The role of Kampo medicine in modern clinical practice in Japan. Oikawa T1, Odaguchi H1, Hanawa T1,2: 3rd PolyU Botanical Symposium (2015/12/3), Hong Kong, China. (‹yì“N˜Y1, ¬“cŒû_1, ‰Ô—֏r•F1,2: 1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç)

721021. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) –k—¢“ŒˆãŒ€‚Ì“`“`—ð‘ã3Š’·‚©‚狳‚Š‚Ä’ž‚¢‚œ‚±‚Ɓ`. ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/12), •xŽR.

722220. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘hŽU‚É‚æ‚é—}‚€‚‚̊ɘaEŽ¡—ÂɌü‚¯‚œŠî‘bŒ€‹†‚©‚ç—Տ°‚ւ̃Aƒvƒ[ƒ`. ‰iˆä—²”V1, ¬Ž›‹`’j, ŽR’†‹I‰›Žq, ¬—ѐ玡, ¬Ž›‹Ml, Ö“¡’B–ç, ‘åÎ³“¹, ˆÉ“¡’ŒŽ÷1, ŠÖª–ƒ—Žq1, Žá™ˆÀŠó”T1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2, ŽR“c—zé, ŽŒŽŠ°Í1 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ32‰ñ˜aŠ¿ˆã–òŠw‰ïŠwp‘å‰ï (2015/8/23), •xŽR.

722221. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹@”\«ƒfƒBƒXƒyƒvƒVƒA‚𒆐S‚Æ‚µ‚œ”Œ‰ÄŒú–p“’‚ÌŽg‚¢•û`ŒÃ“T‚ÉŠî‚¢‚œŽg—p–Ú•W‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚ā`. ‹yì“N˜Y1, ˆÉ“¡@„1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ12‰ñ“ú–{Á‰»ŠÇŠw‰ï‘‰ïŠwpW‰ï (2016/2/27), “Œ‹ž.

723971. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”Œ‰ÄŒú–p“’‚̏Á‰»ŠÇ‹@”\‚ɑ΂·‚éŒø‰Ê`Œ’í¬l‚ð‘ΏۂƂµ‚œ“ñd–ÓŒŸ”äŠrŽŽŒ±`. ‹yì“N˜Y1, ¬“cŒû_1, Žá™ˆÀŠó”T1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ101‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2015/4/24), ‹{é.

723972. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹È’Œ£—¬‚ÌŒûŒEˆãˆÄ‚É’–Ú‚µ‚œw˜aŠ¿Ž[ŒŸ—v•ûxw–{–M–Œˆã—ވāx‚̉ðÍ. ¯–ì‘ì”V1, ¬‘]ŒË—m1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ116‰ñ“ú–{ˆãŽjŠw‰ï‘‰ïEŠwp‘å‰ï (2015/4/25), ‘åã.

723973. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) í÷–@‚̐¬—§‹NŒ¹‹y‚Ñ‚»‚ÌŒoˆÜ‚ÉŠÖ‚·‚錀‹†|]ŒË––Šú‚©‚珺˜a‚É‚©‚¯‚ā|. â“cKŽ¡1, ‘å—¢^“Þ”ü1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ116‰ñ“ú–{ˆãŽjŠw‰ï‘‰ïEŠwp‘å‰ï (2015/4/25), ‘åã.

723974. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)w—cXV‘xŠˆøwç‹à—ƒ•ûx‚ÌŒŸ“¢. –x“cL–ž1, ¬‘]ŒË—m1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ116‰ñ“ú–{ˆãŽjŠw‰ï‘‰ïEŠwp‘å‰ï (2015/4/25), ‘åã.

723975. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒÃ“Tˆã‘‚É‚š‚¯‚é•—ŽsŒŠ‚Ì‹Lq‚ɂ‚¢‚Ä. ÎŒŽ@•1, ‘š~@‘s1, ˆÉ“¡—Yˆê1, ¬à_Žu”¿1, •Šâ“ށXŽq1, ˆä“c„l1, ¬ŽR@Šî1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ64‰ñ (ŒöŽÐ) ‘S“ú–{èI‹„Šw‰ïŠwp‘å‰ï‚Ó‚­‚µ‚Ü‘å‰ï (2015/5/22), •Ÿ“‡.

723976. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰º”ŒgŒ^—â‚ŠÇ‚Ì•aˆö‚Æä\’†ŒŠ (ŠïŒŠ) ‚̐f’f“IˆÓ‹`. ˆÉ“¡@„1, ‘š~@‘s1, ˆÉ“¡—Yˆê1, ¬à_Žu”¿1, •Šâ“ށXŽq1, ˆä“c„l1, ÎŒŽ@•1, ¬ŽR@Šî1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ64‰ñ (ŒöŽÐ) ‘S“ú–{èI‹„Šw‰ïŠwp‘å‰ï‚Ó‚­‚µ‚Ü‘å‰ï (2015/5/22), •Ÿ“‡.

723977. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰Á—”Á•Ï«‚É‚æ‚鎋—͒ቺ‚ÉèIŽ¡—ªŒø‚¢‚œˆêÇ—á. ˆä“c„l1, ‘š~@‘s1, ˆÉ“¡—Yˆê1, ¬à_Žu”¿1, •Šâ“ށXŽq1, ÎŒŽ@•1, ¬ŽR@Šî1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ64‰ñ (ŒöŽÐ) ‘S“ú–{èI‹„Šw‰ïŠwp‘å‰ï‚Ó‚­‚µ‚Ü‘å‰ï (2015/5/23), •Ÿ“‡.

723978. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •Ð‘€Šç–Êáz¹‚ɑ΂µu–Ú‘‹ŒŠv‚ª—LŒø‚Å‚ ‚Á‚œ1Ç—á. •Šâ“ށXŽq1, ‘š~@‘s1, ˆÉ“¡—Yˆê1, ¬à_Žu”¿1, ˆä“c„l1, ÎŒŽ@•1, ¬ŽR@Šî1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ64‰ñ (ŒöŽÐ) ‘S“ú–{èI‹„Šw‰ïŠwp‘å‰ï‚Ó‚­‚µ‚Ü‘å‰ï (2015/5/23), •Ÿ“‡.

723979. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “«‚̐Uí‚ɑ΂µ‚ÄèI‹„Ž¡—ª—LŒø‚Å‚ ‚Á‚œ1Ç—á. ‘š~@‘s1, ˆÉ“¡—Yˆê1, ¬à_Žu”¿1, ˆä“c„l1, •Šâ“ށXŽq1, ÎŒŽ@•1, ¬ŽR@Šî1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ64‰ñ (ŒöŽÐ) ‘S“ú–{èI‹„Šw‰ïŠwp‘å‰ï‚Ó‚­‚µ‚Ü‘å‰ï (2015/5/23), •Ÿ“‡.

723980. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) S™`ŒŠ‚ւ̉·“›‹„‚ɑ΂·‚éS‘ŸŽ©—¥_Œo”œ‰ž. ˆÉ“¡—Yˆê1, ‘š~@‘s1, ¬à_Žu”¿1, •Šâ“ށXŽq1, ˆä“c„l1, ÎŒŽ@•1, ¬ŽR@Šî1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ64‰ñ (ŒöŽÐ) ‘S“ú–{èI‹„Šw‰ïŠwp‘å‰ï‚Ó‚­‚µ‚Ü‘å‰ï (2015/5/23), •Ÿ“‡.

723981. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŒŽ‹ŽR‚É‚æ‚éwO•û‹K‹éx‰ÁŒž–@‚ÌŽÀ‘H|w‹ŽR•ûlxwŠˆ–@‹@•ûx‚Ì”äŠr|. ¯–ì‘ì”V1, ¬‘]ŒË—m1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723982. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘IŠï“’‚Ì“Ú—p‚ª”­ì«‚Ì“ª’É‚É—LŒø‚Ÿ‚Á‚œ1—á. X—T‹IŽq1, ŒÜ–ì—R‰À—1,2, ‰Ô—Öšæ•F1,3 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2‘‡f—Ã, 3“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723983. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw‚É‚š‚¯‚鐶–ò‚̐V‚µ‚¢•iŽ¿•]‰¿–@ŠJ”­‚Ɛ¶–òŽŽŒ±Í”|‚ÌŽæ‚è‘g‚Ý. ‹yì“N˜Y1, ¬“cŒû_1, Žá™ˆÀŠó”T1, ŠÖª–ƒ—Žq1, ‰Ô—Öšæ•F1,2, ¬—Ñ‹`“T1 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723984. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) wŠÏãڕû—v•âx‚ÌŒ€‹† (‘æ6•ñ)|•¶­”Å‘SŒŽ•û‚Ì4•û‚É1•û‚͈À­”Å‚Å’ù³‚³‚ê‚œ. –x“cL–ž1, “n•Ó_“ñ1, “V–ì—z‰î1, ¬‘]ŒË—m1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723985. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒjƒ…[ƒ‰ƒ‹ƒlƒbƒgƒ[ƒN‚É‚æ‚éƒJƒ‹ƒe€–ڂ̃pƒ^[ƒ“ŠwK‚Əˆ•û‘I‘ðƒ‚ƒfƒ‹\’z‚ÌŽŽ‚Ý. ˆÉ“¡—Yˆê1, Î–Ñ’B–ç1, ì“çˆÉW1, ŠÖª–ƒ—Žq1, Žá™ˆÀŠó”T1, ¬“cŒû_1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723986. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) DŽ_‹…«’†Žš‰Š‚ÉŽÄ–p“’ƒGƒLƒX‚ª—L—p‚Å‚ ‚Á‚œ1Ç—á. Î–Ñ’B–ç1, ¬“cŒû_1, ‹yì“N˜Y1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723987. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Š¿•û–ò‚̐÷o‚É‹y‚Ú‚·‰e‹¿|‰Î‰ÁŒžE÷‚¶ŽžŠÔ|(‘æ2•ñ). ‘å—¢^“Þ”ü1, â“cKŽ¡1, •ûçH1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723988. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Š¿•û–òƒŒƒgƒ‹ƒgƒpƒbƒN•ï‘•‹Æ–±‚̉ü‘P‚Ɛ¬•ªŠÜ—L—Ê‚Ì‘Šˆá. {“¡Šx‘å1, â“cKŽ¡1, •ûçH1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723989. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ÷‚¶–ò‚ÌŒž—ʏˆ•û‚ɂ‚¢‚Ă̈Ӌ`. ‚Û–ƒ“Þ–¢1, â“cKŽ¡1, •ûçH1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723990. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •wl‰ÈŽŸŠ³‚É‚š‚¯‚銿•ûˆãŠw“I‚ÈØ‚ð—‰ð‚µ‚œ•ž–òŽw“±‚ÌŒŸ“¢. Žº¶^çŽq1, â“cKŽ¡1, •ûçH1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723991. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒuƒŒƒ“ƒh’ƒ‚ÌŒŽÞ—¿‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ŽOàV@S1, â“cKŽ¡1, •ûçH1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723992. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Š¿•û–ò—Տ°Œø‰Ê”»’è•û–@‚Æ‚µ‚Ä‚Ìvisual analogue scale (VAS) ‚Ì—L—p«. ¬“cŒû_1, Î–Ñ’B–ç1, ì“çˆÉW1, ˆÉ“¡—Yˆê1, Žá™ˆÀŠó”T1, ŠÖª–ƒ—Žq1, ‹yì“N˜Y1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/13), •xŽR.

723993. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˜•”‚̘ǐҌŠ‚ɑ΂·‚éèI‹„Ž¡—ª‰EãŽˆ‹ßˆÊ•”’ɂɑ΂µ—LŒø‚Å‚ ‚Á‚œ1Ç—á. ¬à_Žu”¿1, ‘š~@‘s1, ˆÉ“¡—Yˆê1, ˆä“c„l1, •ŠâØXŽq1, ÎŒŽ@•1, ¬ŽR@Šî1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/14), •xŽR.

723994. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) —â‚Š‚Ì‚Ú‚¹ (ã”M‰ºŠŠ) ‚Ì•a‘ԉ𖟂Ƃ»‚Ì“Á’¥‚ɂ‚¢‚Ä. ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/14), •xŽR.

723995. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) COIŠÖ˜AuŠ¿•ûf—ÕW€‰»ƒvƒƒWƒFƒNƒgv‘æ2•ñ@Ž©‘ŒŠoŠŒ©—pŽ†‚Ì•W€‰»‚É‚Þ‚¯‚Ä. Žá™ˆÀŠó”T1, Î–Ñ’B–ç1, ƒ~ƒCƒVƒƒƒIƒ†ƒE, ŠÖª–ƒ—Žq1, ˆÉ“¡—Yˆê1, ì“çˆÉW1, ’†àV•¶•F, •Ð‰ªŽ}—¢‰Ô, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/14), •xŽR.

723996. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢Š¿•ûˆãŠw“IŠŒ©ƒvƒƒWƒFƒNƒg‘æ8•ñ@ŠŒ©ÌŽæ‚É‚š‚¯‚éM—Š«‚ÌŒüã‚ð–ÚŽw‚µ‚Ä. ŠÖª–ƒ—Žq1, Žá™ˆÀŠó”T1, ì“çˆÉW1, Î–Ñ’B–ç1, ˆÉ“¡—Yˆê1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/14), •xŽR.

723997. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Š¿•û–ò‚̏ˆ•û„’胍ƒWƒbƒN\’z‚ÌŽŽ‚Ý. ƒ~ƒCƒVƒƒƒIƒ†ƒE, •Ð‰ªŽ}—¢‰Ô, ’r“c@O, ’†àV•¶•F, Î–Ñ’B–ç1, ¬“cŒû_1, ì“çˆÉW1, ˆÉ“¡—Yˆê1, Žá™ˆÀŠó”T1, ŠÖª–ƒ—Žq1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ66‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï (2015/6/14), •xŽR.

723998. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –ƒ‰©‚Í”xŠà×–E‚É‚š‚¢‚ÄHGFŽhŒƒŒã‚ÌMET endocytosis‚š‚æ‚Ñ‚»‚Ì•ª‰ð‚𑣐i‚·‚é. Œ‘ºs¶, “úŒü{”üŽq1, “úŒü¹Ži, ˆÉ“¡˜aK, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ24‰ñ“ú–{‚ª‚ñ“]ˆÚŠw‰ïŠwpW‰ïE‘‰ï (2015/7/23), ‘åã.

723999. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Does stress vulnerability trigger negative cognitive bias in socially defeated mice? ˆÉ“¡’ŒŽ÷1, Birnbaum G Shari, ‹yì“N˜Y1, ‰Ô—Öšæ•F1,2, Eisch J Amelia (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ38‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2015/7/28), •ºŒÉ.

7231000. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘匚’†“’‚̍R‰ŠÇì—p`pŒã’°ŠÇ–ƒáƒƒ‚ƒfƒ‹ƒ}ƒEƒX‚ōR‰Šì—p‚ð”­Šö‚·‚鐶–ò‚Ì“¯’è`. ‰““¡^—1, –x@³•q, ”öè@”Ž, ‹yì“N˜Y1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ32‰ñ˜aŠ¿ˆã–òŠw‰ïŠwp‘å‰ï (2015/8/22), •xŽR.

7231001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽÐ‰ï«ƒXƒgƒŒƒX—U”­‚€‚—ls“®‚Æ‚»‚ê‚É”º‚€”]“à‰ŠÇ”œ‰ž‚ɑ΂·‚鍁‘hŽU‚Ì—}§Œø‰Ê. ˆÉ“¡’ŒŽ÷1, œA£‰hŽ¡, Î“c’BÆ, –x@@Œú, ‰iˆä—²”V1, ¬—Ñ‹`“T1, ŽŒŽŠ°Í1, ‹yì“N˜Y1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ32‰ñ˜aŠ¿ˆã–òŠw‰ïŠwp‘å‰ï (2015/8/22), •xŽR.

7231002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) COIŠÖ˜AuŠ¿•ûf—ÕW€‰»ƒvƒƒWƒFƒNƒgv‘æ3•ñ@•W€‰»Šî–{33ˆ•û‚Ì‘I‘ð. Žá™ˆÀŠó”T1, ŠÖª–ƒ—Žq1, ¬“cŒû_1, ‘ºŒœÄˆê, •À–Ø—²—Y, Vˆä@M, “ˆ“c@–L, ŽÄŒŽ’Œ—˜, ŽOàk’‰“¹, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ32‰ñ˜aŠ¿ˆã–òŠw‰ïŠwp‘å‰ï (2015/8/22), •xŽR.

7231003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) COIŠÖ˜AuŠ¿•ûf—ÕW€‰»ƒvƒƒWƒFƒNƒgv‘æ4•ñ@Ž©‘ŒŠoŠŒ©‚Ì‘I’è. ŠÖª–ƒ—Žq1, Žá™ˆÀŠó”T1, ¬“cŒû_1, ‘ºŒœÄˆê, •À–Ø—²—Y, Vˆä@M, “ˆ“c@–L, ŽÄŒŽ’Œ—˜, ŽOàk’‰“¹, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ32‰ñ˜aŠ¿ˆã–òŠw‰ïŠwp‘å‰ï (2015/8/22), •xŽR.

7231004. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘hŽU÷Ü‚É‚æ‚éR‚€‚—lŠˆ«‚ÉŠÖ˜A‚·‚é”]“àƒ^ƒ“ƒpƒNŽ¿‚Ì’Tõ. ŽR’†‹I‰›Žq, ‰iˆä—²”V1, ¬—ѐ玡, Ö“¡’B–ç, ¬Ž›‹`’j, ˆÉ“¡’ŒŽ÷1, ‰Ô—Öšæ•F1,2, ŽR“c—zé, ŽŒŽŠ°Í1 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ32‰ñ˜aŠ¿ˆã–òŠw‰ïŠwp‘å‰ï (2015/8/23), •xŽR.

7231005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒGƒtƒFƒhƒŠƒ“ƒAƒ‹ƒJƒƒCƒhœ‹Ž–ƒ‰©ƒGƒLƒX (EFM) ‚Ì–ò—ì—p‚ƈÀ‘S«. “úŒü{”üŽq1, “úŒü¹Ži, ‘哈’Œ_, Š™‘q_”V, ŠÛŽR‘ì˜Y, ŒÑ’ˍ‚Žu, “V‘q‹gÍ, ‡“cKL, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ32‰ñ˜aŠ¿ˆã–òŠw‰ïŠwp‘å‰ï (2015/8/23), •xŽR.

7231006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒGƒtƒFƒhƒŠƒ“ƒAƒ‹ƒJƒƒCƒhœ‹Ž–ƒ‰©ƒGƒLƒX (EFM) ‚̐»‘¢–@‚ÆŠˆ«¬•ªherbacetin‚ÌŠÜ—Ê. ‘哈’Œ_, “úŒü{”üŽq1, “úŒü¹Ži, Š™‘q_”V, ŠÛŽR‘ì˜Y, ŒÑ’ˍ‚Žu, “V‘q‹gÍ, ‰Ô—Öšæ•F1,2, ‡“cKL (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ32‰ñ˜aŠ¿ˆã–òŠw‰ïŠwp‘å‰ï (2015/8/23), •xŽR.

7231007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Capsaicin—U”­áu’É‹y‚ÑFormalin—U”­áu’ɂɑ΂·‚é–ƒ‰©‚Ì’Á’ÉŒø‰Ê. ’†Xr•ã, ‚‹Ž@ƒ, “úŒü{”üŽq1, “V‘q‹gÍ, “úŒü¹Ži, ŒÑ’ˍ‚Žu, ‡“cKL, ‰Ô—Öšæ•F1,2, ¬—Ñ‹`“T1 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ32‰ñ˜aŠ¿ˆã–òŠw‰ïŠwp‘å‰ï (2015/8/23), •xŽR.

7231008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘OŒü‚«ƒRƒz[ƒgŒ€‹†‚É‚š‚¯‚é’ǐՍì‹Æ‚ÌŒø—Š‰»‚š‚æ‚ѐ³Šm«‚ÌŠm•Û. ŠÖª–ƒ—Žq1, Žá™ˆÀŠó”T1, ãŒû”üŠó, Îì‚Ü‚èŽq, ì“çˆÉW1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2015 in KOBE (2015/9/12), •ºŒÉ.

7231009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)wŠ¿•ûŽ¡—ÃGƒrƒfƒ“ƒXƒŒƒ|[ƒg2013@402‚ÌRCTx‚ð—p‚¢‚œ•¶Œ£’²ž`QOL•]‰¿‚ɂ‚¢‚ā`. Žá™ˆÀŠó”T1, ŠÖª–ƒ—Žq1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2015 in KOBE (2015/9/13), •ºŒÉ.

7231010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘匚’†“’‚̍\¬¶–òEŠ£›I‚̍R‰ŠÇì—p‚ð‰î‚µ‚œpŒã’°ŠÇ–ƒáƒ‰ü‘PŒø‰Ê. ‰““¡^—1, –x@³•q, ‹yì“N˜Y1, ”öè@”Ž, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ17‰ñ“ú–{_ŒoÁ‰»Ší•aŠw‰ï (2015/11/13), ‰«“ê.

7231011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Formalin—U”­áu’ɂɑ΂·‚é–ƒ‰©ƒGƒLƒX, ƒGƒtƒFƒhƒŠƒ“ƒAƒ‹ƒJƒƒCƒhœ‹Ž–ƒ‰©ƒGƒLƒX (EFE) ‹y‚уGƒtƒFƒhƒŠƒ“‚Ì’Á’ÉŒø‰Ê. ‚‹Ž@ƒ, ’†Xr•ã, “úŒü{”üŽq1, ŽR‰º’‰r, ‘哈’Œ_, ŠÛŽR‘ì˜Y, “úŒü¹Ži, “V‘q‹gÍ, ŒÑ’ˍ‚Žu, ¬“cŒû_1, ‡“cKL, ‰Ô—Öšæ•F1,2, ¬—Ñ‹`“T1 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): “ú–{–òŠw‰ï‘æ136”N‰ï (2016/3/28), _“ސì.

732131. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) ‚—îŽÒ‚ÌŒ’N‚ÆŠ¿•û. ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): `‹æ–¯‘åŠwŒöŠJuÀ (2015/6/18), “Œ‹ž.

732132. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) ‚—îŽÒ‚ÌŒ’N‚ÆŠ¿•û. ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): –k—¢‘åŠw“¯‘‹‰ï“È–ØŒ§Žx•”ŒöŠJu‰‰‰ï (2015/6/20), “È–Ø.

732133. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˜•”‚̘ǐҌŠ‚ɑ΂·‚éèI‹„Ž¡—ª‰EãŽˆ‹ßˆÊ•”’ɂɑ΂µ—LŒø‚Å‚ ‚Á‚œ1Ç—á. ¬à_Žu”¿1, ˆÉ“¡@„1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ2‰ñKAIMèI‹„Ç—áƒVƒ“ƒ|ƒWƒEƒ€ (2015/7/25), “Œ‹ž.

732134. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) “Œ—mˆãŠw‚Ì“ÁŽ¿. ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ37‰ñˆãŠw¶E—Տ°ˆã‚Ì‚œ‚ß‚Ì“Œ—mˆãŠwƒZƒ~ƒi[ (2015/7/27), “Œ‹ž.

732135. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) ƒf[ƒ^‚É‚æ‚é•W€‰»‚Ì•K—v«‚ɂ‚¢‚Ä. ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ3‰ñ–k—¢COIƒVƒ“ƒ|ƒWƒEƒ€ (2015/10/31), “Œ‹ž.

732136. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) “Œ—mˆãŠw‚̐¢ŠE`…@“Œ—mˆãŠw‚ւ̏µ‘ҁ`. ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ç‘ã“c‹æ‚—îŽÒ‘åŠwŒ’NuÀ (2015/11/6), “Œ‹ž.

732137. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) “Œ—mˆãŠw‚̐¢ŠE`…AŠ¿•ûf—Â̎ÀÛ`. ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ç‘ã“c‹æ‚—îŽÒ‘åŠwŒ’NuÀ (2015/11/13), “Œ‹ž.

732138. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) “Œ—mˆãŠw‚̐¢ŠE`…BŠ¿•û‚̍l‚Š•û‚Æ–¢—ˆ‘œ`. ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ç‘ã“c‹æ‚—îŽÒ‘åŠwŒ’NuÀ (2015/11/20), “Œ‹ž.

732139. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) Š¿•ûf—Â̏”’ˆÓ‚Æ‚Ü‚Æ‚ß. ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): •œ¬27”N“xŠ¿•û–òE¶–òŒ€C‰ï (2015/12/13), “Œ‹ž.

733367. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Š¿•û•ûÜu‘hŽUv‚̍R‚€‚—lŠˆ«‚ÉŠÖ˜A‚·‚é”]“àƒ^ƒ“ƒpƒNŽ¿‚Ì’Tõ. ŽR’†‹I‰›Žq, ‰iˆä—²”V1, ¬—ѐ玡, Ö“¡’B–ç, ¬Ž›‹`’j, ˆÉ“¡’ŒŽ÷1, ‰Ô—Öšæ•F1,2, ŽR“c—zé, ŽŒŽŠ°Í1 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ28‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€E‘æ18‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[ (2015/8/6), _“ސì.

733368. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒã‚Ì‘Ì’²•s—ǂɏ¬ŽÄŒÓ“’‚ª—LŒø‚Å‚ ‚Á‚œˆê—á. Â–Ø‚ä‚©‚è1, ˆÉ“¡@„1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ25‰ñŠ¿•ûŽ¡—ÃŒ€‹†‰ï (2015/10/4), “Œ‹ž.

733369. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ˆ•ûŠÓ•Ê‚É‚š‚¯‚é‹qŠÏ“IŠŒ©‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Î–Ñ’B–ç1, ˆÉ“¡—Yˆê1, ì“çˆÉW1, Žá™ˆÀŠó”T1, ŠÖª–ƒ—Žq1, ¬“cŒû_1, ‰Ô—Öšæ•F1,2 (1“Œ—mˆãŠw‘‡Œ€‹†Š, 2“Œ—mˆãŠw‹³ˆç): ‘æ72‰ñ“ú–{“Œ—mˆãŠw‰ïŠÖ“ŒbM‰zŽx•”Šwp‘‰ï (2015/11/22), ç—t.


4•a‰@˜AŒg‹³ˆçŒ€‹†•”–å

[Šw‰ïEŒ€‹†‰ï“™]

723399. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒRƒ“ƒsƒ…[ƒ^ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚É‚æ‚éˆÝŠà‚̐V‚µ‚¢f’f–@: MD-CT‚ð—p‚¢‚œŽîᇂÌ3ŽŸŒ³—§‘̍\’z, ‘̐ϒl‘ª’è‚̗Տ°“IˆÓ‹`‚Ə«—ˆ‚Ö‚Ì“W–]. ‹e’rŽj˜Y1, ŽOd–ì_˜N2, X’JGŒõ2, ×“c@Œj2, ŽR‰ºŒpŽj2, •Ð“c‰Ä–ç2, “n粏¹•F2 (14•a‰@˜AŒg‹³ˆç, 2ŠO‰È): ‘æ77‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2015/11/26), •Ÿ‰ª.


ˆãŠw•”•‘®—Տ°Œ€‹†ƒZƒ“ƒ^[

Šé‰æŠJ”­•”–å^ƒvƒƒWƒFƒNƒgŽÀŽ{•”–å

[Šwp˜_•¶]

110316. [ŒŽ’˜] Pharmacokinetic and bioequivalence evaluation of single-tablet and separate-tablet regimens for once-daily cobicistat-boosted elvitegravir in healthy Japanese male subjects: A randomized, two-way crossover study. Shiomi M, Matsuki S, Ikeda A, Ishikawa T, Nishino N, Kimura M, Kumagai Y1, Irie S : Clin Pharmacol Drug Dev 5-6; 4 (3): 218-25. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

110317. [ŒŽ’˜] Effects of Cremophor EL on the absorption of orally administered saquinavir and fexofenadine in healthy subjects. Tomaru A,Takeda-Morishita M, Maeda K, Banba H, Takayama K, Kumagai Y1, Kusuhara H, Sugiyama Y: Drug Metab Pharmacokinet 2015/6; 30 (3): 221-6. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

110318. [ŒŽ’˜] Comparison of circulating lipid profiles between fasting humans and three animal species used in preclinical studies: mice, rats and rabbits. Ishikawa M, Saito K, Urata M, Kumagai Y1, Maekawa K, Saito Y: Lipids Health Dis 2015/9; 14: 104. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

110319. [ŒŽ’˜] Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study. Morganroth J, Wang Y, Thorn M, Kumagai Y1, Harris S, Stockbridge N, Kleiman R, Shah R: Br J Clin Pharmacol 2015/9; 80 (3): 446-59. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

110320. [ŒŽ’˜] Lack of effect of favipiravir, a novel antiviral agent, on QT interval in healthy Japanese adults. Kumagai Y1, Murakawa Y, Hasunuma T, Aso M, Yuji W, Sakurai T, Noto M, Oe T, Kaneko A: Int J Clin Pharmacol Ther 2015/10; 53 (10): 866-74. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

110321. [ŒŽ’˜] Randomized, Controlled, Thorough QT/QTc Study Shows Absence of QT Prolongation with Luseogliflozin in Healthy Japanese Subjects. Kumagai Y1, Hasunuma T, Sakai S, Ochiai H, Samukawa Y: PLoS One 2015/10; 10 (10): e0139873. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

110322. [ŒŽ’˜] Comparative Pharmacokinetic Study of Acetaminophen in Japanese and Han Chinese Individuals. Sakamoto Y1, Wakisaka M, Maeda M2,3, Song ID1, Fujita T4, Sekine T, Yamazaki A, Tanaka R5, Kumagai Y5: Jpn J Clin Pharmacol Ther 2016/1; 47 (1): 11-6. (â–{‘×—1, ‘O“cŽÀ‰Ô2,3, ‘v@ˆê‘å1, “¡“c•üŒb4, “c’†—‰pŽq5, ŒF’J—YŽ¡5: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2—Տ°ŽŽŒ±ƒZ, 3–òÜ•”, 4–ò—, 5—Տ°Œ€‹†EŠé‰æ)

110323. [ŒŽ’˜] The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study. Nemoto O, Furue M, Nakagawa H, Shiramoto M, Hanada R, Matsuki S, Imayama S, Kato M, Hasebe I, Taira K, Yamamoto M, Mihara R, Kabashima K, RuzickaT, Hanifin J, Kumagai Y1: Br J Dermatol 2016/2; 174 (2): 296-304. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

120064. [ŒŽ’˜] Œ’N¬l‚É‚š‚¯‚éRƒqƒXƒ^ƒ~ƒ“–ò‚Ì’†•—}§ì—p‚ÉŠÖ‚·‚錀‹†|ƒIƒƒpƒ^ƒWƒ“Eƒtƒ}ƒ‹Ž_ƒPƒgƒ`ƒtƒFƒ“EƒtƒFƒLƒ\ƒtƒFƒiƒWƒ“‚Ì”äŠr|. ˜eâ^”ü, ‘v@ˆê‘å1, “cƒ–’J_–M2, “¡“c•üŒb3, ‘O“cŽÀ‰Ô4,5, –쑺¡“úŽq6, ¬—ѐ^”ü, ŽR–{–ŸŽq, â–{‘×—1, “c’†—‰pŽq7, ŒF’J—YŽ¡7 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3–ò—, 4—Տ°ŽŽŒ±ƒZ, 5–òÜ•”, 6“Œ•a‰@ŠÅŒì•”, 7—Տ°Œ€‹†EŠé‰æ): —Տ°–ò— 2015/9; 46 (5): 243-8.

120065. [ŒŽ’˜] Œ’N¬l’j«‚É‚š‚¯‚éƒ~ƒ`ƒOƒŠƒjƒhƒJƒ‹ƒVƒEƒ€…˜a•šŒûo“à•ö‰óù10 mg‚̐¶•šŠw“I“¯“™«ŽŽŒ±. ’†–ì—SŽ÷, ’†“‡@’q, ŠÖ–ì‹v–M, ŒF’J—YŽ¡1 (1—Տ°Œ€‹†EŠé‰æ): –ò—‚ÆŽ¡—à (JPT) 2016/1; 44 (1): 57-64.

120066. [ŒŽ’˜] ‚—p—ʃAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ÌŠÌ‹@”\’lˆÙí‚ÉŠÖ‚·‚é“Á’èŽg—p¬Ñ’²žƒf[ƒ^‚ð—p‚¢‚œ’è—ʉðÍ. ŒF’J—YŽ¡1, “c’†—‰pŽq1, ‘v@ˆê‘å2, â–{‘×—2 (1—Տ°Œ€‹†EŠé‰æ, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): —Տ°–ò— 2016/3; 47 (2): 31-7.

522187. [uÀ]y“ÁW: ‘Û‰»E‘n–òŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€1@ƒOƒ[ƒoƒ‹‚ÈŽ‹“_‚ÅŠw‚Ô‘n–ò‚ÆŽ¡Œ±„i‚Ì‚œ‚߂̉ۑè-3zƒAƒJƒfƒ~ƒA‚É‚š‚¯‚é—Տ°ŽŽŒ±|Academic Research Organization (ARO) “™‚̍‘Û”äŠr. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): _ŒoŽ¡—Êw 2015/5; 32 (3): 391-3.

[’˜@‘]

620131. [Šwp‘] yƒ|ƒPƒbƒg”Ł@—Տ°ˆã–ò•iW2016zŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ), Ó”C•ÒW: ¯@ŒbŽq, –òŽ–“ú•ñŽÐ, “Œ‹ž, 2016/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712039. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Current and Future of Asian Clinical Trials. Kumagai Y1: KoNECT-Kitasato Symposium (2015/5/15), Shirokane. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

712040. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Accelerating Asia clinical development through Korea-Japan collaboration. Kumagai Y1: DIA 2015 51st Annual Meeting (2015/6/16), Washington DC, USA. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

712041. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) AN EPIDEMIOLOGICAL STUDY FOR ELEVATION OF LIVER FUNCTION TESTS IN JAPANESE PATIENTS ADMINISTERED BY HIGH DOSE ACETAMINOPHEN. Kumagai Y1, Song ID2, Maeda M3,4, Tanaka R1, Sakamoto Y4: 12th Congress of the EACPT 2015 (2015/6/27-30), Madrid, Spain. (ŒF’J—YŽ¡1, ‘v@ˆê‘å2, ‘O“cŽÀ‰Ô2, “c’†—‰pŽq1, â–{‘×—4: 1—Տ°Œ€‹†EŠé‰æ, 2—Տ°ŽŽŒ±ƒZ, 3–òÜ•”, 4‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

712042. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Current and Future Cardiac Safety in Clinical Trials. Kumagai Y1: KoNECT International Conference 2015 (2015/11/5), Seoul, Korea. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

713131. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) EVALUATION OF CARDIOVASCULAR SAFETY OF DARINAPARSIN (ORGANIC ARSENIC COMPOUND) IN JAPANESE AND KOREAN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA. Kumagai Y1, Cai H, Barrett J, Shiraishi T, Hayashi Y, Sonehara Y, Nagahama F: 12th Congress of the EACPT 2015 (2015/6/27-30), Madrid, Spain. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

722222. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ì–òÜ«ŠÌáŠQ|‚—p—ʃAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ÌŠÌ‹@”\ŒŸž’l‚ÉŠÖ‚·‚é‰uŠw’²ž‚ð‚à‚ƂɁ|. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): ‘æ37‰ñ“ú–{áu’ÉŠw‰ï (2015/7/3), ŒF–{.

722223. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ì–òÜ«ŠÌáŠQ|‰ä‚ª‘‚É‚š‚¯‚é‰uŠw’²žŒ‹‰Ê‚ð‚à‚ƂɁ|. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ï (2015/10/4), ‰¡•l.

722224. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ‘Û‹€“¯ŠJ”­í—ª‚É‚š‚¯‚é‰ä‚ª‘‚Ì‘ŠúŽŽŒ±‚Ì‚ ‚è•û. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): ‘æ36‰ñ“ú–{—Տ°–ò—Šw‰ïŠwp‘‰ï (2015/12/9), “Œ‹ž.

7231012. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒŽ’†‘ãŽÓ•šƒŒƒxƒ‹‚̐lŽí·. ꎓ¡Œö—º, ‘Oì‹žŽq, Jason Kinchen, ŒF’J—YŽ¡1, Ö“¡‰Ã˜N (1—Տ°Œ€‹†EŠé‰æ): ‘æ36‰ñ“ú–{—Տ°–ò—Šw‰ïŠwp‘‰ï (2015/12/9), “Œ‹ž.

7231013. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ú–{l, ŠØ‘lŒ’N¬l”팱ŽÒ‚ÌŽ¡Œ±ŽQ‰Á“®‹@‚Æ”FŽ¯‚ÉŠÖ‚·‚é”äŠrŒ€‹†-[‘w“I–Ê’k’²ž|. ¬ò—º•ã1, ‘O“cŽÀ‰Ô1,2, XˆŸ–îŽq, ¬‘ò@Šw, ‘v@ˆê‘å2, ²X–Ø‘PM3, ‰¡“cœÄˆê3, “¡“c•üŒb4, Ji-Hye Seo, Ock-Joo Kim, ŒF’J—YŽ¡5 (1“Œ•a‰@–òÜ•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3–òÜ•”, 4–ò—, 5—Տ°Œ€‹†EŠé‰æ): ‘æ36‰ñ“ú–{—Տ°–ò—Šw‰ïŠwp‘‰ï (2015/12/9), “Œ‹ž.

731171. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ì–òÜ«ŠÌáŠQ|‚—p—ʃAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ÌŠÌ‹@”\ŒŸž’l‚ÉŠÖ‚·‚é‰uŠw’²ž‚ð‚à‚ƂɁ|. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): ‘æ175‰ñŒF–{Œ§•a‰@–òÜŽt‰ïŒ€C‰ï (2015/6/6), ŒF–{.

731172. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ì–òÜ«ŠÌáŠQ|‰ä‚ª‘‚É‚š‚¯‚é‰uŠw’²žŒ‹‰Ê‚ð‚à‚ƂɁ|. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): ‰«“ꌧ•a‰@–òÜŽt‰ïu‰‰‰ï (2015/11/19), ‰«“ê.

732140. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) —Տ°ŽŽŒ±Žx‰‡‚ÌŽÀÛ. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): ‘æ16‰ñ—Տ°ŽîᇉĊúƒZƒ~ƒi[ (2015/7/9), •iì.

732141. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ì–òÜ«ŠÌáŠQ|‚—p—ʃAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ÌŠÌ‹@”\ŒŸž’l‚ÉŠÖ‚·‚é‰uŠw’²ž‚ð‚à‚ƂɁ|. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): ‘æ170‰ñŽ­Ž™“‡Œ§•a‰@–òÜŽt‰ïŒ€C‰ï (2015/7/17), Ž­Ž™“‡.

732142. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) FIHŽŽŒ±‚ÌŠî–{“I‚ȍl‚Š•û. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): Ä¶ˆã—Â̎ÀŒ»‰»ƒnƒCƒEƒFƒC‘æ7‰ñ—Ï—’S“–ŽÒ‰ï‹c (2015/7/31), •iì.

732143. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) “ú–{l‘æˆê‘ŠŽŽŒ±ƒf[ƒ^‚Ì•K—v«‚ð‚Ç‚€l‚Š‚é‚©. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): ‘æ17‰ñ—Տ°–ò—ŽŽŒ±Œ€‹†‰ï (2015/8/8), ”’‹à.

732144. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) S“Ő«ŠÖ˜A‚Ì”ñ—Տ°ƒf[ƒ^‚Ì’…–Ú“_‚ð—‰ð‚·‚é‚œ‚߂̐S‘ŸˆÀ‘S«•]‰¿‚ÌŒ»ó. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): ˆÀ‘S«•]‰¿Œ€‹†‰ï “~‚̃Zƒ~ƒi[ (2015/11/28), “Œ‹ž.

732145. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ‘Šú’iŠK—Տ°ŽŽŒ±‚É‚š‚¯‚éˆÀ‘S«Šm•Û. ŒF’J—YŽ¡ (—Տ°Œ€‹†EŠé‰æ): –k—¢|APDD‡“¯ƒVƒ“ƒ|ƒWƒEƒ€ (2016/3/14), ”’‹à.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H25-110002. [ŒŽ’˜] Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects' gender and age. Ishikawa M, Maekawa K, Saito K, Senoo Y, Urata M, Murayama M, Tajima Y, Kumagai Y1, Saito Y: PLoS One 2014/3; 9 (3): e91806. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

H25-110003. [ŒŽ’˜] Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. Yokoyama K, Hirakata H, Akiba T, Fukagawa M, Nakayama M, Sawada K, Kumagai Y1, Block GA: Clin J Am Soc Nephrol, 2014/3; 9 (3): 543-52. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

H26-110003. [ŒŽ’˜] 6ƒÀ-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3/SLC22A8, in healthy subjects. Imamura Y, Tsuruya Y, Damme K, Heer D, Kumagai Y1, Maeda K, Murayama N, Okudaira N, Kurihara A, Izumi T, Sugiyama Y, Kusuhara H: Drug Metab Dispos 2014/4; 42 (4): 685-94. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

H26-110004. [ŒŽ’˜] Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis. Yokoyama K, Akiba T, Fukagawa M, Nakamura M, Sawada K, Kumagai Y1, Chertow GM, Hirakata H: J Ren Nutr 2014/7; 24 (4): 261-7. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

H26-110005. [ŒŽ’˜] Effects of sex, age, and fasting conditions on plasma lipidomic profiles of fasted Sprague-Dawley rats. Saito K, Ishikawa M, Murayama M, Urata M, Senoo Y, Toyoshima K, Kumagai Y1, Maekawa K, Saito Y: PLoS One 2014/11; 9 (11): e112266. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)

H26-110006. [ŒŽ’˜] Levetiracetam pharmacokinetics in Japanese subjects with renal impairment. Yamamoto J, Toublanc N, Kumagai Y1, Stockis A: Clin Drug Investig 2014/11; 34 (11): 819-28. (ŒF’J—YŽ¡1: 1—Տ°Œ€‹†EŠé‰æ)


ƒoƒCƒIƒGƒVƒbƒNƒX•”–å


‘n–òƒV[ƒYŒ€‹†ŠJ”­•”–å


ˆãŠw•”•‘®V¢‹Iˆã—ÊJ”­ƒZƒ“ƒ^[

æ’[ˆã—×̈æŠJ”­•”–å

(“c糁@‘)

[Šwp˜_•¶]

510004. [‘à] Diagnosis of Obscure Gastrointestinal Bleeding. Tanabe S1,2: Clin Endosc 2016/2; doi: 10.5946/ce.2016.004. (“c糁@‘1,2: 1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à)

520007. [‘à] ‘ŠúˆÝŠà‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Â̌»‹µ‚Ə«—ˆ“W–]. “c糁@‘1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à): –k—¢ˆãŠw 2015/6; 45 (1): 1-9.

522029. [uÀ]y“ÁW: Á‰»Ší“àŽ‹‹Ÿf—Âɂš‚¯‚é“KØ‚È’ÁÃ–@|VƒKƒCƒhƒ‰ƒCƒ“‚̐³‚µ‚¢—‰ðE‰^—p‚Ì‚œ‚߂Ɂ|z4. “àŽ‹‹Ÿf—Âɂš‚¯‚é’ÁÃ‚̈Ӌ`‚Ƃ킪‘‚ÌŒ»‹µ. “c糁@‘1,2, ²X–Ø“O2, Œ˜“ce—˜2, “Œ@’q2, ÎŒËŒªŽŸ2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à): —ÕଏÁ‰»Ší“à‰È 2015/5; 30 (5): 539-42.

530005. [‚»‚Ì‘Œ (ƒKƒCƒhƒ‰ƒCƒ“)] Guidelines for sedation in gastroenterological endoscopy. Obara K, Haruma K, Irisawa A, Kaise M, Gotoda T, Sugiyama M, Tanabe S1,2, Horiuchi A, Fujita N, Ozaki M, Yoshida M, Matsui T, Ichinose M, Kaminishi M: Dig Endosc 2015/5; 27 (4): 435-49. (“c糁@‘1,2: 1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à)

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-522002. [uÀ]y“ÁW: ‚±‚±‚Ü‚Å‚Å‚«‚é! Á‰»Ší“àŽ‹‹ŸŽ¡—ÁzÁ‰»ŠÇŽŸŠ³@ã•”Á‰»ŠÇoŒŒ‚ɑ΂·‚é“àŽ‹‹Ÿ“IŽ~ŒŒ. “c糁@‘1,2, ÎŒËŒªŽŸ2, “Œ@’q2, Œ˜“ce—˜2, ˜a“c‘ñ–ç2, –î–ì‹MŽj2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2Á‰»Ší“à): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2015/3; 45 (3): 295-302.


(’·À‰p–Ÿ)

[Šwp˜_•¶]

540062. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y2015”N“x`2017”N“x•¶•”‰ÈŠwÈ‰ÈŠwŒ€‹†”ï•â•‹à Šî”ÕŒ€‹† (C)uƒXƒgƒŒƒX‚É‚æ‚éIP3Žó—e‘Ì‚ð‰î‚µ‚œ“àŽšáŠQ”­¶‚̃ƒJƒjƒYƒ€‚̉𖟁vz’·À‰p–Ÿ (V¢‹Iˆã—ÁEæ’[ˆã—Ã): 2015”N“x`2017”N“x•¶•”‰ÈŠwÈ‰ÈŠwŒ€‹†”ï•â•‹à Šî”ÕŒ€‹† (C)uƒXƒgƒŒƒX‚É‚æ‚éIP3Žó—e‘Ì‚ð‰î‚µ‚œ“àŽšáŠQ”­¶‚̃ƒJƒjƒYƒ€‚̉𖟁v’†ŠÔ•ñ‘ 2016/3.

[Šw‰ïEŒ€‹†‰ï“™]

723891. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “àŽšáŠQ‚ƃXƒgƒŒƒX‚ÌŠÖ˜A«‚̉𖟁\Inositol trisphosphate receptor type|1ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚Ì’®Šo‹@”\|. ’·À‰p–Ÿ1, Ö“¡—Yˆê˜Y, ‰ÍŒŽŽ‰ë2, ‰ª–{–ql3, “¿‘Œú“ñ, ŒäŽqŽÄŽ•F (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2¶—, 3Žš•@ˆôAE“ªèòŠO): ‘æ74‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ïEŠwpu‰‰‰ï (2015/11/27), Šò•Œ, Equilibrium Res (—\eW) 2015; 74 (5): 435.

731173. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “àŽšáŠQ‚ƃXƒgƒŒƒX‚ÌŠÖ˜A«|Inositol trisphosphate receptor-1 (IP3R1) ‚Æ“àŽš‚É‚š‚¯‚é‚»‚̋Ǎ݁|. ’·À‰p–Ÿ (V¢‹Iˆã—ÁEæ’[ˆã—Ã): “Œ‹žé‹Ê_ŒoŽš‰ÈŒ€‹†‰ï (2015/6/20), “Œ‹ž.

731174. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒƒjƒG[ƒ‹•a‚ɑ΂·‚éHydration Therapy (…•ªÛŽæ—Ö@) ‚Æ‚»‚ÌŠî‘bˆãŠw“I”wŒi. ’·À‰p–Ÿ (V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ15‰ñé‹ÊŒ§‚ß‚Ü‚¢E“ï’®Œ€‹†‰ï (2016/2/4), ‚³‚¢‚œ‚Ü.

732146. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ‚ß‚Ü‚¢‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ’·À‰p–Ÿ (V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ45‰ñ•œt‹@”\ŒŸž‹ZpuK‰ï (2015/7/15), “Œ‹ž.


(“c’†@Œ‰)

[Šwp˜_•¶]

522188. [uÀ]y“ÁW: ‚Ö‚»‚ðŽg‚€Žèp‚ÌŽÀÛz—‘‘ƒŽîáŽ. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ¬Ž™ŠO‰È 2016/3; 48 (3): 314-7.

522189. [uÀ]y“Á•ÊŠé‰æ: ‘Û‰»Žž‘ã‚É‚š‚¯‚é–M•¶Šw‰ïŽ‚݂̍è•û (‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï‹L˜^)z‘Û‰»Žž‘ã‚É‚š‚¯‚é“ú–{¬Ž™ŠO‰ÈŠw‰ïŽ‚݂̍è•û. –kì”Žº, ç—t³”Ž, “c’†@Œ‰1, ŽR‚“čs, m”ö³‹L (1V¢‹Iˆã—ÁEæ’[ˆã—Ã): “ú–{ŠO‰ÈŠw‰ïŽGŽ 2015/8; 116 (—ÕŽž‘Š§†2): 27-9.

[’˜@‘]

620132. [Šwp‘ (•ª’SŽ·•M)] y‰Æ‘°«Žîᇊw|‰Æ‘°«Žîᇂ̍ŐVŒ€‹†“®Œü|(“ú–{—Õ଑Š§† (No.1083))zII. Še˜_@1. ÇŒóŒQ@(6) Blue rubber bleb nevus syndrome (ÂFƒSƒ€‚Ü‚è—l•ê”ÁÇŒóŒQ), p.75-9. “c’†@Œ‰ (V¢‹Iˆã—ÁEæ’[ˆã—Ã), “ú–{—Õ଎Ð, ‘åã, 2015/8”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713132. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Intraabdominal drainage is unnecessary for intestinal perforation in neonates. Tanaka K1, Takeda N2, Kakihara T2, Watanabe M2: 28th International Symposium on Paediatric Surgical Research (2015/9/26), Dublin, Ireland. (“c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2, “n粏¹•F2: 1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È)

721022. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘Û‰»Žž‘ã‚É‚š‚¯‚é“ú–{¬Ž™ŠO‰ÈŠw‰ïŽ‚݂̍è•û. –kì”Žº, ç—t³”Ž, “c’†@Œ‰1, ŽR‚“čs, m”ö³‹L (1V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/17), –ŒŒÃ‰®.

7231014. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’_“¹•ÂœÇ‚ɑ΂·‚é’†žŠŽ®’°dÏŒ^lH’°•Ù•t‰ÁRoux-YÄŒš–@‚ð—p‚¢‚œŠÌ–å‹ó’°•«‡p‚Ì—L—p«. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2, “n粏¹•F2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ‘æ115‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2015/4/16), –ŒŒÃ‰®.

7231015. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠO‰ÈŽ¡—ª’x‚ê‚œ, o¶‘Of’fæ“V«’_“¹Šg’£Ç|ŽèpŽžŠú‚ðl‚Š‚é‚€‚Š‚Å‹Md‚È1—á|. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2, “n粏¹•F2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ‘æ52‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï (2015/5/28), _ŒË.

7231016. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ä`¬ØŠJƒAƒvƒ[ƒ`‚É‚æ‚éŽèp‚Æ‚»‚̍H•v. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2, “n粏¹•F2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ‘æ52‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï (2015/5/28), _ŒË

7231017. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™ŠO«’°ŠÇ‘¹‚ÌŒŸ“¢. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2, “n粏¹•F2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ‘æ29‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ïŠwpW‰ï (2015/6/12), ‚³‚¢‚œ‚Ü.

7231018. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V¶Ž™Á‰»ŠÇúEŽèp‚ɃhƒŒ[ƒ“—¯’u‚Í•s—v‚Å‚ ‚é. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ‘æ51‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2015/7/10), •Ÿ‰ª.

7231019. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒŠÇ, ƒŠƒ“ƒpŠÇ•a•Ï‚ÌŽ¡—ÃŒoŒ±. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2, “n粏¹•F2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ‘æ31‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïH‹GƒVƒ“ƒ|ƒWƒEƒ€ (2015/10/31), ŒF–{.

7231020. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) o¶‘O‚É”P“]‚µ—V—£‚µ‚œ• o“à’â—¯ž‘ƒ‚ɑ΂µ• o‹Ÿ•â•‰º“Eop‚ðŽ{s‚µ‚œ1—á. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2, “n粏¹•F2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ‘æ28‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2015/12/11), ‘åã.

731175. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬Ž™ŠO‰È‚ ‚ꂱ‚ê. “c’†@Œ‰ (V¢‹Iˆã—ÁEæ’[ˆã—Ã): 2015”N_“ސìƒtƒ‰ƒe•afEfX˜AŒg‚̉ï (2015/7/25), ‰¡•l.

733370. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚éä`•”¬ØŠJƒAƒvƒ[ƒ`Žèp‚Æ‚»‚̍H•v. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2, “n粏¹•F2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ‘æ1‰ñ“ú–{¬Ž™‚Ö‚»Œ€‹†‰ï (2015/4/16), –ŒŒÃ‰®.

733371. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V¶Ž™‚É‚š‚¯‚銮‘S•ª—£Œ^ƒXƒgƒ}‘¢Ýp. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2, “n粏¹•F2, ŒŒŽN”ü3, ²“¡—ÇŽq3 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È, 3ŠÅŒì•”): ‘æ29‰ñ“ú–{¬Ž™ƒXƒg[ƒ}E”rŸ•ŠÇ—Œ€‹†‰ï (2015/6/27), VŠƒ.

733372. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‡•¹Ç‚ð—L‚µ‚Ä‚¢‚é’_“¹•ÂœÇ¬l—á2—á. “c’†@Œ‰1, •“cŒ›Žq2, Š`ŒŽ@’m2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2ŠO‰È): ‘æ42‰ñ“ú–{’_“¹•ÂœÇŒ€‹†‰ï (2015/11/7), “Œ‹ž


(‹g“cˆê¬)

[Šwp˜_•¶]

540020. [‚»‚Ì‘Œ] tˆÚAƒ`[ƒ€‚©‚ç”­M‚·‚étˆÚAŠ³ŽÒ‚̉h—{ŠÇ—. ‹g“cˆê¬ (V¢‹Iˆã—ÁEæ’[ˆã—Ã): CION‰h—{EHŽ–ƒjƒ…[ƒX 2015/10; 28: 1.

[Šw‰ïEŒ€‹†‰ï“™]

713091. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Three Year Clinical Outcomes Of Once-Daily Tacrolimus Extented-Release Formulation versus Twice-Daily Tacrolimus In De Novo Kidney Transplantation. Yoshida K1,2, Ishii D2, Kohguchi D2, Ohyama T2, Mochizuki K2, Takeuchi Y3, Wakai H, Noguchi F4, Tanaka M4, Ikeda M2: 14th Congress of the Asian Society of Transplantation (2015/8/24), Singapore. (‹g“cˆê¬1,2, Îˆä‘å•ã2, ‚Œû@‘å2, ‘åŽR“N•œ2, –]ŒŽN•œ2, ’|“àN—Y3, Žáˆä—zŠó, –ìŒû•¶”T4, “c’†”üŽ÷4, ’r“c¬]2: 1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí, 3t‘Ÿ“à, 4ŠÅŒì•”)

713094. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) EVEROLIMUS, TAC-ER AND MMF DE NOVO RENAL TRANSPLANT RESULTED GOOD GRAFT FUNCTION. Yoshida K1,2, Ishii D2, Takeuchi Y3, Wakai H, Kohguchi D2, Noguchi F4, Ikeda M2, Tanaka M4: 17th Congress of the European Society for Organ Transplantation (2015/9/16), Brussels, Belgium. (‹g“cˆê¬1,2, Îˆä‘å•ã2, ’|“àN—Y3, Žáˆä—zŠó, ‚Œû@‘å2, –ìŒû•¶”T4, ’r“c¬]2, “c’†”üŽ÷4: 1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí, 3t‘Ÿ“à, 4ŠÅŒì•”)

722092. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) tˆÚA‚É‚š‚¯‚é–ò•š—Ö@‚̏d—v«. ‹g“cˆê¬1,2, Îˆä‘å•ã2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ9‰ñ“ú–{t‘Ÿ•a–ò•š—Ö@Šw‰ï ŠwpW‰ïE‘‰ï2015 (2015/10/25), å‘ä.

722101. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) tˆÚA‚É‚š‚¯‚éƒ`[ƒ€ˆã—Â̏d—v« (ƒI[ƒo[ƒrƒ…[). ‹g“cˆê¬1,2, Îˆä‘å•ã2, –ìŒû•¶”T3, ’r“c¬]2, ‹{â—Dl4, ‹g“c•üŽq5, Œ‘ò—Ç‘Ÿ6 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí, 3ŠÅŒì•”, 4–òÜ•”, 5‰h—{•”, 6ƒŠƒnƒrƒŠ•”): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/24), ’¹Žæ.

723665. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) LDL‹z’…—Ö@‚ÆŒŒ‰t“§Í‚Ì“¯Žž•¹—p—Ö@Ž{s‚ɂ‚¢‚Ä‚ÌŽŽ‚Ý. ‰Í‘º”ŽŽq, Žáˆä—zŠó, à_èG—æŽq, “c•Ó–¢—ˆ, “n粒qŽq, ˆ¢•”“ޒÔü, –Ø‘ºŠG”ü, •º“¡@“§, ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/26), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 640.

723666. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”p—pÇŒóŒQŠ³ŽÒ‚ª•às‰Â”\‚Æ‚È‚Á‚œÇ—á`ˆ€‘·‚ƃo[ƒWƒ“ƒ[ƒh‚ð•à‚Þ‚œ‚߂Ɂ`. ŠÚ–ì—Y‹M, –Ø‘ºŠG”ü, œA]–r–€, ”üK—¯”ü, ›@—L‹I, Žáˆä—zŠó, •º“¡@“§, ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/26), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 686.

723668. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–ƒNƒŠƒjƒbƒN‚Ì‹³ˆçŽå”C‚Æ‚µ‚ĐVlŠÅŒìŽt‚Ö‚ÌŽw“±`“–ƒNƒŠƒjƒbƒN‚̃}ƒjƒ…ƒAƒ‹‚ðŠî‚ÉŽw“±‚ðŽn‚ß‚Ä. ––‰i—TŽq, —Ž‡^Šó, ‚‹Ž@—º, ‚‹Ž_—Y, Šp“c—²r, —é–؁@‘å, ‹g“cˆê¬1,2, Îˆä‘å•ã2, ‚‹Ž—Tˆê˜Y (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/26), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 729.

723670. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆÚAt‹@”\”pâŒã‚ɍݑ‰t“§Í‚𓱓ü‚µ‚œ7Ç—á. Žáˆä—zŠó, ˆ¢•”“ޒÔü, ‰Í‘º”ŽŽq, ™–{’ŒŽq, –Ø‘ºŠG”ü, ŽR’†—¢‰À, •º“¡@“§, ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 753.

723671. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚š‚¯‚é•n¢Š³ŽÒ‚ɑ΂·‚éˆÛŽ“§Í“±“ü‚ÌŒoŒ±. ŠÃ—˜‰ÀŽj, ’†“ˆÍ‹M, ŒŒŽO˜a, Žáˆä—zŠó, “葺—F—², ’·ÀrG, ¬‹v•ÛŒªˆê, •º“¡@“§, ŽÄŒŽL‹v, ‹g“cˆê¬1,2, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 756.

723672. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚š‚¯‚铧Í‰tŽò‰». ‰Y•Órˆê˜Y, ¬“‡@–G, “葺—F—², –Ø‘ºŠG”ü, ˆ¢•”“ޒÔü, ×–썂Žu, Žáˆä—zŠó, ¬‹v•ÛŒªˆê, ’†“‡Í‹M, •º“¡@“§, ‹g“cˆê¬1,2, ’|àV^Œá, ìŒGŽ÷ (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 756.

723673. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ~ƒƒƒ“ƒ}[‚É‚š‚¯‚铧Í‰tŽò‰»Žx‰‡Šˆ“®. –Ø‘ºŠG”ü, ˆ¢•”“ޒÔü, ¬“‡@–G, ÷‘ò‹Mr, ÷‘ò—ž”T, ‰Y•Órˆê˜Y, ‘ëàVˆŸ—R”ü, ˆÀ•”‹M”V, ¬—Ñ‚±‚žŒb, “葺—F—², ¬‹v•ÛŒªˆê, Žáˆä—zŠó, •º“¡@“§, ‹g“cˆê¬1,2, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 756.

723674. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒxƒgƒiƒ€‚É‚š‚¯‚铧Í‰tŽò‰»‚Ö‚ÌŽæ‚è‘g‚ÝŽx‰‡. ŒŒŽO˜a, ¬‹v•ÛŒªˆê, “c’†³ŒÈ, ¬“‡@–G, “葺—F—², Žáˆä—zŠó, ’†“ˆÍ‹M, •º“¡@“§, ŽÄŒŽL‹v, ‹g“cˆê¬1,2, ’|àV^Œá, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 756.

723675. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚š‚¯‚铧ÍŠÖ˜Aˆã—Ï]Ž–ŽÒˆç¬Žx‰‡ƒvƒƒWƒFƒNƒg. Žáˆä—zŠó, •º“¡@“§, ¬‹v•ÛŒªˆê, “葺—F—², ’·ÀrG, ’†“ˆÍ‹M, ŽÄŒŽL‹v, ‹g“cˆê¬1,2, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 757.

723676. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒxƒgƒiƒ€Eƒ~ƒƒƒ“ƒ}[EƒJƒ“ƒ{ƒWƒA‚É‚š‚¯‚ét“§ÍŠÖ˜AŠwp‘gD‚̏ó‹µ. ŒŒŽO˜a, ¬‹v•ÛŒªˆê, ¬“‡@–G, “葺—F—², Žáˆä—zŠó, ’†“ˆÍ‹M, •º“¡@“§, ŽÄŒŽL‹v, ‹g“cˆê¬1,2, ’|àV^Œá, ŽR‰º–Ÿ‘×, ìŒGŽ÷, ì‘º–Ÿ•v (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 757.

723680. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒKƒ“ƒ}ü–Å‹Û‰ñ˜H‚ÌŽg—pŒoŒ±. •œ–ì’š‹v, Â–Ø–ÎŽ÷, ‚‹Ž@—º, ‚‹Ž_—Y, Šp“c—²r, —é–؁@‘å, ‹g“cˆê¬1,2, Îˆä‘å•ã2, ‚‹Ž—Tˆê˜Y (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/27), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 853.

723684. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “§ÍƒNƒŠƒjƒbƒN‚É‚š‚¯‚éî•ñƒZƒLƒ…ƒŠƒeƒB‘΍ô. “n糗FŽq, ŽR’†—¢‰À, –kè‘Žq, ‹g•G”ü, ‘ëŽR—tŽq, ”üK—¯”ü, Žáˆä—zŠó, •º“¡@“§, ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/28), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 960.

723685. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹ß—׏Z–¯‚ÌŠñ•t‚É‚æ‚蓧Í“±“ü‚ÉŽŠ‚Á‚œƒJƒ“ƒ{ƒWƒA‚Å‚Ì––Šút•s‘SŠ³ŽÒ‚Ì“§Íó‹µ‚Ɖh—{ó‘Ô. Žáˆä—zŠó, ’·ÀrG, •º“¡@“§, ‹g“cˆê¬1,2, ìŒGŽ÷, –k“‡KŽ}, “c‘º’qŽq (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ3‰ñ“ú–{t•s‘S‰h—{Œ€‹†‰ïŠwpW‰ïE‘‰ï (2015/7/5), ‰¡•l.

731133. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ADPKDf—ÂɊւ·‚éÅ‹ß‚̘b‘è|–EtŠO—ˆ‚ƃgƒ‹ƒoƒvƒ^ƒ“|. ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘Š–ÍŒŽADPKD•af˜AŒg‚̉ï (2015/7/24), ‘Š–ÍŒŽ.

731142. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “–‰@‚É‚š‚¯‚étˆÚAƒ`[ƒ€ˆã—Í\¬. ‹g“cˆê¬1,2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2”å”AŠí): ‘æ11‰ñ“ì‘åãtˆÚAE“§Íˆã—ÃŒ€‹†‰ï (2015/11/19), ‘åã.


(—é–؁@Ž )

[Šwp˜_•¶]

521030. [‰ðà]yˆã—Ê֌WŽÒ‚ɑ΂·‚é•úŽËü–hŒì‹³ˆç‚Æ‚Í?z•úŽËüf—Âɂš‚¯‚é•úŽËü–hŒì‹³ˆç‚Æ‚Í?|‚»‚̈Ӌ`‚Æ•K—v«|CTŒŸž‚É‚š‚¯‚é•úŽËü–hŒì‹³ˆç‚Æ‚»‚̈Ӌ`. —é–؁@Ž  (V¢‹Iˆã—ÁEæ’[ˆã—Ã): ˆã—Õúü–hNewsletter 2015/7; 73: 14-8.

[Šw‰ïEŒ€‹†‰ï“™]

722225. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) [•K{uK] ˆã—ÈÀ‘SE•úŽËü–hŒì CT (•úŽËü–hŒì‚ÌŒ©’n‚©‚ç). —é–؁@Ž  (V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ74‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2015/4/18), ‰¡•l, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ 2015/2; p.S126.


(‰Á“¡—¢ŠG)

[Šwp˜_•¶]

522190. [uÀ]y“ÁW: –³’É•ª•ØUp to Datez7. d–ŒŠO–³’É•ª•Ø‚É‚æ‚é•êŽ™‚Ö‚Ì•›ì—pE‡•¹Ç‘΍ô. ‰Á“¡—¢ŠG (V¢‹Iˆã—ÁEæ’[ˆã—Ã): ŽY‰È‚Æ•wl‰È 2015/5; 82 (5): 509-14.

522191. [uÀ]y“ÁW: ”D•w‹~‹}‘Ήž‚ÌŽÀ‘H‚ƈã—ÃVƒXƒeƒ€\’z‚Ì‚œ‚߂Ɂz5. ŽY‰È‹~‹}‚Ì“ÁŽê«@”DŽY•w‹~‹}‘Ήž‚É‚š‚¯‚éŽY•wl‰Èˆã‚Æ–ƒŒ/‹~‹}/W’†Ž¡—ÉȈã‚Ƃ̘AŒg‚Ì‚œ‚ß‚É. ‰Á“¡—¢ŠG (V¢‹Iˆã—ÁEæ’[ˆã—Ã): ŽY•wl‰È‚ÌŽÀÛ 2015/9; 64 (9): 1133-9.

[’˜@‘]

620133. [Šwp‘ (•ª’SŽ·•M)]y“ú–{‚Ì”DŽY•w‚ð‹~‚€‚œ‚ß‚É2015zA. Šî–{•Ò@”DŽY•w‹}•ÏŽž‚̏‰Šú‘Ήž, p.86-97. ‰Á“¡—¢ŠG1, ‰œ•xr”V2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2–ƒŒ) Šé‰æ: Î“n@—E, ’r“c’q–Ÿ, ŠÄC: “ú–{ŽY•wl‰Èˆã‰ïˆã—ÈÀ‘SˆÏˆõ‰ï, Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (’nˆæˆã—Êî”ÕŠJ”­„iŒ€‹†Ž–‹Æ) ’r“c”Ç, •Ò: ŠÖ‘ò–Ÿ•F, ’·’Jìˆê, “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2015/4”­s.

620134. [Šwp‘ (•ª’SŽ·•M)]y–ƒŒ‰ÈˆãEW’†Ž¡—Èã‚É•K—v‚ÈŒŒ‰t‹ÃŒÅ, R‹ÃŒÅ, ü—nŒn‚ª•ª‚©‚é–{ ‰ü’ù‘æ2”Łz(—Տ°) 4. ŽY‰ÈoŒŒ‚É‚š‚¯‚é‹ÃŒÅáŠQ‚Ì“Á’¥‚Æ‚»‚̑Ώˆ–@, p.117-31. ‰Á“¡—¢ŠG1, ‰œ•xr”V2 (1V¢‹Iˆã—ÁEæ’[ˆã—Ã, 2–ƒŒ) •Ò: •“cƒŽO, ^‹»ŒðˆÕˆã‘o”Å•”, “Œ‹ž, 2015/6”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722226. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) —r…ÇðÇ. ‰Á“¡—¢ŠG (V¢‹Iˆã—ÁEæ’[ˆã—Ã): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/28), _ŒË

722227. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”DŽY•w‹}•ÏŽž‚̑Ήž. ‰Á“¡—¢ŠG (V¢‹Iˆã—ÁEæ’[ˆã—Ã): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/29), _ŒË

732147. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ’鉀ØŠJ‚ÅŽq‹Ÿ‚ðŽY‚ÞˆÓ–¡‚ðl‚Š‚Ä‚Ý‚æ‚€. ‰Á“¡—¢ŠG (V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ8‰ñŽüpŠúƒZƒ~ƒi[ (2015/5/30), _ŒË

732148. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”DŽY•wICUŠÇ—‚Ì’ˆÓ“_. ‰Á“¡—¢ŠG (V¢‹Iˆã—ÁEæ’[ˆã—Ã): “ú–{W’†Ž¡—ÈãŠw‰ï‘æ13‰ñƒŠƒtƒŒƒbƒVƒƒ[ƒZƒ~ƒi[ (2015/8/2), “Œ‹ž.


‰¡’f“Iˆã—×̈æŠJ”­•”–å

(²X–ØŽ¡ˆê˜Y)

[Šwp˜_•¶]

110324. [ŒŽ’˜] Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol. Hotta K, Sasaki J1, Saeki S, Takigawa N, Katsui K, Takayama K, Nogami N, Shioyama Y, Bessho A, Kishimoto J, Tanimoto M, Kiura K, Ichinose Y: Clin Lung Cancer 2016/1; 17 (1): 75-9. (²X–ØŽ¡ˆê˜Y1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

[’˜@‘]

620135. [Šwp‘ (•ª’SŽ·•M)]yŒÄ‹zŠíŽŸŠ³ ÅV‚ÌŽ¡—à 2016-2018zXV. ŒÄ‹zŠíŽŸŠ³‚ÌŠ³ŽÒŽw“±@5. ”xŠà‚ÌŠO—ˆŠÇ—, p.436-7. ²X–ØŽ¡ˆê˜Y (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: ™ŽRK”äŒÃ, –å“c~ˆê, Œ·ŠÔº•F, “ì]“°, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722228. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ŠÉ˜a—Ö@: ŠÉ˜aˆã—Âð•W€‰»‚·‚é‚É‚Í. ²X–ØŽ¡ˆê˜Y (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ13‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï (2015/7/18), ŽD–y.

722229. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) —Տ°Žîᇈã‚ɑ΂·‚éŠÉ˜aˆã—ÃKƒCƒhƒ‰ƒCƒ“‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²žŒ‹‰Ê•ñ. ²X–ØŽ¡ˆê˜Y1, •œŽR‘א¶2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2“ŒŽD–y•a‰@EŽîᇓà‰È): ‘æ13‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï (2015/7/18), ŽD–y.

722230. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”xŠà—̈æ‚É‚š‚¯‚鎝‘±Œ^G-CSF»Ü‚ÌŽg‚¢•û. ²X–ØŽ¡ˆê˜Y (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ56‰ñ“ú–{”xŠàŠw‰ïŠwpW‰ï(2015/11/28), ‰¡•l.


(‹àˆäº•¶)

[Šwp˜_•¶]

522192. [uÀ]y“ÁW: ’ɂݐf—Âɂš‚¯‚éŒõü—Ö@@I. Œõü—Ö@‚Ì‹@ŠízƒLƒZƒmƒ“ƒ‰ƒCƒgŽ¡—Êí. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ƒyƒCƒ“ƒNƒŠƒjƒbƒN 2016/2; 37 (2): 169-75.

[’˜@‘]

620136. [Šwp‘ (•ª’SŽ·•M)]y’É‚Ý‚ÌScience & Practice 8@—Տ°‚ɖ𗧂_ŒoáŠQ«’É‚Ì—‰ðzIII. Ž¡—э˜_@1. –ò•š—Ö@, p.64-74. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: ˆäŠÖ‰ëŽq, •¶Œõ“°, “Œ‹ž, 2015/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722231. [Šw‰ï (‘S‘)] (ƒXƒ|ƒ“ƒT[ƒhƒVƒ“ƒ|ƒWƒEƒ€) –«áu’ɏǂɂš‚¯‚éƒIƒsƒIƒCƒhŽ¡—Öò‚̈Ӌ`. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{üˆÛ‹Ø’ɏNJw‰ï‘æ7‰ñŠwpW‰ï (2015/10/3), Vh.

7231021. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘±Ò‘‚­‚à–Œ‰º–ƒŒ. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{‹æˆæ–ƒŒŠw‰ï‘æ2‰ñŠwpW‰ï (2015/4/25), ŒQ”n.

731176. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ŒŠ‹–k•”áu’ÉŽ¡—ÃŒ€‹†‰ï (2015/6/26), ”Žs.

731177. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’ɂ݂̍\‘¢. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Chiba Spine Youth Meeting 12th (2015/7/25), ç—t.

731178. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‰¡{‰ê®Œ`ŠO‰Èˆã‰ï 2015/8/5), ‰¡{‰ê.

731179. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚ª‚ñ«’ÉŽ¡—Â̐Ví—ª`Œ»Ž¡—Â̖â‘è“_‚Ƒ΍ô`. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _“ސ쌧‰›’n‹æŠÉ˜aˆã—ÃŒ€‹†‰ï (2015/8/25), _“ސì.

731180. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïŠwpu‰‰‰ï (2015/9/2), ‘Š–Í‘å–ì.

731181. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): é‹ÊŒ§“Œ•”–«áu’ɍ§˜b‰ï (2015/10/15), t“ú•”.

731182. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ188‰ñŠw‚Ú‚€‰ï (2015/12/4), `–ì.

731183. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘å‘D’n‹æ–«áu’ɃJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/1/20), Š™‘q.

731184. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): –Ÿ“ú‚©‚ç–𗧂Âáu’ÉŽ¡—ÃZƒ~ƒi[ (2016/2/10), ’²•z.

731185. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): áu’ɂɂ‚¢‚čl‚Š‚é‰ï (2016/2/17), •lŒ.

733373. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚ÝŽ¡—Â̍l‚Š•û. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): áu’ÉŒ€‹†‰ï (2015/4/10), ‰¡•l.

733374. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‹I”öˆä’¬JointƒZƒ~ƒi[2015 (2015/4/16), “Œ‹ž.

733375. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚­‚à–Œ‰ºƒ|[ƒg‚Ì“K‰ž‚ÆŠÇ—. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‚­‚à–Œ‰ºƒ|[ƒgŒ€C‰ï (2015/6/10), ‘Š–ÍŒŽ.

733376. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ãŽˆ‚š‚æ‚щºŽˆ‚Ì’É‚ÝŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _“ސ쌧—Տ°®Œ`ŠO‰Èˆã‰ï“Á•ÊŠwpu‰‰‰ï (2015/6/24), ‰¡•l.

733377. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Ã“ì_ŒoáŠQ«áu’ÉŒ€‹†‰ï (2015/7/22), “¡‘ò.

733378. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ¬“cŒŽˆãŽt‰ï“’‰ÍŒŽ”ÇŠwpu‰‰‰ï (2015/7/27), Ã‰ª.

733379. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’ɂݐf—Â̔wŒi. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): u‹`J-PAT_“ސì (2015/9/15), ‰¡•l.

733380. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ì•]‰¿‚š‚æ‚Ñ–«áu’É. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): u‹`J-PAT_“ސì (2015/9/15), ‰¡•l.

733381. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«áu’É‚Ì–ò•š—Ö@‚ÌŽÀÛ. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): u‹`J-PAT_“ސì (2015/9/15), ‰¡•l.

733382. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—îŽÒ‚̒ɂ݂ɑ΂·‚é–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘Š–ÍŒŽ–òÜŽt‰ï (2015/9/17), ‘Š–ÍŒŽ.

733383. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ì–ò•šŽ¡—Ã. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoáŠQ«áu’ɃZƒ~ƒi[ in YOKOHAMA (2015/11/19), ‰¡•l.

733384. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ª‚ñf’fŽž‚©‚ç‚ÌWHOŽO’iŠKœ’Ƀ‰ƒ_[‚ÌŒœ”O. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “È–ØŒ§ŠÉ˜aƒPƒA ƒI[ƒ^ƒ€ƒZƒ~ƒi[ (2015/11/20), ‰F“s‹{.

733385. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«’ɂɑ΂·‚éƒuƒvƒŒƒmƒ‹ƒtƒBƒ“‚̍čl. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ4‰ñ‚¢‚í‚ĉ^“®Šíáu’ɍ§˜b‰ï (2016/2/13), ·‰ª.

733386. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚ªˆÓ–¡‚·‚é‚à‚Ì. ‹àˆäº•¶ (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ5‰ñ–k—¢‘åŠwˆãŠw•”•‘®V¢‹Iˆã—ÊJ”­ƒZƒ“ƒ^[ƒVƒ“ƒ|ƒWƒEƒ€ (2016/3/3), ‘Š–Í‘å–ì.


(Vˆä³N)

[Šwp˜_•¶]

522193. [uÀ]y“ÁW: ˆê”Ê•a“ƒi[ƒX‚É‚à–𗧂Â! u‚È‚ñ‚©ƒwƒ“?v‚ðŒ©”²‚­! ‹}•Ï‘O‚ÌŽ@’mšƒAƒZƒXƒƒ“ƒgšƒhƒNƒ^[ƒR[ƒ‹ (RRT—v¿) ƒ~ƒ‰ƒNƒ‹™ƒƒ\ƒbƒhz4.uŒÄ‹zv‚ُ̈í‚ÍSpO2’ቺ‚¶‚á’x‚¢‚Ì‚æ. Vˆä³N (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Emergency Care 2015/8; 28 (8): 31-5.

522194. [uÀ]y“ÁW: ‘å—ʏoŒŒ‚Ì•a‘Ԑ¶—‚Æ—AŒŒí—ªzŠO«‘å—ʏoŒŒ: •a‘ԂƑ΍ô. Vˆä³N (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Thrombosis Medicine 2016/3; 6 (1): 33-9.

[’˜@‘]

622001. [Šwp‘ (–|–ó)]yƒwƒX‚ƃJƒNƒ}ƒŒƒbƒN‚ÌTHElHŒÄ‹zƒuƒbƒN ‘æ2”Å‘æ1üz–ó: “c’†—³”n, £”ö—Ž‘Ÿ˜Y, ˆÀ‘îˆêW, Vˆä³N1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2015”N8ŒŽ”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713133. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Implementation of Critical Care Staff based Rapid Response Team|Effect to the Unpredicted Death|. Arai M1, Koike T, Moriyasu M, Ito S2, Inagaki T3, Hattori J3, Otsuka T2, Yoshino K2, Kuroiwa M2: 28th Annual Congress of the European Society of Intensive Care Medicine (2015 ESICM) (2015/10/6), Berlin, Deutschland. (Vˆä³N1, ˆÉ“¡‘s•œ2, ˆîŠ_‘דl3, •ž•”@3, ‘å’Ë’q‹v2, ‹g–ì˜a‹v2, •Šâ­”V2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2–ƒŒ, 3‹~–œ)

713134. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Impact of the Critical Care Outreach Team based Rapid Response System to the Unpredicted Hospital Death. Arai M1, Koike T, Moriyasu M, Ito S2, Inagaki T3, Hattori J3, Otsuka T2, Yoshino K2, Kuroiwa M2: 12th Congress of the World Federation of Societies of Intensive and Critical Care Medicine in collaboration with WFCCN and WFPICCS (2015/8/30), Seoul, Korea. (Vˆä³N1, ˆÉ“¡‘s•œ2, ˆîŠ_‘דl3, •ž•”@3, ‘å’Ë’q‹v2 ‹g–ì˜a‹v2, •Šâ­”V2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2–ƒŒ, 3‹~–œ)

722232. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’ÁÃ, ‚¹‚ñ–Ï, ‰^“®—Ö@‚ðˆê‘Ì‚Æ‚µ‚œƒ`[ƒ€ƒAƒvƒ[ƒ`‚ƐlHŒÄ‹zŠí—£’E. Vˆä³N1, XˆÀŒbŽÀ, Œ©ˆä“c˜a³2, _’JŒ’‘Ÿ˜Y2, à_èL–Ÿ2, ‘“c³˜a, ¬’r•üF, —é–Ø—D‘Ÿ˜Y3, ‘å’Ë’q‹v3, •Šâ­”V3 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2ƒŠƒnƒrƒŠ•”, 3–ƒŒ): ‘æ37‰ñ“ú–{ŒÄ‹z—Ö@ˆãŠw‰ïŠwpW‰ï (2015/07/17), ‹ž“s.

7231022. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Rapid Response System‹N“®Šî€‚ɁgWorried Callh‚ðÌ—p‚·‚邱‚Ƃ̓VƒXƒeƒ€‚Ì‘Šú‹N“®‚É—LŒø‚Å‚ ‚é. Vˆä³N1, ¬’r•üF, XˆÀŒbŽÀ, ˆÉ“¡‘s•œ2 ,ˆîŠ_‘דl3, •ž•”@3, •Šâ­”V2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2–ƒŒ, 3‹~–œ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ62‰ñŠwpW‰ï (2015/5/28), •Ÿ‰ª.

7231023. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@Rapid Response System‚ªI––Šúˆã—Â֗^‚Š‚é‰e‹¿‚Ì’²ž. Vˆä³N1, ¬’r•üF, XˆÀŒbŽÀ, ‘å’Ë’q‹v2, ‹g–ì˜a‹v2, ˆÉ“¡‘s•œ2, ¬âN°2, —é–Ø—D‘Ÿ˜Y2, ŒàV‹`”V2, •Šâ­”V2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2–ƒŒ): ‘æ43‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2016/2/12), _ŒË.

7231024. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒvƒŒƒ`ƒXƒ‚ƒOƒ‰ƒ€•Ï“®‚©‚ç“Ÿ‚ç‚ê‚é, ”ñNP“IŒÄ‹z‰ñ”‘ª’è‘•’u (NellcorTM PM1000N) ‚ÌŠm‚©‚炵‚³‚ÌŒŸ“¢. Vˆä³N1, ‹g‰ªr•ã2, ãˆä䝗LŽq2, “c’†ˆê¶2, —é–Ø—D‘Ÿ˜Y2, ŒàV‹`”V2, ¬âN°2, ˆÉ“¡‘s•œ2, •Šâ­”V2, ‰ª–{_Žk2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2–ƒŒ): ‘æ43‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2016/2/12), _ŒË.

732149. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ”]ŒŒŠÇŽŸŠ³‚ð‡•¹‚µ‚œt•s‘SŠ³ŽÒ‚Ì–ƒŒŠÇ—. Vˆä³N (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ24‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2015/7/4), –k‹ãB.

732150. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ŽüpŠú‚É‚š‚¯‚éƒ`[ƒ€ˆã—Âðl‚Š‚é: “–‰@‚ÌRST–{–M‚̏«—ˆ. Vˆä³N (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‰¡•lƒoƒCƒ^ƒ‹ƒTƒCƒ“ƒZƒ~ƒi[ (2015/7/11), ‰¡•l.

732151. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) Rapid response system: –ƒŒ‰ÈˆãEW’†Ž¡—Èã‚Ì–ðŠ„. Vˆä³N (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ10‰ñé‹Êˆã‘å—Տ°–ƒŒƒlƒbƒgƒ[ƒN (SMU-CAN) (2015/12/26), é‹Ê.

732152. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) W’†Ž¡—×̈æ‚ł̃GƒR[‚É‚æ‚ézŠÂ•]‰¿. Vˆä³N (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _“ސ얃Œ‰Èˆã‰ï‘æ47‰ñŠwpW‰ïE‘æ7‰ñEcho Rounds_“ސì (2016/02/28), ‰¡•l.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H19-522001. [uÀ]y“ÁW: ³‚µ‚¢‹~‹}ˆ’u@‚»‚̍ª‹’‚ƍ‡—«‚ðl‚Š‚ézII. ŒÄ‹z‚É‚©‚©‚í‚éŽè‹Z@‹¹oúŽhE‹¹oƒhƒŒƒi[ƒW. Vˆä³N (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‹~‹}ˆãŠw 2007/9; 30 (10): 1195-205.

H26-522014. [uÀ] Rapid Response System. Vˆä³N (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): —Տ°–ƒŒ 2014/12; 38 (12): 1711-20.

[Šw‰ïEŒ€‹†‰ï“™]

H26-722004. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “–‰@‚É‚š‚¯‚éICU‚ÆRRT˜AŒg`RRT‚̏W’†Ž¡—ÈオICU‚ÉŠ³ŽÒ‚ð˜A‚ê‚Ä‚­‚é`. Vˆä³N1, ¬’r•üF, XˆÀŒbŽÀ, •Šâ­”V2, •ž•”@3, ˆÉ“¡‘s•œ2, —é–Ø—D‘Ÿ˜Y2, ‘å’Ë’q‹v2, ‹g–ì˜a‹v2, Œ–{ŽœŠ° (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2–ƒŒ, 3‹~–œ): ‘æ42‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2015/2/9), “Œ‹ž.

H26-732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) J-PADƒKƒCƒhƒ‰ƒCƒ“‚̏Љî. Vˆä³N (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ2‰ñ_“ސì’ÁÃEŒÄ‹zƒTƒ|[ƒgƒtƒH[ƒ‰ƒ€ (2015/1/24), ‰¡•l.


(¬—ѐŽ“T)

[Šwp˜_•¶]

110077. [ŒŽ’˜] Adalimumab for the treatment of Japanese patients with intestinal Behet's disease. Tanida S, Inoue N, Kobayashi K1,2, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Nagahori M, Motoya S, Nakamura S, Arora V, Robinson AM, Thakkar RB, Hibi T3: Clin Gastroenterol Hepatol 2015/5; 13 (5): 940-8.e3. (¬—ѐŽ“T1,2, “ú”ä‹I•¶3: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

522026. [uÀ]y“ÁW: ‰ŠÇ«’°ŽŸŠ³f—Â̍őOüz—Տ°Çó‚©‚牊Ç«’°ŽŸŠ³‚𑁂­f’f‚·‚éƒRƒc. ¬—ѐŽ“T1,2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): “ú–{ˆãŽt‰ïŽGŽ 2015/4; 144 (1): 35-9.

522030. [uÀ]y“ÁW: ‰º•”Á‰»ŠÇ: ‰ŠÇ‚©‚ç‚Ì”­Šàz2-2. ‰ŠÇ”­Šà‚̐f’f@(2) ŠëŒ¯ˆöŽq. ¬—ѐŽ“T1,2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): Intestine 2015/7; 19 (4): 356-60.

522032. [uÀ]y“ÁW: ’×ᇐ«‘å’°‰Š‚̍œKŽ¡—ÂƗՏ°“I–â‘è‚ւ̑΍ôz5-ASA»Ü‚ð‚Ç‚€Žg‚€‚©|‚»‚ÌŽ¡—Ð헪|. ¬—ѐŽ“T1,2, ìŠÝ‰Á“Þ2, ‘剪³•œ2, ‰¡ŽR@ŒO2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): Á‰»Ší‚̗Տ° 2015/8; 18 (4): 345-50.

522034. [uÀ]y“ÁW: ŒŒ•Ö‚ð‚Ý‚œ‚çz‘˜_@‰º•”Á‰»ŠÇoŒŒ‚ɑ΂·‚éf’fƒAƒ‹ƒSƒŠƒYƒ€. ¬—ѐŽ“T1,2, ‘剪³•œ2, ìŠÝ‰Á“Þ2, ‰¡ŽR@ŒO2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2015/10; 27 (10): 1608-15.

[’˜@‘]

620022. [Šwp‘ (•ª’SŽ·•M)]yŽÀ—Տ°‚ɖ𗧂ÂIBD“àŽ‹‹Ÿz‘æ2Í IBD‚Ì“àŽ‹‹Ÿf’f@2. ‘ŒŽŸŠ³‚Æ‚ÌŠÓ•Ê 1. ’°ŠÇƒx[ƒ`ƒFƒbƒg•aE’Pƒ«’×á‡, p.37-43. ¬—ѐŽ“T1,2, ‰¡ŽR@ŒO2, ²“c”ü˜a2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à), ŠÄC: “ú”ä‹I•¶3, ŽR–{”Ž“¿, •Ò: ‹vŒ—ˆê, –î–ì’q‘¥ (3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È), “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2015/10”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722015. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBDŠÖ˜AÁ‰»ŠÇŠà‚ɑ΂·‚é“àŽ‹‹Ÿf—Ẩۑè‚Ə«—ˆ“W–]z’×ᇐ«‘å’°‰ŠŠÖ˜AŽîᇂɑ΂·‚é“àŽ‹‹Ÿf’f‚Ì—L—p«‚Æ–â‘è“_. ¬—ѐŽ“T1,2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): ‘æ89‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2015/5/30), –ŒŒÃ‰®, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 628.

722027. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBD‚ɑ΂·‚éŠàƒT[ƒxƒCƒ‰ƒ“ƒX‚ÌŒ»ó‚ƍ¡Œã‚Ì“W–]z’×ᇐ«‘å’°‰Š‚ɑ΂·‚éŠàƒT[ƒxƒCƒ‰ƒ“ƒXEƒvƒƒOƒ‰ƒ€‚ÌŽÀÛ. ŽÂè@‘å1, ¬—ѐŽ“T2,3, ‹vŒ—ˆê, ’·À@œ, ‚‹ŽŒ«ˆê (1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•‘®•a‰@ŠO‰È, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3Á‰»Ší“à): ‘æ70‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2015/11/14), –ŒŒÃ‰®, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2015/9; 68 (9): 619.

723168. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å’°“àŽ‹‹Ÿ”²‹ŽŽžŠÔ‚Æ‘BŽîŒŸo—Š‚ÌŠÖŒW@‘œŽ{Ý‹€“¯Œ€‹†. ‰Í‘º‘ì“ñ1, ”ö“c@‹±, ¬—ѐŽ“T2,3, Œ“c_“ñ, “c’†¹l, –Ø“cŒõL3 (1‹ž“s‘æ“ñÔ\Žš•a‰@, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3Á‰»Ší“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2164.

731007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘Šú‘å’°Šà‚Ì“àŽ‹‹Ÿf’f‚Æ“àŽ‹‹ŸŽ¡—Â̐i•à. ¬—ѐŽ“T1,2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): •œ¬27”N“x¬“cŒŽˆãŽt‰ï‚ª‚ñŒŸf‘‰ï (2015/9/3), ¬“cŒŽ.

731012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) IBD‚Ì“àŽ‹‹Ÿf’f|—Þ‰ŽŸŠ³‚Ƃ̊ӕʐf’f‚âcolitic cancer‚̐f’f‚ðŠÜ‚߂ā|. ¬—ѐŽ“T1,2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): ‘æ177‰ñ‰¡•lÁ‰»Ší“àŽ‹‹Ÿˆã‰ïW’k‰ï (2016/2/10), ‰¡•l.

732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) IBDf’f‚ÌŠî–{ƒAƒ‹ƒSƒŠƒYƒ€|—Տ°Œo‰ß‚Æ“àŽ‹‹ŸŒŸž‚ÌŠî–{‚ð“Ç‚Ý‰ð‚­|. ¬—ѐŽ“T1,2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): ‘æ44‰ñIBD Club JrŒ€‹†‰ï (2015/6/6), “Œ‹ž.

H26”N“xˆÈ‘O•ª

[’˜@‘]

H26-620006. [Šwp‘ (•ª’SŽ·•M)]y‚ׂ©‚ç‚žW2015 Don'ts in Endoscopy (Á‰»Ší“àŽ‹‹Ÿ2ŒŽ‘‘卆)zu‘å’°v‚ׂ©‚ç‚ž@EUS|5‚‚ׂ̂©‚ç‚ž, p.270-1. ¬—ѐŽ“T1,2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2015/2”­s.

H26-620007. [Šwp‘ (•ª’SŽ·•M)]y‘‚í‚©‚è Á‰»Ší“àŽ‹‹ŸŠÖ˜AƒKƒCƒhƒ‰ƒCƒ“‚Ì‚·‚×‚Ä (Á‰»Ší“àŽ‹‹Ÿ3ŒŽ‘‘卆)zŠe˜_ [Á‰»ŠÇ‘S”Ê‚É‹y‚Ô‚à‚Ì]@ƒGƒrƒfƒ“ƒX‚ƃRƒ“ƒZƒ“ƒTƒX‚𓝍‡‚µ‚œ’×ᇐ«‘å’°‰Š‚̐f—ÃKƒCƒhƒ‰ƒCƒ“, p.486-9. ¬—ѐŽ“T1,2, ‰¡ŽR@ŒO2, ²“c”ü˜a2, ¬ò˜aŽO˜Y2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à), “Œ‹žˆãŠwŽÐ, “Œ‹ž, 2015/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H26-731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’×ᇐ«‘å’°‰ŠŽ¡—Â̍ŋ߂̓®Œü‚Ɛf—ÃKƒCƒhƒ‰ƒCƒ“‰ü’ù‚ÉŒü‚¯‚œŽæ‚è‘g‚Ý. ¬—ѐŽ“T1,2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Á‰»Ší“à): ‘æ28‰ñìŒûÁ‰»Ší•a§˜b‰ï (2015/2/12), ìŒû.


(‚ŽR—zŽq)

[Šwp˜_•¶]

110325. [ŒŽ’˜] Modified Hodge test using Mueller-Hinton agar supplemented with cloxacillin improves screening for carbapenemase-producing clinical isolates of Enterobacteriaceae. Takayama Y1,2, Adachi Y3, Nihonyanagi S2,3, Okamoto R4: J Med Microbiol 2015/7; 64 (7): 774-7. (‚ŽR—zŽq1,2, ˆÀ’B@÷3, “ñ–{–öL2,3, ‰ª–{—¹ˆê4: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2ŠŽõŠÇ—Žº, 3—ÕŒŸ•”, 4”÷¶•š)

522195. [uÀ]y“ÁW: ¬Ž™ŠŽõÇ2015|¬Ž™ŠŽõÇ‚̃}ƒl[ƒWƒƒ“ƒg|zIII. ¬Ž™‚Å’ˆÓ‚·‚ׂ«‘ϐ«‹Û@4. ƒƒ`ƒVƒŠƒ“‘ϐ«‰©FƒuƒhƒE‹…‹Û (MRSA). ‚ŽR—zŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ¬Ž™‰È—Տ° 2015/12; 68 (12): 2610-6.

[Šw‰ïEŒ€‹†‰ï“™]

7231025. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éDaptomycin“Š—^—á‚ÉŠÖ‚·‚éŒã‚ëŒü‚«Ç—áWÏŒ€‹†. ‚ŽR—zŽq1, “àŽRŸ•¶2, ‘åìŒŽ—TŽ÷3, ˜a“c’B•F4, “¡–Ø‚­‚ÉŽq5, ’†‘º³Ž÷6, “ñ–{–öL7, »ìŒc‰î5, ‰Ô–؏G–Ÿ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2®ŠO, 3–òÜ•”, 4äPŒŽ•aEŠŽõ“à, 5ŠŽõŠÇ—Žº, 6ˆã—Éq¶Šw•”, 7—ÕŒŸ•”): ‘æ89‰ñ“ú–{ŠŽõÇŠw‰ïŠwpu‰‰‰ï (2015/4/17), ‹ž“s.

7231026. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) AIDS‚ɍ‡•¹‚µ‚œRamsay HuntÇŒóŒQ‚̈ê—á. ‚ŽR—zŽq1, ˜a“c’B•F2, Ž™‹Ê‰ØŽq2, ŒŽ}@—C3, ‰iˆä—§•v2, “c’†Z–Ÿ2, œA”šr¬2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2äPŒŽ•a¥ŠŽõ“à, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ29‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ïE‘‰ï (2015/11/30), “Œ‹ž.


(ÂŽR’Œ‘P)

[Šwp˜_•¶]

110326. [ŒŽ’˜] Clinical Characteristics of Patients on Hemodialysis With Peripheral Arterial Disease. Matsuzawa R, Aoyama N1, Yoshida A: Angiology 2015/11; 66 (10): 911-7. (Œ‘ò—Ç‘Ÿ, ÂŽR’Œ‘P1, ‹g“c@àˆ: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

521031. [‰ðà] ’·Šú‚É“œ”A•aœëŠ³‚µ‚Ä‚¢‚œŠ³ŽÒ‚ª“Ë‘RŽ€‚µ‚œ‚͈̂ãŽt‚ªS“d}‚É—¯ˆÓ‚¹‚ž, ‹•ŒŒ«SŽŸŠ³‚ð‹^‚í‚È‚©‚Á‚œ‚ß‚Æ‚µ‚Ä‘¹ŠQ”…ž‚ð‹‚ß‚œŽ–—á. ÂŽR’Œ‘P (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ˆãŽ–”»—á‰ðà 2015/4; 55: 112-4.

521032. [‰ðà] ”­”M‚Æšq‹C‚ð‘i‚Š‚銳ŽÒ‚ɒljÁŒŒ‰tŒŸž‚ðs‚í‚ž, dÇ‚È‹}«S‹Ø‰Š‚©‚犳ŽÒ‚ðŽ€–S‚³‚¹‚œ‚Æ‚µ‚Ä‘¹ŠQ”…ž‚ð‹‚ß‚œŽ–—á. ÂŽR’Œ‘P (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ˆã—Ô»—á‰ðà 2015/12; 59: 11-5.

522196. [uÀ]y“ÁW: Çó•ÊEŽŸŠ³•Ê‚É‚Ý‚œ’ˆÓ‚ð—v‚·‚éS“d}ŠŒ©z‹¹’É: Œ€ÇŒ^S‹Ø‰Š. ÂŽR’Œ‘P (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŒÄ‹z‚ƏzŠÂ 2016/3; 64 (3): 235-41.

[’˜@‘]

620137. [Šwp‘ (•ª’SŽ·•M)]yV‚µ‚¢zŠÂŠí•a‚̃oƒCƒIƒ}[ƒJ[|—Տ°“IˆÓ‹`‚ð—‰ð‚·‚é|(Heart View 2015”N11ŒŽ‘Š§†)z2. f—Ãc[ƒ‹‚Æ‚µ‚ẴoƒCƒIƒ}[ƒJ[‚ðŽ¯‚é@d. ‹}«S•s‘S, p.39-43. ÂŽR’Œ‘P (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), Šé‰æE\¬: •›“‡O•¶, ¬ì‹v—Y, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2015/10”­s.


(•œ“cŒõ”Ž)

[Šw‰ïEŒ€‹†‰ï“™]

7231027. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘åÃ–¬Žèp‚Æ‚»‚̍H•v ‰º‘åÃ–¬Žîᇐ؏œŽž‚ÌŒŒsŽÕ’f–@‚Æ‚µ‚Ä‚Ì’PƒŽÕ’f–@‚Ì—L—p«. •œ“cŒõ”Ž1, ”ü“‡—˜º2, “c‘ºK•ä2, ‘å‹v•Û”Ž¢2, ‹{’n@ŠÓ2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2S‘ŸŒŒŠÇŠO): ‘æ35‰ñ“ú–{Ã–¬Šw‰ï‘‰ï (2015/7-10-11), “Þ—Ç, Ã–¬Šw 2015/6; 26 (2): 131.

7231028. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚ɉ—‚¯‚édÇ‹•ŒŒŽˆ‚ɑ΂·‚éWŠw“IŽ¡—Â̐¬Ñ. •œ“cŒõ”Ž1, ”ü“‡—˜º2, ‘å‹v•Û”Ž¢2, “c‘ºK•ä2, ‘å—F—EŽ÷2, ‹ß“¡@^2, “c’†—C‹M2, —F•Û‹M”Ž2, ‹gˆä@„2, ’†‘º—SŠó2, ™–{Wˆê2, •ó—ˆ“N–ç2, –k‘º@—¥2, ’¹ˆäWŽO3, ‹{’n@ŠÓ2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2S‘ŸŒŒŠÇŠO, 3ˆã—ËZp‹³ˆç): ‘æ46‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2016/2/15-17), –ŒŒÃ‰®.


(‰¬–ì”üŒbŽq)

[Šwp˜_•¶]

110327. [ŒŽ’˜] Opinions of Japanese and American ALS caregivers regarding tracheostomy with invasive ventilation (TIV). Christodoulou G, Goetz R, Ogino M1, Mitsumoto H, Rabkin J: Amyotroph Lateral Scler Frontotemporal Degener 2015/8; 17 (1-2): 47-54. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

110328. [ŒŽ’˜] Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study. Murata M, Hasegawa K, Kanazawa I, Fukasaka J, Kochi K, Shimazu R; Japan Zonisamide on PD Study Group (Ogino M1): Mov Disord 2015/9; 30 (10): 1343-50. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

110329. [ŒŽ’˜] Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool. Yoshii F, Takagi S, Nagata E, Hasegawa Y, Kunika N, Maki F, Mochizuki H, Ogino M1, Kuroiwa Y: J Neurol Sci 2015/12; 359 (1-2): 323-7. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

110330. [ŒŽ’˜] Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients. Nagata E, Ogino M1, Iwamoto K, Kitagawa Y, Iwasaki Y, Yoshii F, Ikeda JE: PLoS One 2016/2; 11 (2): e0149509. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

110331. [ŒŽ’˜] Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients. Nagata E1, Ogino M1,2, Iwamoto K1, Kitagawa Y1, Iwasaki Y1, Yoshii F1, Joh-E. Ikeda1 (1ALS Consortium Investigators): PLoS One 2016/3; 11 (3): e0152845. (‰¬–ì”üŒbŽq1,2: 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

220011. [€ŒŽ’˜] ‘œŽ€Žž‘ã‚ÉŒü‚¯‚Ä‚Ç‚Ì‚æ‚€‚É”õ‚Š‚é‚Ì‚©. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _“ސ쌧ˆãŽt‰ï•ñ 2016/1; 795: 12-4.

511002. [‰ðà]yALS-UNTANGLEDzALSUntangled No. 27: Precision Stem Cell. Ogino M1,2 (1ALSUntangled Group): Amyotroph Lateral Scler Frontotemporal Degener 2015/5; 16 (3E4): 282-5. (‰¬–ì”üŒbŽq1,2: 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

511003. [‰ðà]yALS-UNTANGLEDzALSUntangled No. 28: Acupuncture. Ogino M1,2 (1ALSUntangled Group): Amyotroph Lateral Scler Frontotemporal Degener 2015/5; 16 (3E4): 286-9. (‰¬–ì”üŒbŽq1,2: 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

511004. [‰ðà]yALS-UNTANGLEDzALSUntangled No. 29: MitoQ. Ogino M1,2 (1ALSUntangled Group): Amyotroph Lateral Scler Frontotemporal Degener 2015/6; 16 (5E6): 427-9. (‰¬–ì”üŒbŽq1,2: 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

522077. [uÀ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€: ALS‚ÆFTLD‚ÌŒ€‹†EŽ¡—Â̌»Ý’n‚ð’m‚éz‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—Êw 2015/5; 32 (3): 295-8.

522080. [uÀ]y“ÁW/‘Û‰»E‘n–òŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€: _ŒoŽ¡—ÂÌunmet medical needs|‚»‚Ì‰ðŒˆ–@‚ð’T‚éz2. ƒŒƒZƒvƒg‚©‚猩‚œ’nˆæ‚É‚æ‚é_ŒoŽŸŠ³Ž¡—Â̂΂ç‚‚«‚Ì•ªÍ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—Êw 2015/5; 32 (3): 400-3.

522081. [uÀ]y“ÁW/‘Û‰»E‘n–òŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€: _ŒoŽ¡—ÂÌunmet medical needs|‚»‚Ì‰ðŒˆ–@‚ð’T‚éz3-4. ŠeŽŸŠ³‚É‚š‚¯‚éV–ò³”FEŽ¡—Â̎Àî‚ƍ¡Œã‚Ì“W–]: ‹ØˆÞk«‘€õd‰»Ç. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—Êw 2015/5; 32 (3): 416-9.

522197. [uÀ]y‘æ32‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï“ÁW2: ƒVƒ“ƒ|ƒWƒEƒ€4@ALS‚ÆFTLD‚ÌŒ€‹†EŽ¡—Â̌»Ý’n‚ð’m‚éz2. ‹ØˆÞk«‘€õd‰»Ç‚ÌŒo‰ß‚É‚š‚¯‚é‘O“ª‘€“ª—t•Ï«Ç‡•¹. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—Êw 2015/5; 32 (3): 295-8.

522198. [uÀ]y˜AÚŠé‰æ: ALSˆã—ÁzALS‚É‚š‚¯‚éV–ò³”FEŽ¡Œ±‚ÌŒ»ó‚ƍ¡Œã‚Ì“W–]. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•a‚ƍݑîƒPƒA 2015/6; 21 (3): 50-1.

522199. [uÀ]y“ÁW: Œ»ó‚̊ɘaƒPƒAz‘æ1•”: QOL‚̈ێ‚ð–ÚŽw‚µ‚œŠÉ˜aƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•a‚ƍݑîƒPƒA 2015/8; 21 (8): 9-12.

522200. [uÀ]y“ÁW: _Œo“ï•a‚̏I––Šúˆã—Áz_Œo“ï•a‚̏I––Šúˆã—Ã. ‰¬–ì”üŒbŽq1, ’JŒü@m, X@@Œ[ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): BRAIN and NERVE|_ŒoŒ€‹†‚̐i•à 2015/8; 67 (8): 983-92.

522201. [uÀ]y“ÁW: _Œo“ï•a‚̏I––Šúˆã—Áz_Œo“ï•aI––ŠúŠÉ˜aƒPƒA‚ƍݑîˆã—Ã. ‰¡ŽR˜a³, ‰¬–ì”üŒbŽq1, ÎŠ_‘ב¥, •ž•”MF (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): BRAIN and NERVE|_ŒoŒ€‹†‚̐i•à 2015/8; 67 (8): 1015-24.

522202. [uÀ]y“ÁW: ‚Å‚«‚Ä‚¢‚Ü‚·‚©? ”ñ‚ª‚ñŽŸŠ³‚̊ɘaƒPƒAzCase Study…E@‹ØˆÞk«‘€õd‰»Ç (ALS)`•ê‚Æ‚µ‚Ä‚Ì–ðŠ„‚ð‘S‚€‚µ‚œ‚¢Š³ŽÒ‚̃P[ƒX. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Gƒm[ƒg 2015/10; 2 (5): 714-21.

522203. [uÀ]y“ÁW: _Œo“ï•az_Œo“ï•aƒlƒbƒgƒ[ƒN‚ÌŽÀÛ‚Æ‚»‚Ì–â‘è“_@_Œo“ï•a‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{Ý‘îˆãŠw‰ïŽGŽ 2016/2: 17 (2): 65-9.

522204. [uÀ]y“ÁW: ’°“à×‹Û‘p‚©‚ç‚Ý‚œ—Տ°‚̍őOü|ƒx[ƒ‹‚ð’E‚¢‚Ÿ‘Ì“àƒp[ƒgƒi[‚Ì‹@”\zŸ—Տ°Œ»ê‚É‚š‚¯‚é’°“à×‹Û Campylobavter jejuni’°‰Š‚ÆGuillain-BarrŽÇŒóŒQ@GBS‚̐f’f‚ÆŽ¡—Â̊Tà, CJ‚ÌGBS‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): f’f‚ÆŽ¡—à 2016/2; :104 (2): 215-9.

522205. [uÀ] ˜_’d: _Œo“ï•a‚̗Տ°—Ï—. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): —Տ°—Ï— 2016/2; 4: 32-8.

522206. [uÀ]y“ÁW: ‚—îŽÒ‚É‚š‚¯‚é_Œo•Ï«ŽŸŠ³z‹ØˆÞk«‘€õd‰»Ç‚̍ݑî‰h—{—Ö@‚ƌċzŠÇ—. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Geriatric Medicine 2016/3; 54 (3): 243-6.

530020. [‚»‚Ì‘Œ (Ž˜^)]yPoster Communications: Theme 1 Clinical ManagementzDID MORPHINE USAGE BECOME MORE POPULAR IN JAPAN? BASED ON THE FINDINGS FROM 2015 NATIONWIDE SURVEY. Ogino M1, Tominaga N2, Uchino A3, Takahashi K2, Nagashima K, Yanagita K, Ogino Y2: Amyotroph Lateral Scler Frontotemporal Degener 2015/10; 16 (suppl 1): 71. (‰¬–ì”üŒbŽq1, •x‰i“Þ•Û”ü2, “à–쏲Žq3, ‚‹Ž˜a¹2, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

540063. [‚»‚Ì‘Œ] ƒ‚ƒ‹ƒqƒl‚ňӎ¯•Û‚¿‚È‚ª‚ç‹ê’ÉŒyŒž. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Medical Tribune 2015/5/14; p.14.

540064. [‚»‚Ì‘Œ (V•·‹LŽ–)] “–’Œˆã‚ð–éŠÔ‰f‚É. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‚—îŽÒZ‘îV•· 2015/8/5; p.36.

540065. [‚»‚Ì‘Œ (ŽGŽ‹LŽ–)] ˆãŽt‚Å‚à‰Æ‘°‚Å‚à‚È‚¢“¬•a‚Ì”º‘–ŽÒ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): AERA 2015/9/7; p.23.

540066. [‚»‚Ì‘Œ (V•·‹LŽ–)] ’nˆæˆã—Ï]Ž–ŽÒ‚ç@I––Šú‚𐡌€‚Å. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‚—îŽÒZ‘îV•· 2015/9/23; p.14.

540067. [‚»‚Ì‘Œ]uÅŒã‚Ü‚Å‚æ‚¢l¶‚ð‚ß‚Ž‚·‰ïE‘Š–ÍŒŽv‚ÌŠˆ“®‚Æ‚»‚Ì”wŒi@ÅŒã‚ðŒ}‚Š‚él‚à‚»‚̉Ƒ°‚àK‚¹‚Å‚ ‚é‚œ‚ß‚É. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ƒAƒSƒ‰ 2016; 76 (t): 40-6.

540068. [‚»‚Ì‘Œ (Œ€‹†‰ï‹L˜^W)] ’m. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x_Œo“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï‹L˜^W 2016/3; p.38-9, p.55-86.

540069. [‚»‚Ì‘Œ (Œ€‹†‰ï‹L˜^W)] ƒ‚ƒ‹ƒqƒl‚ÌŽg‚¢•û. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x_Œo“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï‹L˜^W 2016/3; p.188-97.

540070. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†vz“ï•aŠÉ˜aƒPƒA‚Ì•‹y, Œ[”­. ‰¬–ì”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆêl, A’|“ú“Þ, ¬“c—LŒá, “ï”g—æŽq, ŽO‰Y–õ•F, ‰¬–ì@—T2, –kŽR’ʘN, ™‰Y@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x`27”N“x‘‡Œ€‹†•ñ‘ 2016/3; p.92-6.

540071. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“xz“ï•aŠÉ˜aƒPƒA‚Ì•‹y, Œ[”­. ‰¬–ì”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆêl, A’|“ú“Þ, ¬“c—LŒá, “ï”g—æŽq, ŽO‰Y–õ•F, ‰¬–ì@—T2, –kŽR’ʘN, ™‰Y@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2016/3; p.115-8.

540072. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzƒrƒbƒJ[ƒXƒ^ƒbƒt”]Š²”]‰Š‚Ì”F’èŠî€, —Տ°’²žŒÂl•[‚ƍ¡Œã‚̉ۑè. “í@@i, ’r“cCˆê, ŠC“cŒ«ˆê, Š@—Ž™Z, _“c@—², ŒKŒŽ@‘, ‰€¶‰ëO, ‘c•ƒ]Œ³, ç—tŒú˜Y, ‰¬–ì”üŒbŽq1, –쑺‹±ˆê, Ž…—DŽq, ŽðˆäN¬, Œ”öG“¿, ‰¡“c—²“¿, –쑺–FŽq, •“¡‘œ’ØY, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Œˆä@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2016/3; p.19-20.

540073. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzŽ©ŒÈ–Ɖu«”]‰ŠE”]Ç. _“c@—², Œˆä@^, ’r“cCˆê, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, ‹v•Û“c—Ž“ñ, Ž…—DŽq, —é–Ø‘¥G, ŒàV³–L, –쑺‹±ˆê, ŒŽ@Žõ˜Y, ‰¡“c—²“¿, “n•Ó@C, Œ¢’ˁ@‹M, ’†‘º—Ž•¶, –쑺–FŽq, ŽR–ì‰Ã‹v, •Ä“c@œ, ŒIŽR’·–å, ‹Ê˜‹ÅŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2016/3; p.28-9.

540074. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzdÇ‹Ø–³—͏ǂ̐f’fŠî€‚̉ü’ù. ‹gìO–Ÿ, Ž…@, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, Ž…—DŽq, —é–Ø‘¥G, ’|“à‰p”V, ‰€¶‰ëO, V–쐳–Ÿ, –쑺‹±ˆê, ŽðˆäN¬, Œ”öG“¿, –{‘º­Ÿ, ìŒû’ŒŽ÷, ŒSŽR’B’j, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Œˆä@^, —é–؏d–Ÿ, Šâ²˜a•v, âˆäŒ’“ñ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2016/3; p.30-4.

540075. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzƒ‰ƒ“ƒo[ƒgEƒC[ƒgƒ“‚̐f’fŠî€ô’è. ‹gìO–Ÿ, Ž…@, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, Ž…—DŽq, —é–Ø‘¥G, ’|“à‰p”V, ‰€¶‰ëO, V–쐳–Ÿ, –쑺‹±ˆê, ŽðˆäN¬, Œ”öG“¿, –{‘º­Ÿ, ìŒû’ŒŽ÷, ŒSŽR’B’j, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Œˆä@^, —é–؏d–Ÿ, Šâ²˜a•v, âˆäŒ’“ñ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2016/3; p.35-7.

540076. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vz••“ü‘̋؉Šf’f‚É—p‚¢‚éŒú˜JÈŠî€‚ÆEuropean Neuromuscular Center (ENMC) Šî€‚Ì”äŠrŒŸ“¢. Ž…@, ‹gìO–Ÿ, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, Ž…—DŽq, —é–Ø‘¥G, ’|“à‰p”V, ‰€¶‰ëO, V–쐳–Ÿ, –쑺‹±ˆê, ŽðˆäN¬, Œ”öG“¿, –{‘º­Ÿ, ìŒû’ŒŽ÷, ŒSŽR’B’j, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Œˆä@^, —é–؏d–Ÿ, Šâ²˜a•v, âˆäŒ’“ñ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2016/3; p.68-9.

540077. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzƒŒƒZƒvƒgƒf[ƒ^‚©‚ç‚Ý‚œ‘œ”­«d‰»Ç‚ÌŽ¡—Ó®ŒüŒ€‹†‚ɂ‚¢‚Ä ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬27”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2016/3; p.97-8.

[’˜@‘]

620138. [Šwp‘ (•ª’SŽ·•M)]yƒAƒNƒ`ƒ…ƒAƒ‹”]E_ŒoŽŸŠ³‚̗Տ°@‚·‚ׂĂª‚í‚©‚é_Œo“ï•aˆã—ÁzIV. _Œo“ï•a‚ÌŠÅŒìE‰îŒì@ŠÉ˜aƒPƒA‚ÆŠÅŽæ‚è, p.145-52. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), ‘•ÒW: ’ҁ@ÈŽŸ, ê–å•ÒW: ŒàV³–L, ’†ŽR‘“X, “Œ‹ž, 2015/5”­s.

620139. [Šwp‘ (•ª’SŽ·•M)] y–Ɖu«_ŒoŽŸŠ³|Šî‘bE—Տ°Œ€‹†‚̍ŐV’mŒ©|(“ú–{—Õ଑Š§† (No.1085))zVII. “Á˜_@7. ˆã—ÃŒoÏŠw“IŽ‹“_‚©‚ç‚Ý‚œ‘œ”­«d‰»ÇŽ¡—Ẩۑè, p.862-8. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), “ú–{—Õ଎Ð, ‘åã, 2015/9”­s.

620140. [Šwp‘ (•ª’SŽ·•M)]yÝ‘îˆã—ÃeƒLƒXƒg (‘æ3”Å)z‘æ4Í ŽŸŠ³‚̐isŠú‚̈ãŠw“IŠÇ—@2. ‹ØˆÞk«‘€õd‰»Ç (ALS), p.1118-21. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), Šé‰æE•ÒW: Ý‘îˆã—ÃeƒLƒXƒg•ÒWˆõ‰ï, Ý‘îˆã—Ï•¬ —E”ü‹L”Oà’c, “Œ‹ž, 2015/11”­s.

620141. [Šwp‘ (•ª’SŽ·•M)]yÝ‘îˆã—ÃeƒLƒXƒg (‘æ3”Å)z‘æ4Í ŽŸŠ³‚̐isŠú‚̈ãŠw“IŠÇ—@3. ƒp[ƒLƒ“ƒ\ƒ“•a, p.122-5. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), Šé‰æE•ÒW: Ý‘îˆã—ÃeƒLƒXƒg•ÒWˆõ‰ï, Ý‘îˆã—Ï•¬ —E”ü‹L”Oà’c, “Œ‹ž, 2015/11”­s.

620142. [Šwp‘ (•ª’SŽ·•M)]y“ï•aŽ–“Tz¡_Œo@‹ØˆÞk«‘€õd‰»Ç (ALS)@‘œŒn“ˆÞkÇ (MSA): ƒVƒƒƒCEƒhƒŒ[ƒK[ÇŒóŒQ (SDS), p.43-4. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), Ó”C•ÒW: ”öè³ˆê, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/12”­s.

620143. [Šwp‘ (•ª’SŽ·•M)]y¡“ú‚̗Տ°ƒTƒ|[ƒg (‰ü’ù‘æ2”Å)z‹ØˆÞk«‘€õd‰»Ç, https://clinicalsup.jp/contentlist/101.html. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), ‘‡•ÒWˆÏˆõ: ‰iˆä—ÇŽO, •ŸˆäŽŸ–î, ã‘º’ŒŽÀ, –Ø‘ºŒ’“ñ˜Y, ŒK“‡@ŠÞ, ¡ˆä@–õ, “ˆ“c@Œ³, ƒGƒ‹ƒ[ƒrƒAEƒWƒƒƒpƒ“, “Œ‹ž, 2015.

620144. [Šwp‘ (•ª’SŽ·•M)]y—Տ°_Œo“à‰ÈŠwzSection VI _Œo“à‰ÈŽ¡—Á@2. _Œo“à‰È“ÁŽêŽ¡—Á@5. “ï•a‚̊ɘaˆã—Ã, p.896-902. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), ŠÄC: •œŽRŒbŽO, •Ò: œA£Œ¹“ñ˜Y, “c‘ã–M—Y, Š‹ŒŽ–ÎŽ÷, “ìŽR“°, “Œ‹ž, 2016/2”­s.

620145. [Šwp‘ (•ª’SŽ·•M)]y‰ü’ù”Å _Œo“ï•aÝ‘î—×{ƒnƒ“ƒhƒuƒbƒN|‚æ‚è‚æ‚¢ŠÉ˜aƒPƒA’ñ‹Ÿ‚Ì‚œ‚߂Ɂ|z‘æ1Í ŠÉ˜aƒPƒA‚ÌŠT”O (_Œo“à‰È‚É‚š‚¯‚éŠÉ˜aƒPƒA‚Ì•K—v«), p.11-6. ‘æ2Í _Œo“ï•a‚̍’m‚Æ–Ê’k‚ÌŽd•û (f’f–ŒEŒ»ó‚š‚æ‚ÑŒ©’Ê‚µ‚ðŠ³ŽÒ‚³‚ñ‚₲‰Æ‘°‚É“`‚Š‚é), p.17-26. ‘æ4Í _Œo“ï•a‚É‚š‚¯‚é‹ê’ɏǏó‚Æ‚»‚̑Ήž, p.71-98. ‰¬–ì”üŒbŽq1, ‚‹Ž‹M”üŽq, “ï”g—æŽq, ¬“c—LŒá, ‹Ž–{@Ži, •ˆä–ƒŽq, –îèˆê—Y, ‰ª–{–Ÿ‘å, ™–{_Žq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: ¬“c—LŒá, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2016/3”­s.

620146. [Šwp‘ (•ª’SŽ·•M)]yƒAƒNƒ`ƒ…ƒAƒ‹”]E_ŒoŽŸŠ³‚̗Տ°@–Ɖu«_ŒoŽŸŠ³|•a‘Ô‚ÆŽ¡—Â̂·‚ׂāz’Ž‚Šz‚ȖƉu—Ö@‚͂킪‘‚̈ã—ÃŒoÏ‚ð”j’]‚³‚¹‚é‚©, p.533-8. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), ‘•ÒW: ’ҁ@ÈŽŸ, ê–å•ÒW: ‹g—Ǐˆê, ’†ŽR‘“X, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713135. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) DID MORPHINE USAGE BECOME MORE POPULAR IN JAPAN? BASED ON THE FINDINGS FROM 2015 NATIONWIDE SURVEY. Ogino M1, Tominaga N2, Uchino A3, Takahashi K2, Nagashima K, Yanagita K, Ogino Y2: 26th ALS/MND international symposium 2015 (2015/12/11), Orlando, USA, Amyotroph Lateral Scler Frontotemporal Degener 2015; 16 (suppl 1): 71. (‰¬–ì”üŒbŽq1, •x‰i“Þ•Û”ü2, “à–쏲Žq3, ‚‹Ž˜a¹2, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

722233. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘œŽ€Žž‘ã‚ÉŒü‚¯‚Ä‚Ç‚Ì‚æ‚€‚É”õ‚Š‚é‚Ì‚©@’Œ…OŽ€¶Šw (I––Šúˆã—Ã, ‘ŸŠíˆÚA, ŠÉ˜aˆã—Ã) Šé‰æ2@’Ž‚—îŽÐ‰ï‚É‚š‚¯‚éI––Šúˆã—Âðl‚Š‚é. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ29‰ñ“ú–{ˆãŠw‰ï‘‰ï2015ŠÖŒ (2015/4/12), ‹ž“s, ‘æ29‰ñ“ú–{ˆãŠw‰ï‘‰ï2015ŠÖŒŽ˜^W 2015; p.172.

722234. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) _Œo“ï•aEALS‚ÉŽæ‚è‘g‚Þ‚Æ‚« I––Šú‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ17‰ñ“ú–{Ý‘îˆãŠw‰ï‚à‚è‚š‚©‘å‰ï (2015/4/25), ·‰ª, ‘æ17‰ñ“ú–{Ý‘îˆãŠw‰ï‘å‰ïŽ˜^W 2015; p.106.

722235. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŽÐ‰ï‚Ì’†‚̐_ŒoŠwNS-04 “ï•aŠÉ˜aƒPƒA‚ÆŽ©ŒÈŒˆ’èŽx‰‡. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/21), VŠƒ, —Տ°_ŒoŠw2015; 55 (•Êû): S28.

722236. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘ŒŠw‰ï‚©‚çŠw‚Ô’j—‹€“¯ŽQ‰æS-3 “ú–{_ŒoŠw‰ïƒLƒƒƒŠƒAŒ`¬‘£iˆÏˆõ‰ï@3”NŠÔ‚Ì•à‚݂ƍ¡Œã‚ÌŽæ‚è‘g‚Ý. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/23), VŠƒ, —Տ°_ŒoŠw 2015; 55 (•Êû): S111.

722237. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·zê–å—̈æ‚ƊɘaƒPƒA‚̃Rƒ‰ƒ{ƒŒ[ƒVƒ‡ƒ“. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ20‰ñ“ú–{ŠÉ˜aˆã—Êw‰ïŠwp‘å‰ï (2015/6/20), ‰¡•l.

722238. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€1: ’nˆæ‚ÅŠÅŽæ‚é…@@ŽŸŠ³‚É‚æ‚ézS1-3: _Œo“ï•a‚̍ݑîŠÅŽæ‚è‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ26‰ñ“ú–{Ý‘îˆã—Êw‰ïŠwpW‰ï (2015/7/19), “Œ‹ž, ‘æ26‰ñ“ú–{Ý‘îˆã—Êw‰ïŠwpW‰ïŽ˜^W 2015; p.62.

722239. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”ñ‚ª‚ñ‚̊ɘa‚ÌŒ»ó‚ƍ¡Œã. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ26‰ñ“ú–{Ý‘îˆã—Êw‰ïŠwpW‰ï (2015/7/19), “Œ‹ž, ‘æ26‰ñ“ú–{Ý‘îˆã—Êw‰ïŠwpW‰ïŽ˜^W p.103-5.

722240. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ƒŒƒZƒvƒgƒf[ƒ^‚ðŠˆ—p‚µ‚œ‰ä‚ª‘‚Ì‘œ”­«d‰»Ç‚ÌŽ¡—ÃŽÀ‘Ô‹y‚шã—ÔÍ. ‰¬–ì”üŒbŽq1, ‰Í“à@ò, ‘å’|ˆê‰Ã, ‘Ÿ“c_”V, ‘å’Ë—TŽŸ˜Y, ŠâèG‰î, œA‹L‘  (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ27‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï (2015/9/15), Šò•Œ, “ú–{_Œo–ƉuŠw‰ï‹@ŠÖŽ 2015; 20 (1): 86.

722241. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Šó­E“«ŽŸŠ³@Žx‰‡‚ւ̘AŒg‚Ƒ΍ô‚ɂ‚¢‚Ä. ’†“c‹œŽq, ŽR“c—²Ži, —¢’†—˜Œb, •Ÿ‰iG•q, ‰¬–ì”üŒbŽq1, ˆÉ“¡‚œ‚Ä‚š (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ3‰ñ“ú–{“ï•aˆã—Ãlƒbƒgƒ[ƒNŠw‰ïŠwpW‰ï (2015/11/14), å‘ä.

722242. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ƒ}ƒ‰ƒ\ƒ“ƒŒƒNƒ`ƒƒ[12: _ŒoŽŸŠ³‚ւ̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ33‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2015/11/27), –ŒŒÃ‰®, _ŒoŽ¡—à 2015; 32 (5): 660.

722243. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ‹³ˆçu‰‰8: _Œo“ï•aŠ³ŽÒ‚ÌŒö“IEŽÐ‰ïŽ‘Œ¹Šˆ—p‚ÌŒ»ó‚Æ“W–]. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ33‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2015/11/27), –ŒŒÃ‰®, _ŒoŽ¡—à 2015; 32 (5): 643.

7231029. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Efficacy of steroid pulse therapy in multiple sclerosisi and neuromyelitis optica. Kira J, Yamazaki R, Matsusita T, Fukazawa T, Yokoyama K, Fujiwara K, ‰¬–ì”üŒbŽq1, Yokota T, Miyamoto K, Niino M, Nomura K, Jaman Ms/Nmo Pulse Therapy Study Group (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ56‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2015/5/20), VŠƒ, Ž˜^W p.413, —Տ°_ŒoŠw 2015; 55: S288.

7231030. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘œEŽí‚Å‹€‚É‚š‚±‚È‚€ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“Œ€C‚Ì•K—v«@ALSŠ³ŽÒŒÄ‹z‹ê‘ˆ«Žž‚̃Vƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“ŽÀŽ{ƒAƒ“ƒP[ƒg‚ÌŒ‹‰Ê‚©‚ç. ‘ºã¬”ü, ŽR”š‰À“Ä, ŽR˜e³‰i, ‰¬–ì”üŒbŽq1, “n•ÓN‰î, _–ìŒN•v, “yˆä³Ž÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ23‰ñ“ú–{ƒzƒXƒsƒXEÝ‘îƒPƒAŒ€‹†‰ï‘S‘‘å‰ïin‰¡•l (2015/8/29), ‰¡•l, ƒzƒXƒsƒXƒPƒA‚ƍݑîƒPƒA 2015/8; 23 (2): 215.

731186. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _Œo“ï•a‚̊ɘaƒPƒA`ALS‚𒆐S‚Ɂ`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ15‰ñŒ‹{ŠÉ˜aˆã—ÃŒ€‹†‰ï (2015/8/8), •ºŒÉ.

731187. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘œŽ€Žž‘ã‚É‚Þ‚¯‚Ä‚Ç‚Ì‚æ‚€‚É”õ‚Š‚é‚Ì‚©. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ57‰ñ_“ސìˆãŠw‘‰ïEŠwp‘å‰ï (2015/11/23), ‰¡•l _“ސ쌧ˆãŽt‰ï•ñ 2016/1; 795: 12-4.

732153. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) •a‹C‚ªis‚µ‚œ‚Æ‚«‚Ì‚œ‚ß‚É. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ24‰ñƒp[ƒLƒ“ƒ\ƒ“•aŒ’N‹³Žºin ‰ªŽR (2015/4/11), ‰ªŽR.

732154. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) 2025”N‚ðŒ©˜‚Š‚œC’nˆæƒj[ƒY‚ɉž‚Š‚éˆã—Ë@”\•ª‰»‚ƈã—ÁE‰îŒì˜AŒg‚ÌŽÀ‘H. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): SSKƒZƒ~ƒi[ (2015/9/5), “Œ‹ž.

732155. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚É‚š‚¯‚é—Տ°—Ï—. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬27”N“x_ŒoE‹Ø“ï•aŠÅŒìƒGƒLƒXƒp[ƒgƒi[ƒXŒ€C (2015/11/7), ’·è.

732156. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚ÌŠî‘b’mŽ¯‚ƑΉž‚ɂ‚¢‚ā`’m‚©‚çI––Šú‚܂Ł`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬27”N“xÝ‘î“ï•aŠ³ŽÒ•ÛŒ’•ŸŽƒ]Ž–ŽÒŒ€C (2015/11/18), `–ì.

732157. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ÅŠú‚Ü‚Å—Ç‚¢l¶‚ð‚ß‚Ž‚·‚ɂ́`•a‹C‚É‚È‚Á‚Ä‚àQ‚Ä‚È‚¢‚œ‚߂Ɂ`. ‰¬–ì”üŒbŽq1, ‘Œ (ÅŠú‚Ü‚Å—Ç‚¢l¶‚ð‚ß‚Ž‚·‰ïE‘Š–ÍŒŽ) (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ2‰ñ’nˆæˆã—ÁE•ŸŽƒ‚ɂ‚¢‚Ä (2015/12/20), ‘Š–ÍŒŽ.

732158. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ”ñ‚ª‚ñ‚̊ɘaƒPƒA`ALS‚𒆐S‚Ɂ`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ3‰ñ‚ ‚»‚©ƒrƒn[ƒ‰ŠÉ˜aƒPƒAƒŒƒNƒ`ƒƒ[ (2016/1/22), ‹ž“s.

732159. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•aŽx‰‡, ’nˆæ‚Å‚Å‚«‚邱‚Æ‚ðl‚Š‚é`ALS‚ɂ‚¢‚ā`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ’¬“cŽs•ÛŒ’ŠE’¬“cŽs–K–âŠÅŒìƒXƒe[ƒVƒ‡ƒ“˜A—‰ï‹€Ã2015”N“x’¬“cŽs•ÛŒ’Š“ï•au‰‰‰ï (2016/1/25), ’¬“c.

732160. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a—×{ŽÒ‚̌ċzŠÇ—EƒPƒA‚ÌŠî–{. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): –L“c“à‰ÈƒNƒŠƒjƒbƒNu‰‰‰ï (2016/1/29), ‘Š–ÍŒŽ.

732161. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) I––Šú‚̈ӎvŒˆ’è. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘Š–ÍŒŽ“ì•”Ž–‹ÆŽÒ˜A—‰ï (2016/2/17), ‘Š–ÍŒŽ.

733387. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ï•aŠÉ˜aƒPƒA‚Ì•‹y, Œ[”­. ‰¬–ì”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆêl, A’|“ú“Þ, ¬“c—LŒá, “ï”g—æŽq, ŽO‰Y–õ•F, ‰¬–ì@—T2, –kŽR’ʘN, ™‰Y@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹Æ@“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†@•œ¬27”N“x”ljï‹c (2016/1/9), “Œ‹ž.

733388. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒrƒbƒJ[ƒXƒ^ƒbƒt”]Š²”]‰Š‚Ì”F’èŠî€, —Տ°’²žŒÂl•[‚ƍ¡Œã‚̉ۑè. “í@@i, ’r“cCˆê, ŠC“cŒ«ˆê, Š@—Ž™Z, _“c@—², ŒKŒŽ@‘, ‰€¶‰ëO, ‘c•ƒ]Œ³, ç—tŒú˜Y, ‰¬–ì”üŒbŽq1, –쑺‹±ˆê, Ž…—DŽq, ŽðˆäN¬, Œ”öG“¿, ‰¡“c—²“¿, –쑺–FŽq, •“¡‘œ’ØY, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Œˆä@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁ@•œ¬27”N“x‡“¯”ljï‹c (2016/1/20), “Œ‹ž.

733389. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒ“ƒo[ƒgEƒC[ƒgƒ“‹Ø–³—͏njóŒQ‚̐f’fŠî€ô’è. ‹gìO–Ÿ, Ž…@, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, Ž…—DŽq, —é–Ø‘¥G, Žà‘º–Ÿ¶, ‰€¶‰ëO, V–쐳–Ÿ, –쑺‹±ˆê, ŒŽ@Žõ˜Y, Œ”öG“¿, –{‘º­Ÿ, ìŒû’ŒŽ÷, ŒSŽR’B’j, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Šâ²˜a•v, —é–؏d–Ÿ, ”š’†—TŒÈ, âˆäŒ’“ñ, Œˆä@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁ@•œ¬27”N“x‡“¯”ljï‹c (2016/1/20), “Œ‹ž.

733390. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒŒƒZƒvƒgƒf[ƒ^‚©‚ç‚Ý‚œ‘œ”­«d‰»Ç‚ÌŽ¡—Ó®Œü. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁ@•œ¬27”N“x‡“¯”ljï‹c (2016/1/20), “Œ‹ž.

733391. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž©ŒÈ–Ɖu‹@˜‚ªl‚Š‚ç‚ê‚é”]‰ŠE”]Ç‘S‘’²ž. _“c@—², Œˆä@^, ’r“cCˆê, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, ‹v•Û“c—Ž“ñ, Ž…—DŽq, —é–Ø‘¥G, ŒàV³–L, –쑺‹±ˆê, ŒŽ@Žõ˜Y, ‰¡“c—²“¿, “n粁@C, Œ¢’ˁ@‹M, ’†‘º—Ž•¶, –쑺–FŽq, ŽR–ì‰Ã‹v, •Ä“c@œ, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, “c’†ŒbŽq, ŒÃ‰ê“¹–Ÿ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁ@•œ¬27”N“x‡“¯”ljï‹c (2016/1/20), “Œ‹ž.

733392. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇ‹Ø–³—͏ǂ̐f’fŠî€‚̉ü’ù. ‹gìO–Ÿ, Ž…@, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, Ž…—DŽq, —é–Ø‘¥G, Žà‘º–Ÿ¶, ‰€¶‰ëO, V–쐳–Ÿ, –쑺‹±ˆê, ŒŽ@Žõ˜Y, Œ”öG“¿, –{‘º­Ÿ, ìŒû’ŒŽ÷, ŒSŽR’B’j, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Šâ²˜a•v, —é–؏d–Ÿ, âˆäŒ’“ñ, Œˆä@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁ@•œ¬27”N“x‡“¯”ljï‹c (2016/1/20), “Œ‹ž.

733393. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ••“ü‘̋؉Šf’f‚É—p‚¢‚éŒú˜JÈŠî€‚ÆEuropean Neuromusclar Center (ENMC) Šî€‚Ì”äŠrŒŸ“¢. Ž…@, ‹gìO–Ÿ, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, Ž…—DŽq, —é–Ø‘¥G, Žà‘º–Ÿ¶, ‰€¶‰ëO, V–쐳–Ÿ, –쑺‹±ˆê, ŒŽ@Žõ˜Y, Œ”öG“¿, –{‘º­Ÿ, ìŒû’ŒŽ÷, ŒSŽR’B’j, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Šâ²˜a•v, —é–؏d–Ÿ, âˆäŒ’“ñ, Œˆä@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁ@•œ¬27”N“x‡“¯”ljï‹c (2016/1/20), “Œ‹ž.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H17-530001. [‚»‚Ì‘Œ (Proceeding)] The issues on the induction of invasive mechanical ventilation in Japanese ALS patients. Ogino M1, Ogino Y2, Kobayashi N, Sakai F: ALS and motor neuron disorders 2005; 6 (Suppl 1): 157. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H17-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]y¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vz—ÃŒìŽ{Ý‚É‚š‚¯‚éALSŽó‚¯“ü‚ê‚ÌŒ»ó|‘æ1•ñ‚±‚ê‚Ü‚Å‚ÌŒoˆÜ|. ‰¬–ì”üŒbŽq1, ŒÃàV‰p–Ÿ, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬17”N“x‘Š‡¥•ª’SŒ€‹†•ñ‘ 2006/3; p.34-7.

H17-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzu_Œo“ï•a‚̃Rƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“áŠQ‚ɑ΂·‚鉇•Žè’ivƒŠƒXƒg‚̍쐬. ‰¬–ì”üŒbŽq1, ’†Œ_Ži, ’†ŠÛ‹I‹v”ü, g—с@Šó, ¡ŠÖˆŸ—R”ü, ’|“àŠ°l (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬17”N“x‘Š‡¥•ª’SŒ€‹†•ñ‘ 2006/3; p.38-40.

H17-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzALS‚ɑ΂·‚éSNIP‚Ì—L—p«|‘æ1•ñ|. ‰¬–ì”üŒbŽq1, ão’Œl, •œ‰ê‚悵‚Ý, —Rˆäi‘Ÿ˜Y, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬17”N“x•ª’SŒ€‹†•ñ‘ 2006/3; p.49-52.

H17-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzALSI––Šú‚É‚š‚¯‚éŠÉ˜aƒPƒA‚ɂ‚¢‚ā|“–‰@‚É‚š‚¯‚éƒIƒsƒIƒCƒh“™‚ÌŽg—pŒoŒ±|. ‰¬–ì”üŒbŽq1, ”у–’J”ü•ô2, —Rˆäi‘Ÿ˜Y, ‰¬–ì@—T2, âˆä•¶•F, “IêŒ³O, ‘同GŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬17”N“x•ª’SŒ€‹†•ñ‘ 2006/3; p.82-5.

H17-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†vzƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ‚Ì’·Šú—\Œã. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, “ü]KŽq, ‹ààV’Œ”ü3, âˆä•¶•F, Ä“¡–L˜a (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à, 3•a‘ԁEf—ÃŒn): Œú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬17”N“x‘Š‡¥•ª’SŒ€‹†•ñ‘ 2006/3; p.160-1.

H18-210001. [€ŒŽ’˜] The present status and problems eith upper extremity orthosis in patients with Amyotrophic Lateral Sclerosis. Imazaki A, Ogino M1, Ogino Y2, Kamide N, Asai N. Sakai F: ALS and motor neuron disorders 2006; 7 (suppl 1): 74-5. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H18-522002. [uÀ] ƒhƒLƒ…ƒƒ“ƒg: NP“IlHŒÄ‹z—Ö@‚ð‘I‘ð‚µ‚È‚¢ALSŠ³ŽÒ‚³‚ñ‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•a‚ƍݑîƒPƒA 2006/12; 12 (9): 23-6.

H18-530001. [Ž˜^ (Proceeding)] Long-term prognosis of Guillain-Barre syndrome. Ogino M1, Ogino Y2, Irie S, Kanazawa N, Saito T, Sakai F: J Neuroimmunology 2006; 178 (Suppl 1): 222. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H18-530002. [Ž˜^ (Proceeding)] The present status and problems eith upper extremity orthosis in patients with Amyotrophic Lateral Sclerosis. Imazaki A, Ogino M1, Ogino Y2, Kamide N, Asai N, Sakai F: ALS and motor neuron disorders 2006; 7 (Suppl 1): 74-5. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H18-530003. [Ž˜^ (Proceeding)] Usefulness of Sniff Nasal Inspiratory Pressure (SNIP) for Japanese Patients with ALS. Kamide N, Ogino M1, Ogino Y2, Fukuda M, Sumida S, Hiraga Y, Sakai F: ALS and motor neuron disorders 2006; 7 (Suppl 1): 83. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H18-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzNPPVÅV‚Ì‹@Ží”äŠr. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, âˆä•¶•F, ‰Z¶Lˆê (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“x‘Š‡¥•ª’SŒ€‹†•ñ‘ 2007/3; p.47-50.

H18-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vz_Œo“ï•a‚É‚š‚¯‚鎩—§Žx‰‡–@“±“üŒã‚ÌŒ»ó‚Ɖۑè‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, ãžŠáÁŽq, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“x‘Š‡¥•ª’SŒ€‹†•ñ‘ 2007/3; p.51-3.

H18-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzNIPPV‚Ì‹@Ží”äŠr‚ƃCƒ“ƒ^[ƒtƒFƒCƒX. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“x•ª’SŒ€‹†•ñ‘ 2007/3; p.97-101.

H18-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzALS/MND‚É‚š‚¯‚éRTX (‘ÌŠOŽ®lHŒÄ‹zŠí) ‚Ì—L—p«|‘æ1•ñ|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“x•ª’SŒ€‹†•ñ‘ 2007/3; p.102-3.

H18-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzALS‚É‚š‚¯‚éSniff Nasal Inspiratory Pressure‚Ì—L—p«|‘æ2•ñ|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“x•ª’SŒ€‹†•ñ‘ 2007/3; p.104-7.

H18-540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†vzGBS‚É‚š‚¯‚éCD1ˆâ“`Žq‘œŒ^. ‰¬–ì”üŒbŽq1, ‹ààV’Œ”ü2, “ü]KŽq, ‰¬–ì@—T3, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2•a‘ԁEf—ÃŒn, 3_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬18”N“x‘Š‡¥•ª’SŒ€‹†•ñ‘ 2007/3; p.160-1.

H19-120001. [ŒŽ’˜] ‰îŒì•ÛŒ¯ƒT[ƒrƒX—˜—pó‹µ‚ª‰îŒì•‰’SŠŽ‚É—^‚Š‚é‰e‹¿‚ÌŒŸ“¢. –ìŠÔ‹M—Y, ²“¡Žu–ì, ‰¬–ì”üŒbŽq1, ão’Œl2, •Ÿ“c—Ï–ç2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2ˆã—Éq¶Šw•”): –k—¢—Šw—Ö@Šw 2008/3; 11: 109-12.

H19-120002. [ŒŽ’˜] sniff nasal inspiratory pressure‚̑Ó–«‚ÌŒŸ“¢‚Æ“ú–{l‚É‚š‚¯‚é—\‘ªŽ®‚̍쐬|ALSŠ³ŽÒ‚ɑ΂·‚éV‚µ‚¢ŒÄ‹z‹@”\•]‰¿–@‚ÌŠm—§‚É‚Þ‚¯‚ā|. ŽR‰È“TŽq, ¬o‚©‚‚ç, ²“¡ŽO“ÞŠó, ‰¬–ì”üŒbŽq1, ão’Œl2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2ˆã—Éq¶Šw•”): –k—¢—Šw—Ö@Šw 2008/3; 11: 133-6.

H19-530001. [‚»‚Ì‘Œ (Proceeding)] Myocardial [(123)I] metaiodobenzylguanidine is preserved uptake in hereditary Parkinson's disease with LRRK2 I2020T mutation (HPD Sagamihara family). Ogino Y1, Ogino M2, Ujiie S, Sakai F: Movement Disorders 2007; 22 (suppl 16): S241. (‰¬–ì@—T1, ‰¬–ì”üŒbŽq2: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H19-530002. [Ž˜^ (Proceeding)] Assessment of Sniff Nasal Inspiratory Pressure (SNIP) is useful in prediction of prognosis in Japan. Ogino M1, Kamide N, Sumida S, Ogino Y2, Hiraga Y, Kasuga M, Fukuda M, Yamazaki T, Kitamura E, Sakai F: Amyotroph Lateral Scler 2007; 8 (Supl 1): 81. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H19-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzALS‚̍ݑî‚Ý‚Æ‚è‚Ö‚ÌŽæ‚è‘g‚Ý. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, ’r“cŠxŽi, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2008/3; p.88-91.

H19-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vz_Œo“ï•a‚É‚š‚¯‚éƒp[ƒJƒbƒVƒ‡ƒlƒA‚Ì—L—p«. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, ‰Z¶Lˆê, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2008/3; 80-1.

H19-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzNPPV‚Ì‹@Ší‚ƃCƒ“ƒ^[ƒtƒFƒCƒX. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2008/3; p.82-4.

H20-220001. [€ŒŽ’˜] _Œo“à‰ÈŽ¡—ÂƗϗ“I”z—¶. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—à 2008; 25: 669-73.

H20-220002. [€ŒŽ’˜] ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“‚ÌŽi‰ï‚ðI‚Š‚Ä. _’Á@m, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—à 2008; 25: 717-8.

H20-522001. [uÀ]y“ÁW: lHŒÄ‹z—Ö@‚©‚ç”­¶‚·‚é•ŸŠQ‚̑Ήžô [‘æ1•”]zÝ‘îlHŒÄ‹z—Ö@‚É‚š‚¯‚閝«ŒÄ‹zŠíŠŽõÇ‚̍R‹Û—Ö@. ‰¬–ì@—T1, ‰¬–ì”üŒbŽq2 (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•a‚ƍݑîƒPƒA 2008/10; 14 (7): 9-11.

H20-530001. [‚»‚Ì‘Œ (Proceeding)] Giving the diagnosis of ALS and patient's choice in Japan. Ogino M1, Ogino Y2, Sakai F: Amyotroph Lateral Scler 2008; 9 (Supl 1): 13. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H20-530002. [‚»‚Ì‘Œ (Proceeding)] Effectiveness of monitoring sniff nasal inspiratory pressure (SNIP) and trans cutaneous PCO2 to foresee prognosis of patients with ALS. Ogino Y1, Ogino M2, Kamide N, Sumida S, Sakai F: Amyotroph Lateral Scler 2008; 9 (Supl 1): 141. (‰¬–ì@—T1, ‰¬–ì”üŒbŽq2: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H20-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†vzƒMƒ‰ƒ“¥ƒoƒŒ[ÇŒóŒQ RƒKƒ“ƒOƒŠƒIƒVƒhR‘Ì—z«‹}«‰ŠÇ«ƒjƒ…[ƒƒpƒ`[‚É‚š‚¯‚éR‘Ì‚Ì’·ŠúŒo‰ß. ‰¬–ì”üŒbŽq1, “ü]KŽq, ‹ààV’Œ”ü2, à_“cˆê3, âˆä•¶•F, ‰¬–ì@—T3 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2Œ`‘ԁEf—ÃŒn, 3_Œo“à): Œú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬20”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2009/3; p.149-51.

H20-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vz_“ސì_Œo“ï•aƒlƒbƒgƒ[ƒNŽn“®‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, âˆä•¶•F, ‹gˆä•¶‹Ï, •Šâ‹`”V (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x‘Š‡¥•ª’SŒ€‹†•ñ‘ 2009/3; p.49-50.

H20-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzƒI[ƒfƒBƒbƒg’²ž‚É‚æ‚éALSˆã—Â̍‘Û”äŠrŒ€‹† ’†“‡@F, ˆÉ“¡”Ž–Ÿ, OLIVER David, OLIVER David, “ï”g—æŽq, ‰¬–ì”üŒbŽq1, “¡ˆä’ŒŽ÷, M‘Œ\Œá, –xì—g, ŒF–{rG, ”üŒŽ@”Õ, ìˆä@[, ‹{•‘Žq, •Ÿ‰iGr, ‰€“cŽŠl, CAMPBELL Colin, SLOAN Richard, SYKES Nigel, TALLON Carole, WEBB Sandi, ALBERT Steven (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x‘Š‡¥•ª’SŒ€‹†•ñ‘ 2009/3; p.89-95.

H20-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†vz“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2009/3; p.11-56.

H20-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzÝ‘ƒ‹ƒqƒlŽg—p‚Ì–â‘è“_. ‰¬–ì”üŒbŽq1, âˆä•¶•F, •Î”NO (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2009/3; p.42-3.

H20-540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vz–k—¢ê–åŠÅŒìŽtu“ï•aŠÅŒìvˆç¬ƒvƒƒOƒ‰ƒ€‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, âˆä•¶•F, ‘Oì‹±Žq, ‹gŒŽçŒb, ‘å’J—æŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2009/3; 44-6.

H21-522001. [uÀ]y“ÁW: “ï•aŠ³ŽÒ‚Ì‚œ‚߂̃AƒCƒfƒAW [‘æ1•”]zŠ³ŽÒŽ©g‚É‚æ‚é—×{‚̃AƒCƒfƒA‚̐”X. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•a‚ƍݑîƒPƒA 2009/8; 15 (5): 7-12.

H21-522002. [uÀ]ylHŒÄ‹z—Ö@z”ñNP“IlHŒÄ‹zŠí‚̍ŐV‚Ì‹@Ží”äŠr. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•a‚ƍݑîƒPƒA 2009/11; 15 (8): 29-32.

H21-522003. [uÀ]y“ÁW: ‹}«Ž©—¥«ŠŽŠo«ƒjƒ…[ƒƒpƒ`[z‹}«Ž©—¥«ŠŽŠo«ƒjƒ…[ƒƒpƒ`[‚ÌŒo‰ß—\Œã. ‰¬–ì@—T1, ‰¬–ì”üŒbŽq2 (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŒŽŠ§_Œo“à‰È 2009/12; 71 (6): 589-93.

H21-522004. [uÀ]y˜AÚ: ALSŠ³ŽÒ‚̍ݑîˆã—ÁzŒÄ‹zŠÇ—@…AÝ‘îlHŒÄ‹zŠí‚ɂ‚¢‚Ä. ‰¬–ì@—T1, ‰¬–ì”üŒbŽq2 (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): J Clin Rehabil 2010/2; 19 (2): 177-82.

H21-530001. [‚»‚Ì‘Œ (Proceeding)] The survey report of the ALS physicians in Japan. Ogino M1, Ogino Y2, Hamada J2: Amyotroph Lateral Scler 2009; 10 (suppl 1): 48. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, à_“cˆê2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H21-530002. [‚»‚Ì‘Œ (Proceeding)] A Therapeutic agent (NDDPX08) Delays disease progression, improves motor function and prolongs survival in a mouse model of ALS. Tanaka K, Kanno T, Yanagisawa Y, Aoki M, Hadano S, Itoyama Y, Ogino M1, Iwasaki Y, Yoshii F, Ikeda J-E: Amyotroph Lateral Scler 2009; 10 (suppl 1): 75. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H21-530003. [‚»‚Ì‘Œ (Proceeding)] The study of NIPPV using full-face mask remodeled to support endoscope in per-endoscopic gastrostomy in ALS patients. Ogino Y1, Yabuki S, Ogino M2: Amyotroph Lateral Scler 2009; 10 (suppl 1): 188. (‰¬–ì@—T1, ‰¬–ì”üŒbŽq2: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H21-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzƒp[ƒJƒbƒVƒ‡ƒlƒA“±“ü‚̃AƒZƒXƒƒ“ƒg. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, Šâè‹€, ‰Z¶Lˆê (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2010/3; p.47-50.

H21-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzƒXƒRƒ|ƒ‰ƒ~ƒ““îp‚Ì—L—p«‚ÌŒ€‹†. ‰¬–ì”üŒbŽq1, ‹{ì¹D, –]ŒŽGŽ÷, ‘O“cŽÀ‰Ô, •ì­ˆê (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2010/3; p.49-50.

H21-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzALS‚ÆŒûoƒPƒA: NPPV‘•’…Š³ŽÒ‚Ì•a“ŒûoƒPƒA‚̐¬Œ÷—á‚Æ‘ŠúŽ•‰È‰î“ü‚Ì•K—v«‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, ²“¡‚Ý‚³‚ð, “n糍WG, ‘åê@ƒ, ²–ì‚ ‚ä‚Ý, –Ø‘º—F”ü (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x‘Š‡¥•ª’SŒ€‹†•ñ‘ 2010/3; p.46-8.

H21-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†vzƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ: ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒXŠŽõ‚ÆGBS. ‰¬–ì”üŒbŽq1, “ü]KŽq, ‹ààV’Œ”ü2, –]ŒŽGŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2•a‘ԁEf—ÃŒn): Œú¶˜J“­È“Á’莟Š³‘΍ôŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬21”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2010/3; p.139-42.

H22-120002. [ŒŽ’˜] ˆÞk«‘€õd‰»ÇŠ³ŽÒ‚É‚š‚¯‚éŒg‘ÑŒ^—A‰tƒ|ƒ“ƒv‚ð—p‚¢‚œÝ‘î‚Å‚Ìmorphine hydrochlorideŽ‘±”牺’‚ɂ‚¢‚Ä. –k‘º‰p“ñ1, ‰¬–ì”üŒbŽq2, à_“cˆê1, –]ŒŽGŽ÷, “y”ì’ŒŽ÷ (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‹Ø_ŒoŽ¡—Êw 2011/3; 28 (2): 163-6.

H22-220001. [€ŒŽ’˜] ”ñ‚ª‚ñŽŸŠ³‚ɍݑîŠÉ˜aƒPƒA‚ÌŒõ‚ð! _Œo“ï•a (“Á‚ÉALS) ‚̊ɘaƒPƒA‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{Ý‘îˆãŠw‰ïŽGŽ 2010; 12: 56-7.

H22-220002. [€ŒŽ’˜] _Œo“à‰È—̈æ‚É‚š‚¯‚éI––Šú‚Ì—Ï—“I–â‘è‚ɂ‚¢‚Ä ALSI––ŠúƒPƒA‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²žŒ‹‰Ê. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): —Տ°_Œo 2010; 50: 1026-8.

H22-220003. [€ŒŽ’˜] _Œo“ï•a‚Ɗɘaˆã—ÁEI––Šúˆã—Á|ƒIƒsƒIƒCƒhEƒ‚ƒ‹ƒqƒl‚ÌŽg—p‚𒆐S‚É. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—Êw 2011/1; 28 (1): 25-8.

H22-522001. [uÀ] ƒgƒsƒbƒNƒjƒ…[ƒX: ƒJƒtƒAƒVƒXƒg‚Ì•ÛŒ¯“K‰ž‚Æ“±“üŽžŠú. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•a‚ƍݑîƒPƒA 2010/6; 16 (3): 4-6.

H22-522002. [uÀ]y“ÁW: ’·ŠúlHŒÄ‹zŠÇ—‚̃mƒEƒnƒE [‘æ3•”]zŒÄ‹z‹@”\•]‰¿‚š‚æ‚ÑNPPV“±“ü‚ÌŽÀÛ. …–ìŒö•ã, •œ‰ê‚悵‚Ý, ão’Œl, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•a‚ƍݑîƒPƒA 2010/11; 16 (8): 19-22.

H22-522003. [uÀ]y“ÁW: Ò’ŐҐ‘ŽŸŠ³‚Ɖ^“®ƒjƒ…[ƒƒ“ŽŸŠ³‚̊ӕʁzBrachial amyotrophic diplegiaèò’ŏǂƂ̊֘A«. ‘êŽR—eŽq1, ‰¬–ì”üŒbŽq2 (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Ò’ŐҐ‘ƒWƒƒ[ƒiƒ‹ 2010/12; 23 (12): 1091-5.

H22-522004. [uÀ]y“ÁWII: _Œo“à‰È—̈æ‚É‚š‚¯‚éI––Šú‚Ì—Ï—“I–â‘èzALSI––ŠúƒPƒA‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²žŒ‹‰Ê. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŒŽŠ§_Œo“à‰È 2011/2; 74 (2): 170-5.

H22-530001. [‚»‚Ì‘Œ (Proceeding)] Possession of assistive devices among persons with amyotrophic lateral sclerosis. Otera A, Takahashi K, Ogino M1, Fukuda M: Amyotroph Lateral Scler 2010; 11 (suppl 1): 133. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H22-530002. [‚»‚Ì‘Œ (Proceeding)] ALS patients on mechanical ventilation have greater risk of cholecystitis. Ogino M1, Kitamura E, Ogino Y2, Mochizuki H: Amyotroph Lateral Scler 2010; 11 (suppl 1): 155-6. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H22-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vzˆã—Ô‚ç‚Ý‚œ“ï•a. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vƒ[ƒNƒVƒ‡ƒbƒv‹L˜^W(u“ï•av‚Æ‚Í?`—ðŽj, ’è‹`, ‘Û”äŠr`) 2011/3; p.37-44.

H22-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†vz“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ (Žå”CŒ€‹†ŽÒ) 2011/3; p.11-49.

H22-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzALSƒ`[ƒ€ˆã—Âɂš‚¯‚éî•ñ‹€—L‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2011/3; p.53-5.

H22-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzƒI[ƒgƒXƒpƒCƒAS-507‚ð—p‚¢‚œSniff Nasal Inspiratory Pressure (SNIP) ‘ª’è‚Ì—L—p«. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, …–ìŒö•ã, •œ‰ê‚悵‚Ý, t“ú”ü•Û, “¡‹Ž‹Is, ‹{é‚µ‚Ù, ¬–쎛ˆŸ–í, ão’Œl, •Ÿ“c—Ï–ç (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2011/3; p.p.56-8.

H22-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzALSŠ³ŽÒ‚̏I––ŠúƒPƒA|NPPV’·ŠúŽg—pŠ³ŽÒ‚̃PƒA‚Å’Œ–Ê‚·‚é–â‘è‚©‚ç|. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, ìã@—B, ‘å’J—æŽq, ‘Oì‹±Žq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2011/3; p.59-61.

H22-540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzŽ‹ü“ü—͈ӎv“`’B‘•’u‚ð—p‚¢‚œ•¶Žš“ü—Í‚ÉŠÖ‚·‚錟“¢. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, ‘Oê—m—C, ’|“àŠ°l, ‘厛ˆŸ—R”ü, ‚‹Ž‘ãŽq, ’†Œ_Ži, •Ÿ“c—Ï–ç (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2011/3; p.62-3.

H22-540007. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vz‹ØˆÞk«‘€õd‰»ÇŠ³ŽÒ‚É‚š‚¯‚é‰h—{áŠQ‚ÌŒã•ûŽ‹“IŒ€‹†-‘œŽ{Ý‹€“¯Œ€‹†-. Ž…r•v, ’·‰ªŽŽq, ì“c–ŸL, “B–{çt, •Šâ‹`”V, ìˆä[, ‰º”š‹—Ç, ŒàV³–L, ”üŒŽ@”Õ, r”š@‘n, “¡ˆä’ŒŽ÷, “ï”g—æŽq, ˆÉ“¡”Ž–Ÿ, ¡ˆä®Žu, ‹ß“¡Ž•F, ‰¬–ì”üŒbŽq1, Mš Œ\Œá, ’†“‡@F, ¬X“N•v (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x ‘Š‡¥•ª’SŒ€‹†•ñ‘ 2011/3; p.174-6.

H22-540008. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vz“«ŽŸŠ³‚É‚š‚¯‚éŒÄ‹zƒPƒACI––ŠúƒPƒACƒ`[ƒ€ˆã—Ó™‚ÌŒ€‹†. ‰¬–ì”üŒbŽq1, ‹{ì¹D, âˆä•¶•F, –]ŒŽGŽ÷, Šâè‹€, ‰Z¶Lˆê, ãðáÁŽq, ŒÃìŠì”ü, •Î”NO, ‘Oì‹±Žq, ‹gŒŽçŒb, ‘å’J—æŽq, ìã@—B, ‘O“cŽÀ‰Ô, •ì­ˆê, …–ìŒö•ã, •œ‰ê‚悵‚Ý, t“ú”ü•Û, “¡‹Ž‹Is, ‹{é‚µ‚Ù, ¬–쎛ˆŸ–í, ‘Oê—m—C, ’|“àŠ°l, ‘厛ˆŸ—R”ü, ‚‹Ž‘ãŽq, ’†Œ_Ži, ão’Œl, •Ÿ“c—Ï–ç, –k—¢‘åŠw“Œ•a‰@ALSƒ`[ƒ€ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life,QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬20-22”N“x ‘‡Œ€‹†•ñ‘ 2011/3; p.49-56.


H22-540009. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†vz‘Š‡Œ€‹†•ñ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x`22”N“x‘‡Œ€‹†•ñ‘ 2011/3; p.7-42.

H22-540010. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†vz‘Š‡Œ€‹†•ñ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.11-25.

H22-540011. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†vzƒŒƒZƒvƒgƒf[ƒ^‚ðŠî‚É‚µ‚œ•ªÍ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘•Êû 2011/3; p.1-651.

H22-540012. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vz‹ØˆÞk«‘€õd‰»ÇŠ³ŽÒ‚̈ӌü‚Ì‘žd‚ƃPƒA (Ž–‘OŽwŽŠ) ‚ÉŠÖ‚·‚錟“¢’†ŠÔ•ñ‘. ”ˆäFˆë˜Y, ˆÉ“¡”Ž–Ÿ, ˆÉ“¡“¹Æ, ˆî—tˆêl, ¡ˆä®Žu, ‘å‹÷‰xŽq, ‰¬–ì”üŒbŽq1, ’†“‡@F, “ï”g—æŽq (Ž–‘OŽwŽŠŒŸ“¢ƒ[ƒLƒ“ƒOƒOƒ‹[ƒv) (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v2011/3; p.6-46.

H22-540013. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzŽ©•E‹€•EŒö•‚ði‚ß‚é‚œ‚ß‚É. ‰¬–ì”üŒbŽq1, –k—¢‘åŠw“Œ•a‰@ALSƒ`[ƒ€, ‰¬–ì@—T2, à_“cˆê2, ²“¡‚Ý‚³‚ð, “n糍WG, ‘åê@ƒ, ²–ì‚ ‚ä‚Ý, –Ø‘º—F”ü, á–{—R”ü, ˆÀ“cØ•ä, ‹gàVŒ’‘Ÿ˜Y, `@ŽáØ, •Ÿ“c—Ï–ç, ³˜Ò@—², ‹gˆä•¶‹Ï, •Šâ‹`”V, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬20-22”N“x•ª’SŒ€‹†•ñ‘ 2011/3; p.57-63.

H22-540014. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzTPPVŽg—p’†‚ÌALSŠ³ŽÒ‚É‚š‚¯‚éƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“•û–@EÛHó‹µ (Œ»ó•ñ). ‰¬–ì”üŒbŽq1, á–{—R”ü, `@ŽáØ, ³˜Ò@—², •Ÿ“c—Ï–ç, –]ŒŽGŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x•ª’SŒ€‹†•ñ‘ 2011/3; p.62-3.

H22-540015. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vz‹ØˆÞk«‘€õd‰»Ç“™_Œo“ï•aŠ³ŽÒ‚ð’S“–‚·‚é_Œo“à‰ÈˆãŽt“™‚ɑ΂·‚鎖‘OŽwŽŠ‚ÉŠÖ‚·‚é’²ž. ˆÉ“¡“¹Æ, ”ˆäFˆë˜Y, ˆÉ“¡”Ž–Ÿ, ˆî—tˆêl, ¡ˆä®Žu, ‘å‹÷‰xŽq, ‰¬–ì”üŒbŽq1, ’†“‡@F, “ï”g—æŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬20-22”N“x‘‡Œ€‹†•ñ‘ 2011/3; 46-53.

H22-540016. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vz‹ØˆÞk«‘€õd‰»Ç“™_Œo“ï•aŠ³ŽÒ‚ð’S“–‚·‚é_Œo“à‰ÈˆãŽt“™‚ɑ΂·‚鎖‘OŽwŽŠ‚ÉŠÖ‚·‚é’²ž (2)@ˆãŽt‘Ώے²ž‚ɂ݂鎖‘OŽwŽŠ‚Ì–â‘è“_|‰Û‘è‚Æ‰ðŒˆô|. ˆÉ“¡“¹Æ, ”ˆäFˆë˜Y, ˆÉ“¡”Ž–Ÿ, ˆî—tˆêl, ¡ˆä®Žu, ‘å‹÷‰xŽq, ‰¬–ì”üŒbŽq1, ’†“‡@F, “ï”g—æŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.47-50.

H23-110001. [ŒŽ’˜] Occurrence of cholelithiasis and cholecystitis in amyotrophic lateral sclerosis patients with long-term tracheostomy invasive ventilation. Kitamura E1, Ogino M2: Intern Med 50 (20): 2291-5. (–k‘º‰p“ñ1, ‰¬–ì”üŒbŽq2: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H23-522001. [uÀ]y“ÁWII: I––Šú‚Ì‹ê’ɊɘaƒPƒA [‘æ4•”]zNPPV‚ƏI––ŠúƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•a‚ƍݑîƒPƒA 2011/5; 17 (2): 21-5.

H23-522002. [uÀ]y“ÁW: ALS|—Տ°‚Æ•ªŽq•a‘ÔŒ€‹†‚̐i•àzALS‚ÌŽ¡—ÂƃPƒA@‰îŒì¥Žx‰‡ƒVƒXƒeƒ€. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Clin Neurosci 2011/9; 29 (9): 1068-71.

H23-522003. [uÀ]y“ÁW: ‚»‚Ì‚â‚è•û‚ÅOK? æ”yƒGƒLƒXƒp[ƒg‚ÉŠw‚Ô‹zˆøE”rႃeƒNƒjƒbƒN‚Ì‚·‚ׂāz6. ‹@Ší‚ð—p‚¢‚œ”rá‚. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŒÄ‹zŠíƒPƒA 2011/9; 9 (9): 908-11.

H23-522004. [uÀ]yŽãƒfƒBƒx[ƒgzL-ƒhƒp‚ÌŽŠ“K—p—Ê‚Í300 mg/“ú‚ð’Ž‚Š‚Ä‚æ‚¢‚©?uYesv‚Ì—§ê‚©‚ç. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Front Parkinson Dis 2011/11; 4 (4): 190-2.

H23-530001. [‚»‚Ì‘Œ (Proceeding)] Opinions and behaviors of Japanese and American neurologists regarding tracheostomy with invasive ventilation (TIV). Dirienzo A, Ogino M1, Rabkin J, Goetz R, Pasmantier M, Mcelhiney M, Mitsumoto H, TIV STUDY GROUP: Amyotroph Lateral Scler 2011; 12 (suppl 1): 29-30. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H23-530002. [‚»‚Ì‘Œ (Proceeding)] Analysis of the end of life situation in 115 consecutive ALS patienta in the past nine years. Ogino M1, Kitamura E, Miyakawa S, Utino A, Urano Y, Nagai M, Ogino Y2: Amyotroph Lateral Scler 2011; 12 (suppl 1): 61. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H23-540001. [‚»‚Ì‘Œ (V•·‹LŽ–)] ÐŠQˆã—ÃŒ©’Œ‚µ ”À‘—, ’ʐM–ԁEEE‰Û‘è‘œ‚­. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “Ç”„V•· 2011/12/27; p.13.

H23-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vz’m. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï‹L˜^W 2012/3; p.1,57-76.

H23-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vzlHŒÄ‹zŠí‘•’…Š³ŽÒ‚̍Lˆæ”À‘—‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vu“ï•a‚ƍЊQ‘΍ôvƒtƒH[ƒ‰ƒ€`Lˆæˆã—ÔÀ‘—‚Æ“dŒ¹Šm•Û‘΍ô`‹L˜^W 2012/3; p.34-9.

H23-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vzu“ï•a‚Ì’è‹`v‚ÌŒŸ“¢‚š‚æ‚сu“ï•a‚̊ɘaƒPƒAŒ€C‰ïv‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, ”ˆäFˆë˜Y, ˆÉ“¡”Ž–Ÿ, ˆÉ“¡“¹Æ, ˆî—tˆêl, A’|“ú“Þ, ì‡áÁˆê, –Ø‘º@Ši, Š‹ŒŽ–ÎŽ÷, Ž™‹Ê’mŽq, Ž…“N˜Y, ¬“c—LŒá, “ï”g—æŽq, “n•Ó@Žç (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.215-6.

H23-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†vz–Ɖu«_ŒoŽŸŠ³‚̈ã—Ôï\‘¢ ‚Šzˆã—Â𒆐S‚É. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.91-2.

H23-540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†vz‹}«Ž©—¥«ŠŽŠo«‰^“®«ƒjƒ…[ƒƒpƒ`[ (AASMN) Š³ŽÒŒŒŽ’†‚ÌŽ©ŒÈR‘Ì‚ÌŒŸõ. “ì@@®, ’·‰–@—º, ‹ààV’Œ”ü1, “ü]KŽq, ²“¡—Yˆê, ‰¬–ì”üŒbŽq2 (1•a‘ԁEf—ÃŒn, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬23”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2012/3; p.162-3.

H24-110003. [ŒŽ’˜] Clinical features in Gullain-Barre syndrome with anti-Gal-C antibody. Samukawa M, Hamada Y, Kuwahara M, Takada K, Hirano M, Mitsui Y, Sonoo M,Kusunoki S, Japanese GBS Study Group (Imai T, Ugawa Y, Yoshikawa Y, Hiraga H, Kaida K, Yokota T, Terao Y, Takeuchi S, Ogino M1, Sobue G, Koike H, Kojima Y, Nakamura Y, Kohara N, Ochi K, Tsuji S, Kira J, Matsunaga K): J Neurol Sci 2014/2; 337 (1-2): 55-60. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H24-520001. [‘à]y•W€“I_ŒoŽ¡—Ã: dÇ_Œo“ï•a‚̌ċzƒPƒAEŒÄ‹zŠÇ—‚ƃŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“zIII. ‹ØˆÞk«‘€õd‰»Ç‚É‚š‚¯‚éŒÄ‹zƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—Êw 2013/3; 30 (2): 203-6.

H24-522001. [uÀ]y“ÁW: ¡, ”F’mÇ‚É‚Ç‚€Œü‚«‡‚€‚©zÀ’k‰ï: ”ñê–åˆã‚ª‚Ç‚Ì‚æ‚€‚É”F’mÇ‚ÉŒü‚«‡‚Á‚œ‚ç‚æ‚¢‚©? ‰¬–ì”üŒbŽq1, ‰Í‘º@–ž, ŽO‘º@›’, •œŒŽ²“lŽi (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “à‰È 2012/5; 109 (5): 847-60.

H24-522002. [uÀ]y‘æ53‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï: ƒVƒ“ƒ|ƒWƒEƒ€2z5. ŽÐ‰ï•Ûá§“x‚̉üŠv‚Ɛ_Œo“à‰Èf—Ã: ‰œ‚ª‚Ç‚€•Ï‚í‚é‚Ì‚©?@H24f—ÕñV‰ü’è‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): —Տ°_ŒoŠw 2012/11; 52 (11): 1094.

H24-522003. [uÀ]y˜AÚ: _ŒoŽŸŠ³Ž¡—Ãm[ƒgz‹ØˆÞk«‘€õd‰»Ç (ALS)EÒ‘«‹ØˆÞkÇ (SMA). –k‘º‰p“ñ1, ‰¬–ì”üŒbŽq2 (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Clinical Neuroscience 2012/11; 30 (11): 1318-9.

H24-530001. [‚»‚Ì‘Œ (Proceeding)] Opinions and behaviors of Japanese and American ALS caregivers regarding tracheostomy with invasive ventilation (TIV). Rabkin J, Ogino M1, Goetz R, Mcelhiney M, Marziliano A, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H1: Amyotroph Lateral Scler 2012; 13 (Suppl 1): 151. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H24-530002. [‚»‚Ì‘Œ (Proceeding)] Opinions and behaviors of Japanese and American ALS patients regarding tracheostomy with invasive ventilation (TIV). Rabkin J, Ogino M1, Goetz R, Mcelhiney M, Marziliano A, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H: Amyotroph Lateral Scler 2012; 13 (Suppl 1): 152. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H24-540002. [‚»‚Ì‘Œ (Ž˜^)] _ŒoŠŽõÇ‚̐f’fƒVƒXƒeƒ€. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Neuroinfection 2012/10; 17 (2): 175.

H24-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vz’m. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬24”N“x“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï‹L˜^W 2013/3; p.1,27-45, p.139-145.

H24-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vzƒ‚ƒ‹ƒqƒl‚ÌŽg‚¢•û. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬24”N“x“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï‹L˜^W 2013/3; p.139-45.

H24-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vzƒ‚ƒ‹ƒqƒl‚ÌŽg‚¢•û. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x_Œo“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï‹L˜^W 2013/3; p.152-60.

H25-110004. [ŒŽ’˜] Efficacy of methylprednisolone pulse therapy for acute relapse in Japanese patients with multiple sclerosis and neuromyelitis optica: A multicenter retrospective analysis-1. Whole group analysis. Kira J, Yamasaki R, Yoshimura S, Fukazawa T, Yokoyama K, Fujiwara K, Ogino M1, Yokota T, Miyamoto K, Niino M, Kaida K, Matsui M, Nakatsuji Y, Ochi H, Fukaura H, Kanda T, Nagaishi A, Togo K, Mizusawa H, Kawano Y: Clinical and Expremental Neuroemmunology 2013/12; 4 (3): 306-317. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H25-110005. [€ŒŽ’˜] ALSUntangled No. 20: the Deanna protocol. ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M1, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E: Amyotroph Lateral Scler Frontotemporal Degener 2013/5; 14 (4): 319-23. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H25-210001. [€ŒŽ’˜] ALS Untangled No.21: Fecal transplants. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2013/9; 14 (5-6): 482-5. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H25-210002. [€ŒŽ’˜] ALS Untangled No.22: Propofol. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2013; 14: 640-2. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H25-210003. [€ŒŽ’˜] ALS Untangled No.23: The Rife machine and retroviruses. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2014/3; 15 (1-2): 157-9. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H25-220001. [€ŒŽ’˜] “ï•a‚É‚š‚¯‚é’É‚Ýsuffering‚ւ̑Ώˆ‚ÆŽx‰‡‚Ì‚ ‚è•û: ALS‚É‚š‚¯‚é‹ê’ɂ̊ɘa. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{“ï•aŠÅŒìŠw‰ïŽ 2013/12; 18 (2): 128-30.

H25-220002. [€ŒŽ’˜]u–œv‚ðl‚Š‚鋳ˆç. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ÂŽRƒXƒ^ƒ“ƒ_[ƒh˜_W 2013; 8: 27-39.

H25-220003. [€ŒŽ’˜] ˆãŽt‚ÌŽg–œ‚ðl‚Š‚é@ˆãŽtEˆãŠw¶‚Ì—§ê‚©‚ç. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): J Seizon and Life Sci 2013; 14: 116-23.

H25-220004. [€ŒŽ’˜] III. ‹ØˆÞk«‘€õd‰»Ç‚É‚š‚¯‚éŒÄ‹zƒPƒA@“ú–{_ŒoŽ¡—Êw‰ïŽ¡—ÃŽwjì¬ˆÏˆõ‰ï@•W€“I_ŒoŽ¡—Ã: dÇ_Œo“ï•a‚̌ċzƒPƒAEŒÄ‹zŠÇ—‚ƃŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _ŒoŽ¡—Êw 2013; 30: 203-6.

H25-522006. [uÀ]y“ÁW: “ž—ˆ “ñl‚Ɉêl”]‘²’†Žž‘ãzÀ’k‰ï: ‘‘S‘Ì‚Å”]‘²’†‚É—§‚¿Œü‚©‚€‚É‚Í‚Ç‚€‚µ‚œ‚ç‚æ‚¢‚Ì‚©? ‰¬–ì”üŒbŽq1, –L“cˆê‘¥, ‰–ì–Fº, “cŒû”ŽŠî (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “à‰È 2013/5; 111 (5): 937-50.

H25-530001. [‚»‚Ì‘Œ (Proceeding)] THE TRACE TO THE FIGHT FOR THE IMPROVEMENT IN PALLIATIVE CARE OF THE PATIENTS WITH ALS IN JAPAN. Ogino M1, Minami S, Kanazawa N, Takahashi-Narita K, Ogino Y2: Amyotroph Lateral Scler Frontotemporal Degener 2013; 14 (Suppl 2): 68. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H25-530002. [‚»‚Ì‘Œ (Proceeding)] HOW MUCH IS THE OPTIMAL INITIAL DOSE OF MORPHINE FOR ALS PATIENTS? Ogino Y1, Miyakawa S, Urano Y, Kitamura E, Uchino A, Kaneko J, Tominaga N, Takahashi-Narita K, Nagashima K, Nagai M, Ogino M2: Amyotroph Lateral Scler Frontotemporal Degener 2013; 14 (Suppl 2): 79. (‰¬–ì@—T1, ‰¬–ì”üŒbŽq2: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H25-540002. [‚»‚Ì‘Œ] ƒ‚ƒ‹ƒqƒl. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ˆã—˃lƒbƒTƒ“ƒX 2013/10/29; 5687: p.16.

H25-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vz’m. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x_Œo“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï‹L˜^W 2014/3; p.1,8-10, p.16-17, p.34-50.

H25-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vz“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ïE“ï•a‚Ì’è‹`E“ï•a‚̈ã—Ôï‰ðÍ‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬23`25”N“x‘‡Œ€‹†•ñ‘ 2014/3; p.266-7.

H25-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†vz“ï•a‚̊ɘaƒPƒAŒ€C‰ïE“ï•a‚̈ã—Ôï‰ðÍ‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬25”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2014/3; p.202-3.

H25-540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†vzƒvƒƒeƒI[ƒ€‰ðÍ‚ð—p‚¢‚œ–Ɖu«_ŒoŽŸŠ³ŽÒŒŒŽ’†‚ÌŽ©ŒÈR‘Ì‚ÌŒŸõ‚š‚æ‚іƉu«_ŒoŽŸŠ³‚̈ã—ÔÍ‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, “ì@@®, ’·‰–@—º, ‹ààV’Œ”ü2, “ü]KŽq, ²“¡—Yˆê (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2•a‘ԁEf—ÃŒn): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬23`25”N“x‘‡Œ€‹†•ñ‘ 2014/3; p.19-20, p.114.

H25-540007. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†vz“ï•aV§“x‚É‚š‚¯‚éˆã—ÔŒÈ•‰’S—\‘ª‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬25”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2014/3; p.90-1.

H26-110020. [ŒŽ’˜] Japanese and American ALS patient preferences regarding TIV (tracheostomy with incasice ventilation): A cross-national survey. Rabkin J, Ogino M1, Goetz R, McElhiney M, Hupf J, Heitzman D, Heiman-Patterson T, Miller R, Katz J, Lomen-Hoerth C, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H: Amyotroph Lateral Scler Fronttemporal Degener 2014/6; 15 (3-4): 185-91. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H26-110021. [ŒŽ’˜] Syntactic comprehension in patients with amyotrophic lateral sclerosis. Yoshizawa K, Yasuda N, Fukuda M, Yukimoto Y, Ogino M1, Hata W, Ishizaka I, Higashikawa M: Behav Neurol 2014; 2014: 230578. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H26-210001. [€ŒŽ’˜] ALS Untangled No.24: VitaminD. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2014; 15: 318-20. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H26-210002. [€ŒŽ’˜] ALS Untangled No.25: ursodiol. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2014; 15: 475-8. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H26-522015. [uÀ]y“ÁW: ‚±‚ê‚Ÿ‚¯‚Í’m‚Á‚Ä‚š‚«‚œ‚¢! “à‰Èˆã‚Ì‚œ‚߂̐_ŒoŽŸŠ³f—ÁzsEditorialtˆÓŠO‚Æ‘œ‚¢_ŒoŽŸŠ³. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “à‰È 2014/5; 113 (5): 800-2.

H26-522016. [uÀ]y“ÁW2: ŽáŽèˆãŽt‚É‚æ‚é“ï•aŽx‰‡‚Ì‚ ‚è•ûzŽáŽèˆãŽt‚É‚æ‚é“ï•aŽx‰‡‚Ì‚ ‚è•û‚Ö‚Ì’²ž‚š‚æ‚Ñ’ñŒŸ. ŽOˆä—Ç”V, Œˆä–¢ŽÑ, –ìÈ’qŽk, Œ¹@^Šó, ‰¬–ì”üŒbŽq1, àV“crˆê, ‹·ŠÔŒhŒ› (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{“ï•aˆã—Ãlƒbƒgƒ[ƒNŠw‰ï‹@ŠÖŽ† 2015/3; 2 (2): 24-30.

H26-530002. [‚»‚Ì‘Œ (Proceeding)] THE AMERICAN AND JAPANESE TIV STUDY GROUP: AN UPDATE ON OPINIONS AND BEHAVIORS OF JAPANESE AND AMERICAN ALS CAREGIVERS REGARDING TRACHEOSTOMY WITH INVASIVE VENTILATION (TIV). Christodoulou G, Ogino M1, Goetz R, Mitsumoto H, Rabkin J: Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 105. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H26-530003. [‚»‚Ì‘Œ (Proceeding)] 5% SCOPOLAMINE OINTMENT IS CLASSICAL BUT STILL USEFUL FOR ALS AND OTHER NEUROLOGICAL DISEASES. Nagashima K, Ogino M1, Tominaga N2, Uchino A, Ogino Y2, Nishiyama K2: Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 108. (‰¬–ì”üŒbŽq1, •x‰i“Þ•Û”ü2, ‰¬–ì@—T2, ŒŽR˜a—˜2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H26-530004. [‚»‚Ì‘Œ (Proceeding)] MORPHINE USAGE IN ALS PATIENTS ON NPPV DOES NOT MAKE LIFE PROGNOSIS WORSE. Tominaga N1, Ogino M2, Kaneko J1, Nagashima K, Nagai M1, Uchino A, Urano Y, Ogino Y1, Nishiyama K1: Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 112. (•x‰i“Þ•Û”ü1, ‰¬–ì”üŒbŽq2, ‹àŽq~‘Ÿ˜Y1, ‰iˆä^‹MŽq1, ‰¬–ì@—T1, ŒŽR˜a—˜1: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H26-530005. [‚»‚Ì‘Œ (Proceeding)] RESPIRATORY-AIDED, LONG-TERM SURVIVAL CASES OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) WITH COMMUNICATION ABILITIES, MOTONEURON SYSTEM-CONFINED DEGENERATION, AND SCANTY TDP-43 AGGREGATION-A SUBGROUP OF ALS? Mochizuki Y, Hayashi K, Nakayama Y, Shimizu T, Kamide M, Ogino M1, Komori T, Isozaki E, Nakano I: Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 160. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H26-540004. [‚»‚Ì‘Œ (Œ€‹†‰ïŽ‘—¿)] •œ¬26”N“x_Œo“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï‰^‰c—pŽ‘—¿ (2014”N“x). ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x_Œo“ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï‰^‰c—pŽ‘—¿ 2014/10; p.1-234.

H26-540005. [‚»‚Ì‘Œ] ’nˆæ‚̍‚—‚ðŽx‚Š, I––Šú‚̐¶‚«•û‚ðl‚Š‚é. ‰¬–ì”üŒbŽq1,2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2uÅŒã‚Ü‚Å‚æ‚¢l¶‚ð‚ß‚Ž‚·‰ïE‘Š–ÍŒŽv‘ã•\): “Œ‹žl 2014: 334: 114.

H26-540006. [‚»‚Ì‘Œ (Œ€‹†‰ïŽ‘—¿•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àuEˆæ‚É‚š‚¯‚é’†“ráŠQŽÒ‚ÌŽÀ‘Ô’²ž‚Æ‚»‚ê‚ÉŠî‚­ŠÖŒWŽÒŠÔ‚Ì–]‚Ü‚µ‚¢˜AŒg‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†vzŠ³ŽÒ‚³‚ñ‚ÉŠñ‚è“Y‚€—Տ°ˆã‚ÆŠ³ŽÒ‰ï‚Ì—§ê‚©‚çŠw‚Ô‰Û‘è‚ÆŽY‹Æ•ÛŒ’E‚Ö‚ÌŠú‘ҁ|_Œo“à‰Èˆã‚Ì—§ê‚©‚çŽY‹Æ•ÛŒ’E‚ÉŠú‘Ò‚·‚é–ðŠ„|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬26”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àuEˆæ‚É‚š‚¯‚é’†“ráŠQŽÒ‚ÌŽÀ‘Ô’²ž‚Æ‚»‚ê‚ÉŠî‚­ŠÖŒWŽÒŠÔ‚Ì–]‚Ü‚µ‚¢˜AŒg‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†v‘æ1‰ñŽY‹ÆˆãEŽY‹ÆŠÅŒìE‚Ì—§ê‚©‚ç“ï•aŠ³ŽÒE’†“ráŠQŽÒ‚̏A˜JŒp‘±Žx‰‡‚ðl‚Š‚錀‹†‰ï•ñ‘ 2015/1.

H26-540007. [‚»‚Ì‘Œ (Œ€‹†‰ïŽ‘—¿•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹Æu“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†vz“ï•aŠÉ˜aƒPƒA‚Ì•‹y, Œ[”­, A˜JŽx‰‡‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆêl, A’|“ú“Þ, ¬“c—LŒá, “ï”g—æŽq, ŽO‰Y–õ•F, ‰¬–ì@—T2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹Æu“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2015/3; p.71-3.

H26-540008. [‚»‚Ì‘Œ (Œ€‹†‰ïŽ‘—¿•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vz‘œ”­«d‰»ÇEŽ‹_ŒoÒ‘‰Šf’fŠî€•À‚тɏdÇ“xŠî€‚̍쐬. ‹g—Ǐˆê, áÁèŸ‹v, ²“¡áÁ–ç, ‹g‘º@—å, ŽRè@—º, Œ‰º‘ñ–ç, V–쐳–Ÿ, Œˆä@^, ‰¬–ì”üŒbŽq1, Žà‘º–Ÿ¶, “c’†³”ü, ’†’Ò—SŽi, ŒàV³–L, –쑺‹±ˆê, ŒŽ@Žõ˜Y, “¡ŒŽˆê’j, ŽR‘º@—², ‘匎‹`˜N, ‚¹@¯, ŒSŽR’B˜Y, Ö“cF•F, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Ž…—DŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2015/3; p.17-20.

H26-540009. [‚»‚Ì‘Œ (Œ€‹†‰ïŽ‘—¿•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzdÇ‹Ø–³—͏Njy‚Ñ••“ü‘̋؉Š‚̏dÇ“x•ª—Þ‚Ì’ñˆÄ. ‹gìO–Ÿ, Ž…, , ‰¬–ì”üŒbŽq1, Š@—Ž™Z, Ž…—DŽq, —é–Ø‘¥G, Žà‘º–Ÿ¶, ‰€¶‰ëO, V–쐳–Ÿ, –쑺‹±ˆê, ŒŽ@Žõ˜Y, Œ”öG“¿, –{‘º­Ÿ, ìŒû’ŒŽ÷, ŒSŽR’B’j, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Œˆä@^, —é–؏d–Ÿ, Šâ²˜a•v, âˆäŒ’“ñ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2015/3; p.21-38.

H26-540010. [‚»‚Ì‘Œ (Œ€‹†‰ïŽ‘—¿•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vzƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ‚š‚æ‚Ñ—Þ‰ŽŸŠ³‚̐f’fŠî€, dÇ“x•ª—Þ. “í@@i, ‰¬–ì”üŒbŽq1, ŠC“cŒ«ˆê, Š@—Ž™Z, _“c@—², ŒKŒŽ@‘, ‰€¶‰ëO, ‘c•ƒ]Œ³, ç—tŒú˜Y, –쑺‹±ˆê, ’r“cCˆê, Ž…—DŽq, ŒŽ@Žõ˜Y, Œ”öG“¿, ‰¡“c—²“¿, –쑺–FŽq, •“¡‘œ’ØY, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Œˆä@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2015/3; p.39-44.

H26-540011. [‚»‚Ì‘Œ (Œ€‹†‰ïŽ‘—¿•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†vz‚»‚Ì‘Œ‚̐_Œo–ƉuŽŸŠ³. Žà‘º–Ÿ¶, Œˆä@^, ’r“cCˆê, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, _“c@—², ‹v•Û“c—Ž“ñ, Ž…—DŽq, —é–Ø‘¥G, ŒàV³–L, –쑺‹±ˆê, ŒŽ@Žõ˜Y, ‰¡“c—²“¿, “n粁@C, Œ¢’ˁ@‹M, ’†‘º—Ž•¶, –쑺–FŽq, ŽR–ì‰Ã‹v, •Ä“c@œ, ŒIŽR’·–å, ‹Ê˜‹ÅŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹ÆuƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ_Œo–ƉuŽŸŠ³‚Ì‘Šúf’fŠî€EdÇ“x•ª—ށEŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2015/3; p.53-6.

[’˜@‘]

H17-620001. [Šwp‘ (•ª’SŽ·•M)]yÝ‘îˆã—Ã¥‰îŒìŠî–{Žè‹Zƒ}ƒjƒ…ƒAƒ‹@‰ü’ù‘æ2”Łz_Œo“ï•a‚̍ݑîƒPƒA, p.592-606. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: •ì@Ž, ‰iˆä‘“X, “Œ‹ž, 2005/10”­s.

H21-620001. [Šwp‘ (•ª’SŽ·•M)]yÝ‘îˆã—ÃeƒLƒXƒg‘æ2”Łz‹ØˆÞk«‘€õd‰»Ç (ALS), p.108-11. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), Šé‰æE•ÒW: Ý‘îˆã—ÃeƒLƒXƒg•ÒWˆõ‰ï, Ý‘îˆã—Ï•¬ —E”ü‹L”Oà’c, “Œ‹ž, 2009/10”­s.

H22-620001. [Šwp‘ (•ª’SŽ·•M)]yAnnual Review _Œo2010z_Œo“ï•aŽŸŠ³‚̈ã—Ôï\‘¢‰ðÍ‚Ì–â‘è“_, p.65-70. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: —é–Ø‘¥G, ‘Œ, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/11”­s.

H23-620001. [Šwp‘ (•ª’SŽ·•M)]yÝ‘îˆã—Â̋Z‚Æ‚±‚±‚ë: ƒ`ƒƒƒŒƒ“ƒW!@”ñ‚ª‚ñŽŸŠ³‚̊ɘaƒPƒAzŽŸŠ³•Ê‚̊ɘaƒPƒA‚ÌŽÀÛ|_Œo“ï•a‚̊ɘaƒPƒA…@‹ØˆÞk«‘€õd‰»Ç (ALS)|, p.114-27. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), “ìŽR“°, “Œ‹ž, 2011/8”­s.

H23-620002. [Šwp‘ (•ª’SŽ·•M)]yƒCƒ“ƒ^[ƒvƒƒtƒFƒbƒVƒ‡ƒiƒ‹Eƒwƒ‹ƒXƒPƒA|ƒ`[ƒ€ˆã—Â̎ÀÛ‚Æ‹³ˆçƒvƒƒOƒ‰ƒ€zŽÀ‘H•Ò@ƒ`[ƒ€ˆã—ɉK‚Ì“WŠJ—á@_Œo“ï•a|_Œo“ï•a‚Æ‚»‚̑΍ô|, p.209-14. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), ˆãŽ•–òo”Å, “Œ‹ž, 2011/10”­s.

H23-620003. [Šwp‘ (•ª’SŽ·•M)]y_Œo“ï•aÝ‘î—×{ƒnƒ“ƒhƒuƒbƒN@‚æ‚è‚æ‚¢ŠÉ˜aƒPƒA’ñ‹Ÿ‚Ì‚œ‚߂Ɂz_Œo“ï•a‚É‚š‚¯‚é‹ê’ɏǏó‚Æ‚»‚̑Ήž,p.63-86. ‰¬–ì”üŒbŽq1, ‚‹Ž‹M”üŽq, “ï”g—æŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: ¬“c—LŒá, ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, ‘åã, 2011/10”­s.

H23-620004. [Šwp‘ (•ª’SŽ·•M)]y_ŒoŽŸŠ³ÅV‚ÌŽ¡—Ã2012-2014z_ŒoŽŸŠ³‚Ì•ŸŽƒE‰îŒìŽ{õ, p402-7. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), “ì]“°, “Œ‹ž, 2012/3”­s.

H24-610001. [Šwp‘ (•ª’SŽ·•M)]yHome Care Handbook for People with Intractable Neurological Disease: Aiming to distribute better palliative care in Japanz4. Pain in neurological intractable disease, p.43-59. Ogino M1, Takahashi K, Nammba R, Editors: Narita Y, Fukuro Shuppan, Okayama, 2012/11. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H24-620001. [Šwp‘ (•ª’SŽ·•M)]y’m‚Á‚Ä‚š‚«‚œ‚¢“à‰ÈÇŒóŒQ (“à‰È2012”N6ŒŽ‘‘卆)zI. _ŒoE‹Øs–Ɖu«EŠŽõ«_ŒoŽŸŠ³t@15. ƒtƒBƒbƒVƒƒ[ÇŒóŒQ, p.952-3. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), “ì]“°, “Œ‹ž, 2012/6”­s.

H25-620001. [Šwp‘ (•ª’SŽ·•M)]yÅVƒAƒvƒ[ƒ`ALSE‰^“®ƒjƒ…[ƒƒ“ŽŸŠ³@ƒAƒNƒ`ƒ…ƒAƒ‹”]E_ŒoŽŸŠ³‚̗Տ°zALS‚ɑ΂·‚éŠÉ˜aˆã—Ã, p.306-13. ‹{ì¹D, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: ’ҁ@ÈŽŸ, ’†ŽR‘“X, “Œ‹ž, 2013/6”­s.

H25-620002. [Šwp‘ (ŠÄC)]y¡“ú‚̗Տ°ƒTƒ|[ƒgz‹ØˆÞk«‘€õd‰»Ç. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), _Œo•ª–ìŠÄC, •Ò: ‚‹Ž—TG, ‰iˆä—ÇŽO, •ŸˆäŽŸ–î, –Ø‘ºŒ’“ñ˜Y, ã‘º’ŒŽÀ, ŒK“‡@ŠÞ, ¡ˆä@–õ, “ˆ“c@Œ³, ƒGƒ‹ƒ[ƒrƒAEƒWƒƒƒpƒ“, 2013 (ƒEƒFƒuƒTƒCƒg: http://clinicalsup.jp/jpoc/)

H25-620003. [Šwp‘ (•ª’SŽ·•M)]y¡“ú‚ÌŽ¡—ÃŽwj2014zÝ‘î_Œo“ï•aŠ³ŽÒ‚̃PƒA, p.1426-7. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), ŠÄC: ŽRŒû@“O, –kŒŽŒõ•v, •Ò: •ŸˆäŽŸ–î, ‚–؁@œ, ¬Žºˆê¬, ˆãŠw‘‰@, “Œ‹ž, 2014/1”­s.

H26-620022. [Šwp‘ (•ª’SŽ·•M)]yƒzƒXƒsƒXŠÉ˜aƒPƒA”’‘2014z‘æII•” Šw‰ïEŠwp’c‘̂̊ɘaƒPƒAƒw‚ÌŽæ‚è‘g‚݁@3. _Œo“ï•aE“ï•a, p.51-4. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •ÒW‹Š—Í: “ú–{ƒzƒXƒsƒXEŠÉ˜aƒPƒAŒ€‹†U‹»à’c, ÂŠCŽÐ, “Œ‹ž, 2014/4”­s.

H26-620023. [Šwp‘ (•ª’SŽ·•M)]yMBA—¬ƒP[ƒXƒƒ\ƒbƒh‚ÅŠw‚Ôˆã—ÃŒo‰c“ü–åzˆã—ÃŒo‰c‚©‚ç‚Ý‚œÝ‘îˆã—Â̂µ‚­‚Ý, p.138-40. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: a’J–Ÿ—² (ˆã—ÈÀ‘SEŠÇ—), “úŒoBPŽÐ, “Œ‹ž, 2014/5”­s.

H26-620024. [Šwp‘ (•ª’SŽ·•M)]yƒeƒLƒXƒg—Տ°Ž€¶Šwz‘æ9Í _Œo“ï•a (ALS) ‚ª•ø‚Š‚é‰Û‘è, p.109-21. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), •Ò: —Տ°Ž€¶ŠwƒeƒLƒXƒg•ÒWˆÏˆõ‰ï, ™€‘‘–[, “Œ‹ž, 2014/6”­s.

H26-620025. [Šwp‘ (•ª’SŽ·•M)]y_Œo“à‰ÈŠÅŒì‚Ì’mŽ¯‚ÆŽÀÛz5. ‹ØˆÞk«‘€õd‰»Ç, p.81-9. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), ŠÄC: Œ–{¹‘×, •Ò: ŠÛŽR”Ž•¶, •S“c•Ži, ƒƒfƒBƒJo”Å, ‘åã, 2015/1”­s.

H26-620026. [Šwp‘ (•ª’SŽ·•M)]y_Œo“à‰ÈŒ€Cƒm[ƒgz—«ˆãŽt‚Ö‚ÌŒ€CƒAƒhƒoƒCƒX, p.11-3. ˆã—Õی¯§“x‚ƉîŒì•ÛŒ¯§“x, p.648-53. gáŽÒ”F’èE“ï•a“™ˆã—Ô¬E‰îŒì‚Ì‚œ‚߂̏‘—ނ̏‘‚«•û, p.679-85. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã), ŠÄC: ‰iˆä—ÇŽO, •Ò: —é–Ø‘¥G‘Œ, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2015/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H17-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The issues on the induction of invasive mechanical ventilation in Japanese ALS patients. Ogino M1, Ogino Y2, Kobayashi N, Sakai F: 16th international symposium on ALS/MND (2005/12/8-10), Dublin, Ireland, ALS and motor neuron disorders 2005; 6 (Suppl 1): 157. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H17-713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Sleep disorders in PARK8 sagamihara family (I2020T). Ogino Y1, Ogino M2, Sakai F: 4th international Parkinson`s Disease Symposium in Takamatsu (2006/3/9-11), Takamatsu (‰¬–ì@—T1, ‰¬–ì”üŒbŽq2: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H17-722001. [Šw‰ï(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ALS‚É‚š‚¯‚é—Ï—“I¥ŽÐ‰ï“I–â‘è. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ23‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2005/6/9-10), ’¹‰H, _ŒoŽ¡—Êw 2005; 22 (3): 331.

H17-722002. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ALSf—Âɂš‚¯‚éNPPV‚Ì’·Š‚Æ–â‘è. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ1‰ñ_Œo“ï•a‚Ì”ñNPŒÄ‹zƒPƒAEƒ[ƒNƒVƒ‡ƒbƒv (2005/9/17), “Œ‹ž, Ž˜^W p.10-1.

H17-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) g‘̏áŠQŽÒ—ÃŒìŽ{Ý‚É‚š‚¯‚é‹ØˆÞk«‘€õd‰»Ç (ALS) Š³ŽÒŽó‚¯“ü‚ê‚Ì–â‘è“_. ŒÃ‘ò‰p–Ÿ, ‰¬–ì”üŒbŽq1, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€¥Ž˜^W 2005; 46: 135.

H17-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)u‹Ù‹}Žž‚̑Ώˆ•û–@ƒJ[ƒhv(Ž–‘OŽw’菑) “±“üŒã‚Ì•]‰¿. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ46‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€¥Ž˜^W 2005; 46: 135.

H17-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) _Œo“ï•a—‰ð‚É‚Þ‚¯‚ĈãŠw•”‹³ˆç‚É‚š‚¯‚éŽæ‚è‘g‚Ý. ¬ì‰Ê—Ñ, •Ÿ“c—Ï–ç, ‰¬–ì”üŒbŽq1, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€¥Ž˜^W 2005; 46: 209.

H17-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ALSŠ³ŽÒ‚É‚š‚¯‚éŽåŠÏ“IQOL—vˆö‚ÌŒŸ“¢. ¬—Ñ”ü“ÞŽq, ‰¬–ì”üŒbŽq1, Ö“¡–L˜a (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€¥Ž˜^W 2005; 46: 210.

H17-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) PARK8 (‘Š–ÍŒŽ’n‹æˆâ“`«ƒp[ƒLƒ“ƒ\ƒ“•a) ‚̗Տ°“I“Á’¥‚Æ’·ŠúŒo‰ß. ‰¬–ì@—T1, ‰¬–ì”üŒbŽq2, ŒÃ‘ò‰p–Ÿ, âˆä•¶•F (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€¥Ž˜^W 2005; 46: 293.

H17-723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆÓŽv“`’B‘•’u‘€ìƒXƒCƒbƒ`‚Ì‘I‘ðŠî€|Œ’íŽÒ‚É‚š‚¯‚éŠç“®ìƒXƒCƒbƒ`‚Ì‘€ì”äŠr|. ¡ŠÖˆŸ—R”ü, ’†Œ_Ži, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ39‰ñ“ú–{ì‹Æ—Ö@Šw‰ï (2005/6/23-26), ˆïé, “ú–{ì‹Æ—Ö@Šw‰ïŽ 2005; 39: 258.

H17-723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ALS‚É‚š‚¯‚éƒJƒtƒ}ƒV[ƒ“, ƒp[ƒJƒbƒVƒ‡ƒlƒA‚Ì—L—p«. –î–ì‹M‹vŽq, ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, ”уP’J”ü•ô2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ23‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2005/6/9-10), ’¹‰H, _ŒoŽ¡—Êw 2005; 22: 401.

H17-723008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) H“¹¬×–EŠà‚ɍ‡•¹‚µ, —ǍD‚ÈŒo‰ß‚ð‚Æ‚Á‚œparaneoplastic neuropathy‚̈ê—á. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, âˆä•¶•F, ‰º“c‘ñ–ç3, ¬ò˜aŽO˜Y3 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à, 3Á‰»Ší“à): ‘æ16‰ñ“ú–{––œ_ŒoŠw‰ïŠwpW‰ï (2005/7/22-23), ‹à‘ò, Ž˜^W p.47, ––œ_Œo 2005; 16: 130-3.

H17-723009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ALS‚É‚š‚¯‚éNIPPVÝ‘“ü. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ8‰ñ“ú–{Ý‘îˆãŠw‰ï‘å‰ï (2006/2/11-12), ç—t, Ž˜^W p.112, “ú–{Ý‘îˆãŠw‰ïŽGŽ 2006; 8 (1): 109.

H17-723010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹Ž–{•a‚ðŠî‘bŽŸŠ³‚É”­Ç‚µ‚œ•Ó‰Œn”]Ç‚̈ê—á. ˆäorŒõ, ‰¬–ì”üŒbŽq1, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ18‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï (2006/3/2-3), –ŒŒÃ‰®, _Œo–ƉuŠw 2006; 14 (1): 105.

H17-723011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹}‘¬‚ɐis‚·‚é‹ØˆÞkCš‹‰ºáŠQ‚𔺂¢ƒXƒeƒƒCƒh—Ö@‚ª’˜Œø‚µ‚œƒ|ƒŠƒjƒ…[ƒƒpƒ`[‚̈ê—á. ”у–’J”ü•ô2, ˆ¢‹v’Óñ•v2, ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ18‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï (2006/3/2-3), –ŒŒÃ‰®, _Œo–ƉuŠw 2006; 14 (1): 123.

H17-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) _Œo“ï•a‚̃Rƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“áŠQ‚ɑ΂·‚鉇•Žè’i. ‰¬–ì”üŒbŽq2, ’†Œ_Ži, ’†ŠÛ‹I‹v”ü, g—с@Šó, ¡ŠÖˆŸ—R”ü, ’|“àŠ°l (2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬17”N“x”ÇŒ€‹†‰ï‹c (2006/1/6-7), “Œ‹ž.

H17-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) —ÃŒìŽ{Ý‚É‚š‚¯‚éALSŽó‚¯“ü‚ê‚ÌŒ»ó|‘æ1•ñ‚±‚ê‚Ü‚Å‚ÌŒoˆÜ|. ‰¬–ì”üŒbŽq1, ŒÃàV‰p–Ÿ, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬17”N“x”ÇŒ€‹†‰ï‹c (2006/1/6-7), “Œ‹ž.

H17-732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ALS‚É‚š‚¯‚éSNIP‚Ì—L—p«‚ɂ‚¢‚ā|‘æ1•ñ|. ‰¬–ì”üŒbŽq1, ão’Œl, •œ‰ê‚悵‚Ý, —Rˆäi‘Ÿ˜Y, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬17”N“xŒ€‹†•ñ‰ï (2006/1/8-9), “Œ‹ž, Ž˜^W p7.

H17-732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ALSI––Šú‚É‚š‚¯‚éŠÉ˜aƒPƒA‚ɂ‚¢‚ā|“–‰@‚É‚š‚¯‚éƒIƒsƒIƒCƒh“™‚ÌŽg—pŒoŒ±|. ‰¬–ì”üŒbŽq1, ”у–’J”ü•ô2, —Rˆäi‘Ÿ˜Y, ‰¬–ì@—T2, âˆä•¶•F, “IêŒ³O, ‘同GŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬17”N“xŒ€‹†•ñ‰ï (2006/1/8-9), “Œ‹ž, Ž˜^W p46.

H17-732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ‚Ì’·Šú—\Œã. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, “ü]KŽq, ‹ààV’Œ”ü3, âˆä•¶•F, Ä“¡–L˜a (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à, 3•a‘ԁEf—ÃŒn): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†”ǁv•œ¬17”N“x”ljï‹c (2006/1/25-26), “Œ‹ž.

H17-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) g‘̏áŠQŽÒ—ÃŒìŽ{ÝALSê—p‹Žº‚ÌŠˆ—p„i‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬17”N“x•Ÿ‰ªŒ§dÇ_Œo“ï•aŠ³ŽÒ“ü‰@Ž{ÝŠm•ÛŽ–‹Æ•Ÿ‰ªƒuƒƒbƒNŒ€C‰ï (2006/2/3), •Ÿ‰ª.

H17-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘Sg‚ÌŠŽŠo’EŽž‚ð”F‚ß‚œ–TŽîᇐ«ŠŽŠo«ƒjƒ…[ƒƒpƒ`[‚̈ê—á. –î–ì‹M‹vŽq, ”у–’J”ü•ô1, —Rˆäi‘Ÿ˜Y, ‰¬–ì”üŒbŽq2, âˆä•¶•F (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ173‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2005/6/4), “Œ‹ž.

H17-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) g‘̏áŠQŽÒ—ÃŒìŽ{Ý‚É‚š‚¯‚é‹ØˆÞk«‘€õd‰»Ç (ALS) Š³ŽÒŽó‚¯“ü‚ê‚Ì–â‘è“_. ŒÃàV‰p–Ÿ, ‰¬–ì”üŒbŽq1, ŽR“c’JßŽq, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ2‰ñ“ú–{“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€‹†‰ï (2005/9/30), å‘ä.

H18-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Long-term prognosis of Guillain-Barre syndrome. Ogino M1, Ogino Y2, Irie S, Kanazawa N3, Saito T, Sakai F: 8th International Congress of Neuroimmunology (2006/10/15-19), Nagoya, J Neuroimmunology 2006; 178 (suppl 1): 222. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, ‹ààV’Œ”ü3: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à, 3•a‘ԁEf—ÃŒn)

H18-713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Usefulness of Sniff Nasal Inspiratory Pressure (SNIP) for Japanese Patients with ALS. Kamide N, Ogino M1, Ogino Y2, Fukuda M, Sumida S, Hiraga Y, Sakai F: 17ht ALS/MND international symposium (2006/11/30-12/2), Yokohama, ALS and motor neuron disorders 2006; 7 (Suppl 1): 83. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H18-713003. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The present status and problems eith upper extremity orthosis in patients with Amyotrophic Lateral Sclerosis. Imazaki A, Ogino M1, Ogino Y2, kamide N, Asai N, Sakai F: 17ht ALS/MND international symposium (2006/11/30-12/2), Yokohama, ALS and motor neuron disorders 2006; 7 (Suppl 1): 74-5. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H18-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ALSŠ³ŽÒ‚É‚š‚¯‚éŽåŠÏ“IQOL‚Ì”äŠr. ¬—Ñ”ü“ÞŽq, ‰¬–ì”üŒbŽq1, Ä“¡–L˜a (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ47‰ñ“ú–{_ŒoŠw‰ï (2006/5/11-13), “Œ‹ž, —Տ°_ŒoŠw 2006; 46 (12): 1024.

H18-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™‰È—̈æ‚É‚š‚¯‚éEasy asthma program (EAP) ‚Ì—L—p«‚ÌŒŸ“¢. •œ£–Ÿ•F1, “ñ‹{“¹l, ˜a“c³•¶, ŽR‰ª¬Í, ¬“ì@—², ‰¬–ì”üŒbŽq2, ‘ŠŒŽ_‹P, ¬—Ñ‚ß‚®‚Ý, _ŒËŽsŒ•”¬Ž™‰ÈƒOƒ‹[ƒv (1Œö•¶•a‰@, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ17‰ñ“ú–{¬Ž™‰Èˆã‰ïƒZƒ~ƒi[ (2006/6/10-11), •ºŒÉ, “ú–{¬Ž™‰Èˆã‰ï‰ï•ñ 2006/10; 32: 99-100.

H18-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ý‘îALSŠ³ŽÒ‚ɑ΂·‚éQOLŒüã‚Ì‚œ‚߂̃‚ƒ‹ƒqƒl‚ÌŽg—p. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, ”у–’J”ü•ô2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ9‰ñ“ú–{Ý‘îˆãŠw‰ï‘å‰ï (2007/3/17-18), ŽD–y.

H18-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”ñNP“IlHŒÄ‹z—Ö@‚É‚š‚¯‚é‹@Ží”äŠr. ‰¬–ì@—T1, ‰¬–ì”üŒbŽq2, ‰Z¶Lˆê, âˆä•¶•F (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ9‰ñ“ú–{Ý‘îˆãŠw‰ï‘å‰ï (2007/3/17-18), ŽD–y.

H18-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰)u_Œo“à‰Èf—Âɂš‚¯‚éŽÀ‘H“Iƒe[ƒ}vALSI––ŠúŠÉ˜aƒPƒA‚Æ‚µ‚Ä‚Ì–ƒ–òŽg—p. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ49‰ñ_Œo“à‰È§˜b‰ï (2006/8/5), “Œ‹ž.

H18-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ƒ^ƒNƒƒŠƒ€ƒX’P“ƗÖ@‚É‚š‚¯‚é’·ŠúŒo‰ß. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ5‰ñdÇ‹Ø–³—͏ǂƃvƒƒOƒ‰ƒtŒ€‹†‰ï (2006/11/18), “Œ‹ž.

H18-732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) NIPPV‚Ì‹@Ží”äŠr‚ƃCƒ“ƒ^[ƒtƒFƒCƒX. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“xŒ€‹†•ñ‰ï (2006/12/22-23), “Œ‹ž, Ž˜^W p.47.

H18-732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ALS/MND‚É‚š‚¯‚éRTX (‘ÌŠOŽ®lHŒÄ‹zŠí) ‚Ì—L—p«|‘æ1•ñ|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“xŒ€‹†•ñ‰ï (2006/12/22-23), “Œ‹ž, Ž˜^W p.56.

H18-732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ALS‚É‚š‚¯‚éSniff Nasal Inspiratory Pressure‚Ì—L—p«\‘æ2•ñ\. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“xŒ€‹†•ñ‰ï (2006/12/22-23), “Œ‹ž, Ž˜^W p.57.

H18-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) NPPVÅV‚Ì‹@Ží”äŠr. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, âˆä•¶•F, ‰Z¶Lˆê (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“xŒ€‹†•ñ‰ï (2007/1/8), “Œ‹ž.

H18-732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) _Œo“ï•a‚É‚š‚¯‚鎩—§Žx‰‡–@“±“üŒã‚ÌŒ»ó‚Ɖۑè‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, ãžŠáÁŽq, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬18”N“xŒ€‹†•ñ‰ï (2007/1/8), “Œ‹ž.

H18-732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) GBS‚É‚š‚¯‚éCD1ˆâ“`Žq‘œŒ^. ‰¬–ì”üŒbŽq1, ‹à‘ò’Œ”ü2, “ü]KŽq, ‰¬–ì@—T3, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2•a‘ԁEf—ÃŒn, 3_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†”ǁv•œ¬18”N“xŒ€‹†•ñ‰ï (2007/1/24-25), “Œ‹ž, Ž˜^W p.128-9.

H18-732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) –«Šú‚©‚çI––Šú‚ւ̈ã—ØAŒg|‚Ç‚Ì‚æ‚€‚ɐ¶‚«‚«‚é‚©|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)F‘æ2‰ñƒjƒ…[ƒƒwƒ‹ƒXƒPƒAƒtƒH[ƒ‰ƒ€ (2007/3/8), ‰¡•l.

H18-732010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ)u“ï•a—̈æ‚É‚š‚¯‚éˆã—ÁE•ŸŽƒ§“x•ÏX‚̉e‹¿’²ž@ƒ[ƒLƒ“ƒOƒOƒ‹[ƒvvDPC‚ɂ‚¢‚ā@DPC‚É‚š‚¯‚é_Œo“ï•a. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†”ǁvŒ€‹†•ñ‰ï (2007/3/10), “Œ‹ž.

H18-732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ)u“ï•a—̈æ‚É‚š‚¯‚éˆã—ÁE•ŸŽƒ§“x•ÏX‚̉e‹¿’²ž@ƒ[ƒLƒ“ƒOƒOƒ‹[ƒvváŠQŽÒŽ{Ý“™“ü‰@Šî–{—¿@Œ»ó‚ƍ¡Œã. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†”ǁvŒ€‹†•ñ‰ï (2007/3/10), “Œ‹ž.

H18-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) º‘Ñ–ƒáƒ‚ª‰”­Çó‚ƍl‚Š‚ç‚ê‚é‹…Ò‘«‹ØˆÞkÇ (SBMA) ‚Ì71Î’j«—á. ”у–’J”ü•ô1, ‰¬–ì”üŒbŽq2, ‰¬–ì@—T1, Ž‰ÆKŽq, âˆä•¶•F (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ179‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2006/11/25), “Œ‹ž, —Տ°_ŒoŠw 2007; 47 (7): 463.

H18-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ALSŠ³ŽÒ‚É‚š‚¯‚é“ú–{Œê”ÅALSAQ-40‚Ì—L—p«‚ÌŒŸ“¢. ¬—Ñ”ü“ÞŽq, ‹ÄŒŽŒc‘Ÿ, ‰¬–ì”üŒbŽq1, âV“¡–L˜a (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ15‰ñé‹ÊŒ§—Šw—Ö@Šw‰ï (2007/1/7), ‘å‹{.

H19-722001. [Šw‰ï(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ALSŠ³ŽÒ‚³‚ñ‚̊ɘa—Ö@`ƒIƒsƒIƒCƒhEƒ‚ƒ‹ƒqƒl‚ÌŽg—p‚𒆐S‚Ɂ`@‹ØˆÞk«‘€õd‰»Ç (ALS) Š³ŽÒ‚³‚ñ‚ÆŒü‚«‡‚€‚œ‚ß‚É. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ11‰ñVŠƒ_Œo“à‰ÈƒVƒ“ƒ|ƒWƒEƒ€ (2007), VŠƒ.

H19-731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹ØˆÞk«‘€õd‰»Ç (ALS) ‚ɂ‚¢‚ā|ŠÉ˜aƒPƒA‚𒆐S‚Ɂ|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ÂXŒ§_Œo“à‰ÈŠwpu‰‰‰ï (2007/7/26), ÂX.

H19-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰)u“ï•a‚ÌŠî‘b’mŽ¯v‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•aŠ³ŽÒ“™ƒz[ƒ€ƒwƒ‹ƒp[—{¬Œ€C (2007/10/22), ŠƒPè.

H19-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ‹ØˆÞk«‘€õd‰»Ç‚Ì•a‹C‚Ɨ×{¶Šˆ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬19”N“xALSŒð—¬‰ï (2007/11/5), •œ’Ë.

H19-732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALSf—Á@•a–Œ’m‚©‚çŠÉ˜aƒPƒA‚Ü‚Å. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŠâŽèŒ§—§•a‰@ˆãŠw‰ïu_Œo“à‰È•ª‰È‰ïv (2007/11/10), ŠâŽèŒ§.

H19-732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬19”N“x‘Š–ÍŒŽŽs‰îŒìŽx‰‡ê–åˆõŒ€C‰ï (2008/1/17), ‘Š–ÍŒŽ.

H19-732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•aŠ³ŽÒ‚̈ã—ʋ«E—×{ŠÂ‹«‚ÌŒ»ó‚Æ“W–]. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬19”N“x“ï•aŒ€C‰ï (2008/1/19), ‘啪.

H19-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ƒe[ƒ}uˆã—Ë@ŠÖ‚Æ‚ÌŠÖŒWC‰Æ‘°ŠÖŒWCž_“IƒTƒ|[ƒg‚È‚Ç‘œ–â‘è‚ð•ø‚Š‚œ‹ØˆÞk«‘€õd‰»Ç (ALS) Ž–—á‚ւ̑Ήžv •œ¬19”N“x‘å˜a•ÛŒ’•ŸŽƒŽ––±Š“ï•aŒ€C‰ï (Ž–—ጟ“¢‰ï) ‚É‚š‚¯‚鏕ŒŸ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬19”N“x‘å˜a•ÛŒ’•ŸŽƒŽ––±Š“ï•aŒ€C‰ï (2008/2/22), ‘å˜a.

H19-732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•a‚É‚š‚¯‚éÝ‘îƒ^[ƒ~ƒiƒ‹ (ƒIƒsƒIƒCƒh»Ü‚ÌŽg—p‚̉”\«). ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “s’}Ý‘îƒ^[ƒ~ƒiƒ‹Œ€‹†‰ï (2008/3/11), “s’}‹æ.

H19-732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ALS‚̍ݑî‚Ý‚Æ‚è‚Ö‚ÌŽæ‚è‘g‚Ý. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, ’r“cŠxŽi, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x”ljï‹c (2008/3), “Œ‹ž.

H19-732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) _Œo“ï•a‚É‚š‚¯‚éƒp[ƒJƒbƒVƒ‡ƒlƒA‚Ì—L—p«. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, ‰Z¶Lˆê, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x”ljï‹c (2008/3), “Œ‹ž.

H19-732010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) NPPV‚Ì‹@Ší‚ƃCƒ“ƒ^[ƒtƒFƒCƒX. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x”ljï‹c (2008/3), “Œ‹ž.

H19-732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ALS‚É‚š‚¯‚éSNIP‚Ì—L—p«|‘æ3•ñ|. ‹÷“cËŽq, ão’Œl, ‰¬–ì”üŒbŽq1, •Ÿ“c—Ï–ç, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x”ljï‹c (2008/3), “Œ‹ž.

H19-732012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ˆã—ψ’u‚̃Cƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚ðŽx‚Š‚銳ŽÒŽx‰‡ƒc[ƒ‹‚ÌŒŸ“¢. ‰¬–ì”üŒbŽq1, X‰i—F–í, ™‘ºKM, ‹gŒŽçŒb, ‘Oì‹±Žq, ŒŒŽN”ü, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x”ljï‹c (2008), “Œ‹ž.

H19-732013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) —ÃŒìŽ{Ý‚É‚š‚¯‚éÐŠQŒoŒ±. ‰¬–ì”üŒbŽq1, ŽR“c’JßŽq, ŒÃàV‰p–Ÿ, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x”ljï‹c (2008), “Œ‹ž.

H19-732014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) u‰‰‚ð’Ê‚µ‚œŽ©ŒÈŽÀŒ»|ˆãŠw•”u‰‰‚ðŒoŒ±‚µ‚ā|. ‰¬–ì”üŒbŽq1, ŽOˆä•qÆ, ŒÃàV‰p–Ÿ, Žç‰®—˜‰À2, ˆ¢•”@’Œ, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2ˆãŠw‹³ˆç): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬19”N“x”ljï‹c (2008), “Œ‹ž.

H19-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “ª•”MRIãC‘̘H‚ÉŒÀ‹Ç‚µ‚œˆÙí‚𔺂Á‚œ¬l”­ÇKrabbe•a‚Ì36Î—«—á. –k‘º‰p“ñ1, ‰¬–ì”üŒbŽq2, ‰¬–ì@—T1, ˆ¢‹v’Óñ•v1, âˆä•¶•F (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ181‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2007/6/2), “Œ‹ž, —Տ°_ŒoŠw 2008; 48 (6) 433.

H19-733003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) MRI‚ÅOpsoclonus‚̐ӔC•a‘ƒ‚ª„’肵‚Š‚œ‘œ”­«d‰»Ç‚̈ê—á. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, Ž‰ÆKŽq, –k‘º‰p“ñ2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ35‰ñ‰^“®áŠQŒ€‹†‰ï (2008/1/26), “Œ‹ž.

H20-722001. [Šw‰ï(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) _Œo“ï•a‚̌ċz—Ö@ƒNƒŠƒjƒJƒ‹ƒpƒX. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ30‰ñ“ú–{ŒÄ‹z—Ö@ˆãŠw‰ïŠwp‘‰ï (2008/7/4-5), Œ–{, Ž˜^W p.80.

H20-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Sniff nasal inspiratory pressure‚Ɖ¡Šu–Œ‹Ø—Í‚Æ‚ÌŠÖ˜A. ŽR‰È“TŽq, ¬o‚©‚‚ç, ²“¡ŽO“ÞŠó, ão’Œl, ‰¬–ì”üŒbŽq1, ‚•œ®L (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ43‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï (2008/5/15-17), •Ÿ‰ª, —Šw—Ö@Šw 2008/4; 35 (Suppl 2): 571.

H20-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»Ç (ALS) Š³ŽÒ‚É‚š‚¯‚ésniff nasal inspiratory pressure‚Æpeak cough flow‚Æ‚ÌŠÖ˜A. ŽRèŠx”V, ão’Œl, …–ìŒö•ã, ‹÷“cËŽq, •œ‰ê‚悵‚Ý, •Ÿ“c—Ï–ç, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ43‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï (2008/5/15-17), •Ÿ‰ª, —Šw—Ö@Šw 2008/4; 35 (Suppl 2): 813.

H20-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”ñNP“IlHŒÄ‹zŠí‚Ì‹@Ží”äŠr|—Տ°HŠwŽm‚̃Aƒ“ƒP[ƒg’²ž‚æ‚è|. ‰¬–ì@—T1, ‰¬–ì”üŒbŽq2, ‰Z¶Lˆê, âˆä•¶•F (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ26‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2008/6/26), ‰¡•l, _ŒoŽ¡—Êw 2008/5; 25 (3): 290.

H20-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’·ŠúlHŒÄ‹zŠí‘•’…Š³ŽÒ‚Ì’_ÎE’_ùN‰Š‚Ì”­Ç‚ɂ‚¢‚Ä. –k‘º‰p“ñ1, ‰¬–ì”üŒbŽq2, âˆä•¶•F (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ26‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2008/6/27), ‰¡•l, _ŒoŽ¡—Êw 2008/5; 25 (3): 291.

H20-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹}«Ž©—¥«ŠŽŠo«‰^“®«ƒjƒ…[ƒƒpƒ`[ (AASMN) ‚Ì’·Šú—\Œã. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ19‰ñ“ú–{––œ_ŒoŠw‰ïŠwpW‰ï (2008/9/5), –ŒŒÃ‰®, ––œ_Œo 2008/12; 19 (2): 331-4.

H20-723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚é‹ØˆÞk«‘€õd‰»ÇŠ³ŽÒ‚Ìš‹‰º‹@”\•]‰¿‚ÌŽÀ‘Ô. ˆÀ“cØ•ä, •Ÿ“c—Ï–ç, `@ŽáØ, á–{—R”ü, ³˜Ò@—², ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ14‰ñ“ú–{ÛHEš‹‰ºƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ï (2008/9/13-14), ç—t, “ú–{ÛHEš‹‰ºƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽGŽ 2008/12; 12 (3): 445.

H20-723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —zE‰Aˆ³‘ÌŠOŽ®lHŒÄ‹zŠí (RTX) ‚̍ݑîlHŒÄ‹z—Ö@Žw“±‚ÌŽŽ‚݁@ALSŠ³ŽÒ‚̉îŒìŽÒ‚Ö‚ÌŽw“±‚ÌŽÀÛ. ìã@—B, ‘Oì‹±Žq, ‰Z¶Lˆê, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ18‰ñ“ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2008/10/24-25), ˆ€•Q, “ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ 2008/10; 18 (Suppl): 115s.

H20-723008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»Ç (ALS) Ý‘îŠÅŽæ‚è‚ÌŽÀ‘H‚Æ–â‘è“_. ‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, à_“cˆê2, âˆä•¶•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ11‰ñ“ú–{Ý‘îˆãŠw‰ï‘å‰ï (2009/3/1), Ž­Ž™“‡, Ž˜^W p.148.

H20-723009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) FisherÇŒóŒQ‚É‚š‚¯‚éRGQ1bR‘Ì‚Ì’·ŠúŒo‰ß. “ü]KŽq, ‰¬–ì”üŒbŽq1, ‹ààV’Œ”ü2, à_“cˆê3, âˆä•¶•F, ‰¬–ì@—T3 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2•a‘ԁEf—ÃŒn, 3_Œo“à): ‘æ21‰ñ“ú–{_Œo–ƉuŠw‰ïŠwpW‰ï (2009/3/12-13), ‘åã, _Œo–ƉuŠw(Neuroimmunol) 2009/3; 17 (1): 98.

H20-731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ALS‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬20”N“x’·èŒ§“ï•aŽx‰‡ƒlƒbƒgƒ[ƒNˆÏˆõ‰ï (2009/3/19), ’·è.

H20-731002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹ØˆÞk«‘€õd‰»Ç (ALS) ‚ÌŽ¡—ÂƃPƒA‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): –L“c_ŒoŽŸŠ³ƒtƒH[ƒ‰ƒ€ (2009/3/30), ˆ€’m.

H20-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šî’²u‰‰) ƒe[ƒ}u“ï•a`‚»‚̐l‚炵‚³‚ðŽx‚Š‚év“ï•aALS‚Æ‚Í. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): 12Žü”N‹L”OŽ–—á”­•\‰ï (2008/6/21), “s’}‹æ.

H20-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰)u“ï•a‚ÌŠî‘b’mŽ¯v‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬20”N“x“ï•aŠ³ŽÒ“™ƒz[ƒ€ƒwƒ‹ƒp[—{¬Œ€C (2008/7/7), “¡‘ò.

H20-732003. [Šw‰ï(’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) Œ»ó‚̈ã—ÕŸŽƒ‘̐§‚̉îŒìE•ŸŽƒŽ{Ý‚̐_Œo‹Ø“ï•aŠ³ŽÒ‚Ö‚ÌŠˆ—p‚̉ۑè. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ5‰ñ“ú–{“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€‹†‰ï (2008/8/28), “Œ‹ž.

H20-732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šî’²u‰‰) ’nˆæƒPƒA‚É‚š‚¯‚é’†Šj•a‰@‚Ì–ðŠ„‚Æ‰Û‘è. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ6‰ñŽO“‡E–k‰Í“à’nˆæ_Œo“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€C‰ï (2008/9/6), ‘åã.

H20-732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚ÌŽå—v‚ȏnjó‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ23‰ñ–k—¢‘åŠw“Œ•a‰@_Œo“ï•aŒ€C‰ï (2008/9/19), ‘Š–ÍŒŽ.

H20-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰)u‘œ”­«d‰»Çv‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬20”N“xˆã—ÑŠ’kŽ–‹Æ (2008/9/25), ‘Š–ÍŒŽ.

H20-732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ‹ØˆÞk«‘€õd‰»Ç‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‹ØˆÞk«‘€õd‰»Çu‰‰‰ï (2008/11/10), ‰¡{‰ê.

H20-732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ƒe[ƒ}u‹ØˆÞk«‘€õd‰»Ç‚Ì—‰ð‚ƃPƒAvê–åˆã‚©‚ç. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ALSŽx‰‡]Ž–ŽÒŒ€C‰ï (2009/1/31), ‰¡•l.

H20-732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚̊ɘaƒPƒA‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Ý‘î“ï•aŠ³ŽÒ•ÛŒ’•ŸŽƒ]Ž–ŽÒŒ€C‰ï (2009/2/10), `–ì.

H20-732010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ‘œ”­«d‰»Ç‚ÌŽ¡—Âɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ2‰ñƒRƒƒfƒBƒJƒ‹MSƒnƒ“ƒYƒIƒ“ƒZƒ~ƒi[ (2009/2/12), ‘Š–Í‘å–ì.

H20-732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚̐isŠú‚©‚çI––Šú‚̃PƒA`“ï•a‚ÌŠ³ŽÒ‚³‚ñ‚Æ‚Ç‚€Œü‚«‡‚€‚©`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _Œo“à‰È—Տ°‰Û‘è‰ðŒˆƒVƒŠ[ƒY (‘æ2’e) (2009/3/25), ˆ€’m.

H20-732012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) “«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x”ljï‹c (2009), “Œ‹ž.

H20-732013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) Ý‘ƒ‹ƒqƒlŽg—p‚Ì–â‘è“_. ‰¬–ì”üŒbŽq1, âˆä•¶•F, •Î”NO (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x”ljï‹c (2009), “Œ‹ž.

H20-732014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) –k—¢ê–åŠÅŒìŽtu“ï•aŠÅŒìvˆç¬ƒvƒƒOƒ‰ƒ€‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, âˆä•¶•F, ‘Oì‹±Žq, ‹gŒŽçŒb, ‘å’J—æŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x”ljï‹c (2009), “Œ‹ž.

H20-732015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) _“ސì_Œo“ï•aƒlƒbƒgƒ[ƒNŽn“®‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, âˆä•¶•F, ‹gˆä•¶‹Ï, •Šâ‹`”V (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x”ljï‹c (2009), “Œ‹ž.

H20-732016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ƒI[ƒfƒBƒbƒg’²ž‚É‚æ‚éALSˆã—Â̍‘Û”äŠrŒ€‹†. ’†“‡@F, ˆÉ“¡”Ž–Ÿ1, Oliver David, “ï”g—æŽq, ‰¬–ì”üŒbŽq2, “¡ˆä’ŒŽ÷, M‘Œ\Œá, –xì@—g, ŒF–{rG, ”üŒŽ@”Õ, ìˆä@[, ‹{•‘Žq, •Ÿ‰iGr, ‰€“cŽŠl, Campbell Colin, Sloan Richard, Sykes Nigel, Tallon Carole, Webb Sandi, Albert Steven (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚ÌŽ©—§Žx‰‡‘̐§‚ÌŠm—§‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x”ljï‹c (2009), “Œ‹ž.

H20-732017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ƒMƒ‰ƒ“¥ƒoƒŒ[ÇŒóŒQ RƒKƒ“ƒOƒŠƒIƒVƒhR‘Ì—z«‹}«‰ŠÇ«ƒjƒ…[ƒƒpƒ`[‚É‚š‚¯‚éR‘Ì‚Ì’·ŠúŒo‰ß. ‰¬–ì”üŒbŽq1, “ü]KŽq, ‹ààV’Œ”ü2, à_“cˆê3, âˆä•¶•F, ‰¬–ì@—T3 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2•a‘ԁEf—ÃŒn, 3_Œo“à): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†”ǁv•œ¬20”N“x”ljï‹c (2009), “Œ‹ž.

H21-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The survey report of the ALS physicians in Japan. Ogino M1, Ogino Y2, Hamada J2: 20th International symposium on ALS/MND (2009/12/8-10), Berlin, Germany, ALS 2009; 10 (suppl 1): 48. (‰¬–ì”üŒbŽq1, ‰¬–ì@—T2, à_“cˆê2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H21-713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) A Therapeutic agent(NDDPX08) Delays disease progression, improves motor function and prolongs survival in a mouse model of ALS. Tanaka K, Kanno T, Yanagisawa Y, Aoki M, Hadano S, Itoyama Y, Ogino M1, Iwasaki Y, Yoshii F, Ikeda J-E: 20th International symposium on ALS/MND (2009/12/8-10), Berlin, Germany, ALS 2009; 10 (suppl 1): 75. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H21-713003. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The study of NIPPV using full-face mask remodeled to support endoscope in per-endoscopic gastrostomy in ALS patients. Ogino Y1, Yabuki S, Ogino M2: 20th International symposium on ALS/MND (2009/12/8-10), Berlin, Germany, ALS 2009; 10 (suppl 1): 188. (‰¬–ì@—T1, ‰¬–ì”üŒbŽq2: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H21-713004. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Dilemma and integrity of medical professionals. Ogino M1: 20th International symposium on ALS/MND (2009/12/8-10), Berlin, Germany. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H21-722001. [Šw‰ï(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) _Œo“ï•a (“Á‚ÉALS) ‚̊ɘaƒPƒA‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ12‰ñ“ú–{Ý‘îˆãŠw‰ï‘å‰ï (2010/2/27-28), “Œ‹ž, “ú–{Ý‘îˆãŠw‰ïŽGŽ 2010; 12: 56-7.

H21-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ý‘ŽÒ‚Ì–K–⃊ƒnƒrƒŠ‚ւ̃j[ƒY‚ÉŠÖ‚·‚é’²ž|_Œo¥‹ØŽŸŠ³Š³ŽÒ‚ð‘ΏۂƂµ‚œ’²ž•ñ|. ão’Œl, •Ÿ“c—Ï–ç, ²“¡Žu–ì, –ìŠÔ‹M—Y, •Ÿ“c—Ï–ç, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ44‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï (2009/5/28-29), “Œ‹ž, —Šw—Ö@Šw 2009; 36 (‘å‰ï“Á•Ê†2 (DVD-ROM)): ROMBUNNO.P2-195.

H21-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»ÇŠ³ŽÒ‚É‚š‚¯‚éSniff Nasal Inspiratory Pressure‚ð—p‚¢‚œ‹z‹C‹Ø‹Ø—Í•]‰¿‚Ì—L—p«@ŽÀ‘ª’l‚Æ—\‘ª’l‚Æ‚Ì”äŠr. …–ìŒö•ã, ão’Œl, •œ‰ê‚悵‚Ý, t“ú”ü•Û, “¡‹Ž‹Is, ‘厛ˆŸ—R”ü, ‰¬–ì”üŒbŽq1, •Ÿ“c—Ï–ç (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ44‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï (2009/5/28-29), “Œ‹ž, —Šw—Ö@Šw 2010/3; 37 (Suppl 2): 752.

H21-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ALSŠ³ŽÒ‚Ì‚Öƒ‹ƒƒbƒgŒ^ƒ}ƒXƒNŽg—p‚ÌŽŽ‚݁|”畆áŠQ‰ü‘P‚ÉŒü‚¯‚ă}ƒXƒNŽg—pŒoŒ±•ñ|. ìã@—B, ‘Oì‹±Žq, ‰Z¶Lˆê, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ31‰ñ“ú–{ŒÄ‹z—Ö@ˆãŠw‰ïŠwp‘‰ï2009 (2009/7/10), ŽRŒ`, “ú–{ŒÄ‹z—Ö@ˆãŠw‰ïŠwp‘‰ïƒvƒƒOƒ‰ƒ€¥Ž˜^W 2009; 31st: 150.

H21-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) _Œo“ï•a‚ð‘èÞ‚Æ‚µ‚čs‚Á‚œ—Տ°—Ï—‹³ˆç‚Ì•]‰¿‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, ¬ì‰Ê—Ñ, à_“cˆê2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ41‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï (2009/7/24-25), ‘åã, ˆãŠw‹³ˆç 2009/7; 40 (Suppl): 68.

H21-731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ALS‚̕“IƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ13‰ñé‹ÊŒ§_Œo“à‰Èˆã‰ï‘‰ï (2009/7/16), ‘å‹{.

H21-731002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹ØˆÞk«‘€õd‰»Ç|Å‹ß‚̘b‘è‚Æ’mŒ©|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬21”N“x­ôˆã—Ãlƒbƒgƒ[ƒNu_ŒoE‹ØŽŸŠ³vŒ€C‰ï (2009/10/31), ŽD–y.

H21-731003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) NP“IlHŒÄ‹zŠí‚ð‘I‘ð‚µ‚È‚¢ê‡‚ÌALSŠ³ŽÒ‚³‚ñ‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ2‰ñ_ŒoŽŸŠ³ƒPƒAƒVƒ“ƒ|ƒWƒEƒ€|“ú–{ALS‹Š‰ï’·–쌧Žx•”‚̍Č‹¬‚ð‹L”O‚µ‚ā| (2010/2/13), Œ–{.

H21-731004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ALS‚̕“IƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ5‰ñì‰z_Œo“à‰È§˜b‰ï (2010/3/10), é‹Ê.

H21-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•a‚ÌŠî‘b’mŽ¯. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•aŠ³ŽÒ“™ƒz[ƒ€ƒwƒ‹ƒp[—{¬Œ€C‰ï (2009/6/30), “¡‘ò.

H21-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ’ߊª‰·ò•a‰@‰@“à•×‹­‰ï (2009/7/7), _“ސì.

H21-732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚̍ݑîˆã—Ã. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú¶‹ŠÝ‘îˆã—ÃtƒFƒ[ƒVƒbƒv“Œ‹žŒöŠJu‰‰‰ï (2009/9/19), “Œ‹ž.

H21-732004. [Šw‰ï(’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) MI-E‚̈ã—Õی¯®”õó‹µ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ5‰ñ_Œo“ï•a‚Ì”ñNPŒÄ‹zƒPƒAEƒ[ƒNƒVƒ‡ƒbƒv (2009/10/3), “Œ‹ž, Ž˜^W p.11-5.

H21-732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆË—Š‰‰‘è) ALS‚É‚š‚¯‚éNPPV. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ23‰ñ”ñNP“IŠ·‹C—Ö@Œ€‹†‰ï (2009/11/4), _ŒË.

H21-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) Ý‘îlHŒÄ‹z—Ö@‚ƃŒƒXƒpƒCƒg“ü‰@. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ342‰ñŒ»’nŒ€C‰ïuÝ‘îdÇ“ï•aŠ³ŽÒ‚Ö‚Ì’nˆæƒPƒAv (2009/12/20), ²‰ê.

H21-732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚Ì—‰ð‚ƑΉž. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬21”N“x“ï•aŽx‰‡’S“–ŽÒŒ€C (2010/3/29), ‘Š–ÍŒŽ.

H21-732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ƒMƒ‰ƒ“¥ƒoƒŒ[ÇŒóŒQ ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒXŠŽõ‚ÆGBS. ‰¬–ì”üŒbŽq1, “ü]KŽq, ‹ààV’Œ”ü2, –]ŒŽGŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2•a‘ԁEf—ÃŒn): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†”ǁv•œ¬21”N“x”ljï‹c (2010), “Œ‹ž.

H21-732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ƒp[ƒJƒbƒVƒ‡ƒlƒA“±“ü‚̃AƒZƒXƒƒ“ƒg. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, Šâè‹€, ‰Z¶Lˆê (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x”ljï‹c (2010), “Œ‹ž.

H21-732010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ƒXƒRƒ|ƒ‰ƒ~ƒ““îp‚Ì—L—p«‚ÌŒ€‹†. ‰¬–ì”üŒbŽq1, ‹{ì¹D, –]ŒŽGŽ÷, ‘O“cŽÀ‰Ô2, •ì­ˆê (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2–òÜ•”): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x”ljï‹c (2010), “Œ‹ž.

H21-732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) “«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“«ŽŸŠ³‚̈ã—Ôï\‘¢‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x”ljï‹c (2010), “Œ‹ž.

H21-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“ƒjƒYƒ€‚ð’悵CGFAPˆâ“`Žq•ÏˆÙ‚ð”F‚ß‚œ¬lŒ^Alexander•a‚Ì58Î’j«—á. –k‘º‰p“ñ1, ‰¬–ì”üŒbŽq2, ‹ààV’Œ”ü3, âˆä•¶•F, ’Җ쐞ˆê (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3•a‘ԁEf—ÃŒn)F‘æ190‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2009/9/16), “Œ‹ž, —Տ°_ŒoŠw 2009/9; 49 (9): 609.

H21-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’·Šú‚É‚í‚œ‚èÒ‘•a•Ï‚ÌŽî‘å‚ð”F‚ß‚œ‘œ”­«d‰»Ç‚Ì56Î—«—á ‹{ì¹D, ‰¬–ì”üŒbŽq1, ‰Y–ì‹`Í, ˆ¢‹v’Óñ•v2, –]ŒŽGŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ192‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2010/3/6), “Œ‹ž, —Տ°_ŒoŠw 2011/1; 51 (1)F70.

H22-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) ALS patients on mechanical ventilation have greater risk of cholecystitis. Ogino M1, Kitamura E2, Ogino Y2, Mochizuki H: 21st International Symposium on ALS/MND (2010/12/11) , Orlando, Florida, USA, ALS 2010; 11 (suppl 1): 155-6. (‰¬–ì”üŒbŽq1, –k‘º‰p“ñ2, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H22-713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Possession of assistive devices among persons with amyotrophic lateral sclerosis. Otera A, Takahashi K, Ogino M1, Fukuda M: 21st International Symposium on ALS/MND (2010/12/12), Orlando, Florida, USA, ALS 2010; 11 (suppl 1): 133. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H22-722001. [Šw‰ï(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‚Ë‚ç‚¢. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/20-22), “Œ‹ž, —Տ°_Œo 2010; 50: 1025.

H22-722002. [Šw‰ï(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ALSI––ŠúƒPƒA‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²žŒ‹‰Ê. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/20-22), “Œ‹ž, —Տ°_Œo 2010; 50: 1026-8.

H22-722003. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) _Œo“ï•a‚Ɗɘaˆã—Ã¥I––Šúˆã—Ã. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ28‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2010/7/15-16), ‰¡•l, _ŒoŽ¡—Êw 2010/5; 27 (3): 334.

H22-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) SNIP‚ðŽg—p‚µ‚œALSŒÄ‹z‹@”\•]‰¿‚ɂ‚¢‚Ä. ‰¬–ì@—T1, ‰¬–ì”üŒbŽq2, ão’Œl, –]ŒŽGŽ÷, ão’Œl, •œ‰ê‚悵‚Ý, •Ÿ“c—Ï–ç (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/20), “Œ‹ž, —Տ°_Œo2010; 50: 1125.

H22-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Advance Directives (Ž–‘OŽwŽŠ) ‚ÌŒŽ‘¥‚ð‚ß‚®‚Á‚ā|‹ØˆÞk«‘€õd‰»Ç‚𒆐S‚Ɂ|. ˆÉ“¡”Ž–Ÿ1, ’†“‡@F, ”ˆäFˆë˜Y, ˆÉ“¡“¹Æ, “ï”g—æŽq, ‰¬–ì”üŒbŽq2, ‘å‹÷‰xŽq, ¡ˆä®Žu (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/21), “Œ‹ž, —Տ°_Œo 2010; 50: 1200.

H22-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) _Œo‹ØŽŸŠ³‚É‚š‚¯‚éƒXƒRƒ|ƒ‰ƒ~ƒ““îp‚Ì—L—p«. ‹{ì¹D, ‰¬–ì”üŒbŽq1, ‰Y–ì‹`Í, –]ŒŽGŽ÷, •ŽR­ˆê2, ‘O“cŽÀ‰Ô3 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2“Œ•a‰@–òÜ•”, 3–òÜ•”): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/22), “Œ‹ž, —Տ°_Œo 2010; 50: 1262.

H22-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ALSŠÉ˜aƒPƒA‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²žŒ‹‰Ê‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, ‰¬–ì@—T2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/22), “Œ‹ž, —Տ°_Œo 2010; 50; 1266.

H22-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»ÇŠ³ŽÒ‚É‚š‚¯‚é•ŸŽƒ—p‹ï“±“ü‚ÌŽÀ‘Ô’²ž|ì‹Æ—Ö@Žm‚ª‘I’肵‚œ•ŸŽƒ—p‹ï‚ɏœ_‚𓖂Ăā|. ‘厛ˆŸ—R”ü, •Ÿ“c—Ï–ç, ŠJàV–¢Šó, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ44‰ñ“ú–{ì‹Æ—Ö@Šw‰ï‘‰ï (2010/6/11-13), å‘ä, Ž˜^W (CD-ROM) 2010; 44th: ROMBUNNO.O334.

H22-723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»ÇŠ³ŽÒ‚É‚š‚¯‚é‹z‹C‹Ø”æ˜J‚Ì•]‰¿•û–@‚ÌŒŸ“¢|maximum relaxation rate‚É‚æ‚é•]‰¿|. ão’Œl, •Ÿ“c—Ï–ç, …–ìŒö•ã, ŽRèŠx”V, ‹{é‚µ‚Ù, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ44‰ñ“ú–{ì‹Æ—Ö@Šw‰ï‘‰ï (2010/6/11-13), å‘ä, —Šw—Ö@ 2010; 37 (‘å‰ï“Á•Ê†2 (DVD-ROM)): ROMBUNNO.SE2-011.

H22-723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»Ç (ALS) ‚̊ɘaƒPƒA‚Ì–â‘è“_. ‰¬–ì”üŒbŽq1, ‹{ì¹D, ‰Y–ì‹`Í, –k‘º‰p“ñ2, –]ŒŽGŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ15‰ñ“ú–{ŠÉ˜aˆã—Êw‰ïŠwp‘å‰ï (2010/6/19), “Œ‹ž, Ž˜^W 2010/6; 319.

H22-723008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»Ç (ALS) ‚É‚š‚¯‚éŒo”çŒoH“¹ˆÝŠÇ‘}“üp (P-TEG) ‚ÌŒoŒ±. ‰¡“c˜aŽq, ‰¬–ì”üŒbŽq1, ‹{ì¹D, ‰Y–ì‹`Í, –k‘º‰p“ñ2, –]ŒŽGŽ÷, ‰¬–ì@—T2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): ‘æ28‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2010/7/16), ‰¡•l, _ŒoŽ¡—Êw 2010/5; 27 (3): 421.

H22-723009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šù‘¶Ž¡—ÖòNDDPX08‚Ì”­ÇŒã“Š—^‚ÍALSƒ}ƒEƒXƒ‚ƒfƒ‹‚̉^“®‹@”\‚ð‰ü‘P‚µC”­ÇŒã‚̐¶‘¶ŠúŠÔ‚ð‰„’·‚·‚é (The therapeutic agent NDDPX08 promotes sustainable motor performance and extends a post-onset survival interval in an ALS mouse model). “c’†ˆê‘¥, ›–ì‘ñ–ç, –ö‘ò‰ÀŽq, Â–ؐ³Žu, `–ìL“ñ, Ž…ŽR‘אl, ‰¬–ì”üŒbŽq1, Šâè‘×—Y, ‹gˆä•¶‹Ï, ’r“cât‰q (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Neuro2010 (‘æ33‰ñ“ú–{_Œo‰ÈŠw‘å‰ïE‘æ53‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ïE‘æ20‰ñ“ú–{_Œo‰ñ˜HŠw‰ï‘å‰ï‡“¯‘å‰ï) (2010/9/2-4), _ŒË, _Œo‰»Šw 2010/8; 49 (2-3): 671.

H22-723010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ALSÝ‘îŠÅŽæ‚è‚ÌŒ»ó|Ý‘îƒXƒ^ƒbƒt‚Ì‚š‚à‚¢|. ‰¬–ì”üŒbŽq1, ‰““¡@Šî, ‹{ì¹D, Ôì’Œ”V, –]ŒŽGŽ÷, ’†ìŒb“sŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ13‰ñ“ú–{Ý‘îˆãŠw‰ï‘å‰ï (2011/3/12), ‘åã, Ž˜^W p.81. (Ž†ã”­•\)

H22-723011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘åŠw•a‰@ƒŠƒjƒ…[ƒAƒ‹Œv‰æ‚É‚š‚¯‚éÝ‘îŽx‰‡•a“\‘z|‚±‚ç‚©‚ç‚Ì‘åŠw•a‰@‚É‚š‚¯‚éÝ‘î˜AŒg‚݂̍è•û|. ‰¬–ì”üŒbŽq1, ‹e’rŽj˜Y2, a’J–Ÿ—²3 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 24•a‰@˜AŒg‹³ˆç, 3ˆã—ÈÀ‘SEŠÇ—): ‘æ13‰ñ“ú–{Ý‘îˆãŠw‰ï‘å‰ï (2011/3/12), ‘åã, Ž˜^W p.138. (Ž†ã”­•\)

H22-731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ALS‚Ì—Ï—“I–â‘è‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ7‰ñNEUROLOGY CONFERENCE IN HYOGO (2010/4/24), _ŒË.

H22-731002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _Œo“ï•a‚̍ݑîˆã—Âƈã—ØAŒg. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘Š–ÍŒŽÝ‘îˆã—ÃŒ€‹†‰ï (2010/4/27), ‘Š–Í‘å–ì.

H22-731003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) _Œo“ï•a‚̍Ž•ž‚ÆŽ©‘îŽx‰‡`¡‚Å‚«‚邱‚Æ‚©‚ç`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{_ŒoŠw‰ïŽåÃŒöŠJŽs–¯uÀ`_Œo“ï•a‚̍Ž•ž‚ƍݑîŽx‰‡‚ÉŒü‚¯‚ā` (2010/8/7), ‰ªŽR.

H22-731004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ALSisŠú‚̈ã—ØAŒg‚ƃPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ22‰ñ–k˜a_Œo“à‰ÈŒ€‹†‰ï (2011/2/10), “Þ—Ç.

H22-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) dÇ‹Ø–³—͏ǂɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘S‘dÇ‹Ø–³—͏ǗF‚̉ï_“ސìŽx•” (2010/5/29), ‰¡•l.

H22-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚É‚š‚¯‚éu‰‰‰ï‚ƈӌ©ŒðŠ·. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _Œo“ï•aŒ€‹†‰ï (2010/6/5), ’¹Žæ.

H22-732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚ÌŽ¡—ÂƃPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ9‰ñ“ú–{ALS‹Š‰ïé‹ÊŒ§Žx•”‘‰ï (2010/6/19), é‹Ê.

H22-732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•a‚ÌŠî‘b’mŽ¯. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•aŠ³ŽÒ“™ƒz[ƒ€ƒwƒ‹ƒp[—{¬Œ€C (2010/6/25), “¡‘ò.

H22-732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹L”Ou‰‰) _Œo“ï•aÝ‘ŽÒ‚ÌŽ¡—ÂƃPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): é‹ÊŒ§“ï•a‘Š’kEŽx‰‡ƒZƒ“ƒ^[1Žü”N‹L”Ou‰‰‰ï (2010/7/27), é‹Ê.

H22-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ˆã—ØAŒg‚ÆŠÅŽæ‚è‚Ì–â‘è. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ1‰ñALSƒtƒH[ƒ‰ƒ€`ALSÅ‘Oü` (2010/8/28), “Œ‹ž.

H22-732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚̊ɘaƒPƒA`I––Šú‚𒆐S‚Ɂ`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ5‰ñ_Œo“ï•aƒtƒH[ƒ‰ƒ€ (2010/9/8), ‹ž“s.

H22-732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚Ì—‰ð`‹ØˆÞk«‘€õd‰»ÇCƒp[ƒLƒ“ƒ\ƒ“•a‚𒆐S‚Ɂ`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬22”N“x“ï•aŒ€C‰ï (2010/9/2), ‘å˜a.

H22-732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) NPPV“±“ü‚Ì‚±‚Â. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ7‰ñ“ú–{“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€‹†‰ï (2010/10/1), ‰¡•l.

H22-732010. [Šw‰ï(’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŠÖ“ŒƒuƒƒbƒN. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ7‰ñ“ú–{“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€‹†‰ï (2010/10/1-2), ‰¡•l.

H22-732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•a‚Æ‚ª‚ñ‚̃^[ƒ~ƒiƒ‹‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬22”N“x“ï•aê–匀C‰ï (2010/10/3), ˆ€•Q.

H22-732012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚ÌŽå—v‚ȏnjó‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ25‰ñ–k—¢“Œ•a‰@_Œo“ï•aŒ€C‰ï (2010/10/25), ‘Š–ÍŒŽ.

H22-732013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰)u_Œo“à‰Èê–åˆã‚©‚ç‚Ý‚é, Ý‘î‚Ƃ̘AŒg‚ɂ‚¢‚āv`ALSŠ³ŽÒ‚̘b‚µ‚𒆐S‚Ɂ`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •×‹­‰ï (2010/11/2), “Œ‹ž.

H22-732014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‹`) I. _Œo“ï•a‚̗Տ°Œ»ê‚É‚š‚¯‚鎀¶ŠÏ. II. _Œo“ï•a‚ÌŒ»ê‚ƐlŒ —iŒì. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘ˆî“c‘åŠwlŠÔ‰ÈŠwŠwp‰@u—Տ°Ž€¶ŠwŠT˜_vu‹` (Šw•”‚š‚æ‚ђʐM‰Û’ö) (2010/11/16), Š‘ò.

H22-732015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (u‹`) II. _Œo“ï•a‚ÌŒ»ê‚ƐlŒ —iŒì. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘ˆî“c‘åŠwlŠÔ‰ÈŠwŠwp‰@uŽÐ‰ï•ŸŽƒŒ»êŽÀKŽw“±vu‹` (Šw•”)) (2010/11/16), Š‘ò.

H22-732016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚̊ɘaƒPƒA`’m‚©‚çI––Šú‚܂Ł`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬22”N“x_Œo“ï•aˆã—ÃŒ€C‰ï (2010/11/16), ŒQ”n.

H22-732017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚ÌŽŸŠ³‚Ì—‰ð‚ƑΉž‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬22”N“x‘æ1‰ñ“ï•aŠ³ŽÒ“™ƒz[ƒ€ƒwƒ‹ƒp[—{¬Œ€C (Šî‘b‰Û’öI) (2010/12/20), ‘Š–ÍŒŽ.

H22-732018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰)yÝ‘î“ï•a—×{ŽÒ‚̈À‘SEˆÀS‚È‚œ‚ñ‚Ì‹zˆø‚Ɛê–å“I”r‚œ‚ñ–@‚ɂ‚¢‚āzŒÄ‹z‹@”\‚Ì•]‰¿‚Ɛê–å“I”r‚œ‚ñƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬22”N“x‘æ2‰ñ“Œ‹ž“s_Œo“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€C‰ïE“ï•aƒZƒ~ƒi[ (2011/1/14), “Œ‹ž.

H22-732019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚ÌŽŸŠ³‚Ì—‰ð‚ƑΉž‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬22”N“x‘æ2‰ñ“ï•aŠ³ŽÒ“™ƒz[ƒ€ƒwƒ‹ƒp[—{¬Œ€C (Šî‘b‰Û’öI) (2011/1/25), ‘Š–ÍŒŽ.

H22-732020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALSƒPƒA‚ÌŽÀÛ. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ25‰ñìèŒÄ‹zƒPƒAŒ€‹†‰ï (2011/2/17), ìèŽs.

H22-732021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ‹ØˆÞk«‘€õd‰»Ç‚̍ŐVˆã—ÂÆQOLŒüã‚ׂ̈̎x‰‡‚ðl‚Š‚é. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ’nˆæ‚ÅŽx‰‡‚·‚él‚Ì‚œ‚߂̈ã—Íu‰‰‰ïEˆÓŒ©ŒðŠ·‰ï (2011/2/22), ‰¡•l.

H22-732022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚̊ɘaƒPƒA`ALS‚𒆐S‚É. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ24‰ñŒF–{_Œo“ï•aŒ€‹†‰ï (2011/3/4), ŒF–{.

H22-732023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ALSƒ`[ƒ€ˆã—Âɂš‚¯‚éî•ñ‹€—L‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x”ljï‹c (2011), “Œ‹ž.

H22-732024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ƒI[ƒgƒXƒpƒCƒAS-507‚ð—p‚¢‚œSniff Nasal Inspiratory Pressure (SNIP) ‘ª’è‚Ì—L—p«. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, …–ìŒö•ã, •œ‰ê‚悵‚Ý, t“ú”ü•Û, “¡‹Ž‹Is, ‹{é‚µ‚Ù, ¬–쎛ˆŸ–í, ão’Œl, •Ÿ“c—Ï–ç (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x”ljï‹c (2011), “Œ‹ž.

H22-732025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ALSŠ³ŽÒ‚̏I––ŠúƒPƒA|NPPV’·ŠúŽg—pŠ³ŽÒ‚̃PƒA‚Å’Œ–Ê‚·‚é–â‘è‚©‚ç|. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, ìã@—B, ‘å’J—æŽq, ‘Oì‹±Žq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x”ljï‹c (2011), “Œ‹ž.

H22-732026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) Ž‹ü“ü—͈ӎv“`’B‘•’u‚ð—p‚¢‚œ•¶Žš“ü—Í‚ÉŠÖ‚·‚錟“¢. ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷, ‘Oê—m—C, ’|“àŠ°l, ‘厛ˆŸ—R”ü, ‚‹Ž‘ãŽq, ’†Œ_Ži, •Ÿ“c—Ï–ç (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x”ljï‹c (2011), “Œ‹ž.

H22-732027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ‹ØˆÞk«‘€õd‰»ÇŠ³ŽÒ‚É‚š‚¯‚é‰h—{áŠQ‚ÌŒã•ûŽ‹“IŒ€‹†|‘œŽ{Ý‹€“¯Œ€‹†|. Ž…r•v, ’·‰ªŽŽq, ì“c–ŸL, “B–{çt, •Šâ‹`”V, ìˆä@[, ‰º”š‹—Ç, ŒàV³–L, ”üŒŽ@”Õ, r”š@‘n, “¡ˆä’ŒŽ÷, “ï”g—æŽq, ˆÉ“¡”Ž–Ÿ1, ¡ˆä®Žu, ‹ß“¡Ž•F, ‰¬–ì”üŒbŽq2, Mš Œ\Œá, ’†“‡@F, ¬X“N•v (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­È“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚É‚š‚¯‚鐶Šˆ‚ÌŽ¿ (Quality of Life, QOL) ‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x”ljï‹c (2011), “Œ‹ž.

H22-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚—î”­Ç‰Æ‘°«ƒAƒ~ƒƒCƒh[ƒVƒX‚Ì’j«“ñ—á. –S•œ, ‰¬–ì”üŒbŽq1, ‹{ì¹D, –]ŒŽGŽ÷, ŠÖ“‡—ÇŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ193‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2010/6/5), “Œ‹ž, —Տ°_ŒoŠw 2010/6; 50 (6): 440.

H22-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘œŒn“ˆÞkÇ‚ɉ^“®ƒjƒ…[ƒƒ“áŠQ‚ð‡•¹‚µ‚œˆê—á. ‰Y–ì‹`Í, ‰iˆä^‹MŽq, “í@~ˆê, ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ194‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2010/9/4), “Œ‹ž, —Տ°_ŒoŠw 2011/5; 51 (5): 391.

H22-733003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw“Œ•a‰@‚É‚š‚¯‚é’èŠú“IƒŒƒXƒpƒCƒgƒPƒA`ƒŒƒXƒpƒCƒg“ü‰@‚ªŠ³ŽÒE‰Æ‘°‚É‚à‚œ‚ç‚·ƒƒŠƒbƒg‚Ɖ^‰c‚ÌŽÀÛ`. ‘Oì‹±Žq1, Œä‰€¶–­Žq1, ²“¡Žu•Û, ‰¬–ì”üŒbŽq2, –]ŒŽGŽ÷ (1“Œ•a‰@ŠÅŒì•”, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ7‰ñ“ú–{“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€‹†‰ï (2010/10/1), ‰¡•l.

H22-733004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) lHŒÄ‹zŠí‚©‚ç—£’E‚µ‚ж‚«‚邱‚Æ‚ð‘I‘ð‚µ‚œALSŠ³ŽÒ‚Ì1Ç—á@`‰@“àŠOƒ`[ƒ€ˆã—Â̎‹“_‚©‚ç`. “n•””ü˜a, ‘Oì‹±Žq1, ‹{ì¹D, ‰¬–ì”üŒbŽq2, –]ŒŽGŽ÷ (1“Œ•a‰@ŠÅŒì•”, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ7‰ñ“ú–{“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€‹†‰ï (2010/10/1), ‰¡•l.

H22-733005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒgƒLƒ\ƒvƒ‰ƒYƒ}Ò‘‰Š‚ÆŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚œƒuƒ^‰ñ’Ž«Ò‘‰Š‚Ì54Î’j«—á. ’ç@ãĕœ1, “à–쏲Žq2, ‹{ì¹D, ‰¬–ì”üŒbŽq3 (1Žš•@ˆôAE“ªèòŠO, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ196‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2011/3/5), “Œ‹ž, —Տ°_ŒoŠw 2011/8; 51 (8): 627.

H23-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Opinions and behaviors of Japanese and American neurologists regarding tracheostomy with invasive ventilation (TIV). Dirienzo A, Ogino M1, Rabkin J, Goetz R, Pasmantier M, Mcelhiney M, Mitsumoto H, TIV STUDY GROUP: 22nd International Symposium on ALS/MND (2011/12/1), Sydney, Australia, ALS 2011; 12 (suppl 1): 29-30. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H23-713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Analysis of the end of life situation in 115 consecutive ALS patienta in the past nine years. Ogino M1, Kitamura E2, Miyakawa S, Utino A, Urano Y, Nagai M2, Ogino Y2: 22nd International Symposium on ALS/MND (2011/12/1), Sydney, Australia, ALS 2011; 12 (suppl 1): 61. (‰¬–ì”üŒbŽq1, –k‘º‰p“ñ2, ‰iˆä^‹MŽq2, ‰¬–ì@—T2: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à)

H23-722001. [Šw‰ï(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ÐŠQŽx‰‡Žó‚¯“ü‚ê•a‰@‚Æ‚µ‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/18-20), –ŒŒÃ‰®.

H23-722002. [Šw‰ï(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Œã•ûŽx‰‡‚ÌŒoŒ±‚©‚ç‚Ì–â‘è“_. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ29‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2011/11/17-18), •Ÿˆä, _ŒoŽ¡—Êw 2012; 29: 227-30.

H23-722003. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) _Œo“ï•a‚Ɗɘaˆã—ÁEI––Šúˆã—Á|ƒIƒsƒIƒCƒhEƒ‚ƒ‹ƒqƒl‚ÌŽg—p‚𒆐S‚Ɂ|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ29‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2011/11/17-18), •Ÿˆä.

H23-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) LRRK2 (I2020T) ‘Š–ÍŒŽ‰ÆŒn‚Ì”ñ‰^“®Çó‚ÌŒŸ“¢. ‰¬–ì@—T1, ‰¬–ì”üŒbŽq2, Ž‰ÆKŽq, —À@³•£, –]ŒŽGŽ÷, ’·’JìˆêŽq1, …–ì”ü–M (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/18), –ŒŒÃ‰®, —Տ°_ŒoŠw 2011; 51: 1223.

H23-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw“Œ•a‰@_Œo“à‰È‚É‚š‚¯‚é_Œo“ï•a–K–âf—Â̌»ó. ì˜Q@•¶1, ‰¬–ì”üŒbŽq2, •Ÿ“c—Ï–ç, ‰iˆä^‹MŽq1, ‰““¡@Šî, ‹{ì¹D, –k‘º‰p“ñ1, ²“Œ–ƒ‹|, “à–쏲Žq3, –]ŒŽGŽ÷ (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/18), –ŒŒÃ‰®, —Տ°_ŒoŠw 2011; 51: 1274.

H23-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) GBS‚Ì—\Œã‚Ì•Ï‘J@Å‹ß‚Ì—\Œã‚Í‚Ç‚€‚È‚Á‚Ä‚¢‚é‚Ì‚©. ²“Œ–ƒ‹|, ‰Y–ì‹`Í, “à–쏲Žq1, ‹{ì¹D, ‰¬–ì”üŒbŽq2, –]ŒŽGŽ÷ (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/18), –ŒŒÃ‰®, —Տ°_ŒoŠw 2011; 51: 1291.

H23-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘œ”­«d‰»Ç‚̍‚ŽŸ”]‹@”\|BRB-N‚ð—p‚¢‚œŒŸ“¢|. ‹gˆä•¶‹Ï, ‚–ؔɎ¡, ‰i“c‰hˆê˜Y, ìŒûç‰ÀŽq, •Šâ‹`”V, —é–Ø‚ä‚ß, ’·’Jì‘׍O, š ®–ç, áÁ–Ø“ñ—t, –]ŒŽGŽ÷, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/19), –ŒŒÃ‰®, —Տ°_ŒoŠw 2011; 51: 1314.

H23-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»Ç‚É‚š‚¯‚é‰h—{áŠQ‚ÌŒã•ûŽ‹“I’²ž; ‘œŽ{Ý‹€“¯Œ€‹†. Ž…r•v, ’·‰ªŽŽq, ì“c–ŸL, “B–{çt, •Šâ‹`”V, ìˆä@[, ‰º”š‹—Ç, ŒàV³–L, ”üŒŽ@”Õ, r”š@‘n, “¡ˆä’ŒŽ÷, “ï”g—æŽq, ˆÉ“¡”Ž–Ÿ1, ¡ˆä®Žu, ‹ß“¡Ž•F, ‰¬–ì”üŒbŽq2, Mš Œ\Œá, ’†ŽR—D‹G, ’†“‡@F, ¬X“N•v (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/20), –ŒŒÃ‰®, —Տ°_ŒoŠw 2011; 51: 1391.

H23-723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ALS‚ÌŽ€–Só‹µ‚Ì•ªÍ@‰ß‹Ž9”NŠÔ˜A‘±100Ž€–S—á‚©‚ç. ‰¬–ì”üŒbŽq1, –k‘º‰p“ñ2, ‹{ì¹D, “à–쏲Žq3, ‰Y–ì‹`Í, –]ŒŽGŽ÷, ‰¬–ì@—T2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/20), –ŒŒÃ‰®, —Տ°_ŒoŠw 2011; 51: 1392.

H23-723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒŒƒr[¬‘̂𔺂Á‚œ72ÎPARK2–UŒŸ—á. ‹{ì¹D, –k‘º‰p“ñ1, ‰¬–ì”üŒbŽq2, à_“cˆê1, –]ŒŽGŽ÷, ‰º@‘׎i, •ž•”MF, ‘ºŽR”É—Y (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/20), –ŒŒÃ‰®, —Տ°_ŒoŠw 2011; 51: 1428.

H23-723008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒXƒpƒCƒƒ[ƒ^‚ð—˜—p‚µ‚œSniff Nasal Inspiratory Pressure (SNIP) ‘ª’è|Œ’í¬l‚Ƌ؈ޏk«‘€õd‰»ÇŠ³ŽÒ‚É‚æ‚錟Ø|. …–ìŒö•ã, •œ‰ê‚悵‚Ý, t“ú”ü•Û, “¡‹Ž‹Is, ‹{é‚µ‚Ù, ¬–쎛ˆŸ–í, •Ÿ“c—Ï–ç, ão’Œl, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï (2011/5/27-29), ‹{è, —Šw—Ö@Šw 2011; 38‘å‰ï“Á•Ê†2(DVD-ROM)): ROMBUNNO.OS3-051.

H23-723009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) TPPV‚𓱓ü‚µ‚œALS/MNDŠ³ŽÒ‚É‚š‚¯‚éƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“•û–@¥ÛHó‹µ (Œ»ó•ñ). á–{—R”ü, ˆÀ“cØ•ä, ‹gàVŒ’‘Ÿ˜Y, `@ŽáØ, •Ÿ“c—Ï–ç, ³˜Ò@—², ‰¬–ì”üŒbŽq1, –]ŒŽGŽ÷ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ12‰ñ“ú–{ŒŸŒê’®ŠoŠw‰ï (2011/6/17-18), ŒSŽR, Ž˜^W 2011/5; 12th: 175. (kÐ‚Ì‚œ‚ߎ†ã”­•\)

H23-723010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹ü“ü—͈ӎv“`’B‘•’u‚É‚š‚¯‚镶Žš“ü—Í‚Ì“Á«. ‘Oê—m—C, ’|“àŠ°l, ‘厛ˆŸ—R”ü, •Ÿ“c—Ï–ç, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ45‰ñ“ú–{ì‹Æ—Ö@Šw‰ï‘‰ï (2011/6/24-26), é‹Ê, “ú–{ì‹Æ—Ö@Šw‰ïŽ˜^W (CD-ROM) 2011; 45th: ROMBUNNO.P19056.

H23-723011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹ü“ü—͈ӎv“`’B‘•’u‚ÌŽg—p‚É‚š‚¯‚é”æ˜J“Á«. ’|“àŠ°l, ‘Oê—m—C, ‚‹Ž‘ãŽq, •Ÿ“c—Ï–ç, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ45‰ñ“ú–{ì‹Æ—Ö@Šw‰ï‘‰ï (2011/6/24-26), é‹Ê, “ú–{ì‹Æ—Ö@Šw‰ïŽ˜^W (CD-ROM) 2011; 45th: ROMBUNNO.P19057.

H23-723012. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»ÇŠ³ŽÒ‚̍\•¶—‰ð”\—Í‚ÌŒŸ“¢. ‹gàVŒ’‘Ÿ˜Y, ˆÀ“cØ•ä, á–{—R”ü, •Ÿ“c—Ï–ç, `@ŽáØ, •Ÿ“c—Ï–ç, ‰¬–ì”üŒbŽq1 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ35‰ñ“ú–{_ŒoS—Šw‰ï‘‰ï (2011/9/15-16), ‰F“s‹{, ƒvƒƒOƒ‰ƒ€¥—\eW 2011/8; 35th: 124.

H23-732001. [Šw‰ï(’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) _Œo“à‰È—̈æ‚É‚š‚¯‚éV‹K•ÛŒ¯f—Ã. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ8‰ñ“ú–{_ŒoŠw‰ï¶ŠU‹³ˆçƒZƒ~ƒi[ (2011/5/17), –ŒŒÃ‰®, Ž˜^W p.61.

H23-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a—×{ŽÒ‚̌ċzŠÇ—E‹zˆø‚ÌŠî–{. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬23”N“x‘œ–€—§ì•ÛŒ’Š“ï•au‰‰‰ï (2011/6/20), ‘œ–€.

H23-732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚É‚š‚¯‚é—Տ°—Ï—. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬23”N“x_ŒoE‹Ø“ï•aŠÅŒìƒGƒLƒXƒp[ƒgƒi[ƒXŒ€C (2011/10/17), ’·è.

H23-732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚̏I––ŠúƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬23”N“x_Œo“ï•aˆã—ÃŒ€C‰ï (2011/10/24), ŒQ”n.

H23-732005. [Šw‰ï(’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ¢_Œo“ï•a‚̊ɘaˆã—Áv‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ8‰ñ“ú–{“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€‹†‰ï (2011/10/28-29), ’·è, Ž˜^W p.27.

H23-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•a‚ðŽ‚Âl‚Ö‚Ì—‰ð. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬23”N“x–K–âŠÅŒìƒXƒe[ƒVƒ‡ƒ“Eˆã—Ë@ŠÖŠÅŒìŽt‘ŠŒÝŒ€C (2011/11/5), ‰¡•l.

H23-732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a—×{ŽÒ‚̌ċzŠÇ—EƒPƒA‚ÌŠî–{|‚œ‚ñ‹zˆø‚ð‚ß‚®‚éÅ‹ß‚Ì“®Œü‚𓥂܂Š‚ā|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬23”N“x_Œo“ï•au‰‰‰ï (2011/11/21), ¬•œŽs.

H23-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •a—Šw“I‚ÉTDP-43—z«••“ü‘Ì‚ªL”Í‚É”F‚ß‚ç‚ê‚œALS-D‚Ì74Î—«—á. “à–쏲Žq1, ‰¬–ì”üŒbŽq2, ‰Y–ì‹`Í, à_“cˆê3, ‘ºŽR”É—Y (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3_Œo“à): ‘æ198‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2011/9/3), “Œ‹ž, —Տ°_Œo 2012; 52: 592.

H23-733003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰ß–°‚Å”­Ç‚µ, L”͈͂Ȕ][•”•a•Ï‚ð”F‚ß‚œ, RAQP4R‘Ì—z«27Î—«—á. ‹{ì¹D, –k‘º‰p“ñ1, “à–쏲Žq2, _—с@’, ‰¬–ì”üŒbŽq3 (1_Œo“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ200‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2012/3/3), “Œ‹ž, —Տ°_ŒoŠw 2013; 53: 169.

H24-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) OPINIONS AND BEHAVIORS OF JAPANESE AND AMERICAN PATIENTS REGARDING TRACHEOSTOMY WITH INVASIVE VENTILATION (TIV). Rabkin J, Ogino M1, Goetz R, Mcelhiney M, Marziliano A, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H: 23rd international symposium on ALS/MND (2012/12/06), Chicago, USA. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H24-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ØˆÞk«‘€õd‰»Ç‚̐lHŒÄ‹z—Ö@’†Ž~‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²ž. ˆÉ“¡”Ž–Ÿ1, ”ˆäFˆë˜Y, ˆÉ“¡“¹Æ, ˆî—tˆêl, ¡ˆä®Žu, ‘å‹÷‰xŽq, ‰¬–ì”üŒbŽq2, “ï”g—æŽq (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ53‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2012/5/22-25), “Œ‹ž, —Տ°_Œo 2012; 52: 1607.

H24-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ_ƒuƒ‹ƒTƒNƒVƒ‡ƒ“‚É‚æ‚鎩“®‹zˆøƒVƒXƒeƒ€‚ÌŒø‰Ê‚ƈÀ‘S«‚ɂ‚¢‚Ä. ‰Y–ì‹`Í, ‰¬–ì”üŒbŽq1, “à–쏲Žq2, –k‘º‰p“ñ3, ‹{ì¹D, ‰iˆä^‹MŽq3 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3_Œo“à): ‘æ30‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2012/11/29), –k‹ãB, _ŒoŽ¡—Êw 2012/9; 29 (5): 643.

H24-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) Šm”F‚µ‚œ‚¢IÝ‘î‚ł̌ċzŠÇ—‚ÆŠÅŒìƒPƒA`¡‚±‚»‹‚ß‚ç‚ê‚éŠÅŒì‚̗́I`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “Œ‹ž“s“ì‘œ–€•ÛŒ’Š (2012/6/9), ‘œ–€.

H24-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALSŠ³ŽÒ‚ðŽx‚Š‚éˆã—ÃŒ»ê‚Å‚ÌŽÀ‘H. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬24”N“x“ú–{ALS‹Š‰ï“Œ‹ž“sŽx•”‘‰ï (2012/6/23), Vh.

H24-732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚É‚š‚¯‚éÝ‘îŽx‰‡‚̉ۑè. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŠÖ“Œ˜JÐ•a‰@ˆã—ØAŒgu‰‰‰ï (2012/7/11), ìè.

H24-732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ‹~‰‡‚âLˆæ”À‘—‚È‚Ç‚ðŠÜ‚ß‚œŠÏ“_‚©‚ç. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “‡ªŒ§“ï•a‘Š’kEŽx‰‡ƒZƒ“ƒ^[C’¹ŽæŒ§“ï•aˆã—ØA—‹Š‹c‰ï2012”N‰Ä‹G“ï•aŒ€C‰ï (2012/8/4), “‡ª.

H24-732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALSŠ³ŽÒ‚̍ݑîˆã—Â̎¡—ÂƃPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‹ž“s•{ˆãŽt‰ïE‹ž“s•{“ï•a‘Š’kŽx‰‡ƒZƒ“ƒ^[ (2012/8/11), ‹ž“s.

H24-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a—×{ŽÒ‚̌ċzŠÇ—EƒPƒA‚ÌŠî–{. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•au‰‰‰ï (2012/9/10), ’¬“c.

H24-732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚É‚š‚¯‚é—Տ°—Ï—. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬24”N“x_ŒoE‹Ø“ï•aŠÅŒìƒGƒLƒXƒp[ƒgƒi[ƒXŒ€C (2012/10/15), ’·è.

H24-732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚ÌŽŸŠ³‚Ì—‰ð‚ƑΉž. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬24”N“x“ï•aŠ³ŽÒ“™ƒz[ƒ€ƒwƒ‹ƒp[—{¬Œ€C (Šî‘b‰Û’öI) (2012/10/22), ‘Š–ÍŒŽ.

H24-732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ÅŠú‚Ü‚ÅŽ©•ª‚炵‚­¶‚«‚é‚œ‚߂ɂ́H`•a‹C‚É‚È‚Á‚Ä‚à‚ ‚í‚Ä‚È‚¢‚œ‚߂Ɂ`. ‰¬–ì”üŒbŽq1, ‘Œ (ÅŠú‚Ü‚Å—Ç‚¢l¶‚ð‚ß‚Ž‚·‰ïE‘Š–ÍŒŽ) (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ˆêÂ‰ï•¶‰»u‰‰‰ï (2012/11/3), ‘Š–ÍŒŽ.

H24-732010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a—̈æ‚̊ɘaˆã—Ã. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ1‰ñ–kŠC“¹_Œo“ï•aŒ€‹†ƒZƒ“ƒ^[“Á•Ê‹L”Ou‰‰‰ï (2012/11/4), ŽD–y.

H24-732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚ÌŽå—v‚ȏnjó‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): –k—¢‘åŠw“Œ•a‰@“ï•aŽ¡—ÃŒ€‹†ƒZƒ“ƒ^[‘æ27‰ñ_Œo“ï•aŒ€C‰ï (2012/11/19), ‘Š–ÍŒŽ.

H24-732012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•a‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬24”N“xL“‡Œ§’nˆæŠÉ˜aƒPƒA„i‘‡‘΍ôŽ–‹ÆŠÉ˜aƒPƒAu‰‰‰ï (2012/11/23), L“‡.

H24-732013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALSŠ³ŽÒ‚̗×{‚ðŽx‚Š‚é|ALSŠ³ŽÒ‚̍ݑî‚ł̃PƒA‚Ɖۑ蓙‚ɂ‚¢‚ā|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬24”N“x‘æ1‰ñ•ºŒÉŒ§_Œo“ï•aˆã—Ãlƒbƒgƒ[ƒNŒ€C‰ï (2012/11/24), •ºŒÉ.

H24-732014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚̊ɘaƒPƒA|’m‚©‚çI––Šú‚܂Ł|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŽRŒûŒ§Œ’N•ŸŽƒà’cŽRŒûŒ§Œ’N‚­‚èƒZƒ“ƒ^[ŽåÃ“ï•a“™ê–匀C‰ï (2012/12/11), ŽRŒû.

H24-732015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ‹ØˆÞk«‘€õd‰»Ç‚̊ɘaƒPƒA|’m‚©‚çI––Šú‚܂Ł|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): _“ސ쌧Šƒ–è•ÛŒ’•ŸŽƒŽ––±Š (2013/1/21), _“ސì.

H24-732016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ”ñ‚ª‚ñŽŸŠ³‚̊ɘaƒPƒA|ALSI––Šú‚𒆐S‚Ɂ|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŠÉ˜aƒPƒA”F’èŠÅŒìŽtƒtƒHƒ[ƒAƒbƒvŒ€C (2013/1/26), “Œ‹ž.

H24-732017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ƒ[ƒ‹ƒ‚ƒfƒ‹‚©‚çŠw‚ԏ—«ˆãŽtƒLƒƒƒŠƒA‚̉”\«. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •¶•”‰ÈŠwÈÌ‘ðŽ–‹Æu5‘åŠw•a‰@˜AŒg‚“xˆã—Ðl—{¬„iŽ–‹Æ (Œ€Cˆã‚Ì‘œ—l‚È—v–]‚ɉž‚Š‚éê–åˆã—{¬Ž–‹Æ)v•œ¬24”N“x—«ˆãŽtƒVƒ“ƒ|ƒWƒEƒ€ (2013/1/27), ç—t.

H24-732018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•a‚̍ݑîˆã—Âðl‚Š‚é|ALSŠ³ŽÒ‚̍ݑîˆã—Â̎¡—ÂƃPƒA|part2. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‹ž“s•{ˆãŽt‰ïC‹ž“s•{“ï•a‘Š’kEŽx‰‡ƒZƒ“ƒ^[ (2013/2/23), ‹ž“s.

H24-732019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‚ ‚»‚©‘æ2f—ÏŠƒrƒn[ƒ‰ƒz[ƒ‹ (2013/2/24), ‹ž“s.

H24-732020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ÅŠú‚Ü‚ÅŽ©•ª‚炵‚­¶‚«‚é‚œ‚߂ɂ́H`•a‹C‚É‚È‚Á‚Ä‚à‚ ‚í‚Ä‚È‚¢‚œ‚߂Ɂ`. ‰¬–ì”üŒbŽq1, ‘Œ (ÅŠú‚Ü‚Å—Ç‚¢l¶‚ð‚ß‚Ž‚·‰ïE‘Š–ÍŒŽ) (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘Š–Í‘ä‚݂悵Ž©Ž¡‰ïu‰‰‰ï (2013/3/17), ‘Š–ÍŒŽ.

H24-732021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALS‚̊ɘaƒPƒA|’m‚©‚çI––Šú‚܂Ł|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)“‡ªŒ§“ï•aˆã—ØA—‹Š‹c‰ïE“‡ªŒ§ŽåÃ•œ¬24”N“x“ï•aˆã—Ï]Ž–ŽÒŒ€C (2013/3/23), “‡ª.

H25-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) THE AMERICAN AND JAPANESE TIV STUDY GROUP: AN UPDATE ON OPINIONS AND BEHAVIORS OF JAPANESE AND AMERICAN ALS CAREGIVERS REGARDING TRACHEOSTOMY WITH INVASIVE VENTILATION (TIV). Christodoulou G, Ogino M1, Goetz R, Mitsumoto H, Rabkin J: 25th international symposium on ALS/MND (2014/12/5-7), Brussels, Belgium, Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15 (Suppl 1): 105. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H25-713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) MORPHINE USAGE IN ALS PATIENTS ON NPPV DOES NOT MAKE LIFE PROGNOSIS WORSE. Tominaga N1, Ogino M2, Kaneko J1, Nagashima K, Nagai M1, Uchino A3, Urano Y, Ogino Y1, Nishiyama K1: 25th international symposium on ALS/MND (2014/12/5-7) Brussels, Belgium, Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 112. (•x‰i“Þ•Û”ü1, ‰¬–ì”üŒbŽq2, ‹àŽq~‘Ÿ˜Y1, ‰iˆä^‹MŽq1, “à–쏲Žq3, ‰¬–ì@—T1, ŒŽR˜a—˜1: 1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

H25-713003. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) RESPIRATORY-AIDED, LONG-TERM SURVIVAL CASES OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) WITH COMMUNICATION ABILITIES, MOTONEURON SYSTEM-CONFINED DEGENERATION, AND SCANTY TDP-43 AGGREGATION-A SUBGROUP OF ALS? Mochizuki Y, Hayashi K, Nakayama Y, Shimizu T, Kamide M, Ogino M1, Komori T, Isozaki E, Nakano I: 25th international symposium on ALS/MND (2014/12/5-7), Brussels, Belgium, Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 160. (‰¬–ì”üŒbŽq1: 1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã)

H25-722003. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) _ŒoŽŸŠ³‚ɑ΂·‚éŠÉ˜aƒPƒA (ALS‚𒆐S‚É). ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ16‰ñ“ú–{ŠÉ˜aˆã—Êw‰ï‹³ˆçƒZƒ~ƒi[ (2014/1/11), •Ÿ‰ª.

H25-722004. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ˆÓŽvŒˆ’èŽx‰‡‚ðl‚Š‚é~ˆãŽt‚Ì—§ê‚©‚ç`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{“ï•aŠÅŒìŠw‰ïŠé‰æƒZƒ~ƒi[u” ª‚ÅŠw‚Ԑ_Œo“ï•aŠÅŒìvƒVƒŠ[ƒY5@’m‚Ì•‹yu_Œo“ï•aŠÅŒìƒeƒLƒXƒg‚ÌŽÀ‘Hv(2014/2/15), ¬“cŒŽ, Ž˜^W p.7-26.

H25-723010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Bromocriptine mesilate ‚̋؈ޏk«‘€õd‰»Ç‚ɑ΂·‚éˆãŽtŽå“±—Տ°Œ€‹†. ’r“cõ‰q, ‹gˆä•¶‹Ï, ‚–ؔɎ¡, Šâè‘×—Y, ‰¬–ì”üŒbŽq1, ‰i“c‰hˆê˜Y, Šâ–{N”V‰î, ‘åŠÑ—DŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ54‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2013/6/1), “Œ‹ž, —Տ°_Œo 2013; 53: 1593.

H25-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚Ì—‰ð. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬25”N“x_“ސ쌧–K–âŠÅŒìŽt—{¬uK‰ï (2013/4/22), ‰¡•l.

H25-732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚̈ã—š‚æ‚уPƒA‚ÌUpdate|ALS‚𒆐S‚Ɂ|. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw“ï•aŽ¡—ÃŒ€‹†ƒZƒ“ƒ^[‘æ79‰ñ“«ŽŸŠ³Œ€C‰ï (2013/7/29), ìè.

H25-732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) “ï•aŠÉ˜aƒPƒAŒ€CŒ€‹†‰ï•ñE“ï•a‚̈ã—Ôï‰ðÍ‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆêl, A’|“ú“Þ, Ž…“N˜Y, ¬“c—LŒá, “ï”g—æŽq, ŽO‰Y–õ•F (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³“™Ž•žŒ€‹†Ž–‹ÆuŠó­«“«ŽŸŠ³Š³ŽÒ‚ÉŠÖ‚·‚éˆã—Â̌üã‹y‚ÑŠ³ŽÒŽx‰‡‚݂̍è•û‚ÉŠÖ‚·‚錀‹†v•œ¬25”N“x”ljï‹c (2013/12/13), “Œ‹ž.

H25-732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ‹ê’ɏǏó‚̊ɘa@ŒÄ‹zŠÇ—EƒPƒA‚ÌŠî–{. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‹ž“s•{ˆã—ÃgƒŒ[ƒjƒ“ƒOƒZƒ“ƒ^[ Ý‘îˆã—ÃŽÀ’nŒ€Cu_ŒoE‹Ø“ï•aƒVƒŠ[ƒYv…C (2014/1/18), ‹ž“s.

H25-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) “ï•aV§“x‚É‚š‚¯‚éˆã—ÔŒÈ•‰’S—\‘ª‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³“™Ž•žŒ€‹†Ž–‹Æu–Ɖu«_ŒoŽŸŠ³‚ÉŠÖ‚·‚é’²žŒ€‹†”ǁv•œ¬25”N“x”ljï‹c (2014/1/22), “Œ‹ž, Ž˜^W p.72-3.

H25-732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) CIDP‚Ì•a‹C‚ÌŠî‘b’mŽ¯‚⎡—Ö@EÝ‘î‚ł̉߂²‚µ•û‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ŒË’Ë‹æ–ðŠ‚—îEáŠQŽx‰‡‰ÛCIDPu‰‰‰ï (2014/2/10), ŒË’Ë.

H25-732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚̊ɘaƒPƒA`ALS‚𒆐S‚Ɂ`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ12‰ñ_Œo“ï•aˆã—Ãlƒbƒgƒ[ƒN„iŽ–‹ÆŒ€C‰ï (2014/2/22), “È–Ø.

H25-732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ÅŠú‚Ü‚ÅŽ©•ª‚炵‚­¶‚«‚é‚œ‚߂ɂ́H`•a‹C‚É‚È‚Á‚Ä‚àQ‚Ä‚È‚¢‚œ‚߂Ɂ`. ‰¬–ì”üŒbŽq1, ‘Œ (ÅŠú‚Ü‚Å—Ç‚¢l¶‚ð‚ß‚Ž‚·‰ïE‘Š–ÍŒŽ) (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): éŽR’n‹æŽÐ‹ŠŽåÃu‰‰‰ï (2014/3/9), ‘Š–ÍŒŽ.

H26-722005. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€1: Šó­E“«ŽŸŠ³@Žx‰‡‚ւ̘AŒg‚Ƒ΍ô‚ɂ‚¢‚āz’†“c‹œŽq, ŽR“c—²Ži, —¢’†—˜Œb, •Ÿ‰iG•q, ‰¬–ì”üŒbŽq1, ˆÉ“¡‚œ‚Ä‚š (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ‚Q‰ñ“ú–{“ï•aƒlƒbƒgƒ[ƒNŠw‰ïŠwpW‰ï (2014/11/15), Ž­Ž™“‡.

H26-731003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “ï•aŠ³ŽÒ‚ւ̍’m‚ÆŽx‰‡ŽÒ‚ÌŠÖ‚í‚è‚ɂ‚¢‚Ä. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •Ÿ‰ªŒ§dÇ_Œo“ï•a“ü‰@Ž{ÝŠm•ÛŽ–‹Æ•œ¬25”N“x–k‹ãBE’}–LƒuƒƒbƒNŒ€C‰ï (2014/9/27), –k‹ãB.

H26-732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) ÅŒã‚Ü‚ÅŽ©•ª‚炵‚­¶‚«‚é‚œ‚߂ɂ́H ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): –k—¢‘åŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[Žs–¯uÀ (2014/5/16), é‹Ê.

H26-732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ‘±EˆÓŽvŒˆ’èŽx‰‡1‚š‚æ‚Ñ2. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{“ï•aŠÅŒìŠw‰ïŠé‰æƒZƒ~ƒi[u” ª‚ÅŠw‚Ԑ_Œo“ï•aŠÅŒìvƒVƒŠ[ƒY6@’m‚Ì•‹yu_Œo“ï•aŠÅŒìƒeƒLƒXƒg‚ÌŽÀ‘Hv (2014/5/31), _“ސì.

H26-732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ÅŠú‚Ü‚ÅŽ©•ª‚炵‚­¶‚«‚é‚œ‚ß‚É. ‰¬–ì”üŒbŽq1, ‘Œ (ÅŠú‚Ü‚Å—Ç‚¢l¶‚ð‚ß‚Ž‚·‰ïE‘Š–ÍŒŽ) (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘Š–Í‘ä’n‹æŽÐ‰ï•ŸŽƒ‹Š‹c‰ï•ŸŽƒuÀ (2014/6/8), ‘Š–Í‘ä.

H26-732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) “ï•a‚ÌŠî‘b’mŽ¯I. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ï•aŠ³ŽÒ“™ƒz[ƒ€ƒwƒ‹ƒp[—{¬Œ€C (Šî‘b‰Û’öI) (2014/8/4), é‹Ê.

H26-732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ‹ØˆÞk«‘€õd‰»Ç: ALS`•a‹C‚Ì—‰ð‚Æ•t‚«‡‚¢•û`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): é‹ÊŒ§ƒ‘ƒ•ÛŒ’Šˆã—Íu‰‰‰ïuALS‚̍ݑî—×{‚ɖ𗧂Ž¡—ÂƃPƒAv(2014/9/8), é‹Ê.

H26-732010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šî’²u‰‰) ”ñ‚ª‚ñŽŸŠ³‚̊ɘaƒPƒA@Œ»ó‚ƍ¡Œã`ALS‚̊ɘaƒPƒA‚ÌŒoŒ±‚𓥂܂Š‚ā`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ39‰ñ‘œŽ{ÝŠÉ˜aƒPƒAŒ€‹†‰ï (2014/9/13), “Œ‹ž.

H26-732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) –Ɖu«_ŒoŽŸŠ³@CIDP‚ÆMG. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “ú–{»–òŒ€C‰ï (2014/9/29), ‘å‹{.

H26-732012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ‘œ”­«d‰»Ç“™_Œo“ï•aŠ³ŽÒ‚Ì’nˆæˆã—Ã. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ11‰ñŽR—œ_Œo“ï•aƒZƒ~ƒi[ (2014/10/22), b•{.

H26-732013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‹ØˆÞk«‘€õd‰»Ç‚𒆐S‚Æ‚µ‚œ_Œo“ï•aŠ³ŽÒ‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): –öˆäˆã—ÃZƒ“ƒ^[ŠÉ˜aƒPƒAu‰‰‰ï (2014/11/5), ŽRŒû.

H26-732014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ÅŠú‚Ü‚ÅŽ©•ª‚炵‚­¶‚«‚é‚œ‚ß‚É. ‰¬–ì”üŒbŽq1, ‘Œ (ÅŠú‚Ü‚Å—Ç‚¢l¶‚ð‚ß‚Ž‚·‰ïE‘Š–ÍŒŽ) (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘åÀŽ©Ž¡‰ïu‰‰‰ï (2014/11/8), ‘Š–ÍŒŽ.

H26-732015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ÅŠú‚Ü‚ÅŽ©•ª‚炵‚­¶‚«‚é‚œ‚ß‚É. ‰¬–ì”üŒbŽq1, ‘Œ (ÅŠú‚Ü‚Å—Ç‚¢l¶‚ð‚ß‚Ž‚·‰ïE‘Š–ÍŒŽ) (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): –ƒa’n‹æŽÐ‹Šu‰‰‰ï (2014/11/8), ‘Š–ÍŒŽ.

H26-732016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) I––Šú‚̃Cƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚ƈӎvŒˆ’èŽx‰‡. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): –k—¢‘åŠw•a‰@ˆÚAƒR[ƒfƒBƒl[ƒ^[•×‹­‰ï (2014/11/10), ‘Š–ÍŒŽ.

H26-732017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) Š³ŽÒ‚³‚ñ‚ÉŠñ‚è“Y‚€—Տ°ˆã‚ÆŠ³ŽÒ‰ï‚Ì—§ê‚©‚çŠw‚Ô‰Û‘è‚ÆŽY‹Æ•ÛŒ’E‚Ö‚ÌŠú‘ҁ`_Œo“à‰Èˆã‚Ì—§ê‚©‚çŽO†•ÛŒ’E‚ÉŠú‘Ò‚·‚é–ðŠ„`. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬26”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àuEˆæ‚É‚š‚¯‚é’†“ráŠQŽÒ‚ÌŽÀ‘Ô’²ž‚Æ‚»‚ê‚ÉŠî‚­ŠÖŒWŽÒŠÔ‚Ì–]‚Ü‚µ‚¢˜AŒg‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†v‘æ1‰ñŽY‹ÆˆãEŽY‹ÆŠÅŒìE‚Ì—§ê‚©‚ç“ï•aŠ³ŽÒE’†“ráŠQŽÒ‚̏A˜JŒp‘±Žx‰‡‚ðl‚Š‚錀‹†‰ï (2014/11/22), “Œ‹ž.

H26-732018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) _Œo“ï•a‚É‚š‚¯‚é—Տ°—Ï—. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬26”N“x_ŒoE‹Ø“ï•aŠÅŒìƒGƒLƒXƒp[ƒgƒi[ƒXŒ€C (2014/11/27), ’·è.

H26-732019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ‹ØˆÞk«‘€õd‰»Ç‚š‚æ‚Ñ‘O“ª‘€“ªŒ^”F’mÇ‚É‚š‚¯‚éALS-FTD-Q’²žŒ€‹†. “n•Ó•Û—T, ‘«—§–FŽ÷, ŒŽR˜a—˜1, ‰Ô“‡—¥Žq1, ‰¬–ì”üŒbŽq2, Ž…r•v, –Ø‘º‰p‹I, ‘c•ƒ]Œ³, “n•ÓG‹v, ”M“c’ŒŽ÷, –‘“c“¹l, ‹ÀêˆèŽq, Žsì”Ž—Y, ‹g–ì@‰p, ‰¡“c@C, ’r“c@Šw, ˜aò—BM, –쌳³O, Â–ؐ³Žu, ’·’JìˆêŽq1, ’†“‡Œ’“ñ (1_Œo“à, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³­ôŒ€‹†Ž–‹Æu_Œo•Ï«ŽŸŠ³—̈æ‚É‚š‚¯‚éŠî”Õ“I’²žŒ€‹†v•œ¬26”N“x”ljï‹c (2014/12/19), “Œ‹ž, Ž˜^W p.9.

H26-732020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ‘œ”­«d‰»ÇEŽ‹_ŒoÒ‘‰Šf’fŠî€•À‚тɏdÇ“xŠî€‚̍쐬. ‹g—Ǐˆê, áÁèŸ‹v, ²“¡áÁ–ç, ‹g‘º@—å, ŽRè@—º, Œ‰º‘ñ–ç, V–쐳–Ÿ, ‰¬–ì”üŒbŽq1, Žà‘º–Ÿ¶, “c’†³”ü, ’†’Ò—SŽi, ŒàV³–L, –쑺‹±ˆê, ŒŽ@Žõ˜Y, “¡ŒŽˆê’j, ŽR‘º@—², ‘匎‹`˜Y, ‚¹@¯, ŒSŽR’B˜Y, Ö“cF•F, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã):uŒú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁv•œ¬26”N“x‡“¯”ljï‹c (2015/1/21), “Œ‹ž, Ž˜^Wp.8-10.

H26-732021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) dÇ‹Ø–³—͏ǂš‚æ‚Ñ••“ü‘̋؉Š‚̏dÇ“x•ª—Þ‚Ì’ñˆÄ. ‹gìO–Ÿ, Ž…@, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, Ž…—DŽq, —é–Ø‘¥G, Žà‘º–Ÿ¶, ‰€¶‰ëO, V–쐳–Ÿ, –쑺‹±ˆê, ŒŽ@Žõ˜Y, Œ”öG“¿, –{‘º­Ÿ, ìŒû’ŒŽ÷, ŒSŽR’B’j, –쑺–FŽq, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Šâ²˜a•v, —é–؏d–Ÿ, âˆäŒ’“ñ, Œˆä@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã):uŒú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁv•œ¬26”N“x‡“¯”ljï‹c (2015/1/21), “Œ‹ž, Ž˜^W p.11-2.

H26-732022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ‚š‚æ‚Ñ—Þ‰ŽŸŠ³‚̐f’fŠî€CdÇ“x•ª—Þ. “í@@i, ‰¬–ì”üŒbŽq1, ŠC“cŒ«ˆê, Š@—Ž™Z, _“c@—², ŒKŒŽ@‘, ‰€¶‰ëO, ‘c•ƒ]Œ³, ç—tŒú˜Y, –쑺‹±ˆê, ’r“cCˆê, Ž…—DŽq, ŒŽ@Žõ˜Y, Œ”öG“¿, ‰¡“c—²“¿, –쑺–FŽq, •“¡‘œ’ØY, ŒIŽR’·–å, ‹Ê˜‹ÅŽq, Œˆä@^ (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã):uŒú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁv•œ¬26”N“x‡“¯”ljï‹c (2015/1/21), “Œ‹ž, Ž˜^W p.13-6.

H26-732023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) ‚»‚Ì‘Œ‚̐_Œo–ƉuŽŸŠ³. Žà‘º–Ÿ¶, Œˆä@^, ’r“cCˆê, ‰¬–ì”üŒbŽq1, Š@—Ž™Z, _“c@—², ‹v•Û“c—Ž“ñ, Ž…—DŽq, —é–Ø‘¥G, ŒàV³–L, –쑺‹±ˆê, ŒŽ@Žõ˜Y, ‰¡“c—²“¿, “n粁@C, Œ¢’ˁ@‹M, ’†‘º—Ž•¶, –쑺–FŽq, ŽR–ì‰Ã‹v, •Ä“c@œ, ŒIŽR’·–å, ‹Ê˜‹ÅŽq (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã):uŒú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁv•œ¬26”N“x‡“¯”ljï‹c (2015/1/21), “Œ‹ž, Ž˜^W p.21-4.

H26-732024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) CIDP‚Ì•a‘ԉ𖟁CŽ¡—Ö@ŠJ”­‚ÉŒü‚¯‚œ‘OŒü‚«ƒRƒz[ƒgŒ€‹†: —Տ°EƒQƒmƒ€î•ñC¶‘ÌŽŽ—¿ƒŠƒ\[ƒX\’z. ‘c•ƒ]Œ³, ”Ñ“‡³”Ž, ¬’rtŽ÷, ŒKŒŽ@‘, ‹g—Ǐˆê, ’r“cCˆê, ‰¬–ì”üŒbŽq1, ŠC“cŒ«ˆê, Š@—Ž™Z, _“c@—², ‰€¶‰ëO, ‚“ˆ@”Ž, ç—tŒú˜Y, –쑺‹±ˆê, •“¡‘œ’ØY, ‰¡“c—²“¿, Œˆä@^, “í@@i (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã):uŒú¶˜J“­È“«ŽŸŠ³ (_Œo–ƉuŽŸŠ³) ­ô‚š‚æ‚ÑŽÀ—p‰»Œ€‹†”ǁv•œ¬26”N“x‡“¯”ljï‹c (2015/1/22), “Œ‹ž, Ž˜^W p.102-3.

H26-732025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ)y‚±‚ê‚©‚ç‚Ì“ï•aŒ€‹†`V‚µ‚¢Ž¡—Ö@‚ÌŠJ”­`z“ï•aŽ¡—Âɂš‚¯‚銳ŽÒ˜AŒgEŽx‰‡. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬26”N“xŒú¶˜J“­‰ÈŠwŒ€‹†u“«ŽŸŠ³“™Ž•žŒ€‹† (“«ŽŸŠ³“™ŽÀ—p‰»Œ€‹†)v„iŽ–‹ÆŒ€‹†”­•\‰ï (2015/1/25), “Œ‹ž.

H26-732026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) I––Šú‚É‚ ‚éALSŠ³ŽÒ‚̊ɘaƒPƒA. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): “Œ‹ž“s—§_Œo•a‰@ (2014/1/26), “Œ‹ž.

H26-732027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (h‘è•ñ) “ï•aŠÉ˜aƒPƒA‚Ì•‹y, Œ[”­. ‰¬–ì”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆêl, A’|“ú“Þ, ¬“c—LŒá, “ï”g—æŽq, ŽO‰Y–õ•F, ‰¬–ì@—T2 (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 2_Œo“à): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àu“«ŽŸŠ³­ôŒ€‹†Ž–‹Æ“ï•aŠ³ŽÒ‚Ö‚ÌŽx‰‡‘̐§‚ÉŠÖ‚·‚錀‹†v•œ¬26”N“x”ljï‹c (2015/2/7), “Œ‹ž.

H26-732028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹ØˆÞk«‘€õd‰»Ç (ALS). ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ƒGƒ“ƒhƒIƒuƒ‰ƒCƒtEƒPƒA|ÅŠú‚̃vƒƒZƒX‚̗Տ°—Ï—| (2015/2/8), “Œ‹ž.

H26-732029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ALSŠ³ŽÒ (—˜—pŽÒ) ‚̌ċz‹ê‚̊ɘa‚Æ—Ï—“I”z—¶. ‰¬–ì”üŒbŽq (V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): •œ¬26”N“x‹ž“s•{ˆã—ÃgƒŒ[ƒjƒ“ƒOƒZƒ“ƒ^[Ý‘îˆã—ÃŽÀ’nŒ€Cu_ŒoE‹Ø“ï•aƒVƒŠ[ƒYv …CALS‚É‚š‚¯‚éó‘Ô,‹}•Ï‘Ήž‚Æ‚Ì‘œEŽí˜AŒgE—Ï—“I”z—¶ (2015/3/7), ‹ž“s.

H26-732030. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀE‹³ˆçu‰‰) ŒÄ‹zƒPƒA‚æ‚ë‚ž‘Š’k. ¬ì_³, Œ‰ª—zŽq, ‘åò—¢, •x“c^‹I, ‘êŒû®Žq, •’m—R‰ÀŽq, ¬X“N•v, ‰¬–ì”üŒbŽq1, ‰Z¶Lˆê, ‹{ì“N•v (1V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ3‰ñ_Œo‹ØE“ï•a‚ÉŠÖ‚·‚éŒÄ‹z—Ö@Œ€‹†‰ï (2015/3/14), “Œ‹ž.


ˆãŠw•”‹³ˆçŒn‹ZpEˆõ

Œ`‘ÔŒn

[Šwp˜_•¶]

120001. [ŒŽ’˜] –쐶ƒƒ_ƒJ‚ÉŒ©o‚³‚ê‚œ”X–E‚ÉŠÖ‚·‚é•a—‘gDŠw“IŠŒ©. Œ–Šr”V1, Ÿ‘ºŒ[Žj2, ”ö“c³“ñ, ¬‰êŒú“¿, ¬ìŒ³”V2, ‘Ÿ“c”ŽŽ÷2 (1Œ`‘ÔŒn, 2‰ð–U): ‹›•aŒ€‹†2016/3: 51 (1); 8-14.

[Šw‰ïEŒ€‹†‰ï“™]

723011. [Šw‰ï(‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ò’ōœ•ÏŒ`ƒƒ_ƒJ‚Ì”÷×Œ`‘ÔŠw“I‚ÈŠÏŽ@. Œê r”V1, “à“cŒ’‘Ÿ˜Y, Ÿ‘ºŒ[Žj, ‘åŠÑ—TŽq, ”ö“c³“ñ, ¬‰êŒú“¿, ‚‘Š»Žm2, ‘Ÿ“c”ŽŽ÷3, ¬ìŒ³”V3 (1Œ`‘ÔŒn, 2®ŠO, 3‰ð–U): ‘æ121‰ñ“ú–{‰ð–UŠw‰ï‘‰ï‘S‘ŠwpW‰ï (2016/3/28-30), •Ÿ“‡.


¶•š•š—Œn

[Šw‰ïEŒ€‹†‰ï“™]

110296. [ŒŽ’˜] Epileptogenesis and epileptic maturation in phosphorylation site-specific SNAP-25 mutant mice. Watanabe S1, Yamamori S2, Otsuka S, Saito M3, Suzuki E, Kataoka M, Miyaoka H3, Takahashi M2: Epilepsy Research 2015/9; 115: 30-44. (“n•Ó@Ž 1, ŽRX‘D2, âV“¡³”Í3, ‹{‰ª@“™3, ‚‹Ž³g2: 1¶•š•š—Œn, 2¶‰», 3ž_)


ˆâ“`Žq‚ŽŸ‹@”\‰ðÍƒZƒ“ƒ^[

[Šw‰ïEŒ€‹†‰ï“™]

732162. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€)yƒvƒƒgƒR[ƒ‹‚ɏ‘‚©‚ê‚È‚¢¶BHŠw‹Zp‚̃Rƒcz–k—¢‘åŠw‚É‚š‚¯‚éƒ}ƒEƒXãóˆÚA‚ÌŽÀÛ`—‘ŠÇˆÚA‚𒆐S‚Ɂ`. ²“¡‹M•¶1, ‹v•Û’nœŽi1, ˆ¢•”^Œå1, ŠŒŽ—Y–ç1 (1ˆâ“`Žq‰ðÍƒZ): ‘æ17‰ñREG•”‰ïu‰‰‰ï (2015/11/14), “Œ‹ž.

733394. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Ž©‘R”ɐB‚Å‚ÍŒn“ˆÛŽ‚ª¢“ï‚ÈSNAP-25ƒmƒbƒNƒCƒ“ƒ}ƒEƒXŒn“‚ɑ΂·‚鐶BHŠw‹Zp‚Ì“K—p. ‹v•Û’nœŽi1, ²“¡‹M•¶1, ˆ¢•”^Œå1, ŠŒŽ—Y–ç1, ‚‹Ž@W1, ŽRX‘D2, ‚‹Ž³g2, ²“¡rÆ1,3, “Œ@’åG3 (1ˆâ“`Žq‰ðÍƒZ, 2¶‰», 3ŽÀŒ±“®•š): ‘æ32‰ñ“®•š¶BHŠwŒ€‹†‰ï (2015/12/5), _“ސì.


Œ’NŠÇ—ƒZƒ“ƒ^[

[Šwp˜_•¶]

120067. [ŒŽ’˜]u‘œ•¶‰»ŽÐ‰ïŒ^‹êŠŠŽŽÚ“xv‚ÌŠJ”­‚ÆŠˆ—p|‘œ•¶‰»‹€¶‚ð–Ú“I‚Æ‚·‚é’nˆæ“ú–{Œê‹³Žº‚ÌŠˆ“®‰ü‘P‚ÉŒü‚¯‚ā|. Î’ˏ¹•Û1, ™àVŒoŽq2, ˆ¢•”@—T3, ŽRŒ—D“ñ4, ‰Í–k—SŽq5, ŽR•Ó^—Žq6 (1Œ’NŠÇ—ƒZ, 2“Œ‹žŠO‘Œê‘åŠw‘œŒŸŒêE‘œ•¶‰»‹³ˆçŒ€‹†ƒZƒ“ƒ^[, 3–ŸŽ¡Šw‰@‘åŠwS—Šw•”, 4‘ˆî“c‘åŠw•¶ŠwŠwp‰@, 5ã’q‘åŠw’ZŠú‘åŠw•”ƒT[ƒrƒXƒ‰[ƒjƒ“ƒOƒZƒ“ƒ^[, 6—§‹³‘åŠw): ‘œŒŸŒê‘œ•¶‰»|ŽÀ‘H‚ÆŒ€‹† 2015/11; 7: 92-114.

210006. [€ŒŽ’˜] Short Note: Low Levels of Serum 1,5-Anhydroglucitol during Pregnancy Compared to Blood Glucose Measured by Continuous Glucose Monitoring. Moriya T1, Kishihara E1, Matsubara M1, Mori H, Okada Y, Koga M: Ann Clin Lab Sci 2016/3; 46 (2): 227-8. (Žç‰®’B”ü1, ŠÝŒŽŠG—œŽq1, ŒŒŽ‚Ü‚Ç‚©1: 1Œ’NŠÇ—ƒZ)

522207. [uÀ]y“ÁW: ‚ ‚È‚œ‚à–Œˆã! “œ”A•a«tÇ‚ð‚Ç‚€Ž¡—·‚é?@ŠO—ˆ‚Å‚±‚±‚Ü‚Å‚â‚ë‚€!z‘æ1Í “œ”A•a«tÇ‚ÌŠî–{‚ð‰Ÿ‚³‚Š‚Ä‚š‚±‚€!@6. “œ”A•a«tÇ‚Ì•a—. ŒŒŽ‚Ü‚Ç‚©1, Žç‰®’B”ü1 (1Œ’NŠÇ—ƒZ): jmedmook42 2016/2; 42: 24-8.

522208. [uÀ]y“ÁW: •a—‚ŃKƒbƒeƒ“! “œ”A•a@Š³ŽÒ‚³‚ñ‚ð‚à•Ï‚Š‚éƒ~ƒNƒ‰æ‘œzII. ‡•¹ÇE•¹”­Ç‚Ì•a—Šw@–Ú‚ÅŒ©‚é“œ”A•a«tÇ|t‘gDŠŒ©‚Í‚±‚ñ‚È‚ÉŒƒ‚µ‚¢. Žç‰®’B”ü1, ŒŒŽ‚Ü‚Ç‚©1 (1Œ’NŠÇ—ƒZ): “œ”A•af—Ã}ƒXƒ^[ 2016/3; 14 (3): 175-80.

[’˜@‘]

620147. [Šwp‘] (•ª’SŽ·•M)y‚±‚ê‚Ÿ‚¯‚Í’m‚Á‚Ä‚š‚«‚œ‚¢IŠO‘l‘Š’k‚ÌŠî‘b’mŽ¯z‘æ3•”50Í ƒJƒ‹ƒ`ƒƒ[ƒVƒ‡ƒbƒNEˆÙ•¶‰»‚ƃXƒgƒŒƒX, p235-6. Â–ö‚è‚ÂŽq, Î’ˏ¹•Û1, ‘åŠÑ’qŒbŽq, ¬ì_ˆê, ¬“cìˆ»‰¹, ‰Á“¡”Ž‹`, ‘q—Ñ‚é‚Ý‚¢, ¬•œ’B–ç, ŸNˆäç•ä, ‘O“cßŽq, –öŒŽçH, ˆË“cŒöˆê, “n•”“TŽq, V‹‚Ý‚Ç‚è (1Œ’NŠÇ—ƒZ), ŠÄC: ™àVŒoŽq, ŠÖ@‘‰î, ˆ¢•”@—T, Œ”ŽÐ, “Œ‹ž, 2015/6”­s.

620148. [Šwp‘] (•ª’SŽ·•M)y“œ”A•a‚ƍ‡•¹Ç (Œã•Ñ)@“œ”A•a‡•¹Ç (ÅVçΛ{70Šª7ŒŽ‘Š§†)z×¬ŒŒŠÇáŠQ‚Ƒ匌ŠÇáŠQ@“œ”A•a«tÇ‚Ì•a—|‹@”\‚Æ‚ÌŠÖ˜A|, p.1405-14. Žç‰®’B”ü1, ‹g“c—F‹I1, ŠÝŒŽŠG—œŽq1, ŒŒŽ‚Ü‚Ç‚©1 (1Œ’NŠÇ—ƒZ), ÅVçΛ{ŽÐ, ‘åã, 2015/7”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713136. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Type 2 diabetic patients with rapid renal function decline had increased glomerular filtration rate at the baseline: Japan Diabetes Complications Study. Moriya T1, Tanaka S, Sone H, Ishibashi S, Matsunaga S, Ohashi Y, Akanuma Y, Yamada N, Haneda M, Katayama S: 75th Scientific Sessions of American Diabetes Association (2015/6/5-9), Boston, USA. (Žç‰®’B”ü1: 1Œ’NŠÇ—ƒZ)

721023. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) “œ”A•a«tÇ‚̐t‹@”\’ቺ‚ð—\‘ª‚·‚é‚Ì‚ÍŽÀ‚Í“œ”A•a–Ô–ŒÇ? Žç‰®’B”ü (Œ’NŠÇ—ƒZ): ‘æ21‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï (2015/11/27-28), –ŒŒÃ‰®.

722244. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) “ú–{l2Œ^“œ”A•a‚̐³í|”÷—ʃAƒ‹ƒuƒ~ƒ“”AŠú‚̐t‘gDE‹@”\˜AŠÖ‚Æ’·Šú‹@”\—\Œã. Žç‰®’B”ü (Œ’NŠÇ—ƒZ): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/21-24), ‰ºŠÖ.

722245. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) “œ”A•a«tÇ‚É‚š‚¯‚é’`”’§ŒÀH|‚»‚ÌŒø‰Ê‚ÆŒÀŠE. Žç‰®’B”ü (Œ’NŠÇ—ƒZ): ‘æ50‰ñ“œ”A•aŠw‚̐i•à (2016/2/19-20), “Œ‹ž.

722246. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) “œ”A•a«tÇ‚̕“If—Â̏d—v«. Žç‰®’B”ü (Œ’NŠÇ—ƒZ): “ú–{–òŠw‰ï‘æ136”N‰ï (2016/3/26-29), ‰¡•l.

7231031. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•aŠ³ŽÒ‚̐t‹@”\ŒŸž‚É“KØ‚ÈŽw•W‚͉œ‚©? ‘呺˜a‹K1, ‰ª“cç•ä1, Â–ØŠG–ƒ1, •œ“ˆ—EŽm1, ‹’°’ŒŽ÷1, “c’†GŽ÷1, —é–Ø“Þ’ÃŽq1, ‘åXˆÀŒb1, ŠÝŒŽŠG—œŽq2, ŒŒŽ‚Ü‚Ç‚©2, Žç‰®’B”ü2 (1ŠC˜V–Œ‘‡•a‰@“œ”A•aƒZƒ“ƒ^[, 2Œ’NŠÇ—ƒZ): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/22), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S142.

7231032. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•a‡•¹”DP‚É‚š‚¯‚éHbA1c‚Í, “SŒ‡–Ró‘Ô‚Ì‚œ‚ß‚ÉGA‚ƈقȂ茌“œƒRƒ“ƒgƒ[ƒ‹‚𔜉f‚µ‚È‚¢. ŠÝŒŽŠG—œŽq1, ŒŒŽ‚Ü‚Ç‚©1, Žµ—¢áÁ‹`2, ŒÃ‰ê³Žj3, Žç‰®’B”ü1 (1Œ’NŠÇ—ƒZ, 2“à•ª”å‘ãŽÓ“à, 3ìŒŽs—§ìŒ•a‰@): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/22), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S275.

7231033. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ³í`Œ°«ƒAƒ‹ƒuƒ~ƒ“”AŠú‚Ì2Œ^“œ”A•aŠ³ŽÒ‚É‚š‚¯‚éƒCƒ“ƒXƒŠƒ“‚ÆDPP-IV‘jŠQ–ò•¹—p—Ö@‚ÌŒø‰Ê. ŒŒŽ‚Ü‚Ç‚©1, ŠÝŒŽŠG—œŽq1, Žµ—¢áÁ‹`2, Žç‰®’B”ü1 (1Œ’NŠÇ—ƒZ, 2“à•ª”å‘ãŽÓ“à): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/23), ‰ºŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S364.

7231034. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “d‹C‚¯‚¢‚ê‚ñ—Ö@ƒNƒŠƒjƒJƒ‹ƒpƒX‰ü’ù‚ÉŒü‚¯‚Ä. àVŽRŒb”g1, ‰º‘º—TŒ©Žq2, –{‘œ—Œb3, ‰ÄŽR@‘ì4 ,‹{’nLŒá3, ‘åÎ@’q3, àVŽR@“§3, “c‘º‘ñ–²5, ŠÖX‘쉛5, —é–؁@‘ñ5, Ž@„Žm5, ŽRŒû–ŸŽq5, ŒFâ^—R”ü5, ŒË“c‰ë–ç6, ’|˜Q–¯]6, ‹{‰ª@“™3 (1Œ’NŠÇ—ƒZ, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ž_, 4’nˆæŽ™“¶ž_, 5“Œ•a‰@ŠÅŒì•”, 6–ƒŒ): ‘æ111‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2015/6/5), ‘åã, ž__ŒoŠw‰ïŽ@ 2015/4; 117Šª (“Á•Ê†): 551.

7231035. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw‘Š–ÍŒŽƒLƒƒƒ“ƒpƒX•~’n“à‘S–Ê‹Ö‰Œ‰»‚ÌŽæ‚è‘g‚Ý. ŒŒŽ‚Ü‚Ç‚©1, ŠÝŒŽŠG—œŽq1, àVŽRŒb”g1, ‹g“c—F‹I1, Žç‰®’B”ü1, 傖Œ—Ï–€2, ’z–ì’qŒb1, ìã”ü’q‘ã2, Ž…@–F2, ŽR“c—TŽq1, Œ“‡^—R1, ‚‹Ž–Ÿ‹`3, ²“¡”Vr3,4, –k—¢‰p˜Y3,5 (1Œ’NŠÇ—ƒZ, 2ŠÅŒì•”, 3–k—¢‘åŠw‹Ö‰Œƒ[ƒLƒ“ƒOƒOƒ‹[ƒv, 4ŒÄ‹zŠíŠO, 5ˆã—Éq¶Šw•”): ‘æ53‰ñ‘S‘‘åŠw•ÛŒ’ŠÇ—Œ€‹†W‰ï (2015/9/10), ·‰ª, ‘S‘‘åŠw•ÛŒ’ŠÇ—Œ€‹†W‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W53‰ñ 2015/8; p.52.

7231036. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Šw¶‘Š’kIŒ‹ŽžƒAƒ“ƒP[ƒg‚©‚ç’T‚éŠw¶‘Š’k‚̃vƒƒZƒX‚ÆŒø‰Ê. ŽR“c—TŽq1, Î’ˏ¹•Û1, ‘å’¬’m‹v1, ‰ÍŒŽ‹v”üŽq1, “c’†‚ ‚ä‚Ý1, ŽRèˆ»”T1, àVŽRŒb”g1, ‹g“c—F‹I1, ŒŒŽ‚Ü‚Ç‚©1, Žç‰®’B”ü1 (1Œ’NŠÇ—ƒZ): ‘æ53‰ñ‘S‘‘åŠw•ÛŒ’ŠÇ—Œ€‹†W‰ï (2015/9/10), ·‰ª, ‘S‘‘åŠw•ÛŒ’ŠÇ—Œ€‹†W‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W53‰ñ 2015/8; p.102.

7231037. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “d‹C‚¯‚¢‚ê‚ñ—Ö@ƒNƒŠƒjƒJƒ‹ƒpƒX‰ü’ù‚ÉŒü‚¯‚ā|‚»‚Ì1|. ‰º‘º—TŒ©Žq1, àVŽRŒb”g2, –{‘œ—Œb3, ‰ÄŽR@‘ì4, ‹{’nLŒá3, ‘åÎ@’q3, ‹{‰ª@“™3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Œ’NŠÇ—ƒZ, 3ž_, 4’nˆæŽ™“¶ž_): ‘æ16‰ñ“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŠwpW‰ï (2015/11/13), ç—t, “ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŽ 2015/10; 17 (4): 570.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H19-310001. [Ç—á•ñ] Reversible Paroxetine-Induced Symptomatic Hypothyroidism. Takahashi M1, Sawayama E2, Sawayama T1, Miyaoka H1: Pharmacopsychiatry 2007/9; 40 (5): 201-2. (‚‹Ž@Œb1, àVŽRŒb”g2, àVŽR@“§1, ‹{‰ª@“™1: 1ž_, 2Œ’NŠÇ—ƒZ)

H20-110001. [ŒŽ’˜] Interpersonal communication skills of patients with schizophrenia, depression, neurotic disorder, and eating disorder. Inoue A, Takahashi M1, Sawayama E2, Nakajima K1, Tanaka S1, Miyaoka H1: Kitasato Med J 2008//9; 38 (2): 128-33. (ˆäã@Ê, ‚‹Ž@Œb1,àVŽRŒb”g2, ’†“‡Œ[‰î1, “c’†‘”ü1, ‹{‰ª@“™1: 1ž_, 2Œ’NŠÇ—ƒZ)

H20-110002. [ŒŽ’˜] Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy. Sawayama E1, Takahashi M2, Inoue A, Nakajima K2, Kano A, Sawayama T2, Okutomi T3, Miyaoka H2: J ECT 2008/9; 24 (3): 195-8. (àVŽRŒb”g1, ‚‹Ž@Œb2, ˆäã@Ê, ’†“‡Œ[‰î2, àVŽR@“§2, ‰œ•xr”V3, ‹{‰ª@“™2: 1Œ’NŠÇ—ƒZ, 2ž_, 3–ƒŒ)

H20-110003. [ŒŽ’˜] Assessing Multi-Dimensional Cognition of Drinking Among Alcohol-Dependent Patients: Development and Validation of a Drinking-Related Cognition Scale (DRCS). Sawayama T1, Yoneda J, Tanaka K2, Shirakawa N, Sawayama E3, Higuchi S, Miyaoka H1: Addictive Behaviors 2009/1; 34 (1): 82-5. (àVŽR@“§1, “c’†Žr2, àVŽRŒb”g3, ‹{‰ª@“™1: 1ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3Œ’NŠÇ—ƒZ)

H21-110001. [ŒŽ’˜] Characteristics of elderly people using the psychiatric emergency system. Sawayama E1, Takahashi M2, Arai H3, Kano A2, Sawayama T2, Miyaoka H2: Psychiatry and Clinical Neurosciences 2009/8; 63 (8): 577-9. (àVŽRŒb”g1, ‚‹Ž@Œb2, Vˆä‹v–«3, ‰Ã”[–ŸŽq2, àVŽR@“§2, ‹{‰ª@“™2: 1Œ’NŠÇ—ƒZ, 2ž_, 3‹~–œ)

H22-521001. [‰ðà]y¡•é‚µ‚ÆŒ’N‘Š’kŽºz‚€‚•a‚Ì“d‹C‚¯‚¢‚ê‚ñ—Ö@. àVŽRŒb”g1, ‚‹Ž@Œb2 (1Œ’NŠÇ—ƒZ, 2ž_): •é‚炵‚ÆŒ’N 2010/9; 10ŒŽ†: 84.

[’˜@‘]

H22-620002. [Šwp‘ (•ª’SŽ·•M)]yž_‰È—Տ°ƒxƒXƒgƒAƒhƒ”ƒ@ƒCƒX@ƒ}ƒjƒ…ƒAƒ‹‚©‚ç‚Í“Ÿ‚ç‚ê‚È‚¢Œ»ê‚Ì‹Zp‚Ì‚·‚ׂāzK. C³Œ^“d‹C‚¯‚¢‚ê‚ñ—Ö@|³‚µ‚­s‚€‚œ‚ß‚É, p.202-6. àVŽRŒb”g (Œ’NŠÇ—ƒZ), •Ò: ó–ì@œ, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2010/4”­s.

H23-620005. [Šwp‘ (•ª’SŽ·•M)]yƒXƒgƒŒƒX‰ÈŠwŽ«“TzŽ©—¥_ŒoŽž’²Ç, p.491. g‘Ì•\Œ»«Ž©—¥_Œo‹@”\•s‘S, p.523. àVŽRŒb”g1, ‹{‰ª@“™2 (1Œ’NŠÇ—ƒZ, 2ž_), ŠÄC: “ú–{ƒXƒgƒŒƒXŠw‰ï, à’c–@lƒpƒuƒŠƒbƒNƒwƒ‹ƒXƒŠƒT[ƒ`ƒZƒ“ƒ^[, ŽÀ–±‹³ˆço”Å, “Œ‹ž, 2011/6”­s.

H25-622004. [Šwp‘ (–|–ó)]yž_•a«‚€‚•a@•a‘Ô‚ÌŒ©—§‚Ä‚ÆŽ¡—Ázã“c@—@, àVŽRŒb”g1 (1Œ’NŠÇ—ƒZ), ¯˜a‘“X, “Œ‹ž, 2013”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H18-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ž_‰È‹~‹}‚É‚¯‚鍂—îŽÒ‚ÌŽÀ‘Ô. àVŽRŒb”g1, ‚‹Ž@Œb2, ’†“‡Œ[‰î2, ‹{‰ª@“™2 (1Œ’NŠÇ—ƒZ, 2ž_): ‘æ26‰ñ“ú–{ŽÐ‰ïž_Šw‰ï (2007/3/23), ‰¡•l.

H23-723013. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Š–ÍŒŽŽs­—ߎw’è“sŽsˆÚsŒã‚ÌŽ©ŽE‘΍ô‚ÌŽæ‚è‘g‚Ý. ‘å’|ŽOç‘ã, àVŽRŒb”g1, —é–ØŽu–ƒŽq2, ‘Œ (1Œ’NŠÇ—ƒZ, 2ž_): ‘æ35‰ñ“ú–{Ž©ŽE—\–hŠw‰ï‘‰ï (2011/12/15-17), ‰«“ê.

H25-723011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) C³Œ^“d‹C‚¯‚¢‚ê‚ñ—Ö@‚ª—LŒø‚Å‚ ‚Á‚œ”]“®–¬áŽ‚ð‡•¹‚µ‚œ‚€‚•aÇ—á. “‡–ì•ü–ç1, ‘å—Ñ‘ñŽ÷, ‹àŽq°, ‰ÄŽR@‘ì2, àVŽRŒb”g3, ‹{’nLŒá1, ’|˜Q–¯]4, ‘åÎ@’q1, ‹{‰ª@“™1 (1ž_, 2’nˆæŽ™“¶ž_, 3Œ’NŠÇ—ƒZ, 4–ƒŒ): ‘æ26‰ñ“ú–{‘‡•a‰@ž_ˆãŠw‰ï‘‰ï (2013/11/29-30), ‹ž“s.


–k—¢‘åŠw•a‰@

ŠÅŒì•”

[Šwp˜_•¶]

120068. [ŒŽ’˜] “§ÍƒNƒŠƒjƒbƒN‚ƈڐA•a‰@‚̘AŒg‚É‚š‚¯‚铧ÍŠÅŒìŽt‚Ì–ðŠ„. ”ªŒŽñ“ú‰À‘ã, —Ž‡—¢“Þ, ‚‹Ž_—Y, –ìŒû•¶”T1, Îˆä‘å•ã2, ‹g“cˆê¬3, ‚‹Ž—Tˆê˜Y (1ŠÅŒì•”, 2”å”AŠí, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): “ú–{—Տ°tˆÚAŠw‰ïŽGŽ 2015/12; 3 (2): 276-8.

120069. [ŒŽ’˜] ¶‘̐tƒhƒi[‚ÌŽx‰‡‘̐§|ŠO—ˆŠÅŒìƒAƒZƒXƒƒ“ƒgŽÀŽ{‚ÆŠO—ˆŠÅŒìŽt‰î“ü|. “c’†”üŽ÷1, –ìŒû•¶”T1, ˆä‘º—[•P1, ‹g“c•üŽq2, ’r“c¬]3, ‰Í“c‘œ‰Á1, Îˆä‘å•ã3, ‹g“cˆê¬4 (1ŠÅŒì•”, 2‰h—{•”, 3”å”AŠí, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): “ú–{—Տ°tˆÚAŠw‰ïŽGŽ 2015/12; 3 (2): 279-82.

522209. [uÀ]y“ÁW: VlŠÅŒìEˆõŒ€C“w—Í‹`–±‰»‚©‚ç5”N@¡‚±‚»ˆç‚Ä‚éu—Տ°ŠÅŒì‹³ˆçv‚̃XƒyƒVƒƒƒŠƒXƒgz[À’k‰ï: ¡‚±‚»ˆç‚Ä‚éu—Տ°ŠÅŒì‹³ˆçv‚̃XƒyƒVƒƒƒŠƒXƒg] ƒPƒA‚ÌŽ¿‚ð‚‚ß‚éu—Տ°‹³ˆçŽÒvˆç¬‚Ì•û–@˜_. ‰œ@—T”ü1, ²X–ØŠô”ü2, •Ê•{çŒb3, ŽO‰Y—F—Žq1 (1¹˜H‰Á‘Û‘åŠw, 2“ú–{Ô\ŽšŠÅŒì‘åŠw, 3ŠÅŒì•”): ŠÅŒìŠÇ— 2015/6; 25 (6): 468-75.

522210. [uÀ]y“ÁW: ŠÅŒìŠÇ—ŽÒ‚̃Rƒ“ƒsƒeƒ“ƒV[@L‚ª‚éŽæ‚è‘g‚݂Ɛi‰»z–k—¢‘åŠw•a‰@‚É‚š‚¯‚éŠÅŒìŠÇ—ŽÒ‚̃Rƒ“ƒsƒeƒ“ƒV[: ƒNƒŠƒjƒJƒ‹ƒ‰ƒ_[‚ƘA“®‚³‚¹‚œƒLƒƒƒŠƒAƒpƒX‚ÌŠJ”­. •Ê•{çŒb (ŠÅŒì•”): ŠÅŒìŠÇ— 2015/7; 25 (7): 571-8.

522211. [uÀ]y“ÁW: ˆê”Ê•a“ƒi[ƒX‚É‚à–𗧂Â! u‚È‚ñ‚©ƒwƒ“?v‚ðŒ©”²‚­! ‹}•Ï‘O‚ÌŽ@’mšƒAƒZƒXƒƒ“ƒgšƒhƒNƒ^[ƒR[ƒ‹ (RRT—v¿) ƒ~ƒ‰ƒNƒ‹™ƒƒ\ƒbƒhzXˆÀŒbŽÀ (ŠÅŒì•”ERST/RRTŽº): Emergency Care 2015/8; 28 (8): “ÁW•ÒW.

522212. [uÀ]y“ÁW: ˆê”Ê•a“ƒi[ƒX‚É‚à–𗧂Â! u‚È‚ñ‚©ƒwƒ“?v‚ðŒ©”²‚­! ‹}•Ï‘O‚ÌŽ@’mšƒAƒZƒXƒƒ“ƒgšƒhƒNƒ^[ƒR[ƒ‹ (RRT—v¿) ƒ~ƒ‰ƒNƒ‹™ƒƒ\ƒbƒhz2. ƒhƒNƒ^[ƒR[ƒ‹, ‰ž‰‡—v¿ (MET/RRTŠÜ‚Þ) Žž‚Í‚±‚ê‚𒍈ӂµ‚Ä! XˆÀŒbŽÀ (ŠÅŒì•”ERST/RRTŽº): Emergency Care 2015/8; 28 (8): 758-61.

522213. [uÀ]y“ÁW: ˆê”Ê•a“ƒi[ƒX‚É‚à–𗧂Â! u‚È‚ñ‚©ƒwƒ“?v‚ðŒ©”²‚­! ‹}•Ï‘O‚ÌŽ@’mšƒAƒZƒXƒƒ“ƒgšƒhƒNƒ^[ƒR[ƒ‹ (RRT—v¿) ƒ~ƒ‰ƒNƒ‹™ƒƒ\ƒbƒhz5. ŒŒˆ³‚Ÿ‚¯‚Å‚Í”»’f‚Å‚«‚È‚¢?!@”‚Š‚ĐG‚ê‚Ä‘š‚Š‚éuzŠÂv‚ُ̈í. ꎓ¡k•œ (ŠÅŒì•”): Emergency Care 2015/8; 28 (8): 774-81.

522214. [uÀ]y“ÁW: ˆê”Ê•a“ƒi[ƒX‚É‚à–𗧂Â! u‚È‚ñ‚©ƒwƒ“?v‚ðŒ©”²‚­! ‹}•Ï‘O‚ÌŽ@’mšƒAƒZƒXƒƒ“ƒgšƒhƒNƒ^[ƒR[ƒ‹ (RRT—v¿) ƒ~ƒ‰ƒNƒ‹™ƒƒ\ƒbƒhz6.uˆÓŽ¯v‚ُ̈í‚ÍŒX–°, žNžO, ‚¹‚ñ–Ï, •s‰ž, ‚È‚Ç‚È‚Ç‚©‚ç. “à“¡ˆŸŽ÷ (ŠÅŒì•”): Emergency Care 2015/8; 28 (8): 782-6.

522215. [uÀ]y“ÁW: ˆê”Ê•a“ƒi[ƒX‚É‚à–𗧂Â! u‚È‚ñ‚©ƒwƒ“?v‚ðŒ©”²‚­! ‹}•Ï‘O‚ÌŽ@’mšƒAƒZƒXƒƒ“ƒgšƒhƒNƒ^[ƒR[ƒ‹ (RRT—v¿) ƒ~ƒ‰ƒNƒ‹™ƒƒ\ƒbƒhz7.u‚È‚ñ‚©S”zv, ‘æ˜ZŠŽ‚ðM‚¶‚Ä, Œû‚ɏo‚µ‚Ä‚Ý‚Ä. XˆÀŒbŽÀ (ŠÅŒì•”ERST/RRTŽº): Emergency Care 2015/8; 28 (8): 787-91.

522216. [uÀ]y“ÁW: ˆê”Ê•a“ƒi[ƒX‚É‚à–𗧂Â! u‚È‚ñ‚©ƒwƒ“?v‚ðŒ©”²‚­! ‹}•Ï‘O‚ÌŽ@’mšƒAƒZƒXƒƒ“ƒgšƒhƒNƒ^[ƒR[. ‘å’J®–ç (ŠÅŒì•”): Emergency Care 2015/8; 28 (8): 792-5.

522217. [uÀ]y“ÁW: ƒpƒpƒb‚ÆŒ©‚ăYƒoƒb‚Æ‚í‚©‚é! Œ©“Š‚·‚È! ‹~‹}Š³ŽÒ‚̏ǏóEŠŒ©30`‹Ù‹}‘Ήž? Œo‰ßŠÏŽ@?`z8. –ƒáƒ. ŠŽR˜a”ü (ŠÅŒì•”): Emergency Care 2015/9; 28 (9): 860-1.

522218. [uÀ]y“ÁW: ƒpƒpƒb‚ÆŒ©‚ăYƒoƒb‚Æ‚í‚©‚é! Œ©“Š‚·‚È! ‹~‹}Š³ŽÒ‚̏ǏóEŠŒ©30`‹Ù‹}‘Ήž? Œo‰ßŠÏŽ@?`z23. ‰º—Ÿ. ŠŽR˜a”ü (ŠÅŒì•”): Emergency Care 2015/9; 28 (9): 886-7.

522219. [uÀ]y“ÁW: ‘æ20‰ñ¹˜H‰ÁŠÅŒìŠw‰ïŠwp‘å‰ïƒVƒ“ƒ|ƒWƒEƒ€z‹³ˆç‚ÆŽÀ‘H‚̃n[ƒ‚ƒj[: –k—¢‘åŠw•a‰@ŠÅŒì•”‚Æ–k—¢‘åŠwŠÅŒìŠw•”‚ÌŽæ‚è‘g‚Ý‚ð’Ê‚µ‚Ä. •Ê•{çŒb (ŠÅŒì•”): ¹˜H‰ÁŠÅŒìŠw‰ïŽ 2016/1; 19 (2): 68-71.

522220. [uÀ]y“ÁW: ƒCƒU!‚̏ê–Ê‚à‚ ‚í‚Ä‚È‚¢ IABPEPCPSƒPƒA‚ð‚œ‚·‚¯‚é‹ÉˆÓ20z ‹ÉˆÓ (‚»‚Ì5) oŒŒ‘΍ô‚É‚Í, ‘}“ü•”‚ÌŠÇ—‚ƍR‹ÃŒÅŠÇ—‚ðŠmŽÀ‚ɍs‚€! ꎓ¡k•œ (ŠÅŒì•”): ƒn[ƒgƒi[ƒVƒ“ƒO 2016/1; 29 (1): 36-7.

522221. [uÀ]y“ÁW: Feature Topic@‘ŠúŠÉ˜aƒPƒA‚̐³‘́z[ƒCƒ“ƒ^ƒrƒ…[]uf’fŽž‚©‚ç‚̊ɘaƒPƒAv‚Ɓu‘Šú‚©‚ç‚̊ɘaƒPƒAv‚ÌŠÔ‚É‚ ‚é‚à‚Ì. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): Cancer Board Square 2016/2; 2 (1): 48-54.

522222. [uÀ]y“ÁW: ‚¹‚ñ–ς̃Aƒhƒoƒ“ƒXƒh‚È’mŽ¯‚ÆŽÀ‘H|ŠÉ˜aƒPƒA‚̃GƒLƒXƒp[ƒg‚É•K{‚̃XƒLƒ‹z‚¹‚ñ–ÏŽ¡—Öò‚Ì“Ú—p‚̍H•v@ƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“: ‚¹‚ñ–ÏŠ³ŽÒ‚ƉƑ°‚̑Ήž. Šâ–{ƒŽq (ŠÅŒì•”): ŠÉ˜aƒPƒA 2016/3; 26 (2): 135-8.

[’˜@‘]

620149. [Šwp‘] (•ÒW)yˆê”Ê•a“‚Å‚Å‚«‚é! ‚ª‚ñŠ³ŽÒ‚ÌŠÅŽæ‚è‚̃PƒA ‰ü’ù”Łz•Ò: à_ŒûŒbŽq1, ¬”—•y”üŒb2, çø“”ü“oŽq3, ‚‹Ž”ü‰êŽq4, ‘å’J–Ø–õŽq5 (1‚ª‚ñŒ€‹†‰ï—L–Ÿ•a‰@, 2‰¡•lŽs—§Žs–¯•a‰@, 3ŠÅŒì•”, 4¹˜H‰Á‘Û•a‰@, 5Œ³º˜a‘åŠw‰¡•lŽs–k•”•a‰@), “ú–{ŠÅŒì‹Š‰ïo”ʼnï, “Œ‹ž, 2015/6”­s.

620150. [Šwp‘] (‹€’˜)yˆê”Ê•a“‚Å‚Å‚«‚é! ‚ª‚ñŠ³ŽÒ‚ÌŠÅŽæ‚è‚̃PƒA ‰ü’ù”Łz‘æ2Í ‚ª‚ñŠ³ŽÒ‚ª‚œ‚Ç‚é—×{‰ß’ö‚ÆŠÅŽæ‚è‚̃PƒA@1. ‚ª‚ñŠ³ŽÒ‚ª‚œ‚Ç‚é—×{‰ß’ö‚Ì“Á’¥, p.54-8. çø“”ü“oŽq1, –]ŒŽ”ü•ä1 (1ŠÅŒì•”), •Ò: à_ŒûŒbŽq2, ¬”—•y”üŒb3, çø“”ü“oŽq1, ‚‹Ž”ü‰êŽq4, ‘å’J–Ø–õŽq5 (2‚ª‚ñŒ€‹†‰ï—L–Ÿ•a‰@, 3‰¡•lŽs—§Žs–¯•a‰@, 4¹˜H‰Á‘Û•a‰@, 5Œ³º˜a‘åŠw‰¡•lŽs–k•”•a‰@), “ú–{ŠÅŒì‹Š‰ïo”ʼnï, “Œ‹ž, 2015/6”­s.

620151. [Šwp‘] (‹€’˜)yˆê”Ê•a“‚Å‚Å‚«‚é! ‚ª‚ñŠ³ŽÒ‚ÌŠÅŽæ‚è‚̃PƒA ‰ü’ù”Łz‘æ2Í ‚ª‚ñŠ³ŽÒ‚ª‚œ‚Ç‚é—×{‰ß’ö‚ÆŠÅŽæ‚è‚̃PƒA@3. —ՏIŠú‚̃PƒA, p.63-7. çø“”ü“oŽq1, ’·’Jì“ÞŽq1 (1ŠÅŒì•”), •Ò: à_ŒûŒbŽq2, ¬”—•y”üŒb3, çø“”ü“oŽq1, ‚‹Ž”ü‰êŽq4, ‘å’J–Ø–õŽq5 (2‚ª‚ñŒ€‹†‰ï—L–Ÿ•a‰@, 3‰¡•lŽs—§Žs–¯•a‰@, 4¹˜H‰Á‘Û•a‰@, 5Œ³º˜a‘åŠw‰¡•lŽs–k•”•a‰@), “ú–{ŠÅŒì‹Š‰ïo”ʼnï, “Œ‹ž, 2015/6”­s.

620152. [Šwp‘] (•ª’SŽ·•M)yê–åŠÅŒìŽt‚ÌŽvl‚ÆŽÀ‘Hz‘æIIIÍ ŽÀ‘H‚̃ŠƒtƒŒƒNƒVƒ‡ƒ“@CASE 11. •êe‚̏I––Šú‚É, ‰Æ‘°‚Ì‹­‚Ý‚ðˆø‚«o‚·Žx‰‡ (1)@ˆã—ÃŽÒ‚ÌŽv‚¢‚ÆŒ»ó‚Ì‚ž‚ê‚ðC³‚µ, ‰Æ‘°Žx‰‡‚Ì–Ú•W‚𗧂Ăé, p.76-81. ‚Œ©‹IŽq1 (1ŠÅŒì•”), ŠÄC: ˆä•”rŽq2, ‘吶’è‹`3 (2¹˜H‰Á‘Û‘åŠw, 3—§‹³‘åŠwŽÐ‰ïŠw•”), •Ò: ê–åŠÅŒìŽt‚̗Տ°„˜_Œ€‹†‰ï, ˆãŠw‘‰@, “Œ‹ž, 2015/6”­s.

620153. [Šwp‘] (•ª’SŽ·•M)yê–åŠÅŒìŽt‚ÌŽvl‚ÆŽÀ‘Hz‘æIVÍ Š³ŽÒ‚Æ‚ÌŽ¡—ÓIƒp[ƒgƒi[ƒVƒbƒv‚ÌŒ`¬@CASE 12. •êe‚̏I––Šú‚É, ‰Æ‘°‚Ì‹­‚Ý‚ðˆø‚«o‚·Žx‰‡ (2)@ŒÂX‚̉Ƒ°‚ɈӐ}“I‚ɉî“ü‚µ, Žc‚³‚ê‚œŽžŠÔ‚ð‰Æ‘°‚ʼn߂²‚·, p.84-9. ‚Œ©‹IŽq1 (1ŠÅŒì•”), ŠÄC: ˆä•”rŽq2, ‘吶’è‹`3 (2¹˜H‰Á‘Û‘åŠw, 3—§‹³‘åŠwŽÐ‰ïŠw•”), •Ò: ê–åŠÅŒìŽt‚̗Տ°„˜_Œ€‹†‰ï, ˆãŠw‘‰@, “Œ‹ž, 2015/6”­s.

620154. [Šwp‘] (’P’˜)y—Տ°E‚ª‚ñƒTƒoƒCƒo[ƒVƒbƒvg¶‚«‚Ê‚­—́h‚ð‚‚ß‚é‚©‚©‚í‚èz‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”), ŠÄC: “ì@—TŽq (‚’mŒ§—§‘åŠw), ’‡‘º‘—Ñ, “Œ‹ž, 2015/10”­s.

620155. [Šwp‘] (•ª’SŽ·•M)yV‘ÌŒnŠÅŒìŠw‘S‘@ê–啪–ìII¬lŠÅŒìŠw…I@—«¶BŠíz˜Í —«¶BŠíŽŸŠ³‚ð‚à‚¬l‚ð—‰ð‚·‚é‚œ‚߂Ɂ@II. —«¶BŠíŽŸŠ³‚Ì“Á«‚Æ‹ß”N‚ÌŒXŒü, p.5-15. ‘ºã”üŒb1 (1ŠÅŒì•”), •Ò: ‰¶“c‹MŽu2, ’|‘º’õŽq1 (2•wl), ƒƒaƒJƒ‹ƒtƒŒƒ“ƒhŽÐ, “Œ‹ž, 2015/11”­s.

620156. [Šwp‘] (•ª’SŽ·•M)yV‘ÌŒnŠÅŒìŠw‘S‘@ê–啪–ìII¬lŠÅŒìŠw…I@—«¶BŠíz[‘æ2•Ò —«¶BŠíŽŸŽŸŠ³Š³ŽÒ‚ÌŠÅŒì]@‘æ1Í ŠÅŒìŠˆ“®‚ÌŠî–{, p.196-224. ²“¡Ø1 (1ŠÅŒì•”), •Ò: ‰¶“c‹MŽu2, ’|‘º’õŽq1 (2•wl), ƒƒaƒJƒ‹ƒtƒŒƒ“ƒhŽÐ, “Œ‹ž, 2015/11”­s.

620157. [Šwp‘] (•ª’SŽ·•M)yV‘ÌŒnŠÅŒìŠw‘S‘@ê–啪–ìII¬lŠÅŒìŠw…I@—«¶BŠíz[‘æ2•Ò —«¶BŠíŽŸŽŸŠ³Š³ŽÒ‚ÌŠÅŒì]@‘æ5Í Ž–—á‚É‚æ‚éŠÅŒì‰ß’ö‚Ì“WŠJ@1. œ”Õ“àÄ”­‚ð‚µ‚œŽq‹{èò‚ª‚ñŠ³ŽÒ‚̍ݑî‚Ö‚ÌŽx‰‡, p.330-7. ²“¡Ø1, ²“¡”ü‹I1 (1ŠÅŒì•”), •Ò: ‰¶“c‹MŽu2, ’|‘º’õŽq1 (2•wl), ƒƒaƒJƒ‹ƒtƒŒƒ“ƒhŽÐ, “Œ‹ž, 2015/11”­s.

620158. [Šwp‘] (•ÒW)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNzŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’1, XˆÀŒbŽÀ2 (1’}”g‘åŠw•a‰@, 2ŠÅŒì•”ERST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620159. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@1. ‚š‚³‚Š‚Ä‚š‚­‚ׂ«Šî–{ƒPƒA@EˆÓŽ¯ƒŒƒxƒ‹‚ÌŠm”F, p.8-13. ˜a’m—ÉŽq1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620160. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@1. ‚š‚³‚Š‚Ä‚š‚­‚ׂ«Šî–{ƒPƒA@E“µE‚Æ–ƒŒ‚ÌŠÏŽ@, p.14-9. ŠÖ@ˆê”n1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620161. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@2. zŠÂŠÇ—@A. Šî‘b’mŽ¯@EzŠÂ“®‘Ԃ̍l‚Š•û, p.96-9. “à“¡ˆŸŽ÷1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620162. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@2. zŠÂŠÇ—@B. ƒ‚ƒjƒ^ƒŠƒ“ƒO@E“®–¬ƒJƒe[ƒeƒ‹, p.104-7. “c’†—R—œˆŸ1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620163. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@3. ŒÄ‹zŠÇ—@A. Šî‘b’mŽ¯@EŒÄ‹zó‘Ԃ̍l‚Š•û, p.152-5. “à“¡ˆŸŽ÷1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620164. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@3. ŒÄ‹zŠÇ—@B. ƒ‚ƒjƒ^ƒŠƒ“ƒO@EŒÄ‹z‰¹‚Ì’®Žæ, p.156-61. “ñˆä—DŽq1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620165. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@3. ŒÄ‹zŠÇ—@B. ƒ‚ƒjƒ^ƒŠƒ“ƒO@E“®–¬ŒŒƒKƒX•ªÍ, p.162-7. ˆÀdŽµ‰Ä1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620166. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@3. ŒÄ‹zŠÇ—@B. ƒ‚ƒjƒ^ƒŠƒ“ƒO@Eƒpƒ‹ƒXƒIƒLƒVƒƒgƒŠ[, p.168-71. ‰i‰ª@–õ1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620167. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@3. ŒÄ‹zŠÇ—@C. Ž_‘f—Ö@@EŽ_‘f—Ö@, p.176-9. ŒÃŽs‘¥Œõ1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620168. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@3. ŒÄ‹zŠÇ—@D. ‹C“¹Šm•Û‚ÆŠÇ—@E‹CŠÇ‘}ŠÇ, p.184-9. Œ“cGˆê1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620169. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ1Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚ÌŠÅŒìƒPƒA@3. ŒÄ‹zŠÇ—@E. lHŒÄ‹z—Ö@@ENPPV (”ñNP“I—zˆ³Š·‹C), p.234-40. ìŒû^—1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620170. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ2ÍƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚Ì‚š‚à‚ÈŽŸŠ³@EÒ‘‘¹, p.301-5. ’·–ì—F‹IŽq1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620171. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ2Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚Ì‚š‚à‚ÈŽŸŠ³@EÁ‰»ŠÇúEpŒã, p.383-8. –x]çŒbŽq1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620172. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ2Í ƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚Ì‚š‚à‚ÈŽŸŠ³@EdÇ‹}«äX‰Š, p.396-402. ²X–ØŒ°Žq1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620173. [Šwp‘] (•ª’SŽ·•M)yICUƒi[ƒXƒ|ƒPƒbƒgƒuƒbƒNz‘æ2ÍƒNƒŠƒeƒBƒJƒ‹ƒPƒA—̈æ‚Ì‚š‚à‚ÈŽŸŠ³@E”M, p.403-8. “y‰®Žu•Û1 (1ŠÅŒì•”), ŠÄC: JSEPTICŠÅŒì•”‰ï, •Ò: ‰K–ì–ØŒ’2, XˆÀŒbŽÀ1,3 (2’}”g‘åŠw•a‰@, 3RST/RRTŽº), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2015/11”­s.

620174. [Šwp‘] (•ª’SŽ·•M)y•Ç‚ðæ‚è‰z‚Š‚Ä‚«‚œŠÅŒìŠÇ—ŽÒ‚œ‚¿@‚»‚ÌŽæ‚è‘g‚Ý‚Æ“Ë”j—Í (ŠÅŒì“W–]2016”N1ŒŽ‘Š§†)zPart 2-•”’·E•›•”’·•Ò@2. •a“E•a°ŠÇ—@•Ï‰»‚ðƒ`ƒƒƒ“ƒX‚É: ŠÅŒì•”Žå“±‚É‚æ‚é•a°ƒ}ƒlƒWƒƒ“ƒg‚Ö‚Ì’§í p.142-7. —é–Ø”üŽ}Žq (ŠÅŒì•”), ƒƒaƒJƒ‹ƒtƒŒƒ“ƒhŽÐ, “Œ‹ž, 2015/12”­s.

620175. [Šwp‘] (•ª’SŽ·•M)y•Ç‚ðæ‚è‰z‚Š‚Ä‚«‚œŠÅŒìŠÇ—ŽÒ‚œ‚¿@‚»‚ÌŽæ‚è‘g‚Ý‚Æ“Ë”j—Í (ŠÅŒì“W–]2016”N1ŒŽ‘Š§†)zPart3-Žt’·•Ò@2. ‘ŒEŽí‚Æ‚Ì‹Š“­@V‚œ‚ÈŠO—ˆf—Â̑̐§‚­‚è‚É‚š‚¯‚鍢“ï‚Æ‚»‚ê‚ðæ‚è‰z‚Š‚Ä“Ÿ‚œ‚à‚Ì: f—ÃAƒVƒXƒ^ƒ“ƒg“±“ü‚Ü‚Å‚ÌŒoˆÜ, p208-13. ’†“ˆO”ü (ŠÅŒì•”), ƒƒWƒJƒ‹ƒtƒŒƒ“ƒhŽÐ, “Œ‹ž, 2016/1”­s.

620176. [Šwp‘] (ŠÄC)y‚š‚œ‚·‚¯ŠÅŒìƒiƒrƒJ[ƒh ‘æ2”ŁzŠÄC: ’––”ŽŽq1, Ž…@–F2 (1Œ³ŠÅŒì•”, 2ŠÅŒì•”), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2016/3”­s.

620177. [Šwp‘] (•ÒW)y<‚ª‚ñŠÅŒìŽÀ‘HƒKƒCƒh> ‚ª‚ñŠÅŒì‚Ì“úí‚É‚ ‚é—Ï—@ŠÅŒìŽt‚ªŒ©“Š‚³‚È‚©‚Á‚œ13Ž–—ázŠÄC: ˆê”ÊŽÐ’c–@l “ú–{‚ª‚ñŠÅŒìŠw‰ï, •Ò: ‹ß“¡‚Ü‚ä‚Ý1, ”~“c@Œb2 (1ŠÅŒì•”, 2º˜a‘åŠw‘åŠw‰@•ÛŒ’ˆã—ÊwŒ€‹†‰È), ˆãŠw‘‰@, “Œ‹ž, 2016/3”­s.

620178. [Šwp‘] (•ª’SŽ·•M)y<‚ª‚ñŠÅŒìŽÀ‘HƒKƒCƒh> ‚ª‚ñŠÅŒì‚Ì“úí‚É‚ ‚é—Ï—@ŠÅŒìŽt‚ªŒ©“Š‚³‚È‚©‚Á‚œ13Ž–—áz‘æ1Í ‘˜_@‚ª‚ñŠÅŒì‚Ì“úí‚Æ—Ï—@1. ŠÅŒìŽt‚É‹‚ß‚ç‚ê‚é–ðŠ„‚Æ‚Í, p.2-10. ‹ß“¡‚Ü‚ä‚Ý1 (1ŠÅŒì•”), ŠÄC: ˆê”ÊŽÐ’c–@l “ú–{‚ª‚ñŠÅŒìŠw‰ï, •Ò: ‹ß“¡‚Ü‚ä‚Ý1, ”~“c@Œb2 (2º˜a‘åŠw‘åŠw‰@•ÛŒ’ˆã—ÊwŒ€‹†‰È), ˆãŠw‘‰@, “Œ‹ž, 2016/3”­s.

620179. [Šwp‘] (•ª’SŽ·•M)y<‚ª‚ñŠÅŒìŽÀ‘HƒKƒCƒh> ‚ª‚ñŠÅŒì‚Ì“úí‚É‚ ‚é—Ï—@ŠÅŒìŽt‚ªŒ©“Š‚³‚È‚©‚Á‚œ13Ž–—áz‘æ1Í ‘˜_@‚ª‚ñŠÅŒì‚Ì“úí‚Æ—Ï—@4. ‘Ώۂł ‚銳ŽÒ‚Ì—Í‚ð‘š‚Š‚鎋“_|‚ª‚ñƒTƒoƒCƒo[ƒVƒbƒv‚ƃZƒ‹ƒtƒAƒhƒ{ƒJƒV[ , p.37-40. ‹ß“¡‚Ü‚ä‚Ý1 (1ŠÅŒì•”), ŠÄC: ˆê”ÊŽÐ’c–@l “ú–{‚ª‚ñŠÅŒìŠw‰ï, •Ò: ‹ß“¡‚Ü‚ä‚Ý1, ”~“c@Œb2 (2º˜a‘åŠw‘åŠw‰@•ÛŒ’ˆã—ÊwŒ€‹†‰È), ˆãŠw‘‰@, “Œ‹ž, 2016/3”­s.

620180. [Šwp‘] (•ª’SŽ·•M)y<‚ª‚ñŠÅŒìŽÀ‘HƒKƒCƒh> ‚ª‚ñŠÅŒì‚Ì“úí‚É‚ ‚é—Ï—@ŠÅŒìŽt‚ªŒ©“Š‚³‚È‚©‚Á‚œ13Ž–—áz‘æ2Í Ž–—á‚Æ‚Æ‚à‚ɍl‚Š‚é ‚ª‚ñŠÅŒì‚Ì“úí‚É‚ ‚é—Ï— [Š³ŽÒ‚̈ӎvŒˆ’è]@6. Š³ŽÒ‚̈ӌü‚𓥂܂Š‚œŽ¡—Â̑I‘ð|‚ç‚ê‚Ä‚¢‚È‚¢Š³ŽÒ‚ÌŽv‚¢‚âƒj[ƒY‚ւ̑Ήž, p.89-97. Ž™‹Ê”ü—R‹I1 (1ŠÅŒì•”), ŠÄC: ˆê”ÊŽÐ’c–@l “ú–{‚ª‚ñŠÅŒìŠw‰ï, •Ò: ‹ß“¡‚Ü‚ä‚Ý1, ”~“c@Œb2 (2º˜a‘åŠw‘åŠw‰@•ÛŒ’ˆã—ÊwŒ€‹†‰È), ˆãŠw‘‰@, “Œ‹ž, 2016/3”­s.

620181. [Šwp‘] (•ª’SŽ·•M)y<‚ª‚ñŠÅŒìŽÀ‘HƒKƒCƒh> ‚ª‚ñŠÅŒì‚Ì“úí‚É‚ ‚é—Ï—@ŠÅŒìŽt‚ªŒ©“Š‚³‚È‚©‚Á‚œ13Ž–—áz‘æ2Í Ž–—á‚Æ‚Æ‚à‚ɍl‚Š‚é ‚ª‚ñŠÅŒì‚Ì“úí‚É‚ ‚é—Ï— [ƒ`[ƒ€“à‚̈ӌ©‚̏ՓË]@14. Žó‚¯Ž‚¿ŠÅŒìŽt‚ÆŠÅŒìƒ`[ƒ€‚ÌŽv‚¢‚Ì‘Šˆá|—Dæ‚³‚ê‚銳ŽÒ‚Ì—˜‰v‚ɂ‚¢‚Ä, ŠÅŒìŽtŠÔ‚ł̈ӌ©‚ª•ª‚©‚ê‚é, p.174-84. Šâ–{ƒŽq1 (1ŠÅŒì•”), ŠÄC: ˆê”ÊŽÐ’c–@l “ú–{‚ª‚ñŠÅŒìŠw‰ï, •Ò: ‹ß“¡‚Ü‚ä‚Ý1, ”~“c@Œb2 (2º˜a‘åŠw‘åŠw‰@•ÛŒ’ˆã—ÊwŒ€‹†‰È), ˆãŠw‘‰@, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722247. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) ‚ ‚Ƃǂ̈ʂł·‚©? ‚Æ•·‚©‚ê‚œ‚ç: ‚Ç‚Ì‚æ‚€‚É—\Œã‚ð—\‘ª‚µ, ‚Ç‚Ì‚æ‚€‚ɘb‚µ‡‚€‚©. X“c’B–ç1, Hui David2, •œŒŽ²“lŽi3, çø“”ü“oŽq4 (1¹—êŽO•ûŒŽ•a‰@, 2ƒeƒLƒTƒX‘åŠwMDƒAƒ“ƒ_[ƒ\ƒ“ƒLƒƒƒ“ƒT[ƒZƒ“ƒ^[, 3ŠŒŽf—ÏŠ, 4ŠÅŒì•”): ‘æ20‰ñ“ú–{ŠÉ˜aˆã—Êw‰ïŠwp‘å‰ï (2015/6/20), _“ސì, ‘æ20‰ñ“ú–{ŠÉ˜aˆã—Êw‰ïŠwp‘å‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/6; p.131-4.

722248. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) ‹~‹}EW’†Ž¡—Â̗§ê‚©‚çI––ŠúŠ³ŽÒ‰Æ‘°‚̃PƒA‚ðl‚Š‚é. ‚‹Ž@Œb (ŠÅŒì•”): ‘æ28‰ñ“ú–{”]Ž€E”]‘h¶Šw‰ï‘‰ïEŠwpW‰ï (2015/7/5), –ŒŒÃ‰®, ”]Ž€E”]‘h¶ 2015/7; 28 (1): 49.

722249. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ’†Œ˜ŠÅŒìŽt‚ÌŽdŽ–‚ÌŒp‘±‚ðŽx‰‡‚·‚é. ²“¡^‹IŽq (ŠÅŒì•”): ‘æ19‰ñ“ú–{ŠÅŒìŠÇ—Šw‰ïŠwpW‰ï (2015/8/29), •Ÿ“‡.

722250. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) —Ž–‰ïŠé‰æ: ‰Æ‘°Žx‰‡ê–åŠÅŒìŽt‚Æ‚µ‚Ă̏[ŽÀ‚Ɛ¬’·‚Ì‚œ‚ß‚É. ‚Œ©‹IŽq1, ŽRŒûŒjŽq2 (1ŠÅŒì•”, 2“ú–{•ŸŽƒ‘åŠw): “ú–{‰Æ‘°ŠÅŒìŠw‰ï‘æ22‰ñŠwpW‰ï (2015/9/5), _“ސì, “ú–{‰Æ‘°ŠÅŒìŠw‰ï‘æ22‰ñŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^ 2015/9; p.58.

722251. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y‘œEŽíŒð—¬ƒZƒbƒVƒ‡ƒ“z¬Ž™Š³ŽÒ‚Ì‘Šú—£°‚ðl‚Š‚æ‚€. ìã‘å•ã (ŠÅŒì•”): ‘æ23‰ñ¬Ž™W’†Ž¡—ρ[ƒNƒVƒ‡ƒbƒv (2015/11/8), ‚‚­‚Î, ‘æ23‰ñ¬Ž™W’†Ž¡—ρ[ƒNƒVƒ‡ƒbƒvŽ‘—¿W 2015; p.193.

722252. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) •Û‘¶Šú/“§Í/ˆÚA/ŠÅŒìƒRƒ‰ƒ{‚µ‚Ü‚¹‚ñ‚©?`¢‚Á‚œ!‚©‚ç‚í‚©‚Á‚œ!‚É‚È‚ë‚€!CKDŠÅŒì‚Ì‚ ‚ꂱ‚ê`. –ìŒû•¶”T1, ¬âŽu•Û2 (1ŠÅŒì•”, 2ã’q‘åŠw): ‘æ18‰ñ“ú–{t•s‘SŠÅŒìŠw‰ïŠwpW‰ïE‘‰ï (2015/11/15), –ŒŒÃ‰®, ‘æ18‰ñ“ú–{t•s‘SŠÅŒìŠw‰ïŠwpW‰ïE‘‰ïŽ˜^ 2015; p.245.

722253. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‘œ—l‰»‚·‚鎡—ÑI‘ð‚É‚š‚¯‚éˆÓŽuŒˆ’èŽx‰‡`æ‚ðŒ©˜‚Š‚œŠ³ŽÒE‰Æ‘°‚Ö‚ÌŽx‰‡`. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2016/2/20), ç—t, ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2016/1; 30 (Suppl): 131.

722254. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) tˆÚAƒ`[ƒ€‚̐¬n‚ƘAŒg‹­‰»‚Ì‚œ‚߂̃R[ƒfƒBƒl[ƒg`RTC‚̈ڐAƒ`[ƒ€‚ւ̃R[ƒfƒBƒl[ƒg‚ÌŽÀÛ`. –ìŒû•¶”T1, ’r“c¬]2, “c’†”üŽ÷1, ˆä‘º—[•P1, ‹g“c•üŽq3, ‹{â—Dl4, Œ‘ò—Ç‘Ÿ5, Îˆä‘å•ã2, ‹g“cˆê¬6 (1ŠÅŒì•”, 2”å”AŠí, 3‰h—{•”, 4–òÜ•”, 5ƒŠƒnƒrƒŠ•”, 6V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/24), ’¹Žæ, ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2016; p.122.

722255. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) ¶‘̃hƒi[Žx‰‡‘̐§‚̍č\’z|‘æ2•ñ|ƒV[ƒ€ƒŒƒX‚ÈŽx‰‡‚ð–ÚŽw‚µ‚Ä. “c’†”üŽ÷1, –ìŒû•¶”T1, ˆä‘º—[•P1, ’r“c¬]2, ‰Í“c‘œ‰Á1, Îˆä‘å•ã2, ‹g“cˆê¬3 (1ŠÅŒì•”, 2”å”AŠí, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/24), ’¹Žæ.

7231038. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠÅŒìê–åŠO—ˆ‚Æ‚µ‚Ä‚àƒXƒLƒ“ƒPƒAŠO—ˆÝ’u‚܂ł̃vƒƒZƒX`‰ß‹Ž11”NŠÔ‚Ì•Ï‘J‚ƍ¡Œã‚̉ۑè`. ŒŒŽN”ü1, Ž‹{”ü‰r1, ²“¡—ÇŽq2, ì‘º”ü‹IŽq2 (1ŠÅŒì•”, 2“Œ•a‰@ŠÅŒì•”): ‘æ24‰ñ“ú–{‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ïŠwpW‰ï (2015/5/30), ç—t, ‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ïŽ 2015/4; 19 (2): 206.

7231039. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠÅŒìê–åŠO—ˆ‚Æ‚µ‚Ä‚àƒXƒLƒ“ƒPƒAŠO—ˆ‚ÌŒ»ó‚ƍ¡Œã‚̉ۑè. Ž‹{”ü‰r1, ŒŒŽN”ü1, ²“¡—ÇŽq2, ì‘º”ü‹IŽq2 (1ŠÅŒì•”, 2“Œ•a‰@ŠÅŒì•”): ‘æ24‰ñ“ú–{‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ïŠwpW‰ï (2015/5/30), ç—t, ‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ïŽ 2015/4; 19 (2): 207.

7231040. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ü‰@Žx‰‡‚É‚š‚¯‚éCNS‚Ì–ðŠ„‚ÉŠÖ‚·‚錟“¢`”F’m‹@”\’ቺ‚ª¶‚¶‚Ä‚¢‚鎖—á‚ւ̉î“ü‚ð’Ê‚µ‚ā`. “c‹v•Û”üç‘ã (ŠÅŒì•”): ‘æ2‰ñ“ú–{CNSŠÅŒìŠw‰ï (2015/6/13), “Œ‹ž, ‘æ2‰ñ“ú–{CNSŠÅŒìŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2015/5; p.86.

7231041. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Š³ŽÒƒT[ƒrƒXŒüã‚Ì‚œ‚߂̃Rƒ“ƒVƒFƒ‹ƒWƒ…‚Ì–ðŠ„. ’†“ˆO”ü1, —é–Ø”üŽ}Žq1 (1ŠÅŒì•”): ‘æ65‰ñ“ú–{•a‰@Šw‰ï (2015/6/18), Œyˆä‘ò, ‘æ65‰ñ“ú–{•a‰@Šw‰ïŽ˜^ 2015/6; p.184.

7231042. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˆÚAŠ³ŽÒ‚Ì“§ÍÄ“±“üŽž‚ÌŒ»ó‚Ɛt•s‘SŠÅŒì˜AŒg. –ìŒû•¶”T1, “c’†”üŽ÷1, ’r“c¬]2, rì–@Žq1, Îˆä‘å•ã2, ‹g“cˆê¬3 (1ŠÅŒì•”, 2”å”AŠí, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/28), _“ސì, “ú–{“§ÍˆãŠw‰ïŽGŽ 2015/5; 48 (1): 582.

7231043. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éu“û–[ÄŒšpŒãƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒvƒƒOƒ‰ƒ€v‚̍쐬`‘æ1•ñ`. Ž™‹Ê”ü—R‹I1, _•Û•‘¥2, ’|“àŠ°l2, Œy•”“ÖŽq2, ’J–ì—Tˆê3, åÎ‹I•F3, ˜m’J”ü“Þ3, Œ‹{—mŽj3, “‡‘qNl4, H–{•ôŽ4, ÎìS‰î4 (1ŠÅŒì•”, 2ƒŠƒnƒrƒŠ•”, 3ŠO‰È, 4Œ`¬E”üŠO): ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2015/7/3), “Œ‹ž.

7231044. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Ï‹É“IŽ¡—Ã’†Ž~Œã‚É‘Sgó‘Ô‚ª‰ü‘P‚µ, RST‚ÌŠÖ—^‚É‚æ‚èlHŒÄ‹zŠí‚©‚ç‚Ì—£’E‚ª¬Œ÷‚µ‚œ‚ƍl‚Š‚ç‚ê‚œˆê—á. ¬ŽR–Ÿ—¢1, XˆÀŒbŽÀ1, ¬’r•üF1, ‘å’Ë’q‹v2, ‹g–ì˜a‹v2, ˆÉ“¡‘s•œ2, •Šâ­”V2, Vˆä³N3 (1ŠÅŒì•”/RSTERRTŽº, 2–ƒŒ, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ37‰ñ“ú–{ŒÄ‹z—Ö@ˆãŠw‰ïŠwpW‰ï (2015/7/18), ‹ž“s.

7231045. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “Æ‹Š³ŽÒ‚Ì‘Þ‰@Žx‰‡‚𑣐i‚·‚éŠÅŒìŽt‚Ì–ðŠ„`I––Šú‚ª‚ñŠ³ŽÒ‚ÌŽ–—á‚ð—p‚¢‚œlŽ@`. ŠÖ–{‰ØŽq1, ‚Œ©‹IŽq1, â‰º’qŽìŽq1 (1ŠÅŒì•”): ‘æ26‰ñ“ú–{Ý‘îˆã—Êw‰ïŠwpW‰ï (2015/7/19), “Œ‹ž, ‘æ26‰ñ“ú–{Ý‘îˆã—Êw‰ïŠwpW‰ïŽ˜^W 2015/6; p.253.

7231046. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬Ž™”MŠ³ŽÒE‰Æ‘°‚ɑ΂·‚éŠO—ˆŠÅŒìŽÀ‘H‚Æ‚»‚̍ª‹’|ŠO—ˆŠÅŒìŽt‚ւ̃Aƒ“ƒP[ƒg‚ð‚à‚ƂɁ|. _’J–FŠG1, ˆÉ“¡FŽq1 (1ŠÅŒì•”): “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ï (2015/7/25), ç—t, “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ïu‰‰W 2015/6; p.163.

7231047. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) PICU‚É‚š‚¯‚éŠÅŒìŽt‚Æ•ÛˆçŽm‚Ì‹Š“­‚ÉŒü‚¯‚œ‚Æ‚è‚­‚Ý‚ª•ÛˆçŽm‚É‹y‚Ú‚µ‚œ‰e‹¿. ˆÉ“¡FŽq (ŠÅŒì•”): “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ï (2015/7/25), ç—t, “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ïu‰‰W 2015/6; p.193.

7231048. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬Ž™W’†Ž¡—Âɂš‚¯‚éŒo•@‹CŠÇƒ`ƒ…[ƒuŒÅ’è‚̈ã—Ê֘A‹@Šíˆ³”—‘n”­¶‚ÉŠÖ‚·‚é—vˆö‚ƍ¡Œã‚̉ۑè. ŽÄ“cƒŽq1, ˆÉ“¡FŽq1 (1ŠÅŒì•”): “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ï (2015/7/25), ç—t, “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ïu‰‰W 2015/6; p.205.

7231049. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬W’†Ž¡—ÃŽº‚É‚š‚¯‚é‘œEŽí˜AŒg‚É‚æ‚éŒÄ‹z—Ö@’ñ‹Ÿ‚ÉŒü‚¯‚œ‚Æ‚è‚­‚݁|¬Ž™RST (Respiratory Support Team) Šˆ“®‚ƍ¡Œã‚̉ۑè|. ’†“cŒ›G1, ˆÉ“¡FŽq1 (1ŠÅŒì•”): “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ï (2015/7/25), ç—t, “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ïu‰‰W 2015/6; p.206.

7231050. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ¬Ž™Šú‚ɐ¶‘̊̈ڐA‚ðŽó‚¯‚œŠ³ŽÒ‚Ì‘ÌŒ±|—×{¶Šˆ‚ɂ‚¢‚Ä‚ÌŒê‚è|. Œ“à‰ÀŽq1, ¬“‡‚ЂŎq2 (1ŠÅŒì•”, 2‘åŠw‰@ŠÅŒìŠwŒ€‹†‰È): “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ï (2015/7/26), ç—t, “ú–{¬Ž™ŠÅŒìŠw‰ï‘æ25‰ñŠwpW‰ïu‰‰W 2015/6; p.138.

7231051. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “¯ŽíœˆÚAp‚̐f—ÕñV‰ü’ù‚ÉŒü‚¯‚œ‘̐ς ‚œ‚è‚Ì“¯Žíœ‘gDì¬”ï—p‚ÌŽZo. Š}ŒŽ‚Ý‚Ç‚è1, “à“cŒ’‘Ÿ˜Y2, ˆäã@Œº2, ‘å’JŒö‹M3, “àŽRŸ•¶2, ˆä‘º‹M”V2, •Ÿ“‡Œ’‰î2, ¬£NŽ¡2, è•”@Œ›2, Ž…–ž·Œ›4 (1ŠÅŒì•”, 2®ŠO, 3œƒoƒ“ƒN, 4”ª‹ã\‰ï‚”ö•a‰@): ‘æ14‰ñ“ú–{‘gDˆÚAŠw‰ï‘‰ïEŠwpW‰ï (2015/8/29), ‘åã, ‘æ14‰ñ“ú–{‘gDˆÚAŠw‰ï‘‰ïEŠwpW‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2015/8; p.38.

7231052. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) A‘åŠw•a‰@ƒNƒŠƒeƒBƒJƒ‹—̈æ‚É‚š‚¯‚é‰ß‹Ž5”NŠÔ‚̈ã—Ê֘A‹@Šíˆ³”—‘n‚Ì”­¶ó‹µ‚Æ—\–h‘΍ô. ŒÑ“c«Žk1, ŒŒŽN”ü1 (1ŠÅŒì•”EåñጊǗŽº): ‘æ17‰ñ“ú–{åñጊw‰ïŠwpW‰ï (2015/8/29), ‹{é, “ú–{åñጊw‰ïŽ 2015/7; 17 (3): 401.

7231053. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) CRC‹Æ–±ƒ}ƒjƒ…ƒAƒ‹‚̍쐬`2•a‰@‚Ì‘gD“‡‚ðŒoŒ±‚µ‚ā`. ŽR–{–ŸŽq1, –ìŒûŒbŽq2, Œ¢’Ë’qŽq2, –쑺¡“úŽq2, ‘O“cŽÀ‰Ô3, ‰¡“cœÄˆê1,3, Œú“cKˆê˜Y3, ŒF’J—YŽ¡1,4 (1—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 2ŠÅŒì•”, 3–òÜ•”, 4—Տ°Œ€‹†EŠé‰æ): ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2015 in KOBE (2015/9/12), _ŒË, ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2015 in KOBEŽ˜^W 2015/8; p.208.

7231054. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚ðŽæ‚è“ü‚ê‚œŽèpŽºŠÅŒìŽt‚Ì‹³ˆç|‘ŸŠí’ñ‹Ÿ”­¶Žž‚̏€”õ‚ƑΉž|. œ}“cŽ1, ‚‹Ž@Œb1, “c‘º¹D1, •º“®—SŽq1 (1ŠÅŒì•”): ‘æ37‰ñ“ú–{ŽèpˆãŠw‰ï‘‰ï (2015/10/2), ‘åã, “ú–{ŽèpˆãŠw‰ïŽ 2015/9; 36: 79.

7231055. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) tˆÚAŒo‰ß‹L˜^‚̃fƒWƒ^ƒ‹‰»`ƒAƒiƒƒO42”N‚Ì—ðŽj‚©‚ç‚̃pƒ‰ƒ_ƒCƒ€ƒ`ƒFƒ“ƒW`. –ìŒû•¶”T1, ’r“c¬]2, “c’†”üŽ÷1, ˆä‘º—[•P1, Â–Ø—L‰Á—¢1, Ž…›’“1, “ü–Ø—›Œb2, rì–@Žq1, Îˆä‘å•ã3, ‹g“cˆê¬4 (1ŠÅŒì•”, 2Ž––±•”, 3”å”AŠí, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ51‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2015/10/2), ŒF–{, ˆÚA 2015/9; 50 (—ÕŽž): 357.

7231056. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”ñˆÚAŽÀŽ{Ž{Ý (AžŒ^VADŽÀŽ{Ž{Ý) ‚É‚š‚¯‚郌ƒVƒsƒGƒ“ƒgˆÚAƒR[ƒfƒBƒl[ƒ^[‚Ì•Ï‘J‚Æ–ðŠ„. ’†“‡ßŽq1, —шŸŠóŽq1, –k‘º@—¥2, ’––”FŒ³3, ’|“àˆê˜Y4, •ó—ˆ“N–ç2, ‹{’n@ŠÓ2, ˆ¢ŒÃ–ç3, ŽR–{‰À“1, ¬‰z–Ÿ”ü1 (1ŠÅŒì•”, 2S‘ŸŒŒŠÇŠO, 3zŠÂŠí“à, 4‹~–œ): ‘æ51‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2015/10/2), ŒF–{, ˆÚA 2015/9; 50 (—ÕŽž): 433.

7231057. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) tˆÚAŠO—ˆ‚ł̃tƒbƒgƒPƒA‚Ì“±“ü`ŠÅŒì‚ÌŽÀÛ‚ƍ¡Œã‚̉ۑè`. ˆä‘º—[•P1, –ŒŽq‰®ˆ€—1, ‘åŠÑŒbŽq1, â–{”~Žq1, “c’†”üŽ÷1, –ìŒû•¶”T1, Â–Ø—L‰Á—¢1, Îˆä‘å•ã2, ‹g“cˆê¬3 (1ŠÅŒì•”, 2”å”AŠí, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ51‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2015/10/2), ŒF–{, ˆÚA 2015; 50 (‘‰ï—ÕŽž): 429.

7231058. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¶‘̐tƒhƒi[‚̐t’ñ‹Ÿ‘O‚©‚ç‚Ì‘Ì’²ŠÇ—‚Ö‚ÌŽæ‚è‘g‚Ý. “c’†”üŽ÷1, –ìŒû•¶”T1, ˆä‘º—[•P1, ‹g“c•üŽq2, ’r“c¬]3, ‰Í“c‘œ‰Á1, Îˆä‘å•ã3, ‹g“cˆê¬4 (1ŠÅŒì•”, 2‰h—{•”, 3”å”AŠí, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ51‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2015/10/3), ŒF–{, ˆÚA 2015; 50 (‘‰ï—ÕŽž): 479.

7231059. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “`’BuK‚ð‰Û‘è‚Æ‚µ‚œBLSƒXƒLƒ‹ƒAƒbƒvŒ€C‚ÌŒø‰Ê. ‹Ë–{çŒb”ü1, ’J@Kˆê1, dM@—º1, ’·–ì—F‹IŽq1 (1ŠÅŒì•”): ‘æ17‰ñ“ú–{‹~‹}ŠÅŒìŠw‰ïŠwpW‰ï (2015/10/16), ²‰ê, “ú–{‹~‹}ŠÅŒìŠw‰ïŽGŽ 2015/10; 17 (3): 182.

7231060. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¬Ž™ŠO—ˆ‚É‚š‚¯‚éƒgƒŠƒA[ƒW“±“ü‚ÉŒü‚¯‚œŽæ‚è‘g‚Ý. ìã‘å•ã (ŠÅŒì•”): ‘æ17‰ñ“ú–{‹~‹}ŠÅŒìŠw‰ïŠwpW‰ï (2015/10/16), ²‰ê, “ú–{‹~‹}ŠÅŒìŠw‰ïŽGŽ 2015/10; 17 (3): 193.

7231061. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œv‰æŠO”²ŠÇ”Œž­‚ÖŒü‚¯‚œŽæ‚è‘g‚Ý‚Ì•ñ. ›–삳‚â‚©1, ˆÉ“¡FŽq1, ’†–ìKŽq1 (1ŠÅŒì•”): ‘æ25‰ñ“ú–{V¶Ž™ŠÅŒìŠw‰ïŠwpW‰ï (2015/10/24), ŠâŽè, “ú–{V¶Ž™ŠÅŒìŠw‰ïu‰‰W25‰ñ 2015/10; p.129.

7231062. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹ŠàŽüpŠúƒTƒ|[ƒgƒ`[ƒ€ (SPEC) ‚É‚š‚¯‚鎕‰È‰î“ü‚ÌŒø‰Ê. ²“¡‚Ý‚³‚ð, ŒE“cç», “ñ‹{‘ì‘å, ‰ª“c—SŽq1, ’·’Jì“ÞŽq1, ‹e’r“Þ•äŽq2, [‘ò²ŒbŽq2, _•Û•‘¥3, ‹{é ‚µ‚Ù3, ‰ª•”‘•c, Ž–ì—R”y4, ‘Ÿ“c’q”Ž5, X’JGŒõ6, •Ð“c‰Ä–ç6, “n粏¹•F6 (1ŠÅŒì•”, 2‰h—{•”, 3ƒŠƒnƒrƒŠ•”, 4Žš•@ˆôAE“ªèòŠO, 5“Œ•a‰@–òÜ•”, 6ŠO‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29), ‹ž“s.

7231063. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) A‘åŠw•a‰@ŒŒ‰t“à‰ÈEÁ‰»Ší“à‰È•a“‚É‚š‚¯‚éR‚ª‚ñÜ”˜˜I‚ÌŒ»ó’²ž. ‚”ö^‹I1, ²“¡‹vŽq1, ‚‹Ž‚©‚š‚é1, ²X–ØŽ¡ˆê˜Y2, ›ŒŽ[L3, ”ԏ ÍŽq1 (1ŠÅŒì•”, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3–òÜ•”): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2015/10/29-31), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2015/9; 50 (3): 433.

7231064. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) NICU‚É‚š‚¯‚é•êe‚ւ̃PƒAƒŠƒ“ƒOê–Ê‚ÌŽÀÛ. ’ҁ@•üŽq (ŠÅŒì•”): ‘æ46‰ñ“ú–{ŠÅŒìŠw‰ï|ƒwƒ‹ƒXƒvƒƒ‚[ƒVƒ‡ƒ“|ŠwpW‰ï (2015/11/6), •xŽR, ‘æ46‰ñ“ú–{ŠÅŒìŠw‰ï|ƒwƒ‹ƒXƒvƒƒ‚[ƒVƒ‡ƒ“|ŠwpW‰ïŽ˜^W 2015/10; p.83.

7231065. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) d–ŒŠO’Á’É•ª•Ø‚Ì’²ž‚Ə•ŽYƒPƒA‚ÌŽÀ‘Ô. ’|‘º’õŽq1, “V–썹D1, •xàV‚³‚È‚Ý1, “ü]‹ÅŽq1, ‰Á“¡—¢ŠG2, ‰œ•xr”V3, “V–ì@Š®4, –]ŒŽƒŽq4, ŠC–ìM–ç4 (1ŠÅŒì•”, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3–ƒŒ, 4ŽY‰È): ‘æ38‰ñ“ú–{ŽY•wl‰ÈŽèpŠw‰ï/‘æ119‰ñ“ú–{ŽY‰È–ƒŒŠw‰ïŠwpW‰ï (2015/11/28), “Œ‹ž, ‘æ119‰ñ“ú–{ŽY‰È–ƒŒŠw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2015/11; p.80.

7231066. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) d–ŒŠO’Á’É•ª•Ø‚ɑ΂·‚éˆãŽt‚Ə•ŽYŽt‚ÌŽv‚¢|ƒAƒ“ƒP[ƒg’²ž‚©‚ç|. “V–썹D1, ’|‘º’õŽq1, •xàV‚³‚È‚Ý1, “ü]‹ÅŽq1 (1ŠÅŒì•”): ‘æ38‰ñ“ú–{ŽY•wl‰ÈŽèpŠw‰ï/‘æ119‰ñ“ú–{ŽY‰È–ƒŒŠw‰ïŠwpW‰ï (2015/11/28), “Œ‹ž, ‘æ119‰ñ“ú–{ŽY‰È–ƒŒŠw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2015/11; p.81.

7231067. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éHIV/AIDSŠ³ŽÒ‚̏A˜Jó‹µ‚ɂ‚¢‚Ä. ‰Á“¡@Î1, ˜a“c’B•F2, Ö“¡‘Žq1, ŒŽRW‘ã1, —F“c‹g‘¥3, Œ–{Œ\—S3, ‘O“cŒiŽq1,4, ‚ŽR—zŽq5 (1ŠÅŒì•”, 2äPŒŽ•aEŠŽõ“à, 3–òÜ•”, 4ƒg[ƒ^ƒ‹ƒTƒ|[ƒgƒZƒ“ƒ^[, 5V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ29‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ïE‘‰ï (2015/11/30), “Œ‹ž, “ú–{ƒGƒCƒYŠw‰ïŽ 2015/11; 17 (4): 413.

7231068. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ú–{l, ŠØ‘lŒ’N¬l”팱ŽÒ‚ÌŽ¡Œ±ŽQ‰Á“®‹@‚Æ”FŽ¯‚ÉŠÖ‚·‚é”äŠrŒ€C|[‘w“I–Ê’k’²ž|. ¬ò—º•ã1, ‘O“cŽÀ‰Ô2, XˆŸ–îŽq3, ¬‘ò@Šw3, ‘v@ˆê‘å4, ²X–Ø‘PM2, ‰¡“cœÄˆê1,2, “¡“c•üŒb5, Ji-Hye Seo, Ock-Kim, ŒF’J—Y“ñ1,6 (1—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 2–òÜ•”, 3ŠÅŒì•”, 4‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 5–ò—, 6—Տ°Œ€‹†EŠé‰æ): ‘æ36‰ñ“ú–{—Տ°–ò—Šw‰ïŠwp‘‰ï (2015/12/9), “Œ‹ž, —Տ°–ò— 2015/11; 46: 177.

7231069. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž¡Œ±‚ÉŽQ‰Á‚·‚é“ú–{l‚ÌŒ’Nƒ{ƒ‰ƒ“ƒeƒBƒA‚ÌŽQ‰Á“®‹@‚Æ”FŽ¯‚ÉŠÖ‚·‚éˆÓŽ¯’²ž`ƒAƒ“ƒP[ƒg‚É‚æ‚鉡’f’²ž, ƒCƒ“ƒ^ƒrƒ…[‚É‚æ‚鎿“IŒ€‹†’²ž‚ðŽÀŽ{‚µ‚ā`. XˆŸ–îŽq1, ¬‘ò@Šw1, ¬ò—º•ã2, –쑺¡“úŽq1, ‘O“cŽÀ‰Ô3, “¡“c•üŒb4, ŒF’J—Y“ñ1,5 (1ŠÅŒì•”, 2—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 3–òÜ•”, 4–ò—, 5—Տ°Œ€‹†EŠé‰æ): ‘æ36‰ñ“ú–{—Տ°–ò—Šw‰ïŠwp‘‰ï (2015/12/9), “Œ‹ž, —Տ°–ò— 2015/11; 46: 178.

7231070. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹}«ŠúƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Žž‚̃uƒŠ[ƒtƒBƒ“ƒOEƒfƒuƒŠ[ƒtƒBƒ“ƒO‚ÌŒø‰Ê|ŠëŒ¯—\’ms“®‚ƃCƒ“ƒVƒfƒ“ƒgŒ”‚̕ω»|. •œ‰êç]”ü1, ‘“c³˜a1, ŒÃŽs‘¥Œõ1, Œ©ˆä“c˜a³2, “c’†—R—œˆŸ1 (1ŠÅŒì•”, 2ƒŠƒnƒrƒŠ•”): ‘æ43‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2016/2/12), •ºŒÉ.

7231071. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹~–œ‹~‹}ƒZƒ“ƒ^[‚É‚š‚¯‚éƒOƒŠ[ƒtƒPƒA. ‘“c‰~‰À1, “y‰®Žu•Û1,2, •Ð‰ª—Sˆê3, Vˆä‹v–«3, ‚‹Ž@Œb1,4, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”, 2ˆã—Â̎¿EˆÀ‘S„iŽº, 3‹~–œ, 4ˆã—ÃŽx‰‡•”): ‘æ43‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2016/2/14), •ºŒÉ.

7231072. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠO—ˆŠÅŒì‚É‚š‚¯‚邪‚ñŠ³ŽÒE‰Æ‘°‚̐¶ŠˆKŠµ—§‚Ä’Œ‚µŽx‰‡‚Ì•‹y‚ð‚ß‚Ž‚µ‚œCNS‚Ì“­‚«‚©‚¯‚Æ”g‹yŒø‰Ê. “n糐çt1, ’†“ˆO”ü1, ŒÃ¯Ž”ü1, “c•Ó—Œb1, ‰vŽR“Þ•äŽq1, Œ–{@ˆ²1, ¶’J”ü•ä1, ”–ؐ́1, ‘å’J^”ü1, ŽRé—¯”üŽq1, X“c—zŽ}1, ŽOŽŸ^—2, ”“c’ŒŽÀ2, ‰““¡Œb”üŽq2 (1ŠÅŒì•”, 2•‘ –ì‘åŠwŠÅŒìŠw•”): ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2016/2/20), ç—t, ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ïŽ˜^ 2016/1; 30 (Suppl): 145.

7231073. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •a“‚ÅŠJÃ‚·‚é•wl‰È‚ª‚ñƒTƒƒ“‚ÌŽÀ‘H‚Ɖۑè. ²“¡”ü‹I1, ‘ºã”üŒb1, ‹ß“¡‚Ü‚ä‚Ý1 (1ŠÅŒì•”): ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2016/2/20), ç—t, ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ïŽ˜^ 2016/1; 30 (Suppl): 231.

7231074. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Žq‹{‚ª‚ñ‘ÌŒ±ŽÒ‚̏î•ñƒj[ƒY|‚ª‚ñf’f‚©‚ç’·Šú¶‘¶‚ÉŽŠ‚é‰ß’ö‚ɏœ_‚ð‚ ‚Ä‚Ä|. ŠÝª–ƒ—¢Žq1, ‹v•ÛŒÜŒŽ2 (1ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2016/2/21), ç—t, ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ïŽ˜^ 2016/1; 30 (Suppl): 254.

7231075. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Ž€‚É’Œ–Ê‚µ‹ê”Y‚·‚é‘s”NŠú‚ª‚ñŠ³ŽÒ‚Ƃ̃PƒAƒŠƒ“ƒOƒp[ƒgƒi[ƒVƒbƒv‚̃vƒƒZƒX. ¬‘ò@ (ŠÅŒì•”): ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2016/2/21), ç—t, ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ïŽ˜^ 2016/1; 30 (Suppl): 258.

7231076. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)u‹ê’ɃXƒNƒŠ[ƒjƒ“ƒOv“±“ü6ƒ–ŒŽŠÔ‚ÌŽÀ‘H•ñ@‚»‚Ì1|ŠÉ˜aƒPƒAƒ`[ƒ€‚ÌOCNS‚ªˆË—Š, ‘Š’k‚ðŽó‚¯‚œƒP[ƒX‚ÌŠT—v|. Šâ–{ƒŽq1, Ž™‹Ê”ü—R‹I1, ‹ß“¡‚Ü‚ä‚Ý1 (1ŠÅŒì•”): ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2016/2/21), ç—t, ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ïŽ˜^ 2016/1; 30 (Suppl): 260.

7231077. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) u‹ê’ɃXƒNƒŠ[ƒjƒ“ƒOv“±“ü6ƒ–ŒŽŠÔ‚ÌŽÀ‘H•ñ@‚»‚Ì2|ŠÉ˜aƒPƒAƒ`[ƒ€‚ÌOCNS‚ªs‚Á‚œ‘Ήž‚Ɛ¬‰Ê‚ɏœ_‚ð‚ ‚Ä‚Ä|. Ž™‹Ê”ü—R‹I1, Šâ–{ƒŽq1, ‹ß“¡‚Ü‚ä‚Ý1 (1ŠÅŒì•”): ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2016/2/21), ç—t, ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ïŽ˜^ 2016/1; 30 (Suppl): 260.

7231078. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)u‹ê’ɃXƒNƒŠ[ƒjƒ“ƒOv“±“ü6ƒ–ŒŽŠÔ‚ÌŽÀ‘H•ñ@‚»‚Ì3|‰@“à‚ւ̊ɘaƒPƒA“±“ü, Z“§‚ÉŒü‚¯‚Ä‚ÌŠÅŒì‚ÌŽæ‚è‘g‚݁|. ‹ß“¡‚Ü‚ä‚Ý1, Šâ–{ƒŽq1, Ž™‹Ê”ü—R‹I1 (1ŠÅŒì•”): ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2016/2/21), ç—t, ‘æ30‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ïŽ˜^ 2016/1; 30 (Suppl): 260.

7231079. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) dÇŠÇ—‚É‚š‚¯‚é‰h—{ŠÇ—‚ÉŠÖ‚·‚éƒCƒ“ƒVƒfƒ“ƒg‚ÌŒ»ó‚Æ”wŒi—vˆö. ’·“à—mˆê1, “y‰®Žu•Û1,2, ˜a’m—ÉŽq1, _œä’m“¹3, •Ð‰ª—Sˆê3 (1ŠÅŒì•”, 2ˆã—Â̎¿EˆÀ‘S„iŽº, 3‹~–œ): ‘æ31‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ïŠwpW‰ï (2016/2/25), •Ÿ‰ª, “ú–{Ã–¬Œo’°‰h—{Šw‰ïŽGŽ 2016/1; 31 (1): 258.

7231080. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÈˆÕŒœ‘÷–@‚É‚æ‚éŒo’°‰h—{ƒ`ƒ…[ƒu•ÂÇ‰ñ”ð‚Ì‚œ‚߂̑΍ô‚Æ‚»‚ÌŒø‰Ê. –Lèm”ü1, •Ð‰ª—Sˆê2, _œä’m“¹2, Î‘q@ˆ€1, ‘Ÿ“cŽ¡¢1, Œ‘ò@Ê1 (1ŠÅŒì•”, 2‹~–œ): ‘æ31‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ïŠwpW‰ï (2016/2/26), •Ÿ‰ª, “ú–{Ã–¬Œo’°‰h—{Šw‰ïŽGŽ 2016/1; 31 (1): 606.

7231081. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚é, HIV/AIDSŠ³ŽÒ‚ւ̏A˜JŽx‰‡‚ÌŒŸ“¢. ‰Á“¡@Î1, Ö“¡‘Žq1, ŒŽRW‘ã1, ‘O“cŒiŽq1,2, ˜a“c’B•F3, ‚ŽR—zŽq4 (1ŠÅŒì•”, 2ƒg[ƒ^ƒ‹ƒTƒ|[ƒgƒZƒ“ƒ^[, 3äPŒŽ•aEŠŽõ“à, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ22‰ñHIV/AIDSŠÅŒìŠw‰ï‘‰ïEŒ€‹†”­•\‰ï (2016/3/5), ŽD–y.

7231082. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–•a“‰‚ÌŒ£tˆÚA|ˆÚAŒã‚̍s“®•Ï—e‚ÉŒü‚¯‚œŠÅŒì‰î“ü‰Û‘è|. ™–{—T”ü1, “c’†”üŽ÷1, –ìŒû•¶”T1, ‰Í“c‘œ‰Á1, Îˆä‘å•ã2, ‹g“cˆê¬3 (1ŠÅŒì•”, 2”å”AŠí, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/23), •ÄŽq.

7231083. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “§ÍƒNƒŠƒjƒbƒN‚Å‚ÌŒ£tˆÚA“o˜^Š³ŽÒ‚Ì‘Ò‹@ŠÇ—‚ƈڐAŽ{Ý‚̘AŒg. —Ž‡—¢“Þ, ”ªŒŽñ“ú‰À‘ã, ‚‹Ž_—Y, –ìŒû•¶”T1, Îˆä‘å•ã2, ’†‘º“¹˜Y, ‹g“cˆê¬3, ‚‹Ž—Tˆê˜Y (1ŠÅŒì•”, 2”å”AŠí, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/24), •ÄŽq.

7231084. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) t‘ŸRTC‚̃LƒƒƒŠƒAŠJ”­ (‘æˆê•ñ). –ìŒû•¶”T1, “c’†”üŽ÷1, ’r“c¬]2, rì–@Žq1, Îˆä‘å•ã2, ‹g“cˆê¬3 (1ŠÅŒì•”, 2”å”AŠí, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/25), ’¹Žæ, ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2016; p.336.

731188. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) tˆÚA‚ðt•s‘SŠÅŒì‚ÌŽ‹“_‚©‚çl‚Š‚æ‚€`Ž„‚œ‚¿‚ª‚Å‚«‚ét•s‘SŠÅŒì‚Á‚ĉœ‚Ÿ‚ë‚€?`. –ìŒû•¶”T (ŠÅŒì•”): ‘æ13‰ñ_“ސ쌧‰›“§ÍŠÅŒì§˜b‰ï (2016/1/31), “Œ‹ž.

731189. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰@“àƒR[ƒfƒBƒl[ƒ^[‚ÌŠˆ“®‚ÌŽÀÛ. ‚‹Ž@Œb (ŠÅŒì•”): L“‡Œ§‰@“àCoŒ€C‰ï (2016/3/7), L“‡.

732163. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ÒŒû‰‰) ˆÚAˆã—ÃŽx‰‡Žº‚ÌŠˆ“®`‰@“à‘̐§®”õ‚ÌŽæ‚è‘g‚݁`. ‚‹Ž@Œb1, Îˆä‘å•ã2 (1ŠÅŒì•”, 2”å”AŠí): ‘S‘‘ŸŠíˆÚAˆã—ÃŽx‰‡•”–åu‰‰‰ï (2015/10/24), –ŒŒÃ‰®.

733395. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‚‹@”\Š³ŽÒƒVƒ~ƒ…ƒŒ[ƒ^[‚ðŽg—p‚µ‚œ”]Ž€‰º‘ŸŠí’ñ‹ŸŒP—û‚ÌŽÀÛ. ‚‹Ž@Œb1, ’†“‡ßŽq1, “ü–Ø—›Œb2, rì–@Žq1, •Ð‰ª—Sˆê3, ‹g“cˆê¬4 (1ŠÅŒì•”, 2Ž––±•”, 3‹~–œ, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ26‰ñ_“ސìˆÚAˆãŠw‰ï (2015/6/6), ‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2015/7; 42 (2): 322.

733396. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) V•a‰@ŠJ‰@‚É‚Æ‚à‚È‚€f—ÃAƒVƒXƒ^ƒ“ƒg‚ÌŽæ‚è‘g‚Ý. –òŽtŽ›“Þ1, ‘º“c”ü‹I1, ]¬‚ß‚®‚Ý1, –k–썁‰€—¢1, ŒÃ¯Ž”ü2, —é–Ø”üŽ}Žq2 (1ˆã—ÃŽx‰‡•”, 2ŠÅŒì•”): “ú–{ˆãŽtŽ––±ì‹Æ•â•Œ€‹†‰ï‘æ5‰ñ‘S‘‘å‰ï (2015/6/28), ‹{è, “ú–{ˆãŽtŽ––±ì‹Æ•â•Œ€‹†‰ï ‘æ5‰ñ‘S‘‘å‰ïW˜^ 2015/6; p.62.

733397. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Šù‰—ð‚Ì‚È‚¢Žá”N—«‚É”­Ç‚µ‚œWernicke”]Ç‚̈ê—á. ˜a’m—ÉŽq1, “y‰®Žu•Û1,2, _œä’m“¹3, •Ð‰ª—Sˆê3 (1ŠÅŒì•”, 2ˆã—Â̎¿EˆÀ‘S„iŽº, 3‹~–œ): ‘æ18‰ñ_“ސìNSTƒtƒH[ƒ‰ƒ€ (2015/11/14), ‰¡•l.

733398. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‚’£«ŒoŒû’°ŠÇôòÜ‚Ì•ž—p—Ê‚ÌŒž—Ê‚Ö‚ÌŽæ‚è‘g‚Ý. ¬àV’m”ü1, “¡“c–ƒ”üŽq1, ‘OàV”ü“ÞŽq1, ‹v•Û“c”ü˜a2 (1ŠÅŒì•”, 2Á‰»Ší“à): ‘æ33‰ñŠÖ“ŒÁ‰»Ší“àŽ‹‹Ÿ‹ZŽt‰ï (2015/11/22), “Œ‹ž.

733399. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠO‚É‚æ‚éƒnƒ[ƒxƒXƒg‘•’…Š³ŽÒ‚Ìåñጔ­¶Ž–—á‚ðU‚è•Ô‚Á‚ā`åñጔ­¶—vˆö‚ÌŒŸ“¢`. à_’†”ü“ÞŽq1, ã‘º—RŽ—1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.28.

733400. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹Ù‹}‚ŃXƒg[ƒ}‘¢Ýp‚ð‚€‚¯‚œŠ³ŽÒ‚ւ̃Aƒvƒ[ƒ``ƒ}[ƒKƒŒƒbƒgEƒjƒ…[ƒ}ƒ“‚ÌŒ’N—˜_‚ðŠˆ—p‚µ‚ā`. ¬ì—œŽÑ1, ’·–ì—F‹IŽq1, ŽR–ì•Ó‚Ý‚¿Žq1, ŒŒŽN”ü1,2 (1ŠÅŒì•”, 2åñጊǗŽº): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.29.

733401. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒhƒNƒ^[ƒJ[ŠÅŒìŽt‚ÌŠÅŒìŽÀ‘H‚©‚ç‚Ý‚Š‚œ¡Œã‚̉ۑè. ‰ºˆä–ƒ‹IŽq1, Î‘q@ˆ€1, ŠŽR˜a”ü1, žÒŒ‹v”üŽq1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.30.

733402. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒNƒŠƒeƒCƒJƒ‹ƒPƒA‚É‚š‚¯‚銳ŽÒ‚̈ӎvŒˆ’èŽx‰‡`‘œEŽí˜AŒg‚É‚æ‚Á‚ÄŒoŒ±‚µ‚œŽ©‘î‘Þ‰@‚̈ê—á`. ’ÖŽR@“O1, “y‰®Žu•Û1,2, ŽR–ì•Ó‚Ý‚¿Žq1, Žsì‰êˆê3 (1ŠÅŒì•”, 2ˆã—Â̎¿EˆÀ‘S„iŽº, 3MSW): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.31.

733403. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ÐŠQ‘΍ôƒ`[ƒ€‚É‚æ‚é’Ê”NŒ€C‚ÌŠˆ“®•ñ. ˜a’m—ÉŽq1, ’J@Kˆê1, ŠÛŽR’ŒŽq1, “y‰®Žu•Û1,2, ŽR–ì•Ó‚Ý‚¿Žq1, ã‘º—RŽ—1, ŠŽR˜a”ü1 (1ŠÅŒì•”, 2ˆã—Â̎¿EˆÀ‘S„iŽº): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.34.

733404. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Ý‘î—×{Šó–]‚ª‹­‚¢“Æ‹Š³ŽÒ‚Ö‚Ì‘Þ‰@Žx‰‡`’nˆæƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚ð’Ê‚µ‚Ä‚ÌŠw‚с`. ‘åèm”ü1, ŒŒŽ’mŽ}1, –ì“cçŽq1, ‚–ìt”ü1, ‚Œ©‹IŽq1, â‰º’qŽìŽq1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.34.

733405. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) dÇŒÄ‹z•s‘SŠ³ŽÒ‚Ö‚Ì‘Þ‰@Žx‰‡`’nˆæ‚ɂ‚Ȃ®ƒ`[ƒ€ƒAƒvƒ[ƒ``. ŒŒŽ’mŽ}1, V–x“ÖŽj1, –ì“cçŽq1, ‚–ìt”ü1, ‚Œ©‹IŽq1, â‰º’qŽìŽq1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.36.

733406. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’®ŠoáŠQ‚ð‚à‚Š³ŽÒ‚̉Ƒ°‹@”\‚ɑ΂·‚éŠÅŒì‚ÌŽÀÛ`Žè˜b’Ê–óŽÒ‚Æ‚µ‚Ẳî“ü‚ð’Ê‚µ‚ā`. ‹g“c—æŽq1, “n•Ó—mŽq1, “c‹v•Û”üç‘ã1, ‚Œ©‹IŽq1, â‰º’qŽìŽq1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.41.

733407. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) is”x‚ª‚ñŠ³ŽÒE‰Æ‘°‚ւ̃Gƒ“ƒhEƒIƒuEƒ‰ƒCƒtƒPƒA‚̈êlŽ@|NNN‚É‚æ‚éŠÅŒì“WŠJ‚ðŽŽ‚Ý‚Ä|. V–ì’mŽq1, çø“”ü“oŽq1, ŽœŠÔ‰pŽÀ1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.46.

733408. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰)u‹ê’ɃXƒNƒŠ[ƒjƒ“ƒOv“±“ü6ƒ–ŒŽŠÔ‚Ì•ñ@‚»‚Ì1|ŠÉ˜aƒPƒAƒ`[ƒ€‚ÌOCNS‚ªˆË—Š, ‘Š’k‚ðŽó‚¯‚œƒP[ƒX‚ÌŠT—v|. Šâ–{ƒŽq1, Ž™‹Ê”ü—R‹I1, ‹ß“¡‚Ü‚ä‚Ý1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.47.

733409. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰)u‹ê’ɃXƒNƒŠ[ƒjƒ“ƒOv“±“ü6ƒ–ŒŽŠÔ‚Ì•ñ@‚»‚Ì2|ŠÉ˜aƒPƒAƒ`[ƒ€‚ÌOCNS‚ªs‚Á‚œ‘Ήž‚Ɛ¬‰Ê‚ɏœ_‚ð‚ ‚Ä‚Ä|. Ž™‹Ê”ü—R‹I1, Šâ–{ƒŽq1, ‹ß“¡‚Ü‚ä‚Ý1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.48.

733410. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰)u‹ê’ɃXƒNƒŠ[ƒjƒ“ƒOv“±“ü6ƒ–ŒŽŠÔ‚Ì•ñ@‚»‚Ì3|‰@“à‚ւ̊ɘaƒPƒA“±“ü, Z“§‚ÉŒü‚¯‚Ä‚ÌŠÅŒì‚ÌŽæ‚è‘g‚݁|. ‹ß“¡‚Ü‚ä‚Ý1, Šâ–{ƒŽq1, Ž™‹Ê”ü—R‹I1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.49.

733411. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “xd‚Ȃ鐶–œŠë‹@‚©‚琶ŠÒ‚µ‚œŽq‚Ç‚à‚ð‚à‚‰Ƒ°‚Æ‚Ì‚©‚©‚í‚è|’·Šú“I‚ÈŠÅŒì‚Ì‚ ‚è•û‚ðl‚Š‚é|. •äÏØ•ä1, ˆÉ“¡FŽq1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.55.

733412. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘gD‰»‚µ‚œŠˆ“®‚É‚æ‚édÇ“x, ˆã—ÁEŠÅŒì•K—v“x‚̈ê’v—ŠŒüã|„i•”‰ï”­‘«‚Ì’[‚Æ‚È‚Á‚œŠˆ“®•ñ|. —`…@—D1, “c’†—uŽq1, Žt‰ªŒbŽq1, ’Ë–{“l”ü1, Ñ—¬”ü1, ”’’¹—FŠî1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.57.

733413. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) DVT—\–hƒfƒoƒCƒX‚É‚æ‚鉺Žˆ‚Ìåñ጗\–h‚ÉŠÖ‚·‚éˆÓŽ¯’²ž`’e«ƒXƒgƒbƒLƒ“ƒO‚É‚æ‚éåñጔ­¶‚ÌŽ–—á‚ðU‚è•Ô‚Á‚ā`. ˆ¢•”•‘ˆß1, ã‘º—RŽ—1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.59.

733414. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) PICU‚É‚š‚¯‚é––œÃ–¬ƒ‰ƒCƒ“‚̈ã—Ë@ŠíŠÖ˜Aˆ³”—‘¹‚ÉŠÖ‚·‚élŽ@. …ŠÔ—S‰Á1, ÂŽR@ˆ€1, ŽÄ“cƒŽq1, ˆÉ“¡FŽq1 (1ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.61.

733415. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) “àƒVƒƒƒ“ƒg‚ÉŠÖ‚í‚éƒCƒ“ƒVƒfƒ“ƒg–hŽ~‚Ö‚ÌŽæ‚è‘g‚݁`ˆãŽtEŠÅŒìŽt‚Å‚Ì‹Š“­‚ð’Ê‚µ‚ā`. ’†‘º’qŽq1, ’r“c—R—¢1, “c•Ó—Œb1, ŒK–ŒŽõ”ü1, ²“¡^‹IŽq1, ÂŽR“ŒŒÜ2 (1ŠÅŒì•”, 2t‘Ÿ“à): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.65.

733416. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) AŠO—ˆ‚ÅŠÅŒìŽt‚ªs‚Á‚Ä‚¢‚éfŽ@‘O–âf‚ÌŒø‰Ê`ˆãŽt‚©‚ç‚Ì•]‰¿‚ɏœ_‚ð‚ ‚Ä‚Ä`. ”š’†^—R1, ‹v•Û“cˆŸ¹”ü1, ìèˆ€Žq1, ‰““¡G”ü1, “àŽR—¥Žq1, ì’[–[ŠG1,2, ²“¡”ü‹I1, £ŒË–qŽq1, ²“¡^‹IŽq1 (1ŠÅŒì•”, 2•úŽËüEIVRƒZƒ“ƒ^[): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.66.

733417. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹}«Šú‚̉Ƒ°‰î“ü‚É‚š‚¯‚éŠÅŒì—˜_‚ÌŠˆ—p|“n•ÓŽ®‰Æ‘°ƒAƒZƒXƒƒ“ƒgƒ‚ƒfƒ‹‚ð—p‚¢‚ā|. •œ‰êç]”ü (ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.67.

733418. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) š‹‰º‚ɑ΂·‚éƒl[ƒUƒ‹ƒnƒCƒtƒ[‘•’…‚̉e‹¿‚ÉŠÖ‚·‚錟“¢. Î‘q@ˆ€1, ‹{è—FŒb1, –Lèm”ü1, ‘Ÿ“cŽ¡¢1, ŠŽR˜a”ü1, —é–Ø—§r2, •Ð‰ª—Sˆê3, _œä’m“¹3, ó—˜@–õ3 (1ŠÅŒì•”, 2Žš•”ˆôAE“ªèòŠO, 3‹~–œ): ‘æ2‰ñ_“ސì‹}«Šú‰h—{ŠÇ—Œ€‹†‰ï (2015/12/14), _“ސì.

733419. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŒŒŠÇ“à—¯’uƒJƒe[ƒeƒ‹‚ÌŠÇ—|•a“–K–â‚É‚æ‚éƒJƒe[ƒeƒ‹ôò‚ðŽn‚߂ā|. ’·‰ª@‰~1, š ‹g’qŽq1, ¬–ì@–r1 (1ŠÅŒì•”): •œ¬27”N“x_“ސ쌧ŠÅŒì‹Š‰ï‘Š–ÍŒŽŽx•”ŠÅŒìŒ€‹†”­•\‰ï (2016/1/21), _“ސì, •œ¬27”N“x_“ސ쌧ŠÅŒì‹Š‰ï‘Š–ÍŒŽŽx•”ŠÅŒìŒ€‹†”­•\‰ïW˜^W 2016/1; p.21.

733420. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “àŽ‹‹ŸŒŸž•”–å‚É‚š‚¯‚錟ž‘Ò‚¿ŽžŠÔ‚ÌŒ»ó‚Æ‘Ò‚¿ŽžŠÔ’Zk‚ÉŒü‚¯‚Ä‚ÌŽæ‚è‘g‚Ý. Îìˆ»”T1, ŽOŽ}Ž–1 (1ŠÅŒì•”): •œ¬27”N“x_“ސ쌧ŠÅŒì‹Š‰ï‘Š–ÍŒŽŽx•”ŠÅŒìŒ€‹†”­•\‰ï (2016/1/21), _“ސì, •œ¬27”N“x_“ސ쌧ŠÅŒì‹Š‰ï‘Š–ÍŒŽŽx•”ŠÅŒìŒ€‹†”­•\‰ïW˜^W 2016/1; p.40-3.

733421. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) n—ûŠÅŒìŽt‚ª“à•žŽ©ŒÈŠÇ—”\—Í‚ðƒAƒZƒXƒƒ“ƒg‚·‚éÛ‚ÌŽvl‚â”»’f‚Ì–ŸŠm‰»|Šî€‰»‚ÌŒŸ“¢‚ÉŒü‚¯‚ā|. ˆÉ“Œ¬•S‡ (ŠÅŒì•”): •œ¬27”N“x_“ސ쌧ŠÅŒì‹Š‰ï‘Š–ÍŒŽŽx•”ŠÅŒìŒ€‹†”­•\‰ï (2016/1/21), _“ސì, •œ¬27”N“x_“ސ쌧ŠÅŒì‹Š‰ï‘Š–ÍŒŽŽx•”ŠÅŒìŒ€‹†”­•\‰ïW˜^W 2016/1; p.48.

733422. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) •v‚ÌŠÅŽæ‚莞Šú‚ÉŽ©•ª‚ðÓ‚ß‹ê”Y‚·‚éÈ‚Ö‚ÌŠÖ‚í‚è|M, ƒjƒ…[ƒ}ƒ“‚Ì—˜_‚ÉŠî‚¢‚œŠÅŒìŽÀ‘H|. ŽÄ“c‚â‚æ‚¢1, Ž™‹Ê”ü—R‹I1, ‰¡ŽR—˜1 (1ŠÅŒì•”): •œ¬27”N“x_“ސ쌧ŠÅŒì‹Š‰ï‘Š–ÍŒŽŽx•”ŠÅŒìŒ€‹†”­•\‰ï (2016/1/21), _“ސì, •œ¬27”N“x_“ސ쌧ŠÅŒì‹Š‰ï‘Š–ÍŒŽŽx•”ŠÅŒìŒ€‹†”­•\‰ïW˜^W 2016/1; p.63.

733423. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “œ”A•aŠ³ŽÒ‚̗ǍD‚ȃgƒ‰ƒ“ƒWƒVƒ‡ƒ“‚ðl‚Š‚é`ŠÅŒìŽt‚ÌŽ‹“_‚©‚ç`. ‘åŠÑŒbŽq1, —с@“N”Í2, â–{”~Žq1, Žsì—‹Žt2, ‚–ìK˜H2, Žµ—¢áÁ‹`2 (1ŠÅŒì•”, 2“à•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2016/1/23), ‰¡•l, ‘æ53‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2016/1; p.106.

733424. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) d–ŒŠO’Á’É•ª•Ø‚É‚š‚¯‚鏕ŽYŽt‚̐ê–含‚ÉŠÖ‚·‚éˆêlŽ@|•ŽYŽt‚ւ̃Aƒ“ƒP[ƒg’²ž‚æ‚è|. •xàV‚³‚È‚Ý1, ’|‘º’õŽq1, “V–썹D1, “ü]‹ÅŽq1, ‰Á“¡—¢ŠG2, ‰œ•xr”V3, “V–ì@Š®4, –]ŒŽƒŽq4, ŠC–ìM–ç4 (1ŠÅŒì•”, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3–ƒŒ, 4ŽY‰È): ‘æ29‰ñ_“ސì•ê«‰q¶Šw‰ïŠwpW‰ï (2016/2/6), _“ސì, _“ސì•ê«‰q¶Šw‰ïŽ 2016/2; 19 (1): 55.

733425. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹~‹}ŠO—ˆ‚ÅŠÅŽæ‚銳ŽÒ‚̉Ƒ°‚Ö‚ÌŠÖ‚í‚è. ’†’JG”ü1, ‰ºˆä–ƒ‹IŽq1, Î‘q@ˆ€1 (1ŠÅŒì•”): ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ï (2016/2/6), “Œ‹ž, ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2016/2; p.160.

733426. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹~‹}•a“‚É‚š‚¯‚é‘ŸŠí’ñ‹Ÿ‚ÉŠÖ‚·‚éHAS (•a‰@ˆÓŽ¯’²ž) ‚ÌŽæ‚è‘g‚݁`ŠÅŒìŽt‚̈ӎ¯’²ž‚ƍ¡Œã‚̉ۑè`. ‚‹ŽŠ°“Þ1, ŠŽR˜a”ü1, ‚‹Ž@Œb1 (1ŠÅŒì•”): ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ï (2016/2/6), “Œ‹ž, ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2016/2; p.161.

733427. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “Ë‘R‚ÌŽ€‚ÆŒü‚«‡‚€‰Æ‘°‚̑㗝ˆÓŽvŒˆ’èŽx‰‡`Ç—ጟ“¢‚©‚ç“Ÿ‚ç‚ê‚œ‹~‹}ŠÅŒì‚݂̍è•û`. ‘Ÿ“cŽ¡¢1, ã‘º—RŽ—1, ‚‹Ž@Œb1, Î‘q@ˆ€1, ŠŽR˜a”ü1 (1ŠÅŒì•”): ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ï (2016/2/6), “Œ‹ž, ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2016/2; p.164.

733428. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹~–œ‹~‹}•a“‚É‚š‚¯‚é“]“|“]—Ž–hŽ~‘΍ô‚Ì‚œ‚ß‚ÌŠˆ“®•ñ. ¯–쐳—T1, •ÄŽR‰ÄŽÀ, žÒŒ‹v”üŽq1, Î‘q@ˆ€1, ŠŽR˜a”ü1 (1ŠÅŒì•”): ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ï (2016/2/6), “Œ‹ž, ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2016/2; p.165.

733429. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘åŠw•a‰@‚É‚š‚¯‚é‘ŒEŽíŒŸ“¢‰ï‚ÌŒø‰Ê‚ɂ‚¢‚Ă̍lŽ@. Î‘q@ˆ€1, ÂŽR’Œ‘P2, ¬–ì‘òŽ 3, ’†‘ºŒ³”ü4, ¶‰E“c“N3, ì’JOŽq1,5 (1ŠÅŒì•”, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3ƒg[ƒ^ƒ‹ƒTƒ|[ƒgƒZƒ“ƒ^[, 4ž_, 5Š³ŽÒƒT[ƒrƒXƒZƒ“ƒ^[): ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ï (2016/2/6), “Œ‹ž, ‘æ66‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2016/2; p.167.

733430. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ˆÚA“K‰žŒŸ“¢‚Å“ïa‚µ‚œŠO‘lŠ³ŽÒ‚ÌŒoŒ±. ’†“‡ßŽq (ŠÅŒì•”): ‘æ15‰ñŠÌˆÚAˆã—ÃtƒH[ƒ‰ƒ€ (2016/2/20), “Œ‹ž.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H25-120002. [ŒŽ’˜] _“ސ쌧AŽs•ÛŒ’ˆã—ÃZƒ“ƒ^[‚ł́u”DP‘O‹³Žºv‚ÌŽÀÛ|•s”D—\–h‹³ˆç‚Ɛe‚É‚È‚é‚œ‚ß‚ÌŒ’N‹³Žº|. ãàV‰xŽq, •Ÿ“ˆ—TŽq, —V²_Žq1, Š„“cC•œ, Š„“cßŽq, ‰ÍˆäŽ‰À, ì“à”Žl2 (1ŠÅŒì•”, 2•wl): “ú–{•s”DƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ïŽ 2013/4; 12 (1): 47-8.

H26-120007. [ŒŽ’˜] M. Newman‚́uŠg’£‚·‚éˆÓŽ¯‚Æ‚µ‚Ä‚ÌŒ’N—˜_v‚ÉŠî‚­‚ª‚ñŠÅŒìŽÀ‘H|Šñ‚è“Y‚¢‚Ì‘ÌŒ±‚©‚琶‚Ü‚ê‚œŠÅŒìŽt‚̐¬’·‰ß’ö|. çø“”ü“oŽq1, —äŠÝGŽq2 (1ŠÅŒì•”, 2Œ³ŠÅŒìŠw•”): –k—¢ŠÅŒìŠwŽ 2015/3; 17 (1): 26-33.


—Տ°ŒŸž•”

[Šwp˜_•¶]

110332. [ŒŽ’˜] Influence of hearing inspection using headphone and bone conduction vibrator on a programmable valve shunt system. Obata S1, Ujihashi Y1, Munekata S1, Ishii N2, kanoh Y1,3: Kitasato Med J 2016/3; 46 (1): 8-14. (¬”Š@i1, ‰FŽ¡‹Ž‘PŸ1, “•ûLˆê1, Îˆä’Œm2, Žë–ì—Lì1,3: 1—ÕŒŸ•”, 2ˆã—Éq¶Šw•”, 3—ÕŒŸŠw)

120070. [ŒŽ’˜]g”]”g‚ª“Ç‚ß‚éh‚ÆŠw¶‚ªŽÀŠŽ‚Å‚«‚é”]”g‹³ˆç–@‚ÌŽÀ‘H. ŠŽi–r•¶1, Â–؁@˜j2, ¬–ìàV—T–ç3 (1‹ãB•ÛŒ’•ŸŽƒ‘åŠw, 2“ú–{ˆã‰È‘åŠw•a‰@, 3—ÕŒŸ•”): —Տ°ŒŸž‹³ˆç 2015/9; 7 (2): 179-86.

120071. [ŒŽ’˜] ”]”gŒŸž‚É‚š‚¯‚錟žž“xŒüã‚Ö‚ÌŽæ‚è‘g‚Ý‚Æ‚»‚Ì•]‰¿. ŽRè–ƒ–¢1, ¬–ìàV—T–ç2, ˆ¢•”‚³‚â‚©1, ‹à‰Æ–Ÿ”ü1, ‰i’ˈç]1, –ìè”Ž”V1 (1ìèŽs—§ìè•a‰@, 2—ÕŒŸ•”): _“ސ쌧—Տ°ŒŸž‹ZŽt‰ïŽGŽ 2015/12; 50 (167): 13-6.

120072. [ŒŽ’˜] Šç–ʐ_Œo–ƒáƒ‚É‚š‚¯‚é ‹­‚³EŠúŠÔ‹Èü‚Ì—L—p«‚ɂ‚¢‚Ä. –Ñ—˜’m—å1, ¬–ìàV—T–ç1, ‰º‰ÍƒiƒIƒ~1, ‰Í“‡]ŽÀ1, ‰Ÿ“cD”ü1, ¬”Š@i1, ‰FŽ¡‹Ž‘PŸ1, “•ûLˆê1 (1—ÕŒŸ•”): _“ސ쌧—Տ°ŒŸž‹ZŽt‰ïŽGŽ 2015/12; 50 (167): 17-21.

120073. [ŒŽ’˜] Moraxella catarrhalis‚ÌŒŸoó‹µ‚Æ–òÜŠŽŽó«‚̐„ˆÚ. “ñ–{–öL1, ˜a“c’B•F2, ˆÀ’B@÷1, “¡‘º—T”ü1, “•ûLˆê1, Žë–ì—Lì3 (1—ÕŒŸ•”, 2äPŒŽ•aEŠŽõ“à, 3—ÕŒŸŠw): ˆãŠwŒŸž 2016; 63 (3): 268-74.

522223. [uÀ]y“ÁW: R‹Û–ò, RƒEƒCƒ‹ƒX–ò|‚¢‚ÂŽn‚ß‚é‚Ì, ‚¢‚ÂŽ~‚ß‚é‚Ì?z[‘˜_] R‹Û–ò‚̑ϐ«‹@˜|Žå‚ɃOƒ‰ƒ€‰A«ž…‹Û‚̑ϐ«ƒƒJƒjƒYƒ€‚ɂ‚¢‚ā|. “ñ–{–öL1, ‰Ô–؏G–Ÿ2 (1—ÕŒŸ•”, 2–k—¢¶–œ‰ÈŠwŒ€‹†ŠŠŽõ–hŒäŠwuÀ/RŠŽõÇ–òŒ€‹†ƒZƒ“ƒ^[ ): ¬Ž™“à‰È 2015/4; 47 (4): 468-73.

522224. [uÀ]y¡ŒŽ‚Ì“ÁW2: ƒOƒ[ƒoƒ‹‰»Žž‘ã‚̑ϐ«‹ÛŠŽõÇzƒƒ`ƒVƒŠƒ“‘ϐ«‰©FƒuƒhƒE‹…‹Û. “ñ–{–öL1, ‰Ô–؏G–Ÿ2 (1—ÕŒŸ•”, 2–k—¢¶–œ‰ÈŠwŒ€‹†ŠŠŽõ–hŒäŠwuÀ/RŠŽõÇ–òŒ€‹†ƒZƒ“ƒ^[ ): —Տ°ŒŸž 2016/1; 60 (1): 52-60.

522225. [uÀ]y“ÁW: ¡‚±‚»’m‚è‚œ‚¢‰ES‹@”\‚̏d—v«‚Æ•]‰¿–@z5. Ç—á‰ðà@4) C³‘匌ŠÇ“]ˆÊ. ꠓcŠì”V (—ÕŒŸ•”): Medical Technology 2016/3; 44 (3): 281-5.

[’˜@‘]

620182. [Šwp‘] (•ª’SŽ·•M)y’Ž‰¹”gƒGƒLƒXƒp[ƒg15@èò•”ƒGƒR[‚̃XƒNƒŠ[ƒjƒ“ƒO‚ƃXƒeƒbƒvƒAƒbƒvƒKƒCƒh (ŒŽŠ§Medical Technology•Êû)zI. bó‘B@3. ‚Ñ‚Ü‚ñ«bó‘BŽŸŠ³‚Ì’Ž‰¹”g‘œ, p.33-45. ’†Œ‹vK (—ÕŒŸ•”), •Ò: —ˆZ–ìC, ‚—œ@ž, ˆãŽ•–òo”ÅŠ”Ž®‰ïŽÐ, “Œ‹ž, 2015/5”­s.

620183. [Šwp‘] (•ª’SŽ·•M)y_Œo¶—ŒŸž‹Zp‹³–{z4Í —U”­“dˆÊŒŸž@4.4 Ž‹Šo—U”­“dˆÊ, p.129-34. ¬–ìàV—T–ç (—ÕŒŸ•”), ŠÄC: “ú–{—Տ°‰q¶ŒŸž‹ZŽt‰ï, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

[Šw‰ïEŒ€‹†‰ï“™]

7231085. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •s‹K‘¥R‘̃XƒNƒŠ[ƒjƒ“ƒOŒŸž‚ÌŒø—Š“I‰^—p‚ɂ‚¢‚Ä. ³–؈ǓÞ1, “c•”—T“ñ1, ¬–{”ü“Þ1, ‚–ì”g—¯”ü1, •—ŠÔ‚ ‚«‚Ý1, “à“cˆêO1, ‘å’JTˆê2, Žë–ì—Lì3 (1—ÕŒŸ•”, 2—AŒŒE×–EˆÚA, 3—ÕŒŸŠw): ‘æ64‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2015/5/16), •Ÿ‰ª, ˆãŠwŒŸž‘æ64‰ñ“ú–{ˆãŠwŒŸžŠw‰ïƒvƒƒOƒ‰ƒ€W 2015/3; p.55.

7231086. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘SŽ©“®—AŒŒŒŸž‹@ŠíAutoVue‚Ì24ŽžŠÔ‰^—p‚É”º‚€—AŒŒ“ú“–’ŒŽÒ‚ւ̃gƒŒ[ƒjƒ“ƒO–@. “c•”—T“ñ1, ³–؈ǓÞ1, ¬–{”ü“Þ1, ‚–ì”g—¯”ü1, •—ŠÔ‚ ‚«‚Ý1, “à“cˆêO1, ‘å’JTˆê2, Žë–ì—Lì3 (1—ÕŒŸ•”, 2—AŒŒE×–EˆÚA, 3—ÕŒŸŠw): ‘æ64‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2015/5/17), •Ÿ‰ª, ˆãŠwŒŸž‘æ64‰ñ“ú–{ˆãŠwŒŸžŠw‰ïƒvƒƒOƒ‰ƒ€W 2015/3; p.76.

7231087. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒAƒ“ƒ‚ƒjƒA‘ª’莎–ò‚ÌŽ©“®•ªÍ‘•’u‰ËÝðŒ‚É‚æ‚é‰e‹¿‚š‚æ‚щñ”ð•û–@. ŽÂŒŽ—º‘Ÿ1, “y•M’q»1, ¬ŽRhŽq1, ’†èLŽq1, “à“cˆêO1, “•ûLˆê1, Žë–ì—Lì1,2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ64‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2015/5/16-17), •Ÿ‰ª, ˆãŠwŒŸž‘æ64‰ñ“ú–{ˆãŠwŒŸžŠw‰ïƒvƒƒOƒ‰ƒ€W 2015/3; p.65.

7231088. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒŠÇ’Ž‰¹”gŒŸž‚ÌŒ©•ûEl‚Š•ûE“`‚Š•û|èò“®–¬’Ž‰¹”gŒŸž|. ’†Œ‹vK (—ÕŒŸ•”): ‘æ40‰ñ“ú–{’Ž‰¹”gŒŸžŠw‰ïŠwpW‰ï (2015/5/16), _“ސì, ’Ž‰¹”gŒŸž‹Zp 2015/6; 40: S60.

7231089. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ºŽˆÃ–¬ƒGƒR[‚ÌŒ©•ûEl‚Š•ûE“`‚Š•û|[•”Ã–¬ŒŒðÇ‚𒆐S‚Ɂ|. ‰FŽ¡‹Ž‘PŸ (—ÕŒŸ•”): ‘æ40‰ñ“ú–{’Ž‰¹”gŒŸžŠw‰ïŠwpW‰ï (2015/5/16), _“ސì, ’Ž‰¹”gŒŸž‹Zp 2015/6; 40: S62.

7231090. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’Ž‰¹”gŒŸž‚Ì•W€‰»‚Í‚Ç‚±‚܂Ői‚ß‚é‚©`’Ž‰¹”gƒŒƒ|[ƒg‚Ì•W€‰»`. ‰FŽ¡‹Ž‘PŸ (—ÕŒŸ•”): ‘æ40‰ñ“ú–{’Ž‰¹”gŒŸžŠw‰ïŠwpW‰ï (2015/5/17), _“ސì, ’Ž‰¹”gŒŸž‹Zp 2015/6; 40: S73.

7231091. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰@“àŠŽõ‘΍ô‚ð–Ú“I‚Æ‚µ‚œ’Ž‰¹”gƒ[ƒŠ[‚̉q¶ŠÇ—‚ÉŠÖ‚·‚錀‹†. •œ“cçL1, ŽRŒû“oŠóŽq1, ꠓcŠì”V1, ’†Œ‹vK1, ‰FŽ¡‹Ž‘PŸ1, “¡–Ø‚­‚ÉŽq2, •œ“c‘×—Ç2, Žë–ì—Lì1,3 (1—ÕŒŸ•”, 2ŠŽõŠÇ—Žº, 3—ÕŒŸŠw): ‘æ40‰ñ“ú–{’Ž‰¹”gŒŸžŠw‰ïŠwpW‰ï (2015/5/17), _“ސì, ’Ž‰¹”gŒŸž‹Zp 2015/6; 40: S131.

7231092. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V•a‰@ŠJ‰@‚É”º‚€—AŒŒ‹Æ–±‘̐§‚̕ύX. ¬–{”ü“Þ1, ³–؈ǓÞ1, “c•”—T“ñ1, ‚–ì”g—¯”ü1, •—ŠÔ‚ ‚«‚Ý1, ‘å’JTˆê2 (1—ÕŒŸ•”, 2—AŒŒE×–EˆÚA): ‘æ63‰ñ“ú–{—AŒŒE×–EŽ¡—Êw‰ï‘‰ï (2015/5/28), “Œ‹ž, “ú–{—AŒŒ×–EŽ¡—Êw‰ïŽ 2015/4; 61 (2): 309.

7231093. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚Ì‚š‚¯‚éMRSAŒŸoó‹µ‚š‚æ‚Ñ–òÜŠŽŽó«‚̐„ˆÚ‚ɂ‚¢‚Ä. ˆÀ’B@÷1,2, “ñ–{–öL1,3, ‚ŽR—zŽq3,4, ŒˆäGm2, ‰Ô–؏G–Ÿ2 (1—ÕŒŸ•”, 2–k—¢¶–œ‰ÈŠwŒ€‹†ŠŠŽõÇ–òŒ€‹†ƒZƒ“ƒ^[, 3ŠŽõŠÇ—Žº, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ63‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2015/6/4), Vh, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ 2015/6; 63: 153.

7231094. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘œ€–ÚŽ©“®ŒŒ‹…•ªÍ‘•’uXNƒVƒŠ[ƒY‚É‚š‚¯‚éPLT-1‚ÆPLT-F“¯Žž‘ª’è‚ɂ‚¢‚ā`^’l•ñ‚ƐԌŒ‹…Œ`‘Ԉُí‚Ì—\‘ª`. ²‹vŠÔ“ÖŽq1, ãŒŽ—R‰À—1, ’†Œ@ŒO1, ˆ¢•”—L1, “à“cˆêO1, “•ûLˆê1, Žë–ì—Lì1,2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ16‰ñ“ú–{ŒŸžŒŒ‰tŠw‰ïŠwpW‰ï (2015/7/11), –ŒŒÃ‰®, “ú–{ŒŸžŒŒ‰tŠw‰ïŽ 2015/6; 16: S135.

7231095. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”AƒAƒ‹ƒuƒ~ƒ“³í“œ”A•aƒ‰ƒbƒg‚É‚š‚¢‚ÄŽ_‰»ƒXƒgƒŒƒX˜Ži‚ªtƒƒKƒŠƒ“‚š‚æ‚уLƒ…ƒrƒŠƒ“”­Œ»‚É‹y‚Ú‚·‰e‹¿. •èËŽj1,2, ŒÜ\—’‘åŽm2, ˆ¢•”@“Ä2, ˆä–{–Ÿ”ü1,2, “y•M’q»3, ¬”Š@i3, \—ÇàVŸ—Y4, —é–؉p–Ÿ5, ‰¡ê³“T1,2, ’r‰iGŽ÷6, Â–Ø–F˜a7, Žsì‘ž•¶1,2, ’|’†P•v8, •Ð‹Ë^l1,2, Îˆä’Œm1,2 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3—ÕŒŸ•”, 4º˜a‘åŠw“¡‚ª‹u•a‰@, 5•ÛŒ’‰q¶ê–åŠw‰@, 6’r‰it“à‰ÈƒNƒŠƒjƒbƒN, 7_“ސ쌧—\–hˆãŠw‹Š‰ï, 8‘Ûˆã—ÕŸŽƒ‘åŠwŽR‰€•a‰@): ‘æ55‰ñ“ú–{—Տ°‰»Šw‰ï”NŽŸŠwpW‰ï (2015/10/30-11/1), ‘åã, —Տ°‰»Šw 2015/10; 44 (Supp 1): 249.

7231096. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ÀˆÊdS“®—hŒŸž‚ÌŠî‘b“IŒŸ“¢. ¬”Š@i1, ¬–ìàV—T–ç1, –ìàV»Žq1, –³‘Ÿ˜Y1, –Ñ—˜’m—å1, ‰FŽ¡‹Ž‘PŸ1, “•ûLˆê1, Îˆä’Œm2, •Ð‹Ë^l2, Žë–ì—Lì1,3 (1—ÕŒŸ•”, 2ˆã—Éq¶Šw•”, 3—ÕŒŸŠw): ‘æ62‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ï (2015/11/19-22), Šò•Œ, —Տ°•a— 2015/11; 63 (•âû): 117.

7231097. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž_‰»ƒXƒgƒŒƒX‚ª˜Ži‚µ‚Ä‚¢‚étÇ”­Ç‘O‚Ì“œ”A•a‚̔玿‚É‚š‚¯‚éƒ}ƒCƒgƒtƒ@ƒW[‚Æ’áŽ_‘f‰ž“š‚ɂ‚¢‚Ä. Îˆä’Œm1,2, •èËŽj1,2, ˆä–{–Ÿ”ü1,2, ˆ¢•”@“Ä2, ŒÜ\—’‘åŽm2, “y•M’q»3, ¬”Š@i3, \—ÇàVŸ—Y4, —é–؉p–Ÿ5, ‰¡ê³“T1,2, ’r‰iGŽ÷6, Â–Ø–F˜a7, Žsì‘ž•¶1,2, ’|’†P•v8, •Ð‹Ë^l1,2 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3—ÕŒŸ•”, 4º˜a‘åŠw“¡‚ª‹u•a‰@, 5•ÛŒ’‰q¶ê–åŠw‰@, 6’r‰it“à‰ÈƒNƒŠƒjƒbƒN, 7_“ސ쌧—\–hˆãŠw‹Š‰ï, 8‘Ûˆã—ÕŸŽƒ‘åŠwŽR‰€•a‰@): ‘æ62‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ï (2015/11/19-22), Šò•Œ, —Տ°•a— 2015/11; 63 (•âû): 178.

7231098. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ßˆÊ”A×ŠÇã”ç×–E‚É‚š‚¢‚č‚ƒOƒ‹ƒR[ƒX‚š‚æ‚уAƒ‹ƒuƒ~ƒ“•‰‰×‚ªƒ~ƒgƒRƒ“ƒhƒŠƒAPí«ˆÛŽ‹@\‚É‹y‚Ú‚·‰e‹¿. ˆä–{–Ÿ”ü1,2, •èËŽj1,2, ŒÜ\—’‘åŽm2, ˆ¢•”@“Ä2, “y•M’q»3, ¬”Š@i3, \—ÇàVŸ—Y4, —é–؉p–Ÿ5, ‰¡ê³“T1,2, ’r‰iGŽ÷6, Â–Ø–F˜a7, Žsì‘ž•¶1,2, ’|’†P•v8, •Ð‹Ë^l1,2, Îˆä’Œm1,2 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3—ÕŒŸ•”, 4º˜a‘åŠw“¡‚ª‹u•a‰@, 5•ÛŒ’‰q¶ê–åŠw‰@, 6’r‰it“à‰ÈƒNƒŠƒjƒbƒN, 7_“ސ쌧—\–hˆãŠw‹Š‰ï, 8‘Ûˆã—ÕŸŽƒ‘åŠwŽR‰€•a‰@): ‘æ62‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ï (2015/11/19-22), Šò•Œ, —Տ°•a— 2015/11; 63 (•âû): 178.

7231099. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Leber•a‚̈â“`Žq‰ðÍ`ŒŸžŽÀŽ{13”NŠÔ‚ÌŒŸØŒ‹‰Ê‚ɂ‚¢‚ā`. ˆÀ–{—Ž”n, ŸNˆäŒc‘¢, ‹{‰º—F—¢, —é–؁@•à, ŽR•Ó°”ü1, ’†èM•F, “•ûLˆê1, Îì@‹Ï2, Žá‘q‰ë“o3, ‚“cŽj’j4, Žë–ì—Lì5 (1—ÕŒŸ•”, 2ˆã—Éq¶Šw•”, 3Šá‰È, 4‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 5—ÕŒŸŠw): ‘æ62‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ï (2015/11/19-22), Šò•Œ.

733431. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’Ž‰¹”gƒhƒvƒ‰–@‚ð—p‚¢‚œäX“ª\“ñŽw’°ØœŒã‚Ì–å–¬ŒŒ—¬“®‘Ô‚Ì•]‰¿‚ɂ‚¢‚Ä. –öŒŽ”ü’qŽq1, “¡ˆä@Ž 1, ‘ŽR–ƒ‹LŽq2, –{é‚ß‚®‚Ý2, “•ûLˆê1, Žë–ì—Lì1,2,3, ŒGŒ³—Y‰î4, •Ð‹ËŠ°”V4, ŠC’ËMŽj4, ‹v•Û”CŽj4, “c“‡@O4 (1—ÕŒŸ•”, 2“Œ•a‰@—ÕŒŸ•”, 3—ÕŒŸŠw, 4ŠO‰È): ‘æ10‰ñ–k—¢ŒŒŠÇƒtƒH[ƒ‰ƒ€ (2015/6/1), ‘Š–ÍŒŽ.

733432. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆã—Ðl‚É‹‚ß‚ç‚ê‚éÚ‹ö‰ž‘΂Ƃ́|Ú‹ö‰ž‘΃ƒ“ƒvƒ‰ƒXƒLƒƒƒ“ƒy[ƒ“‚ÌŠˆ“®•ñ|. ¬–ìŽRŽuD1, ‰FŽ¡‹Ž‘PŸ1, “•ûLˆê1, Žë–ì—Lì1,2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ5‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ï (2015/7/18), “Œ‹ž, ‘æ4‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ïŽ˜^W 2015/7; p.9.

733433. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠwV•a‰@ŠJ‰@‚É”º‚€—AŒŒ‹Æ–±‘̐§‚̕ύX‚ɂ‚¢‚Ä. ¬–{”ü“Þ1,2, ì‹Ø“ߌŽ1,2, _“c’mŽq1,2, ³–؈ǓÞ1,2, “c•”—T“ñ1,2, ŽR•Ó°”ü1,2, ‚–ì”g—¯”ü1,2, •—ŠÔ‚ ‚«‚Ý1,2, “à“cˆêO1,2, “•ûLˆê2, ‘å’JTˆê1,2,3, Žë–ì—Lì4 (1—AŒŒ•”, 2—ÕŒŸ•”, 3—AŒŒE×–EˆÚA, 4—ÕŒŸŠw): ‘æ5‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ï (2015/7/18), “Œ‹ž, ‘æ4‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ïŽ˜^W 2015/7; p.9.

733434. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚Ì‚š‚¯‚éMRSAŒŸoó‹µ‚š‚æ‚Ñ–òÜŠŽŽó«‚̐„ˆÚ‚ɂ‚¢‚Ä. ˆÀ’B@÷1,2, “ñ–{–öL1,3, ‚ŽR—zŽq3,4, ŒˆäGm2, ‰Ô–؏G–Ÿ2 (1—ÕŒŸ•”, 2–k—¢¶–œ‰ÈŠwŒ€‹†ŠŠŽõÇ–òŒ€‹†ƒZƒ“ƒ^[, 3ŠŽõŠÇ—Žº, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ28‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€E‘æ18‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[Œ€‹†W‰ï (2015/8/6), ‘Š–ÍŒŽ.

733435. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠŽõŠÇ—Žº‚̉î“ü‚É‚æ‚èŽû‘©‚µ‚œRalstonia picketii‚Ì“`”dŽ–—á. “ñ–{–öL1,2, ‚ŽR—zŽq1,3, ˜a“c’B•F1,4, ‘åìŒŽ—SŽ÷1, ¬–ìçt1, ²“¡Š°¶1, Â–ö²’qŽq1, ‚é—R”üŽq1, “¡–Ø‚­‚ÉŽq1, ‘ì˜ad1,5 (1ŠŽõŠÇ—Žº, 2—ÕŒŸ•”, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 4äPŒŽ•aEŠŽõ“à, 5•úŽËü (Žîá‡)): ‘æ28‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€E‘æ18‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[Œ€‹†W‰ï (2015/8/6), ‘Š–ÍŒŽ.

733436. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) tÇ”­Ç‘O‚Ì“œ”A•a‚̔玿‚É‚š‚¯‚é’áŽ_‘f‰ž“š‚ƃ}ƒCƒgƒtƒ@ƒW[‚ɂ‚¢‚Ä. Îˆä’Œm1,2, ŽR“c—D–ç3, •èËŽj1,2, ˆ¢•”@“Ä2, ŒÜ\—’‘åŽm2, ˆä–{–Ÿ”ü1,2, “y•M’q»4, ¬”Š@i4, —é–؉p–Ÿ5, ‰¡ê³“T1,2, ¬Ž›‹`’j6, Žsì‘ž•¶1,2, •Ð‹Ë^l1,2 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‰¡{‰ê‹€Ï•a‰@, 4—ÕŒŸ•”, 5•ÛŒ’‰q¶ê–åŠw‰@, 6—Šw•”): ‘æ28‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€E‘æ18‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[Œ€‹†W‰ï (2015/8/7), ‘Š–ÍŒŽ, ‘æ28‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€Ž˜^W 2015/8; 65: 75.

733437. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ§‰›’n‹æ7•a‰@‚É‚š‚¯‚é×‹Û‚ÌŒŸoó‹µ‚Æ–òÜŠŽŽó«‚̐„ˆÚ. à_“c@‹±, “ñ–{–öL1, ¬ŠÑ’q¢1, ˆÀ’B@÷1, ’†èM•F1, Žë–ì—Lì2, ˜a“c’B•F3, ‚ŽR—zŽq4, œA”šr¬3 (1—ÕŒŸ•”, 2—ÕŒŸŠw, 3äPŒŽ•aEŠŽõ“à, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ78‰ñ_“ސ쌧ŠŽõÇˆãŠw‰ï (2015/9/12), ‰¡•l.

733438. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž‘±–u‹NÇ‚Ì1Ç—á. “¡ˆä@Ž 1, ’†Œ‹vK1, ꠓcŠì”V1, ‰FŽ¡‹Ž‘PŸ1 (1—ÕŒŸ•”): “ú–{’Ž‰¹”gŒŸžŠw‰ïŠÖ“ŒbM‰z@‘æ30‰ñ’n•û‰ïŠwpW‰ï (2015/10/11), “Œ‹ž, ’Ž‰¹”gŒŸž‹Zp 2016/2; 41 (1): 58.

733439. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠwV•a‰@ŠJ‰@‚É”º‚€ŒÄ‹z‹@”\ŒŸž”‚̐„ˆÚ‚ɂ‚¢‚Ä. ‰¶’nŒb—1, ¬–ìŽRŽuD1, ‹{“à˜a”ü1, “¡¶”ü”T1, ²‹Ž‹v”üŽq1, “•ûLˆê1, Žë–ì—Lì1,2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ï (2015/11/15), ‰¡•l, ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ïƒvƒƒOƒ‰ƒ€Eu‰‰Ž˜^W 2016/11; p.79.

733440. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –³üLAN“‹ÚS“dŒv‚ð—˜—p‚µ‚œS“d}ŠÇ—ƒVƒXƒeƒ€‚̍\’z‚ɂ‚¢‚Ä. ¬–ìŽRŽuD1, ¬–ìàV—T–ç1, ’†Œ‹vK1, ‰FŽ¡‹Ž‘PŸ1, “à“cˆêO1, “•ûLˆê1, Žë–ì—Lì1,2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ï (2015/11/15), ‰¡•l, ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ïƒvƒƒOƒ‰ƒ€Eu‰‰Ž˜^W 2016/11; p.81.

733441. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CML‚É‚š‚¯‚é––œŒŒ‰tŒŸž‚̏d—v«‚ɂ‚¢‚ā|‰”­Žž‚ÌŒŸžƒf[ƒ^‚©‚ç‚í‚©‚邱‚Ɓ|. –Ñ—˜ŒõŠó1, ’†Œ@ŒO1, ˆ¢•”—L1, “à“cˆêO1, “•ûLˆê1, Žë–ì—Lì1,2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ï (2015/11/15), ‰¡•l, ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ïƒvƒƒOƒ‰ƒ€Eu‰‰Ž˜^W 2016/11; p.84.

733442. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚é‹Ù‹}—AŒŒ‚ÌŒ»ó. ì‹Ø“ߌŽ1, ³–؈ǓÞ1, “c•”—T“ñ1, ŽR•Ó°”ü1, ‚–ì”g—¯”ü1, •—ŠÔ‚ ‚«‚Ý1, ¬–{”ü“Þ1, “à“cˆêO1 (1—ÕŒŸ•”): ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ï (2015/11/15), ‰¡•l, ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ïƒvƒƒOƒ‰ƒ€Eu‰‰Ž˜^W 2016/11; p.97.

733443. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw4•a‰@‚É‚š‚¯‚é×‹Û‚ÌŒŸoó‹µ‚Æ–òÜŠŽŽó«‚̐„ˆÚ. “ñ–{–öL1,2 (1—ÕŒŸ•”, 2ŠŽõŠÇ—Žº): •œ¬27”N“x‘æ2‰ñ4•a‰@ŠŽõŠÇ—•”‰ïEŠŽõŠÇ—Œ€‹†‰ï (2016/3/5), “Œ‹ž.

733444. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Neisseria gonorrhoeae (—Ò‹Û) ‚ÌŒoŽž“I¶‹Û”‚̐„ˆÚ‚ÉŠÖ‚·‚錟“¢. ‹à–؁@—y, “ñ–{–öL1, ˜a“c’B•F2, ˆÀ’B@÷1, ¬ŠÑ’q¢1, ’†èM•F1, ‚ŽR—zŽq3, œA”šr¬2 (1—ÕŒŸ•”, 2äPŒŽ•aEŠŽõ“à, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ79‰ñ_“ސ쌧ŠŽõÇˆãŠw‰ï (2016/3/12), ìè.

733445. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}«’_”X‰Š‚É•¹”­‚µ‚œ’_ùNúE‚Ì2—á. ‰FŽ¡‹Ž‘PŸ1, ’†Œ‹vK1, “¡ˆä@Ž 1, –öŒŽ”ü’qŽq1, —é–ؐ­Žq1, H“¡—ß—Ç1, •œ“cçL1, ˆÉ“¡ˆŸŠóŽq1, ”ª–ØŽá“Þ1, ŠOŽR‚©‚š‚è1, â–{D1, ꠓcŠì”V1 (1—ÕŒŸ•”): “ú–{’Ž‰¹”gŒŸžŠw‰ïŠÖ“ŒbM‰z‘æ32‰ñ’n•û‰ïŠwpW‰ï (2016/3/20), é‹Ê, ’Ž‰¹”gŒŸž‹Zp 2016/6; 41 (3): 341.


•úŽËü•”

[Šw‰ïEŒ€‹†‰ï“™]

722256. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Chest Dual Energy Subtraction. ŠÖ@«Žu (•úŽËü•”): ‘æ71‰ñ“ú–{•úŽËü‹ZpŠw‰ï‘‰ïŠwp‘å‰ï (2015/4/17), ‰¡•l, ‘æ71‰ñ“ú–{•úŽËü‹ZpŠw‰ï‘‰ïŠwp‘å‰ï—\eW 2015; p.87.

7231100. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽB‰eƒvƒƒgƒR[ƒ‹‘I‘ð‚É‚æ‚铪•”CT angiography: “àèò“®–¬‚̉掿‰ü‘P‚ÌŒŸ“¢. ’Ë–ì@—D1, ”·@G“T1, ²“¡@œ1, `@”Ž•¶1, ˆäã—D‰î2 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): ‘æ71‰ñ“ú–{•úŽËü‹ZpŠw‰ï‘‰ïŠwp‘å‰ï (2015/4/16), ‰¡•l, ‘æ71‰ñ“ú–{•úŽËü‹ZpŠw‰ï‘‰ïŠwp‘å‰ï—\eW 2015; p.150.

7231101. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Œ‹@ŽíŠÔ‚É‚š‚¯‚éECG Dose Moduration‚Ì‹€“¯‚Ì”äŠr. ²“¡@œ1, ”·@G“T1, ’Ë–ì@—D1, `@”Ž•¶1, ˆäã—D‰î2 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): ‘æ71‰ñ“ú–{•úŽËü‹ZpŠw‰ï‘‰ïŠwp‘å‰ï (2015/4/16), ‰¡•l, ‘æ71‰ñ“ú–{•úŽËü‹ZpŠw‰ï‘‰ïŠwp‘å‰ï—\eW 2015; p.280.

7231102. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 1.5T‚Æ3T‘•’u‚É‚š‚¯‚éGd-EOB-DTPA‘¢‰eMRI‚ÌŠÌŽÀŽ¿‘‹­Œø‰ÊŽw•W‚ÌŒŸ“¢. `@”Ž•¶1, ˆäã—D‰î2, ’†“ˆ@—•1, ¬Œ©³‘Ÿ˜Y1 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/11), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ïŽGŽ 2015; 35 (Suppl): 268.

7231103. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 3D ASL CBF‰æ‘œ‚É‚š‚¯‚é•Ó‰•”‚M†ƒA[ƒ`ƒtƒ@ƒNƒg‚̐¬ˆö‚̃tƒ@ƒ“ƒgƒ€‚É‚æ‚錟“¢. ˆ¢•”@–L1, `@”Ž•¶1, ˆäã—D‰î2, “c’†’õl1, …ãT–ç3 (1•úŽËü•”, 2•úŽËü (‰æ‘œ), 3ˆã—Éq¶Šw•”): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/11), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ïŽGŽ 2015; 35 (Suppl): 363.

7231104. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 1.5T‘•’u‚Æ3T‘•’u‚ð—p‚¢‚œ3D ASL–@‚É‚æ‚é”]ŒŒ—¬—Ê‘ª’è‚É‚š‚¯‚é‘•’uŠÔ·‚ÌŒŸ“¢. “c’†’õl1, ˆäã—D‰î2, ˆ¢•”@–L1, ‹{•”ä˜CŽ÷1, `@”Ž•¶1 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/11), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ïŽGŽ 2015; 35 (Suppl): 364.

7231105. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Æ—§Œ^‹­Ž¥«‘Ì’T’mŠí‚ÌŠeŽí‹à‘®»•i‚ɑ΂·‚銎“x’²ž. “n粁@1, —é–Ø’‰Žm1, `@”Ž•¶1, ˆäã—D‰î2 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): ‘æ43‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2015/9/11), “Œ‹ž, “ú–{Ž¥‹C‹€–ˆãŠw‰ïŽGŽ 2015; 35 (Suppl): 432.

7231106. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ñ‹@Ží‚Å‚Ì’·ŠúŠÔ‚É‚í‚œ‚éƒgƒŒ[ƒTƒuƒ‹Na-22“_óüŒ¹‚Ì‘ª’è•ñ. ‹{•”ä˜CŽ÷1, ’·’Jì’q”V2, ˆ¢•”@–L1, ‹e’r@Œh1, ˆäã—D‰î3 (1•úŽËü•”, 2ˆã—Éq¶Šw•”, 3•úŽËü (‰æ‘œ)): ‘æ43‰ñ“ú–{•úŽËü‹ZpŠw‰ïH‹GŠwp‘å‰ï (2015/10/8), ‹à‘ò, “ú–{•úŽËü‹ZpŠw‰ïŽGŽ 2015; 71 (9): 827-8.

7231107. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 2‚‚̌ċz“¯ŠúÆŽËƒVƒXƒeƒ€‚É‚š‚¯‚éÆŽË’x‰„ŽžŠÔ‚̈Ⴂ‚É‚æ‚éü—Ê•ª•z‚ւ̉e‹¿. –ì“c–Η˜1, ˆî“c—ŽŽi1, “n糏r–Ÿ1, Žñ“¡éº1, Ž›è„Žj1, Îã@–«1, ÎŽR”ŽžŠ2, ‘ì˜ad2 (1•úŽËü•”, 2•úŽËü (Žîá‡)): ‘æ43‰ñ“ú–{•úŽËü‹ZpŠw‰ïH‹GŠwp‘å‰ï (2015/10/9), ‹à‘ò, “ú–{•úŽËü‹ZpŠw‰ïŽGŽ 2015; 71 (9): 878.

7231108. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒAƒNƒŠƒ‹‹zŽû‘̃gƒŒ[ƒTƒuƒ‹Ge-68/Ga-68“_óüŒ¹‚ð—p‚¢‚é’è—ʐ«•]‰¿Z³–@. ’·’Jì’q”V1, ‹{•”ä˜CŽ÷2, ‹e’r@Œh2, ˆäã—D‰î3, ²“¡@‘×4, ŽR“c’—T5, D“cŒ\ˆê6, ˜a“cNO7, âŒû˜a–ç7, ˆÀ“¡@—Ä1, ŠOŽR@w1 (1ˆã—Éq¶Šw•”, 2•úŽËü•”, 3•úŽËü (‰æ‘œ), 4ŽY‘Œ€, 5ƒAƒCƒ\ƒg[ƒv‹Š‰ï, 6–kŠC“¹‰ÈŠw‘å, 7—Œ€•ªŽqƒCƒ[ƒWƒ“ƒO): ‘æ55‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ï (2015/11/6), “Œ‹ž, ŠjˆãŠw 2015/9; 52 (3): 291.

7231109. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒhƒpƒ~ƒ“ƒgƒ‰ƒ“ƒXƒ|[ƒ^[ƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚É‚š‚¯‚éDaTView‚ÌŽQÆ—̈挈’è–@‚ÌŒŸ“¢. “n糂 ‚ä‚Ý1, ˆäã—D‰î2, ‹e’r@Œh1, ‹{•”ä˜CŽ÷1, “¿d‘žé1, Œ‰i”ü1, “c’†’õl1 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): ‘æ55‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ïE‘æ35‰ñ“ú–{ŠjˆãŠw‹ZpŠw‰ï‘‰ïŠwp‘å‰ï (2015/11/6), “Œ‹ž, ŠjˆãŠw‹Zp 2015; 35 (Suppl): 357.

7231110. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t“®‘ÔƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚É‚š‚¯‚ét‚̐[‚³‚Ì’Ž’áü—ÊCT‚ð—p‚¢‚œ‘ª’è. ˆÉ“¡Š°‘×1, ˆäã—D‰î2, “cã_ˆê1, ‘åŠÖ—T‰î1, ‹{•”ä˜CŽ÷1, ‹e’r@Œh1 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): ‘æ55‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ïE‘æ35‰ñ“ú–{ŠjˆãŠw‹ZpŠw‰ï‘‰ïŠwp‘å‰ï (2015/11/6), “Œ‹ž, ŠjˆãŠw‹Zp 2015; 35 (Suppl): 359.

7231111. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒhƒpƒ~ƒ“ƒgƒ‰ƒ“ƒXƒ|[ƒ^[ƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚É‚š‚¯‚錞Žã•â³‚ÌŒŸ“¢. “n糂 ‚ä‚Ý1, ˆäã—D‰î2, ó–ì—Y“ñ2, ‹{•”ä˜CŽ÷1, “¿d‘žé1 (1•úŽËü•”, 2•úŽËü (‰æ‘œ)): ‘æ55‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ïE‘æ35‰ñ“ú–{ŠjˆãŠw‹ZpŠw‰ï‘‰ïŠwp‘å‰ï (2015/11/7), “Œ‹ž, ŠjˆãŠw‹Zp 2015; 35 (Suppl): 371.

7231112. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Evalution of dose reductions caused by air-gaps between bolus and skin surface in Helical Tomotherapy. Ž›è„Žj1, –ì“c–Η˜1, Žñ“¡éº1, ÎŽR”ŽžŠ2, Îã@–«1, ˆî“c—ŽŽi1, ‘ì˜ad2 (1•úŽËü•”, 2•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ï‘æ28‰ñŠwp‘å‰ï (2015/11/20), ‘O‹Ž, ‘æ28‰ñ“ú–{•úŽËüŽîᇊw‰ïŠwp‘å‰ï•ñ•¶W 2015; p.229.

7231113. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 3DƒAƒjƒ[ƒVƒ‡ƒ“‚ð—p‚¢‚œ•úŽËüŽ¡—ʳŽÒŒü‚¯ƒIƒŠƒGƒ“ƒe[ƒVƒ‡ƒ““®‰æ‚̍쐬. ‰Ä–Ú”Ž–Ÿ1, “n糗S‰î2, Žñ“¡éº1, ˆÉ“¡—T‰î2, ¬“‡‘D2, ¬•œ“Þ‰›Žq2, ŠÖŒûˆ©ˆß3, ‘ì˜ad3 (1•úŽËü•”, 2ˆã—Éq¶Šw•”, 3•úŽËü (Žîá‡)): ‘æ31‰ñ “ú–{f—ÕúŽËü‹ZŽtŠwp‘å‰ï (2015/11/22), ‹ž“s, “ú–{f—ÕúŽËü‹ZŽt‰ïŽ 2015/11; 62 (11): 1319.

7231114. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) FFFƒr[ƒ€‚ÆSyncTraX‚ð—p‚¢‚œ, ”xSBRTŽ{sŽž‚̍œKÆŽËƒQ[ƒg•‚ÌŒŸ“¢. –ì“c–Η˜1, Žñ“¡éº1, ˆî“c—ŽŽi1, “n糏r–Ÿ1, Îã@–«1, Ž›è„Žj1, ‘ì˜ad2 (1•úŽËü•”, 2•úŽËü (Žîá‡)): ‘æ29‰ñ‚ž“x•úŽËüŠO•”ÆŽË•”‰ïŠwp‘å‰ï (2016/2/27), “Œ‹ž, ‘æ29‰ñ‚ž“x•úŽËüŽ¡—ÊO•”ÆŽË•”‰ïŠwp‘å‰ï@ƒvƒƒOƒ‰ƒ€EŽ˜^W 2016; p.44.

7231115. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”xSRT‚ɑ΂·‚éŒÄ‹z“¯ŠúIGRT‚ð—p‚¢‚œÆŽË’†‚̈ʒu•â³‚ÉŠÖ‚·‚錟“¢. Îã@–«1, ŽR–{˜a³1, Ž›è„Žj1, –ì“c–Η˜1, ˆî“c—ŽŽi1, Žñ“¡éº1, ÎŽR”ŽžŠ2, ‘ì˜ad2 (1•úŽËü•”, 2•úŽËü (Žîá‡)): ‘æ29‰ñ‚ž“x•úŽËüŠO•”ÆŽË•”‰ïŠwp‘å‰ï (2016/2/27), “Œ‹ž, ‘æ29‰ñ‚ž“x•úŽËüŽ¡—ÊO•”ÆŽË•”‰ïŠwp‘å‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2016; p.48.

733446. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) IMRTŒŸØ‚ÌŒø—Š‰»‚ðŒ©˜‚Š‚œŒŸØŒ‹‰Ê‚̉ðÍ. ŽR–{˜a³1, Ž›è„Žj1, ˆî“c—ŽŽi1, –ì“c–Η˜1, Îã@–«1, “n糏r–Ÿ1, Žñ“¡éº1 (1•úŽËü•”): (ŒöŽÐ) “ú–{•úŽËü‹ZpŠw‰ï‘æ62‰ñŠÖ“ŒŽx•”Œ€‹†”­•\‘å‰ï (2015/12/12), ’·–ì, ‘æ62‰ñŠÖ“ŒŽx•”Œ€‹†”­•\‘å‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2015; p.68.

733447. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒLƒƒƒiŠŽ“x‚̂΂ç‚‚«‚ªƒtƒBƒ‹ƒ€‰ðÍŒ‹‰Ê‚É—^‚Š‚é‰e‹¿. Ž›è„Žj1, ŽR–{˜a³1, –ì“c–Η˜1, ˆî“c—ŽŽi1, Îã@–«1, “n糏r–Ÿ1, Žñ“¡éº1, ÎŽR”ŽžŠ2 (1•úŽËü•”, 2•úŽËü (Žîá‡)): (ŒöŽÐ) “ú–{•úŽËü‹ZpŠw‰ï‘æ62‰ñŠÖ“ŒŽx•”Œ€‹†”­•\‘å‰ï (2015/12/12), ’·–ì, ‘æ62‰ñŠÖ“ŒŽx•”Œ€‹†”­•\‘å‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2015; p.69.

733448. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •GŠÖßŽB‰e‚É‚š‚¯‚éŽB‰eðŒ‚Ì•W€‰»‚Ö‚ÌŽŽ‚Ý. ŠÖ@«Žu1, ‰ª–{Œ[Œö1, ŸìŒö‹I1, ‚Œ‘Ÿ˜Y1, ŠÛ”öGŽ÷1, ŽR›œ‰ëŽj1, ãŒŽŒ›“ñ1 (1•úŽËü•”): (ŒöŽÐ) “ú–{•úŽËü‹ZpŠw‰ï‘æ62‰ñŠÖ“ŒŽx•”Œ€‹†”­•\‘å‰ï (2015/12/13), ’·–ì, ‘æ62‰ñŠÖ“ŒŽx•”Œ€‹†”­•\‘å‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2015; p.91.

733449. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹’Å‘€–Ê‘œ‚É‚š‚¯‚éü—ÊŠÇ—•‚ÌŒŸ“¢. ‰ª–{Œ[Œö1, ŠÖ@«Žu1, ŽR›œ‰ëŽj1, ãŒŽŒ›“ñ1, ‘ŠàV@^1 (1•úŽËü•”): (ŒöŽÐ) “ú–{•úŽËü‹ZpŠw‰ï‘æ62‰ñŠÖ“ŒŽx•”Œ€‹†”­•\‘å‰ï (2015/12/13), ’·–ì, ‘æ62‰ñŠÖ“ŒŽx•”Œ€‹†”­•\‘å‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2015; p.91.

733450. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒLƒƒƒiŠŽ“x‚̂΂ç‚‚«‚ªƒtƒBƒ‹ƒ€‰ðÍŒ‹‰Ê‚É—^‚Š‚é‰e‹¿. Ž›è„Žj1, ŽR–{˜a³1, –ì“c–Η˜1, ˆî“c—ŽŽi1, Îã@–«1, Žñ“¡éº1, ÎŽR”ŽžŠ2, ‘ì˜ad2 (1•úŽËü•”, 2•úŽËü (Žîá‡)): ‘æ58‰ñ‰¡•l•úŽËüŽ¡—ͧ˜b‰ï (2016/3/7), ‰¡•l.

733451. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒBƒ‹ƒ€‚Æ3ŽŸŒ³”Œ“±‘ÌŒŸoŠí‚É‚æ‚éIMRTŒŸØŒ‹‰Ê‚̉ðÍ. ŽR–{˜a³1, Ž›è„Žj1, ˆî“c—ŽŽi1, –ì“c–Η˜1, Îã@–«1, Žñ“¡Mº1, ÎŽR”ŽžŠ2, ‘ì˜ad2 (1•úŽËü•”, 2•úŽËü (Žîá‡)): ‘æ58‰ñ‰¡•l•úŽËüŽ¡—ͧ˜b‰ï (2016/3/7), ‰¡•l.


–òÜ•”

[Šwp˜_•¶]

110333. [ŒŽ’˜] Dipeptidyl peptidase-4 greatly contributes to the hydrolysis of vildagliptin in human liver. Asakura M1, Fujii H1, Atsuda K1,2, Itoh T1, Fujiwara R1: Drug Metab Dispos 2015/4; 43 (4): 477-84. (Œú“cKˆê˜Y1,2: 1–òŠw•”, 2–òÜ•”)

110334. [ŒŽ’˜] Insulin degludec requires lower bolus insulin doses than does insulin glargine in Japanese diabetic patients with insulin-dependent state. Komuro M1, Inoue G1, Tabata M, Yamada Y, Atsuda K1,2, Matsubara H1, Irie J, Uchida J, Nakajima C, Izumi H, Shimada M, Yamada S: J Diabetes Sci Technol 2015/5; 9 (3): 632-8. (Œú“cKˆê˜Y1,2: 1–òŠw•”, 2–òÜ•”)

110335. [ŒŽ’˜] Construction of a model for predicting creatinine clearance in Japanese patients treated with Cisplatin therapy. Yajima A1, Uesawa Y, Ogawa C, Yatabe M, Kondo N, Saito S, Suzuki Y, Atsuda K1,2, Kagaya H: Anticancer Res 2015/5; 35 (5): 2909-14. (–ˆ€—1, Œú“cKˆê˜Y1,2: 1–òŠw•”, 2–òÜ•”)

110336. [ŒŽ’˜] Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patients. Komatsu T1, Morita M, Miyaji F1, Inomata T2, Ako J2, Atsuda K1: J Pharm Health Care Sci 2015/9; 1: 25. (¬Œ•q²1, ‹{“¹“ñ—t1, ’––”FŒ³2, ˆ¢ŒÃÆ2, Œú“cKˆê˜Y1: 1–òÜ•”, 2zŠÂŠí“à)

110337. [ŒŽ’˜] Association between pharmacokinetic variables and neutropenia after treatment with docetaxel, cisplatin, and 5-fluorouracil in patients with esophageal squamous cell carcinoma. Sugawara M1, Katada C2, Komatsu T1, Takahashi K3, Azuma M2, Higuchi K2, Koizumi W2, Atsuda K4: Esophagus 2015; 12 (3): 209-18. (›ŒŽ[L1, Œ˜“ce—˜2, ¬Œ•q²1, ‚‹Ž‚©‚š‚é3, “Œ@’q2, ”óŒûŸ•F2, ¬ò˜aŽO˜Y2, Œú“cKˆê˜Y1,4: 1–òÜ•”, 2Á‰»Ší“à, 3ŠÅŒì•”, 4–òŠw•”)

120074. [ŒŽ’˜] Ž‰Ž¿ˆÙíÇ‚ð‡•¹‚·‚é2Œ^“œ”A•aŠ³ŽÒ‚É‚š‚¯‚鐅—n«‚š‚æ‚ÑŽ‰—n«ƒXƒgƒƒ“ƒOƒXƒ^ƒ`ƒ“‚Ì—LŒø«‚ƈÀ‘S«‚ÉŠÖ‚·‚郁ƒ^ƒAƒiƒŠƒVƒX. Œüˆäˆê1, Î•—F‹I1, {“c“NŽj2, ”ö’¹Ÿ–ç1, Œú“cKˆê˜Y1,3 (1–òŠw•”, 2Š”Ž®‰ïŽÐƒCƒmƒxƒCƒVƒ‡ƒ“ƒIƒuƒƒfƒBƒJƒ‹ƒT[ƒrƒX, 3–òÜ•”): ˆã—ÖòŠw 2015/9; 41 (9): 656-66.

120075. [ŒŽ’˜] ŒÄ‹zŠí—̈悪‚ñŠ³ŽÒ‚É‚š‚¯‚é—\‘ªƒNƒŒƒAƒ`ƒjƒ“ƒNƒŠƒAƒ‰ƒ“ƒX‚̐„§ŽZo–@‚ÌŒŸ“¢. –ˆ€—1, A‘ò–FL2, ˆî–ì@Š°3, ‰v“c“TK4, ”ö’¹Ÿ–ç1, Œú“cKˆê˜Y1,3, ‰Á‰ê’J”£2 (1–òŠw•”, 2–ŸŽ¡–ò‰È‘åŠw–òŠw•”, 3–òÜ•”, 4ŒÄ‹zŠí“à): “ú–{ŠÉ˜aˆã—ÖòŠwŽGŽ 2016/3; 9 (1): 17-23.

520016. [‘à] ƒrƒ‹ƒ_ƒOƒŠƒvƒ`ƒ“‚Ì‘ãŽÓy‘f‚Æ‘Ì“à“®‘Ô•Ï“®ˆöŽq‚ÉŠÖ‚·‚éÅ‹ß‚ÌŒ€‹†. ’©‘q[r1, “¡ŒŽ—ºˆê1, ˆÉ“¡’q•v1, Œú“cKˆê˜Y1,2 (1–òŠw•”, 2–òÜ•”): ‚­‚·‚è‚Æ“œ”A•a 2015/9; 4 (2): 155-65.

522226. [uÀ]y“ÁW: S•s‘S|‰h—{ŠÇ—‚ÌŽÀ‘Hƒ|ƒCƒ“ƒgzS•s‘SŠ³ŽÒ‚̃`[ƒ€ˆã—Á|–òÜŽt‚Ì–ðŠ„‚Æ˜AŒg. ¬Œ•q²1, Œú“cKˆê˜Y1 (1–òÜ•”): —Տ°‰h—{ 2015/9; 127 (3): 316-21.

522227. [uÀ]y“ÁW: ‹}«–ò•š’†“Å ž_ŽŸŠ³‚ðŽ‚ÂŠ³ŽÒ‚ÌŽ©ŽEŠé}‚ւ̃Aƒvƒ[ƒ`z¡‹}«–ò•š’†“Å‚ÌŠ³ŽÒ‚ª‹~‹}”À‘—! ‹‚ß‚ç‚ê‚éî•ñ’ñ‹Ÿ“à—e‚̓RƒŒ‚Ÿ!@E‹}«–ò•šŽ¡—Âɂ‚¢‚Ä‚Ì“ú‰¢•Ä‚Ƃ̈Ⴂ‚ƍ¡Œã‚Ì“W–]. ‹ß“¡—¯”üŽq (–òÜ•”): –ò‹Ç 2015/10; 66 (11): 110-3.

522228. [uÀ]Œ€‹†í—ª: –òÜ‚̌•ʉ»“Š—^ÝŒv‚ÉŒü‚¯|ŒŒ’†”Z“xŠÇ—‚ð’Ê‚µ‚ā|. ¬Œ•q²1, Œú“cKˆê˜Y1 (1–òÜ•”): –òŽ–“ú•ñ –òŠw¶V•· 2015/11/1; 11–Ê.

522229. [uÀ]y“ÁW: “O’ꗝ‰ð! Á“Å–ò ˆã—Ê֘AŠŽõ‘΍ô‚ð—LŒø‚ÉŽÀŒ»‚·‚é‚œ‚߂Ɂz¡ÅVƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œŠŽõÇEƒRƒ“ƒ^ƒ~ƒl[ƒVƒ‡ƒ“‚ւ̑Ήž@ElHŒÄ‹zŠíŠÖ˜A”x‰Š. ¬—я¹G1, Œú“cKˆê˜Y1 (1–òÜ•”): –ò‹Ç 2016/2; 67 (2): 214-7.

540078. [‚»‚Ì‘Œ (Šñe)] ¬Ž™‚ª‚ñ‚̔ӊú‡•¹Ç‚ƏA˜J–â‘è‚ɂ‚¢‚ā`ŒoŒ±ŽÒ‚Ì—§ê‚©‚ç`. Œ“¡]—œ1, ¬Œ•q²1,2, ‘C–{‘å•ã1, ‰Á“¡Šó1, ‘å’Ë‹MŒb1, ˆä–{Œ\—S1 (1¬Ž™‚ª‚ñŒoŒ±ŽÒƒlƒbƒgƒ[ƒNƒVƒFƒCƒNƒnƒ“ƒY, 2–òÜ•”): ¬Ž™‚ª‚ñŠÅŒì 2015/9; 10 (1): 40-2.

[’˜@‘]

620184. [Šwp‘] (•ª’SŽ·•M)yÅV ®Œ`ŠO‰Èˆã‚ª’m‚Á‚Ä‚š‚«‚œ‚¢–ò‚ÌŽg‚¢•û (ŠÖßŠO‰È2015”N10ŒŽ‘Š§†)zV. Žê‚È–òÜ@R‹ÃŒÅ–ò, p.244-51. ‚•œL®1, •yàV@~2 (1ˆã—Éq¶Šw•”, 2–òÜ•”), Šé‰æE•ÒW: ’Ÿ²‰x’j, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2015/10”­s.

620185. [Šwp‘] (•ª’SŽ·•M)y2ƒy[ƒW‚Å—‰ð‚·‚é•W€–ò•šŽ¡—Ãtƒ@ƒCƒ‹ ‰ü’ù2”Łz¡ˆ««Žîᇁ@62. ˆ««ƒŠƒ“ƒpŽî, p.124-5. ‹{“‡—¥Žq (–òÜ•”), •Ò: “ú–{ƒAƒvƒ‰ƒCƒhEƒZƒ‰ƒsƒ…[ƒeƒBƒNƒXŠw‰ï, “ìŽR“°, “Œ‹ž, 2015/12”­s.

620186. [Šwp‘] (•ª’SŽ·•M)y2ƒy[ƒW‚Å—‰ð‚·‚é•W€–ò•šŽ¡—Ãtƒ@ƒCƒ‹ ‰ü’ù2”Łz¡ˆ««Žîᇁ@63. ‘œ”­«œ‘Žî, p.126-7. ‹{“‡—¥Žq (–òÜ•”), •Ò: “ú–{ƒAƒvƒ‰ƒCƒhEƒZƒ‰ƒsƒ…[ƒeƒBƒNƒXŠw‰ï, “ìŽR“°, “Œ‹ž, 2015/12”­s.

620187. [Šwp‘] (•ª’SŽ·•M)y2ƒy[ƒW‚Å—‰ð‚·‚é•W€–ò•šŽ¡—Ãtƒ@ƒCƒ‹ ‰ü’ù2”Łz¡ˆ««Žîᇁ@64. ”­”M«Œû’†‹}Œž­Ç, p.128-9. ‹{“‡—¥Žq (–òÜ•”), •Ò: “ú–{ƒAƒvƒ‰ƒCƒhEƒZƒ‰ƒsƒ…[ƒeƒBƒNƒXŠw‰ï, “ìŽR“°, “Œ‹ž, 2015/12”­s.

620188. [Šwp‘] (•ª’SŽ·•M)y2ƒy[ƒW‚Å—‰ð‚·‚é•W€–ò•šŽ¡—Ãtƒ@ƒCƒ‹ ‰ü’ù2”Łz¡ˆ««Žîᇁ@65. R‚ª‚ñÜ‚É‚æ‚鈫SEšq“f, p.130-1. ‹{“‡—¥Žq (–òÜ•”), •Ò: “ú–{ƒAƒvƒ‰ƒCƒhEƒZƒ‰ƒsƒ…[ƒeƒBƒNƒXŠw‰ï, “ìŽR“°, “Œ‹ž, 2015/12”­s.

620189. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽwj 2016”N”Łz•ž–òŽw“±E–òÜî•ñ. Œú“cKˆê˜Y (–òÜ•”), ŠÄC: ŽRŒû@“O, –kŒŽŒõ•v, ‘•ÒW: •ŸˆäŽŸ–î, ‚–؁@œ, ¬Žºˆê¬, ˆãŠw‘‰@, “Œ‹ž, 2016/1”­s.

620190. [Šwp‘] (•ª’SŽ·•M)yPocket Drugs 2016zŠà@65. Rˆ««Žîᇖò (‘ãŽÓhR–ò), p.600-8. ‰ª–{Œb”üŽq1, ¬ò˜aŽO˜Y2 (1–òÜ•”/—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 2Á‰»Ší“à), ŠÄC: •ŸˆäŽŸ–î, •Ò:¬ŒNG, “n糗TŽi, ˆãŠw‘‰@, “Œ‹ž, 2016/1”­s.

620191. [Šwp‘] (•ª’SŽ·•M)yŽ¡—ÃåZƒnƒ“ƒhƒuƒbƒN2016zp.642-8. p.677-85. p.691-4. Œú“cKˆê˜Y (–òÜ•”), ŠÄC: ‚‹vŽj–›, •Ò: –x @³“ñ, ›–쌒‘Ÿ˜Y, –å˜e@F, Š£@Œ«ˆê, —с@¹—m, ‚¶‚Ù‚€, “Œ‹ž, 2016/1”­s.

621004. [Šwp‘] (•ÒW)yŽÊ^•t/•ž–òŽw“±CD-ROM 2016”N3ŒŽ”ŁzŒú“cKˆê˜Y (–òÜ•”), •Ò: Š³ŽÒŒü‚¯ˆã–ò•iî•ñCD‰»•ÒWˆÏˆõ‰ï, ‚¶‚Ù‚€, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713137. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Management of peripheral neuropathy induced by paclitaxel and nanoparticle albumin-bound paclitaxel. Miyaji F1, Waraya M2, Sengoku N2, Tanino H2, Atsuda K1,3: 75th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2015 (2015/9/29-10/3), Dusseldorp, Germany, 75th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2015online abstract 2015/9. (‹{“¹“ñ—t1, ˜m’J”ü“Þ2, åÎ‹I•F2, ’J–ì—Tˆê2, Œú“cKˆê˜Y1,3: 1–òÜ•”, 2ŠO‰È, 3–òŠw•”)

713138. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Acetaminophen|protein adducts and GSH levels at intake of N-acetylcysteine in acetaminophen-treated mice. Fukumoto M, Yamaguchi M, Tomoda Y1, Atsuda K1: North American Congress of Clinical Toxicology 2015 (2015/10/8-12), San Francisco, USA, Clinical Toxicology 2015; 53 (7): 684. (—F“c‹g‘¥1, Œú“cKˆê˜Y1: 1–òÜ•”)

713139. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effects of vildagliptin and its metabolite on inflammation-associated genes in human hepatoma HepG2 and monocytic HL-60 cells. Asakura M1, Fujii H1, Atsuda K1,2, Itoh T1, Fujiwara R1: 55th Annual Meeting and ToxExpo (2016/3/15), New Orleans, Louisiana, USA, SOT 2016/3; p.196. (Œú“cKˆê˜Y1,2: 1–òŠw•”, 2–òÜ•”)

7231116. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –«S•s‘SŠ³ŽÒ‚ɑ΂·‚鎊“K–ò•š—Ö@‚ÌŒ»ó”cˆ¬. ¬Œ•q²1, ’––”FŒ³2, ŽO‰Y@‹P1, ˆ¢ŒÃ–ç2, Œú“cKˆê˜Y1 (1–òÜ•”, 2zŠÂŠí“à): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/24-26), ‘åã, ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpŽ˜^W (ƒCƒ“ƒ^[ƒlƒbƒg”Å) 2014/4.

7231117. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒWƒSƒLƒVƒ“‚ÌŒo‘Ù”Õ“I“Š—^‚É‚š‚¢‚Ä•ê‘Ì‹y‚Ñ‘ÙŽ™‚ÌŒŒ’†”Z“x‚𑪒肵‚œ2Ç—á. ’†‘º@—D1, ‰Ô“‡—æŽq1, ‘•ªG–ç1, ‹ß“¡—¯”üŽq1, Œú“cKˆê˜Y1,2 (1–òÜ•”, 2–òŠw•”): ‘æ32‰ñ“ú–{TDMŠw‰ïEŠwp‘å‰ï (2015/5/23-24), Œ–{, ‘æ32‰ñ“ú–{TDMŠw‰ïEŠwp‘å‰ï—vŽ| 2015/5; 32: 159.

7231118. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’ŽË—pƒJƒ‹ƒoƒyƒlƒ€ŒnR‹Û–ò‚ÌŽg—p—ʐ„ˆÚ‚Æ‚»‚̉e‹¿ˆöŽq‚ÌŒŸ“¢. ‘åìŒŽ—TŽ÷1, ˜a“c’B•F2, ‚ŽR—zŽq3, Œú“cKˆê˜Y1, »ìŒc‰î4 (1–òÜ•”, 2äPŒŽ•aEŠŽõ“à, 3V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 4ŠŽõŠÇ—Žº): ‘æ63‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2015/6/6), “Œ‹ž.

7231119. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ûŠàŽ¡—Âɂš‚¯‚étri-weekly nab-paclitaxel‚Æweekly paclitaxel‚Ì•›ì—p’²ž. ‹{“¹“ñ—t1, Œ‹{—mŽj2, ˜m’J”ü“Þ2, ¬â–ùŒ«2, åÎ‹I•F2, ’J–ì—Tˆê2, Œú“cKˆê˜Y1,3 (1–òÜ•”, 2ŠO‰È, 3–òŠw•”): ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2015/7/2-4), “Œ‹ž, ‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïŽ˜^W 2015/7; p.575.

7231120. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒoŒûR‚ª‚ñÜ‚Æ•¹—p–ò‚É‚æ‚é–ò•šŠÔ‘ŠŒÝì—p‚ÉŠÖ‚·‚é’²ž. £ŒË—Ç‹³1, “n糍_Žk1, ‘•ªG–ç1, ‹ß“¡—¯”üŽq1, Œú“cKˆê˜Y1,2 (1–òÜ•”, 2–òŠw•”): ‘æ13‰ñ—Տ°Žîᇊw‰ïŠwpW‰ï (2015/7/16-18), ŽD–y, ‘æ13‰ñ—Տ°Žîᇊw‰ïŠwpW‰ï—vŽ|W 2015/7; p.270.

7231121. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) V‹K‚Ì’†“Å‹Nˆö•šŽ¿‚Í‚Ç‚ñ‚ȏî•ñŒ¹‚ðŒŸõ‚·‚ׂ«‚©. —F“c‹g‘¥1, •Ÿ–{^—Žq2, ¬‘qŒhŽj2, Œú“cKˆê˜Y1,2 (1–òÜ•”, 2–òŠw•”): ‘æ37‰ñ“ú–{’†“ÅŠw‰ï‘‰ïEŠwpW‰ï (2015/7/17-18), ˜a‰ÌŽR, ’†“ÅŒ€‹† 2015/9; 28 (2): 173.

7231122. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “KØ‚©‚ˆÀ‘S‚ÈŽ¡Œ±–òŠÇ—‘̐§‚̍\’z`‹Æ–±‚Ì“ˆê‚ð–ÚŽw‚µ‚ā`. ³‘º—DŽq1,2, ’†ì’qŽ}1,2, ‘O“cŽÀ‰Ô1,2, ’†‘º’q”ü1,2, ²“¡‰pG1,2, ¬ò—º•ã1,2, ‰¡“cœÄˆê1,2, •ŽR­ˆê3, Œú“cKˆê˜Y1,2, ŒF’J—YŽ¡2,4 (1–òÜ•”, 2—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 3“Œ•a‰@–òÜ•”, 4—Տ°Œ€‹†EŠé‰æ): ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c 2015 in KOBE (2015/9/12-13), _ŒË, ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2015 in KOBE ƒvƒƒOƒ‰ƒ€EŽ˜^W 2015/9; p.143.

7231123. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) »‘¢”Ì”„Œã’²žŽó‘õŽž‚̉@“à‘̐§‚̐®”õ. ²“¡‰pG1,2, ‘O“cŽÀ‰Ô1,2, ‰¡“cœÄˆê1,2, •ŽR­ˆê3, Œú“cKˆê˜Y1,2, ŒF’J—YŽ¡2,4 (1–òÜ•”, 2—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 3“Œ•a‰@–òÜ•”, 4—Տ°Œ€‹†EŠé‰æ): ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c 2015 in KOBE (2015/9/12-13), _ŒË, ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2015 in KOBE ƒvƒƒOƒ‰ƒ€EŽ˜^W 2015/9; p.195.

7231124. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) CRC‹Æ–±ƒ}ƒjƒ…ƒAƒ‹‚̍쐬`2•a‰@‚Ì‘gD“‡‚ðŒoŒ±‚µ‚ā`. ŽR–{–ŸŽq1,2, í“cˆ€Žq1,2, –ìŒûŒbŽq2,3, Œ¢’Ë’qŽq2,3, –쑺¡“úŽq2,3, ‘O“cŽÀ‰Ô1,2, ‰¡“cœÄˆê1,2, Œú“cKˆê˜Y1,2, ŒF’J—YŽ¡2,4 (1–òÜ•”, 2—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 3ŠÅŒì•”, 4—Տ°Œ€‹†EŠé‰æ): ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c 2015 in KOBE (2015/9/12-13), _ŒË, ‘æ15‰ñCRC‚ƗՏ°ŽŽŒ±‚Ì‚ ‚è•û‚ðl‚Š‚é‰ï‹c2015 in KOBE ƒvƒƒOƒ‰ƒ€EŽ˜^W 2015/9; p.208.

7231125. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) DPP-4‘jŠQ–òƒrƒ‹ƒ_ƒOƒŠƒvƒ`ƒ“‚Ì“K³Žg—p‚ÉŒü‚¯‚œin vitro–ò•š“®‘ÔŒ€‹†. ’©‘q[r1, “¡ŒŽ—ºˆê1, ˆÉ“¡’q•v1, Œú“cKˆê˜Y1,2 (1–òÜ•”, 2–òŠw•”): ‘æ4‰ñ“ú–{‚­‚·‚è‚Æ“œ”A•aŠw‰ïŠwpW‰ï (2015/9/26-27), VŠƒ, “ú–{‚­‚·‚è‚Æ“œ”A•aŠw‰ï 2015/9; p.128.

7231126. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –@“I”]Ž€”»’è‚É‚š‚¯‚é–òÜŽt‚̏d—v«. —F“c–ŸŽq1, ’Ł@@’1, ‹ß“¡—¯”üŽq1, rì–@Žq2, ‚‹Ž@Œb2, ‹g“cˆê¬3, Œú“cKˆê˜Y1,4 (1–òÜ•”, 2ŠÅŒì•”, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã, 4–òŠw•”): ‘æ51‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2015/10/2), ŒF–{, ˆÚA 2015; 50 (‘‰ï—ÕŽž): 420.

7231127. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ä”­“«ˆ««ƒŠƒ“ƒpŽî‚É‚š‚¯‚éƒQƒ€ƒVƒ^ƒrƒ“•¹—p—Ö@‚Ì—LŒø«‚ƈÀ‘S«‚ÉŠÖ‚·‚é•ñ. ‹{“‡—¥Žq1, Œ‰ª˜aº2, ’hŒŽŠ²•v2, “ŒŒŽ³–Ÿ2, Œú“cKˆê˜Y1 (1–òÜ•”, 2ŒŒ‰t“à): ‘æ77‰ñ“ú–{ŒŒ‰tŠw‰ïŠwpW‰ï (2015/10/16-18), Îì, —Տ°ŒŒ‰t 2015/9; 56: 485.

7231128. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) V¶Ž™‚̏㎺«•s®–¬Ç—á‚É‚š‚¯‚éƒtƒŒƒJƒCƒjƒhŒoŒûÜ‚Æ•ê“û‚Æ‚Ì‘ŠŒÝì—p. ˆäà_ˆ€“Þ1, ¬ì‹v”üŽq1, çݎ@Šw2, ¬—я¹G1, ‘•ªG–ç1, ‹ß“¡—¯”üŽq1, Îˆä³_2, Œú“cKˆê˜Y1 (1–òÜ•”, 2¬Ž™): ‘æ60‰ñ“ú–{V¶Ž™¬ˆçˆãŠw‰ïEŠwpW‰ï (2015/10/24), ·‰ª, ‘æ60‰ñ“ú–{V¶Ž™¬ˆçˆãŠw‰ïEŠwpW‰ï—vŽ|W 2015/9; 27 (3): 627.

7231129. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) tˆÚAŠ³ŽÒ‚É‚š‚¯‚éƒ^ƒNƒƒŠƒ€ƒX™•ú«»Ü‚Ì•êW’c–ò•š“®‘Ô‰ðÍ. ‹{â—Dl1, ‘•ªG–ç1, ²–ì—TŽi2, ‹g“cˆê¬3, Îˆä‘å•ã4, ’|“àN—Y5, Œú“cKˆê˜Y1,2 (1–òÜ•”, 2–òŠw•”, 3V¢‹Iˆã—ÁEæ’[ˆã—Ã, 4”å”AŠí, 5t‘Ÿ“à): ‘æ9‰ñ“ú–{t‘Ÿ•a–ò•š—Ö@Šw‰ïŠwpW‰ïE‘‰ï2015 (2015/10/24), å‘ä, “ú–{t‘Ÿ•a–ò•š—Ö@Šw‰ï‰ïŽ 2015/9; 4 (2): S103.

7231130. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒ[ƒtƒ@ƒŠƒ“‚̏ˆ•ûŽx‰‡‚ð’Ê‚µ‚ā`ƒAƒ~ƒIƒ_ƒƒ“‚Æ‚Ì‘ŠŒÝì—p‚𒆐S‚Ɂ`. ’ˈ䖃ŽÀ1, ¬Œ•q²1, ¬—я¹G1, ‘•ªG–ç1, ‹ß“¡—¯”üŽq1, Œú“cKˆê˜Y1,2 (1–òÜ•”, 2–òŠw•”): ‘æ25‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2015/11/21-23), ‰¡•l, ‘æ25‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2015/11; p.264.

7231131. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆÚAŒãŠ³ŽÒ‚Ö‚ÌŽw“±ŠÇ—‚É‚š‚¯‚é–òÜŽt‚ÌŠÖ—^. ‹{â—Dl1, ¬—я¹G1, ˆî–ì@Š°1, ‹g“cˆê¬2, Îˆä‘å•ã3, ’|“àN—Y4, ’r“c¬]5, –ìŒû•¶”T5,6, “c’†”üŽ÷5,6, Œú“cKˆê˜Y1,7 (1–òÜ•”, 2V¢‹Iˆã—ÁEæ’[ˆã—Ã, 3”å”AŠí, 4t‘Ÿ“à, 5ƒŒƒVƒsƒGƒ“ƒgˆÚAƒR[ƒfƒBƒl[ƒ^[, 6ŠÅŒì•”, 7–òŠw•” ): ‘æ25‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2015/11/21-23), ‰¡•l, ‘æ25‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2015/11; p.295.

7231132. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚鏬Ž™–ò—p—ʃ`ƒFƒbƒNƒVƒXƒeƒ€“±“ü‚É‚æ‚郊ƒXƒNƒ}ƒlƒWƒƒ“ƒg‚Ö‚ÌŽæ‚è‘g‚Ý. ”ª–؍GŽ÷1, —F“c–ŸŽq1, ’Ł@@’1, ‹ß“¡—¯”üŽq1, Šâèr”V2, Œú“cKˆê˜Y1,3 (1–òÜ•”, 2¬Ž™, 3–òŠw•”): ‘æ25‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2015/11/21-23), ‰¡•l, ‘æ25‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2015/11; p.375.

7231133. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “œ”A•aê–åƒNƒŠƒjƒbƒN‚É‚š‚¯‚é–¯ŠÔ—Ö@‚ÌŽÀ‘ԁ|ƒAƒ“ƒP[ƒg’²ž‚É‚æ‚錟“¢|. Œüˆäˆê1, •œ’Ë—D‰Á1, ‹àX@W1, ”ö’¹Ÿ–ç1, Œú“cKˆê˜Y1,2 (1–òÜ•”, 2–òŠw•”): ‘æ25‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2015/11/23), ‰¡•l, ‘æ25‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2015/11; p.469

7231134. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) _Œo•Ï«ŽŸŠ³“™‚É”º‚€—¬ŸµÇ‚ð—L‚·‚銳ŽÒ‚ð‘ΏۂƂµ‚œƒXƒRƒ|ƒ‰ƒ~ƒ“5%“îp (‰@“à»Ü) Œo”çŽg—pŽž‚Ì–ò•š“®‘Ô‚š‚æ‚Ñ–ò—ÍŠw‚Ì’Tõ“IŒŸ“¢. ‘O“cŽÀ‰Ô1,2, ¬ò—º•ã1,2, ¬ŒŽ”ü]3, –{ŠÔ‰ëŽm1, •œŽR•Ži3, •ŽR­ˆê3, ‰¬–ì”üŒbŽq4, ˆ¢‹v’Óñ•v5, ŒŽR˜a—˜5, ŒF’J—YŽ¡2,6 (1–òÜ•”, 2—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 3“Œ•a‰@–òÜ•”, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 5_Œo“à, 6—Տ°Œ€‹†EŠé‰æ): ‘æ36‰ñ“ú–{—Տ°–ò—Šw‰ïŠwp‘‰ï (2015/12/9), Vh, —Տ°–ò— 2015/11; 46(suppl): s164.

7231135. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ú–{l, ŠØ‘lŒ’N¬l”팱ŽÒ‚ÌŽ¡Œ±ŽQ‰Á“®‹@‚Æ”FŽ¯‚ÉŠÖ‚·‚錀‹†|[‘w“I’f–Ê’²ž|. ¬ò—º•ã1,2, ‘O“cŽÀ‰Ô1,2, XˆŸ–îŽq1,2, ¬‘ò@Šw1,2, ‘v@ˆê‘å3, ²X–Ø‘PM1,2, ‰¡“cœÄˆê1,2, “¡“c•üŒb2,4, Ji-Hye Seo5, Ock-Joo Kim5, ŒF’J—YŽ¡2,6 (1–òÜ•”, 2—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4–ò—, 5Depertment of the History of Medicine and Medical Humanities College of Medicine Seoul National University, 6—Տ°Œ€‹†EŠé‰æ): ‘æ36‰ñ“ú–{—Տ°–ò—Šw‰ïŠwp‘‰ï (2015/12/9), Vh, —Տ°–ò— 2015/11; 46(suppl): s177.

7231136. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž¡Œ±‚ÉŽQ‰Á‚·‚é“ú–{l‚ÌŒ’Nƒ{ƒ‰ƒ“ƒeƒBƒA‚ÌŽQ‰Á“®‹@‚Æ”FŽ¯‚ÉŠÖ‚·‚éˆÓŽ¯’²ž|ƒAƒ“ƒP[ƒg‚É‚æ‚鉡’f’²ž, ƒCƒ“ƒ^ƒrƒ…[‚É‚æ‚鎿“IŒ€‹†’²ž‚ðŽÀŽ{‚µ‚ā|. XˆŸ–îŽq1,2, ¬‘ò@Šw1,2, ¬ò—º•ã2,3, ‘O“cŽÀ‰Ô2,3, “¡“c•üŒb2,4, ŒF’J—YŽ¡2,5 (1ŠÅŒì•”, 2—Տ°ŽŽŒ±ƒZƒ“ƒ^[, 3–òÜ•”, 4–ò—, 5—Տ°Œ€‹†EŠé‰æ): ‘æ36‰ñ“ú–{—Տ°–ò—Šw‰ïŠwp‘‰ï (2015/12/9), Vh, —Տ°–ò— 2015/11; 46(suppl): s178.

7231137. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) MRSAŠŽõ§ŒäUP TO DATE: MRSAŠŽõÇŽ¡—Â̍ŋ߂̘b‘è. ¬—я¹G (–òÜ•”): ‘æ31‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ïEŠwpW‰ï (2016/2/19-20), ‹ž“s, “ú–{ŠÂ‹«ŠŽõŠw‰ïŽ 2016/2; 31S: 204.

7231138. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éˆã–ò•i‚̐V‹KÌ—p‚ÌŒ»ó‚ƍ¡Œã‚̉ۑè. â–{‚©‚š‚è1, —F“c–ŸŽq1, ’Ł@@’1, ‹ß“¡—¯”üŽq1, Œú“cKˆê˜Y1,2 (1–òÜ•”, 2–òŠw•”): “ú–{–òŠw‰ï‘æ136”N‰ï (2016/3/27), ‰¡•l, “ú–{–òŠw‰ï‘æ136”N‰ï—vŽ|W 2016/3; p.1521.

7231139. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 2Œ^“œ”A•aŽ¡—Öòƒrƒ‹ƒ_ƒOƒŠƒvƒ`ƒ“‚É‚æ‚éS100A8/A9‚Ì”­Œ»—U“±. ’©‘q[r1, “¡ŒŽ—ºˆê1, “¡ˆäG–Ÿ1, Œú“cKˆê˜Y1,2, ˆÉ“¡’q•v1 (1–òŠw•”, 2–òÜ•”): “ú–{–òŠw‰ï‘æ136”N‰ï (2016/3/26-29), ‰¡•l.

733452. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚é’²Ü–ò‚Ì”pŠüó‹µ’²ž. t“úˆäŒö”ü1, â–{”ü˜aŽq1, —F“c‹g‘¥1,2, ‹{“‡—¥Žq2, –{ŠÔ‰ëŽm2, “c‘º˜aŒh2, â‘q’qŽq2, ”ö’¹Ÿ–ç1, ¬ìK—Y2, Œú“cKˆê˜Y1,2 (1–òŠw•”, 2–òÜ•”): ‘æ14‰ñ‚©‚È‚ª‚í–òÜŽtŠwp‘å‰ï (2016/1/17), ‰¡•l, ‘æ14‰ñ‚©‚È‚ª‚í–òÜŽtŠwp‘å‰ïu‰‰—vŽ|W 2016/1; p.54.


ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•”

[Šwp˜_•¶]

110338. [ŒŽ’˜] Quadriceps Strength as a Predictor of Mortality in Coronary Artery Disease. Kamiya K1,2, Masuda T3, Tanaka S1,2, Hamazaki N1,2, Matsue Y, Mezzani A, Matsuzawa R, Nozaki K, Maekawa E4, Noda C4, Yamaoka-Tojo M3, Arai Y5, Matsunaga A3, Izumi T4, Ako J4: Am J Med 2015/11; 128 (11): 1212-9. (_’JŒ’‘Ÿ˜Y1,2, ‘“c@‘ì3, “c’†L–í1,2, à_èL–Ÿ1,2, ‘OìŒb”ü4, –ì“cçt4, “ŒžŠ”ü“ÞŽq3, rˆäN•v5, Œ‰i“Ä•F3, ˜aò@“O4, ˆ¢ŒÃÆ4: 1ƒŠƒnƒrƒŠ•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”, 4zŠÂŠí“à, 5ˆã—Ïî•ñŠÇ—Žº)

110339. [ŒŽ’˜] Japanese Adaptation of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39): Comparative Study among Different Types of Aphasia. Kamiya A, Kamiya K1, Tatsumi H, Suzuki M, Horiguchi S: J Stroke Cerebrovasc Dis 2015/11; 24 (11): 2561-4. (_’JŒ’‘Ÿ˜Y1: 1ƒŠƒnƒrƒŠ•”)

110340. [ŒŽ’˜] Safety of neuromuscular electrical stimulation in patients implanted with cardioverter defibrillators. Kamiya K1,2, Satoh A3, Niwano S3, Tanaka S1,2, Miida K1, Hamazaki N1,2, Maekawa E3, Matsuzawa R, Nozaki K, Masuda T4, Ako J3: J Electrocardiol. 2016/1-2; 49 (1): 99-101. (_’JŒ’‘Ÿ˜Y1,2, ²“¡@—z3, ’ë–ìTˆê3, “c’†L–í1,2, Œ©ˆä“c˜a³1, à_èL–Ÿ1,2, ‘OìŒb”ü3, ‘“c@‘ì4, ˆ¢ŒÃÆ3: 1ƒŠƒnƒrƒŠ•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3zŠÂŠí“à, 4ˆã—Éq¶Šw•”)

120076. [ŒŽ’˜] ŒÒŠÖßO‘¹Š³ŽÒ‚̉ºŽˆ‹@”\‚ÉŠÖ‚·‚錟“¢|femoroacetabular impingement‚Æ‚»‚Ì‘Œ‚̐¬ˆö‚Å‚Ì”äŠr|. Žsì‹M•¶1, š“ߏrŽ÷1, …–ìŒö•ã2, —é–ؗǘa1, •Ÿ“‡Œ’‰î3, “àŽRŸ•¶3, ‚‘Š»Žm3, ‚•œ®L4 (1“Œ•a‰@ƒŠƒnƒrƒŠ•”, 2ƒŠƒnƒrƒŠ•”, 3®ŠO, 4ˆã—Éq¶Šw•”): Hip joint 2015/8; 41 (Suppl): 304-8.

220012. [€ŒŽ’˜] ŠÖßŽüˆÍ‘œÜƒJƒNƒeƒ‹—Ö@‚É‚š‚¯‚éƒXƒeƒƒCƒh‚Ì—LŒø«|—Œ‘€“¯“úlH•GŠÖß’uŠ·p‚É‚š‚¯‚鍶‰E”äŠr|. ìèrŽ÷1, ‘q’Ø—º‘Ÿ2, ‘Š‘òŽuânŽq3, ç—t˜aG1, Š™“cC”Ž1 (1‚¯‚¢‚ä‚€•a‰@®Œ`ŠO‰È, 2ƒŠƒnƒrƒŠ•”, 3‚¯‚¢‚ä‚€•a‰@ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”): “ú–{lHŠÖßŠw‰ïŽ 2015/12; 45: 627-8.

320055. [Ç—á•ñ] ¶Žº•â•lHS‘Ÿ‚ð‘•’…‚µ‚œŠ³ŽÒ‚ɑ΂·‚鍂‹­“xƒCƒ“ƒ^[ƒoƒ‹ƒgƒŒ[ƒjƒ“ƒO‚ÌŒø‰Ê. à_èL–Ÿ1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y,1 –k‘º@—¥3, ’––”FŒ³4, Œ©ˆä“c˜a³1, –؉ºt“Þ5, ‰Í–ì^—1, 傖Œ—R‰Á—¢1, ŒÜ\—’ˆŸŠóŽq1, –ì“cçt4, ˆ¢ŒÃÆ4, ‹{’n@ŠÓ3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3S‘ŸŒŒŠÇŠO, 4zŠÂŠí“à, 5ME•”) S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ 2015/3; 20 (1): 268-72.

510008. [‘à] Frailty and Survival in Patients with End-Stage Renal Disease. Matsuzawa R1, Matsunaga A2: Journal of Yoga & Physical Therapy 2016; 6: 1. (Œ‘ò—Ç‘Ÿ1, Œ‰i“Ä•F2: 1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”)

522230. [uÀ]y“ÁW: ’m‚Á‚Ä‚š‚«‚œ‚¢¶ŠˆKŠµ•aƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“zS‘Ÿ•a‚ƃŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‘“c@‘ì1, _’JŒ’‘Ÿ˜Y2 (1ˆã—Éq¶Šw•”, 2ƒŠƒnƒrƒŠ•”): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2015/11; 45 (11): 1335-9.

522231. [uÀ]y“ÁW: ‹}«ŠúƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚É‚š‚¯‚éƒ`[ƒ€ˆã—Áz‹}«ŠúƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚É‚š‚¯‚鍜Ši‹Ø“d‹CŽhŒƒ—Ö@‚ÌŒø‰Ê‚Ɖۑè. _’JŒ’‘Ÿ˜Y (ƒŠƒnƒrƒŠ•”): Mon Book Med Rehabil 2015/11; 190; 64-8.

522232. [uÀ]yƒVƒ“ƒ|ƒWƒEƒ€4: ‚±‚ê‚©‚ç‚Ì—Šw—Ö@Œ€‹†|¢ŠE‚Ö‚Ì”­M|zzŠÂŠí—Šw—Ö@‚Ì—§ê‚©‚ç. _’JŒ’‘Ÿ˜Y (ƒŠƒnƒrƒŠ•”): —Šw—Ö@Šw 2015; 42 (8): 706-7.

522233. [uÀ]y“ÁW: t‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“z[ƒƒfƒBƒJƒ‹ƒXƒ^ƒbƒt‚Ì–ðŠ„] —Šw—Ö@ŽmEì‹Æ—Ö@Žm‚©‚ç|ŒŒ‰t“§ÍŠ³ŽÒ‚Ì“úí¶ŠˆŠˆ“®‚ðŠÇ—‚·‚éˆÓ‹`|. Œ‘ò—Ç‘Ÿ (ƒŠƒnƒrƒŠ•”): t‚Æ“§Í 2016/2: 80 (2): 245-8.

[’˜@‘]

620192. [Šwp‘] (•ª’SŽ·•M)yƒGƒrƒfƒ“ƒX‚ÉŠî‚­—Šw—Ö@ (‘æ2”Å)z‘æ2Í ŽŸŠ³E•a‘Ô‚©‚ç‚Ý‚œƒGƒrƒfƒ“ƒX‚ÉŠî‚­—Šw—Ö@‚ÌŽÀÛ@14. –«S•s‘S, p.227-42. _’JŒ’‘Ÿ˜Y (ƒŠƒnƒrƒŠ•”), •Ò: “àŽR@–õ, ˆãŽt–òo”Å, “Œ‹ž, 2015/6”­s.

620193. [Šwp‘] (•ª’SŽ·•M)yPTEOT ƒrƒWƒ…ƒAƒ‹ƒeƒLƒXƒg@ADLz‘æ4Í ‰î••û–@‚Æ—ûKŽw“±: ‰ž—p•Ò (”]‘²’†CÒ‘‘¹ˆÈŠO‚ÌŽŸŠ³)@(1) ƒp[ƒLƒ“ƒ\ƒ“•a@(2) _Œo‹ØŽŸŠ³. ŽÄ@Šì’1, …–ìŒö•ã2, ‘厛ˆŸ—R”ü3 (1ˆã—Éq¶Šw•”, 2ƒŠƒnƒrƒŠ•”, 3“Œ•a‰@ƒŠƒnƒrƒŠ•”), •Ò: ŽÄ@Šì’1, ‰º“cM–Ÿ, —r“yŽÐ, “Œ‹ž, 2015/10”­s.

620194. [Šwp‘] (•ª’SŽ·•M)y–«S•s‘S‚Ì‚ ‚œ‚炵‚¢ƒPƒA‚ÆŠÇ—zII. Šî‘b•Ò: ‰Ÿ‚³‚Š‚Ä‚š‚­‚ׂ«S•s‘S‚̍ŐV’mŽ¯@C. S•s‘SŽ¡—Â̍ŐV’mŽ¯@3. ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“, p.139-142. _’JŒ’‘Ÿ˜Y (ƒŠƒnƒrƒŠ•”), •Ò: •S‘ºLˆê, —é–؁@œ, “ì]“°, “Œ‹ž, 2015/11”­s.

620195. [Šwp‘] (•ª’SŽ·•M)y—Šw—Ö@Mook 17: —Šw—Ö@‹Zp‚̍ČŸØ@‰ÈŠw“I‹Zp‚ÌŠm—§‚ÉŒü‚¯‚āz‘æ3Í “à•”áŠQƒAƒvƒ[ƒ`‚ɑ΂·‚錟Ø@4. S•s‘S‚Ì—Šw—Ö@‹Zp‚ÌŒŸØ. _’JŒ’‘Ÿ˜Y (ƒŠƒnƒrƒŠ•”), ƒVƒŠ[ƒY•ÒWEÓ”C•ÒW: •Ÿˆä@•×, _’Á@—æ, ‘唚ŒõŽi, b“c@Žk, ŽO—֏‘“X, “Œ‹ž, 2015”­s.

620196. [Šwp‘] (•ª’SŽ·•M)yd•¡áŠQ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“z‘æ4Í d•¡áŠQ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ÌŽÀÛ@Case 6: t•s‘S‚ð‡•¹‚µ‚œS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Š³ŽÒ‚ւ̉^“®ˆ•û, p.422-7. ‘“c@‘ì1, _’JŒ’‘Ÿ˜Y2 (1ˆã—Éq¶Šw•”, 2ƒŠƒnƒrƒŠ•”), •Ò: ãŒŽ³”Ž, ŽO—֏‘“X, “Œ‹ž, 2015”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713140. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Development of a New Gait Analysis Technique Using a Smartphone -investagation of an Application for the Elderly. Mizuno K1, Shiba Y, Sato H, Kamide N, Suzuki Y, Arisaka N, Tsuruta H, Takeuchi A, Fukuda M, Ikeda N: World Conferderation for Physical Therapy Congress 2015 (2015/5/1-4), Singapore. (…–ìŒö•ã1: 1ƒŠƒnƒrƒŠ•”)

713141. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) A Single Session of Inspiratory Muscle Training Using a Slow Deep Breath with Inspiratory Load Ameliorates Autonomic Imbalance in Patients with Chronic Heart Failure. Hamazaki N1, Masuda T2, Kamiya K1, Matsuzawa R1, Nozaki K1, Tabata M3, Tanaka S4, Aoyama A4, Maekawa E5, Ako J5: EuroPRevent 2015 (ƒˆ[ƒƒbƒp—\–hŠw‰ï2015) (2015/5/14-16), Lisbon, Portugal. (à_èL–Ÿ1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, Œ‘ò—Ç‘Ÿ1, –ìèN•œ1, “c’†L–í4, ÂŽRW‘å4, ‘OìŒb”ü5, ˆ¢ŒÃÆ5: 1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3–L‹Ž‘n‘¢‘åŠw, 4‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 5zŠÂŠí“à)

713142. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Decreased six-minute walk distance at hospital discharge is an independent predictor for poor instrumental activities of daily living after discharge in patients with chronic heart failure. Nozaki K1, Masuda T2, Kamiya K1, Hamazaki N1, Matsuzawa R1, Tanaka S3, Maekawa E4, Ako J4: European Society of Cardiology Congress 2015 (2015/8/29-9/2), London, UK. (–ìèN•œ1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, à_èL–Ÿ1, Œ‘ò—Ç‘Ÿ1, “c’†L–í3, ‘OìŒb”ü4, ˆ¢ŒÃÆ4: 1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4zŠÂŠí“à)

713143. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Stage 3 or 4 chronic kidney disease disrupts the improvement in exercise capacity after hospital discharge in patients with ischemic heart disease. Matsuzawa R1, Masuda T2, Kamiya K1, Hamazaki N1, Nozaki K1, Tanaka S3, Maekawa E4, Ako J4: European Society of Cardiology Congress 2015 (2015/8/29-9/2), London, UK. (Œ‘ò—Ç‘Ÿ1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, à_èL–Ÿ1, –ìèN•œ1, “c’†L–í3, ‘OìŒb”ü4, ˆ¢ŒÃÆ4: 1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4zŠÂŠí“à)

713144. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Increased Respiratory Muscle Strength Ameliorates Ventilation-perfusion Mismach during Exercise via the Improvement of Inefficient Ventilation in Patients with Chronic Heart Failure. Hamazaki N1, Masuda T2, Kamiya K1, Matsuzawa R1, Nozaki K1, Tanaka S3, Aoyama A3, Yabu K3, Nakamura T3, Tabata M4, Maekawa E5, Noda C5, Yamaoka-Tojo M2, Ako J5: American Heart Association (AHA) 2015 (2015/11/7-11), Orlando, Florida, USA. (à_èL–Ÿ1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, Œ‘ò—Ç‘Ÿ1, –ìèN•œ1, “c’†L–í3, ÂŽRW‘å3, åM@•c3, ’†‘ºŠxŽj3, ‘OìŒb”ü5, –ì“cçt5, “ŒžŠ”ü“ÞŽq2, ˆ¢ŒÃÆ5: 1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4–L‹Ž‘n‘¢‘åŠw, 5zŠÂŠí“à)

721024. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) SŽŸŠ³Š³ŽÒ‚ɑ΂·‚é_Œo‹Ø“d‹CŽhŒƒ—Ö@‚̉”\«. _’JŒ’‘Ÿ˜Y (ƒŠƒnƒrƒŠ•”): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/18-19), •Ÿ‰ª.

722257. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™)y‚±‚ê‚©‚ç‚Ì—Šw—Ö@Œ€‹†: ¢ŠE‚Ö‚Ì”­MzzŠÂŠí—Šw—Ö@Œ€‹†‚Ì—§ê‚©‚ç. _’JŒ’‘Ÿ˜Y (ƒŠƒnƒrƒŠ•”): ‘æ50‰ñ“ú–{—Šw—Ö@Šwp‘å‰ï (2015/6/5-7), “Œ‹ž.

722258. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) “§ÍŠ³ŽÒ‚̐g‘Ì‹@”\“Á«‚Ɖ^“®—Ö@. Œ‘ò—Ç‘Ÿ (ƒŠƒnƒrƒŠ•”): ‘æ7‰ñ“ú–{‰ºŽˆ‹~ÏE‘«•aŠw‰ïŠwpW‰ï (2015/7/11-12), ‰¡•l.

722259. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ŒŒ‰t“§ÍŠ³ŽÒ‚ɑ΂·‚é‰^“®—Ö@EŽw“±‚ª’·Šú—\Œã‚É‹y‚Ú‚·‰e‹¿. Œ‘ò—Ç‘Ÿ (ƒŠƒnƒrƒŠ•”): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/18-19), •Ÿ‰ª.

722260. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ŒŒ‰t“§ÍŠ³ŽÒ‚É‚š‚¯‚ég‘Ì“IƒtƒŒƒCƒ‹‚ðˆÓŽ¯‚µ‚œŽŸŠ³ŠÇ—. Œ‘ò—Ç‘Ÿ1, •Ä–؁@Œc2,3, ŒŽ“cˆ€‰i2, Îì—œ”n2, “n粍F–Ÿ2, ‰º“c—²‘å2, Œ–{”ü2, ˆ¢•”‹`Žj2,4, ‰ÍŒŽŽ‰ë5, Œ‰i“Ä•F6 (1ƒŠƒnƒrƒŠ•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‚³‚ª‚ݏzŠÂŠíƒNƒŠƒjƒbƒN, 4ŽÐ‰ï•ŸŽƒ–@lŽOˆä‹L”O•a‰@ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”, 5¶—, 6ˆã—Éq¶Šw•”): ‘æ6‰ñ“ú–{t‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2016/3/26-27), ‰ªŽR.

7231140. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Respiratory Muscle Weakness Decreases Ventilatory Efficiency Aggravating the Ventilation-perfusion Mismatch during Exercise in Patients with Compensated Chronic Heart Failure. à_èL–Ÿ1,2, ‘“c@‘ì3, _’JŒ’‘Ÿ˜Y1,2, Œ‘ò—Ç‘Ÿ2, –ìèN•œ2, ‰Í–ì^—4, HŽRˆ»Žq1, Š™“c—TŽÀ1, “c’†L–í1, ÂŽRW‘å1, ‘OìŒb”ü5, –ì“cçt5, “ŒžŠ”ü“ÞŽq3, ˆ¢ŒÃÆ5 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ƒŠƒnƒrƒŠ•”, 3ˆã—Éq¶Šw•”, 4ŠÅŒì•”, 5zŠÂŠí“à): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/24-26), ‘åã.

7231141. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒ‰t“§ÍŠ³ŽÒ‚É‚š‚¯‚é––œ“®–¬ŽŸŠ³‚̍‡•¹—Š‚Æ‚»‚̊댯ˆöŽq‚ÉŠÖ‚·‚錟“¢|––œ“®–¬ŽŸŠ³‚̐i“W‚š‚æ‚Ñ”­Ç‚ð—\–h‚·‚é‚œ‚߂Ɂ|. Œ‘ò—Ç‘Ÿ1, ÂŽR’Œ‘P2, Œ‰i“Ä•F3, ‘“c@‘ì3, ‹g“c@àˆ4 (1ƒŠƒnƒrƒŠ•”, 2V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã, 3ˆã—Éq¶Šw•”, 4‚³‚ª‚ݏzŠÂŠíƒNƒŠƒjƒbƒN): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/24-26), ‘åã.

7231142. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Chronic Kidney Disease Stage 3 or 4 Disturbs the Accomplishment of Optimum Physical Activity in Patients with Ischemic Heart Disease. Œ‘ò—Ç‘Ÿ1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, à_èL–Ÿ1, –ìèN•œ1, “c’†L–í3, ‰Í–ì^—4, ÂŽRW‘å3, –ì“cçt5, “ŒžŠ”ü“ÞŽq2, ‘OìŒb”ü5, ˆ¢ŒÃÆ5 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4ŠÅŒì•”, 5zŠÂŠí“à): ‘æ79‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2015/4/24-26), ‘åã.

7231143. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Total Support Team‚ÌŠˆ“®‚ðŒ©’Œ‚µ‚œŒã‚̐¬‰Ê•ñ|ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ÌŒ©’n‚©‚ç|. Œ©ˆä“c˜a³1, •Ð‰ª—Sˆê2, ‹{è“¹‹P1, _•Û•‘¥1, ‰Ô“‡@Ž‘2, •ž•”@2, _œä’m“¹2, ó—˜@–õ2 (1ƒŠƒnƒrƒŠ•”, 2‹~–œ): ‘æ29‰ñ“ú–{ŠOŠw‰ï (2015/6/11), ŽD–y.

7231144. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) d“xg‘̏áŠQŽÒŽx‰‡Ž{Ý‚É‚š‚¯‚é‰îŒìEˆõ‚̉îŒì•‰’S‚ÉŠÖ‚·‚é’²ž|“úí¶Šˆ“®ì‚̉îŒì•‰’S‚Æ“üŠŽÒ‚Ì“Á«‚š‚æ‚ѐSg‹@”\‚Æ‚ÌŠÖ˜A|. ¬—шŸ—¢1, ‘厛ˆŸ—R”ü1, …–ìŒö•ã2, •œ–ì“ÄŽj1 (1“Œ•a‰@ƒŠƒnƒrƒŠ•”, 2ƒŠƒnƒrƒŠ•”): ‘æ49‰ñ“ú–{ì‹Æ—Ö@Šw‰ï (2015/6/19-21), _ŒË, “ú–{ì‹Æ—Ö@Šw‰ïŽ˜^W 2015/6; 49th: 2595.

7231145. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ºŽˆ‹Ø—Í‚ÌŒ’N“x‚͍‚—îzŠÂŠíŽŸŠ³Š³ŽÒ‚̐¶–œ—\Œã•À‚Ñ‚É‹@”\—\Œã‚ð—\‘ª‚·‚é. _’JŒ’‘Ÿ˜Y1,2, ‘“c@‘ì3, “c’†L–í2, à_èL–Ÿ1,2, Œ‘ò—Ç‘Ÿ1, –ìèN•œ1, ‰Í–ì^—4, ŒÜ\—’ˆŸŠóŽq4, Šâ‘º‹M”ü4, ‘OìŒb”ü5, –ì“cçt5, Œ‰i“Ä•F2, “ŒžŠ”ü“ÞŽq2, ˆ¢ŒÃÆ5 (1ƒŠƒnƒrƒŠ•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”, 4ŠÅŒì•”, 5zŠÂŠí“à): ‘æ51‰ñ“ú–{zŠÂŠí•a—\–hŠw‰ïŠwpW‰ï (2015/6/26-27), ‘åã.

7231146. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ºŽˆ‹Ø—͂͐SŒŒŠÇŽŸŠ³Š³ŽÒ‚Ì’·Šú—\Œã‚ð—\‘ª‚·‚é. _’JŒ’‘Ÿ˜Y1,2, ‘“c@‘ì3, “c’†L–í2, à_èL–Ÿ1,2, Œ‘ò—Ç‘Ÿ1, –ìèN•œ1, ‰Í–ì^—4, ŒÜ\—’ˆŸŠóŽq4, Šâ‘º‹M”ü4, ‘OìŒb”ü5, –ì“cçt5, ––‰i—SÆ, Œ‰i“Ä•F3, “ŒžŠ”ü“ÞŽq3, ˜aò@“O5, ˆ¢èÆ5 (1ƒŠƒnƒrƒŠ•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”, 4ŠÅŒì•”, 5zŠÂŠí“à): ‘æ51‰ñ“ú–{zŠÂŠí•a—\–hŠw‰ïŠwpW‰ï (2015/6/26-27), ‘åã.

7231147. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A single session of respiratory muscle training ameliorates autonomic imbalance resulting in the reduction of stress reaction in patients with chronic heart failure. à_èL–Ÿ1,2, ‘“c@‘ì3, _’JŒ’‘Ÿ˜Y1,2, Œ‘ò—Ç‘Ÿ2, –ìèN•œ2, “c’†L–í1, Šâ‘º‹M”ü4, ‰Í–ì^—4, ŒÜ\—’ˆŸŠóŽq4, HŽRˆ»Žq1, Š™“c—TŽÀ1, ÂŽRW‘å1, ‘OìŒb”ü5, –ì“cçt5, “ŒžŠ”ü“ÞŽq3, ˆ¢ŒÃÆ5 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ƒŠƒnƒrƒŠ•”, 3ˆã—Éq¶Šw•”, 4ŠÅŒì•”, 5zŠÂŠí“à): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/18-19), •Ÿ‰ª.

7231148. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰º‘Ú‚ÌŽüŒa‚͐S•s‘SŠ³ŽÒ‚̐¶–œ—\Œã‚ð—\‘ª‚·‚é. _’JŒ’‘Ÿ˜Y1,2, à_èL–Ÿ1,2, Œ‘ò—Ç‘Ÿ1, “c’†L–í2, –ìèN•œ1, Šâ‘º‹M”ü3, ‰Í–ì^—3, ŒÜ\—’ˆŸŠóŽq3, ‘OìŒb”ü4, –ì“cçt4, “ŒžŠ”ü“ÞŽq5, ’––”FŒ³4, Œ‰i“Ä•F5, ‘“c@‘ì5, ˆ¢ŒÃÆ4 (1ƒŠƒnƒrƒŠ•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ŠÅŒì•”, 4zŠÂŠí“à, 5ˆã—Éq¶Šw•”): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/19), •Ÿ‰ª.

7231149. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) T1‰ñ‚ÌŠO—ˆ‰^“®—Ö@‚Ɖ®ŠO‰^“®‚ÌŽw“±‚É‚æ‚è‰^“®‘Ï—e”\‚ª‰ü‘P‚µ‚œŠÔŸ[«æês‚Ì‚ ‚éˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚̈ê—á. “c’†L–í1, _’JŒ’‘Ÿ˜Y2, à_èL–Ÿ1,2, Œ‘ò—Ç‘Ÿ2, –ìèN•œ2, Šâ‘º‹M”ü3, ‰Í–ì^—3, ŒÜ\—’ˆŸŠóŽq3, Ž…—Ç—S1, HŽRˆ»Žq1, Š™“c—TŽÀ1, ÂŽRW‘å1, ’†‘ºŠxŽj1, åM@•c1, ‘OìŒb”ü4, –ì“cçt4, “ŒžŠ”ü“ÞŽq5, •œ“cŒõ”Ž6, ‘“c@‘ì5, ˆ¢ŒÃÆ4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ƒŠƒnƒrƒŠ•”, 3ŠÅŒì•”, 4zŠÂŠí“à, 5ˆã—Éq¶Šw•”, 6V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/19), •Ÿ‰ª.

7231150. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ü‰@Šú‚ɃtƒŒƒCƒ‹‚ð‡•¹‚µ‚œ‚—îS•s‘SŠ³ŽÒ‚Å‚Í‘Þ‰@Œã‚̉^“®‘Ï—e”\‚̉ñ•œ‚ª’˜‚µ‚­‘jŠQ‚³‚ê‚é. –ìèN•œ1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, à_èL–Ÿ1,3, Œ‘ò—Ç‘Ÿ1, “c’†L–í3, Šâ‘º‹M”ü4, ‰Í–ì^—4, ŒÜ\—’ˆŸŠóŽq4, ‘OìŒb”ü5, –ì“cçt5, “ŒžŠ”ü“ÞŽq2, ˆ¢ŒÃÆ5 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4ŠÅŒì•”, 5zŠÂŠí“à): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/19), •Ÿ‰ª.

7231151. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÛŽŠú‚—î‹•ŒŒ«SŽŸŠ³Š³ŽÒ‚ɑ΂·‚éŠÄŽ‹Œ^ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚̉^“®‹@”\‚Ö‚ÌŒø‰Ê. ‰“ŒŽ^ˆê, š“ߏrŽ÷, Š¡’J‰p‹I1, –q–쏲G, ŠÖªŒb”üŽq, ‚‹Ž—R”ü, –Ø‘º‰ë•F2, –ì“cçt3, “ŒžŠ”ü“ÞŽq2, Œ‰i“Ä•F2, ‘“c@‘ì2, ˆ¢ŒÃÆ3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/19), •Ÿ‰ª.

7231152. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—î‹•ŒŒ«SŽŸŠ³Š³ŽÒ‚̉^“®‹@”\‚ÆŒŒ’†”]«ƒiƒgƒŠƒEƒ€ƒyƒvƒ`ƒh’l‚Æ‚ÌŠÖ˜A. š“ߏrŽ÷, Š¡’J‰p‹I1, ‰“ŒŽ^ˆê, –q–쏲G, ŠÖªŒb”üŽq, ‚‹Ž—R”ü, –Ø‘º‰ë•F2, –ì“cçt3, “ŒžŠ”ü“ÞŽq2, Œ‰i“Ä•F2, ‘“c@‘ì2, ˆ¢ŒÃÆ3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ21‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2015/7/19), •Ÿ‰ª.

7231153. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”rႂɗzE‰Aˆ³‘ÌŠOŽ®lHŒÄ‹zŠí‚ª—L—p‚Å‚ ‚Á‚œ‹¹Šs‰^“®§ŒÀ‚ð’悵‚œƒ¿ƒWƒXƒgƒƒOƒŠƒJƒmƒpƒ`[‚̈ê—á. •À–Ø—DŽq1, ‰¡ŽR”ü²Žq2, ã“cN‹v, ¬—ю匣1, ‹àŽq’‰O3, “yŠò@•œ3, ”~ŒŽ@ŽÀ, •Ÿ“c—Ï–ç2 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3¬Ž™): ‘æ48‰ñ“ú–{¬Ž™ŒÄ‹zŠíŠw‰ï (2015/10/23-24), ‘q•~.

7231154. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œg‘яî•ñ’[––‚ð—p‚¢‚œ’nˆæ‚—îŽÒ‚̉^“®”\—Í‘ª’è‚Ì‚œ‚ß‚Ì•às•]‰¿ƒVƒXƒeƒ€‚̉ü—Ç. —Lã’ŒÆ1, …–ìŒö•ã2, ão’Œl1, Žç“cŒ›’1, ŽÄ@Šì’1, ’ß“c—z˜a1 (1ˆã—Éq¶Šw•”, 2ƒŠƒnƒrƒŠ•”): ‘æ35‰ñˆã—Ïî•ñŠw˜A‡‘å‰ï (‘æ16‰ñ“ú–{ˆã—Ïî•ñŠw‰ïŠwp‘å‰ï) (2015/11/1-4), ‰«“ê, ˆã—Ïî•ñŠw˜A‡‘å‰ï˜_•¶W 2015/11; 35: 708-11.

7231155. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) •a“ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ““±“ü‚É‚æ‚é‹}«Šú”][ÇŠ³ŽÒ‚Ì‹@”\—\Œã‹y‚Ñ“]‹Aæ‚ւ̉e‹¿. ŒŠÛƒ‰À1, •Ÿ“c—Ï–ç2, ˆä“‡‘å•ã3, ˆ¢‹v’Óñ•v3, ŒŽR˜a—˜3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3_Œo“à): ‘æ33‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2015/11/28), –ŒŒÃ‰®, _ŒoŽ¡—Êw 2015/9; 32 (5): 804.

7231156. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 枖ς𔭏ǂµ‚œsepsisŠ³ŽÒ‚ɑ΂·‚é‹@”\—\Œã‰e‹¿ˆöŽq‚©‚ç‚Ý‚œƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Ì–ðŠ„. ‹{è“¹‹P1, •Ð‰ª—Sˆê2, Œ©ˆä“c˜a³1, _œä’m“¹2, •ž•”@2, ó—˜@–õ2 (1ƒŠƒnƒrƒŠ•”, 2‹~–œ): ‘æ43‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2016/2/13), _ŒË.

7231157. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Œ‘€“¯“úlH•GŠÖß’uŠ·pŒã3ƒ–ŒŽ‚ł̈ړ®EŠOo‚Ɛg‘Ì‹@”\‚Æ‚ÌŠÖŒW|“ú–{”Å•GŠÖßÇ‹@”\•]‰¿ŽÚ“x‚̉ºˆÊŽÚ“x‚ð—p‚¢‚œŒŸ“¢|. ˜a“cW•œ1, ìèrŽ÷2, ‘q’Ø—º‘Ÿ3, ‘Š‘òŽuânŽq1, ç—t˜aG2, ìã“rs4, “c’†‚³‚ŠŽq1 (1‚¯‚¢‚ä‚€•a‰@ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”, 2‚¯‚¢‚ä‚€•a‰@®Œ`ŠO‰È, 3ƒŠƒnƒrƒŠ•”, 4Œcœä‹`m‘åŠwˆãŠw•”ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆãŠw‹³Žº): ‘æ46‰ñ“ú–{lHŠÖßŠw‰ï (2016/2/27), ‘åã.

7231158. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Œ‘€“¯“úlH•GŠÖß’uŠ·pŒã‘Šú‚Ì‹N—§“®ì‚ÉŠÖ˜A‚·‚éˆöŽq. ‘Š‘òŽuânŽq1, ‘q’Ø—º‘Ÿ2, ìèrŽ÷3, ç—t˜aG3, ìã“rs4, “c’†‚³‚ŠŽq1 (1‚¯‚¢‚ä‚€•a‰@ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”, 2ƒŠƒnƒrƒŠ•”, 3‚¯‚¢‚ä‚€•a‰@®Œ`ŠO‰È, 4Œcœä‹`m‘åŠwˆãŠw•”ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆãŠw‹³Žº): ‘æ46‰ñ“ú–{lHŠÖßŠw‰ï (2016/2/27), ‘åã.

7231159. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÖßŽüˆÍ‘œÜƒJƒNƒeƒ‹—Ö@‚É‚š‚¯‚éƒXƒeƒƒCƒh‚Æ‚µ‚Đ…—n«Œœ‘÷‰t‚Í—L—p‚©?|—Œ‘€“¯“úlH•GŠÖß’uŠ·p‚É‚š‚¯‚鍶‰E”äŠr|. ìèrŽ÷1, ‘q’Ø—º‘Ÿ2, ‘Š‘òŽuânŽq3, ç—t˜aG1, Š™“cC”Ž1 (1‚¯‚¢‚ä‚€•a‰@®Œ`ŠO‰È, 2ƒŠƒnƒrƒŠ•”, 3‚¯‚¢‚ä‚€•a‰@ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”): ‘æ46‰ñ“ú–{lHŠÖßŠw‰ï (2016/2/27), ‘åã.

7231160. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Frailty deteriorates autonomic imbalance assessed by pupillary responses to light in elderly patients with chronic heart failure. –ìèN•œ1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, à_èL–Ÿ1, Œ‘ò—Ç‘Ÿ1, “c’†L–í3, ‘OìŒb”ü4, “ŒžŠ”ü“ÞŽq2, ˆ¢ŒÃÆ4 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4zŠÂŠí“à): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/18-20), å‘ä.

7231161. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Respiratory Muscle Weakness Elicits Inefficiient Ventilation Resulting in the Deterioration of Exercise Intolerance in Patients with Chronic Heart Failure. à_èL–Ÿ1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, Œ‘ò—Ç‘Ÿ1, –ìèN•œ1, “c’†L–í3, HŽRˆ»Žq3, ÂŽRW‘å3, åM@•c3, ’†‘ºŠxŽj3, ‘OìŒb”ü4, –ì“cçt4, “ŒžŠ”ü“ÞŽq2, ˆ¢ŒÃÆ4 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 4zŠÂŠí“à): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/18-20), å‘ä.

733453. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ARCRpŒã‚ÌShoulder36‚ªpŒã3-6ƒ–ŒŽ‚Ì—ŠwŠŒ©Œo‰ß‚É—^‚Š‚é‰e‹¿. ‘q’Ø—º‘Ÿ1, ²X–؏Gˆê2, Œ©–Ú’q‹I3, ’|“àŠ°l1, ‘厛ˆŸ—R”ü2, “n粗T”V4, ’†àVr”V3, ‚‘Š»Žm3, •Ÿ“c—Ï–ç1,2,4 (1ƒŠƒnƒrƒŠ•”, 2“Œ•a‰@ƒŠƒnƒrƒŠ•”, 3®ŠO, 4ˆã—Éq¶Šw•”): ‘æ12‰ñŒš‚̉^“®‹@”\Œ€‹†‰ï (2015/10/9), å‘ä.

H26”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H26-320010. [Ç—á•ñ] ¶Žº•â•lHS‘Ÿ‚ð‘•’…‚µ‚œŠ³ŽÒ‚ɑ΂·‚鍂‹­“xƒCƒ“ƒ^[ƒoƒ‹ƒgƒŒ[ƒjƒ“ƒO‚ÌŒø‰Ê. à_èL–Ÿ1,2, ‘“c@‘ì3, _’JŒ’‘Ÿ˜Y1,2, –k‘º@—¥4, ’––”FŒ³5, Œ©ˆä“c˜a³1, –؉ºt“Þ1, ‰Í–ì^—1, 傖Œ—R‰Á—¢1, ŒÜ\—’ˆŸŠóŽq1, –ì“cçt5, ˆ¢ŒÃÆ5, ‹{’n@ŠÓ4 (1ƒŠƒnƒrƒŠ•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”, 4S‘ŸŒŒŠÇŠO, 5zŠÂŠí“à): S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ 2015/3; 20 (1): 268-72.


‰h—{•”

[’˜@‘]

620197. [Šwp‘] (•ª’SŽ·•M)y‰h—{Žw“±ƒXƒLƒ‹ƒAƒbƒv (NutritionCare 2015”Nt‹G‘Š§)z[‘æ4Í Ç—á‚ÅŠw‚ԁ@‰h—{Žw“±‚Ì‚·‚·‚ß‚©‚œ]@3. ŒŒ‰t“§Í“±“üÇ—á‚̉h—{Žw“±, p.92-102. ‹g“c•üŽq (‰h—{•”), •Ò: •ŒŒ›ˆê˜Y, ƒƒfƒBƒJo”Å, ‘åã, 2015/5”­s.

620198. [Šwp‘] (•ª’SŽ·•M)yVlƒXƒ^ƒbƒt‚Ì‚œ‚ß‚Ì“§ÍuÀ Q&A110 (“§ÍƒPƒA2015”N‰Ä‹G‘Š§)z“§ÍŠ³ŽÒ‚̉h—{‚ÌŠî–{, p.204-7. ‹g“c•üŽq (‰h—{•”), •Ò: ‘å’Ø‚Ý‚Í‚é, ƒƒfƒBƒJo”Å, ‘åã, 2015/6”­s.

620199. [Šwp‘] (•ª’SŽ·•M)yVlƒXƒ^ƒbƒt‚Ì‚œ‚ß‚Ì“§ÍuÀ Q&A110 (“§ÍƒPƒA2015”N‰Ä‹G‘Š§)zƒRƒ‰ƒ€Vl‚Ì‚Æ‚«‚ÌŽž”s’k, p.212. ‹g“c•üŽq (‰h—{•”), •Ò: ‘å’Ø‚Ý‚Í‚é, ƒƒfƒBƒJo”Å, ‘åã, 2015/6”­s.

620200. [Šwp‘] (•ª’SŽ·•M)y‰h—{Žw“±EŠÇ—‚Ì‚œ‚߂̃XƒLƒ‹ƒAƒbƒvƒVƒŠ[ƒY vol.4@CKD (–«t‘Ÿ•a) ‚̍ŐVHŽ–—Ö@‚Ì‚È‚º‚É“š‚Š‚é@ŽÀ‘H•Ò (—Տ°‰h—{•Êû)zŽw“±•û–@@Q-17uH•i•W€¬•ª•\v‚âut‘Ÿ•aH•iŒðŠ·•\v‚ð—p‚¢‚ĉh—{ŒvŽZ‚·‚邱‚Æ‚ª‚Å‚«‚È‚¢Š³ŽÒ‚Ö‚ÌŽw“±‚ð‚Ç‚€s‚Š‚΂悢‚Ì‚Å‚µ‚å‚€‚©?@W’cŽw“±‚Å‚ ‚éut‘Ÿ•a‹³Žºv‚ÌŒø‰Ê‚Í‚Ç‚€‚Å‚µ‚å‚€‚©?, p.70-3. ‹g“c•üŽq (‰h—{•”), •Ò: ‹ààV—ÇŽ}, ›–ìä•v, ’†”ör”V, Žðˆä@Œª, ˆãŽ•–òo”Å, “Œ‹ž, 2015/11”­s.

620201. [Šwp‘] (•ª’SŽ·•M)y‰h—{Žw“±EŠÇ—‚Ì‚œ‚߂̃XƒLƒ‹ƒAƒbƒvƒVƒŠ[ƒY vol.4@CKD (–«t‘Ÿ•a) ‚̍ŐVHŽ–—Ö@‚Ì‚È‚º‚É“š‚Š‚é@ŽÀ‘H•Ò (—Տ°‰h—{•Êû)zŽw“±•û–@@Q-18ut‘Ÿ•aH•iŒðŠ·•\v‚ðŽg‚€‚Æ‚«, •\1`4‚Ì’PˆÊ”t•ª‚Í‚Ç‚€‚â‚Á‚ÄŒˆ‚ß‚é‚ׂ«‚Å‚µ‚å‚€‚©?@’ˆÓ‚·‚ׂ«‚±‚Æ‚ð‹³‚Š‚Ä‚­‚Ÿ‚³‚¢. ‚Ü‚œŽ¡—×p“ÁŽêH•i‚Í‚Ç‚Ì‚æ‚€‚É‘g‚Ý“ü‚ê‚œ‚ç‚æ‚¢‚Å‚µ‚å‚€‚©?, p.74-7. ‹g“c•üŽq1, ²“¡ÆŽq1 (1‰h—{•”), •Ò: ‹ààV—ÇŽ}, ›–ìä•v, ’†”ör”V, Žðˆä@Œª, ˆãŽ•–òo”Å, “Œ‹ž, 2015/11”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722261. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) tˆÚAƒ`[ƒ€‚ō\’z‚µ‚œŠÇ—‰h—{Žm‚̐ϋɓI‚ȉî“ü‚ÌŽæ‚è‘g‚݁`tˆÚAŠO—ˆ‚ł̏풓‚É‚æ‚é‰h—{‘Š’k‚Əp‘O‚©‚ç‚ÌŒp‘±‰î“ü‚ÌŒø‰Ê`. ‹g“c•üŽq1, –ìŒû•¶”T2, “c’†”üŽ÷2, ŽÂèŒb—¢1, ˆä‘º—[•P2, ²“¡ÆŽq1, ’r“c¬]3, Îˆä‘å•ã3, ‹g“cˆê¬4 (1‰h—{•”, 2ŠÅŒì•”, 3”å”AŠí, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ51‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2015/10/3), ŒF–{, ˆÚA 2015; 50 (‘‰ï—ÕŽž): 263.

722262. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ƒ`[ƒ€ˆã—Âði‰»‚³‚¹‚éƒ`[ƒ€ˆã—Â̌ø‰Ê‚ÌŒŸØ@“œ”A•a«tÇŠ³ŽÒ‚ɑ΂·‚é‘œEŽí‰î“ü‚ÌŒø‰Ê‚ðŒŸØ‚·‚é. lŒ©–ƒ”üŽq1, ²“¡ÆŽq1, Žç‰®’B”ü2 (1‰h—{•”, 2Œ’NŠÇ—ƒZ): ‘æ19‰ñ“ú–{•a‘Ô‰h—{Šw‰ï (2016/1/10), ‰¡•l, ‘æ19‰ñ“ú–{•a‘Ô‰h—{Šw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2016; 19 (suppl): S62.

7231162. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘œEŽí‰î“ü‚Í“œ”A•a«tÇŠ³ŽÒ‚Ì“§Í“±“üŽž‚ɗǍD‚ÈŒø‰Ê‚ð‚à‚œ‚ç‚·‚©? lŒ©–ƒ”üŽq1, –ìŒû‹…Žq1, ìã—IŽq1, ŽÄ“c‘D1, ‘åŠÑŒbŽq2, â–{”~Žq2, ŽO‰Y–F“T3, •x“c”ü4, Žç‰®’B”ü5 (1‰h—{•”, 2ŠÅŒì•”, 3—ÕŒŸ•”, 4–òÜ•”, 5Œ’NŠÇ—ƒZ): ‘æ58‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2015/5/21-24), ŽRŒû, “œ”A•a 2015; 58 (suppl 1): s-291.

7231163. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) tˆÚAŠO—ˆ‚É‚š‚¯‚铧ÍÄ“±“ü‘O‚̃ŒƒVƒsƒGƒ“ƒg‚Ö‚ÌŠÇ—‰h—{Žm‚ÌŠÖ‚í‚è. ‹g“c•üŽq1, –ìŒû•¶”T2, “c’†”üŽ÷2, ’r“c¬]3, Îˆä‘å•ã3, ‹g“cˆê¬4 (1‰h—{•”, 2ŠÅŒì•”, 3”å”AŠí, 4V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ60‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2015/6/28), ‰¡•l, “§Í‰ïŽ 2015; 48 (Suppl 1): 617.

7231164. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) H“¹ŠàŽüpŠúƒTƒ|[ƒgƒ`[ƒ€ (SPEC) ‚É‚š‚¯‚éŠÇ—‰h—{Žm‚Ì–ðŠ„‚ÆˆÓ‹`. ‹e’r“Þ•äŽq1, [‘ò²ŒbŽq1, ‹ß“¡‰{Žq1, ²“¡‚Ý‚³‚ð2, ŒE“cç»2, “ñ‹{‘ì‘å2, ‰ª“c—SŽq3, ’·’Jì“ÞŽq3, _•Û•‘¥4, ‹{é‚µ‚Ù4, ‰ª•”‘•c5, Ž–ì—R”y5, X’JGŒõ6, •Ð“c‰Ä–ç6, “n粏¹•F6 (1‰h—{•”, 2Ž•‰È, 3ŠÅŒì•”, 4ƒŠƒnƒrƒŠ•”, 5Žš•@ˆôAE“ªèòŠO, 6ŠO‰È): ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï‘‰ï (2015/10/31), ‹ž“s, ‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€W 2015/10; 50 (3): 2730.

7231165. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) H“¹ŠàŽüpŠúƒTƒ|[ƒgƒ`[ƒ€‚ÅŽæ‚è‘g‚ޏpŒãH‰a—Ö@. ‹e’r“Þ•äŽq1, ‰““¡^“Þ”ü2, ²“¡ÆŽq1, ˆÀ“cØ•ä3, ’·’Jì“ÞŽq4, X’JGŒõ5, •Ð“c‰Ä–ç5 (1‰h—{•”, 2“Œ•a‰@‰h—{•”, 3“Œ•a‰@ƒŠƒnƒrƒŠ•”, 4ŠÅŒì•”, 5ŠO‰È): ‘æ19‰ñ“ú–{•a‘Ô‰h—{Šw‰ï (2016/1/10), ‰¡•l, ‘æ19‰ñ“ú–{•a‘Ô‰h—{Šw‰ï 2016; 19 (suppl): S156.

7231166. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’·ŠúŠÔICU“ü‰@‚Æ‚È‚Á‚œdÇ‹~‹}Š³ŽÒ‚É‚š‚¯‚é–Ú•W“Š—^ƒGƒlƒ‹ƒM[‚ÉŠÖ‚·‚錟“¢. ’†‰®—¢¹1, ²“¡ÆŽq1, ¶‹î^—Žq1, [‘ò²ŒbŽq1, ‹g“c•üŽq1, ‹ß“¡‰{Žq1, “y‰®Žu•Û2, ˜a’m—ÉŽq2, ’†‘º@—D3, _@ˆê–²3, _œä’m“¹4, •Ð‰ª—Sˆê4 (1‰h—{•”, 2ŠÅŒì•”, 3–òÜ•”, 4‹~–œ): ‘æ31‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ïŠwpW‰ï (2016/2/25-26), •Ÿ‰ª, ‘æ31‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€W 2016/1; 96: O-269.

7231167. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ü‰@‚ðŒJ‚è•Ô‚·S•s‘SŠÇ—¢“ŽÒ‚ɑ΂·‚éÝ‘î–K–â‰h—{Žw“±Ž–—á. ‹ß“¡‰{Žq1, ’––”FŒ³2, ¶‹î^—Žq1, ’†‘º“ÞŽq3, Ž…”ü²Žq4, ²“¡ÆŽq1, –ڍ•Œ’‘Ÿ˜Y2, ˆ¢ŒÃÆ2 (1‰h—{•”, 2zŠÂŠí“à, 3ŠÅŒì•”, 4‘åŠw•a‰@ƒg[ƒ^ƒ‹ƒTƒ|[ƒgƒZƒ“ƒ^[): ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (2016/3/18), å‘ä, ‘æ80‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€W 2016/3; p.330.

7231168. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ`[ƒ€‚ō\’z‚µ‚œtˆÚAƒŒƒVƒsƒGƒ“ƒg‚Ö‚Ì’èŠú“I‰h—{Žw“±‚ÌŒø‰Ê. ‹g“c•üŽq1, –ìŒû•¶”T2, “c’†”üŽ÷2, •ÛìŒb—¢1, ²“¡ÆŽq1, ’r“c¬]3, ’|“àN—Y4, Îˆä‘å•ã3, ‹g“cˆê¬5 (1‰h—{•”, 2ŠÅŒì•”, 3”å”AŠí, 4t‘Ÿ“à, 5V¢‹Iˆã—ÁEæ’[ˆã—Ã): ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2016/3/25), •ÄŽq, ‘æ49‰ñ“ú–{—Տ°tˆÚAŠw‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2016/2; p.318.

733454. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠO—ˆ‰»Šw—Ö@’†‚ÌŠ³ŽÒ‚ÖŠÇ—‰h—{Žm–Ê’k‚ðs‚€Žæ‚è‘g‚Ý. ‹g“c•üŽq1, ‹ß“¡‰{Žq1, [‘ò²ŒbŽq1, ¡ˆä‰ë¢1, V–xˆ»Žq2, ”ª–öçt2, ˆÉ“¡‚Š‚èŽq2, ²“¡‹vŽq2, ”ԏ ÍŽq2, ²“¡ÆŽq1, ²X–Ø“O3, ²X–ØŽ¡ˆê˜Y4 (1‰h—{•”, 2ŠÅŒì•”, 3Á‰»Ší“à, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ30‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2016/2/19), ‘Š–ÍŒŽ.


•a‰@•a—•”

[Šwp˜_•¶]

120077. [ŒŽ’˜] ƒAƒ‹ƒMƒ“Ž_ƒiƒgƒŠƒEƒ€‚ð—p‚¢‚œƒZƒ‹ƒuƒƒbƒN–@‚ÌŒŸ“¢. “c’†@Œ\1, Œ‘º—R—¢2, rˆä‚ä‚èŽq2, Š`ÀœA–M3, ’¬“c‘å•ã3, ŽR‰º˜a–ç3, Œ–{˜a«4, ‘å•”@œ2, ²“¡—Yˆê2, •ž•”@Šw2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3•a—•”, 4”å”AŠí): _“ސ쌧—Տ°×–EŠw‰ïŽ 2015/8; 20 (1): 15-23.

521033. [‰ðà]y‹ZpuÀz•a—†ŠƒVƒŠ[ƒY ŒŸž‹ZŽt‚É‹‚ß‚ç‚ê‚銎õ–hŒä‘΍ôE1@ŠŽõÇ—á‚Ì•a—‰ð–U: Šî‘b‚ÆŽÀ‘H. ŽR‰º˜a–ç1, ŽOŽ}@M2, ‘º‰_–FŽ÷2 (1•a—•”, 2•a—): ŒŸž‚Æ‹Zp 2015/10; 43 (11): 1098-104.

522234. [uÀ]y“ÁW: ˆã–ò•iŠÖ˜A‚̍ŐV‹ZpE‘•’uzˆã—ÃŽ{Ý‚É‚š‚¯‚é—L‹@—nÜ–\˜I‘΍ô@‹ÇŠˆ—‚Ì—L‹@—nÜ–\˜I‘΍ô‚Ì—LŒø«‚ɂ‚¢‚Ä. _’J˜a•F1, …–ì—Ž•v1, ŽR‰º˜a–ç2 (1ƒgƒ‹ƒlƒbƒNƒXŠ”Ž®‰ïŽÐ, 2•a—•”): Clean Technology 2015/7; 25 (7): 20-2.

[Šw‰ïEŒ€‹†‰ï“™]

7231169. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Á‰»ŠíŒn‘gDÞ—¿‚É—LŒø‚Å‚ ‚Á‚œ•a—‘ŸŠí•ÏŒ`–hŽ~ƒsƒ“—¯‚ߌŒè‚̐V’ñˆÄ. ‹vê@Ž÷1, ŽR‰º˜a–ç1, ’¬“c‘å•ã1, ‹g“c@Œ÷2, ‘º‰_–FŽ÷2 (1•a—•”, 2•a—): ‘æ64‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2015/5/16), •Ÿ‰ª, ˆãŠwŒŸž 2015/4; 64 (•Êû): 369.

7231170. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –ƉuõF•ŠŠˆ‰»—n‰t’†‚É—V—£‚·‚éŠjŽ_‚É‚æ‚éˆâ“`Žq‰ðÍ‚ւ̉e‹¿. ŽR‰º˜a–ç1, ‹vê@Ž÷1, ’¬“c‘å•ã1, ‹g“c@Œ÷2, ‘º‰_–FŽ÷2 (1•a—•”, 2•a—): ‘æ64‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2015/5/16), •Ÿ‰ª, ˆãŠwŒŸž 2015/4; 64 (•Êû): 377.

7231171. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) •a—f’fŒ‹‰Ê‚̉{——ŠÄŽ‹ƒVƒXƒeƒ€\’z‚É‚š‚¯‚éƒ|ƒCƒ“ƒg‚Æ–â‘è“_. ’¬“c‘å•ã1, âŒû@”E1, ‹vê@Ž÷1, ŽR‰º˜a–ç1, ‹g“c@Œ÷2, ‘º‰_–FŽ÷2 (1•a—•”, 2•a—): ‘æ64‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2015/5/16), •Ÿ‰ª, ˆãŠwŒŸž 2015/4; 64 (•Êû): 396.

731190. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éƒzƒ‹ƒ}ƒŠƒ“ŠÇ—. ŽR‰º˜a–ç1, ‘º‰_–FŽ÷2 (1•a—•”, 2•a—): •a—•”‹ZpŽÒuK‰ï (2015/5/15), •Ÿ‰ª.

732164. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçƒZƒ~ƒi[) ƒzƒ‹ƒ}ƒŠƒ“ŒÅ’è‚Æ‚»‚ÌŠÇ—. ŽR‰º˜a–ç (•a—•”): ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ï (2015/11/14), _“ސì, ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ï‰‰‘菎˜^W 2015/11; p.46.

733455. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʉ‰‘è) ×–EŠ”‚ð—p‚¢‚œ–Ɖu‘gDõFƒ}ƒ‹ƒ`ƒRƒ“ƒgƒ[ƒ‹ŽŽ—¿‚̍쐻‚Æ•W€‰»‚ÌŠî‘b“IŒŸ“¢. ŽR‰º˜a–ç1, ²“¡—Yˆê2, ‹vê@Ž÷1, ‹g“c²“yŽq1, ‘º‰_–FŽ÷3 (1•a—•”, 2ˆã—Éq¶Šw•”, 3•a—): ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ï (2015/11/14), _“ސì, ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ï‰‰‘菎˜^W 2015/11; p.121.

H26”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H23-723014. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒÄ‹zŠí×–Ef‚Ìpitfall ŒÄ‹zŠí×–Ef‚É‚š‚¯‚é‘BŒnˆÙŒ^×–E‚ÌŒŸ“¢@—ǐ«•a•Ï‚ð‘BŠà‚ÆŒë‚ç‚È‚¢‚œ‚ß‚É. Š`ÀœA–M1, ‰¡ŽR@‘å1, –L‰i^Ÿ1, Œ‘º—R—¢2, •ž•”@Šw2, ŽR‰º˜a–ç1, ˆÉ˜¬“c–Ÿ, ²“¡”Vr3, ŽOã“N•v4, ŽOŽ}@M4 (1•a—•”, 2ˆã—Éq¶Šw•”, 3ŒÄ‹zŠíŠO, 4•a—): ‘æ52‰ñ“ú–{—Տ°×–EŠw‰ï‘‰ïtŠú‘å‰ï (2011/5/21), •Ÿ‰ª, “ú–{—Տ°×–EŠw‰ïŽGŽ 2011/3; 50 (Suppl 1): 113.


ME•”

[Šwp˜_•¶]

120078. [ŒŽ’˜] lHS”xŸó—¬’†‚É‚š‚¯‚élH”x—¬—Ê’ïR’l‚ÌŒŸ“¢. ‘哇O”V1, “ŒžŠŒ\ˆê1, ŒÃ•œ@‘1, •“cÍ”1, ’·‘º–ΑŸ1, —L”n@Ži1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘ÌŠOzŠÂ‹Zp 2015/12; 42 (4): 400-6.

[Šw‰ïEŒ€‹†‰ï“™]

7231172. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽèpˆãŠw‚Ì‹³ˆç|ŽŸ¢‘ã‚ð‚¢‚©‚É‹³ˆç‚·‚é‚© —Տ°HŠw‹ZŽm‚̐lÞˆç¬|“ž’B“x•]‰¿‚𒆐S‚Æ‚µ‚œ‹³ˆçŒ€CƒVƒXƒeƒ€‚ð—p‚¢‚Ä. ŒÃ•œ@‘1, —§–ì@‘1, ”’ˆä“ÖŽj1, ¬ŽR@œ1, “¡ˆä³ŽÀ1, –؉ºt“Þ1, •“cÍ”1, ‘‘¬TŒá1, ‘哇O”V1, “ŒžŠŒ\ˆê1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘æ37‰ñ“ú–{ŽèpˆãŠw‰ï‘‰ï (2015/10/2-3), ‘åã, “ú–{ŽèpˆãŠw‰ïŽ 2015/10; 36 (Suppl): 49.

7231173. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) lHS”xŸó—¬’†‚É‚š‚¯‚élH”x—¬—Ê’ïR’l‚ÌŒŸ“¢. ‘哇O”V1, “ŒžŠŒ\ˆê1, ŒÃ•œ@‘1, •“cÍ”1, ’·‘º–ΑŸ1, —L”n@Ži1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘æ41‰ñ“ú–{‘ÌŠOzŠÂ‹ZpˆãŠw‰ï‘å‰ï (2015/10/17-18), _ŒË, ‘ÌŠOzŠÂ‹Zp 2015/10; 42 (3): 308.

7231174. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™ŠJSp‚É‚š‚¯‚élH”x”roˆêŽ_‰»’Y‘f”Z“x‚ƉŠÇ”œ‰ž, ŒÄ‹z‹@”\‚ÉŠÖ‚·‚錟“¢. ŒÃ•œ@‘1, ’†‘º—SŠó2, ™–{Wˆê2, ‹gˆä@„2, ’¹ˆäWŽO3, –k‘º@—¥2, •ó—ˆ“N–ç2, •œ“cŒõ”Ž4, ”ü“‡—˜º2, ‘å‹v•Û”Ž¢2, “c’†—C‹M2, Œ‘ã‘ì–ç2, ‹ß“¡@^2, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO, 3ˆã—ËZp‹³ˆç, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ46‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2016/2/15-17), –ŒŒÃ‰®.

733456. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹ßÔŠOŒõ–³NP¬‡ŒŒŽ_‘f–O˜a“xŠÄŽ‹‘•’u‚Ì”w•”‚š‚æ‚Ñ‘å‘Ú•”‚Ö‚ÌŠˆ—p. ‘哇O”V1, “ŒžŠŒ\ˆê1, ŒÃ•œ@‘1, •“cÍ”1, ’·‘º–ΑŸ1, —L”n@Ži1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘æ22‰ñ“ú–{‘ÌŠOzŠÂ‹ZpˆãŠw‰ïŠÖ“ŒbM‰z’n•û‘å‰ï (2015/4/18-19), _“ސì, ‘ÌŠOzŠÂ‹Zp 2015/6; 42 (2): 156-7.

733457. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) lH”x‚É‚š‚¯‚é”äŠrŒŸ“¢: ]—ˆ•i‚Æ‚Ì”äŠr. —L”n@Ži1, “ŒžŠŒ\ˆê1, ŒÃ•œ@‘1, •“cÍ”1, ‘哇O”V1, ’·‘º–ΑŸ1, ‹{’n@ŠÓ2 (1ME•”, 2S‘ŸŒŒŠÇŠO): ‘æ22‰ñ“ú–{‘ÌŠOzŠÂ‹ZpˆãŠw‰ïŠÖ“ŒbM‰z’n•û‘å‰ï (2015/4/18-19), _“ސì, ‘ÌŠOzŠÂ‹Zp 2015/6; 42 (2): 157.


—Տ°ŽŽŒ±ƒZƒ“ƒ^[


ˆã—Â̎¿EˆÀ‘S„iŽº


ŠŽõŠÇ—Žº

[Šw‰ïEŒ€‹†‰ï“™]

7231175. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠŽõŠÇ—’S“–ŠÅŒìŽt‚É‚æ‚éR‹Û–ò“K³Žg—pŠÇ—‚Ö‚Ì–ðŠ„. “¡–Ø‚­‚ÉŽq1, ‘åìŒŽ—TŽ÷2, ˜a“c’B•F3, ‚ŽR—zŽq4, ‰Ô–؏G–Ÿ, »ìŒc‰î1 (1ŠŽõŠÇ—Žº, 2–òÜ•”, 3äPŒŽ•aEŠŽõ“à, 4V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ63‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2015/6/5), “Œ‹ž.

7231176. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠŽõŠÇ—‹Æ–±‚É‚š‚¯‚é˜J–±ŠÇ—‚Ì–â‘è“_. “¡–Ø‚­‚ÉŽq1, Â–ö²’qŽq1, ‚é—R”üŽq1, ‘åìŒŽ—TŽ÷2, “ñ–{–öL3, ˜a“c’B•F4, ‚ŽR—zŽq5, ‰Ô–؏G–Ÿ, »ìŒc‰î1 (1ŠŽõŠÇ—Žº, 2–òÜ•”, 3—ÕŒŸ•”, 4äPŒŽ•aEŠŽõ“à, 5V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ31‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï¥ŠwpW‰ï (2016/2/19-20), ‹ž“s.

7231177. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠŽõ–hŽ~‰ÁŽZƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚ª‰ÁŽZ2‚ÌŽ{Ý‚Ö‚à‚œ‚ç‚·Œø‰Ê. Â–ö²’qŽq1, ‚é—R”üŽq1, “¡–Ø‚­‚ÉŽq1, ‘åìŒŽ—TŽ÷2, “ñ–{–öL3, ˜a“c’B•F4, ‚ŽR—zŽq5 (1ŠŽõŠÇ—Žº, 2–òÜ•”, 3—ÕŒŸ•”, 4äPŒŽ•aEŠŽõ“à, 5V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ31‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï¥ŠwpW‰ï (2016/2/19-20), ‹ž“s.

7231178. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚̏W’†Ž¡—Õ”–å‚É‚š‚¯‚éŽèŽw‰q¶‚̍¡Œã‚̉ۑè. ‚é—R”üŽq1, ‘åìŒŽ—TŽ÷2, Â–ö²’qŽq1, “ñ–{–öL3, “¡–Ø‚­‚ÉŽq1, ˜a“c’B•F4, ‚ŽR—zŽq5 (1ŠŽõŠÇ—Žº, 2–òÜ•”, 3—ÕŒŸ•”, 4äPŒŽ•aEŠŽõ“à, 5V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ31‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï¥ŠwpW‰ï (2016/2/19-20), ‹ž“s.


f—Ïî•ñŠÇ—Žº


–k—¢‘åŠw“Œ•a‰@

“Œ•a‰@ŠÅŒì•”

[Šw‰ïEŒ€‹†‰ï“™]

7231179. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒxƒbƒhƒTƒCƒh‚Ì5Sƒ}ƒjƒ…ƒAƒ‹‚ðŠˆ—p‚µ‚œƒŠƒXƒNƒ}ƒl[ƒWƒƒ“ƒg‚ÌŽÀÛ. ŽO“cŒÜŒŽŽq1, V•á’mŒb1, ’†‘º“TŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ46‰ñ“ú–{ŠÅŒìŠw‰ï-ŠÅŒìŠÇ—-ŠwpW‰ï (2015/9/8), •Ÿ‰ª, ‘æ46‰ñ“ú–{ŠÅŒìŠw‰ï˜_•¶W 2016/4; p.263.

7231180. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ECTƒpƒX’E—ŽÇ—ᕪÍ‚©‚çƒpƒX‰ü’ù‚Ö‚Ì“¹’ö|‚»‚Ì2|. ŠÖX‘쉛1, “c‘º‘ñ–²1, —é–؁@‘ñ1, Ž@„Žm1, ŽRŒû–ŸŽq1, ‰ÄŽR@‘ì2, àVŽRŒb”g3, ‹{’nLŒá4, ŒË“c‰ë–ç5, ‹{‰ª@“™4 (1“Œ•a‰@ŠÅŒì•”, 2’nˆæŽ™“¶ž_, 3Œ’NŠÇ—ƒZ, 4ž_, 5–ƒŒ): ‘æ16‰ñ“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŠwpW‰ï (2015/11/13), ç—t, “ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŽ 2015/10; 17 (4): 570.

733458. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ª‚ñŠ³ŽÒ‚ðe‚É‚à‚ÂŽq‚Ç‚à‚̃OƒŠ[ƒtƒPƒA‚ɑΉž‚·‚éˆã—ÃŽÒ‚Ì‚œ‚ß‚ÌŠî‘b‹³ˆçƒvƒƒOƒ‰ƒ€‚ÌŒp‘±“I•]‰¿. ¬“‡‚ЂŎq1, —Ñ“Þ”üŽq2, –û’J˜aŽq3, Ž™‹Ê”ü—R‹I4 (1ŠÅŒìŠw•”, 2–Ú”’‘åŠwŠÅŒìŠw•”, 3“Œ•a‰@ŠÅŒì•”, 4ŠÅŒì•”): ‘æ39‰ñ“ú–{Ž€‚̗Տ°Œ€‹†‰ï”NŽŸ‘å‰ï (2015/10/11-12), Šò•Œ, ‘æ39‰ñ“ú–{Ž€‚̗Տ°Œ€‹†‰ïƒvƒƒOƒ‰ƒ€E—\eW 2015/9; 38: 363.

733459. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Œ»ó•ªÍ‚©‚ç–Ÿ‚ç‚©‚É‚È‚Á‚œ‹³ˆç‘̐§‚Ö‚ÌŽæ‚è‘g‚݁`Ž©•ª‚̍l‚Š‚𔭐M‚Å‚«‚éŠÂ‹«ì‚è‚âŒã”yˆç¬`. “c‰ª—D”üŽq1, ŒFâ^—R”ü1 (1“Œ•a‰@ŠÅŒì•”): ‘æ17‰ñ_“ސìŠÅŒìŠw‰ï (2015/12/5), _“ސì, ‘æ17‰ñ_“ސìŠÅŒìŠw‰ïW˜^ 2015/10; p.57-9.

733460. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œEŽí‚Æ‹Š“­‚µ‚œÝ‘î’²®‚ðŒoŒ±‚µ‚Ä. “Þ—Ç’Œ”ü1, ‘ëàVD1, –Ñ’Ë—R”üŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.38.

733461. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”F’mÇ‚Ì•û‚Ì‚»‚̐l‚炵‚³‚ðŽx‚Š‚é‚œ‚߂̃PƒA`Ž©‘î‚̐¶Šˆ‚ɋ߂¯‚œ“ü‰@ŠÂ‹«‚Ì’²®`. ’†‘º—F‹I1, ²“¡—ÇŽq1, –Ñ’Ë—R”üŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.39.

733462. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) —Ï—ƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚̏d—v«`ƒWƒ‡ƒ“ƒZƒ“‚Ì4‚‚̘g‘g‚Ý‚ðŽg—p‚µ‚œŠÅŒìŠÏ‚ð‚‚ß‚éŽæ‚è‘g‚Ý‚ð’Ê‚µ‚ā`. ›ŒŽ”ü¹ (“Œ•a‰@ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.50.

733463. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ž_‰È•a“‚É‚š‚¯‚éŠëŒ¯•š‚ÌŽæ‚舵‚¢‚ÉŠÖ‚·‚錻ó•ªÍ‚©‚ç‚Ý‚Š‚Ä‚«‚œ‚±‚Ɓ`ŒÂl‚̃ŠƒXƒNŠ®¬‚ðŠˆ‚©‚µƒ`[ƒ€ƒ‚ƒjƒ^ƒŠƒ“ƒO‚ɂ‚Ȃ°‚Ä‚¢‚­‚œ‚߂Ɂ`. ¬—э»•ä—1, à_“c–œŽõ‘ã1, ŒFâ^—R”ü1 (1“Œ•a‰@ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.51.

733464. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”F’mÇŠÅŒì”F’èŠÅŒìŽt‚̉¡’f“IŠˆ“®‚ÌŒ»ó|14‰ÓŒŽŠÔ‚Ì‘Š’kŠˆ“®‚ðU‚è•Ô‚Á‚ā|. sr‰Âˆ€ (“Œ•a‰@ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.68.

733465. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘îEŠÉ˜aŽx‰‡ƒZƒ“ƒ^[ŠJÝŒã5ƒ–ŒŽ‚ÌŽÀ‘Ô’²ž. ŒºŠC‘׎q1, –Ñ’Ë—R”üŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2015/12/12), _“ސì, ‘æ15‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€Ž˜^ 2015/11; p.69.


“Œ•a‰@—Տ°ŒŸž•”

[Šw‰ïEŒ€‹†‰ï“™]

733466. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) lŠÔƒhƒbƒN‚̐S‘Ÿ’Ž‰¹”gŒŸž‚É‚š‚¯‚éV‚œ‚ÈŽæ‚è‘g‚Ý. Œ‰º‹G (“Œ•a‰@—ÕŒŸ•”): ‘æ5‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ï (2015/7/18), “Œ‹ž, ‘æ5‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ïŽ˜^W 2015/7; p.5.

733467. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒŠƒjƒ…[ƒAƒ‹ƒI[ƒvƒ“‚µ‚œ–k—¢‘åŠw“Œ•a‰@‚É‚š‚¯‚éÚ‹ö‰ž‘΂Ɋւ·‚éV‚œ‚ÈŽæ‚è‘g‚݂ɂ‚¢‚Ä. ‘ŽR–ƒ‹LŽq1, •P“c‹v”ü1, ÎìˆŸŠóŽq1, —é–؏~Žq1, “•ûLˆê2, Žë–ì—Lì2,3 (1“Œ•a‰@—ÕŒŸ•”, 2—ÕŒŸ•”, 3—ÕŒŸŠw): ‘æ5‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ï (2015/7/18), “Œ‹ž, ‘æ5‰ñ–k—¢‘åŠw4•a‰@—Տ°ŒŸž•”ŠwpW‰ïŽ˜^W 2015/7; p.9.

733468. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw“Œ•a‰@‚É‚š‚¯‚é‚ß‚Ü‚¢‚̗Տ°ŒŸž‚ÆŽÀÑ‚ɂ‚¢‚Ä. Îì‘‹I1, ‰Ÿ“cD”ü2, •P“c‹v”ü1, ‰Í“‡]”ü1, —é–؏~Žq1, “•ûLˆê2, Žë–ì—Lì3 (1“Œ•a‰@—ÕŒŸ•”, 2—ÕŒŸ•”, 3—ÕŒŸŠw): ‘æ4‰ñ“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ï (2015/11/15), ‰¡•l, •œ¬27”N“x“ú—Õ‹ZŽñ“sŒ—Žx•”ˆãŠwŒŸžŠw‰ïu‰‰Ž˜^W 2015/11; p.75.

733469. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Neisseria gonorrhoeae (—Ò‹Û) ‚ÌŒoŽž“I¶‹Û”‚̐„ˆÚ‚ÉŠÖ‚·‚錟“¢. ‹à–؁@—y1, “ñ–{–öL2,3, ˜a“c’B•F3,4, ˆÀ’B@÷2, ¬ŠÑ’q¢2, ’†èM•F2, ‚ŽR—zŽq3,5, œA”šr¬4 (1“Œ•a‰@—ÕŒŸ•”, 2—ÕŒŸ•”, 3ŠŽõŠÇ—Žº, 4äPŒŽ•aEŠŽõ“à, 5V¢‹Iˆã—ÁE‰¡’f“Iˆã—Ã): ‘æ79‰ñ_“ސ쌧ŠŽõÇˆãŠw‰ï (2016/3/12), ìè, ‘æ79‰ñ_“ސ쌧ŠŽõÇˆãŠw‰ïƒvƒƒOƒ‰ƒ€Eu‰‰Ž˜^W 2016/3; p.18.


“Œ•a‰@–òÜ•”

[’˜@‘]

620202. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z1. Á‰»«’×ᇎ¡—Öò (PPI, H2Žó—e‘̝hR–ò), p.1-22. ‘ŠàV­–Ÿ1, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (1‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620203. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z2. 5-HT3Žó—e‘̝hR§“f–ò, p.23-32. ‘ŠàV­–Ÿ1, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (1‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620204. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z4. ‘O—§‘B”ì‘åÇE”r”AáŠQŽ¡—Öò (ƒ¿1ŽÕ’f–ò), p.55-66. ‘ŠàV­–Ÿ1, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (1‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620205. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z5. ‰ßŠˆ“®äNã÷Ž¡—Öò (RƒRƒŠƒ“–ò), p.67-80. ‘ŠàV­–Ÿ1, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (1‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620206. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z7. ƒCƒ“ƒXƒŠƒ“»Ü, p.105-24. ‘ŠàV­–Ÿ2, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (2‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620207. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z8. œ‘e頏ǎ¡—Öò (ŒoŒûƒrƒXƒzƒXƒzƒl[ƒg»Ü), p.125-38. ‘ŠàV­–Ÿ1, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (2‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620208. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z10. ƒAƒŒƒ‹ƒM[«ŽŸŠ³Ž¡—Öò (ƒƒfƒBƒG[ƒ^[Žó—e‘̝hR–ò), p.157-70. ‘ŠàV­–Ÿ1, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (1‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620209. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z11. ƒAƒŒƒ‹ƒM[«Œ‹–ŒŽŸŠ³Ž¡—Öò (“_Šá–ò), p.171-80. ‘ŠàV­–Ÿ1, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (1‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž
”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620210. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z13. —ΓàáŽ¡—Öò (“_Šá–ò), p.201-12. ‘ŠàV­–Ÿ1, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (1‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620211. [Šwp‘] (•ª’SŽ·•M)y‚±‚ÌŠ³ŽÒE‚±‚̏Ǘá‚É‚¢‚¿‚΂ñ“KØ‚È–òÜ‚ª‘I‚ׂé@“¯Œø–ò”äŠrƒKƒCƒh2z14. ƒjƒ…[ƒLƒmƒƒ“ŒnR‹Û–ò, p.213-26. ‘ŠàV­–Ÿ1, Vˆä–œ—Žq2, ŠC–ì—RŽq3, ì–ìçq2, ŠÝ“c‰xŽq4, •“c‚¿‚©]2, •ŽR­ˆê2, ¬ŒŽ”ü]2, _‹{’ŒŽq2, —é–؁@—•4, ‚‹Ž”ü—R‹I5, ’ß“c•S‡4, “a’Ë‘•S‡4, ”ò“c—[‹I2, ’·’J@ˆ»4, •œŽR•Ži2, –{ŠÔ‰ëŽm6, ‘O“cŽÀ‰Ô6,7, ŽO‰Y‹`•F4 (1‘Š–Í‘ä•a‰@, 2“Œ•a‰@–òÜ•”, 3“Œ‹žˆã‰È‘åŠw•a‰@, 4“ú–{ˆã‰È‘åŠw•‘®•a‰@, 5Œ³“Œ•a‰@–òÜ•”, 6–òÜ•”, 7—Տ°ŽŽŒ±ƒZƒ“ƒ^[), •ÒW‘ã•\: •ŽR­ˆê2, •Ò: –ŸÎ‹M—Y, •ÐŽRŽu˜Y, ‚‹Ž”ü—R‹I5, •œŽR•Ži2, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620212. [Šwp‘] (•ª’SŽ·•M)yÝ‘îˆã—ÃQ&A •œ¬27”N”Ł@•ž–òŽx‰‡‚Æ‘œEŽí‹Š“­E˜AŒg‚̃|ƒCƒ“ƒgz‘æ‚VÍ ŠÉ˜aƒPƒA‚Ì’mŽ¯, p.180-224. ˆÀ•”DO1, rˆäN”V2, ‰PˆäŽ÷Žq3, ‘åàVŒõŽi4, ‘Ÿ“cGŽ÷5, ‰êš‘׎q6, ‹àˆäGŽ÷7, ì‰z³•œ8, ì“Y“NŽk9, –Ø‘º˜a“N10, –Ø‘º‰ë•F11, ŒD@ŠîŽ¡12, ‘q“c‚È‚š‚Ý13, •ŽR­ˆê14, â–{ŠxŽu15, ŽÂŒŽ‹vmŽq16, ‚‹Ž@Šw17, ‚‹ŽáÁ¶18, ”‹“c‹ÏŽi19, •œŽR•Ži14, •Ÿ“‡‹IŽq20, –{ŠÔ@º21, ‘O“c_—˜22, ŽRì^—Žq8, ŽR–{M•v23 (1ƒPƒCƒƒ“–ò‹Ç, 2¶‚«‚¢‚«f—ÏŠE‚ä‚€‚«, 3“Œ‹žŽœŒb‰ïˆã‰È‘åŠw, 4‘å‘ò’²Ü–ò‹Ç, 5ˆã—Ö@lƒAƒXƒ€ƒX, 6––åŽRã•a‰@, 7‚È‚Ì‚Í‚È’²Ü–ò‹Ç, 8‚ ‚š‚Œ‚çf—ÏŠ, 9“썑•a‰@, 10–ŒŒÃ‰®Žs—§‘åŠw•a‰@, 11‚ ‚¯‚Ú‚Ì–ò‹Ç, 12‚€‚Š‚Ü‚Â’²Ü–ò‹Ç, 13º˜a‘åŠw, 14“Œ•a‰@–òÜ•”, 15‚ ‚¯‚Ú‚Ì–ò‹Ç, 16ƒtƒ[ƒ‰–ò‹Ç, 17ˆÀ“c’²Ü–ò‹Ç, 18ƒJƒlƒ}ƒ^–ò‹Ç, 19–ò‹Ç‚‚΂߃tƒ@[ƒ}ƒV[, 20‘OŒcœä‹`m‘åŠw, 21”F’mÇ‰îŒìŒ€‹†EŒ€C“Œ‹žƒZƒ“ƒ^[, 22Žq‚Ç‚àÝ‘îƒNƒŠƒjƒbƒN‚ ‚š‚Œ‚çf—ÏŠ–n“c, 23•Û¶“°–ò‹Ç), ŠÄC: “ú–{–òÜŽt‰ï, •Ò: ‚¶‚Ù‚€, ‚¶‚Ù‚€, “Œ‹ž, 2015/8”­s.

620213. [Šwp‘] (•ª’SŽ·•M)yŽ¡—Öòƒnƒ“ƒhƒuƒbƒN2016@–òÜ‘I‘ð‚Əˆ•û‚̃|ƒCƒ“ƒgz“¯Œø–ò”äŠr•\, p.24, 79, 105, 137, 155, 196, 312, 367, 368, 619, 676, 788, 803, 1108, 1142, 1143. •œŽR•Ži1, ”ò“c—[‹I1, ì–ìçq1, •ŽR­ˆê1, ‘Œ (1“Œ•a‰@–òÜ•”), ŠÄC: ‚‹vŽj–›, •Ò: –x@³“ñ, ›–쌒‘Ÿ˜Y, –å˜e@F, Š£@Œ«ˆê, —с@¹—m, ‚¶‚Ù‚€, “Œ‹ž, 2016/1”­s.

620214. [Šwp‘] (•ª’SŽ·•M)yŽ¡—Öòƒnƒ“ƒhƒuƒbƒN2016@–òÜ‘I‘ð‚Əˆ•û‚̃|ƒCƒ“ƒgzR‹Û–ò“K‰ž‹ÛŽíˆê——, p.1143-528. •œŽR•Ži1, ”ò“c—[‹I1, ì–ìçq1, •ŽR­ˆê1, ‘Œ (1“Œ•a‰@–òÜ•”), ŠÄC: ‚‹vŽj–›, •Ò: –x@³“ñ, ›–쌒‘Ÿ˜Y, –å˜e@F, Š£@Œ«ˆê, —с@¹—m, ‚¶‚Ù‚€, “Œ‹ž, 2016/1”­s.

620215. [Šwp‘] (•ª’SŽ·•M)y•a‹C‚Æ‚­‚·‚è2016@Šî‘b‚ÆŽÀ‘HExpert's Guide (–ò‹Ç2016”N‘Š§†Vol.67 No.4)z1. ž_E_ŒoŒn‚Ì•a‹C‚Æ‚­‚·‚è@B ’†•ŒnŽŸŠ³@E•s–°, •s–°Ç, p.555-64. •“c‚¿‚©]1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”), “ìŽR“°, “Œ‹ž, 2016/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713145. [Šw‰ï (‘Û) (ƒ|ƒXƒ^[) A Comparison of Analgesic Effectiveness between Transdermal Fentanyl Patches Developed in Japan, Requiring Replacement Every 24 Hours,and Conventional Transdermal Fentanyl Patches Requiring Replacement Every 72 Hours. Hirayama T1,2, Tashiro K2, Kawano C1,2, Naito M3, Watanabe M3, Sasaki T4, Koizumi W4, Kuroyama M1,2: 14th World Congress of the European Association for Pallitive Care (2015/5/9), Copenhagen, Denmark, European Journal of Palliative Care 2015/5; p.176. (•œŽR•Ži1,2, ì–ìçq1,2, “à“¡³‹K3, “n粏¹•F3, ²X–Ø“O4, ¬ò˜aŽO˜Y4, •ŽR­ˆê1,2: 1“Œ•a‰@–òÜ•”, 2–òŠw•”, 3ŠO‰È, 4Á‰»Ší“à)

722263. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ƒIƒsƒIƒCƒh’Á’É–ò‚ð–òŠw“IŽ‹“_‚©‚çŽg‚¢‚±‚È‚»‚€!|ƒtƒFƒ“ƒ^ƒjƒ‹»Ü‚𒆐S‚Ɂ|. •œŽR•Ži (“Œ•a‰@–òÜ•”): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ï (2015/10/4), ‰¡•l, ‘æ9‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ïƒvƒƒOƒ‰ƒ€E—vŽ|W 2015/10; p.173.

7231181. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒtƒFƒ“ƒ^ƒjƒ‹“\•tÜ‚Ì24ŽžŠÔ–ˆ“\‚è‘Ö‚ŠŒ^»Ü‚Æ72ŽžŠÔ–ˆ“\‚è‘Ö‚ŠŒ^»Ü‚Ì’Á’ÉŒø‰Ê‚Ì”äŠr‚ÉŠÖ‚·‚錀‹†. •œŽR•Ži1,2, ì–ìçq1,2, “à“¡³‹K3, ²X–Ø“O4, “n粏¹•F3, ¬ò˜aŽO˜Y4, •ŽR­ˆê1,2 (1–òŠw•”, 2“Œ•a‰@–òÜ•”, 3ŠO‰È, 4Á‰»Ší“à): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ï (2015/10/4), ‰¡•l, ‘æ9‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ïƒvƒƒOƒ‰ƒ€E—vŽ|W 2015/10; p.200.

7231182. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚ª‚ñ‰»Šw—Ö@—U”­«ˆ«SEšq“f‚ÌQuality of Life•s—LjöŽq‚Ì’P•Ï—ʉðÍ‚É‚æ‚錀‹†. ì–ìçq1,2, “V–쑁‹I2, •œŽR•Ži1,2, ¬ò˜aŽO˜Y3, •ŽR­ˆê1,2 (1“Œ•a‰@–òÜ•”, 2–òŠw•”, 3Á‰»Ší“à): ‘æ9‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ï (2015/10/4), ‰¡•l, ‘æ9‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï”N‰ïƒvƒƒOƒ‰ƒ€E—vŽ|W 2015/10; p.215.

7231183. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œüž_–ò‚Ì“K³Žg—p„i‚ÉŠÖ‚í‚éf—ÕñV‰ü’è‘OŒã‚É‚š‚¯‚鏈•ûŽÀ‘Ô. ”ò“c—[‹I1,2, ’†“ˆ—º•ã2, •“c‚¿‚©]1, •œŽR•Ži1,2, ‹{‰ª@“™3, •ŽR­ˆê1,2 (1“Œ•a‰@–òÜ•”, 2–òŠw•”, 3ž_): ‘æ4‰ñ“ú–{ž_‰ÈˆãŠw‰ïŠwp‘å‰ï (2015/10/8), ‰«“ê, ‘æ4‰ñ“ú–{ž_‰ÈˆãŠw‰ïŠwp‘å‰ïu‰‰—vŽ|W 2015/10; p.299.

732165. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ‚ª‚ñáu’ÉŽ¡—Öò‚Ì“K³Žg—p‚ɂ‚¢‚Ä. •œŽR•Ži (“Œ•a‰@–òÜ•”): ’É‚Ý‚ðl‚Š‚é–òÜŽt‚̉ï (2015/5/30), “Œ‹ž.

733470. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚š–ò‚̈ù‚Ý•û|Šî–{•Ò|. ‹ß“¡Ã (“Œ•a‰@–òÜ•”): ƒfƒCƒPƒAS—‹³ˆçƒvƒƒOƒ‰ƒ€ (2015/6/11), ‘Š–ÍŒŽ.

733471. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ƒIƒLƒVƒRƒhƒ“™•úù‚©‚çƒtƒFƒ“ƒ^ƒjƒ‹“\•tÜ‚ւ̃IƒsƒIƒCƒhƒXƒCƒbƒ`ƒ“ƒO‚É‚æ‚é•Ö”é‚ÌŒyŒžŒø‰Ê‚ÉŠÖ‚·‚錀‹†. ˆîŒ©@—I1, •œŽR•Ži1,2, ì–ìçq1,2, “à“¡³‹K3, ²X–Ø“O4, “n粏¹•F3, ¬ò˜aŽO˜Y4, •ŽR­ˆê1,2 (1–òŠw•”, 2“Œ•a‰@–òÜ•”, 3ŠO‰È, 4Á‰»Ší“à): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ45‰ñŠwp‘å‰ï (2015/8/1), ˆïé, “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ45‰ñŠwp‘å‰ïu‰‰—vŽ|W 2015/8; p.204.

733472. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) –k—¢‘åŠw“Œ•a‰@‚É‚š‚¯‚鐇–°–ò‚š‚æ‚эR•sˆÀ–ò‚̏ˆ•ûŽÀ‘Ô‚ÉŠÖ‚·‚錀‹†. •Ð–ì—¢‰h1, •“c‚¿‚©]2, ”ò“c—[‹I1,2, •œŽR•Ži1,2, ‹{’nLŒá3, ‘åÎ@’q3, “cƒ–’J_–M4, ‹{‰ª@“™3, •ŽR­ˆê1,2 (1–òŠw•”, 2“Œ•a‰@–òÜ•”, 3ž_, 4ˆã—Éq¶Šw•”): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ45‰ñŠwp‘å‰ï (2015/8/1), ˆïé, “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ45‰ñŠwp‘å‰ïu‰‰—vŽ|W 2015/8; p.225.

733473. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ‚ª‚ñ‰»Šw—Ö@—U”­«ˆ«SEšq“f‚ÌQuality of Life•s—LjöŽq‚Ì‘œ•Ï—ʉðÍ‚É‚æ‚錀‹†. “V–쑁‹I1, ì–ìçq1,2, •œŽR•Ži1,2, ¬ò˜aŽO˜Y3, •ŽR­ˆê1,2 (1–òŠw•”, 2“Œ•a‰@–òÜ•”, 3Á‰»Ší“à): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ45‰ñŠwp‘å‰ï (2015/8/2), ˆïé, “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ45‰ñŠwp‘å‰ïu‰‰—vŽ|W 2015/8; p.296.

733474. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) “‡Žž’²ÇŠ³ŽÒ‚É‚š‚¯‚éRž_•a–ò‚É‚æ‚é‘̏d•Ï‰»‚š‚æ‚Ñ‘ãŽÓˆÙí‚ÉŠÖ‚·‚錀‹†. —с@–ƒˆß1, ”ò“c—[‹I1,2, •œŽR•Ži1,2, ‹{’nLŒá3, ‹{‰ª@“™3, •ŽR­ˆê1,2 (1–òŠw•”, 2“Œ•a‰@–òÜ•”, 3ž_): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ45‰ñŠwp‘å‰ï (2015/8/2), ˆïé, “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ45‰ñŠwp‘å‰ïu‰‰—vŽ|W 2015/8; p.364.

733475. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “‡Žž’²Ç‚Ì–ò‚Á‚Ä‚Ç‚ñ‚È–ò?|–ò‚Ì“Á’¥‚ÆŒø‰Ê, •›ì—p‚ɂ‚¢‚ā|. •“c‚¿‚©] (“Œ•a‰@–òÜ•”): •œ¬27”N“x“–Ž–ŽÒŽx‰‡ƒZƒ~ƒi[ (2015/8/11), “¡‘ò.

733476. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw“Œ•a‰@‚ÌŒ»ó`–«Šúˆã—Âƍݑîˆã—Â𒆐S‚Ɂ`. ¬ŒŽ”ü] (“Œ•a‰@–òÜ•”): –k—¢‘åŠw•a‰@E“Œ•a‰@E‹ß—וی¯–ò‹Çî•ñŒðŠ·‰ï (2015/8/28), ‘Š–ÍŒŽ.

733477. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ž_‰È‚É‚š‚¯‚é–ò•š—Ö@ (•ž–òŽw“±ESST‚È‚Ç). •“c‚¿‚©] (“Œ•a‰@–òÜ•”): ž_ŠÅŒìƒI[ƒvƒ“ƒZƒ~ƒi[ (2015/10/17), ‘Š–ÍŒŽ.

733478. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ‚ª‚ñ‰»Šw—Ö@—U”­«ˆ«SEšq“f‚ÌQuality of Life•s—LjöŽq‚ÉŠÖ‚·‚錀‹†. ì–ìçq1,2, •œŽR•Ži1,2, ”ò“c—[‹I1,2, •ŽR­ˆê1,2 (1–òŠw•”, 2“Œ•a‰@–òÜ•”): ‘æ35‰ñ”’‹àƒVƒ“ƒ|ƒWƒEƒ€ (2015/12/22), “Œ‹ž, ‘æ35‰ñ”’‹àƒVƒ“ƒ|ƒWƒEƒ€u‰‰—vŽ|W 2015/12; p.56.

733479. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ˆ•û‚¹‚ñ‹^‹`Æ‰ïŒã‚̏ˆ•ûƒI[ƒ_C³‘ãs‚Ö‚Ì–òÜŽt‚ÌŠÖ‚í‚è. ŽR‘º¹‹I1, ¬ŒŽ”ü]1, —é–ØŒh‘Ÿ1, ‹ß“¡Ã1, ‘åŒG—Ç‘Ÿ1, Œ‰ª—zŽq1, Ô—䑏•F1, ‰F–ì^—Žq1, •“c‚¿‚©]1, Î’ˁ@ˆ€1, Vˆä–œ—Žq1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): ‘æ14‰ñ‚©‚È‚ª‚í–òÜŽtŠwp‘å‰ï (2016/1/17), ‰¡•l, ‘æ14‰ñ‚©‚È‚ª‚í–òÜŽtŠwp‘å‰ïu‰‰—vŽ|W 2016/1; p.49.